Citrus Sinensis ID: 043333
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 809 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGN2 | 1020 | Probable leucine-rich rep | yes | no | 0.971 | 0.770 | 0.590 | 0.0 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.953 | 0.809 | 0.601 | 0.0 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.969 | 0.773 | 0.566 | 0.0 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.960 | 0.750 | 0.552 | 0.0 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.960 | 0.748 | 0.550 | 0.0 | |
| Q9FXF2 | 1021 | Probable LRR receptor-lik | no | no | 0.965 | 0.764 | 0.523 | 0.0 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.953 | 0.756 | 0.502 | 0.0 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.964 | 0.755 | 0.429 | 1e-177 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.960 | 0.752 | 0.430 | 1e-177 | |
| O64778 | 807 | G-type lectin S-receptor- | no | no | 0.312 | 0.313 | 0.484 | 2e-70 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 954 bits (2466), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 474/803 (59%), Positives = 602/803 (74%), Gaps = 17/803 (2%)
Query: 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLW-KQANGAIPK 61
+LK+Q+L G LP +L+ LPFLQE+DLTRNYLNG+IP EW + L+N+ L + +G+IPK
Sbjct: 93 VLKAQDLQGSLPTDLSGLPFLQELDLTRNYLNGSIPPEWGASSLLNISLLGNRISGSIPK 152
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+ +++TL+ L LE+NQ SG +P ELGNL NL++L L+SNN +G++P +FA LT L R
Sbjct: 153 ELGNLTTLSGLVLEYNQLSGKIPPELGNLPNLKRLLLSSNNLSGEIPSTFAKLTTLTDLR 212
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181
ISDN FTG IPD+IQNW LEKL I+ SGL GPIPS I L LTDLRI+DL+GPE PFP
Sbjct: 213 ISDNQFTGAIPDFIQNWKGLEKLVIQASGLVGPIPSAIGLLGTLTDLRITDLSGPESPFP 272
Query: 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMY 240
L N+ +M YLILR+ N+ G++P YLGQ L+ LDLSFNKLSG IP+ +SG S + ++Y
Sbjct: 273 PLRNMTSMKYLILRNCNLTGDLPAYLGQNRKLKNLDLSFNKLSGPIPATYSGLSDVDFIY 332
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSE-GSNSTGIV 299
T N+L G VP W+V + + ID++YNNF ++ C+ +SVN F+S+S +N++ V
Sbjct: 333 FTSNMLNGQVPSWMVDQGDT-IDITYNNFSKDKTEE-CQQKSVNTFSSTSPLVANNSSNV 390
Query: 300 SCLKSFTCPTNHSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGHFI 359
SCL +TCP LHINCGG ++ +N + D D G ++ S+ W S TG+F+
Sbjct: 391 SCLSKYTCPKTFYGLHINCGGNEITSNETKYDADTWDTPG---YYDSKNGWVSSNTGNFL 447
Query: 360 DNSTRENSYIQI-NTSRLLMDDS----QLYTEARISPISLTYYGYCMVNGNYTVNLHFAE 414
D+ N + N+S L + +S +LYT+AR+S ISLTY C+ GNYTVNLHFAE
Sbjct: 448 DDDRTNNGKSKWSNSSELKITNSSIDFRLYTQARLSAISLTYQALCLGKGNYTVNLHFAE 507
Query: 415 ILFTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRL 474
I+F + Y +LGRR FD+Y+QGK +KDFNI +EA GVGKA+VK F VTNG +EIRL
Sbjct: 508 IMFNEKNMYSNLGRRYFDIYVQGKREVKDFNIVDEAKGVGKAVVKKFPVMVTNGKLEIRL 567
Query: 475 YWAGKGTTDIPYKGVYGPLISAISLYTPDI---ASPLVNGSSNSTNVGMVVGIVAAAAFI 531
WAGKGT IP +GVYGPLISA+S+ PD P S+ +V ++A+ F+
Sbjct: 568 QWAGKGTQAIPVRGVYGPLISAVSV-DPDFIPPKEPGTGTGGGSSVGTVVGSVIASTVFL 626
Query: 532 LILIVSILWWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPV 591
++LI ILWW+GC + K +E++ K LD SF+LRQIK AT+NF P NKIGEGGFGPV
Sbjct: 627 VLLIGGILWWRGCLRPKSQMEKDFKNLDFQISSFSLRQIKVATDNFDPANKIGEGGFGPV 686
Query: 592 YKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651
+KG++ DG VIAVKQLS+KSKQGNREF+NEI MISALQHP+LVKLYGCC+EG+QLLL+YE
Sbjct: 687 HKGIMTDGTVIAVKQLSAKSKQGNREFLNEIAMISALQHPHLVKLYGCCVEGDQLLLVYE 746
Query: 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL 711
Y+ENNSLARALFGP+E ++ L+WP R IC+G+ARGLAYLHEESRLKIVHRDIKATNVLL
Sbjct: 747 YLENNSLARALFGPQETQIPLNWPMRQKICVGIARGLAYLHEESRLKIVHRDIKATNVLL 806
Query: 712 DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALE 771
DK+LNPKISDFGLAKLDEE+NTHISTR+AGT+GYMAPEYAMRG+LTDKADVYSFG+VALE
Sbjct: 807 DKELNPKISDFGLAKLDEEENTHISTRVAGTYGYMAPEYAMRGHLTDKADVYSFGVVALE 866
Query: 772 IVSGRSNVICRTKEAQFCLLDWV 794
IV G+SN R+K F LLDWV
Sbjct: 867 IVHGKSNTSSRSKADTFYLLDWV 889
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 946 bits (2445), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/800 (60%), Positives = 584/800 (73%), Gaps = 29/800 (3%)
Query: 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLW-KQANGAIP 60
R LK +NL G LP EL LP LQEIDL+RNYLNG+IP EW LPLVN+ L + G IP
Sbjct: 68 RNLKRENLQGSLPKELVGLPLLQEIDLSRNYLNGSIPPEWGVLPLVNIWLLGNRLTGPIP 127
Query: 61 KAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHF 120
K +I+TL L LE NQ SG+LP ELGNL N++++ L+SNNF G++P +FA LT L+ F
Sbjct: 128 KEFGNITTLTSLVLEANQLSGELPLELGNLPNIQQMILSSNNFNGEIPSTFAKLTTLRDF 187
Query: 121 RISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPF 180
R+SDN +G IPD+IQ WTKLE+LFI+ SGL GPIP IASLVEL DLRISDLNGPE PF
Sbjct: 188 RVSDNQLSGTIPDFIQKWTKLERLFIQASGLVGPIPIAIASLVELKDLRISDLNGPESPF 247
Query: 181 PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPS---NFSGSGLT 237
P+L N+K M LILR+ N+ G++P+YLG++ + LDLSFNKLSG IP+ N G
Sbjct: 248 PQLRNIKKMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYINLRDGG-- 305
Query: 238 YMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTG 297
Y+Y TGN+L G VPDW+V K K IDLSYNNF +++ C+ +V
Sbjct: 306 YIYFTGNMLNGSVPDWMVNKGYK-IDLSYNNFSVDPTNAVCKYNNV-------------- 350
Query: 298 IVSCLKSFTCPTNHSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGH 357
+SC++++ CP ++LHINCGG ++ NG+ D D ++ SR W + G
Sbjct: 351 -LSCMRNYQCPKTFNALHINCGGDEMSINGTIYESDKYDRL--ESWYESRNGWFSNNVGV 407
Query: 358 FIDNS-TRENSYIQINTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEIL 416
F+D+ E I+ N+S L + D LYT+ARIS ISLTYY C+ NGNY VNLHFAEI+
Sbjct: 408 FVDDKHVPERVTIESNSSELNVVDFGLYTQARISAISLTYYALCLENGNYNVNLHFAEIM 467
Query: 417 FTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRLYW 476
F + +Y SLGRR FD+YIQ KL +KDFNI EA VG ++K F + +G +EIRLYW
Sbjct: 468 FNGNNNYQSLGRRFFDIYIQRKLEVKDFNIAKEAKDVGNVVIKTFPVEIKDGKLEIRLYW 527
Query: 477 AGKGTTDIPYKGVYGPLISAISLYTPDIASPLVNGSSNSTNVGMVVGIVAAAAFILILIV 536
AG+GTT IP + VYGPLISAIS+ + SP NG S T + +V + FI+ L+
Sbjct: 528 AGRGTTVIPKERVYGPLISAISVDSSVNPSPR-NGMSTGT---LHTLVVILSIFIVFLVF 583
Query: 537 SILWWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLL 596
LW KG + K +E++ K L+L SF+LRQIK ATNNF N+IGEGGFGPVYKG L
Sbjct: 584 GTLWKKGYLRSKSQMEKDFKSLELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKL 643
Query: 597 ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENN 656
DG +IAVKQLS+ SKQGNREF+NEIGMISAL HPNLVKLYGCC+EG QLLL+YE++ENN
Sbjct: 644 FDGTIIAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENN 703
Query: 657 SLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 716
SLARALFGP+E +L+LDWPTR ICIG+ARGLAYLHEESRLKIVHRDIKATNVLLDK LN
Sbjct: 704 SLARALFGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLN 763
Query: 717 PKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
PKISDFGLAKLDEED+THISTRIAGTFGYMAPEYAMRG+LTDKADVYSFGIVALEIV GR
Sbjct: 764 PKISDFGLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGR 823
Query: 777 SNVICRTKEAQFCLLDWVTL 796
SN I R+K F L+DWV +
Sbjct: 824 SNKIERSKNNTFYLIDWVEV 843
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 852 bits (2200), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/807 (56%), Positives = 587/807 (72%), Gaps = 23/807 (2%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLP-LWKQANGAIPKA 62
LKSQNL G +PPE ++L L+ +DL+RN L G+IP EWAS+ L +L + + +G PK
Sbjct: 97 LKSQNLTGIVPPEFSKLRHLKVLDLSRNSLTGSIPKEWASMRLEDLSFMGNRLSGPFPKV 156
Query: 63 VASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRI 122
+ ++ L +L+LE NQFSG +P ++G L++LEKLHL SN FTG L E L L RI
Sbjct: 157 LTRLTMLRNLSLEGNQFSGPIPPDIGQLVHLEKLHLPSNAFTGPLTEKLGLLKNLTDMRI 216
Query: 123 SDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPR 182
SDN+FTG IPD+I NWT++ KL + G GL GPIPS I+SL LTDLRISDL G FP
Sbjct: 217 SDNNFTGPIPDFISNWTRILKLQMHGCGLDGPIPSSISSLTSLTDLRISDLGGKPSSFPP 276
Query: 183 LSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYL 241
L NL+++ LILR IIG +P+Y+G + L+ LDLSFN LSG IPS+F ++YL
Sbjct: 277 LKNLESIKTLILRKCKIIGPIPKYIGDLKKLKTLDLSFNLLSGEIPSSFENMKKADFIYL 336
Query: 242 TGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSS--DSNCENQSVNLFASSSEGSNSTGIV 299
TGN LTG VP++ V +RNK++D+S+NNF D SS +C + NL S + G+ S
Sbjct: 337 TGNKLTGGVPNYFV-ERNKNVDVSFNNFTDESSIPSHDCNRVTSNLVESFALGNKSHKGS 395
Query: 300 SC-LKSFTC--PTNHS--SLHINCGGKQVIANGSTTFEDDLDAAGPSRFFI-SRTNWAFS 353
+C L+ C P + L+INCGG +V + T++ D + G S + + + WA S
Sbjct: 396 TCFLQRMPCVHPKRYHLYKLYINCGGGEVKVDKEITYQADDEPKGASMYVLGANKRWALS 455
Query: 354 TTGHFIDNSTRENSYIQINTSRLLMDDSQ----LYTEARISPISLTYYGYCMVNGNYTVN 409
+TG+F+DN + Y NTSRL ++ S LY AR+SP+SLTYYG C+ NGNYTVN
Sbjct: 456 STGNFMDNDDDADEYTVQNTSRLSVNASSPSFGLYRTARVSPLSLTYYGICLGNGNYTVN 515
Query: 410 LHFAEILFTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGT 469
LHFAEI+FTDD + SLG+R+FD+Y+Q +LV+K+FNI+ A G GK I+K F VT+ T
Sbjct: 516 LHFAEIIFTDDNTLYSLGKRLFDIYVQDQLVIKNFNIQEAARGSGKPIIKSFLVNVTDHT 575
Query: 470 MEIRLYWAGKGTTDIPYKGVYGPLISAISLYTPDIASPLVNGSSNSTNVGMVVGI-VAAA 528
++I L WAGKGTT IP +GVYGP+ISAIS+ P+ P+ ++ ++ + VG+ VAAA
Sbjct: 576 LKIGLRWAGKGTTGIPIRGVYGPMISAISV-EPNFKPPVY---YDTKDIILKVGVPVAAA 631
Query: 529 AFILILIVSILWWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGF 588
+L +IV + W K + K+ +++EL+GLDL TG+FTLRQIKAAT+NF KIGEGGF
Sbjct: 632 TLLLFIIVGVFWKKR--RDKNDIDKELRGLDLQTGTFTLRQIKAATDNFDVTRKIGEGGF 689
Query: 589 GPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648
G VYKG L++GK+IAVKQLS+KS+QGNREFVNEIGMISALQHPNLVKLYGCC+EGNQL+L
Sbjct: 690 GSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLIL 749
Query: 649 IYEYMENNSLARALFGPEEH-RLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKAT 707
+YEY+ENN L+RALFG +E RLKLDW TR I +G+A+GL +LHEESR+KIVHRDIKA+
Sbjct: 750 VYEYLENNCLSRALFGKDESSRLKLDWSTRKKIFLGIAKGLTFLHEESRIKIVHRDIKAS 809
Query: 708 NVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGI 767
NVLLDKDLN KISDFGLAKL+++ NTHISTRIAGT GYMAPEYAMRGYLT+KADVYSFG+
Sbjct: 810 NVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAGTIGYMAPEYAMRGYLTEKADVYSFGV 869
Query: 768 VALEIVSGRSNVICRTKEAQFCLLDWV 794
VALEIVSG+SN R E LLDW
Sbjct: 870 VALEIVSGKSNTNFRPTEDFVYLLDWA 896
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 831 bits (2146), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/804 (55%), Positives = 562/804 (69%), Gaps = 27/804 (3%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLW-KQANGAIPKA 62
L+ NL G +PPE L L EIDL N+L+GTIP+ + +PL L + + +G P
Sbjct: 95 LRGFNLRGIIPPEFGNLTRLTEIDLVLNFLSGTIPTTLSQIPLEILAVTGNRLSGPFPPQ 154
Query: 63 VASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRI 122
+ I+TL D+ +E N F+G LP LGNL +L++L ++SNN TG++PES +NL L +FRI
Sbjct: 155 LGQITTLTDVIMESNLFTGQLPPNLGNLRSLKRLLISSNNITGRIPESLSNLKNLTNFRI 214
Query: 123 SDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPR 182
N +G+IPD+I NWT+L +L ++G+ + GPIP+ I++L LT+LRI+DL GP PFP
Sbjct: 215 DGNSLSGKIPDFIGNWTRLVRLDLQGTSMEGPIPASISNLKNLTELRITDLRGPTSPFPD 274
Query: 183 LSNLKNMNYLILRSGNIIGEMPEYLG-QMIGLRVLDLSFNKLSGVIPSNF-SGSGLTYMY 240
L N+ NM L+LR+ I +PEY+G M L++LDLS N L+G IP F S + +MY
Sbjct: 275 LQNMTNMERLVLRNCLIREPIPEYIGTSMTMLKLLDLSSNMLNGTIPDTFRSLNAFNFMY 334
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVS 300
L N LTGPVP +I+ + ++IDLSYNNF + S C VNL +S +N++ +
Sbjct: 335 LNNNSLTGPVPQFILDSK-QNIDLSYNNFTQPPTLS-CNQLDVNLISSYPSVTNNS-VQW 391
Query: 301 CL-KSFTCP--TNHSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGH 357
CL K CP +HSSL INCGG ++ + + DDL+ G S F W +S++G
Sbjct: 392 CLRKDLPCPGDAHHSSLFINCGGNRLKVD-KDEYADDLNKRGASTFSSVSERWGYSSSGA 450
Query: 358 FIDNSTRENSYIQINTSRLLMDDS-QLYTEARISPISLTYYGYCMVNGNYTVNLHFAEIL 416
++ N +Y+ +T L+ + + + Y AR++ SL YYG CM G+Y V L+FAEI+
Sbjct: 451 WLGNDGA--TYLATDTFNLINESTPEYYKTARLASQSLKYYGLCMRRGSYKVQLYFAEIM 508
Query: 417 FTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNG-TMEIRLY 475
F++D++Y SLGRR+FD+Y+QG L+ +DFNI AGGVGK ++ NG T+EI L
Sbjct: 509 FSNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKPFLRQVDEVQVNGSTLEIHLK 568
Query: 476 WAGKGTTDIPYKGVYGPLISAISL---YTPDIASPLVNGSSNSTNVGMVVGIVAAAAFIL 532
W GKGT IP +GVYGPLISAI++ + D PL NG +V GIV AA
Sbjct: 569 WTGKGTNVIPTRGVYGPLISAITVTPNFKVDTGKPLSNG--------VVAGIVIAACVAF 620
Query: 533 -ILIVSILWWKGCFKRKHTLE-QELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGP 590
+L++ IL G K E +EL+GLDL TGSFTL+QIK ATNNF P+NKIGEGGFGP
Sbjct: 621 GLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGP 680
Query: 591 VYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650
VYKG+LADG IAVKQLSSKSKQGNREFV EIGMISALQHPNLVKLYGCCIEG +LLL+Y
Sbjct: 681 VYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVY 740
Query: 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVL 710
EY+ENNSLARALFG E+ RL LDW TR+ +CIG+A+GLAYLHEESRLKIVHRDIKATNVL
Sbjct: 741 EYLENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVL 800
Query: 711 LDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVAL 770
LD LN KISDFGLAKLDEE+NTHISTRIAGT GYMAPEYAMRGYLTDKADVYSFG+V L
Sbjct: 801 LDLSLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCL 860
Query: 771 EIVSGRSNVICRTKEAQFCLLDWV 794
EIVSG+SN R KE LLDW
Sbjct: 861 EIVSGKSNTNYRPKEEFIYLLDWA 884
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 829 bits (2141), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/804 (55%), Positives = 560/804 (69%), Gaps = 27/804 (3%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLP-LWKQANGAIPKA 62
LKS +LPG PPE L L+EIDL+RN+LNGTIP+ + +PL L + + +G P
Sbjct: 97 LKSFSLPGIFPPEFGNLTRLREIDLSRNFLNGTIPTTLSQIPLEILSVIGNRLSGPFPPQ 156
Query: 63 VASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRI 122
+ I+TL D+ LE N F+G LP LGNL +L++L L++NNFTG++PES +NL L FRI
Sbjct: 157 LGDITTLTDVNLETNLFTGPLPRNLGNLRSLKELLLSANNFTGQIPESLSNLKNLTEFRI 216
Query: 123 SDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEG-PFP 181
N +G+IPD+I NWT LE+L ++G+ + GPIP I++L LT+LRI+DL G FP
Sbjct: 217 DGNSLSGKIPDFIGNWTLLERLDLQGTSMEGPIPPSISNLTNLTELRITDLRGQAAFSFP 276
Query: 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMY 240
L NL M L+LR+ I G +PEY+G M L+ LDLS N L+GVIP F +M+
Sbjct: 277 DLRNLMKMKRLVLRNCLIRGPIPEYIGSMSELKTLDLSSNMLTGVIPDTFRNLDAFNFMF 336
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVS 300
L N LTGPVP +I+ + +++DLS NNF + S C VNL +S ++++ +
Sbjct: 337 LNNNSLTGPVPQFIINSK-ENLDLSDNNFTQPPTLS-CNQLDVNLISSYPSVTDNS-VQW 393
Query: 301 CLKS-FTCPTN--HSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGH 357
CL+ CP + SSL INCGG + + G T+ DDL++ G S F W +S++G
Sbjct: 394 CLREGLPCPEDAKQSSLFINCGGSR-LKIGKDTYTDDLNSRGQSTFSSVSERWGYSSSGV 452
Query: 358 FIDNSTRENSYIQINTSRLLMDDS-QLYTEARISPISLTYYGYCMVNGNYTVNLHFAEIL 416
++ + Y+ + L+ + + Y AR+SP SL YYG C+ G+Y + LHFAEI+
Sbjct: 453 WL--GKEDAGYLATDRFNLINGSTPEYYKTARLSPQSLKYYGLCLRRGSYKLQLHFAEIM 510
Query: 417 FTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNG-TMEIRLY 475
F++D+++ SLGRRIFD+Y+QG L+ +DFNI AGGVGK ++ NG T+EI L
Sbjct: 511 FSNDQTFNSLGRRIFDIYVQGNLLERDFNIAERAGGVGKPFIRQIDGVQVNGSTLEIHLQ 570
Query: 476 WAGKGTTDIPYKGVYGPLISAISL---YTPDIASPLVNGSSNSTNVGMVVGIVAAAAFIL 532
W GKGT IP +GVYGPLISAI++ + D PL NG+ V GIV AA +
Sbjct: 571 WTGKGTNVIPTRGVYGPLISAITITPNFKVDTGKPLSNGA--------VAGIVIAACAVF 622
Query: 533 -ILIVSILWWKGCFKRKHTLE-QELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGP 590
+L++ IL G K E +EL+GLDL TGSFTL+QIK ATNNF P+NKIGEGGFGP
Sbjct: 623 GLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGP 682
Query: 591 VYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650
VYKG+LADG IAVKQLSSKSKQGNREFV EIGMISALQHPNLVKLYGCCIEG +LLL+Y
Sbjct: 683 VYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVY 742
Query: 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVL 710
EY+ENNSLARALFG E+ RL LDW TR+ ICIG+A+GLAYLHEESRLKIVHRDIKATNVL
Sbjct: 743 EYLENNSLARALFGTEKQRLHLDWSTRNKICIGIAKGLAYLHEESRLKIVHRDIKATNVL 802
Query: 711 LDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVAL 770
LD LN KISDFGLAKL++++NTHISTRIAGT GYMAPEYAMRGYLTDKADVYSFG+V L
Sbjct: 803 LDLSLNAKISDFGLAKLNDDENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCL 862
Query: 771 EIVSGRSNVICRTKEAQFCLLDWV 794
EIVSG+SN R KE LLDW
Sbjct: 863 EIVSGKSNTNYRPKEEFVYLLDWA 886
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 792 bits (2045), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/802 (52%), Positives = 540/802 (67%), Gaps = 21/802 (2%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWAS--LPLVNLPLWKQANGAIPK 61
K NLPG LP ++ +LP+L+EIDL NY+NGT+P EWAS L ++L L + +G IPK
Sbjct: 107 FKDHNLPGTLP-QIVKLPYLREIDLAYNYINGTLPREWASSNLTFISL-LVNRLSGEIPK 164
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+ S+L L LE N FSG +P ELGNL++L+KL L+SN TG LP S A L + FR
Sbjct: 165 EFGN-SSLTYLDLESNAFSGTIPQELGNLVHLKKLLLSSNKLTGTLPASLARLQNMTDFR 223
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181
I+D +G IP YIQNW +LE+L + SGL GPIPS I+ L L +LRISD+ GP PFP
Sbjct: 224 INDLQLSGTIPSYIQNWKQLERLEMIASGLTGPIPSVISVLSNLVNLRISDIRGPVQPFP 283
Query: 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYL 241
L N+ + +IL++ NI G++P YL + L LDLSFNKL G IPS L ++ L
Sbjct: 284 SLKNVTGLTKIILKNCNISGQIPTYLSHLKELETLDLSFNKLVGGIPSFAQAENLRFIIL 343
Query: 242 TGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSN-CE---NQSVNLFASSSEGSNSTG 297
GN+L G PD ++R +DLSYNN S +S C N ++NLF S+S S+
Sbjct: 344 AGNMLEGDAPDELLRD-GITVDLSYNNLKWQSPESRACRPNMNLNLNLFQSTST-KKSSK 401
Query: 298 IVSCLKSFTCPTNHSSLHINCGGKQVIANGSTTFE----DDLDAAGPSRFFIS-RTNWAF 352
+ C+K F CP S LH+NCGG + T E D G +++F+ NW F
Sbjct: 402 FLPCIKDFKCPRYSSCLHVNCGGSDMYVKEKKTKELYEGDGNVEGGAAKYFLKPDANWGF 461
Query: 353 STTGHFIDNSTRENSYIQINTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHF 412
S+TG F+D++ +N+ + + S LY ARI+P+SLTY+ C+ NGNYT+NL F
Sbjct: 462 SSTGDFMDDNNFQNTRFTMFVPA--SNQSDLYKSARIAPVSLTYFHACLENGNYTINLDF 519
Query: 413 AEILFTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEI 472
AEI FT+D++Y LGRR+FD+YIQ KLV KDFNI +EA G I+KP +A VTN + I
Sbjct: 520 AEIRFTNDENYNRLGRRLFDIYIQEKLVAKDFNIMDEAKGAQTPIIKPLTAYVTNHFLTI 579
Query: 473 RLYWAGKGTTDIPYKGVYGPLISAISLYTPDIASPLVNGSSNSTNVGMVVGIVAAAAFIL 532
RL WAGKGTT IP +GVYGP+ISAIS+ + S + G + I A ++
Sbjct: 580 RLSWAGKGTTRIPTRGVYGPIISAISIVS---DSKPCERPKTGMSPGAYIAIGIGAPCLI 636
Query: 533 ILIVSILWWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVY 592
I I+ LW GC R ++ +L +G+FTLRQIK AT++F P NKIGEGGFG V+
Sbjct: 637 IFILGFLWICGCLPRCGRQRKDPYEEELPSGTFTLRQIKFATDDFNPTNKIGEGGFGAVF 696
Query: 593 KGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652
KG+LADG+V+AVKQLSSKS+QGNREF+NEIG IS LQHPNLVKL+G C+E QLLL YEY
Sbjct: 697 KGVLADGRVVAVKQLSSKSRQGNREFLNEIGAISCLQHPNLVKLHGFCVERAQLLLAYEY 756
Query: 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD 712
MENNSL+ ALF P+ ++ +DWPTR IC G+A+GLA+LHEES LK VHRDIKATN+LLD
Sbjct: 757 MENNSLSSALFSPKHKQIPMDWPTRFKICCGIAKGLAFLHEESPLKFVHRDIKATNILLD 816
Query: 713 KDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEI 772
KDL PKISDFGLA+LDEE+ THIST++AGT GYMAPEYA+ GYLT KADVYSFG++ LEI
Sbjct: 817 KDLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAPEYALWGYLTFKADVYSFGVLVLEI 876
Query: 773 VSGRSNVICRTKEAQFCLLDWV 794
V+G +N CLL++
Sbjct: 877 VAGITNSNFMGAGDSVCLLEFA 898
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 726 bits (1873), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/808 (50%), Positives = 526/808 (65%), Gaps = 37/808 (4%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLW-KQANGAIPK 61
LK+ +L G+LPPELT+LP+L+ I+L RNYL+GTIP EWA + L ++ + +G +P
Sbjct: 101 LKTMSLRGKLPPELTKLPYLKSIELCRNYLSGTIPMEWAKMAYLTSISVCANNLSGNLPA 160
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+ + L L +E NQFSG +P ELGNL +L L L SN FTG LP + A L L+ R
Sbjct: 161 GLQNFKNLTFLGVEGNQFSGPIPDELGNLTSLTGLELASNKFTGILPGTLARLVNLERVR 220
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181
I DN+FTG IP YI NWT+L+KL + SGL GPIP + L L +L +SD G + FP
Sbjct: 221 ICDNNFTGIIPAYIGNWTRLQKLHLYASGLTGPIPDAVVRLENLLELSLSDTTGIKS-FP 279
Query: 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVI------PSNFSGSG 235
LS+ K + LILR+ + G +P Y+ + L++LDLSFNKL+G++ P N
Sbjct: 280 NLSS-KGLKRLILRNVGLSGPIPSYIWNLTDLKILDLSFNKLNGIVQGVQNPPKN----- 333
Query: 236 LTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQS-VNLFASSSEGSN 294
+YLTGNLL+G + + +IDLSYNNF S S+C+ S +N + SS +N
Sbjct: 334 ---IYLTGNLLSGNIESGGLLNSQSYIDLSYNNF---SWSSSCQKGSTINTYQSSYSKNN 387
Query: 295 STGIVSCLKSFTCPTNHSSLHINCGGKQV-IAN--GSTTFEDD----LDAAGPSRFFISR 347
TG+ C C LHINCGG++V I N G T++ D +AA +F
Sbjct: 388 LTGLPPCAVPANCKKYQRFLHINCGGEEVSIRNSLGKITYQTDNSRQTNAASNQQF---- 443
Query: 348 TNWAFSTTGHFIDNSTRENSYIQINTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYT 407
W S TG F D+++ + Y L D LY AR S +SL YY +C+ NGNY
Sbjct: 444 DYWGVSNTGDFTDDNSDHDEYYTSTNLTLSGDYPDLYKTARRSALSLVYYAFCLENGNYN 503
Query: 408 VNLHFAEILFTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTN 467
V LHF EI F+D + Y LGRRIFDVY+QGKL L+DFNI EA G K ++K +A VTN
Sbjct: 504 VKLHFMEIQFSDKEVYSRLGRRIFDVYVQGKLFLRDFNINKEANGNMKPVIKEINATVTN 563
Query: 468 GTMEIRLYWAGKGTTDIPYKGVYGPLISAISLYTPDIASPLVNGSSNSTNVGMVVGIVAA 527
+EIRLYWAGKGTT IP +G YGPLISAISL V + + +++G A
Sbjct: 564 HMLEIRLYWAGKGTTLIPKRGNYGPLISAISLCHSQEPLCGVEKTKHHIKYPLILGASGA 623
Query: 528 AAFILILIVSILWWKGCFKRKHTLEQE-LKGLDLHTGSFTLRQIKAATNNFAPDNKIGEG 586
I++L V I + +G ++R + + L+ L T F+ RQ++ ATNNF NK+GEG
Sbjct: 624 LVTIVLLAVGI-YARGIYRRDNNRRERDLRAQGLQTVCFSWRQLQTATNNFDQANKLGEG 682
Query: 587 GFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQL 646
GFG V+KG L+DG +IAVKQLSSKS QGNREFVNEIGMIS L HPNLVKLYGCC+E +QL
Sbjct: 683 GFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIGMISGLNHPNLVKLYGCCVERDQL 742
Query: 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKA 706
LL+YEYMENNSLA ALFG ++ LKLDW R IC+G+ARGL +LH+ S +++VHRDIK
Sbjct: 743 LLVYEYMENNSLALALFG--QNSLKLDWAARQKICVGIARGLEFLHDGSAMRMVHRDIKT 800
Query: 707 TNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFG 766
TNVLLD DLN KISDFGLA+L E ++THIST++AGT GYMAPEYA+ G LT+KADVYSFG
Sbjct: 801 TNVLLDTDLNAKISDFGLARLHEAEHTHISTKVAGTIGYMAPEYALWGQLTEKADVYSFG 860
Query: 767 IVALEIVSGRSNVICRTKEAQFCLLDWV 794
+VA+EIVSG+SN + L++W
Sbjct: 861 VVAMEIVSGKSNTKQQGNADSVSLINWA 888
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 623 bits (1607), Expect = e-177, Method: Compositional matrix adjust.
Identities = 347/807 (42%), Positives = 516/807 (63%), Gaps = 27/807 (3%)
Query: 8 NLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLW--KQANGAIPKAVAS 65
++ G +PPEL L +L ++L +N L G++P +L + + +G +PK +
Sbjct: 110 DVVGPIPPELWTLTYLTNLNLGQNVLTGSLPPAIGNLTRMQWMTFGINALSGPVPKEIGL 169
Query: 66 ISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN 125
++ L L + N FSG +P E+G L++++++S+ +G++P SFANL +L+ I+D
Sbjct: 170 LTDLRLLGISSNNFSGSIPDEIGRCTKLQQMYIDSSGLSGRIPLSFANLVQLEQAWIADL 229
Query: 126 HFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSN 185
T QIPD+I +WTKL L I G+GL+GPIPS ++L LT+LR+ D++ + +
Sbjct: 230 EVTDQIPDFIGDWTKLTTLRIIGTGLSGPIPSSFSNLTSLTELRLGDISSGSSSLDFIKD 289
Query: 186 LKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSN-FSGSGLTYMYLTGN 244
+K+++ L+LR+ N+ G +P +G+ LR +DLSFNKL G IP++ F+ S LT+++L N
Sbjct: 290 MKSLSVLVLRNNNLTGTIPSTIGEHSSLRQVDLSFNKLHGPIPASLFNLSQLTHLFLGNN 349
Query: 245 LLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDS--NCENQSVNLFAS--SSEGSNSTGI-- 298
L G P + +++D+SYN+ + GS S + + +NL A+ + EG ++ +
Sbjct: 350 TLNGSFPTQKTQSL-RNVDVSYND-LSGSLPSWVSLPSLKLNLVANNFTLEGLDNRVLPG 407
Query: 299 VSCL-KSFTCPTN---HSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISR-TNWAFS 353
++CL K+F C +S INCGG + + FE + + GP+ FF+S WA S
Sbjct: 408 LNCLQKNFPCNRGKGIYSDFSINCGGPEKRSVTGALFEREDEDFGPASFFVSAGQRWAAS 467
Query: 354 TTGHFIDNSTRENSYIQINTSRLLMD-DSQLYTEARISPISLTYYGYCMVNGNYTVNLHF 412
+ G F +S N YI + S+ + DS+L+ AR+S S+ YYG + NG YTV L F
Sbjct: 468 SVGLFAGSS--NNIYIATSQSQFVNTLDSELFQSARLSASSVRYYGLGLENGGYTVTLQF 525
Query: 413 AEI--LFTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAG-GVGKAIVKPFSAAVTNGT 469
AEI L + ++ LGRR FD+Y+QG+LV KDF++ AG +A+ + + A V+
Sbjct: 526 AEIQILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQRVYKANVSENH 585
Query: 470 MEIRLYWAGKGTTDIPYKGVYGPLISAISLYTPDIASPLVNG--SSNSTNVGMVVGIVAA 527
+E+ L+WAGKGT IP +G YGPLISA+S TPD + N S G +VG++
Sbjct: 586 LEVHLFWAGKGTCCIPIQGAYGPLISAVSA-TPDFTPTVANKPPSKGKNRTGTIVGVIVG 644
Query: 528 AAFILILIVSILWWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGG 587
+ IL +++ ++++T ++EL G+D+ FT ++K+AT +F P NK+GEGG
Sbjct: 645 VGLLSILAGVVMFTIRKRRKRYTDDEELLGMDVKPYIFTYSELKSATQDFDPSNKLGEGG 704
Query: 588 FGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647
FGPVYKG L DG+V+AVK LS S+QG +FV EI IS++ H NLVKLYGCC EG +
Sbjct: 705 FGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHRM 764
Query: 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKAT 707
L+YEY+ N SL +ALFG + L LDW TR+ IC+G+ARGL YLHEE+ ++IVHRD+KA+
Sbjct: 765 LVYEYLPNGSLDQALFG--DKTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKAS 822
Query: 708 NVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGI 767
N+LLD L P+ISDFGLAKL ++ THISTR+AGT GY+APEYAMRG+LT+K DVY+FG+
Sbjct: 823 NILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGV 882
Query: 768 VALEIVSGRSNVICRTKEAQFCLLDWV 794
VALE+VSGR N +E + LL+W
Sbjct: 883 VALELVSGRPNSDENLEEEKKYLLEWA 909
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 621 bits (1602), Expect = e-177, Method: Compositional matrix adjust.
Identities = 346/804 (43%), Positives = 510/804 (63%), Gaps = 27/804 (3%)
Query: 11 GRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLW--KQANGAIPKAVASIST 68
G +P +L L +L ++L +N L G++P +L + + +G IPK + ++
Sbjct: 112 GSIPQQLWTLEYLTNLNLGQNVLTGSLPPALGNLTRMRWMTFGINALSGPIPKEIGLLTD 171
Query: 69 LADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFT 128
L L++ N FSG +P E+G L++++++S+ +G LP SFANL L+ I+D T
Sbjct: 172 LRLLSISSNNFSGSIPDEIGRCTKLQQIYIDSSGLSGGLPVSFANLVELEQAWIADMELT 231
Query: 129 GQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKN 188
GQIPD+I +WTKL L I G+GL+GPIP+ ++L LT+LR+ D++ + ++K+
Sbjct: 232 GQIPDFIGDWTKLTTLRILGTGLSGPIPASFSNLTSLTELRLGDISNGNSSLEFIKDMKS 291
Query: 189 MNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSN-FSGSGLTYMYLTGNLLT 247
++ L+LR+ N+ G +P +G+ LR LDLSFNKL G IP++ F+ LT+++L N L
Sbjct: 292 LSILVLRNNNLTGTIPSNIGEYSSLRQLDLSFNKLHGTIPASLFNLRQLTHLFLGNNTLN 351
Query: 248 GPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSS----EGSNS---TGIVS 300
G +P + + ++D+SYN+ + GS S ++NL ++ EG ++ +G+
Sbjct: 352 GSLPTQKGQSLS-NVDVSYND-LSGSLPSWVSLPNLNLNLVANNFTLEGLDNRVLSGLNC 409
Query: 301 CLKSFTCPTN---HSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISR-TNWAFSTTG 356
K+F C +S INCGG ++ + FE + + GP+ F +S WA S+ G
Sbjct: 410 LQKNFPCNRGKGIYSDFSINCGGPEIRSVTEAVFEREDEDLGPASFVVSAGQRWAASSVG 469
Query: 357 HFIDNSTRENSYIQINTSRLLMD-DSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEI 415
F +S N YI + S+ + DS+L+ AR+S SL YYG + NG YTV L FAEI
Sbjct: 470 LFAGSSN--NIYISTSQSQFVNTLDSELFQSARLSASSLRYYGLGLENGGYTVTLQFAEI 527
Query: 416 --LFTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAG-GVGKAIVKPFSAAVTNGTMEI 472
L + ++ LGRR FD+Y+QG+LV KDF++ AG +A+ + + A V+ +EI
Sbjct: 528 QILGSTSNTWRGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQREYKANVSQNHLEI 587
Query: 473 RLYWAGKGTTDIPYKGVYGPLISAISLYTPDIASPLVNG--SSNSTNVGMVVGIVAAAAF 530
L+WAGKGT IP +G YGPLISA+ TPD + N S + G +VG++
Sbjct: 588 HLFWAGKGTCCIPIQGAYGPLISAVGA-TPDFTPTVGNRPPSKGKSMTGTIVGVIVGVGL 646
Query: 531 ILILIVSILWWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGP 590
+ I+ +++ ++++T ++E+ +D+ +FT ++K+AT +F P NK+GEGGFGP
Sbjct: 647 LSIISGVVIFIIRKRRKRYTDDEEILSMDVKPYTFTYSELKSATQDFDPSNKLGEGGFGP 706
Query: 591 VYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650
VYKG L DG+ +AVK LS S+QG +FV EI ISA+QH NLVKLYGCC EG LL+Y
Sbjct: 707 VYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQHRNLVKLYGCCYEGEHRLLVY 766
Query: 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVL 710
EY+ N SL +ALFG E L LDW TR+ IC+G+ARGL YLHEE+RL+IVHRD+KA+N+L
Sbjct: 767 EYLPNGSLDQALFG--EKTLHLDWSTRYEICLGVARGLVYLHEEARLRIVHRDVKASNIL 824
Query: 711 LDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVAL 770
LD L PK+SDFGLAKL ++ THISTR+AGT GY+APEYAMRG+LT+K DVY+FG+VAL
Sbjct: 825 LDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVAL 884
Query: 771 EIVSGRSNVICRTKEAQFCLLDWV 794
E+VSGR N ++ + LL+W
Sbjct: 885 ELVSGRPNSDENLEDEKRYLLEWA 908
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64778|Y1142_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61420 OS=Arabidopsis thaliana GN=At1g61420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 268 bits (684), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 137/283 (48%), Positives = 187/283 (66%), Gaps = 30/283 (10%)
Query: 514 NSTNVGMVVGIVAAAAFILILIVSILWWKGCFKRKHTLE----------------QELKG 557
N + IV+ + ++I V+ +W+ ++ KH + Q++ G
Sbjct: 421 NKRKKAITASIVSLSLVVIIAFVAFCFWR--YRVKHNADITTDASQVSWRNDLKPQDVPG 478
Query: 558 LDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNRE 617
LD F + I+ ATNNF+ NK+G+GGFGPVYKG L DGK IAVK+LSS S QG E
Sbjct: 479 LDF----FDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEE 534
Query: 618 FVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTR 677
F+NEI +IS LQH NLV++ GCCIEG + LLIYE+M NNSL LF + RL++DWP R
Sbjct: 535 FMNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRK-RLEIDWPKR 593
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL----DEEDNT 733
I G+ARG+ YLH +S LK++HRD+K +N+LLD+ +NPKISDFGLA++ + +DNT
Sbjct: 594 LDIIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNT 653
Query: 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
R+ GT GYMAPEYA G ++K+D+YSFG++ LEI+SG
Sbjct: 654 R---RVVGTLGYMAPEYAWTGMFSEKSDIYSFGVLMLEIISGE 693
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 809 | ||||||
| 302142829 | 1036 | unnamed protein product [Vitis vinifera] | 0.972 | 0.759 | 0.711 | 0.0 | |
| 359493983 | 1007 | PREDICTED: probable leucine-rich repeat | 0.972 | 0.781 | 0.711 | 0.0 | |
| 359493981 | 1007 | PREDICTED: probable leucine-rich repeat | 0.970 | 0.779 | 0.708 | 0.0 | |
| 302142832 | 906 | unnamed protein product [Vitis vinifera] | 0.977 | 0.873 | 0.702 | 0.0 | |
| 359493985 | 1011 | PREDICTED: probable leucine-rich repeat | 0.971 | 0.777 | 0.704 | 0.0 | |
| 255567064 | 1007 | ATP binding protein, putative [Ricinus c | 0.969 | 0.778 | 0.682 | 0.0 | |
| 302142826 | 869 | unnamed protein product [Vitis vinifera] | 0.950 | 0.884 | 0.680 | 0.0 | |
| 255567058 | 985 | ATP binding protein, putative [Ricinus c | 0.941 | 0.773 | 0.662 | 0.0 | |
| 357492929 | 996 | Cysteine-rich receptor-like protein kina | 0.967 | 0.786 | 0.652 | 0.0 | |
| 356542343 | 1111 | PREDICTED: probable leucine-rich repeat | 0.971 | 0.707 | 0.638 | 0.0 |
| >gi|302142829|emb|CBI20124.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1159 bits (2998), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 565/794 (71%), Positives = 662/794 (83%), Gaps = 7/794 (0%)
Query: 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPL-WKQANGAIPK 61
+LK+QNLPG LPPEL +LP+LQEID TRNYL+G+IP EW ++ LVN+ L + G+IPK
Sbjct: 119 VLKTQNLPGSLPPELVKLPYLQEIDFTRNYLDGSIPPEWGTMQLVNISLIGNRLTGSIPK 178
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+ +ISTLA+LT+EFNQ SG LP ELGNL ++E++ L SNNFTG+LP++FA LT LK FR
Sbjct: 179 ELGNISTLANLTVEFNQLSGVLPQELGNLPSIERILLTSNNFTGELPQTFAGLTTLKDFR 238
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181
+ DN FTG+IP++IQNWTKLEKL I+GSG +GPIPSGIA L ++TDLRISDLNG E FP
Sbjct: 239 VGDNQFTGKIPNFIQNWTKLEKLVIQGSGFSGPIPSGIALLTKITDLRISDLNGTEATFP 298
Query: 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMY 240
LS+++N+ LILRS NI+G +P+YLG+M L+ LDLSFNKL+G IPS+F G S YMY
Sbjct: 299 PLSDMRNLKTLILRSCNIVGPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSNADYMY 358
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVS 300
TGN+LTG VPDW++ KR + DLSYNNF SS C+ +SVNLF SSS G N+ GIVS
Sbjct: 359 FTGNMLTGAVPDWML-KRGDNYDLSYNNFTSESS-RGCQERSVNLFGSSS-GGNNFGIVS 415
Query: 301 CLKSFTCPTNHSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGHFID 360
CL+SF CP S+HINCGGK+VI +G+TT+EDD D+ GPS+F+ SRTNWAFS+TGHF+D
Sbjct: 416 CLRSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDTDSGGPSKFYQSRTNWAFSSTGHFMD 475
Query: 361 NSTRENSYIQINTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEILFTDD 420
+ +S+I N SRL M++S LYT AR+S +SLTYYG+C+ NGNYTV LHFAEI FTDD
Sbjct: 476 DDRPTDSFIGTNVSRLTMENSGLYTTARLSALSLTYYGFCLENGNYTVKLHFAEITFTDD 535
Query: 421 KSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRLYWAGKG 480
K+Y SLGRR+FDVY+Q +LVLKDF+IE++AGGV K I+K F+A VTN T+EIR YWAGKG
Sbjct: 536 KTYSSLGRRLFDVYVQDELVLKDFDIEDDAGGVSKEIIKYFTAVVTNNTLEIRFYWAGKG 595
Query: 481 TTDIPYKGVYGPLISAISLYTPDIASPLVNGSSNSTNVGMVVGIVAAAAFILILIVSILW 540
TT IP +GVYGPLISAIS+ PD P NGSS S +VG+VVG VA ++ L++ ILW
Sbjct: 596 TTGIPVRGVYGPLISAISV-DPDFIPPTKNGSS-SKSVGIVVGHVAGVILLVFLVIGILW 653
Query: 541 WKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGK 600
W+GC +RK TLEQELKGLDL TG FTLRQIKAATNNF NKIGEGGFG VYKG+L+DG
Sbjct: 654 WRGCLRRKDTLEQELKGLDLQTGLFTLRQIKAATNNFDAANKIGEGGFGSVYKGVLSDGT 713
Query: 601 VIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLAR 660
+IAVKQLSSKSKQGNREFVNE+GMISALQHP+LVKLYGCCIEGNQLLLIYEYMENNSLAR
Sbjct: 714 IIAVKQLSSKSKQGNREFVNELGMISALQHPHLVKLYGCCIEGNQLLLIYEYMENNSLAR 773
Query: 661 ALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 720
ALFGPEE +L+LDWPTRH IC+G+ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS
Sbjct: 774 ALFGPEECQLQLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 833
Query: 721 DFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVI 780
DFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSN
Sbjct: 834 DFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNTT 893
Query: 781 CRTKEAQFCLLDWV 794
R KE LLDW
Sbjct: 894 YRPKEECTYLLDWA 907
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493983|ref|XP_002283596.2| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1158 bits (2995), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 565/794 (71%), Positives = 662/794 (83%), Gaps = 7/794 (0%)
Query: 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPL-WKQANGAIPK 61
+LK+QNLPG LPPEL +LP+LQEID TRNYL+G+IP EW ++ LVN+ L + G+IPK
Sbjct: 90 VLKTQNLPGSLPPELVKLPYLQEIDFTRNYLDGSIPPEWGTMQLVNISLIGNRLTGSIPK 149
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+ +ISTLA+LT+EFNQ SG LP ELGNL ++E++ L SNNFTG+LP++FA LT LK FR
Sbjct: 150 ELGNISTLANLTVEFNQLSGVLPQELGNLPSIERILLTSNNFTGELPQTFAGLTTLKDFR 209
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181
+ DN FTG+IP++IQNWTKLEKL I+GSG +GPIPSGIA L ++TDLRISDLNG E FP
Sbjct: 210 VGDNQFTGKIPNFIQNWTKLEKLVIQGSGFSGPIPSGIALLTKITDLRISDLNGTEATFP 269
Query: 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMY 240
LS+++N+ LILRS NI+G +P+YLG+M L+ LDLSFNKL+G IPS+F G S YMY
Sbjct: 270 PLSDMRNLKTLILRSCNIVGPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSNADYMY 329
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVS 300
TGN+LTG VPDW++ KR + DLSYNNF SS C+ +SVNLF SSS G N+ GIVS
Sbjct: 330 FTGNMLTGAVPDWML-KRGDNYDLSYNNFTSESS-RGCQERSVNLFGSSS-GGNNFGIVS 386
Query: 301 CLKSFTCPTNHSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGHFID 360
CL+SF CP S+HINCGGK+VI +G+TT+EDD D+ GPS+F+ SRTNWAFS+TGHF+D
Sbjct: 387 CLRSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDTDSGGPSKFYQSRTNWAFSSTGHFMD 446
Query: 361 NSTRENSYIQINTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEILFTDD 420
+ +S+I N SRL M++S LYT AR+S +SLTYYG+C+ NGNYTV LHFAEI FTDD
Sbjct: 447 DDRPTDSFIGTNVSRLTMENSGLYTTARLSALSLTYYGFCLENGNYTVKLHFAEITFTDD 506
Query: 421 KSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRLYWAGKG 480
K+Y SLGRR+FDVY+Q +LVLKDF+IE++AGGV K I+K F+A VTN T+EIR YWAGKG
Sbjct: 507 KTYSSLGRRLFDVYVQDELVLKDFDIEDDAGGVSKEIIKYFTAVVTNNTLEIRFYWAGKG 566
Query: 481 TTDIPYKGVYGPLISAISLYTPDIASPLVNGSSNSTNVGMVVGIVAAAAFILILIVSILW 540
TT IP +GVYGPLISAIS+ PD P NGSS S +VG+VVG VA ++ L++ ILW
Sbjct: 567 TTGIPVRGVYGPLISAISV-DPDFIPPTKNGSS-SKSVGIVVGHVAGVILLVFLVIGILW 624
Query: 541 WKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGK 600
W+GC +RK TLEQELKGLDL TG FTLRQIKAATNNF NKIGEGGFG VYKG+L+DG
Sbjct: 625 WRGCLRRKDTLEQELKGLDLQTGLFTLRQIKAATNNFDAANKIGEGGFGSVYKGVLSDGT 684
Query: 601 VIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLAR 660
+IAVKQLSSKSKQGNREFVNE+GMISALQHP+LVKLYGCCIEGNQLLLIYEYMENNSLAR
Sbjct: 685 IIAVKQLSSKSKQGNREFVNELGMISALQHPHLVKLYGCCIEGNQLLLIYEYMENNSLAR 744
Query: 661 ALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 720
ALFGPEE +L+LDWPTRH IC+G+ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS
Sbjct: 745 ALFGPEECQLQLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 804
Query: 721 DFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVI 780
DFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSN
Sbjct: 805 DFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNTT 864
Query: 781 CRTKEAQFCLLDWV 794
R KE LLDW
Sbjct: 865 YRPKEECTYLLDWA 878
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493981|ref|XP_003634703.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1122 bits (2901), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 561/792 (70%), Positives = 657/792 (82%), Gaps = 7/792 (0%)
Query: 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLW-KQANGAIPK 61
+LK+QNLPG LPPEL +LP+LQEID TRNYLNG+IP EW ++ LVN+ L Q G+IPK
Sbjct: 90 VLKTQNLPGSLPPELVKLPYLQEIDFTRNYLNGSIPPEWGTMQLVNISLIGNQLTGSIPK 149
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+ +ISTLA+LT+EFNQ SG LP ELGNL ++E++ L SNNFTG+LP++FA LT LK FR
Sbjct: 150 ELGNISTLANLTVEFNQLSGVLPQELGNLPSIERILLTSNNFTGELPQTFAGLTTLKDFR 209
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181
+ DN FTG+IP++IQNWTKLEKL I+GSG +GPIPSGIA L ++TDLRISDLNG E FP
Sbjct: 210 VGDNQFTGKIPNFIQNWTKLEKLVIQGSGFSGPIPSGIALLTKITDLRISDLNGTEATFP 269
Query: 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMY 240
LS+++++ LILRS NI+ +P+YLG+M L+ LDLSFNKL+G IPS+F G S YMY
Sbjct: 270 PLSDMRDLKTLILRSCNIVDPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSNADYMY 329
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVS 300
TGN+LTG VPDW++ KR + DLSYNNF SS C+ +SVNLF SSS G+NS IVS
Sbjct: 330 FTGNMLTGAVPDWML-KRGDNYDLSYNNFTSESS-RGCQERSVNLFGSSSGGNNSG-IVS 386
Query: 301 CLKSFTCPTNHSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGHFID 360
CL+SF CP S+HINCGGK+VI +G+TT+EDD D+ GPS+F+ SRTNWAFS+TGHF+D
Sbjct: 387 CLRSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDTDSGGPSKFYQSRTNWAFSSTGHFMD 446
Query: 361 NSTRENSYIQINTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEILFTDD 420
+ +S+I N SRL+M++S LYT AR+S +SLTYYG+C+ NGNYTV LHFAEI FTDD
Sbjct: 447 DDRPTDSFIGTNVSRLIMENSGLYTTARLSALSLTYYGFCLENGNYTVKLHFAEITFTDD 506
Query: 421 KSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRLYWAGKG 480
K+Y SLGRR+FDVY+Q KLVLKDFNIE+EAGGV K I+K F+A VTN T+EIR YWAGKG
Sbjct: 507 KTYSSLGRRLFDVYVQDKLVLKDFNIEDEAGGVSKEILKYFTAVVTNNTLEIRFYWAGKG 566
Query: 481 TTDIPYKGVYGPLISAISLYTPDIASPLVNGSSNSTNVGMVVGIVAAAAFILILIVSILW 540
TT IP +GVYGPLISAIS+ PD P NGSS+ + +V IVA ++ L++ ILW
Sbjct: 567 TTGIPVRGVYGPLISAISV-DPDFIPPTENGSSSISVGVVVG-IVAGVILLVFLLIGILW 624
Query: 541 WKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGK 600
W+ C +RK TLEQELKGLDL TG FTLRQIKAATNNF NKIGEGGFG VYKG+L+DG
Sbjct: 625 WRDCLRRKDTLEQELKGLDLQTGLFTLRQIKAATNNFDAANKIGEGGFGSVYKGVLSDGT 684
Query: 601 VIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLAR 660
+IAVKQLSSKSKQGNREFVNEIGMISALQHP+LVKLYGCCIEGNQLLLIYEYMENNSLAR
Sbjct: 685 IIAVKQLSSKSKQGNREFVNEIGMISALQHPHLVKLYGCCIEGNQLLLIYEYMENNSLAR 744
Query: 661 ALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 720
ALFGPEE +L+LDWPTRH IC+G+ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS
Sbjct: 745 ALFGPEECQLQLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 804
Query: 721 DFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVI 780
DFGLAKLDEEDNTHISTRIAGT+GYMAPEYAMRGYLTDKADVYSFG+VALEIVSGRSN
Sbjct: 805 DFGLAKLDEEDNTHISTRIAGTYGYMAPEYAMRGYLTDKADVYSFGVVALEIVSGRSNTT 864
Query: 781 CRTKEAQFCLLD 792
R KE LLD
Sbjct: 865 YRPKEESIYLLD 876
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142832|emb|CBI20127.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1108 bits (2865), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 562/800 (70%), Positives = 656/800 (82%), Gaps = 9/800 (1%)
Query: 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLW-KQANGAIPK 61
+LK+QNLPG LPPEL +LP+LQEID TRNYLNG+IP EW ++ LVN+ L + G+IPK
Sbjct: 90 VLKTQNLPGSLPPELVKLPYLQEIDFTRNYLNGSIPPEWGTMQLVNISLMGNRLTGSIPK 149
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+ +ISTLA+LT+E NQ SG LP ELGNL ++E++ L SNNFTG+LPE+FA LT LK FR
Sbjct: 150 ELGNISTLANLTVESNQLSGVLPQELGNLPSIERILLTSNNFTGELPETFAGLTTLKDFR 209
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181
++DN FTG+IP++IQNWTKLEKL I GSG +GPIPSGIA L ++TDLRISDLNG E FP
Sbjct: 210 VADNQFTGKIPNFIQNWTKLEKLVIHGSGFSGPIPSGIALLTKITDLRISDLNGTEATFP 269
Query: 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMY 240
LS+++N+ LILRS +I+G +P+YLG+M L+ LDLSFNKL+G IPS+F G S Y+Y
Sbjct: 270 PLSDMRNLKTLILRSCSIVGPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSKADYIY 329
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVS 300
TGN+LTG VPDW++ KR + DLSYNNF SS C+ +SVNLF SSS G+NS IVS
Sbjct: 330 FTGNMLTGAVPDWML-KRGDNYDLSYNNFTSESS-RGCQERSVNLFGSSSGGNNSG-IVS 386
Query: 301 CLKSFTCPTNHSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGHFID 360
CL+SF CP S+HINCGGK+VI +G+TT+EDD D+ GPS+F+ SRTNWAFS+TGHF+D
Sbjct: 387 CLRSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDKDSGGPSKFYQSRTNWAFSSTGHFMD 446
Query: 361 NSTRENSYIQINTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEILFTDD 420
+ +S+I N SRL M++S LYT AR+S +SLTYYG+C+ NGNYTV LHFAEI FTDD
Sbjct: 447 DDHPTDSFIGTNVSRLAMENSGLYTTARLSALSLTYYGFCLENGNYTVKLHFAEITFTDD 506
Query: 421 KSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRLYWAGKG 480
K+Y SLGRR+FDVY+Q +LVLKDFNIE+EAGGV K I+K F+A VTN T+EIR YWAGKG
Sbjct: 507 KTYSSLGRRLFDVYVQDELVLKDFNIEDEAGGVSKEILKFFTAIVTNNTLEIRFYWAGKG 566
Query: 481 TTDIPYKGVYGPLISAISLYTPDIASPLVN---GSSNSTNVGMVVGIVAAAAFILILIVS 537
TT IP +GVYGPLISAIS+ PD P N S VG+VVGIVA ++ L++
Sbjct: 567 TTGIPVRGVYGPLISAISV-DPDFIPPTENRSSSISVGIVVGVVVGIVAGVILLVFLVIG 625
Query: 538 ILWWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLA 597
ILWW+ C +RK TLEQELKGLDL TG FTLRQIKAATNNF NKIGEGGFG VYKG+L+
Sbjct: 626 ILWWRVCLRRKDTLEQELKGLDLQTGLFTLRQIKAATNNFDAANKIGEGGFGSVYKGVLS 685
Query: 598 DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNS 657
DG +IAVKQLSSKSKQGNREFV EIGMISALQHP+LVKLYGCCIEGNQLLLIYEYMENNS
Sbjct: 686 DGTIIAVKQLSSKSKQGNREFVTEIGMISALQHPHLVKLYGCCIEGNQLLLIYEYMENNS 745
Query: 658 LARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 717
LARALFGPEE +L+LDWPTRH IC+G+ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP
Sbjct: 746 LARALFGPEECQLQLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 805
Query: 718 KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRS 777
KISDFGLAKLDEE NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFG+VALEIVSGRS
Sbjct: 806 KISDFGLAKLDEEYNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGVVALEIVSGRS 865
Query: 778 NVICRTKEAQFCLLDWVTLA 797
N R KE LLD V L
Sbjct: 866 NTTYRPKEESIYLLDRVILT 885
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493985|ref|XP_002283578.2| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1106 bits (2861), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 560/795 (70%), Positives = 654/795 (82%), Gaps = 9/795 (1%)
Query: 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLW-KQANGAIPK 61
+LK+QNLPG LPPEL +LP+LQEID TRNYLNG+IP EW ++ LVN+ L + G+IPK
Sbjct: 90 VLKTQNLPGSLPPELVKLPYLQEIDFTRNYLNGSIPPEWGTMQLVNISLMGNRLTGSIPK 149
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+ +ISTLA+LT+E NQ SG LP ELGNL ++E++ L SNNFTG+LPE+FA LT LK FR
Sbjct: 150 ELGNISTLANLTVESNQLSGVLPQELGNLPSIERILLTSNNFTGELPETFAGLTTLKDFR 209
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181
++DN FTG+IP++IQNWTKLEKL I GSG +GPIPSGIA L ++TDLRISDLNG E FP
Sbjct: 210 VADNQFTGKIPNFIQNWTKLEKLVIHGSGFSGPIPSGIALLTKITDLRISDLNGTEATFP 269
Query: 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMY 240
LS+++N+ LILRS +I+G +P+YLG+M L+ LDLSFNKL+G IPS+F G S Y+Y
Sbjct: 270 PLSDMRNLKTLILRSCSIVGPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSKADYIY 329
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVS 300
TGN+LTG VPDW++ KR + DLSYNNF SS C+ +SVNLF SSS G+NS IVS
Sbjct: 330 FTGNMLTGAVPDWML-KRGDNYDLSYNNFTSESS-RGCQERSVNLFGSSSGGNNSG-IVS 386
Query: 301 CLKSFTCPTNHSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGHFID 360
CL+SF CP S+HINCGGK+VI +G+TT+EDD D+ GPS+F+ SRTNWAFS+TGHF+D
Sbjct: 387 CLRSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDKDSGGPSKFYQSRTNWAFSSTGHFMD 446
Query: 361 NSTRENSYIQINTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEILFTDD 420
+ +S+I N SRL M++S LYT AR+S +SLTYYG+C+ NGNYTV LHFAEI FTDD
Sbjct: 447 DDHPTDSFIGTNVSRLAMENSGLYTTARLSALSLTYYGFCLENGNYTVKLHFAEITFTDD 506
Query: 421 KSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRLYWAGKG 480
K+Y SLGRR+FDVY+Q +LVLKDFNIE+EAGGV K I+K F+A VTN T+EIR YWAGKG
Sbjct: 507 KTYSSLGRRLFDVYVQDELVLKDFNIEDEAGGVSKEILKFFTAIVTNNTLEIRFYWAGKG 566
Query: 481 TTDIPYKGVYGPLISAISLYTPDIASPLVN---GSSNSTNVGMVVGIVAAAAFILILIVS 537
TT IP +GVYGPLISAIS+ PD P N S VG+VVGIVA ++ L++
Sbjct: 567 TTGIPVRGVYGPLISAISV-DPDFIPPTENRSSSISVGIVVGVVVGIVAGVILLVFLVIG 625
Query: 538 ILWWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLA 597
ILWW+ C +RK TLEQELKGLDL TG FTLRQIKAATNNF NKIGEGGFG VYKG+L+
Sbjct: 626 ILWWRVCLRRKDTLEQELKGLDLQTGLFTLRQIKAATNNFDAANKIGEGGFGSVYKGVLS 685
Query: 598 DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNS 657
DG +IAVKQLSSKSKQGNREFV EIGMISALQHP+LVKLYGCCIEGNQLLLIYEYMENNS
Sbjct: 686 DGTIIAVKQLSSKSKQGNREFVTEIGMISALQHPHLVKLYGCCIEGNQLLLIYEYMENNS 745
Query: 658 LARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 717
LARALFGPEE +L+LDWPTRH IC+G+ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP
Sbjct: 746 LARALFGPEECQLQLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 805
Query: 718 KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRS 777
KISDFGLAKLDEE NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFG+VALEIVSGRS
Sbjct: 806 KISDFGLAKLDEEYNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGVVALEIVSGRS 865
Query: 778 NVICRTKEAQFCLLD 792
N R KE LLD
Sbjct: 866 NTTYRPKEESIYLLD 880
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255567064|ref|XP_002524514.1| ATP binding protein, putative [Ricinus communis] gi|223536188|gb|EEF37841.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1061 bits (2745), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 544/797 (68%), Positives = 643/797 (80%), Gaps = 13/797 (1%)
Query: 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLW-KQANGAIPK 61
+LKSQNL G LP +L +L FLQ IDLTRNYLNGTIP EW S+ L + L + +G IP+
Sbjct: 90 VLKSQNLQGTLPTDLGKLQFLQLIDLTRNYLNGTIPPEWGSMQLRYISLLGNRLSGPIPR 149
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+ +I+TL +L +EFNQFSG+LP ELGNL ++ +L SNNFTGKLP +FA LT L FR
Sbjct: 150 ELGNITTLLELVIEFNQFSGELPQELGNLGSIRRLLFTSNNFTGKLPATFAKLTTLIDFR 209
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDL-NGPEGPF 180
I DN FTGQIPD IQNWT L+KL I+GSGL+GP+PSGI+ L +TD+RISDL NG E PF
Sbjct: 210 IGDNKFTGQIPDLIQNWTNLQKLVIQGSGLSGPVPSGISLLANITDMRISDLSNGTETPF 269
Query: 181 PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYM 239
P LS++KN+ LILRS NI+G++P YLG M LR LDLSFNKL+G IPS+FS Y+
Sbjct: 270 PALSSMKNLKTLILRSCNIVGQLPLYLGGMTNLRTLDLSFNKLTGGIPSDFSNIQKADYI 329
Query: 240 YLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIV 299
YLTGN L G VPDWI++K N +IDLSYNNFID S+ C+ +S+NLF SSS N+T IV
Sbjct: 330 YLTGNRLNGTVPDWILQKGN-NIDLSYNNFIDQST---CQQRSINLFGSSSM-ENATEIV 384
Query: 300 SCLKSFTCPTNHSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGHFI 359
SCL+S CP N S HINCGGK+ + N T+E+D+D+ GPSRF+ SRTNWAFS+TGHF+
Sbjct: 385 SCLRSHRCPKNFYSFHINCGGKEAVIN-RNTYEEDVDSGGPSRFYQSRTNWAFSSTGHFL 443
Query: 360 DNSTRENSYIQINTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEILFTD 419
D+ +SY NT++L S LYT+AR+SP+SLTYYG+CM NGNYTV+LHFAEI+FT
Sbjct: 444 DDDRPTDSYTWTNTTKLSSGISALYTDARLSPLSLTYYGFCMGNGNYTVDLHFAEIIFTA 503
Query: 420 DKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRLYWAGK 479
D +Y SLGRR+FD+YIQGKLV KDFNI ++AGGVGKAI+K F+A VTN T+EIR YW GK
Sbjct: 504 DNTYSSLGRRMFDIYIQGKLVGKDFNIADDAGGVGKAIIKKFTAIVTNHTLEIRFYWDGK 563
Query: 480 GTTDIPYKGVYGPLISAISLYTPDIASPLVNGSSNSTNVGMVVGIVAAAAFILILIVSIL 539
GTT IP +G+YGPLISAIS+ TP+ P N SS+S + G V GIV ++ L++ +L
Sbjct: 564 GTTGIPLRGIYGPLISAISV-TPNFVPPSEN-SSSSISTGTVAGIVIVVVVVVFLVLGVL 621
Query: 540 WWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADG 599
WWKGC +K T++Q LKGLDL TGSFTL+QIKAAT+NF DNKIGEGGFG VYKGLL+DG
Sbjct: 622 WWKGCLGQKDTVDQALKGLDLQTGSFTLKQIKAATHNFNLDNKIGEGGFGSVYKGLLSDG 681
Query: 600 KVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLA 659
+IAVKQLSSKSKQGNREFVNEIGMISALQHP+LVKLYGCCIE NQLLL+YEYMENNSLA
Sbjct: 682 TIIAVKQLSSKSKQGNREFVNEIGMISALQHPHLVKLYGCCIEENQLLLVYEYMENNSLA 741
Query: 660 RALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 719
RALFGPEE +L LDWPTRH IC+G+ARGLA+LHEESRLKIVHRDIKATNVLLDK+LNPKI
Sbjct: 742 RALFGPEECQLDLDWPTRHKICVGIARGLAFLHEESRLKIVHRDIKATNVLLDKNLNPKI 801
Query: 720 SDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNV 779
SDFGLAKLDEE+NTHISTR+AGTFGYMAPEYAMRG+LTDKADVYSFGIVALEIVSGRSN
Sbjct: 802 SDFGLAKLDEEENTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNT 861
Query: 780 ICRTKEAQFC--LLDWV 794
R + C LLDW
Sbjct: 862 SYRLNLKENCVYLLDWA 878
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142826|emb|CBI20121.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1061 bits (2745), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 542/797 (68%), Positives = 638/797 (80%), Gaps = 28/797 (3%)
Query: 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLW-KQANGAIPK 61
+LK+QNLPG LPPEL +LP+LQEID TRNYLNG+IP EW ++ LVN+ L Q G+IPK
Sbjct: 90 VLKTQNLPGSLPPELVKLPYLQEIDFTRNYLNGSIPPEWGTMQLVNISLIGNQLTGSIPK 149
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+ +ISTLA+LT+EFNQ SG LP ELGNL ++E++ L SNNFTG+LP++FA LT LK FR
Sbjct: 150 ELGNISTLANLTVEFNQLSGVLPQELGNLPSIERILLTSNNFTGELPQTFAGLTTLKDFR 209
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181
+ DN FTG+IP++IQNWTKLEKL I+GSG +GPIPSGIA L ++TDLRISDLNG E FP
Sbjct: 210 VGDNQFTGKIPNFIQNWTKLEKLVIQGSGFSGPIPSGIALLTKITDLRISDLNGTEATFP 269
Query: 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMY 240
LS+++++ LILRS NI+ +P+YLG+M L+ LDLSFNKL+G IPS+F G S YMY
Sbjct: 270 PLSDMRDLKTLILRSCNIVDPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSNADYMY 329
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVS 300
TGN+LTG VPDW++ KR + DLSYNNF SS C+ +SVNLF SSS G+NS IVS
Sbjct: 330 FTGNMLTGAVPDWML-KRGDNYDLSYNNFTSESS-RGCQERSVNLFGSSSGGNNSG-IVS 386
Query: 301 CLKSFTCPTNHSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGHFID 360
CL+SF CP S+HINCGGK+VI +G+TT+EDD D+ GPS+F+ SRTNWAFS+TGHF+D
Sbjct: 387 CLRSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDTDSGGPSKFYQSRTNWAFSSTGHFMD 446
Query: 361 NSTRENSYIQINTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEILFTDD 420
+ +S+I N SRL+M++S LYT AR+S +SLTYYG+C+ NGNYTV LHFAEI FTDD
Sbjct: 447 DDRPTDSFIGTNVSRLIMENSGLYTTARLSALSLTYYGFCLENGNYTVKLHFAEITFTDD 506
Query: 421 KSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRLYWAGKG 480
K+Y SLGRR+FDVY+Q KLVLKDFNIE+EAGGV K I+K F+A VTN T+EIR YWAGKG
Sbjct: 507 KTYSSLGRRLFDVYVQDKLVLKDFNIEDEAGGVSKEILKYFTAVVTNNTLEIRFYWAGKG 566
Query: 481 TTDIPYKGVYGPLISAISLYTPDIASPLVNGSSNSTNVGMVVGIVAAAAFILILIVSILW 540
TT IP +GVYGPLISAIS+ PD P NGSS+ + +V IVA ++ L++ ILW
Sbjct: 567 TTGIPVRGVYGPLISAISV-DPDFIPPTENGSSSISVGVVVG-IVAGVILLVFLLIGILW 624
Query: 541 WKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGK 600
W+ C +RK TLEQELKGLDL TG FTLRQIKAATNNF NKIGEGGFG VYKG+L+DG
Sbjct: 625 WRDCLRRKDTLEQELKGLDLQTGLFTLRQIKAATNNFDAANKIGEGGFGSVYKGVLSDGT 684
Query: 601 VIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLAR 660
+IAVKQLSSKSKQGNREFVNEIGMISALQHP+LVKLYGCCIEGNQLLLIYEYMENNSLAR
Sbjct: 685 IIAVKQLSSKSKQGNREFVNEIGMISALQHPHLVKLYGCCIEGNQLLLIYEYMENNSLAR 744
Query: 661 ALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 720
ALFGPEE +L+LDWPTRH IC+G+ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS
Sbjct: 745 ALFGPEECQLQLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 804
Query: 721 DFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVI 780
DFGLAKLDEEDNTHISTRIAGT+ FG+VALEIVSGRSN
Sbjct: 805 DFGLAKLDEEDNTHISTRIAGTY---------------------FGVVALEIVSGRSNTT 843
Query: 781 CRTKEAQFCLLDWVTLA 797
R KE LLD V L
Sbjct: 844 YRPKEESIYLLDRVILT 860
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255567058|ref|XP_002524511.1| ATP binding protein, putative [Ricinus communis] gi|223536185|gb|EEF37838.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1060 bits (2742), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 527/796 (66%), Positives = 626/796 (78%), Gaps = 34/796 (4%)
Query: 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPL-WKQANGAIPK 61
I+K+Q+L G LP +L RLPFLQEID TRNYLNGTIP EW ++ LVN+ L + G IPK
Sbjct: 90 IVKAQSLQGTLPRDLDRLPFLQEIDFTRNYLNGTIPPEWGTIQLVNISLIGNRLTGPIPK 149
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+ +ISTLA T EFNQ SG+LP ELG+L ++E++ L+SNN TG+LP +FA + L+ FR
Sbjct: 150 ELGNISTLASFTAEFNQLSGELPPELGDLRSIERILLSSNNLTGQLPPTFAKMVTLQDFR 209
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDL-NGPEGPF 180
I DN FTGQIP+ IQNWT LEKL I+GSGL+GPIPSGI L ++TDLRISDL NG E PF
Sbjct: 210 IGDNQFTGQIPNLIQNWTNLEKLVIQGSGLSGPIPSGIGLLGKMTDLRISDLSNGTETPF 269
Query: 181 PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMY 240
P LSN+KN+ LI R+ NI+GE+P+YLG M L+VLDLSFNKL+G IPS+FSG T
Sbjct: 270 PPLSNMKNLKTLICRTCNIVGELPQYLGGMTKLKVLDLSFNKLTGEIPSSFSGLANT--- 326
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVS 300
+IDLSYNN + S+C+ S+NLF SSS +N + VS
Sbjct: 327 -------------------DYIDLSYNNL---TFQSSCQQGSINLFGSSSM-ANVSATVS 363
Query: 301 CLKSFTCPTNHSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGHFID 360
CL+S+ CP N S HINCGGK+ I +G T +EDD+D+ GPS+F+ SRTNWAFS+TGHF+D
Sbjct: 364 CLRSYRCPKNFYSFHINCGGKEAIISGKT-YEDDIDSGGPSKFYQSRTNWAFSSTGHFLD 422
Query: 361 NSTRENSYIQINTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEILFTDD 420
+ + +SYI NT++L S LY +AR+SPISLTYYG+CM NGNYTV+LHFAEI+FT+D
Sbjct: 423 DDRQPDSYIWTNTTKLYAGTSALYMDARLSPISLTYYGFCMGNGNYTVSLHFAEIMFTND 482
Query: 421 KSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRLYWAGKG 480
+Y SLGRRIFD+YIQG+LV KDFNI EAGG GKAI+K F+A V N T+EIR YW GKG
Sbjct: 483 STYSSLGRRIFDIYIQGELVKKDFNIAEEAGGAGKAIIKSFAAIVINHTLEIRFYWNGKG 542
Query: 481 TTDIPYKGVYGPLISAISLYTPDIASPLVNGSSNSTNVGMVVGIVAAAAFILILIVSILW 540
TT IP +GVYGPLISAIS+ T D P N + ++G V+GIVA A ++ I+ +LW
Sbjct: 543 TTGIPVRGVYGPLISAISV-TSDFVPPSEN--NKRISIGTVIGIVATAIAVIFFILGVLW 599
Query: 541 WKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGK 600
WKGC RK L+Q+L+GL+L TGSFTL+QIKAATNNF PDNKIGEGGFG VYKGLL+DG
Sbjct: 600 WKGCLGRKDILDQDLRGLELQTGSFTLKQIKAATNNFDPDNKIGEGGFGSVYKGLLSDGT 659
Query: 601 VIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLAR 660
IAVKQLSSKSKQGNREF+ EIGMISALQHP+LVKLYGCCI+GNQL L+YEYMENNSLAR
Sbjct: 660 AIAVKQLSSKSKQGNREFITEIGMISALQHPHLVKLYGCCIDGNQLFLLYEYMENNSLAR 719
Query: 661 ALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 720
ALFGPEE +L LDWPTRH IC+G+ARGLA+LHEESRLKIVHRDIKATNVLLDK+L+PKIS
Sbjct: 720 ALFGPEECQLNLDWPTRHKICVGIARGLAFLHEESRLKIVHRDIKATNVLLDKNLDPKIS 779
Query: 721 DFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVI 780
DFGLAKLDEE+NTHISTR+AGTFGYMAPEYAMRG+LTDKADVYSFGIVALEIVSGRSN
Sbjct: 780 DFGLAKLDEEENTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNTS 839
Query: 781 CRT--KEAQFCLLDWV 794
R KE F LLDW
Sbjct: 840 LRQNMKEDCFYLLDWA 855
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357492929|ref|XP_003616753.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355518088|gb|AES99711.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1040 bits (2690), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/795 (65%), Positives = 620/795 (77%), Gaps = 12/795 (1%)
Query: 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLW-KQANGAIPK 61
+LK QNLPG LP EL RLP+LQEIDL+RNYLNGTIP EW S+ LVN+ L + G IP
Sbjct: 92 LLKQQNLPGTLPKELVRLPYLQEIDLSRNYLNGTIPDEWGSMNLVNISLIGNRLTGKIPI 151
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
A+ +ISTL L LE NQFSG+LP E GNL ++++ ++SNNFTG+LP + A LT L+ R
Sbjct: 152 AITNISTLQSLVLESNQFSGNLPPEFGNLTQIQRVLISSNNFTGELPATLAKLTTLQDIR 211
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPE-GPF 180
I DN F+G+IPD+IQ+WT L KL IEGSGL+GPIPSGI+ L +LTDLRISDL+G E PF
Sbjct: 212 IQDNQFSGKIPDFIQSWTSLTKLIIEGSGLSGPIPSGISKLEKLTDLRISDLSGSEFSPF 271
Query: 181 PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYM 239
P+L +LK + LILR+ NI G +PEYLG M L+ LDLSFNKLSG IPSN+ + Y+
Sbjct: 272 PQLKDLK-LKTLILRNCNINGTLPEYLGTMTTLKNLDLSFNKLSGPIPSNYDPLRKVDYI 330
Query: 240 YLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIV 299
YLTGNLLTGPVP W + N +D+SYNNF C++ +VN F SSS N +G+V
Sbjct: 331 YLTGNLLTGPVPAWTQKADN--LDISYNNFTISQGSQPCQDGNVNYF-SSSLTRNESGVV 387
Query: 300 SCLKSFTCPTNHSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGHFI 359
SCLKSF CP +L INCGGK V NGST ++DD D A P+RF S TNW FSTTG+F+
Sbjct: 388 SCLKSFVCPKTSYALRINCGGKSVTVNGST-YDDDSDTAAPARFHQSGTNWGFSTTGNFM 446
Query: 360 DNSTRENSYIQINTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEILFTD 419
DN + Y N S+L + +++LYT AR+SP SLTYYG+CM NGNYTVNL FAEI+FT+
Sbjct: 447 DNDGGD-YYTWSNRSKLSIANAELYTNARVSPTSLTYYGFCMANGNYTVNLQFAEIMFTN 505
Query: 420 DKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRLYWAGK 479
D+++ SLGRR+FD+YIQGKLV KDF+I EAGGV K + KPF+A VT+ T+EIRLYWAGK
Sbjct: 506 DQTFNSLGRRVFDIYIQGKLVKKDFDIAKEAGGVDKEVTKPFTAVVTDSTLEIRLYWAGK 565
Query: 480 GTTDIPYKGVYGPLISAISLYTPDIASPLVNGSSNSTNVGMVVGIVAAAAFILILIVSIL 539
GTT IP++ VYGPLISAIS+ + D +P NGSS S + + IL+ IL
Sbjct: 566 GTTGIPFRSVYGPLISAISVQS-DFPAPSENGSSISIGAVVGIVAAVVIVIILLF--GIL 622
Query: 540 WWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADG 599
WWKGCF +K +LE E+KGL+L F +RQIK ATNNF NKIGEGGFGPVYKG L+DG
Sbjct: 623 WWKGCFGKKSSLENEVKGLNLQMSLFNVRQIKGATNNFDISNKIGEGGFGPVYKGRLSDG 682
Query: 600 KVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLA 659
+IAVK LSSKSKQGNREF+NEIGMISALQHP+LVKLYGCC+EG+QL+LIYEY+ENNSLA
Sbjct: 683 TLIAVKLLSSKSKQGNREFLNEIGMISALQHPHLVKLYGCCVEGDQLMLIYEYLENNSLA 742
Query: 660 RALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 719
RALFGP EH+++LDWPTR+ IC+G+ARGLAYLHEESRLK+VHRDIKATNVLLDKDLNPKI
Sbjct: 743 RALFGPAEHQIRLDWPTRYKICVGIARGLAYLHEESRLKVVHRDIKATNVLLDKDLNPKI 802
Query: 720 SDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNV 779
SDFGLAKLDEE+NTHISTRIAGT+GYMAPEYAM GYLTDKADVYSFGIVALEI+ G +N
Sbjct: 803 SDFGLAKLDEEENTHISTRIAGTYGYMAPEYAMHGYLTDKADVYSFGIVALEILHGSNNT 862
Query: 780 ICRTKEAQFCLLDWV 794
I R KE F LLDW
Sbjct: 863 ILRQKEEAFHLLDWA 877
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542343|ref|XP_003539626.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1019 bits (2636), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/797 (63%), Positives = 618/797 (77%), Gaps = 11/797 (1%)
Query: 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLP-LWKQANGAIPK 61
+LKSQNL G LP EL RLP+LQEIDL+RNYLNGTIPS+W S+ LVN+ L + G+IPK
Sbjct: 198 VLKSQNLSGTLPTELVRLPYLQEIDLSRNYLNGTIPSQWGSMNLVNISILGNRLTGSIPK 257
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+ +I+TL L LEFNQ SG LP ELGNL LE+L L SN FTG LP +F+ LTRLK R
Sbjct: 258 ELGNITTLKSLVLEFNQLSGVLPPELGNLPRLERLLLTSNYFTGNLPATFSRLTRLKQLR 317
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181
+ DN F+G +P+++Q+WT LE+L ++GSG +GPIPSGI+ L LTDLRISDL GP+ FP
Sbjct: 318 LGDNQFSGTLPNFMQSWTSLERLVMQGSGFSGPIPSGISFLNNLTDLRISDLKGPDSLFP 377
Query: 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMY 240
+L NL ++ L+LRS N++G PEYLG + LR LDLSFNKL+G IP G + + +Y
Sbjct: 378 QLKNLTSLQTLVLRSCNLVGMAPEYLGNVTTLRSLDLSFNKLTGSIPRTLGGLNDINLLY 437
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNF-IDGSSDSNCENQSVNLFASSSEGSNSTGIV 299
LTGNL TGP+P+WI R + DLSYNN I+ C+ SVNLFASS +G N G++
Sbjct: 438 LTGNLFTGPLPNWI--DRPDYTDLSYNNLTIENPEQLTCQQGSVNLFASSLKGKN-LGMI 494
Query: 300 SCLKSFTCPTNHSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGHFI 359
CL + CP SLHINCGGK +I+NG+ ++DD AGP+RF + +NW FS TGHF
Sbjct: 495 PCLGNSNCPKTWYSLHINCGGK-LISNGNMKYDDDSLEAGPARFRRTGSNWVFSNTGHFF 553
Query: 360 DNSTRENSYIQINTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEILFTD 419
D S+R + Y NT++L MD+ +LY +AR+S +SLTYY +CM NG+YTV+LHFAEI+FTD
Sbjct: 554 D-SSRLDYYTWSNTTKLAMDNGELYMDARVSALSLTYYAFCMGNGSYTVSLHFAEIMFTD 612
Query: 420 DKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRLYWAGK 479
D++Y SLGRR+FD+YIQ KLV+KDFNI EAGGVGKAI+K F+ V T+EIRL WAGK
Sbjct: 613 DQTYSSLGRRVFDIYIQRKLVVKDFNIAKEAGGVGKAIIKKFNVTVNISTLEIRLQWAGK 672
Query: 480 GTTDIPYKGVYGPLISAISLYTPDIASPLVNGSSNSTNVGMVVGIVAAAAFILILIVSIL 539
GTT IP+ V+GPLISAIS+ PD N + T V +V IV A ++I+I I
Sbjct: 673 GTTGIPFGSVHGPLISAISV-DPDFTPREEN--RDGTPVQFIVAIVVTGALVIIIIFGIA 729
Query: 540 WWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADG 599
WWKGC RK +LE+EL+G+DL TG F+LRQ+KAATNNF KIGEGGFGPVYKG+L+DG
Sbjct: 730 WWKGCLGRKGSLERELRGVDLQTGLFSLRQMKAATNNFDIAFKIGEGGFGPVYKGVLSDG 789
Query: 600 KVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLA 659
KVIAVKQLSSKSKQGNREF+NE+GMISALQHP LVKLYGCC+EG+QL+LIYEYMENNSLA
Sbjct: 790 KVIAVKQLSSKSKQGNREFINEVGMISALQHPCLVKLYGCCMEGDQLMLIYEYMENNSLA 849
Query: 660 RALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 719
RALF E+ +LKLDW TR IC+G+A+GLAYLH ESRLKIVHRDIKATNVLLDK+LNPKI
Sbjct: 850 RALFAQEKCQLKLDWSTRQRICVGIAKGLAYLHGESRLKIVHRDIKATNVLLDKNLNPKI 909
Query: 720 SDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNV 779
SDFGLAKLDEE THI+TRIAGT+GYMAPEYAM GYLTDKADVYSFGIVALEI+SG+SN
Sbjct: 910 SDFGLAKLDEEGYTHITTRIAGTYGYMAPEYAMHGYLTDKADVYSFGIVALEIISGKSNS 969
Query: 780 ICRTKEAQFCLLDWVTL 796
+ TKE F L+DWV L
Sbjct: 970 MNWTKEGCFSLVDWVHL 986
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 809 | ||||||
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.965 | 0.754 | 0.542 | 1.7e-217 | |
| TAIR|locus:2203847 | 1021 | RKF1 "receptor-like kinase in | 0.962 | 0.762 | 0.518 | 7.7e-206 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.608 | 0.507 | 0.432 | 7.7e-196 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.957 | 0.718 | 0.487 | 3.1e-193 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.935 | 0.794 | 0.492 | 6.8e-182 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.959 | 0.751 | 0.427 | 3.4e-164 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.951 | 0.735 | 0.389 | 2e-134 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.260 | 0.163 | 0.490 | 8e-80 | |
| TAIR|locus:2005507 | 976 | ER "ERECTA" [Arabidopsis thali | 0.273 | 0.226 | 0.418 | 4.6e-79 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.259 | 0.176 | 0.5 | 1.3e-76 |
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2101 (744.6 bits), Expect = 1.7e-217, P = 1.7e-217
Identities = 433/798 (54%), Positives = 551/798 (69%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLW-KQANGAIPKA 62
L+ NL G +PPE L L EIDL N+L+GTIP+ + +PL L + + +G P
Sbjct: 95 LRGFNLRGIIPPEFGNLTRLTEIDLVLNFLSGTIPTTLSQIPLEILAVTGNRLSGPFPPQ 154
Query: 63 VASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRI 122
+ I+TL D+ +E N F+G LP LGNL +L++L ++SNN TG++PES +NL L +FRI
Sbjct: 155 LGQITTLTDVIMESNLFTGQLPPNLGNLRSLKRLLISSNNITGRIPESLSNLKNLTNFRI 214
Query: 123 SDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPR 182
N +G+IPD+I NWT+L +L ++G+ + GPIP+ I++L LT+LRI+DL GP PFP
Sbjct: 215 DGNSLSGKIPDFIGNWTRLVRLDLQGTSMEGPIPASISNLKNLTELRITDLRGPTSPFPD 274
Query: 183 LSNLKNMNYLILRSGNIIGEMPEYLG-QMIGLRVLDLSFNKLSGVIPSNF-SGSGLTYMY 240
L N+ NM L+LR+ I +PEY+G M L++LDLS N L+G IP F S + +MY
Sbjct: 275 LQNMTNMERLVLRNCLIREPIPEYIGTSMTMLKLLDLSSNMLNGTIPDTFRSLNAFNFMY 334
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVS 300
L N LTGPVP +I+ + ++IDLSYNNF + S C VNL +S +N++ +
Sbjct: 335 LNNNSLTGPVPQFILDSK-QNIDLSYNNFTQPPTLS-CNQLDVNLISSYPSVTNNS-VQW 391
Query: 301 CL-KSFTCP--TNHSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGH 357
CL K CP +HSSL INCGG ++ + + DDL+ G S F W +S++G
Sbjct: 392 CLRKDLPCPGDAHHSSLFINCGGNRLKVD-KDEYADDLNKRGASTFSSVSERWGYSSSGA 450
Query: 358 FIDNSTRENSYIQINTSRLLMDDS-QLYTEARISPISLTYYGYCMVNGNYTVNLHFAEIL 416
++ N +Y+ +T L+ + + + Y AR++ SL YYG CM G+Y V L+FAEI+
Sbjct: 451 WLGNDGA--TYLATDTFNLINESTPEYYKTARLASQSLKYYGLCMRRGSYKVQLYFAEIM 508
Query: 417 FTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNG-TMEIRLY 475
F++D++Y SLGRR+FD+Y+QG L+ +DFNI AGGVGK ++ NG T+EI L
Sbjct: 509 FSNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKPFLRQVDEVQVNGSTLEIHLK 568
Query: 476 WAGKGTTDIPYKGVYGPLISAISLYTPDIASPLVNGSSNSTNVGMXXXXXXXXXXXXXXX 535
W GKGT IP +GVYGPLISAI++ TP+ SN G+
Sbjct: 569 WTGKGTNVIPTRGVYGPLISAITV-TPNFKVDTGKPLSNGVVAGIVIAACVAFGLLVLVI 627
Query: 536 XXXXWWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGL 595
+ G ++ +EL+GLDL TGSFTL+QIK ATNNF P+NKIGEGGFGPVYKG+
Sbjct: 628 LRLTGYLG--GKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGV 685
Query: 596 LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMEN 655
LADG IAVKQLSSKSKQGNREFV EIGMISALQHPNLVKLYGCCIEG +LLL+YEY+EN
Sbjct: 686 LADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLEN 745
Query: 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL 715
NSLARALFG E+ RL LDW TR+ +CIG+A+GLAYLHEESRLKIVHRDIKATNVLLD L
Sbjct: 746 NSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSL 805
Query: 716 NPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 775
N KISDFGLAKLDEE+NTHISTRIAGT GYMAPEYAMRGYLTDKADVYSFG+V LEIVSG
Sbjct: 806 NAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSG 865
Query: 776 RSNVICRTKEAQFCLLDW 793
+SN R KE LLDW
Sbjct: 866 KSNTNYRPKEEFIYLLDW 883
|
|
| TAIR|locus:2203847 RKF1 "receptor-like kinase in flowers 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1991 (705.9 bits), Expect = 7.7e-206, P = 7.7e-206
Identities = 415/800 (51%), Positives = 535/800 (66%)
Query: 5 KSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWAS--LPLVNLPLWKQANGAIPKA 62
K NLPG LP ++ +LP+L+EIDL NY+NGT+P EWAS L ++L L + +G IPK
Sbjct: 108 KDHNLPGTLP-QIVKLPYLREIDLAYNYINGTLPREWASSNLTFISL-LVNRLSGEIPKE 165
Query: 63 VASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRI 122
+ S+L L LE N FSG +P ELGNL++L+KL L+SN TG LP S A L + FRI
Sbjct: 166 FGN-SSLTYLDLESNAFSGTIPQELGNLVHLKKLLLSSNKLTGTLPASLARLQNMTDFRI 224
Query: 123 SDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPR 182
+D +G IP YIQNW +LE+L + SGL GPIPS I+ L L +LRISD+ GP PFP
Sbjct: 225 NDLQLSGTIPSYIQNWKQLERLEMIASGLTGPIPSVISVLSNLVNLRISDIRGPVQPFPS 284
Query: 183 LSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLT 242
L N+ + +IL++ NI G++P YL + L LDLSFNKL G IPS L ++ L
Sbjct: 285 LKNVTGLTKIILKNCNISGQIPTYLSHLKELETLDLSFNKLVGGIPSFAQAENLRFIILA 344
Query: 243 GNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSN-CE---NQSVNLFASSSEGSNSTGI 298
GN+L G PD ++R +DLSYNN S +S C N ++NLF S+S S+
Sbjct: 345 GNMLEGDAPDELLRD-GITVDLSYNNLKWQSPESRACRPNMNLNLNLFQSTST-KKSSKF 402
Query: 299 VSCLKSFTCPTNHSSLHINCGGKQVIANGSTT---FEDDLDA-AGPSRFFISR-TNWAFS 353
+ C+K F CP S LH+NCGG + T +E D + G +++F+ NW FS
Sbjct: 403 LPCIKDFKCPRYSSCLHVNCGGSDMYVKEKKTKELYEGDGNVEGGAAKYFLKPDANWGFS 462
Query: 354 TTGHFIDNSTRENSYIQINTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFA 413
+TG F+D++ +N+ + + S LY ARI+P+SLTY+ C+ NGNYT+NL FA
Sbjct: 463 STGDFMDDNNFQNTRFTMFVPA--SNQSDLYKSARIAPVSLTYFHACLENGNYTINLDFA 520
Query: 414 EILFTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIR 473
EI FT+D++Y LGRR+FD+YIQ KLV KDFNI +EA G I+KP +A VTN + IR
Sbjct: 521 EIRFTNDENYNRLGRRLFDIYIQEKLVAKDFNIMDEAKGAQTPIIKPLTAYVTNHFLTIR 580
Query: 474 LYWAGKGTTDIPYKGVYGPLISAISLYTPDIASPLVNGSSNSTNVGMXXXXXXXXXXXXX 533
L WAGKGTT IP +GVYGP+ISAIS+ + + P + + G
Sbjct: 581 LSWAGKGTTRIPTRGVYGPIISAISIVSD--SKPCERPKTGMSP-GAYIAIGIGAPCLII 637
Query: 534 XXXXXXWWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYK 593
W GC R ++ +L +G+FTLRQIK AT++F P NKIGEGGFG V+K
Sbjct: 638 FILGFLWICGCLPRCGRQRKDPYEEELPSGTFTLRQIKFATDDFNPTNKIGEGGFGAVFK 697
Query: 594 GLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653
G+LADG+V+AVKQLSSKS+QGNREF+NEIG IS LQHPNLVKL+G C+E QLLL YEYM
Sbjct: 698 GVLADGRVVAVKQLSSKSRQGNREFLNEIGAISCLQHPNLVKLHGFCVERAQLLLAYEYM 757
Query: 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK 713
ENNSL+ ALF P+ ++ +DWPTR IC G+A+GLA+LHEES LK VHRDIKATN+LLDK
Sbjct: 758 ENNSLSSALFSPKHKQIPMDWPTRFKICCGIAKGLAFLHEESPLKFVHRDIKATNILLDK 817
Query: 714 DLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 773
DL PKISDFGLA+LDEE+ THIST++AGT GYMAPEYA+ GYLT KADVYSFG++ LEIV
Sbjct: 818 DLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAPEYALWGYLTFKADVYSFGVLVLEIV 877
Query: 774 SGRSNVICRTKEAQFCLLDW 793
+G +N CLL++
Sbjct: 878 AGITNSNFMGAGDSVCLLEF 897
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1019 (363.8 bits), Expect = 7.7e-196, Sum P(2) = 7.7e-196
Identities = 219/506 (43%), Positives = 306/506 (60%)
Query: 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLW-KQANGA 58
H +L+ NLPGRLPP L + L+ IDL NYL G+IP EWASLP L ++ + + +G
Sbjct: 102 HFVLQKFNLPGRLPPMLYKFRHLESIDLYNNYLYGSIPMEWASLPYLKSISVCANRLSGD 161
Query: 59 IPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLK 118
IPK + L L LE NQFSG +P ELGNL+NL+ L L+SN G LP++ A LT+L
Sbjct: 162 IPKGLGKFINLTLLVLEANQFSGTIPKELGNLVNLQGLGLSSNQLVGGLPKTLAKLTKLT 221
Query: 119 HFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEG 178
+ +SDN G IP++I KL++L + SGL GPIP I L L D+RISD G
Sbjct: 222 NLHLSDNRLNGSIPEFIGKLPKLQRLELYASGLRGPIPDSIFHLENLIDVRISDTVAGLG 281
Query: 179 PFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTY 238
P++++ ++ YL+LR+ N+ G +P + + L LDLSFN+L+G IP+ + Y
Sbjct: 282 HVPQITST-SLKYLVLRNINLSGPIPTSIWDLPSLMTLDLSFNRLTGEIPAYATAP--KY 338
Query: 239 MYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNC-ENQSVNLFASSSEGSNSTG 297
YL GN+L+G V + +IDLSYNNF + C E +++N + SS + T
Sbjct: 339 TYLAGNMLSGKVETGAFLTASTNIDLSYNNF---TWSPMCKERKNINTYESSHSKNRLTR 395
Query: 298 IVSCLKSFTCPTNHSSLHINCGGKQV-IAN--GSTTFE-DDLDAAGPSRFFISRTNWAFS 353
++ C C SLHINCGG V I N G +E D+ G + + R NW +S
Sbjct: 396 LLPCSAIKQCQNYSRSLHINCGGPDVTIENSRGRFLYEGDNYGLTGSATNYY-RKNWGYS 454
Query: 354 TTGHFIDNSTRENSYIQINTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFA 413
TG F+D++ E++Y + S + LY AR SP+SL YY +C NG+Y V LHFA
Sbjct: 455 NTGDFMDDAITEDTYTVSSESAVSAKYPDLYQNARRSPLSLAYYAFCFENGSYNVKLHFA 514
Query: 414 EILFTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIR 473
EI F+D + Y L +R+F++YIQGKL+ +DF+I EA G K +++ + VT+ T+EIR
Sbjct: 515 EIQFSDVEPYTKLAKRVFNIYIQGKLIWEDFSIREEANGTHKEVIREVNTTVTDNTLEIR 574
Query: 474 LYWAGKGTTDIPYKGVYGPLISAISL 499
LYWAGKGT IP +G YG LISA+S+
Sbjct: 575 LYWAGKGTMIIPQRGYYGSLISAVSV 600
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1872 (664.0 bits), Expect = 3.1e-193, P = 3.1e-193
Identities = 394/809 (48%), Positives = 522/809 (64%)
Query: 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLW-KQANGA 58
H +LK+ +LPGRLPPE ++L +L+ IDL RNYL G+IP EWASLP L ++ + + G
Sbjct: 102 HFVLKTFSLPGRLPPEFSKLRYLEFIDLCRNYLYGSIPMEWASLPYLKSISVCANRLTGD 161
Query: 59 IPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLK 118
IPK + L L LE NQFSG +P ELGNL+NLE L +SN G +P++ A L +L
Sbjct: 162 IPKGLGKFINLTQLGLEANQFSGTIPKELGNLVNLEGLAFSSNQLVGGVPKTLARLKKLT 221
Query: 119 HFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEG 178
+ R SDN G IP++I N +KL++L + SGL PIP I L L DLRISD G
Sbjct: 222 NLRFSDNRLNGSIPEFIGNLSKLQRLELYASGLKDPIPYSIFRLENLIDLRISDTAAGLG 281
Query: 179 PFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTY 238
P +++ K++ +L+LR+ N+ G +P L + L LDLSFN+L+G +P++ S Y
Sbjct: 282 QVPLITS-KSLKFLVLRNMNLTGPIPTSLWDLPNLMTLDLSFNRLTGEVPADASAP--KY 338
Query: 239 MYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGI 298
YL GN+L+G V + +IDLSYNNF S S E ++N +ASS ++ T +
Sbjct: 339 TYLAGNMLSGKVESGPFLTASTNIDLSYNNFT--WSQSCKERNNINTYASSRSTNSLTRL 396
Query: 299 VSCLKSFTCPTNHSSLHINCGGKQV-IAN--GSTTFE-DDLDAAGPSRFFISRTNWAFST 354
+ C C + SLHINCGG V I N G +E D+ G + + + NW FS
Sbjct: 397 LPCSAINLCQNYNRSLHINCGGPDVTIENSRGRFLYEGDNYGLTGSATNYYGK-NWGFSN 455
Query: 355 TGHFIDNSTRENSYIQINTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAE 414
TG F+D++ E++Y + S + LY AR SP+SL Y+ C NG+Y V LHFAE
Sbjct: 456 TGDFMDDAITEDTYTVSSESAVSAKYPDLYQNARRSPLSLAYFAICFENGSYNVKLHFAE 515
Query: 415 ILFTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRL 474
I F+D++ + L +R+F++Y+QGKL+ +DF+I EA G K ++K + VT+ T+EIRL
Sbjct: 516 IQFSDEEPFSRLAKRVFNIYVQGKLIWEDFSIREEANGTHKEVIKEVNTTVTDNTLEIRL 575
Query: 475 YWAGKGTTDIPYKGVYGPLISAISLY--------TPDIASPLVNGSSNSTNVGMXXXXXX 526
YWAGKGTT IP +G YG LISAIS+ P P+ +
Sbjct: 576 YWAGKGTTIIPKRGNYGSLISAISVCPSSESECGVPVQIHPVTKQQHKQRKYHLILGIAA 635
Query: 527 XXXXXXXXXXXXXWWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEG 586
+W+ C + E +G SF+LRQ+K AT++F P NKIGEG
Sbjct: 636 LIVSLSFLILGALYWRICVSNA---DGEKRG------SFSLRQLKVATDDFNPLNKIGEG 686
Query: 587 GFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQL 646
GFG VYKG L +G +IAVK+LSSKS QGN+EF+NEIG+I+ LQHPNLVKLYGCC+E QL
Sbjct: 687 GFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGIIACLQHPNLVKLYGCCVEKTQL 746
Query: 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKA 706
LL+YEY+ENN LA ALFG LKLDW TRH IC+G+ARGLA+LHE+S +KI+HRDIK
Sbjct: 747 LLVYEYLENNCLADALFG--RSGLKLDWRTRHKICLGIARGLAFLHEDSAVKIIHRDIKG 804
Query: 707 TNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFG 766
TN+LLDKDLN KISDFGLA+L E+D +HI+TR+AGT GYMAPEYAMRG+LT+KADVYSFG
Sbjct: 805 TNILLDKDLNSKISDFGLARLHEDDQSHITTRVAGTIGYMAPEYAMRGHLTEKADVYSFG 864
Query: 767 IVALEIVSGRSNVICRTKEAQFC--LLDW 793
+VA+EIVSG+SN T + + C LLDW
Sbjct: 865 VVAMEIVSGKSNANY-TPDNECCVGLLDW 892
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1765 (626.4 bits), Expect = 6.8e-182, P = 6.8e-182
Identities = 386/784 (49%), Positives = 499/784 (63%)
Query: 27 DLTRNYLNGTIPSEWASLPLVN-LPLWKQ-ANGAIPKAVASISTLADLTLEFNQFSGDLP 84
+L R L G++P E LPL+ + L + NG+IP + L ++ L N+ +G +P
Sbjct: 69 NLKRENLQGSLPKELVGLPLLQEIDLSRNYLNGSIPPEWG-VLPLVNIWLLGNRLTGPIP 127
Query: 85 AELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKL 144
E GN+ L L L +N +G+LP NL ++ +S N+F G+IP T L
Sbjct: 128 KEFGNITTLTSLVLEANQLSGELPLELGNLPNIQQMILSSNNFNGEIPSTFAKLTTLRDF 187
Query: 145 FIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP-RLSNLKNMNYLILRSGNIIG-E 202
+ + L+G IP I +L L I +G GP P +++L + L R ++ G E
Sbjct: 188 RVSDNQLSGTIPDFIQKWTKLERLFIQ-ASGLVGPIPIAIASLVELKDL--RISDLNGPE 244
Query: 203 MP-EYLGQMIGLRVLDLSFNKLSGVIPSNFSG--SGLTYMYLTGNLLTGPVPDWIVRKRN 259
P L + + L L L+G +P ++ G + ++ L+ N L+G +P+ + R+
Sbjct: 245 SPFPQLRNIKKMETLILRNCNLTGDLP-DYLGKITSFKFLDLSFNKLSGAIPNTYINLRD 303
Query: 260 KHIDLSYNNFIDGSSDSNCENQSVNLFAS----SSEGSNST----GIVSCLKSFTCPTNH 311
N ++GS N+ + S S + +N+ ++SC++++ CP
Sbjct: 304 GGYIYFTGNMLNGSVPDWMVNKGYKIDLSYNNFSVDPTNAVCKYNNVLSCMRNYQCPKTF 363
Query: 312 SSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGHFIDNS-TRENSYIQ 370
++LHINCGG ++ NG+ D D ++ SR W + G F+D+ E I+
Sbjct: 364 NALHINCGGDEMSINGTIYESDKYDRL--ESWYESRNGWFSNNVGVFVDDKHVPERVTIE 421
Query: 371 INTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEILFTDDKSYCSLGRRI 430
N+S L + D LYT+ARIS ISLTYY C+ NGNY VNLHFAEI+F + +Y SLGRR
Sbjct: 422 SNSSELNVVDFGLYTQARISAISLTYYALCLENGNYNVNLHFAEIMFNGNNNYQSLGRRF 481
Query: 431 FDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRLYWAGKGTTDIPYKGVY 490
FD+YIQ KL +KDFNI EA VG ++K F + +G +EIRLYWAG+GTT IP + VY
Sbjct: 482 FDIYIQRKLEVKDFNIAKEAKDVGNVVIKTFPVEIKDGKLEIRLYWAGRGTTVIPKERVY 541
Query: 491 GPLISAISLYTPDIASPLVNGSSNSTNVGMXXXXXXXXXXXXXXXXXXXWWKGCFKRKHT 550
GPLISAIS+ + SP NG S T + W KG + K
Sbjct: 542 GPLISAISVDSSVNPSPR-NGMSTGT---LHTLVVILSIFIVFLVFGTLWKKGYLRSKSQ 597
Query: 551 LEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSK 610
+E++ K L+L SF+LRQIK ATNNF N+IGEGGFGPVYKG L DG +IAVKQLS+
Sbjct: 598 MEKDFKSLELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTG 657
Query: 611 SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRL 670
SKQGNREF+NEIGMISAL HPNLVKLYGCC+EG QLLL+YE++ENNSLARALFGP+E +L
Sbjct: 658 SKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQL 717
Query: 671 KLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730
+LDWPTR ICIG+ARGLAYLHEESRLKIVHRDIKATNVLLDK LNPKISDFGLAKLDEE
Sbjct: 718 RLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEE 777
Query: 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCL 790
D+THISTRIAGTFGYMAPEYAMRG+LTDKADVYSFGIVALEIV GRSN I R+K F L
Sbjct: 778 DSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYL 837
Query: 791 LDWV 794
+DWV
Sbjct: 838 IDWV 841
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1598 (567.6 bits), Expect = 3.4e-164, P = 3.4e-164
Identities = 343/803 (42%), Positives = 504/803 (62%)
Query: 11 GRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLW--KQANGAIPKAVASIST 68
G +PPEL L +L ++L +N L G++P +L + + +G +PK + ++
Sbjct: 113 GPIPPELWTLTYLTNLNLGQNVLTGSLPPAIGNLTRMQWMTFGINALSGPVPKEIGLLTD 172
Query: 69 LADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFT 128
L L + N FSG +P E+G L++++++S+ +G++P SFANL +L+ I+D T
Sbjct: 173 LRLLGISSNNFSGSIPDEIGRCTKLQQMYIDSSGLSGRIPLSFANLVQLEQAWIADLEVT 232
Query: 129 GQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKN 188
QIPD+I +WTKL L I G+GL+GPIPS ++L LT+LR+ D++ + ++K+
Sbjct: 233 DQIPDFIGDWTKLTTLRIIGTGLSGPIPSSFSNLTSLTELRLGDISSGSSSLDFIKDMKS 292
Query: 189 MNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSN-FSGSGLTYMYLTGNLLT 247
++ L+LR+ N+ G +P +G+ LR +DLSFNKL G IP++ F+ S LT+++L N L
Sbjct: 293 LSVLVLRNNNLTGTIPSTIGEHSSLRQVDLSFNKLHGPIPASLFNLSQLTHLFLGNNTLN 352
Query: 248 GPVPDWIVRKRNKHIDLSYNNFIDGSSDS--NCENQSVNLFASSS--EGSNSTGI--VSC 301
G P + +++D+SYN+ + GS S + + +NL A++ EG ++ + ++C
Sbjct: 353 GSFPTQKTQSL-RNVDVSYND-LSGSLPSWVSLPSLKLNLVANNFTLEGLDNRVLPGLNC 410
Query: 302 L-KSFTCPTN---HSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISR-TNWAFSTTG 356
L K+F C +S INCGG + + FE + + GP+ FF+S WA S+ G
Sbjct: 411 LQKNFPCNRGKGIYSDFSINCGGPEKRSVTGALFEREDEDFGPASFFVSAGQRWAASSVG 470
Query: 357 HFIDNSTRENSYIQINTSRLLMD-DSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEI 415
F +S N YI + S+ + DS+L+ AR+S S+ YYG + NG YTV L FAEI
Sbjct: 471 LFAGSSN--NIYIATSQSQFVNTLDSELFQSARLSASSVRYYGLGLENGGYTVTLQFAEI 528
Query: 416 --LFTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAG-GVGKAIVKPFSAAVTNGTMEI 472
L + ++ LGRR FD+Y+QG+LV KDF++ AG +A+ + + A V+ +E+
Sbjct: 529 QILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQRVYKANVSENHLEV 588
Query: 473 RLYWAGKGTTDIPYKGVYGPLISAISLYTPDIASPLVNG--SSNSTNVGMXXXXXXXXXX 530
L+WAGKGT IP +G YGPLISA+S TPD + N S G
Sbjct: 589 HLFWAGKGTCCIPIQGAYGPLISAVSA-TPDFTPTVANKPPSKGKNRTGTIVGVIVGVGL 647
Query: 531 XXXXXXXXXWWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGP 590
+ ++++T ++EL G+D+ FT ++K+AT +F P NK+GEGGFGP
Sbjct: 648 LSILAGVVMFTIRKRRKRYTDDEELLGMDVKPYIFTYSELKSATQDFDPSNKLGEGGFGP 707
Query: 591 VYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650
VYKG L DG+V+AVK LS S+QG +FV EI IS++ H NLVKLYGCC EG +L+Y
Sbjct: 708 VYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVY 767
Query: 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVL 710
EY+ N SL +ALFG + L LDW TR+ IC+G+ARGL YLHEE+ ++IVHRD+KA+N+L
Sbjct: 768 EYLPNGSLDQALFG--DKTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNIL 825
Query: 711 LDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVAL 770
LD L P+ISDFGLAKL ++ THISTR+AGT GY+APEYAMRG+LT+K DVY+FG+VAL
Sbjct: 826 LDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVAL 885
Query: 771 EIVSGRSNVICRTKEAQFCLLDW 793
E+VSGR N +E + LL+W
Sbjct: 886 ELVSGRPNSDENLEEEKKYLLEW 908
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1317 (468.7 bits), Expect = 2.0e-134, P = 2.0e-134
Identities = 314/806 (38%), Positives = 457/806 (56%)
Query: 9 LPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQA-NGAIPKAVASI 66
L G +P E+ L L+ + ++ N +G++P+E S L + + +G IP + A+
Sbjct: 134 LSGPIPKEIGLLTDLRLLGISSNNFSGSLPAEIGSCTKLQQMYIDSSGLSGGIPLSFANF 193
Query: 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126
L + + +G +P +G L L + +G +P SF+NL L R+ D
Sbjct: 194 VELEVAWIMDVELTGRIPDFIGFWTKLTTLRILGTGLSGPIPSSFSNLIALTELRLGDIS 253
Query: 127 FTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPR-LSN 185
D+I++ L L + + L G IPS I L + +S N GP P L N
Sbjct: 254 NGSSSLDFIKDMKSLSVLVLRNNNLTGTIPSTIGGYTSLQQVDLS-FNKLHGPIPASLFN 312
Query: 186 LKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNL 245
L + +L L + + G +P GQ L LD+S+N LSG +PS S L + N
Sbjct: 313 LSRLTHLFLGNNTLNGSLPTLKGQ--SLSNLDVSYNDLSGSLPSWVSLPDLKLNLVANNF 370
Query: 246 LTGPVPDWIVRKRNKHIDLSYN---NFIDGSSDSNCENQSVNLFA-----SSSEGSNSTG 297
+ + ++ H L N N +G N + S +F+ + +GSN
Sbjct: 371 TLEGLDNRVLS--GLHC-LQKNFPCNRGEGICKCNKKIPSQIMFSMLNVQTYGQGSNVLL 427
Query: 298 IVSCLKSFTCP-TNHSSLHINCGGKQVIANGSTTFE-DDLDAAGPSRFFISRTN-WAFST 354
+C K+F + INCGG ++ + FE +D D GP+ F +S WA S+
Sbjct: 428 EKNCFKTFAIDWCLDYNFSINCGGPEIRSVSGALFEKEDADL-GPASFVVSAAKRWAASS 486
Query: 355 TGHFIDNSTRENSYIQINTSRLLMD-DSQLYTEARISPISLTYYGYCMVNGNYTVNLHFA 413
G+F +S N YI + ++ + DS+L+ AR+S SL YYG + NG YTV L FA
Sbjct: 487 VGNFAGSSN--NIYIATSLAQFINTMDSELFQSARLSASSLRYYGLGLENGGYTVTLQFA 544
Query: 414 EILFTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVG-KAIVKPFSAAVTNGTMEI 472
E+ S+ +GRR F++Y+QG+LV KDF+I AGG +A+ + + V+ +E+
Sbjct: 545 EVQIEGSNSWKGIGRRRFNIYVQGRLVEKDFDIRRTAGGSSVRAVQREYKTNVSENHLEV 604
Query: 473 RLYWAGKGTTDIPYKGVYGPLISAISL---YTPDIAS-PLVNGSSNS-TNVGMXXXXXXX 527
L+WAGKGT IP +G YGPLI+A+S +TP +A+ P G S + T VG+
Sbjct: 605 HLFWAGKGTCCIPIQGAYGPLIAAVSATPDFTPTVANRPPSKGKSRTGTIVGVIVGVGLL 664
Query: 528 XXXXXXXXXXXXWWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGG 587
K ++ +T ++E+ +D+ +FT ++K AT +F NK+GEGG
Sbjct: 665 SIFAGVVILVIR--KR--RKPYTDDEEILSMDVKPYTFTYSELKNATQDFDLSNKLGEGG 720
Query: 588 FGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647
FG VYKG L DG+ +AVKQLS S+QG +FV EI IS++ H NLVKLYGCC EG+ L
Sbjct: 721 FGAVYKGNLNDGREVAVKQLSIGSRQGKGQFVAEIIAISSVLHRNLVKLYGCCFEGDHRL 780
Query: 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKAT 707
L+YEY+ N SL +ALFG + L LDW TR+ IC+G+ARGL YLHEE+ ++I+HRD+KA+
Sbjct: 781 LVYEYLPNGSLDQALFGDKS--LHLDWSTRYEICLGVARGLVYLHEEASVRIIHRDVKAS 838
Query: 708 NVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGI 767
N+LLD +L PK+SDFGLAKL ++ THISTR+AGT GY+APEYAMRG+LT+K DVY+FG+
Sbjct: 839 NILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGV 898
Query: 768 VALEIVSGRSNVICRTKEAQFCLLDW 793
VALE+VSGR N +E + LL+W
Sbjct: 899 VALELVSGRKNSDENLEEGKKYLLEW 924
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 522 (188.8 bits), Expect = 8.0e-80, Sum P(3) = 8.0e-80
Identities = 104/212 (49%), Positives = 142/212 (66%)
Query: 566 TLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSK-QGNREFVNEIGM 624
T I AT NF+ + IG+GGFG VYK L +G+ +A+K+L + QG+REF+ E+
Sbjct: 991 TADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQFQGDREFLAEMET 1050
Query: 625 ISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGL 684
I ++HPNLV L G C+ G++ LIYEYMEN SL L + L WP R IC+G
Sbjct: 1051 IGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEALGWPDRLKICLGS 1110
Query: 685 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG 744
ARGLA+LH I+HRD+K++N+LLD++ P++SDFGLA++ TH+ST IAGTFG
Sbjct: 1111 ARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACETHVSTDIAGTFG 1170
Query: 745 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
Y+ PEY + T K DVYSFG+V LE+++GR
Sbjct: 1171 YIPPEYGLTMKSTTKGDVYSFGVVMLELLTGR 1202
|
|
| TAIR|locus:2005507 ER "ERECTA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 447 (162.4 bits), Expect = 4.6e-79, Sum P(2) = 4.6e-79
Identities = 93/222 (41%), Positives = 135/222 (60%)
Query: 558 LDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNRE 617
L ++ I T N + IG G VYK +L + K +A+K+L S + Q ++
Sbjct: 629 LHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPVAIKRLYSHNPQSMKQ 688
Query: 618 FVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTR 677
F E+ M+S+++H NLV L + LL Y+Y+EN SL L GP + + LDW TR
Sbjct: 689 FETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWDLLHGPTKKKT-LDWDTR 747
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 737
I G A+GLAYLH + +I+HRD+K++N+LLDKDL +++DFG+AK +H ST
Sbjct: 748 LKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDFGIAKSLCVSKSHTST 807
Query: 738 RIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNV 779
+ GT GY+ PEYA LT+K+DVYS+GIV LE+++ R V
Sbjct: 808 YVMGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTRRKAV 849
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 518 (187.4 bits), Expect = 1.3e-76, Sum P(2) = 1.3e-76
Identities = 105/210 (50%), Positives = 134/210 (63%)
Query: 567 LRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMIS 626
L I AT++F+ N IG+GGFG VYK L K +AVK+LS QGNREF+ E+ +
Sbjct: 907 LGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLG 966
Query: 627 ALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLAR 686
++HPNLV L G C + LL+YEYM N SL L LDW R I +G AR
Sbjct: 967 KVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAAR 1026
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYM 746
GLA+LH I+HRDIKA+N+LLD D PK++DFGLA+L +H+ST IAGTFGY+
Sbjct: 1027 GLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYI 1086
Query: 747 APEYAMRGYLTDKADVYSFGIVALEIVSGR 776
PEY T K DVYSFG++ LE+V+G+
Sbjct: 1087 PPEYGQSARATTKGDVYSFGVILLELVTGK 1116
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| C0LGN2 | Y3148_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5902 | 0.9715 | 0.7705 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00027899001 | SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (1036 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 809 | |||
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 6e-58 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-38 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-36 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-36 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-35 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-32 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-32 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-29 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-27 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-26 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-25 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 2e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.003 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.003 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.003 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.004 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.004 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 6e-58
Identities = 88/188 (46%), Positives = 108/188 (57%), Gaps = 28/188 (14%)
Query: 313 SLHINCGGKQVIANGSTTFEDD-LDAAGPSRFFISRTNWAFSTTGHFIDNSTRENSYIQI 371
L INCGG + + T+E D G + +++S TN + S G
Sbjct: 2 VLAINCGGPEHTDSDGITYEADTYFTGGSADYYVSDTNGSSSIAG--------------- 46
Query: 372 NTSRLLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEILFTDDKSYCSLGRRIF 431
D +LY R SP S +YY C+ NGNYTV LHFAEI F +D LGRR+F
Sbjct: 47 ------TTDPELYQTERYSPSSFSYYIPCLENGNYTVILHFAEIYFGED----GLGRRVF 96
Query: 432 DVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAA-VTNGTMEIRLYWAGKGTTDIPYKGVY 490
DVY+QGKLVLKDF+I EAGG GK K + VT+GT+EI YWAGKGT IP++GVY
Sbjct: 97 DVYVQGKLVLKDFDIVAEAGGKGKTAHKEYIPVTVTDGTLEIHFYWAGKGTLLIPFRGVY 156
Query: 491 G-PLISAI 497
G P ISAI
Sbjct: 157 GNPKISAI 164
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 5e-52
Identities = 74/194 (38%), Positives = 106/194 (54%), Gaps = 11/194 (5%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLYGCC 640
+GEGGFG VY GK +A+K + + E + EI ++ L HPN+VKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 641 IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIV 700
+ N L L+ EY E SL L +E+ KL I + + GL YLH I+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 701 HRDIKATNVLLDKD-LNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE-YAMRGYLTD 758
HRD+K N+LLD D K++DFGL+KL + + I GT YMAPE +GY ++
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKL-LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 759 KADVYSFGIVALEI 772
K+D++S G++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 3e-50
Identities = 77/201 (38%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 580 DNKIGEGGFGPVYKGLL--ADGKV---IAVKQL-SSKSKQGNREFVNEIGMISALQHPNL 633
K+GEG FG VYKG L GK +AVK L S+Q EF+ E ++ L HPN+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
VKL G C E L ++ EYME L L ++R KL S + +ARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLE- 119
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR 753
+HRD+ A N L+ ++L KISDFGL++ +D+ + +MAPE
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 754 GYLTDKADVYSFGIVALEIVS 774
G T K+DV+SFG++ EI +
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 3e-49
Identities = 77/205 (37%), Positives = 106/205 (51%), Gaps = 14/205 (6%)
Query: 581 NKIGEGGFGPVYKGLL--ADGKVI--AVKQL-SSKSKQGNREFVNEIGMISALQHPNLVK 635
K+GEG FG VYKG L DGK AVK L S++ ++F+ E ++ L HPN+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 636 LYGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
L G C E L L+ EYME L P + L S I +A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT-FGYMAPE 749
L K VHRD+ A N L+ +DL KISDFGL++ +D+ + +MAPE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 750 YAMRGYLTDKADVYSFGIVALEIVS 774
G T K+DV+SFG++ EI +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 4e-49
Identities = 72/203 (35%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 580 DNKIGEGGFGPVYKGLLADGKV-----IAVKQL-SSKSKQGNREFVNEIGMISALQHPNL 633
K+GEG FG VYKG L +AVK L S+Q EF+ E ++ L HPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
VKL G C E L+++ EYM L L L S + +ARG+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELS--LSDLLSFALQIARGMEYLE- 120
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRIAGTFGYMAPEYA 751
+HRD+ A N L+ ++L KISDFGL++ D++ ++ +MAPE
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESL 176
Query: 752 MRGYLTDKADVYSFGIVALEIVS 774
G T K+DV+SFG++ EI +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 75/204 (36%), Positives = 107/204 (52%), Gaps = 19/204 (9%)
Query: 582 KIGEGGFGPVYKGLL------ADGKVIAVKQL-SSKSKQGNREFVNEIGMISALQHPNLV 634
K+GEG FG VYKG L + KV AVK L S++ EF+ E ++ L HPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKV-AVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
+L G C +G L ++ EYM L L +H KL + + +A+G+ YL
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLES- 120
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG---YMAPEYA 751
VHRD+ A N L+ ++L KISDFGL++ ED+ + G +MAPE
Sbjct: 121 --KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESL 176
Query: 752 MRGYLTDKADVYSFGIVALEIVSG 775
G T K+DV+SFG++ EI +
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 8e-47
Identities = 70/199 (35%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 582 KIGEGGFGPVYKG-LLADGKVIAVKQL--SSKSKQGNREFVNEIGMISALQHPNLVKLYG 638
K+G G FG VYK GK++AVK L S+ + ++ EI ++ L HPN+V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+ + L L+ EY E L L L I + + RGL YLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGG-PLSEDEAKKIALQILRGLEYLHSNG--- 118
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE-YAMRGYLT 757
I+HRD+K N+LLD++ KI+DFGLAK + ++ ++T GT YMAPE
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYG 177
Query: 758 DKADVYSFGIVALEIVSGR 776
K DV+S G++ E+++G+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 68/199 (34%), Positives = 105/199 (52%), Gaps = 11/199 (5%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLYG 638
K+GEG FG VY GK++A+K + K + +RE + EI ++ L+HPN+V+LY
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+ ++L L+ EY E L L + R +L + L YLH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLHS---KG 117
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
IVHRD+K N+LLD+D + K++DFGLA+ + D T GT YMAPE +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLAR--QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 759 KADVYSFGIVALEIVSGRS 777
D++S G++ E+++G+
Sbjct: 176 AVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 74/205 (36%), Positives = 108/205 (52%), Gaps = 19/205 (9%)
Query: 581 NKIGEGGFGPVYKGLLAD-GKVIAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKLY 637
+G G FG VY L D G+++AVK LS S++ EI ++S+LQHPN+V+ Y
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 638 GCCI--EGNQLLLIYEYMENNSLARAL--FGP-EEHRLKLDWPTRHSICIGLARGLAYLH 692
G E N L + EY+ SL+ L FG E ++ +++ I GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIR-----KYTRQI--LEGLAYLH 118
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAGTFGYMAPEYA 751
IVHRDIK N+L+D D K++DFG AK L + + + + GT +MAPE
Sbjct: 119 SN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 752 MRGYLTDKADVYSFGIVALEIVSGR 776
AD++S G +E+ +G+
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 71/196 (36%), Positives = 106/196 (54%), Gaps = 9/196 (4%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
KIG+GGFG VYK GK +A+K + +SK+ + +NEI ++ +HPN+VK YG
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 641 IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIV 700
++ ++L ++ E+ SL L + L +C L +GL YLH I+
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSN---GII 120
Query: 701 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKA 760
HRDIKA N+LL D K+ DFGL+ + +T + GT +MAPE KA
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 761 DVYSFGIVALEIVSGR 776
D++S GI A+E+ G+
Sbjct: 179 DIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 5e-39
Identities = 74/206 (35%), Positives = 113/206 (54%), Gaps = 25/206 (12%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLS--SKSKQGNREFVNEIGMISALQHPNLVKLY 637
+ IG G FG VYKGL L G +A+KQ+S ++ + + EI ++ L+HPN+VK
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 638 GCCIEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLA---RGLAYLH 692
G + L +I EY EN SL + + FGP L + + + +GLAYLH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL---------VAVYVYQVLQGLAYLH 116
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRIAGTFGYMAPE-Y 750
E+ ++HRDIKA N+L KD K++DFG+A KL++ + GT +MAPE
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVI 171
Query: 751 AMRGYLTDKADVYSFGIVALEIVSGR 776
M G + +D++S G +E+++G
Sbjct: 172 EMSG-ASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 70/198 (35%), Positives = 114/198 (57%), Gaps = 15/198 (7%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKLYG 638
KIGEG G VYK A GK +A+K+ L ++K+ +NEI ++ +HPN+V Y
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYYD 82
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+ G++L ++ EYM+ SL + ++ ++++ P +C + +GL YLH
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDII---TQNFVRMNEPQIAYVCREVLQGLEYLH---SQN 136
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLT 757
++HRDIK+ N+LL KD + K++DFG A+L +E + S + GT +MAPE R
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYG 194
Query: 758 DKADVYSFGIVALEIVSG 775
K D++S GI+ +E+ G
Sbjct: 195 PKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 73/195 (37%), Positives = 101/195 (51%), Gaps = 12/195 (6%)
Query: 583 IGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIE 642
IG+G FG V G KV AVK L S F+ E +++ L+HPNLV+L G ++
Sbjct: 14 IGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 643 GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHR 702
GN L ++ EYM SL L + L + + + G+ YL E+ VHR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 703 DIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADV 762
D+ A NVL+ +DL K+SDFGLAK E S ++ + APE + K+DV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTKSDV 182
Query: 763 YSFGIVALEIVS-GR 776
+SFGI+ EI S GR
Sbjct: 183 WSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 70/205 (34%), Positives = 109/205 (53%), Gaps = 20/205 (9%)
Query: 577 FAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKL 636
F + K+G G FG V++GL + +A+K L S ++F E+ + L+H +L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIG--LARGLAYLHEE 694
+ C G + +I E ME SL L PE L P I + +A G+AYL E+
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVL----PVASLIDMACQVAEGMAYLEEQ 123
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED-----NTHISTRIAGTFGYMAPE 749
+HRD+ A N+L+ +DL K++DFGLA+L +ED + I + + APE
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTAPE 174
Query: 750 YAMRGYLTDKADVYSFGIVALEIVS 774
A G + K+DV+SFGI+ E+ +
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-35
Identities = 94/257 (36%), Positives = 143/257 (55%), Gaps = 15/257 (5%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSE---WASLPLVNLPLWKQAN---G 57
L + N G +P +P L+ +DL+ N L+G IP++ ++SL +++L N G
Sbjct: 125 LSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDL----GGNVLVG 178
Query: 58 AIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRL 117
IP ++ ++++L LTL NQ G +P ELG + +L+ ++L NN +G++P LT L
Sbjct: 179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSL 238
Query: 118 KHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPE 177
H + N+ TG IP + N L+ LF+ + L+GPIP I SL +L L +SD N
Sbjct: 239 NHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSD-NSLS 297
Query: 178 GPFPRL-SNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SG 235
G P L L+N+ L L S N G++P L + L+VL L NK SG IP N +
Sbjct: 298 GEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNN 357
Query: 236 LTYMYLTGNLLTGPVPD 252
LT + L+ N LTG +P+
Sbjct: 358 LTVLDLSTNNLTGEIPE 374
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 78/201 (38%), Positives = 109/201 (54%), Gaps = 17/201 (8%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKLYG 638
K+G G FG V+ G +AVK L K G F+ E ++ L+H LV+LY
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
C E + ++ EYM SL L E +L+L P + +A G+AYL ESR
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYL--ESR-N 123
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEYAMRGYL 756
+HRD+ A N+L+ ++L KI+DFGLA+L E+D + R F + APE A G
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDD--EYTAREGAKFPIKWTAPEAANYGRF 181
Query: 757 TDKADVYSFGIVALEIVS-GR 776
T K+DV+SFGI+ EIV+ GR
Sbjct: 182 TIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 71/205 (34%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGN--REFVNEIGMISALQHPNLVKLY 637
NKIG G FG VY + L G+++AVK++ + +E +E+ ++ L+HPNLVK Y
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
G + ++ + EY +L L EH LD + L GLAYLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG---YMAPEYAMRG 754
IVHRDIK N+ LD + K+ DFG A + + T + + G YMAPE G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 755 YLTDK---ADVYSFGIVALEIVSGR 776
AD++S G V LE+ +G+
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 12/202 (5%)
Query: 577 FAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVK 635
F K+GEG +G VYK + G+V+A+K + + +E + EI ++ P +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
YG + L ++ EY S++ + + L +I +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAILYQTLKGLEYLH--- 116
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR-G 754
K +HRDIKA N+LL+++ K++DFG++ + +T I GT +MAPE G
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIG 175
Query: 755 YLTDKADVYSFGIVALEIVSGR 776
Y +KAD++S GI A+E+ G+
Sbjct: 176 Y-NNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 73/199 (36%), Positives = 112/199 (56%), Gaps = 9/199 (4%)
Query: 581 NKIGEGGFGPVYKGLL-ADGKVIAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKLY 637
NKIG+G FG V+K + AD +V A+KQ LS +++ E ++E +++ L +++ Y
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
++ +L ++ EY EN L + L L D R I I L GLA+LH +
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL--GLAHLHSK--- 120
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLT 757
KI+HRDIK+ N+ LD N KI D G+AKL DNT+ + I GT Y++PE
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTNFANTIVGTPYYLSPELCEDKPYN 179
Query: 758 DKADVYSFGIVALEIVSGR 776
+K+DV++ G+V E +G+
Sbjct: 180 EKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 583 IGEGGFGPVYKGLL-------ADGKVIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLV 634
+G+G FG VY+GL + +V A+K ++ + R EF+NE ++ ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRV-AIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLA---RALFGPEEHRLKLDWPTR---HSICIGLARGL 688
+L G G L++ E M L R+ E+ L PT + +A G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 689 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAGTFGYMA 747
AYL K VHRD+ A N ++ +DL KI DFG+ + + E D + +MA
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 748 PEYAMRGYLTDKADVYSFGIVALEIVS-------GRSN 778
PE G T K+DV+SFG+V E+ + G SN
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 27/213 (12%)
Query: 583 IGEGGFGPVYKGLLADGK------VIAVKQLS-SKSKQGNREFVNEIGMISALQHPNLVK 635
+GEG FG V+ G + ++AVK L + S ++F E +++ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTR--------HSICIGLA 685
YG C EG+ ++++EYME+ L + L GP+ LK I + +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT--- 742
G+ YL + VHRD+ N L+ DL KI DFG+++ D + R+ G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-DVYTTDYY--RVGGHTML 186
Query: 743 -FGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+M PE M T ++DV+SFG+V EI +
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 581 NKIGEGGFGPVYKGLL-----ADGKVIAVKQLS-SKSKQGNREFVNEIGMISALQHPNLV 634
++GEG FG V G+ +AVK L+ S +Q +F EI ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 635 KLYGCCIE--GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
K G C + G L LI EY+ + SL L + HR +++ + +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAG---TFGYMAPE 749
+ + +HRD+ A N+L++ + KISDFGLAK+ ED + + G F Y APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 750 YAMRGYLTDKADVYSFGIVALEIVS-GRSN 778
+ +DV+SFG+ E+ + G +
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 20/205 (9%)
Query: 580 DNKIGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLV 634
+ IG G FG V +G L +A+K L + S R +F+ E ++ HPN++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
+L G + +++I EYMEN SL + L E+ K + G+A G+ YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIASGMKYL--- 122
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR-----IAGTFGYMAPE 749
S + VHRD+ A N+L++ +L K+SDFGL++ E+ +T+ I T APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APE 178
Query: 750 YAMRGYLTDKADVYSFGIVALEIVS 774
T +DV+SFGIV E++S
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (310), Expect = 3e-31
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 576 NFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLS-SKSKQGNREFV-NEIGMISALQHPN 632
+ +IG+G FG VY +DGK+ +K++ S + RE NE+ ++ L HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSI---CIGLARGLA 689
++K Y E +L ++ EY + L++ + ++ + + I + L L
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKI---KKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE 749
YLH KI+HRDIK N+ L + K+ DFG++K+ T + GT Y++PE
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE 173
Query: 750 -YAMRGYLTDKADVYSFGIVALEIVSGR 776
+ Y K+D++S G V E+ + +
Sbjct: 174 LCQNKPY-NYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 8e-31
Identities = 107/347 (30%), Positives = 162/347 (46%), Gaps = 42/347 (12%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEW----ASLPLVNLPLWKQANGAI 59
L +N+ G++ + RLP++Q I+L+ N L+G IP + +SL +NL G+I
Sbjct: 76 LSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSN-NNFTGSI 134
Query: 60 PKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKH 119
P+ SI L L L N SG++P ++G+ +L+ L L N GK+P S NLT L+
Sbjct: 135 PR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEF 192
Query: 120 FRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELT--DLRISDLNGPE 177
++ N GQIP + L+ +++ + L+G IP I L L DL ++L GP
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 178 GPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIP--------- 228
L NLKN+ YL L + G +P + + L LDLS N LSG IP
Sbjct: 253 P--SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNL 310
Query: 229 -------SNFSGS---------GLTYMYLTGNLLTGPVPDWIVRKRNKHI-DLSYNNFID 271
+NF+G L + L N +G +P + + N + DLS NN
Sbjct: 311 EILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTG 370
Query: 272 GSSDSNCENQSVN---LFASSSEGS--NSTGIVSCLKSFTCPTNHSS 313
+ C + ++ LF++S EG S G L+ N S
Sbjct: 371 EIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-30
Identities = 94/266 (35%), Positives = 138/266 (51%), Gaps = 5/266 (1%)
Query: 8 NLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWK-QANGAIPKAVAS 65
NL G +P E+ L L +DL N L G IPS +L L L L++ + +G IP ++ S
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 66 ISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN 125
+ L L L N SG++P + L NLE LHL SNNFTGK+P + +L RL+ ++ N
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 126 HFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPR-LS 184
F+G+IP + L L + + L G IP G+ S L L I N EG P+ L
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL-ILFSNSLEGEIPKSLG 401
Query: 185 NLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPS-NFSGSGLTYMYLTG 243
+++ + L+ + GE+P ++ + LD+S N L G I S + L + L
Sbjct: 402 ACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLAR 461
Query: 244 NLLTGPVPDWIVRKRNKHIDLSYNNF 269
N G +PD KR +++DLS N F
Sbjct: 462 NKFFGGLPDSFGSKRLENLDLSRNQF 487
|
Length = 968 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 71/208 (34%), Positives = 106/208 (50%), Gaps = 30/208 (14%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLS-----SKSKQGNREFVNEIGMISALQHPNLVKL 636
+G G FG VY+GL L DG AVK++S ++ ++ EI ++S LQHPN+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 637 YGCCIEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWP-----TRHSICIGLARGLA 689
G E + L + E + SLA+ L +G P TR + GL
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGS------FPEPVIRLYTRQ-----ILLGLE 116
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE 749
YLH+ VHRDIK N+L+D + K++DFG+AK E + S + G+ +MAPE
Sbjct: 117 YLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK--GSPYWMAPE 171
Query: 750 YAMR-GYLTDKADVYSFGIVALEIVSGR 776
+ G AD++S G LE+ +G+
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 67/196 (34%), Positives = 106/196 (54%), Gaps = 7/196 (3%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCI 641
K+G G FG V++GL + +AVK L + +F+ E ++ L+HP L++LY C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 642 EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVH 701
+ ++ E M+ SL L G LKL P + +A G+AYL ++ +H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 702 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKAD 761
RD+ A NVL+ ++ K++DFGLA++ +ED + APE A+ + K+D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 762 VYSFGIVALEIVS-GR 776
V+SFGI+ EIV+ GR
Sbjct: 187 VWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 65/199 (32%), Positives = 111/199 (55%), Gaps = 14/199 (7%)
Query: 583 IGEGGFGPVYKGL-LADGKVI----AVKQL-SSKSKQGNREFVNEIGMISALQHPNLVKL 636
+G G FG VYKG+ + +G+ + A+K L S + N+E ++E +++++ HP++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
G C+ +Q+ LI + M L + H+ + + C+ +A+G++YL EE R
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYV---RNHKDNIGSQYLLNWCVQIAKGMSYL-EEKR 129
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT-FGYMAPEYAMRGY 755
L VHRD+ A NVL+ + KI+DFGLAKL + D +MA E +
Sbjct: 130 L--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187
Query: 756 LTDKADVYSFGIVALEIVS 774
T K+DV+S+G+ E+++
Sbjct: 188 YTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN-EIGMISALQHPNLVKLYGC 639
IG+G FG VYK + +V+A+K + + + E + EI +S + P + K YG
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
++G++L +I EY S L KLD I + GL YLHEE
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEE---GK 119
Query: 700 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRI------AGTFGYMAPEYAMR 753
+HRDIKA N+LL ++ + K++DFG++ +++ + GT +MAPE +
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPFWMAPEVIKQ 172
Query: 754 GYLTDKADVYSFGIVALEIVSG 775
+KAD++S GI A+E+ G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 582 KIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLYGC 639
+G+G G VYK GK+ A+K++ + R + + E+ + + + P +VK YG
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTR--HSICIGLARGLAYLHEESRL 697
+ ++ ++ EYM+ SLA L + P I + +GL YLH ++
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDYLH--TKR 119
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIA------GTFGYMAPEYA 751
I+HRDIK +N+L++ KI+DFG++K + + GT YM+PE
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISK-------VLENTLDQCNTFVGTVTYMSPERI 172
Query: 752 MRGYLTDKADVYSFGIVALEIVSGR 776
+ AD++S G+ LE G+
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 66/206 (32%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVKLYG 638
IG G VY + L + + +A+K++ + Q + + + E+ +S HPN+VK Y
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLK---LDWPTRHSICIGLARGLAYLHEES 695
+ G++L L+ Y+ SL + + LD ++ + +GL YLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIM----KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHIS-TRIAGTFGYMAPE--Y 750
+ +HRDIKA N+LL +D + KI+DFG++ D D T GT +MAPE
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 751 AMRGYLTDKADVYSFGIVALEIVSGR 776
+ GY KAD++SFGI A+E+ +G
Sbjct: 180 QVHGY-DFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 74/201 (36%), Positives = 108/201 (53%), Gaps = 18/201 (8%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNRE---FVNEIGMISALQHPNLVKLYG 638
K+G G FG V+ G +A+K L KQG+ F+ E ++ LQHP LV+LY
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+ + +I EYMEN SL L PE +L + + +A G+A++ R
Sbjct: 69 V-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTI--NKLIDMAAQIAEGMAFIE---RKN 122
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEYAMRGYL 756
+HRD++A N+L+ + L KI+DFGLA+L E + + R F + APE G
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 757 TDKADVYSFGIVALEIVS-GR 776
T K+DV+SFGI+ EIV+ GR
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 4e-28
Identities = 73/215 (33%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 576 NFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHP- 631
++ K+GEG FG VY D K++A+K L+ K + F+ EI ++++L HP
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 632 NLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYL 691
N+VKLY + L L+ EY++ SL L + L I + L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 692 HEESRLKIVHRDIKATNVLLDKDLN-PKISDFGLAKLDEEDNTHISTR-----IAGTFGY 745
H + I+HRDIK N+LLD+D K+ DFGLAKL + + S GT GY
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 746 MAPEYAM---RGYLTDKADVYSFGIVALEIVSGRS 777
MAPE + Y + +D++S GI E+++G
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 8e-28
Identities = 85/269 (31%), Positives = 133/269 (49%), Gaps = 8/269 (2%)
Query: 7 QN-LPGRLPPELTRLPFLQEIDLTRNYLNGTIPS---EWASLPLVNLPLWKQANGAIPKA 62
QN L G +PP + L L +DL+ N L+G IP + +L +++L G IP A
Sbjct: 269 QNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHL-FSNNFTGKIPVA 327
Query: 63 VASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRI 122
+ S+ L L L N+FSG++P LG NL L L++NN TG++PE + L +
Sbjct: 328 LTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLIL 387
Query: 123 SDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPR 182
N G+IP + L ++ ++ + +G +PS L + L IS+ N R
Sbjct: 388 FSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSR 447
Query: 183 LSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNF-SGSGLTYMYL 241
++ ++ L L G +P+ G L LDLS N+ SG +P S S L + L
Sbjct: 448 KWDMPSLQMLSLARNKFFGGLPDSFGSK-RLENLDLSRNQFSGAVPRKLGSLSELMQLKL 506
Query: 242 TGNLLTGPVPDWIVR-KRNKHIDLSYNNF 269
+ N L+G +PD + K+ +DLS+N
Sbjct: 507 SENKLSGEIPDELSSCKKLVSLDLSHNQL 535
|
Length = 968 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 583 IGEGGFGPVYK-GLLADGKVIAVKQLSSKSKQGNREFV---NEIGMISALQHPNLVKLYG 638
+G+G FG V GK+ A+K L K +E E ++S + HP +VKL+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+L L+ EY L L +E R + ++ I LA L YLH L
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLA--LEYLH---SLG 113
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
I++RD+K N+LLD D + K++DFGLAK + + +T GT Y+APE +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYGK 172
Query: 759 KADVYSFGIVALEIVSGRS 777
D +S G++ E+++G+
Sbjct: 173 AVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 68/211 (32%), Positives = 108/211 (51%), Gaps = 21/211 (9%)
Query: 582 KIGEGGFGPVY----KGLL--ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVK 635
++GEG FG V+ LL D ++AVK L S+ ++F E +++ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARAL--FGPEEHRL---------KLDWPTRHSICIGL 684
YG C EG LL+++EYM + L R L GP+ L +L +I +
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 685 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAGTF 743
A G+ YL + L VHRD+ N L+ + L KI DFG+++ + D + R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 744 GYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+M PE + T ++D++SFG+V EI +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 59/195 (30%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 583 IGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIE 642
+G G FG V+ G +A+K + + +F+ E ++ L HPNLV+LYG C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 643 GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHR 702
+ ++ EYM N L L E + KL +C + + YL +HR
Sbjct: 71 QRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 703 DIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKA 760
D+ A N L+ +D K+SDFGLA+ LD++ + T+ + PE + K+
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFSSKS 182
Query: 761 DVYSFGIVALEIVSG 775
DV+SFG++ E+ S
Sbjct: 183 DVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 63/203 (31%), Positives = 114/203 (56%), Gaps = 24/203 (11%)
Query: 581 NKIGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVK 635
KIGEG G V +A G+ +AVK++ + KQ RE + NE+ ++ QHPN+V+
Sbjct: 25 VKIGEGSTGIV---CIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
+Y + G++L ++ E++E +L + +++ ++C+ + + L++LH +
Sbjct: 81 MYSSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHAQ- 134
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTR--IAGTFGYMAPEYAM 752
++HRDIK+ ++LL D K+SDFG A++ +E + R + GT +MAPE
Sbjct: 135 --GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----VPRRKSLVGTPYWMAPEVIS 188
Query: 753 RGYLTDKADVYSFGIVALEIVSG 775
R + D++S GI+ +E+V G
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 71/212 (33%), Positives = 109/212 (51%), Gaps = 29/212 (13%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQL------SSKSKQGNREFV----NEIGMISALQHP 631
IG+G +G VY L G+++AVKQ+ + + ++ V +EI + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 632 NLVKLYGCCIEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLARGLA 689
N+V+ G L + EY+ S+ L +G E +L R L GLA
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL-----VRFFTEQVL-EGLA 122
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE--DNTHISTRIAGTFGYMA 747
YLH + I+HRD+KA N+L+D D KISDFG++K ++ DN + + G+ +MA
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ-NMSMQGSVFWMA 178
Query: 748 PEY---AMRGYLTDKADVYSFGIVALEIVSGR 776
PE +GY + K D++S G V LE+ +GR
Sbjct: 179 PEVIHSYSQGY-SAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-26
Identities = 80/252 (31%), Positives = 128/252 (50%), Gaps = 6/252 (2%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIP-SEWASLPLVNLPLWKQA-NGAIPK 61
L S G +P L + L +DL+ N L G IP +S L L L+ + G IPK
Sbjct: 339 LWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
++ + +L + L+ N FSG+LP+E L + L +++NN G++ ++ L+
Sbjct: 399 SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLS 458
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181
++ N F G +PD + +LE L + + +G +P + SL EL L++S+ N G P
Sbjct: 459 LARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSE-NKLSGEIP 516
Query: 182 R-LSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYM 239
LS+ K + L L + G++P +M L LDLS N+LSG IP N L +
Sbjct: 517 DELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQV 576
Query: 240 YLTGNLLTGPVP 251
++ N L G +P
Sbjct: 577 NISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLS-----SKSKQGNREFVNEIGMISALQHPNLV 634
IG+G FG V K +DGK++ K++ K KQ + V+E+ ++ L+HPN+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQ---QLVSEVNILRELKHPNIV 62
Query: 635 KLYGCCI-EGNQLLLIY-EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+ Y I NQ L I EY E LA+ + ++ R ++ I L L H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 693 --EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY 750
+ ++HRD+K N+ LD + N K+ DFGLAK+ D++ T GT YM+PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYMSPEQ 181
Query: 751 AMRGYLTDKADVYSFGIVALEIVSGR 776
+K+D++S G + E+ +
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 59/193 (30%), Positives = 102/193 (52%), Gaps = 7/193 (3%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCI 641
+IG G FG V+ G + + +A+K + + +F+ E ++ L HP LV+LYG C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 642 EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVH 701
E + + L++E+ME+ L+ L R K T +C+ + G+AYL + ++H
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 702 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKAD 761
RD+ A N L+ ++ K+SDFG+ + +D ST + +PE + K+D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 762 VYSFGIVALEIVS 774
V+SFG++ E+ S
Sbjct: 184 VWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 31/205 (15%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGC 639
+IG G +G VYK +A G+++A+K + + EI M+ +HPN+V +G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 640 CIEGNQLLLIYEYMENNSLA---RALFGP-EEHRLKLDWPTRHSICIGLARGLAYLHEES 695
+ ++L ++ EY SL + GP E ++ +C +GLAYLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-------VCRETLKGLAYLHE-- 119
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIA------GTFGYMAPE 749
+HRDIK N+LL +D + K++DFG++ ++ IA GT +MAPE
Sbjct: 120 -TGKIHRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYWMAPE 171
Query: 750 YA---MRGYLTDKADVYSFGIVALE 771
A +G K D+++ GI A+E
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 68/204 (33%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 581 NKIGEGGFGPVYKG--LLADGKVI--AVKQLS-SKSKQGNREFVNEIGMISALQHPNLVK 635
++G G FG V KG L+ GK + AVK L G +EF+ E +++ L HP +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEE---HRLKLDWPTRHSICIGLARGLAYLH 692
L G C +G L+L+ E L + L E LK + +A G+AYL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE-LAHQ------VAMGMAYL- 111
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEY 750
E VHRD+ A NVLL KISDFG+++ + + AG + + APE
Sbjct: 112 ESKHF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC 169
Query: 751 AMRGYLTDKADVYSFGIVALEIVS 774
G + K+DV+S+G+ E S
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 6e-26
Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 18/207 (8%)
Query: 577 FAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREF----VNEIGMISALQHP 631
+ K+GEG +G VYK G+++A+K++ + + EI ++ L+HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58
Query: 632 NLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYL 691
N+VKL +L L++EY + + L + L ++ L SI L RGLAY
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDMD-LKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 692 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE-- 749
H S +I+HRD+K N+L+++D K++DFGLA+ + + T Y APE
Sbjct: 115 H--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEIL 170
Query: 750 YAMRGYLTDKADVYSFGIVALEIVSGR 776
+ Y T D++S G + E+++G+
Sbjct: 171 LGSKHYST-AVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVK--QLSSKSKQGNREFVNEIGMISALQHPNLVKLY 637
++G G G V K L GK++AVK +L ++ + E+ ++ P +V Y
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI-QKQILRELDILHKCNSPYIVGFY 65
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
G + + EYM+ SL + L +E + ++ I + + +GL YLHE +
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHE--KH 120
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLT 757
KI+HRD+K +N+L++ K+ DFG++ + N+ ++ GT YMAPE +
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSG--QLVNS-LAKTFVGTSSYMAPERIQGNDYS 177
Query: 758 DKADVYSFGIVALEIVSGR 776
K+D++S G+ +E+ +GR
Sbjct: 178 VKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 72/211 (34%), Positives = 114/211 (54%), Gaps = 26/211 (12%)
Query: 583 IGEGGFGPVYKGLLA-DGKVIAVKQL-----SSKSKQGNREFVN----EIGMISALQHPN 632
IG G FG VY G+ A G+++AVKQ+ S+ SK R ++ EI ++ LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLARGLAY 690
+V+ G ++ + L + EY+ S+A L +G E L ++ + + +GL Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------ILKGLNY 121
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIA-----GTFGY 745
LH I+HRDIK N+L+D KISDFG++K E ++ T A G+ +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 746 MAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
MAPE + T KAD++S G + +E+++G+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 67/204 (32%), Positives = 113/204 (55%), Gaps = 9/204 (4%)
Query: 576 NFAPDNKIGEGGFGPVYK-GLLADGKVIAVKQ--LSSKSKQGNREFVNEIGMISALQHPN 632
+F K+G+G +G VYK L+D + A+K+ L S S++ + VNEI +++++ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
++ ++GN+L ++ EY L++A+ ++ R + I I L RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM 752
E KI+HRD+K+ N+LL + KI D G++K+ + T+I GT YMAPE
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQI-GTPHYMAPEVWK 174
Query: 753 RGYLTDKADVYSFGIVALEIVSGR 776
+ K+D++S G + E+ +
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 75/234 (32%), Positives = 109/234 (46%), Gaps = 32/234 (13%)
Query: 583 IGEGGFGPVYKG---LLADGK---VIAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVK 635
+GEG FG VYKG + +A+K L + +EF E ++S LQHPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALF------------GPEEHRLKLDWPTRHSICIG 683
L G C + +++EY+ + L L G E + LD I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD-EEDNTHISTRIAGT 742
+A G+ YL S VHRD+ A N L+ + L KISDFGL++ D + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 743 FGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GRSN--VICRTKEAQ 787
+M PE + G T ++D++SFG+V EI S G SN VI + Q
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 63/197 (31%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLYGCC 640
KIG+G FG VYKG+L +AVK S + F+ E ++ HPN+VKL G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 641 IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIV 700
++ + ++ E + SL L + RL + + + A G+ YL ES+ +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKN-RLTVK--KLLQMSLDAAAGMEYL--ESK-NCI 115
Query: 701 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEYAMRGYLTD 758
HRD+ A N L+ ++ KISDFG+++ +EE + + + APE G T
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 759 KADVYSFGIVALEIVSG 775
++DV+S+GI+ E S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 68/201 (33%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGN--REFVNEIGMISALQHPNLVKLYG 638
+IGEG G V+K G+ +A+K+++ + +G + + EI + A QHP +VKL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
G+ +L+ EYM + L+ L EE L S L +G+AY+H
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVL-RDEERPLPE--AQVKSYMRMLLKGVAYMHAN---G 119
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKL-DEEDNTHISTRIAGTFGYMAPE--YAMRGY 755
I+HRD+K N+L+ D KI+DFGLA+L EE+ S ++A T Y APE Y R Y
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYGARKY 178
Query: 756 LTDKADVYSFGIVALEIVSGR 776
D+++ G + E+++G
Sbjct: 179 -DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 69/227 (30%), Positives = 111/227 (48%), Gaps = 31/227 (13%)
Query: 576 NFAPDNKIGEGGFGPVYKGL------LADGKVIAVKQLSSKSKQGN-REFVNEIGMISAL 628
N +GEG FG V K A +AVK L + R+ ++E ++ +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 629 QHPNLVKLYGCCIEGNQLLLIYEYMENNSLARAL------------FGPEEHRLKLDWPT 676
HP+++KLYG C + LLLI EY + SL L + LD P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 677 RHSICIG--------LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728
++ +G ++RG+ YL E +K+VHRD+ A NVL+ + KISDFGL++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 729 EEDNTHIS-TRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
E+++++ ++ +MA E T ++DV+SFG++ EIV+
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREF----VNEIGMISALQHPNLVK 635
+IGEG +G VYK G+++A+K++ + + F + EI ++ L+HPN+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 636 LYGCCIE--GNQLLLIYEYMEN--NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYL 691
L + +++EYM++ L +K L GL YL
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLD------SPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 692 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE-- 749
H I+HRDIK +N+L++ D K++DFGLA+ + N+ T T Y PE
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 750 -----YAMRGYLTDKADVYSFGIVALEIVSGR 776
Y + D++S G + E+ G+
Sbjct: 174 LGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 71/234 (30%), Positives = 105/234 (44%), Gaps = 45/234 (19%)
Query: 575 NNFAPDNKIGEGGFGPVYK----GLLADGK--VIAVKQLSSK-SKQGNREFVNEIGMISA 627
NN IG+G FG V++ GLL ++AVK L + S +F E +++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 628 LQHPNLVKLYGCCIEGNQLLLIYEYME----NN-----------SLARA---LFGPEEHR 669
HPN+VKL G C G + L++EYM N SL+ + +
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 670 LKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA---- 725
L L + I +A G+AYL E K VHRD+ N L+ +++ KI+DFGL+
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 726 -----KLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
K E D I +M PE T ++DV+++G+V EI S
Sbjct: 182 SADYYKASENDAIPIR--------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 71/206 (34%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCI 641
K+G G FG V+ G + +AVK L + + F+ E ++ LQH LV+LY
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 642 EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVH 701
+ + +I EYM SL L E ++ L P +A G+AY+ R +H
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 702 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEYAMRGYLTDK 759
RD++A NVL+ + L KI+DFGLA++ E++ + R F + APE G T K
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 760 ADVYSFGIVALEIVS-------GRSN 778
+DV+SFGI+ EIV+ G SN
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 67/206 (32%), Positives = 107/206 (51%), Gaps = 29/206 (14%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFV-NEIGMISALQH---PNLVKLY 637
IG G +G VY+G + G+V+A+K ++ + + + E+ ++S L+ PN+ K Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 638 GCCIEGNQLLLIYEYMENNSLARALF--GPEEHRLKLDWPTRHSICIGLA-----RGLAY 690
G ++G +L +I EY E S+ R L GP + I + L Y
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEK-----------YISVIIREVLVALKY 116
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY 750
+H+ ++HRDIKA N+L+ N K+ DFG+A L ++++ ST GT +MAPE
Sbjct: 117 IHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEV 172
Query: 751 AMRGYLTD-KADVYSFGIVALEIVSG 775
G D KAD++S GI E+ +G
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 71/203 (34%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 577 FAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGN---REFVNEIGMISALQHPN 632
F +IG G FG VY + +V+A+K++S KQ N ++ + E+ + L+HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
++ GC + + L+ EY L A E H+ L +IC G +GLAYLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEY----CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE--Y 750
+ +HRDIKA N+LL + K++DFG A L N+ + GT +MAPE
Sbjct: 133 S---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVIL 184
Query: 751 AM-RGYLTDKADVYSFGIVALEI 772
AM G K DV+S GI +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 67/202 (33%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 583 IGEGGFGPVYKGLLADGKV-IAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCI 641
+G+G +G VY +V IA+K++ + + + EI + S L+H N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 642 EGNQLLLIYEYMENNSLA---RALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
E + E + SL+ R+ +GP LK + T + GL YLH+ +
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGP----LKDNEQTIIFYTKQILEGLKYLHD---NQ 128
Query: 699 IVHRDIKATNVLLDKDLNP-KISDFGLAKLDEEDNTHISTRIAGTFGYMAPE---YAMRG 754
IVHRDIK NVL++ KISDFG +K N T GT YMAPE RG
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPRG 187
Query: 755 YLTDKADVYSFGIVALEIVSGR 776
Y AD++S G +E+ +G+
Sbjct: 188 Y-GAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 72/213 (33%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGC- 639
IGEG +G VYK G+++A+K + + E E ++ HPN+ YG
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 640 -----CIEGNQLLLIYEYMENNS---LARALFGPEEHRLKLDWPTRHSICIGLARGLAYL 691
+QL L+ E S L + L + RLK +W I RGLAYL
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIA--YILRETLRGLAYL 129
Query: 692 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDEED---NTHISTRIAGTFGYMA 747
HE K++HRDIK N+LL K+ K+ DFG+ A+LD NT I GT +MA
Sbjct: 130 HEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-----GTPYWMA 181
Query: 748 PE-----YAMRGYLTDKADVYSFGIVALEIVSG 775
PE ++DV+S GI A+E+ G
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 28/207 (13%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQG--NREFVNEIGMISALQHPNLVKLYG 638
KIGEG +G VYK G+++A+K++ + + + + EI ++ L HPN++KL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 639 CCIEGNQLLLIYEYMENN---SLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
L L++E+M+ + + G E +K S L +GLA+ H
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIK-------SYLYQLLQGLAFCH--- 115
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN---TH-ISTRIAGTFGYMAPE-- 749
I+HRD+K N+L++ + K++DFGLA+ TH + TR Y APE
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPELL 170
Query: 750 YAMRGYLTDKADVYSFGIVALEIVSGR 776
+GY + D++S G + E++S R
Sbjct: 171 LGDKGY-STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 582 KIGEGGFGPVYKG--LLADGKVI--AVKQLSSKSKQGN-REFVNEIGMISALQHPNLVKL 636
K+G+G FG V +G + GKVI AVK L S +F+ E ++ +L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
YG + + L+++ E SL L + T + +A G+ YL +
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLI--STLCDYAVQIANGMRYLESK-- 116
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGL--AKLDEEDNTHISTRIAGTFGYMAPEYAMRG 754
+ +HRD+ A N+LL D KI DFGL A ED+ + + F + APE
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 755 YLTDKADVYSFGIVALEIVS 774
+ +DV+ FG+ E+ +
Sbjct: 176 TFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 70/198 (35%), Positives = 108/198 (54%), Gaps = 12/198 (6%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCI 641
K+G+G FG V+ G +A+K L + F+ E ++ L+H LV+LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 642 EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVH 701
E + ++ EYM SL L G L+L P + +A G+AY+ R+ VH
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVH 125
Query: 702 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEYAMRGYLTDK 759
RD++A N+L+ ++L K++DFGLA+L EDN + + R F + APE A+ G T K
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 760 ADVYSFGIVALEIVS-GR 776
+DV+SFGI+ E+ + GR
Sbjct: 184 SDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQ------LSSKSKQGNREFVNEIGMIS 626
NF + KIG+G F VYK + L DG+V+A+K+ + +K++Q + + EI ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57
Query: 627 ALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLAR 686
L HPN++K IE N+L ++ E + L+R + ++ + + T + L
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYM 746
L ++H + +I+HRDIK NV + K+ D GL + T + + GT YM
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 173
Query: 747 APEYAMRGYLTDKADVYSFGIVALEIVSGRS 777
+PE K+D++S G + E+ + +S
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-24
Identities = 72/198 (36%), Positives = 106/198 (53%), Gaps = 12/198 (6%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCI 641
K+G G FG V+ G +AVK L + F+ E ++ L+H LV+LY
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 642 EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVH 701
E + ++ EYM SL L E LKL P + +A G+AY+ R+ +H
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 702 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEYAMRGYLTDK 759
RD+++ N+L+ L KI+DFGLA+L EDN + + R F + APE A+ G T K
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLI-EDNEY-TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 760 ADVYSFGIVALEIVS-GR 776
+DV+SFGI+ E+V+ GR
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 65/199 (32%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 583 IGEGGFGPVYKGLL-ADGK---VIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLY 637
IG G FG V++G+L G+ +A+K L + R +F++E ++ H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
G + ++I EYMEN +L + L +H + + G+A G+ YL S +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGMKYL---SDM 126
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG--YMAPEYAMRGY 755
VHRD+ A N+L++ +L K+SDFGL+++ E+D T G + APE
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 756 LTDKADVYSFGIVALEIVS 774
T +DV+SFGIV E++S
Sbjct: 187 FTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 583 IGEGGFGPVYK------GLLADGKVIAVK---QLSSKSKQGNREFVNEIGMISALQHPNL 633
+G+G FG VYK GL A K+I ++ +L +F+ EI ++S +HPN+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE--------DFMVEIDILSECKHPNI 64
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
V LY N+L ++ E+ + +L + E L P +C + L +LH
Sbjct: 65 VGLYEAYFYENKLWILIEFCDGGALDSIM---LELERGLTEPQIRYVCRQMLEALNFLHS 121
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRIAGTFGYMAPEYAM 752
K++HRD+KA N+LL D + K++DFG+ AK T I GT +MAPE
Sbjct: 122 H---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVA 176
Query: 753 RGYLTD-----KADVYSFGIVALEIVSGR 776
D KAD++S GI +E+
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 70/210 (33%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 583 IGEGGFGPVYKG----LLADGK---VIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLV 634
+G G FG VY+G +L G +AVK L + Q +EF+ E ++S HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLK---LDWPTRHSICIGLARGLAYL 691
KL G C+ +I E ME L L R L IC+ +A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 692 HEESRLKIVHRDIKATNVLL-----DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG-- 744
++ +HRD+ A N L+ D D KI DFGLA+ D + + G
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLLPVR 178
Query: 745 YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+MAPE + G T ++DV+SFG++ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 583 IGEGGFGPVYKGLLAD------GKVIAVKQL-SSKSKQGNREFVNEIGMISAL-QHPNLV 634
+GEG FG V K +AVK L +++ + V+E+ M+ + +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 635 KLYGCCIEGNQLLLIYEYMENNSL-----AR-------ALFGPEEHRLKLDWPTRHSICI 682
L G C + L ++ EY + +L AR + P L S
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 683 GLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT 742
+ARG+ +L S+ K +HRD+ A NVL+ +D KI+DFGLA+ D + G
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLAR-DIHHIDYYRKTTNGR 195
Query: 743 FGY--MAPEYAMRGYLTDKADVYSFGIVALEIVS 774
MAPE T ++DV+SFG++ EI +
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 61/196 (31%), Positives = 107/196 (54%), Gaps = 12/196 (6%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
KIG+G G VY + +A G+ +A+KQ++ + + +NEI ++ +HPN+V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 641 IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIV 700
+ G++L ++ EY+ SL + +D ++C + L +LH +++
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 701 HRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDK 759
HRDIK+ N+LL D + K++DFG A++ E + + + GT +MAPE R K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 195
Query: 760 ADVYSFGIVALEIVSG 775
D++S GI+A+E+V G
Sbjct: 196 VDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 31/226 (13%)
Query: 575 NNFAPDNKIGEGGFGPVYKG-LLADGKVIAVKQLSSK--SKQGNREFVN-EIGMISAL-Q 629
++F IGEG F V K A+K L + K+ ++V E +++ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 630 HPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLA 689
HP ++KLY + L + EY N L + + LD + L
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLALE 116
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIA--------- 740
YLH I+HRD+K N+LLDKD++ KI+DFG AK+ + +++ S +
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 741 ----------GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
GT Y++PE +D+++ G + ++++G+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGC 639
+ K+G G FG V+ +AVK + S F+ E ++ LQH LVKL+
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
+ + +I E+M SL L E + L P +A G+A++ + +
Sbjct: 70 -VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---Y 123
Query: 700 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEYAMRGYLT 757
+HRD++A N+L+ L KI+DFGLA++ EDN + + R F + APE G T
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTA-REGAKFPIKWTAPEAINFGSFT 181
Query: 758 DKADVYSFGIVALEIVS-GR 776
K+DV+SFGI+ +EIV+ GR
Sbjct: 182 IKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 25/204 (12%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYG 638
IG+G FG V D K+ A+K ++ + K R +NE ++ L HP LV L+
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 639 CCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
+ + L+ + + L + F E ++K I LA L YLH
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLSQKVKF--SEEQVKF-----WICEIVLA--LEYLHS 118
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRIAGTFGYMAPEYAM 752
+ I+HRDIK N+LLD+ + I+DF +A K+ + T T +GT GYMAPE
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLC 172
Query: 753 RGYLTDKADVYSFGIVALEIVSGR 776
R + D +S G+ A E + G+
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 7e-23
Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 19/216 (8%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLL------ADGKVIAVKQLSSKSKQGNREFVNEIGMISAL 628
+N ++GEG FG V+ D ++AVK L S ++F E +++ L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 629 QHPNLVKLYGCCIEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRH-------S 679
QH ++VK YG C+EG+ L++++EYM++ L + L GP+ +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 680 ICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTR 738
I +A G+ YL + VHRD+ N L+ ++L KI DFG+++ + D +
Sbjct: 125 IAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 739 IAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+M PE M T ++DV+S G+V EI +
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 8e-23
Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 11/195 (5%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCI 641
++G G FG V G +A+K + S + EF+ E ++ L H LV+LYG C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 642 EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVH 701
+ + ++ EYM N L L EH + +C + G+AYL ES+ + +H
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYL--ESK-QFIH 123
Query: 702 RDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDK 759
RD+ A N L+D K+SDFGL++ LD+E + + ++ + PE + + K
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYSKFSSK 181
Query: 760 ADVYSFGIVALEIVS 774
+DV++FG++ E+ S
Sbjct: 182 SDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 8e-23
Identities = 71/200 (35%), Positives = 108/200 (54%), Gaps = 12/200 (6%)
Query: 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGC 639
D K+G+G FG V+ G +A+K L + F+ E ++ L+H LV LY
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
E + ++ E+M SL L + LKL P + +A G+AY+ R+
Sbjct: 70 VSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKL--PQLVDMAAQIADGMAYIE---RMNY 123
Query: 700 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEYAMRGYLT 757
+HRD++A N+L+ +L KI+DFGLA+L EDN + + R F + APE A+ G T
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLI-EDNEY-TARQGAKFPIKWTAPEAALYGRFT 181
Query: 758 DKADVYSFGIVALEIVS-GR 776
K+DV+SFGI+ E+V+ GR
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 9e-23
Identities = 69/206 (33%), Positives = 104/206 (50%), Gaps = 25/206 (12%)
Query: 583 IGEGGFGPV----YKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLY 637
+G+G FG V Y L + G+V+AVK+L + + R+F EI ++ +LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 638 GCCIEG--NQLLLIYEYMENNSLARALFGPEEHRLKLDWPT----RHSICIGLARGLAYL 691
G C L L+ EY+ SL L ++HR +LD IC +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQIC----KGMEYL 124
Query: 692 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAG---TFGYMAP 748
+ VHRD+ N+L++ + KI DFGL K+ +D + R G F Y AP
Sbjct: 125 ---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-AP 180
Query: 749 EYAMRGYLTDKADVYSFGIVALEIVS 774
E + +DV+SFG+V E+ +
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 66/199 (33%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 583 IGEGGFGPVYKGLLA-DGK---VIAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLY 637
IG G FG V G L GK +A+K L + +++ R+F++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
G + ++++ EYMEN SL L +H + + G+A G+ YL S +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMKYL---SDM 125
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG--YMAPEYAMRGY 755
VHRD+ A N+L++ +L K+SDFGL+++ E+D T G + APE
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 756 LTDKADVYSFGIVALEIVS 774
T +DV+S+GIV E++S
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
KIG+G G VY + +A G+ +A+KQ++ + + +NEI ++ ++PN+V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 641 IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIV 700
+ G++L ++ EY+ SL + +D ++C + L +LH +++
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 701 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKA 760
HRDIK+ N+LL D + K++DFG + + ST + GT +MAPE R K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 761 DVYSFGIVALEIVSG 775
D++S GI+A+E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-22
Identities = 71/235 (30%), Positives = 116/235 (49%), Gaps = 35/235 (14%)
Query: 582 KIGEGGFGPVY----KGLLA---------DGK--VIAVKQLSSK-SKQGNREFVNEIGMI 625
K+GEG FG V+ +GL DG+ ++AVK L + +K +F+ EI ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 626 SALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSI 680
S L++PN+++L G C+ + L +I EYMEN L R + H + + ++
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 681 ---CIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHIS 736
+ +A G+ YL + L VHRD+ N L+ KI+DFG+++ L D I
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 737 TRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLL 791
R +MA E + G T +DV++FG+ E+ + +C KE + LL
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT-----LC--KEQPYSLL 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 59/196 (30%), Positives = 109/196 (55%), Gaps = 12/196 (6%)
Query: 582 KIGEGGFGPV-YKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
KIGEG G V + + GK++AVK++ + +Q NE+ ++ QH N+V++Y
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 641 IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIV 700
+ G++L ++ E++E +L + +++ ++C+ + + L+ LH + ++
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQG---VI 138
Query: 701 HRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDK 759
HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE R +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPE 196
Query: 760 ADVYSFGIVALEIVSG 775
D++S GI+ +E+V G
Sbjct: 197 VDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 3e-22
Identities = 61/195 (31%), Positives = 106/195 (54%), Gaps = 10/195 (5%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
KIG+G G V+ + +A G+ +A+KQ++ + + +NEI ++ L++PN+V
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 641 IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIV 700
+ G++L ++ EY+ SL + +D ++C + L +LH +++
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 701 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKA 760
HRDIK+ NVLL D + K++DFG + + ST + GT +MAPE R K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 761 DVYSFGIVALEIVSG 775
D++S GI+A+E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 27/207 (13%)
Query: 583 IGEGGFGPVYKGLL-ADGK---VIAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLY 637
IG G FG V +G L GK +A+K L S +++ R+F++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 638 GCCIEGNQLLLIYEYMENNSLARAL------FGPEEHRLKLDWPTRHSICIGLARGLAYL 691
G + +++I E+MEN +L L F ++L R G+A G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV----IQLVGMLR-----GIAAGMKYL 122
Query: 692 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH--ISTRIAGTFG--YMA 747
E + VHRD+ A N+L++ +L K+SDFGL++ E+D + ++ + G + A
Sbjct: 123 SE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 748 PEYAMRGYLTDKADVYSFGIVALEIVS 774
PE T +DV+S+GIV E++S
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 18/199 (9%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCI 641
IGEG FG V +G G+ +AVK + K + F+ E +++ L H NLV+L G I
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGV-I 68
Query: 642 EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVH 701
N L ++ E M +L F R + + +A G+ YL ES+ K+VH
Sbjct: 69 LHNGLYIVMELMSKGNLVN--FLRTRGRALVSVIQLLQFSLDVAEGMEYL--ESK-KLVH 123
Query: 702 RDIKATNVLLDKDLNPKISDFGLAKLDEE--DNTHISTRIAGTFGYMAPEYAMRGYLTDK 759
RD+ A N+L+ +D K+SDFGLA++ DN+ + + + APE + K
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSK 177
Query: 760 ADVYSFGIVALEIVS-GRS 777
+DV+S+G++ E+ S GR+
Sbjct: 178 SDVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 28/215 (13%)
Query: 582 KIGEGGFGPVYKGLLA---------DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPN 632
++GEG FG V+ LA D ++AVK L + ++F E +++ LQH +
Sbjct: 12 ELGEGAFGKVF---LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGL------ 684
+VK YG C +G+ L++++EYM++ L + L GP+ L P + +GL
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 685 ----ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRI 739
A G+ YL + VHRD+ N L+ +L KI DFG+++ + D +
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 740 AGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+M PE M T ++DV+SFG++ EI +
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-22
Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 577 FAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGN---REFVNEIGMISALQHPN 632
F+ +IG G FG VY + + +V+A+K++S KQ N ++ + E+ + L+HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
++ GC + + L+ EY L A E H+ L ++ G +GLAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEY----CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM 752
+ ++HRD+KA N+LL + K+ DFG A + N + GT +MAPE +
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184
Query: 753 ---RGYLTDKADVYSFGIVALEI 772
G K DV+S GI +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 4e-22
Identities = 72/208 (34%), Positives = 112/208 (53%), Gaps = 25/208 (12%)
Query: 577 FAPDNKIGEGGFGPVYKGLLADGK---VIAVKQLSSKSKQGNREFVN-EIGMISALQHPN 632
F +IG+G FG V+KG+ D + V+A+K + + + E + EI ++S P
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNS---LARALFGP-EEHRLKLDWPTRHSICIGLARGL 688
+ K YG ++G +L +I EY+ S L RA GP +E ++ ++ + +GL
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIA-------TMLKEILKGL 114
Query: 689 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR-IAGTFGYMA 747
YLH E K +HRDIKA NVLL + + K++DFG+A + +T I GT +MA
Sbjct: 115 DYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMA 169
Query: 748 PEYAMRGYLTDKADVYSFGIVALEIVSG 775
PE + KAD++S GI A+E+ G
Sbjct: 170 PEVIQQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 5e-22
Identities = 70/219 (31%), Positives = 107/219 (48%), Gaps = 29/219 (13%)
Query: 582 KIGEGGFGPVY------------KGLLADGK-----VIAVKQLSSKSKQGNR-EFVNEIG 623
K+GEG FG V+ K D ++AVK L + + R +F+ EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 624 MISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRH--- 678
++S L+ PN+++L CI + L +I EYMEN L + L P+E K D T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 679 --SICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHI 735
+ +A G+ YL S L VHRD+ N L+ K+ KI+DFG+++ L D I
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
R +M+ E + G T +DV++FG+ EI++
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 6e-22
Identities = 70/202 (34%), Positives = 107/202 (52%), Gaps = 13/202 (6%)
Query: 577 FAPDNKIGEGGFGPVYKGLLADGK-VIAVKQLSSKSKQGNREFVN-EIGMISALQHPNLV 634
F +IG+G FG VYKG+ K V+A+K + + + E + EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
+ YG ++G +L +I EY+ S A L P L+ +I + +GL YLH E
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS-ALDLLKPG----PLEETYIATILREILKGLDYLHSE 120
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-TRIAGTFGYMAPEYAMR 753
+ +HRDIKA NVLL + + K++DFG+A + +T I GT +MAPE +
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 754 GYLTDKADVYSFGIVALEIVSG 775
KAD++S GI A+E+ G
Sbjct: 176 SAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 8e-22
Identities = 71/223 (31%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 581 NKIGEGGFGPVYKGLLA--DGKV----IAVKQL-SSKSKQGNREFVNEIGMISALQHPNL 633
+G G FG VY+GL DG +AVK L S S+Q +F+ E ++S H N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHS------ICIGLARG 687
V+L G E ++ E M L L E+R + + P+ + +A+G
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFL---RENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 688 LAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAK-LDEEDNTHISTRIAGTF 743
YL EE+ +HRDI A N LL KI+DFG+A+ + R
Sbjct: 129 CKYL-EENHF--IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 744 GYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRTKE 785
+M PE + G T K DV+SFG++ EI S G RT +
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 8e-22
Identities = 71/211 (33%), Positives = 100/211 (47%), Gaps = 36/211 (17%)
Query: 583 IGEGGFGPV--YKGLLAD---GKVIAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKL 636
+GEG FG V Y A+ G+++AVK L + Q N + EI ++ L H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 637 YGCCIEGNQ--LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIG--------LAR 686
GCC E L LI EY+ SL D+ +H + + +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSL-------------RDYLPKHKLNLAQLLLFAQQICE 118
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAG---TF 743
G+AYLH + +HRD+ A NVLLD D KI DFGLAK E + + R G F
Sbjct: 119 GMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175
Query: 744 GYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
Y A E + +DV+SFG+ E+++
Sbjct: 176 WY-AVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 8e-22
Identities = 67/199 (33%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKL 636
++IG G FG VY + +V+AVK++S KQ N ++ + E+ + L+HPN ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
GC ++ + L+ EY L A E H+ L +I G +GLAYLH +
Sbjct: 87 KGCYLKEHTAWLVMEY----CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN- 141
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM---R 753
++HRDIKA N+LL + K++DFG A N+ + GT +MAPE +
Sbjct: 142 --MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDE 194
Query: 754 GYLTDKADVYSFGIVALEI 772
G K DV+S GI +E+
Sbjct: 195 GQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 71/202 (35%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 577 FAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN-EIGMISALQHPNLV 634
F KIG+G FG V+KG+ KV+A+K + + + E + EI ++S P +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
K YG ++ +L +I EY+ S A L P LD +I + +GL YLH E
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPG----PLDETQIATILREILKGLDYLHSE 120
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-TRIAGTFGYMAPEYAMR 753
+ +HRDIKA NVLL + K++DFG+A + +T I GT +MAPE +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 754 GYLTDKADVYSFGIVALEIVSG 775
KAD++S GI A+E+ G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 9e-22
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQL---SSKSKQGNREFVN---EIGMISALQHPNLV 634
+G+G +G VY GL G++IAVKQ+ +S +E+ E+ ++ +L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+ G C++ N + + E++ S++ L FGP L P + G+AYLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGP------LPEPVFCKYTKQILDGVAYLH 119
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-----TRIAGTFGYMA 747
+VHRDIK NV+L + K+ DFG A+ H + + GT +MA
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 748 PEYAMRGYLTDKADVYSFGIVALEIVSGR 776
PE K+D++S G E+ +G+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 28/210 (13%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLS----SKSKQGN--REFVNEIGMISALQHPNLVK 635
+G G F Y+ + G ++AVKQ++ + S+Q EI +++ L HP++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
+ G E + L E+M S++ L +G + + +++ L RGL+YLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY------TEQLLRGLSYLHE 121
Query: 694 ESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAKLDEEDNT---HISTRIAGTFGYMA 747
+I+HRD+K N+L+D + L +I+DFG A T ++ GT +MA
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 748 PEYAMRGYLTDKA-DVYSFGIVALEIVSGR 776
PE +RG ++ DV+S G V +E+ + +
Sbjct: 177 PE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-21
Identities = 58/196 (29%), Positives = 107/196 (54%), Gaps = 12/196 (6%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
KIG+G G VY + +A G+ +A++Q++ + + +NEI ++ ++PN+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 641 IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIV 700
+ G++L ++ EY+ SL + +D ++C + L +LH +++
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 701 HRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDK 759
HRDIK+ N+LL D + K++DFG A++ E + + + GT +MAPE R K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 196
Query: 760 ADVYSFGIVALEIVSG 775
D++S GI+A+E++ G
Sbjct: 197 VDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 67/216 (31%), Positives = 115/216 (53%), Gaps = 11/216 (5%)
Query: 576 NFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGN-REFVNEIGMISALQHPNL 633
NF K+GEG + VYKG G+++A+K++ +++G + EI ++ L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
V+L+ N+L+L++EYM+ + L + + R LD T S L +G+A+ HE
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD-LKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM- 752
+++HRD+K N+L++K K++DFGLA+ S + T Y AP+ +
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLG 174
Query: 753 -RGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQ 787
R Y T D++S G + E+++GR E Q
Sbjct: 175 SRTYST-SIDIWSVGCIMAEMITGRPLFPGTNNEDQ 209
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-21
Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGN---REFVNEIGMISALQHPN 632
F +IG G FG VY +V+A+K++S KQ N ++ + E+ + ++HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
++ GC + + L+ EY L A E H+ L +I G +GLAYLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEY----CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM 752
+ ++HRDIKA N+LL + K++DFG A + N+ + GT +MAPE +
Sbjct: 143 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVIL 194
Query: 753 ---RGYLTDKADVYSFGIVALEI 772
G K DV+S GI +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 59/200 (29%), Positives = 104/200 (52%), Gaps = 20/200 (10%)
Query: 582 KIGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLY 637
KIGEG G V +A G+ +AVK + + +Q NE+ ++ QH N+V++Y
Sbjct: 28 KIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
+ G +L ++ E+++ +L + + +L+ ++C + + L YLH +
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQG-- 137
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR--IAGTFGYMAPEYAMRGY 755
++HRDIK+ ++LL D K+SDFG +D + R + GT +MAPE R
Sbjct: 138 -VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKSLVGTPYWMAPEVISRTP 193
Query: 756 LTDKADVYSFGIVALEIVSG 775
+ D++S GI+ +E+V G
Sbjct: 194 YGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 65/203 (32%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQ-----LSSKSKQGNREFVNEIGMISALQHPNLVKL 636
+G+G FG VY D G+ +AVKQ S ++K+ EI ++ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 637 YGCCIEGNQLLLIYEYMENNSLAR--ALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
YGC + L + EYM S+ +G + + TR + G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKY-TRQ-----ILEGVEYLH-- 121
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS--TRIAGTFGYMAPEYAM 752
IVHRDIK N+L D N K+ DFG +K + + + + GT +M+PE
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 753 -RGYLTDKADVYSFGIVALEIVS 774
GY KADV+S G +E+++
Sbjct: 181 GEGY-GRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 5e-21
Identities = 70/229 (30%), Positives = 110/229 (48%), Gaps = 27/229 (11%)
Query: 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQAN--GAIP 60
IL S +L G +P L L+ + L N +G +PSE+ LPLV N G I
Sbjct: 386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRIN 445
Query: 61 KAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHF 120
+ +L L+L N+F G LP G+ LE L L+ N F+G +P +L+ L
Sbjct: 446 SRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQL 504
Query: 121 RISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPF 180
++S+N +G+IPD + + KL L + + L+G IP+ + + L+ L +S
Sbjct: 505 KLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS--------Q 556
Query: 181 PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPS 229
+LS GE+P+ LG + L +++S N L G +PS
Sbjct: 557 NQLS----------------GEIPKNLGNVESLVQVNISHNHLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 5e-21
Identities = 59/196 (30%), Positives = 105/196 (53%), Gaps = 12/196 (6%)
Query: 582 KIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
KIGEG G V GK +AVK++ + +Q NE+ ++ H N+V +Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 641 IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIV 700
+ G++L ++ E++E +L + +++ ++C+ + R L+YLH + ++
Sbjct: 89 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQG---VI 140
Query: 701 HRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDK 759
HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE R +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTE 198
Query: 760 ADVYSFGIVALEIVSG 775
D++S GI+ +E++ G
Sbjct: 199 VDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 583 IGEGGFGPVY----KGLLADGK--VIAVKQLSSKSKQG-NREFVNEIGMISALQHPNLVK 635
+G G FG V+ KG+ +G ++ VK L + EF E+ M L H N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALF--GPEEHRLK---LDWPTRHSICIGLARGLAY 690
L G C E +I EY + L + L ++ +LK L + ++C +A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY 750
L S + VHRD+ A N L+ K+S L+K + ++APE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 751 AMRGYLTDKADVYSFGIVALEIVS 774
+ K+DV+SFG++ E+ +
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 8e-21
Identities = 61/199 (30%), Positives = 106/199 (53%), Gaps = 14/199 (7%)
Query: 583 IGEGGFGPVYKGL-LADGKVI----AVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKL 636
+G G FG V+KG+ + +G I A+K + +S +Q +E + + + +L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
G C G L L+ + SL + +HR LD + C+ +A+G+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV---RQHRDSLDPQRLLNWCVQIAKGMYYLEEH-- 128
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAGTFGYMAPEYAMRGY 755
++VHR++ A N+LL D +I+DFG+A L +D + + +MA E + G
Sbjct: 129 -RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 756 LTDKADVYSFGIVALEIVS 774
T ++DV+S+G+ E++S
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 1e-20
Identities = 67/205 (32%), Positives = 113/205 (55%), Gaps = 26/205 (12%)
Query: 583 IGEGGFGPVYKGL-LADGKVI----AVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKL 636
+G G FG VYKG+ + +G+ + A+K L+ + + N EF++E +++++ HP+LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHR------LKLDWPTRHSICIGLARGLAY 690
G C+ + L+ + M + L + EH+ L L+W C+ +A+G+ Y
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYV---HEHKDNIGSQLLLNW------CVQIAKGMMY 124
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT-FGYMAPE 749
L EE RL VHRD+ A NVL+ + KI+DFGLA+L E D + +MA E
Sbjct: 125 L-EERRL--VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181
Query: 750 YAMRGYLTDKADVYSFGIVALEIVS 774
T ++DV+S+G+ E+++
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 23/202 (11%)
Query: 582 KIGEGGFGPVYK------GLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVK 635
++G+G FG VYK G LA KVI +KS++ +++ EI +++ HP +VK
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVI-----ETKSEEELEDYMVEIEILATCNHPYIVK 73
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
L G +L ++ E+ ++ + E L P IC + L YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIML---ELDRGLTEPQIQVICRQMLEALQYLHS-- 128
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGY 755
+KI+HRD+KA NVLL D + K++DFG++ + + + I GT +MAPE M
Sbjct: 129 -MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCET 186
Query: 756 LTD-----KADVYSFGIVALEI 772
+ D KAD++S GI +E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 581 NKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQG-NREFVNEIGMISALQHPNLVKLYG 638
+++GEG G V K L G + A+K +++ ++ + E+ + + + P +VK YG
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 639 CCIE--GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
++ + + + EY E SL ++ ++ I + +GL+YLH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-- 124
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYL 756
KI+HRDIK +N+LL + K+ DFG++ E N+ T GT YMAPE
Sbjct: 125 -KIIHRDIKPSNILLTRKGQVKLCDFGVS--GELVNSLAGT-FTGTSFYMAPERIQGKPY 180
Query: 757 TDKADVYSFGIVALEIVSGR 776
+ +DV+S G+ LE+ R
Sbjct: 181 SITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 28/207 (13%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN--EIGMISALQ-HPNLVKLY 637
++G+G FG VY G+++A+K++ K E +N E+ + L HPN+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLK 64
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHR--LKLDWPTRHSICIGLARGLAYLHEES 695
E ++L ++EYME N L+ + R SI + +GLA++H
Sbjct: 65 EVFRENDELYFVFEYMEGN-----LYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--- 116
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN-----THISTRIAGTFGYMAPEY 750
+ HRD+K N+L+ KI+DFGLA+ E + ++STR Y APE
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WYRAPEI 169
Query: 751 AMR-GYLTDKADVYSFGIVALEIVSGR 776
+R + D+++ G + E+ + R
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 578 APDNKIGEGGFGPVYKGLLADGK----VIAVKQLSSKSKQGNRE-FVNEIGMISALQHPN 632
IGEG FG VY+G+ + +AVK + + RE F+ E ++ HP+
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+VKL G E N + ++ E L L + ++ LD + L+ LAYL
Sbjct: 69 IVKLIGVITE-NPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYL- 123
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM 752
ES+ + VHRDI A NVL+ K+ DFGL++ E+++ + +++ +MAPE
Sbjct: 124 -ESK-RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 753 RGYLTDKADVYSFGIVALEIVS 774
T +DV+ FG+ EI+
Sbjct: 182 FRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 576 NFAPDNKIGEGGFGP--VYKGLLADGKVIAVKQ--LSSKSKQGNREFVNEIGMISALQHP 631
++ P +G+G FG +Y+ D ++ K+ L+ S++ R+ +NEI ++S LQHP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 632 NLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSI--CIGLARGLA 689
N++ Y ++ N LL+ EY +L + + + + + ++
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKI----VRQKGQLFEEEMVLWYLFQIVSAVS 115
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE 749
Y+H+ I+HRDIK N+ L K K+ DFG++K+ + + T + GT YM+PE
Sbjct: 116 YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPE 171
Query: 750 YAMRGYLTDKADVYSFGIVALEI 772
K+D+++ G V E+
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 11/199 (5%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQL--SSKSKQGNREFVNEIGMISALQHPNLVKLYG 638
+GEG +G V K A G+++A+K+ S + + + E+ ++ L+H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+L L++EY+E L E L S L + +AY H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELL----EASPGGLPPDAVRSYIWQLLQAIAYCH---SHN 120
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
I+HRDIK N+L+ + K+ DFG A+ T T Y APE +
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180
Query: 759 KA-DVYSFGIVALEIVSGR 776
K DV++ G + E++ G
Sbjct: 181 KPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 19/200 (9%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAV-KQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
++G+G FG VYK + V+A K + +KS++ +++ EI ++++ HPN+VKL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 641 IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIV 700
N L ++ E+ ++ + E L P +C L YLHE KI+
Sbjct: 72 YYENNLWILIEFCAGGAVDAVML---ELERPLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 701 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR---IAGTFGYMAPEYAMRGYLT 757
HRD+KA N+L D + K++DFG++ NT R GT +MAPE M
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 758 D-----KADVYSFGIVALEI 772
D KADV+S GI +E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 17/212 (8%)
Query: 576 NFAPDNKIGEGGFGPVYKGLLADG--KVIAVKQLS---------SKSKQGN-REFVNEIG 623
+A +G G FG VYK + ++A+K+++ + + + + V+E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 624 MI-SALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICI 682
+I L+HPN+V+ Y +E ++L ++ + +E L +E + + +I +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 683 GLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT 742
+ L YLH+E R IVHRD+ N++L +D I+DFGLAK + ++ T + GT
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGT 176
Query: 743 FGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
Y PE +KADV++FG + ++ +
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 581 NKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGC 639
+K+G G +G VY+G+ +AVK L + + EF+ E ++ ++HPNLV+L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
C +I E+M +L L E +R +++ + ++ + YL E +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL--EKK-NF 125
Query: 700 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT---FGYMAPEYAMRGYL 756
+HRD+ A N L+ ++ K++DFGL++L D T AG + APE
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 757 TDKADVYSFGIVALEIVS 774
+ K+DV++FG++ EI +
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-20
Identities = 65/210 (30%), Positives = 118/210 (56%), Gaps = 24/210 (11%)
Query: 577 FAPDNKIGEGGFGPVYKGL-LADGKVI----AVKQL-SSKSKQGNREFVNEIGMISALQH 630
F +G G FG VYKGL + +G+ + A+K+L + S + N+E ++E +++++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 631 PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEH---RLKLDWPTRHSICIGLARG 687
P++ +L G C+ + + LI + M L + +++ + L+W C+ +A+G
Sbjct: 69 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL---DEEDNTHISTRIAGTFG 744
+ YL EE RL VHRD+ A NVL+ + KI+DFGLAKL DE++ ++
Sbjct: 122 MNYL-EERRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP--IK 176
Query: 745 YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+MA E + T ++DV+S+G+ E+++
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYG 638
+G+GGFG V + GK+ A K+L K ++G + +NE ++ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 639 CCIEGNQLLLIYEYMENNSLARALF-----GPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
+ L L+ M L ++ G E R + IC GL +LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAI--FYAAQIIC-----GLEHLHQ 113
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR 753
+IV+RD+K NVLLD N +ISD GLA ++ + I R AGT GYMAPE
Sbjct: 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGR-AGTPGYMAPEVLQG 168
Query: 754 GYLTDKADVYSFGIVALEIVSGRS 777
D ++ G E+++GRS
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 7e-20
Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 47/232 (20%)
Query: 582 KIGEGGFGPVY--------------------KG--LLADGKVIAVKQL-SSKSKQGNREF 618
K+GEG FG V+ KG LL +AVK L +K +F
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLL-----VAVKILRPDANKNARNDF 66
Query: 619 VNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARAL---------------F 663
+ E+ ++S L+ PN+++L G C++ + L +I EYMEN L + L
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 664 GPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723
P + + + + + +A G+ YL S L VHRD+ N L+ ++L KI+DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 724 LAK-LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+++ L D I R +MA E + G T +DV++FG+ EI+
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 7e-20
Identities = 56/193 (29%), Positives = 94/193 (48%), Gaps = 7/193 (3%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCI 641
++G G FG V+ G +A+K ++ + +F+ E ++ L HP LV+LYG C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 642 EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVH 701
+ L ++ E+MEN L L + + KL S+C + G+ YL S +H
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 702 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKAD 761
RD+ A N L+ K+SDFG+ + +D S+ + PE + K+D
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 762 VYSFGIVALEIVS 774
V+SFG++ E+ +
Sbjct: 184 VWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 9e-20
Identities = 58/199 (29%), Positives = 109/199 (54%), Gaps = 14/199 (7%)
Query: 583 IGEGGFGPVYKGLLA-DGKVI----AVKQL-SSKSKQGNREFVNEIGMISALQHPNLVKL 636
+G G FG VYKG+ DG+ + A+K L + S + N+E ++E +++ + P + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
G C+ + + L+ + M L + E++ ++ + C+ +A+G++YL E
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYV---RENKDRIGSQDLLNWCVQIAKGMSYLEE--- 127
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT-FGYMAPEYAMRGY 755
+++VHRD+ A NVL+ + KI+DFGLA+L + D T +MA E +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187
Query: 756 LTDKADVYSFGIVALEIVS 774
T ++DV+S+G+ E+++
Sbjct: 188 FTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 69/219 (31%), Positives = 103/219 (47%), Gaps = 51/219 (23%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGN------REFVNEIGMISALQHPNL 633
N+IG G G VYK + G++ A+K + GN R+ EI ++ + HPN+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVI-----YGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLAR----GLA 689
VK + ++ ++ E+M+ SL +E L +AR G+A
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIA-DEQFLA-----------DVARQILSGIA 182
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG----LAKLDEEDNTHISTRIAGTFGY 745
YLH R IVHRDIK +N+L++ N KI+DFG LA+ + N+ + GT Y
Sbjct: 183 YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIAY 234
Query: 746 MAPEY--------AMRGYLTDKADVYSFGIVALEIVSGR 776
M+PE A GY D++S G+ LE GR
Sbjct: 235 MSPERINTDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 70/211 (33%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 575 NNFAPDNKIGEGGFGPVYK----GLLADGKVI--AVKQLSSKSKQGNRE-FVNEIGMISA 627
NN + +G G FG V + GL V+ AVK L + RE ++E+ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 628 L-QHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLAR 686
L H N+V L G C G +L+I EY L L E L L+ S +A+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE--DLLSFSYQVAK 152
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI---STRIAGTF 743
G+A+L ++ +HRD+ A NVLL KI DFGLA+ D+ ++ + R+
Sbjct: 153 GMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP--V 207
Query: 744 GYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+MAPE T ++DV+S+GI+ EI S
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 71/230 (30%), Positives = 106/230 (46%), Gaps = 37/230 (16%)
Query: 573 ATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQ-LSSKSKQGNREF----VNEIGMIS 626
++ K+GEG FG VYK + G+V+A+K+ L K G F + EI ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62
Query: 627 ALQHPNLVKLYGCCIE-----GNQLLLIY---EYMENNSLARALFGPEEHRLKLDWPTRH 678
L+HPN+V L +E + +Y YM+++ L+ L P +KL
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHD-LSGLLENP---SVKLTESQIK 118
Query: 679 SICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED------- 731
+ L G+ YLHE I+HRDIKA N+L+D KI+DFGLA+ +
Sbjct: 119 CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 732 ---NTHISTRIAGTFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGR 776
T T + T Y PE + R Y T D++ G V E+ + R
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 576 NFAPDNKIGEGGFGPVYKG-LLADGKVIAVKQ------LSSKSKQGNREFVNEIGMISAL 628
NF + KIG G F VY+ L DG +A+K+ + +K++ + + EI ++ L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 59
Query: 629 QHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGL 688
HPN++K Y IE N+L ++ E + L+R + ++ + + T + L L
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 689 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAP 748
++H +++HRDIK NV + K+ D GL + T + + GT YM+P
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSP 175
Query: 749 EYAMRGYLTDKADVYSFGIVALEIVSGRS 777
E K+D++S G + E+ + +S
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 73/205 (35%), Positives = 110/205 (53%), Gaps = 23/205 (11%)
Query: 583 IGEGGFGPVYKGLL--ADGKVI--AVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLY 637
IG+G FG VY G L +DG+ I AVK L+ + E F+ E ++ HPN++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 638 GCCI--EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPT-RHSICIGL--ARGLAYLH 692
G C+ EG+ L+++ YM++ L R E H PT + I GL A+G+ YL
Sbjct: 63 GICLPSEGSPLVVL-PYMKHGDL-RNFIRSETHN-----PTVKDLIGFGLQVAKGMEYLA 115
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEE-DNTHISTRIAGTFGYMAPE 749
+ K VHRD+ A N +LD+ K++DFGLA+ D+E + H T +MA E
Sbjct: 116 SK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 750 YAMRGYLTDKADVYSFGIVALEIVS 774
T K+DV+SFG++ E+++
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 60/194 (30%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 583 IGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLYGCCI 641
+G+G FG V+KG L D +AVK Q + +F++E ++ HPN+VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 642 EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVH 701
+ + ++ E + L ++ LK + ++ A G+AYL ES+ +H
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDE-LKTKQLVKFAL--DAAAGMAYL--ESK-NCIH 116
Query: 702 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT-FGYMAPEYAMRGYLTDKA 760
RD+ A N L+ ++ KISDFG+++ E+D + S+ + + APE G + ++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 761 DVYSFGIVALEIVS 774
DV+S+GI+ E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 582 KIGEGGFGPVYKGLL-----ADGKVIAVKQLSS-KSKQGNREFVNEIGMISALQHPNLVK 635
++GE FG +YKG L +++A+K L + Q EF E +++ L HPN+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEH-------------RLKLDWPTRHSICI 682
L G + + +++EY+ L L H + LD I I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 683 GLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAG 741
+A G+ YL S VH+D+ A N+L+ + L+ KISD GL++ + D + +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 742 TFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+M PE M G + +D++SFG+V EI S
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 67/198 (33%), Positives = 99/198 (50%), Gaps = 18/198 (9%)
Query: 583 IGEGGFGPVYKGLLAD--GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
IG+G FG V +L D G +AVK + K+ + F+ E +++ L+H NLV+L G
Sbjct: 14 IGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 641 IEGN-QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
+E L ++ EYM SL L R L + + + YL +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---F 123
Query: 700 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDK 759
VHRD+ A NVL+ +D K+SDFGL K E +T + ++ + APE + K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTK 179
Query: 760 ADVYSFGIVALEIVS-GR 776
+DV+SFGI+ EI S GR
Sbjct: 180 SDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 68/213 (31%), Positives = 100/213 (46%), Gaps = 39/213 (18%)
Query: 583 IGEGGFGPVYKG-LLADGKVIAVKQLSSKSKQGNREFVNEIGM---ISALQH--PNLVKL 636
IG G G VYK G V+AVKQ+ + GN+E I M + H P +VK
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 637 YGCCIEGNQLLLIYEYMEN--NSLARALFGP-EEHRLKLDWPTRHSICIGLARGLAYLHE 693
YG I + + + E M + L + + GP E L + + + + L YL E
Sbjct: 80 YGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-------KMTVAIVKALHYLKE 132
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE---- 749
+ ++HRD+K +N+LLD N K+ DFG++ + TR AG YMAPE
Sbjct: 133 KH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDP 188
Query: 750 ------YAMRGYLTDKADVYSFGIVALEIVSGR 776
Y +R ADV+S GI +E+ +G+
Sbjct: 189 PDPNPKYDIR------ADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 7e-19
Identities = 74/207 (35%), Positives = 105/207 (50%), Gaps = 35/207 (16%)
Query: 583 IGEGGFGPVYKGLLAD----GKVIAVKQLSS----KSKQGNREFV-NEIGMISALQHPNL 633
+G G FG V +L GK A+K LS K KQ E V NE ++ +++HP L
Sbjct: 9 LGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQ--VEHVLNEKRILQSIRHPFL 63
Query: 634 VKLYGCCIEGNQLLLIYEYM---ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
V LYG + + L L+ EY+ E S R R ++ + LA L Y
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVLA--LEY 116
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY 750
LH L IV+RD+K N+LLD D KI+DFG AK + T+ + GT Y+APE
Sbjct: 117 LH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGRTYT---LCGTPEYLAPEI 169
Query: 751 AM-RGYLTDKA-DVYSFGIVALEIVSG 775
+ +GY KA D ++ GI+ E+++G
Sbjct: 170 ILSKGY--GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 34/212 (16%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREF---VNEIGMISALQHPNLVK 635
I +G +G V+ LA G + A+K + + + E ++S Q P +VK
Sbjct: 1 ISKGAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARAL--FG--PEEHRLKLDWPTRHSIC-IGLARGLAY 690
LY L L+ EY+ LA L G E+ R I I LA L Y
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV-------ARIYIAEIVLA--LEY 108
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-------LDEEDNTHISTRIAGTF 743
LH I+HRD+K N+L+D + + K++DFGL+K ++ D+ RI GT
Sbjct: 109 LH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165
Query: 744 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 775
Y+APE + + D +S G + E + G
Sbjct: 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-19
Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 36/210 (17%)
Query: 582 KIGEGGFGPVYKGLLADGKV---------IAVKQLSSKSKQGNREFVNEIGMISALQHPN 632
KIGEG FG +Y LA K I + ++ K K+ ++ E+ +++ ++HPN
Sbjct: 7 KIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKMKHPN 60
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLAR-------ALFGPEEHRLKLDWPTRHSICIGLA 685
+V + E +L ++ EY + L + LF E ++ L W + ++
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQI-LSW------FVQIS 111
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLDEEDNTHISTRIAGTFG 744
GL ++H+ KI+HRDIK+ N+ L K+ + K+ DFG+A+ D+ ++ GT
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSMELAYTCVGTPY 167
Query: 745 YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
Y++PE +K D++S G V E+ +
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 9e-19
Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCC 640
+G G +G VYKG + G++ A+K + + E EI M+ H N+ YG
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 641 IEGN------QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
I+ N QL L+ E+ S+ + + + LK +W IC + RGL++LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLHQH 130
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDE---EDNTHISTRIAGTFGYMAPEY 750
K++HRDIK NVLL ++ K+ DFG+ A+LD NT I GT +MAPE
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEV 182
Query: 751 AMRGYLTD-----KADVYSFGIVALEIVSG 775
D K+D++S GI A+E+ G
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 9e-19
Identities = 64/209 (30%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 576 NFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQ--LSSKSKQGNREFVNEIGMISALQHPN 632
NF KIGEG +G VYK G+V+A+K+ L ++++ + EI ++ L HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+VKL N+L L++E++ + L + + + L P S L +GLA+ H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKSYLFQLLQGLAFCH 117
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEEDNTHISTRIAGTFGYMAPE 749
+++HRD+K N+L++ + K++DFGLA+ + TH T Y APE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPE 170
Query: 750 YAM-RGYLTDKADVYSFGIVALEIVSGRS 777
+ Y + D++S G + E+V+ R+
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 33/207 (15%)
Query: 576 NFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN-----EIGMISALQ 629
+ K+GEG + VYK G+++A+K++ ++ ++ +N EI ++ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 630 HPNLVKLYGCCIEGNQLLLIYEYME--------NNSLARALFGPEEHRLKLDWPTRHSIC 681
HPN++ L + + L++E+ME + S+ + P + + S
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIK---------SYM 108
Query: 682 IGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAG 741
+ RGL YLH I+HRD+K N+L+ D K++DFGLA+ N ++ ++
Sbjct: 109 LMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV- 164
Query: 742 TFGYMAPE--YAMRGYLTDKADVYSFG 766
T Y APE + R Y D++S G
Sbjct: 165 TRWYRAPELLFGARHY-GVGVDMWSVG 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 11/197 (5%)
Query: 583 IGEGGFGPVYKGLLA-DGK---VIAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVKLY 637
+G G FG + +G L K +A+ L + S + R F+ E + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
G GN ++++ EYM N +L L +H +L + GLA G+ YL E +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYLSE---M 126
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLT 757
VH+ + A VL++ DL KIS F + D+ + + + + APE + +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 758 DKADVYSFGIVALEIVS 774
+DV+SFGIV E++S
Sbjct: 187 SASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-18
Identities = 71/239 (29%), Positives = 120/239 (50%), Gaps = 38/239 (15%)
Query: 65 SISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPES-FANLTRLKHFRIS 123
+ S + + L SG + + + L ++ ++L++N +G +P+ F + L++ +S
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 124 DNHFTGQIPD-YIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGP--EGPF 180
+N+FTG IP I N LE L + + L+G IP+ I S + L++ DL G G
Sbjct: 127 NNNFTGSIPRGSIPN---LETLDLSNNMLSGEIPNDIGS---FSSLKVLDLGGNVLVGKI 180
Query: 181 P-RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIP----------- 228
P L+NL ++ +L L S ++G++P LGQM L+ + L +N LSG IP
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 229 -----SNFSG---------SGLTYMYLTGNLLTGPVPDWIVRKRNK-HIDLSYNNFIDG 272
+N +G L Y++L N L+GP+P I + +DLS +N + G
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLS-DNSLSG 298
|
Length = 968 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 582 KIGEGGFGPVY----------------KGLLADGKV-IAVKQL-SSKSKQGNREFVNEIG 623
K+GEG FG V+ + AD V +AVK L S +F+ E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 624 MISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHS-- 679
++S L PN+ +L G C L +I EYMEN L + L E L + +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 680 ---ICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHI 735
+ +A G+ YL L VHRD+ N L+ K+ KI+DFG+++ L D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
R +MA E + G T K+DV++FG+ EI++
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 30/206 (14%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLS-SKSKQGNREF-VNEIGM---ISALQHPNLV 634
+IGEG +G VYK L G+ +A+K++ S++G + EI + + + +HPN+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 635 KLYGCCI-----EGNQLLLIYEYMENNSLARAL-----FGPEEHRLKLDWPTRHSICIGL 684
+L C +L L++E+++ + LA L G +K R L
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQD-LATYLSKCPKPGLPPETIK--DLMRQ-----L 116
Query: 685 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG 744
RG+ +LH +IVHRD+K N+L+ D KI+DFGLA++ T + T
Sbjct: 117 LRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSVVVTLW 171
Query: 745 YMAPEYAMRGYLTDKADVYSFG-IVA 769
Y APE ++ D++S G I A
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFA 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-18
Identities = 55/160 (34%), Positives = 86/160 (53%), Gaps = 1/160 (0%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWK-QANGAIPKA 62
+ + NL GR+ +P LQ + L RN G +P + S L NL L + Q +GA+P+
Sbjct: 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRK 494
Query: 63 VASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRI 122
+ S+S L L L N+ SG++P EL + L L L+ N +G++P SF+ + L +
Sbjct: 495 LGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL 554
Query: 123 SDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASL 162
S N +G+IP + N L ++ I + L G +PS A L
Sbjct: 555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFL 594
|
Length = 968 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 576 NFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLS-SKSKQG-NREFVNEIGMISALQHPN 632
F N+IGEG +G VY+ G+++A+K++ + G + EI ++ L+HPN
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 633 LVKLYGCCIEGNQL---LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLA 689
+V+L + G L L+ EY E + LA L + + + L RGL
Sbjct: 68 IVELKE-VVVGKHLDSIFLVMEYCEQD-LASLL---DNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE 749
YLHE I+HRD+K +N+LL KI+DFGLA+ ++ ++ T Y APE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178
Query: 750 --YAMRGYLTDKADVYSFGIVALEIVSGR 776
Y T D+++ G + E+++ +
Sbjct: 179 LLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 31/209 (14%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKLYG 638
KIGEG +G VYK G+++A+K+ L ++ + + EI ++ L HPN+V+L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 639 CCIEGNQLLLIYEYMEN------NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
N+L L++E+++ +S P +K S L +G+AY H
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPP--LIK-------SYLYQLLQGIAYCH 116
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEEDNTHISTRIAGTFGYMAPE 749
S +++HRD+K N+L+D++ K++DFGLA+ + TH T Y APE
Sbjct: 117 --SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPE 169
Query: 750 YAM--RGYLTDKADVYSFGIVALEIVSGR 776
+ R Y T D++S G + E+V+ R
Sbjct: 170 ILLGSRQYST-PVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 70/210 (33%), Positives = 104/210 (49%), Gaps = 28/210 (13%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCC 640
+G G +G VYKG + G++ A+K + + E EI M+ H N+ YG
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 641 IE------GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
I+ +QL L+ E+ S+ + + + LK DW IC + RGLA+LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLHAH 140
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDE---EDNTHISTRIAGTFGYMAPEY 750
K++HRDIK NVLL ++ K+ DFG+ A+LD NT I GT +MAPE
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEV 192
Query: 751 AMRGYLTD-----KADVYSFGIVALEIVSG 775
D ++D++S GI A+E+ G
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 582 KIGEGGFGPVYKGLLADGKV-------IAVKQLSSKSKQGNR-EFVNEIGMISALQHPNL 633
++G+G FG VY+G+ A G V +A+K ++ + R EF+NE ++ ++
Sbjct: 13 ELGQGSFGMVYEGI-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLA---RALFGPEEHRLKLDWPT-RHSICIG--LARG 687
V+L G +G L+I E M L R+L E+ P+ + I + +A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAGTFGYM 746
+AYL+ K VHRD+ A N ++ +D KI DFG+ + + E D + +M
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 747 APEYAMRGYLTDKADVYSFGIVALEIVS 774
+PE G T +DV+SFG+V EI +
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 583 IGEGGFGPVYKGLLAD-----GKVIAVK--QLSSKSKQGNREFVNEIGMISALQHPNLVK 635
+GEG FG V +G L+ KV AVK +L + EF++E + HPN++K
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKV-AVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 636 LYGCCIEGNQL------LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSI--CIGLARG 687
L G C E + L ++I +M++ L L L P + + + +A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT-FGYM 746
+ YL S +HRD+ A N +L +D+ ++DFGL+K + + RIA ++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 747 APEYAMRGYLTDKADVYSFGIVALEIVS 774
A E T K+DV++FG+ EI +
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 71/214 (33%), Positives = 108/214 (50%), Gaps = 38/214 (17%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQLSSKS-KQGNREFVNEIGMISALQH-PNLVKLYG- 638
IG G FG V K L G ++AVK++ S ++ + + ++ ++ P +VK YG
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 639 ------C--CIE--GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGL 688
C C+E L Y+Y+ + PEE K I + + L
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVI---PEEILGK--------IAVATVKAL 120
Query: 689 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRIAGTFGYMA 747
YL EE LKI+HRD+K +N+LLD++ N K+ DFG++ +L ++ TR AG YMA
Sbjct: 121 NYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMA 175
Query: 748 PE----YAMRGYLTD-KADVYSFGIVALEIVSGR 776
PE A GY D ++DV+S GI E+ +G+
Sbjct: 176 PERIDPSARDGY--DVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 14/209 (6%)
Query: 576 NFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQ------LSSKSKQGNREFVNEIGMISAL 628
NF + KIG G F VY+ L D K +A+K+ + +K++Q + V EI ++ L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQL 59
Query: 629 QHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGL 688
HPN++K IE N+L ++ E + L++ + ++ + + T + L +
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 689 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAP 748
++H SR +++HRDIK NV + K+ D GL + T + + GT YM+P
Sbjct: 120 EHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSP 175
Query: 749 EYAMRGYLTDKADVYSFGIVALEIVSGRS 777
E K+D++S G + E+ + +S
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLYGCC 640
+G G G V K + G V+A K + +K R + + E+ ++ + P +V YG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 641 IEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+ N + + E+M+ SL R GP + ++ I + + GL YL+ R
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGP----IPVE--ILGKIAVAVVEGLTYLYNVHR-- 124
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
I+HRDIK +N+L++ K+ DFG++ E N+ I+ GT YM+PE G T
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVS--GELINS-IADTFVGTSTYMSPERIQGGKYTV 181
Query: 759 KADVYSFGIVALEIVSGR 776
K+DV+S GI +E+ G+
Sbjct: 182 KSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 582 KIGEGGFGPVYKGLL---ADG---KVIAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLV 634
++GE FG VYKG L A G + +A+K L K++ RE F +E M S LQHPN+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEH------------RLKLDWPTRHSICI 682
L G + L +I+ Y ++ L L H + L+ I
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 683 GLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAG 741
+A G+ +L S +VH+D+ NVL+ LN KISD GL + + D +
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 742 TFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+M+PE M G + +D++S+G+V E+ S
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 34/218 (15%)
Query: 580 DNKIGEGGFGPVYKGLLA-DGKVI--AVKQLSS-KSKQGNREFVNEIGMISAL-QHPNLV 634
++ IGEG FG V + ++ DG + A+K L S+ +R+F E+ ++ L HPN++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 635 KLYGCCIEGNQLLLIYEYMENNSL------ARAL-----FGPEEHRLKLDWPTRH--SIC 681
L G C L + EY +L +R L F +EH ++
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFA-KEHGTASTLTSQQLLQFA 125
Query: 682 IGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAG 741
+A G+ YL E+ + +HRD+ A NVL+ ++L KI+DFGL++ +E +
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEE-------VYVKK 175
Query: 742 TFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
T G +MA E T K+DV+SFG++ EIVS
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 582 KIGEGGFGPVYKGLLAD---GKV---IAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLV 634
++G+G FG VY+G D G+ +AVK ++ + R EF+NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLA---RALFGPEEHRLKLDWPTRHSI---CIGLARGL 688
+L G +G L++ E M + L R+L E+ PT + +A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 689 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAGTFGYMA 747
AYL+ + K VHRD+ A N ++ D KI DFG+ + + E D + +MA
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 748 PEYAMRGYLTDKADVYSFGIVALEIVS 774
PE G T +D++SFG+V EI S
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGC 639
+G G FG V+ AD K++ +KQ+ + +K NE ++ L HPN+++ Y
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
+E L+++ EY +LA + + LD T + + L ++H + I
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVHTK---LI 122
Query: 700 VHRDIKATNVLLDKDLNP-KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
+HRD+K N+LLDK KI DFG++K + + + GT Y++PE
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 759 KADVYSFGIVALEIVS 774
K+D+++ G V E+ S
Sbjct: 181 KSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 27/205 (13%)
Query: 582 KIGEGGFGPVYKGLLA----DGKVIAVKQL--SSKSKQGNREFVNEIGMISALQHPNLVK 635
KIGEG FG K +L DGK +K++ S S + E E+ ++S ++HPN+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 636 LYGCCIEGNQLLLIYEYMENNSL------ARALFGPEEHRLKLDWPTRHSICIGLARGLA 689
E L ++ +Y E L R + PE+ LDW + IC+ L
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ--ILDWFVQ--ICLALK---- 115
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE 749
++H+ KI+HRDIK+ N+ L KD K+ DFG+A++ ++ GT Y++PE
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPE 171
Query: 750 YAMRGYLTDKADVYSFGIVALEIVS 774
+K+D+++ G V E+ +
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 582 KIGEGGFGPVYKGLLADGKV---IAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLY 637
++G G FG V KG+ K +A+K L +++++ R E + E ++ L +P +V++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGL---ARGLAYLHEE 694
G C E L+L+ E L + L G K D T ++ + + G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSG------KKDEITVSNVVELMHQVSMGMKYLEGK 114
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEYAM 752
+ VHRD+ A NVLL KISDFGL+K D+++ R AG + + APE
Sbjct: 115 N---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 753 RGYLTDKADVYSFGIVALEIVS 774
+ ++DV+S+GI E S
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 16/196 (8%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLS-SKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
+G G G VYK L +++AVK + + + ++ ++E+ ++ P ++ YG
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 641 IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIV 700
N++ + E+M+ SL PE I + + +GL YL LKI+
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPE--------HVLGRIAVAVVKGLTYLWS---LKIL 117
Query: 701 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKA 760
HRD+K +N+L++ K+ DFG++ + I+ GT YMAPE +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 761 DVYSFGIVALEIVSGR 776
DV+S GI +E+ GR
Sbjct: 175 DVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 24/207 (11%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLS-SKSKQGNREF----VNEIGMISALQHPNLV 634
N+I EG +G VY+ G+++A+K+L K K+G F + EI ++ LQHPN+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIV 67
Query: 635 KL----YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
+ G + +++ ++ EY+E++ L + E + + + L G+A+
Sbjct: 68 TVKEVVVGSNL--DKIYMVMEYVEHD-LKSLM---ETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY 750
LH+ I+HRD+K +N+LL+ KI DFGLA+ + T++ T Y APE
Sbjct: 122 LHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLVVTLWYRAPEL 177
Query: 751 AM-RGYLTDKADVYSFGIVALEIVSGR 776
+ + D++S G + E+++ +
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 18/206 (8%)
Query: 581 NKIGEGGFGPVYKG----LLADGKVIAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVK 635
++IG G FG V G ++ +V+ VK+L +S + F+ E+ L HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVV-VKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEH-RLKLDWPTRHSICIGLARGLAYLHEE 694
G CIE LL+ E+ L L + +A GL +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-- 117
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD-EEDNTHISTRIAGTFGYMAPEYA-- 751
+ +H D+ N L DL+ KI D+GLA ED A ++APE
Sbjct: 118 -QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 752 -----MRGYLTDKADVYSFGIVALEI 772
+ T K++++S G+ E+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 583 IGEGGFGPVY------KGLLADGKVIAVKQLSSKSKQGN-REFVNEIGMISALQHPNLVK 635
+GEG FG V +G G+ +AVK L +S + + EI ++ L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 636 LYGCCIE--GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
G C E GN + LI E++ + SL L ++ K++ + + + +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLG- 126
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEEDNTHISTRIAGTFGYMAPEY 750
SR + VHRD+ A NVL++ + KI DFGL K D+E T + F Y APE
Sbjct: 127 -SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APEC 183
Query: 751 AMRGYLTDKADVYSFGIVALEIVS 774
++ +DV+SFG+ E+++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 44/148 (29%), Positives = 79/148 (53%), Gaps = 10/148 (6%)
Query: 582 KIGEGGFGPVYKGLLAD-GKVIAVK--QLSSKSKQGNREFVNEIGMISALQHPNLVKLYG 638
KIGEG +G V+K + +++A+K +L + + EI ++ L+H N+V+LY
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+L L++EY + + L + + +D S L +GLA+ H
Sbjct: 67 VLHSDKKLTLVFEYCDQD-LKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAK 726
++HRD+K N+L++K+ K++DFGLA+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 582 KIGEGGFGPVYKGLL-ADGKVIAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVKLYGC 639
+IG G FG V+ G L AD +AVK + +F+ E ++ HPN+V+L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
C + + ++ E ++ E RLK+ + + A G+ YL ES+
Sbjct: 62 CTQKQPIYIVMELVQGGDF-LTFLRTEGPRLKVKELIQ--MVENAAAGMEYL--ESK-HC 115
Query: 700 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT----FGYMAPEYAMRGY 755
+HRD+ A N L+ + KISDFG+++ +EED + ST G + APE G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYAST--GGMKQIPVKWTAPEALNYGR 172
Query: 756 LTDKADVYSFGIVALEIVS 774
+ ++DV+SFGI+ E S
Sbjct: 173 YSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKLYG 638
KIGEG +G VYKG G+++A+K+ L S+ + + EI ++ LQHPN+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 639 CCIEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
++ ++L LI+E++ + L + L ++ +D S + +G+ + H
Sbjct: 67 VLMQESRLYLIFEFLSMD-LKKYLDSLPKGQY---MDAELVKSYLYQILQGILFCH---S 119
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRI----AGTFGYMAPEYAM 752
+++HRD+K N+L+D K++DFGLA+ I R+ T Y APE +
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLAR-----AFGIPVRVYTHEVVTLWYRAPEVLL 174
Query: 753 RG--YLTDKADVYSFGIVALEIVSGR 776
Y T D++S G + E+ + +
Sbjct: 175 GSPRYST-PVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 583 IGEGGFGPVYKGLLA-DGKVI--AVKQLSS-KSKQGNREFVNEIGMISAL-QHPNLVKLY 637
IGEG FG V K + DG + A+K++ SK +R+F E+ ++ L HPN++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 638 GCCIEGNQLLLIYEYMENNSL------ARALFG----PEEHRLKLDWPTRHSICIG--LA 685
G C L L EY + +L +R L + ++ + +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGY 745
RG+ YL ++ + +HRD+ A N+L+ ++ KI+DFGL++ E R+ +
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 177
Query: 746 MAPEYAMRGYLTDKADVYSFGIVALEIVS 774
MA E T +DV+S+G++ EIVS
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQL-SSKSKQGNREFVNE--IGMISALQHPNLVKLYG 638
+G G +G V K + G ++AVK++ ++ + Q + + + I M S P V YG
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV-DCPYTVTFYG 67
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+ + E M+ SL + + L + I + + + L YLH +L
Sbjct: 68 ALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLS 124
Query: 699 IVHRDIKATNVLLDKDLNPKISDFG--------LAKLDEEDNTHISTRIAGTFGYMAPE- 749
++HRD+K +NVL++++ K+ DFG +AK T AG YMAPE
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK----------TIDAGCKPYMAPER 174
Query: 750 ----YAMRGYLTDKADVYSFGIVALEIVSGR 776
+GY K+DV+S GI +E+ +GR
Sbjct: 175 INPELNQKGYDV-KSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAVKQLS------------SKSKQGNREFVNEIGMISALQ 629
++G+G FG VY L+ D K +A ++L +++ Q N+E ++S L
Sbjct: 7 RLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSKLD 60
Query: 630 HPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLA 689
HP +VK + +E + +I EY E L L + L I L G+
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE 749
Y+H+ +I+HRD+KA N+ L +L KI DFG+++L + ++T GT YM+PE
Sbjct: 121 YMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRL-LMGSCDLATTFTGTPYYMSPE 175
Query: 750 -YAMRGYLTDKADVYSFGIVALEI 772
+GY + K+D++S G + E+
Sbjct: 176 ALKHQGYDS-KSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 4e-16
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 564 SFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIG 623
S T+ I ++ +N I G G YKG + V + + + ++G
Sbjct: 682 SITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMG 738
Query: 624 MISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIG 683
LQHPN+VKL G C LI+EY+E +L+ L L W R I IG
Sbjct: 739 ---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIG 788
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF 743
+A+ L +LH +V ++ +++D P + L L D +
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS----- 842
Query: 744 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRS 777
Y+APE +T+K+D+Y FG++ +E+++G+S
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKS 876
|
Length = 968 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 583 IGEGGFGPVYK----GLLADGK----VIAVKQLSSKSKQGN-REFVNEIGMISAL-QHPN 632
+GEG FG V + G+ +AVK L + + + ++E+ ++ + +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSL-----AR-------ALFGPEEHRLKLDWPTRHSI 680
++ L G C + L +I EY +L AR + +L + S
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 681 CIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIA 740
+ARG+ YL ESR + +HRD+ A NVL+ +D KI+DFGLA+ I
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDYYKK 192
Query: 741 GTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+ G +MAPE T ++DV+SFGI+ EI +
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 582 KIGEGGFGPVYKG---LLADGKVIAVKQLSSKSKQG--NREFVNEIGMISALQHPNLVKL 636
++G G FG V KG + K +AVK L + + E + E ++ L +P +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
G C E +L+ E E L + L + K H + +G+ YL E +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMK----YLEETN- 115
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEYAMRG 754
VHRD+ A NVLL KISDFGL+K D + + G + + APE
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 755 YLTDKADVYSFGIVALEIVS 774
+ K+DV+SFG++ E S
Sbjct: 174 KFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 6e-16
Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 32/208 (15%)
Query: 583 IGEGGFGPVY---KGLLAD-GKVIAVKQLSSKSKQGNREFV---NEIGMISALQHPNLVK 635
+G+G FG V+ K D G++ A+K L K+ R+ V E +++ + HP +VK
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLK-KATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 636 L-YGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLA 689
L Y EG +L LI +++ L +F E+ + L LA L
Sbjct: 63 LHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL---------AELALALD 112
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRIAGTFGYMA 747
+LH L I++RD+K N+LLD++ + K++DFGL+K +D E + GT YMA
Sbjct: 113 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMA 166
Query: 748 PEYAMRGYLTDKADVYSFGIVALEIVSG 775
PE R T AD +SFG++ E+++G
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 583 IGEGGFGPVYKGLLADGKVI---AVK--QLSSKSKQGNREFVNEIGMISALQHPNLVKLY 637
+GEG FG V +G L I AVK +++ ++ +F++E + HPN+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 638 GCCIEGNQL------LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSI--CIGLARGLA 689
G C++ + ++I +M++ L L PT+ + +A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT-FGYMAP 748
YL S +HRD+ A N +L++++N ++DFGL+K + + RIA ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 749 EYAMRGYLTDKADVYSFGIVALEIVS 774
E T K+DV+SFG+ EI +
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 582 KIGEGGFGPVYKGLL---ADGKVIAVKQLSSKSKQG---NREFVNEIGMISALQHPNLVK 635
IG G +G VYK DGK A+K+ +Q ++ EI ++ L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 636 LYGCCIEGNQ--LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
L +E + L+++Y E++ F + R+ + S+ + G+ YLH
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 694 ESRLKIVHRDIKATNVLLDKDLNP----KISDFGLAK--------LDEEDNTHISTRIAG 741
++HRD+K N+L+ + KI D GLA+ L + D +
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD------PVVV 177
Query: 742 TFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVS 774
T Y APE + R Y T D+++ G + E+++
Sbjct: 178 TIWYRAPELLLGARHY-TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 59/186 (31%), Positives = 89/186 (47%), Gaps = 27/186 (14%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQ-LSSKSKQGNREF----VNEIGMISALQHPNLV 634
KIG+G FG V+K +++A+K+ L K+G F + EI ++ L+H N+V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVV 74
Query: 635 KLYGCC----IEGN----QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLAR 686
L C N L++E+ E++ LA L +K + L
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLLSNK---NVKFTLSEIKKVMKMLLN 130
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEEDNTHISTRIAGTF 743
GL Y+H R KI+HRD+KA N+L+ KD K++DFGLA+ L + + T T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 744 GYMAPE 749
Y PE
Sbjct: 188 WYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 34/219 (15%)
Query: 583 IGEGGFGPVYK----GLLAD--GKV--IAVKQLSSKSKQGN-REFVNEIGMISAL-QHPN 632
+GEG FG V GL + +V +AVK L S + + + + ++E+ M+ + +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRH------------SI 680
++ L G C + L +I EY +L L ++ + S
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 681 CIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIA 740
+ARG+ YL + K +HRD+ A NVL+ +D KI+DFGLA+ D HI
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 198
Query: 741 GTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
T G +MAPE T ++DV+SFG++ EI +
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYG 638
+G+GGFG V + + GK+ A K+L K K G + + E ++ + P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
L L+ M L ++ E L+++ +S I G+ +LH +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI--TCGILHLHS---MD 115
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
IV+RD+K NVLLD N ++SD GLA ++ +D I+ R AGT GYMAPE +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTITQR-AGTNGYMAPEILKEEPYSY 173
Query: 759 KADVYSFGIVALEIVSGRS 777
D ++ G E+V+GR+
Sbjct: 174 PVDWFAMGCSIYEMVAGRT 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 68/212 (32%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 583 IGEGGFGPVYK-GLLADGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYG 638
+G+GGFG V + A GK+ A K+L K ++G +NE ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 639 CCIEGNQLLLIYEYMENNSLARALF-----GPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
+ L L+ M L ++ G EE R IC GL LH+
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF---YAAEICCGLE----DLHQ 120
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR 753
E +IV+RD+K N+LLD + +ISD GLA E T I R+ GT GYMAPE
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKN 175
Query: 754 GYLTDKADVYSFGIVALEIVSGRSNVICRTKE 785
T D ++ G + E+++G+S R K+
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 29/204 (14%)
Query: 583 IGEGGFGPVYKGLLAD----GKVIAVKQLS-----SKSKQGNREFVNEIGMISALQHPNL 633
I +G FG VY LA G A+K L +K++ N + I MI + P +
Sbjct: 4 ISKGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQG-ESPYV 59
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLARGLAYL 691
KLY + L L+ EY+ A + G L DW ++ + L G+ L
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG----LPEDWAKQYIAEVVL--GVEDL 113
Query: 692 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYA 751
H+ I+HRDIK N+L+D+ + K++DFGL++ N + + GT Y+APE
Sbjct: 114 HQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETI 165
Query: 752 MRGYLTDKADVYSFGIVALEIVSG 775
+ +D +S G V E + G
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 27/207 (13%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQL--SSKSKQGNREFVN----EIGMISALQHPNLVK 635
+G G FG VY AD G+ +AVKQ+ S++ ++E VN EI ++ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68
Query: 636 LYGCC--IEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLARGLAYL 691
YGC E +L + EYM S+ L +G + + TR + +G++YL
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRY-TRQ-----ILQGVSYL 122
Query: 692 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE---DNTHISTRIAGTFGYMAP 748
H IVHRDIK N+L D N K+ DFG +K + T I + + GT +M+P
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSP 178
Query: 749 EY-AMRGYLTDKADVYSFGIVALEIVS 774
E + GY KADV+S +E+++
Sbjct: 179 EVISGEGY-GRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 70/221 (31%), Positives = 102/221 (46%), Gaps = 17/221 (7%)
Query: 567 LRQIKAATNNFAPDNKIGEGGFGPVYK-GLLADGKVIAVKQLSSKSKQGNREFVNEIGMI 625
L + T+ + IG+G +G VYK DG + AVK L S + E E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNIL 72
Query: 626 SAL-QHPNLVKLYGCCIE-----GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHS 679
+L HPN+VK YG + G QL L+ E S+ + G +LD
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 680 ICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRI 739
I G GL +LH +I+HRD+K N+LL + K+ DFG++ +T +
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 740 AGTFGYMAPEY----AMRGYLTD-KADVYSFGIVALEIVSG 775
GT +MAPE Y D + DV+S GI A+E+ G
Sbjct: 190 -GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 32/218 (14%)
Query: 583 IGEGGFGPVY--------KGLLADGKVIAVKQLSSKSKQGN-REFVNEIGMISAL-QHPN 632
+GEG FG V K + +AVK L + + + + V+E+ M+ + +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSL-----ARALFG----------PEEHRLKLDWPTR 677
++ L G C + L +I EY +L AR G P+E ++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE---QMTFKDL 139
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHIS 736
S +ARG+ YL + K +HRD+ A NVL+ ++ KI+DFGLA+ ++ D +
Sbjct: 140 VSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 737 TRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
T +MAPE T ++DV+SFG++ EI +
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 38/211 (18%)
Query: 582 KIGEGGFGPVYKGLLAD-GKVIAVKQL--SSKSKQGNREFVNEIGMISALQHPNLVKLYG 638
KIGEG +G V+K + G+++A+K+ S + + EI M+ L+HPNLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 639 CCIEGNQLLLIYEYMEN---NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
+L L++EY ++ N L + G EH +K I + + + H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-------KIIWQTLQAVNFCH--- 117
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKL----DEEDNTHISTRIAGTFGYMAPE-- 749
+ +HRD+K N+L+ K K+ DFG A++ ++ +++TR Y APE
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPELL 172
Query: 750 -----YAMRGYLTDKADVYSFGIVALEIVSG 775
Y DV++ G V E+++G
Sbjct: 173 VGDTQYG------PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-15
Identities = 57/206 (27%), Positives = 106/206 (51%), Gaps = 15/206 (7%)
Query: 575 NNFAPDNKIGEGGFGPVYK-GLLADGKVIAVKQLSSKSKQGNR-EFVNEIGMISALQHPN 632
++F +++G G G V K G ++A K + + K R + + E+ ++ P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+V YG ++ + E+M+ SL + L E R+ + + SI + RGLAYL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAV--LRGLAYLR 120
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRIAGTFGYMAPEY 750
E+ +I+HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+PE
Sbjct: 121 EKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPER 173
Query: 751 AMRGYLTDKADVYSFGIVALEIVSGR 776
+ + ++D++S G+ +E+ GR
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 36/216 (16%)
Query: 583 IGEGGFGPVYK------GLLADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVK 635
IGEG FG V K GL D + +K+ +SK +R+F E+ ++ L HPN++
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKLGHHPNIIN 72
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGL----------- 684
L G C L L EY + +L L + +S L
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 685 -ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF 743
ARG+ YL S+ + +HRD+ A N+L+ ++ KI+DFGL++ E + T
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 182
Query: 744 G-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
G +MA E T +DV+S+G++ EIVS
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 68/208 (32%), Positives = 106/208 (50%), Gaps = 25/208 (12%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQLS--SKSKQGNREFVN---EIGMISALQHPNLVKL 636
+G+G FG VY D G+ +A KQ+ +S + ++E EI ++ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 637 YGCCIE-GNQLLLIY-EYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
YGC + + L I+ EYM S+ L +G + + TR + G++YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY-TRQ-----ILEGMSYLH 123
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE---DNTHISTRIAGTFGYMAPE 749
IVHRDIK N+L D N K+ DFG +K + T I + + GT +M+PE
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPE 179
Query: 750 Y-AMRGYLTDKADVYSFGIVALEIVSGR 776
+ GY KADV+S G +E+++ +
Sbjct: 180 VISGEGY-GRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 576 NFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 634
+F +IG G +G VYK + G++ A+K + + + EI M+ +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARA--LFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+G + ++L + E+ SL + GP ++ + +R ++ +GL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSE-SQIAYVSRETL-----QGLYYLH 123
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIA------GTFGYM 746
+ ++ HRDIK N+LL + + K++DFG++ I+ IA GT +M
Sbjct: 124 SKGKM---HRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWM 173
Query: 747 APEYAM---RGYLTDKADVYSFGIVALEI 772
APE A +G D+++ GI A+E+
Sbjct: 174 APEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 577 FAPDNKIGEGGFGPVYKG--LLADGKVIAVKQLSSKSKQGNREF--VNEIGMISALQ--- 629
+ +IGEG +G V+K L G+ +A+K++ ++ + + E+ ++ L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 630 HPNLVKLYGCCI-----EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGL 684
HPN+V+L+ C +L L++E+++ + PE + T + L
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDMMFQL 119
Query: 685 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG 744
RGL +LH ++VHRD+K N+L+ K++DFGLA++ T + T
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTLW 174
Query: 745 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
Y APE ++ D++S G + E+ +
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 20/201 (9%)
Query: 583 IGEGGFGPVYKGLL---ADGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLY 637
+G+G +G V L+ DGK +K+L+ + S++ + E ++S L+HPN+V Y
Sbjct: 8 VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AY 64
Query: 638 GCCIEGN--QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSI--CIGLARGLAYLHE 693
EG L ++ + E L L +E + KL P + + +A L YLHE
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKL---KEQKGKL-LPENQVVEWFVQIAMALQYLHE 120
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR 753
+ I+HRD+K NV L + K+ D G+A++ E ST I GT YM+PE
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSN 176
Query: 754 GYLTDKADVYSFGIVALEIVS 774
K+DV++ G E+ +
Sbjct: 177 KPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 9e-15
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 583 IGEGGFGPVYK-GLLADGKVIAVKQLSSKSKQGNREFVNEIGM----ISALQHPNLVKLY 637
+G+GGFG V + A GK+ A K+L+ K + + + E M I A H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGY--EGAMVEKRILAKVHSRFIVSL 58
Query: 638 GCCIEGN-QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
+ L L+ M L ++ +E P + GL +LH+
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYL 756
+I++RD+K NVLLD D N +ISD GLA ++ +D + AGT G+MAPE ++G
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGTPGFMAPEL-LQGEE 173
Query: 757 TDKA-DVYSFGIVALEIVSGRSNVICR 782
D + D ++ G+ E+++ R R
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRAR 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-15
Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLS---SKSKQGNREFVNEIGMISALQHPNLVKLY 637
IG+GG G VY + +A+K++ S++ + F+ E + + L HP +V +Y
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFG-------PEEHRLKLDWPTRHSICIGLARGLAY 690
C +G+ + Y+E +L L +E K SI + + Y
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEED--------------NT 733
+H S+ ++HRD+K N+LL I D+G A L+EED +
Sbjct: 129 VH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
I +I GT YMAPE + ++ D+Y+ G++ ++++
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
++G G +G VYK L G++ AVK + + EI M+ +H N+V +G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 641 IEGNQLLLIYEYMENNSLARA--LFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+ +L + EY SL + GP L++ + R ++ +GLAYLH + ++
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSE-LQIAYVCRETL-----QGLAYLHSKGKM- 128
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIA------GTFGYMAPEYAM 752
HRDIK N+LL + + K++DFG+A I+ IA GT +MAPE A
Sbjct: 129 --HRDIKGANILLTDNGDVKLADFGVA-------AKITATIAKRKSFIGTPYWMAPEVAA 179
Query: 753 ---RGYLTDKADVYSFGIVALEI 772
G D+++ GI A+E+
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 583 IGEGGFGPVY--------KGLLADGKVIAVKQLSSKSKQGN-REFVNEIGMISAL-QHPN 632
+GEG FG V K +AVK L + + + V+E+ M+ + +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFG---------------PEEHRLKLDWPTR 677
++ L G C + L ++ EY +L L PEE +L +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE---QLTFKDL 136
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHIS 736
S +ARG+ YL + K +HRD+ A NVL+ +D KI+DFGLA+ + D +
Sbjct: 137 VSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 737 TRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
T +MAPE T ++DV+SFG++ EI +
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 68/208 (32%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQLSSKS---KQGNREFVNE---IGMISALQHPNLVK 635
IG GGFG VY AD GK+ A+K L K KQG +NE + ++S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 636 LYGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
+ ++L I + M L +F E R I +GL
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-----YAAEIILGLE----- 111
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY 750
H +R +V+RD+K N+LLD+ + +ISD GLA + H S GT GYMAPE
Sbjct: 112 -HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166
Query: 751 AMRGYLTD-KADVYSFGIVALEIVSGRS 777
+G D AD +S G + +++ G S
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 68/208 (32%), Positives = 97/208 (46%), Gaps = 28/208 (13%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQLSSKS---KQGNREFVNE---IGMISALQHPNLVK 635
IG GGFG VY AD GK+ A+K L K KQG +NE + ++S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 636 LYGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
+ ++L I + M L +F +E R I +GL
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYAT-----EIILGLE----- 111
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY 750
H +R +V+RD+K N+LLD+ + +ISD GLA + H S GT GYMAPE
Sbjct: 112 -HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166
Query: 751 AMRGYLTD-KADVYSFGIVALEIVSGRS 777
+G D AD +S G + +++ G S
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 583 IGEGGFGPVYK-GLLADGKVIAVKQLSSKSKQGNRE---FVNEIGMISALQHPNLVKLYG 638
+G GGFG V + + + A+K + + + +E ++ HP +VKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSI-CIGLARGLAYLHEESRL 697
+ + ++ EY L L + L ++ R I C+ LA YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL---RDRGLFDEYTARFYIACVVLA--FEYLH---NR 112
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAGTFGYMAPEYAM-RGY 755
I++RD+K N+LLD + K+ DFG AK L T GT Y+APE + +GY
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGY 169
Query: 756 LTDKADVYSFGIVALEIVSGR 776
D +S GI+ E+++GR
Sbjct: 170 -DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 582 KIGEGGFGPVYKGLLAD-GKVIAVKQL--SSKSKQGNREFVNEIGMISALQHPNLVKLYG 638
+GEG +G V K + G+++A+K+ S K + + EI M+ L+H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 639 CCIEGNQLLLIYEYMEN---NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
+L L++E++++ + L + G +E R++ + RG+ + H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR-------KYLFQILRGIEFCHSHN 120
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGY 755
I+HRDIK N+L+ + K+ DFG A+ + T T Y APE +
Sbjct: 121 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDT 176
Query: 756 LTDKA-DVYSFGIVALEIVSG 775
+A D+++ G + E+++G
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 69/208 (33%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ----HPNLVK 635
KIGEG F V K GK A+K + K + E VN + I AL+ HPN+++
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 636 LYGCCIE--GNQLLLIYEYMENN--SLARALFGP-EEHRLKLDWPTRHSICIGLARGLAY 690
L + +L L++E M+ N L + P E R+K S L + L +
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVK-------SYMYQLLKSLDH 115
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNT-HISTRIAGTFGYMA 747
+H R I HRDIK N+L+ D+ K++DFG + + T +ISTR Y A
Sbjct: 116 MH---RNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTR-----WYRA 166
Query: 748 PEYAMR-GYLTDKADVYSFGIVALEIVS 774
PE + GY K D+++ G V EI+S
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 60/191 (31%), Positives = 92/191 (48%), Gaps = 30/191 (15%)
Query: 577 FAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLS-SKSKQGNREF----VNEIGMISALQH 630
F +IGEG +G VYK D G+++A+K++ K+G F + EI ++ L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKILRQLNH 65
Query: 631 PNLVKLYGCCIEGNQLL----------LIYEYMENNSLARALFGPEEHRLKLDWPTRH-- 678
N+V L + L L++EYM+++ L G E L + + H
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGL-VHFSEDHIK 119
Query: 679 SICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 738
S L GL Y H+++ L HRDIK +N+LL+ K++DFGLA+L + + T
Sbjct: 120 SFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176
Query: 739 IAGTFGYMAPE 749
T Y PE
Sbjct: 177 KVITLWYRPPE 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 579 PDNKIGEGGFGPVYKGL-LADGKVIAVKQLSS------KSKQGNRE-----FVNEIGMIS 626
PD IG G FG V+ DGK +A+K++ + K+ RE F ++S
Sbjct: 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63
Query: 627 ALQ--HPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPE----EHRLKLDWPTRHSI 680
AL P + + ++ ++ E M+++ L + + P+ +H +K+
Sbjct: 64 ALDILQPPHIDPF------EEIYVVTELMQSD-LHKIIVSPQPLSSDH-VKV-------F 108
Query: 681 CIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIA 740
+ RGL YLH I+HRDIK N+L++ + KI DFGLA+++E D + T+
Sbjct: 109 LYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEV 165
Query: 741 GTFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGR 776
T Y APE M R Y T D++S G + E++ R
Sbjct: 166 VTQYYRAPEILMGSRHY-TSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQG-NREFVNEIGMISALQHPNLVKLYGC 639
K+GEG + VYKG+ +G+++A+K +S K+++G + E ++ L+H N+V L+
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 640 CIEGNQLLLIYEYMENNSLARALF----GPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
L ++EYM + LA+ + G + ++L L RGLAY+H
Sbjct: 72 IHTKETLTFVFEYMHTD-LAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIH--- 120
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG- 754
I+HRD+K N+L+ K++DFGLA+ + S+ + T Y P+ +
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGAT 179
Query: 755 -YLTDKADVYSFGIVALEIVSGR 776
Y + D++ G + +E++ G+
Sbjct: 180 DYSSA-LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 583 IGEGGFGPVYKGLLADGK----VIAVKQLSSKSKQGNREFVNEIGM----ISALQ--HPN 632
+G+G FG V LLA+ K + AVK L K + V E M + AL HP
Sbjct: 3 LGKGSFGKV---LLAELKGTDELYAVKVLK-KDVILQDDDV-ECTMTEKRVLALAGKHPF 57
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
L +L+ C ++L + EY+ L + R ++ I L GL +LH
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAEIVL--GLQFLH 113
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRIAGTFGYMAPEY 750
E I++RD+K NVLLD + + KI+DFG+ K + T + GT Y+APE
Sbjct: 114 ER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEI 167
Query: 751 AMRGYLTDKADVYSFGIVALEIVSGRS 777
D ++ G++ E+++G+S
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 583 IGEGGFGPVYK-GLLADGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYG 638
+G+GGFG V + A GK+ A K+L K ++G +NE ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 639 CCIEGNQLLLIYEYMENNSLARALF-----GPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
+ L L+ M L ++ G EE R I GL LH
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF---YAAEILCGLE----DLHR 120
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRIAGTFGYMAPEYAM 752
E+ V+RD+K N+LLD + +ISD GLA K+ E ++ I R+ GT GYMAPE
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVLN 174
Query: 753 RGYLTDKADVYSFGIVALEIVSGRS 777
T D + G + E++ G+S
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 6e-14
Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 55/223 (24%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN---------EIGMISALQHPN 632
IG G +G V + G+ +A+K++ + F + EI ++ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 633 LVKLYGCCI-----EGNQLLLIYEYMENNSLARALFGP----EEHRLKLDWPTRHSICIG 683
++ L + N + ++ E ME + L + + P ++H ++ +
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETD-LHKVIKSPQPLTDDHI-------QYFLY-Q 111
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS------- 736
+ RGL YLH ++HRD+K +N+L++ + + KI DFGLA+ + D
Sbjct: 112 ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 737 TRIAGTFGYMAPE--YAMRGYLTDKA-DVYSFGIVALEIVSGR 776
TR Y APE + Y KA D++S G + E+++ +
Sbjct: 169 TRW-----YRAPELLLSSSRY--TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKLYG 638
KIGEG +G VYK + IA+K+ L + + + EI ++ +QH N+V+L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPE---EHRLKLDWPTRHSICIGLARGLAYLHEES 695
+L L++EY++ + P+ RL + + RG+AY H
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLI------KTYLYQILRGIAYCHSH- 121
Query: 696 RLKIVHRDIKATNVLLDKDLNP-KISDFGLAK---LDEEDNTHISTRIAGTFGYMAPEYA 751
+++HRD+K N+L+D+ N K++DFGLA+ + TH T Y APE
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPEIL 175
Query: 752 M--RGYLTDKADVYSFGIVALEIVSGR 776
+ R Y T D++S G + E+V+ +
Sbjct: 176 LGSRHYST-PVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 27/209 (12%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQL--SSKSKQGNREFVN----EIGMISALQHPNLVK 635
+G+G FG VY AD G+ +AVKQ+ +S + ++E VN EI ++ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VNALECEIQLLKNLLHERIVQ 68
Query: 636 LYGCCIEGNQ--LLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLARGLAYL 691
YGC + + L + E+M S+ L +G + + TR + G++YL
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKY-TRQ-----ILEGVSYL 122
Query: 692 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE---DNTHISTRIAGTFGYMAP 748
H IVHRDIK N+L D N K+ DFG +K + T + + + GT +M+P
Sbjct: 123 HSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSP 178
Query: 749 EY-AMRGYLTDKADVYSFGIVALEIVSGR 776
E + GY KAD++S G +E+++ +
Sbjct: 179 EVISGEGY-GRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 9e-14
Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 36/217 (16%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLY---- 637
+G G G V+ + +D K +AVK++ Q + + EI +I L H N+VK+Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 638 ----------GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHS--ICIGLA 685
G E N + ++ EYME + LA L E+ L H+ L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVL---EQGPL----SEEHARLFMYQLL 124
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTH---ISTRIAG 741
RGL Y+H + ++HRD+K NV ++ +DL KI DFGLA++ + +H +S +
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 742 TFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGR 776
+ Y +P + Y T D+++ G + E+++G+
Sbjct: 182 KW-YRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-14
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGN-REFVNEIGMISALQHPNLVKLYG 638
+++G+G +G VYK L G +A+K++ + + + + E+ ++ P +V YG
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+ + EYM+ SL + L+ + I + +GL +L EE
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY------AM 752
I+HRD+K TNVL++ + K+ DFG++ ++ G YMAPE
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 753 RGYLTDKADVYSFGIVALEIVSGR 776
T ++DV+S G+ LE+ GR
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 15/198 (7%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLYGCC 640
+G G G V K L G ++A K + + K R + + E+ ++ P +V YG
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68
Query: 641 IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIV 700
++ + E+M+ SL + L + R+ + + SI + RGL YL E+ KI+
Sbjct: 69 YSDGEISICMEHMDGGSLDQVL--KKAGRIPENILGKISIAV--LRGLTYLREK--HKIM 122
Query: 701 HRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+PE + T
Sbjct: 123 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQGTHYTV 177
Query: 759 KADVYSFGIVALEIVSGR 776
++D++S G+ +E+ GR
Sbjct: 178 QSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 53/206 (25%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNR-EFVNEIGMISALQHPN 632
++F +++G G G V+K G ++A K + + K R + + E+ ++ P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+V YG ++ + E+M+ SL + L + ++ + I + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 120
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRIAGTFGYMAPEY 750
E+ KI+HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+PE
Sbjct: 121 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPER 173
Query: 751 AMRGYLTDKADVYSFGIVALEIVSGR 776
+ + ++D++S G+ +E+ GR
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 583 IGEGGFGPVYK-GLLADGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYG 638
+G+GGFG V + A GK+ A K+L K ++G +NE ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 639 CCIEGNQLLLIYEYMENNSLARALF-----GPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
+ L L+ M L ++ G +E R I GL LH
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF---YAAEITCGLE----DLHR 120
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR 753
E +IV+RD+K N+LLD + +ISD GLA ++ + I R+ GT GYMAPE
Sbjct: 121 E---RIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRV-GTVGYMAPEVVKN 175
Query: 754 GYLTDKADVYSFGIVALEIVSGRS 777
T D + G + E++ G+S
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 67/205 (32%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISALQH------PNLVK 635
IG+G FG VY+ D ++ A+K LS K +E + IG + L P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIG-LARGLAYLHEE 694
L + L L+ +YM L L +E R D R I L L +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSED---RAKFYIAELVLALEHLHKY 115
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM-- 752
IV+RD+K N+LLD + + DFGL+K + DN +T GT Y+APE +
Sbjct: 116 D---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDE 171
Query: 753 RGYLTDKADVYSFGIVALEIVSGRS 777
+GY T D +S G++ E+ G S
Sbjct: 172 KGY-TKHVDFWSLGVLVFEMCCGWS 195
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 577 FAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREF--VNEIGMISALQ---H 630
+ P +IG G +G VYK G +A+K + ++ + V E+ ++ L+ H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 631 PNLVKLYGCCIEGN-----QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLA 685
PN+V+L C ++ L++E+++ + L L L + T +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQD-LRTYLDKVPPPGLPAE--TIKDLMRQFL 118
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-TRIAGTFG 744
RGL +LH IVHRD+K N+L+ K++DFGLA++ + ++ T + T
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLW 172
Query: 745 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEA-QFC 789
Y APE ++ D++S G + E+ R + C EA Q
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLG 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 576 NFAPDNKIGEGGFGPVY----KGLLADGKVIAVKQLSSKS---KQGNREFV-NEIGMISA 627
NF +G G +G V+ G GK+ A+K L + K E E ++ A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 628 LQH-PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIG-LA 685
++ P LV L+ +L LI +Y+ L L+ E + + I +
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE-----SEVRVYIAEIV 115
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL---DEEDNTHISTRIAGT 742
L +LH+ L I++RDIK N+LLD + + ++DFGL+K +EE+ + GT
Sbjct: 116 LALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGT 169
Query: 743 FGYMAPEYAMRGYLT-DKA-DVYSFGIVALEIVSGRS 777
YMAPE G DKA D +S G++ E+++G S
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 39/214 (18%)
Query: 585 EGGFGPVYKGLLADGK--------VIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKL 636
EG FG ++ G+L D K V VK +S+ Q + E ++ L H N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEI-QVTL-LLQESCLLYGLSHQNILPI 73
Query: 637 YGCCIEGNQL-LLIYEYMENNSLARAL----FGPEEHRLKLDWPTRHSICIGL--ARGLA 689
CIE + ++Y YM +L L G + L T+ + + + A G++
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS--TQQLVHMAIQIACGMS 131
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---------LDEEDNTHISTRIA 740
YLH + ++H+DI A N ++D++L KI+D L++ L + +N +
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---- 184
Query: 741 GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+MA E + + +DV+SFG++ E+++
Sbjct: 185 ----WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 68/241 (28%), Positives = 105/241 (43%), Gaps = 27/241 (11%)
Query: 583 IGEGGFGPVYKG-LLADGKVIAVKQLSSKSKQGNREFVNEIGMIS------ALQHPNLVK 635
+G+G FG V+ L + A+K L + + E M+ A +HP L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFLTH 60
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEE-HRLKLDWPTRHSICIGLARGLAYLHEE 694
LY L + EY+ L +F + H+ L T ++ I GL +LH +
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIIC--GLQFLHSK 115
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG 754
IV+RD+K N+LLD D + KI+DFG+ K + + T GT Y+APE +
Sbjct: 116 G---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQ 171
Query: 755 YLTDKADVYSFGIVALEIVSGRSNVICRTKEAQF--------CLLDWVTLALTDFRFPLF 806
D +SFG++ E++ G+S +E F C W+T D LF
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLF 231
Query: 807 L 807
+
Sbjct: 232 V 232
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLYGC- 639
IG+G +G V+K L +G AVK L + E E ++ AL HPN+VK YG
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 640 ----CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
G+QL L+ E S+ + G + +++ P I GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY----- 750
K +HRD+K N+LL + K+ DFG++ +T + GT +MAPE
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQ 200
Query: 751 AMRGYLTDKADVYSFGIVALEIVSG 775
+ + DV+S GI A+E+ G
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 582 KIGEGGFGPVYKGLLADGKVIA---VKQL--SSKSKQGNREFVNEIGMISALQHPNLVKL 636
+IG G FG V + +A VK+L ++ SK+ N EF+ + LQHPN+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN-EFLQQGDPYRILQHPNILQC 60
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
G C+E LL++EY E L L + HR + +A G+ ++H +
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLD-EEDNTHISTRIAGTFGYMAPEY--AMR 753
+H D+ N L DL K+ D+G+ +ED ++APE
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 754 GYL-----TDKADVYSFGIVALEI 772
G L T ++V++ G+ E+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 581 NKIGEGGFGPVYKGL--LADGKVIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLY 637
+K+GEG + VYKG L D ++A+K++ + ++G + E+ ++ L+H N+V L+
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEE----HRLKLDWPTRHSICIGLARGLAYLHE 693
L L++EY++ + L + L H +KL L RGL Y H
Sbjct: 71 DIIHTEKSLTLVFEYLDKD-LKQYLDDCGNSINMHNVKL-------FLFQLLRGLNYCH- 121
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR 753
R K++HRD+K N+L+++ K++DFGLA+ S + T Y P+ +
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLG 178
Query: 754 GY-LTDKADVYSFGIVALEIVSGR 776
+ + D++ G + E+ +GR
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 53/227 (23%), Positives = 99/227 (43%), Gaps = 39/227 (17%)
Query: 580 DNKIGEGGFGPVYKGL-LADGKVIAVKQLS----SKSKQGNREFVNEIGM---------- 624
+GEG +G V K GK++A+K++ S +R+ V G+
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 625 ISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGL 684
++ ++H N++ L +EG+ + L+ + M ++ L + + + +++L I + +
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV----DRKIRLTESQVKCILLQI 128
Query: 685 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-------------KLDEED 731
GL LH+ +HRD+ N+ ++ KI+DFGLA K +
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 732 NTHISTRIAGTFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGR 776
T T Y APE M Y D++S G + E+++G+
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKY-HFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 8e-13
Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 40/217 (18%)
Query: 581 NKIGEGGFGPVYKGLLAD---GKVIAVK------QLSSKSKQGNRE--FVNEIGMISALQ 629
K+G+G +G V+K + D +V+A+K + ++ +++ RE F+ E+G
Sbjct: 13 QKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----D 65
Query: 630 HPNLVKLYGC--CIEGNQLLLIYEYMEN--NSLARALFGPEEHRLKLDWPTRHSICIGLA 685
HPN+VKL + L++EYME +++ RA + H+ I L
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHK--------RYIMYQLL 117
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK----LDEEDNTHISTRIAG 741
+ L Y+H S ++HRD+K +N+LL+ D K++DFGLA+ L+E + T
Sbjct: 118 KALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 742 TFGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 776
T Y APE Y T D++S G + E++ G+
Sbjct: 175 TRWYRAPEILLGSTRY-TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 582 KIGEGGFGPVYKGLLADG---KVIAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVKLY 637
+IG G FG V G + G + VK+L S S Q +F+ E +LQH NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEE-HRLKLDWPTRHSICIGLARGLAYLHEESR 696
G C E LL+ E+ L L + + D T + +A GL +LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLD-EEDNTHISTRIAGTFGYMAPEYA--MR 753
+H D+ N LL DL KI D+GL+ +ED ++ ++APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 754 GYL-----TDKADVYSFGIVALEI 772
G L T +++V+S G+ E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKS---KQGNREFVNEIG-MISALQHPNLV 634
IG+G FG V LLA + K AVK L K+ K+ + ++E ++ ++HP LV
Sbjct: 3 IGKGSFGKV---LLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
L+ ++L + +Y+ L L + R L+ P +A L YLH
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHL---QRERCFLE-PRARFYAAEIASALGYLHS- 114
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG 754
L IV+RD+K N+LLD + ++DFGL K + E N ST GT Y+APE +
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQ 171
Query: 755 YLTDKADVYSFGIVALEIVSG 775
D + G V E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLADGK-VIAVKQLSSKSKQGNREF----VNEIGMISALQ 629
N F +GEG +G V K + K ++A+K+ K + N E + E+ M+ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 630 HPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLA 689
N+V+L +L L++EY+E N L EE + S L + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELL----EEMPNGVPPEKVRSYIYQLIKAIH 114
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE 749
+ H+ IVHRDIK N+L+ + K+ DFG A+ E + T T Y +PE
Sbjct: 115 WCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 750 YAMRGYLTDKADVYSFGIVALEIVSGR 776
+ D++S G + E+ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 10/155 (6%)
Query: 624 MISALQHPNLVKLYGCCIEGNQ-LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICI 682
+ A +HP L L+ C + + L + EY+ L + R ++ I
Sbjct: 49 LALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEI 105
Query: 683 GLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT 742
GL +LH++ I++RD+K NVLLDKD + KI+DFG+ K + ST GT
Sbjct: 106 IC--GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGT 159
Query: 743 FGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRS 777
Y+APE + D +SFG++ E++ G+S
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 53/197 (26%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 582 KIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLYGC 639
K+GEG + VYKG +GK++A+K + + ++G + E ++ L+H N+V L+
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
L L++EY+ + L + + ++H L L RGL+Y+H+ I
Sbjct: 72 IHTKETLTLVFEYVHTD-LCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 700 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGY-LTD 758
+HRD+K N+L+ K++DFGLA+ + S + T Y P+ + +
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 759 KADVYSFGIVALEIVSG 775
D++ G + +E++ G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 581 NKIGEGGFGPVYKGL--LADGKVIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLY 637
K+GEG + V+KG L + ++A+K++ + ++G + E+ ++ L+H N+V L+
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFG----PEEHRLKLDWPTRHSICIGLARGLAYLHE 693
L L++EY++ + L + + H +K+ + RGLAY H
Sbjct: 71 DIVHTDKSLTLVFEYLDKD-LKQYMDDCGNIMSMHNVKI-------FLYQILRGLAYCH- 121
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM- 752
R K++HRD+K N+L+++ K++DFGLA+ S + T Y P+ +
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 178
Query: 753 RGYLTDKADVYSFGIVALEIVSGR 776
+ + D++ G + E+ SGR
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 71/245 (28%), Positives = 107/245 (43%), Gaps = 45/245 (18%)
Query: 583 IGEGGFGPVYKGLLAD----GKVIAVKQL------------SSKSKQGNREFVNEIGMIS 626
+G G FG V LLA+ G++ A+K L S ++ R F +
Sbjct: 7 LGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEK--RIFE----TAN 57
Query: 627 ALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWP--TRHSICIGL 684
+ +HP LV L+ C + + + EY L + H P ++ C+ L
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVL 112
Query: 685 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG 744
GL YLHE KIV+RD+K N+LLD + KI+DFGL K ST GT
Sbjct: 113 --GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPE 166
Query: 745 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQF-CLLDWVTLALTDFRF 803
++APE T D + G++ E++ G S +E F +++ + R+
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN------DEVRY 220
Query: 804 PLFLS 808
P FLS
Sbjct: 221 PRFLS 225
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 56/203 (27%), Positives = 106/203 (52%), Gaps = 19/203 (9%)
Query: 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLYG 638
+K+GEG + V+KG ++A+K++ + ++G + E+ ++ L+H N+V L+
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICI---GLARGLAYLHEES 695
L L++EY++++ L + L ++ L + H++ I L RGL+Y H+
Sbjct: 71 IIHTERCLTLVFEYLDSD-LKQYL----DNCGNL--MSMHNVKIFMFQLLRGLSYCHKR- 122
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG- 754
KI+HRD+K N+L+++ K++DFGLA+ S + T Y P+ +
Sbjct: 123 --KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGST 179
Query: 755 -YLTDKADVYSFGIVALEIVSGR 776
Y T D++ G + E+ +GR
Sbjct: 180 EYST-PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 63/232 (27%), Positives = 92/232 (39%), Gaps = 53/232 (22%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFV------NEIGMISALQHPN 632
IG G FG V+ L G+V A+K L KS R + +I + A P
Sbjct: 9 IGRGAFGEVW---LVRDKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDI-LADA-DSPW 62
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSIC-IGLARGLAYL 691
+VKLY + L L+ EYM L L + + R I + LA L +
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLI--RKDVFPEET-ARFYIAELVLA--LDSV 117
Query: 692 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK------------------------- 726
H +L +HRDIK N+L+D D + K++DFGL K
Sbjct: 118 H---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 727 ---LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 775
D + + GT Y+APE + D +S G++ E++ G
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFVNEIG----MISALQHPNLV 634
IG+G FG V LLA DGK AVK L K +E + + ++ ++HP LV
Sbjct: 3 IGKGSFGKV---LLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
L+ +L + +++ L F + R P +A L YLH
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGEL---FFHLQRER-SFPEPRARFYAAEIASALGYLHS- 114
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRIAGTFGYMAPEYAM 752
+ IV+RD+K N+LLD + ++DFGL K + + D T T GT Y+APE
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIR 169
Query: 753 RGYLTDKADVYSFGIVALEIVSGRSNVICR 782
+ + D + G V E++ G CR
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 583 IGEGGFGPVYK-GLLADGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYG 638
+G+GGFG V + A GK+ A K+L K ++G +NE ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 639 CCIEGNQLLLIYEYMENNSLARALF-----GPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
+ L L+ M L ++ G +E R +C GL L
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF---YAAELCCGLED----LQR 120
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR 753
E +IV+RD+K N+LLD + +ISD GLA E T + R+ GT GYMAPE
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINN 175
Query: 754 GYLTDKADVYSFGIVALEIVSGRS 777
T D + G + E++ G+S
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 576 NFAPDNKIGEGGFGPVY---------KGLLADGKVIAVKQLSSKSKQGNREFVNEIGMIS 626
NF +G G +G V+ G L KV+ + K+K +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 627 ALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLAR 686
Q P LV L+ +L LI +Y+ L L + R K +S I LA
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL--SQRERFKEQEVQIYSGEIVLA- 117
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYM 746
L +LH +L I++RDIK N+LLD + + ++DFGL+K ED + GT YM
Sbjct: 118 -LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 747 APEYAMRGYLT--DKA-DVYSFGIVALEIVSGRS 777
AP+ +RG DKA D +S G++ E+++G S
Sbjct: 174 APD-IVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKS----KQGNREFVNEIGMISALQHPNLV 634
IG+G FG V LLA DG AVK L K+ K+ N ++ L+HP LV
Sbjct: 3 IGKGSFGKV---LLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
L+ +L + +Y+ L F + R L+ P +A + YLH
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLE-PRARFYAAEVASAIGYLHS- 114
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRIAGTFGYMAPEYAM 752
L I++RD+K N+LLD + ++DFGL K ++ E+ T + GT Y+APE
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLR 169
Query: 753 RGYLTDKADVYSFGIVALEIVSG 775
+ D + G V E++ G
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 583 IGEGGFGPVYKGLLADG----KVIAVKQLSS----KSKQGNREFVNEIGMISALQHPNLV 634
+G+GG+G V++ G K+ A+K L ++++ E ++ A++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLAR---GLAYL 691
L G +L LI EY+ L L E + ++ + C L+ L +L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFME----DTACFYLSEISLALEHL 116
Query: 692 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYA 751
H + I++RD+K N+LLD + K++DFGL K + T T GT YMAPE
Sbjct: 117 H---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPEIL 172
Query: 752 MRGYLTDKADVYSFGIVALEIVSG 775
MR D +S G + ++++G
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 29/211 (13%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLY 637
+ IGEG +G V G +A+K++S Q R + EI ++ +H N++ +
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHENIIGIL 69
Query: 638 GCCIEG-----NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGL---ARGLA 689
N + ++ E ME + L + + + L D H I L RGL
Sbjct: 70 DIIRPPSFESFNDVYIVQELMETD-LYKLI---KTQHLSND----H-IQYFLYQILRGLK 120
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD--EEDNTHISTRIAGTFGYMA 747
Y+H + ++HRD+K +N+LL+ + + KI DFGLA++ E D+T T T Y A
Sbjct: 121 YIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 748 PEYAM--RGYLTDKADVYSFGIVALEIVSGR 776
PE + +GY T D++S G + E++S R
Sbjct: 178 PEIMLNSKGY-TKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 29/194 (14%)
Query: 599 GKVIAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENN 656
++AVK+ L S SK+ + EI LQHPN++ I ++L ++ M
Sbjct: 25 NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA-- 82
Query: 657 SLARALFGPEEHRLKLDWPTRHS------ICIGLARGLAYLHEESRLKIVHRDIKATNVL 710
+G E LK +P I + L Y+H +HR +KA+++L
Sbjct: 83 ------YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHIL 133
Query: 711 LDKDLNPKISDFGLA-KLDEEDN----THISTR-IAGTFGYMAPEY---AMRGYLTDKAD 761
L D +S + + + H + +++PE ++GY +K+D
Sbjct: 134 LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSD 192
Query: 762 VYSFGIVALEIVSG 775
+YS GI A E+ +G
Sbjct: 193 IYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 54/160 (33%), Positives = 81/160 (50%), Gaps = 24/160 (15%)
Query: 626 SALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL------ARALFGPEEH-RLKLDWPTRH 678
+A HP LV L+ C ++L + E++ L R L PEEH R +
Sbjct: 51 TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKL--PEEHARF-------Y 101
Query: 679 SICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 738
S I LA L +LHE I++RD+K NVLLD + + K++D+G+ K ST
Sbjct: 102 SAEISLA--LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST- 155
Query: 739 IAGTFGYMAPEYAMRGYLTD-KADVYSFGIVALEIVSGRS 777
GT Y+APE +RG D ++ G++ E+++GRS
Sbjct: 156 FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 70/233 (30%), Positives = 103/233 (44%), Gaps = 23/233 (9%)
Query: 583 IGEGGFGPVYKGLL----ADGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVK 635
+G+G FG V +L A GK A+K L + +K + E ++ +HP L
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
L ++L + EY+ L F R+ + TR + L YLH
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRF-YGAEIVSALDYLHSG- 114
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGY 755
KIV+RD+K N++LDKD + KI+DFGL K D + T GT Y+APE
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDND 171
Query: 756 LTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFLS 808
D + G+V E++ GR + E F L + + D +FP LS
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-----ILMEDIKFPRTLS 219
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 61/228 (26%), Positives = 106/228 (46%), Gaps = 28/228 (12%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSS--KSKQGNREFVNEIGMISALQH 630
TN + +G G FG V G+ +A+K++ + + E+ ++ L+H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 631 PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSIC----IGLAR 686
N++ L I + L IY E L G + HRL P + R
Sbjct: 69 ENIISL--SDIFISPLEDIYFVTE-------LLGTDLHRLLTSRPLEKQFIQYFLYQILR 119
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFGY 745
GL Y+H +VHRD+K +N+L++++ + KI DFGLA++ + T ++STR Y
Sbjct: 120 GLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----Y 171
Query: 746 MAPEYAM--RGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLL 791
APE + + Y + D++S G + E++ G+ + QF ++
Sbjct: 172 RAPEIMLTWQKY-DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII 218
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFVNEIG----MISALQHPNLV 634
IG+G FG V LA DGK AVK L K+ +E + + ++ ++HP LV
Sbjct: 3 IGKGSFGKVL---LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
L+ ++L + +Y+ L F + R + P +A L YLH
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPE-PRARFYAAEIASALGYLHS- 114
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG 754
L I++RD+K N+LLD + ++DFGL K E + ST GT Y+APE +R
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPE-VLRK 170
Query: 755 YLTDKA-DVYSFGIVALEIVSG 775
D+ D + G V E++ G
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREF---VNEIGMIS-ALQHPNLV 634
+G+G FG V +LA G++ AVK L + + + E ++S A HP L
Sbjct: 3 LGKGSFGKV---MLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
+LY C ++L + E++ L +F ++ R + D + L +LH++
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSR-RFDEARARFYAAEITSALMFLHDK 115
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG 754
I++RD+K NVLLD + + K++DFG+ K + ST GT Y+APE
Sbjct: 116 G---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEM 171
Query: 755 YLTDKADVYSFGIVALEIVSGRS 777
D ++ G++ E++ G +
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHA 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 53/157 (33%), Positives = 77/157 (49%), Gaps = 20/157 (12%)
Query: 627 ALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL----ARALFGPEEHRLKLDWPTRHSICI 682
A HP LV L+ C ++L + EY+ L R PEEH +S I
Sbjct: 52 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH------ARFYSAEI 105
Query: 683 GLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRIA 740
LA L YLHE I++RD+K NVLLD + + K++D+G+ K L D T +
Sbjct: 106 SLA--LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFC 157
Query: 741 GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRS 777
GT Y+APE D ++ G++ E+++GRS
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 60/193 (31%), Positives = 92/193 (47%), Gaps = 26/193 (13%)
Query: 627 ALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHS------I 680
A +P LV L+ C ++L L+ EY+ L +F + R KL P H+ I
Sbjct: 52 ASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQR-KL--PEEHARFYAAEI 105
Query: 681 CIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTR 738
CI L +LHE I++RD+K NVLLD D + K++D+G+ K L D T +
Sbjct: 106 CIALN----FLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---ST 155
Query: 739 IAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLAL 798
GT Y+APE D ++ G++ E+++GRS T D++ +
Sbjct: 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI 215
Query: 799 TD--FRFPLFLSL 809
+ R P FLS+
Sbjct: 216 LEKPIRIPRFLSV 228
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQ--LSSKSKQGNREFVNEIGMISALQH-PNLVKLY 637
KIGEG +G VYK GK++A+K+ L + + EI ++ L +V+L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 638 GCCIEGN-------QLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLARGL 688
+E L L++EY++++ L + + G R L T S L +G+
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGR-PLPAKTIKSFMYQLLKGV 123
Query: 689 AYLHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAK---LDEEDNTHISTRIAGTFG 744
A+ H + ++HRD+K N+L+DK KI+D GL + + + TH I T
Sbjct: 124 AHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH---EIV-TLW 176
Query: 745 YMAPEYAM--RGYLTDKADVYSFGIVALEIVSG 775
Y APE + Y T D++S G + E+
Sbjct: 177 YRAPEVLLGSTHYST-PVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 42/121 (34%), Positives = 59/121 (48%), Gaps = 9/121 (7%)
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMA 747
L YLH +V+RD+K N++LDKD + KI+DFGL K D + T GT Y+A
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLA 163
Query: 748 PEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFL 807
PE D + G+V E++ GR + E F L + + + RFP L
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-----ILMEEIRFPRTL 218
Query: 808 S 808
S
Sbjct: 219 S 219
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 34/207 (16%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQL----SSKSKQGNREFVNEIGMISALQHPNLV 634
+GEG FG + LL + A+K++ SS + + +R+ E +++ ++HPN+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIV 61
Query: 635 KLYGCCIEGN-QLLLIYEY------MENNSLARALFGPEEHRLKLDWPTRHSICIGLARG 687
+ E + L ++ EY M+ L R PE+ L W + +C+G+
Sbjct: 62 A-FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPED--TILQWFVQ--MCLGVQ-- 114
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMA 747
++HE+ +++HRDIK+ N+ L ++ K+ DFG A+L + T + GT Y+
Sbjct: 115 --HIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVP 168
Query: 748 PEYAMRGYLTDKADVYSFGIVALEIVS 774
PE +K+D++S G + E+ +
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-11
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 36/199 (18%)
Query: 599 GKVIAVKQLSSKSKQGNRE---FVNEIGMISALQHPNLVKLY--GCCIEGNQLLLIYEYM 653
G +A+K L + + + + F E + + L HPN+V L G G L ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYV 61
Query: 654 ENNSLAR------ALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKAT 707
+L AL E RL L + LA H + IVHRD+K
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQ----------VLDALACAHNQG---IVHRDLKPQ 108
Query: 708 NVLL---DKDLNPKISDFGLAKL----DEEDNTHIS--TRIAGTFGYMAPEYAMRGY-LT 757
N+++ + K+ DFG+ L + D ++ T + GT Y APE +RG +T
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVT 167
Query: 758 DKADVYSFGIVALEIVSGR 776
+D+Y++G++ LE ++G+
Sbjct: 168 PNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 68/233 (29%), Positives = 100/233 (42%), Gaps = 22/233 (9%)
Query: 583 IGEGGFGPVYKGLL----ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ---HPNLVK 635
+G+G FG V +L A G+ A+K L + E + + LQ HP L
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
L ++L + EY L F R+ + R + L YLH E
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARF-YGAEIVSALDYLHSEK 115
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGY 755
+V+RD+K N++LDKD + KI+DFGL K +D + T GT Y+APE
Sbjct: 116 --NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 756 LTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFLS 808
D + G+V E++ GR + E F L + + + RFP LS
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-----ILMEEIRFPRTLS 220
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 33/206 (16%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKS----KQGNREFV-NEIGMISALQHPNLVKL 636
+G G FG V+ A+K ++ KQ + V NE ++ + HP +++L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ--EQHVHNEKRVLKEVSHPFIIRL 66
Query: 637 YGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAYL 691
+ + L ++ EY+ L F +C L YL
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY----ASEIVC-----ALEYL 117
Query: 692 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE-Y 750
H +IV+RD+K N+LLDK+ + K++DFG AK D T + GT Y+APE
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRTWT---LCGTPEYLAPEVI 170
Query: 751 AMRGYLTDKA-DVYSFGIVALEIVSG 775
+G+ +KA D ++ GI+ E++ G
Sbjct: 171 QSKGH--NKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-11
Identities = 37/123 (30%), Positives = 61/123 (49%), Gaps = 23/123 (18%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAV 63
L +Q L G +P ++++L LQ I+L+ N + G IP ++
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRG----------------------NIPPSL 462
Query: 64 ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESF-ANLTRLKHFRI 122
SI++L L L +N F+G +P LG L +L L+LN N+ +G++P + L F
Sbjct: 463 GSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522
Query: 123 SDN 125
+DN
Sbjct: 523 TDN 525
|
Length = 623 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 583 IGEGGFGPVYKGLL----ADGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKL 636
+G+G FG V + L + +AVK L + S EF+ E + HPN++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 637 YGCCIEGNQL------LLIYEYMENNSLARALFGPE--EHRLKLDWPTRHSICIGLARGL 688
G + ++I +M++ L L E L T I +A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 689 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRIAGTFGYMA 747
YL S +HRD+ A N +L++++ ++DFGL+ K+ D ++A
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 748 PEYAMRGYLTDKADVYSFGIVALEIVS 774
E T +DV++FG+ EI++
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 53/222 (23%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 576 NFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPN 632
+ P IG G +G V + GK +A+K++ + + E+ ++ +H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 633 LVKLYGCCI---------EGNQLLLIYEYMENNSLARALFG----PEEHRLKLDWPTRHS 679
++ I + + ++ + ME++ L + EEH R+
Sbjct: 66 II-----AIRDILRPPGADFKDVYVVMDLMESD-LHHIIHSDQPLTEEH-------IRYF 112
Query: 680 ICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL---DEEDNTHIS 736
+ L RGL Y+H ++HRD+K +N+L+++D +I DFG+A+ ++ +
Sbjct: 113 L-YQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 737 TRIAGTFGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 776
T T Y APE ++ Y T D++S G + E++ GR
Sbjct: 169 TEYVATRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEML-GR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 583 IGEGGFGPVYKG-LLADGKVIAVKQLSSKSKQGNRE----FVNEIGMISALQHPNLVKLY 637
+G+G FG V L G+ AVK L + + V + + A ++P L LY
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHS---ICIGLARGLAYLHEE 694
L + E++ L + ++ R L T ++ +C GL +LH +
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHI--QDKGRFDLYRATFYAAEIVC-----GLQFLHSK 115
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG 754
I++RD+K NV+LD+D + KI+DFG+ K + + ST GT Y+APE
Sbjct: 116 G---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGL 171
Query: 755 YLTDKADVYSFGIVALEIVSGRS 777
T D +SFG++ E++ G+S
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 624 MISALQHPNLVKLYGCCIEGNQLLLI--------YEYMENNSLARALFGPEEHRLKLDWP 675
++ + HP+++++ + G ++ Y Y+ S P P
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS------RP--------LP 155
Query: 676 TRHSICI--GLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733
++ I + GL YLH + +I+HRD+K N+ ++ I D G A+
Sbjct: 156 IDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212
Query: 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+ +AGT APE R KAD++S GIV E+++
Sbjct: 213 FLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 566 TLRQIKAATNNFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSS--KSKQGNREFVNEI 622
T+ ++ N +P +G G +G V G +AVK+LS +S + E+
Sbjct: 11 TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 67
Query: 623 GMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRL----KLDWPTRH 678
++ ++H N++ L L E + L L G + + + KL
Sbjct: 68 RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 123
Query: 679 SICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHIST 737
+ + RGL Y+H I+HRD+K +N+ +++D KI DFGLA+ D+E +++T
Sbjct: 124 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 180
Query: 738 RIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRS 777
R Y APE + + D++S G + E+++GR+
Sbjct: 181 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 24/235 (10%)
Query: 553 QELKGLDLH------TGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKV--IAV 604
Q LK L LH + R+ K +F +G G FG V + +A+
Sbjct: 2 QFLKNLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAI 61
Query: 605 KQLSS----KSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLAR 660
K+ K KQ + F +E +++ + HP V LYG + + L L+ E++
Sbjct: 62 KRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT 120
Query: 661 ALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 720
L R +P C A+ + L IV+RD+K N+LLDKD K++
Sbjct: 121 FL------RRNKRFPNDVG-CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMT 173
Query: 721 DFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 775
DFG AK+ + T T + GT Y+APE + AD ++ GI EI+ G
Sbjct: 174 DFGFAKVVD---TRTYT-LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 68/233 (29%), Positives = 100/233 (42%), Gaps = 23/233 (9%)
Query: 583 IGEGGFGPVYKGLL----ADGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVK 635
+G+G FG V +L A G+ A+K L + +K V E ++ +HP L
Sbjct: 3 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
L ++L + EY L F R+ + R + L YLH
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARF-YGAEIVSALEYLHSRD 115
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGY 755
+V+RDIK N++LDKD + KI+DFGL K D + T GT Y+APE
Sbjct: 116 ---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 756 LTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFLS 808
D + G+V E++ GR + E F L + + + RFP LS
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-----ILMEEIRFPRTLS 219
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 43/147 (29%), Positives = 80/147 (54%), Gaps = 9/147 (6%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLYGC 639
K+GEG + VYKG G+++A+K++ + ++G + E ++ L+H N+V L+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
L L++EY++ + L + + ++ L L RGLAY H+ ++
Sbjct: 72 IHTKKTLTLVFEYLDTD-LKQYM---DDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RV 124
Query: 700 VHRDIKATNVLLDKDLNPKISDFGLAK 726
+HRD+K N+L+ + K++DFGLA+
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 33/210 (15%)
Query: 583 IGEGGFGPVYKGLLADGKV---IAVKQLSS--KSKQGNREFVNEIGMISALQHPNLVKLY 637
+G G +G V D ++ +AVK+LS +S R E+ ++ ++H N++ L
Sbjct: 23 VGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 638 -----GCCIEG-NQLLLIYEYM--ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLA 689
IE N++ L+ M + N++ + +EH L + L RGL
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ--------LLRGLK 132
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAGTFGYMAP 748
Y+H I+HRD+K +NV +++D +I DFGLA+ D+E +++TR Y AP
Sbjct: 133 YIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAP 184
Query: 749 EYAMRG-YLTDKADVYSFGIVALEIVSGRS 777
E + + D++S G + E++ G++
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 27/204 (13%)
Query: 582 KIGEGGFGPVYKGLLAD-GKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLY 637
++G+GG+G V+ D G+++A+K++ R + E +++ + LVKL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFG-----PEEHRLKLDWPTRHSICIGLARGLAYLH 692
+ L L EY+ R L E+H R + + + LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDH-------ARFYM-AEMFEAVDALH 118
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM 752
L +HRD+K N L+D + K++DFGL+K + + G+ YMAPE
Sbjct: 119 ---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLR 171
Query: 753 -RGYLTDKADVYSFGIVALEIVSG 775
+GY D +S G + E + G
Sbjct: 172 GKGY-DFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 22/216 (10%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLL---ADGKVIAVKQLSSKSKQGNRE----FVNEIGMISA 627
+F + +G G FG V ++ A G + A+K + KS +E F E ++S
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMK-KSVLLAQETVSFFEEERDILSI 57
Query: 628 LQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARG 687
P + +L + + L L+ EY L L + + D LA
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFD---EDMAQFYLAEL 111
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMA 747
+ +H ++ VHRDIK NVL+D+ + K++DFG A + S GT Y+A
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 748 PEY--AMRGYLTDKADV----YSFGIVALEIVSGRS 777
PE M G V +S G++A E++ GRS
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 581 NKIGEGGFGPV-YKGLLADGKVIAVKQLSS----KSKQGNREFVNEIGMISALQHPNLVK 635
+G G FG V G+ A+K L K KQ + E ++ L HP +V
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSHPFIVN 82
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
+ + N++ + E++ L L + R D + + LA YLH
Sbjct: 83 MMCSFQDENRVYFLLEFVVGGELFTHL--RKAGRFPNDVAKFYHAELVLA--FEYLHS-- 136
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM-RG 754
I++RD+K N+LLD + K++DFG AK D T + GT Y+APE +G
Sbjct: 137 -KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFT---LCGTPEYLAPEVIQSKG 191
Query: 755 YLTDKA-DVYSFGIVALEIVSG 775
+ KA D ++ G++ E ++G
Sbjct: 192 H--GKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 31/93 (33%), Positives = 55/93 (59%), Gaps = 10/93 (10%)
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFG 744
RGL Y+H I+HRD+K +N+ +++D KI DFGLA+ +++ T +++TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 745 YMAPEYAM-RGYLTDKADVYSFGIVALEIVSGR 776
Y APE + + D++S G + E+++G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 567 LRQIKAATNNFAPDNKIGEGGFGPV----YKGLLADGKVIAVKQLSSKS--KQGNREFVN 620
+R+++ ++ IG G FG V +K + KV A+K LS K+ + F
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 621 EIGMISALQH-PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHS 679
E I A + P +V+L+ + L ++ EYM L + + + W ++
Sbjct: 92 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYT 148
Query: 680 ICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTR 738
+ LA L +H + ++HRD+K N+LLDK + K++DFG K+DE T
Sbjct: 149 AEVVLA--LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA 203
Query: 739 IAGTFGYMAPEYAMR----GYLTDKADVYSFGIVALEIVSG 775
+ GT Y++PE GY + D +S G+ E++ G
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 583 IGEGGFGPVYKGLLADGK----VIAVKQLSSKSKQGNREFVNEIGMIS------ALQHPN 632
+G+G FG V +LA+ K V A+K L + + + M A +HP
Sbjct: 3 LGKGSFGKV---MLAELKGTDEVYAIKVLKKDVILQDDDV--DCTMTEKRILALAAKHPF 57
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
L L+ C ++L + EY+ L +F + R K D P + L +LH
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSR-KFDEPRSRFYAAEVTLALMFLH 113
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM 752
R +++RD+K N+LLD + + K++DFG+ K + N +T GT Y+APE
Sbjct: 114 ---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQ 169
Query: 753 RGYLTDKADVYSFGIVALEIVSGR 776
D ++ G++ E+++G+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 67/214 (31%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 576 NFAPDNKIGEGGFGPVY---------KGLLADGKVIAVKQLSSKSKQGNREFVNEIGMIS 626
NF +G G +G V+ G L KV+ L K+K +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 627 ALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLAR 686
Q P LV L+ +L LI +Y+ + L+ + D +S I LA
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILA- 117
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRIAGTFG 744
L +LH +L IV+RDIK N+LLD + + ++DFGL+K L EE S GT
Sbjct: 118 -LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIE 171
Query: 745 YMAPEYAMRGYLTDKA-DVYSFGIVALEIVSGRS 777
YMAPE KA D +S GI+ E+++G S
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS 205
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 35/92 (38%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 683 GLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRIAG 741
L LAYLH I+HRD+K N+ LD+ N + DFG A KLD +T +G
Sbjct: 193 RLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 742 TFGYMAPEY-AMRGYLTDKADVYSFGIVALEI 772
T +PE A+ Y K D++S G+V E+
Sbjct: 250 TLETNSPELLALDPYCA-KTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 57/225 (25%), Positives = 104/225 (46%), Gaps = 31/225 (13%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQG---NREFVNEIGMISALQHPNLVKLYG 638
K+G G +G VYK DGK K+ + K +G + EI ++ L+HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 639 CCIEGN--QLLLIYEYMENNSLARALFGPEEHR--------LKLDWPTRHSICIGLARGL 688
+ + ++ L+++Y E++ F HR ++L S+ + G+
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKF----HRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 689 AYLHEESRLKIVHRDIKATNVLLDKDLNP-----KISDFGLAKLDEEDNTHIS--TRIAG 741
YLH ++HRD+K N+L+ + P KI+D G A+L ++ +
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 742 TFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRTKE 785
TF Y APE + + T D+++ G + E+++ CR ++
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 26/206 (12%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSS--KSKQGNREFVNEIGMISALQHPNLVKL--- 636
+G G +G V + G+ +A+K+LS +S+ + E+ ++ +QH N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 637 YGCCIEGNQL---LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
+ + G++ L+ YM+ + + + G K+ + +C GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLC-----GLKYIHS 135
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAGTFGYMAPEYAM 752
I+HRD+K N+ +++D KI DFGLA+ D E ++ TR Y APE +
Sbjct: 136 AG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVIL 187
Query: 753 RG-YLTDKADVYSFGIVALEIVSGRS 777
+ D++S G + E+++G++
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 6/157 (3%)
Query: 620 NEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTR-H 678
+E+ ++A H +VK + ++LLLI EY L + + + RLK P + +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI----KQRLKEHLPFQEY 169
Query: 679 SICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHIST 737
+ + + + L E K++HRD+K+ N+ L K+ DFG +K + + +++
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 738 RIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
GT Y+APE R + KAD++S G++ E+++
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 43/218 (19%)
Query: 583 IGEGGFGPVYKGLL-------ADGKVIAVKQLSSKSKQGNR---EFVNEIGMISALQHPN 632
+G+G F +YKG+L G V + +R F ++S L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 633 LVKLYGCCI-EGNQLLLIYEYME----NNSLARALFGPEEH-RLKLDWPTRHSICIGLAR 686
LVKLYG C+ + N ++ EY++ + L R H +L + LA
Sbjct: 63 LVKLYGVCVRDENIMVE--EYVKFGPLDVFLHREKNNVSLHWKLDVAK--------QLAS 112
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDK-DLNP------KISDFGLAKLDEEDNTHISTRI 739
L YL ++ K+VH ++ N+L+ + LN K+SD G+ + RI
Sbjct: 113 ALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-RI 168
Query: 740 AGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSG 775
++APE G LT AD +SFG LEI S
Sbjct: 169 P----WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 37/94 (39%), Positives = 56/94 (59%), Gaps = 8/94 (8%)
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI---STRIA 740
+ARG+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ +D ++ S R+
Sbjct: 183 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 741 GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+MAPE T ++DV+SFG++ EI S
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 576 NFAPDNKIGEGGFGPVYKGLLAD----GKVIAVKQLSSKSKQGNREFVNEIGMIS----A 627
+F +G+G FG V +LA+ ++ A+K L + + E M+ A
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDV--ECTMVEKRVLA 55
Query: 628 LQH--PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLA 685
LQ P L +L+ C ++L + EY+ L + + K P ++
Sbjct: 56 LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEIS 111
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR-IAGTFG 744
GL +LH I++RD+K NV+LD + + KI+DFG+ K D ++TR GT
Sbjct: 112 VGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPD 166
Query: 745 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
Y+APE D +++G++ E+++G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 582 KIGEGGFGPVYKGLLADG---KVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYG 638
K+G G +G VYK DG + A+KQ+ + EI ++ L+HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 65
Query: 639 CCIE--GNQLLLIYEYMENNSLARALFGPEEHR--------LKLDWPTRHSICIGLARGL 688
+ ++ L+++Y E++ F HR ++L S+ + G+
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKF----HRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 689 AYLHEESRLKIVHRDIKATNVLLDKDLNP-----KISDFGLAKLDEEDNTHIS--TRIAG 741
YLH ++HRD+K N+L+ + P KI+D G A+L ++ +
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 742 TFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRTKE 785
TF Y APE + + T D+++ G + E+++ CR ++
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 29/206 (14%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLS------SKSKQGNREFVNEIGMISALQHPNLVK 635
IG G G V G +AVK+LS + +K+ RE V ++ + H N++
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELV----LLKCVNHKNIIS 84
Query: 636 LYGCCI------EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLA 689
L E + L+ E M+ N L + + +H ++ + +C G+
Sbjct: 85 LLNVFTPQKSLEEFQDVYLVMELMDAN-LCQVIHMELDHE-RMSYLLYQMLC-----GIK 137
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE 749
+LH I+HRD+K +N+++ D KI DFGLA+ + T T Y APE
Sbjct: 138 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPE 192
Query: 750 YAMRGYLTDKADVYSFGIVALEIVSG 775
+ + D++S G + E+V G
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 37/94 (39%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF 743
+ARG+ +L ++ VHRD+ A NVLL + KI DFGLA+ D+ ++S TF
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK--GSTF 300
Query: 744 ---GYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+MAPE T +DV+S+GI+ EI S
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 36/94 (38%), Positives = 55/94 (58%), Gaps = 8/94 (8%)
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI---STRIA 740
+ARG+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ +D ++ R+
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 741 GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+MAPE T ++DV+SFG++ EI S
Sbjct: 239 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 38/215 (17%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSS--KSKQGNREFVNEIGMISALQHPNLVKLYGC 639
IG+G +G V + G+ +A+K+++ + + EI ++ L+HP++V++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 640 CI-----EGNQLLLIYEYME---------NNSLARALFGPEEHRLKLDWPTRHSICIGLA 685
+ E + +++E ME N+ L PE H+ L L
Sbjct: 68 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLT-----PEHHQFFL---------YQLL 113
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED--NTHISTRIAGTF 743
R L Y+H + + HRD+K N+L + D KI DFGLA++ D T T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 744 GYMAPEY--AMRGYLTDKADVYSFGIVALEIVSGR 776
Y APE + T D++S G + E+++G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 631 PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
P L +L+ C ++L + EY+ L + + + P +A GL +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI----QQVGRFKEPHAVFYAAEIAIGLFF 116
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY 750
LH + I++RD+K NV+LD + + KI+DFG+ K + D T GT Y+APE
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYIAPEI 172
Query: 751 AMRGYLTDKADVYSFGIVALEIVSGRS 777
D ++FG++ E+++G++
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 583 IGEGGFGPVYKGLLADGK----VIAVKQLSSKSKQGNREFVNEIGMIS----ALQH--PN 632
+G+G FG V +LA+ K + A+K L + + E M+ AL P
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDV--ECTMVEKRVLALPGKPPF 62
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLARGLAY 690
L +L+ C ++L + EY+ L + G K P +A GL +
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFF 116
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR-IAGTFGYMAPE 749
LH + I++RD+K NV+LD + + KI+DFG+ K E +TR GT Y+APE
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPE 171
Query: 750 YAMRGYLTDKADVYSFGIVALEIVSGR 776
D ++FG++ E+++G+
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 583 IGEGGFGPVYKG----LLADGKV----IAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 634
+G+G F ++KG + G++ + +K L + + F M+S L H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
YG C+ G++ +++ EY++ SL L ++ + + W + + LA L +L ++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISW--KLEVAKQLAWALHFLEDK 119
Query: 695 SRLKIVHRDIKATNVLL-----DKDLNP---KISDFGL--AKLDEEDNTHISTRIAGTFG 744
+ H ++ A NVLL K NP K+SD G+ L +E + RI
Sbjct: 120 ---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE---ILLERIP---- 169
Query: 745 YMAPEYAMRG-YLTDKADVYSFGIVALEIVSG 775
++ PE L+ AD +SFG EI SG
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 37/100 (37%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 678 HSICIG--LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735
IC +A+G+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ +D ++
Sbjct: 180 DLICYSFQVAKGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236
Query: 736 STRIAG-TFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
A +MAPE T ++DV+SFG++ EI S
Sbjct: 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 38/113 (33%), Positives = 60/113 (53%), Gaps = 8/113 (7%)
Query: 665 PEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724
EE L LD S +A+G+++L ++ +HRD+ A N+LL KI DFGL
Sbjct: 204 LEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGL 260
Query: 725 AKLDEEDNTHI---STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
A+ D+ ++ + R+ +MAPE T ++DV+S+GI+ EI S
Sbjct: 261 ARDIRNDSNYVVKGNARLP--VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 583 IGEGGFGPV----YKGLLADGKVIAVKQLSSKS--KQGNREFVNEIGMISAL-QHPNLVK 635
IG G FG V +K + +V A+K LS K+ + F E I A +V+
Sbjct: 51 IGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ 107
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
L+ + L ++ EYM L + + + W ++ + LA L +H
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARFYTAEVVLA--LDAIH--- 159
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRIAGTFGYMAPEYAMR- 753
+ +HRD+K N+LLDK + K++DFG K+D T + GT Y++PE
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQ 218
Query: 754 ---GYLTDKADVYSFGIVALEIVSG 775
GY + D +S G+ E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 44/172 (25%), Positives = 74/172 (43%), Gaps = 9/172 (5%)
Query: 612 KQGNRE-FVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRL 670
K G R E ++ A+ HP++++L G LI + + L+ +
Sbjct: 123 KAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD-----LYCYLAAKR 177
Query: 671 KLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730
+ +I + R + YLHE I+HRDIKA N+ ++ + + DFG A +
Sbjct: 178 NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234
Query: 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782
N + AGT APE R D++S GIV E+ + ++ +
Sbjct: 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286
|
Length = 391 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 9/98 (9%)
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI---STRIA 740
+A+G+ +L ++ +HRD+ A NVLL KI DFGLA+ D+ ++ + R+
Sbjct: 221 VAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 741 GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRS 777
+MAPE T ++DV+S+GI+ EI S G+S
Sbjct: 278 --VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAGTFG 744
+GL Y+H I+HRD+K N+ +++D KI DFGLA+ D E ++ TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 745 YMAPEYAMRG-YLTDKADVYSFGIVALEIVSGR 776
Y APE + + T D++S G + E+++G+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 35/230 (15%)
Query: 571 KAATNNFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISALQ 629
++ ++ N IG G FG VY+ + D + +A+K++ + NRE + ++ L
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLN 117
Query: 630 HPNLVKL----YGCCIEGNQ----LLLIYEYM-ENNSLARALFGPEEHRLKLDWPTRHSI 680
H N++ L Y C + N+ L ++ E++ + + H L L +S
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYS- 176
Query: 681 CIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAK---LDEEDNTHIS 736
L R LAY+H + I HRD+K N+L+D + + K+ DFG AK + ++I
Sbjct: 177 -YQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232
Query: 737 TRIAGTFGYMAPEYAMRGY-LTDKADVYSFGIVALEIV------SGRSNV 779
+R Y APE + T D++S G + E++ SG+S+V
Sbjct: 233 SRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 36/94 (38%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF 743
+A G+ +L ++ VHRD+ A NVL+ + KI DFGLA+ D+ +IS TF
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK--GSTF 302
Query: 744 ---GYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+MAPE T +DV+SFGI+ EI +
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 26/76 (34%), Positives = 44/76 (57%)
Query: 57 GAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTR 116
G IP ++ + L + L N G++P LG++ +LE L L+ N+F G +PES LT
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 117 LKHFRISDNHFTGQIP 132
L+ ++ N +G++P
Sbjct: 492 LRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 33/197 (16%)
Query: 599 GKVIAVK--QLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENN 656
G ++ V+ L + +++ + NE+ + +HPN++ + G+ L +I +M
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA-- 82
Query: 657 SLARALFGPEEHRLKLDWPTRHS------ICIGLARGLAYLHEESRLKIVHRDIKATNVL 710
+G LK +P S I G RGL YLH+ +HR+IKA+++L
Sbjct: 83 ------YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHIL 133
Query: 711 LDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG--------YMAPEYA---MRGYLTDK 759
+ D +S GL+ L ++ F +++PE + GY K
Sbjct: 134 ISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGY-NVK 190
Query: 760 ADVYSFGIVALEIVSGR 776
+D+YS GI A E+ +GR
Sbjct: 191 SDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 33/206 (16%)
Query: 583 IGEGGFGPV---YKGLLADGKVIAVKQLS------SKSKQGNREFVNEIGMISALQHPNL 633
IG G G V Y +L + +A+K+LS + +K+ RE V ++ + H N+
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKNI 78
Query: 634 VKLYGCCI------EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARG 687
+ L E + L+ E M+ N L + + +++LD + + G
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCG 131
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMA 747
+ +LH I+HRD+K +N+++ D KI DFGLA+ + + T T Y A
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 186
Query: 748 PEYAMRGYLTDKADVYSFGIVALEIV 773
PE + + D++S G + E+V
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 48/197 (24%)
Query: 602 IAVKQLS------SKSKQGNREFVNEIGMISALQHPNLVKLYGCCI------EGNQLLLI 649
+A+K+LS + +K+ RE V ++ + H N++ L E + L+
Sbjct: 44 VAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99
Query: 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNV 709
E M+ N L + + +H ++ + +C G+ +LH I+HRD+K +N+
Sbjct: 100 MELMDAN-LCQVIQMDLDHE-RMSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNI 149
Query: 710 LLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGY----------LTDK 759
++ D KI DFGLA R AGT M P R Y +
Sbjct: 150 VVKSDCTLKILDFGLA------------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 197
Query: 760 ADVYSFGIVALEIVSGR 776
D++S G + E++ G
Sbjct: 198 VDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 53/219 (24%)
Query: 583 IGEGGFGPV---YKGLLADGKVIAVKQLS------SKSKQGNREFVNEIGMISALQHPNL 633
IG G G V Y +L + +A+K+LS + +K+ RE V ++ + H N+
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKNI 85
Query: 634 VKLYGCCI------EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARG 687
+ L E + ++ E M+ N L + + +++LD + + G
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCG 138
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMA 747
+ +LH I+HRD+K +N+++ D KI DFGLA R AGT M
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGTSFMMT 183
Query: 748 PEYAMRGY----------LTDKADVYSFGIVALEIVSGR 776
P R Y + D++S G + E++ G
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 67/244 (27%), Positives = 100/244 (40%), Gaps = 52/244 (21%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFV----NEIGMISALQ 629
++F IG G FG V D G + A+K+L KS+ +E V E +++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEAD 59
Query: 630 HPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLA 689
+P +VKLY + N L LI EY+ + L +K D T +A +
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL-------MKKDTFTEEETRFYIAETIL 112
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL----------------------AKL 727
+ +L +HRDIK N+LLD + K+SDFGL L
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 728 DEEDNTHISTRIA---------------GTFGYMAPEYAMR-GYLTDKADVYSFGIVALE 771
D S R A GT Y+APE ++ GY + D +S G++ E
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYE 231
Query: 772 IVSG 775
++ G
Sbjct: 232 MLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 27/72 (37%), Positives = 41/72 (56%), Gaps = 4/72 (5%)
Query: 181 PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYM 239
+L +L+++N L +I G +P LG + L VLDLS+N +G IP + + L +
Sbjct: 439 SKLRHLQSIN---LSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRIL 495
Query: 240 YLTGNLLTGPVP 251
L GN L+G VP
Sbjct: 496 NLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 24/221 (10%)
Query: 567 LRQIKAATNNFAPDNKIGEGGFGPV----YKGLLADGKVIAVKQLSSKS--KQGNREFVN 620
+R ++ ++ IG G FG V +K + KV A+K LS K+ + F
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 621 EIGMISALQH-PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHS 679
E I A + P +V+L+ + L ++ EYM L + + + W ++
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYT 148
Query: 680 ICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTR 738
+ LA L +H + +HRD+K N+LLDK + K++DFG K+++E T
Sbjct: 149 AEVVLA--LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 203
Query: 739 IAGTFGYMAPEYAMR----GYLTDKADVYSFGIVALEIVSG 775
+ GT Y++PE GY + D +S G+ E++ G
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 32/87 (36%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY--AM- 752
+L VHRDIK NVLLDK+ + +++DFG D T S GT Y++PE AM
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 753 --RGYLTDKADVYSFGIVALEIVSGRS 777
+G + D +S G+ E++ G +
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 8/95 (8%)
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF 743
L RGL Y+H + ++HRD+K +N+LL+ + + KI DFGLA+ E ++ + T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TR 172
Query: 744 GYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGR 776
Y APE + Y T DV+S G + E++ GR
Sbjct: 173 WYRAPELLLNCSEY-TTAIDVWSVGCIFAELL-GR 205
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 57/184 (30%), Positives = 82/184 (44%), Gaps = 32/184 (17%)
Query: 326 NGSTTFEDDL--DAAGPSRF------FISRTNWAFSTTGHFIDNSTRENSYIQ-INTSRL 376
G + F++D D G RF F S ++ A ST S N Y + + S L
Sbjct: 200 AGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNFYPESLYQSAL 259
Query: 377 LMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEILFTDDKSYCSLGRRIFDVYIQ 436
+ D+Q L+Y N NY+V LHFAEI D S + G+R+FDV I
Sbjct: 260 VSTDTQ---------PDLSYTMDVDPNRNYSVWLHFAEI----DNSITAEGKRVFDVLIN 306
Query: 437 GKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRLYWAGKGTTDIPYKGVYGPLISA 496
G KD +I +G A+V + AV+ T+ I L P KG + +I+A
Sbjct: 307 GDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQ---------PKKGTHA-IINA 356
Query: 497 ISLY 500
I ++
Sbjct: 357 IEVF 360
|
Length = 623 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 27/164 (16%)
Query: 629 QHPNLVKLYGCCIEGNQ-LLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLA 685
++P +V ++ C E + L ++ EY+E A L G L +D + LA
Sbjct: 59 ENPFVVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNIGA----LPVDMARMYFAETVLA 113
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--------------LDEED 731
L YLH IVHRD+K N+L+ + K++DFGL+K ++++
Sbjct: 114 --LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 775
+ ++ GT Y+APE +R D ++ GI+ E + G
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 4e-07
Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 56/244 (22%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLADG--------KVIAVKQLSSKSKQGNREFVNEIGMIS 626
N + KIG G FG V+ L+ K I+ + L + K + V E+ ++
Sbjct: 13 NEYEVIKKIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKS---QLVIEVNVMR 67
Query: 627 ALQHPNLVKLYGCCI-EGNQ-LLLIYEYMENNSLAR------ALFGPEEHRLKLDWPTRH 678
L+H N+V+ + + NQ L ++ E+ + L+R +FG E +D
Sbjct: 68 ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD----- 122
Query: 679 SICIGLARGLAYLHE----ESRLKIVHRDIKATNVLLD-------------KDLN----P 717
I L LAY H + +++HRD+K N+ L +LN
Sbjct: 123 -ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 718 KISDFGLAK-LDEEDNTHISTRIAGTFGYMAPE---YAMRGYLTDKADVYSFGIVALEIV 773
KI DFGL+K + E H GT Y +PE + + Y DK+D+++ G + E+
Sbjct: 182 KIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSY-DDKSDMWALGCIIYELC 237
Query: 774 SGRS 777
SG++
Sbjct: 238 SGKT 241
|
Length = 1021 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 29/88 (32%), Positives = 50/88 (56%), Gaps = 4/88 (4%)
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMA 747
L LH+ +++RD+K N+LLD + + DFGL KL+ +D+ +T GT Y+A
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLA 161
Query: 748 PEYAMRGYLTDKADVYSFGIVALEIVSG 775
PE + T D ++ G++ E+++G
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 15/204 (7%)
Query: 583 IGEGGFGPVYKGLLADG-KVIAVKQLSSKSKQGNRE---FVNEIGMISALQHPNLVKLYG 638
IG G FG V L + KV A+K L+ E F E ++ + + L+
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+ N L L+ +Y L L E RL D + LA + + +L
Sbjct: 69 AFQDENNLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFY-----LAEMVIAIDSVHQLH 122
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY--AM---R 753
VHRDIK N+L+D + + +++DFG ED T S+ GT Y++PE AM +
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 754 GYLTDKADVYSFGIVALEIVSGRS 777
G + D +S G+ E++ G +
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 46/165 (27%), Positives = 83/165 (50%), Gaps = 23/165 (13%)
Query: 618 FVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTR 677
F ++S + H +L ++G C+ G++ +++ E++E+ L E+ R+ + W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAW--K 119
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK-----DLNP--KISDFG--LAKLD 728
++ LA L+YL +++ +VH ++ A N+LL + +P K+SD G L
Sbjct: 120 ITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 729 EEDNTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEI 772
E+ RI ++APE G L+ AD +SFG LEI
Sbjct: 177 REERVE---RIP----WIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 15/157 (9%)
Query: 575 NNFAPDNKIGEGGFGPV-YKGLLADGKVIAVKQL--SSKSKQGNREFVN-EIGMISALQH 630
+F IG+G FG V GK+ A+K L S K+ V E +++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 631 PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSI--CIGLARGL 688
P +V LY + L LI E++ L L + + TR + C+ LA +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMAECV-LA--I 114
Query: 689 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725
+H +L +HRDIK N+L+D+ + K+SDFGL+
Sbjct: 115 EAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-07
Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG--- 744
LA H S+ ++HRDIK+ N+LL + K+ DFG +K+ T +S + TF
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKM--YAAT-VSDDVGRTFCGTP 209
Query: 745 -YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
Y+APE R + KAD++S G++ E+++
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-07
Identities = 26/91 (28%), Positives = 49/91 (53%)
Query: 72 LTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQI 131
L L+ G +P ++ L +L+ ++L+ N+ G +P S ++T L+ +S N F G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 132 PDYIQNWTKLEKLFIEGSGLAGPIPSGIASL 162
P+ + T L L + G+ L+G +P+ +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 17/153 (11%)
Query: 583 IGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEI----GMISALQHPNLVKLY 637
I G FG VY G + K+ AVK + K+ N+ V+++ ++ + P +V LY
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 638 GCCIEGNQLLLIYEYMENNSLAR--ALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
N + L+ EY+ + ++G D +A L YLH
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRHG 124
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728
I+HRD+K N+L+ + + K++DFGL+K+
Sbjct: 125 ---IIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 31/100 (31%), Positives = 42/100 (42%), Gaps = 18/100 (18%)
Query: 403 NGNYTVNLHFAEILFTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFS 462
N Y V LHFAEI SL R FD+YI GK V D + + G A+ F
Sbjct: 252 NFEYYVYLHFAEIQ--------SLETREFDIYINGKTVYGDVSPK-YLGTDTGALYLDFP 302
Query: 463 AAVTNGTM-EIRLYWAGKGTTDIPYKGVYGPLISAISLYT 501
V+ G + I L T PL++A+ ++
Sbjct: 303 VNVSGGGLLNISLVPTSGST--------LPPLLNALEIFK 334
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 68/280 (24%), Positives = 102/280 (36%), Gaps = 75/280 (26%)
Query: 577 FAPDNKIGEGGFGPVY------KGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQH 630
F +G+G G V+ G L KV+ K++ ++K E +++ L H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT--EQEILATLDH 60
Query: 631 PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLAR---- 686
P L LY L L+ +Y L R L L + +AR
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE----------VARFYAA 110
Query: 687 ----GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---------------- 726
L YLH L IV+RD+K N+LL + + +SDF L+K
Sbjct: 111 EVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 727 -------------LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKA-DVYSFGIVALEI 772
EE + S GT Y+APE + G A D ++ GI+ E+
Sbjct: 168 SRRSSVNSIPSETFSEEPSF-RSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEM 225
Query: 773 VSGR------------SNVICRTKEAQFCLLDWVTLALTD 800
+ G SN++ KE F V+ + D
Sbjct: 226 LYGTTPFKGSNRDETFSNIL--KKEVTFPGSPPVSSSARD 263
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 43/139 (30%), Positives = 65/139 (46%), Gaps = 11/139 (7%)
Query: 644 NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRD 703
N L L+ +Y L L E RL D + +A + +H +L VHRD
Sbjct: 74 NYLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFY-----IAEMVLAIHSIHQLHYVHRD 127
Query: 704 IKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY--AMR---GYLTD 758
IK NVLLD + + +++DFG +D T S+ GT Y++PE AM G
Sbjct: 128 IKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGP 187
Query: 759 KADVYSFGIVALEIVSGRS 777
+ D +S G+ E++ G +
Sbjct: 188 ECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 3e-06
Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 19/163 (11%)
Query: 620 NEIGMISALQHPNLVKLYGCC-IEGNQLLL-------IYEYMENNSLARALFGPEEHRLK 671
NEI + L H N++K+ E N ++ +Y +M + + +
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-------DWKDRP 264
Query: 672 LDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731
L TR +I L + Y+H++ K++HRDIK N+ L+ D + DFG A E++
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
GT +PE + D++S G++ L+++S
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 48/199 (24%), Positives = 86/199 (43%), Gaps = 28/199 (14%)
Query: 591 VYKGLLADGKVI--AVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGN---- 644
+YKG+ + +VI K+ K NEI + + N++K+YG I+
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDI 704
+L LI EY L L ++ L + T+ + I +GL L++ + ++++
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNL 149
Query: 705 KATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD------ 758
+ + L+ ++ KI GL K+ +S+ +M Y L D
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-------LSSPPFKNVNFMV--YFSYKMLNDIFSEYT 200
Query: 759 -KADVYSFGIVALEIVSGR 776
K D+YS G+V EI +G+
Sbjct: 201 IKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 41/227 (18%)
Query: 561 HTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVN 620
H G T QI A N+ D++ + K +L K L + + F
Sbjct: 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVIL--------KVLDPSHRDISLAFFE 53
Query: 621 EIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEE---HRLK--LDWP 675
M+ + H ++V LYG C+ + +++ E++E FGP + HR L P
Sbjct: 54 TASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVE--------FGPLDLFMHRKSDVLTTP 105
Query: 676 TRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL-----DKDLNP--KISDFG--LAK 726
+ + LA L+YL ++ +VH ++ N+LL D + P K+SD G +
Sbjct: 106 WKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV 162
Query: 727 LDEEDNTHISTRIAGTFGYMAPEYAM-RGYLTDKADVYSFGIVALEI 772
L ++ RI ++APE L+ AD +SFG EI
Sbjct: 163 LSRQECVE---RIP----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEEDNTHISTRIAGT 742
GL Y+H + ++HRD+K N+L++ D KI DFGLA+ + +N T T
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 743 FGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGR 776
Y APE + + Y T DV+S G + E++ +
Sbjct: 173 RWYRAPEIMLSFQSY-TKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 58/260 (22%), Positives = 98/260 (37%), Gaps = 58/260 (22%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYG 638
IG G FG V D + A+K L + E +++ + +VKLY
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 639 CCIEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
+ + L + +Y+ + L G E L R I L + +H +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-----ARFYIA-ELTCAIESVH---K 119
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLA---------------------------KLDE 729
+ +HRDIK N+L+D+D + K++DFGL + E
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 730 EDNTHIST---------------RIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
D + + GT Y+APE +R T D +S G++ E++
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239
Query: 775 GRSNVICRTK-EAQFCLLDW 793
G+ + T E Q +++W
Sbjct: 240 GQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-05
Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 143 KLFIEG-----SGLAGPIPSGIASLVELTDLRISDLNGPEGPFP-RLSNLKNMNYLILRS 196
K FI+G GL G IP+ I+ L L + +S N G P L ++ ++ L L
Sbjct: 417 KWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSG-NSIRGNIPPSLGSITSLEVLDLSY 475
Query: 197 GNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG 233
+ G +PE LGQ+ LR+L+L+ N LSG +P+ G
Sbjct: 476 NSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 15/148 (10%)
Query: 630 HPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLA 689
+PN +KLY +LI +Y+++ L F + KL I L L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAKLDEEDNTHISTRIAGTFGYMAP 748
LH + I+H DIK NVL D+ + + D+GL K + GT Y +P
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSP 175
Query: 749 EYAMRGYLTDKA-DVYSFGIVALEIVSG 775
E ++G+ D + D ++ G++ E+++G
Sbjct: 176 E-KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 28/80 (35%), Positives = 40/80 (50%), Gaps = 3/80 (3%)
Query: 96 LHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPI 155
L L++ G +P + L L+ +S N G IP + + T LE L + + G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 156 PSGIASLVELTDLRISDLNG 175
P SL +LT LRI +LNG
Sbjct: 483 P---ESLGQLTSLRILNLNG 499
|
Length = 623 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 34/147 (23%), Positives = 62/147 (42%), Gaps = 47/147 (31%)
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLA------------------KLDEEDNTH--- 734
++ +HRDIK N+L+D+D + K++DFGL + D D ++
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 735 -------------------------ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVA 769
++ + GT Y+APE +R T D +S G++
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 770 LEIVSGRSNVICRTK-EAQFCLLDWVT 795
E++ G+ + +T E Q +++W T
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINWQT 265
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 5e-05
Identities = 21/60 (35%), Positives = 31/60 (51%), Gaps = 2/60 (3%)
Query: 212 GLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNF 269
L+ LDLS N+L+ + F G L + L+GN LT P+ + + +DLS NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 33/149 (22%), Positives = 56/149 (37%), Gaps = 16/149 (10%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLV-KLYGC 639
+ G VY L + +K S+ K +RE E+ ++ L + V K+
Sbjct: 5 LLKGGLTNRVYL-LGTKDEDYVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
L+ E++E +L + + + I LA LA LH+ L +
Sbjct: 62 GESDGWSYLLMEWIEGETL--------DEVSEEEKE---DIAEQLAELLAKLHQLPLLVL 110
Query: 700 VHRDIKATNVLLDKDLNPKISDFGLAKLD 728
H D+ N+L+D I D+ A
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 1e-04
Identities = 18/60 (30%), Positives = 27/60 (45%)
Query: 92 NLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGL 151
NL+ L L++N T +F L LK +S N+ T P+ L L + G+ L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 56/232 (24%), Positives = 89/232 (38%), Gaps = 47/232 (20%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEI----GMISALQHPNLVKLY 637
IG G FG V D G V A+K L K+ +E V I ++ +VK++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
+ L LI E++ + L +K D T +A + + +L
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLL-------MKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGL--------------------------------- 724
+HRDIK N+LLD + K+SDFGL
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 725 -AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 775
A+ + + ++ GT Y+APE M+ D +S G++ E++ G
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 62/275 (22%), Positives = 105/275 (38%), Gaps = 72/275 (26%)
Query: 577 FAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVN---EIGMISALQHPN 632
F +G G FG V D + A+K L K + + E +++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+VKLY + + L + +Y+ + L R+++ +P LAR Y+
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-----RMEV-FPEV------LAR--FYIA 108
Query: 693 E-----ES--RLKIVHRDIKATNVLLDKDLNPKISDFGLAK------------------- 726
E ES ++ +HRDIK N+L+D D + K++DFGL
Sbjct: 109 ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQ 168
Query: 727 --------LDEEDNTHISTR-------------------IAGTFGYMAPEYAMRGYLTDK 759
D+ N R + GT Y+APE +R T
Sbjct: 169 DSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228
Query: 760 ADVYSFGIVALEIVSGRSNVICRT-KEAQFCLLDW 793
D +S G++ E++ G+ + T E Q +++W
Sbjct: 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 4e-04
Identities = 20/60 (33%), Positives = 30/60 (50%), Gaps = 2/60 (3%)
Query: 69 LADLTLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHF 127
L L L N+ + +P L NL+ L L+ NN T PE+F+ L L+ +S N+
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-04
Identities = 34/102 (33%), Positives = 46/102 (45%), Gaps = 8/102 (7%)
Query: 675 PTRHSICIGLARGL----AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730
P + +AR L Y+H E I+HRDIK NVL++ + + DFG A
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARG 312
Query: 731 D-NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALE 771
+T IAGT APE T D++S G+V E
Sbjct: 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 55/240 (22%), Positives = 94/240 (39%), Gaps = 47/240 (19%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEI----GMISALQ 629
++F IG G FG V D G + A+K L K+ +E V I ++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDILVEAD 59
Query: 630 HPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLA 689
+VK++ + L LI E++ + L +K D + + +A +
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL-------MKKDTLSEEATQFYIAETVL 112
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL------------------------- 724
+ +L +HRDIK N+LLD + K+SDFGL
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 725 ---------AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 775
A+ +++ ++ GT Y+APE M+ D +S G++ E++ G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 29/78 (37%), Positives = 43/78 (55%), Gaps = 8/78 (10%)
Query: 583 IGEGGFGPVYK----GLLADGKV--IAVKQLSSKSKQGNRE-FVNEIGMISAL-QHPNLV 634
+G G FG V + GL + V +AVK L + + RE ++E+ ++S L QH N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 635 KLYGCCIEGNQLLLIYEY 652
L G C G +L+I EY
Sbjct: 106 NLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 66/223 (29%), Positives = 102/223 (45%), Gaps = 10/223 (4%)
Query: 56 NGAIPKAVASISTLADLTLEFNQF--SGDLPAELGNLINLEKLHLNSNNFTGKLPESFAN 113
+ + +S+S L L L S D L NL+ L L LN N + E
Sbjct: 56 SNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELL-E 114
Query: 114 LTRLKHFRISDNHFTGQIPDYIQNWT-KLEKLFIEGSGLAGPIPSGIASLVELTDLRISD 172
LT L + +N+ T IP I L++L + + + +PS + +L L +L +S
Sbjct: 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172
Query: 173 LNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFS 232
+ + P LSNL N+N L L SGN I ++P + + L LDLS N + ++ S +
Sbjct: 173 NDLSDLP-KLLSNLSNLNNLDL-SGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSN 230
Query: 233 GSGLTYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNFIDGSS 274
L+ + L+ N L P+ I N + +DLS N SS
Sbjct: 231 LKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQISSISS 272
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 20/60 (33%), Positives = 29/60 (48%), Gaps = 1/60 (1%)
Query: 188 NMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLL 246
N+ L L + + + L+VLDLS N L+ + P FSG L + L+GN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 23/157 (14%)
Query: 631 PNLVKLYGCCIEGNQLLLIYEYMENNSL----ARALFGPEEHRLKLDWPTRHSICIGLAR 686
PN+V L+ + + + L+ ++ E L ++ L PEE W +
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEE--CVKRWAAEMVV------ 96
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE--DNTHISTRIAGTFG 744
L LH E IV RD+ N+LLD + +++ F E+ D +
Sbjct: 97 ALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------ 147
Query: 745 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781
Y APE T+ D +S G + E+++G++ V C
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 21/70 (30%), Positives = 39/70 (55%), Gaps = 2/70 (2%)
Query: 184 SNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSN--FSGSGLTYMYL 241
+N + + L NI G++ + ++ ++ ++LS N+LSG IP + + S L Y+ L
Sbjct: 66 NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 242 TGNLLTGPVP 251
+ N TG +P
Sbjct: 126 SNNNFTGSIP 135
|
Length = 968 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 44/161 (27%), Positives = 72/161 (44%), Gaps = 27/161 (16%)
Query: 630 HPNLVKLYGCCIEGNQLLLIYEYMENNSLARAL----FGPEEHRLKLDWPTRHSICIGLA 685
HPN+V I N+L ++ +M S A+ L F L + + I G+
Sbjct: 58 HPNIVPYRATFIADNELWVVTSFMAYGS-AKDLICTHFMDGMSELAIAY-----ILQGVL 111
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG- 744
+ L Y+H + VHR +KA+++L+ D +S GL N R+ F
Sbjct: 112 KALDYIHH---MGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPK 166
Query: 745 -------YMAPEYA---MRGYLTDKADVYSFGIVALEIVSG 775
+++PE ++GY K+D+YS GI A E+ +G
Sbjct: 167 YSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 56/233 (24%), Positives = 90/233 (38%), Gaps = 40/233 (17%)
Query: 570 IKAATNNFAPDNKIGEGGFGPVYKGLLADGK-VIAVKQLSSKSKQGNREFVNEIGMISAL 628
I +T F + +GEG FG V + K AVK + + K R+ EI + +
Sbjct: 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY-TRDAKIEIQFMEKV 182
Query: 629 QHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRH---------S 679
+ + + L+ I Y +N + + P+ LDW +H
Sbjct: 183 RQADPADRF-------PLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQ 235
Query: 680 ICIGLARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNP-------------KISDFG 723
I L Y H E L ++H D+K N+L+ D ++P +I D G
Sbjct: 236 IIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293
Query: 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
DE H T I T Y +PE + D++S G + E+ +G+
Sbjct: 294 -GCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 51/178 (28%), Positives = 76/178 (42%), Gaps = 15/178 (8%)
Query: 99 NSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSG 158
S+N LP S + L L S + + + N L L + + L I S
Sbjct: 54 LSSNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNI-SE 111
Query: 159 IASLVELTDL-----RISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGL 213
+ L LT L I+D+ G SNLK ++ S N I +P L + L
Sbjct: 112 LLELTNLTSLDLDNNNITDIPPLIGLLK--SNLKELDL----SDNKIESLPSPLRNLPNL 165
Query: 214 RVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNFI 270
+ LDLSFN LS + + S L + L+GN ++ +P I + +DLS N+ I
Sbjct: 166 KNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII 222
|
Length = 394 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.004
Identities = 28/98 (28%), Positives = 37/98 (37%), Gaps = 27/98 (27%)
Query: 679 SICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD-----EEDNT 733
++C+ L LH R K+ N+LL D GL KLD +
Sbjct: 21 AVCLQCLGALRELH---------RQAKSGNILLTWD--------GLLKLDGSVAFKTPEQ 63
Query: 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALE 771
+MAPE T+KAD+YS GI E
Sbjct: 64 SRPDPY-----FMAPEVIQGQSYTEKADIYSLGITLYE 96
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 809 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.98 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.98 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.98 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.98 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.98 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.98 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.92 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.92 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.9 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.88 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.86 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.86 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.84 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.82 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.82 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.78 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.78 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.78 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.77 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.75 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.65 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.63 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.46 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.41 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.39 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.37 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.24 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.19 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.16 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.14 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.13 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.12 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.08 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.07 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.06 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.03 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.01 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.96 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.96 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.93 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.91 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.83 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.82 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.74 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.73 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.72 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.7 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.64 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.64 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.56 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.51 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.5 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.44 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.44 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.4 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.37 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.29 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.27 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-66 Score=646.60 Aligned_cols=643 Identities=25% Similarity=0.374 Sum_probs=445.8
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCC-CCchhhcCCccCcEEeecccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANG-AIPKAVASISTLADLTLEFNQ 78 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~-~ip~~l~~l~~L~~L~L~~N~ 78 (809)
+|+|++|++.+.+|..+..+++|++|+|++|.+.+.+|..+..++ |+.|++++|.+. .+|..+..+++|+.|+|++|.
T Consensus 240 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~ 319 (968)
T PLN00113 240 HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNN 319 (968)
T ss_pred EEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCc
Confidence 478999999999999999999999999999999988998888875 888999888774 678888999999999999999
Q ss_pred cccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCcc
Q 043333 79 FSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSG 158 (809)
Q Consensus 79 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 158 (809)
+++.+|..+..+++|+.|+|++|++++.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|++++|++.+.+|..
T Consensus 320 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~ 399 (968)
T PLN00113 320 FTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKS 399 (968)
T ss_pred cCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHH
Confidence 99889999999999999999999999889999999999999999999999889988888889999999999998888888
Q ss_pred ccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccE
Q 043333 159 IASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTY 238 (809)
Q Consensus 159 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~ 238 (809)
+..+++|+.|++++|+++...+..+.++++|+.|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|..+..++|+.
T Consensus 400 ~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~ 479 (968)
T PLN00113 400 LGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLEN 479 (968)
T ss_pred HhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceE
Confidence 88889999999999988877777888888899999999888888888888888888888888888888887776688888
Q ss_pred EEeeCccCCCCCChhhhh-ccCccccccCCccccCCCCCcccccccceeccccCC---CCCCccccccccCCCCCCCcce
Q 043333 239 MYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEG---SNSTGIVSCLKSFTCPTNHSSL 314 (809)
Q Consensus 239 L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~c~~~~~~~~~~~~~ 314 (809)
|+|++|++++.+|..+.. ..++.|+|++|++.+..|..+.....+..+..+.+. ..+......++.......+|..
T Consensus 480 L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 559 (968)
T PLN00113 480 LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQL 559 (968)
T ss_pred EECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcc
Confidence 888888888888776654 456788888888887777665544444433333222 1222222223333333333332
Q ss_pred eecCCCceeeecCCeeecCCCCCCCCcceeecCCceeeeeeccccCCCCCCccceEecccccccCchhhhcccccCceee
Q 043333 315 HINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGHFIDNSTRENSYIQINTSRLLMDDSQLYTEARISPISL 394 (809)
Q Consensus 315 ~~~C~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (809)
.-. .+. .+. .......+.++...+ +|.+++... |.+. .+.+
T Consensus 560 ~~~---~p~------~l~---~l~~L~~l~ls~N~l----~~~~p~~~~--------------------~~~~--~~~~- 600 (968)
T PLN00113 560 SGE---IPK------NLG---NVESLVQVNISHNHL----HGSLPSTGA--------------------FLAI--NASA- 600 (968)
T ss_pred ccc---CCh------hHh---cCcccCEEeccCCcc----eeeCCCcch--------------------hccc--Chhh-
Confidence 100 000 000 011111222222211 111111000 0000 0000
Q ss_pred eeeeeeeeCceEEEEEEEEeeEecCCcccccCCceeEEEEecCeeeccccceeeccCCcCceEEEeeeeeeecCeeEEEE
Q 043333 395 TYYGYCMVNGNYTVNLHFAEILFTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRL 474 (809)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 474 (809)
|
T Consensus 601 -~------------------------------------------------------------------------------ 601 (968)
T PLN00113 601 -V------------------------------------------------------------------------------ 601 (968)
T ss_pred -h------------------------------------------------------------------------------
Confidence 0
Q ss_pred EecCCCccccCCCCCcCCccccccccCCCCCCCCCCCCCCCcccceeehhHHHHHHHHHHH-HHHHhhhcccccc-chhh
Q 043333 475 YWAGKGTTDIPYKGVYGPLISAISLYTPDIASPLVNGSSNSTNVGMVVGIVAAAAFILILI-VSILWWKGCFKRK-HTLE 552 (809)
Q Consensus 475 ~w~g~~~~~~p~~~~~~p~~~~~~~~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~l~-~~~~~~~~~~~r~-~~~~ 552 (809)
+|.+..|.+ + .+... ++- ...+.....+++++++++++++++++ +++++++++++++ ++.+
T Consensus 602 --~~n~~lc~~------~-------~~~~~-~~c-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (968)
T PLN00113 602 --AGNIDLCGG------D-------TTSGL-PPC-KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVE 664 (968)
T ss_pred --cCCccccCC------c-------cccCC-CCC-ccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccc
Confidence 000000000 0 00000 000 00001111223333333333332222 2233322221111 1111
Q ss_pred hhhcc--ccCC----CCCccHHHHHHHhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHH
Q 043333 553 QELKG--LDLH----TGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMI 625 (809)
Q Consensus 553 ~~~~~--~~~~----~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l 625 (809)
.+... .... ...++.++ ....|...+.||+|+||.||+|+. .+++.||||++..... ...+|++.+
T Consensus 665 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l 737 (968)
T PLN00113 665 NEDGTWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADM 737 (968)
T ss_pred cccccccccccccccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHH
Confidence 11000 0000 11223333 345678889999999999999996 5789999999864322 123568899
Q ss_pred hhcCCCceEeEEeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 043333 626 SALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIK 705 (809)
Q Consensus 626 ~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk 705 (809)
++++|||||+++|+|.+.+..++|||||++|+|.++++ .++|..+.+++.|+|+||+|||+.+.++|+|||||
T Consensus 738 ~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk 810 (968)
T PLN00113 738 GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810 (968)
T ss_pred hhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCC
Confidence 99999999999999999999999999999999999993 37999999999999999999997766799999999
Q ss_pred CCCEEEcCCCceEEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcc
Q 043333 706 ATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKE 785 (809)
Q Consensus 706 p~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~ 785 (809)
|+||+++.++.+++. ||.+...... ....+|+.|+|||++.+..++.++|||||||++|||+||+.||+... .
T Consensus 811 p~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~ 883 (968)
T PLN00113 811 PEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-G 883 (968)
T ss_pred HHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-C
Confidence 999999999988876 6655432211 12357889999999999999999999999999999999999995422 2
Q ss_pred cchhHHHHHHHhhc
Q 043333 786 AQFCLLDWVTLALT 799 (809)
Q Consensus 786 ~~~~l~~~~~~~~~ 799 (809)
....+++|++....
T Consensus 884 ~~~~~~~~~~~~~~ 897 (968)
T PLN00113 884 VHGSIVEWARYCYS 897 (968)
T ss_pred CCCcHHHHHHHhcC
Confidence 34456777765543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=428.96 Aligned_cols=244 Identities=54% Similarity=0.911 Sum_probs=214.6
Q ss_pred CCCCccHHHHHHHhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEE
Q 043333 561 HTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640 (809)
Q Consensus 561 ~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~ 640 (809)
....|+++++..||++|...+.||+|+||.||+|.+.+|+.||||++.....+..++|.+|++++++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34579999999999999999999999999999999999999999988655432156799999999999999999999999
Q ss_pred EeCC-eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEE
Q 043333 641 IEGN-QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 719 (809)
Q Consensus 641 ~~~~-~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 719 (809)
.+.+ +.+||||||++|+|.++||..... +++|.+|++||.++|+||+|||+.++++||||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 599999999999999999875543 8999999999999999999999999889999999999999999999999
Q ss_pred EecCCccccCC-CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhh
Q 043333 720 SDFGLAKLDEE-DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLAL 798 (809)
Q Consensus 720 ~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~ 798 (809)
+|||+|+.... .... .....||.+|+|||++..+..+.|+|||||||+++||+||++|.+.....+...+++|+...+
T Consensus 219 sDFGLa~~~~~~~~~~-~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSV-STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCccccce-eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999976654 2222 111179999999999999999999999999999999999999998755555667999998888
Q ss_pred ccCCCCcCC
Q 043333 799 TDFRFPLFL 807 (809)
Q Consensus 799 ~~~~~p~~~ 807 (809)
.+.++.+.+
T Consensus 298 ~~~~~~eii 306 (361)
T KOG1187|consen 298 EEGKLREIV 306 (361)
T ss_pred HCcchhhee
Confidence 877666554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=362.76 Aligned_cols=202 Identities=31% Similarity=0.538 Sum_probs=180.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
..+|...+.||+|+||+||+|+++ ++..||||.+..+ .....+.+..|+++|+.++|||||++++++.+++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888888999999999999965 5889999999776 4445566789999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC------CceEEEecCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD------LNPKISDFGL 724 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~------~~~kl~DfGl 724 (809)
|||.+|+|.+|++. +..+++..+..++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999954 33789999999999999999999999 89999999999999764 4689999999
Q ss_pred ccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
|+.+... ......+|++-|||||+++..+|+.|+|+||.|+|+|||++|+.||+..+.
T Consensus 162 AR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 162 ARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 9988743 233457899999999999999999999999999999999999999986543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=346.37 Aligned_cols=219 Identities=28% Similarity=0.418 Sum_probs=189.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|++.+.||+|+||+||.++.+ .++.+|+|++++.. ....+...+|..+|.+++||.||++.-.|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999965 58899999998763 23456678999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
+||+.||.|..+|. ....+++..+..++.+|+.||.|||+. +||||||||+|||||++|+++|+|||+++..-
T Consensus 104 ld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999993 344688888999999999999999999 89999999999999999999999999998654
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhccC-CCCcC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDF-RFPLF 806 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~~-~~p~~ 806 (809)
..+. .+..++||+.|||||++.+..++..+|+||+||++|||++|.+||... +..+|.+...... +.|+.
T Consensus 177 ~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~------~~~~~~~~I~~~k~~~~p~ 247 (357)
T KOG0598|consen 177 KDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE------DVKKMYDKILKGKLPLPPG 247 (357)
T ss_pred cCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc------cHHHHHHHHhcCcCCCCCc
Confidence 3322 233479999999999999999999999999999999999999999763 3455666666664 55544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=362.28 Aligned_cols=221 Identities=30% Similarity=0.524 Sum_probs=194.0
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
.+|...+.||+|||++||+++. ..|+.||+|++.++. ....+...+|+++.+.++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999996 789999999997752 333566789999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
|+|++|+|..++ +.+.+++++.+..+..||+.||.|||++ +|+|||||-.|++|+++.++||+|||+|.....
T Consensus 98 ELC~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999988 3566899999999999999999999999 899999999999999999999999999988765
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhccCCCCcCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFLS 808 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~ 808 (809)
++.. ....||||.|.|||++....++..+||||+|||+|.|+.|++||+..+-.+. +-+-...++.+|..+|
T Consensus 171 ~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket-----y~~Ik~~~Y~~P~~ls 242 (592)
T KOG0575|consen 171 DGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET-----YNKIKLNEYSMPSHLS 242 (592)
T ss_pred cccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH-----HHHHHhcCcccccccC
Confidence 4333 2357999999999999999999999999999999999999999987543222 3455566788888776
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=358.57 Aligned_cols=201 Identities=38% Similarity=0.631 Sum_probs=174.8
Q ss_pred CCCeeccCCCccEEEeEeeCCeEEEEEEecccCccc--chhHHHHHHHHhhcCCCceEeEEeEEEeCC-eEEEEEEcccC
Q 043333 579 PDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQG--NREFVNEIGMISALQHPNLVKLYGCCIEGN-QLLLIYEYMEN 655 (809)
Q Consensus 579 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~--~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~-~~~lV~ey~~~ 655 (809)
..+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.++. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345599999999999999755559999997653322 568999999999999999999999999987 79999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-ceEEEecCCccccCCCCcc
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~ 734 (809)
|+|.++++.. ....+++..+++++.|||+||+|||++.+ ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 9999999764 45679999999999999999999999832 99999999999999997 99999999998654322 2
Q ss_pred eeccccccccccchhhhc--cCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 735 ISTRIAGTFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~~--~~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
..+...||+.|||||++. ...++.|+|||||||++|||+||+.||.....
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 233467999999999999 66999999999999999999999999987543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=338.24 Aligned_cols=210 Identities=30% Similarity=0.445 Sum_probs=181.2
Q ss_pred CCCCeeccCCCccEEEeEee-CCeEEEEEEeccc-CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCC-eEEEEEEccc
Q 043333 578 APDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGN-QLLLIYEYME 654 (809)
Q Consensus 578 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~-~~~lV~ey~~ 654 (809)
+..+.||+|..|+|||++++ +++.+|+|++... .....+++.+|++++++.+||+||.++|.|+... ++.++||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34678999999999999976 6889999999544 3344678999999999999999999999999998 5999999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
+|||++.+.. ..++++....+|+.++++||.|||+. .+||||||||+|||++..|++||||||.++.+...
T Consensus 162 gGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 162 GGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 9999998843 25689999999999999999999974 28999999999999999999999999999876433
Q ss_pred eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC--CcccchhHHHHHHH
Q 043333 735 ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR--TKEAQFCLLDWVTL 796 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~--~~~~~~~l~~~~~~ 796 (809)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+... ...+...+..++..
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD 296 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence 345678999999999999999999999999999999999999999763 23445555555443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.83 Aligned_cols=223 Identities=30% Similarity=0.456 Sum_probs=193.4
Q ss_pred cCCCCCCeeccCCCccEEEeE-eeCCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEG--NQLLLI 649 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lV 649 (809)
+.|+..++||+|.||.||+|+ ..+|+.||+|+++.... ..-.-..+||.+|+++.||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 456667889999999999999 56799999999976642 2234457899999999999999999999886 689999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
+|||++ +|.-++.. ....++..++..+++|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||||+++.
T Consensus 197 FeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999987 77777733 345789999999999999999999999 89999999999999999999999999999887
Q ss_pred CCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhccCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFP 804 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~~~~p 804 (809)
.......+..+-|..|+|||++.+ ..|+..+|+||.|||+.||++||+.|.++++.+|.+.+.-+.....+.-||
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 776665667778999999999887 479999999999999999999999999999888888777666666665566
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=331.35 Aligned_cols=206 Identities=29% Similarity=0.468 Sum_probs=180.2
Q ss_pred CCCCCCeeccCCCccEEEeE-eeCCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEe-EEEeCCe-EEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYG-CCIEGNQ-LLLIY 650 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~-~~~~~~~-~~lV~ 650 (809)
+|.+.++||+|.||+|||+. +.+|+.||.|.+.-. +....+....|+.+|++++|||||++++ .+.++.+ +++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46677899999999999998 568999999988633 3344567889999999999999999999 5555555 79999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL-KIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
||+.+|+|...+...++.+..+++..+++++.|+++||.++|..-+. -|+||||||.||+|+.+|.+|++|||+++++.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999977667778899999999999999999999995332 27899999999999999999999999999887
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.... .....+|||.||+||.+....++.||||||+||++|||+.-++||.++
T Consensus 180 s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 180 SKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred chhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 5433 334578999999999999999999999999999999999999999876
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=317.88 Aligned_cols=218 Identities=27% Similarity=0.420 Sum_probs=190.8
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||.|+||+|-.++.+ +|..+|+|++..... ...+...+|..+|+.+.||+++++.+.|.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46788899999999999999954 588999999976532 23445678999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|.|..+|+ ...+++.+.+..+|.||+.||+|||+. .|++||+||+|||||.+|.+||+|||.|+....
T Consensus 124 eyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999994 345688999999999999999999998 899999999999999999999999999987653
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhccCCCCcCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFLS 808 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~ 808 (809)
. +...|||+.|+|||++..+.+...+|.|||||++|||+.|.+||...+. +.-+-+-...+.+||+++|
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~iY~KI~~~~v~fP~~fs 265 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQIYEKILEGKVKFPSYFS 265 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HHHHHHHHhCcccCCcccC
Confidence 2 4568999999999999999999999999999999999999999976433 2334455667799999987
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=346.10 Aligned_cols=215 Identities=33% Similarity=0.520 Sum_probs=182.7
Q ss_pred CCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCch
Q 043333 579 PDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL 658 (809)
Q Consensus 579 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 658 (809)
..+.||+|-||.||.|.++....||||.++... ...++|.+|+++|++++|+|||+++|+|..++.++||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 457899999999999999877799999997653 3357899999999999999999999999999999999999999999
Q ss_pred hhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceecc
Q 043333 659 ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 738 (809)
Q Consensus 659 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 738 (809)
.+||.. ..+..++..+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||+|+...++....+..
T Consensus 289 l~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 289 LDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred HHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 999965 3455688899999999999999999998 89999999999999999999999999999655544443333
Q ss_pred ccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHHHHHhhccCCCCc
Q 043333 739 IAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRTKEAQFCLLDWVTLALTDFRFPL 805 (809)
Q Consensus 739 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~~~~~~~l~~~~~~~~~~~~~p~ 805 (809)
..-...|.|||.+..+.++.|||||||||+||||+| |+.|+...+. .+-++.+-..+|+|.
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------~ev~~~le~GyRlp~ 425 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------EEVLELLERGYRLPR 425 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH------HHHHHHHhccCcCCC
Confidence 334568999999999999999999999999999998 7888865332 233444555566653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=333.18 Aligned_cols=200 Identities=29% Similarity=0.451 Sum_probs=171.5
Q ss_pred HhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcc-------cchhHHHHHHHHhhcCCCceEeEEeEEEeCC
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQ-------GNREFVNEIGMISALQHPNLVKLYGCCIEGN 644 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~-------~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~ 644 (809)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+.... ......+|+++|++++|||||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456788899999999999999984 57999999999754211 1233468999999999999999999999999
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CceEEEe
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKISD 721 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~D 721 (809)
..|+|||||++|+|.+++... ..+.+..-..+++|++.|+.|||++ +|+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 999999999999999988543 3456667788999999999999999 89999999999999766 7799999
Q ss_pred cCCccccCCCCcceeccccccccccchhhhccCC---CCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 722 FGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGY---LTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 722 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
||+|+... ....+...|||+.|.|||++.++. +..++|+||+||++|.+++|.+||..
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~ 383 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE 383 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence 99999876 334556789999999999997654 33488999999999999999999965
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=336.06 Aligned_cols=218 Identities=32% Similarity=0.490 Sum_probs=189.4
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
++|...+.||+|.||+||||+- .+.+.||+|.+.+.. ..+.+.+.+|++++++++|||||.++++|....++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5677888999999999999994 468999999986543 2335668899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+.+ +|..+| +....+++..+..++.++..||.|||+. +|+|||+||.|||++.++.+|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9987 999999 3455799999999999999999999998 899999999999999999999999999998765
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhcc-CCCCcCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTD-FRFPLFL 807 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~-~~~p~~~ 807 (809)
+....+.+.||+.|||||+..++.++..+|.||+|||+|||++|++||-.+ .+.+-++....| .++|.-+
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~v~~p~~~ 223 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDPVKPPSTA 223 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCCCCCcccc
Confidence 344556678999999999999999999999999999999999999999653 234456666665 6676644
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=305.88 Aligned_cols=227 Identities=28% Similarity=0.394 Sum_probs=194.5
Q ss_pred cCCCCCCeeccCCCccEEEeE-eeCCeEEEEEEecccCcc--cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
++|...+.+|+|.||.||+|+ ...|+.||||+++..... -.....+|++.|+.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467778899999999999999 457999999999766433 24567899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
||+. +|+..+. .....+.-.++..++.++.+|++|||++ .|+||||||.|+|++++|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9987 8988884 3455788889999999999999999998 7999999999999999999999999999988655
Q ss_pred Ccceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhccCCCCcCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFLSL 809 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~ 809 (809)
+... +..+-|..|+|||.+.+ +.|+..+||||.|||+.||+-|.+-|.+.++-+|...+.-+-..-.+..||+.-+|
T Consensus 155 ~~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NRIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Cccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 4332 33367899999999987 56899999999999999999999888887777777777666667777888876554
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=316.15 Aligned_cols=210 Identities=25% Similarity=0.388 Sum_probs=179.1
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
+.|+...++|+|+||.|||++.+ .|+.||||++....+ ...+-.++|+++|++++|+|+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46777889999999999999965 599999999976533 223456899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|++.- +.+-| +.....++.....+++.|++.|+.|+|++ ++|||||||+|||++.++.+|+||||+|+.+..
T Consensus 82 ~~dhT-vL~eL---e~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDHT-VLHEL---ERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecchH-HHHHH---HhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 99874 33334 33455688899999999999999999998 899999999999999999999999999998764
Q ss_pred Ccceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHH
Q 043333 732 NTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLD 792 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~ 792 (809)
.....+.++.|.+|+|||.+.+ ..|+..+|||+.||++.||++|.+-|-+++..++..+++
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ 215 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIR 215 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHH
Confidence 3334466788999999999987 689999999999999999999999888776555554443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=330.70 Aligned_cols=223 Identities=27% Similarity=0.429 Sum_probs=186.5
Q ss_pred HhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEeccc---CcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSK---SKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 647 (809)
...+|...+.||+|+|++||+|+. ..++.+|||++.+. .....+-...|-++|.+| .||.|++|+..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 456788999999999999999994 56899999998665 222234456788899999 8999999999999999999
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+|+||+++|+|.++++. ...+++.....++.+|..||+|||++ +||||||||+|||||++++++|+|||.|+.
T Consensus 151 FvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999953 35688999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcc---------e-e--ccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHH
Q 043333 728 DEEDNTH---------I-S--TRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVT 795 (809)
Q Consensus 728 ~~~~~~~---------~-~--~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~ 795 (809)
+.+.... . . ..++||..|.+||++..+..++.+|+|+||||+|+|+.|++||...++- .-..+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-----liFqk 298 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-----LIFQK 298 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-----HHHHH
Confidence 7532211 1 1 3478999999999999999999999999999999999999999764332 11233
Q ss_pred HhhccCCCCcCC
Q 043333 796 LALTDFRFPLFL 807 (809)
Q Consensus 796 ~~~~~~~~p~~~ 807 (809)
-.--++.||+-+
T Consensus 299 I~~l~y~fp~~f 310 (604)
T KOG0592|consen 299 IQALDYEFPEGF 310 (604)
T ss_pred HHHhcccCCCCC
Confidence 334467777754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=352.06 Aligned_cols=209 Identities=32% Similarity=0.551 Sum_probs=177.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 646 (809)
+.+....+.||+|.||+||+|... +...||||.+++.... ..++|++|+++++.++|||||+|+|.|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 445566788999999999999843 3467999999887665 678999999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhccCCCc----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc
Q 043333 647 LLIYEYMENNSLARALFGPEE----------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 716 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 716 (809)
++|+|||..|+|.+||..... .+.+++..+.+.||.|||.||+||-++ .+|||||..+|+|+.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 999999999999999953211 134588999999999999999999998 7999999999999999999
Q ss_pred eEEEecCCccccCC-CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 043333 717 PKISDFGLAKLDEE-DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRTKE 785 (809)
Q Consensus 717 ~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~~~ 785 (809)
+||+|||+++-.-. +..+......-..+|||||.|..++++++||||||||+|||+++ |+.|+.+.+.+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 99999999985432 22222223334569999999999999999999999999999998 88999875443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=349.17 Aligned_cols=219 Identities=31% Similarity=0.520 Sum_probs=185.3
Q ss_pred CCCCCeeccCCCccEEEeEee-CC---eEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DG---KVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g---~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
..+.++||.|.||.||+|+++ .| ..||||.++... ....++|+.|+.+|+++.||||++|.|+.......++|.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 456789999999999999965 23 479999998764 3456789999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
||++|+|+.||+.. ..++.+.+...++++||.||.||.+. ++|||||.++|||++.+..+||+|||+++.+.++
T Consensus 711 yMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 711 YMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999553 35688999999999999999999987 8999999999999999999999999999988665
Q ss_pred Ccceeccccc--cccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHHHHHhhccCCCCcCC
Q 043333 732 NTHISTRIAG--TFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRTKEAQFCLLDWVTLALTDFRFPLFL 807 (809)
Q Consensus 732 ~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~~~~~~~l~~~~~~~~~~~~~p~~~ 807 (809)
.....+..-| ..+|.|||.+..++++..+|||||||+|||.|+ |.+||..-+.++ =++.+..++++|+=+
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd------VIkaIe~gyRLPpPm 857 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD------VIKAIEQGYRLPPPM 857 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH------HHHHHHhccCCCCCC
Confidence 5332222212 358999999999999999999999999999765 999997643322 256666778888744
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=333.20 Aligned_cols=223 Identities=30% Similarity=0.510 Sum_probs=192.4
Q ss_pred cCCCCCCeeccCCCccEEEeE-eeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
..|....+||+|+-|.||.|. ...++.||||++........+-+.+|+.+|+..+|+|||+++..|...+++|.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 457777899999999999998 4568899999997766555566789999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.+.+ ....+++.++..|+.++++||+|||.+ +|+|||||++|||++.+|++||+|||++..+.....
T Consensus 353 ~ggsLTDvV-----t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVV-----TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhh-----hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999988 344589999999999999999999999 899999999999999999999999999987766544
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhccCCCCcCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFLS 808 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~ 808 (809)
. ...++||+.|||||++....|++|.||||||++++||+-|++||-..+.- ..+......-.++.+.|+-+|
T Consensus 425 K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl--rAlyLIa~ng~P~lk~~~klS 496 (550)
T KOG0578|consen 425 K-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIATNGTPKLKNPEKLS 496 (550)
T ss_pred c-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH--HHHHHHhhcCCCCcCCccccC
Confidence 3 34578999999999999999999999999999999999999999653322 233444556666677776665
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=309.24 Aligned_cols=227 Identities=24% Similarity=0.364 Sum_probs=193.7
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccc--hhHHHHHHHHhhcCCCceEeEEeEEEe--CCeEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGN--REFVNEIGMISALQHPNLVKLYGCCIE--GNQLLLI 649 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~--~~f~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~lV 649 (809)
+.|+..+.|++|.||.||+|+. ++++.||+|+++....... -.-++|+.+|.+++|||||.+..+... -+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4577789999999999999994 5689999999976542211 124789999999999999999988875 3679999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
||||+. +|...+... ..++...++..+..|+++|++|||+. -|+|||||++|+|++..|.+||+|||+|+.+.
T Consensus 156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999987 788888543 35688889999999999999999998 79999999999999999999999999999886
Q ss_pred CCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhccCCCCcCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFLS 808 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~ 808 (809)
+.- ...+..+-|..|+|||.+.+ ..|++..|+||+|||+.||+++++-|.+..+-+|.+.+.-+...-.+-.||.|..
T Consensus 229 sp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 229 SPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred CCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 643 33456778999999999876 5689999999999999999999999999888888888877888888889998865
Q ss_pred C
Q 043333 809 L 809 (809)
Q Consensus 809 ~ 809 (809)
|
T Consensus 308 l 308 (419)
T KOG0663|consen 308 L 308 (419)
T ss_pred c
Confidence 3
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.69 Aligned_cols=217 Identities=25% Similarity=0.361 Sum_probs=184.5
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
..++|+....||+|+||.||.|+.+ .|+.+|+|++++.. ....+...+|-.+|....+|+||+++-.|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999965 59999999998763 3345667889999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||++||++..+|. ....|++..+..++.+++.|++-+|+. ++|||||||+|+|||..|++||+||||+.-+
T Consensus 219 iMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999883 345688888999999999999999998 8999999999999999999999999998522
Q ss_pred CC-----------------------CCc----ce-------------------eccccccccccchhhhccCCCCchHHH
Q 043333 729 EE-----------------------DNT----HI-------------------STRIAGTFGYMAPEYAMRGYLTDKADV 762 (809)
Q Consensus 729 ~~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~ksDV 762 (809)
.. +.. .. ....+|||.|||||++.+..++..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 10 000 00 012579999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCcc-cchhHHHHHHH
Q 043333 763 YSFGIVALEIVSGRSNVICRTKE-AQFCLLDWVTL 796 (809)
Q Consensus 763 wSlGvil~elltGk~P~~~~~~~-~~~~l~~~~~~ 796 (809)
||+|||+|||+.|-+||...+.. .-..++.|...
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~ 406 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET 406 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh
Confidence 99999999999999999886644 34456667643
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=333.13 Aligned_cols=222 Identities=27% Similarity=0.464 Sum_probs=190.0
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 647 (809)
..++|...++||+|.||+|+++..+ +++.+|||++++.. ..+.+..+.|.+++... +||.+++++.+|++.++++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4567889999999999999999965 57899999998763 34456778898888877 5999999999999999999
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
.||||+.||++..+. ....+++..+..++..|+.||.|||++ +||+||||-+|||||.+|++||+|||+++.
T Consensus 446 fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence 999999999965555 334689999999999999999999999 899999999999999999999999999985
Q ss_pred cCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhccCCCCcCC
Q 043333 728 DEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFL 807 (809)
Q Consensus 728 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~~~~p~~~ 807 (809)
.--... .+...+||+.|||||++.+..|+..+|+|||||+||||+.|+.||.+.++++.++ .-...|...|.++
T Consensus 518 ~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd-----sI~~d~~~yP~~l 591 (694)
T KOG0694|consen 518 GMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD-----SIVNDEVRYPRFL 591 (694)
T ss_pred cCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-----HHhcCCCCCCCcc
Confidence 432222 3456899999999999999999999999999999999999999999876665432 2234557888887
Q ss_pred C
Q 043333 808 S 808 (809)
Q Consensus 808 ~ 808 (809)
|
T Consensus 592 s 592 (694)
T KOG0694|consen 592 S 592 (694)
T ss_pred c
Confidence 6
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.31 Aligned_cols=222 Identities=26% Similarity=0.433 Sum_probs=184.7
Q ss_pred HhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEeccc----Cc-ccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCe
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSK----SK-QGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~----~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~ 645 (809)
..++|...+.||+|+||+|+.|.. .+++.||||++... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456889999999999999999985 46899999977553 11 22445668999999999 9999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CceEEEecCC
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGL 724 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGl 724 (809)
.++||||+.+|+|.+++.. ..++.+..+.+++.|++.|++|+|++ +|+||||||+|||+|.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999943 45688899999999999999999998 89999999999999999 9999999999
Q ss_pred ccccCCCCcceeccccccccccchhhhccCC-C-CchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhccCC
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMRGY-L-TDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFR 802 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~~~ 802 (809)
+.... .........+||+.|+|||++.+.. | +.++||||+||+||.|++|+.||+..+ ...+.+ .-.-.++.
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~---~~~l~~--ki~~~~~~ 241 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN---VPNLYR--KIRKGEFK 241 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc---HHHHHH--HHhcCCcc
Confidence 99774 2223345678999999999998865 5 588999999999999999999997622 111111 13344577
Q ss_pred CCcCC
Q 043333 803 FPLFL 807 (809)
Q Consensus 803 ~p~~~ 807 (809)
+|+++
T Consensus 242 ~p~~~ 246 (370)
T KOG0583|consen 242 IPSYL 246 (370)
T ss_pred CCCCc
Confidence 88776
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=316.25 Aligned_cols=201 Identities=32% Similarity=0.522 Sum_probs=169.8
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCC--eEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGN--QLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~--~~~lV~e 651 (809)
.++...+.||+|+||+||++... +|+..|||.+........+.+.+|+++|++++|||||+++|...... ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 34556788999999999999965 48999999986653333566889999999999999999999866554 6899999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCceEEEecCCccccCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLDEE 730 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~ 730 (809)
|+++|||.+++.... . .+++..+..+..||++||+|||++ +||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999994332 1 699999999999999999999998 8999999999999999 79999999999986653
Q ss_pred --CCcceeccccccccccchhhhccCC-CCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 731 --DNTHISTRIAGTFGYMAPEYAMRGY-LTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 731 --~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
..........||+.|||||++..+. ...++||||+||++.||+||++||..
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 1222233578999999999998643 34599999999999999999999975
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=321.49 Aligned_cols=207 Identities=26% Similarity=0.412 Sum_probs=179.2
Q ss_pred HhcCCCCCCeeccCCCccEEEeE-eeCCeEEEEEEecccCcccchh-HHHHHHHHhhcC-CCceEeEEeEEEeCC-eEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE-FVNEIGMISALQ-HPNLVKLYGCCIEGN-QLLL 648 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~~~~-f~~Ei~~l~~l~-H~nIv~l~~~~~~~~-~~~l 648 (809)
..++|...++||.|.||.||+|+ ...|+.||||+++.+....++- =++|++.|+++. |||||++.+.+.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 45678888999999999999999 5578999999998765443222 368999999998 999999999999988 9999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
|||||+. +|++.+.++ +..+++..+..|+.||.+||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+..
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999975 899988543 56799999999999999999999999 8999999999999999999999999999977
Q ss_pred CCCCcceeccccccccccchhhhc-cCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccch
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQF 788 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~ 788 (809)
.... ..+.++.|..|+|||++. .+.|+.+.|+|++|||++|+.+=++-|-+.++-++.
T Consensus 161 ~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi 219 (538)
T KOG0661|consen 161 RSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI 219 (538)
T ss_pred ccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH
Confidence 6443 345678999999999765 578999999999999999999999999876554443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=293.09 Aligned_cols=223 Identities=27% Similarity=0.452 Sum_probs=189.9
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
+-++|++.+.||+|-||.||.|+.+ ++-.||+|++.+.. .+..+++.+|+++-+.++||||+++++++.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3467899999999999999999954 57799999987652 3345788999999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
++||.+.|++...|+.. ...+++......+..|+|.||.|+|.. +||||||||+|+|++.++..|++|||-+...
T Consensus 100 ilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999643 234577788889999999999999998 8999999999999999999999999998764
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhccCCCCcCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFLS 808 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~ 808 (809)
.. ......+||..|.|||...+..++..+|+|++||+.||++.|.+||+.....+ -+.+-.-.+..+|+.++
T Consensus 175 p~---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-----tYkrI~k~~~~~p~~is 246 (281)
T KOG0580|consen 175 PS---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-----TYKRIRKVDLKFPSTIS 246 (281)
T ss_pred CC---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-----HHHHHHHccccCCcccC
Confidence 42 22345789999999999999999999999999999999999999998754221 23444556777787664
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.62 Aligned_cols=193 Identities=35% Similarity=0.528 Sum_probs=161.2
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhh--cCCCceEeEEeEEEeCC----eEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISA--LQHPNLVKLYGCCIEGN----QLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~~~~~~~~----~~~l 648 (809)
......++||+|.||.||||.+.+ +.||||++... ..+.|++|-++.+. ++|+||++++++-.... +.+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 344566889999999999999864 89999999643 34678888777765 58999999999987655 8999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE------SRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
|+||.+.|||.+|| ....++|....+|+..|++||+|||+. .+++|+|||||++|||+.+|++++|+||
T Consensus 286 Vt~fh~kGsL~dyL-----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL-----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHH-----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 99999999999999 455799999999999999999999965 4578999999999999999999999999
Q ss_pred CCccccCCCCc-ceeccccccccccchhhhccCC-C-----CchHHHHHHHHHHHHHHcCC
Q 043333 723 GLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGY-L-----TDKADVYSFGIVALEIVSGR 776 (809)
Q Consensus 723 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~-----~~ksDVwSlGvil~elltGk 776 (809)
|+|..+..... ......+||.+|||||++.+.- + -.+.||||+|.|+|||++.=
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC 421 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC 421 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence 99987653322 1122378999999999997642 2 23689999999999999863
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=323.24 Aligned_cols=205 Identities=32% Similarity=0.536 Sum_probs=173.6
Q ss_pred HHHHHHhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe
Q 043333 568 RQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 568 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 645 (809)
++.....+.+...+.||+|.||+||+|.|. | .||||++.... .+..+.|..|+.++++-||.||+-+.|||..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 445555566677899999999999999985 3 48999997663 3446789999999999999999999999998877
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.+|..+|++-+|+.+||..+ .+++..+.+.||+|||+||.|||.+ +|||||||+.||+|++++.+||+|||++
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred -eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 99999999999999998754 4689999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCC-Ccceeccccccccccchhhhcc---CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 726 KLDEED-NTHISTRIAGTFGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 726 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.....- .........|...|||||+++. .++++.+||||||+|+|||+||..||..
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi 595 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI 595 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC
Confidence 643211 1111112346779999999864 4789999999999999999999999974
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=323.46 Aligned_cols=202 Identities=25% Similarity=0.352 Sum_probs=174.0
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||+||+|... +++.||||+++... ......+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999854 58899999986542 222356788999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999843 34689999999999999999999998 899999999999999999999999999875432
Q ss_pred CCc----------------------------------ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCC
Q 043333 731 DNT----------------------------------HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776 (809)
Q Consensus 731 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk 776 (809)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012357999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 043333 777 SNVICRT 783 (809)
Q Consensus 777 ~P~~~~~ 783 (809)
.||...+
T Consensus 234 ~Pf~~~~ 240 (363)
T cd05628 234 PPFCSET 240 (363)
T ss_pred CCCCCCC
Confidence 9997644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=300.88 Aligned_cols=229 Identities=27% Similarity=0.387 Sum_probs=189.0
Q ss_pred cCCCCCCeeccCCCccEEEeE-eeCCeEEEEEEecccCcc-c-chhHHHHHHHHhhcCCCc-eEeEEeEEEeCC------
Q 043333 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQ-G-NREFVNEIGMISALQHPN-LVKLYGCCIEGN------ 644 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~-~-~~~f~~Ei~~l~~l~H~n-Iv~l~~~~~~~~------ 644 (809)
..|...++||+|.||+||+|+ ..+|+.||+|+++....+ . -....+|+.++++++|+| ||++++++.+..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 345566789999999999999 457899999999876542 2 234578999999999999 999999999877
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
.+++|+||++. +|..++.........++...+..++.|+.+||+|||++ +|+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78899999976 89888854332224567788999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCcceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhccCCC
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRF 803 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~~~~ 803 (809)
|+...-.. ...+..++|..|+|||++.+. .|++..||||+|||++||++++.-|.+..+.++...+.-+...-.+..|
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 99654322 224567789999999999876 7899999999999999999999999887776666666566666666777
Q ss_pred CcCCC
Q 043333 804 PLFLS 808 (809)
Q Consensus 804 p~~~~ 808 (809)
|.--+
T Consensus 246 p~v~~ 250 (323)
T KOG0594|consen 246 PGVSS 250 (323)
T ss_pred CCccc
Confidence 76543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=314.83 Aligned_cols=207 Identities=32% Similarity=0.506 Sum_probs=177.1
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
......+.++||+|-||.|-.+....+..||||+++..... ...+|..|+++|.+++||||++++|+|..++.+++++|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 34556778999999999999999887899999999877544 45889999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
||++|+|.+|+...... .++-....+|+.|||.||+||.+. ++|||||.++|+|+|.++++||+|||+++.+-..
T Consensus 616 YmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999543221 134556678999999999999997 8999999999999999999999999999865443
Q ss_pred C-cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc--CCCCCCCCCc
Q 043333 732 N-THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS--GRSNVICRTK 784 (809)
Q Consensus 732 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt--Gk~P~~~~~~ 784 (809)
+ .+...+.+-..+|||||.+.-+++++++|||+|||.+||+++ ...||...+.
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 3 344445566779999999999999999999999999999865 6789966443
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=305.99 Aligned_cols=203 Identities=31% Similarity=0.429 Sum_probs=169.0
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCC-----eEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGN-----QLLLI 649 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~lV 649 (809)
.|...+++|.|+||.||+|... +++.||||+.-.+.+.. -+|+++|+++.|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566789999999999999965 46899999886543321 26899999999999999999887532 34689
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CceEEEecCCcccc
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLD 728 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~ 728 (809)
|||||. +|++.++.....+..++.-.+.-+..|+.+||.|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999997 89998865444566777778888999999999999997 89999999999999987 99999999999987
Q ss_pred CCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccch
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQF 788 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~ 788 (809)
....... .+..|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.+..++.
T Consensus 177 ~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL 235 (364)
T KOG0658|consen 177 VKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL 235 (364)
T ss_pred ccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH
Confidence 6555443 3456889999999987 57999999999999999999999999886554443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=303.61 Aligned_cols=203 Identities=27% Similarity=0.400 Sum_probs=175.4
Q ss_pred hcCCCCCCeeccCCCccEEEeE-eeCCeEEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.+.|+..+.||.|.-++||+|+ ...++.||||++....-. ..+.+.+|+..|+.++||||++++..|..+.++|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4678889999999999999999 456799999999765433 35788999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
||.+||+.+.+... ....+++..+..|.+++++||.|||++ +.||||||+.||||+.+|.+||+|||.+..+.+.
T Consensus 105 fMa~GS~ldIik~~--~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTY--YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHH--ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999988543 233489999999999999999999999 8999999999999999999999999987654333
Q ss_pred Cccee---ccccccccccchhhhcc--CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 732 NTHIS---TRIAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 732 ~~~~~---~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
..+.. ...+||+.|||||+++. ..|+.|+||||||+...||.+|+.||..
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k 234 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK 234 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence 32211 34689999999999643 4689999999999999999999999964
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=322.22 Aligned_cols=206 Identities=24% Similarity=0.362 Sum_probs=175.7
Q ss_pred HHHHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe
Q 043333 570 IKAATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 570 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 645 (809)
+....++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3445678999999999999999999965 57899999986431 2234557889999999999999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999998832 3478889999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcceeccccccccccchhhhccC----CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 726 KLDEEDNTHISTRIAGTFGYMAPEYAMRG----YLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 726 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
..............+||+.|+|||++.+. .++.++||||+||++|||++|+.||...+
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 86643332223346799999999998653 37889999999999999999999997643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.00 Aligned_cols=199 Identities=26% Similarity=0.372 Sum_probs=173.6
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC--CeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD--GKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
.++|+..+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568889999999999999998543 3689999986432 2234567889999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999843 34588999999999999999999998 8999999999999999999999999999865
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 182 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 182 DTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred CCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 4321 23568999999999998889999999999999999999999997643
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=306.76 Aligned_cols=200 Identities=31% Similarity=0.404 Sum_probs=173.3
Q ss_pred CCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 577 FAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
|+..+.||+|+||.||+|.. .+|+.||||.+.... ......+.+|++++++++|+||+++.+++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66788999999999999985 478999999986542 22234678899999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999998887432 233589999999999999999999998 89999999999999999999999999998654322
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 157 T--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred e--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 1 234568999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.78 Aligned_cols=187 Identities=31% Similarity=0.489 Sum_probs=166.1
Q ss_pred CCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCch
Q 043333 579 PDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL 658 (809)
Q Consensus 579 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 658 (809)
..+-||.|+-|.||.|++. ++.||||+++.-. ..+++-|++++||||+.+.|+|.....+++|||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3567999999999999986 5779999885322 2578999999999999999999999999999999999999
Q ss_pred hhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceecc
Q 043333 659 ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 738 (809)
Q Consensus 659 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 738 (809)
...|. ...++.-.....+.++||.||.|||.+ .|||||||+-||||+.+..+||+|||-++...+... ...
T Consensus 200 ~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST--kMS 270 (904)
T KOG4721|consen 200 YEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST--KMS 270 (904)
T ss_pred HHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhh--hhh
Confidence 99994 344677778889999999999999998 899999999999999999999999999987765433 335
Q ss_pred ccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 739 IAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 739 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
++||..|||||++.+.+.++|+||||||||||||+||..||...
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 78999999999999999999999999999999999999999653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.01 Aligned_cols=198 Identities=25% Similarity=0.362 Sum_probs=173.6
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999965 68899999986432 123456788999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999843 34688999999999999999999998 899999999999999999999999999986543
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 154 RT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred Cc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 23468999999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=319.69 Aligned_cols=201 Identities=24% Similarity=0.365 Sum_probs=171.6
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.|+..+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999854 57899999986542 2234568899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999843 23578889999999999999999998 8999999999999999999999999997533110
Q ss_pred Cc----------------------------------------------ceeccccccccccchhhhccCCCCchHHHHHH
Q 043333 732 NT----------------------------------------------HISTRIAGTFGYMAPEYAMRGYLTDKADVYSF 765 (809)
Q Consensus 732 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSl 765 (809)
.. ......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123469999999999998889999999999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 043333 766 GIVALEIVSGRSNVICRT 783 (809)
Q Consensus 766 Gvil~elltGk~P~~~~~ 783 (809)
||++|||++|+.||...+
T Consensus 235 G~il~elltG~~Pf~~~~ 252 (381)
T cd05626 235 GVILFEMLVGQPPFLAPT 252 (381)
T ss_pred hhHHHHHHhCCCCCcCCC
Confidence 999999999999997644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=319.75 Aligned_cols=202 Identities=26% Similarity=0.387 Sum_probs=173.7
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999964 68899999986532 223456788999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999843 33589999999999999999999998 899999999999999999999999999875432
Q ss_pred CCcc-------------------------------------eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHH
Q 043333 731 DNTH-------------------------------------ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 773 (809)
Q Consensus 731 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ell 773 (809)
.... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011246999999999999989999999999999999999
Q ss_pred cCCCCCCCCC
Q 043333 774 SGRSNVICRT 783 (809)
Q Consensus 774 tGk~P~~~~~ 783 (809)
+|+.||...+
T Consensus 234 ~G~~Pf~~~~ 243 (364)
T cd05599 234 VGYPPFCSDN 243 (364)
T ss_pred cCCCCCCCCC
Confidence 9999997643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=312.72 Aligned_cols=194 Identities=28% Similarity=0.370 Sum_probs=168.4
Q ss_pred CeeccCCCccEEEeEe-eCCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCC
Q 043333 581 NKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENN 656 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 656 (809)
+.||+|+||.||+++. .+|+.||||+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999987542 223456788999999999999999999999999999999999999
Q ss_pred chhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCccee
Q 043333 657 SLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 736 (809)
Q Consensus 657 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 736 (809)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cc
Confidence 99998843 34688999999999999999999998 899999999999999999999999999875322221 12
Q ss_pred ccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 737 TRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 737 ~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
...+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 3456999999999999989999999999999999999999999664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=319.83 Aligned_cols=202 Identities=25% Similarity=0.358 Sum_probs=171.9
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999985 468899999986432 223456788999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999843 34578889999999999999999998 899999999999999999999999999863211
Q ss_pred CCc-------------c---------------------------------eeccccccccccchhhhccCCCCchHHHHH
Q 043333 731 DNT-------------H---------------------------------ISTRIAGTFGYMAPEYAMRGYLTDKADVYS 764 (809)
Q Consensus 731 ~~~-------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS 764 (809)
... . .....+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 000 0 001246999999999999889999999999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 043333 765 FGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 765 lGvil~elltGk~P~~~~~ 783 (809)
|||++|||++|+.||....
T Consensus 234 lGvil~elltG~~Pf~~~~ 252 (377)
T cd05629 234 LGAIMFECLIGWPPFCSEN 252 (377)
T ss_pred cchhhhhhhcCCCCCCCCC
Confidence 9999999999999997643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=318.32 Aligned_cols=209 Identities=23% Similarity=0.360 Sum_probs=177.6
Q ss_pred HHHHHHHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEe
Q 043333 567 LRQIKAATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIE 642 (809)
Q Consensus 567 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~ 642 (809)
.+++....++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445556689999999999999999999965 57899999986432 2223457789999999999999999999999
Q ss_pred CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 643 GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 643 ~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
.+..++||||+++|+|.+++.. ..++...+..++.|++.||+|||++ +|+||||||+|||++.++++||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999998832 3478888899999999999999998 8999999999999999999999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhccC----CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG----YLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
|++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 99986654333233356799999999998753 37889999999999999999999997644
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=313.66 Aligned_cols=197 Identities=24% Similarity=0.389 Sum_probs=173.8
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999965 58899999986542 223456889999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999998843 34578889999999999999999998 899999999999999999999999999986543
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 22 2356899999999999988999999999999999999999999654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=312.07 Aligned_cols=220 Identities=26% Similarity=0.406 Sum_probs=185.1
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
+-|+..+.||.|+-|.|-.|++. .|+.+|||++.+... .....+.+|+-+|+-++|||++++++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 44667889999999999999964 699999999976522 22355778999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|-|.+++. .+.++.+..+.+++.||..|+.|+|.. +|+|||+||+|+|||..+++||+|||+|.+-..
T Consensus 92 Eyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999983 455789999999999999999999998 899999999999999999999999999986543
Q ss_pred CCcceeccccccccccchhhhccCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhccCCCCcCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFLS 808 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~ 808 (809)
+ ..-...||++.|.|||++++..| +.++||||.|||||.|+||+.||++. ....|. .+-....|.||.++|
T Consensus 165 g--klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~LL--lKV~~G~f~MPs~Is 236 (786)
T KOG0588|consen 165 G--KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRVLL--LKVQRGVFEMPSNIS 236 (786)
T ss_pred C--ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHHHH--HHHHcCcccCCCcCC
Confidence 3 33345789999999999998765 68999999999999999999999753 222233 222334578887765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=298.65 Aligned_cols=200 Identities=24% Similarity=0.449 Sum_probs=178.2
Q ss_pred cCCCCCCeeccCCCccEEEeE-eeCCeEEEEEEecccCcccc---hhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~~---~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
.+|++.+.||+|.||.|-+|+ ...|+.||||.+++....++ -.+.+|+++|+.++||||+.++.+|...+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 456777889999999999998 46799999999987654443 34678999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||..+|.|++|+. .+..+++..+.+++.||..|+.|+|.+ +++|||||.+|||||.++++||+|||++..+..
T Consensus 133 EYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999993 456799999999999999999999998 899999999999999999999999999987764
Q ss_pred CCcceeccccccccccchhhhccCCC-CchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. .-+.+||++-|.+||++.+..| ++.+|-||+||+||.|+.|..||++++
T Consensus 206 ~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 206 KK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred cc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 43 3456899999999999988766 678999999999999999999998753
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.90 Aligned_cols=201 Identities=34% Similarity=0.526 Sum_probs=170.2
Q ss_pred CCCCCCeeccCCCccEEEeEeeC--C--eE-EEEEEeccc---CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLAD--G--KV-IAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~~--g--~~-vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
+....++||+|.||.||+|.+.. + .. ||||..+.. .....++|+.|+++|++++|||||+++|++....+++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 33445899999999999999653 2 23 899998753 3555788999999999999999999999999999999
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+|||+|.||+|.++|... ...++..+++.++.++|+||+|||++ ++|||||.++|+|++.++.+||+|||+++.
T Consensus 238 ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999999543 23689999999999999999999998 899999999999999999999999999876
Q ss_pred cCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 728 DEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
......... ...-...|+|||.+..+.+++++|||||||++||+++ |..||.+..
T Consensus 312 ~~~~~~~~~-~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 312 GSQYVMKKF-LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred Ccceeeccc-cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 431111110 1113458999999999999999999999999999999 899997743
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=314.24 Aligned_cols=198 Identities=25% Similarity=0.348 Sum_probs=174.6
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+..|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999965 58899999987542 223456888999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999842 34588999999999999999999998 899999999999999999999999999976543
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 1234568999999999999899999999999999999999999997644
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=313.74 Aligned_cols=207 Identities=29% Similarity=0.456 Sum_probs=171.1
Q ss_pred HhcCCCCCCeeccCCCccEEEeEe------eCCeEEEEEEecccCc-ccchhHHHHHHHHhhc-CCCceEeEEeEEEeCC
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLL------ADGKVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLYGCCIEGN 644 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 644 (809)
..++|+..+.||+|+||.||+|.. .+++.||||+++.... ...+.+..|++++.++ +||||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456788999999999999999974 2356899999875432 2345788999999999 8999999999988654
Q ss_pred -eEEEEEEcccCCchhhhccCCCc--------------------------------------------------------
Q 043333 645 -QLLLIYEYMENNSLARALFGPEE-------------------------------------------------------- 667 (809)
Q Consensus 645 -~~~lV~ey~~~gsL~~~L~~~~~-------------------------------------------------------- 667 (809)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999998864221
Q ss_pred --cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce-ecccccccc
Q 043333 668 --HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI-STRIAGTFG 744 (809)
Q Consensus 668 --~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~ 744 (809)
...++++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++......... .....++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 023588899999999999999999998 89999999999999999999999999998653322211 122345678
Q ss_pred ccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 745 YMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 745 y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999899999999999999999997 99999763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=318.60 Aligned_cols=203 Identities=23% Similarity=0.329 Sum_probs=173.0
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
..++|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3567889999999999999999864 58899999986432 2233457789999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999998842 3477888889999999999999998 8999999999999999999999999999765
Q ss_pred CCCCcceeccccccccccchhhhccC----CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRG----YLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 43322222345799999999998653 47889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=309.60 Aligned_cols=195 Identities=29% Similarity=0.376 Sum_probs=168.2
Q ss_pred CeeccCCCccEEEeEe-eCCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCC
Q 043333 581 NKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENN 656 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 656 (809)
+.||+|+||.||++.. .+|+.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999987542 223456778999999999999999999999999999999999999
Q ss_pred chhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCccee
Q 043333 657 SLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 736 (809)
Q Consensus 657 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 736 (809)
+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 152 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence 99988842 33688999999999999999999998 899999999999999999999999999875322221 12
Q ss_pred ccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 737 TRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 737 ~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 23568999999999998899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=298.09 Aligned_cols=204 Identities=29% Similarity=0.442 Sum_probs=168.7
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc---------cc-----chhHHHHHHHHhhcCCCceEeE
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK---------QG-----NREFVNEIGMISALQHPNLVKL 636 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~---------~~-----~~~f~~Ei~~l~~l~H~nIv~l 636 (809)
..-++|++.+.||+|.||.|-+|+. .+++.||||++.+... .. .+...+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457899999999999999999984 4789999999965411 11 2367789999999999999999
Q ss_pred EeEEEeC--CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC
Q 043333 637 YGCCIEG--NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD 714 (809)
Q Consensus 637 ~~~~~~~--~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~ 714 (809)
+.+..++ +.+|||+|||..|.+... ......++..++.+++.++..||+|||.+ +||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 9998875 578999999999876532 12233389999999999999999999999 89999999999999999
Q ss_pred CceEEEecCCccccCCC----CcceeccccccccccchhhhccC----CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 715 LNPKISDFGLAKLDEED----NTHISTRIAGTFGYMAPEYAMRG----YLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 715 ~~~kl~DfGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
|++||+|||.+...... ....-...+||+.|+|||...++ ..+.+.||||+||.||.|+.|+-||...
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 99999999999766222 11122347899999999998763 2467889999999999999999999663
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=303.34 Aligned_cols=202 Identities=25% Similarity=0.427 Sum_probs=170.9
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
++|...+.||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999854 688999999865432 2345678999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 985 898887432 23578899999999999999999998 89999999999999999999999999987543222
Q ss_pred cceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 733 THISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
. ......+++.|+|||.+.+ ..++.++||||+||++|||+||+.||...+.
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~ 209 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV 209 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1 1223467899999998865 5689999999999999999999999976543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=336.31 Aligned_cols=207 Identities=34% Similarity=0.555 Sum_probs=174.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC--Ce----EEEEEEeccc-CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD--GK----VIAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~--g~----~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 646 (809)
.++.+..+.||+|.||.||+|.+.+ |. .||||.++.. +.+...+|++|..+|++++|||||+++|.|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3455667889999999999999653 43 4899998766 445577899999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhccCCC---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 647 LLIYEYMENNSLARALFGPE---EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
++++|||++|+|..||+..+ .....+.....+.++.|||+|+.||+++ ++|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999996543 2245689999999999999999999998 89999999999999999999999999
Q ss_pred Ccccc-CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 724 LAKLD-EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 724 la~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
+|+-+ ..+......+..-...|||||.+..+.++.|+|||||||++||++| |..||...+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~ 909 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS 909 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc
Confidence 99943 3222221112122358999999999999999999999999999998 788997654
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=318.77 Aligned_cols=201 Identities=23% Similarity=0.367 Sum_probs=171.2
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5778899999999999999854 67899999986542 2234568889999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999998843 23578888999999999999999998 8999999999999999999999999997532100
Q ss_pred C----------------------------------------------cceeccccccccccchhhhccCCCCchHHHHHH
Q 043333 732 N----------------------------------------------THISTRIAGTFGYMAPEYAMRGYLTDKADVYSF 765 (809)
Q Consensus 732 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSl 765 (809)
. .......+||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000112468999999999999899999999999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 043333 766 GIVALEIVSGRSNVICRT 783 (809)
Q Consensus 766 Gvil~elltGk~P~~~~~ 783 (809)
||++|||++|+.||...+
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (382)
T cd05625 235 GVILYEMLVGQPPFLAQT 252 (382)
T ss_pred hHHHHHHHhCCCCCCCCC
Confidence 999999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=309.66 Aligned_cols=195 Identities=29% Similarity=0.376 Sum_probs=168.9
Q ss_pred CeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCC
Q 043333 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENN 656 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 656 (809)
+.||+|+||.||++... +|+.||||++.... ......+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999854 68999999987542 233456788999999999999999999999999999999999999
Q ss_pred chhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCccee
Q 043333 657 SLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 736 (809)
Q Consensus 657 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 736 (809)
+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cc
Confidence 99988843 34689999999999999999999998 899999999999999999999999999875432221 12
Q ss_pred ccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 737 TRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 737 ~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 34579999999999998899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=317.57 Aligned_cols=201 Identities=24% Similarity=0.367 Sum_probs=171.5
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
+|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999854 58899999986532 2234567889999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999843 33578888899999999999999998 8999999999999999999999999997532100
Q ss_pred C------------------------------------------cceeccccccccccchhhhccCCCCchHHHHHHHHHH
Q 043333 732 N------------------------------------------THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVA 769 (809)
Q Consensus 732 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil 769 (809)
. .......+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001134699999999999998999999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 043333 770 LEIVSGRSNVICRT 783 (809)
Q Consensus 770 ~elltGk~P~~~~~ 783 (809)
|||++|+.||....
T Consensus 235 yell~G~~Pf~~~~ 248 (376)
T cd05598 235 YEMLVGQPPFLADT 248 (376)
T ss_pred eehhhCCCCCCCCC
Confidence 99999999997644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.88 Aligned_cols=192 Identities=24% Similarity=0.379 Sum_probs=167.4
Q ss_pred eccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCch
Q 043333 583 IGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL 658 (809)
Q Consensus 583 LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 658 (809)
||+|+||.||+|... +++.||+|++.... ......+.+|++++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 57899999986532 23345678899999999999999999999999999999999999999
Q ss_pred hhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceecc
Q 043333 659 ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 738 (809)
Q Consensus 659 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 738 (809)
.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccc
Confidence 999843 34588999999999999999999998 899999999999999999999999999975432221 2234
Q ss_pred ccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 739 IAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 739 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 57899999999999989999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=310.32 Aligned_cols=202 Identities=24% Similarity=0.316 Sum_probs=173.1
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|...+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999964 57889999986431 222345788999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999532 34688999999999999999999998 899999999999999999999999999976654
Q ss_pred CCcceeccccccccccchhhhcc-----CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
..........||+.|+|||++.+ +.++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 33322334569999999999875 46788999999999999999999999653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=303.50 Aligned_cols=202 Identities=25% Similarity=0.366 Sum_probs=173.4
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999975 57899999986542 2234567899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|++++.+..+.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999987765442 234588999999999999999999998 8999999999999999999999999999866433
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.........|++.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 3222234568999999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=293.78 Aligned_cols=194 Identities=33% Similarity=0.510 Sum_probs=160.7
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhh--cCCCceEeEEeEEEeCC----e
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISA--LQHPNLVKLYGCCIEGN----Q 645 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~~~~~~~~----~ 645 (809)
...++....+.||+|.||.||+|.|+ |+.||||++.... ++.+.+|.++... ++|+||+.+++.-..+. +
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 34467778899999999999999997 7889999996433 4556667776654 69999999999876543 6
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEEcCCCCCCEEEcCCCceEEE
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE-----ESRLKIVHRDIKATNVLLDKDLNPKIS 720 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~iiH~Dlkp~NILl~~~~~~kl~ 720 (809)
+|||.+|.+.|||.||| .+..++-...++++..+|.||+|||. +++|.|.|||||++|||+.+++.+.|+
T Consensus 284 LwLvTdYHe~GSL~DyL-----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYL-----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEeeecccCCcHHHHH-----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 89999999999999999 45678999999999999999999994 478899999999999999999999999
Q ss_pred ecCCccccCCCCcce---eccccccccccchhhhccCC------CCchHHHHHHHHHHHHHHc
Q 043333 721 DFGLAKLDEEDNTHI---STRIAGTFGYMAPEYAMRGY------LTDKADVYSFGIVALEIVS 774 (809)
Q Consensus 721 DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~~~ksDVwSlGvil~ellt 774 (809)
|+|+|.......... ....+||.+|||||++...- .-..+||||||.|+||+.-
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 999998665443221 23468999999999986431 1236899999999999864
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=314.05 Aligned_cols=202 Identities=25% Similarity=0.363 Sum_probs=173.6
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||.||++... +++.||||+++... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999864 58899999986532 223456788999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.+++++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999843 34588999999999999999999998 899999999999999999999999999864421
Q ss_pred CCc----------------------------------ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCC
Q 043333 731 DNT----------------------------------HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776 (809)
Q Consensus 731 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk 776 (809)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 100 0112357999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 043333 777 SNVICRT 783 (809)
Q Consensus 777 ~P~~~~~ 783 (809)
.||...+
T Consensus 234 ~Pf~~~~ 240 (360)
T cd05627 234 PPFCSET 240 (360)
T ss_pred CCCCCCC
Confidence 9997644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.98 Aligned_cols=202 Identities=26% Similarity=0.331 Sum_probs=172.8
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc---CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|++.+.||+|+||.||+++.. +++.||||++... .....+.|.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999954 5889999998642 2223456888999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999843 234588899999999999999999998 899999999999999999999999999876544
Q ss_pred CCcceeccccccccccchhhhcc-----CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
..........||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 33322333568999999999863 45788999999999999999999999653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.55 Aligned_cols=202 Identities=25% Similarity=0.332 Sum_probs=172.3
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||.||++... .++.||+|++.... ....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999965 47889999986431 222345788999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999953 234588999999999999999999998 899999999999999999999999999876543
Q ss_pred CCcceeccccccccccchhhhc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 3333333457999999999986 346788999999999999999999999654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=305.32 Aligned_cols=194 Identities=26% Similarity=0.373 Sum_probs=166.9
Q ss_pred CeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|... +++.||||+++... ....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 57899999997542 22345578899999888 699999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-T 152 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-c
Confidence 999988732 34689999999999999999999998 899999999999999999999999999875322211 2
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 23457999999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=305.09 Aligned_cols=195 Identities=29% Similarity=0.449 Sum_probs=167.0
Q ss_pred CeeccCCCccEEEeEe----eCCeEEEEEEecccC----cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 581 NKIGEGGFGPVYKGLL----ADGKVIAVKQLSSKS----KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~----~~g~~vAVK~~~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+.||+|+||.||+++. ..++.||||+++... ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357899999986532 22234577899999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++|+|.+++.. ...+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999998842 34577888899999999999999998 89999999999999999999999999987533222
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 1 1233568999999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=304.94 Aligned_cols=200 Identities=25% Similarity=0.414 Sum_probs=174.6
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++|+..+.||+|+||.||+++.. +|..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367889999999999999999965 58899999986542 2234678999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999843 335889999999999999999999863 6999999999999999999999999998755332
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred c---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 22356899999999999989999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=291.39 Aligned_cols=212 Identities=25% Similarity=0.417 Sum_probs=177.8
Q ss_pred HhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEe-----CC
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIE-----GN 644 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~-----~~ 644 (809)
....|...+.||+|+||.|+.+.. .+|+.||||++... .....++..+|+++|+.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345566678999999999999985 47899999998743 33445778899999999999999999999875 34
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
..|+|+|+|+ -+|...++ ....++......+..|+++||.|+|+. +|+|||+||+|++++.+...||+|||+
T Consensus 100 DvYiV~elMe-tDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHHh-hHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 6899999995 48888883 334488999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCC-Ccceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHH
Q 043333 725 AKLDEED-NTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLD 792 (809)
Q Consensus 725 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~ 792 (809)
|+..... .....+.++.|..|+|||++.. ..++...||||.|||+.||++||+-|.+.+..+|..+..
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~ 241 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLIL 241 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 9977532 1233466788999999998754 689999999999999999999999998877666655443
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=303.55 Aligned_cols=200 Identities=25% Similarity=0.366 Sum_probs=170.0
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCC-ceEeEEeEEEeCCeEEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHP-NLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~-nIv~l~~~~~~~~~~~lV~ 650 (809)
+|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+..|.+++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999865 57899999986542 23345678899999999765 5888999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999998843 34578999999999999999999998 899999999999999999999999999874322
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... ......||+.|+|||++.+..++.++||||+||++|||+||+.||...+
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 111 1234568999999999999899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=319.46 Aligned_cols=204 Identities=21% Similarity=0.304 Sum_probs=176.2
Q ss_pred CCCCCCeeccCCCccEEEeEee-C-CeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-D-GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~-g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.|...+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999843 3 5778888775544444456788999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.++++.......++++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998865434455789999999999999999999998 899999999999999999999999999986543321
Q ss_pred -ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 734 -HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 734 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 2233457999999999999999999999999999999999999999754
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=310.23 Aligned_cols=195 Identities=28% Similarity=0.372 Sum_probs=167.7
Q ss_pred CeeccCCCccEEEeEe-eCCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCC
Q 043333 581 NKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENN 656 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 656 (809)
+.||+|+||.||++.. .+|+.||+|++.... ......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468899999987542 223456778999999999999999999999999999999999999
Q ss_pred chhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 657 SLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 657 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~- 152 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT- 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-
Confidence 99988842 3468999999999999999999997 5 8999999999999999999999999998754322221
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~ 200 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence 223568999999999999899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=299.70 Aligned_cols=201 Identities=25% Similarity=0.428 Sum_probs=170.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++|+..+.||+|+||.||+|... +++.||||++..... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467899999999999999999965 688999999875432 223467889999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|++ ++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 578777743 234578889999999999999999998 8999999999999999999999999998754322
Q ss_pred Ccceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 1223567899999998865 45789999999999999999999999763
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=303.57 Aligned_cols=200 Identities=25% Similarity=0.381 Sum_probs=170.0
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
+|...+.||+|+||.||+|... +++.||||++.... ....+.+..|.+++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999865 57899999987542 22234566788888777 5899999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999988843 33588999999999999999999998 899999999999999999999999999875432
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 154 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred CCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 221 2234578999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=304.37 Aligned_cols=193 Identities=25% Similarity=0.378 Sum_probs=166.6
Q ss_pred CeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|... +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 68899999997542 22235578899999888 699999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 999988732 34689999999999999999999998 89999999999999999999999999987432211 12
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 2345789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=304.24 Aligned_cols=198 Identities=28% Similarity=0.421 Sum_probs=167.8
Q ss_pred CCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHH---hhcCCCceEeEEeEEEeCCeEEEE
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMI---SALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l---~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
|++.+.||+|+||.||+|... +++.||||+++... ....+.+..|++++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999864 68899999987542 22234566666554 567899999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++|+|..+++ ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999998873 23589999999999999999999998 89999999999999999999999999987533
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.... .....+|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 153 GFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred CCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 2221 1234578999999999999899999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=294.79 Aligned_cols=204 Identities=28% Similarity=0.413 Sum_probs=171.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEee----CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA----DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.... ...+.|.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356788899999999999999853 356899999876532 334578999999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998532 34689999999999999999999998 8999999999999999999999999987654
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 3222111112335678999999999999999999999999999875 999997643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=306.00 Aligned_cols=200 Identities=27% Similarity=0.358 Sum_probs=170.4
Q ss_pred CCCCCCeeccCCCccEEEeEe----eCCeEEEEEEecccC----cccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCeE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLL----ADGKVIAVKQLSSKS----KQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~~~~~~----~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~ 646 (809)
+|+..+.||+|+||.||+++. .+++.||+|++.... ....+.+..|++++.+++ ||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 257899999986432 122356778999999994 99999999999999999
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++||||+++|+|.+++.. +..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999998843 34588999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 727 LDEEDNTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
..............||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 6543333333346799999999998764 4788999999999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=303.74 Aligned_cols=195 Identities=25% Similarity=0.415 Sum_probs=167.1
Q ss_pred CeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|+.. +++.||||++.... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 57899999987542 22345577888888876 799999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 999988843 34588999999999999999999998 899999999999999999999999999875432221 2
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 234568999999999998899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=310.76 Aligned_cols=202 Identities=28% Similarity=0.379 Sum_probs=176.1
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|...+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999965 68999999987542 233466889999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999998432 4688999999999999999999997 899999999999999999999999999976543
Q ss_pred CC----------------------------cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DN----------------------------THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11122356899999999999999999999999999999999999999764
Q ss_pred C
Q 043333 783 T 783 (809)
Q Consensus 783 ~ 783 (809)
+
T Consensus 234 ~ 234 (350)
T cd05573 234 T 234 (350)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=296.20 Aligned_cols=196 Identities=29% Similarity=0.433 Sum_probs=169.5
Q ss_pred eccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCch
Q 043333 583 IGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL 658 (809)
Q Consensus 583 LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 658 (809)
||+|+||+||++... +++.||||++..... ...+.+..|++++++++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999854 688999999865422 2235677899999999999999999999999999999999999999
Q ss_pred hhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceecc
Q 043333 659 ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 738 (809)
Q Consensus 659 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 738 (809)
.+++.........+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 988865444455789999999999999999999998 8999999999999999999999999999765433221 223
Q ss_pred ccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 739 IAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 739 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 56899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.99 Aligned_cols=193 Identities=24% Similarity=0.324 Sum_probs=165.9
Q ss_pred CCeeccCCCccEEEeEeeCCeEEEEEEecccCccc---chhHHHHHHHHhhcCCCceEeEEeEEEe----CCeEEEEEEc
Q 043333 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQG---NREFVNEIGMISALQHPNLVKLYGCCIE----GNQLLLIYEY 652 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~---~~~f~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ey 652 (809)
...||+|++|.||+|.+ +|+.||||+++...... .+.|.+|++++++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46799999999999988 68999999987653332 3667899999999999999999999987 3468999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++|+|.+++.. ...++|..+..++.|++.||.|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999953 346889999999999999999999742 57799999999999999999999999988654322
Q ss_pred cceeccccccccccchhhhcc--CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 23457889999999876 678999999999999999999999997643
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.69 Aligned_cols=202 Identities=32% Similarity=0.464 Sum_probs=177.0
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
..|+..+.||+|.||.||+|.. ..++.||+|++..... ...+++++|+.++.+++|+||.+++|.+..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4566778999999999999995 4688999999987643 3457788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
|.+|++.+.|.. ...+++....-|+.++..|+.|||.+ +.+|||||+.|||+..+|.+|++|||++..+....
T Consensus 93 ~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999832 23346777778999999999999999 89999999999999999999999999998776544
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
... ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 433 568899999999999988999999999999999999999999966443
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=309.73 Aligned_cols=202 Identities=27% Similarity=0.344 Sum_probs=174.6
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|...+.||+|+||.||++... +|+.||+|+++... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999854 68899999987542 223456788999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999998432 24689999999999999999999998 899999999999999999999999999987654
Q ss_pred CCcceeccccccccccchhhhc------cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAM------RGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 4333333456899999999986 456788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=302.28 Aligned_cols=193 Identities=26% Similarity=0.387 Sum_probs=165.7
Q ss_pred CeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 57899999987542 22334577888888776 799999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 999888732 34689999999999999999999998 899999999999999999999999999875322221 1
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 2345789999999999999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=302.02 Aligned_cols=195 Identities=27% Similarity=0.432 Sum_probs=165.1
Q ss_pred CeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|... +++.||||+++... ....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 57889999987542 22234556677777654 899999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999998843 33588899999999999999999998 89999999999999999999999999997543222 22
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 234578999999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.84 Aligned_cols=205 Identities=29% Similarity=0.494 Sum_probs=170.4
Q ss_pred cCCCCCCeeccCCCccEEEeEeeC-----------------CeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLAD-----------------GKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKL 636 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l 636 (809)
++|...+.||+|+||.||+|.+++ +..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568888999999999999997532 3479999987543 2234678999999999999999999
Q ss_pred EeEEEeCCeEEEEEEcccCCchhhhccCCC---------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 043333 637 YGCCIEGNQLLLIYEYMENNSLARALFGPE---------------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVH 701 (809)
Q Consensus 637 ~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~---------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 701 (809)
++++.+.+..++||||+++|+|.+++.... .....++|..+.+++.|++.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999884321 1123578899999999999999999998 8999
Q ss_pred cCCCCCCEEEcCCCceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc--CCCC
Q 043333 702 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS--GRSN 778 (809)
Q Consensus 702 ~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt--Gk~P 778 (809)
|||||+|||+++++.+||+|||+++....... .......++..|+|||++..+.++.++|||||||++|||++ ++.|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999976543222 12223445788999999988899999999999999999987 5667
Q ss_pred CCCC
Q 043333 779 VICR 782 (809)
Q Consensus 779 ~~~~ 782 (809)
|...
T Consensus 242 ~~~~ 245 (304)
T cd05096 242 YGEL 245 (304)
T ss_pred CCcC
Confidence 7653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.11 Aligned_cols=201 Identities=26% Similarity=0.464 Sum_probs=166.4
Q ss_pred cCCCCCCeeccCCCccEEEeEee--CCeEEEEEEecccCcc--cchhHHHHHHHHhhc---CCCceEeEEeEEEe-----
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA--DGKVIAVKQLSSKSKQ--GNREFVNEIGMISAL---QHPNLVKLYGCCIE----- 642 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l---~H~nIv~l~~~~~~----- 642 (809)
++|+..+.||+|+||.||+|... +++.||||+++..... ....+.+|+++++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999853 4688999988654322 234566777777665 69999999999863
Q ss_pred CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 643 GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 643 ~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
....++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 346899999997 58988885322 23588999999999999999999998 8999999999999999999999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
|+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|++||....
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 999765432 12234568999999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=301.28 Aligned_cols=200 Identities=25% Similarity=0.373 Sum_probs=169.8
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCeEEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 650 (809)
+|+..+.||+|+||+||+|... +|+.||+|++.... ....+.+..|.+++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999854 68899999987542 223456778888888885 577888999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999998842 34589999999999999999999998 899999999999999999999999999875432
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 221 1223568999999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=288.16 Aligned_cols=220 Identities=24% Similarity=0.316 Sum_probs=180.1
Q ss_pred CCCCCeeccCCCccEEEeEeeC-CeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 577 FAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
|+..+.||+|.-|+||.+..++ +..+|+|++.+.. .....+.+.|-+||+.+.||.+++|++.+..++..++||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 4456789999999999999764 5899999997653 23345677899999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC--
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE-- 730 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~-- 730 (809)
|+||+|...++.+. ...++...+..++.++.-||+|||-. |||.|||||+|||+-++|++-|+||.++.....
T Consensus 159 CpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred CCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999886543 34578889999999999999999998 899999999999999999999999998742210
Q ss_pred -------------------------------CCc----------------------ceeccccccccccchhhhccCCCC
Q 043333 731 -------------------------------DNT----------------------HISTRIAGTFGYMAPEYAMRGYLT 757 (809)
Q Consensus 731 -------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~ 757 (809)
... ..+...+||-.|.|||++.+..++
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 011125799999999999999999
Q ss_pred chHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhccCCCCcC
Q 043333 758 DKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLF 806 (809)
Q Consensus 758 ~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~~~~p~~ 806 (809)
.++|+|+|||++|||+.|+.||.+.+.++-. ..-+..+-+||+.
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl-----~NIv~~~l~Fp~~ 357 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETL-----RNIVGQPLKFPEE 357 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhH-----HHHhcCCCcCCCC
Confidence 9999999999999999999999886654432 2223344566653
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=301.75 Aligned_cols=195 Identities=26% Similarity=0.443 Sum_probs=167.1
Q ss_pred CeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|... +++.||||++.... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 58899999986542 23345677888888876 699999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-T 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-c
Confidence 999998843 34588999999999999999999998 899999999999999999999999999875432221 2
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 234578999999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=300.90 Aligned_cols=195 Identities=29% Similarity=0.460 Sum_probs=165.9
Q ss_pred CeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|... +++.||||+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57899999987542 22344566788888764 899999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 999998842 34688999999999999999999998 899999999999999999999999999875322211 1
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 234568999999999998899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=300.33 Aligned_cols=200 Identities=25% Similarity=0.424 Sum_probs=173.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++|+..+.||+|+||.||++... +++.+|+|.+..... .....+.+|++++++++||||++++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468899999999999999999965 578899998865422 234568899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ +++||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999843 335788999999999999999999753 6999999999999999999999999998755322
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred c---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 1 12346889999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.44 Aligned_cols=201 Identities=30% Similarity=0.404 Sum_probs=173.4
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
+|+..+.||+|+||.||++... +++.||||++.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999854 68899999986532 1223457889999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888532 234589999999999999999999998 8999999999999999999999999998765432
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. .....|++.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 21 123468999999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=292.01 Aligned_cols=204 Identities=29% Similarity=0.420 Sum_probs=179.9
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc---CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
..+.|+.-++||+|+||.||-++.+ .|+.+|.|++.++ .++.+.-.+.|-.+|.++..+.||.+--.|.+++.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3467888899999999999999855 6999999988655 33445567889999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
|+..|.||+|.-+|.... ...+++..+..++.+|+.||++||++ .||.||+||+|||||+.|+++|+|+|+|..+
T Consensus 263 VLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999998886543 35689999999999999999999998 8999999999999999999999999999877
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.+.... ...+||.+|||||++.++.|+...|+||+||++|||+.|+.||....
T Consensus 338 ~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 338 PEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred CCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 655433 23489999999999999999999999999999999999999996643
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.36 Aligned_cols=200 Identities=26% Similarity=0.444 Sum_probs=167.3
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCC-----eEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGN-----QLL 647 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~ 647 (809)
+|+..+.||+|+||.||+|+.. +|+.||||++.... .....++.+|++++++++||||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999954 68999999986432 223456889999999999999999999886432 479
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+||||++ ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 688888732 34589999999999999999999998 899999999999999999999999999975
Q ss_pred cCCCCc--ceeccccccccccchhhhcc--CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 728 DEEDNT--HISTRIAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
...... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...+
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 432211 11234578999999999865 678999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=306.98 Aligned_cols=194 Identities=24% Similarity=0.322 Sum_probs=168.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
..+|+..+.||+|+||.||++.. ..++.||+|... .+.+.+|++++++++||||+++++++...+..++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 35799999999999999999985 468899999753 23567899999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+. ++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 85 688887732 34588999999999999999999998 89999999999999999999999999997543322
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
........||+.|+|||++.+..++.++|||||||++|||++|+.||-.
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 2223346799999999999998999999999999999999999988743
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=287.89 Aligned_cols=201 Identities=28% Similarity=0.475 Sum_probs=172.6
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
++|+..+.||+|+||.||++.+.++..+|+|.+... ....++|..|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457778899999999999999888888999987643 2334678899999999999999999999999999999999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
+|+|.++++.. ...++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.++........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999998542 23588999999999999999999998 8999999999999999999999999998755332222
Q ss_pred eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 735 ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~ 205 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 2222335568999999988889999999999999999999 89999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=300.67 Aligned_cols=195 Identities=27% Similarity=0.418 Sum_probs=165.9
Q ss_pred CeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|... +|+.||+|+++... ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 58899999987542 22344566788887754 899999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 999988843 34578999999999999999999998 89999999999999999999999999987432211 12
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 234678999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=301.92 Aligned_cols=194 Identities=28% Similarity=0.413 Sum_probs=168.0
Q ss_pred CeeccCCCccEEEeEe----eCCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 581 NKIGEGGFGPVYKGLL----ADGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~----~~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
+.||+|+||.||++.. .+|+.||+|++..... .....+..|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3578999999875422 223456789999999999999999999999999999999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999998842 34689999999999999999999998 899999999999999999999999999876543322
Q ss_pred eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 735 ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 223457899999999999888899999999999999999999999764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=304.12 Aligned_cols=206 Identities=31% Similarity=0.459 Sum_probs=171.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCc-ccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 645 (809)
.++|+..+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+++++.+ +|+||++++++|.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457888999999999999998742 235799999975432 2345688999999999 89999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCc----------------------------------------------------------
Q 043333 646 LLLIYEYMENNSLARALFGPEE---------------------------------------------------------- 667 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~---------------------------------------------------------- 667 (809)
.++||||+++|+|.++++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998853210
Q ss_pred --------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc-eecc
Q 043333 668 --------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH-ISTR 738 (809)
Q Consensus 668 --------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~ 738 (809)
...++++..+.+++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 123578899999999999999999998 8999999999999999999999999999765432221 1112
Q ss_pred ccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 739 IAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 739 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
..++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 234568999999998899999999999999999997 99999653
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=301.53 Aligned_cols=195 Identities=29% Similarity=0.455 Sum_probs=164.9
Q ss_pred CeeccCCCccEEEeEe-eCCeEEEEEEecccC---cccchhHHHHHH-HHhhcCCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS---KQGNREFVNEIG-MISALQHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|+. .+|+.||||++.... ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 468999999986542 222345555654 46778999999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|..++. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 99998884 234688999999999999999999998 89999999999999999999999999987532221 12
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 234578999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=301.03 Aligned_cols=195 Identities=29% Similarity=0.449 Sum_probs=164.7
Q ss_pred CeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHH-HHhhcCCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIG-MISALQHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||+||+|+.. +|+.||||++.... ....+++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 68999999986542 222344555554 56789999999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999998843 34688999999999999999999998 89999999999999999999999999987532221 12
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 234578999999999999899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=304.70 Aligned_cols=206 Identities=31% Similarity=0.452 Sum_probs=171.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEe------eCCeEEEEEEecccC-cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL------ADGKVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 645 (809)
.++|+..+.||+|+||.||+|++ ..+..||||+++... ....+.+.+|++++..+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34678889999999999999973 235689999986543 23345688999999999 89999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCc----------------------------------------------------------
Q 043333 646 LLLIYEYMENNSLARALFGPEE---------------------------------------------------------- 667 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~---------------------------------------------------------- 667 (809)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998854221
Q ss_pred -------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 668 -------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 668 -------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
....++|..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 123578999999999999999999998 8999999999999999999999999999765433221
Q ss_pred e-eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 735 I-STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 735 ~-~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
. .....++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 1 112334567999999999999999999999999999998 88899653
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=299.86 Aligned_cols=194 Identities=29% Similarity=0.429 Sum_probs=163.6
Q ss_pred CeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHH-HHhhcCCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIG-MISALQHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 58899999986532 122344555554 57889999999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 999888732 34578888899999999999999998 89999999999999999999999999987532221 12
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 23457899999999999888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=315.30 Aligned_cols=208 Identities=21% Similarity=0.308 Sum_probs=176.6
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCC----
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGN---- 644 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~---- 644 (809)
...++|.+.+.||+|+||+||+|.. .+|+.||||++.... ......+.+|+..+..++|+||+++...+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457899999999999999999985 468999999986542 233456788999999999999999988776432
Q ss_pred ----eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEE
Q 043333 645 ----QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 720 (809)
Q Consensus 645 ----~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 720 (809)
..++||||+++|+|.+++.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 36899999999999999865444456789999999999999999999998 89999999999999999999999
Q ss_pred ecCCccccCCCC-cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 721 DFGLAKLDEEDN-THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 721 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~ 248 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999997654321 12223467999999999999999999999999999999999999999754
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=301.04 Aligned_cols=204 Identities=26% Similarity=0.462 Sum_probs=179.6
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe-EEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ-LLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~-~~lV 649 (809)
.++|...+++|+|+||.++..+++ +++.+++|.+.... ....+...+|+.++++++|||||.+.+.+.+++. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357888999999999999998854 57889999987653 2334467889999999999999999999999988 8999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|+|++||++.+.+...+ ...+++.++..++.|++.|+.|||++ .|+|||||++||+++++..+||+|||+|+.+.
T Consensus 83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999885432 45688999999999999999999987 89999999999999999999999999999887
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.+.. ....++||+.||+||.+.+.+|..|+||||+||++|||++-|++|...+
T Consensus 158 ~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~ 210 (426)
T KOG0589|consen 158 PEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN 210 (426)
T ss_pred Cchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc
Confidence 6542 3345789999999999999999999999999999999999999997643
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=303.77 Aligned_cols=201 Identities=28% Similarity=0.436 Sum_probs=170.2
Q ss_pred CCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCC-----eEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGN-----QLL 647 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~ 647 (809)
+|+..+.||+|+||.||++.. .+|+.||||++.... ....+++.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999985 468999999986432 223467889999999999999999999998776 789
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+|+||++ ++|.+++. ....+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 57777763 234689999999999999999999998 899999999999999999999999999986
Q ss_pred cCCCCcceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 728 DEEDNTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 728 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
.............+++.|+|||++.+. .++.++||||+||++|||++|+.||...+.
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 210 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH
Confidence 543333333345678899999998764 578999999999999999999999977543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=294.67 Aligned_cols=202 Identities=24% Similarity=0.432 Sum_probs=170.1
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
++|...+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999864 578899999865432 2345678899999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++ +|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 985 78887743 233578899999999999999999998 89999999999999999999999999987543322
Q ss_pred cceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 733 THISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
.. .....+++.|+|||.+.+ ..++.++||||+||++|||+||+.||...+.
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 210 (309)
T cd07872 159 KT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210 (309)
T ss_pred cc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 11 223457889999998865 5688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=300.93 Aligned_cols=194 Identities=30% Similarity=0.484 Sum_probs=163.0
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
+|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3456788999999999999854 689999999865432 23467889999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.+.. ..++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999986533 345677889999999999999998 899999999999999999999999999986543221
Q ss_pred ceeccccccccccchhhhcc-----CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
......||..|+|||++.. ...+.++|||||||++|||++|+.||..
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 1233568999999998743 3345689999999999999999999974
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=321.15 Aligned_cols=205 Identities=25% Similarity=0.405 Sum_probs=173.9
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|++.++||+|+||.||+|... +|+.||||+++.... ...++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999864 588999999875422 22457899999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCC-------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 651 EYMENNSLARALFGPE-------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
||+++|+|.+++.... ......++..++.++.|+++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 1123467888899999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCc-----------------ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 724 LAKLDEEDNT-----------------HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 724 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+++....... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9976521110 0111246999999999999999999999999999999999999999653
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=285.62 Aligned_cols=203 Identities=32% Similarity=0.501 Sum_probs=174.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.++|+..++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35688899999999999999998888889999876433 23567899999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999999998543 234578899999999999999999998 899999999999999999999999999986644322
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
.......++..|+|||++....++.++|||||||++|||+| |+.||...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 22222345678999999988889999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=275.09 Aligned_cols=208 Identities=25% Similarity=0.400 Sum_probs=176.2
Q ss_pred HhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++.|+..+.||+|.|+.||++.+ ..|+.+|+|++... +..+.+++.+|+++-+.++||||+++...+.+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356677788999999999999885 46889999987543 344677888999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCceEEEecCCcc
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAK 726 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~ 726 (809)
+|+|.+|+|..-+- .+...++..+-....||+.||.|+|.+ +|||||+||.|++|.. .--+|++|||+|.
T Consensus 89 Fe~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999976552 234567778889999999999999998 8999999999999953 3458999999998
Q ss_pred ccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHH
Q 043333 727 LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLD 792 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~ 792 (809)
... +.......+|||+|||||++...+++..+|||+-|||+|-|+.|..||.+. ++..+.+
T Consensus 162 ~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~---~~~rlye 222 (355)
T KOG0033|consen 162 EVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYE 222 (355)
T ss_pred EeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc---cHHHHHH
Confidence 776 333344678999999999999999999999999999999999999999773 3444444
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=294.94 Aligned_cols=195 Identities=27% Similarity=0.429 Sum_probs=166.8
Q ss_pred CeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|... +++.||||+++... ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 57899999987542 22345567888888888 699999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 999988843 33689999999999999999999998 899999999999999999999999999875322221 1
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 223568999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=288.76 Aligned_cols=198 Identities=38% Similarity=0.622 Sum_probs=165.4
Q ss_pred CCeeccCCCccEEEeEee-----CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 580 DNKIGEGGFGPVYKGLLA-----DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.+.||.|.||.||+|.+. .+..|+||.++.... ...++|.+|++.+++++||||++++|+|...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999977 256899999965433 34678999999999999999999999999888899999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC-
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN- 732 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~- 732 (809)
++|+|.++|+.. ....+++..+..|+.|+|+||.|||++ +++|+||+++||++++++.+||+|||++.......
T Consensus 84 ~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999543 245689999999999999999999998 89999999999999999999999999998663221
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
............|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 122223446779999999999889999999999999999999 78898654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-33 Score=273.12 Aligned_cols=208 Identities=25% Similarity=0.344 Sum_probs=178.0
Q ss_pred HhcCCCCCCeeccCCCccEEEeE-eeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCC-----eE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGN-----QL 646 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~ 646 (809)
..++|.+.+.+|+|||+-||.++ ..+++.+|+|++.....++.+..++|++..++++|||++++++++..+. +.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45789999999999999999998 5678999999998777777788999999999999999999999876543 48
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
|++++|...|+|.+.+.....+...+++.+.+.|+.++++||++||+..+ ++.||||||.|||+.+.+.+++.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999997666666689999999999999999999999853 79999999999999999999999999986
Q ss_pred ccCCC--Ccc------eeccccccccccchhhhc---cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 727 LDEED--NTH------ISTRIAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 727 ~~~~~--~~~------~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
...-. +.. .......|..|+|||.+. +...++++|||||||++|+||.|..||+.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 44211 000 011234788999999874 45688999999999999999999999975
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=298.45 Aligned_cols=195 Identities=29% Similarity=0.427 Sum_probs=163.3
Q ss_pred CeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHH-HHHhhcCCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEI-GMISALQHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei-~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 57889999986532 12233444454 356788999999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|.+++.. ...+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence 999998843 33577888889999999999999998 899999999999999999999999999875432221 2
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 234579999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=285.86 Aligned_cols=202 Identities=28% Similarity=0.466 Sum_probs=172.5
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
++|...+.||+|+||.||+|.+.++..||||.+.... ....+|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3567788999999999999988777779999886443 234678999999999999999999999999999999999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
+|+|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.++........
T Consensus 83 ~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999998532 23689999999999999999999998 8999999999999999999999999998765433222
Q ss_pred eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 735 ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 2222335668999999988889999999999999999999 999996543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=284.93 Aligned_cols=203 Identities=32% Similarity=0.519 Sum_probs=174.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.++|+..+.||+|+||.||+|...+++.||||.++... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688899999999999999998778889999986543 23567899999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||++++++.++|+|||++........
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999985432 34689999999999999999999998 899999999999999999999999999986653222
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
........+..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 208 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 11111223457999999998899999999999999999999 99999654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=302.97 Aligned_cols=204 Identities=24% Similarity=0.359 Sum_probs=173.2
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcC-C-----CceEeEEeEEEeCCeEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-H-----PNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H-----~nIv~l~~~~~~~~~~~ 647 (809)
.+|.+.+.||+|.||.|.+|.. ..++.||||+++....- .++-+.|+.+|..++ | -|+|++++|+...++.|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 3788999999999999999984 46899999999765332 355577999999997 4 38999999999999999
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC--CceEEEecCCc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD--LNPKISDFGLA 725 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DfGla 725 (809)
+|+|.+.. +|+++|.... ...++...+..++.||+.||.+||+. +|||+||||+||||.+- .++||+|||.+
T Consensus 265 iVfELL~~-NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhhhh-hHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 99998865 9999996543 33588899999999999999999988 89999999999999644 47999999999
Q ss_pred cccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchh
Q 043333 726 KLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFC 789 (809)
Q Consensus 726 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~ 789 (809)
+.....- ..+..+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+.++.++..
T Consensus 339 c~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~ 398 (586)
T KOG0667|consen 339 CFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLA 398 (586)
T ss_pred cccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHH
Confidence 8754321 14567889999999999999999999999999999999998888766655543
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=285.43 Aligned_cols=193 Identities=30% Similarity=0.420 Sum_probs=166.1
Q ss_pred eccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCch
Q 043333 583 IGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL 658 (809)
Q Consensus 583 LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 658 (809)
||+|+||.||++... +|+.||+|++.... ....+.+..|++++++++||||+++.+++.+....++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999854 68999999986432 12234566799999999999999999999999999999999999999
Q ss_pred hhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceecc
Q 043333 659 ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 738 (809)
Q Consensus 659 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 738 (809)
.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 9887532 234588999999999999999999998 89999999999999999999999999987654322 1233
Q ss_pred ccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 739 IAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 739 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
..|+..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 56899999999999888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=306.42 Aligned_cols=201 Identities=24% Similarity=0.354 Sum_probs=165.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeC--------C
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEG--------N 644 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--------~ 644 (809)
.++|+..+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999964 58899999885432 2345799999999999999999987542 2
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-ceEEEecC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFG 723 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfG 723 (809)
..++||||+++ +|.+++.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46789999985 67776643333455789999999999999999999998 899999999999999664 79999999
Q ss_pred CccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 724 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||...+.
T Consensus 217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 217 SAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred cchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9986543322 223568999999999876 4689999999999999999999999977543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=295.40 Aligned_cols=204 Identities=27% Similarity=0.409 Sum_probs=179.7
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeC-CeEEEEEEecccCcc---cchhHHHHHHHHhhcC-CCceEeEEeEEEeCCeEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQ---GNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~---~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~ 647 (809)
....|+..+.||+|.||.||+++... |+.+|+|.+.+.... ......+|+++|+++. |||||.+.+.+.+.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 35678888999999999999999664 999999999766443 3357889999999998 999999999999999999
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC----CceEEEecC
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD----LNPKISDFG 723 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DfG 723 (809)
+|||++.+|.|.+.+... .+++..+..++.|++.|+.|||+. +|+|||+||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999988543 388999999999999999999997 89999999999999643 579999999
Q ss_pred CccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCccc
Q 043333 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEA 786 (809)
Q Consensus 724 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~ 786 (809)
++..... .......+||+.|+|||++....++..+||||+||++|.|+.|.+||...++.+
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~ 245 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE 245 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH
Confidence 9998765 333456789999999999999999999999999999999999999998865443
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=293.98 Aligned_cols=201 Identities=29% Similarity=0.522 Sum_probs=169.2
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCe----EEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGK----VIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
.+|+..+.||+|+||.||+|++. +++ .||||+++... ....++|.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999854 343 48999986543 23456788999999999999999999999864 5679
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999998542 34588999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCccee-ccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 729 EEDNTHIS-TRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 729 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
........ ....++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 54332211 12234668999999999999999999999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=288.03 Aligned_cols=205 Identities=30% Similarity=0.544 Sum_probs=174.1
Q ss_pred cCCCCCCeeccCCCccEEEeEeeC------CeEEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLAD------GKVIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
++|...+.||+|+||.||+|...+ ++.||||.+...... ..+.|.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778999999999999998633 478999998765443 4568999999999999999999999999999999
Q ss_pred EEEEcccCCchhhhccCCC----------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCce
Q 043333 648 LIYEYMENNSLARALFGPE----------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 717 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 717 (809)
+||||+++|+|.+++.... .....+++..+..++.|++.|+.|||++ +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999986432 2234588999999999999999999998 89999999999999999999
Q ss_pred EEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 718 KISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 718 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
+|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999875432221 11223345778999999999999999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=282.69 Aligned_cols=200 Identities=29% Similarity=0.466 Sum_probs=170.6
Q ss_pred CCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+|+..+.||+|+||.||+|.+.++..+|+|.+.... ....+|.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 467789999999999999998777789999986432 2345788999999999999999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
++|.+++... ...++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...+.....
T Consensus 84 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 84 GCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999998532 23689999999999999999999998 89999999999999999999999999987654322211
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 112223457999999998899999999999999999999 89999654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-34 Score=281.94 Aligned_cols=196 Identities=32% Similarity=0.499 Sum_probs=174.3
Q ss_pred CCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
|.+.++||+|+||.||+|.++ +|++||||.+...+ +.+++..|+.+|.+++.|++|+++|.|.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 556788999999999999965 69999999986543 357889999999999999999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|++.+.++ ..+.++.+..+..++...+.||+|||.. .-||||||+.||||+.+|.+|++|||.|..+.+.-..
T Consensus 113 GSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK- 185 (502)
T KOG0574|consen 113 GSISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK- 185 (502)
T ss_pred CcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-
Confidence 99999884 3456899999999999999999999987 6799999999999999999999999999766432222
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
...+.||+-|||||++..-.|..++||||+|+...||..||+||..
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD 231 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD 231 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence 2346799999999999998999999999999999999999999965
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-33 Score=307.12 Aligned_cols=208 Identities=33% Similarity=0.508 Sum_probs=176.6
Q ss_pred CCCCCeeccCCCccEEEeEe-eCCe----EEEEEEeccc-CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 577 FAPDNKIGEGGFGPVYKGLL-ADGK----VIAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~-~~g~----~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
....++||.|+||+||+|.| ..|+ +||+|++... ..+..+++++|+-+|.+++|||+++++|+|..+. ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34578899999999999995 3443 6899998765 3455788999999999999999999999999876 88999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
+|||.|+|.+|++. ++..+--...+.|+.|||+||.|||++ .++||||.++|||+.+-..+||.|||+++....
T Consensus 777 q~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999954 566788889999999999999999998 899999999999999999999999999998766
Q ss_pred CCcceecc-ccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCcccchhHH
Q 043333 731 DNTHISTR-IAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRTKEAQFCLL 791 (809)
Q Consensus 731 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~~~~~~~l~ 791 (809)
+....... ..-.+.|||-|.+....++.++|||||||.+||++| |..|+++...++..++.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll 913 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL 913 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH
Confidence 55433222 223458999999999999999999999999999988 89999886655554443
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=300.50 Aligned_cols=205 Identities=29% Similarity=0.422 Sum_probs=171.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCc-ccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~ 645 (809)
.++|.+.+.||+|+||.||+|+.. .+..||||+++.... ...+.|.+|+++++++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 567888999999999999999852 134799999965433 23457899999999996 9999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCc----------------------------------------------------------
Q 043333 646 LLLIYEYMENNSLARALFGPEE---------------------------------------------------------- 667 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~---------------------------------------------------------- 667 (809)
.++||||+++|+|.++++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998864211
Q ss_pred ----------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC
Q 043333 668 ----------------------------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK 713 (809)
Q Consensus 668 ----------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~ 713 (809)
....+++..+..++.|++.||+|||+. +|+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 012478889999999999999999998 8999999999999999
Q ss_pred CCceEEEecCCccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 043333 714 DLNPKISDFGLAKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVIC 781 (809)
Q Consensus 714 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~ 781 (809)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 999999999999765332221 1122346778999999998899999999999999999997 9999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=310.61 Aligned_cols=205 Identities=24% Similarity=0.321 Sum_probs=170.9
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCC-eEEEEEEecccCcccchhHHHHHHHHhhcC-CCceEeEEeE-EEe------CCe
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADG-KVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLYGC-CIE------GNQ 645 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g-~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~-~~~------~~~ 645 (809)
.++++.+.|.+|||+.||.|....+ ..||+|++-..+....+...+|+++|++++ |+|||.+++. ... ..+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3455778999999999999997765 999999987777777788899999999997 9999999994 221 247
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.+|.||||++|+|.+++..+.. ..|.+..+++|+.|+++|+++||.. +++|||||||-+||||+.++..||||||.|
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 8999999999999999954333 3499999999999999999999987 568999999999999999999999999998
Q ss_pred cccCCCC-cce-------eccccccccccchhhh---ccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 726 KLDEEDN-THI-------STRIAGTFGYMAPEYA---MRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 726 ~~~~~~~-~~~-------~~~~~gt~~y~aPE~~---~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.-..... ... .....-|+.|+|||++ .+..+++|+|||+|||+||-|+....||+..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 6321111 100 0113468999999987 4678999999999999999999999999764
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=286.14 Aligned_cols=200 Identities=29% Similarity=0.381 Sum_probs=171.8
Q ss_pred CCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
|+..+.||+|+||+||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999864 688999999865422 2234577899999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999888532 234689999999999999999999998 89999999999999999999999999987654322
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1 123468999999999998899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=285.47 Aligned_cols=199 Identities=30% Similarity=0.406 Sum_probs=171.3
Q ss_pred CCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc---cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ---GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
|+..+.||+|+||.||++... +++.||||.+...... ..+.+..|+.++++++|++|+++.+.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999864 6889999998654221 234577899999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999988532 223588999999999999999999997 89999999999999999999999999987654322
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
. .....|+..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 2 12346899999999999989999999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=285.65 Aligned_cols=206 Identities=33% Similarity=0.541 Sum_probs=172.7
Q ss_pred cCCCCCCeeccCCCccEEEeEeeC------CeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLAD------GKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
++|+..+.||+|+||.||+|.... .+.||+|.+..... ....+|.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357788999999999999998542 25799999865432 23456889999999999999999999999999999
Q ss_pred EEEEcccCCchhhhccCCCc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC
Q 043333 648 LIYEYMENNSLARALFGPEE------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL 715 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 715 (809)
++|||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999854321 114688999999999999999999998 899999999999999999
Q ss_pred ceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 716 NPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 716 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
.++|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999975533221 22233456788999999988899999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-33 Score=276.94 Aligned_cols=223 Identities=28% Similarity=0.387 Sum_probs=186.8
Q ss_pred HhcCCCCCCeeccCCCccEEEeE-eeCCeEEEEEEecccCc---ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
..++|...++||+|.||.|-.++ ...|+.+|+|++++... .....-+.|-++|...+||.+..+.-.++..+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 34677888999999999999998 45799999999987633 223445678899999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||..+|.|.-+|.. ...+++.....+-..|..||.|||++ +||.||+|.+|.|||++|++||+|||+++.-
T Consensus 246 VMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999888833 33567777778889999999999998 8999999999999999999999999999854
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhccCCCCcCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFLS 808 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~ 808 (809)
-... ..+...|||+.|.|||++....|+..+|+|.+||++|||+.|+.||..++.+.-+ -.-.+.|.+||+-+|
T Consensus 319 I~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLF-----eLIl~ed~kFPr~ls 392 (516)
T KOG0690|consen 319 IKYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF-----ELILMEDLKFPRTLS 392 (516)
T ss_pred cccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHH-----HHHHhhhccCCccCC
Confidence 3332 2345689999999999999999999999999999999999999999765333222 223567789998775
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=283.22 Aligned_cols=193 Identities=26% Similarity=0.431 Sum_probs=168.7
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEeccc-CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
++|+..+.||+|+||.||+|.. .+++.||+|++... .....++|.+|++++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577889999999999999985 46889999998654 233346788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999986543 367888999999999999999998 89999999999999999999999999987553321
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 2235688999999999988899999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=286.98 Aligned_cols=206 Identities=30% Similarity=0.541 Sum_probs=174.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 356788899999999999999742 34578999987665555667999999999999999999999999999999
Q ss_pred EEEEcccCCchhhhccCCC---------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceE
Q 043333 648 LIYEYMENNSLARALFGPE---------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 718 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~---------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 718 (809)
+||||+++++|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999985322 1233589999999999999999999998 899999999999999999999
Q ss_pred EEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 719 ISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 719 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999975533221 11223345778999999998889999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=284.99 Aligned_cols=208 Identities=27% Similarity=0.429 Sum_probs=172.5
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 645 (809)
.+++|+..+.||+|+||.||+|... .++.||||++.... .....+|.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4677999999999999999998743 24679999885432 2234568899999999999999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEE
Q 043333 646 LLLIYEYMENNSLARALFGPEE------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 719 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 719 (809)
.++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854221 123468899999999999999999998 8999999999999999999999
Q ss_pred EecCCccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 720 SDFGLAKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 720 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ |+.||....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999998755332221 1112345678999999998899999999999999999999 788986543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=300.82 Aligned_cols=200 Identities=32% Similarity=0.519 Sum_probs=172.3
Q ss_pred CCCCCeeccCCCccEEEeE-eeCCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeC------CeEEE
Q 043333 577 FAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEG------NQLLL 648 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~------~~~~l 648 (809)
+...+.||+|+||.||+|+ ...|+.||||.++... ....+...+|+++|++++|||||++++.-.+. +...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3456779999999999999 4579999999997753 33456678999999999999999999986654 36799
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc--CCC--ceEEEecCC
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD--KDL--NPKISDFGL 724 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~--~~kl~DfGl 724 (809)
|||||.+|||...|... ++...+++...+.++.+++.||.|||++ +|+||||||.||++- ++| .-||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999654 5667799999999999999999999988 899999999999983 333 359999999
Q ss_pred ccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
|+-..++. .....+||..|.+||+... +.++..+|.|||||++||..||..||...
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99877654 4456889999999999984 88999999999999999999999999763
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=282.50 Aligned_cols=202 Identities=27% Similarity=0.465 Sum_probs=172.2
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.+|...+.||+|+||.||+|... .++.||+|++... ....+++.+|++++++++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34677889999999999999965 5789999998643 333567899999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++++|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999998542 234589999999999999999999998 899999999999999999999999999986543322
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 209 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 21112234568999999998899999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=286.34 Aligned_cols=201 Identities=28% Similarity=0.523 Sum_probs=175.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
..+|+..+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35788889999999999999985 46889999998765555567788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.+++. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 99999999883 23578999999999999999999998 89999999999999999999999999987654322
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. .....+++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 223468889999999998889999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=278.80 Aligned_cols=200 Identities=30% Similarity=0.441 Sum_probs=171.6
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc-----ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK-----QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~-----~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
++|...+.||+|++|.||+|.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788899999999999999985 4688999998864321 123467889999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999998842 33578889999999999999999998 8999999999999999999999999998755
Q ss_pred CCCCccee--ccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 729 EEDNTHIS--TRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 729 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
........ ....++..|+|||.+.+..++.++||||+|+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 43221111 234577899999999988899999999999999999999999965
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=282.85 Aligned_cols=205 Identities=34% Similarity=0.553 Sum_probs=177.9
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
...+|+..+.||+|+||.||+|...+++.+|+|.+.........++..|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888999999999999999888899999998766554567789999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999996432 34689999999999999999999998 89999999999999999999999999997654322
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 11 112345678999999988889999999999999999998 899996643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=284.80 Aligned_cols=205 Identities=30% Similarity=0.498 Sum_probs=171.3
Q ss_pred cCCCCCCeeccCCCccEEEeEe-----eCCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-----ADGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
++|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+|.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567789999999999999984 245789999987543 2334678899999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCC-------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC
Q 043333 649 IYEYMENNSLARALFGPE-------------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL 715 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 715 (809)
||||+++|+|.+++.... .....+++.++..++.|++.||+|||++ +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999885321 1123578999999999999999999998 899999999999999999
Q ss_pred ceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 716 NPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 716 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999976533221 11223345678999999988889999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=315.23 Aligned_cols=209 Identities=27% Similarity=0.328 Sum_probs=184.6
Q ss_pred HHHHHHHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc---CcccchhHHHHHHHHhhcCCCceEeEEeEEEe
Q 043333 567 LRQIKAATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYGCCIE 642 (809)
Q Consensus 567 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~ 642 (809)
.++++-..++|.+.++||+|+||.|..++.+ .++++|.|++.+. ......-|.+|-.+|..-..+.|+++.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3455556789999999999999999999965 5899999999763 23445678999999999999999999999999
Q ss_pred CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 643 GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 643 ~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
.+++|+|||||+||+|..++... . +++...+..++..|.-||.-||+. |+|||||||.|||||..|++|++||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~---~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF---D-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc---C-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999998332 2 588888999999999999999998 8999999999999999999999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhc----c-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAM----R-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
|.+-.+..++.-.+...+|||.|.+||++. + +.|++.+|+||+||++|||+.|..||...
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 999888777776777889999999999985 3 67899999999999999999999999653
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=267.35 Aligned_cols=201 Identities=27% Similarity=0.445 Sum_probs=173.0
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc----ccc----hhHHHHHHHHhhc-CCCceEeEEeEEEe
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK----QGN----REFVNEIGMISAL-QHPNLVKLYGCCIE 642 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~----~~~----~~f~~Ei~~l~~l-~H~nIv~l~~~~~~ 642 (809)
.-..|...+.+|+|..++|.++.++ .|+..|+|++..... +.. +.-.+|+++|+++ .||+|+.+.++|..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 4467888999999999999988854 578899998864421 111 2345789999998 59999999999999
Q ss_pred CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 643 GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 643 ~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
+...++|+|.|+.|.|.|+| .....+++....+|+.|+..|++|||.. +||||||||+|||+|++.++||+||
T Consensus 95 ~sF~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 99999999999999999999 3456789999999999999999999998 8999999999999999999999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhcc------CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMR------GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
|.++.+..... -...|||++|.|||.+.. ..|+...|+|+.|||+|.|+.|-+||..+
T Consensus 168 GFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR 231 (411)
T KOG0599|consen 168 GFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR 231 (411)
T ss_pred ceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH
Confidence 99998765443 245799999999999853 35788999999999999999999999765
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=280.64 Aligned_cols=200 Identities=28% Similarity=0.420 Sum_probs=171.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
.++|+..+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++.+++||||+++++++...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788999999999999999995 46889999998765444456678899999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.++++. ..++++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998843 34578999999999999999999998 89999999999999999999999999997653222
Q ss_pred cceeccccccccccchhhhc---cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
. ......++..|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 1 112346788999999874 34578899999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=280.68 Aligned_cols=202 Identities=31% Similarity=0.509 Sum_probs=170.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.++|++.++||+|+||.||+|...++..||+|++.... ...++|.+|++++++++||||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35688899999999999999987766779999987533 23467899999999999999999999874 45679999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999999542 233578999999999999999999998 899999999999999999999999999976543332
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
.......++..|+|||+..+..++.++|||||||++|||+| |+.||...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 22222345678999999988899999999999999999999 88898654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=280.83 Aligned_cols=201 Identities=32% Similarity=0.491 Sum_probs=171.8
Q ss_pred cCCCCCCeeccCCCccEEEeEeeC----CeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLAD----GKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
++|+..+.||+|+||.||+|.+.. ...||||.++.... ....+|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998642 35799998865432 3346788999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998542 23689999999999999999999997 89999999999999999999999999998764
Q ss_pred CCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 043333 730 EDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVIC 781 (809)
Q Consensus 730 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~ 781 (809)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 22221 1222334678999999998899999999999999999998 9999965
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=286.86 Aligned_cols=198 Identities=27% Similarity=0.432 Sum_probs=171.6
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
++|+..+.||+|+||.||++... ++..+|+|.+..... ....++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999854 578899998865422 2345688999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.+++.. ...+++..+..++.|++.||.|||+.. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999843 245889999999999999999999742 79999999999999999999999999987543221
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 1235688899999999888899999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=279.92 Aligned_cols=203 Identities=27% Similarity=0.430 Sum_probs=174.4
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999954 68999999875432 223456889999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.........+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988854333445688899999999999999999998 899999999999999999999999999886543
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 3221 1234578899999999888899999999999999999999999954
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=295.89 Aligned_cols=197 Identities=21% Similarity=0.278 Sum_probs=169.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEee---CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA---DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
..+|.+.+.||+|+||.||++... .++.||||.+... +.+.+|++++++++||||+++++++...+..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457889999999999999999743 3578999987542 34568999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+. ++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.++|+|||++.....
T Consensus 166 e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9986 68888872 345689999999999999999999998 899999999999999999999999999976543
Q ss_pred CCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 322 12234579999999999999899999999999999999999999996643
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=285.68 Aligned_cols=201 Identities=25% Similarity=0.437 Sum_probs=169.4
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999864 57899999986543 22334677899999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
++ ++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 5888887432 33578999999999999999999998 89999999999999999999999999987543222
Q ss_pred cceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
. ......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||...+
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1123456889999998865 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=281.78 Aligned_cols=201 Identities=30% Similarity=0.486 Sum_probs=166.5
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCe----EEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGK----VIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
++|+..+.||+|+||.||+|.+. +++ .|++|.+..... ...+++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46778899999999999999863 344 477787754322 223567788889999999999999998854 55788
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
|+||+++|+|.+++.. ....++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999953 234689999999999999999999998 7999999999999999999999999999865
Q ss_pred CCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 729 EEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 729 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
...... ......++..|+|||.+.++.++.++|||||||++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 433221 2223456778999999998899999999999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=275.91 Aligned_cols=196 Identities=28% Similarity=0.456 Sum_probs=166.7
Q ss_pred CeeccCCCccEEEeEeeCCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCchh
Q 043333 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLA 659 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~ 659 (809)
++||+|+||.||+|...+++.||+|.+..... .....|.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999999865432 22346889999999999999999999999999999999999999999
Q ss_pred hhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceeccc
Q 043333 660 RALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRI 739 (809)
Q Consensus 660 ~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 739 (809)
+++... ...+++..+..++.|++.||.|+|+. +++||||||+||++++++.+|++|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 988432 34578999999999999999999998 899999999999999999999999999875432211111122
Q ss_pred cccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 740 AGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 740 ~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
.++..|+|||++.++.++.++|||||||++|||++ |+.||...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 34567999999998899999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=284.41 Aligned_cols=205 Identities=29% Similarity=0.532 Sum_probs=173.7
Q ss_pred cCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
++|...+.||+|+||.||+|... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35677889999999999999742 345789999876555555778999999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCC------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc
Q 043333 649 IYEYMENNSLARALFGPE------------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 716 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 716 (809)
||||+++++|.+++.... .....++|..++.++.|++.||+|||++ +++||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999985432 1223589999999999999999999998 8999999999999999999
Q ss_pred eEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 717 PKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 717 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
++|+|||++........ .......++..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999975543221 11223456788999999998899999999999999999999 99998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=282.55 Aligned_cols=200 Identities=28% Similarity=0.462 Sum_probs=165.1
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc--cchhHHHHHHHHhhc---CCCceEeEEeEEEeC-----C
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ--GNREFVNEIGMISAL---QHPNLVKLYGCCIEG-----N 644 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l---~H~nIv~l~~~~~~~-----~ 644 (809)
+|++.+.||+|+||.||+|... +++.||+|.++..... ....+.+|+++++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999865 6889999998654322 234566777776665 699999999998752 4
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
..++||||+++ +|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57999999985 8888874322 23589999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
++....... .....||..|+|||++.+..++.++||||+||++|||++|++||....
T Consensus 155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 155 ARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred cccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 986543221 223567889999999998899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=296.20 Aligned_cols=192 Identities=29% Similarity=0.405 Sum_probs=160.6
Q ss_pred eccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhc---CCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 583 IGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISAL---QHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 583 LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l---~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
||+|+||+||+|+.. +++.||||++..... .....+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999854 589999999864321 1223455666676655 699999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.++|+|||+++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 999988842 34588999999999999999999998 899999999999999999999999999875432221 1
Q ss_pred eccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
....+||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 2345789999999998754 4789999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=276.27 Aligned_cols=203 Identities=29% Similarity=0.472 Sum_probs=176.1
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 78999999886432 223567889999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.........+++..+..++.+++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998865444455689999999999999999999998 899999999999999999999999999876543
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.... .....++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 2211 1234578899999999888899999999999999999999999954
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=277.71 Aligned_cols=202 Identities=31% Similarity=0.503 Sum_probs=171.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.++|++.+.||+|+||.||+|...++..||+|.+..... ..+.|.+|++++++++|+|++++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 356788899999999999999988888899999865433 3467899999999999999999999875 45689999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++++|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 83 SKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999999998543 233579999999999999999999998 899999999999999999999999999976543322
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 207 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 22222335568999999988889999999999999999999 89999653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=283.76 Aligned_cols=200 Identities=29% Similarity=0.526 Sum_probs=175.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
..+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36788999999999999999985 46899999998765555556788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.+++. ...+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999999883 23578899999999999999999998 89999999999999999999999999987654332
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. .....+++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~ 218 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 22346788999999999888999999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=293.56 Aligned_cols=199 Identities=25% Similarity=0.381 Sum_probs=167.8
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCC-----
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGN----- 644 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~----- 644 (809)
..++|+..+.||+|+||.||++... .|+.||||++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999854 5889999998643 2233456788999999999999999999987543
Q ss_pred -eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 645 -QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 645 -~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
..++||||+++ +|.+.++ ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 47999999976 5666552 2478888999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 724 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
+++...... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||...+
T Consensus 169 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 169 LARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred CccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 997543221 2234568999999999999899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=291.43 Aligned_cols=206 Identities=29% Similarity=0.451 Sum_probs=170.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCc-ccchhHHHHHHHHhhc-CCCceEeEEeEEEeC-C
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLYGCCIEG-N 644 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~-~ 644 (809)
.++|++.+.||+|+||.||+|... .++.||+|+++.... ...+.+..|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457889999999999999999632 247899999875432 2245678899999999 799999999988754 5
Q ss_pred eEEEEEEcccCCchhhhccCCCc---------------------------------------------------------
Q 043333 645 QLLLIYEYMENNSLARALFGPEE--------------------------------------------------------- 667 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~--------------------------------------------------------- 667 (809)
..++|+||+++|+|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998853211
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce-ecccccccccc
Q 043333 668 HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI-STRIAGTFGYM 746 (809)
Q Consensus 668 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~ 746 (809)
...+++|..+..++.||+.||+|||+. +|+||||||+|||+++++.++|+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 013689999999999999999999998 89999999999999999999999999998654332221 12234567899
Q ss_pred chhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 747 APEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 747 aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=277.43 Aligned_cols=202 Identities=34% Similarity=0.541 Sum_probs=172.6
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.++|+..++||+|+||.||+|...+++.||+|.+..... ..++|.+|++++++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 467888999999999999999988889999999865432 3467889999999999999999999864 56789999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 83 ENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999999988542 234689999999999999999999987 899999999999999999999999999976543222
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
.......++..|+|||++....++.++|||||||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 22222345678999999988889999999999999999999 99999653
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=304.85 Aligned_cols=203 Identities=21% Similarity=0.277 Sum_probs=164.9
Q ss_pred HHHHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCC------CceEeEEeEEEe
Q 043333 570 IKAATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQH------PNLVKLYGCCIE 642 (809)
Q Consensus 570 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H------~nIv~l~~~~~~ 642 (809)
+...+++|++.+.||+|+||+||+|... .++.||||+++.... ..+++..|++++..++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3345688999999999999999999864 578899999864322 23455667777777655 458899998876
Q ss_pred C-CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC------
Q 043333 643 G-NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL------ 715 (809)
Q Consensus 643 ~-~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~------ 715 (809)
. +..++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++. +||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccc
Confidence 4 5688999988 6788888742 346899999999999999999999742 799999999999998765
Q ss_pred ----------ceEEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 716 ----------NPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 716 ----------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 499999998764321 12346799999999999999999999999999999999999999976543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=277.24 Aligned_cols=202 Identities=32% Similarity=0.497 Sum_probs=174.9
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+|+..+.||+|++|.||+|... +++.|++|.+... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999964 6889999988643 233456788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.++++... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999986432 34688999999999999999999998 89999999999999999999999999988654432
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. .....|++.|+|||+..+..++.++|||||||++|||++|+.||...+
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 21 223467889999999999889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=281.78 Aligned_cols=205 Identities=30% Similarity=0.525 Sum_probs=172.7
Q ss_pred cCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
++|...++||+|+||.||++... ++..+|+|.+........+.|.+|+++++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677899999999999999632 356899999876655556789999999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCce
Q 043333 649 IYEYMENNSLARALFGPEE-----------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 717 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 717 (809)
||||+++|+|.+++..... ....+++..++.++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999864321 123589999999999999999999998 89999999999999999999
Q ss_pred EEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 718 KISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 718 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
||+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 9999999875433221 11122335678999999998899999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=275.15 Aligned_cols=194 Identities=28% Similarity=0.460 Sum_probs=162.3
Q ss_pred eeccCCCccEEEeEee---CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCc
Q 043333 582 KIGEGGFGPVYKGLLA---DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNS 657 (809)
Q Consensus 582 ~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gs 657 (809)
.||+|+||.||+|.+. .+..||+|++..... ...++|.+|++++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 355799999865533 23456889999999999999999999885 457899999999999
Q ss_pred hhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCccee-
Q 043333 658 LARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS- 736 (809)
Q Consensus 658 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~- 736 (809)
|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999853 234689999999999999999999998 899999999999999999999999999976543322211
Q ss_pred -ccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 737 -TRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 737 -~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 202 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence 11223568999999988889999999999999999996 99999654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=283.51 Aligned_cols=200 Identities=30% Similarity=0.548 Sum_probs=175.3
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.+|+..+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688889999999999999984 568999999987655555677889999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++++|.+++. ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999999883 23589999999999999999999998 899999999999999999999999999876543322
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
. .....++..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred c-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 223468889999999998889999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=285.53 Aligned_cols=197 Identities=26% Similarity=0.448 Sum_probs=160.4
Q ss_pred CCeeccCCCccEEEeEee---CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEe--CCeEEEEEEccc
Q 043333 580 DNKIGEGGFGPVYKGLLA---DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIE--GNQLLLIYEYME 654 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~lV~ey~~ 654 (809)
.++||+|+||+||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. ....++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 45789999986432 23567889999999999999999999864 456789999986
Q ss_pred CCchhhhccCCC-----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----cCCCceEEEecCCc
Q 043333 655 NNSLARALFGPE-----EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLA 725 (809)
Q Consensus 655 ~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla 725 (809)
+ +|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 7877663211 1233588999999999999999999998 89999999999999 45678999999999
Q ss_pred cccCCCCc--ceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 726 KLDEEDNT--HISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 726 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+....... .......||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 86543221 11234578999999999876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=276.72 Aligned_cols=197 Identities=27% Similarity=0.452 Sum_probs=165.2
Q ss_pred CeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCch
Q 043333 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL 658 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 658 (809)
+.||+|+||.||+|+.. +++.||+|...... ......|.+|++++++++||||++++++|...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999964 68999999876443 23346789999999999999999999999999999999999999999
Q ss_pred hhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce-ec
Q 043333 659 ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI-ST 737 (809)
Q Consensus 659 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~ 737 (809)
.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......... ..
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999843 234588999999999999999999998 89999999999999999999999999987543221110 01
Q ss_pred cccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 738 RIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 738 ~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
....+..|+|||.+.++.++.++|||||||++|||++ |+.||....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 1123457999999998889999999999999999998 888996543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=279.64 Aligned_cols=208 Identities=31% Similarity=0.441 Sum_probs=171.9
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeC------CeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLAD------GKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 645 (809)
.+++|...+.||+|+||.||+|.+.+ +..||+|...... ......|..|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678889999999999999999653 5678999886443 2334568999999999999999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCC---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---ceEE
Q 043333 646 LLLIYEYMENNSLARALFGPE---EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NPKI 719 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl 719 (809)
.++||||+++++|.+++.... .....++|..+..++.||+.||+|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 999999999999999985432 1224689999999999999999999998 899999999999998764 5899
Q ss_pred EecCCccccCCCCcce-eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 720 SDFGLAKLDEEDNTHI-STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 720 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||...+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999998653222111 112233568999999999999999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=292.91 Aligned_cols=199 Identities=24% Similarity=0.357 Sum_probs=168.2
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeC------
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEG------ 643 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~------ 643 (809)
..++|...+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999854 57899999986542 22345678899999999999999999987643
Q ss_pred CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 644 NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
...++||||+++ +|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999975 6766662 2478889999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 724 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
+++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 998654321 2234568999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=279.28 Aligned_cols=199 Identities=30% Similarity=0.480 Sum_probs=170.4
Q ss_pred CCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 556788999999999999965 4788999998665555566788999999999999999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|..++.. ...++++..+..++.|++.||.|||+. +++||||||+||+++.++++||+|||++....... ..
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 999988743 234689999999999999999999998 89999999999999999999999999987543221 11
Q ss_pred eccccccccccchhhhc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.....++..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 22356888999999974 345778999999999999999999999654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=279.13 Aligned_cols=203 Identities=28% Similarity=0.457 Sum_probs=174.9
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||.||+|.. .+++.||||.+.... .....++.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677888999999999999995 478999999876432 223457889999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998854333445689999999999999999999998 899999999999999999999999999876543
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 3221 1234688899999999888899999999999999999999999965
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=275.46 Aligned_cols=204 Identities=35% Similarity=0.545 Sum_probs=175.0
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
..++|.+.+.||+|+||.||+|...+++.||||.+.... ...+++.+|++++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 356788999999999999999998777889999987543 3356789999999999999999999999998999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.+++.... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.++++|||++.......
T Consensus 83 ~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999995432 24589999999999999999999998 89999999999999999999999999987654322
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
........++..|+|||.+.+..++.++||||+||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 111122234568999999998889999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=279.83 Aligned_cols=197 Identities=30% Similarity=0.451 Sum_probs=173.0
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999864 58899999986532 223456889999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999843 24688999999999999999999998 899999999999999999999999999886543
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
. .....+++.|+|||.+.+...+.++||||||+++|||++|+.||...
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 3 22346889999999998888899999999999999999999999654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=280.26 Aligned_cols=205 Identities=33% Similarity=0.491 Sum_probs=170.1
Q ss_pred CCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
+|+..+.||+|+||.||+|... ....+|+|.+..... ...+++.+|+++++.++||||++++++|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999853 235789998865432 234678899999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCC--------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 043333 649 IYEYMENNSLARALFGPE--------------------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATN 708 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N 708 (809)
|+||+++|+|.+++.... ....++++..+..++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999875321 1124588999999999999999999998 89999999999
Q ss_pred EEEcCCCceEEEecCCccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 709 VLLDKDLNPKISDFGLAKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 709 ILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
|++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999765332221 1122345678999999988889999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=275.33 Aligned_cols=201 Identities=31% Similarity=0.498 Sum_probs=169.9
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
++|...+.||+|+||.||+|...++..||+|++.... ...+.+.+|++++++++|||++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577889999999999999998777789999876433 23467889999999999999999998875 456899999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
+|+|.++++.. ....++|..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999543 233578999999999999999999998 8999999999999999999999999999765433222
Q ss_pred eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 735 ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
......++..|+|||+..+..++.++|||||||++|||+| |+.||...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 207 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2222345678999999998899999999999999999999 89999664
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=279.39 Aligned_cols=199 Identities=27% Similarity=0.411 Sum_probs=171.1
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
++|...+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++.+.+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46677788999999999999854 68899999987654444556788999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999998842 34688999999999999999999998 899999999999999999999999999875533221
Q ss_pred ceeccccccccccchhhhc---cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
......|+..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 122356889999999874 45688899999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=290.42 Aligned_cols=203 Identities=27% Similarity=0.460 Sum_probs=175.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC-CeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
..+....++||.|-||.||.|+|+. .-.||||.++.+.. ..++|+.|+.+|+.++|||+|+++|+|.....+|+|.||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3345567899999999999999864 56799999976544 368999999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
|.+|+|.+||+.. .+..++-...+.+|.||+.||+||..+ ++|||||.++|+|+.++..+||+|||+++++..+.
T Consensus 345 M~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 345 MCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred ccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 9999999999654 345577778899999999999999988 89999999999999999999999999999987654
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
...-....-...|.|||.+....++.|+|||+|||+|||+.| |-.||-+.
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi 470 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI 470 (1157)
T ss_pred eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence 332222233568999999999999999999999999999987 67788553
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=278.23 Aligned_cols=202 Identities=28% Similarity=0.448 Sum_probs=169.5
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+|+..+.||+|++|.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777899999999999999964 68899999986542 22245688899999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
++ ++|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 68888874322 234689999999999999999999998 89999999999999999999999999987543221
Q ss_pred cceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 11223456889999998865 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=277.63 Aligned_cols=198 Identities=34% Similarity=0.513 Sum_probs=171.9
Q ss_pred CCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccc--hhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGN--REFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~--~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
|+..+.||+|+||+||++... +++.||+|++........ .....|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999965 567899999976643322 23456999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++++|.+++. ....+++..+..++.|+++||+|||+. +++|+||||+||+++++++++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred cccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 9999999994 355689999999999999999999998 899999999999999999999999999875422 22
Q ss_pred ceeccccccccccchhhhc-cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.......++..|+|||.+. +...+.++||||+|+++|+|++|+.||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2334567899999999998 788999999999999999999999999765
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=282.73 Aligned_cols=204 Identities=30% Similarity=0.445 Sum_probs=169.2
Q ss_pred CCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
+|...+.||+|+||.||+|... +++.||||++...... ..+.|.+|+++++.++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556788999999999999853 2478999998755332 23568889999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCC------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc
Q 043333 649 IYEYMENNSLARALFGPE------------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 716 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 716 (809)
++||+++++|.+++.... ..+..+++..+..++.|++.||+|||+. +++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999884211 1234588999999999999999999998 8999999999999999999
Q ss_pred eEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 717 PKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 717 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999876533221 11222345778999999988889999999999999999998 88898654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=313.36 Aligned_cols=208 Identities=25% Similarity=0.400 Sum_probs=171.5
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeE
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEG--NQL 646 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 646 (809)
...++|.+.+.||+|+||+||+|... .++.||+|.+.... ......|..|+.++.+++|||||++++++.+. +.+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999964 57889999886432 22346788999999999999999999988653 568
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEEcCCCCCCEEEcCC--------
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR----LKIVHRDIKATNVLLDKD-------- 714 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~iiH~Dlkp~NILl~~~-------- 714 (809)
++||||+++|+|.++|.........+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999986533334578999999999999999999998531 259999999999999643
Q ss_pred ---------CceEEEecCCccccCCCCcceeccccccccccchhhhcc--CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 715 ---------LNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 715 ---------~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3489999999986543221 234568999999999854 4588999999999999999999999965
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=273.78 Aligned_cols=199 Identities=31% Similarity=0.505 Sum_probs=174.9
Q ss_pred cCCCCCCeeccCCCccEEEeEeeC-CeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
++|+..+.||+|+||.||+|...+ ++.||+|.+..... .+++.+|++++++++||||+++++++.+.+..++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999999764 78999999865433 578999999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++++|.+++.. ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999843 235689999999999999999999998 899999999999999999999999999886543321
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 122345788999999999889999999999999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=279.40 Aligned_cols=201 Identities=30% Similarity=0.461 Sum_probs=171.9
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
+.|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999965 58899999987665555677889999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++++|..++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 92 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 99999887743 234589999999999999999999998 899999999999999999999999999865432211
Q ss_pred ceeccccccccccchhhhc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
......+++.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 112345788999999884 345688999999999999999999999653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=274.61 Aligned_cols=193 Identities=31% Similarity=0.460 Sum_probs=162.3
Q ss_pred eeccCCCccEEEeEee---CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCC
Q 043333 582 KIGEGGFGPVYKGLLA---DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENN 656 (809)
Q Consensus 582 ~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 656 (809)
.||+|+||.||+|.++ +++.+|+|+++.... ...+++..|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 578899999864432 23467889999999999999999999885 45678999999999
Q ss_pred chhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce-
Q 043333 657 SLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI- 735 (809)
Q Consensus 657 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~- 735 (809)
+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999842 23588999999999999999999998 89999999999999999999999999998654332211
Q ss_pred -eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 736 -STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 736 -~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
.....++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234578999999988889999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=276.37 Aligned_cols=202 Identities=31% Similarity=0.480 Sum_probs=170.4
Q ss_pred cCCCCCCeeccCCCccEEEeEee-C---CeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-D---GKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~---g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
++|++.+.||+|+||.||+|... + +..+|+|.++... ....+.|..|++++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999853 2 3479999886543 22346788999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++|+|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.++++|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999998532 24589999999999999999999998 89999999999999999999999999998665
Q ss_pred CCCcceec--cccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 730 EDNTHIST--RIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 730 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
........ ...++..|+|||++.+..++.++|||||||++||+++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~ 213 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence 43322111 1223568999999998889999999999999999887 99999654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=279.81 Aligned_cols=207 Identities=25% Similarity=0.423 Sum_probs=173.7
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeC-----CeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEe-CCe
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLAD-----GKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIE-GNQ 645 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~-~~~ 645 (809)
..++|...+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45678889999999999999999765 6889999886542 2334668899999999999999999999876 467
Q ss_pred EEEEEEcccCCchhhhccCCCcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEe
Q 043333 646 LLLIYEYMENNSLARALFGPEEH----RLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 721 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 721 (809)
.++++||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998543222 25689999999999999999999998 899999999999999999999999
Q ss_pred cCCccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 722 FGLAKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 722 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
||+++.+...... ......++..|+|||++.+..++.++|||||||++||+++ |+.||...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 9999865433222 1122345678999999988889999999999999999999 99999653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=276.57 Aligned_cols=201 Identities=26% Similarity=0.399 Sum_probs=171.4
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999965 58999999886442 2234567899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|++++.|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999988877632 23589999999999999999999998 8999999999999999999999999999866443
Q ss_pred Ccceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 154 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 154 GDD-YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred ccc-ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 211 123457789999999876 557889999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=278.31 Aligned_cols=202 Identities=28% Similarity=0.512 Sum_probs=168.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCe----EEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGK----VIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
.++|+..+.||+|+||+||+|.+. +++ .||+|+++... ....+++.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 356788899999999999999853 444 48999986543 2335678899999999999999999999975 4578
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+++||+++|+|.++++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999998542 34689999999999999999999998 899999999999999999999999999986
Q ss_pred cCCCCcce-eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 728 DEEDNTHI-STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 728 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
........ .....++..|+|||...+..++.++|||||||++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 64332211 112234668999999998899999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=291.45 Aligned_cols=199 Identities=25% Similarity=0.362 Sum_probs=168.0
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeC------
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEG------ 643 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~------ 643 (809)
..++|+..+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999854 57899999986542 22345677899999999999999999998654
Q ss_pred CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 644 NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
...++||||+++ ++.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 347999999975 5666652 2478889999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 724 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred ccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 998653321 2234568999999999998899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=282.56 Aligned_cols=197 Identities=27% Similarity=0.452 Sum_probs=160.0
Q ss_pred CCeeccCCCccEEEeEee---CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEe--CCeEEEEEEccc
Q 043333 580 DNKIGEGGFGPVYKGLLA---DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIE--GNQLLLIYEYME 654 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~lV~ey~~ 654 (809)
..+||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 467999999999999864 34689999886432 23567889999999999999999999864 457899999987
Q ss_pred CCchhhhccCCC-----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----cCCCceEEEecCCc
Q 043333 655 NNSLARALFGPE-----EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLA 725 (809)
Q Consensus 655 ~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla 725 (809)
+ +|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 6777663211 1234588999999999999999999998 89999999999999 56679999999999
Q ss_pred cccCCCCcc--eeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 726 KLDEEDNTH--ISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 726 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+........ ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 865433211 1223568999999999876 45799999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=277.03 Aligned_cols=199 Identities=27% Similarity=0.409 Sum_probs=163.3
Q ss_pred CeeccCCCccEEEeEeeC---CeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCC
Q 043333 581 NKIGEGGFGPVYKGLLAD---GKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENN 656 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~---g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 656 (809)
+.||+|+||.||+|...+ +..+|+|.++.... .....|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998543 45789998865532 23457888999999999999999999999999999999999999
Q ss_pred chhhhccCCCc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 657 SLARALFGPEE-HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 657 sL~~~L~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
+|.++++.... .....++..+..++.|++.||+|||+. +++||||||+||+++.+++++++|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999964322 233567888889999999999999998 89999999999999999999999999987543322211
Q ss_pred -eccccccccccchhhhccC-------CCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 736 -STRIAGTFGYMAPEYAMRG-------YLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 736 -~~~~~gt~~y~aPE~~~~~-------~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
.....++..|+|||++.+. .++.++|||||||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 1234567889999998642 35789999999999999996 99999654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=277.10 Aligned_cols=204 Identities=30% Similarity=0.398 Sum_probs=172.9
Q ss_pred HHHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 571 KAATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 571 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
+.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 446677777889999999999999854 5788999998766555567889999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCceEEEecCCcc
Q 043333 650 YEYMENNSLARALFGPEEHRLKL--DWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAK 726 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~ 726 (809)
+||+++++|.+++.... ..+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+|||++.
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 84 MEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999985321 234 7888899999999999999998 8999999999999986 6799999999987
Q ss_pred ccCCCCcceeccccccccccchhhhccCC--CCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 727 LDEEDNTHISTRIAGTFGYMAPEYAMRGY--LTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
....... ......++..|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 6533222 122345788999999986643 78899999999999999999999964
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=273.99 Aligned_cols=201 Identities=30% Similarity=0.567 Sum_probs=171.7
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
.+|+..+.||+|+||.||+|.+.+++.+|+|++.... ....+|.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3567789999999999999998778889999886432 234678999999999999999999999999999999999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
+++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999998432 33578999999999999999999998 8999999999999999999999999998755332221
Q ss_pred eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 735 ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
......++.+|+|||++.++.++.++|||||||++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 1222335678999999998889999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=278.26 Aligned_cols=200 Identities=30% Similarity=0.477 Sum_probs=168.5
Q ss_pred cCCCCCCeeccCCCccEEEeEee-----CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-----DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEG--NQLL 647 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~ 647 (809)
.+|++.+.||+|+||.||++... +++.||+|++........+.|.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778899999999999999742 4789999998766555567889999999999999999999987643 4689
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+|+||+++|+|.+++... ...++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999998432 34589999999999999999999998 899999999999999999999999999986
Q ss_pred cCCCCcce--eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 043333 728 DEEDNTHI--STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVI 780 (809)
Q Consensus 728 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~ 780 (809)
........ .....++..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 64332211 111223446999999988889999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=279.92 Aligned_cols=200 Identities=30% Similarity=0.438 Sum_probs=171.8
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999964 68999999987553 23346788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+ +++|.+++... ...+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999988532 24689999999999999999999998 89999999999999999999999999998665433
Q ss_pred cceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
........++..|+|||.+.+. .++.++||||+||++|||++|++||...
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 2222345688899999988654 4689999999999999999998888654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=291.30 Aligned_cols=206 Identities=29% Similarity=0.446 Sum_probs=171.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCcc-cchhHHHHHHHHhhcC-CCceEeEEeEEEeCCe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSKQ-GNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~ 645 (809)
.++|...+.||+|+||.||+|++. .++.||||+++..... ..+.++.|++++.++. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345777899999999999999853 2468999999754322 2356889999999997 9999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCc----------------------------------------------------------
Q 043333 646 LLLIYEYMENNSLARALFGPEE---------------------------------------------------------- 667 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~---------------------------------------------------------- 667 (809)
.++|+||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999964321
Q ss_pred ------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043333 668 ------------------------------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL 711 (809)
Q Consensus 668 ------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 711 (809)
....++|..+..++.|++.||+|||+. +++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 112467888999999999999999987 89999999999999
Q ss_pred cCCCceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 712 DKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 712 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999976432221 11122356788999999998889999999999999999998 89998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=279.39 Aligned_cols=207 Identities=28% Similarity=0.430 Sum_probs=173.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC------CeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD------GKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 646 (809)
.++|...+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+++++.++||||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578888999999999999998542 3689999986443 23345788999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhccCCCc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEE
Q 043333 647 LLIYEYMENNSLARALFGPEE------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 720 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 720 (809)
++||||+++|+|.+++..... ....++|..+..++.|++.||.|||+. +++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999999864322 123478999999999999999999998 89999999999999999999999
Q ss_pred ecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 721 DFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 721 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |+.||...+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 9999875533221 11223446789999999988889999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=295.67 Aligned_cols=193 Identities=25% Similarity=0.310 Sum_probs=166.6
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
...|.+.+.||+|+||.||+|... .++.||||... ...+.+|++++++++|+|||++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457899999999999999999965 47889999632 23467899999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+. ++|.+++.. ....++|..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 688888743 223689999999999999999999998 89999999999999999999999999998654322
Q ss_pred c-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCC
Q 043333 733 T-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNV 779 (809)
Q Consensus 733 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~ 779 (809)
. .......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 1 1223457999999999999999999999999999999999988765
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=276.39 Aligned_cols=203 Identities=28% Similarity=0.443 Sum_probs=168.0
Q ss_pred CCCCCeeccCCCccEEEeEeeC----CeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe-----
Q 043333 577 FAPDNKIGEGGFGPVYKGLLAD----GKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ----- 645 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~----- 645 (809)
|.+.+.||+|+||.||+|.... +..||||+++... ......+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4577899999999999998642 3679999987542 2234578899999999999999999999876554
Q ss_pred -EEEEEEcccCCchhhhccCCC--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 646 -LLLIYEYMENNSLARALFGPE--EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 646 -~~lV~ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
.++|+||+++|+|..++.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 799999999999999885432 2234689999999999999999999998 8999999999999999999999999
Q ss_pred CCccccCCCCcce-eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 723 GLAKLDEEDNTHI-STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 723 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
|+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~ 219 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 9998654332211 112234668999999988889999999999999999999 89999654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=282.75 Aligned_cols=209 Identities=29% Similarity=0.443 Sum_probs=173.9
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEeeC------CeEEEEEEecccC-cccchhHHHHHHHHhhc-CCCceEeEEeEEEeC
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLLAD------GKVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEG 643 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~ 643 (809)
...++|+..+.||+|+||.||++.... ...+|+|++.... .....++.+|++++.++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 345678889999999999999998642 3689999987542 23345688999999999 799999999999999
Q ss_pred CeEEEEEEcccCCchhhhccCCC------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043333 644 NQLLLIYEYMENNSLARALFGPE------------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL 711 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 711 (809)
+..++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence 99999999999999999985421 2345689999999999999999999998 89999999999999
Q ss_pred cCCCceEEEecCCccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 712 DKDLNPKISDFGLAKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 712 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 99999999999999865432211 1112234568999999988899999999999999999997 999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=278.18 Aligned_cols=203 Identities=30% Similarity=0.481 Sum_probs=170.8
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEeC------
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEG------ 643 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~------ 643 (809)
.+++.|+..+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678888999999999999999864 57899999986543 3345788899999998 699999999998763
Q ss_pred CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 644 NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
...++||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 4589999999999999988542 234588999999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCcceeccccccccccchhhhc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 724 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
++........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9876543221 223456889999999986 34578899999999999999999999964
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=274.64 Aligned_cols=200 Identities=29% Similarity=0.484 Sum_probs=171.4
Q ss_pred CCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCc------ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSK------QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
+|...+.||+|+||.||+|...+++.+|||.+..... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677899999999999999987889999998864321 1234578899999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
+||+++++|.+++.. ..++++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999843 23578999999999999999999998 79999999999999999999999999987542
Q ss_pred CCC-----cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 730 EDN-----THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 730 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
... ........++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence 211 11122346888999999999888999999999999999999999999653
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=278.86 Aligned_cols=202 Identities=29% Similarity=0.478 Sum_probs=173.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
.++|++.+.||+|+||.||+|... +++.||+|.+........+.|.+|++++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888899999999999999964 6889999998765555566789999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999998843 234689999999999999999999998 89999999999999999999999999987543322
Q ss_pred cceeccccccccccchhhhc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. .....+++.|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 158 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 158 QK-RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred cc-cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 21 22345888999999875 345678999999999999999999999654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=275.97 Aligned_cols=200 Identities=29% Similarity=0.404 Sum_probs=168.2
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-----ccchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-----QGNREFVNEIGMISALQHPNLVKLYGCCIEG--NQL 646 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-----~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 646 (809)
.+|+..+.||+|+||.||+|... +++.||||.+..... ...+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999864 588999998753321 1234678899999999999999999998764 467
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999998842 23578888999999999999999998 89999999999999999999999999987
Q ss_pred ccCCCCc--ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 727 LDEEDNT--HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 727 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
....... .......++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 5432111 112234588899999999888899999999999999999999999965
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=289.21 Aligned_cols=198 Identities=26% Similarity=0.413 Sum_probs=167.9
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeC-----
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEG----- 643 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~----- 643 (809)
...++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3567899999999999999999985 4678999999865422 2345677899999999999999999987643
Q ss_pred -CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 644 -NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 644 -~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
...++++|++ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3578999988 778988772 34589999999999999999999998 8999999999999999999999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 999865432 123568999999999876 56889999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=282.68 Aligned_cols=207 Identities=30% Similarity=0.448 Sum_probs=171.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee--------CCeEEEEEEecccC-cccchhHHHHHHHHhhc-CCCceEeEEeEEEeC
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA--------DGKVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEG 643 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~ 643 (809)
.++|.+.+.||+|+||.||++... ++..+|+|.+.... .....++..|++++.++ +||||++++++|...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357889999999999999999742 23469999987542 23345688899999999 799999999999999
Q ss_pred CeEEEEEEcccCCchhhhccCCCc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043333 644 NQLLLIYEYMENNSLARALFGPEE------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL 711 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 711 (809)
+..++||||+++|+|.+++..... ....++|..++.++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999964321 123589999999999999999999988 89999999999999
Q ss_pred cCCCceEEEecCCccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 712 DKDLNPKISDFGLAKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 712 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
++++.+||+|||.++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999998755332111 1111224568999999998889999999999999999998 888986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=280.21 Aligned_cols=207 Identities=28% Similarity=0.430 Sum_probs=171.1
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 645 (809)
..++|++.+.||+|+||.||+|... .+..||+|.+..... .....+.+|++++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578899999999999999999753 245799998764432 223467889999999999999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEE
Q 043333 646 LLLIYEYMENNSLARALFGPEE------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 719 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 719 (809)
.++||||+++|+|.+++..... .....++..+..++.|++.||.|||++ +|+||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999954221 134567888899999999999999998 8999999999999999999999
Q ss_pred EecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 720 SDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 720 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
+|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |+.||...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999875433221 11122335678999999998899999999999999999998 78898653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=280.62 Aligned_cols=213 Identities=31% Similarity=0.457 Sum_probs=177.2
Q ss_pred ccHHHHHHHhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEe
Q 043333 565 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIE 642 (809)
Q Consensus 565 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~ 642 (809)
++++++..++++|+..+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 45566667789999999999999999999986 468899999986432 2245677899999998 79999999999976
Q ss_pred CC-----eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCce
Q 043333 643 GN-----QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 717 (809)
Q Consensus 643 ~~-----~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 717 (809)
.+ ..++|+||+++|+|.++++........+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 43 58999999999999998864333445689999999999999999999998 89999999999999999999
Q ss_pred EEEecCCccccCCCCcceeccccccccccchhhhccC-----CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 718 KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG-----YLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 718 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
||+|||++......... .....|+..|+|||.+... .++.++|||||||++|||++|+.||...
T Consensus 168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 99999998765432211 1234678899999987643 3688999999999999999999999654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=272.08 Aligned_cols=196 Identities=29% Similarity=0.492 Sum_probs=168.0
Q ss_pred CeeccCCCccEEEeEeeC--C--eEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLAD--G--KVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~--g--~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+.|..|++.+++++||||+++++++.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999877655 456788999999999999999999999988 889999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc-
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH- 734 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 734 (809)
|+|.+++..... ..++|..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999855322 4689999999999999999999998 8999999999999999999999999999866432221
Q ss_pred -eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 735 -ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 735 -~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
......++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1112446779999999998889999999999999999999 99999654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=281.81 Aligned_cols=203 Identities=32% Similarity=0.487 Sum_probs=167.7
Q ss_pred cCCCCCCeeccCCCccEEEeEeeC-Ce--EEEEEEeccc-CcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLAD-GK--VIAVKQLSSK-SKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~--~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV 649 (809)
++|++.+.||+|+||.||+|...+ +. .+|+|.++.. .....+.|.+|++++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999998653 33 4788887643 233346788999999999 799999999999999999999
Q ss_pred EEcccCCchhhhccCCCc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCce
Q 043333 650 YEYMENNSLARALFGPEE------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 717 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 717 (809)
+||+++|+|.++++.... ....+++..+..++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999864321 123588999999999999999999998 89999999999999999999
Q ss_pred EEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 718 KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 718 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~ 222 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999864321111 111123457999999988889999999999999999997 99999654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=279.10 Aligned_cols=199 Identities=27% Similarity=0.424 Sum_probs=172.0
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
++|+..+.||+|+||+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46777889999999999999854 58899999876543 23356789999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.+++.. ...+++..+..++.+++.||.|||+.. +++||||||+||+++++++++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999998843 235899999999999999999999742 79999999999999999999999999986543221
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
. ....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 159 A---DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred c---CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 1 2346889999999998888999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=274.33 Aligned_cols=203 Identities=31% Similarity=0.474 Sum_probs=172.5
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
..++|+..+.||+|+||.||++...++..+|+|.+.... ...+.|.+|++++++++|+||+++.+++.+ ...++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 346788899999999999999997777889999886432 234678899999999999999999999887 778999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999998543 234578999999999999999999997 89999999999999999999999999987654322
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
........++..|+|||++..+.++.++|||||||++|||+| |+.||...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 222222345678999999998889999999999999999999 99999654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=276.20 Aligned_cols=198 Identities=26% Similarity=0.376 Sum_probs=160.7
Q ss_pred eeccCCCccEEEeEeeC---CeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCc
Q 043333 582 KIGEGGFGPVYKGLLAD---GKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNS 657 (809)
Q Consensus 582 ~LG~G~fG~Vy~~~~~~---g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gs 657 (809)
.||+|+||.||+|...+ ...+|+|.+.... ......|.+|++.++.++||||+++++++.+.+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3568888875443 2334568899999999999999999999999999999999999999
Q ss_pred hhhhccCCCc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc-e
Q 043333 658 LARALFGPEE-HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH-I 735 (809)
Q Consensus 658 L~~~L~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 735 (809)
|.+++..... .....++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999865432 223456888899999999999999998 8999999999999999999999999998654322211 1
Q ss_pred eccccccccccchhhhcc-------CCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMR-------GYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.||...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 122345678999998743 356889999999999999999 78888654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=292.01 Aligned_cols=191 Identities=35% Similarity=0.561 Sum_probs=166.5
Q ss_pred CCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcc---cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 577 FAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQ---GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
|...+.||.|+||.||-|+. .+.++||||++.-..++ ...+++.|+++|.+++|||++.+.|||......||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44556799999999999984 57889999998654333 356789999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
|-| |-.|.+ ...+.++-...+..|+.+.+.||+|||+. +.||||||+.||||++.|.+|++|||.|.+..+.+
T Consensus 108 ClG-SAsDll---eVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 108 CLG-SASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred Hhc-cHHHHH---HHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 964 666766 33566788899999999999999999998 89999999999999999999999999998765433
Q ss_pred cceeccccccccccchhhhc---cCCCCchHHHHHHHHHHHHHHcCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNV 779 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltGk~P~ 779 (809)
.++|||.|||||++. .+.|+-|+||||+|+...||.-.|+|.
T Consensus 181 -----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 181 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred -----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence 468999999999874 578999999999999999999999996
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=278.07 Aligned_cols=196 Identities=33% Similarity=0.473 Sum_probs=165.5
Q ss_pred CCCCeeccCCCccEEEeEe-----eCCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeEEEE
Q 043333 578 APDNKIGEGGFGPVYKGLL-----ADGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEG--NQLLLI 649 (809)
Q Consensus 578 ~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lV 649 (809)
...+.||+|+||+||++.+ .+++.||+|.++.... ...+.|.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7789999999999988653 3577899999875432 3356788999999999999999999998764 457899
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++...
T Consensus 87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999832 3589999999999999999999998 89999999999999999999999999998654
Q ss_pred CCCcc--eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 730 EDNTH--ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 730 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
..... ......++..|+|||.+....++.++|||||||++|||+||+.|+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 33221 11122355679999999888899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=274.74 Aligned_cols=202 Identities=26% Similarity=0.445 Sum_probs=165.1
Q ss_pred CCCCeeccCCCccEEEeEeeC-Ce--EEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeC------CeE
Q 043333 578 APDNKIGEGGFGPVYKGLLAD-GK--VIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEG------NQL 646 (809)
Q Consensus 578 ~~~~~LG~G~fG~Vy~~~~~~-g~--~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~------~~~ 646 (809)
.+.+.||+|+||.||+|...+ +. .||+|.++.. .....+.|..|+++++.++||||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 467889999999999999654 32 6899988654 233356788999999999999999999988642 246
Q ss_pred EEEEEcccCCchhhhccCCC--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 647 LLIYEYMENNSLARALFGPE--EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
++|+||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874221 2334589999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 725 AKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 725 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
++........ ......+++.|+|||+..+..++.++|||||||++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 218 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9865432211 1122345678999999998899999999999999999999 88999653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=267.33 Aligned_cols=203 Identities=24% Similarity=0.396 Sum_probs=169.9
Q ss_pred HHHHHHHhcCCCCCCeeccCCCccEEEeE-eeCCeEEEEEEecccCcccchhHHHHHHHHhhcC-CCceEeEEeEEEeCC
Q 043333 567 LRQIKAATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGN 644 (809)
Q Consensus 567 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~ 644 (809)
+++.-..| .+.||+|+|+.|-.++ +.+|..+|||++.+.......+..+|++++.+.+ |+||++++.+|.++.
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 45555554 4679999999998887 6789999999998876677778889999999996 999999999999999
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---ceEEEe
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NPKISD 721 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~D 721 (809)
.+|||||-|.+|+|..+++ .+..+++..+.++.++||.||.+||.+ +|.|||+||+|||-.+-. -+||+|
T Consensus 150 ~FYLVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred eEEEEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeec
Confidence 9999999999999999985 344678889999999999999999999 899999999999996544 479999
Q ss_pred cCCccccCCCC------cceeccccccccccchhhhc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 722 FGLAKLDEEDN------THISTRIAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 722 fGla~~~~~~~------~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
|.++.-+.... ...-...+|+..|||||+.. ...|+.++|.||+|||+|-|+.|.+||.+
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 98875332111 11112357889999999863 34688899999999999999999999965
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=276.02 Aligned_cols=198 Identities=33% Similarity=0.486 Sum_probs=173.5
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
++|+..+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999965 68899999986543 33346788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.+++.. .++++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999843 2789999999999999999999998 89999999999999999999999999998665332
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
. ......++..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~ 200 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 1 12234678899999999988899999999999999999999999965
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=281.02 Aligned_cols=207 Identities=29% Similarity=0.453 Sum_probs=172.3
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee--------CCeEEEEEEecccC-cccchhHHHHHHHHhhc-CCCceEeEEeEEEe
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA--------DGKVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLYGCCIE 642 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~ 642 (809)
..++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+++.+|+++++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567788899999999999999741 24579999886542 23356788999999999 89999999999999
Q ss_pred CCeEEEEEEcccCCchhhhccCCCc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043333 643 GNQLLLIYEYMENNSLARALFGPEE------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVL 710 (809)
Q Consensus 643 ~~~~~lV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL 710 (809)
.+..++||||+++|+|.+++..... ....++|..+..++.|++.||+|||++ +++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 9999999999999999999864321 123578999999999999999999998 8999999999999
Q ss_pred EcCCCceEEEecCCccccCCCCcce-eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 711 LDKDLNPKISDFGLAKLDEEDNTHI-STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 711 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
+++++.+||+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999998664332211 122345678999999988889999999999999999998 78888654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=278.56 Aligned_cols=206 Identities=30% Similarity=0.478 Sum_probs=170.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-----------------CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-----------------DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVK 635 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-----------------~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~ 635 (809)
.++|+..+.||+|+||.||++... ++..||+|++.... .....+|.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998532 23478999987543 233467899999999999999999
Q ss_pred EEeEEEeCCeEEEEEEcccCCchhhhccCCCc-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 043333 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEE-------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATN 708 (809)
Q Consensus 636 l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N 708 (809)
+++++...+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 99999999999999999999999999864321 123478899999999999999999998 89999999999
Q ss_pred EEEcCCCceEEEecCCccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc--CCCCCCCC
Q 043333 709 VLLDKDLNPKISDFGLAKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS--GRSNVICR 782 (809)
Q Consensus 709 ILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt--Gk~P~~~~ 782 (809)
|++++++.++|+|||+++........ ......++..|+|||....+.++.++|||||||++|||++ |..||...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999999765332211 1122334678999999888889999999999999999998 77888654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=274.78 Aligned_cols=200 Identities=28% Similarity=0.463 Sum_probs=170.4
Q ss_pred CCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc------ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK------QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
+|+..+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999984 5688999999864321 123568899999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-ceEEEecCCccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKL 727 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~ 727 (809)
|+||+++++|.+++.. ..++++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999842 34688999999999999999999998 899999999999998775 599999999876
Q ss_pred cCCCCcc---eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 728 DEEDNTH---ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 728 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
....... ......++..|+|||.+.+..++.++||||+|+++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 5432111 112346788999999998888999999999999999999999999653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=280.25 Aligned_cols=213 Identities=29% Similarity=0.428 Sum_probs=176.2
Q ss_pred ccHHHHHHHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEE-
Q 043333 565 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCI- 641 (809)
Q Consensus 565 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~- 641 (809)
+.++.+..+.++|+..+.||+|+||.||++... +++.+|+|++.... ....++.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445566678899999999999999999999854 57899999875432 2235678899999999 6999999999985
Q ss_pred ----eCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCce
Q 043333 642 ----EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 717 (809)
Q Consensus 642 ----~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 717 (809)
..+..++||||+++++|.+++.........+++..+..++.|+++||.|||+. +++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 34568999999999999998754333445688999999999999999999998 89999999999999999999
Q ss_pred EEEecCCccccCCCCcceeccccccccccchhhhcc-----CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 718 KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 718 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+|+|||++........ ......|++.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999876543221 1223468899999998753 45788999999999999999999999653
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=273.34 Aligned_cols=201 Identities=29% Similarity=0.466 Sum_probs=175.0
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
++|+..+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999864 57889999987665555678899999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++++|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 83 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 99999998843 224688999999999999999999998 899999999999999999999999999876543221
Q ss_pred ceeccccccccccchhhhccC---CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRG---YLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~---~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
......++..|+|||.+.+. .++.++|||||||++|||+||+.||...
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 12234678899999998776 7899999999999999999999999654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=291.34 Aligned_cols=194 Identities=34% Similarity=0.480 Sum_probs=168.9
Q ss_pred CeeccCCCccEEEeEeeC-CeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCchh
Q 043333 581 NKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLA 659 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~ 659 (809)
-+||+|.||+||.|+..+ ...+|||.+..+.....+-+.+|+...++++|+|||+++|.|.+.+.+-+.||-+|||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 369999999999999654 4579999998887777788999999999999999999999999999999999999999999
Q ss_pred hhccCCCccCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCCceEEEecCCccccCCCCccee
Q 043333 660 RALFGPEEHRLKL--DWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTHIS 736 (809)
Q Consensus 660 ~~L~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~ 736 (809)
+.|.. .-.++ ++.+.-.+.+||++||.|||++ .|||||||-.|||++ -.|.+||+|||-++.+..-+. .+
T Consensus 661 sLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~T 733 (1226)
T KOG4279|consen 661 SLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CT 733 (1226)
T ss_pred HHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc-cc
Confidence 99953 22344 6778888999999999999998 899999999999996 468999999999886643322 23
Q ss_pred ccccccccccchhhhccC--CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 737 TRIAGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 737 ~~~~gt~~y~aPE~~~~~--~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
..+.||..|||||++..+ .|+..+|||||||.+.||.|||+||..
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 346799999999999875 588999999999999999999999965
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=274.86 Aligned_cols=204 Identities=26% Similarity=0.415 Sum_probs=171.3
Q ss_pred cCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
++|+..+.||+|+||.||+|+.. +.+.||+|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999853 2467999988654333 3467899999999999999999999999989999
Q ss_pred EEEEcccCCchhhhccCCCcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 648 LIYEYMENNSLARALFGPEEH-----RLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
+||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998643321 12689999999999999999999998 8999999999999999999999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVIC 781 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~ 781 (809)
|++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9987543222222223346778999999988888999999999999999998 7889854
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=282.94 Aligned_cols=203 Identities=31% Similarity=0.490 Sum_probs=168.0
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCe--EEEEEEecccC-cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGK--VIAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~--~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV 649 (809)
++|+..+.||+|+||.||+|... ++. .+|+|.+.... ....++|.+|++++.++ +||||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46788899999999999999864 454 46777765432 23346788999999999 899999999999999999999
Q ss_pred EEcccCCchhhhccCCC------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCce
Q 043333 650 YEYMENNSLARALFGPE------------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 717 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 717 (809)
+||+++|+|.++++... .....+++..+..++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999986432 1223588999999999999999999998 89999999999999999999
Q ss_pred EEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 718 KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 718 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
||+|||++........ .....++..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 164 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred EeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 9999999864321111 111224567999999988889999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=273.77 Aligned_cols=191 Identities=24% Similarity=0.396 Sum_probs=160.2
Q ss_pred CeeccCCCccEEEeEeeC-------------CeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 581 NKIGEGGFGPVYKGLLAD-------------GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~-------------g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
+.||+|+||.||+|++.. ...||+|.+..........|.+|+.+++.++||||+++++++.+....+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358899876655444567888999999999999999999999999999
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc-------eEEE
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN-------PKIS 720 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-------~kl~ 720 (809)
+||||+++|+|..+++. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999988743 234589999999999999999999998 8999999999999987664 8999
Q ss_pred ecCCccccCCCCcceeccccccccccchhhhc-cCCCCchHHHHHHHHHHHHHH-cCCCCCCCC
Q 043333 721 DFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM-RGYLTDKADVYSFGIVALEIV-SGRSNVICR 782 (809)
Q Consensus 721 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwSlGvil~ell-tGk~P~~~~ 782 (809)
|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.||...
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 99998654322 1235778999999886 467899999999999999997 688888653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=245.22 Aligned_cols=223 Identities=24% Similarity=0.380 Sum_probs=185.3
Q ss_pred CCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcc--cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+|...++||+|.||+||+|+. ..++.||+|+++..... .-....+|+.+++.++|+|||++++....++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455567899999999999994 46889999998765432 234678999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
|.. +|..+.. .-...++...+..++.|+.+||.++|++ ++.|||+||.|.|++.+|+.|++|||+++.+.-.-
T Consensus 83 cdq-dlkkyfd---slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 975 6777662 2345688899999999999999999998 89999999999999999999999999999765433
Q ss_pred cceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHHHHHhhccCCCCcC
Q 043333 733 THISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVS-GRSNVICRTKEAQFCLLDWVTLALTDFRFPLF 806 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~ellt-Gk~P~~~~~~~~~~~l~~~~~~~~~~~~~p~~ 806 (809)
.. ....+-|..|++|.++.+. -+++..|+||.|||+.|+.. |++-|-+.+-.++..-+.|+.....+..||.-
T Consensus 156 rc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred Ee-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 22 2345678999999999875 57889999999999999976 55556666566677777788888888888864
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=274.54 Aligned_cols=203 Identities=31% Similarity=0.515 Sum_probs=170.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CC---eEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DG---KVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g---~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
.++|+..+.||+|+||.||+|... ++ ..+|+|.+.... ....+++..|++++++++||||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346778899999999999999864 33 379999886542 2234678899999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++++|.+++.. ....+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999843 234689999999999999999999998 8999999999999999999999999998765
Q ss_pred CCCCccee--ccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 729 EEDNTHIS--TRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 729 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
........ .....+..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 43222111 11223457999999988889999999999999999997 99999653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=272.08 Aligned_cols=201 Identities=29% Similarity=0.423 Sum_probs=168.9
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-----ccchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-----QGNREFVNEIGMISALQHPNLVKLYGCCIEG--NQL 646 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-----~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 646 (809)
.+|+..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 588999998864321 1234578899999999999999999998763 567
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++|+||+++++|.+++.. ...+++.....++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999843 23578899999999999999999987 89999999999999999999999999987
Q ss_pred ccCCCCc--ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 727 LDEEDNT--HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 727 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
....... .......++..|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 5532111 1112245788999999999888999999999999999999999999653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=273.25 Aligned_cols=200 Identities=32% Similarity=0.526 Sum_probs=170.1
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCccc---------chhHHHHHHHHhhcCCCceEeEEeEEEeCCe
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQG---------NREFVNEIGMISALQHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~---------~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 645 (809)
+|.....||+|+||.||+|... +++.||+|.+....... .+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999854 57899999886543221 2457889999999999999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999843 24578899999999999999999998 8999999999999999999999999998
Q ss_pred cccCCCCc-----ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 726 KLDEEDNT-----HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 726 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+....... .......|+..|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 76542211 1111245788999999999888999999999999999999999999653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=276.55 Aligned_cols=203 Identities=29% Similarity=0.427 Sum_probs=169.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC----CeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD----GKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
.++|...+.||+|+||.||+|...+ ...||||...... ....+.|.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3457788999999999999998643 2468999886554 3345678999999999999999999998875 56789
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999999432 33589999999999999999999998 8999999999999999999999999998765
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
............++..|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 4432222222334568999999988889999999999999999986 999996643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=286.00 Aligned_cols=205 Identities=31% Similarity=0.511 Sum_probs=175.5
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEeeC---Ce--EEEEEEeccc-CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLLAD---GK--VIAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~---g~--~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 645 (809)
...+.....++||+|-||.||+|++.+ |+ .||||.-+.. .....+.|++|..+|+.++||||++++|.|.+ ..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 344455567889999999999999643 33 5889987664 44557789999999999999999999999986 47
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.|+|||.++-|.|..||.. ++..++......++.|+..||+|||+. .+|||||..+|||+.....+|++|||++
T Consensus 465 ~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred eeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence 8999999999999999954 445688889999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 726 KLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 726 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
+.+.++.....+...-...|||||.+.-++++.++|||.|||++||++. |..||.+..
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk 597 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK 597 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc
Confidence 9887766554444445679999999999999999999999999999754 999998743
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=281.39 Aligned_cols=195 Identities=29% Similarity=0.500 Sum_probs=169.5
Q ss_pred CCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCc
Q 043333 579 PDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNS 657 (809)
Q Consensus 579 ~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gs 657 (809)
....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999854 688999999866544455678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceec
Q 043333 658 LARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 737 (809)
Q Consensus 658 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 737 (809)
|.+++. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........ ...
T Consensus 105 L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 105 LTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred HHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 998772 24588999999999999999999998 899999999999999999999999999875543221 122
Q ss_pred cccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 738 RIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 738 ~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
...|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 356889999999999888999999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=271.73 Aligned_cols=201 Identities=25% Similarity=0.433 Sum_probs=173.8
Q ss_pred CCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+|+..+.||+|+||.||.++. .+++.+++|.+.... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999884 458899999876542 33456788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999985432 34689999999999999999999998 89999999999999999999999999997654433
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
. ......+++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 2 223356889999999998888899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=273.95 Aligned_cols=201 Identities=31% Similarity=0.524 Sum_probs=168.5
Q ss_pred CCCCCCeeccCCCccEEEeEeeC-C---eEEEEEEeccc-CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLAD-G---KVIAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
+|+..+.||+|+||.||+|.... + ..||||.+... .....++|..|++++++++||||+++.+++.+.+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999999642 3 36999998654 2333567999999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||++.....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998532 34589999999999999999999998 899999999999999999999999999876543
Q ss_pred CCcce--ecccc--ccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 731 DNTHI--STRIA--GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 731 ~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
..... ..... .+..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 22111 11111 2457999999998899999999999999999986 99999654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=281.61 Aligned_cols=197 Identities=28% Similarity=0.519 Sum_probs=170.3
Q ss_pred CCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
|.....||+|+||.||++... +++.||||.+........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 344567999999999999854 5889999998665544556788999999999999999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
++|.+++. ...+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||++.........
T Consensus 104 ~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~- 174 (292)
T cd06658 104 GALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK- 174 (292)
T ss_pred CcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-
Confidence 99999883 23578999999999999999999998 8999999999999999999999999998754332211
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.....|+..|+|||+..+..++.++|||||||++|||++|+.||...
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 221 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 221 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22346888999999998888999999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=276.43 Aligned_cols=206 Identities=29% Similarity=0.459 Sum_probs=172.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC-----------------CeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD-----------------GKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVK 635 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~ 635 (809)
..+|+..+.||+|+||.||+|...+ +..||+|.+.... ....+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578889999999999999987532 2468999987543 234567889999999999999999
Q ss_pred EEeEEEeCCeEEEEEEcccCCchhhhccCCCc-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 043333 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEE-------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATN 708 (809)
Q Consensus 636 l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N 708 (809)
+++++...+..++|+||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999854321 123689999999999999999999998 89999999999
Q ss_pred EEEcCCCceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc--CCCCCCCC
Q 043333 709 VLLDKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS--GRSNVICR 782 (809)
Q Consensus 709 ILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt--Gk~P~~~~ 782 (809)
|+++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999876533221 12223446778999999988889999999999999999998 67788653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=279.61 Aligned_cols=204 Identities=31% Similarity=0.437 Sum_probs=171.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCc-ccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 645 (809)
.++|...+.||+|+||.||+|... .+..||||+++.... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 356888999999999999999741 345799998865432 2345688999999999 79999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++||||+++|+|.++++... ...+++.++..++.|++.||+|||++ +++|+||||+||+++.++.++++|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999985422 23389999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 726 KLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 726 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
+........ ......++..|+|||.+.+..++.++||||+||++|||++ |+.||...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 765433221 1112345678999999998889999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=277.03 Aligned_cols=201 Identities=25% Similarity=0.443 Sum_probs=168.8
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
++|+..+.||+|++|.||+|... +++.||||.+...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999965 6889999998654322 234577899999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++ +|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 899888532 23688999999999999999999998 89999999999999999999999999987543211
Q ss_pred cceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
. ......++..|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1 1122346788999998865 457899999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=275.79 Aligned_cols=191 Identities=25% Similarity=0.394 Sum_probs=158.8
Q ss_pred eeccCCCccEEEeEeeC-------------------------CeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeE
Q 043333 582 KIGEGGFGPVYKGLLAD-------------------------GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKL 636 (809)
Q Consensus 582 ~LG~G~fG~Vy~~~~~~-------------------------g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l 636 (809)
.||+|+||.||+|.+.. ...||+|++........++|.+|+++++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13588998866544445678889999999999999999
Q ss_pred EeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-
Q 043333 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL- 715 (809)
Q Consensus 637 ~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~- 715 (809)
+++|.+.+..++||||+++|+|..++.. ....+++..+..++.|+++||+|||++ +|+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 9999999999999999999999998843 234688999999999999999999998 899999999999998643
Q ss_pred ------ceEEEecCCccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHH-HcCCCCCCCCC
Q 043333 716 ------NPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEI-VSGRSNVICRT 783 (809)
Q Consensus 716 ------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~el-ltGk~P~~~~~ 783 (809)
.+|++|||++....... ...++..|+|||.+.+ ..++.++|||||||++||| ++|+.||....
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred ccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 37999999876432211 2346778999998865 5689999999999999998 57999997643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=278.23 Aligned_cols=205 Identities=29% Similarity=0.472 Sum_probs=169.3
Q ss_pred cCCCCCCeeccCCCccEEEeEeeC---------------CeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEe
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLAD---------------GKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYG 638 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~---------------g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~ 638 (809)
++|++.+.||+|+||.||++.... ...||+|.++... ......|.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987532 2358999986542 223456889999999999999999999
Q ss_pred EEEeCCeEEEEEEcccCCchhhhccCCC--------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043333 639 CCIEGNQLLLIYEYMENNSLARALFGPE--------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVL 710 (809)
Q Consensus 639 ~~~~~~~~~lV~ey~~~gsL~~~L~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL 710 (809)
++...+..++||||+++++|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 9999999999999999999999885321 1123478999999999999999999998 8999999999999
Q ss_pred EcCCCceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc--CCCCCCCC
Q 043333 711 LDKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS--GRSNVICR 782 (809)
Q Consensus 711 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt--Gk~P~~~~ 782 (809)
+++++.+||+|||++........ .......++..|+|||++.++.++.++|||||||++|||++ |..||...
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999999999999875533221 11122345678999999988899999999999999999998 56787654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=277.78 Aligned_cols=202 Identities=28% Similarity=0.448 Sum_probs=170.3
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|++++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999965 68999999886542 22346788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.+++.... ....+++..+..++.|++.||.|||+.. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999998885421 2346899999999999999999999742 79999999999999999999999999987553221
Q ss_pred cceeccccccccccchhhhccCC------CCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGY------LTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~------~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.....++..|+|||.+.+.. ++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 12345788999999985543 478999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=271.89 Aligned_cols=201 Identities=22% Similarity=0.349 Sum_probs=172.8
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc-CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
+|+..+.||+|+||.||++... +++.+|+|.++.. .....+.+..|+++++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999854 6889999988643 2334567788999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++++|||++........
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 999999988432 233578899999999999999999998 899999999999999999999999999876543222
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 203 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC
Confidence 222356888999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=270.59 Aligned_cols=198 Identities=35% Similarity=0.561 Sum_probs=172.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.++|+..+.||+|+||.||+|... |+.||||.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356788899999999999999864 78899999876544 4577899999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 83 AKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999985322 23689999999999999999999998 899999999999999999999999999986532211
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
....+..|+|||++..+.++.++||||||+++|||++ |+.||...
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 2234568999999988889999999999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=279.80 Aligned_cols=206 Identities=29% Similarity=0.454 Sum_probs=170.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEee--------CCeEEEEEEecccC-cccchhHHHHHHHHhhc-CCCceEeEEeEEEeC
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA--------DGKVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEG 643 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~ 643 (809)
.++|.+.+.||+|+||.||++... ....||+|.++... .....++..|+++++++ +||||++++++|.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357788999999999999999742 24579999887542 23345688999999999 699999999999999
Q ss_pred CeEEEEEEcccCCchhhhccCCCc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043333 644 NQLLLIYEYMENNSLARALFGPEE------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL 711 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 711 (809)
+..++||||+++|+|.+++..... ....++|..+..++.|++.||+|||++ +++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 999999999999999999854321 124589999999999999999999998 89999999999999
Q ss_pred cCCCceEEEecCCccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 712 DKDLNPKISDFGLAKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 712 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
++++.+||+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |+.||...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999765432211 1111224467999999998889999999999999999999 89998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=270.61 Aligned_cols=201 Identities=29% Similarity=0.412 Sum_probs=169.0
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-----cccchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-----KQGNREFVNEIGMISALQHPNLVKLYGCCIEG--NQL 646 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 646 (809)
.+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999854 58899999874321 12235688899999999999999999998764 457
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999998842 23578889999999999999999998 89999999999999999999999999997
Q ss_pred ccCCCCc--ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 727 LDEEDNT--HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 727 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
....... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 5532111 1112345888999999998888899999999999999999999999653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=270.22 Aligned_cols=198 Identities=33% Similarity=0.499 Sum_probs=171.1
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-----cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-----KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
+|+..+.||+|+||.||+|... +++.||+|.+.... .+..+.+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667889999999999999965 78999999886543 22346788999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999843 23588999999999999999999998 89999999999999999999999999987654
Q ss_pred CCCcceeccccccccccchhhhccCC-CCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGY-LTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
... ......++..|+|||.+.... ++.++|+|||||++|||++|+.||...
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 332 123355788999999987766 899999999999999999999999653
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=274.33 Aligned_cols=199 Identities=30% Similarity=0.470 Sum_probs=167.6
Q ss_pred cCCCCCCeeccCCCccEEEeEe-----eCCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-----ADGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEG--NQL 646 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 646 (809)
+.|+..+.||+|+||.||.+.+ .+++.||+|.++... ....+.+.+|++++++++||||+++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999974 347889999986543 23346788999999999999999999999875 568
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++||||+++++|.+++... ...++|..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999998432 23589999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcc--eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCC
Q 043333 727 LDEEDNTH--ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNV 779 (809)
Q Consensus 727 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~ 779 (809)
........ ......++..|+|||++.+..++.++|||||||++|||+|++.|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 65432221 112344667899999998888999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=273.49 Aligned_cols=198 Identities=32% Similarity=0.508 Sum_probs=171.6
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
..|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34667788999999999999864 58899999886442 23356788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++|+|.+++. ..++++..+..++.|++.||+|||+. +++|+||+|+||+++++++++|+|||++.......
T Consensus 84 ~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 99999999883 23578899999999999999999998 89999999999999999999999999997654322
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
. ......++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1 12234578899999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=264.74 Aligned_cols=206 Identities=27% Similarity=0.399 Sum_probs=169.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEee---C--CeEEEEEEecccCcc--cchhHHHHHHHHhhcCCCceEeEEeEEEe-CCe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA---D--GKVIAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLYGCCIE-GNQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~---~--g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~-~~~ 645 (809)
...|+....||+|.||.||+|.-. + .+.+|+|+++...+. ......+|+..++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 346888899999999999999632 2 236899998765332 23567899999999999999999998887 778
Q ss_pred EEEEEEcccCCchhhhccCC-CccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC----CceEEE
Q 043333 646 LLLIYEYMENNSLARALFGP-EEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD----LNPKIS 720 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~ 720 (809)
.++++||.+. +|.+.++-. ......++-.++.+|+.||..|+.|||++ =|+||||||.|||+..+ |++||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 788877532 22335788999999999999999999998 58999999999999876 999999
Q ss_pred ecCCccccCCCCcc--eeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 721 DFGLAKLDEEDNTH--ISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 721 DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
|||+++.+...-.. ....++-|..|+|||.+.+ ..|+++.|||+.|||+.||+|-++-|.++.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999987543221 2335678999999999887 568999999999999999999999887643
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=269.90 Aligned_cols=199 Identities=38% Similarity=0.596 Sum_probs=171.4
Q ss_pred CeeccCCCccEEEeEeeC----CeEEEEEEecccCccc-chhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLAD----GKVIAVKQLSSKSKQG-NREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|.... +..||+|.+....... .+.+.+|++.+..++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 7789999987654333 57788999999999999999999999999999999999999
Q ss_pred CchhhhccCCCcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 656 NSLARALFGPEEH-----RLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 656 gsL~~~L~~~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
++|.+++...... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999553211 36789999999999999999999998 899999999999999999999999999986654
Q ss_pred CCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 731 DNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 731 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
... .......++..|+|||.+....++.++||||+||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 321 11223457889999999988889999999999999999999 69999764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=278.51 Aligned_cols=201 Identities=24% Similarity=0.364 Sum_probs=170.5
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||.||++... .++.||+|.+..... ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999965 578999998865432 23456788999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999833 34588999999999999999999998 899999999999999999999999999864211
Q ss_pred CC--------------cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DN--------------THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. ........++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 00 00111235788999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=279.17 Aligned_cols=204 Identities=27% Similarity=0.362 Sum_probs=173.5
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc---cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ---GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||.||+|... +++.||+|.+...... ..+.+..|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999965 4899999998654322 3456888999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999988532 234689999999999999999999998 899999999999999999999999999865432
Q ss_pred CCcc----------------------------eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DNTH----------------------------ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 011246788999999999888999999999999999999999999654
Q ss_pred C
Q 043333 783 T 783 (809)
Q Consensus 783 ~ 783 (809)
+
T Consensus 236 ~ 236 (316)
T cd05574 236 N 236 (316)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=277.47 Aligned_cols=201 Identities=25% Similarity=0.397 Sum_probs=170.8
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
++|+..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999975 588999998765422 234568899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++++|.++... ...++|..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999998887632 23489999999999999999999998 8999999999999999999999999998765433
Q ss_pred Ccceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 22 2223457889999999875 457889999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=275.16 Aligned_cols=202 Identities=27% Similarity=0.438 Sum_probs=168.5
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++++|...+.||+|+||.||+|... +|+.||+|++...... ....+.+|+++++.++|+||+++.+++.+.+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578889999999999999999854 6889999998655332 2346788999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||++ +++.+++... ...+.+..+..++.|++.||.|||+. +|+|+||||+||+++.+++++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 6777766322 23577888999999999999999998 899999999999999999999999999875432
Q ss_pred CCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 156 PSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 211 1123456889999999875 35788999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=280.81 Aligned_cols=198 Identities=20% Similarity=0.267 Sum_probs=163.1
Q ss_pred CCCeeccC--CCccEEEeEe-eCCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 579 PDNKIGEG--GFGPVYKGLL-ADGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 579 ~~~~LG~G--~fG~Vy~~~~-~~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
..++||+| +|++||++.. .+|+.||||++..... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35779999 6789999985 4689999999865422 22356778999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999884321 23588999999999999999999998 899999999999999999999999986543221111
Q ss_pred c------eeccccccccccchhhhcc--CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 734 H------ISTRIAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 734 ~------~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0 0112346778999999876 4588999999999999999999999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=284.95 Aligned_cols=192 Identities=23% Similarity=0.324 Sum_probs=164.0
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++.+.+..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999965 4678999975322 23568999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred ccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 995 688888743 234689999999999999999999998 8999999999999999999999999998754322
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNV 779 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~ 779 (809)
. ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 P--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 122456899999999999989999999999999999999866554
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=275.73 Aligned_cols=201 Identities=26% Similarity=0.384 Sum_probs=173.0
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
++|+..+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999965 57899999886542 2334678899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|++++.+..+.. ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877766552 234588999999999999999999998 8999999999999999999999999999876544
Q ss_pred CcceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.........++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 33223345678899999999887 8899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=276.89 Aligned_cols=199 Identities=30% Similarity=0.537 Sum_probs=173.6
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
++|...+.||+|+||.||++.. .+++.||+|.+........+.+..|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6788899999999999999985 467889999986554444567889999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++++|.+++. +..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999983 23578999999999999999999998 899999999999999999999999998875543322
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
. .....+++.|+|||.+....++.++|||||||++|||++|+.||...
T Consensus 171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 22346888999999998888999999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=269.34 Aligned_cols=202 Identities=25% Similarity=0.388 Sum_probs=171.3
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeC-CeEEEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEG-NQLLLIYE 651 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~lV~e 651 (809)
+|+..+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++|+|++++.+.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999854 57889999986542 23345688899999999999999999987644 46789999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++++|.+++... ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999998532 234589999999999999999999998 8999999999999999999999999999866433
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. ......+++.|+|||++.+..++.++||||+||+++||++|+.||...+
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 22 2233567889999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=276.47 Aligned_cols=200 Identities=28% Similarity=0.419 Sum_probs=169.1
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc-----cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ-----GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
+|+..+.||+|+||.||+|... +++.||||++...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999964 6889999998755322 234567899999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+ +|+|.+++.... ..+++..+..++.|+++||.|||++ +++||||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 899999985322 3689999999999999999999998 89999999999999999999999999997654
Q ss_pred CCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|.+||....
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 43221 122346778999998865 467899999999999999999988886543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=273.02 Aligned_cols=202 Identities=30% Similarity=0.538 Sum_probs=169.4
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCe----EEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGK----VIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
.+|+..+.||+|+||.||+|... +|+ .||+|....... ....++.+|++++++++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56778899999999999999864 333 589998765532 334678899999999999999999999987 78899
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
|+||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999998542 33589999999999999999999997 8999999999999999999999999999866
Q ss_pred CCCCccee-ccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 729 EEDNTHIS-TRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
........ ....++..|+|||.+....++.++|||||||++||+++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 53322211 11223568999999988889999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=275.89 Aligned_cols=206 Identities=32% Similarity=0.504 Sum_probs=171.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 646 (809)
.++|+..+.||+|+||.||+|... ++..||+|++.... ....++|.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999853 46789999986543 23346788999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhccCCC------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 043333 647 LLIYEYMENNSLARALFGPE------------------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATN 708 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N 708 (809)
++|+||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999985321 1223578999999999999999999998 89999999999
Q ss_pred EEEcCCCceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 709 VLLDKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 709 ILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
|++++++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999875432211 11112234567999999998899999999999999999997 88898653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=275.64 Aligned_cols=202 Identities=26% Similarity=0.439 Sum_probs=166.6
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHH-HhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGM-ISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~-l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
++|++.+.||+|+||.||+|+.. +|+.||+|+++... .....++..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999964 68999999986543 2233456666665 566789999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|++ |+|.+++.........+++..+..++.|++.||+|||++. +++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 6888877543334467899999999999999999999863 7999999999999999999999999998765432
Q ss_pred Ccceeccccccccccchhhhcc----CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMR----GYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 1 1123457889999998864 4468899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=288.62 Aligned_cols=195 Identities=28% Similarity=0.503 Sum_probs=164.1
Q ss_pred CCCCeeccCCCccEEEeEee-CCeEEEEEEec--cc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe--EEEEE
Q 043333 578 APDNKIGEGGFGPVYKGLLA-DGKVIAVKQLS--SK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ--LLLIY 650 (809)
Q Consensus 578 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~--~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~--~~lV~ 650 (809)
+...+||+|.|-+||||... .|..||--.++ +. +....+.|..|+++|+.++||||++++.++.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34578999999999999854 46677633222 21 23334789999999999999999999999997654 78999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CceEEEecCCccccC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLDE 729 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~~ 729 (809)
|.|..|+|..|+. ....++.....+|+.||++||.|||++. |+|||||||..||+++.+ |.+||+|+|+|....
T Consensus 123 EL~TSGtLr~Y~k----k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRK----KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHH----HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 9999999999984 3345778899999999999999999985 589999999999999865 999999999999876
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.... ..+.|||.|||||+.. ..|.+.+||||||++++||+|+..||..
T Consensus 198 ~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 198 KSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred cccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence 4432 2478999999999987 6789999999999999999999999953
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=271.89 Aligned_cols=197 Identities=31% Similarity=0.487 Sum_probs=162.3
Q ss_pred CeeccCCCccEEEeEeeC-Ce--EEEEEEecccC-cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLAD-GK--VIAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~-g~--~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|...+ +. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999653 43 47888876432 33346788999999999 799999999999999999999999999
Q ss_pred CchhhhccCCCc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 656 NSLARALFGPEE------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 656 gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999864321 123578999999999999999999997 89999999999999999999999999
Q ss_pred CccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 724 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
++........ ......+..|+|||++....++.++|||||||++|||++ |+.||...
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 9863221111 111223567999999988889999999999999999997 99999653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=267.45 Aligned_cols=212 Identities=24% Similarity=0.309 Sum_probs=169.2
Q ss_pred HHHHHHhcCCCCCCee--ccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEeC
Q 043333 568 RQIKAATNNFAPDNKI--GEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEG 643 (809)
Q Consensus 568 ~~l~~~~~~f~~~~~L--G~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~ 643 (809)
.+.....++|++.+.+ |+|+||.||++.. .+++.+|+|.+....... .|+.....+ +||||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444455677777776 9999999999985 467889999986432211 122222222 699999999999999
Q ss_pred CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-ceEEEec
Q 043333 644 NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDF 722 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~Df 722 (809)
+..++||||+++|+|.+++.. ...+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 999999999999999999843 23789999999999999999999998 799999999999999998 9999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHh
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLA 797 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~ 797 (809)
|++....... ...++..|+|||++.+..++.++||||+||++|||++|+.||..... +..+...|....
T Consensus 155 g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~ 223 (267)
T PHA03390 155 GLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ 223 (267)
T ss_pred ccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh
Confidence 9987654221 23578899999999988899999999999999999999999975322 223344444443
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=273.03 Aligned_cols=198 Identities=24% Similarity=0.413 Sum_probs=159.2
Q ss_pred eeccCCCccEEEeEeeCC---eEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCc
Q 043333 582 KIGEGGFGPVYKGLLADG---KVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNS 657 (809)
Q Consensus 582 ~LG~G~fG~Vy~~~~~~g---~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gs 657 (809)
.||+|+||.||+|...++ ..+++|.+.... ....+.|.+|++.++.++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985443 346677665433 2345678999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC-ccee
Q 043333 658 LARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN-THIS 736 (809)
Q Consensus 658 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~~~ 736 (809)
|.++++.........++..+..++.|+++||+|||+. +++||||||+|||++.++.++|+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999965433344567778889999999999999998 89999999999999999999999999986432211 1112
Q ss_pred ccccccccccchhhhcc-------CCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 737 TRIAGTFGYMAPEYAMR-------GYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 737 ~~~~gt~~y~aPE~~~~-------~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
....++..|+|||++.. ..++.++|||||||++|||++ |+.||...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 212 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence 23467889999998753 245789999999999999997 56688543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=283.50 Aligned_cols=206 Identities=28% Similarity=0.430 Sum_probs=168.6
Q ss_pred hcCCCCCCeeccCCCccEEEeEe------eCCeEEEEEEecccCc-ccchhHHHHHHHHhhc-CCCceEeEEeEEEeC-C
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL------ADGKVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLYGCCIEG-N 644 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~-~ 644 (809)
.++|+..+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|++++.++ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45788999999999999999973 3468899999875432 2345688999999999 689999999988765 4
Q ss_pred eEEEEEEcccCCchhhhccCCCc---------------------------------------------------------
Q 043333 645 QLLLIYEYMENNSLARALFGPEE--------------------------------------------------------- 667 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~--------------------------------------------------------- 667 (809)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999998854211
Q ss_pred ------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc-eecccc
Q 043333 668 ------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH-ISTRIA 740 (809)
Q Consensus 668 ------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~ 740 (809)
....++|..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 012478889999999999999999998 8999999999999999999999999998765332211 111233
Q ss_pred ccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 741 GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 741 gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 5668999999988889999999999999999997 99999653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=267.12 Aligned_cols=196 Identities=32% Similarity=0.507 Sum_probs=166.9
Q ss_pred CeeccCCCccEEEeEeeCCeEEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCchh
Q 043333 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLA 659 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~ 659 (809)
++||+|+||.||++...+++.||+|++...... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999777899999988765333 4567899999999999999999999999999999999999999999
Q ss_pred hhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCccee-cc
Q 043333 660 RALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-TR 738 (809)
Q Consensus 660 ~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~-~~ 738 (809)
+++... ...+++..+..++.+++.||+|||++ +++||||||+||+++.++.++|+|||++........... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 998532 23578999999999999999999998 899999999999999999999999999875542211111 11
Q ss_pred ccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 739 IAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 739 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
...+..|+|||.+.++.++.++|||||||++|||+| |+.||...
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~ 199 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM 199 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence 223567999999988899999999999999999999 88898654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=276.73 Aligned_cols=197 Identities=32% Similarity=0.513 Sum_probs=169.7
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3555677999999999999854 57899999886443 233457889999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++++|.+++. ...+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++++|||++........
T Consensus 85 ~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999999883 24588999999999999999999998 899999999999999999999999999876543221
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
. .....++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 157 K-RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred h-hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 1 1224578899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=268.69 Aligned_cols=201 Identities=29% Similarity=0.487 Sum_probs=176.0
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
++|+..+.||+|++|.||+|+.. +++.||||++..... ...+.+.+|++++.+++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999976 489999999876543 3457789999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
+++++|.+++.. ...+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999843 2568999999999999999999999 7 8999999999999999999999999998865433
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 222 123457889999999998899999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=269.54 Aligned_cols=189 Identities=29% Similarity=0.471 Sum_probs=159.8
Q ss_pred CeeccCCCccEEEeEeeCCe-----------EEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 581 NKIGEGGFGPVYKGLLADGK-----------VIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~g~-----------~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
+.||+|+||.||+|...+.. .|++|.+...... ...|.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999975432 5778877544333 6788999999999999999999999988 788999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-------ceEEEec
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL-------NPKISDF 722 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-------~~kl~Df 722 (809)
|||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999998542 22688999999999999999999998 899999999999999887 7999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhccC--CCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
|++...... ....++..|+|||++... .++.++|||||||++|||++ |..||...
T Consensus 153 g~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 153 GIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred Ccccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 998765431 123466789999998876 78999999999999999999 57788654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=268.71 Aligned_cols=195 Identities=32% Similarity=0.476 Sum_probs=166.1
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEe-CCeEEEEEEcc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIE-GNQLLLIYEYM 653 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~~lV~ey~ 653 (809)
++|...+.||+|+||.||++... |+.||+|..+... ..+.|.+|+.++++++|+|++++++++.. .+..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999764 7789999886432 34678899999999999999999998654 45789999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.+++... ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+|++|||+++......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 999999998542 223588999999999999999999998 89999999999999999999999999987543322
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVIC 781 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~ 781 (809)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 12234568999999988889999999999999999997 9999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=268.70 Aligned_cols=194 Identities=31% Similarity=0.491 Sum_probs=162.6
Q ss_pred CeeccCCCccEEEeEeeC----CeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLAD----GKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|.+.. +..||+|.+..... ...+++.+|+++++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998532 26899999875543 24567899999999999999999999876 4568999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999532 2689999999999999999999998 89999999999999999999999999998654332221
Q ss_pred ec--cccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 736 ST--RIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 736 ~~--~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
.. ...++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 11 1223467999999998899999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=272.83 Aligned_cols=200 Identities=30% Similarity=0.479 Sum_probs=169.3
Q ss_pred CCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeEEEEEE
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEG--NQLLLIYE 651 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e 651 (809)
|+..+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|++++++++|||++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999965 58899999997653 23345688999999999999999999999988 88999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++ +|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9985 888887432 24689999999999999999999998 8999999999999999999999999999866543
Q ss_pred Ccceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3222233456788999997764 457899999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=283.78 Aligned_cols=220 Identities=25% Similarity=0.417 Sum_probs=183.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
...|.+...||+|.|+.|..|++. .+..||+|.+.+..- ...+.+.+|+++|..++|||||+++.+...+..+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467888999999999999999964 589999999876532 22345789999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+.+|.+.++|... .......+..++.|+.+|++|||++ .|+|||||++||||+.+..+||+|||++.++..
T Consensus 135 eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999533 2344467888999999999999999 799999999999999999999999999988764
Q ss_pred CCcceeccccccccccchhhhccCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCc-ccchhHHHHHHHhhccCCCCcCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGY-LTDKADVYSFGIVALEIVSGRSNVICRTK-EAQFCLLDWVTLALTDFRFPLFLS 808 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwSlGvil~elltGk~P~~~~~~-~~~~~l~~~~~~~~~~~~~p~~~~ 808 (809)
. ......+|++.|.|||++.+.. .++++|+||+||++|-|+.|..||++.+- +-.. +-.+..+++|.|+|
T Consensus 208 ~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------rvl~gk~rIp~~ms 279 (596)
T KOG0586|consen 208 G--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------RVLRGKYRIPFYMS 279 (596)
T ss_pred c--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc------hheeeeecccceee
Confidence 3 2334578999999999998754 57899999999999999999999987542 2111 22334466666654
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=270.86 Aligned_cols=203 Identities=28% Similarity=0.523 Sum_probs=170.6
Q ss_pred CCCCCCeeccCCCccEEEeEeeC--CeEEEEEEecccC----------cccchhHHHHHHHHhh-cCCCceEeEEeEEEe
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLAD--GKVIAVKQLSSKS----------KQGNREFVNEIGMISA-LQHPNLVKLYGCCIE 642 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~~~~~~----------~~~~~~f~~Ei~~l~~-l~H~nIv~l~~~~~~ 642 (809)
.|+..+.||+|+||.||+|.... ++.+|+|.+.... .....++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778899999999999999754 6889999875431 1123456778888765 799999999999999
Q ss_pred CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 643 GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 643 ~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
.+..++||||+++++|.+++.........+++..++.++.|++.||.|||+.. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999987543334456899999999999999999999642 7999999999999999999999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
|++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 9998654432 223456888999999999888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=269.88 Aligned_cols=199 Identities=35% Similarity=0.557 Sum_probs=172.5
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc--cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+|...+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999854 6889999998765432 467789999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.+++.. ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999843 23478899999999999999999998 89999999999999999999999999988664433
Q ss_pred cceec---cccccccccchhhhccCC---CCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 733 THIST---RIAGTFGYMAPEYAMRGY---LTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 733 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
..... ...++..|+|||++.... .+.++||||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~ 208 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence 22111 245788999999988766 88999999999999999999999965
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=269.14 Aligned_cols=204 Identities=30% Similarity=0.469 Sum_probs=174.8
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
++|+..+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999954 67899999986543 23456789999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.+++..... ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999854221 24689999999999999999999998 89999999999999999999999999987654332
Q ss_pred cc---eeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 733 TH---ISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 733 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. ......|+..|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 22 22334688899999998876 7899999999999999999999999653
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=322.43 Aligned_cols=268 Identities=34% Similarity=0.511 Sum_probs=129.1
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccC-CCCchhhcCCccCcEEeeccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQAN-GAIPKAVASISTLADLTLEFNQF 79 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~-~~ip~~l~~l~~L~~L~L~~N~l 79 (809)
|+|++|++.+.+|. ..+++|++|+|++|.+++.+|..+..++ |+.|++++|.+ +.+|..+.++++|++|+|++|.+
T Consensus 123 L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 200 (968)
T PLN00113 123 LNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQL 200 (968)
T ss_pred EECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCC
Confidence 45555555554443 2344555555555555544554444443 45555544443 24444555555555555555555
Q ss_pred ccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccc
Q 043333 80 SGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGI 159 (809)
Q Consensus 80 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 159 (809)
.+.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..++++++|+.|+|++|++++.+|..+
T Consensus 201 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l 280 (968)
T PLN00113 201 VGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280 (968)
T ss_pred cCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhH
Confidence 54455555555555555555555554455555555555555555555554455555555555555555555544444444
Q ss_pred cCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccE
Q 043333 160 ASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTY 238 (809)
Q Consensus 160 ~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~ 238 (809)
.++++|+.|++++|.+....+..+.++++|+.|+|++|.+.+.+|..+..+++|+.|+|++|.+++.+|..+.. ++|+.
T Consensus 281 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~ 360 (968)
T PLN00113 281 FSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360 (968)
T ss_pred hhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcE
Confidence 44555555555555444444444444444444444444444444444444444444444444444444443333 44444
Q ss_pred EEeeCccCCCCCChhhhh-ccCccccccCCcccc
Q 043333 239 MYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFID 271 (809)
Q Consensus 239 L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~ 271 (809)
|+|++|++++.+|..+.. ..++.|++++|++.+
T Consensus 361 L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~ 394 (968)
T PLN00113 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEG 394 (968)
T ss_pred EECCCCeeEeeCChhHhCcCCCCEEECcCCEecc
Confidence 444444444444443322 223334444444433
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=280.02 Aligned_cols=205 Identities=30% Similarity=0.446 Sum_probs=169.9
Q ss_pred cCCCCCCeeccCCCccEEEeEeeC--------CeEEEEEEecccC-cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCC
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLAD--------GKVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGN 644 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 644 (809)
.+|.+.+.||+|+||.||+|.... +..||+|.++... ....+++.+|+++++++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 467889999999999999997421 2368999886542 23356788999999999 7999999999999999
Q ss_pred eEEEEEEcccCCchhhhccCCC------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc
Q 043333 645 QLLLIYEYMENNSLARALFGPE------------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD 712 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 712 (809)
..++|+||+++|+|.+++.... .....++|..+..++.|++.||+|||+. +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999985432 1234588999999999999999999998 899999999999999
Q ss_pred CCCceEEEecCCccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 713 KDLNPKISDFGLAKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 713 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
+++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999765432211 1112234567999999999899999999999999999998 88898654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=273.79 Aligned_cols=200 Identities=24% Similarity=0.403 Sum_probs=172.8
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.-|...+.||+|.|+.|-.|++- .|+.||||++.+.. ......+.+|++.|+-++|||||+++.+...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45677788999999999988853 79999999997653 2335668889999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE-cCCCceEEEecCCccccCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL-DKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl-~~~~~~kl~DfGla~~~~~ 730 (809)
.-.+|+|.+|+-. +...+.+..+.+++.||..|+.|+|+. .+|||||||+||.+ .+-|-+|+.|||++..+.+
T Consensus 98 LGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999943 445688999999999999999999998 79999999999886 5668999999999977664
Q ss_pred CCcceeccccccccccchhhhccCCCC-chHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLT-DKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
... -...||+..|-|||++.+..|+ +.+||||+|||||.|+.|+.||+.-
T Consensus 172 G~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA 222 (864)
T KOG4717|consen 172 GKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA 222 (864)
T ss_pred cch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc
Confidence 432 2457899999999999987665 6789999999999999999999763
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=285.95 Aligned_cols=199 Identities=28% Similarity=0.465 Sum_probs=170.8
Q ss_pred CCeeccCCCccEEEeEee--CCe--EEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 580 DNKIGEGGFGPVYKGLLA--DGK--VIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~--~g~--~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
.++||+|.||.|++|.|. +|+ .||||.++..... ...+|++|+.+|.+|+|||+++|+|...+ ....||+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 467999999999999986 354 5899999876544 56889999999999999999999999988 67889999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
.|||.+.|+. ..+..+-......++.|||.||.||..+ ++|||||..+|+||-..-.+||+|||+.+.+......
T Consensus 194 lGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 194 LGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 9999999976 3455677888899999999999999998 8999999999999999999999999999977544332
Q ss_pred e-ec-cccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 043333 735 I-ST-RIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRTK 784 (809)
Q Consensus 735 ~-~~-~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~~ 784 (809)
. +. ...-...|+|||.+..+.++.++|||+|||.+|||+| |+.||.+...
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g 321 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG 321 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH
Confidence 2 11 1223458999999999999999999999999999998 6789987544
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=272.66 Aligned_cols=202 Identities=27% Similarity=0.423 Sum_probs=171.9
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEG--NQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 650 (809)
++|+..+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||++++++|.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778899999999999999964 578999999865432 3356788999999999999999999998754 4689999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988754333445688999999999999999999998 899999999999999999999999999875432
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
... ....++..|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 211 1345778999999999889999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=270.85 Aligned_cols=191 Identities=31% Similarity=0.390 Sum_probs=157.7
Q ss_pred eeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHh---hcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 582 KIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMIS---ALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 582 ~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~---~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
.||+|+||.||++... +++.||+|.+..... .....+.+|..++. ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 588999998865422 11233445544433 3479999999999999999999999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++........
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 9999998842 34689999999999999999999998 899999999999999999999999999875432221
Q ss_pred eeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 735 ISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 23468999999998864 55789999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=269.26 Aligned_cols=195 Identities=29% Similarity=0.445 Sum_probs=158.8
Q ss_pred CeeccCCCccEEEeEeeC----CeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEe-CCeEEEEEEccc
Q 043333 581 NKIGEGGFGPVYKGLLAD----GKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIE-GNQLLLIYEYME 654 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~~lV~ey~~ 654 (809)
+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+.+++.++||||+++++++.. ++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 3579999875432 2335678899999999999999999998764 456789999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
+|+|.+++... .....+..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998532 23467888899999999999999998 8999999999999999999999999998754332111
Q ss_pred ---eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcC-CCCCCC
Q 043333 735 ---ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG-RSNVIC 781 (809)
Q Consensus 735 ---~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltG-k~P~~~ 781 (809)
......++..|+|||++.+..++.++|||||||++|||++| .+||..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 11123456789999999888999999999999999999995 556643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=271.18 Aligned_cols=199 Identities=30% Similarity=0.439 Sum_probs=173.8
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999965 58899999986542 2335678899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++++|.+++.. ..++++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999843 24688999999999999999999998 8999999999999999999999999998765433
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
. ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||....
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 2 1223457889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=274.39 Aligned_cols=197 Identities=25% Similarity=0.430 Sum_probs=166.1
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+|+..+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999964 688999999865422 2245678899999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
++ ++|.+++.. ....+++..+..++.|+++||.|||+. +++||||||+||+++.+++++|+|||+++......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 478777743 234589999999999999999999998 89999999999999999999999999987553322
Q ss_pred cceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVI 780 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~ 780 (809)
.. .....++..|+|||++.+. .++.++|||||||++|||+||+.|+.
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 11 1234578899999988764 46899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=265.85 Aligned_cols=201 Identities=36% Similarity=0.576 Sum_probs=170.7
Q ss_pred CCCCCeeccCCCccEEEeEeeC-----CeEEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 577 FAPDNKIGEGGFGPVYKGLLAD-----GKVIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
+++.+.||+|+||.||++...+ +..||+|++...... ..+.+..|++++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3467889999999999999653 378999998665433 4568899999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999854221 1289999999999999999999998 899999999999999999999999999976654
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
..........++..|+|||.+.+..++.++||||+|++++||++ |+.||...
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32222112336789999999988889999999999999999998 88888653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=269.17 Aligned_cols=199 Identities=31% Similarity=0.450 Sum_probs=167.9
Q ss_pred CCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcc----------cchhHHHHHHHHhhcCCCceEeEEeEEEeCC
Q 043333 576 NFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQ----------GNREFVNEIGMISALQHPNLVKLYGCCIEGN 644 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~----------~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~ 644 (809)
+|...+.||+|+||.||+|.. .+|+.||+|.++..... ..+.+.+|++++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466788999999999999985 46889999987542111 1235778999999999999999999999999
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
..++|+||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999998432 4688999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCc-ceeccccccccccchhhhccCC--CCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 725 AKLDEEDNT-HISTRIAGTFGYMAPEYAMRGY--LTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 725 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
++....... .......++..|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 875432211 1122345788999999987654 78999999999999999999999954
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=275.18 Aligned_cols=201 Identities=30% Similarity=0.546 Sum_probs=166.3
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCe----EEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGK----VIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
++|+..+.||+|+||.||+|... +|+ .||+|.+..... ....++.+|+.++++++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46778899999999999999853 443 478888765432 2234688999999999999999999999764 4678
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
|+||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 9999999999999843 233578999999999999999999998 8999999999999999999999999999865
Q ss_pred CCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 729 EEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 729 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
...... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 432221 1122345678999999998899999999999999999997 99999653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=269.62 Aligned_cols=198 Identities=31% Similarity=0.534 Sum_probs=170.2
Q ss_pred CCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC-cccchhHHHHHHHHhhcC---CCceEeEEeEEEeCCeEEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS-KQGNREFVNEIGMISALQ---HPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~~lV~ 650 (809)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+++.+|++++++++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999996 468899999986542 333467888999999987 999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998832 2689999999999999999999998 899999999999999999999999999976654
Q ss_pred CCcceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.... .....|+..|+|||++.++ .++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 3322 2234688899999988654 4688999999999999999999999653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=273.34 Aligned_cols=201 Identities=26% Similarity=0.429 Sum_probs=168.7
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc--cchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLYGCCIEG--NQLLLI 649 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lV 649 (809)
++|+..+.||+|+||.||+|... +++.||+|.++..... ....+.+|++++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999965 5889999998654322 234567899999999999999999999887 889999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
+||+++ +|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999974 898887432 23689999999999999999999998 89999999999999999999999999988654
Q ss_pred CCCcceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
..... .....+++.|+|||.+.+. .++.++||||+|+++|||++|+.||....
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 43211 1234567899999988754 46899999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=269.46 Aligned_cols=197 Identities=34% Similarity=0.513 Sum_probs=170.5
Q ss_pred CCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
-|+..+.||+|+||.||+|.. .+++.||+|...... ....+.+.+|++.+++++||||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 466788999999999999985 468899999875432 223456889999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++++|.+++. ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999883 23588999999999999999999998 899999999999999999999999999876543221
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
. .....++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 157 K-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred h-hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 1 1234578899999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=268.25 Aligned_cols=206 Identities=29% Similarity=0.479 Sum_probs=173.0
Q ss_pred CCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEe--CCeEEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIE--GNQLLLIY 650 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~lV~ 650 (809)
+|+..+.||.|+||.||++.. .+++.||+|++.... ....+++..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999985 467899999886432 2334568889999999999999999998864 34679999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES--RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||+++++|.+++........++++..++.++.|++.||+|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998654344567899999999999999999999332 238999999999999999999999999999876
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 543321 22346888999999999888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=271.07 Aligned_cols=199 Identities=28% Similarity=0.392 Sum_probs=168.6
Q ss_pred CCCCCCeeccCCCccEEEeEe----eCCeEEEEEEecccCc----ccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLL----ADGKVIAVKQLSSKSK----QGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~~~~~~~----~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 646 (809)
+|+..+.||+|+||.||++.. .+|+.||+|+++.... ...+.+..|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999985 3688999999865322 2235678899999999 599999999999999999
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++++||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999843 34578889999999999999999998 89999999999999999999999999997
Q ss_pred ccCCCCcceeccccccccccchhhhccC--CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 727 LDEEDNTHISTRIAGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
..............|+..|+|||.+... .++.++||||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 6544332222345688899999998753 467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=269.60 Aligned_cols=202 Identities=30% Similarity=0.493 Sum_probs=170.5
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
+|+..+.||+|++|.||+|+.. +|+.||||+++..... ....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999965 6889999998765332 3456778999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++ +|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||+++++++++++|||++........
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 8888874332 234689999999999999999999998 899999999999999999999999999875533211
Q ss_pred ceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1123456889999998865 456889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=272.03 Aligned_cols=199 Identities=33% Similarity=0.528 Sum_probs=165.2
Q ss_pred CeeccCCCccEEEeEeeC-------CeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 581 NKIGEGGFGPVYKGLLAD-------GKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+.||+|+||.||+|+..+ ++.+|||.+.... .....+|.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998542 2579999876543 23456788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-----ceEEEecCC
Q 043333 653 MENNSLARALFGPEE---HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL-----NPKISDFGL 724 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-----~~kl~DfGl 724 (809)
+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999964321 234578999999999999999999987 799999999999999887 899999999
Q ss_pred ccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 725 AKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 725 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
++....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 875432211 11112235678999999999999999999999999999998 99999653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=270.20 Aligned_cols=202 Identities=26% Similarity=0.423 Sum_probs=166.6
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
++|+..+.||+|++|.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999965 688999998865432 223568899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCceEEEecCCccccCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLDEE 730 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~ 730 (809)
|++ ++|.+++... .....++..+..++.|++.||+|||++ +++||||+|+||++++ ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 5787776332 223457888889999999999999998 8999999999999985 56799999999975433
Q ss_pred CCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... ......+++.|+|||++.+ ..++.++||||+||++|||+||+.||...+
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 211 1123456889999998866 457899999999999999999999997643
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=274.24 Aligned_cols=204 Identities=26% Similarity=0.399 Sum_probs=168.5
Q ss_pred CCCCCCeeccCCCccEEEeEee---CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA---DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEG--NQLL 647 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~ 647 (809)
+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999964 47899999987643 33346678899999999999999999999988 7899
Q ss_pred EEEEcccCCchhhhccCCCc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC----CCceEEEec
Q 043333 648 LIYEYMENNSLARALFGPEE-HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK----DLNPKISDF 722 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~Df 722 (809)
+||||+++ +|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 66665533222 223688999999999999999999998 8999999999999999 899999999
Q ss_pred CCccccCCCCc--ceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 723 GLAKLDEEDNT--HISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 723 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
|++........ .......++..|+|||++.+ ..++.++|||||||+++||++|+.||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99986543222 11223467889999998866 457899999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=266.85 Aligned_cols=201 Identities=26% Similarity=0.423 Sum_probs=172.4
Q ss_pred CCCCCCeeccCCCccEEEeEe-eCCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+|+..+.||+|+||.||++.. .+|+.||+|++... .....+++.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999985 46889999998643 223345788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988532 223578999999999999999999998 89999999999999999999999999997654322
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. .....|++.|+|||+..+..++.++|||||||+++||++|+.||...
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 11 22345788999999998888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=270.93 Aligned_cols=203 Identities=26% Similarity=0.347 Sum_probs=167.8
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCe-----
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQ----- 645 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~----- 645 (809)
++|+..+.||+|+||.||+|... +++.||||+...... ...+.+.+|++++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999964 689999998765432 23456888999999995 6999999999987665
Q ss_pred EEEEEEcccCCchhhhccCCCcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCceEEEecC
Q 043333 646 LLLIYEYMENNSLARALFGPEEH-RLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFG 723 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfG 723 (809)
.++||||+++ +|.+++...... ...+++..+..++.||+.||+|||+. +++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 788887543322 45689999999999999999999998 8999999999999998 8999999999
Q ss_pred CccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 724 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
++........ ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9875532211 1122356788999998865 45789999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=269.69 Aligned_cols=193 Identities=30% Similarity=0.412 Sum_probs=165.7
Q ss_pred eccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCch
Q 043333 583 IGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL 658 (809)
Q Consensus 583 LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 658 (809)
||+|+||+||++... +|+.||+|.+.... ....+.+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68899999986532 22345677899999999999999999999999999999999999999
Q ss_pred hhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceecc
Q 043333 659 ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 738 (809)
Q Consensus 659 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 738 (809)
.+++.... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+........ ...
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccc
Confidence 99985432 23689999999999999999999998 899999999999999999999999999876543211 123
Q ss_pred ccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 739 IAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 739 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
..++..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 45778999999998888999999999999999999999999664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=274.22 Aligned_cols=202 Identities=30% Similarity=0.463 Sum_probs=168.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc--cchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLYGCCIEG--NQLLL 648 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~l 648 (809)
.++|+..+.||+|+||.||+|... +|+.||+|+++..... ....+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467889999999999999999964 5899999998654322 233567899999999999999999998765 56899
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++ +|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 788877432 35689999999999999999999998 8999999999999999999999999999866
Q ss_pred CCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
...... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 433211 223345778999998865 457899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=273.78 Aligned_cols=205 Identities=27% Similarity=0.419 Sum_probs=167.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc--cchhHHHHHHHHhhcCCCceEeEEeEEEeCC------
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLYGCCIEGN------ 644 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 644 (809)
.++|+..+.||+|+||.||+|... +++.||||++...... ....+.+|++++++++||||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357889999999999999999964 6899999988644222 2345678999999999999999999987654
Q ss_pred --eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 645 --QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 645 --~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
..++||||+++ +|.+++.. ....+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 35999999975 78777733 223689999999999999999999998 8999999999999999999999999
Q ss_pred CCccccCCCCcc---eeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCcc
Q 043333 723 GLAKLDEEDNTH---ISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRTKE 785 (809)
Q Consensus 723 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~~~ 785 (809)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~ 230 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ 230 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999765332211 11234567899999988664 4688999999999999999999999765443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=272.09 Aligned_cols=204 Identities=27% Similarity=0.428 Sum_probs=169.6
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCC----
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGN---- 644 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~---- 644 (809)
...++|+..+.||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999965 588999999865432 23356778999999999999999999988655
Q ss_pred ------eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceE
Q 043333 645 ------QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 718 (809)
Q Consensus 645 ------~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 718 (809)
..++|+||+++ ++.+.+.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 67666633 234689999999999999999999998 899999999999999999999
Q ss_pred EEecCCccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 719 ISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 719 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
|+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998665433222223346778999998765 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=269.88 Aligned_cols=197 Identities=28% Similarity=0.517 Sum_probs=170.9
Q ss_pred CCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
.|...+.||+|++|.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 345567999999999999985 4688999998865544445678899999999999999999999999999999999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
+++|.+++.. .++++..+..++.|++.||+|||+. +++||||+|+||+++.++.++++|||.+........
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 9999998843 3588999999999999999999998 899999999999999999999999998875433221
Q ss_pred eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 735 ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 12234588899999999888899999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=275.82 Aligned_cols=194 Identities=27% Similarity=0.436 Sum_probs=168.8
Q ss_pred CCeeccCCCccEEEeEee-CCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCC
Q 043333 580 DNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENN 656 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 656 (809)
.+.||.|-||+||-|+++ +|+.||||++.+. ....+.++.+|+.+|..++||.||.+..-|...+..+.|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 688999999999999965 6999999998664 2344577889999999999999999999999999999999999665
Q ss_pred chhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CceEEEecCCccccCCCCc
Q 043333 657 SLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 657 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~~~~~~~ 733 (809)
-|...| . ....++++..-..++.||+.||.|||.+ +|+|+||||+||||... ..+||||||.|+++.+...
T Consensus 649 MLEMIL-S--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 649 MLEMIL-S--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred HHHHHH-H--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 555555 2 2345688888888999999999999998 89999999999999654 4689999999999876543
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
...++||+.|.|||++..+.|...-|+||.|||+|.-++|..||..
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 3457899999999999999999999999999999999999999964
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=266.95 Aligned_cols=191 Identities=30% Similarity=0.400 Sum_probs=158.1
Q ss_pred eeccCCCccEEEeEee-CCeEEEEEEecccCcc---cchhHHHHHH---HHhhcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 582 KIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ---GNREFVNEIG---MISALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 582 ~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~---~~~~f~~Ei~---~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
.||+|+||.||+|... +++.||+|.+...... ....+..|.. .++...||+|+++.+++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999854 5889999998654221 1223444433 3444579999999999999999999999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 9999988832 34689999999999999999999998 899999999999999999999999999875432221
Q ss_pred eeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 735 ISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
....|+..|+|||.+.++ .++.++||||+||++|||++|+.||...
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 234688999999998754 6889999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=264.81 Aligned_cols=192 Identities=27% Similarity=0.380 Sum_probs=167.3
Q ss_pred eccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCch
Q 043333 583 IGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL 658 (809)
Q Consensus 583 LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 658 (809)
||+|+||.||+++.. +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 488999999865422 2346788999999999999999999999999999999999999999
Q ss_pred hhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceecc
Q 043333 659 ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 738 (809)
Q Consensus 659 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 738 (809)
.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 999943 23478899999999999999999997 89999999999999999999999999998664432 1223
Q ss_pred ccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 739 IAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 739 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
..++..|+|||.+....++.++|+||+|+++|||++|+.||....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 467889999999988889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=275.44 Aligned_cols=200 Identities=28% Similarity=0.429 Sum_probs=168.6
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEeccc--CcccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCeEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSK--SKQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 650 (809)
...|++.++||+||.+.||++.-.+.+.+|+|++... +.+....|..|++.|.+++ |.+||++++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4568889999999999999999877788898877543 3444678999999999996 999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||= ..+|..+|.... ....+| .+..+..||+.|+.++|++ +|||.||||.|+|+-+ |.+||+|||+|..+..
T Consensus 440 E~G-d~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred ecc-cccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 955 569999995432 223446 7788999999999999999 8999999999999976 5899999999998876
Q ss_pred CCcce-eccccccccccchhhhccC-----------CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 731 DNTHI-STRIAGTFGYMAPEYAMRG-----------YLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 731 ~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
+.... ....+||+.||+||.+... +++.++||||+|||||+|+.||+||..
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 65543 3356899999999998532 367899999999999999999999953
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=269.02 Aligned_cols=201 Identities=30% Similarity=0.464 Sum_probs=170.1
Q ss_pred cCCCCCCeeccCCCccEEEeEee-----CCeEEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEEe--CCeE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-----DGKVIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCIE--GNQL 646 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~ 646 (809)
+.|+..+.||+|+||.||+|.+. +++.||||.+...... ..+.|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999854 3678999998755443 45679999999999999999999999987 5578
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999543 23589999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcce--eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 727 LDEEDNTHI--STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 727 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 214 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence 765322211 1122345579999999888899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=270.12 Aligned_cols=204 Identities=32% Similarity=0.504 Sum_probs=172.3
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCC------
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGN------ 644 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~------ 644 (809)
++++|+..+.||+|+||.||+|... +++.+|+|++..... ..++|.+|+++++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5688999999999999999999964 578899999865433 346789999999999 6999999999997654
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999998854433346789999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeccccccccccchhhhcc-----CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
+......... .....++..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 160 SAQLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred ceecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 8765432221 223458889999998753 3467889999999999999999999964
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=268.72 Aligned_cols=203 Identities=26% Similarity=0.383 Sum_probs=170.1
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV 649 (809)
.+|....+||+|+||.|-.|.-+ ..+.+|||++++... .+.+--+.|-++|... +-|.++++..+++.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888999999999999998743 457899999987632 2223345566777665 578899999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+.+|+|-.++++.. ++.++.+..+|.+||-||-+||++ +||.||||..|||||.+|++||+|||+++.--
T Consensus 429 MEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999988885433 455678889999999999999999 89999999999999999999999999997432
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcc
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKE 785 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~ 785 (809)
.+. ..+...+||+.|+|||++...+|+..+|+|||||+||||+.|++||++.+++
T Consensus 502 ~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~ 556 (683)
T KOG0696|consen 502 FDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 556 (683)
T ss_pred cCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 222 2334589999999999999999999999999999999999999999885443
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=269.45 Aligned_cols=202 Identities=32% Similarity=0.570 Sum_probs=175.6
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++.|+..+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++++++|+|++++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999976 688999999875544 45678899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999995322 3789999999999999999999997 8999999999999999999999999988654432
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. ......++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~ 219 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE 219 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 21 112345778999999998888999999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=271.33 Aligned_cols=201 Identities=30% Similarity=0.478 Sum_probs=168.9
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+|+..+.||.|++|.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999864 68899999886543 22335788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
++ ++|.+++... ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 6888887543 234689999999999999999999998 89999999999999999999999999987553322
Q ss_pred cceeccccccccccchhhhccCC-CCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGY-LTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
. ......++..|+|||.+.+.. ++.++|||||||++|||+||+.||...+
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1 112334678999999876644 6889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=269.89 Aligned_cols=190 Identities=26% Similarity=0.425 Sum_probs=159.2
Q ss_pred CeeccCCCccEEEeEeeC--------CeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 581 NKIGEGGFGPVYKGLLAD--------GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~--------g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 234888887655444556788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc--------eEEEecCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN--------PKISDFGL 724 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~kl~DfGl 724 (809)
+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999543 23688999999999999999999998 8999999999999987765 59999998
Q ss_pred ccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCC-CCCCC
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGR-SNVIC 781 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk-~P~~~ 781 (809)
+...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+..
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 8654321 12457789999999876 45789999999999999999995 56544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=270.01 Aligned_cols=209 Identities=30% Similarity=0.479 Sum_probs=173.3
Q ss_pred cHHHHHHHhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEe-
Q 043333 566 TLRQIKAATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIE- 642 (809)
Q Consensus 566 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~- 642 (809)
++.++..+.+.|+..+.||+|+||.||+|.. .+++.||+|++.... ....++..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4556666778999999999999999999996 467899999885443 2345678899999998 69999999999863
Q ss_pred -----CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCce
Q 043333 643 -----GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 717 (809)
Q Consensus 643 -----~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 717 (809)
.+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 457899999999999999884322 23578888999999999999999998 89999999999999999999
Q ss_pred EEEecCCccccCCCCcceeccccccccccchhhhc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 718 KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 718 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
+|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 228 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence 9999999875432211 122356888999999875 34678899999999999999999999965
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=292.11 Aligned_cols=203 Identities=21% Similarity=0.309 Sum_probs=160.2
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeC--CeEEEEEE--------------ecc---cCcccchhHHHHHHHHhhcCCCce
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLAD--GKVIAVKQ--------------LSS---KSKQGNREFVNEIGMISALQHPNL 633 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~--------------~~~---~~~~~~~~f~~Ei~~l~~l~H~nI 633 (809)
..++|++.+.||+|+||+||++..+. +..+++|. +.+ ........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987542 22222221 100 111223457899999999999999
Q ss_pred EeEEeEEEeCCeEEEEEEcccCCchhhhccCCC-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc
Q 043333 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPE-EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD 712 (809)
Q Consensus 634 v~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 712 (809)
+++++++.+.+..++|+|++. ++|.+++.... ..........+..++.|++.||+|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999985 46777664322 1122234556778999999999999998 899999999999999
Q ss_pred CCCceEEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCC
Q 043333 713 KDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNV 779 (809)
Q Consensus 713 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~ 779 (809)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.|+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999876544333333467999999999999999999999999999999999998644
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=265.76 Aligned_cols=196 Identities=30% Similarity=0.504 Sum_probs=166.2
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
++|+..+.||+|+||.||++.. .++.||+|..+... ..+.+.+|+.++++++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4577889999999999999975 57789999986432 245788999999999999999999998754 5799999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
+|+|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 82 KGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 999999985432 33578999999999999999999997 89999999999999999999999999987543221
Q ss_pred eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 735 ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
.....+..|+|||++.++.++.++|||||||++|||++ |+.||...+
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 202 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence 11223568999999988899999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=264.96 Aligned_cols=200 Identities=28% Similarity=0.438 Sum_probs=171.4
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+|+..+.||+|+||.||++... +++.+|||++.... ....+.+..|++++++++||||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999854 67889999986542 23356788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CceEEEecCCccccCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLDEED 731 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~~~~ 731 (809)
+++++|.+++... ....+++..+..++.+++.||+|||++ +++||||||+||+++++ +.++++|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999542 234588999999999999999999998 89999999999999865 46899999999865433
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 21 22356788999999999888899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=271.01 Aligned_cols=193 Identities=29% Similarity=0.532 Sum_probs=168.3
Q ss_pred CeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCchh
Q 043333 581 NKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLA 659 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~ 659 (809)
.+||+|+||.||++.. .+++.||||++........+.+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5699999999999986 468999999986554445567889999999999999999999999999999999999999999
Q ss_pred hhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceeccc
Q 043333 660 RALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRI 739 (809)
Q Consensus 660 ~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 739 (809)
+++. ...+++.....++.|++.||+|||+. +++||||+|+||++++++.++|+|||++........ .....
T Consensus 106 ~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 106 DIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 9873 23578999999999999999999998 899999999999999999999999999875543221 12235
Q ss_pred cccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 740 AGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 740 ~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.+++.|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 6888999999998888899999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=268.84 Aligned_cols=199 Identities=28% Similarity=0.470 Sum_probs=172.8
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
++|+..+.||+|+||.||++... +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35677889999999999999965 68899999986653 23456788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
+++++|.+++... ...+++..+..++.|++.||+|||+ . +++||||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999998432 2568889999999999999999999 6 8999999999999999999999999998755322
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
... ...++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 211 156788999999999889999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=259.86 Aligned_cols=199 Identities=36% Similarity=0.570 Sum_probs=175.4
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999975 688999999976655456788999999999999999999999999999999999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
+++|.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999988432 24689999999999999999999997 899999999999999999999999999876654321
Q ss_pred eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 735 ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.....++..|+|||++.....+.++||||||+++|||++|+.||...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23456788999999998888999999999999999999999999654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=246.27 Aligned_cols=200 Identities=26% Similarity=0.401 Sum_probs=164.4
Q ss_pred CCCCCeeccCCCccEEEeEe-eCCeEEEEEEeccc-CcccchhHHHHHHHHhh-cCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 577 FAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSK-SKQGNREFVNEIGMISA-LQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~-l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
......||+|+||.|-+-++ .+|+..|||+++.. ..+..++.+.|+.+..+ ..+|.+|.++|.+.+....|+.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 34457799999999988775 47999999999765 34445677788877555 47999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
.- ||+.+-...-.....+++...-+||..+.+||.|||++ ..+||||+||+|||++.+|++|+||||++..+.+.-
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi- 203 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI- 203 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh-
Confidence 65 77665433234556788999999999999999999998 489999999999999999999999999997665322
Q ss_pred ceeccccccccccchhhhcc----CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMR----GYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~----~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
..+...|-..|||||.+.. ..|+-|+||||+|+.+.||.+++.||+.
T Consensus 204 -Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 204 -AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred -HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 1223457778999998853 3688999999999999999999999975
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=265.01 Aligned_cols=203 Identities=26% Similarity=0.442 Sum_probs=165.7
Q ss_pred CCCCCeeccCCCccEEEeEee----CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCC------
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA----DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGN------ 644 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 644 (809)
|...+.||+|+||.||+|... .++.||||++.... ....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556788999999999999853 36789999986542 233567889999999999999999999987542
Q ss_pred eEEEEEEcccCCchhhhccCCC--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 645 QLLLIYEYMENNSLARALFGPE--EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
..++++||+++|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875321 2234578999999999999999999998 8999999999999999999999999
Q ss_pred CCccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 723 GLAKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 723 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
|+++........ ......+++.|++||.+....++.++|||||||++|||++ |+.||...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 998865432211 1122335568999999988889999999999999999999 89998654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=270.59 Aligned_cols=195 Identities=34% Similarity=0.557 Sum_probs=166.1
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
+.|...+.||+|+||.||+|... +++.||+|++..... ...+++.+|+++++.++||||+++.++|.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 55888899999999999999864 688999998864432 22356889999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||++ |++.+++.. ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 577666632 234589999999999999999999998 899999999999999999999999999876543
Q ss_pred CCcceeccccccccccchhhhc---cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.. ...++..|+|||++. ...++.++||||||+++|||+||+.||..
T Consensus 168 ~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 168 AN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred CC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 22 245778999999874 45688899999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=264.30 Aligned_cols=202 Identities=31% Similarity=0.496 Sum_probs=175.0
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+|+..+.||+|+||.||++... +++.+|+|.+.... .....++.+|++++++++|+||+++.+++.+.+..++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999854 67899999986542 23345678899999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999855333446789999999999999999999998 8999999999999999999999999999866543
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
......++..|+|||...+..++.++|+||+|+++|||++|+.||...+
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1123457889999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=275.78 Aligned_cols=200 Identities=26% Similarity=0.433 Sum_probs=166.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCC-----eE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGN-----QL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~ 646 (809)
+++|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++||||+++++++...+ ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 468999999986432 223456788999999999999999999876543 57
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++|+||+++ +|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 999999975 7877762 34689999999999999999999998 89999999999999999999999999987
Q ss_pred ccCCCCcc--eeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 727 LDEEDNTH--ISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 727 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
........ ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 65332211 1123568899999998754 56899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=263.63 Aligned_cols=197 Identities=29% Similarity=0.387 Sum_probs=163.3
Q ss_pred CCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc-ccchhHHHHHHHHhhcC-CCceEeEEeEEEeC--CeEEEEEE
Q 043333 577 FAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK-QGNREFVNEIGMISALQ-HPNLVKLYGCCIEG--NQLLLIYE 651 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~e 651 (809)
|+..+.||+|+||.||+|.. .+++.||+|+++.... ........|+.++.++. |+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 55678899999999999985 4688999999865422 22334557888898885 99999999999987 88999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|++ |+|.+++... ...++|..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 5888877432 24689999999999999999999998 8999999999999999 99999999999765432
Q ss_pred Ccceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... ....++..|+|||++.. +.++.++||||+||++|||++|+.||...+
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 221 23457889999997654 567889999999999999999999997643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-31 Score=286.75 Aligned_cols=342 Identities=19% Similarity=0.163 Sum_probs=184.5
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCC-CCccccccccccCCCCch-hhcCCccCcEEeeccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWAS-LPLVNLPLWKQANGAIPK-AVASISTLADLTLEFNQF 79 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~-l~L~~L~l~~n~~~~ip~-~l~~l~~L~~L~L~~N~l 79 (809)
|+|.+|.|+..-..++..++.|++||||.|.|+...-..|.. .++++|+|++|.|+.+-. .|.++.+|..|.|+.|.+
T Consensus 130 L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNri 209 (873)
T KOG4194|consen 130 LDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRI 209 (873)
T ss_pred EeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcc
Confidence 455555555555555555555555555555555444444443 345555555555555532 445555555555555555
Q ss_pred ccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccc
Q 043333 80 SGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGI 159 (809)
Q Consensus 80 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 159 (809)
+...+..|.+|++|+.|+|..|+|.-..--.|.+|++|+.|.|..|.++..-...|..+.++++|+|+.|+++..--.++
T Consensus 210 ttLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~l 289 (873)
T KOG4194|consen 210 TTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWL 289 (873)
T ss_pred cccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccc
Confidence 53333345555555555555555552223345555555555555555554444445555566666666666654445555
Q ss_pred cCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccE
Q 043333 160 ASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTY 238 (809)
Q Consensus 160 ~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~ 238 (809)
.+++.|+.|++++|.|..+....++..++|++|+|+.|+|+...+..|..|..|+.|+|++|.|+.+-...|.+ ++|+.
T Consensus 290 fgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~ 369 (873)
T KOG4194|consen 290 FGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHK 369 (873)
T ss_pred cccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhh
Confidence 66666666666666666666666666666666666666666666666666666666666666666555555555 66666
Q ss_pred EEeeCccCCCCCChhhh----hccCccccccCCccccCCCCCcccccccceeccccCCCCCCcccccc--ccCCCCCCCc
Q 043333 239 MYLTGNLLTGPVPDWIV----RKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVSCL--KSFTCPTNHS 312 (809)
Q Consensus 239 L~Ls~N~l~~~~p~~~~----~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~--~~~~~~~~~~ 312 (809)
|||++|.|+..+.+.-. ..+++.|+|.+|++...+-..+.+...+..+..+++....--.-... .......+..
T Consensus 370 LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSs 449 (873)
T KOG4194|consen 370 LDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSS 449 (873)
T ss_pred hcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhccc
Confidence 66666666654443221 13445666666666655554444444443333332222111100000 2334456778
Q ss_pred ceeecCCCceeee---cCCeeecCCCCCCCCcce
Q 043333 313 SLHINCGGKQVIA---NGSTTFEDDLDAAGPSRF 343 (809)
Q Consensus 313 ~~~~~C~~~~~~~---~~~~~~~~~~~~~g~~~~ 343 (809)
++-|||+..|+.. ...........|+-|.++
T Consensus 450 sflCDCql~Wl~qWl~~~~lq~sv~a~CayPe~L 483 (873)
T KOG4194|consen 450 SFLCDCQLKWLAQWLYRRKLQSSVIAKCAYPEPL 483 (873)
T ss_pred ceEEeccHHHHHHHHHhcccccceeeeccCCccc
Confidence 8999999888643 222223334566666655
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-31 Score=305.27 Aligned_cols=201 Identities=35% Similarity=0.487 Sum_probs=169.2
Q ss_pred cCCCCCCeeccCCCccEEEeE-eeCCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
-++.....||.|.||.||.|. ..+|+..|||.++-. .....+...+|+.++..++|||+|+++|+-...+..++.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 456667889999999999998 557999999977543 33345667889999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
||++|+|++.+. .....++.....+..|++.|+.|||++ +||||||||.||+|+.+|.+|.+|||.|......
T Consensus 1315 yC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1315 YCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999882 333456666677889999999999998 8999999999999999999999999999866433
Q ss_pred Cc---ceeccccccccccchhhhccC---CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 732 NT---HISTRIAGTFGYMAPEYAMRG---YLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 732 ~~---~~~~~~~gt~~y~aPE~~~~~---~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. ..-....||+.|||||++.+. ...-+.||||+|||++||+|||+||..-
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc
Confidence 21 112247899999999999753 3566899999999999999999999654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=252.85 Aligned_cols=198 Identities=28% Similarity=0.460 Sum_probs=165.2
Q ss_pred CCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc-CcccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCeEEEEEEcc
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK-SKQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.+....||.|..|.|++++++ .|..+|||.+... +.+..++++..++++.+-. .|.||+.+|||..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 345677999999999999976 4899999998765 4555677888888776654 899999999999999999999998
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
.. .++.+|. ....++++..+-++...+..||.||-+++ +|+|||+||+|||+|+.|.+|+||||++..+.+...
T Consensus 174 s~-C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 174 ST-CAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HH-HHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 64 4555552 23456888888899999999999998875 899999999999999999999999999987654433
Q ss_pred ceeccccccccccchhhhcc---CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+ ++.+|-+.|||||.+.- ..|+-++||||||+.++||.||+.||...
T Consensus 248 h--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c 297 (391)
T KOG0983|consen 248 H--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC 297 (391)
T ss_pred c--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC
Confidence 3 45678899999999853 46788999999999999999999999773
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=262.91 Aligned_cols=201 Identities=25% Similarity=0.449 Sum_probs=171.4
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+|+..+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677899999999999999965 57889999986542 23345788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-ceEEEecCCccccCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDEED 731 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~ 731 (809)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++ .++++|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999988532 233579999999999999999999998 899999999999999885 4699999998765433
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. ......|++.|+|||+..+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 22 222345888999999998888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=265.69 Aligned_cols=199 Identities=30% Similarity=0.484 Sum_probs=167.4
Q ss_pred CCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
|+..+.||+|++|.||+|... +|+.||+|++..... ...+.+.+|++++++++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999864 689999999865432 22356889999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
+ ++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 68999885332 13689999999999999999999998 899999999999999999999999999875432211
Q ss_pred ceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
. .....++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1223467899999987654 5788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=260.17 Aligned_cols=203 Identities=27% Similarity=0.457 Sum_probs=176.9
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+|+..+.||+|+||.||++... +++.||+|++..... ...+++.+|++++++++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999965 588999999865533 4456788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.+++.........+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999865433346789999999999999999999998 89999999999999999999999999997654432
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.......|++.|+|||...+..++.++||||+|+++++|++|+.||...
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 1223346888999999998888999999999999999999999999664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=274.40 Aligned_cols=204 Identities=25% Similarity=0.407 Sum_probs=170.8
Q ss_pred cHHHHHHHhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEe
Q 043333 566 TLRQIKAATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIE 642 (809)
Q Consensus 566 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~ 642 (809)
..+++...+++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 4556667889999999999999999999984 468999999986532 2234567889999999999999999998864
Q ss_pred C------CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc
Q 043333 643 G------NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 716 (809)
Q Consensus 643 ~------~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 716 (809)
. ...++|++++ +++|.+++. ...+++..+..++.|+++||+|||+. +++||||||+||++++++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 3 3467888876 778988773 23589999999999999999999998 8999999999999999999
Q ss_pred eEEEecCCccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 717 PKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 717 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999998754322 123457889999998866 56788999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=263.47 Aligned_cols=194 Identities=29% Similarity=0.438 Sum_probs=167.0
Q ss_pred eccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCch
Q 043333 583 IGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL 658 (809)
Q Consensus 583 LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 658 (809)
||+|+||.||++... +|+.||+|.+..... ...+.+.+|++++.+++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999865433 3456788899999999999999999999999999999999999999
Q ss_pred hhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc-----
Q 043333 659 ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT----- 733 (809)
Q Consensus 659 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~----- 733 (809)
.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9998432 2689999999999999999999998 899999999999999999999999999875433211
Q ss_pred --ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 734 --HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 734 --~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.......++..|+|||.......+.++||||||+++|||++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 11223457889999999988888999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=251.84 Aligned_cols=227 Identities=24% Similarity=0.349 Sum_probs=186.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc---CcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK---SKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~l 648 (809)
..+|...++||+|+|++|..+++. ..+.+|+|++++. ..++....+.|-.+..+. +||.+|-+..+++....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467889999999999999999854 5788999998765 344456678888888777 69999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
|.||+++|+|--+++ ...++++..+..+...|.-||.|||++ +||.||||..|||+|..|++|++|+|+++.-
T Consensus 329 vieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999866553 344688999999999999999999999 8999999999999999999999999999754
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC---CCcc-cchhHHHHHHHhhccCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC---RTKE-AQFCLLDWVTLALTDFRFP 804 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~---~~~~-~~~~l~~~~~~~~~~~~~p 804 (809)
-.+ ...+...+||+.|.|||++.+..|...+|+|++||+++||+.|+.||+- .+.+ ..++.. +.--.-.+.++|
T Consensus 402 l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl-fqvilekqirip 479 (593)
T KOG0695|consen 402 LGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL-FQVILEKQIRIP 479 (593)
T ss_pred CCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH-HHHHhhhccccc
Confidence 332 2334568999999999999999999999999999999999999999963 2222 222222 112233458899
Q ss_pred cCCCC
Q 043333 805 LFLSL 809 (809)
Q Consensus 805 ~~~~~ 809 (809)
+.+|+
T Consensus 480 rslsv 484 (593)
T KOG0695|consen 480 RSLSV 484 (593)
T ss_pred ceeeh
Confidence 88874
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=268.40 Aligned_cols=193 Identities=32% Similarity=0.545 Sum_probs=164.3
Q ss_pred CCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+..|++++++++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 556788999999999999954 688999999864422 2235688899999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
++ |+|.+.+.. ...+++|..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 97 477776632 234689999999999999999999998 8999999999999999999999999998754322
Q ss_pred cceeccccccccccchhhhc---cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
....++..|+|||++. .+.++.++|||||||++|||++|+.||..
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 2245788999999874 45688999999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=261.06 Aligned_cols=190 Identities=27% Similarity=0.375 Sum_probs=159.9
Q ss_pred CeeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHH-HhhcCCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGM-ISALQHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~-l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|... +|+.||||++..... .....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 588999999865422 122334455444 3455899999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999843 23578899999999999999999998 899999999999999999999999999875432
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 12345788999999998888899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=266.99 Aligned_cols=204 Identities=29% Similarity=0.477 Sum_probs=169.5
Q ss_pred hcCCCCCCeeccCCCccEEEeE-eeCCeEEEEEEeccc--Cccc-----chhHHHHHHHHhhcCCCceEeEEeEEE-eCC
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSK--SKQG-----NREFVNEIGMISALQHPNLVKLYGCCI-EGN 644 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~--~~~~-----~~~f~~Ei~~l~~l~H~nIv~l~~~~~-~~~ 644 (809)
.++|-..++||+|||+.||+|. +...+.||||+-... ..+. .+...+|.++.+.+.||-||++++|+. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3567778899999999999998 456788999986432 1111 244678999999999999999999998 457
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCceEEEe
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISD 721 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~D 721 (809)
.+|-|+|||++.+|+-||. ...-+++..+..|++||+.||.||.+. .++|||-||||.||||.. .|++||+|
T Consensus 542 sFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 7899999999999999993 334578889999999999999999987 468999999999999954 48899999
Q ss_pred cCCccccCCCCcc------eeccccccccccchhhhcc----CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 722 FGLAKLDEEDNTH------ISTRIAGTFGYMAPEYAMR----GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 722 fGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
||+++.+.++... .....+||.+|.+||.+.- .+++.|+||||.|||+|..+.|+.||...
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 9999988655432 3445789999999997643 35788999999999999999999999653
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=265.53 Aligned_cols=201 Identities=21% Similarity=0.236 Sum_probs=152.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC----CeEEEEEEecccCcccc-----------hhHHHHHHHHhhcCCCceEeEEe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD----GKVIAVKQLSSKSKQGN-----------REFVNEIGMISALQHPNLVKLYG 638 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~~~~~-----------~~f~~Ei~~l~~l~H~nIv~l~~ 638 (809)
.++|.+.+.||+|+||.||+|...+ +..+|+|+......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4678899999999999999999654 34566665432221110 11222334456678999999999
Q ss_pred EEEeCC----eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC
Q 043333 639 CCIEGN----QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD 714 (809)
Q Consensus 639 ~~~~~~----~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~ 714 (809)
++.... ..++++|++.. ++.+.+.. ....++..+..++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 877654 34677777643 55555421 12356788899999999999999998 89999999999999999
Q ss_pred CceEEEecCCccccCCCCcc------eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 715 LNPKISDFGLAKLDEEDNTH------ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 715 ~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+.++|+|||+|+........ ......||+.|+|||+..+..++.++|||||||++|||++|+.||...
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999865322211 112246999999999999999999999999999999999999999764
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=274.47 Aligned_cols=199 Identities=24% Similarity=0.355 Sum_probs=167.9
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeC------
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEG------ 643 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~------ 643 (809)
..++|+..+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999854 6889999998643 222345677899999999999999999998644
Q ss_pred CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 644 NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
...++||||++ ++|.+.+.. .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35699999996 488887732 278889999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 724 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 9986543221 223457889999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=269.83 Aligned_cols=203 Identities=31% Similarity=0.476 Sum_probs=166.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc--cchhHHHHHHHHhhcCCCceEeEEeEEEeCC------
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLYGCCIEGN------ 644 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 644 (809)
.++|+..+.||+|+||.||+|... +++.||||++...... ....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468899999999999999999964 6889999988654322 2346778999999999999999999876533
Q ss_pred --eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 645 --QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 645 --~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
..++|+||++. ++...+.. ....+++..+..++.|+++||+|||+. +++||||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999975 67666643 234689999999999999999999998 8999999999999999999999999
Q ss_pred CCccccCCCCcc----------eeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 723 GLAKLDEEDNTH----------ISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 723 Gla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
|++......... ......+++.|+|||.+.+ ..++.++|||||||++|||++|++||...+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 999755332211 1122456788999998765 457899999999999999999999997644
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=272.75 Aligned_cols=201 Identities=28% Similarity=0.456 Sum_probs=167.6
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc--CcccchhHHHHHHHHhhc-CCCceEeEEeEEEeC--CeE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK--SKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEG--NQL 646 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~--~~~ 646 (809)
..++|+..+.||+|+||.||+|... +++.||||++... .......+.+|+.++.++ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888899999999999999965 5889999988543 223345677899999999 999999999998754 368
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++||||++ ++|.+++.. ..++|..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 589888732 2678999999999999999999998 89999999999999999999999999997
Q ss_pred ccCCCCc----ceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 727 LDEEDNT----HISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 727 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
....... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 6543321 12234568899999998765 56788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=256.74 Aligned_cols=200 Identities=34% Similarity=0.489 Sum_probs=174.2
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeEEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEG--NQLLLIY 650 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 650 (809)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+.+. +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999976 688999999865542 3457788999999999999999999999988 8899999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998432 2789999999999999999999997 899999999999999999999999999886654
Q ss_pred CCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.... ......++..|+|||.......+.++||||||++++||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3321 122356788999999998888999999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=272.15 Aligned_cols=212 Identities=25% Similarity=0.394 Sum_probs=174.6
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
-|..++.||-|+||.|.++... ....+|.|.+++.+. .......+|-.||.....+.||+|+-.|.+++.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 3667888999999999999854 467899999977632 334456789999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc---
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD--- 728 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~--- 728 (809)
|++||++-.+|.. ...+.+..+..++.++++|+++.|.. ++|||||||.|||||.+|++||+|||++.-+
T Consensus 710 YIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999888743 23467777888889999999999997 8999999999999999999999999998522
Q ss_pred ------CCCCcce--------------------------------eccccccccccchhhhccCCCCchHHHHHHHHHHH
Q 043333 729 ------EEDNTHI--------------------------------STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVAL 770 (809)
Q Consensus 729 ------~~~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ 770 (809)
.+.+... .-..+||+.|+|||++....++.-+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 1110000 00146999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCC-cccchhHHHHH
Q 043333 771 EIVSGRSNVICRT-KEAQFCLLDWV 794 (809)
Q Consensus 771 elltGk~P~~~~~-~~~~~~l~~~~ 794 (809)
||+.|+.||...+ .+.+..+..|-
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~ 887 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWR 887 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehh
Confidence 9999999997755 44555555664
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=256.93 Aligned_cols=198 Identities=33% Similarity=0.524 Sum_probs=173.4
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+|+..+.||+|++|.||++... +++.||+|.+..... ...+.+.+|++++++++|||++++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 578999999876543 3456789999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999998843 24689999999999999999999998 89999999999999999999999999998665433
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.. .....++..|+|||...+...+.++||||+|+++|||++|+.||..
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 22 2234578899999999887889999999999999999999999965
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-31 Score=254.77 Aligned_cols=225 Identities=28% Similarity=0.453 Sum_probs=185.3
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-ccc-chhHHHHHHHHhhcCCCceEeEEeEEEeC--------
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQG-NREFVNEIGMISALQHPNLVKLYGCCIEG-------- 643 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~-~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~-------- 643 (809)
..|....+||+|.||.||+|+.. .|+.||+|++-... ++. -...++|+++|..++|+|+++++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34555678999999999999955 57788998764332 222 23457899999999999999999988742
Q ss_pred CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 644 NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
..+++||++|+. +|+-.|.. ...+++...+.++++++..||.|+|.. .|+|||+||.|+|++.++.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 358999999987 78777732 235688889999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCc---ceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhc
Q 043333 724 LAKLDEEDNT---HISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALT 799 (809)
Q Consensus 724 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~ 799 (809)
+++.+..... ...+..+-|..|++||.+.+ +.++++.|||+.|||+.||+||.+-+.+.++..+..++.-....+.
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 9986643322 12334556999999998876 5789999999999999999999999999888888999999999998
Q ss_pred cCCCCcC
Q 043333 800 DFRFPLF 806 (809)
Q Consensus 800 ~~~~p~~ 806 (809)
..-||.-
T Consensus 250 kevWP~~ 256 (376)
T KOG0669|consen 250 KEVWPNV 256 (376)
T ss_pred cccCCCc
Confidence 8888863
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=279.32 Aligned_cols=199 Identities=27% Similarity=0.450 Sum_probs=170.4
Q ss_pred CCCCCCeeccCCCccEEEeEeeC-CeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
-|.++..||.|+||.||+|+.++ +-..|.|++..++.+..++|+-|+++|..+.||+||++++.|+..+.+|+..|||+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 35566779999999999999664 44567788877777777889999999999999999999999999999999999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
||-++..+.. -...+...++..+++|++.||.|||++ +|||||||+.|||++-+|.++++|||.+...... ..
T Consensus 113 GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~q 185 (1187)
T KOG0579|consen 113 GGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQ 185 (1187)
T ss_pred CchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-Hh
Confidence 9999887643 345789999999999999999999999 8999999999999999999999999997533211 11
Q ss_pred eeccccccccccchhhhc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 735 ISTRIAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
....+.||++|||||+.+ ..+|+.++||||||+.|.||..+.+|-..
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 223467999999999875 45789999999999999999999998754
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=269.36 Aligned_cols=201 Identities=24% Similarity=0.395 Sum_probs=165.0
Q ss_pred cCCCC-CCeeccCCCccEEEeEee-CCeEEEEEEecccCccc--------------chhHHHHHHHHhhcCCCceEeEEe
Q 043333 575 NNFAP-DNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQG--------------NREFVNEIGMISALQHPNLVKLYG 638 (809)
Q Consensus 575 ~~f~~-~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~--------------~~~f~~Ei~~l~~l~H~nIv~l~~ 638 (809)
++|.. .+.||+|+||.||+|... +++.||||+++...... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45543 467999999999999854 68999999886542221 124778999999999999999999
Q ss_pred EEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceE
Q 043333 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 718 (809)
Q Consensus 639 ~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 718 (809)
++...+..++||||++ |+|.+++. ....+++.....++.|++.||+|||+. +++||||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999997 68988883 234588999999999999999999998 899999999999999999999
Q ss_pred EEecCCccccCCCC-------------cceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 719 ISDFGLAKLDEEDN-------------THISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 719 l~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
|+|||++....... ........++..|+|||.+.+. .++.++||||+||++|||++|+.||...+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999987554110 1111123467889999998764 46899999999999999999999997643
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=265.02 Aligned_cols=199 Identities=28% Similarity=0.400 Sum_probs=168.0
Q ss_pred CCCCCCeeccCCCccEEEeEee----CCeEEEEEEecccC----cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA----DGKVIAVKQLSSKS----KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 646 (809)
+|+..+.||+|+||.||++... +++.||||+++... ....+.+..|++++.++ +||||+++++.+...+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3667889999999999998742 56889999986432 22345678899999999 599999999999999999
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999998843 23578899999999999999999997 89999999999999999999999999987
Q ss_pred ccCCCCcceeccccccccccchhhhccCC--CCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 727 LDEEDNTHISTRIAGTFGYMAPEYAMRGY--LTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 65433322223356888999999987654 78899999999999999999999954
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=270.71 Aligned_cols=196 Identities=24% Similarity=0.433 Sum_probs=164.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCC------
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGN------ 644 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 644 (809)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999985 468999999986532 222356789999999999999999999987543
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
..++|+||+.. +|.++. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46999999974 666654 22578999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 164 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 164 ARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 87543221 23457889999999876 468899999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=265.55 Aligned_cols=201 Identities=30% Similarity=0.444 Sum_probs=163.6
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCeEEEEEEc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..++||||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4455678999999999999854 58899999986543 233567889999999996 99999999999999999999999
Q ss_pred ccCCchhhhccC-CCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 653 MENNSLARALFG-PEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 653 ~~~gsL~~~L~~-~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
++. ++.++... .......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 55443211 1112356899999999999999999999752 7999999999999999999999999998755332
Q ss_pred CcceeccccccccccchhhhccC---CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRG---YLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.. .....|+..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 21 1234578899999998776 689999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=271.84 Aligned_cols=202 Identities=24% Similarity=0.404 Sum_probs=168.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEe----CCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIE----GNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~ 646 (809)
.++|+..+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468889999999999999999854 689999999865422 334567789999999999999999998763 3468
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++|+||+. |+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 689888843 33489999999999999999999998 89999999999999999999999999987
Q ss_pred ccCCCCc---ceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 727 LDEEDNT---HISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 727 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
....... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 5533221 11223468889999998865 468899999999999999999999996643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=261.29 Aligned_cols=199 Identities=30% Similarity=0.475 Sum_probs=165.7
Q ss_pred CCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc--cchhHHHHHHHHhhc---CCCceEeEEeEEEeCCe-----
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ--GNREFVNEIGMISAL---QHPNLVKLYGCCIEGNQ----- 645 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l---~H~nIv~l~~~~~~~~~----- 645 (809)
|++.+.||+|+||.||+|... +++.||+|+++..... ....+.+|++++.++ +||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999976 4899999998754322 234566787777665 59999999999998776
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.+++|||+++ +|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999974 7888874322 23589999999999999999999998 8999999999999999999999999998
Q ss_pred cccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 726 KLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 726 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
......... ....++..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 155 RIYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred eeccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 765433221 23347889999999999899999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=262.32 Aligned_cols=199 Identities=29% Similarity=0.444 Sum_probs=169.7
Q ss_pred CCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc--cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
|+..+.||+|++|.||+|... +++.+|+|++...... ....+..|++++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556788999999999999864 6889999998655332 3467888999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++ +|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 88887743 224789999999999999999999998 89999999999999999999999999987665433
Q ss_pred ceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.......++..|+|||.+.+. .++.++||||+|+++|+|+||+.||...+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234577889999998776 78999999999999999999999996644
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=269.31 Aligned_cols=198 Identities=24% Similarity=0.415 Sum_probs=167.1
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCC----
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGN---- 644 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~---- 644 (809)
...++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567899999999999999999984 468999999985432 222356788999999999999999999987643
Q ss_pred --eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 645 --QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 645 --~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
..++||||+ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 678888773 24689999999999999999999998 8999999999999999999999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
|++....... ....+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...
T Consensus 163 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 163 GLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9987654321 23457889999999876 45889999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=263.11 Aligned_cols=202 Identities=27% Similarity=0.439 Sum_probs=173.6
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCeEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV 649 (809)
++|...+.||+|+||.||+|... +++.||+|++.... ....+.+..|++++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999964 68999999986532 233466888999999998 99999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.+++++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999843 23689999999999999999999998 89999999999999999999999999987654
Q ss_pred CCCc-------------------ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNT-------------------HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.... .......++..|+|||......++.++||||||++++|+++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 3221 11123457889999999988889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=270.10 Aligned_cols=200 Identities=26% Similarity=0.448 Sum_probs=167.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeC-----Ce
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEG-----NQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~ 645 (809)
.++|...+.||+|+||+||+|+.. +++.||||.+... .......+.+|+++++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888999999999999999854 6889999998653 223345677899999999999999999988754 34
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 688888732 34689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 726 KLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 726 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
....... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 8654322 12233457889999998865 46889999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=269.82 Aligned_cols=200 Identities=26% Similarity=0.422 Sum_probs=171.3
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCC-----eEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGN-----QLL 647 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~ 647 (809)
+|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++||||+++.+++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999965 48899999987643 334567889999999999999999999998875 789
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+||||++ ++|.+++.. ..++++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999998 488888843 23789999999999999999999998 899999999999999999999999999986
Q ss_pred cCCCCc--ceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 728 DEEDNT--HISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 544321 112234578899999999887 78999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-31 Score=258.19 Aligned_cols=197 Identities=30% Similarity=0.426 Sum_probs=162.1
Q ss_pred CCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEEEcccCC
Q 043333 580 DNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYMENN 656 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~g 656 (809)
...||.|.||+|+|-.++ .|+.+|||+++.... .+.++++.|.+...+- +.||||+++|.+..++.-|+.||.|.-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 467999999999998854 699999999987654 4567788888775554 699999999999999999999999964
Q ss_pred chhhhcc-CCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 657 SLARALF-GPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 657 sL~~~L~-~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
||+.+.. ........+++...-+|..-+..||.||-+.. .|||||+||+|||+|..|.+|+||||++..+.+. -.
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--iA 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--IA 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH--HH
Confidence 5554321 12234556888888899999999999998774 8999999999999999999999999998765432 23
Q ss_pred eccccccccccchhhhcc--CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.+..+|-..|||||.+.. ..++-++||||+|+.|+|+.||+.|+..
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 345678889999999864 3488899999999999999999999965
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=270.15 Aligned_cols=221 Identities=23% Similarity=0.322 Sum_probs=184.8
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCe-EEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGK-VIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~-~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
.+++.+..||-|+||.|=.+...+.+ .+|+|++++.. ....+....|-.+|...+.|.||+++..|.++++.|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556678999999999888765433 48888887652 233455678999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
|-|-+|.|...|. .+..++..+...++..+.+|++|||.+ +||.|||||+|.+||.+|-+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999994 455678888899999999999999999 899999999999999999999999999998765
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhccCCCCcCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFL 807 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~~~~p~~~ 807 (809)
.. .+..++||+.|.|||++.++.++..+|.||+|+++|||++|++||.+.++ ..-..-+..-+.-+.||..+
T Consensus 573 g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp---mktYn~ILkGid~i~~Pr~I 644 (732)
T KOG0614|consen 573 GR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP---MKTYNLILKGIDKIEFPRRI 644 (732)
T ss_pred CC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHhhhhhhhccccc
Confidence 43 34568999999999999999999999999999999999999999987543 33334455555556666554
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=263.33 Aligned_cols=200 Identities=30% Similarity=0.471 Sum_probs=164.6
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC-CeEEEEEEecccCc-ccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCeEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSK-QGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 650 (809)
.++|+..+.||+|+||.||+|...+ ++.||||+++.... ....++..|++++.+.. ||||++++++|.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567889999999999999999764 89999999865432 23455677887777775 999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++ ++.+++.. ....+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||++.....
T Consensus 94 e~~~~-~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99864 66665522 1236899999999999999999999742 799999999999999999999999999876543
Q ss_pred CCcceeccccccccccchhhhccCC----CCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGY----LTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 168 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 168 SKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 2221 2335778999999987553 78899999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=266.17 Aligned_cols=200 Identities=26% Similarity=0.410 Sum_probs=168.1
Q ss_pred HHHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEe-CCeE
Q 043333 571 KAATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIE-GNQL 646 (809)
Q Consensus 571 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~ 646 (809)
...+++|+..+.||+|+||.||+|... +++.||||++.... ....+.+..|++++.+++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999854 78999999875432 2234677889999999999999999999876 4578
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++|+||+ +++|.+++. ..++++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+.
T Consensus 86 ~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999998 468888873 23578888889999999999999998 89999999999999999999999999987
Q ss_pred ccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 727 LDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 157 IQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred ccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 543221 22456789999998765 568999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=270.90 Aligned_cols=201 Identities=28% Similarity=0.433 Sum_probs=165.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeC---------
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEG--------- 643 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--------- 643 (809)
..+|...+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367889999999999999999854 6889999998766555567788999999999999999999776543
Q ss_pred -----CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCCce
Q 043333 644 -----NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNP 717 (809)
Q Consensus 644 -----~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~ 717 (809)
...++|+||++ ++|.+++. ...+++..+..++.|++.||.|||+. +++||||||+||+++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 35789999997 58888773 23588999999999999999999998 899999999999997 45678
Q ss_pred EEEecCCccccCCCCcc--eeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 718 KISDFGLAKLDEEDNTH--ISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 718 kl~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
+++|||++......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||...+
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999765322111 1122357889999998654 567889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-28 Score=261.28 Aligned_cols=193 Identities=33% Similarity=0.548 Sum_probs=163.6
Q ss_pred CCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
|...+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999854 688999999864422 2235678899999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+. |++.+++.. ...++++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA- 174 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence 96 577777632 234689999999999999999999998 8999999999999999999999999998643221
Q ss_pred cceeccccccccccchhhhc---cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
....|+..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2346788999999974 45688899999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=273.52 Aligned_cols=278 Identities=21% Similarity=0.192 Sum_probs=250.8
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCc-hhhcCCccCcEEeecccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIP-KAVASISTLADLTLEFNQ 78 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip-~~l~~l~~L~~L~L~~N~ 78 (809)
+|+|++|.+...-+..|.++++|++++|.+|.++ .+|....... ++.|+|.+|.|.++. +.+.-++.|+.||||.|.
T Consensus 82 ~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~ 160 (873)
T KOG4194|consen 82 TLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNL 160 (873)
T ss_pred eeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhch
Confidence 4899999999999999999999999999999999 7887766665 999999999999995 588999999999999999
Q ss_pred cccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCcc
Q 043333 79 FSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSG 158 (809)
Q Consensus 79 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 158 (809)
|+.+.-.+|..-.+|++|+|++|+|+......|.++.+|..|.|++|+++...+..|.++++|+.|+|..|+|.-.--..
T Consensus 161 is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~lt 240 (873)
T KOG4194|consen 161 ISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLT 240 (873)
T ss_pred hhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhh
Confidence 99555567888889999999999999888889999999999999999999777788999999999999999998444668
Q ss_pred ccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCcc
Q 043333 159 IASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLT 237 (809)
Q Consensus 159 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~ 237 (809)
|.++++|+.|.|..|++..+.-..|..+.++++|+|+.|+++.+-..++-+|++|+.|+||+|.|..+.++.+.. ++|+
T Consensus 241 FqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~ 320 (873)
T KOG4194|consen 241 FQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLK 320 (873)
T ss_pred hcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccce
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999998 9999
Q ss_pred EEEeeCccCCCCCChhhhh-ccCccccccCCccccCCCCCccc
Q 043333 238 YMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDGSSDSNCE 279 (809)
Q Consensus 238 ~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~~~~~~~~ 279 (809)
+|+|++|+|+...+..+.. ..++.|+|++|.++..--..+-+
T Consensus 321 ~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~ 363 (873)
T KOG4194|consen 321 ELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVG 363 (873)
T ss_pred eEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHH
Confidence 9999999999988888866 45699999999987654433333
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=275.15 Aligned_cols=205 Identities=23% Similarity=0.289 Sum_probs=156.5
Q ss_pred HhcCCCCCCeeccCCCccEEEeEe-----------------eCCeEEEEEEecccCcccc--------------hhHHHH
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLL-----------------ADGKVIAVKQLSSKSKQGN--------------REFVNE 621 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~-----------------~~g~~vAVK~~~~~~~~~~--------------~~f~~E 621 (809)
..++|++.++||+|+||.||+|.. .+++.||||++........ +.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 2356799999865432222 234457
Q ss_pred HHHHhhcCCCce-----EeEEeEEEe--------CCeEEEEEEcccCCchhhhccCCCc--------------------c
Q 043333 622 IGMISALQHPNL-----VKLYGCCIE--------GNQLLLIYEYMENNSLARALFGPEE--------------------H 668 (809)
Q Consensus 622 i~~l~~l~H~nI-----v~l~~~~~~--------~~~~~lV~ey~~~gsL~~~L~~~~~--------------------~ 668 (809)
+.++.+++|.++ ++++++|.. .++.++||||+++|+|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888877654 677888763 3568999999999999999874211 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceeccccccccccch
Q 043333 669 RLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAP 748 (809)
Q Consensus 669 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP 748 (809)
...++|..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12357888999999999999999998 899999999999999999999999999975543222111223357899999
Q ss_pred hhhccCC----------------------CCchHHHHHHHHHHHHHHcCCC-CCC
Q 043333 749 EYAMRGY----------------------LTDKADVYSFGIVALEIVSGRS-NVI 780 (809)
Q Consensus 749 E~~~~~~----------------------~~~ksDVwSlGvil~elltGk~-P~~ 780 (809)
|.+.... ...+.||||+||+++||++|.. ||.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 9875432 1234799999999999999985 775
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-28 Score=252.44 Aligned_cols=192 Identities=29% Similarity=0.414 Sum_probs=166.6
Q ss_pred eccCCCccEEEeEee-CCeEEEEEEecccCcc---cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCch
Q 043333 583 IGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ---GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL 658 (809)
Q Consensus 583 LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 658 (809)
||+|+||.||++... +++.+|+|.+...... ....+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 5889999998654322 345788999999999999999999999999999999999999999
Q ss_pred hhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceecc
Q 043333 659 ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 738 (809)
Q Consensus 659 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 738 (809)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 999843 23589999999999999999999997 89999999999999999999999999987654322 12234
Q ss_pred ccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 739 IAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 739 ~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
..++..|+|||...+...+.++|+||||+++|||++|+.||...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 56788999999998888899999999999999999999999654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=260.63 Aligned_cols=198 Identities=27% Similarity=0.416 Sum_probs=166.8
Q ss_pred CCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCeEEEEEEcc
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
|.+.+.||+|+||.||+|+.. +++.||||++..... .......+|++.+++++ ||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999975 478899999865432 22334567899999999 999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
+|+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889998885432 24689999999999999999999998 899999999999999999999999999976543222
Q ss_pred ceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.....++..|+|||++.+ ..++.++||||||++++||++|+.||...
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 123457889999998754 55789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=259.73 Aligned_cols=199 Identities=31% Similarity=0.466 Sum_probs=169.2
Q ss_pred CCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|++++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999965 58999999987653 333466788999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
+ ++|.+++... ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 5899998432 14689999999999999999999998 899999999999999999999999999876543322
Q ss_pred ceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
. .....++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 1 1223456789999998776 78999999999999999999999996643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=263.23 Aligned_cols=195 Identities=22% Similarity=0.254 Sum_probs=159.1
Q ss_pred CeeccCCCccEEEeEeeCCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCch
Q 043333 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL 658 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 658 (809)
+.+|.|+++.||++.. +++.||||++... .....+.+..|+++++.++||||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3345555555555544 6899999998654 333456789999999999999999999999999999999999999999
Q ss_pred hhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc-----
Q 043333 659 ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT----- 733 (809)
Q Consensus 659 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~----- 733 (809)
.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++++|||.+........
T Consensus 87 ~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 87 EDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9998543 223578899999999999999999998 899999999999999999999999998864432111
Q ss_pred -ceeccccccccccchhhhcc--CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 734 -HISTRIAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 734 -~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 11123456778999999876 3578899999999999999999999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=262.64 Aligned_cols=194 Identities=31% Similarity=0.528 Sum_probs=164.1
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+++.+|+++++.++|+|++++.+++...+..++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4666788999999999999954 57889999886432 2224567889999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+. |++.+++.. ...++++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 997 678777632 234578999999999999999999998 8999999999999999999999999998765432
Q ss_pred Ccceeccccccccccchhhhc---cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
....++..|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 2345788999999874 35678899999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=264.27 Aligned_cols=197 Identities=23% Similarity=0.331 Sum_probs=160.0
Q ss_pred CeeccC--CCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEG--GFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G--~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
..||+| +||+||++... +|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 89999999864 689999999865422 2246688899999999999999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999885432 23588999999999999999999988 89999999999999999999999998654322111100
Q ss_pred ------eccccccccccchhhhccC--CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 736 ------STRIAGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 736 ------~~~~~gt~~y~aPE~~~~~--~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 0112345679999998763 4789999999999999999999999653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=256.35 Aligned_cols=201 Identities=27% Similarity=0.382 Sum_probs=165.9
Q ss_pred CCCCCCeeccCCCccEEEeEeeC-CeEEEEEEeccc-----CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSK-----SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
+|.+.+.||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998543 444555555432 122234566789999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
+||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998865444456799999999999999999999998 8999999999999986 569999999987654
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.... ......|+..|+|||...+..++.++||||||+++|+|++|+.||..
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3222 12234578899999999888889999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=262.81 Aligned_cols=200 Identities=27% Similarity=0.386 Sum_probs=163.4
Q ss_pred CCCCCCeeccCCCccEEEeEee-C--CeEEEEEEecccC--cccchhHHHHHHHHhhc-CCCceEeEEeEEEeC----Ce
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-D--GKVIAVKQLSSKS--KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEG----NQ 645 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~--g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~----~~ 645 (809)
+|+..+.||+|+||.||++... . ++.||+|++.... ....+.+.+|++++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999964 3 6789999986432 22245678899999999 599999999976533 45
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++++||++ ++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788899886 588888832 34689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcc---eeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 726 KLDEEDNTH---ISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 726 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
......... ......|+..|+|||++.+ ..++.++||||+||++|||++|+.||...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 765432211 1223568899999998765 468999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=280.82 Aligned_cols=206 Identities=33% Similarity=0.508 Sum_probs=170.7
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee----C----CeEEEEEEecccCc-ccchhHHHHHHHHhhc-CCCceEeEEeEEEe
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA----D----GKVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLYGCCIE 642 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~----~----g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~ 642 (809)
..++....+.+|+|.||.|++|... . ...||||.++.... .+.+.++.|+++|+.+ +|+||+.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3444456669999999999999843 1 34799999876533 4567899999999998 69999999999999
Q ss_pred CCeEEEEEEcccCCchhhhccCCC---cc-------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043333 643 GNQLLLIYEYMENNSLARALFGPE---EH-------R--LKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVL 710 (809)
Q Consensus 643 ~~~~~lV~ey~~~gsL~~~L~~~~---~~-------~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL 710 (809)
++..++|.||++.|+|.++|+..+ .. . ..+.....+.++.|||.||+||++. ++|||||.++|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEE
Confidence 999999999999999999996544 00 1 2388999999999999999999998 8999999999999
Q ss_pred EcCCCceEEEecCCccccCCCCcceeccccc--cccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 043333 711 LDKDLNPKISDFGLAKLDEEDNTHISTRIAG--TFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVIC 781 (809)
Q Consensus 711 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~ 781 (809)
+.++..+||+|||+|+..............+ ...|||||.+....++.|+|||||||++|||+| |..|+.+
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999998654433332222222 346999999999999999999999999999998 7788865
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=282.21 Aligned_cols=145 Identities=28% Similarity=0.410 Sum_probs=129.1
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|.+.+.||+|+||.||+|... +++.||||+++.... ...+.+..|++++..++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999965 688999999865432 22356788999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
||+++++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999843 23578889999999999999999998 89999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=266.12 Aligned_cols=197 Identities=24% Similarity=0.429 Sum_probs=167.4
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe----
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ---- 645 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~---- 645 (809)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999965 57899999886432 2234567789999999999999999998876655
Q ss_pred --EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 646 --LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 646 --~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
.++|+||+ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 569998883 24689999999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 724 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
++...... .....++..|+|||.+.+ ...+.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 98765432 123457889999998865 46789999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=279.73 Aligned_cols=197 Identities=32% Similarity=0.497 Sum_probs=155.2
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCC-----
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGN----- 644 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~----- 644 (809)
+-..+|++.+.||+||||.||+++.+ ||+.+|||++.... ......+.+|++.+++++|||||+++..+.+..
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567889999999999999999954 89999999997653 333456788999999999999999987632110
Q ss_pred --------------------------------------------------------------------------------
Q 043333 645 -------------------------------------------------------------------------------- 644 (809)
Q Consensus 645 -------------------------------------------------------------------------------- 644 (809)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ----------------------------------eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHH
Q 043333 645 ----------------------------------QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690 (809)
Q Consensus 645 ----------------------------------~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~y 690 (809)
.+|+-||||+.-.+.++++...... .-...++++.+|+.||.|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence 1356677777766666663322111 356778999999999999
Q ss_pred HHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC----------C-------CCcceeccccccccccchhhhcc
Q 043333 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE----------E-------DNTHISTRIAGTFGYMAPEYAMR 753 (809)
Q Consensus 691 LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~----------~-------~~~~~~~~~~gt~~y~aPE~~~~ 753 (809)
+|++ +||||||||.||+||++..+||+|||+|.... . .+....+..+||.-|+|||++.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9998 79999999999999999999999999997611 0 01112345789999999999876
Q ss_pred C---CCCchHHHHHHHHHHHHHHc
Q 043333 754 G---YLTDKADVYSFGIVALEIVS 774 (809)
Q Consensus 754 ~---~~~~ksDVwSlGvil~ellt 774 (809)
. .|+.|+|+||+|||++||+.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc
Confidence 4 49999999999999999985
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=246.69 Aligned_cols=217 Identities=20% Similarity=0.296 Sum_probs=175.6
Q ss_pred HHHHHHHhcCCCCCCeeccCCCccEEEeEeeC------CeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeE
Q 043333 567 LRQIKAATNNFAPDNKIGEGGFGPVYKGLLAD------GKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGC 639 (809)
Q Consensus 567 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~ 639 (809)
..++....++++....+-+|.||+||+|.|++ .+.|-||.++.... -....++.|.-.+..+.|||+..+.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34555667788888899999999999997653 34577887765533 334568889889999999999999999
Q ss_pred EEeC-CeEEEEEEcccCCchhhhccCC----CccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC
Q 043333 640 CIEG-NQLLLIYEYMENNSLARALFGP----EEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD 714 (809)
Q Consensus 640 ~~~~-~~~~lV~ey~~~gsL~~~L~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~ 714 (809)
+.+. +..+..|.++.-|+|..+|... ....+.+.-.+...++.|++.||+|||++ ++||.||.++|.++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 9875 4568889999999999999622 23345577788899999999999999998 89999999999999999
Q ss_pred CceEEEecCCccccC-CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCccc
Q 043333 715 LNPKISDFGLAKLDE-EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRTKEA 786 (809)
Q Consensus 715 ~~~kl~DfGla~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~~~~ 786 (809)
.++||+|=.+++-+- .+.............||+||.+.+..++..+|||||||++|||+| |+.|+..-++.+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH
Confidence 999999999987443 332223333344568999999999999999999999999999988 899997755443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=267.96 Aligned_cols=207 Identities=30% Similarity=0.481 Sum_probs=175.8
Q ss_pred HHHHHHhcCCCCCCeeccCCCccEEEeE-eeCCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEe---
Q 043333 568 RQIKAATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIE--- 642 (809)
Q Consensus 568 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~--- 642 (809)
+.+...++.|++.+.||.|.+|.||+++ .++++.+|||++..... ..+++..|.++++.. .|||++.++|++..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 3344457789999999999999999999 45789999999865433 346677888999888 59999999999885
Q ss_pred --CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEE
Q 043333 643 --GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 720 (809)
Q Consensus 643 --~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 720 (809)
++++|||||||.+||.-|++.+.. ...+.|..+..|+..+++|+.+||.. .++|||+|-.|||+++++.+|+.
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 478999999999999999886544 56799999999999999999999998 89999999999999999999999
Q ss_pred ecCCccccCCCCcceeccccccccccchhhhccC-----CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 721 DFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG-----YLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 721 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
|||++...+..-. ......||+.|||||++... .++.++|+||+|++..||--|++|+..
T Consensus 166 DFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D 230 (953)
T KOG0587|consen 166 DFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD 230 (953)
T ss_pred eeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence 9999876654322 23346799999999998643 467789999999999999999999965
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=246.02 Aligned_cols=180 Identities=24% Similarity=0.266 Sum_probs=152.5
Q ss_pred CCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCchhhhccC
Q 043333 586 GGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFG 664 (809)
Q Consensus 586 G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~ 664 (809)
|.||.||++.. .+++.||+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999985 468899999986543 233455555566799999999999999999999999999999998843
Q ss_pred CCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceecccccccc
Q 043333 665 PEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG 744 (809)
Q Consensus 665 ~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~ 744 (809)
...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+....... ....++..
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~ 147 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENM 147 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcc
Confidence 23589999999999999999999998 89999999999999999999999999876543221 12345678
Q ss_pred ccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 745 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 745 y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
|+|||.+.+..++.++||||+||++|||++|+.|+..
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 9999999888889999999999999999999988754
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=247.47 Aligned_cols=208 Identities=28% Similarity=0.404 Sum_probs=174.0
Q ss_pred CCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeC-----CeEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEG-----NQLL 647 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~~ 647 (809)
+.+..+.||-|.||.||..+. ++|+.||.|++.... -...+.+.+|++++..++|.|++..++...-. .++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345678899999999999885 579999999986542 23457788999999999999999998877643 3568
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
.|.|.|.. +|...+ .....++-+.+.-+..||.+||.|||+. +|.||||||.|.|++.+..+||+|||+|+.
T Consensus 134 V~TELmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence 88898854 777766 3455688888899999999999999998 899999999999999999999999999998
Q ss_pred cCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHH
Q 043333 728 DEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLL 791 (809)
Q Consensus 728 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~ 791 (809)
...+....++..+-|..|+|||++++ +.|+...||||.|||+.||+..|--|...+..++.+++
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI 270 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI 270 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH
Confidence 77666666667778999999999987 56899999999999999999999888776665555444
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=238.35 Aligned_cols=199 Identities=34% Similarity=0.507 Sum_probs=171.1
Q ss_pred CCCCCeeccCCCccEEEeEeeC-CeEEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 577 FAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
|...+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999764 789999999765444 56788899999999999999999999999999999999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
+++|.+++.... ..+++..+..++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999984322 1178999999999999999999998 8999999999999999999999999998876543211
Q ss_pred eeccccccccccchhhh-ccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 735 ISTRIAGTFGYMAPEYA-MRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~-~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22234577789999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=240.03 Aligned_cols=198 Identities=23% Similarity=0.315 Sum_probs=163.8
Q ss_pred hcCCCCC-CeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEe----CCeE
Q 043333 574 TNNFAPD-NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIE----GNQL 646 (809)
Q Consensus 574 ~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~----~~~~ 646 (809)
+++|++. ++||-|-.|.|-.+..+ .|+.+|+|++.+. ....+|++..-+. .|||||+++++|.. .+.+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4555543 57999999999988854 6889999998654 3345788876555 59999999999864 4578
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCceEEEecC
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFG 723 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfG 723 (809)
++|||.|+||.|.+.+... ....+++.++..|+.||+.|+.|||+. +|.||||||+|+|... +..+|++|||
T Consensus 135 LiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 8999999999999988543 344688999999999999999999998 8999999999999964 4578999999
Q ss_pred CccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 724 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
+|+...... . ....+-|+.|.|||++...+++..+|+||+||++|-|+.|-+||....
T Consensus 210 FAK~t~~~~-~-L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 210 FAKETQEPG-D-LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_pred cccccCCCc-c-ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence 998655322 2 234567999999999998899999999999999999999999997644
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-27 Score=256.56 Aligned_cols=194 Identities=26% Similarity=0.390 Sum_probs=161.7
Q ss_pred HhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
+++.|.....+|.|+|+.|-.+.. .+++..+||++.+.. .+-.+|+.++... +||||+++.+.+.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 456677788899999999988774 457889999997652 2234567666666 6999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE-cCCCceEEEecCCccccC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL-DKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl-~~~~~~kl~DfGla~~~~ 729 (809)
|.+.++-+.+.+.... ..-..+..|+.+|+.|+.|||++ ++|||||||+|||+ +..++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 9999998877774322 22256778999999999999998 89999999999999 588999999999998765
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. ....+-|..|.|||+.....+++.+||||||++||||++|+.||...
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~ 516 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH 516 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC
Confidence 44 22234578999999999999999999999999999999999999763
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=252.64 Aligned_cols=196 Identities=25% Similarity=0.367 Sum_probs=166.6
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc---c-----chhHHHHHHHHhhcC---CCceEeEEeEEEe
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ---G-----NREFVNEIGMISALQ---HPNLVKLYGCCIE 642 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~---~-----~~~f~~Ei~~l~~l~---H~nIv~l~~~~~~ 642 (809)
.+|...+.+|+|+||.|+.|.++ +...|+||.+.+.+.- + .-..-.|+.+|..++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45888999999999999999965 4678999988654211 1 112446999999997 9999999999999
Q ss_pred CCeEEEEEEccc-CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEe
Q 043333 643 GNQLLLIYEYME-NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 721 (809)
Q Consensus 643 ~~~~~lV~ey~~-~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 721 (809)
++..||+||-.. +.+|.+++ +.+..+++..+..|++|++.|+++||++ +|||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 999999999754 45888888 4566799999999999999999999999 899999999999999999999999
Q ss_pred cCCccccCCCCcceeccccccccccchhhhccCCC-CchHHHHHHHHHHHHHHcCCCCCC
Q 043333 722 FGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNVI 780 (809)
Q Consensus 722 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltGk~P~~ 780 (809)
||.|.......-. .++||.+|.|||++.+.+| +..-|||++|+++|.++....||.
T Consensus 714 fgsaa~~ksgpfd---~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGPFD---VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCCcc---eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999876544332 4689999999999988665 566799999999999999988884
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=246.56 Aligned_cols=214 Identities=24% Similarity=0.328 Sum_probs=173.8
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcC-C-Cc----eEeEEeEEEeCC
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-H-PN----LVKLYGCCIEGN 644 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H-~n----Iv~l~~~~~~~~ 644 (809)
..+++|.+...+|+|.||.|-++... .+..||||+++...+. .+..+-|++++.++. + |+ +|.+.+++.-.+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 45789999999999999999998744 4689999999765433 344567999999994 2 22 778889999999
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc------------
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD------------ 712 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~------------ 712 (809)
+.++|+|.| +-|+.++|..+ +..+++..++..|+.|++++++|||+. +++|.||||+|||+.
T Consensus 165 hiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence 999999977 55999999543 345677889999999999999999998 899999999999993
Q ss_pred --------CCCceEEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 713 --------KDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 713 --------~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
++..+||+|||.|....+.. ...+.|..|+|||++.+-.++.++||||+||||.|+.||..-|...+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe- 313 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE- 313 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC-
Confidence 13458999999998765443 34678899999999999999999999999999999999999997643
Q ss_pred ccchhHHHHHHHhhc
Q 043333 785 EAQFCLLDWVTLALT 799 (809)
Q Consensus 785 ~~~~~l~~~~~~~~~ 799 (809)
+-+.| ..+++.+.
T Consensus 314 -n~EHL-aMMerIlG 326 (415)
T KOG0671|consen 314 -NLEHL-AMMERILG 326 (415)
T ss_pred -cHHHH-HHHHHhhC
Confidence 22222 45555555
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=266.12 Aligned_cols=201 Identities=24% Similarity=0.300 Sum_probs=143.0
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-C----CeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeE------EE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-D----GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGC------CI 641 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~----g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~------~~ 641 (809)
..++|+..+.||+|+||.||+|+.. + +..||||++..... .+.+..| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999965 4 68899998754321 1111111 1222222222222211 24
Q ss_pred eCCeEEEEEEcccCCchhhhccCCCcc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 043333 642 EGNQLLLIYEYMENNSLARALFGPEEH----------------RLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIK 705 (809)
Q Consensus 642 ~~~~~~lV~ey~~~gsL~~~L~~~~~~----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk 705 (809)
..++.++||||+++++|.+++...... ........+..++.|++.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 567899999999999999988542110 00112334567999999999999998 89999999
Q ss_pred CCCEEEcC-CCceEEEecCCccccCCCCcceeccccccccccchhhhccC----------------------CCCchHHH
Q 043333 706 ATNVLLDK-DLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG----------------------YLTDKADV 762 (809)
Q Consensus 706 p~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ksDV 762 (809)
|+|||+++ ++.+||+|||+|+..............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 58999999999986544333334456789999999965322 23456799
Q ss_pred HHHHHHHHHHHcCCCCCC
Q 043333 763 YSFGIVALEIVSGRSNVI 780 (809)
Q Consensus 763 wSlGvil~elltGk~P~~ 780 (809)
|||||++|||+++..|++
T Consensus 363 wSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred HHHHHHHHHHHhCcCCCc
Confidence 999999999999877654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=231.30 Aligned_cols=186 Identities=31% Similarity=0.527 Sum_probs=163.8
Q ss_pred CCccEEEeEee-CCeEEEEEEecccCccc-chhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCchhhhccC
Q 043333 587 GFGPVYKGLLA-DGKVIAVKQLSSKSKQG-NREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFG 664 (809)
Q Consensus 587 ~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~ 664 (809)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+||+++++++......++|+||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999987665444 67899999999999999999999999999999999999999999998843
Q ss_pred CCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceecccccccc
Q 043333 665 PEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG 744 (809)
Q Consensus 665 ~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~ 744 (809)
. ..+++..+..++.++++++.|||+. +++|+||+|+||++++++.++++|||.+....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 2 2288999999999999999999998 89999999999999999999999999998665432 2234567889
Q ss_pred ccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 745 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 745 y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
|+|||......++.++||||+|++++||++|+.||..
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999888889999999999999999999999965
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=218.94 Aligned_cols=193 Identities=22% Similarity=0.403 Sum_probs=160.5
Q ss_pred hcCCCCCCeeccCCCccEEEeE-eeCCeEEEEEEecccCcccchhHHHHHHHHhhcC-CCceEeEEeEEEeCC--eEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGN--QLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~--~~~lV 649 (809)
.++|++.+++|+|.|+.||.|. ..+.+.++||++++... +.+.+|+++|..++ ||||+++++...++. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678889999999999999998 45678899999976543 56789999999997 999999999998764 46899
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CceEEEecCCcccc
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLD 728 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~ 728 (809)
+||+.+-+..... ..++...+...+.+++.||.|+|+. ||+|||+||.|+++|.. -.++++|+|+|.+.
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999997766543 2456667788999999999999998 89999999999999965 56899999999987
Q ss_pred CCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
...... ...+.+..|.-||.+.. ..++..-|+|||||++.+|+..|.||-.
T Consensus 184 Hp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 184 HPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred CCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 644322 12345668899998765 5677788999999999999999999943
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-27 Score=255.30 Aligned_cols=297 Identities=24% Similarity=0.315 Sum_probs=153.8
Q ss_pred cCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCC--CCchhhcCCccCcEEeecccccccCCCcccc
Q 043333 12 RLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANG--AIPKAVASISTLADLTLEFNQFSGDLPAELG 88 (809)
Q Consensus 12 ~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~--~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 88 (809)
.+|+.++.|.+|+.|.+++|++. .+-.+++.++ |..+.+++|+++ .||..+..+..|+.||||+|+|+ ..|..+.
T Consensus 46 ~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE 123 (1255)
T KOG0444|consen 46 QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLE 123 (1255)
T ss_pred hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhh
Confidence 34444444444555555555444 3333444443 444444444442 34555555555555555555555 4555555
Q ss_pred CCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEE
Q 043333 89 NLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDL 168 (809)
Q Consensus 89 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 168 (809)
.-+++..|+||+|+|..+...-|.+|+.|-+||||+|++. .+|..+..+..|++|+|++|.+...--..+..+++|+.|
T Consensus 124 ~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vL 202 (1255)
T KOG0444|consen 124 YAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVL 202 (1255)
T ss_pred hhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhh
Confidence 5555555555555555222223445555555555555555 444445555555555555555543333334444555555
Q ss_pred eccCCCCCCCC-CccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCC
Q 043333 169 RISDLNGPEGP-FPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLT 247 (809)
Q Consensus 169 ~l~~n~l~~~~-~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~ 247 (809)
.+++.+-+-.. +..+..+.||..+|||+|++. ..|+.+-++++|+.|+||+|+|+..-...-.-.+|+.|+||.|+|+
T Consensus 203 hms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt 281 (1255)
T KOG0444|consen 203 HMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT 281 (1255)
T ss_pred hcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc
Confidence 55554333322 234556666666666666664 4466666667777777777776654433322256777777777776
Q ss_pred CCCChhhhh-ccCccccccCCccccC-CCCCcccccccceeccccC--CCCCCccccccccCCCCCCCcc
Q 043333 248 GPVPDWIVR-KRNKHIDLSYNNFIDG-SSDSNCENQSVNLFASSSE--GSNSTGIVSCLKSFTCPTNHSS 313 (809)
Q Consensus 248 ~~~p~~~~~-~~l~~L~Ls~N~l~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~c~~~~~~~~~~~~ 313 (809)
.+|..++. .+++.|.+.+|+++.. +|........+..|....+ ...+.++.-|++.....+++|.
T Consensus 282 -~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~Nr 350 (1255)
T KOG0444|consen 282 -VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNR 350 (1255)
T ss_pred -cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccccCchhhhhhHHHHHhcccccc
Confidence 45555443 4556677777766533 2333333333333333222 2345666667666555444443
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-27 Score=253.74 Aligned_cols=295 Identities=19% Similarity=0.253 Sum_probs=222.5
Q ss_pred ccccCCCCC-ccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeeccccc
Q 043333 2 RILKSQNLP-GRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQF 79 (809)
Q Consensus 2 L~L~~nnl~-~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l 79 (809)
.|+++|.++ +..|.++..++.++.|.|...++. .+|.+++.++ |+.|++.+|++..+-..++.++.|+.+++.+|+|
T Consensus 12 vDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~L 90 (1255)
T KOG0444|consen 12 VDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNL 90 (1255)
T ss_pred ccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhcccc
Confidence 467888887 577888888888888888888887 6788888775 8888888888888888888888888888888888
Q ss_pred cc-CCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCcc
Q 043333 80 SG-DLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSG 158 (809)
Q Consensus 80 ~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 158 (809)
.. -+|..+..+..|+.||||+|+++ ..|..+...+++-+|+||+|+|..+....|-+++.|-.|||++|++. .+|..
T Consensus 91 KnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ 168 (1255)
T KOG0444|consen 91 KNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQ 168 (1255)
T ss_pred ccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHH
Confidence 63 46777778888888888888888 77888888888888888888888433344778888888888888887 66777
Q ss_pred ccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeecccccc-CCCChhhhccccccEEeccCCCCCCCCCCCCCCCCcc
Q 043333 159 IASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNII-GEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLT 237 (809)
Q Consensus 159 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~ 237 (809)
+..+..|+.|.|++|.+.......+..+++|+.|.+++.+-+ .-+|..+..|.+|..+|||.|.|.-.+.-.+...+|+
T Consensus 169 ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~Lr 248 (1255)
T KOG0444|consen 169 IRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLR 248 (1255)
T ss_pred HHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhh
Confidence 778888888888888888877777888888888888876544 4477788888888888888888875544444458888
Q ss_pred EEEeeCccCCCCCChhhhhccCccccccCCccccCCCCCcccccccceeccccCCCCCCcccc
Q 043333 238 YMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVS 300 (809)
Q Consensus 238 ~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (809)
.|+||+|+|+......-...++.+|+||.|+++.. |+..|....+.-+-..++.....|+++
T Consensus 249 rLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~L-P~avcKL~kL~kLy~n~NkL~FeGiPS 310 (1255)
T KOG0444|consen 249 RLNLSGNKITELNMTEGEWENLETLNLSRNQLTVL-PDAVCKLTKLTKLYANNNKLTFEGIPS 310 (1255)
T ss_pred eeccCcCceeeeeccHHHHhhhhhhccccchhccc-hHHHhhhHHHHHHHhccCcccccCCcc
Confidence 88888888886554444446778888888888764 667777666655444444444444444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-25 Score=250.98 Aligned_cols=197 Identities=30% Similarity=0.417 Sum_probs=157.3
Q ss_pred CCCCCeeccCCCccE-EEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 577 FAPDNKIGEGGFGPV-YKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 577 f~~~~~LG~G~fG~V-y~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
|...+++|.|+-|+| |+|.+. |+.||||++-... ..-..+|+..|..- +|||||++++.-.++...|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 455677899998764 999984 7899999985432 23456899999887 59999999999999999999999995
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---C--CceEEEecCCccccC
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK---D--LNPKISDFGLAKLDE 729 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~--~~~kl~DfGla~~~~ 729 (809)
. +|.+++...........-.....+..|++.||++||+. +||||||||.||||+. + .+++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 4 99999955311111111134567889999999999997 8999999999999976 3 578999999999776
Q ss_pred CCCcce--eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcC-CCCCCC
Q 043333 730 EDNTHI--STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG-RSNVIC 781 (809)
Q Consensus 730 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltG-k~P~~~ 781 (809)
.+.... .....||-+|+|||.+....-+..+||||+||++|+.++| ++||..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 544322 3356799999999999988888899999999999999887 899965
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-25 Score=221.47 Aligned_cols=195 Identities=26% Similarity=0.425 Sum_probs=161.2
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCC------e
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGN------Q 645 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~------~ 645 (809)
.+|.....+|.|.- .|..+.. -.++.||+|++... .....++..+|...+..++|+||++++.++.-.. +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666777888886 4544442 24788999987544 2334566788999999999999999999987543 5
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++|||||.. +|...++ -.++-.+...|..|+.+|+.|||+. +|+||||||+||++..++.+||.|||+|
T Consensus 96 ~y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 7999999965 8888774 2467778899999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 726 KLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 726 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+..... ...+.++.|..|.|||++.+..+.+.+||||.||++.||++|+--|.+.
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 864432 4566788999999999998888999999999999999999999888654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-25 Score=215.40 Aligned_cols=218 Identities=19% Similarity=0.345 Sum_probs=164.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC-CeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEe-EEEeCCeEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYG-CCIEGNQLLLIY 650 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~-~~~~~~~~~lV~ 650 (809)
.+.|.+.+.+|+|.||.+-.+.++. .+.+++|.+... ....++|.+|...--.+ .|.||+.-++ .|+..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4678889999999999999999764 678889987543 22357899998765555 4899996554 567778889999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE-cC-CCceEEEecCCcccc
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL-DK-DLNPKISDFGLAKLD 728 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl-~~-~~~~kl~DfGla~~~ 728 (809)
||+|.|+|.+-+ ....+-+....+++.|+++|++|+|++ ++||||||.+|||+ +. ..++|+||||+.+..
T Consensus 102 E~aP~gdL~snv-----~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNV-----EAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhc-----CcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999877 334567778899999999999999999 89999999999998 33 358999999998743
Q ss_pred CCCCcceeccccccccccchhhhccC-----CCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchh---HHHHHHHhhcc
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRG-----YLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFC---LLDWVTLALTD 800 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~---l~~~~~~~~~~ 800 (809)
...- ...--+..|.|||..... ...+.+|||.||++++..+||+.||+.. ...+.. ..+|.++..+
T Consensus 174 g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~~rk~~- 247 (378)
T KOG1345|consen 174 GTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWLKRKNP- 247 (378)
T ss_pred Ccee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHhcccCc-
Confidence 3211 112234579999987432 3567789999999999999999999742 222333 3445555443
Q ss_pred CCCCcCC
Q 043333 801 FRFPLFL 807 (809)
Q Consensus 801 ~~~p~~~ 807 (809)
+.|..+
T Consensus 248 -~~P~~F 253 (378)
T KOG1345|consen 248 -ALPKKF 253 (378)
T ss_pred -cCchhh
Confidence 455443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-26 Score=236.91 Aligned_cols=262 Identities=23% Similarity=0.285 Sum_probs=235.4
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCC-CccccccccccCCCCchhhcCCccCcEEeecccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASL-PLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFS 80 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l-~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~ 80 (809)
|+|++|++. .+-+.+.++..|.+|++.+|++. ..|.++..+ .++.++.++|++.++|..+..+.+|..|+.++|.+.
T Consensus 50 lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~ 127 (565)
T KOG0472|consen 50 LILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELK 127 (565)
T ss_pred hhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhcccccee
Confidence 678999998 66677999999999999999999 566666666 499999999999999999999999999999999999
Q ss_pred cCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCcccc
Q 043333 81 GDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIA 160 (809)
Q Consensus 81 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 160 (809)
.+|+.++.+..|+.|+..+|+++ ..|..+.++.+|..|++.+|+++...|..+ +|+.|++||...|-++ .+|..++
T Consensus 128 -el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg 203 (565)
T KOG0472|consen 128 -ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-TLPPELG 203 (565)
T ss_pred -ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-cCChhhc
Confidence 88889999999999999999999 778899999999999999999995555545 4999999999999998 8899999
Q ss_pred CCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEE
Q 043333 161 SLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMY 240 (809)
Q Consensus 161 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ 240 (809)
.+.+|.-|++.+|++..+| .|.+++.|++|+++.|+|.....+...++++|..|||.+|+++..+.+.....+|++||
T Consensus 204 ~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLD 281 (565)
T KOG0472|consen 204 GLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLD 281 (565)
T ss_pred chhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhc
Confidence 9999999999999999988 89999999999999999987777777899999999999999998877766669999999
Q ss_pred eeCccCCCCCChhhhhccCccccccCCccccC
Q 043333 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDG 272 (809)
Q Consensus 241 Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~ 272 (809)
||+|.+++.++ .++...++.|-+.||++...
T Consensus 282 lSNN~is~Lp~-sLgnlhL~~L~leGNPlrTi 312 (565)
T KOG0472|consen 282 LSNNDISSLPY-SLGNLHLKFLALEGNPLRTI 312 (565)
T ss_pred ccCCccccCCc-ccccceeeehhhcCCchHHH
Confidence 99999996544 56666889999999999753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=221.43 Aligned_cols=132 Identities=23% Similarity=0.409 Sum_probs=109.8
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcC-----C---CceEeEEeEEEeC--
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-----H---PNLVKLYGCCIEG-- 643 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-----H---~nIv~l~~~~~~~-- 643 (809)
.+|...++||.|-|++||++.. .+.+.||+|+.+... .-.+..+.|+++|++++ | ..||+|+++|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6888999999999999999984 456889999986542 22455678999999985 2 3699999999864
Q ss_pred --CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc
Q 043333 644 --NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD 712 (809)
Q Consensus 644 --~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 712 (809)
.+.+||+|++ |.+|..++... ....++...+.+|++||+.||.|||.+| +|||.||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4789999988 55888888543 3345788999999999999999999998 899999999999993
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=205.41 Aligned_cols=183 Identities=40% Similarity=0.664 Sum_probs=157.6
Q ss_pred eccCCCccEEEeEeeC-CeEEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCchhh
Q 043333 583 IGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLAR 660 (809)
Q Consensus 583 LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~ 660 (809)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++|+||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 889999998765432 34678999999999999999999999999999999999999999999
Q ss_pred hccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCceEEEecCCccccCCCCcceeccc
Q 043333 661 ALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLDEEDNTHISTRI 739 (809)
Q Consensus 661 ~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 739 (809)
++.... ..+++..+..++.++++++.|||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 984321 4688999999999999999999998 8999999999999999 89999999999986644321 12234
Q ss_pred cccccccchhhhccC-CCCchHHHHHHHHHHHHH
Q 043333 740 AGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEI 772 (809)
Q Consensus 740 ~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~el 772 (809)
.+...|++||..... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 567799999998877 888999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-24 Score=237.55 Aligned_cols=199 Identities=28% Similarity=0.469 Sum_probs=171.6
Q ss_pred HhcCCCCCCeeccCCCccEEEeE-eeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
..++|+....+|.|.||.|||++ .+.++..|||+++........-.++|+-+++..+|||||.++|.+...+..|++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 34678889999999999999999 45789999999988777777778889999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+.+|+|.+.-|. ..++++.++..+++...+||+|||+. +-+|||||-.||++++.+.+|++|||.+..+...
T Consensus 93 ycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred ecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999997653 44788899999999999999999998 6689999999999999999999999998654322
Q ss_pred Ccceeccccccccccchhhh---ccCCCCchHHHHHHHHHHHHHHcCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYA---MRGYLTDKADVYSFGIVALEIVSGRSNV 779 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~ksDVwSlGvil~elltGk~P~ 779 (809)
-. ....+.||+.|||||+. ..+.+..++|||+.|+...|+---++|.
T Consensus 166 i~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 166 IA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred hh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 11 12346799999999986 4567899999999999999986666554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=219.31 Aligned_cols=199 Identities=31% Similarity=0.467 Sum_probs=164.3
Q ss_pred HHHHhcCCCCCCeeccCCCccEEEeEee----CCeEEEEEEecccCcccchhHHHHHHHHhhcC-CCceEeEEeEEEeCC
Q 043333 570 IKAATNNFAPDNKIGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGN 644 (809)
Q Consensus 570 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~ 644 (809)
+....+.|..+++||+|.|++||++... ..+.||+|.+...+.. ....+|+++|..+. +.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3345567889999999999999999843 3578999998655433 45789999999995 999999999999999
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CceEEEecC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFG 723 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfG 723 (809)
...+|+||++.....++.. .++...+..++..+..||.++|.+ +||||||||+|+|.+.. ++-.|.|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence 9999999999988888773 356778889999999999999998 89999999999999865 778999999
Q ss_pred CccccCCC-------C--------------------------cc----------eeccccccccccchhhhcc-CCCCch
Q 043333 724 LAKLDEED-------N--------------------------TH----------ISTRIAGTFGYMAPEYAMR-GYLTDK 759 (809)
Q Consensus 724 la~~~~~~-------~--------------------------~~----------~~~~~~gt~~y~aPE~~~~-~~~~~k 759 (809)
+|...+.. . .. .....+||+||+|||++.. ..-+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 99721000 0 00 0011469999999999865 567889
Q ss_pred HHHHHHHHHHHHHHcCCCCCC
Q 043333 760 ADVYSFGIVALEIVSGRSNVI 780 (809)
Q Consensus 760 sDVwSlGvil~elltGk~P~~ 780 (809)
+||||-|||++-+++++.||-
T Consensus 259 iDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred cceeeccceeehhhccccccc
Confidence 999999999999999999994
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=220.49 Aligned_cols=168 Identities=23% Similarity=0.243 Sum_probs=130.5
Q ss_pred HHHHHHhcCCCCCCeeccCCCccEEEeEee--CCeEEEEEEecccC-----cccchhHHHHHHHHhhcCCCceEe-EEeE
Q 043333 568 RQIKAATNNFAPDNKIGEGGFGPVYKGLLA--DGKVIAVKQLSSKS-----KQGNREFVNEIGMISALQHPNLVK-LYGC 639 (809)
Q Consensus 568 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~-l~~~ 639 (809)
.+.....++|...+.||+|+||+||+|... +++.||||++.... ....+.|.+|++++++++|+|+++ +++
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~- 89 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA- 89 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence 344556788999999999999999999864 57888999875331 112456899999999999999985 443
Q ss_pred EEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC-CCCCEEEcCCCceE
Q 043333 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDI-KATNVLLDKDLNPK 718 (809)
Q Consensus 640 ~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~k 718 (809)
.+..++||||+++++|.... .. . ...++.++++||+|||+. +|+|||| ||+|||++.++++|
T Consensus 90 ---~~~~~LVmE~~~G~~L~~~~----~~----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 90 ---TGKDGLVRGWTEGVPLHLAR----PH----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred ---cCCcEEEEEccCCCCHHHhC----cc----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEE
Confidence 24679999999999996321 00 0 145788999999999998 8999999 99999999999999
Q ss_pred EEecCCccccCCCCcce-------eccccccccccchhhhcc
Q 043333 719 ISDFGLAKLDEEDNTHI-------STRIAGTFGYMAPEYAMR 753 (809)
Q Consensus 719 l~DfGla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 753 (809)
|+|||+|+......... -....+++.|+|||++..
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999998765432111 124568889999999853
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-24 Score=225.01 Aligned_cols=213 Identities=22% Similarity=0.287 Sum_probs=173.4
Q ss_pred CccHHHHHHHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcC------CCceEeE
Q 043333 564 SFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQ------HPNLVKL 636 (809)
Q Consensus 564 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~------H~nIv~l 636 (809)
-|.+.-.+....+|.+....|+|-|++|.+|... -|..||||+++..... .+.=+.|+++|++++ --|.+++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 3445555566788999999999999999999854 4779999999754221 233467999999996 2478899
Q ss_pred EeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-C
Q 043333 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD-L 715 (809)
Q Consensus 637 ~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~ 715 (809)
+..|...+++|||+|-+ ..+|.+.|.... ....|....+..++.|+.-||..|-.. +|+|.||||.|||+++. .
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 99999999999999966 458888885443 334577778889999999999999886 89999999999999876 5
Q ss_pred ceEEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcc
Q 043333 716 NPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKE 785 (809)
Q Consensus 716 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~ 785 (809)
.+||||||.|....+... +.+.-+.-|.|||++.+-.|+...|+||.||+||||.||+-.|-+.+..
T Consensus 575 iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred eeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 679999999987654432 3444566899999999999999999999999999999999999886543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-24 Score=223.23 Aligned_cols=244 Identities=26% Similarity=0.371 Sum_probs=220.9
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCC-CccccccccccCCCCchhhcCCccCcEEeecccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASL-PLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFS 80 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l-~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~ 80 (809)
|++++|+++ ++|++++.+.+++.|+.++|++. .+|..+..+ .+.+++++.|.+.++|+.++.+..|+.|+..+|+++
T Consensus 73 l~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~ 150 (565)
T KOG0472|consen 73 LNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELKELPDSIGRLLDLEDLDATNNQIS 150 (565)
T ss_pred EEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccccceeecCchHHHHhhhhhhhccccccc
Confidence 567888888 89999999999999999999999 566665555 599999999999999999999999999999999999
Q ss_pred cCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCcccc
Q 043333 81 GDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIA 160 (809)
Q Consensus 81 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 160 (809)
..|+.+.++.+|..|++.+|+++...|..+ +++.|++||+..|-+. .+|..++.+.+|+.|+|.+|+|. ..| .|.
T Consensus 151 -slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~ 225 (565)
T KOG0472|consen 151 -SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFP 225 (565)
T ss_pred -cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCC
Confidence 889999999999999999999995555444 5999999999999998 88999999999999999999999 777 899
Q ss_pred CCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEE
Q 043333 161 SLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMY 240 (809)
Q Consensus 161 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ 240 (809)
++..|.+|+++.|.+..++......+.+|..|||++|++. +.|+.++-+.+|+.||+|+|.|++.+++.-.. +|+.|-
T Consensus 226 gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~ 303 (565)
T KOG0472|consen 226 GCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLA 303 (565)
T ss_pred ccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehh
Confidence 9999999999999999999999999999999999999996 56889999999999999999999998887655 999999
Q ss_pred eeCccCCCCCChhh
Q 043333 241 LTGNLLTGPVPDWI 254 (809)
Q Consensus 241 Ls~N~l~~~~p~~~ 254 (809)
|.||++..+--+.+
T Consensus 304 leGNPlrTiRr~ii 317 (565)
T KOG0472|consen 304 LEGNPLRTIRREII 317 (565)
T ss_pred hcCCchHHHHHHHH
Confidence 99999985433333
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.9e-24 Score=217.72 Aligned_cols=306 Identities=20% Similarity=0.219 Sum_probs=218.1
Q ss_pred cCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCC-chhhcCCccCcEEeecc-cccccCCCcccc
Q 043333 12 RLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAI-PKAVASISTLADLTLEF-NQFSGDLPAELG 88 (809)
Q Consensus 12 ~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~i-p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~ 88 (809)
.+|..+. +...+++|..|+|+...|..|..++ |++|+|++|.|..| |.+|..+.+|..|-+.+ |+|+....+.|+
T Consensus 60 eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~ 137 (498)
T KOG4237|consen 60 EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFG 137 (498)
T ss_pred cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhh
Confidence 6666665 5567888888888877778888885 88888888888888 67888888777776666 888854445788
Q ss_pred CCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCch-hhhcccccceEecccCcC------------CCCC
Q 043333 89 NLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPD-YIQNWTKLEKLFIEGSGL------------AGPI 155 (809)
Q Consensus 89 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l------------~~~~ 155 (809)
+|..|+.|.+.-|++..+..+.|..|++|..|.|.+|.+. .++. .|..+..++.++++.|.+ ....
T Consensus 138 gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~ 216 (498)
T KOG4237|consen 138 GLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMN 216 (498)
T ss_pred hHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhc
Confidence 8888888888888888777778888888888888888888 4444 688888888888888872 2233
Q ss_pred CccccCCCCCCEEeccCCCCCCCCCccccC-CcCCceeeeccccccCCCC-hhhhccccccEEeccCCCCCCCCCCCCCC
Q 043333 156 PSGIASLVELTDLRISDLNGPEGPFPRLSN-LKNMNYLILRSGNIIGEMP-EYLGQMIGLRVLDLSFNKLSGVIPSNFSG 233 (809)
Q Consensus 156 p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~-l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 233 (809)
|..++......-..+.+.++..++...|.. ++.+..-..+.+.....-| ..|..|++|+.|+|++|+|+.+-+..|..
T Consensus 217 ~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~ 296 (498)
T KOG4237|consen 217 PIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEG 296 (498)
T ss_pred hhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcc
Confidence 455555555555566666666665554432 2333332333444555555 46888999999999999999888888888
Q ss_pred -CCccEEEeeCccCCCCCChhhhh-ccCccccccCCccccCCCCCcccccccceeccccCCCCCCccccccccCCCCCCC
Q 043333 234 -SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVSCLKSFTCPTNH 311 (809)
Q Consensus 234 -~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~ 311 (809)
..++.|+|..|+|..+-...|.. ..++.|+|++|++++..|-.+....++ .+...-.
T Consensus 297 ~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l---------------------~~l~l~~ 355 (498)
T KOG4237|consen 297 AAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSL---------------------STLNLLS 355 (498)
T ss_pred hhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccccee---------------------eeeehcc
Confidence 88999999999988665555544 456888999999988877666544433 2455668
Q ss_pred cceeecCCCceeee-cCCeeecCCCCCCCCc
Q 043333 312 SSLHINCGGKQVIA-NGSTTFEDDLDAAGPS 341 (809)
Q Consensus 312 ~~~~~~C~~~~~~~-~~~~~~~~~~~~~g~~ 341 (809)
|||.|||...|+.. ..+..-.++..|..|.
T Consensus 356 Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~ 386 (498)
T KOG4237|consen 356 NPFNCNCRLAWLGEWLRKKSVVGNPRCQSPG 386 (498)
T ss_pred CcccCccchHHHHHHHhhCCCCCCCCCCCCc
Confidence 99999998877643 1111144566777775
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-21 Score=189.86 Aligned_cols=168 Identities=43% Similarity=0.702 Sum_probs=111.5
Q ss_pred eeecCCCceeeecCCeeecCCCCCCCCcc-eeecCCceeeeeeccccCCCCCCccceEecccccccCchhhhcccccCce
Q 043333 314 LHINCGGKQVIANGSTTFEDDLDAAGPSR-FFISRTNWAFSTTGHFIDNSTRENSYIQINTSRLLMDDSQLYTEARISPI 392 (809)
Q Consensus 314 ~~~~C~~~~~~~~~~~~~~~~~~~~g~~~-~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (809)
+.++|++..........|+.|....|..+ ++.+.. .............++.+++||+|+|.+|.
T Consensus 3 ~~IN~Gg~~~~~~~g~~w~~D~~~~~g~~~y~~~~~---------------~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~ 67 (174)
T PF11721_consen 3 LRINAGGPAYTDSSGIVWEADQYYTGGSWGYYVSSD---------------NNGSTSSTNSSIPGTTDDPLYQTERYGPS 67 (174)
T ss_dssp EEEEETSSSEEETTTEEE-SSSSSTTSS--------------------------SSTTS--TTS-HHHHHTTT-----SS
T ss_pred EEEECCCCcccCCCCCEEcCCCCCCCCCcccccccc---------------cccccccccccccCCCchhhhHhhcCCCC
Confidence 56899999986677788888877655543 222100 00001122344556889999999999999
Q ss_pred eeeeeeeeeeCceEEEEEEEEeeEecCCcccccCCceeEEEEecCeeeccccceeeccCCcCceEEEee-eeeeecCeeE
Q 043333 393 SLTYYGYCMVNGNYTVNLHFAEILFTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPF-SAAVTNGTME 471 (809)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 471 (809)
+++|..-|+.||.|+|+|||||+.+..+..++..|+|+|||+|+|+.++++|||..++|+..+++.+.+ ...|.++.+.
T Consensus 68 ~f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~ 147 (174)
T PF11721_consen 68 SFSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLN 147 (174)
T ss_dssp SEEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEE
T ss_pred ceEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEE
Confidence 999999999999999999999999999999999999999999999999999999999999998888888 8899999999
Q ss_pred EEEEecCCCccccCCCCCcC-Ccccc
Q 043333 472 IRLYWAGKGTTDIPYKGVYG-PLISA 496 (809)
Q Consensus 472 ~~~~w~g~~~~~~p~~~~~~-p~~~~ 496 (809)
+++.|+++++.++|..+.++ |.+++
T Consensus 148 i~f~~~~~~~~~i~~~~~~~~p~Isa 173 (174)
T PF11721_consen 148 IQFVWAGKGTLCIPFIGSYGNPLISA 173 (174)
T ss_dssp TTEEEE--SEEEEEEESSSSSSSEEE
T ss_pred EEEEecCCCcEEeeccccCCCcEEee
Confidence 99999999999998866655 77765
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=201.44 Aligned_cols=201 Identities=23% Similarity=0.239 Sum_probs=163.4
Q ss_pred CCCCCCeeccCCCccEEEeEeeCC--eEEEEEEecccCcccchhHHHHHHHHhhcCC----CceEeEEeEE-EeCCeEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLADG--KVIAVKQLSSKSKQGNREFVNEIGMISALQH----PNLVKLYGCC-IEGNQLLL 648 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~~g--~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H----~nIv~l~~~~-~~~~~~~l 648 (809)
+|.+.+.||+|+||.||++...+. +.+|+|............+..|+.++..+.. +++..+++.. ...+..++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999996543 5788888765433333367889999988873 5888999888 47778899
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-----CceEEEecC
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD-----LNPKISDFG 723 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-----~~~kl~DfG 723 (809)
||+.. +.+|.++..... ...++..+...|+.|+..+|+++|+. +++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99965 779998663332 45688999999999999999999998 89999999999999765 458999999
Q ss_pred Ccc--ccCCCCcc----e---eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 724 LAK--LDEEDNTH----I---STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 724 la~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+++ .+...... . .....||..|++++...+...+.+.|+||++.++.|++.|..||...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 998 32211110 1 12355999999999999999999999999999999999999999653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-21 Score=235.19 Aligned_cols=148 Identities=17% Similarity=0.190 Sum_probs=114.1
Q ss_pred hcCC-CceEeEEeEE-------EeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 043333 627 ALQH-PNLVKLYGCC-------IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698 (809)
Q Consensus 627 ~l~H-~nIv~l~~~~-------~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 698 (809)
.++| +||++++++| .+.+.++.++||+ .++|.++|.. ....+++..++.++.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4455 5788888887 2334677889987 5599999953 234589999999999999999999998 8
Q ss_pred eEEcCCCCCCEEEcC-------------------CCceEEEecCCccccCCCCc---------------ceecccccccc
Q 043333 699 IVHRDIKATNVLLDK-------------------DLNPKISDFGLAKLDEEDNT---------------HISTRIAGTFG 744 (809)
Q Consensus 699 iiH~Dlkp~NILl~~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~ 744 (809)
|+||||||+||||+. ++.+|++|||+++....... ......+||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999964 44566666666653211000 00112457889
Q ss_pred ccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 745 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 745 y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
|||||++.+..++.++|||||||++|||++|..|+..
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 9999999999999999999999999999999988753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-19 Score=194.12 Aligned_cols=201 Identities=35% Similarity=0.557 Sum_probs=168.8
Q ss_pred CCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcc---cchhHHHHHHHHhhcCCC-ceEeEEeEEEeCCeEEEEEEc
Q 043333 577 FAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQ---GNREFVNEIGMISALQHP-NLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~---~~~~f~~Ei~~l~~l~H~-nIv~l~~~~~~~~~~~lV~ey 652 (809)
|...+.||.|+||.||++... ..+|+|.+...... ....|.+|+.++..+.|+ +|+++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999876 78899988765332 367799999999999988 799999999877778999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-ceEEEecCCccccCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDEED 731 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~ 731 (809)
+.++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++... .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999766322111 3688889999999999999999998 799999999999999988 7999999999855443
Q ss_pred Ccc-----eeccccccccccchhhhcc---CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 NTH-----ISTRIAGTFGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... ......|+..|+|||.+.. ...+...|+||+|++++++++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 321 2345679999999999987 578899999999999999999999976543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=181.60 Aligned_cols=203 Identities=23% Similarity=0.302 Sum_probs=167.5
Q ss_pred hcCCCCCCeeccCCCccEEEeE-eeCCeEEEEEEecccCcccchhHHHHHHHHhhcCC-CceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQH-PNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e 651 (809)
..+|..+++||.|+||.+|.|. ..+|+.||||.-..... ..++..|.++.+.++| ..|..+..|..+.+.-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4688999999999999999998 67899999998654433 3567889999999975 677788888888889999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CceEEEecCCcccc
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKISDFGLAKLD 728 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~~ 728 (809)
.. +-||.+.+.- -...++..+.+-++-|+..-++|+|.+ ++|||||||+|+|..-+ ..+.++|||+|+.+
T Consensus 92 LL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 77 6689887732 233578889999999999999999998 79999999999999644 56899999999876
Q ss_pred CCCCcc------eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcc
Q 043333 729 EEDNTH------ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKE 785 (809)
Q Consensus 729 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~ 785 (809)
.+.... ......||.+|.+-....+.+.+.+.|+-|+|.++.+.--|..||++....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 543221 123457999999998888888889999999999999999999999885543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.1e-23 Score=211.01 Aligned_cols=272 Identities=22% Similarity=0.227 Sum_probs=220.8
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-cccccc-ccccCCCCch-hhcCCccCcEEeeccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPL-WKQANGAIPK-AVASISTLADLTLEFN 77 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l-~~n~~~~ip~-~l~~l~~L~~L~L~~N 77 (809)
++.|-.|.|+.+.|.+|+.+++|++||||+|.|+.+.|..|..++ +.+|.+ .+|+|..+|+ .|.+|..|+.|.+.-|
T Consensus 71 eirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan 150 (498)
T KOG4237|consen 71 EIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNAN 150 (498)
T ss_pred EEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChh
Confidence 467889999988889999999999999999999999999999997 666655 5599999998 7789999999999999
Q ss_pred ccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccc------------cCcCchhhhcccccceEe
Q 043333 78 QFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHF------------TGQIPDYIQNWTKLEKLF 145 (809)
Q Consensus 78 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l------------~~~~p~~~~~l~~L~~L~ 145 (809)
++.-.....|..+++|..|.|.+|.+..+--.+|..+..++.+.+..|.+ ....|..++...-..-..
T Consensus 151 ~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~r 230 (498)
T KOG4237|consen 151 HINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYR 230 (498)
T ss_pred hhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHH
Confidence 99988888999999999999999999944444899999999999999983 234455566666666666
Q ss_pred cccCcCCCCCCccccCC-CCC-CEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCC
Q 043333 146 IEGSGLAGPIPSGIASL-VEL-TDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKL 223 (809)
Q Consensus 146 L~~N~l~~~~p~~~~~l-~~L-~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 223 (809)
|..+++..+-+..|... .++ ..+....+.....+...|..+++|+.|+|++|+++++-+.+|.++..|++|.|..|+|
T Consensus 231 l~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l 310 (498)
T KOG4237|consen 231 LYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKL 310 (498)
T ss_pred HHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchH
Confidence 77777765555544322 222 1233334445555566689999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCC-CCccEEEeeCccCCCCCChhhhh-ccCccccccCCccccC
Q 043333 224 SGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDG 272 (809)
Q Consensus 224 ~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~ 272 (809)
..+-...|.. ..|+.|+|.+|+|+...|..|.. .++..|+|-.|+|.|.
T Consensus 311 ~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~Cn 361 (498)
T KOG4237|consen 311 EFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCN 361 (498)
T ss_pred HHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCc
Confidence 8877777777 88999999999999888888865 5668889999998774
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.7e-20 Score=216.32 Aligned_cols=231 Identities=23% Similarity=0.275 Sum_probs=142.9
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeeccccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSG 81 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~ 81 (809)
|+|+.|++. .+|+.+. ++|+.|++++|+|+. +|... -.|+.|++++|++..+|.. .++|+.|+|++|.|+
T Consensus 206 LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~lp--~~Lk~LdLs~N~LtsLP~l---p~sL~~L~Ls~N~L~- 275 (788)
T PRK15387 206 LNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPALP--PELRTLEVSGNQLTSLPVL---PPGLLELSIFSNPLT- 275 (788)
T ss_pred EEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCCC--CCCcEEEecCCccCcccCc---ccccceeeccCCchh-
Confidence 688999888 7888876 479999999999984 55432 2378899999999888853 357888888888887
Q ss_pred CCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccC
Q 043333 82 DLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIAS 161 (809)
Q Consensus 82 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 161 (809)
.+|..+ .+|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++ +|.. ..+|+.|++++|+|+ .+|..
T Consensus 276 ~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~-~LP~l--- 340 (788)
T PRK15387 276 HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLT-SLPTL--- 340 (788)
T ss_pred hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCccc-ccccc---
Confidence 455432 45777788888777 44532 3567778888887774 4432 234666666666666 34431
Q ss_pred CCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEe
Q 043333 162 LVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYL 241 (809)
Q Consensus 162 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L 241 (809)
..+|+.|++++|+++.++.. ..+|+.|++++|++.. +|.. ..+|+.|+|++|+|+++++. .++|+.|++
T Consensus 341 p~~Lq~LdLS~N~Ls~LP~l----p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~LP~l---~s~L~~LdL 409 (788)
T PRK15387 341 PSGLQELSVSDNQLASLPTL----PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSLPVL---PSELKELMV 409 (788)
T ss_pred ccccceEecCCCccCCCCCC----Ccccceehhhcccccc-Cccc---ccccceEEecCCcccCCCCc---ccCCCEEEc
Confidence 13566667776666665421 2355556666666554 3322 23456666666666543321 145566666
Q ss_pred eCccCCCCCChhhhhccCccccccCCcccc
Q 043333 242 TGNLLTGPVPDWIVRKRNKHIDLSYNNFID 271 (809)
Q Consensus 242 s~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~ 271 (809)
++|+|++ +|... ..++.|++++|+++.
T Consensus 410 S~N~Lss-IP~l~--~~L~~L~Ls~NqLt~ 436 (788)
T PRK15387 410 SGNRLTS-LPMLP--SGLLSLSVYRNQLTR 436 (788)
T ss_pred cCCcCCC-CCcch--hhhhhhhhccCcccc
Confidence 6666654 33322 234555555665553
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-20 Score=219.56 Aligned_cols=242 Identities=22% Similarity=0.345 Sum_probs=174.8
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeeccccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSG 81 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~ 81 (809)
|+|++++++ .+|..+. ++|+.|+|++|+|+ .+|..+.. .|+.|++++|.+..+|..+. .+|+.|+|++|+++
T Consensus 183 L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~~-nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~- 254 (754)
T PRK15370 183 LRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQG-NIKTLYANSNQLTSIPATLP--DTIQEMELSINRIT- 254 (754)
T ss_pred EEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhcc-CCCEEECCCCccccCChhhh--ccccEEECcCCccC-
Confidence 567777777 5676664 57888888888888 45554432 57888888888888887654 47888888888888
Q ss_pred CCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccC
Q 043333 82 DLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIAS 161 (809)
Q Consensus 82 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 161 (809)
.+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+++ .+|..+.
T Consensus 255 ~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~- 324 (754)
T PRK15370 255 ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-ALPETLP- 324 (754)
T ss_pred cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cCCcccc-
Confidence 6776654 47888888888888 5676554 47888888888888 4555443 47888888888888 4555443
Q ss_pred CCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEe
Q 043333 162 LVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYL 241 (809)
Q Consensus 162 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L 241 (809)
++|+.|++++|.++.++.. + .++|+.|+|++|++.. +|..+. ++|+.|+|++|+|+.+++... .+|+.|++
T Consensus 325 -~sL~~L~Ls~N~Lt~LP~~-l--~~sL~~L~Ls~N~L~~-LP~~lp--~~L~~LdLs~N~Lt~LP~~l~--~sL~~LdL 395 (754)
T PRK15370 325 -PGLKTLEAGENALTSLPAS-L--PPELQVLDVSKNQITV-LPETLP--PTITTLDVSRNALTNLPENLP--AALQIMQA 395 (754)
T ss_pred -ccceeccccCCccccCChh-h--cCcccEEECCCCCCCc-CChhhc--CCcCEEECCCCcCCCCCHhHH--HHHHHHhh
Confidence 6788888888888876632 2 2688888888888874 565553 678888888888886654422 46888888
Q ss_pred eCccCCCCCChhhhh-----ccCccccccCCcccc
Q 043333 242 TGNLLTGPVPDWIVR-----KRNKHIDLSYNNFID 271 (809)
Q Consensus 242 s~N~l~~~~p~~~~~-----~~l~~L~Ls~N~l~~ 271 (809)
++|+|++ +|..+.. ..+..|+|.+|+|+.
T Consensus 396 s~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 396 SRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred ccCCccc-CchhHHHHhhcCCCccEEEeeCCCccH
Confidence 8888884 4443322 345778888888863
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.8e-20 Score=186.86 Aligned_cols=170 Identities=15% Similarity=0.145 Sum_probs=132.8
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchh---------HHHHHHHHhhcCCCceEeEEeEEEeC
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNRE---------FVNEIGMISALQHPNLVKLYGCCIEG 643 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~---------f~~Ei~~l~~l~H~nIv~l~~~~~~~ 643 (809)
..++|+..+++|.|+||.||.... ++..+|||.+++......+. +.+|++.+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468999999999999999999655 56789999997654332222 57899999999999999998886643
Q ss_pred --------CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC
Q 043333 644 --------NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL 715 (809)
Q Consensus 644 --------~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 715 (809)
...++||||++|.+|.++. .++. ....+++.++..+|+. +++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 3578999999999998864 1221 2456999999999998 899999999999999988
Q ss_pred ceEEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHH
Q 043333 716 NPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEI 772 (809)
Q Consensus 716 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~el 772 (809)
++++|||.......+... ..+.....+..++|+|||||.+...
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHH
Confidence 999999987654322110 1134444566789999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=180.83 Aligned_cols=139 Identities=17% Similarity=0.222 Sum_probs=107.3
Q ss_pred CCeeccCCCccEEEeEeeCCeEEEEEEecccCcc--c-------chhH-----------------HHHHHHHhhcCCCce
Q 043333 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQ--G-------NREF-----------------VNEIGMISALQHPNL 633 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~--~-------~~~f-----------------~~Ei~~l~~l~H~nI 633 (809)
...||+|+||.||+|...+|+.||||+++..... . ...| ..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999878999999998754211 1 1122 348999999988776
Q ss_pred EeEEeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEcCCCCCCEEEc
Q 043333 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYL-HEESRLKIVHRDIKATNVLLD 712 (809)
Q Consensus 634 v~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~Dlkp~NILl~ 712 (809)
.....+.. ...++||||++++++..... ....+++.....++.|++.+|.|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 44333222 22389999999987755431 223678899999999999999999 576 899999999999998
Q ss_pred CCCceEEEecCCcccc
Q 043333 713 KDLNPKISDFGLAKLD 728 (809)
Q Consensus 713 ~~~~~kl~DfGla~~~ 728 (809)
++.++++|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-19 Score=180.70 Aligned_cols=199 Identities=24% Similarity=0.344 Sum_probs=163.8
Q ss_pred CCCCCCeeccCCCccEEEeE-eeCCeEEEEEEecccCcccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCeEEEEEEcc
Q 043333 576 NFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.|.+.++||+|+||..+.|+ +-+++.||||.-..++ ...++..|.+..+.+. .+.|...+-+-.+..+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 56788999999999999998 5578999999754433 3456778888888774 788888887777777889999977
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-----CCceEEEecCCcccc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK-----DLNPKISDFGLAKLD 728 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DfGla~~~ 728 (809)
+-||.|++ +.-...++..++..+|+|+..-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.+
T Consensus 107 -GPSLEDLF---D~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLF---DLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHH---HHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 66888866 22345688899999999999999999999 7999999999999963 345899999999987
Q ss_pred CCCCcce------eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 729 EEDNTHI------STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.+..... .....||.+||+-....+++-+.+.|.-|+|=++.+.+-|..||.+..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 6544321 223569999999999999999999999999999999999999998743
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=174.69 Aligned_cols=140 Identities=18% Similarity=0.200 Sum_probs=110.0
Q ss_pred CCeeccCCCccEEEeEeeCCeEEEEEEecccCccc--------------------------chhHHHHHHHHhhcCCCce
Q 043333 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQG--------------------------NREFVNEIGMISALQHPNL 633 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~--------------------------~~~f~~Ei~~l~~l~H~nI 633 (809)
...||+|+||.||+|...+|+.||||+++...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999997789999999987642110 1123568899999999987
Q ss_pred EeEEeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEEc
Q 043333 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE-ESRLKIVHRDIKATNVLLD 712 (809)
Q Consensus 634 v~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~ 712 (809)
.....+... ..++||||++++++..... ....++......++.|++.++.++|+ . +|+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 544444333 2489999999886543321 12356778889999999999999999 7 899999999999999
Q ss_pred CCCceEEEecCCccccC
Q 043333 713 KDLNPKISDFGLAKLDE 729 (809)
Q Consensus 713 ~~~~~kl~DfGla~~~~ 729 (809)
+++++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.3e-21 Score=215.64 Aligned_cols=244 Identities=20% Similarity=0.254 Sum_probs=162.5
Q ss_pred CCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccC
Q 043333 21 PFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNS 100 (809)
Q Consensus 21 ~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 100 (809)
++|+.|+.++|.++ ..-..+....++.+++++|++..+|+.++.+.+|+.|+..+|+|+ .+|..+...++|+.|.+..
T Consensus 219 ~~l~~L~a~~n~l~-~~~~~p~p~nl~~~dis~n~l~~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~ 296 (1081)
T KOG0618|consen 219 PSLTALYADHNPLT-TLDVHPVPLNLQYLDISHNNLSNLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAY 296 (1081)
T ss_pred cchheeeeccCcce-eeccccccccceeeecchhhhhcchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhh
Confidence 34455555555554 222223333344555555555555554555555555555555553 4444444444444444444
Q ss_pred CccCccCchhhhcccccceeeeecccccC------------------------cCc-hhhhcccccceEecccCcCCCCC
Q 043333 101 NNFTGKLPESFANLTRLKHFRISDNHFTG------------------------QIP-DYIQNWTKLEKLFIEGSGLAGPI 155 (809)
Q Consensus 101 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~------------------------~~p-~~~~~l~~L~~L~L~~N~l~~~~ 155 (809)
|.+. -+|.....++.|++|+|..|+|.. ..| ..=..++.|+.|++.+|.++...
T Consensus 297 nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c 375 (1081)
T KOG0618|consen 297 NELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSC 375 (1081)
T ss_pred hhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccc
Confidence 4444 333344444444444444444441 222 11223567889999999999877
Q ss_pred CccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCC
Q 043333 156 PSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSG 235 (809)
Q Consensus 156 p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 235 (809)
-..+.+.++|+.|+|++|.+..++...+.+++.|+.|+||+|+++.. |..+..+..|++|....|+|...+ +....++
T Consensus 376 ~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~L-p~tva~~~~L~tL~ahsN~l~~fP-e~~~l~q 453 (1081)
T KOG0618|consen 376 FPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTL-PDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQ 453 (1081)
T ss_pred hhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhh-hHHHHhhhhhHHHhhcCCceeech-hhhhcCc
Confidence 77788899999999999999999999999999999999999998754 588999999999999999998655 6555699
Q ss_pred ccEEEeeCccCCCC-CChhhhhccCccccccCCcc
Q 043333 236 LTYMYLTGNLLTGP-VPDWIVRKRNKHIDLSYNNF 269 (809)
Q Consensus 236 L~~L~Ls~N~l~~~-~p~~~~~~~l~~L~Ls~N~l 269 (809)
|+.+|||.|.|+.. +|.....+.+++|||++|..
T Consensus 454 L~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 454 LKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred ceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 99999999999864 44544447889999999985
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.1e-19 Score=207.53 Aligned_cols=226 Identities=21% Similarity=0.310 Sum_probs=183.6
Q ss_pred CCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccC
Q 043333 21 PFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNS 100 (809)
Q Consensus 21 ~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 100 (809)
.+..+|+|++++++ .+|..+.. .+..|++++|.+..+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip~-~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIPE-QITTLILDNNELKSLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred cCceEEEeCCCCcC-cCCccccc-CCcEEEecCCCCCcCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 45789999999999 56665542 48899999999999998775 58999999999999 6777654 4799999999
Q ss_pred CccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCC
Q 043333 101 NNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPF 180 (809)
Q Consensus 101 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~ 180 (809)
|+++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|++++|.++.++.
T Consensus 251 N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~ 321 (754)
T PRK15370 251 NRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALPE 321 (754)
T ss_pred CccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccccCCc
Confidence 9999 7787765 58999999999999 5777654 58999999999999 4665543 579999999999998764
Q ss_pred ccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhhccCc
Q 043333 181 PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNK 260 (809)
Q Consensus 181 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~ 260 (809)
.. .++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+.+ |..+ .++|+.|+|++|+|+.. |..+. ..++
T Consensus 322 ~l---~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~L-P~~l-p~~L~~LdLs~N~Lt~L-P~~l~-~sL~ 391 (754)
T PRK15370 322 TL---PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITVL-PETL-PPTITTLDVSRNALTNL-PENLP-AALQ 391 (754)
T ss_pred cc---cccceeccccCCcccc-CChhhc--CcccEEECCCCCCCcC-Chhh-cCCcCEEECCCCcCCCC-CHhHH-HHHH
Confidence 33 3689999999999987 566553 7999999999999864 4433 27899999999999964 44443 3578
Q ss_pred cccccCCccccC
Q 043333 261 HIDLSYNNFIDG 272 (809)
Q Consensus 261 ~L~Ls~N~l~~~ 272 (809)
.|++++|++...
T Consensus 392 ~LdLs~N~L~~L 403 (754)
T PRK15370 392 IMQASRNNLVRL 403 (754)
T ss_pred HHhhccCCcccC
Confidence 999999999854
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=202.11 Aligned_cols=258 Identities=21% Similarity=0.195 Sum_probs=190.5
Q ss_pred CCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccC
Q 043333 21 PFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNS 100 (809)
Q Consensus 21 ~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 100 (809)
..-..|+|++|.|+ .+|..+.. .+..|++.+|.+..+|.. +++|++|+|++|+|+ .+|.. .++|+.|+|++
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~~-~L~~L~L~~N~Lt~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLPA-HITTLVIPDNNLTSLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchhc-CCCEEEccCCcCCCCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 44678999999999 67776654 588999999999999963 579999999999999 56653 46899999999
Q ss_pred CccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCC
Q 043333 101 NNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPF 180 (809)
Q Consensus 101 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~ 180 (809)
|.|+ .+|..+ ++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++ +|.. ..+|+.|++++|.++.++.
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~LP~ 339 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTSLPT 339 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCccccccc
Confidence 9999 556433 57889999999999 56653 4789999999999995 5542 2468889999999988763
Q ss_pred ccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhhccCc
Q 043333 181 PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNK 260 (809)
Q Consensus 181 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~ 260 (809)
-..+|+.|+|++|++++. |.. ..+|+.|++++|+|+.+ |.. ..+|+.|+|++|+|++ +|... ..++
T Consensus 340 ----lp~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~~L-P~l--~~~L~~LdLs~N~Lt~-LP~l~--s~L~ 405 (788)
T PRK15387 340 ----LPSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTSL-PAL--PSGLKELIVSGNRLTS-LPVLP--SELK 405 (788)
T ss_pred ----cccccceEecCCCccCCC-CCC---CcccceehhhccccccC-ccc--ccccceEEecCCcccC-CCCcc--cCCC
Confidence 225899999999999864 432 35788999999999975 432 2689999999999996 44332 4689
Q ss_pred cccccCCccccCCCCCcccccccceeccccCCCCCCccccccccCCCCCCCccee
Q 043333 261 HIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVSCLKSFTCPTNHSSLH 315 (809)
Q Consensus 261 ~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~~~~ 315 (809)
.|++++|+++..+ ..+.....+.+..+... ..+..+..+.+...+...+|++.
T Consensus 406 ~LdLS~N~LssIP-~l~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 406 ELMVSGNRLTSLP-MLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred EEEccCCcCCCCC-cchhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCC
Confidence 9999999998753 33333333322221111 12222333445555667777764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.7e-19 Score=173.98 Aligned_cols=107 Identities=28% Similarity=0.265 Sum_probs=93.4
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|.+++.. ....++|..+..++.|++.||+|||++ + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 688898843 234699999999999999999999998 3 999999999999999 99988654322
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
..||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 25789999999999999999999999999999999999999653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.7e-18 Score=168.66 Aligned_cols=187 Identities=17% Similarity=0.106 Sum_probs=138.7
Q ss_pred CCCCeeccCCCccEEEeEeeCCeEEEEEEecccCccc----chhHHHHHHHHhhcC-CCceEeEEeEEEeCCeEEEEEEc
Q 043333 578 APDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQG----NREFVNEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 578 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~----~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
.....|++|+||+||.+.- .+..++.+.+.....-. ...|.+|+++|+++. |+++++++++ +..++||||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999996654 56777777665442211 124789999999995 5889999886 456999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC-CCCCEEEcCCCceEEEecCCccccCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDI-KATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
+++.+|.+.+. . ....++.|++++|+++|++ +|+|||| ||+|||++++++++|+|||+|......
T Consensus 80 I~G~~L~~~~~-----~------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPP-----R------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhh-----h------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 99998865431 0 1134778999999999998 8999999 799999999999999999999855432
Q ss_pred Ccc---e---------eccccccccccchhhhcc-CCCC-chHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 NTH---I---------STRIAGTFGYMAPEYAMR-GYLT-DKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~~~---~---------~~~~~gt~~y~aPE~~~~-~~~~-~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... . ......++.|++|+-..- ...+ ...+.++.|.-+|.++||+.|...+.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 210 0 001225678888875432 1223 56799999999999999999886643
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.3e-18 Score=211.03 Aligned_cols=256 Identities=20% Similarity=0.229 Sum_probs=198.1
Q ss_pred CCccCCccCCCCC-CCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeecccccccCCCccc
Q 043333 9 LPGRLPPELTRLP-FLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAEL 87 (809)
Q Consensus 9 l~~~lp~~l~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~ 87 (809)
+...+|..+..++ +|+.|++.++.+. .+|..|..-.|.+|++.++.+..+|..+..+++|+.|+|+++...+.+|. +
T Consensus 576 ~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-l 653 (1153)
T PLN03210 576 VRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNFRPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD-L 653 (1153)
T ss_pred ceeecCcchhhcCcccEEEEecCCCCC-CCCCcCCccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc-c
Confidence 4445777776664 5888888888887 66777766568889998888988888888899999999988764446664 7
Q ss_pred cCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCE
Q 043333 88 GNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTD 167 (809)
Q Consensus 88 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 167 (809)
+.+++|++|+|++|.....+|..++++++|+.|+|++|...+.+|..+ ++++|+.|+|++|.....+|.. ..+|+.
T Consensus 654 s~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~ 729 (1153)
T PLN03210 654 SMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISW 729 (1153)
T ss_pred ccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCe
Confidence 888899999998887666888889999999999999876555777655 7888888888888766566643 357788
Q ss_pred EeccCCCCCCCCCcc-----------------------------ccCCcCCceeeeccccccCCCChhhhccccccEEec
Q 043333 168 LRISDLNGPEGPFPR-----------------------------LSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDL 218 (809)
Q Consensus 168 L~l~~n~l~~~~~~~-----------------------------l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 218 (809)
|++++|.+..++... ....++|+.|+|++|.....+|..+.++++|+.|+|
T Consensus 730 L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~L 809 (1153)
T PLN03210 730 LDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEI 809 (1153)
T ss_pred eecCCCccccccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEEC
Confidence 888888877655321 111357889999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhhccCccccccCCccccC
Q 043333 219 SFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDG 272 (809)
Q Consensus 219 s~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~ 272 (809)
++|..-+.+|.....++|+.|+|++|.....+|... .+++.|+|++|.++..
T Consensus 810 s~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~~~--~nL~~L~Ls~n~i~~i 861 (1153)
T PLN03210 810 ENCINLETLPTGINLESLESLDLSGCSRLRTFPDIS--TNISDLNLSRTGIEEV 861 (1153)
T ss_pred CCCCCcCeeCCCCCccccCEEECCCCCccccccccc--cccCEeECCCCCCccC
Confidence 998655566766666899999999987655566543 4678899999988754
|
syringae 6; Provisional |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4e-19 Score=174.99 Aligned_cols=194 Identities=24% Similarity=0.394 Sum_probs=152.1
Q ss_pred CCeeccCCCccEEEeEeeCCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCc
Q 043333 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNS 657 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gs 657 (809)
.-+|.+...|..|+|+|+.. -+++|++... .....++|.+|.-.++-+.||||+.++|.|..+....++..||+.||
T Consensus 195 ~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 45688888999999999744 4456666433 34445789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE-EcCCCCCCEEEcCCCceEEEecCCccccCCCCccee
Q 043333 658 LARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIV-HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 736 (809)
Q Consensus 658 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii-H~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 736 (809)
|+..||+. .....+-.++.+++.+||+||+|||+.. +++ ---|.+..|++|++.+++|+ .+-+++.-...
T Consensus 274 lynvlhe~--t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris-mad~kfsfqe~---- 344 (448)
T KOG0195|consen 274 LYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEV---- 344 (448)
T ss_pred HHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee-cccceeeeecc----
Confidence 99999864 3445778899999999999999999985 444 44689999999999988875 11112111111
Q ss_pred ccccccccccchhhhccCCC---CchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 737 TRIAGTFGYMAPEYAMRGYL---TDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 737 ~~~~gt~~y~aPE~~~~~~~---~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
...-.+.||+||.++.++- -..+|+|||++++|||.|...||..-..
T Consensus 345 -gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp 394 (448)
T KOG0195|consen 345 -GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP 394 (448)
T ss_pred -ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence 1123568999999987643 3478999999999999999999976443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-20 Score=209.38 Aligned_cols=261 Identities=23% Similarity=0.285 Sum_probs=210.8
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeeccccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSG 81 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~ 81 (809)
|+|++|++. -..+..+.+|+.|....|++... .+....++.|...+|.+..+-.. ..-.+|+++++++|+++
T Consensus 183 ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l---~~~g~~l~~L~a~~n~l~~~~~~-p~p~nl~~~dis~n~l~- 254 (1081)
T KOG0618|consen 183 LDLRYNEME---VLDLSNLANLEVLHCERNQLSEL---EISGPSLTALYADHNPLTTLDVH-PVPLNLQYLDISHNNLS- 254 (1081)
T ss_pred eecccchhh---hhhhhhccchhhhhhhhcccceE---EecCcchheeeeccCcceeeccc-cccccceeeecchhhhh-
Confidence 677777776 23456677778888888877632 22344577777778877643222 23368999999999999
Q ss_pred CCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCcccc-
Q 043333 82 DLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIA- 160 (809)
Q Consensus 82 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~- 160 (809)
.+|.+++.+.+|+.|...+|+|+ .+|..+..+++|+.|++..|+++ .+|.....+++|++|+|..|+|. .+|+.+.
T Consensus 255 ~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~ 331 (1081)
T KOG0618|consen 255 NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLA 331 (1081)
T ss_pred cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHh
Confidence 67799999999999999999997 88999999999999999999999 78888888999999999999998 4544321
Q ss_pred -------------------------CCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccE
Q 043333 161 -------------------------SLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRV 215 (809)
Q Consensus 161 -------------------------~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 215 (809)
.++.|+.|++.+|.+++--.+.|.+..+|+.|+|++|++.......+.++..|++
T Consensus 332 v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~Lee 411 (1081)
T KOG0618|consen 332 VLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEE 411 (1081)
T ss_pred hhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHH
Confidence 2345678888899999888889999999999999999998888888999999999
Q ss_pred EeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhhccCccccccCCccccCCC
Q 043333 216 LDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSS 274 (809)
Q Consensus 216 L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~~~ 274 (809)
|+||+|+|+.++........|+.|...+|+|. ..|+......++.+|+|.|+++....
T Consensus 412 L~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N~L~~~~l 469 (1081)
T KOG0618|consen 412 LNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVLDLSCNNLSEVTL 469 (1081)
T ss_pred HhcccchhhhhhHHHHhhhhhHHHhhcCCcee-echhhhhcCcceEEecccchhhhhhh
Confidence 99999999977655444589999999999998 55576666788999999999986543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.3e-19 Score=196.12 Aligned_cols=185 Identities=29% Similarity=0.367 Sum_probs=153.8
Q ss_pred eccCCCccEEEeE----eeCCeEEEEEEecccCccc--chhHHHHHHHHhhcC-CCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 583 IGEGGFGPVYKGL----LADGKVIAVKQLSSKSKQG--NREFVNEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 583 LG~G~fG~Vy~~~----~~~g~~vAVK~~~~~~~~~--~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+|+|.||.|+.+. .+.|+.+|.|..++..... ......|..++...+ ||.+|++.-.++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999765 3347788999887653221 224556788888887 99999999999999999999999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|.|...+. .....+..........+|-+++++|+. +++|||+|++||+++.+|++++.|||+++..-+....
T Consensus 82 g~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 99988773 333456666677788899999999998 8999999999999999999999999999866443322
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
+||..|||||++. .+...+|.||||++++||+||-.||..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8999999999987 457789999999999999999999965
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.2e-17 Score=207.30 Aligned_cols=257 Identities=22% Similarity=0.264 Sum_probs=177.5
Q ss_pred cccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccc-cCCCCchhhcCCccCcEEeecccccc
Q 043333 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQ-ANGAIPKAVASISTLADLTLEFNQFS 80 (809)
Q Consensus 3 ~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n-~~~~ip~~l~~l~~L~~L~L~~N~l~ 80 (809)
.+.++.+. .+|..+ .+.+|++|+|++|++. .++..+..++ |+.|+++++ .++.+|. ++.+++|+.|+|++|...
T Consensus 595 ~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L 670 (1153)
T PLN03210 595 RWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSL 670 (1153)
T ss_pred EecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCc
Confidence 44444443 666666 4577777888777776 4555555554 777777653 4566663 667777777777776655
Q ss_pred cCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccc-
Q 043333 81 GDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGI- 159 (809)
Q Consensus 81 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~- 159 (809)
..+|..+.++++|+.|+|++|..-..+|..+ ++++|+.|+|++|...+.+|.. .++|+.|+|++|.+. .+|..+
T Consensus 671 ~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~ 745 (1153)
T PLN03210 671 VELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLR 745 (1153)
T ss_pred cccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-ccccccc
Confidence 5777777777777777777764333566554 6777777777777655455542 346667777777665 344321
Q ss_pred -----------------------------cCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhcc
Q 043333 160 -----------------------------ASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQM 210 (809)
Q Consensus 160 -----------------------------~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 210 (809)
...++|+.|++++|......+..+.++++|+.|+|++|...+.+|..+ ++
T Consensus 746 l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L 824 (1153)
T PLN03210 746 LENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NL 824 (1153)
T ss_pred ccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-Cc
Confidence 123578888888886655556678999999999999988777888766 78
Q ss_pred ccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhh-ccCccccccC-CccccC
Q 043333 211 IGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSY-NNFIDG 272 (809)
Q Consensus 211 ~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~-N~l~~~ 272 (809)
++|+.|+|++|..-..+|.. ..+|+.|+|++|.++. +|..+.. .+++.|+|++ |++.+.
T Consensus 825 ~sL~~L~Ls~c~~L~~~p~~--~~nL~~L~Ls~n~i~~-iP~si~~l~~L~~L~L~~C~~L~~l 885 (1153)
T PLN03210 825 ESLESLDLSGCSRLRTFPDI--STNISDLNLSRTGIEE-VPWWIEKFSNLSFLDMNGCNNLQRV 885 (1153)
T ss_pred cccCEEECCCCCcccccccc--ccccCEeECCCCCCcc-ChHHHhcCCCCCEEECCCCCCcCcc
Confidence 99999999998765555543 2689999999999984 5655543 6779999988 555543
|
syringae 6; Provisional |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=168.07 Aligned_cols=139 Identities=18% Similarity=0.326 Sum_probs=106.8
Q ss_pred CCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhc-----CCCceEeEEeEEEeCC---e-EE
Q 043333 577 FAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-----QHPNLVKLYGCCIEGN---Q-LL 647 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-----~H~nIv~l~~~~~~~~---~-~~ 647 (809)
+...+.||+|+||.||. .-.++.. +||++........+.+.+|+++++.+ .||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 2223444 69988765444567799999999999 5799999999999874 4 34
Q ss_pred EEEEc--ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEcCCCCCCEEEcC----CCceEEE
Q 043333 648 LIYEY--MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGL-AYLHEESRLKIVHRDIKATNVLLDK----DLNPKIS 720 (809)
Q Consensus 648 lV~ey--~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~ 720 (809)
+|+|| +++|+|.+++.. ..+++. ..++.+++.++ +|||++ +|+||||||+|||++. +++++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 668999999933 124444 35677888777 999998 8999999999999974 3479999
Q ss_pred e-cCCccc
Q 043333 721 D-FGLAKL 727 (809)
Q Consensus 721 D-fGla~~ 727 (809)
| ||...+
T Consensus 152 Dg~G~~~~ 159 (210)
T PRK10345 152 DNIGESTF 159 (210)
T ss_pred ECCCCcce
Confidence 9 554443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.4e-20 Score=171.07 Aligned_cols=160 Identities=28% Similarity=0.427 Sum_probs=136.9
Q ss_pred CCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCE
Q 043333 17 LTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEK 95 (809)
Q Consensus 17 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 95 (809)
+-.+.+++.|.||+|+++ .+|+.++.+. |+.|++++|++.++|..++.+++|+.|++.-|.+. .+|..|+.++.|+.
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 556778889999999998 5666666664 88889999999999999999999999999999988 88889999999999
Q ss_pred EEccCCccCc-cCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCC
Q 043333 96 LHLNSNNFTG-KLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLN 174 (809)
Q Consensus 96 L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~ 174 (809)
|||..|++.. .+|..|.-++.|+.|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|..++.+..|++|++.+|+
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence 9999988874 67888888899999999999988 88888999999999999999888 788888888888888888888
Q ss_pred CCCCCC
Q 043333 175 GPEGPF 180 (809)
Q Consensus 175 l~~~~~ 180 (809)
++.+++
T Consensus 185 l~vlpp 190 (264)
T KOG0617|consen 185 LTVLPP 190 (264)
T ss_pred eeecCh
Confidence 877764
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-19 Score=196.22 Aligned_cols=269 Identities=22% Similarity=0.286 Sum_probs=184.0
Q ss_pred CccccCCCCC-ccCCccCCCCCCCCEEEccCCCCCCC----CCcccCCCC-ccccccccccCCC-------CchhhcCCc
Q 043333 1 HRILKSQNLP-GRLPPELTRLPFLQEIDLTRNYLNGT----IPSEWASLP-LVNLPLWKQANGA-------IPKAVASIS 67 (809)
Q Consensus 1 ~L~L~~nnl~-~~lp~~l~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~-L~~L~l~~n~~~~-------ip~~l~~l~ 67 (809)
+|+|+.+++. ...+..+..+.+|++|++++|.++.. ++..+...+ ++++++..+.++. ++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4789999998 56666678888899999999998642 333344443 7777777766653 344667778
Q ss_pred cCcEEeecccccccCCCccccCCCC---CCEEEccCCccCc----cCchhhhcc-cccceeeeecccccCc----Cchhh
Q 043333 68 TLADLTLEFNQFSGDLPAELGNLIN---LEKLHLNSNNFTG----KLPESFANL-TRLKHFRISDNHFTGQ----IPDYI 135 (809)
Q Consensus 68 ~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~----~p~~~ 135 (809)
+|+.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 8888888888887656666655555 8888888888873 233445666 7888888888888843 33446
Q ss_pred hcccccceEecccCcCCCC----CCccccCCCCCCEEeccCCCCCCCCCc----cccCCcCCceeeeccccccCCCChhh
Q 043333 136 QNWTKLEKLFIEGSGLAGP----IPSGIASLVELTDLRISDLNGPEGPFP----RLSNLKNMNYLILRSGNIIGEMPEYL 207 (809)
Q Consensus 136 ~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~n~l~~~~~~----~l~~l~~L~~L~Ls~N~l~~~~p~~~ 207 (809)
..+++|+.|+|++|.+++. ++..+..+++|+.|++++|.+...... .+..+++|++|++++|.+.......+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 6677888888888888742 233445567888888888887755433 35667788888888888876444443
Q ss_pred hc-----cccccEEeccCCCCCCCC----CCCCCC-CCccEEEeeCccCCCCCChhh----hh--ccCccccccCCcc
Q 043333 208 GQ-----MIGLRVLDLSFNKLSGVI----PSNFSG-SGLTYMYLTGNLLTGPVPDWI----VR--KRNKHIDLSYNNF 269 (809)
Q Consensus 208 ~~-----l~~L~~L~Ls~N~l~~~~----p~~~~~-~~L~~L~Ls~N~l~~~~p~~~----~~--~~l~~L~Ls~N~l 269 (809)
.. .+.|+.|++++|.++... ...+.. ++|+++++++|.++......+ .. ..++.+++.+|+|
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 32 368888888888886221 122222 678888888888885533222 22 2457777777764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.4e-20 Score=169.78 Aligned_cols=164 Identities=26% Similarity=0.460 Sum_probs=125.6
Q ss_pred hhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhccccc
Q 043333 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKL 141 (809)
Q Consensus 62 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 141 (809)
.+.++.+++.|.|++|+++ .+|+.++.+.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. ..|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4556677778888888888 67777888888888888888888 67778888888888888888877 778888888888
Q ss_pred ceEecccCcCCC-CCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccC
Q 043333 142 EKLFIEGSGLAG-PIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSF 220 (809)
Q Consensus 142 ~~L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 220 (809)
+.|||..|++.. .+|..|..+..|+.|++++|.+..++ +..+++++|+.|.+++|.+. .+|..++.++.|++|++.+
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp-~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILP-PDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCC-hhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 888888887753 45777777777888888887776655 45677777778888777775 4577788888888888888
Q ss_pred CCCCCCCCCC
Q 043333 221 NKLSGVIPSN 230 (809)
Q Consensus 221 N~l~~~~p~~ 230 (809)
|+++-.+|+.
T Consensus 183 nrl~vlppel 192 (264)
T KOG0617|consen 183 NRLTVLPPEL 192 (264)
T ss_pred ceeeecChhh
Confidence 8887666653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-17 Score=196.66 Aligned_cols=198 Identities=20% Similarity=0.241 Sum_probs=158.4
Q ss_pred HHHHhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcC---CCceEeEEeEEEeCCeE
Q 043333 570 IKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ---HPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 570 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~ 646 (809)
.+...+.|.+.+.||+|+||+||+|...+|+.||+|+-+.....+ |.-=.+++.+++ -+-|..+..++.-.+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 344567888999999999999999998889999999987665432 111123444444 34555666667777888
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-------CCCceEE
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD-------KDLNPKI 719 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-------~~~~~kl 719 (809)
++|+||.+.|+|.+++. ....++|...+.++.|+++.+++||.. +||||||||.|.||. +..-++|
T Consensus 770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 99999999999999994 455689999999999999999999998 899999999999994 2345899
Q ss_pred EecCCccccCC-CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCC
Q 043333 720 SDFGLAKLDEE-DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRS 777 (809)
Q Consensus 720 ~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~ 777 (809)
+|||.+--+.- .+...-...++|-.+-.+|+..++.++..+|.|.++-+++.|+.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99998853321 11222345678899999999999999999999999999999999975
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.2e-18 Score=196.16 Aligned_cols=198 Identities=28% Similarity=0.368 Sum_probs=155.5
Q ss_pred CCCCeeccCCCccEEEeEee-CCeEEEEEEeccc--Cccc----chhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 578 APDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK--SKQG----NREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 578 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~----~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
...+.+|.|.+|.|+..... ..+..+.|..+.. .... ...+..|+.+-..++|||++..+..+.+.+...-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999988877633 3344444433210 1111 122566788888899999998888888777777779
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++ +|..++-. ...+....+-.+++|+..|+.|+|+. ++.|||+|++|++++.++.+||+|||.+..+..
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 99988832 23567778888999999999999998 899999999999999999999999999976643
Q ss_pred CCc---ceeccccccccccchhhhccCCCCc-hHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNT---HISTRIAGTFGYMAPEYAMRGYLTD-KADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... ......+|+..|+|||.+.+..|.+ ..||||.||++..|.+|+.||....
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 322 4455678999999999999888766 4699999999999999999996533
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=163.89 Aligned_cols=142 Identities=19% Similarity=0.178 Sum_probs=109.5
Q ss_pred CCCCCCeeccCCCccEEEeE--eeCCeEEEEEEecccCcc------------------------cchhHHHHHHHHhhcC
Q 043333 576 NFAPDNKIGEGGFGPVYKGL--LADGKVIAVKQLSSKSKQ------------------------GNREFVNEIGMISALQ 629 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~--~~~g~~vAVK~~~~~~~~------------------------~~~~f~~Ei~~l~~l~ 629 (809)
-|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46678899999999999998 568999999998654210 0122467999999997
Q ss_pred CCc--eEeEEeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEcCCCC
Q 043333 630 HPN--LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK-IVHRDIKA 706 (809)
Q Consensus 630 H~n--Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-iiH~Dlkp 706 (809)
+.. +.+++++ ...++||||+++++|..+... ...........++.|++.++++||+. + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 533 3344442 235899999999888765421 22345556788999999999999998 7 99999999
Q ss_pred CCEEEcCCCceEEEecCCccccC
Q 043333 707 TNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 707 ~NILl~~~~~~kl~DfGla~~~~ 729 (809)
+||+++ +++++++|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=160.87 Aligned_cols=135 Identities=19% Similarity=0.290 Sum_probs=113.3
Q ss_pred CeeccCCCccEEEeEeeCCeEEEEEEecccCcc--------cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQ--------GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~--------~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
+.||+|++|.||+|.+ +|..|+||+....... ....+.+|++++..++|+++.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 5677899986543221 123577899999999999998888888788888999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
+++++|.+++... .+ .+..++.+++.+|.++|+. +++|||++|.||+++ ++.++++|||.+...
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999988321 12 7888999999999999998 899999999999999 789999999998753
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=182.79 Aligned_cols=141 Identities=20% Similarity=0.306 Sum_probs=114.0
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEE-ecccCc-------ccchhHHHHHHHHhhcCCCceEeEEeEEEeC
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQ-LSSKSK-------QGNREFVNEIGMISALQHPNLVKLYGCCIEG 643 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~-~~~~~~-------~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~ 643 (809)
.....|...+.||+|+||+||+|.+..... ++|+ ...... ...+.+.+|++++..++|++++....++.+.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~-v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRDA-VIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCccc-eeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 334556778999999999999998765443 3443 222111 1124578899999999999999888888887
Q ss_pred CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 644 NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
+..++||||+++++|.+++. .+..++.+++++|.|||+. +++|||+||+|||+ +++.++|+|||
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCc
Confidence 88899999999999998872 3567899999999999998 89999999999999 57799999999
Q ss_pred CccccC
Q 043333 724 LAKLDE 729 (809)
Q Consensus 724 la~~~~ 729 (809)
+++...
T Consensus 473 la~~~~ 478 (535)
T PRK09605 473 LGKYSD 478 (535)
T ss_pred ccccCC
Confidence 998643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.7e-16 Score=157.65 Aligned_cols=144 Identities=20% Similarity=0.207 Sum_probs=111.1
Q ss_pred HHHHhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcc----------------------cchhHHHHHHHHhh
Q 043333 570 IKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQ----------------------GNREFVNEIGMISA 627 (809)
Q Consensus 570 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~----------------------~~~~f~~Ei~~l~~ 627 (809)
+......|...+.||+|+||.||++...+|+.||||+++..... ....+..|..++.+
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33334447788999999999999999888999999987543210 01125678888988
Q ss_pred cCCCc--eEeEEeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 043333 628 LQHPN--LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIK 705 (809)
Q Consensus 628 l~H~n--Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk 705 (809)
+.|++ +...++ ....++||||+++++|...... .....++.+++.++.++|+. +++|||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 88874 444443 2456899999999998765410 23457889999999999997 89999999
Q ss_pred CCCEEEcCCCceEEEecCCccccCC
Q 043333 706 ATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 706 p~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
|+||+++++++++|+|||++.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.6e-16 Score=157.09 Aligned_cols=131 Identities=22% Similarity=0.321 Sum_probs=106.8
Q ss_pred eeccCCCccEEEeEeeCCeEEEEEEecccCcc--------cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 582 KIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQ--------GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 582 ~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~--------~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.||+|+||.||+|.+ +|..|++|+....... ...++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 5678899986543211 1245678999999999988766666666777789999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
++++|.+++.... ..++.+++.+|.++|+. +++|||++|.||+++ +++++++|||++...
T Consensus 80 ~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998873210 07899999999999998 899999999999999 889999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.8e-18 Score=183.05 Aligned_cols=248 Identities=21% Similarity=0.257 Sum_probs=187.8
Q ss_pred EEEccCCCCC-CCCCcccCCCC-ccccccccccC-----CCCchhhcCCccCcEEeeccccccc------CCCccccCCC
Q 043333 25 EIDLTRNYLN-GTIPSEWASLP-LVNLPLWKQAN-----GAIPKAVASISTLADLTLEFNQFSG------DLPAELGNLI 91 (809)
Q Consensus 25 ~L~Ls~n~l~-~~~p~~~~~l~-L~~L~l~~n~~-----~~ip~~l~~l~~L~~L~L~~N~l~~------~~p~~~~~l~ 91 (809)
.|+|..+.++ ...+..+..+. ++++.+.++.+ ..++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 5788888887 33333444443 88999998887 3467778888899999999998872 2345677899
Q ss_pred CCCEEEccCCccCccCchhhhcccc---cceeeeecccccC----cCchhhhcc-cccceEecccCcCCCC----CCccc
Q 043333 92 NLEKLHLNSNNFTGKLPESFANLTR---LKHFRISDNHFTG----QIPDYIQNW-TKLEKLFIEGSGLAGP----IPSGI 159 (809)
Q Consensus 92 ~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~ 159 (809)
+|+.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 9999999999998777777777766 9999999999883 333456667 8999999999999853 34456
Q ss_pred cCCCCCCEEeccCCCCCCCCCc----cccCCcCCceeeeccccccCCC----ChhhhccccccEEeccCCCCCCCCCCCC
Q 043333 160 ASLVELTDLRISDLNGPEGPFP----RLSNLKNMNYLILRSGNIIGEM----PEYLGQMIGLRVLDLSFNKLSGVIPSNF 231 (809)
Q Consensus 160 ~~l~~L~~L~l~~n~l~~~~~~----~l~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 231 (809)
..+++|+.|++++|.+...... .+..+++|+.|+|++|.+.+.. +..+..+++|+.|++++|.+++.....+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 6778999999999998864332 3456679999999999987654 3456678899999999999986322221
Q ss_pred C------CCCccEEEeeCccCCCCCC----hhhhh-ccCccccccCCccccC
Q 043333 232 S------GSGLTYMYLTGNLLTGPVP----DWIVR-KRNKHIDLSYNNFIDG 272 (809)
Q Consensus 232 ~------~~~L~~L~Ls~N~l~~~~p----~~~~~-~~l~~L~Ls~N~l~~~ 272 (809)
. .+.|+.|++++|.++.... ..+.. ..++.+++++|.+...
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 1 2699999999999973222 22222 4679999999999754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-15 Score=159.14 Aligned_cols=199 Identities=22% Similarity=0.263 Sum_probs=127.8
Q ss_pred CCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhcCC----------CceEeEEeEEE--
Q 043333 578 APDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISALQH----------PNLVKLYGCCI-- 641 (809)
Q Consensus 578 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H----------~nIv~l~~~~~-- 641 (809)
...+.||.|+++.||.++.. .++.+|||+...... ...+++.+|.-....+.+ -.++-.++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34678999999999999975 489999998754432 224556666544444322 12222222221
Q ss_pred -------eCC--------eEEEEEEcccCCchhhhc---cCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcC
Q 043333 642 -------EGN--------QLLLIYEYMENNSLARAL---FGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRD 703 (809)
Q Consensus 642 -------~~~--------~~~lV~ey~~~gsL~~~L---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~D 703 (809)
... ..+++|+-+ .++|.+.+ +........+....++.+..|+.+.+++||+. +++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 111 235677766 55887764 22222223455667788889999999999999 899999
Q ss_pred CCCCCEEEcCCCceEEEecCCccccCCCCcceeccccccccccchhhhccC--------CCCchHHHHHHHHHHHHHHcC
Q 043333 704 IKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG--------YLTDKADVYSFGIVALEIVSG 775 (809)
Q Consensus 704 lkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~ksDVwSlGvil~elltG 775 (809)
|||+|++++++|.+.|+||+......+. ... ...+..|.+||..... .++.+.|.|++|+++|.|+.|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTR---YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEE---EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCce---eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999999876543321 111 2345689999987542 478899999999999999999
Q ss_pred CCCCCCCCc
Q 043333 776 RSNVICRTK 784 (809)
Q Consensus 776 k~P~~~~~~ 784 (809)
+.||.....
T Consensus 247 ~lPf~~~~~ 255 (288)
T PF14531_consen 247 RLPFGLSSP 255 (288)
T ss_dssp S-STCCCGG
T ss_pred cCCCCCCCc
Confidence 999976443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.4e-16 Score=183.36 Aligned_cols=196 Identities=23% Similarity=0.285 Sum_probs=149.5
Q ss_pred CCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccC-cccchhHHHHHHH--HhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKS-KQGNREFVNEIGM--ISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~-~~~~~~f~~Ei~~--l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
++...+.||.+.|=+|.+|+.++|. |+||++.+.. .-.-+.|.++++- ...++|||.+++.-.-..++..|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566788999999999999998888 7899886554 3345556554433 4556899999988777777777899999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc--cCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEE 730 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~--~~~ 730 (809)
..+ +|+|.| ..+..+...+.+-|+.|+..|+.-+|.. +|+|||||.+|||++.-.=+.|+||..-+. +.+
T Consensus 103 vkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 866 899888 3455577778888999999999999998 899999999999999988899999976542 222
Q ss_pred CCcce-e---ccccccccccchhhhccC-----------CCCchHHHHHHHHHHHHHHc-CCCCCC
Q 043333 731 DNTHI-S---TRIAGTFGYMAPEYAMRG-----------YLTDKADVYSFGIVALEIVS-GRSNVI 780 (809)
Q Consensus 731 ~~~~~-~---~~~~gt~~y~aPE~~~~~-----------~~~~ksDVwSlGvil~ellt-Gk~P~~ 780 (809)
++... . .....-.+|.|||.+... ..+++-||||+||+++||++ |++||.
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 22110 0 001122379999987431 15678899999999999987 688885
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.6e-14 Score=137.99 Aligned_cols=135 Identities=22% Similarity=0.229 Sum_probs=114.2
Q ss_pred CCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCC--CceEeEEeEEEeCCeEEEEEEcccCC
Q 043333 579 PDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQH--PNLVKLYGCCIEGNQLLLIYEYMENN 656 (809)
Q Consensus 579 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~~~~~~~~~~~lV~ey~~~g 656 (809)
+.+.||+|.++.||++...+ +.++||....... ...+..|+.++..++| ..+++++++...++..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45779999999999999754 7789998865433 4678899999999976 58899999888888899999999987
Q ss_pred chhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 657 SLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 657 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66543 5567778899999999999986445799999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.2e-15 Score=165.27 Aligned_cols=166 Identities=33% Similarity=0.490 Sum_probs=132.7
Q ss_pred HhhcCCCceEeEEeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EEcC
Q 043333 625 ISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI-VHRD 703 (809)
Q Consensus 625 l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i-iH~D 703 (809)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.....+.++++.||+|+|+. +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 3568899999999999999999999999999999999944 456799999999999999999999986 34 8999
Q ss_pred CCCCCEEEcCCCceEEEecCCccccCCC-CcceeccccccccccchhhhccC-------CCCchHHHHHHHHHHHHHHcC
Q 043333 704 IKATNVLLDKDLNPKISDFGLAKLDEED-NTHISTRIAGTFGYMAPEYAMRG-------YLTDKADVYSFGIVALEIVSG 775 (809)
Q Consensus 704 lkp~NILl~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDVwSlGvil~elltG 775 (809)
++++|.++|....+|++|||+....... .........-..-|.|||.+... ..+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998766421 00111112234579999998753 146779999999999999999
Q ss_pred CCCCCCCCc-ccchhHHHHHHH
Q 043333 776 RSNVICRTK-EAQFCLLDWVTL 796 (809)
Q Consensus 776 k~P~~~~~~-~~~~~l~~~~~~ 796 (809)
+.||..... ++...++.+++.
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK 176 (484)
T ss_pred cCccccccccCChHHHHHHHHh
Confidence 999976432 222345555554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.2e-15 Score=172.36 Aligned_cols=169 Identities=26% Similarity=0.387 Sum_probs=121.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC-CeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
..+|+.++.|..|+||.||..+++. .+.+|.|+ .++.- +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee------------------
Confidence 3578889999999999999998763 56777743 32211 0000 22233344433
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC-
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED- 731 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~- 731 (809)
|+-...+. ...+++. +++.+++|+|+. +|+|||+||.|.+++.-|++|++|||+.+.....
T Consensus 136 ---gDc~tllk----~~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLK----NIGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcc----cCCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 44444442 2222322 237789999998 8999999999999999999999999998743111
Q ss_pred -------Cc------ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCccc
Q 043333 732 -------NT------HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEA 786 (809)
Q Consensus 732 -------~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~ 786 (809)
.. .....++||+.|+|||++....|+..+|+|++|+|+||.+.|..||.+.+.|+
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 00 11224689999999999999999999999999999999999999998876554
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2e-14 Score=143.49 Aligned_cols=137 Identities=21% Similarity=0.269 Sum_probs=97.7
Q ss_pred CCeeccCCCccEEEeEeeCCeEEEEEEecccCcc--cchhH----------------------HHHHHHHhhcCCCc--e
Q 043333 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQ--GNREF----------------------VNEIGMISALQHPN--L 633 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~--~~~~f----------------------~~Ei~~l~~l~H~n--I 633 (809)
.+.||+|+||+||+|...+++.||||+++..... ....+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999878999999998653211 11111 24556666665443 3
Q ss_pred EeEEeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEEc
Q 043333 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE-ESRLKIVHRDIKATNVLLD 712 (809)
Q Consensus 634 v~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~ 712 (809)
.+.+++ ...++||||++++.+....... . ... ..+..++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~--~--~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD--V--RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhh--h--hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 344433 2458999999996543211100 0 011 5677899999999999998 6 899999999999999
Q ss_pred CCCceEEEecCCccccC
Q 043333 713 KDLNPKISDFGLAKLDE 729 (809)
Q Consensus 713 ~~~~~kl~DfGla~~~~ 729 (809)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.50 E-value=5.2e-15 Score=160.31 Aligned_cols=123 Identities=26% Similarity=0.432 Sum_probs=106.1
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
+.++.|+++...+|.+||.+.+ ....-+|...+.++.|++.|++| + +.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999996543 33456888999999999999999 4 789999999999999999999999999
Q ss_pred ccccCCCC-----cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc
Q 043333 725 AKLDEEDN-----THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774 (809)
Q Consensus 725 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt 774 (809)
........ ....+..+||..||+||.+.+..++.|+||||+|++++|+++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87654443 222345679999999999999999999999999999999998
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-13 Score=142.13 Aligned_cols=136 Identities=18% Similarity=0.233 Sum_probs=104.5
Q ss_pred CCeec-cCCCccEEEeEeeCCeEEEEEEecccC-------------cccchhHHHHHHHHhhcCCCce--EeEEeEEEeC
Q 043333 580 DNKIG-EGGFGPVYKGLLADGKVIAVKQLSSKS-------------KQGNREFVNEIGMISALQHPNL--VKLYGCCIEG 643 (809)
Q Consensus 580 ~~~LG-~G~fG~Vy~~~~~~g~~vAVK~~~~~~-------------~~~~~~f~~Ei~~l~~l~H~nI--v~l~~~~~~~ 643 (809)
...|| .|+.|+||++... +..++||++.... ......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45688 8999999998875 6678888774311 1123457889999999998885 6777775543
Q ss_pred C----eEEEEEEcccC-CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceE
Q 043333 644 N----QLLLIYEYMEN-NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 718 (809)
Q Consensus 644 ~----~~~lV~ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 718 (809)
. ..++|+||+++ .+|.+++.. .+++.. .+.+++.++.+||+. +|+||||||.|||++.+++++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 689888732 234432 357899999999998 899999999999999999999
Q ss_pred EEecCCcccc
Q 043333 719 ISDFGLAKLD 728 (809)
Q Consensus 719 l~DfGla~~~ 728 (809)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999988753
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.2e-13 Score=141.56 Aligned_cols=145 Identities=28% Similarity=0.438 Sum_probs=106.4
Q ss_pred CCCceEeEEeEEEeC---------------------------CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHH
Q 043333 629 QHPNLVKLYGCCIEG---------------------------NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSIC 681 (809)
Q Consensus 629 ~H~nIv~l~~~~~~~---------------------------~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~ 681 (809)
+|||||++.++|.+. ..+|+||.-.+. +|..++... ..+...+.-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-----~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-----HRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-----CCchHHHHHHH
Confidence 599999998887541 246888887755 888888432 23444566788
Q ss_pred HHHHHHHHHHHhCCCCCeEEcCCCCCCEEE--cCC--CceEEEecCCccccCCCCcc-----eeccccccccccchhhhc
Q 043333 682 IGLARGLAYLHEESRLKIVHRDIKATNVLL--DKD--LNPKISDFGLAKLDEEDNTH-----ISTRIAGTFGYMAPEYAM 752 (809)
Q Consensus 682 ~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl--~~~--~~~kl~DfGla~~~~~~~~~-----~~~~~~gt~~y~aPE~~~ 752 (809)
.|+.+|+.|||.+ +|.|||+|+.|||+ |++ ..+.|+|||.+-......-+ .....-|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 8999999999998 89999999999998 344 34689999987533221111 011234777899999875
Q ss_pred cCC------CCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 753 RGY------LTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 753 ~~~------~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
..+ --.|+|.|+.|.+.||+++...||..+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r 460 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR 460 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCccccc
Confidence 432 124899999999999999999999763
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.4e-13 Score=152.56 Aligned_cols=202 Identities=29% Similarity=0.395 Sum_probs=152.8
Q ss_pred EEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCc-cCcEEeecccccccCCCccccCCCCCCEEEccCCcc
Q 043333 25 EIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASIS-TLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNF 103 (809)
Q Consensus 25 ~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 103 (809)
.|+++.|.+...+......-.+..|++.+|.+..||.....+. +|+.|++++|++. .+|..+..+++|+.|++++|++
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l 175 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL 175 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchh
Confidence 5777777775333332222247778888888888888887775 8888888888888 6666778888888888888888
Q ss_pred CccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccc
Q 043333 104 TGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRL 183 (809)
Q Consensus 104 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l 183 (809)
+ .+|...+.+++|+.|++++|+++ .+|.....+..|++|.+++|.+. ..+..+..+.++..|.+.+|++... ...+
T Consensus 176 ~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~~~~ 251 (394)
T COG4886 176 S-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PESI 251 (394)
T ss_pred h-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-cchh
Confidence 8 66666667788888888888888 67776666677888888888655 5666777888888888888877665 3456
Q ss_pred cCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC
Q 043333 184 SNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG 233 (809)
Q Consensus 184 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 233 (809)
+.+++|++|++++|.++...+ +..+.+|+.|++++|.+...+|.....
T Consensus 252 ~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~ 299 (394)
T COG4886 252 GNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALL 299 (394)
T ss_pred ccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhcc
Confidence 777788888888888887766 888888888888888888777766655
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.9e-14 Score=155.71 Aligned_cols=192 Identities=27% Similarity=0.344 Sum_probs=126.4
Q ss_pred cccccccCCCCchhh--cCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeeccc
Q 043333 49 LPLWKQANGAIPKAV--ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126 (809)
Q Consensus 49 L~l~~n~~~~ip~~l--~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 126 (809)
|.|++.+++..|..= -.+..-...||+.|++. .+|..+..+..|+.|.|..|.|. .+|..++++..|++|||+.|+
T Consensus 55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nq 132 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQ 132 (722)
T ss_pred cccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccch
Confidence 445555555554322 33455556677777777 67777777777777777777777 667777777777777777777
Q ss_pred ccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChh
Q 043333 127 FTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEY 206 (809)
Q Consensus 127 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 206 (809)
++ .+|..+..+ -|+.|.+++|+++ .+|..++.+..|..|+.+.|++..++ ..+.++.+|+.|.++.|++....++
T Consensus 133 lS-~lp~~lC~l-pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slp-sql~~l~slr~l~vrRn~l~~lp~E- 207 (722)
T KOG0532|consen 133 LS-HLPDGLCDL-PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLP-SQLGYLTSLRDLNVRRNHLEDLPEE- 207 (722)
T ss_pred hh-cCChhhhcC-cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhch-HHhhhHHHHHHHHHhhhhhhhCCHH-
Confidence 77 566666555 3677777777777 66777776677777777777766655 4566667777777777777654433
Q ss_pred hhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCC
Q 043333 207 LGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTG 248 (809)
Q Consensus 207 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~ 248 (809)
+..| .|..||+|.|+++.++-..-.+..|++|-|.+|+|+.
T Consensus 208 l~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 208 LCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred HhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCCC
Confidence 4433 4777777777777554444444777777777777773
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.3e-13 Score=151.37 Aligned_cols=202 Identities=30% Similarity=0.428 Sum_probs=170.3
Q ss_pred ccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCC-CCCEEEccCCccCccCchhhhcccccceeeeeccc
Q 043333 48 NLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLI-NLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126 (809)
Q Consensus 48 ~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 126 (809)
.+.+..+.+..-+..+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|+
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 467777777666667777799999999999999 7888788885 9999999999999 677789999999999999999
Q ss_pred ccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChh
Q 043333 127 FTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEY 206 (809)
Q Consensus 127 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 206 (809)
++ .+|...+.++.|+.|++++|+++ .+|........|++|.+++|.+... ...+.++.++..|.+++|++... +..
T Consensus 175 l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~-~~~~~~~~~l~~l~l~~n~~~~~-~~~ 250 (394)
T COG4886 175 LS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIEL-LSSLSNLKNLSGLELSNNKLEDL-PES 250 (394)
T ss_pred hh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcceec-chhhhhcccccccccCCceeeec-cch
Confidence 99 77877778999999999999999 7777766777799999999963333 24578888899999988888765 677
Q ss_pred hhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhh
Q 043333 207 LGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVR 256 (809)
Q Consensus 207 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~ 256 (809)
+..++.|+.|++++|+++.+.+ .....+|+.|++++|.++..+|.....
T Consensus 251 ~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~ 299 (394)
T COG4886 251 IGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLSNALPLIALL 299 (394)
T ss_pred hccccccceecccccccccccc-ccccCccCEEeccCccccccchhhhcc
Confidence 8889999999999999998776 334499999999999999887766544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.3e-12 Score=146.94 Aligned_cols=142 Identities=23% Similarity=0.256 Sum_probs=100.7
Q ss_pred CCeeccCCCccEEEeEeeCCeEEEEEEecccCccc----------------------------------------chhHH
Q 043333 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQG----------------------------------------NREFV 619 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~----------------------------------------~~~f~ 619 (809)
.+.||.|++|.||+|++.+|+.||||+.++..... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 47899999999999999999999999986531100 01345
Q ss_pred HHHHHHhhcC----CCceEeEEeEEE-eCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 043333 620 NEIGMISALQ----HPNLVKLYGCCI-EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLAR-GLAYLHE 693 (809)
Q Consensus 620 ~Ei~~l~~l~----H~nIv~l~~~~~-~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~ 693 (809)
.|++.+.+++ |.+-+.+-..+. .....++||||+++++|.++..... ... .+..++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence 5665555552 333333333332 2445799999999999988763211 112 23456666666 4678888
Q ss_pred CCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 694 ~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
. +++|+|++|.||+++++++++++|||++..+..
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7 899999999999999999999999999976653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.2e-14 Score=162.45 Aligned_cols=216 Identities=25% Similarity=0.320 Sum_probs=163.7
Q ss_pred cCCCCCCeeccCCCccEEEeEeeC--CeEEEEEEecccC--cccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCeEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLAD--GKVIAVKQLSSKS--KQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV 649 (809)
..|...+.||+|.|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456677789999999998776432 3456777664443 122233344667767776 99999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEcCCCCCCEEEcCCC-ceEEEecCCccc
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH-EESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKL 727 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~ 727 (809)
.||..+|++.+.+.. ......+...+..++.|+..++.|+| +. ++.|+|+||+|.+++..+ ..+++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999887731 11113445567788999999999999 66 899999999999999999 999999999986
Q ss_pred cCC--CCcceeccccc-cccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHH
Q 043333 728 DEE--DNTHISTRIAG-TFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTL 796 (809)
Q Consensus 728 ~~~--~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~ 796 (809)
+.. .........+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|++...... .....|...
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~ 246 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSN 246 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeeccc
Confidence 654 33333445678 999999999877 466778999999999999999999997643322 233445444
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.34 E-value=7.1e-14 Score=151.40 Aligned_cols=190 Identities=23% Similarity=0.293 Sum_probs=103.7
Q ss_pred ccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccc
Q 043333 48 NLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHF 127 (809)
Q Consensus 48 ~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 127 (809)
..+++.|...++|..++.+..|+.+.|.+|.+. .+|..++++..|+.|+|+.|+++ .+|..++.| -|+.|-+++|++
T Consensus 79 ~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLkvli~sNNkl 155 (722)
T KOG0532|consen 79 FADLSRNRFSELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-PLKVLIVSNNKL 155 (722)
T ss_pred hhhccccccccCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-cceeEEEecCcc
Confidence 344455555555555555555555555555555 45555555555555555555555 444455444 355555555555
Q ss_pred cCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhh
Q 043333 128 TGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYL 207 (809)
Q Consensus 128 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 207 (809)
+ .+|..++.+.+|..||.+.|.+. .+|..++.+.+|+.|.+..|++..++.... .-.|..||+|.|++. .+|-.|
T Consensus 156 ~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~--~LpLi~lDfScNkis-~iPv~f 230 (722)
T KOG0532|consen 156 T-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELC--SLPLIRLDFSCNKIS-YLPVDF 230 (722)
T ss_pred c-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHh--CCceeeeecccCcee-ecchhh
Confidence 5 45555554455555555555555 444455555555555555555555443322 234666677766664 467778
Q ss_pred hccccccEEeccCCCCCCCCCCCCCC---CCccEEEeeCcc
Q 043333 208 GQMIGLRVLDLSFNKLSGVIPSNFSG---SGLTYMYLTGNL 245 (809)
Q Consensus 208 ~~l~~L~~L~Ls~N~l~~~~p~~~~~---~~L~~L~Ls~N~ 245 (809)
.+|..|++|-|.+|.|...+....-. --.++|+..-++
T Consensus 231 r~m~~Lq~l~LenNPLqSPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 231 RKMRHLQVLQLENNPLQSPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred hhhhhheeeeeccCCCCCChHHHHhccceeeeeeecchhcc
Confidence 88888888888888887544333222 123555555553
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=3e-11 Score=118.42 Aligned_cols=131 Identities=22% Similarity=0.169 Sum_probs=96.9
Q ss_pred CCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceE-eEEeEEEeCCeEEEEEEcccCCch
Q 043333 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLV-KLYGCCIEGNQLLLIYEYMENNSL 658 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ey~~~gsL 658 (809)
.+.++.|.++.||++... ++.|++|....... ....+..|++++..+.+.+++ +++.+. .+..++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999998865 77899998754432 234567899999988765554 455443 3345799999999877
Q ss_pred hhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 659 ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES--RLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 659 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
.+.- . ....++.+++++|+.||+.. +..++|||++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5430 0 11245678999999999874 23469999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.4e-13 Score=132.20 Aligned_cols=213 Identities=22% Similarity=0.233 Sum_probs=96.3
Q ss_pred CCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeecc-cccccCCCc
Q 043333 7 QNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEF-NQFSGDLPA 85 (809)
Q Consensus 7 nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~-N~l~~~~p~ 85 (809)
|=+...+|-.+..+++|+.+.+|.|.-....--...+-.|..+...+..+...|.-+ ....+..+..+. .-.+|..-.
T Consensus 200 ni~~~~l~f~l~~f~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~~~~l~-pe~~~~D~~~~E~~t~~G~~~~ 278 (490)
T KOG1259|consen 200 NIIPNRLSFNLNAFRNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQDVPSLL-PETILADPSGSEPSTSNGSALV 278 (490)
T ss_pred cccccccccchHHhhhhheeeeeccchhheeceeecCchhheeeeeccccccccccc-chhhhcCccCCCCCccCCceEE
Confidence 334556777778888888888888875533222222223444444443332222110 001111111111 011122222
Q ss_pred cccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCC
Q 043333 86 ELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVEL 165 (809)
Q Consensus 86 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 165 (809)
.+...+.|++|||++|.|+ .+.++..-++.++.|++|.|.|. .+.. ++.+++|+.|||++|.++ .+..+-
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh------ 348 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWH------ 348 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhH------
Confidence 2223344555555555555 44444444455555555555554 2221 444455555555555444 222222
Q ss_pred CEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCC--CCCCCCCccEEEeeC
Q 043333 166 TDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIP--SNFSGSGLTYMYLTG 243 (809)
Q Consensus 166 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~~~L~~L~Ls~ 243 (809)
..+.|++.|.|+.|.|... ..+.++-+|..||+++|+|..... ..-..+-|+.|.|.+
T Consensus 349 ------------------~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~ 408 (490)
T KOG1259|consen 349 ------------------LKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTG 408 (490)
T ss_pred ------------------hhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcC
Confidence 2334444455555444322 234455556666666666643321 122225666666677
Q ss_pred ccCCCCC
Q 043333 244 NLLTGPV 250 (809)
Q Consensus 244 N~l~~~~ 250 (809)
|+|.+.+
T Consensus 409 NPl~~~v 415 (490)
T KOG1259|consen 409 NPLAGSV 415 (490)
T ss_pred CCccccc
Confidence 7766433
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.5e-11 Score=136.00 Aligned_cols=145 Identities=15% Similarity=0.206 Sum_probs=94.9
Q ss_pred cCCCCCCeeccCCCccEEEeEeeC-CeEEEEEEecccCcc----------------------------------------
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQ---------------------------------------- 613 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~---------------------------------------- 613 (809)
..|+. +.||.|++|.||+|++++ |+.||||+.++.-..
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 789999999999999887 999999999753100
Q ss_pred cchhHHHHHHHHhhcC----CCceEeEEeEEEe-CCeEEEEEEcccCCchhhh--ccCCCccCCCCCHHHHHHHHHHHHH
Q 043333 614 GNREFVNEIGMISALQ----HPNLVKLYGCCIE-GNQLLLIYEYMENNSLARA--LFGPEEHRLKLDWPTRHSICIGLAR 686 (809)
Q Consensus 614 ~~~~f~~Ei~~l~~l~----H~nIv~l~~~~~~-~~~~~lV~ey~~~gsL~~~--L~~~~~~~~~l~~~~~~~i~~~ia~ 686 (809)
.+-+|.+|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.+.+. +.........+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 0112455655555553 4444444344433 4567899999999999774 2111100111222222222333
Q ss_pred HHHHHHhCCCCCeEEcCCCCCCEEEcCCC----ceEEEecCCccccCC
Q 043333 687 GLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISDFGLAKLDEE 730 (809)
Q Consensus 687 ~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DfGla~~~~~ 730 (809)
++.. +++|+|+||.||+++.++ ++++.|||++..+..
T Consensus 276 ----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3344 899999999999999888 999999999876644
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.3e-12 Score=132.76 Aligned_cols=245 Identities=21% Similarity=0.188 Sum_probs=124.6
Q ss_pred ccCCCCCCCCEEEccCCCCCCCCCcccC----CC-CccccccccccC----CCCch-------hhcCCccCcEEeecccc
Q 043333 15 PELTRLPFLQEIDLTRNYLNGTIPSEWA----SL-PLVNLPLWKQAN----GAIPK-------AVASISTLADLTLEFNQ 78 (809)
Q Consensus 15 ~~l~~l~~L~~L~Ls~n~l~~~~p~~~~----~l-~L~~L~l~~n~~----~~ip~-------~l~~l~~L~~L~L~~N~ 78 (809)
+.+..+..++.|+||+|.+.......++ +. .|++.++++-.. ..+|+ ++...++|++||||+|.
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 3456678889999999998854444332 22 244444444222 22332 33344566666666666
Q ss_pred cccCCCcc----ccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCC
Q 043333 79 FSGDLPAE----LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGP 154 (809)
Q Consensus 79 l~~~~p~~----~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 154 (809)
|...-+.. +..+..|++|.|.||.+.-.--..++. .|..|. .| .-...-++|+.+..++|++...
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~-------kk~~~~~~Lrv~i~~rNrlen~ 172 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VN-------KKAASKPKLRVFICGRNRLENG 172 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HH-------hccCCCcceEEEEeeccccccc
Confidence 55333322 234555666666666555111111110 000000 00 0011223455555555554422
Q ss_pred C----CccccCCCCCCEEeccCCCCCCCCC----ccccCCcCCceeeeccccccCC----CChhhhccccccEEeccCCC
Q 043333 155 I----PSGIASLVELTDLRISDLNGPEGPF----PRLSNLKNMNYLILRSGNIIGE----MPEYLGQMIGLRVLDLSFNK 222 (809)
Q Consensus 155 ~----p~~~~~l~~L~~L~l~~n~l~~~~~----~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~ 222 (809)
. ...|...+.|+.+.+..|.+..-.. ..|..+++|+.|||++|.++.. +...+..+++|+.|++++|.
T Consensus 173 ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcl 252 (382)
T KOG1909|consen 173 GATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCL 252 (382)
T ss_pred cHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccc
Confidence 1 1233344555555555555544332 2356667777777777776654 33455666777777777777
Q ss_pred CCCCCCCCCC------CCCccEEEeeCccCCCCCChhh-----hhccCccccccCCccc
Q 043333 223 LSGVIPSNFS------GSGLTYMYLTGNLLTGPVPDWI-----VRKRNKHIDLSYNNFI 270 (809)
Q Consensus 223 l~~~~p~~~~------~~~L~~L~Ls~N~l~~~~p~~~-----~~~~l~~L~Ls~N~l~ 270 (809)
++.-....+. .++|+.|.|.+|.++..--..+ ..+.+..|+|++|.+.
T Consensus 253 l~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 253 LENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred cccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 7654433321 2677777777777764222111 1245677788888773
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.1e-10 Score=128.22 Aligned_cols=166 Identities=17% Similarity=0.226 Sum_probs=123.8
Q ss_pred eeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHH
Q 043333 596 LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWP 675 (809)
Q Consensus 596 ~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~ 675 (809)
..++.+|.|...+...........+-++.|+.+|||||++++..+..++.+|+|+|-+. .|..++.. +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 45788888888876655334456677899999999999999999999999999999765 35555521 1133
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceeccccccccccchhhhccCC
Q 043333 676 TRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGY 755 (809)
Q Consensus 676 ~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 755 (809)
...-.+.||+.||.+||+.+ +++|++|.-+.|++++.|+.||++|.++......... .....---.|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~-~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP-AKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-cccchhhhcccChhhcCccc
Confidence 44556789999999999886 8999999999999999999999999887543222110 00111122567777654433
Q ss_pred CCchHHHHHHHHHHHHHHcC
Q 043333 756 LTDKADVYSFGIVALEIVSG 775 (809)
Q Consensus 756 ~~~ksDVwSlGvil~elltG 775 (809)
+ ..|.|.||++++|++.|
T Consensus 182 ~--s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 W--SIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--chhhhhHHHHHHHHhCc
Confidence 2 36999999999999999
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.9e-11 Score=116.55 Aligned_cols=81 Identities=32% Similarity=0.534 Sum_probs=23.4
Q ss_pred ccCcEEeecccccccCCCcccc-CCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhh-hcccccceE
Q 043333 67 STLADLTLEFNQFSGDLPAELG-NLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYI-QNWTKLEKL 144 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L 144 (809)
.++++|+|++|+|+ .+. .++ .+.+|+.|+|++|.|+. ++ .+..+++|++|++++|+|+ .++..+ ..+++|++|
T Consensus 19 ~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred cccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 46677778887777 333 344 46777778888877773 33 4667777777777777777 344334 357777777
Q ss_pred ecccCcCC
Q 043333 145 FIEGSGLA 152 (809)
Q Consensus 145 ~L~~N~l~ 152 (809)
+|++|+|.
T Consensus 94 ~L~~N~I~ 101 (175)
T PF14580_consen 94 YLSNNKIS 101 (175)
T ss_dssp E-TTS---
T ss_pred ECcCCcCC
Confidence 77777776
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.3e-11 Score=130.55 Aligned_cols=207 Identities=18% Similarity=0.223 Sum_probs=102.9
Q ss_pred cCCccCcEEeecccccccCCC--ccccCCCCCCEEEccCCccCccC--chhhhcccccceeeeecccccCcCchh-hhcc
Q 043333 64 ASISTLADLTLEFNQFSGDLP--AELGNLINLEKLHLNSNNFTGKL--PESFANLTRLKHFRISDNHFTGQIPDY-IQNW 138 (809)
Q Consensus 64 ~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l 138 (809)
+++.+|+.+.|.+.... ..+ .....+++++.|||+.|-|..-. -.-...|++|+.|+|+.|++.-..... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 44555555556555554 222 23445556666666665555311 122344556666666666555222211 1234
Q ss_pred cccceEecccCcCCCC-CCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCC-hhhhccccccEE
Q 043333 139 TKLEKLFIEGSGLAGP-IPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMP-EYLGQMIGLRVL 216 (809)
Q Consensus 139 ~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L 216 (809)
++|+.|.|+.|.|+.. +...+..+|+|+.|++..|....+......-+..|+.|||++|++....- ...+.++.|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 5556666666655521 12223445566666666654333333334445566666666666654431 234556666666
Q ss_pred eccCCCCCCCC-CCC-----CCC-CCccEEEeeCccCCC--CCChhhhhccCccccccCCcccc
Q 043333 217 DLSFNKLSGVI-PSN-----FSG-SGLTYMYLTGNLLTG--PVPDWIVRKRNKHIDLSYNNFID 271 (809)
Q Consensus 217 ~Ls~N~l~~~~-p~~-----~~~-~~L~~L~Ls~N~l~~--~~p~~~~~~~l~~L~Ls~N~l~~ 271 (809)
+++.+.++.+- |+. ... ++|++|+++.|++.. .+-......+++.|....|.++-
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 66666665432 221 112 667777777777642 11122222344556666666653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.6e-11 Score=137.93 Aligned_cols=107 Identities=21% Similarity=0.329 Sum_probs=52.1
Q ss_pred CCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccC
Q 043333 93 LEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD 172 (809)
Q Consensus 93 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 172 (809)
++.|+|++|.++|.+|..++++++|+.|+|++|.|.|.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 44444444444444444444444444444444444444444444444444444444444444444444444444444444
Q ss_pred CCCCCCCCccccC-CcCCceeeeccccc
Q 043333 173 LNGPEGPFPRLSN-LKNMNYLILRSGNI 199 (809)
Q Consensus 173 n~l~~~~~~~l~~-l~~L~~L~Ls~N~l 199 (809)
|++....+..+.. +.++..+++.+|..
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~ 527 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAG 527 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCcc
Confidence 4444333333332 23455666766654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.2e-09 Score=112.01 Aligned_cols=143 Identities=22% Similarity=0.294 Sum_probs=110.4
Q ss_pred CCeeccCCCccEEEeEeeCCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCC--ceEeEEeEEEeCC---eEEEEEEcc
Q 043333 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHP--NLVKLYGCCIEGN---QLLLIYEYM 653 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~--nIv~l~~~~~~~~---~~~lV~ey~ 653 (809)
.+.|+.|..+.||++...+|+.+++|....... .....+..|++++..+++. .+.+++.+....+ ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 356899999999999887778899998754432 2356788999999999763 4567777776543 568999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE--------------------------------------- 694 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------- 694 (809)
++.++.+.+.. ..++...+..++.+++++|.+||+.
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99888775521 2467777888888888888888852
Q ss_pred --------------CCCCeEEcCCCCCCEEEcC--CCceEEEecCCccc
Q 043333 695 --------------SRLKIVHRDIKATNVLLDK--DLNPKISDFGLAKL 727 (809)
Q Consensus 695 --------------~~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~ 727 (809)
.+..++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1246799999999999998 56789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.6e-11 Score=114.18 Aligned_cols=122 Identities=25% Similarity=0.309 Sum_probs=48.7
Q ss_pred CccccccccccCCCCchhhc-CCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhh-hcccccceeee
Q 043333 45 PLVNLPLWKQANGAIPKAVA-SISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESF-ANLTRLKHFRI 122 (809)
Q Consensus 45 ~L~~L~l~~n~~~~ip~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L 122 (809)
.+++|+|.+|.+..|. .++ .+.+|+.|+|++|+|+ .++ .+..+++|++|+|++|+|+. +...+ ..+++|++|+|
T Consensus 20 ~~~~L~L~~n~I~~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 20 KLRELNLRGNQISTIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYL 95 (175)
T ss_dssp -----------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE-
T ss_pred cccccccccccccccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEEC
Confidence 3445555555555553 344 5789999999999999 444 58889999999999999994 44445 46899999999
Q ss_pred ecccccCcCc-hhhhcccccceEecccCcCCCCCC---ccccCCCCCCEEec
Q 043333 123 SDNHFTGQIP-DYIQNWTKLEKLFIEGSGLAGPIP---SGIASLVELTDLRI 170 (809)
Q Consensus 123 s~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~l 170 (809)
++|+|...-. ..+..+++|+.|+|.+|.++...- ..+..+|+|+.||-
T Consensus 96 ~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 96 SNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred cCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 9999984322 347778889999999998874321 23455666666654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.7e-10 Score=134.08 Aligned_cols=110 Identities=25% Similarity=0.511 Sum_probs=100.1
Q ss_pred cCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecc
Q 043333 68 TLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIE 147 (809)
Q Consensus 68 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 147 (809)
.++.|+|++|.++|.+|..++++++|+.|+|++|+++|.+|..++.+++|+.|+|++|+|+|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCCCccccCC-CCCCEEeccCCCCCC
Q 043333 148 GSGLAGPIPSGIASL-VELTDLRISDLNGPE 177 (809)
Q Consensus 148 ~N~l~~~~p~~~~~l-~~L~~L~l~~n~l~~ 177 (809)
+|+++|.+|..+..+ .++..+++.+|....
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc 529 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLC 529 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCcccc
Confidence 999999999988764 467888888886543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.2e-11 Score=127.52 Aligned_cols=205 Identities=20% Similarity=0.178 Sum_probs=149.8
Q ss_pred ccccccccccCCCCch--hhcCCccCcEEeecccccccCC--CccccCCCCCCEEEccCCccCccCchh-hhccccccee
Q 043333 46 LVNLPLWKQANGAIPK--AVASISTLADLTLEFNQFSGDL--PAELGNLINLEKLHLNSNNFTGKLPES-FANLTRLKHF 120 (809)
Q Consensus 46 L~~L~l~~n~~~~ip~--~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L 120 (809)
|+++.|.+...+..+. ....+++++.|||++|-+.... -.....|++|+.|+|+.|++.....+. -..++.|+.|
T Consensus 123 L~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L 202 (505)
T KOG3207|consen 123 LREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQL 202 (505)
T ss_pred hhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheE
Confidence 7777888877777764 6678899999999999887422 234567899999999999888433322 2356789999
Q ss_pred eeecccccCc-CchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCC-CccccCCcCCceeeecccc
Q 043333 121 RISDNHFTGQ-IPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGP-FPRLSNLKNMNYLILRSGN 198 (809)
Q Consensus 121 ~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~-~~~l~~l~~L~~L~Ls~N~ 198 (809)
.|+.|.|+-. +......+++|+.|+|..|............+..|++|+|++|++...+ ......++.|..|.++.|.
T Consensus 203 ~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tg 282 (505)
T KOG3207|consen 203 VLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTG 282 (505)
T ss_pred EeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccC
Confidence 9999998832 2233566789999999999644344555667788999999998887766 4457888899999999988
Q ss_pred ccCC-CChh-----hhccccccEEeccCCCCCCC--CCCCCCCCCccEEEeeCccCCCCC
Q 043333 199 IIGE-MPEY-----LGQMIGLRVLDLSFNKLSGV--IPSNFSGSGLTYMYLTGNLLTGPV 250 (809)
Q Consensus 199 l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~~--~p~~~~~~~L~~L~Ls~N~l~~~~ 250 (809)
+..+ .|+. ...+++|++|+++.|++... .-.....++|+.|....|.|+.+-
T Consensus 283 i~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e~ 342 (505)
T KOG3207|consen 283 IASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKET 342 (505)
T ss_pred cchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccccc
Confidence 8765 3333 45678899999999998532 223333478888888888888543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.3e-10 Score=118.81 Aligned_cols=155 Identities=23% Similarity=0.323 Sum_probs=117.9
Q ss_pred HHHHhhcCCCceEeEEeEEEeCC-----eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 043333 622 IGMISALQHPNLVKLYGCCIEGN-----QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696 (809)
Q Consensus 622 i~~l~~l~H~nIv~l~~~~~~~~-----~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 696 (809)
..-+-.+.|.|||+++.|+.+.+ +..++.|||..|++..+|...+.....+......+++.||..||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 34556677999999999988654 46889999999999999976666666677777789999999999999986 5
Q ss_pred CCeEEcCCCCCCEEEcCCCceEEEecCCccc---cCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHH
Q 043333 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKL---DEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 773 (809)
Q Consensus 697 ~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~---~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ell 773 (809)
++|+|+++...-|++..++-+|+.----... ...........-.+-++|.|||+-.....+..+|||+||...+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 6899999999999999998888742110000 0000000111223567999999877777788899999999999998
Q ss_pred cCCC
Q 043333 774 SGRS 777 (809)
Q Consensus 774 tGk~ 777 (809)
.|.-
T Consensus 277 ilEi 280 (458)
T KOG1266|consen 277 ILEI 280 (458)
T ss_pred Hhee
Confidence 8764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.1e-09 Score=105.41 Aligned_cols=135 Identities=14% Similarity=0.134 Sum_probs=96.0
Q ss_pred CeeccCCCccEEEeEeeC-------CeEEEEEEecccCc----------cc------------chhH----HHHHHHHhh
Q 043333 581 NKIGEGGFGPVYKGLLAD-------GKVIAVKQLSSKSK----------QG------------NREF----VNEIGMISA 627 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~~~~~~~----------~~------------~~~f----~~Ei~~l~~ 627 (809)
..||.|--+.||.|.-.+ +..+|||+.+.... ++ .+.+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999998543 47899998753200 00 1122 278889988
Q ss_pred cCC--CceEeEEeEEEeCCeEEEEEEcccCCchhh-hccCCCccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEcC
Q 043333 628 LQH--PNLVKLYGCCIEGNQLLLIYEYMENNSLAR-ALFGPEEHRLKLDWPTRHSICIGLARGLAYL-HEESRLKIVHRD 703 (809)
Q Consensus 628 l~H--~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~-~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~D 703 (809)
+.. -++.+++++ ..-++||||+.++.+.. .+ ....++......+..+++.+|..+ |+. +++|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-----kd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-----KDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-----hccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 864 355566654 45689999998754422 22 112344455677889999999999 666 899999
Q ss_pred CCCCCEEEcCCCceEEEecCCcccc
Q 043333 704 IKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 704 lkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
|++.||++++ +.+.++|||-+...
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999974 67999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.8e-11 Score=119.02 Aligned_cols=177 Identities=21% Similarity=0.268 Sum_probs=116.9
Q ss_pred CCCCEEEccCCCCCCCCCcccCCCCcccccccc--ccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEc
Q 043333 21 PFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWK--QANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHL 98 (809)
Q Consensus 21 ~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~--n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 98 (809)
+.|+++...+..++ ..|..+..-.+....-.. ...+.+-..+.....|+.|||++|.++ .+..+..-++.++.|++
T Consensus 237 ptl~t~~v~~s~~~-~~~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~l 314 (490)
T KOG1259|consen 237 PTLQTICVHNTTIQ-DVPSLLPETILADPSGSEPSTSNGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLIL 314 (490)
T ss_pred chhheeeeeccccc-ccccccchhhhcCccCCCCCccCCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEec
Confidence 56777777766554 223222211122221111 112233334445577999999999999 78888888999999999
Q ss_pred cCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCC
Q 043333 99 NSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEG 178 (809)
Q Consensus 99 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~ 178 (809)
+.|.|. .+. .++.|++|+.||||+|.++ .+..+-..+-+.+.|.|++|.|... .++..+-+|..||+++|++...
T Consensus 315 S~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~l 389 (490)
T KOG1259|consen 315 SQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEEL 389 (490)
T ss_pred ccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhH
Confidence 999999 444 3888999999999999998 6666666788899999999998732 3455555566666666555444
Q ss_pred CCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCC
Q 043333 179 PFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVI 227 (809)
Q Consensus 179 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 227 (809)
+. -..++++|-|++|.|.+|.|.+++
T Consensus 390 de-----------------------V~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 390 DE-----------------------VNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred HH-----------------------hcccccccHHHHHhhcCCCccccc
Confidence 31 123556666666666677666543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.4e-10 Score=123.02 Aligned_cols=199 Identities=25% Similarity=0.251 Sum_probs=151.2
Q ss_pred cCCCCCCeecc--CCCccEEEeEe---eCCeEEEEEEecccC--cccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCeE
Q 043333 575 NNFAPDNKIGE--GGFGPVYKGLL---ADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 575 ~~f~~~~~LG~--G~fG~Vy~~~~---~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~ 646 (809)
..|.....+|. |.+|.||.+.. .++..+|+|+-+... ......=.+|+....+++ |+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667788999 99999999886 357889999743322 222233346677767774 99999999999999999
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEcCCCCCCEEEcCC-CceEEEe
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLAR----GLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISD 721 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~D 721 (809)
++-+|++. .+|..+.+... ..++......+..+..+ |+.++|.. +++|-|+||.||+...+ ...+++|
T Consensus 194 fiqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 99999775 68888775432 22455566667777777 99999998 89999999999999999 8899999
Q ss_pred cCCccccCCCCcce----eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 722 FGLAKLDEEDNTHI----STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 722 fGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
||+...+.+.+... ..+..|...|++||...+ -++...|+|++|.+..|..+|-.+...
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccC
Confidence 99988776544211 122356778999998754 568899999999999999888665533
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.2e-11 Score=133.47 Aligned_cols=128 Identities=23% Similarity=0.268 Sum_probs=67.2
Q ss_pred ccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecc
Q 043333 46 LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN 125 (809)
Q Consensus 46 L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 125 (809)
++.+++..|.++.+-..+..+++|+.|+|.+|+|. .+...+..+++|++|+|++|+|+.+.+ +..++.|+.|++++|
T Consensus 74 l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N 150 (414)
T KOG0531|consen 74 LKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGN 150 (414)
T ss_pred HHhhccchhhhhhhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccc--hhhccchhhheeccC
Confidence 44444555555554444555566666666666665 233225555666666666666663322 444555666666666
Q ss_pred cccCcCchhhhcccccceEecccCcCCCCCC-ccccCCCCCCEEeccCCCCCCCC
Q 043333 126 HFTGQIPDYIQNWTKLEKLFIEGSGLAGPIP-SGIASLVELTDLRISDLNGPEGP 179 (809)
Q Consensus 126 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~ 179 (809)
.|+ .+. .+..++.|+.+++++|++...-+ . ...+.+|+.+++.+|.+..+.
T Consensus 151 ~i~-~~~-~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~ 202 (414)
T KOG0531|consen 151 LIS-DIS-GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIE 202 (414)
T ss_pred cch-hcc-CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhccc
Confidence 655 222 23345566666666666553222 1 345555555666655555443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=7.3e-11 Score=121.84 Aligned_cols=198 Identities=18% Similarity=0.212 Sum_probs=124.6
Q ss_pred ccccCCCCCc----cCCccCCCCCCCCEEEccC---CCCCCCCCcccC-------CC-CccccccccccCCCC-----ch
Q 043333 2 RILKSQNLPG----RLPPELTRLPFLQEIDLTR---NYLNGTIPSEWA-------SL-PLVNLPLWKQANGAI-----PK 61 (809)
Q Consensus 2 L~L~~nnl~~----~lp~~l~~l~~L~~L~Ls~---n~l~~~~p~~~~-------~l-~L~~L~l~~n~~~~i-----p~ 61 (809)
|+|++|.+.. .+.+.+.+.+.|++.++|+ -++...+|+.+. .. +|+.++|++|.++.= -.
T Consensus 35 l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ 114 (382)
T KOG1909|consen 35 LDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIRGLEE 114 (382)
T ss_pred EeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchHHHHH
Confidence 6778887764 4556677788899988887 345556665432 22 588899999988652 22
Q ss_pred hhcCCccCcEEeecccccccCCCc--------------cccCCCCCCEEEccCCccCcc----Cchhhhcccccceeeee
Q 043333 62 AVASISTLADLTLEFNQFSGDLPA--------------ELGNLINLEKLHLNSNNFTGK----LPESFANLTRLKHFRIS 123 (809)
Q Consensus 62 ~l~~l~~L~~L~L~~N~l~~~~p~--------------~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls 123 (809)
-+..+.+|++|.|.+|.+. .... -.+.-++|++++..+|++..- +...|...+.|+.+.++
T Consensus 115 ll~s~~~L~eL~L~N~Glg-~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~ 193 (382)
T KOG1909|consen 115 LLSSCTDLEELYLNNCGLG-PEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLS 193 (382)
T ss_pred HHHhccCHHHHhhhcCCCC-hhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEe
Confidence 4577889999999999987 2211 123456788888888887742 23345666778888888
Q ss_pred cccccCc----CchhhhcccccceEecccCcCCCCC----CccccCCCCCCEEeccCCCCCCCCCccc-----cCCcCCc
Q 043333 124 DNHFTGQ----IPDYIQNWTKLEKLFIEGSGLAGPI----PSGIASLVELTDLRISDLNGPEGPFPRL-----SNLKNMN 190 (809)
Q Consensus 124 ~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~l~~n~l~~~~~~~l-----~~l~~L~ 190 (809)
.|.|... +-..|..+++|+.|||.+|-++... ...+..+++|++|++++|.+..-....| ...++|+
T Consensus 194 qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~ 273 (382)
T KOG1909|consen 194 QNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLE 273 (382)
T ss_pred cccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCc
Confidence 8877621 1234566777777777777776332 2344555666666666666555443332 1234444
Q ss_pred eeeecccccc
Q 043333 191 YLILRSGNII 200 (809)
Q Consensus 191 ~L~Ls~N~l~ 200 (809)
.|.|..|.++
T Consensus 274 vl~l~gNeIt 283 (382)
T KOG1909|consen 274 VLELAGNEIT 283 (382)
T ss_pred eeccCcchhH
Confidence 4444444444
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.1e-10 Score=131.47 Aligned_cols=199 Identities=27% Similarity=0.253 Sum_probs=149.2
Q ss_pred cCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccce
Q 043333 64 ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEK 143 (809)
Q Consensus 64 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 143 (809)
..+..++.+++..|.+. .+-..+..+++|+.|+|.+|+|. .+...+..+++|++|+|++|.|+...+ +..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccc--hhhccchhh
Confidence 45677888889999988 34455788899999999999999 444347788999999999999985443 677788999
Q ss_pred EecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCC-ccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCC
Q 043333 144 LFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPF-PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNK 222 (809)
Q Consensus 144 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 222 (809)
|++++|.|+.. ..+..+++|+.+++++|.+..+.. . +..+.+|+.+++..|.+..... +..+..+..+++..|.
T Consensus 145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~--~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEG--LDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccc--hHHHHHHHHhhccccc
Confidence 99999999843 345568999999999999988886 5 6888899999999998876543 3444556666888888
Q ss_pred CCCCCCCCCCCC--CccEEEeeCccCCCCCChhhhhccCccccccCCccccC
Q 043333 223 LSGVIPSNFSGS--GLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDG 272 (809)
Q Consensus 223 l~~~~p~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~ 272 (809)
++.+-+-. ... +|+.+++++|++.......-....+..++++.|.+...
T Consensus 220 i~~~~~l~-~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~~~ 270 (414)
T KOG0531|consen 220 ISKLEGLN-ELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRISNL 270 (414)
T ss_pred ceeccCcc-cchhHHHHHHhcccCccccccccccccccccccchhhcccccc
Confidence 87543322 222 38899999999885432222335567888888887654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1e-08 Score=98.09 Aligned_cols=133 Identities=22% Similarity=0.311 Sum_probs=102.4
Q ss_pred CeeccCCCccEEEeEeeCCeEEEEEEecccC-ccc-------chhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKS-KQG-------NREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~-~~~-------~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
..+++|+-+.+|.+.+. |..+++|.-.++. ... ...-.+|++++.+++--.|....-+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999998764 3446666543331 111 13346789999999877777777778888899999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
+++-.|.+.+... +..++..+-.-+.-||.. +|+|+||.++||++..+. +.++|||++.+..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 9999988888321 345777888888899998 899999999999998775 9999999998543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2e-08 Score=95.49 Aligned_cols=144 Identities=18% Similarity=0.286 Sum_probs=104.3
Q ss_pred CCCeeccCCCccEEEeEeeCCeEEEEEEeccc-Ccc-------cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 579 PDNKIGEGGFGPVYKGLLADGKVIAVKQLSSK-SKQ-------GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 579 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~-~~~-------~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
....+-+|+-+.|+++.+. |+...||.-..+ -.. ..++-.+|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999874 777777754332 111 1345678999999987666665555666766778999
Q ss_pred EcccC-CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---ceEEEecCCcc
Q 043333 651 EYMEN-NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NPKISDFGLAK 726 (809)
Q Consensus 651 ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGla~ 726 (809)
||+++ .++.+++...... +.........+.+|-+.+.-||.. .+|||||..+||+|..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 4677777432211 112223367888999999999998 899999999999997654 35899999986
Q ss_pred cc
Q 043333 727 LD 728 (809)
Q Consensus 727 ~~ 728 (809)
.-
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 43
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.3e-09 Score=121.13 Aligned_cols=194 Identities=22% Similarity=0.207 Sum_probs=146.1
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee--CCeEEEEEEecccCcccch--hHHHHHHHHhhc-CCCceEeEEeEEEeCCeEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA--DGKVIAVKQLSSKSKQGNR--EFVNEIGMISAL-QHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~~~~~~~~~~~--~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 647 (809)
.+.+|..+..||.|.|+.|++...+ ++..+++|.+......... .-..|+-+...+ .|.++++....+...+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4567889999999999999998754 4678999987654322211 124566565555 4999999888888888888
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CceEEEecCCcc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAK 726 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~ 726 (809)
+--||++++++.... .....++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+.
T Consensus 343 ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 999999999887655 2334467778889999999999999987 79999999999999886 888999999886
Q ss_pred ccCCCCcceecccccccccc--chhhhccCCCCchHHHHHHHHHHHHHHcCCC
Q 043333 727 LDEEDNTHISTRIAGTFGYM--APEYAMRGYLTDKADVYSFGIVALEIVSGRS 777 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~ksDVwSlGvil~elltGk~ 777 (809)
.+..... .....-+++ +|+......+..+.|++|||.-+.|.++|..
T Consensus 416 ~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 416 RLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ccceecc----cccccccccccchhhccccccccccccccccccccccccCcc
Confidence 3211110 111222344 5666667788999999999999999998864
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.1e-08 Score=123.33 Aligned_cols=253 Identities=19% Similarity=0.191 Sum_probs=160.6
Q ss_pred CCCCCCCEEEccCCCCCCCCCcccCCCCcccccccccc--CCCCchh-hcCCccCcEEeecccccccCCCccccCCCCCC
Q 043333 18 TRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQA--NGAIPKA-VASISTLADLTLEFNQFSGDLPAELGNLINLE 94 (809)
Q Consensus 18 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~--~~~ip~~-l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 94 (809)
......+++.+-+|.+. .++.......+..|.+..|. +..++.. |..++.|+.|||++|.=-+.+|..+++|-+|+
T Consensus 520 ~~~~~~rr~s~~~~~~~-~~~~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr 598 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIE-HIAGSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR 598 (889)
T ss_pred cchhheeEEEEeccchh-hccCCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence 33467788888888887 55555555567788887775 6777765 56799999999998876678999999999999
Q ss_pred EEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcC--CCCCCccccCCCCCCEEeccC
Q 043333 95 KLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGL--AGPIPSGIASLVELTDLRISD 172 (809)
Q Consensus 95 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l--~~~~p~~~~~l~~L~~L~l~~ 172 (809)
+|+|+...++ .+|..+++|..|.+|++..+.-...+|.....|++|++|.+..... +...-..+.++.+|+.|....
T Consensus 599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~ 677 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITI 677 (889)
T ss_pred cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeec
Confidence 9999999999 8899999999999999998886667778788899999998876642 222233445555555555543
Q ss_pred CCC-------------------------CCCCCccccCCcCCceeeeccccccCCCChhhhc------cccccEEeccCC
Q 043333 173 LNG-------------------------PEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQ------MIGLRVLDLSFN 221 (809)
Q Consensus 173 n~l-------------------------~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N 221 (809)
... .......+..+.+|+.|.+.++.+.......+.. +++|..+...++
T Consensus 678 ~s~~~~e~l~~~~~L~~~~~~l~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~ 757 (889)
T KOG4658|consen 678 SSVLLLEDLLGMTRLRSLLQSLSIEGCSKRTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNC 757 (889)
T ss_pred chhHhHhhhhhhHHHHHHhHhhhhcccccceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcc
Confidence 332 0111223455666666666666665433222111 111222212222
Q ss_pred CCCCCCCCCCCCCCccEEEeeCccCCCCCChhh-hhccCccccccCCccccC
Q 043333 222 KLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWI-VRKRNKHIDLSYNNFIDG 272 (809)
Q Consensus 222 ~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~-~~~~l~~L~Ls~N~l~~~ 272 (809)
..-..+....-.++|+.|++........+.+.. ....++.+-+..+.+.+.
T Consensus 758 ~~~r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 758 HMLRDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred ccccccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence 111111111122899999999877665444433 334445445555555544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.1e-09 Score=125.07 Aligned_cols=207 Identities=19% Similarity=0.258 Sum_probs=144.1
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
..+.+.+.+-+-.|.++.++-+.-. .|...+.|...... ....+....+-.++-..+||-+++..--+.-.....|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4466777788889999999877632 34334444332221 1112222333333333456777766555555678899
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
|++|..+++|...||... ..+..........+..+++|||.. .+.|+|++|.|.+...+++.+++|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999987543 233333344555677789999987 6899999999999999999999999843211
Q ss_pred C------CC------------------------CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCC
Q 043333 729 E------ED------------------------NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSN 778 (809)
Q Consensus 729 ~------~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P 778 (809)
. .. +........||+.|.|||...+......+|+|+.|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 0 00 00112235689999999999999999999999999999999999999
Q ss_pred CCCCCccc
Q 043333 779 VICRTKEA 786 (809)
Q Consensus 779 ~~~~~~~~ 786 (809)
|...+.+.
T Consensus 1035 ~na~tpq~ 1042 (1205)
T KOG0606|consen 1035 FNAETPQQ 1042 (1205)
T ss_pred CCCcchhh
Confidence 97755443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=6.7e-09 Score=83.02 Aligned_cols=59 Identities=36% Similarity=0.540 Sum_probs=27.9
Q ss_pred CCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCc
Q 043333 92 NLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSG 150 (809)
Q Consensus 92 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 150 (809)
+|++|+|++|+|+.+.+..|.++++|++|+|++|.++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444443333444444444444444444444444444444444444444444
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.4e-07 Score=102.64 Aligned_cols=170 Identities=21% Similarity=0.319 Sum_probs=129.5
Q ss_pred CccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEe----CCeEEEEEEcccC-Cchhhh
Q 043333 588 FGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIE----GNQLLLIYEYMEN-NSLARA 661 (809)
Q Consensus 588 fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ey~~~-gsL~~~ 661 (809)
-.+.||+.. .||..|++|++.....+....-..-+++++++.|+|+|++..++.. +..+++||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357799884 5899999999954433333233456899999999999999988773 4578999999986 577775
Q ss_pred ccCCCc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 662 LFGPEE-----------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 662 L~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
-+.... .....++...+.++.|++.||.++|+. |+.-+-|.+++|+++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 543322 233467889999999999999999998 788899999999999999999998888776655
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSN 778 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P 778 (809)
+.. |-+.. -.+-|.=.||.+++-|.||..-
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 431 11111 2246888999999999999543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.72 E-value=8.5e-09 Score=82.40 Aligned_cols=61 Identities=36% Similarity=0.576 Sum_probs=55.9
Q ss_pred ccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccc
Q 043333 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHF 127 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 127 (809)
++|++|+|++|+++...+..|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5789999999999977667999999999999999999988888999999999999999986
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=6.9e-08 Score=95.46 Aligned_cols=125 Identities=23% Similarity=0.300 Sum_probs=80.2
Q ss_pred cEEEeEeeCCeEEEEEEecccC--------------c-------cc-----chhHHHHHHHHhhcCCC--ceEeEEeEEE
Q 043333 590 PVYKGLLADGKVIAVKQLSSKS--------------K-------QG-----NREFVNEIGMISALQHP--NLVKLYGCCI 641 (809)
Q Consensus 590 ~Vy~~~~~~g~~vAVK~~~~~~--------------~-------~~-----~~~f~~Ei~~l~~l~H~--nIv~l~~~~~ 641 (809)
.||.|...+|..+|||+.+... . .. .....+|.+.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998899999999875420 0 00 12346799999999866 455666442
Q ss_pred eCCeEEEEEEccc--CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEcCCCCCCEEEcCCCceE
Q 043333 642 EGNQLLLIYEYME--NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYL-HEESRLKIVHRDIKATNVLLDKDLNPK 718 (809)
Q Consensus 642 ~~~~~~lV~ey~~--~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~Dlkp~NILl~~~~~~k 718 (809)
.-.+||||++ +..+..+... .++......++.++...+..+ |.. +++|||+.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3479999999 5555443311 111223456777887766665 565 89999999999999988 999
Q ss_pred EEecCCcccc
Q 043333 719 ISDFGLAKLD 728 (809)
Q Consensus 719 l~DfGla~~~ 728 (809)
++|||-+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=4e-07 Score=95.52 Aligned_cols=141 Identities=18% Similarity=0.039 Sum_probs=100.3
Q ss_pred CeeccCCCccEEEeEeeCCeEEEEEEecccCc-----------ccchhHHHHHHHHhhcCCCceE--eEEeEEEe-----
Q 043333 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKSK-----------QGNREFVNEIGMISALQHPNLV--KLYGCCIE----- 642 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~-----------~~~~~f~~Ei~~l~~l~H~nIv--~l~~~~~~----- 642 (809)
+.+-+.....|++..+ +|+.+.||+...... .....+.+|.+.+.++...+|. +++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455444455777655 578899997643321 1112477899888888654443 45666543
Q ss_pred CCeEEEEEEcccCC-chhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-------C
Q 043333 643 GNQLLLIYEYMENN-SLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK-------D 714 (809)
Q Consensus 643 ~~~~~lV~ey~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-------~ 714 (809)
...-++|+|++++- +|.+++.... ..+.+...+..++.+++..+.-||+. +|+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999986 7888873211 12345567778999999999999998 8999999999999985 4
Q ss_pred CceEEEecCCccc
Q 043333 715 LNPKISDFGLAKL 727 (809)
Q Consensus 715 ~~~kl~DfGla~~ 727 (809)
..+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 7899999998854
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.9e-08 Score=121.23 Aligned_cols=232 Identities=24% Similarity=0.254 Sum_probs=139.5
Q ss_pred CccCCCCCCCCEEEccCCCCCCCCCcccCCC-CccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCC
Q 043333 14 PPELTRLPFLQEIDLTRNYLNGTIPSEWASL-PLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLIN 92 (809)
Q Consensus 14 p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l-~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 92 (809)
++.|..++.|++|||++|.=.+..|..++.+ .|+.|++++..+.++|..+.+|..|.+||+..+.-...+|..+..|++
T Consensus 564 ~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~ 643 (889)
T KOG4658|consen 564 GEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGISHLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQS 643 (889)
T ss_pred HHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCccccchHHHHHHhhheeccccccccccccchhhhccc
Confidence 3346777888888888776666777777766 477788888888888888888888888888877665556666666788
Q ss_pred CCEEEccCCccC--ccCchhhhcccccceeeeecccccCcCchhhhcccccc----eEecccCcCCCCCCccccCCCCCC
Q 043333 93 LEKLHLNSNNFT--GKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLE----KLFIEGSGLAGPIPSGIASLVELT 166 (809)
Q Consensus 93 L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~ 166 (809)
|++|.|..-... ...-..+.+|.+|+.|....... .+-..+..++.|. .+.+.++... ..+..+..+.+|+
T Consensus 644 Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~ 720 (889)
T KOG4658|consen 644 LRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLE 720 (889)
T ss_pred ccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcc
Confidence 888777665422 23333445555555555543332 1112223333333 3333333333 4456678889999
Q ss_pred EEeccCCCCCCCCCccccCC------cCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEE
Q 043333 167 DLRISDLNGPEGPFPRLSNL------KNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYM 239 (809)
Q Consensus 167 ~L~l~~n~l~~~~~~~l~~l------~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L 239 (809)
.|.+.++.+.++........ +++..+...++... ..+.+.--.++|+.|.+..+.....+...... ..++.+
T Consensus 721 ~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~ 799 (889)
T KOG4658|consen 721 ELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKEL 799 (889)
T ss_pred eEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccE
Confidence 99999998876554332222 22222222222221 12233334588999999887765554443333 666666
Q ss_pred EeeCccCCCC
Q 043333 240 YLTGNLLTGP 249 (809)
Q Consensus 240 ~Ls~N~l~~~ 249 (809)
-+..+.+.+.
T Consensus 800 i~~f~~~~~l 809 (889)
T KOG4658|consen 800 ILPFNKLEGL 809 (889)
T ss_pred Eecccccccc
Confidence 7777777654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.9e-09 Score=120.20 Aligned_cols=180 Identities=24% Similarity=0.239 Sum_probs=122.1
Q ss_pred chhhcCCccCcEEeecccccccCCCccccCC-CCCCEEEccCCccC---ccCch---hhhc---ccccceeeeecccccC
Q 043333 60 PKAVASISTLADLTLEFNQFSGDLPAELGNL-INLEKLHLNSNNFT---GKLPE---SFAN---LTRLKHFRISDNHFTG 129 (809)
Q Consensus 60 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~---~~~p~---~~~~---l~~L~~L~Ls~N~l~~ 129 (809)
|-.|..+.+|++|.|.++.|.. ...+..+ ..|++|.-++ .+. .++.. .+++ ...|.+.+.+.|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~-Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHN-SLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhc-cHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 4456677788888888877763 2222222 2355554433 222 01111 1111 136788888899988
Q ss_pred cCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhc
Q 043333 130 QIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQ 209 (809)
Q Consensus 130 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 209 (809)
....++.-++.|+.|+|++|+++..- .+..++.|..|||+.|.+..++.-.-..+. |+.|.|++|.++... .+.+
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL~--gie~ 252 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTLR--GIEN 252 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhhh--hHHh
Confidence 77778888889999999999988432 677888899999999988888766555565 888888888887653 4678
Q ss_pred cccccEEeccCCCCCCCCC--CCCCCCCccEEEeeCccCCC
Q 043333 210 MIGLRVLDLSFNKLSGVIP--SNFSGSGLTYMYLTGNLLTG 248 (809)
Q Consensus 210 l~~L~~L~Ls~N~l~~~~p--~~~~~~~L~~L~Ls~N~l~~ 248 (809)
|.+|+.|||++|-|.+.-. ..+....|+.|+|.||++..
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 8888888888888875422 12233678888888888774
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.5e-09 Score=121.02 Aligned_cols=199 Identities=18% Similarity=0.127 Sum_probs=125.6
Q ss_pred CccCcEEeecccccccCC-CccccCCCCCCEEEccCCccCccCchhhhcc-cccceeeeeccccc----------CcCch
Q 043333 66 ISTLADLTLEFNQFSGDL-PAELGNLINLEKLHLNSNNFTGKLPESFANL-TRLKHFRISDNHFT----------GQIPD 133 (809)
Q Consensus 66 l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~----------~~~p~ 133 (809)
+++++.|.+-.-.=.+.. |-.+..+.+|+.|.|+++.|.. ...+..+ ..|+.|..+ |.+. |.+..
T Consensus 83 lqkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~n 159 (1096)
T KOG1859|consen 83 LQKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISN 159 (1096)
T ss_pred HhhheeeeecccCCCCCCCCceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhcccccc
Confidence 344445544443333222 4567777888888888888773 2222222 245555332 2222 11111
Q ss_pred hhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccc
Q 043333 134 YIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGL 213 (809)
Q Consensus 134 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 213 (809)
++ .+.+|...+.+.|.+. .+..++.-++.|+.|+|++|++.... .+..+++|++|||+.|.+..+.--...++. |
T Consensus 160 s~-~Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L 234 (1096)
T KOG1859|consen 160 SP-VWNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-L 234 (1096)
T ss_pred ch-hhhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-h
Confidence 11 1346777788888887 66677777888888888888888776 778888888888888888776554455555 8
Q ss_pred cEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCC--CCChhhhhccCccccccCCccccCC
Q 043333 214 RVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTG--PVPDWIVRKRNKHIDLSYNNFIDGS 273 (809)
Q Consensus 214 ~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~--~~p~~~~~~~l~~L~Ls~N~l~~~~ 273 (809)
+.|.|++|.++..- +.-...+|+.|||+.|-|.+ .+-.......++.|+|.||++-|.+
T Consensus 235 ~~L~lrnN~l~tL~-gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 235 QLLNLRNNALTTLR-GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred eeeeecccHHHhhh-hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 88888888887442 11123778888888888775 2233334456678888888887765
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=5.9e-09 Score=93.90 Aligned_cols=83 Identities=23% Similarity=0.358 Sum_probs=45.7
Q ss_pred ccCcEEeecccccccCCCcccc-CCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEe
Q 043333 67 STLADLTLEFNQFSGDLPAELG-NLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLF 145 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 145 (809)
..|+..+|++|.+. ..|+.|. ..+.+++|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..+.+|..|+
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 44555556666655 3444333 2335555666666665 55555555666666666666655 4555555555555565
Q ss_pred cccCcCC
Q 043333 146 IEGSGLA 152 (809)
Q Consensus 146 L~~N~l~ 152 (809)
..+|.+.
T Consensus 130 s~~na~~ 136 (177)
T KOG4579|consen 130 SPENARA 136 (177)
T ss_pred CCCCccc
Confidence 5555555
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.6e-08 Score=91.18 Aligned_cols=111 Identities=23% Similarity=0.322 Sum_probs=92.2
Q ss_pred ccCcEEeecccccccCCCcc---ccCCCCCCEEEccCCccCccCchhhh-cccccceeeeecccccCcCchhhhcccccc
Q 043333 67 STLADLTLEFNQFSGDLPAE---LGNLINLEKLHLNSNNFTGKLPESFA-NLTRLKHFRISDNHFTGQIPDYIQNWTKLE 142 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~---~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 142 (809)
..+..++|++++|- .+++. +.....|+.++|++|.+. ..|..|. ..+.++.|+|++|+|+ .+|..+..|+.|+
T Consensus 27 kE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr 103 (177)
T KOG4579|consen 27 KELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALR 103 (177)
T ss_pred HHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhh
Confidence 35667889998886 55553 455677888999999999 5666665 4468999999999999 8898999999999
Q ss_pred eEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCc
Q 043333 143 KLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181 (809)
Q Consensus 143 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~ 181 (809)
.|+++.|.+. ..|..+..+.+|..|+..+|.+..++..
T Consensus 104 ~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~d 141 (177)
T KOG4579|consen 104 SLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVD 141 (177)
T ss_pred hcccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHH
Confidence 9999999999 7788888888999999888888888766
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.3e-08 Score=98.86 Aligned_cols=213 Identities=21% Similarity=0.171 Sum_probs=111.5
Q ss_pred CCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeecccccc---cCCC-------cc
Q 043333 17 LTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFS---GDLP-------AE 86 (809)
Q Consensus 17 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~---~~~p-------~~ 86 (809)
+..+..+..+|||+|.|......++++. +.+-.+|+..++++--.. ..++ +.
T Consensus 26 l~~~d~~~evdLSGNtigtEA~e~l~~~------------------ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~a 87 (388)
T COG5238 26 LEMMDELVEVDLSGNTIGTEAMEELCNV------------------IANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKA 87 (388)
T ss_pred HHhhcceeEEeccCCcccHHHHHHHHHH------------------HhhhcceeEeehhhhhhcccHHHHHHHHHHHHHH
Confidence 4456788899999999986665554432 333344444444432211 0111 22
Q ss_pred ccCCCCCCEEEccCCccCccCchhh----hcccccceeeeecccccCcCchhh-------------hcccccceEecccC
Q 043333 87 LGNLINLEKLHLNSNNFTGKLPESF----ANLTRLKHFRISDNHFTGQIPDYI-------------QNWTKLEKLFIEGS 149 (809)
Q Consensus 87 ~~~l~~L~~L~L~~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~~p~~~-------------~~l~~L~~L~L~~N 149 (809)
+.++++|++.+||+|.|....|..+ ++-+.|++|.|++|.+.-.--.-+ .+-+.|+......|
T Consensus 88 Llkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrN 167 (388)
T COG5238 88 LLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRN 167 (388)
T ss_pred HhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccc
Confidence 3345555555555555554444332 233455555555555441111111 12345566666666
Q ss_pred cCCCCCCc-----cccCCCCCCEEeccCCCCCCCCCc-----cccCCcCCceeeeccccccCCC----ChhhhccccccE
Q 043333 150 GLAGPIPS-----GIASLVELTDLRISDLNGPEGPFP-----RLSNLKNMNYLILRSGNIIGEM----PEYLGQMIGLRV 215 (809)
Q Consensus 150 ~l~~~~p~-----~~~~l~~L~~L~l~~n~l~~~~~~-----~l~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~ 215 (809)
++.. .+. .|..-.+|..+.+..|.|..-... .+..+.+|+.|||++|.++..- ..+++.++.|+.
T Consensus 168 Rlen-gs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrE 246 (388)
T COG5238 168 RLEN-GSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRE 246 (388)
T ss_pred hhcc-CcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhh
Confidence 5542 111 112223555555555555443222 2455677778888877776553 344556677788
Q ss_pred EeccCCCCCCCCCCCC----C---CCCccEEEeeCccCCC
Q 043333 216 LDLSFNKLSGVIPSNF----S---GSGLTYMYLTGNLLTG 248 (809)
Q Consensus 216 L~Ls~N~l~~~~p~~~----~---~~~L~~L~Ls~N~l~~ 248 (809)
|.+.+|-++......+ . .++|..|-+.+|-..+
T Consensus 247 L~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~ 286 (388)
T COG5238 247 LRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRG 286 (388)
T ss_pred ccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcC
Confidence 8888887765443221 1 1566666666666554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.2e-06 Score=90.03 Aligned_cols=193 Identities=15% Similarity=0.195 Sum_probs=125.4
Q ss_pred CCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeE----EE--eC-CeEEEEE
Q 043333 579 PDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGC----CI--EG-NQLLLIY 650 (809)
Q Consensus 579 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~----~~--~~-~~~~lV~ 650 (809)
..+.||+|+-+.+|..--- +..| .|+.......... +.+++|... .||-+-.=+.+ .. +. ...-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~V-AKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQV-AKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hchh-heeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4677999999999963211 2233 4655443332222 223344443 46644321111 01 11 2245666
Q ss_pred EcccCC-chhhhcc--CCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 651 EYMENN-SLARALF--GPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 651 ey~~~g-sL~~~L~--~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
..+++- .+.+++. ..+.+....+|+..++++..+|.+.+-||+. +.+-||+.++|+|+++++.+.+.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 666553 2233332 1223445689999999999999999999998 788899999999999999999997544333
Q ss_pred cCCCCcceeccccccccccchhhhc-----cCCCCchHHHHHHHHHHHHHHcC-CCCCCC
Q 043333 728 DEEDNTHISTRIAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSG-RSNVIC 781 (809)
Q Consensus 728 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltG-k~P~~~ 781 (809)
.. +.......+|...|.+||.-. +..-+...|-|.+||++++++.| ++||.+
T Consensus 167 ~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 167 NA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred cc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 22 222223457888999999754 33456788999999999999887 999976
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.7e-06 Score=87.93 Aligned_cols=132 Identities=24% Similarity=0.262 Sum_probs=91.4
Q ss_pred CCCCeeccCCCccEEEeEeeCCeEEEEEEecccC----------c-----c-------cchhHHHHHHHHhhcCCC--ce
Q 043333 578 APDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKS----------K-----Q-------GNREFVNEIGMISALQHP--NL 633 (809)
Q Consensus 578 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~----------~-----~-------~~~~f~~Ei~~l~~l~H~--nI 633 (809)
.+..+||.|--+.||.|...+|.++|||.-+... . . ......+|.++|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4568899999999999999999999999643210 0 0 012346788999988644 56
Q ss_pred EeEEeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC
Q 043333 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK 713 (809)
Q Consensus 634 v~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~ 713 (809)
.+.+++ +..++||||+++-.|...= ++-...-.++..|..-+.-+-.. +|||||+.+-||++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 666543 4567999999986554321 11222233444444444444444 8999999999999999
Q ss_pred CCceEEEecCCc
Q 043333 714 DLNPKISDFGLA 725 (809)
Q Consensus 714 ~~~~kl~DfGla 725 (809)
+|.+.++||-=+
T Consensus 238 dg~~~vIDwPQ~ 249 (304)
T COG0478 238 DGDIVVIDWPQA 249 (304)
T ss_pred CCCEEEEeCccc
Confidence 999999999644
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.1e-06 Score=97.41 Aligned_cols=142 Identities=18% Similarity=0.232 Sum_probs=94.6
Q ss_pred CCeeccCCCccEEEeEeeCCeEEEEEEecccCc----------------------c----c----ch----------hHH
Q 043333 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSK----------------------Q----G----NR----------EFV 619 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~----------------------~----~----~~----------~f~ 619 (809)
.+.|+.++-|.||+|++.+|+.||||+.++.-. . . .+ ++.
T Consensus 130 ~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 130 PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 377999999999999999999999999875210 0 0 01 133
Q ss_pred HHHHHHhhcC-----CCceEeEEeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHH-HHHHHh
Q 043333 620 NEIGMISALQ-----HPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARG-LAYLHE 693 (809)
Q Consensus 620 ~Ei~~l~~l~-----H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~-L~yLH~ 693 (809)
.|...+.+++ .+++.-..=|..-.....|+|||++|-.+.+...- .....+ +..++..++++ +..+-.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d---~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGID---RKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCC---HHHHHHHHHHHHHHHHHh
Confidence 4555555442 34443333333345678999999999988886421 112344 23344444433 333333
Q ss_pred CCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 694 ~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
. +++|+|..|.||+++.++++.+.|||+.....+
T Consensus 284 d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 D---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred c---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 3 799999999999999999999999999876544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.27 E-value=3.7e-06 Score=85.23 Aligned_cols=107 Identities=23% Similarity=0.240 Sum_probs=83.0
Q ss_pred chhHHHHHHHHhhcCCCc--eEeEEeEEEeCC----eEEEEEEcccCC-chhhhccCCCccCCCCCHHHHHHHHHHHHHH
Q 043333 615 NREFVNEIGMISALQHPN--LVKLYGCCIEGN----QLLLIYEYMENN-SLARALFGPEEHRLKLDWPTRHSICIGLARG 687 (809)
Q Consensus 615 ~~~f~~Ei~~l~~l~H~n--Iv~l~~~~~~~~----~~~lV~ey~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~ 687 (809)
.....+|...+..++... ..+.+++..... .-++|+|++++- +|.+++.... ..+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 345778888888876444 346677766532 358999999874 7888884321 14556678899999999
Q ss_pred HHHHHhCCCCCeEEcCCCCCCEEEcCCC---ceEEEecCCcccc
Q 043333 688 LAYLHEESRLKIVHRDIKATNVLLDKDL---NPKISDFGLAKLD 728 (809)
Q Consensus 688 L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGla~~~ 728 (809)
+.-||+. +|+|+|++++|||++.+. ++.++||+-++..
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 899999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 809 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-52 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-51 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-50 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-36 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-19 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-19 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-19 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-19 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-19 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-18 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-18 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-09 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-06 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-06 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 5e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-05 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 3e-05 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 3e-05 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 3e-05 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 4e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-04 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 2e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 809 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-157 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-143 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-141 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-80 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-66 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-60 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 6e-59 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-58 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 4e-57 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 6e-57 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 6e-56 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-55 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 3e-55 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-55 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 9e-55 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-54 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-51 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-37 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-32 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-54 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-53 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-52 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-50 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-50 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-49 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-49 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-48 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-36 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-28 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-46 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 8e-46 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-44 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 5e-44 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 9e-44 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-43 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 7e-43 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-42 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-42 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-42 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-42 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-42 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-42 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-42 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-42 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-42 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 4e-42 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 5e-42 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 6e-42 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 6e-42 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 7e-42 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 8e-42 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 8e-42 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 9e-42 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-41 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-41 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-41 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 4e-41 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 6e-41 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 7e-41 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 8e-41 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 8e-41 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 8e-41 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 9e-41 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-40 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-40 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-40 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-40 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-40 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-40 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-40 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-40 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-40 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 7e-40 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 8e-40 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 9e-40 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 9e-40 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 9e-40 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-39 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-39 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 3e-39 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-39 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 7e-39 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 8e-39 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-38 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-38 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-38 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-38 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 5e-38 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 8e-38 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 8e-38 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 9e-38 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-37 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-37 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-37 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-37 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-37 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-37 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 4e-37 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-37 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 6e-37 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-36 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-36 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-36 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-36 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 4e-36 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 4e-36 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 5e-36 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 8e-36 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-35 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-35 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-34 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-33 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-26 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-24 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-35 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-35 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-35 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-32 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-30 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-30 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-28 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-28 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-10 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 7e-34 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-33 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-32 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 8e-28 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-27 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-22 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-21 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-15 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 9e-32 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-31 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-31 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-25 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 9e-25 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-23 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-31 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-30 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-30 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-30 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-30 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-29 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-27 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-27 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-22 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-30 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-30 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 4e-30 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-29 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-29 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-29 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-29 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 6e-29 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 8e-29 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-28 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-28 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-28 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-28 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-25 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-13 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-09 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-28 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-28 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-27 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-27 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-27 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-27 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-27 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 4e-27 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-26 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-26 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-23 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-22 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-19 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 9e-16 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-26 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-26 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-22 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 8e-22 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-15 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-26 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 5e-26 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 8e-26 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-25 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-25 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-25 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 8e-24 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 8e-23 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-20 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-18 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-25 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-25 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 3e-25 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 4e-25 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 5e-25 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 5e-25 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-25 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 5e-25 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 6e-25 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 6e-25 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 7e-25 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 7e-25 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 8e-25 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 8e-25 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 9e-25 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-24 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-24 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-24 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-24 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-24 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-24 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 3e-24 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 5e-24 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 6e-24 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 8e-24 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 8e-24 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 9e-24 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-23 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-23 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-23 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-23 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-23 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-23 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-23 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 5e-23 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 7e-23 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 9e-23 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-22 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-22 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-22 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-22 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-22 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-22 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-21 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-19 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-04 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 4e-22 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-22 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-18 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 8e-06 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-22 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-20 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 4e-20 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-20 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-16 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-11 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 6e-22 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-21 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-21 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-21 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-21 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-21 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-21 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-20 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 7e-18 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-10 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-08 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 8e-04 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 4e-21 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 4e-21 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 5e-21 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 6e-21 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 7e-21 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-18 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 6e-18 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-16 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 9e-21 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-17 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 8e-17 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-15 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-14 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-07 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-20 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 8e-20 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 8e-20 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-19 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-07 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-19 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-17 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 9e-11 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-08 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-19 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-19 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-19 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-16 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-08 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-19 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-16 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 7e-08 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-18 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-18 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-18 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-18 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-17 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-16 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-16 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-13 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-11 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-10 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-18 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-18 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 6e-18 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 6e-18 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-11 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 8e-18 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-11 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 9e-18 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-17 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 8e-17 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 9e-16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-12 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-12 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 9e-04 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-17 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 5e-15 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 7e-09 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-17 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-15 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-17 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-17 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-17 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-17 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-17 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 9e-13 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 3e-17 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-17 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 4e-17 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 4e-17 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 5e-17 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 5e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 8e-08 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-04 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 8e-17 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-16 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-16 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-16 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-16 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-16 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-14 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-10 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-05 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-16 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-15 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 9e-10 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-16 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-16 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-16 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-16 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 3e-16 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 4e-16 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-16 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-10 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-08 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-04 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 5e-16 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 8e-16 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-15 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-08 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-15 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-15 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-14 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 8e-15 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-14 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-14 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-14 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-13 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-11 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-14 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 6e-14 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-10 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-09 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-05 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 7e-14 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-13 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-13 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-11 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 6e-13 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-12 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-11 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-09 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-08 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 4e-08 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-12 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-07 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-05 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-12 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 4e-12 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 5e-12 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 6e-12 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 6e-12 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 8e-12 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-09 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-11 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-10 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-11 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-11 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 9e-08 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-10 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-05 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-10 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-09 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-09 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-09 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-05 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-04 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 6e-09 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-04 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-08 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-06 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 8e-08 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 3e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 5e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-06 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 7e-06 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-06 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-06 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 5e-05 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 7e-06 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 6e-06 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-05 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 1e-05 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-05 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-04 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 8e-04 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-05 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 4e-05 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 8e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 4e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 458 bits (1181), Expect = e-157
Identities = 107/256 (41%), Positives = 158/256 (61%), Gaps = 4/256 (1%)
Query: 552 EQELKGLDL-HTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSK 610
+E + L F+LR+++ A++NF+ N +G GGFG VYKG LADG ++AVK+L +
Sbjct: 6 AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE 65
Query: 611 SKQGN-REFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHR 669
QG +F E+ MIS H NL++L G C+ + LL+Y YM N S+A L E +
Sbjct: 66 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 670 LKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729
LDWP R I +G ARGLAYLH+ KI+HRD+KA N+LLD++ + DFGLAKL +
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNV-ICRTKEAQF 788
+TH++T + GT G++APEY G ++K DV+ +G++ LE+++G+ + R
Sbjct: 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 789 -CLLDWVTLALTDFRF 803
LLDWV L + +
Sbjct: 246 VMLLDWVKGLLKEKKL 261
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 423 bits (1091), Expect = e-143
Identities = 106/240 (44%), Positives = 152/240 (63%), Gaps = 4/240 (1%)
Query: 565 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGM 624
L ++ ATNNF IG G FG VYKG+L DG +A+K+ + +S QG EF EI
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 625 ISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGL 684
+S +HP+LV L G C E N+++LIY+YMEN +L R L+G + + + W R ICIG
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 685 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL-DEEDNTHISTRIAGTF 743
ARGL YLH + I+HRD+K+ N+LLD++ PKI+DFG++K E D TH+ST + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 744 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRF 803
GY+ PEY ++G LT+K+DVYSFG+V E++ RS ++ L +W + + +
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 418 bits (1077), Expect = e-141
Identities = 102/260 (39%), Positives = 148/260 (56%), Gaps = 19/260 (7%)
Query: 552 EQELKGLDLHTGSFTLRQIKAATNNFAP------DNKIGEGGFGPVYKGLLADGKVIAVK 605
+ L+ D SF+ ++K TNNF NK+GEGGFG VYKG + + +AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 606 QLSS----KSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARA 661
+L++ +++ ++F EI +++ QH NLV+L G +G+ L L+Y YM N SL
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 662 LFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 721
L + L W R I G A G+ +LHE +HRDIK+ N+LLD+ KISD
Sbjct: 121 LSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 722 FGLAKL-DEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVI 780
FGLA+ ++ T +++RI GT YMAPE +RG +T K+D+YSFG+V LEI++G V
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV- 234
Query: 781 CRTKEAQFCLLDWVTLALTD 800
+E Q LLD +
Sbjct: 235 DEHREPQ-LLLDIKEEIEDE 253
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 260 bits (665), Expect = 2e-80
Identities = 66/247 (26%), Positives = 99/247 (40%), Gaps = 24/247 (9%)
Query: 565 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGM 624
+ + G FG V+K L + +AVK + KQ + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 625 ISALQHPNLVKLYGCCIEGN----QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSI 680
+ ++H N+++ G G L LI + E SL+ L + W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHI 126
Query: 681 CIGLARGLAYLHEE-------SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733
+ARGLAYLHE+ + I HRDIK+ NVLL +L I+DFGLA E +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 734 HI-STRIAGTFGYMAPEYAMRGYLTD-----KADVYSFGIVALEIVSGRSNVICRTKEAQ 787
+ GT YMAPE + D+Y+ G+V E+ S + E
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 788 FCLLDWV 794
+ +
Sbjct: 247 LPFEEEI 253
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 1e-66
Identities = 66/235 (28%), Positives = 100/235 (42%), Gaps = 36/235 (15%)
Query: 573 ATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNE--IGMISALQH 630
+N IG G +G VYKG L D + +AVK S ++Q F+NE I + ++H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEH 66
Query: 631 PNLVKLYGCCIEGN-----QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLA 685
N+ + + LL+ EY N SL + L DW + + +
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVT 121
Query: 686 RGLAYLHEE------SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL-------DEEDN 732
RGLAYLH E + I HRD+ + NVL+ D ISDFGL+ +
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 733 THISTRIAGTFGYMAPEYAM-------RGYLTDKADVYSFGIVALEIVSGRSNVI 780
+ + GT YMAPE + D+Y+ G++ EI +++
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 1e-60
Identities = 68/199 (34%), Positives = 105/199 (52%), Gaps = 8/199 (4%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGN--REFVNEIGMISALQHPNLVKLYG 638
KIG G FG V++ G +AVK L + EF+ E+ ++ L+HPN+V G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+ L ++ EY+ SL R L +LD R S+ +A+G+ YLH +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLSMAYDVAKGMNYLHNRNP-P 159
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE-YAMRGYLT 757
IVHR++K+ N+L+DK K+ DFGL++L + S AGT +MAPE
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPS-N 217
Query: 758 DKADVYSFGIVALEIVSGR 776
+K+DVYSFG++ E+ + +
Sbjct: 218 EKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 6e-59
Identities = 68/198 (34%), Positives = 102/198 (51%), Gaps = 11/198 (5%)
Query: 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGC 639
+ +G G FG V K K +A+KQ+ +S+ + F+ E+ +S + HPN+VKLYG
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
C+ N + L+ EY E SL L G E S C+ ++G+AYLH +
Sbjct: 70 CL--NPVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 700 VHRDIKATNVLLDKDLN-PKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
+HRD+K N+LL KI DFG A D T G+ +MAPE ++
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 759 KADVYSFGIVALEIVSGR 776
K DV+S+GI+ E+++ R
Sbjct: 183 KCDVFSWGIILWEVITRR 200
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 3e-58
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQL----SSKSKQGNREFVNEIGMISALQHPNLVKL 636
IG GGFG VY+ G +AVK Q E + + L+HPN++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
G C++ L L+ E+ L R L ++ + + +ARG+ YLH+E+
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 697 LKIVHRDIKATNVLLDKDLNP--------KISDFGLAKLDEEDNTHISTRIAGTFGYMAP 748
+ I+HRD+K++N+L+ + + KI+DFGLA+ E T + AG + +MAP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSA-AGAYAWMAP 183
Query: 749 EYAMRGYLTDKADVYSFGIVALEIVSGR 776
E + +DV+S+G++ E+++G
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 4e-57
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 581 NKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGC 639
+G+G FG K G+V+ +K+L ++ R F+ E+ ++ L+HPN++K G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
+ +L I EY++ +L + + + W R S +A G+AYLH + I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 700 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH-------------ISTRIAGTFGYM 746
+HRD+ + N L+ ++ N ++DFGLA+L ++ T + G +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 747 APEYAMRGYLTDKADVYSFGIVALEIVSGR 776
APE +K DV+SFGIV EI+
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRV 219
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 6e-57
Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 25/211 (11%)
Query: 581 NKIGEGGFGPVYKG-LLADGKVIAVKQLSSKSKQGN-------REFVNEIGMISALQHPN 632
+IG+GGFG V+KG L+ D V+A+K L +G +EF E+ ++S L HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+VKLYG N ++ E++ L L + W + + + +A G+ Y+
Sbjct: 85 IVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQ 139
Query: 693 EESRLKIVHRDIKATNVLLDK-----DLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMA 747
++ IVHRD+++ N+ L + K++DFGL++ + H + + G F +MA
Sbjct: 140 NQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMA 194
Query: 748 PE-YAMRGYL-TDKADVYSFGIVALEIVSGR 776
PE T+KAD YSF ++ I++G
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 6e-56
Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYG 638
K+ E G ++KG G I VK L + S + +R+F E + HPN++ + G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 639 CCIE--GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
C LI +M SL L E +D + +ARG+A+LH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG-- 754
I + + +V++D+D+ +IS + + S ++APE A++
Sbjct: 133 -LIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE-ALQKKP 184
Query: 755 --YLTDKADVYSFGIVALEIVSGR 776
AD++SF ++ E+V+
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-55
Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 17/203 (8%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGN--REFVNEIGMISALQHPNLVKLYG 638
+IG G FG VYKG G V AVK L+ + + F NE+G++ +H N++ G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
L ++ ++ E +SL L E K + I ARG+ YLH
Sbjct: 88 YSTAPQ-LAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKL-DEEDNTHISTRIAGTFGYMAPEYAMRGYL- 756
I+HRD+K+ N+ L +D KI DFGLA +H +++G+ +MAPE +R
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDS 199
Query: 757 ---TDKADVYSFGIVALEIVSGR 776
+ ++DVY+FGIV E+++G+
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 9e-55
Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 29/215 (13%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNE--IGMISALQHPNLVKLYG 638
+G+G +G V++G G+ +AVK SS + + + E + L+H N++
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 639 CCIEGN----QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
+ QL LI Y E SL L LD + I + +A GLA+LH E
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 695 -----SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI---STRIAGTFGYM 746
+ I HRD+K+ N+L+ K+ I+D GLA + + + + GT YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 747 APE------YAMRGYLTDKADVYSFGIVALEIVSG 775
APE + D+++FG+V E+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 1e-54
Identities = 73/247 (29%), Positives = 110/247 (44%), Gaps = 8/247 (3%)
Query: 4 LKSQNLPGR--LPPELTRLPFLQEIDLT-RNYLNGTIPSEWASLP-LVNLPLWK-QANGA 58
L NLP +P L LP+L + + N L G IP A L L L + +GA
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 59 IPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRL- 117
IP ++ I TL L +N SG LP + +L NL + + N +G +P+S+ + ++L
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176
Query: 118 KHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPE 177
IS N TG+IP N L + + + L G S + ++ N
Sbjct: 177 TSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK-NSLA 234
Query: 178 GPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLT 237
++ KN+N L LR+ I G +P+ L Q+ L L++SFN L G IP +
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFD 294
Query: 238 YMYLTGN 244
N
Sbjct: 295 VSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-51
Identities = 57/266 (21%), Positives = 106/266 (39%), Gaps = 26/266 (9%)
Query: 8 NLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASIS 67
G L T+ + +DL+ L P IP ++A++
Sbjct: 37 TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP--------------------IPSSLANLP 76
Query: 68 TLADLTL-EFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126
L L + N G +P + L L L++ N +G +P+ + + L S N
Sbjct: 77 YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136
Query: 127 FTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVEL-TDLRISDLNGPEGPFPR-LS 184
+G +P I + L + +G+ ++G IP S +L T + IS N G P +
Sbjct: 137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR-NRLTGKIPPTFA 195
Query: 185 NLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGN 244
NL N+ ++ L + G+ G + + L+ N L+ + L + L N
Sbjct: 196 NL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNN 254
Query: 245 LLTGPVPDWIVRKRN-KHIDLSYNNF 269
+ G +P + + + +++S+NN
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNL 280
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 54/199 (27%), Positives = 86/199 (43%), Gaps = 7/199 (3%)
Query: 77 NQFSGDLPAELGNLINLEKLHLNSNNFTG--KLPESFANLTRLKHFRISD-NHFTGQIPD 133
+ G L + L L+ N +P S ANL L I N+ G IP
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 134 YIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPR-LSNLKNMNYL 192
I T+L L+I + ++G IP ++ + L L S N G P +S+L N+ +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY-NALSGTLPPSISSLPNLVGI 154
Query: 193 ILRSGNIIGEMPEYLGQMIGL-RVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVP 251
I G +P+ G L + +S N+L+G IP F+ L ++ L+ N+L G
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDAS 214
Query: 252 DWIVRKRN-KHIDLSYNNF 269
+N + I L+ N+
Sbjct: 215 VLFGSDKNTQKIHLAKNSL 233
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 51/198 (25%), Positives = 80/198 (40%), Gaps = 11/198 (5%)
Query: 82 DLPAELGNLINL----EKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQ--IPDYI 135
+ +LGN L + + G L ++ R+ + +S + IP +
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 136 QNWTKLEKLFIEGS-GLAGPIPSGIASLVELTDLRISDLNGPEGPFPR-LSNLKNMNYLI 193
N L L+I G L GPIP IA L +L L I+ G P LS +K + L
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH-TNVSGAIPDFLSQIKTLVTLD 131
Query: 194 LRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG--SGLTYMYLTGNLLTGPVP 251
+ G +P + + L + N++SG IP ++ T M ++ N LTG +P
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
Query: 252 DWIVRKRNKHIDLSYNNF 269
+DLS N
Sbjct: 192 PTFANLNLAFVDLSRNML 209
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-54
Identities = 65/235 (27%), Positives = 95/235 (40%), Gaps = 30/235 (12%)
Query: 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNE--IGMISALQHPNLVKLY 637
+IG+G +G V+ G G+ +AVK + + E I ++H N++
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 638 GCCIEGN----QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
I+G QL LI +Y EN SL L LD + + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 694 E-----SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI---STRIAGTFGY 745
E + I HRD+K+ N+L+ K+ I+D GLA D + GT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 746 MAPE------YAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWV 794
M PE AD+YSFG++ E+ R +E Q D V
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLV 266
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-53
Identities = 68/236 (28%), Positives = 105/236 (44%), Gaps = 32/236 (13%)
Query: 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNE--IGMISALQHPNLVKLY 637
IG+G FG V++G G+ +AVK SS + R + E I L+H N++
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102
Query: 638 GCCIEGN----QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
+ N QL L+ +Y E+ SL L +R + + + A GLA+LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 694 E-----SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI---STRIAGTFGY 745
E + I HRD+K+ N+L+ K+ I+D GLA + I GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 746 MAPEYAMRGYL-------TDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWV 794
MAPE + + +AD+Y+ G+V EI R ++ ++ Q D V
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLV 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 4e-52
Identities = 48/211 (22%), Positives = 85/211 (40%), Gaps = 24/211 (11%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGN--REFVNEIGMISALQHPNLVKLYG 638
IG+G FG VY G G+V A++ + + + + F E+ +H N+V G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
C+ L +I + +L + + LD I + +G+ YLH +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHAK---G 150
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKL----DEEDNTHISTRIAGTFGYMAPE----- 749
I+H+D+K+ NV D I+DFGL + G ++APE
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 750 ----YAMRGYLTDKADVYSFGIVALEIVSGR 776
+ + +DV++ G + E+ +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-50
Identities = 75/276 (27%), Positives = 121/276 (43%), Gaps = 20/276 (7%)
Query: 8 NLPGRLP-PELTRLPFLQEIDLTRNYLNGTIPSEWASLP----LVNLPLWK-QANGAIPK 61
L +L L+ +DL+ N ++G W L +L + + +G +
Sbjct: 137 TLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD- 195
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
V+ L L + N FS +P LG+ L+ L ++ N +G + + T LK
Sbjct: 196 -VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLN 253
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIA-SLVELTDLRISDLNGPEGPF 180
IS N F G IP L+ L + + G IP ++ + LT L +S N G
Sbjct: 254 ISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSG-NHFYGAV 310
Query: 181 PR-LSNLKNMNYLILRSGNIIGEMP-EYLGQMIGLRVLDLSFNKLSGVIPSNFSG--SGL 236
P + + L L S N GE+P + L +M GL+VLDLSFN+ SG +P + + + L
Sbjct: 311 PPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASL 370
Query: 237 TYMYLTGNLLTGPVPDWIVRKRNKH---IDLSYNNF 269
+ L+ N +GP+ + + + L N F
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGF 406
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 5e-50
Identities = 70/271 (25%), Positives = 113/271 (41%), Gaps = 14/271 (5%)
Query: 8 NLPGRLPPEL--TRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWK-QANGAIPKAV 63
N G + P L LQE+ L N G IP ++ LV+L L +G IP ++
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 64 ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRIS 123
S+S L DL L N G++P EL + LE L L+ N+ TG++P +N T L +S
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 498
Query: 124 DNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPR- 182
+N TG+IP +I L L + + +G IP+ + L L ++ N G P
Sbjct: 499 NNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT-NLFNGTIPAA 557
Query: 183 LSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFN--KLSGVIPSNFSG-SGLTYM 239
+ + + I G+ Y+ + + N + G+ + S
Sbjct: 558 MFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC 613
Query: 240 YLTGNLLTGPVPDWIVRKRN-KHIDLSYNNF 269
+T + G + +D+SYN
Sbjct: 614 NITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-49
Identities = 79/269 (29%), Positives = 119/269 (44%), Gaps = 12/269 (4%)
Query: 8 NLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWK-QANGAIPKAVAS 65
L G +P EL + L+ + L N L G IPS ++ L + L + G IPK +
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 66 ISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN 125
+ LA L L N FSG++PAELG+ +L L LN+N F G +P + + I+ N
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAAN 568
Query: 126 HFTGQIPDYIQNWTKLEKLFIEGSG--LAGPIPSGIASLVELTDLRISDLNGPEGPFPR- 182
G+ YI+N ++ G+ G + L I+ G
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITS-RVYGGHTSPT 627
Query: 183 LSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYL 241
N +M +L + + G +P+ +G M L +L+L N +SG IP GL + L
Sbjct: 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDL 687
Query: 242 TGNLLTGPVPDWIVRKRN-KHIDLSYNNF 269
+ N L G +P + IDLS NN
Sbjct: 688 SSNKLDGRIPQAMSALTMLTEIDLSNNNL 716
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 7e-49
Identities = 76/274 (27%), Positives = 128/274 (46%), Gaps = 11/274 (4%)
Query: 8 NLPGRLPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLP--LVNLPLWK-QANGAIPKAV 63
N G LP + L ++ L+ +DL+ N +G +P +L L+ L L +G I +
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
Query: 64 --ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+TL +L L+ N F+G +P L N L LHL+ N +G +P S +L++L+ +
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181
+ N G+IP + LE L ++ + L G IPSG+++ L + +S+ N G P
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN-NRLTGEIP 507
Query: 182 R-LSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMY 240
+ + L+N+ L L + + G +P LG L LDL+ N +G IP+
Sbjct: 508 KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK--- 564
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSS 274
+ N + G +I K N ++
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQG 598
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-48
Identities = 72/274 (26%), Positives = 114/274 (41%), Gaps = 17/274 (6%)
Query: 7 QNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPL-WKQANGAIP--KAV 63
+ L L L+ + L+ +++NG++ S L +L L +G + ++
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSL 122
Query: 64 ASISTLADLTLEFNQFSGDLPAELG-NLINLEKLHLNSNNFTGKLPESFA---NLTRLKH 119
S S L L + N G L +LE L L++N+ +G + LKH
Sbjct: 123 GSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKH 182
Query: 120 FRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGP 179
IS N +G + + LE L + + + IP + L L IS N G
Sbjct: 183 LAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISG-NKLSGD 238
Query: 180 FPR-LSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG--SGL 236
F R +S + L + S +G +P + L+ L L+ NK +G IP SG L
Sbjct: 239 FSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTL 296
Query: 237 TYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNF 269
T + L+GN G VP + + + LS NNF
Sbjct: 297 TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 330
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-36
Identities = 52/230 (22%), Positives = 84/230 (36%), Gaps = 28/230 (12%)
Query: 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKA 62
L + + G +P EL L +DL N NGTIP+ G
Sbjct: 520 KLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG--KIAANFIAGKRYVY 577
Query: 63 VASISTLADLTLEFN--QFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHF 120
+ + + N +F G +L L ++ S + G +F N +
Sbjct: 578 IKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637
Query: 121 RISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPF 180
+S N +G IP I + L L + + ++G IP +
Sbjct: 638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV--------------------- 676
Query: 181 PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSN 230
+L+ +N L L S + G +P+ + + L +DLS N LSG IP
Sbjct: 677 ---GDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-28
Identities = 46/223 (20%), Positives = 85/223 (38%), Gaps = 32/223 (14%)
Query: 88 GNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIE 147
+ +++ N + S +LT L+ +S++H G + + L L +
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLS 108
Query: 148 GSGLAGPIPSG--IASLVELTDLRISD--LNGPEGPFPRLSNLKNMNYLILRSGNIIGEM 203
+ L+GP+ + + S L L +S L+ P G L ++ L L + +I G
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFP-GKVSGGLKLNSLEVLDLSANSISGAN 167
Query: 204 PEYL---GQMIGLRVLDLSFNKLSGVIPS--------------NFSG--------SGLTY 238
L+ L +S NK+SG + NFS S L +
Sbjct: 168 VVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQH 227
Query: 239 MYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNFIDGSSDSNCEN 280
+ ++GN L+G I K +++S N F+ ++
Sbjct: 228 LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKS 270
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-46
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 582 KIGEGGFGPVYKGLLADGKV-IAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVKLYGC 639
+IG G FG V+ G L +AVK + +F+ E ++ HPN+V+L G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
C + + ++ E ++ L +L T + A G+ YL +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 700 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGY--MAPEYAMRGYLT 757
+HRD+ A N L+ + KISDFG+++ +E D + ++ APE G +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 758 DKADVYSFGIVALEIVS 774
++DV+SFGI+ E S
Sbjct: 294 SESDVWSFGILLWETFS 310
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-46
Identities = 67/202 (33%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCI 641
+G+G +G VY G L++ IA+K++ + + ++ EI + L+H N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 642 EGNQLLLIYEYMENNSLA---RALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
E + + E + SL+ R+ +GP LK + T + GL YLH+ +
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGP----LKDNEQTIGFYTKQILEGLKYLHDN---Q 142
Query: 699 IVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE---YAMRG 754
IVHRDIK NVL++ KISDFG +K N T GT YMAPE RG
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRG 201
Query: 755 YLTDKADVYSFGIVALEIVSGR 776
Y AD++S G +E+ +G+
Sbjct: 202 Y-GKAADIWSLGCTIIEMATGK 222
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 580 DNKIGEGGFGPVYKGL-LADGKVIAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKL 636
D +IG G F VYKGL +A + +K + F E M+ LQHPN+V+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 637 YGCCI----EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
Y ++L+ E M + +L L + + + S C + +GL +LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFK-VMKIKVLRSWCRQILKGLQFLH 146
Query: 693 EESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYA 751
+ I+HRD+K N+ + + KI D GLA L + GT +MAPE
Sbjct: 147 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMY 202
Query: 752 MRGYLTDKADVYSFGIVALEIVSGR 776
Y + DVY+FG+ LE+ +
Sbjct: 203 EEKY-DESVDVYAFGMCMLEMATSE 226
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-44
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 581 NKIGEGGFGPVYKGLL-----ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVK 635
++G+G FG V G+V+AVK+L +++ R+F EI ++ +LQH N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 636 LYGCCIEGNQ--LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
G C + L LI EY+ SL L ++H+ ++D + +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEYA 751
++ + +HRD+ N+L++ + KI DFGL K+ +D + G + APE
Sbjct: 131 GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 752 MRGYLTDKADVYSFGIVALEIVS 774
+ +DV+SFG+V E+ +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 9e-44
Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 581 NKIGEGGFGPVYKGLL-----ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVK 635
++G+G FG V G+V+AVK+L +++ R+F EI ++ +LQH N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 636 LYGCCIEGNQ--LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
G C + L LI EY+ SL L ++H+ ++D + +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEYA 751
++ + +HRD+ N+L++ + KI DFGL K+ +D + + G + APE
Sbjct: 162 GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 752 MRGYLTDKADVYSFGIVALEIVS 774
+ +DV+SFG+V E+ +
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 581 NKIGEGGFGPVYKGLLA-----DGKVIAVKQL-SSKSKQGNREFVNEIGMISALQHPNLV 634
+GEG FG V G+ +AVK L + EI ++ L H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 635 KLYGCCIE--GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
K G C E GN + LI E++ + SL L +++ K++ + + + +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEY 750
+ VHRD+ A NVL++ + KI DFGL K E D + + + + APE
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200
Query: 751 AMRGYLTDKADVYSFGIVALEIVS 774
M+ +DV+SFG+ E+++
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLT 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-43
Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 24/205 (11%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKLY 637
++G G FG V++ G AVK+ L + E+ + L P +V LY
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLY 116
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
G EG + + E +E SL + + + L GL YLH
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR--- 169
Query: 698 KIVHRDIKATNVLLDKDLNP-KISDFGLAKLDEEDNTHISTR----IAGTFGYMAPEYAM 752
+I+H D+KA NVLL D + + DFG A + D S I GT +MAPE M
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 753 -RGYLTDKADVYSFGIVALEIVSGR 776
+ K D++S + L +++G
Sbjct: 230 GKPC-DAKVDIWSSCCMMLHMLNGC 253
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQL--SSKSKQGNREFVNEIGMISALQHPNLVKLYG 638
++G G FG V G +A+K + S S+ EF+ E ++ L H LV+LYG
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYG 86
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
C + + +I EYM N L L E R + +C + + YL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQ 140
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT---FGYMAPEYAMRGY 755
+HRD+ A N L++ K+SDFGL++ +D T G+ + PE M
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSK 197
Query: 756 LTDKADVYSFGIVALEIVS 774
+ K+D+++FG++ EI S
Sbjct: 198 FSSKSDIWAFGVLMWEIYS 216
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 581 NKIGEGGFGPVYKGLLADGK------VIAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 634
++GEG FG V+ + ++AVK L S+ ++F E +++ LQH ++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 635 KLYGCCIEGNQLLLIYEYMENNSL-----------ARALFGPEEHRLKLDWPTRHSICIG 683
+ +G C EG LL+++EYM + L G + L ++
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF 743
+A G+ YL + L VHRD+ N L+ + L KI DFG+++ + R+ G
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGR- 219
Query: 744 G-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+M PE + T ++DV+SFG+V EI +
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 580 DNKIGEGGFGPVYKGLL-ADGKVI--AVKQL-SSKSKQGNREFVNEIGMISALQHPNLVK 635
D ++G G FG V +G+ K I A+K L K E + E ++ L +P +V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
L G C + L+L+ E L + L R ++ + ++ G+ YL
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEYAMR 753
VHRD+ A NVLL KISDFGL+K D+++ + R AG + + APE
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 754 GYLTDKADVYSFGIVALEIVS 774
+ ++DV+S+G+ E +S
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS 208
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 581 NKIGEGGFGPVYKGLL-----ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVK 635
+++G+G FG V G ++AVKQL R+F EI ++ AL +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 636 LYGCCIEGNQ--LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
G + L L+ EY+ + L L + HR +LD + +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYL-- 143
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEYA 751
SR + VHRD+ A N+L++ + + KI+DFGLAKL D + R G + APE
Sbjct: 144 GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 752 MRGYLTDKADVYSFGIVALEIVS 774
+ ++DV+SFG+V E+ +
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFT 225
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAVKQL--SSKSKQGNREFVNEIGMISALQHPNLVKLYGC 639
++G G FG V G +AVK + S S+ EF E + L HP LVK YG
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
C + + ++ EY+ N L L H L+ +C + G+A+L +
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQF 125
Query: 700 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGY--MAPEYAMRGYLT 757
+HRD+ A N L+D+DL K+SDFG+ + +D + + F APE +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 758 DKADVYSFGIVALEIVS 774
K+DV++FGI+ E+ S
Sbjct: 184 SKSDVWAFGILMWEVFS 200
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 33/226 (14%)
Query: 581 NKIGEGGFGPVYKGLLADGK------VIAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 634
++GEG FG V+ + ++AVK L + ++F E +++ LQH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 635 KLYGCCIEGNQLLLIYEYMENNSL------------ARALFGPEEHRLKLDWPTRHSICI 682
K YG C +G+ L++++EYM++ L P + + +L I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 683 GLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAG 741
+A G+ YL + VHRD+ N L+ +L KI DFG+++ + D +
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH--T 195
Query: 742 TF--GYMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GRSN 778
+M PE M T ++DV+SFG++ EI + SN
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 14/202 (6%)
Query: 580 DNKIGEGGFGPVYKGLLADGK-----VIAVKQL-SSKSKQGNREFVNEIGMISALQHPNL 633
+G G FG VYKGL +A+K+L + S + N+E ++E +++++ +P++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
+L G C+ + + LI + M L + EH+ + + C+ +A+G+ YL
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT-FGYMAPEYAM 752
E R ++VHRD+ A NVL+ + KI+DFGLAKL + +MA E +
Sbjct: 134 EDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 753 RGYLTDKADVYSFGIVALEIVS 774
T ++DV+S+G+ E+++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMT 214
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 14/201 (6%)
Query: 582 KIGEGGFGPVYKGLLADGKV-----IAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVK 635
IG G FG VYKG+L +A+K L + +++ +F+ E G++ H N+++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
L G + +++I EYMEN +L + L E + + G+A G+ YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYL---A 164
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGY--MAPEYAMR 753
+ VHRD+ A N+L++ +L K+SDFGL+++ E+D T G APE
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 754 GYLTDKADVYSFGIVALEIVS 774
T +DV+SFGIV E+++
Sbjct: 225 RKFTSASDVWSFGIVMWEVMT 245
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-42
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 580 DNKIGEGGFGPVYKGLL--ADGKVI--AVKQL-SSKSKQGNREFVNEIGMISALQHPNLV 634
D +G G FG V G L K I A+K L +++ R+F+ E ++ HPN++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
+L G + ++++ EYMEN SL L +H + + G+A G+ YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGY--MAPEYAM 752
S + VHRD+ A N+L++ +L K+SDFGL ++ E+D T G +PE
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 753 RGYLTDKADVYSFGIVALEIVS 774
T +DV+S+GIV E++S
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 64/204 (31%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 581 NKIGEGGFGPVYKGLL-----ADGKVIAVKQL-SSKSKQGNREFVNEIGMISALQHPNLV 634
+GEG FG V G+++AVK L + Q + EI ++ L H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 635 KLYGCCIE--GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
K GCC + L L+ EY+ SL L H + L + G+AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGL--AQLLLFAQQICEGMAYLH 151
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEY 750
+HRD+ A NVLLD D KI DFGLAK E + + R G + APE
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208
Query: 751 AMRGYLTDKADVYSFGIVALEIVS 774
+DV+SFG+ E+++
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLT 232
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-42
Identities = 64/202 (31%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 580 DNKIGEGGFGPVYKGLL--ADGKVI--AVKQL-SSKSKQGNREFVNEIGMISALQHPNLV 634
+ IG G G V G L + + A+K L + +++ R+F++E ++ HPN++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
+L G G +++ EYMEN SL L H + + G+ G+ YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYL--- 167
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGY--MAPEYAM 752
S L VHRD+ A NVL+D +L K+SDFGL+++ E+D T G APE
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 753 RGYLTDKADVYSFGIVALEIVS 774
+ +DV+SFG+V E+++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-42
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 15/198 (7%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQL--SSKSKQGNREFVNEIGMISALQHPNLVKLYG 638
+IG G FG V+ G + +A+K + + S++ +F+ E ++ L HP LV+LYG
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYG 70
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
C+E + L+ E+ME+ L+ L R T +C+ + G+AYL
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYL---EEAC 124
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGY--MAPEYAMRGYL 756
++HRD+ A N L+ ++ K+SDFG+ + +D ++ F +PE
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRY 182
Query: 757 TDKADVYSFGIVALEIVS 774
+ K+DV+SFG++ E+ S
Sbjct: 183 SSKSDVWSFGVLMWEVFS 200
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-42
Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 581 NKIGEGGFGPVYKGLLADGKV-IAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKL 636
+K+G G +G VY+G+ + +AVK L K+ EF+ E ++ ++HPNLV+L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQL 281
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
G C +I E+M +L L + + ++ + YL E +
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYL--EKK 337
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYL 756
+HR++ A N L+ ++ K++DFGL++L D + APE
Sbjct: 338 -NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 757 TDKADVYSFGIVALEIVS 774
+ K+DV++FG++ EI +
Sbjct: 397 SIKSDVWAFGVLLWEIAT 414
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 581 NKIGEGGFGPVYKGLLADGKV-IAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKL 636
+K+G G +G VY+G+ + +AVK L K+ EF+ E ++ ++HPNLV+L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
G C +I E+M +L L + + ++ + YL E +
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYL--EKK 130
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGY--MAPEYAMRG 754
+HRD+ A N L+ ++ K++DFGL++L D F APE
Sbjct: 131 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG--AKFPIKWTAPESLAYN 187
Query: 755 YLTDKADVYSFGIVALEIVS-GRS 777
+ K+DV++FG++ EI + G S
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMS 211
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 8e-42
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 580 DNKIGEGGFGPVYKGLLADGK----VIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLV 634
D IG+G FG VY G D A+K LS ++ F+ E ++ L HPN++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 635 KLYGCCIEGN-QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
L G + ++ YM + L + + + S + +ARG+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYL-- 140
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAGTF--GYMAPEY 750
+ K VHRD+ A N +LD+ K++DFGLA+ + + + + + A E
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 751 AMRGYLTDKADVYSFGIVALEIVS 774
T K+DV+SFG++ E+++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-42
Identities = 67/199 (33%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
IG+G FG V G KV AVK + K+ + F+ E +++ L+H NLV+L G
Sbjct: 27 QTIGKGEFGDVMLGDYRGNKV-AVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 641 IEGN-QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
+E L ++ EYM SL L L + + + YL E
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYL--EGN-NF 138
Query: 700 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDK 759
VHRD+ A NVL+ +D K+SDFGL K E +T + ++ + APE + K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTK 194
Query: 760 ADVYSFGIVALEIVS-GRS 777
+DV+SFGI+ EI S GR
Sbjct: 195 SDVWSFGILLWEIYSFGRV 213
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-42
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 580 DNKIGEGGFGPVYKGLLADGK----VIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLV 634
+ IG G FG VY G L D AVK L+ + G +F+ E ++ HPN++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 635 KLYGCCIEG-NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
L G C+ L++ YM++ L + + +A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG------YMA 747
K VHRD+ A N +LD+ K++DFGLA+ + + + G +MA
Sbjct: 147 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMA 200
Query: 748 PEYAMRGYLTDKADVYSFGIVALEIVS 774
E T K+DV+SFG++ E+++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 71/203 (34%), Positives = 105/203 (51%), Gaps = 18/203 (8%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKLY 637
++G G FG V+ G +AVK L KQG+ F+ E ++ LQH LV+LY
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
+ + +I EYMEN SL L P +L + + +A G+A++
Sbjct: 75 AVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTI--NKLLDMAAQIAEGMAFI---EER 128
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGY--MAPEYAMRGY 755
+HRD++A N+L+ L+ KI+DFGLA+L E++ + R F APE G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGT 186
Query: 756 LTDKADVYSFGIVALEIVS-GRS 777
T K+DV+SFGI+ EIV+ GR
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI 209
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-41
Identities = 67/201 (33%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGN--REFVNEIGMISALQHPNLVKLYG 638
IG+G FG V G KV AVK + K + F+ E +++ L+H NLV+L G
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKV-AVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 639 CCIEGN-QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
+E L ++ EYM SL L L + + + YL E
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYL--EGN- 308
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLT 757
VHRD+ A NVL+ +D K+SDFGL K E +T + ++ + APE +
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFS 364
Query: 758 DKADVYSFGIVALEIVS-GRS 777
K+DV+SFGI+ EI S GR
Sbjct: 365 TKSDVWSFGILLWEIYSFGRV 385
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 38/229 (16%)
Query: 581 NKIGEGGFGPVYKGLLADGK------VIAVKQLSSK-SKQGNREFVNEIGMISALQHPNL 633
++GE FG VYKG L +A+K L K EF +E + + LQHPN+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSL------------ARALFGPEEHRLKLDWPTRHSIC 681
V L G + L +I+ Y + L + + L+ P +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 682 IGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAG 741
+A G+ YL S +VH+D+ NVL+ LN KISD GL + + +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY----KLL 187
Query: 742 TFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GRSN 778
+MAPE M G + +D++S+G+V E+ S G SN
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-41
Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 580 DNKIGEGGFGPVYKGLLADGK-----VIAVKQL-SSKSKQGNREFVNEIGMISALQHPNL 633
+G G FG V+KG+ + +K + +Q + + + I +L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
V+L G C + L L+ +Y+ SL + +HR L + + +A+G+ YL
Sbjct: 78 VRLLGLCPG-SSLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWGVQIAKGMYYL-- 131
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT-FGYMAPEYAM 752
E +VHR++ A NVLL +++DFG+A L D+ + A T +MA E
Sbjct: 132 EEH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 753 RGYLTDKADVYSFGIVALEIVS 774
G T ++DV+S+G+ E+++
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-41
Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 27/238 (11%)
Query: 549 HTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQ- 606
H G+DL T + + + + KIGEG FG DG+ +K+
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI 57
Query: 607 -LSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARAL--- 662
+S S + E E+ +++ ++HPN+V+ E L ++ +Y E L + +
Sbjct: 58 NISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ 117
Query: 663 ---FGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 719
E+ L + + L ++H+ KI+HRDIK+ N+ L KD ++
Sbjct: 118 KGVLFQEDQILD--------WFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQL 166
Query: 720 SDFGLAKLDEEDNTHISTRIAGTFGYMAPE-YAMRGYLTDKADVYSFGIVALEIVSGR 776
DFG+A++ I GT Y++PE + Y +K+D+++ G V E+ + +
Sbjct: 167 GDFGIARVLNSTVELARACI-GTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLK 222
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-41
Identities = 59/197 (29%), Positives = 106/197 (53%), Gaps = 12/197 (6%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGC 639
KIGEG G V G+ +AVK + + +Q NE+ ++ QH N+V++Y
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
+ G +L ++ E+++ +L + +++L+ ++C + + LAYLH + +
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHAQ---GV 162
Query: 700 VHRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
+HRDIK+ ++LL D K+SDFG A++ ++ S + GT +MAPE R
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYAT 220
Query: 759 KADVYSFGIVALEIVSG 775
+ D++S GI+ +E+V G
Sbjct: 221 EVDIWSLGIMVIEMVDG 237
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-41
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 581 NKIGEGGFGPVYKGLLADGK------VIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNL 633
++G+G FG VY+G+ +A+K ++ + R EF+NE ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLA---RALFGPEEHRLKLDWPTRH---SICIGLARG 687
V+L G +G L+I E M L R+L + L P+ + +A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRIAGTFGY- 745
+AYL+ K VHRD+ A N ++ +D KI DFG+ + E D + G
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK-----GLL 202
Query: 746 ----MAPEYAMRGYLTDKADVYSFGIVALEIVS 774
M+PE G T +DV+SFG+V EI +
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-41
Identities = 58/197 (29%), Positives = 107/197 (54%), Gaps = 12/197 (6%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGC 639
KIG+G G VY + +A G+ +A++Q++ + + +NEI ++ ++PN+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
+ G++L ++ EY+ SL + +D ++C + L +LH ++
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 700 VHRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
+HRDIK+ N+LL D + K++DFG A++ E + + + GT +MAPE R
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGP 195
Query: 759 KADVYSFGIVALEIVSG 775
K D++S GI+A+E++ G
Sbjct: 196 KVDIWSLGIMAIEMIEG 212
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-41
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQL---SSKSKQGNREFVNEIGMISALQH 630
NF + KIG G F VY+ L DG +A+K++ + + + EI ++ L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 631 PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
PN++K Y IE N+L ++ E + L+R + ++ + + T + L L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE- 749
+H +++HRDIK NV + K+ D GL + T + + GT YM+PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 750 YAMRGYLTDKADVYSFGIVALEIVSGR 776
GY K+D++S G + E+ + +
Sbjct: 208 IHENGY-NFKSDIWSLGCLLYEMAALQ 233
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-41
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 582 KIGEGGFGPVYKGLLADGK----VIAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVKL 636
IGEG FG V++G+ + +A+K + S +F+ E + HP++VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
G E N + +I E L L + + LD + L+ LAYL
Sbjct: 82 IGVITE-NPVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYL---ES 134
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYL 756
+ VHRDI A NVL+ + K+ DFGL++ E+ + +++ +MAPE
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 757 TDKADVYSFGIVALEIVS 774
T +DV+ FG+ EI+
Sbjct: 195 TSASDVWMFGVCMWEILM 212
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-40
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 580 DNKIGEGGFGPVYKGLL-ADGKVI--AVKQL-SSKSKQGNREFVNEIGMISALQHPNLVK 635
D ++G G FG V +G+ K I A+K L K E + E ++ L +P +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
L G C + L+L+ E L + L R ++ + ++ G+ YL
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGY--MAPEYAMR 753
VHR++ A NVLL KISDFGL+K D+++ + R AG + APE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 754 GYLTDKADVYSFGIVALEIVS 774
+ ++DV+S+G+ E +S
Sbjct: 514 RKFSSRSDVWSYGVTMWEALS 534
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 16/204 (7%)
Query: 580 DNKIGEGGFGPVYKGLL--ADGKVI--AVKQL---SSKSKQGNREFVNEIGMISALQHPN 632
K+G+G FG V +G GK + AVK L + +F+ E+ + +L H N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
L++LYG + + ++ E SL L +H+ T + +A G+ YL
Sbjct: 83 LIRLYGVVLT-PPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYL- 137
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGY--MAPEY 750
E R +HRD+ A N+LL KI DFGL + +++ H + + APE
Sbjct: 138 ESKRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 751 AMRGYLTDKADVYSFGIVALEIVS 774
+ +D + FG+ E+ +
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-40
Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 580 DNKIGEGGFGPVYKGLLADGK----VIAVKQL-SSKSKQGNREFVNEIGMISALQHPNLV 634
+ IG G FG VY G L D AVK L +F+ E ++ HPN++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 635 KLYGCCIEG-NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
L G C+ L++ YM++ L + + +A+G+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL-- 208
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAGTF--GYMAPEY 750
+ K VHRD+ A N +LD+ K++DFGLA+ + +++ + + +MA E
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 751 AMRGYLTDKADVYSFGIVALEIVS 774
T K+DV+SFG++ E+++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 14/202 (6%)
Query: 580 DNKIGEGGFGPVYKGLLADGK-----VIAVKQL-SSKSKQGNREFVNEIGMISALQHPNL 633
+G G FG VYKGL +A+K+L + S + N+E ++E +++++ +P++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
+L G C+ + + LI + M L + EH+ + + C+ +A+G+ YL
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT-FGYMAPEYAM 752
E R ++VHRD+ A NVL+ + KI+DFGLAKL + +MA E +
Sbjct: 134 EDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 753 RGYLTDKADVYSFGIVALEIVS 774
T ++DV+S+G+ E+++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMT 214
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 581 NKIGEGGFGPVYKGLLADGK----VIAVKQL--SSKSKQGNREFVNEIGMISALQHPNLV 634
+G+G FG V + L +AVK L + EF+ E + HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 635 KLYGCCIEG------NQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLAR 686
KL G + ++I +M++ L L E+ L T + +A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG-- 744
G+ YL SR +HRD+ A N +L +D+ ++DFGL++ + + G
Sbjct: 149 GMEYL--SSR-NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASKL 201
Query: 745 ---YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
++A E T +DV++FG+ EI++
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-40
Identities = 66/197 (33%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKLY 637
K+G+G FG V+ G +A+K L K G F+ E ++ L+H LV+LY
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
E + ++ EYM SL L G L+L P + +A G+AY+ E
Sbjct: 246 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYV--ERM- 299
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLT 757
VHRD++A N+L+ ++L K++DFGLA+L E++ + APE A+ G T
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 758 DKADVYSFGIVALEIVS 774
K+DV+SFGI+ E+ +
Sbjct: 360 IKSDVWSFGILLTELTT 376
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 582 KIGEGGFGPVYKGLL--ADGKVI--AVKQL-SSKSKQGNREFVNEIGMISALQHPNLVKL 636
+GEG FG VY+G+ G+ I AVK + +F++E ++ L HP++VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
G E +I E L L E ++ L T + + + +AYL
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYL---ES 131
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT---FGYMAPEYAMR 753
+ VHRDI N+L+ K+ DFGL++ E+++ + + T +M+PE
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESINF 188
Query: 754 GYLTDKADVYSFGIVALEIVS 774
T +DV+ F + EI+S
Sbjct: 189 RRFTTASDVWMFAVCMWEILS 209
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 580 DNKIGEGGFGPVYKGLLADGKV---IAVKQL--SSKSKQGNREFVNEIGMISALQHPNLV 634
D ++G G FG V KG KV +AVK L + E + E ++ L +P +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
++ G C E +L+ E E L + L +++R + + ++ G+ YL
Sbjct: 82 RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNR-HVKDKNIIELVHQVSMGMKYL--- 133
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF--GYMAPEYAM 752
VHRD+ A NVLL KISDFGL+K D + + G + + APE
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 753 RGYLTDKADVYSFGIVALEIVS 774
+ K+DV+SFG++ E S
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFS 215
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-40
Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGC 639
++G+G FG VYK G + A K + +KS++ +++ EI +++ HP +VKL G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
+L ++ E+ ++ + E L P +C + L +LH + +I
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHSK---RI 138
Query: 700 VHRDIKATNVLLDKDLNPKISDFGL-AKLDEED---NTHISTRIAGTFGYMAPEYAMRGY 755
+HRD+KA NVL+ + + +++DFG+ AK + ++ I GT +MAPE M
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCET 193
Query: 756 LTD-----KADVYSFGIVALEIVSG 775
+ D KAD++S GI +E+
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-40
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 581 NKIGEGGFGPVYKGLLADGK----VIAVKQL--SSKSKQGNREFVNEIGMISALQHPNLV 634
+GEG FG V +G L +AVK + + S++ EF++E + HPN++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 635 KLYGCCIEGN-----QLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLARG 687
+L G CIE + + ++I +M+ L L E + T + +A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG--- 744
+ YL S +HRD+ A N +L D+ ++DFGL+K + + G
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMP 212
Query: 745 --YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
++A E T K+DV++FG+ EI +
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 8e-40
Identities = 60/223 (26%), Positives = 86/223 (38%), Gaps = 32/223 (14%)
Query: 581 NKIGEGGFGPVYKGLLADGK------VIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNL 633
+G G FG VY+G ++ +AVK L + + +F+ E +IS H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLA---RALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
V+ G ++ ++ E M L R L + +A G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 691 LHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAKLDEEDNTHISTRIAGTFGY-- 745
L +HRDI A N LL KI DFG+A+ + R G
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YR-KGGCAMLP 208
Query: 746 ---MAPEYAMRGYLTDKADVYSFGIVALEIVS-------GRSN 778
M PE M G T K D +SFG++ EI S +SN
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 9e-40
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 580 DNKIGEGGFGPVYKGLLADGK----VIAVKQL-SSKSKQGNREFVNEIGMISALQHPNLV 634
IGEG FG V++G+ + +A+K + S +F+ E + HP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
KL G E N + +I E L L + + LD + L+ LAYL
Sbjct: 455 KLIGVITE-NPVWIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYL--- 507
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG 754
+ VHRDI A NVL+ + K+ DFGL++ E+ + +++ +MAPE
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 755 YLTDKADVYSFGIVALEIVS 774
T +DV+ FG+ EI+
Sbjct: 568 RFTSASDVWMFGVCMWEILM 587
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-40
Identities = 47/211 (22%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 582 KIGEGGFGPVYKGLLADGKV--------IAVKQLSSKSKQGNREFVNEIGMISALQHPNL 633
+G+G F ++KG+ + + +K L + + F M+S L H +L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
V YG C+ G++ +L+ E+++ SL L ++++ ++ + + LA + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMHFL-- 129
Query: 694 ESRLKIVHRDIKATNVLLDKDLNP--------KISDFGLAK-LDEEDNTHISTRIAGTFG 744
E ++H ++ A N+LL ++ + K+SD G++ + +D
Sbjct: 130 EEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP------ 182
Query: 745 YMAPE-YAMRGYLTDKADVYSFGIVALEIVS 774
++ PE L D +SFG EI S
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-40
Identities = 64/199 (32%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKLY 637
K+G G FG V+ +AVK + K G+ F+ E ++ LQH LVKL+
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKLH 249
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
+ + +I E+M SL L E + L P +A G+A++ +
Sbjct: 250 AVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFI---EQR 303
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGY--MAPEYAMRGY 755
+HRD++A N+L+ L KI+DFGLA++ E++ + R F APE G
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGS 361
Query: 756 LTDKADVYSFGIVALEIVS 774
T K+DV+SFGI+ +EIV+
Sbjct: 362 FTIKSDVWSFGILLMEIVT 380
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-39
Identities = 66/197 (33%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKLY 637
K+G+G FG V+ G +A+K L K G F+ E ++ L+H LV+LY
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
E + ++ EYM SL L G L+L P + +A G+AY+ E
Sbjct: 329 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYV--ERM- 382
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLT 757
VHRD++A N+L+ ++L K++DFGLA+L E++ + APE A+ G T
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 758 DKADVYSFGIVALEIVS 774
K+DV+SFGI+ E+ +
Sbjct: 443 IKSDVWSFGILLTELTT 459
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 18/200 (9%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGC 639
K+GEG +G VYK + G+++A+KQ+ +S +E + EI ++ P++VK YG
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
+ L ++ EY S++ + L +I +GL YLH +
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFM---RK 146
Query: 700 VHRDIKATNVLLDKDLNPKISDFGL-AKLDEED---NTHISTRIAGTFGYMAPEYAMRGY 755
+HRDIKA N+LL+ + + K++DFG+ +L + NT I GT +MAPE
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFWMAPEVIQEIG 201
Query: 756 LTDKADVYSFGIVALEIVSG 775
AD++S GI A+E+ G
Sbjct: 202 YNCVADIWSLGITAIEMAEG 221
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 580 DNKIGEGGFGPVYKGLLADGKV---IAVKQL-SSKSKQGNREFVNEIGMISAL-QHPNLV 634
+ IGEG FG V K + + A+K++ SK +R+F E+ ++ L HPN++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 635 KLYGCCIEGNQLLLIYEYMENNSL------------ARALFGPEEHRLKLDWPTRHSICI 682
L G C L L EY + +L A L
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 683 GLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT 742
+ARG+ YL S+ + +HRD+ A N+L+ ++ KI+DFGL++ E R+
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP-- 204
Query: 743 FGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+MA E T +DV+S+G++ EIVS
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 50/228 (21%), Positives = 84/228 (36%), Gaps = 34/228 (14%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQ--LSSKSKQGNREFVNEIGMISAL-Q 629
T F KIG G FG V+K + DG + A+K+ + + E+ + L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 630 HPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLA 689
H ++V+ + E + +L+ EY SLA A+ + + + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNP-------------------KISDFGLAKLDEE 730
Y+H +VH DIK +N+ + + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 731 DNTHISTRIAGTFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGR 776
G ++A E +L KAD+++ + +
Sbjct: 187 PQVEE-----GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAE 228
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 7e-39
Identities = 34/188 (18%), Positives = 62/188 (32%), Gaps = 31/188 (16%)
Query: 316 INCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGHFIDNSTRENSYIQINTSR 375
+N GG+ + + D G D +
Sbjct: 10 VNAGGESHVDVHGIHYRKDPL---------------EGRVGRASDYGMKLPILRSN---- 50
Query: 376 LLMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEILFTDDKSYCSLGRRIFDVYI 435
+D LY R + S Y G Y + L FAE+ F +++FDV +
Sbjct: 51 --PEDQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFAEVYFA------QSQQKVFDVRV 102
Query: 436 QGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRL---YWAGKGTTDIPYKGVYGP 492
G V+KD +I + G A + ++ G + ++ + GK + + P
Sbjct: 103 NGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNP 161
Query: 493 LISAISLY 500
+ A+ +
Sbjct: 162 KVCALFIM 169
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-39
Identities = 60/223 (26%), Positives = 85/223 (38%), Gaps = 32/223 (14%)
Query: 581 NKIGEGGFGPVYKGLLADGK------VIAVKQLSSKSKQGNR-EFVNEIGMISALQHPNL 633
+G G FG VY+G ++ +AVK L + + +F+ E +IS H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLA---RALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
V+ G ++ ++ E M L R L + +A G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 691 LHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAKLDEEDNTHISTRIAGTFGY-- 745
L +HRDI A N LL KI DFG+A+ R G
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YR-KGGCAMLP 249
Query: 746 ---MAPEYAMRGYLTDKADVYSFGIVALEIVS-------GRSN 778
M PE M G T K D +SFG++ EI S +SN
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 63/244 (25%), Positives = 92/244 (37%), Gaps = 18/244 (7%)
Query: 540 WWKGCFKRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGL-LAD 598
R+ + E G R +F +++G G +G V+K D
Sbjct: 22 SMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKED 81
Query: 599 GKVIAVKQLSSKSKQGNRE---FVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYME 654
G++ AVK+ S +G ++ + E+G + QHP V+L EG L L E
Sbjct: 82 GRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG 140
Query: 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD 714
SL + E L LA+LH + +VH D+K N+ L
Sbjct: 141 P-SLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPR 193
Query: 715 LNPKISDFGLAK-LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 773
K+ DFGL L + G YMAPE Y ADV+S G+ LE+
Sbjct: 194 GRCKLGDFGLLVELGTAGAGE--VQE-GDPRYMAPELLQGSY-GTAADVFSLGLTILEVA 249
Query: 774 SGRS 777
Sbjct: 250 CNME 253
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 39/227 (17%)
Query: 580 DNKIGEGGFGPVYKGLLADGK------VIAVKQLSSKSKQGNR-EFVNEIGMISALQHPN 632
+GEG FG V K K +AVK L + + ++E ++ + HP+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSL--------------------ARALFGPEEHRLKL 672
++KLYG C + LLLI EY + SL + L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 673 DWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732
S +++G+ YL K+VHRD+ A N+L+ + KISDFGL++ E++
Sbjct: 148 TMGDLISFAWQISQGMQYL--AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 733 THISTRIAGTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
++ + + G +MA E T ++DV+SFG++ EIV+
Sbjct: 205 SY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 55/230 (23%), Positives = 99/230 (43%), Gaps = 35/230 (15%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPN 632
++F +G+G FG V K D + A+K++ +++ ++E+ ++++L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 633 LVKLYGCCIEGNQLLL----------IY---EYMENNSLARALFGPEEHRLKLDWPTRHS 679
+V+ Y +E + ++ EY EN +L + L
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWR 120
Query: 680 ICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS--- 736
+ + L+Y+H + I+HRD+K N+ +D+ N KI DFGLAK +
Sbjct: 121 LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 737 ----------TRIAGTFGYMAPE-YAMRGYLTDKADVYSFGIVALEIVSG 775
T GT Y+A E G+ +K D+YS GI+ E++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 41/227 (18%)
Query: 581 NKIGEGGFGPVYKGLLADGK------VIAVKQLSSK-SKQGNREFVNEIGMISALQHPNL 633
IGEG FG V++ ++AVK L + S +F E +++ +PN+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSL--------------------ARALFGPEEHRLKLD 673
VKL G C G + L++EYM L + L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 674 WPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDN 732
+ I +A G+AYL S K VHRD+ N L+ +++ KI+DFGL+ + D
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 733 THISTRIAGTFGY-----MAPEYAMRGYLTDKADVYSFGIVALEIVS 774
M PE T ++DV+++G+V EI S
Sbjct: 230 YKADGN-----DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 69/200 (34%), Positives = 102/200 (51%), Gaps = 19/200 (9%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLYGC 639
KIG+G FG V+KG+ KV+A+K + + + E EI ++S P + K YG
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
++ +L +I EY+ S L LD +I + +GL YLH E K
Sbjct: 89 YLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE---KK 140
Query: 700 VHRDIKATNVLLDKDLNPKISDFGL-AKLDEED---NTHISTRIAGTFGYMAPEYAMRGY 755
+HRDIKA NVLL + K++DFG+ +L + NT + GT +MAPE +
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEVIKQSA 195
Query: 756 LTDKADVYSFGIVALEIVSG 775
KAD++S GI A+E+ G
Sbjct: 196 YDSKADIWSLGITAIELARG 215
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-38
Identities = 62/222 (27%), Positives = 91/222 (40%), Gaps = 31/222 (13%)
Query: 580 DNKIGEGGFGPVYKGLLAD------GKVIAVKQL-SSKSKQGNREFVNEIGMISAL-QHP 631
+G G FG V + +AVK L S+ ++E+ ++S L QH
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 632 NLVKLYGCCIEGNQLLLIYEYMENNSL----------ARALFGPEEHRLKLDWPTRHSIC 681
N+V L G C G +L+I EY L
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 682 IGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAG 741
+A+G+A+L S+ +HRD+ A NVLL KI DFGLA+ D+ + I
Sbjct: 171 SQVAQGMAFL--ASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY----IVK 223
Query: 742 TFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRS 777
+MAPE T ++DV+S+GI+ EI S G +
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 265
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-38
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 580 DNKIGEGGFGPVYKGLLADGK--------VIAVKQLSSKSKQGNR-EFVNEIGMISAL-Q 629
+GEG FG V +AVK L + + + + V+E+ M+ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 630 HPNLVKLYGCCIEGNQLLLIYEYMENNSL------------ARALFGPEEHRLKLDWPTR 677
H N++ L G C + L +I EY +L + ++ +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 737
S LARG+ YL S+ K +HRD+ A NVL+ ++ KI+DFGLA+ + +
Sbjct: 160 VSCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 213
Query: 738 RIAGTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
T G +MAPE T ++DV+SFG++ EI +
Sbjct: 214 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-38
Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 34/222 (15%)
Query: 580 DNKIGEGGFGPVYKGLLADGK------VIAVKQLSSKSKQGNR-EFVNEIGMISAL-QHP 631
+G G FG V + +AVK L + R ++E+ ++S L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 632 NLVKLYGCCIEGNQLLLIYEYMENNSL--------------ARALFGPEEHRLKLDWPTR 677
N+V L G C G L+I EY L + E+ L LD
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 737
S +A+G+A+L + +HRD+ A N+LL KI DFGLA+ + D+ +
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY--- 201
Query: 738 RIAGTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+ +MAPE T ++DV+S+GI E+ S
Sbjct: 202 -VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 577 FAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREF---VNEIGMISALQHPN 632
F+ +IG G FG VY + + +V+A+K++S KQ N ++ + E+ + L+HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
++ GC + + L+ EY S + L E H+ L ++ G +GLAYLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLG-SASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM 752
++HRD+KA N+LL + K+ DFG A + N+ + GT +MAPE +
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVIL 223
Query: 753 R----GYLTDKADVYSFGIVALEIVSG 775
Y K DV+S GI +E+
Sbjct: 224 AMDEGQY-DGKVDVWSLGITCIELAER 249
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLYGC 639
IG G V + +A+K+++ + Q + + + EI +S HPN+V Y
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 640 CIEGNQLLLIYEYMENNSLA----RALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
+ ++L L+ + + S+ + E LD T +I + GL YLH+
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN- 140
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGL-AKL-DEEDNTHISTR--IAGTFGYMAPEYA 751
+HRD+KA N+LL +D + +I+DFG+ A L D T R GT +MAPE
Sbjct: 141 --GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 752 MR--GYLTDKADVYSFGIVALEIVSGR 776
+ GY KAD++SFGI A+E+ +G
Sbjct: 199 EQVRGY-DFKADIWSFGITAIELATGA 224
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 33/221 (14%)
Query: 580 DNKIGEGGFGPVYKGLLAD------GKVIAVKQLSSKSKQGNR-EFVNEIGMISAL-QHP 631
+G G FG V + + +AVK L + ++E+ ++ + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 632 NLVKLYGCC-IEGNQLLLIYEYMENNSL------------ARALFGPEEHRLKLDWPTRH 678
N+V L G C G L++I E+ + +L + + ++ L
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 679 SICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 738
+A+G+ +L + K +HRD+ A N+LL + KI DFGLA+ +D +
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---- 204
Query: 739 IAGTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+ +MAPE T ++DV+SFG++ EI S
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 30/219 (13%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNL 633
+F IG GGFG V+K DGK +K++ K N + E+ ++ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66
Query: 634 VKLYGCCIE----------------GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTR 677
V GC L + E+ + +L + + + KLD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLA 124
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 737
+ + +G+ Y+H + K+++RD+K +N+ L KI DFGL + D T
Sbjct: 125 LELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179
Query: 738 RIAGTFGYMAPE-YAMRGYLTDKADVYSFGIVALEIVSG 775
R GT YM+PE + + Y + D+Y+ G++ E++
Sbjct: 180 RSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHV 217
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 2e-37
Identities = 53/201 (26%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 581 NKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQG-NREFVNEIGMISALQHPNLVKLYG 638
+++G G G V+K G V+A K + + K + + E+ ++ P +V YG
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 639 CCIEGNQLLLIYEYMENNSLARAL--FGP-EEHRLKLDWPTRHSICIGLARGLAYLHEES 695
++ + E+M+ SL + L G E L + I + +GL YL E+
Sbjct: 99 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-------KVSIAVIKGLTYLREK- 150
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGY 755
KI+HRD+K +N+L++ K+ DFG++ + ++ ++ + GT YM+PE +
Sbjct: 151 -HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFV-GTRSYMSPERLQGTH 206
Query: 756 LTDKADVYSFGIVALEIVSGR 776
+ ++D++S G+ +E+ GR
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGR 227
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-37
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 580 DNKIGEGGFGPVYKGLLADGK--------VIAVKQLSSKSKQGNR-EFVNEIGMISAL-Q 629
+GEG FG V +AVK L + + + + V+E+ M+ + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 630 HPNLVKLYGCCIEGNQLLLIYEYMENNSL------------ARALFGPEEHRLKLDWPTR 677
H N++ L G C + L +I EY +L + ++ +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 737
S LARG+ YL S+ K +HRD+ A NVL+ ++ KI+DFGLA+ + +
Sbjct: 206 VSCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 259
Query: 738 RIAGTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
T G +MAPE T ++DV+SFG++ EI +
Sbjct: 260 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 50/204 (24%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQL-SSKSKQGNREFVNEIGMI-SALQHPNLVKLY 637
++G G +G V K + G+++AVK++ ++ + Q + + ++ + + P V Y
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
G + + E M + SL + + + I + + + L +LH + L
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--L 129
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE-----YAM 752
++HRD+K +NVL++ K+ DFG++ + AG YMAPE
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 753 RGYLTDKADVYSFGIVALEIVSGR 776
+GY + K+D++S GI +E+ R
Sbjct: 188 KGY-SVKSDIWSLGITMIELAILR 210
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 57/244 (23%), Positives = 99/244 (40%), Gaps = 25/244 (10%)
Query: 549 HTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQ-- 606
H G+DL T + + + ++ +IG GG V++ L ++ A+K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 61
Query: 607 LSSKSKQGNREFVNEIGMISALQHPNL--VKLYGCCIEGNQLLLIYEYMENNSLARALFG 664
L Q + NEI ++ LQ + ++LY I + ++ E N L L
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-- 118
Query: 665 PEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724
+ + +D R S + + +H+ IVH D+K N L+ K+ DFG+
Sbjct: 119 --KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGI 172
Query: 725 AKLDEEDNTHISTR-IAGTFGYMAPE-----------YAMRGYLTDKADVYSFGIVALEI 772
A + D T + GT YM PE + ++ K+DV+S G + +
Sbjct: 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232
Query: 773 VSGR 776
G+
Sbjct: 233 TYGK 236
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 15/211 (7%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSK-QGNREFVNEIGMI-SALQHP 631
+ +IG G +G V K + G+++AVK++ S + ++ + ++ ++ + P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 632 NLVKLYGCCIEGNQLLLIYEYMENNSLARAL-FGPEEHRLKLDWPTRHSICIGLARGLAY 690
+V+ YG + E M + S + + + I + + L +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE- 749
L E LKI+HRDIK +N+LLD+ N K+ DFG++ + ++ TR AG YMAPE
Sbjct: 141 LKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTRDAGCRPYMAPER 196
Query: 750 ----YAMRGYLTDKADVYSFGIVALEIVSGR 776
+ +GY ++DV+S GI E+ +GR
Sbjct: 197 IDPSASRQGY-DVRSDVWSLGITLYELATGR 226
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 62/227 (27%), Positives = 90/227 (39%), Gaps = 39/227 (17%)
Query: 580 DNKIGEGGFGPVYKGLLADGK------VIAVKQLSSKSKQGNR-EFVNEIGMISAL-QHP 631
+G G FG V +AVK L K+ R ++E+ M++ L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 632 NLVKLYGCCIEGNQLLLIYEYMENNSL-------------------ARALFGPEEHRLKL 672
N+V L G C + LI+EY L + EE L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 673 DWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732
+ +A+G+ +L VHRD+ A NVL+ KI DFGLA+ D+
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 733 THISTRIAGTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
+ + +MAPE G T K+DV+S+GI+ EI S
Sbjct: 227 NY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 19/212 (8%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
K+GEGGF V L DG A+K++ +Q E E M HPN+++L C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 641 IE----GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
+ ++ L+ + + +L + ++ L + +G+ RGL +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-- 153
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIA--------GTFGYMAP 748
HRD+K TN+LL + P + D G + T Y AP
Sbjct: 154 -GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 749 E---YAMRGYLTDKADVYSFGIVALEIVSGRS 777
E + ++ DV+S G V ++ G
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 10/210 (4%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQ--LSSKSKQGNREFVNEIGMISALQHP 631
++ IG G +G K +DGK++ K+ S ++ + V+E+ ++ L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 632 NLVKLYGCCIE--GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLA 689
N+V+ Y I+ L ++ EY E LA + + R LD + L L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 690 YLHE--ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMA 747
H + ++HRD+K NV LD N K+ DFGLA++ D + T + GT YM+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 748 PE-YAMRGYLTDKADVYSFGIVALEIVSGR 776
PE Y +K+D++S G + E+ +
Sbjct: 185 PEQMNRMSY-NEKSDIWSLGCLLYELCALM 213
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 25/212 (11%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQ--LSSKSKQGNREFVNEIGMISALQHPNL--VKL 636
+IG GG V++ L ++ A+K L Q + NEI ++ LQ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
Y I + ++ E N L L + + +D R S + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR-IAGTFGYMAPE------ 749
IVH D+K N L+ K+ DFG+A + D T + GT YM PE
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 750 -----YAMRGYLTDKADVYSFGIVALEIVSGR 776
+ ++ K+DV+S G + + G+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-36
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 580 DNKIGEGGFGPVYKGLLADGK--------VIAVKQLSSKSKQGNR-EFVNEIGMISAL-Q 629
+GEG FG V +AVK L S + + + + ++E+ M+ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 630 HPNLVKLYGCCIEGNQLLLIYEYMENNSL------------ARALFGPEEHRLKLDWPTR 677
H N++ L G C + L +I EY +L + +L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 737
S +ARG+ YL S+ K +HRD+ A NVL+ +D KI+DFGLA+ + +
Sbjct: 194 VSCAYQVARGMEYL--ASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY--- 247
Query: 738 RIAGTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
T G +MAPE T ++DV+SFG++ EI +
Sbjct: 248 -KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-36
Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 25/212 (11%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVKQ--LSSKSKQGNREFVNEIGMISALQHPNL--VKL 636
+IG GG V++ L ++ A+K L Q + NEI ++ LQ + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
Y I + ++ E N L L + + +D R S + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR-IAGTFGYMAPE------ 749
IVH D+K N L+ K+ DFG+A + D T + G YM PE
Sbjct: 175 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 750 -----YAMRGYLTDKADVYSFGIVALEIVSGR 776
+ ++ K+DV+S G + + G+
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 8e-36
Identities = 44/216 (20%), Positives = 80/216 (37%), Gaps = 32/216 (14%)
Query: 581 NKIGEG--GFGPVYKGL-LADGKVIAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVK 635
IG+G V G+ + V++ L + S + E+ + HPN+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHS------ICIGLARGLA 689
I N+L ++ +M S + + + I G+ + L
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAK--------DLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG-LAKLDEEDN-----THISTRIAGTF 743
Y+H VHR +KA+++L+ D +S +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 744 GYMAPE---YAMRGYLTDKADVYSFGIVALEIVSGR 776
+++PE ++GY K+D+YS GI A E+ +G
Sbjct: 200 PWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGH 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 69/216 (31%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 577 FAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLV 634
F +G G +G VYKG + G++ A+K + E EI M+ H N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 635 KLYGC------CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGL 688
YG +QL L+ E+ S+ + + + LK +W IC + RGL
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGL 142
Query: 689 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDEED---NTHISTRIAGTFG 744
++LH+ K++HRDIK NVLL ++ K+ DFG+ A+LD NT I GT
Sbjct: 143 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPY 194
Query: 745 YMAPEYAMRGYLTD-----KADVYSFGIVALEIVSG 775
+MAPE D K+D++S GI A+E+ G
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-35
Identities = 42/283 (14%), Positives = 84/283 (29%), Gaps = 32/283 (11%)
Query: 13 LPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQAN--GAIPKA--VASIS 67
P L ++L N + + + NL N IP S+S
Sbjct: 345 KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAH--NKLKYIPNIFDAKSVS 402
Query: 68 TLADLTLEFNQFSG-------DLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHF 120
++ + +N+ L IN+ ++L++N + E F+ + L
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSI 462
Query: 121 RISDNHFTG-------QIPDYIQNWTKLEKLFIEGSGLAGPIPSGIA--SLVELTDLRIS 171
+ N T + +N L + + + L + +L L + +S
Sbjct: 463 NLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLS 521
Query: 172 D--LNG-PEGPF--PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGV 226
+ P P L N + + E PE + L L + N + V
Sbjct: 522 YNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKV 581
Query: 227 IPSNFSGSGLTYMYLTGNLLTGPVPDWIV-RKRNKHIDLSYNN 268
++ + + N ++ L Y+
Sbjct: 582 NEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-34
Identities = 34/279 (12%), Positives = 86/279 (30%), Gaps = 37/279 (13%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAV 63
L+ GR+P + +L L+ + L + PK +
Sbjct: 88 LEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF------------------GPKGI 129
Query: 64 ASISTLADLTLEFNQFSGDLPAELGNLI--NLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
++ + + +L K +NS+ + +S +
Sbjct: 130 SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIG 189
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181
N+ T + + TKL + ++ S + +
Sbjct: 190 QLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK---- 244
Query: 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSG------ 235
NLK++ + + + + ++P +L + +++++++ N+
Sbjct: 245 -WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPV 303
Query: 236 ---LTYMYLTGN-LLTGPVPDWIVRKRN-KHIDLSYNNF 269
+ +Y+ N L T PV + + + ++ YN
Sbjct: 304 GEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQL 342
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-33
Identities = 41/282 (14%), Positives = 88/282 (31%), Gaps = 23/282 (8%)
Query: 4 LKSQNLPGRLPPELTRLPF--LQEIDLTRNYLNGTIPSEWA-SLPLVNLPLWKQANGAIP 60
+ R F L + + + +I +L + +
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVS 199
Query: 61 KAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHF 120
KAV ++ L + + F + E N E + NL L
Sbjct: 200 KAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDNLKDLTDV 254
Query: 121 RISDNHFTGQIPDYIQNWTKLEKLF--------IEGSGLAGPIPSGIASLVELTDLRISD 172
+ + ++P +++ +++ + E + ++ + I
Sbjct: 255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGY 314
Query: 173 LNGPEGPFPR-LSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNF 231
N P L +K + L + G++P G I L L+L++N+++ + +
Sbjct: 315 NNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFC 373
Query: 232 SGSG-LTYMYLTGNLLTGPVPDWIVRKRNKH---IDLSYNNF 269
+ + + N L +P+ K ID SYN
Sbjct: 374 GFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEI 414
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-26
Identities = 28/270 (10%), Positives = 66/270 (24%), Gaps = 31/270 (11%)
Query: 51 LWKQANGAIPKAVASISTLA---DLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKL 107
+W NG + + E + + L + + L L +G++
Sbjct: 38 IWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRV 97
Query: 108 PESFANLTRLKHFRISDNHFTGQ----IPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLV 163
P++ LT L+ + + P I E+
Sbjct: 98 PDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPRED 157
Query: 164 --ELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFN 221
+L I+ + + N I + + + ++ LR + +
Sbjct: 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQ-LSNNITFVSKAVMRLTKLRQFYMGNS 216
Query: 222 KLSGVIPSNFSG--------------------SGLTYMYLTGNLLTGPVPDWIVRKRN-K 260
LT + + +P ++ +
Sbjct: 217 PFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQ 276
Query: 261 HIDLSYNNFIDGSSDSNCENQSVNLFASSS 290
I+++ N I G + +
Sbjct: 277 LINVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-24
Identities = 44/269 (16%), Positives = 82/269 (30%), Gaps = 73/269 (27%)
Query: 11 GRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLA 70
+ L ++ L ++ N L G +P+ + LA
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEGKLPA------FGSE-----------------IKLA 356
Query: 71 DLTLEFNQFSGDLPAEL-GNLINLEKLHLNSNNFTGKLPESFA--NLTRLKHFRISDNHF 127
L L +NQ + +PA G +E L N +P F +++ + S N
Sbjct: 357 SLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEI 414
Query: 128 TG-------QIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPF 180
+ + + + + ++ ++ L+ + +
Sbjct: 415 GSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG-------- 466
Query: 181 PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMY 240
N L N + + E L +DL FNKL+ + +F + L Y+
Sbjct: 467 ---------NMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYL- 515
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNF 269
IDLSYN+F
Sbjct: 516 -------------------VGIDLSYNSF 525
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 52/229 (22%), Positives = 96/229 (41%), Gaps = 41/229 (17%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE-FVNEIGMISALQHPN 632
+F P +G GGFG V++ D A+K++ +++ RE + E+ ++ L+HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 633 LVKLYGCCIEGNQ------------LLLIYEYMENNSLA-----RALFGPEEHRLKLDWP 675
+V+ + +E N L + + +L R E + L
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI- 123
Query: 676 TRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735
+ +A + +LH + ++HRD+K +N+ D K+ DFGL ++D
Sbjct: 124 -----FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 736 STRIA-----------GTFGYMAPE-YAMRGYLTDKADVYSFGIVALEI 772
+ GT YM+PE Y + K D++S G++ E+
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFEL 223
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQL-SSKSKQGNREFVNEIG-MISALQHPNLVKLYG 638
++G G G V+K G VIAVKQ+ S +K+ N+ + ++ ++ + P +V+ +G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 639 CCIEGNQLLLIYEYMENNSLA--RALFGP-EEHRLKLDWPTRHSICIGLARGLAYLHEES 695
I + + E M + + + GP E L + + + + L YL E+
Sbjct: 92 TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-------KMTVAIVKALYYLKEK- 143
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE------ 749
++HRD+K +N+LLD+ K+ DFG++ + R AG YMAPE
Sbjct: 144 -HGVIHRDVKPSNILLDERGQIKLCDFGISG--RLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 750 YAMRGYLTDKADVYSFGIVALEIVSGR 776
Y +ADV+S GI +E+ +G+
Sbjct: 201 PTKPDY-DIRADVWSLGISLVELATGQ 226
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-35
Identities = 59/295 (20%), Positives = 108/295 (36%), Gaps = 25/295 (8%)
Query: 8 NLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWK------QANGAIPK 61
++PG T L L+ + L+ ++ + + + L + PL + +
Sbjct: 340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399
Query: 62 AVASISTLADLTLEFNQFSGDLPA-ELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHF 120
A + + L L L N+ +L E L N+ +++L+ N + SFA + L+
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459
Query: 121 RISDNHFTG--QIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD------ 172
+ P Q L L + + +A + L +L L +
Sbjct: 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL 519
Query: 173 --LNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSN 230
P GP L L +++ L L S E + L+++DL N L+ + S
Sbjct: 520 WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
Query: 231 FSG-SGLTYMYLTGNLLTGPVPDWIVRKRN--KHIDLSYNNFIDGSSDSNCENQS 282
F+ L + L NL+T +D+ +N F D CE+ +
Sbjct: 580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF-----DCTCESIA 629
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-32
Identities = 56/279 (20%), Positives = 89/279 (31%), Gaps = 33/279 (11%)
Query: 8 NLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASIS 67
L TR L +D+ N ++ P LP
Sbjct: 36 QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLP---------------------- 73
Query: 68 TLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHF 127
L L L+ N+ S NL +LHL SN+ F L +S N
Sbjct: 74 MLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGL 133
Query: 128 TGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASL--VELTDLRISDLNGPEGPFPR-LS 184
+ L++L + + + + L L +S N + P
Sbjct: 134 SSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS-NQIKEFSPGCFH 192
Query: 185 NLKNMNYLILRSGNIIGEMPEYLGQMIG---LRVLDLSFNKLSGVIPSNFSG---SGLTY 238
+ + L L + + + E L + +R L LS ++LS + F G + LT
Sbjct: 193 AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTM 252
Query: 239 MYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNFIDGSSDS 276
+ L+ N L D ++ L YNN S S
Sbjct: 253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS 291
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-30
Identities = 42/227 (18%), Positives = 76/227 (33%), Gaps = 9/227 (3%)
Query: 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126
+ + L L NQ A L L + N + PE L LK + N
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 127 FTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNL 186
+ T L +L + + + + L L +S L
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 187 KNMNYLILRSGNIIGEMPE---YLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLT 242
+N+ L+L S N I + + L+ L+LS N++ P F L ++L
Sbjct: 145 ENLQELLL-SNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203
Query: 243 GNLLTGPVPDWIVRKRN----KHIDLSYNNFIDGSSDSNCENQSVNL 285
L + + + + +++ LS + S+ + + NL
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNL 250
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-30
Identities = 54/285 (18%), Positives = 93/285 (32%), Gaps = 19/285 (6%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP------LVNLPLWKQANG 57
+ +LP L L+ +++ N + G + + L L N +
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371
Query: 58 AIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLP-ESFANLTR 116
+ S L L L N+ S L +LE L L N +L + + L
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 117 LKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAG--PIPSGIASLVELTDLRISD-- 172
+ +S N + + L++L + L PS L LT L +S+
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491
Query: 173 LNG-PEGPFPRLSNLKNM----NYL-ILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGV 226
+ + L L+ + N L L G +L + L +L+L N +
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551
Query: 227 IPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNF 269
F L + L N L + + K ++L N
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-28
Identities = 47/281 (16%), Positives = 84/281 (29%), Gaps = 39/281 (13%)
Query: 8 NLPGRLPPELT---RLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVA 64
L L +L ++ + L+ + L+ T + + L NL
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNL--------------- 250
Query: 65 SISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR--- 121
L L +N + L LE L NN S L +++
Sbjct: 251 -----TMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
Query: 122 ------ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD--L 173
IS Q LE L +E + + G + L+ L L +S+
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365
Query: 174 NGPEGPFPRLSNLKNMN--YLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSN- 230
+ +L + L L I + + L VLDL N++ +
Sbjct: 366 SLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQE 425
Query: 231 FSG-SGLTYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNF 269
+ G + +YL+ N + + + + L
Sbjct: 426 WRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL 466
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-28
Identities = 61/305 (20%), Positives = 100/305 (32%), Gaps = 29/305 (9%)
Query: 8 NLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPL-WKQANGAIPKAVAS 65
L L E+ L N + + + L+ L L +
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 66 ISTLADLTLEFNQFSGDLPAELGNLIN--LEKLHLNSNNFTGKLPESFANLTRLKHFRIS 123
+ L +L L N+ EL N L+KL L+SN P F + RL ++
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203
Query: 124 DNHFTGQIPDYIQ---NWTKLEKLFIEGSGLAGPIPSGIASL--VELTDLRISD--LNG- 175
+ + + + T + L + S L+ + L LT L +S LN
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263
Query: 176 PEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDL---------SFNKLSGV 226
F L L+ Y L NI L + +R L+L S L +
Sbjct: 264 GNDSFAWLPQLE---YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI 320
Query: 227 IPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNFIDGSSDSNCENQSVN 284
+F L ++ + N + G + N K++ LS + S + V+
Sbjct: 321 DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT---SLRTLTNETFVS 377
Query: 285 LFASS 289
L S
Sbjct: 378 LAHSP 382
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-10
Identities = 24/141 (17%), Positives = 38/141 (26%), Gaps = 25/141 (17%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAV 63
L PG L L L ++L N + + L
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF------------------ 560
Query: 64 ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFA-NLTRLKHFRI 122
L + L N + + N ++L+ L+L N T + F L +
Sbjct: 561 ----ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDM 616
Query: 123 SDNHFTGQIP--DYIQNWTKL 141
N F + NW
Sbjct: 617 RFNPFDCTCESIAWFVNWINE 637
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-34
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 576 NFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIG-MISALQHPNLV 634
+F P + +G G G + + D + +AVK++ + E+ + + +HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVI 81
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
+ + + + E +L + E+ ++ GLA+LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 695 SRLKIVHRDIKATNVLL-----DKDLNPKISDFGLAKLDEEDNTHISTR--IAGTFGYMA 747
L IVHRD+K N+L+ + ISDFGL K S R + GT G++A
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 748 PEY---AMRGYLTDKADVYSFGIVALEIVSG 775
PE + T D++S G V ++S
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFV----NEIGMISALQHPNLVKL 636
K+G GG VY +A+K + + E + E+ S L H N+V +
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
E + L+ EY+E +L+ + E L T + + G+ + H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAH---D 129
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAGTFGYMAPEYAMRGY 755
++IVHRDIK N+L+D + KI DFG+AK L E T + + GT Y +PE A
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEA 188
Query: 756 LTDKADVYSFGIVALEIVSGR 776
+ D+YS GIV E++ G
Sbjct: 189 TDECTDIYSIGIVLYEMLVGE 209
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-32
Identities = 46/290 (15%), Positives = 86/290 (29%), Gaps = 55/290 (18%)
Query: 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPK 61
+I N + + RL LQ I + +
Sbjct: 429 QIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV--------------------- 467
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
D ++ + + NL +L + L + +LP+ +L L+
Sbjct: 468 ------DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLN 521
Query: 122 ISDNHFTG---------QIPDYIQNWTKLEKLFIEGSGLAG-PIPSGIASLVELTDLRIS 171
I+ N ++ D K++ ++ + L P + + +V+L L
Sbjct: 522 IACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCV 581
Query: 172 D--LNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQ-MIGLRVLDLSFNKLSGVIP 228
+ + L L N I E+PE + L S NKL IP
Sbjct: 582 HNKVRHL----EAFGTNVKLTDLKL-DYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IP 635
Query: 229 SNFSGSGLTYM---YLTGNLLTGPVPDWIVRKRN------KHIDLSYNNF 269
+ F+ + M + N + + + + LSYN
Sbjct: 636 NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEI 685
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-28
Identities = 42/282 (14%), Positives = 82/282 (29%), Gaps = 34/282 (12%)
Query: 14 PPELTRLPFLQEIDLTRNYLNGTIPSE-WASLP-LVNLPLWKQANG--AIPKAVA--SIS 67
L ++ L N + IP + A + L N IP S+
Sbjct: 588 LEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSH--NKLKYIPNIFNAKSVY 644
Query: 68 TLADLTLEFNQFSGDLPAELG------NLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+ + +N+ + IN + L+ N E FA + +
Sbjct: 645 VMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703
Query: 122 ISDNHFT-------GQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIA--SLVELTDLRISD 172
+S+N T +N L + + + L + +L L+++ +S
Sbjct: 704 LSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSY 762
Query: 173 --LNG-PEGPF--PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVI 227
+ P P +L + I+ + P + L L + N + V
Sbjct: 763 NCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVD 822
Query: 228 PSNFSGSGLTYMYLTGN-LLTGPVPDWIVRKRNKHIDLSYNN 268
L + + N ++ V L Y+
Sbjct: 823 EKLTPQ--LYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-27
Identities = 36/285 (12%), Positives = 87/285 (30%), Gaps = 26/285 (9%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQ------ANG 57
L GR+P + +L L+ + + + ++ ++
Sbjct: 330 LAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK 389
Query: 58 AIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHL-NSNNFTGKLPESFANLTR 116
++ L N+ P + + I+L+ + N N + ++ LT+
Sbjct: 390 MFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTK 449
Query: 117 LKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGP 176
L+ +++ FT E + + ++L +LTD+ + +
Sbjct: 450 LQIIYFANSPFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPN- 503
Query: 177 EGPFPR-LSNLKNMNYLILRSGNIIG---------EMPEYLGQMIGLRVLDLSFNKLSGV 226
P L +L + L + I + + +++ + +N L
Sbjct: 504 MTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEF 563
Query: 227 IPSNFSG--SGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNF 269
S L + N + + + + + L YN
Sbjct: 564 PASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYNQI 607
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-22
Identities = 36/277 (12%), Positives = 77/277 (27%), Gaps = 32/277 (11%)
Query: 16 ELTRLPFLQEIDLTRNYLNGTIPSEWASLP-----------LVNLPLWKQANGAIPKAVA 64
+L + + L G +P L P
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377
Query: 65 SISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISD 124
+ + + + D L L+ + +S +L
Sbjct: 378 ERKHR--IRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT-QIGNLT 434
Query: 125 NHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLS 184
N T I IQ TKL+ ++ S + + + S
Sbjct: 435 NRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELS-----WS 488
Query: 185 NLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGV---------IPSNFSG-S 234
NLK++ + L + + ++P++L + L+ L+++ N+ + +
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGP 548
Query: 235 GLTYMYLTGNLLTG-PVPDWIVRKRN-KHIDLSYNNF 269
+ Y+ N L P + + +D +N
Sbjct: 549 KIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV 585
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 1e-21
Identities = 29/231 (12%), Positives = 68/231 (29%), Gaps = 12/231 (5%)
Query: 65 SISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISD 124
+ + L+L G +P +G L L+ L +++ T
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
Query: 125 NHFTGQIP----DYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPF 180
+ DY Q + L + P S + L D +I +L
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFI 440
Query: 181 PR-LSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTY 238
+ + L + + + + + + + K ++S LT
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKDLTD 495
Query: 239 MYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNFIDGSSDSNCENQSVNLFAS 288
+ L +PD++ + ++++ N I + + + +
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDT 546
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 37/205 (18%), Positives = 67/205 (32%), Gaps = 34/205 (16%)
Query: 6 SQNLPGRLPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVA 64
S N + P E + I L+ N + +IP +
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLM-TSIPEN--------------SLKPKDGNYK 725
Query: 65 SISTLADLTLEFNQFSGDLPAEL--GNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRI 122
+ L + L FN+ + L + L L + ++ N F+ P N ++LK F I
Sbjct: 726 NTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGI 783
Query: 123 ------SDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD---L 173
N Q P I L +L I + + + + +L L I+D +
Sbjct: 784 RHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNI 840
Query: 174 NGPEGPFPRLSNLKNMNYLILRSGN 198
+ ++ Y++L
Sbjct: 841 SIDVTSVC--PYIEAGMYVLLYDKT 863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 9e-32
Identities = 42/203 (20%), Positives = 80/203 (39%), Gaps = 24/203 (11%)
Query: 582 KIGEGGFGPVYKG--LLADGKVIAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLY- 637
I GG G +Y +G+ + +K L + + E ++ + HP++V+++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 638 -GCCIEGNQLLLIY---EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
+ + + Y EY+ SL R+ L + + + L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYLH- 199
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR 753
+ +V+ D+K N++L ++ K+ D G + GT G+ APE R
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGTPGFQAPEIV-R 250
Query: 754 GYLTDKADVYSFGIVALEIVSGR 776
T D+Y+ G +
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDL 273
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 54/203 (26%), Positives = 85/203 (41%), Gaps = 19/203 (9%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFV----NEIGMISALQHPNLVKL 636
+G GG G VY+ +++A+K +S + + F E LQ P++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 637 YGCCIEGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
+ QL + + LA L GP L P +I + L H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGP------LAPPRAVAIVRQIGSALDAAH-- 151
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAGTFGYMAPEYAMR 753
HRD+K N+L+ D + DFG+A +E T + + GT YMAPE
Sbjct: 152 -AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSE 209
Query: 754 GYLTDKADVYSFGIVALEIVSGR 776
+ T +AD+Y+ V E ++G
Sbjct: 210 SHATYRADIYALTCVLYECLTGS 232
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-31
Identities = 54/286 (18%), Positives = 99/286 (34%), Gaps = 15/286 (5%)
Query: 6 SQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLW--KQANGAIPKA 62
+ LP L L L+++ L+ N ++ P L +L + +
Sbjct: 286 TATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345
Query: 63 VASISTLADLTLEFNQ--FSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHF 120
+ ++ L +L L + S +L NL +L+ L+L+ N E+F +L+
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL 405
Query: 121 RISDNHFTGQIPDYI-QNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD---LNGP 176
++ + QN L+ L + S L L L L + G
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGN 465
Query: 177 EGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGL 236
L L + L+L ++ + + +DLS N+L+ S
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525
Query: 237 TYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNFIDGSSDSNCENQ 281
Y+ L N ++ +P + + I+L N D C N
Sbjct: 526 IYLNLASNHISIILPSLLPILSQQRTINLRQNPL-----DCTCSNI 566
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 46/291 (15%), Positives = 77/291 (26%), Gaps = 46/291 (15%)
Query: 9 LPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASIST 68
+PG LP L + + N L + L
Sbjct: 27 IPGTLPNSTECL------EFSFNVLPTIQNTT-----FSRLIN----------------- 58
Query: 69 LADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFT 128
L L L Q + L+ L L +N + + LKH +
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 129 GQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDL-----RISDLNGPEGPFPRL 183
+ N LE L++ + ++ +L L I L + L
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL--SKEDMSSL 176
Query: 184 SNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSG---LTYMY 240
N+ L L +GN I + + L+ + VI S L
Sbjct: 177 QQATNL-SLNL-NGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGT 234
Query: 241 LTGNLLTGPVPDWIVRKRN---KHIDLSYNNF--IDGSSDSNCEN-QSVNL 285
P + I+L + F I ++ Q ++L
Sbjct: 235 FEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDL 285
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-25
Identities = 46/279 (16%), Positives = 86/279 (30%), Gaps = 19/279 (6%)
Query: 6 SQNLPGRLPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQAN---GAIP 60
++ + + L + LT N L + + L +L
Sbjct: 65 TRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF--IQTGISSIDF 122
Query: 61 KAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKH- 119
+ + TL L L N S + L+ L +N E ++L + +
Sbjct: 123 IPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL 182
Query: 120 -FRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIA--SLVELTDLRISDLNG- 175
++ N G I + + L G+ I G+ ++ L D++
Sbjct: 183 SLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE 241
Query: 176 --PEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG 233
F L + ++ + L+ GL+ LDL+ LS +PS G
Sbjct: 242 DISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVG 299
Query: 234 -SGLTYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNFI 270
S L + L+ N + H+ + N
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKR 338
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-23
Identities = 51/286 (17%), Positives = 91/286 (31%), Gaps = 26/286 (9%)
Query: 4 LKSQNLPGRLPPELTRLPF--LQEIDLTRNYLNGTIPSEWASLPLVNLP-LWKQAN---G 57
+ L L P+ + L +++ + Q +
Sbjct: 209 FGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN 268
Query: 58 AIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRL 117
S L +L L S +LP+ L L L+KL L++N F S +N L
Sbjct: 269 ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327
Query: 118 KHFRISDNHFTGQIPDY-IQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG- 175
H I N ++ ++N L +L + + L L+ L+ +L+
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET-SDCCNLQLRNLSHLQSLNLSYN 386
Query: 176 -----PEGPFPRLSNLKNMNYLILRSGNIIGEMPEY--LGQMIGLRVLDLSFNKLSGVIP 228
F L+ L L + + + L+VL+LS + L
Sbjct: 387 EPLSLKTEAFKECPQLE---LLDL-AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442
Query: 229 SNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRN----KHIDLSYNNF 269
F G L ++ L GN + + + LS+ +
Sbjct: 443 QLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 49/213 (23%), Positives = 86/213 (40%), Gaps = 22/213 (10%)
Query: 580 DNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLY 637
+ +G+G V++G G + A+K ++ S + + E ++ L H N+VKL+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 638 GC--CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
+LI E+ SL L P + L + + G+ +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 696 RLKIVHRDIKATNVLL----DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE-- 749
IVHR+IK N++ D K++DFG A+ ED+ + GT Y+ P+
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLHPDMY 187
Query: 750 ------YAMRGYLTDKADVYSFGIVALEIVSGR 776
+ D++S G+ +G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFV----NEIGMISALQHPNLVKL 636
+G GG V+ L D + +AVK L + + F E +AL HP +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 637 Y--GCCIEGNQLLLIY---EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYL 691
Y G E L Y EY++ +L + + + + L +
Sbjct: 78 YDTGE-AETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFS 132
Query: 692 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI--STRIAGTFGYMAPE 749
H + I+HRD+K N+++ K+ DFG+A+ + + + + GT Y++PE
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 750 YAMRGYLTDKADVYSFGIVALEIVSGR 776
A + ++DVYS G V E+++G
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-30
Identities = 58/232 (25%), Positives = 91/232 (39%), Gaps = 42/232 (18%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIG-MISALQHPNL 633
N + +G G G V G+ +AVK++ + EI + + HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALF-------GPEEHRLKLDWPTRHSICIGLAR 686
++ Y L + E N L +E+ S+ +A
Sbjct: 72 IRYYCSETTDRFLYIALELCNLN-----LQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLD-------------KDLNPKISDFGLAKLDEEDNT 733
G+A+LH LKI+HRD+K N+L+ ++L ISDFGL K + +
Sbjct: 127 GVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 734 HISTR---IAGTFGYMAPE-------YAMRGYLTDKADVYSFGIVALEIVSG 775
T +GT G+ APE + LT D++S G V I+S
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 56/279 (20%), Positives = 92/279 (32%), Gaps = 22/279 (7%)
Query: 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIP----SEWASLPLVNLPLWKQANG 57
R+ + L + L + W L LVN G
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF-----G 317
Query: 58 AIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHL--NSNNFTGKLPESFANLT 115
P ++ + L F G +L +LE L L N +F G +S T
Sbjct: 318 QFP----TLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 116 RLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDLRISDLN 174
LK+ +S N + +LE L + S L + SL L L IS
Sbjct: 374 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH-T 431
Query: 175 GPEGPFPR-LSNLKNMNYLILRSGNIIGEM-PEYLGQMIGLRVLDLSFNKLSGVIPSNFS 232
F + L ++ L + + P+ ++ L LDLS +L + P+ F+
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 233 G-SGLTYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNF 269
S L + ++ N + + +D S N+
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-30
Identities = 44/229 (19%), Positives = 77/229 (33%), Gaps = 10/229 (4%)
Query: 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126
+ +L L FN + L+ L L+ ++ +L+ L ++ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 127 FTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPR-LSN 185
+ L+KL + LA I L L +L ++ P SN
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 186 LKNMNYLILRSGNIIGEMPEYLGQMIGLRV----LDLSFNKLSGVIPSNFSGSGLTYMYL 241
L N+ +L L S I L + + + LDLS N ++ + P F L + L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTL 207
Query: 242 TGNLLTGPVPDWIVRK--RNKHIDLSYNNFIDGSSDSNCENQSVNLFAS 288
N + V ++ + L F ++ N E +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEF---RNEGNLEKFDKSALEG 253
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 56/275 (20%), Positives = 84/275 (30%), Gaps = 38/275 (13%)
Query: 8 NLPGRLPPELTRLPFLQEIDLTRNYLN--GTIPSEWASLPLVNLPLWKQANGAIPKAVAS 65
+ G LP L+ +DL+RN L+ G
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT-------------------- 373
Query: 66 ISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPES-FANLTRLKHFRISD 124
+L L L FN + + L LE L +N S F +L L + IS
Sbjct: 374 --SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 125 NHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDLRISDLNGPEGPFPR- 182
H + LE L + G+ I L LT L +S E P
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ-CQLEQLSPTA 489
Query: 183 LSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG--SGLTYMY 240
++L ++ L + N + L+VLD S N + S L ++
Sbjct: 490 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 549
Query: 241 LTGNLLTG-----PVPDWIVRKRNKHIDLSYNNFI 270
LT N WI K + + +
Sbjct: 550 LTQNDFACTCEHQSFLQWI--KDQRQLLVEVERME 582
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-27
Identities = 42/246 (17%), Positives = 73/246 (29%), Gaps = 34/246 (13%)
Query: 9 LPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASIST 68
+P LP L DL+ N L + S P
Sbjct: 22 IPDNLPFSTKNL------DLSFNPLRHLGSYSFFSFPE---------------------- 53
Query: 69 LADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFT 128
L L L + +L +L L L N +F+ L+ L+ + +
Sbjct: 54 LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA 113
Query: 129 GQIPDYIQNWTKLEKLFIEGSGLAG-PIPSGIASLVELTDLRISD--LNG-PEGPFPRLS 184
I + L++L + + + +P ++L L L +S + L
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173
Query: 185 NLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG--SGLTYMYLT 242
+ +N + S N + + + I L L L N S + +GL L
Sbjct: 174 QMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 243 GNLLTG 248
Sbjct: 234 LGEFRN 239
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-27
Identities = 48/294 (16%), Positives = 92/294 (31%), Gaps = 30/294 (10%)
Query: 14 PPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQAN---GAIPKAVASISTL 69
L L + LT N + ++ L L L + + TL
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA--VETNLASLENFPIGHLKTL 126
Query: 70 ADLTLEFNQF-SGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRI----SD 124
+L + N S LP NL NLE L L+SN L ++ + S
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 125 NHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDL---------NG 175
N P + +L KL + + + + + L L + L N
Sbjct: 187 NPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKT--CIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 176 PEGPFPRLSNLKNMNYLILRS---GNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFS 232
+ L L N+ R + ++ + + + L + V +++
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303
Query: 233 GSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCEN-QSVNL 285
G ++ L + K K + + N + S+ + + + ++L
Sbjct: 304 -FGWQHLELVNCKFGQFPTLKL--KSLKRLTFTSNKGGNAFSEVDLPSLEFLDL 354
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-22
Identities = 42/225 (18%), Positives = 75/225 (33%), Gaps = 18/225 (8%)
Query: 6 SQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIP-SEWASLP-LVNLPL-WKQANGAIPKA 62
S N + L L+ +D + L S + SL L+ L + A
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 63 VASISTLADLTLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+S+L L + N F + + L NL L L+ P +F +L+ L+
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG------ 175
+S N+F + L+ L + + + + L +L
Sbjct: 501 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF--PSSLAFLNLTQNDFACT 558
Query: 176 -PEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLS 219
F L +K+ L++ + P G+ VL L+
Sbjct: 559 CEHQSF--LQWIKDQRQLLVEVERMECATPSDKQ---GMPVLSLN 598
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-30
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 580 DNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVKLY 637
++G GGFG V + + G+ +A+KQ + NRE EI ++ L HPN+V
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 638 GCCIE-------GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
+ + LL EY E L + L E + L ++ ++ L Y
Sbjct: 79 -EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRY 136
Query: 691 LHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMA 747
LHE +I+HRD+K N++L + L KI D G AK + + + + GT Y+A
Sbjct: 137 LHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGELCTEFV-GTLQYLA 191
Query: 748 PE-YAMRGYLTDKADVYSFGIVALEIVSGR 776
PE + Y T D +SFG +A E ++G
Sbjct: 192 PELLEQKKY-TVTVDYWSFGTLAFECITGF 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 583 IGEGGFGPVYKG-LLADGKVIAVKQLSSKS--KQGNRE-FVNEIGMISALQHPNLVKLYG 638
+G+GGF ++ +V A K + K RE EI + +L H ++V +G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+ + + ++ E SL + R L P + G YLH R +
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLH---RNR 135
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
++HRD+K N+ L++DL KI DFGLA E D + GT Y+APE + +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 194
Query: 759 KADVYSFGIVALEIVSGR 776
+ DV+S G + ++ G+
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 583 IGEGGFGPVYKG-LLADGKVIAVKQLSSKS--KQGNRE-FVNEIGMISALQHPNLVKLYG 638
+G+GGF ++ +V A K + K RE EI + +L H ++V +G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+ + + ++ E SL + R L P + G YLH R +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLH---RNR 161
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
++HRD+K N+ L++DL KI DFGLA E D + GT Y+APE + +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 220
Query: 759 KADVYSFGIVALEIVSGR 776
+ DV+S G + ++ G+
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-29
Identities = 49/213 (23%), Positives = 86/213 (40%), Gaps = 22/213 (10%)
Query: 580 DNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLY 637
+ +G+G V++G G + A+K ++ S + + E ++ L H N+VKL+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 638 GC--CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
+LI E+ SL L P + L + + G+ +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 696 RLKIVHRDIKATNVLL----DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE-- 749
IVHR+IK N++ D K++DFG A+ ED+ + GT Y+ P+
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLHPDMY 187
Query: 750 ------YAMRGYLTDKADVYSFGIVALEIVSGR 776
+ D++S G+ +G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 25/228 (10%), Positives = 49/228 (21%), Gaps = 41/228 (17%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE---FVNEIGMISALQHPNLVKLYG 638
+ G V+ + + A+K + ++ E + L + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 639 CC--------------------------IEGNQLLLIYEYMENN--SLARALFGPEEHRL 670
LL+ + L L R
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 671 KLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730
H + L R A L +VH N+ + D + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 731 DNTHISTRIAGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGR 776
+ Y E+ T + + G+ +
Sbjct: 247 ----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 31/230 (13%), Positives = 69/230 (30%), Gaps = 26/230 (11%)
Query: 568 RQIKAATNNFAPDNKIGEGGFGPVYKG------LLADGKVIAVKQLSSKSKQGNREFVNE 621
+ + + + +GEG F VY+ + + +K +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 622 IGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL-ARALFGPEEHRLKLDWPTRHSI 680
+ + +K Y + N +L+ E +L + S
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 681 CIGLARGLAYLHEESRLKIVHRDIKATNVLL-----------DKDLNPKISDFGLAK--L 727
+ + + +H+ +I+H DIK N +L D + D G +
Sbjct: 178 AMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 728 DEEDNTHISTRIAGTFGYMAPE-YAMRGYLTDKADVYSFGIVALEIVSGR 776
T + + T G+ E + + + + D + ++ G
Sbjct: 235 LFPKGTIFTAKC-ETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGT 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKS--KQGNRE-FVNEIGMISALQHPNLVKLYG 638
+G+G F VY+ + G +A+K + K+ K G + NE+ + L+HP++++LY
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+ N + L+ E N + R L + + G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLH---SHG 132
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
I+HRD+ +N+LL +++N KI+DFGLA + + T + GT Y++PE A R
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGL 191
Query: 759 KADVYSFGIVALEIVSGR 776
++DV+S G + ++ GR
Sbjct: 192 ESDVWSLGCMFYTLLIGR 209
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-29
Identities = 60/233 (25%), Positives = 95/233 (40%), Gaps = 28/233 (12%)
Query: 556 KGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQG 614
L G F + + + K+G G +G V A+K + K+
Sbjct: 18 GDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR-KTSVS 76
Query: 615 NRE---FVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL-----ARALFGPE 666
+ E+ ++ L HPN++KLY + L+ E + L R F
Sbjct: 77 TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV 136
Query: 667 EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFG 723
+ I + G+ YLH+ IVHRD+K N+LL +KD KI DFG
Sbjct: 137 DAA---------VIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
L+ + E GT Y+APE + Y +K DV+S G++ +++G
Sbjct: 185 LSAVFENQKKM--KERLGTAYYIAPEVLRKKY-DEKCDVWSIGVILFILLAGY 234
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 50/227 (22%), Positives = 92/227 (40%), Gaps = 33/227 (14%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLA--DGKVIAVKQLSSKSKQGNREFV------------- 619
N++ + +G F + L D K A+K+ + R+F
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 620 ----NEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMEN----NSLARALFGPEEHRLK 671
NE+ +I+ +++ + G +++ +IYEYMEN + +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 672 LDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731
+ I + +Y+H + I HRD+K +N+L+DK+ K+SDFG ++ +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 732 NTHISTRIAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGR 776
S GT+ +M PE+ Y K D++S GI +
Sbjct: 206 KIKGS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 31/238 (13%), Positives = 68/238 (28%), Gaps = 52/238 (21%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE------------------------ 617
+G+ + G+ V + +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 618 ----FVNEIGMISALQHPNLVKLYGCC--IEGNQLLLIYEYMENN--SLARALFGPEEHR 669
F+ ++ Q ++++ + +Y M++N + L
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 670 LKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729
L R + + + R LA LH +VH ++ +++LD+ ++ F D
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 730 EDNTHISTRIAGTFGYMAPEY-----------AMRGYLTDKADVYSFGIVALEIVSGR 776
+ + G+ PE R +T D ++ G+V I
Sbjct: 258 ARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 581 NKIGEGGFGPVYKG-LLADGKVIAVKQLS----SKSKQGNREFVNEIGMISALQHPNLVK 635
+G+G FG VY ++A+K L K+ ++ E+ + S L+HPN+++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
LYG + ++ LI EY ++ R L + + + T I LA L+Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFD-EQRTATYIT-ELANALSYCH--- 126
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM-RG 754
+++HRDIK N+LL KI+DFG + + GT Y+ PE R
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPEMIEGRM 183
Query: 755 YLTDKADVYSFGIVALEIVSGR 776
+ +K D++S G++ E + G+
Sbjct: 184 H-DEKVDLWSLGVLCYEFLVGK 204
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 27/233 (11%), Positives = 56/233 (24%), Gaps = 41/233 (17%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREF----------------------- 618
+G+ + G+ V + +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 619 --VNEIGMISALQHPNLVKLYGCCIEGNQ-------LLLIYEYMENNSLARALFGPEEHR 669
+ I ++ P K+ ++ L + L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 670 LKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729
L R + + + R LA LH +VH ++ +++LD+ ++ F D
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 730 EDNTHISTRIAGTFGYMAPE-----YAMRGYLTDKADVYSFGIVALEIVSGRS 777
R A +T D ++ G+ I
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 49/250 (19%), Positives = 85/250 (34%), Gaps = 44/250 (17%)
Query: 12 RLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLAD 71
+ P + RL LQ + + L +P + + L
Sbjct: 95 QFPDQAFRLSHLQHMTIDAAGLM-----------------------ELPDTMQQFAGLET 131
Query: 72 LTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFAN---------LTRLKHFRI 122
LTL N LPA + +L L +L + + +LPE A+ L L+ R+
Sbjct: 132 LTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190
Query: 123 SDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG----PEG 178
+P I N L+ L I S L+ + I L +L +L + P
Sbjct: 191 EWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPI 248
Query: 179 PFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLT 237
+ LIL+ + + +P + ++ L LDL +PS +
Sbjct: 249 ----FGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC 304
Query: 238 YMYLTGNLLT 247
+ + +L
Sbjct: 305 IILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 42/276 (15%), Positives = 80/276 (28%), Gaps = 37/276 (13%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLP----LWKQANGAI 59
+ L++ D R N P +A A
Sbjct: 19 FQGSTALRPYHDVLSQWQRHYNADRNR-------WHSAWRQANSNNPQIETRTGRALKAT 71
Query: 60 PKAV--ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRL 117
+ A+ L L P + L +L+ + +++ +LP++ L
Sbjct: 72 ADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGL 129
Query: 118 KHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPE 177
+ ++ N +P I + +L +L I +P +AS
Sbjct: 130 ETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS------------ 176
Query: 178 GPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGL 236
L N+ L L I +P + + L+ L + + LS + L
Sbjct: 177 ---GEHQGLVNLQSLRL-EWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231
Query: 237 TYMYLTG-NLLTGPVPDWIVRKRN-KHIDLSYNNFI 270
+ L G L P + K + L + +
Sbjct: 232 EELDLRGCTALRN-YPPIFGGRAPLKRLILKDCSNL 266
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 26/196 (13%), Positives = 63/196 (32%), Gaps = 19/196 (9%)
Query: 86 ELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLF 145
+ E L+ + + + R + + H + N +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIET 62
Query: 146 IEGSGL-AGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMP 204
G L A A+ L + + P+ P + L ++ ++ + + E+P
Sbjct: 63 RTGRALKATADLLEDATQPGRVALELRSVPLPQFP-DQAFRLSHLQHMTI-DAAGLMELP 120
Query: 205 EYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRN---- 259
+ + Q GL L L+ N L +P++ + + L + + +P+ +
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179
Query: 260 ------KHIDLSYNNF 269
+ + L +
Sbjct: 180 QGLVNLQSLRLEWTGI 195
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 26/147 (17%), Positives = 48/147 (32%), Gaps = 15/147 (10%)
Query: 129 GQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGP--FPRLSNL 186
G + + + E L+ +GS P L + +D N +N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHD---VLSQWQRHYNADRNRWHSAWRQANSNNP 58
Query: 187 KNMNYLILRSGNIIGEMPEYLGQ--MIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTG 243
+ + R+G + + L G L+L L P S L +M +
Sbjct: 59 Q----IETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDA 113
Query: 244 NLLTGPVPDWIVRKRN-KHIDLSYNNF 269
L +PD + + + + L+ N
Sbjct: 114 AGLME-LPDTMQQFAGLETLTLARNPL 139
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 54/258 (20%), Positives = 93/258 (36%), Gaps = 53/258 (20%)
Query: 552 EQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSK 610
+ + G + G LR + + EGGF VY+ + G+ A+K+L S
Sbjct: 15 QSDFVGQTVELGELRLRVRR----------VLAEGGFAFVYEAQDVGSGREYALKRLLSN 64
Query: 611 SKQGNREFVNEIG-MISALQHPNLVKLYGCCIEGNQ---------LLLIY-------EYM 653
++ NR + E+ M HPN+V+ G + LLL E++
Sbjct: 65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL 124
Query: 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK 713
+ L + LK I R + ++H + I+HRD+K N+LL
Sbjct: 125 KKMESRGPL--SCDTVLK--------IFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSN 173
Query: 714 DLNPKISDFGLAKLDEEDNTHISTRIA-----------GTFGYMAPE---YAMRGYLTDK 759
K+ DFG A + + T Y PE + +K
Sbjct: 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK 233
Query: 760 ADVYSFGIVALEIVSGRS 777
D+++ G + + +
Sbjct: 234 QDIWALGCILYLLCFRQH 251
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 64/234 (27%), Positives = 97/234 (41%), Gaps = 29/234 (12%)
Query: 556 KGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQG 614
L G F ++ + +G+G FG V G+ AVK +S K +
Sbjct: 7 DHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS-KRQVK 65
Query: 615 NREFV----NEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL-----ARALFGP 665
+ E+ ++ L HPN++KLY + L+ E L +R F
Sbjct: 66 QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 666 EEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDF 722
+ I + G+ Y+H+ KIVHRD+K N+LL KD N +I DF
Sbjct: 126 VDAA---------RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDF 173
Query: 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
GL+ E GT Y+APE Y +K DV+S G++ ++SG
Sbjct: 174 GLSTHFEASKKM--KDKIGTAYYIAPEVLHGTY-DEKCDVWSTGVILYILLSGC 224
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 26/197 (13%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVKLYGC 639
+G G F V+ GK+ A+K + KS + NEI ++ ++H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 640 CIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
L+ + + L R ++ ++ + + + YLHE
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS---------LVIQQVLSAVKYLHE- 124
Query: 695 SRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYA 751
IVHRD+K N+L +++ I+DFGL+K+++ + GT GY+APE
Sbjct: 125 --NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEVL 179
Query: 752 MRGYLTDKADVYSFGIV 768
+ + D +S G++
Sbjct: 180 AQKPYSKAVDCWSIGVI 196
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE---FVNEIGMISALQHPNLVKL 636
+G+G FG V K + AVK ++ K+ N++ + E+ ++ L HPN++KL
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 637 YGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAYL 691
+ + + ++ E L R F + I + G+ Y+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA---------RIIKQVFSGITYM 137
Query: 692 HEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAP 748
H+ IVHRD+K N+LL +KD + KI DFGL+ +++ GT Y+AP
Sbjct: 138 HK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAP 192
Query: 749 EYAMRGYLTDKADVYSFGIVALEIVSGR 776
E Y +K DV+S G++ ++SG
Sbjct: 193 EVLRGTY-DEKCDVWSAGVILYILLSGT 219
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 583 IGEGGFGPVYKG-LLADGKVIAVKQLSSKSKQGNREFV----NEIGMISALQHPNLVKLY 637
+G+G FG VY + ++A+K L KS+ EI + S L+HPN++++Y
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLF-KSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
+ ++ L+ E+ L + L + R + + + LA L Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFD-EQRSATFME-ELADALHYCH---ER 133
Query: 698 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM-RGYL 756
K++HRDIK N+L+ KI+DFG + T + GT Y+ PE + +
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPEMIEGKTH- 189
Query: 757 TDKADVYSFGIVALEIVSGR 776
+K D++ G++ E + G
Sbjct: 190 DEKVDLWCAGVLCYEFLVGM 209
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 28/199 (14%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE---FVNEIGMISALQHPNLVKLY 637
+G+G FG V K + AVK ++ K+ N++ + E+ ++ L HPN++KL+
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 638 GCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+ + ++ E L R F + I + G+ Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA---------RIIKQVFSGITYMH 138
Query: 693 EESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE 749
+ IVHRD+K N+LL +KD + KI DFGL+ +++ GT Y+APE
Sbjct: 139 K---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE 193
Query: 750 YAMRGYLTDKADVYSFGIV 768
Y +K DV+S G++
Sbjct: 194 VLRGTY-DEKCDVWSAGVI 211
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 27/200 (13%)
Query: 582 KIGEGGFGPVYKG-LLADGKVIAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVKLYGC 639
K+G G FG V+ + G +K ++ Q E + EI ++ +L HPN++K++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHS--------ICIGLARGLAYL 691
+ + + ++ E E L R+ + + + LAY
Sbjct: 89 FEDYHNMYIVMETCEGGEL----L----ERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 692 HEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAP 748
H +VH+D+K N+L KI DFGLA+L + D T AGT YMAP
Sbjct: 141 HS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAP 195
Query: 749 EYAMRGYLTDKADVYSFGIV 768
E R T K D++S G+V
Sbjct: 196 EVFKRDV-TFKCDIWSAGVV 214
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 46/197 (23%), Positives = 78/197 (39%), Gaps = 26/197 (13%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVKLYGC 639
IG G +G V + A K++ K + + EI ++ +L HPN+++LY
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIP-KYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 640 CIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
+ + L+ E L + +F + I + +AY H+
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---------RIMKDVLSAVAYCHK- 124
Query: 695 SRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYA 751
L + HRD+K N L D K+ DFGLA + GT Y++P+
Sbjct: 125 --LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVL 180
Query: 752 MRGYLTDKADVYSFGIV 768
Y + D +S G++
Sbjct: 181 EGLY-GPECDEWSAGVM 196
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 63/253 (24%), Positives = 106/253 (41%), Gaps = 37/253 (14%)
Query: 546 KRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAV 604
+G+ ++ G + ++ ++ K+G G +G V A+
Sbjct: 7 HSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAI 66
Query: 605 KQLS------------SKSKQGNREFV-NEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651
K + +K+ + E + NEI ++ +L HPN++KL+ + L+ E
Sbjct: 67 KVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTE 126
Query: 652 YMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKA 706
+ E L R F + +I + G+ YLH+ IVHRDIK
Sbjct: 127 FYEGGELFEQIINRHKFDECDAA---------NIMKQILSGICYLHK---HNIVHRDIKP 174
Query: 707 TNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVY 763
N+LL + LN KI DFGL+ +D GT Y+APE + Y +K DV+
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPEVLKKKY-NEKCDVW 231
Query: 764 SFGIVALEIVSGR 776
S G++ ++ G
Sbjct: 232 SCGVIMYILLCGY 244
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-26
Identities = 50/265 (18%), Positives = 87/265 (32%), Gaps = 18/265 (6%)
Query: 14 PPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLT 73
+ L + + L + + +L + + P + L LT
Sbjct: 278 IVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQLKQFPTL--DLPFLKSLT 334
Query: 74 LEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANL--TRLKHFRISDNHFTGQI 131
L N+ S L +L L L+ N + S+++L L+H +S N +
Sbjct: 335 LTMNKGSISFK--KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-M 391
Query: 132 PDYIQNWTKLEKLFIEGSGLAGPIP-SGIASLVELTDLRISD--LNG-PEGPFPRLSNLK 187
+L+ L + S L S SL +L L IS +G F L++L
Sbjct: 392 SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN 451
Query: 188 NMNYLILRSGNIIGEMPEY-LGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNL 245
L + + L LDLS +L + F L + ++ N
Sbjct: 452 ---TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508
Query: 246 LTGPVPDWIVRKRN-KHIDLSYNNF 269
L + + +D S+N
Sbjct: 509 LLFLDSSHYNQLYSLSTLDCSFNRI 533
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-26
Identities = 53/267 (19%), Positives = 90/267 (33%), Gaps = 37/267 (13%)
Query: 11 GRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLA 70
G + + LP L +DL+RN L+ + ++ L +L
Sbjct: 340 GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSL--------------------R 379
Query: 71 DLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPES-FANLTRLKHFRISDNHFTG 129
L L FN + A L L+ L + S F +L +L + IS +
Sbjct: 380 HLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438
Query: 130 QIPDYIQNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDLRISDLNG----PEGPFPRLS 184
T L L + G+ S + A+ LT L +S G F L
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK-CQLEQISWGVFDTLH 497
Query: 185 NLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTG 243
L+ L + N++ + Q+ L LD SFN++ L + LT
Sbjct: 498 RLQ---LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
Query: 244 NLLT-----GPVPDWIVRKRNKHIDLS 265
N + W+ ++ +++
Sbjct: 555 NSVACICEHQKFLQWVKEQKQFLVNVE 581
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 53/271 (19%), Positives = 91/271 (33%), Gaps = 37/271 (13%)
Query: 10 PGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTL 69
PG L P + +P + L+ +P ++P S+
Sbjct: 1 PGSLNPCIEVVPNI-TYQCMDQKLS-KVPD--------DIP----------------SST 34
Query: 70 ADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTG 129
++ L FN N L+ L L+ +++ L L + ++ N
Sbjct: 35 KNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS 94
Query: 130 QIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD--LNGPEGPFPRLSNLK 187
P T LE L + LA I L+ L L ++ ++ + P SNL
Sbjct: 95 FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLP-AYFSNLT 153
Query: 188 NMNYLILRSGNIIGEMPEY----LGQM-IGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLT 242
N+ ++ L S N I + L + LD+S N + + F G L + L
Sbjct: 154 NLVHVDL-SYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212
Query: 243 GNLLTGPVPDWIVR--KRNKHIDLSYNNFID 271
GN + + ++ L F D
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-22
Identities = 47/290 (16%), Positives = 91/290 (31%), Gaps = 30/290 (10%)
Query: 6 SQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVAS 65
S N + + + L E+ L N+ + I L L + + G K +
Sbjct: 189 SLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKT-CLQNLAGLHVHRLILGEF-KDERN 246
Query: 66 ISTLA-------------DLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFA 112
+ + L + D + L N+ + L + E
Sbjct: 247 LEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVP 304
Query: 113 NLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD 172
+ + I Q P + L+ L + + G I +L L+ L +S
Sbjct: 305 KHFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTL--TMNKGSISFKKVALPSLSYLDLSR 359
Query: 173 --LNG-PEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIP- 228
L+ + L ++ +L L S N M + L+ LD + L V
Sbjct: 360 NALSFSGCCSYSDL-GTNSLRHLDL-SFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEF 417
Query: 229 SNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNFIDGSSDS 276
S F L Y+ ++ + + + ++ N+F D + +
Sbjct: 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-15
Identities = 30/171 (17%), Positives = 53/171 (30%), Gaps = 4/171 (2%)
Query: 6 SQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIP-SEWASLP-LVNLPL-WKQANGAIPKA 62
S N + L LQ +D + L S + SL L+ L + +
Sbjct: 384 SFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 63 VASISTLADLTLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+++L L + N F + + N NL L L+ F L RL+
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD 172
+S N+ + L L + + L +++
Sbjct: 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 50/286 (17%), Positives = 92/286 (32%), Gaps = 72/286 (25%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFV-NEIGMISALQHPN 632
+F P +G GGFG V++ D A+K++ +++ RE V E+ ++ L+HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 633 LVKLYGCCIEGNQLLL-----------------------IYEYMENNSLARALFGPEEHR 669
+V+ + +E +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 670 LKLDWPTRHSICIGL-------------ARGLAYLHEESRL-----------------KI 699
+ + I + R E +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 700 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-----------TRIAGTFGYMAP 748
+HRD+K +N+ D K+ DFGL ++D + T GT YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 749 EYAMRGYLTDKADVYSFGIVALEIVSG------RSNVICRTKEAQF 788
E + K D++S G++ E++ R +I + +F
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKF 291
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 50/245 (20%), Positives = 83/245 (33%), Gaps = 54/245 (22%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVK-----QLSSKSKQGNREFVNEIGMISALQHPNLVK 635
IG+G +G V + + A+K ++ + + E+ ++ L HPN+ +
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 636 LYGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRH------------ 678
LY + + L+ E L + + +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 679 -------------------SICIGLARGLAYLHEESRLKIVHRDIKATNVLL--DKDLNP 717
+I + L YLH I HRDIK N L +K
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEI 209
Query: 718 KISDFGLAKL---DEEDNTHISTRIAGTFGYMAPE---YAMRGYLTDKADVYSFGIVALE 771
K+ DFGL+K + T AGT ++APE Y K D +S G++
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAGVLLHL 268
Query: 772 IVSGR 776
++ G
Sbjct: 269 LLMGA 273
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 8e-26
Identities = 52/203 (25%), Positives = 95/203 (46%), Gaps = 23/203 (11%)
Query: 576 NFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 634
+ +G G FG V+K A G +A K + ++ + E NEI +++ L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPE--EHRLKLDWPTRHSICIGLAR----GL 688
+LY N ++L+ EY++ G E + + + I + G+
Sbjct: 150 QLYDAFESKNDIVLVMEYVD---------GGELFDRIIDESYNLTELDTILFMKQICEGI 200
Query: 689 AYLHEESRLKIVHRDIKATNVLL-DKDLNP-KISDFGLAKLDEEDNTHISTRIAGTFGYM 746
++H+ + I+H D+K N+L ++D KI DFGLA+ + GT ++
Sbjct: 201 RHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFL 255
Query: 747 APEYAMRGYLTDKADVYSFGIVA 769
APE +++ D++S G++A
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIA 278
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 52/209 (24%), Positives = 83/209 (39%), Gaps = 39/209 (18%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFV---------NEIGMISALQHP 631
+G G G V K +A++ +S K K EI ++ L HP
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 632 NLVKLYGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLAR 686
++K+ + ++ E ME L +L +
Sbjct: 201 CIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---------YFYQMLL 250
Query: 687 GLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRIAGTF 743
+ YLHE I+HRD+K NVLL ++D KI+DFG +K+ + + + T + GT
Sbjct: 251 AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRT-LCGTP 305
Query: 744 GYMAPE----YAMRGYLTDKADVYSFGIV 768
Y+APE GY D +S G++
Sbjct: 306 TYLAPEVLVSVGTAGY-NRAVDCWSLGVI 333
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 45/163 (27%), Positives = 86/163 (52%), Gaps = 13/163 (7%)
Query: 570 IKAATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN-----EIG 623
+K+ + + +GEG F VYK +++A+K++ + ++ +N EI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 624 MISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIG 683
++ L HPN++ L + + L++++ME + L + +++ L L + +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVII---KDNSLVLTPSHIKAYMLM 120
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726
+GL YLH+ I+HRD+K N+LLD++ K++DFGLAK
Sbjct: 121 TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 59/260 (22%), Positives = 106/260 (40%), Gaps = 23/260 (8%)
Query: 14 PPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADL 72
L L L+E+ L + ++ P +L + +L L N + +++++ L L
Sbjct: 103 ISALQNLTNLRELYLNEDNISDISPLA--NLTKMYSLNLGANHNLSDLSPLSNMTGLNYL 160
Query: 73 TLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIP 132
T+ ++ D+ + NL +L L LN N A+LT L +F N T P
Sbjct: 161 TVTESKVK-DVTP-IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP 216
Query: 133 DYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD--LNGPEGPFPRLSNLKNMN 190
+ N T+L L I + + P +A+L +LT L I ++ + +L +
Sbjct: 217 --VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINA----VKDLTKLK 268
Query: 191 YLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGP 249
L + N I ++ L + L L L+ N+L G + LT ++L+ N +T
Sbjct: 269 MLNV-GSNQISDISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326
Query: 250 VPDWIVRKRN-KHIDLSYNN 268
P + D +
Sbjct: 327 RP--LASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 60/298 (20%), Positives = 112/298 (37%), Gaps = 55/298 (18%)
Query: 15 PELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLP----LWKQANG-AIPKAVASISTL 69
+ L L+ ++L N + PL NL L+ N A+ +++ L
Sbjct: 60 QGIEYLTNLEYLNLNGNQITDIS-------PLSNLVKLTNLYIGTNKITDISALQNLTNL 112
Query: 70 ADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTG 129
+L L + S D+ L NL + L+L +N+ +N+T L + ++++
Sbjct: 113 RELYLNEDNIS-DISP-LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD 169
Query: 130 QIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDL-----RISDLNGPEGPFPRLS 184
P I N T L L + + + P +ASL L +I+D+ ++
Sbjct: 170 VTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP-------VA 218
Query: 185 NLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIP---------------- 228
N+ +N L + N I ++ L + L L++ N++S +
Sbjct: 219 NMTRLNSLKI-GNNKITDLSP-LANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQ 276
Query: 229 ----SNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNFIDGSSDSNCEN 280
S + S L ++L N L + I N + LS N+ D ++
Sbjct: 277 ISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSK 334
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 8e-23
Identities = 50/245 (20%), Positives = 90/245 (36%), Gaps = 41/245 (16%)
Query: 6 SQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVAS 65
N L+ + L + +T + + P + NL
Sbjct: 140 GANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP-------IANLT--------------- 177
Query: 66 ISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN 125
L L+L +NQ D+ L +L +L N T AN+TRL +I +N
Sbjct: 178 --DLYSLSLNYNQIE-DISP-LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNN 231
Query: 126 HFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD--LNGPEGPFPRL 183
T P + N ++L L I + ++ + + L +L L + ++ L
Sbjct: 232 KITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDISV----L 283
Query: 184 SNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLT 242
+NL +N L L + + E E +G + L L LS N ++ + P + S +
Sbjct: 284 NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFA 341
Query: 243 GNLLT 247
++
Sbjct: 342 NQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-20
Identities = 44/271 (16%), Positives = 101/271 (37%), Gaps = 45/271 (16%)
Query: 14 PPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLT 73
L + ++ + + +I + L L L
Sbjct: 37 VVTQEELESITKLVVAGEKVA-SIQ------GIEYLT-----------------NLEYLN 72
Query: 74 LEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPD 133
L NQ + D+ L NL+ L L++ +N T + NLT L+ +++++ + P
Sbjct: 73 LNGNQIT-DISP-LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISP- 127
Query: 134 YIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD--LNGPEGPFPRLSNLKNMNY 191
+ N TK+ L + + S ++++ L L +++ + ++NL ++
Sbjct: 128 -LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP----IANLTDLYS 181
Query: 192 LILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPV 250
L L + N I ++ L + L N+++ + P + + L + + N +T
Sbjct: 182 LSL-NYNQIEDISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLS 237
Query: 251 PDWIVRKRN-KHIDLSYNNFIDGSSDSNCEN 280
P + +++ N D ++ +
Sbjct: 238 P--LANLSQLTWLEIGTNQISDINAVKDLTK 266
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 44/213 (20%), Positives = 82/213 (38%), Gaps = 15/213 (7%)
Query: 69 LADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFT 128
A L + P +L + L + T + L + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 129 GQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKN 188
I I+ T LE L + G+ + P +++LV+LT+L I N L NL N
Sbjct: 58 -SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGT-NKITDI-SALQNLTN 111
Query: 189 MNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTG 248
+ L L + + I ++ L + + L+L N + + +GL Y+ +T + +
Sbjct: 112 LRELYL-NEDNISDISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKD 169
Query: 249 PVPDWIVRKRN-KHIDLSYNNFIDGSSDSNCEN 280
P I + + L+YN D S ++ +
Sbjct: 170 VTP--IANLTDLYSLSLNYNQIEDISPLASLTS 200
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 52/217 (23%), Positives = 84/217 (38%), Gaps = 39/217 (17%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFV---------NEIG 623
+ + +G G G V K +A+K +S K K EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIE 67
Query: 624 MISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRH 678
++ L HP ++K+ + ++ E ME L +
Sbjct: 68 ILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK--------- 117
Query: 679 SICIGLARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHI 735
+ + YLHE I+HRD+K NVLL ++D KI+DFG +K+ + + +
Sbjct: 118 LYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLM 173
Query: 736 STRIAGTFGYMAPE----YAMRGYLTDKADVYSFGIV 768
T + GT Y+APE GY D +S G++
Sbjct: 174 RT-LCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVI 208
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 54/245 (22%), Positives = 98/245 (40%), Gaps = 37/245 (15%)
Query: 546 KRKHTLEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAV 604
+ K T + + K + P + IG G V + + A G AV
Sbjct: 65 QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAV 124
Query: 605 KQLSSKSKQGNREFV--------NEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYMEN 655
K + +++ + E + E ++ + HP+++ L + + L+++ M
Sbjct: 125 KIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK 184
Query: 656 NSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVL 710
L + +E R SI L +++LH IVHRD+K N+L
Sbjct: 185 GELFDYLTEKVALSEKETR---------SIMRSLLEAVSFLHA---NNIVHRDLKPENIL 232
Query: 711 LDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE-------YAMRGYLTDKADVY 763
LD ++ ++SDFG + E + GT GY+APE GY + D++
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEILKCSMDETHPGY-GKEVDLW 289
Query: 764 SFGIV 768
+ G++
Sbjct: 290 ACGVI 294
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 51/199 (25%), Positives = 86/199 (43%), Gaps = 28/199 (14%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGC 639
IG G + + + A AVK + + E EI ++ QHPN++ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI-LLRYGQHPNIITLKDV 84
Query: 640 CIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
+G + ++ E M+ L + F E ++ + + + YLH
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS---------AVLFTITKTVEYLHA- 134
Query: 695 SRLKIVHRDIKATNVLL-DKDLNP---KISDFGLAKLDEEDNTHISTRIAGTFGYMAPE- 749
+VHRD+K +N+L D+ NP +I DFG AK +N + T T ++APE
Sbjct: 135 --QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTANFVAPEV 191
Query: 750 YAMRGYLTDKADVYSFGIV 768
+GY D++S G++
Sbjct: 192 LERQGY-DAACDIWSLGVL 209
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 33/202 (16%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVKLYGC 639
++G G FG V++ + A G+V K ++ ++ V NEI +++ L HP L+ L+
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFIN-TPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 640 CIEGNQLLLIYEYM---ENNSLARALF---GPEEHRLKLDWPTRHSICIGLAR----GLA 689
+ +++LI E++ E LF E++++ + I R GL
Sbjct: 117 FEDKYEMVLILEFLSGGE-------LFDRIAAEDYKMS------EAEVINYMRQACEGLK 163
Query: 690 YLHEESRLKIVHRDIKATNVLL-DKDLNP-KISDFGLAKLDEEDNTHISTRIAGTFGYMA 747
++HE IVH DIK N++ K + KI DFGLA D T + A
Sbjct: 164 HMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAA 218
Query: 748 PEYAMRGYLTDKADVYSFGIVA 769
PE R + D+++ G++
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLG 240
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 46/196 (23%), Positives = 78/196 (39%), Gaps = 13/196 (6%)
Query: 582 KIGEGGFGPVYKGL-LADG-----KVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVK 635
IG+G F V + + G K++ V + +S + E + L+HP++V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
L L +++E+M+ L + + + L Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148
Query: 696 RLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM 752
I+HRD+K VLL + K+ FG+A E R+ GT +MAPE
Sbjct: 149 -NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVK 206
Query: 753 RGYLTDKADVYSFGIV 768
R DV+ G++
Sbjct: 207 REPYGKPVDVWGCGVI 222
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPN 632
+ F + G+G FG V G G +A+K++ + NRE + + ++ L HPN
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 633 LVKLYGCCIEGNQ-------LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLA 685
+V+L + L ++ EY+ + L R ++ L
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAKL--DEEDNTH-ISTRI 739
R + LH S + + HRDIK NVL+++ L K+ DFG AK E N I +R
Sbjct: 140 RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 740 AGTFGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 776
Y APE + + Y T D++S G + E++ G
Sbjct: 197 -----YRAPELIFGNQHY-TTAVDIWSVGCIFAEMMLGE 229
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 38/224 (16%)
Query: 568 RQIKAATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVK--------QLSSKSKQGNREF 618
N+ P +G G V + + K AVK S++ Q RE
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 619 V-NEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLK 671
E+ ++ + HPN+++L L+++ M+ L + +E R
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-- 127
Query: 672 LDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731
I L + LH+ L IVHRD+K N+LLD D+N K++DFG + +
Sbjct: 128 -------KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 732 NTHISTRIAGTFGYMAPE-------YAMRGYLTDKADVYSFGIV 768
+ GT Y+APE GY + D++S G++
Sbjct: 178 EKL--REVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVI 218
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 60/237 (25%), Positives = 92/237 (38%), Gaps = 31/237 (13%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN---------EIGMISALQHPN 632
+G G FG V+ + K + VK + K K ++ EI ++S ++H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
++K+ E ME + LF + +LD P I L + YL
Sbjct: 91 IIKVLDI-FENQGF--FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE-YA 751
I+HRDIK N+++ +D K+ DFG A E T GT Y APE
Sbjct: 148 ---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT-FCGTIEYCAPEVLM 202
Query: 752 MRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFLS 808
Y + +++S G+ +V E FC L+ A P +S
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFE---------ENPFCELEETVEA--AIHPPYLVS 248
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 48/162 (29%), Positives = 83/162 (51%), Gaps = 17/162 (10%)
Query: 571 KAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGN-REFVN-----EIGM 624
+ + K+GEG +G VYK + G+++A+K + + E + EI +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALK----RIRLDAEDEGIPSTAIREISL 72
Query: 625 ISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGL 684
+ L HPN+V L L L++E+ME + L + L +E++ L L
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL---DENKTGLQDSQIKIYLYQL 128
Query: 685 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726
RG+A+ H+ +I+HRD+K N+L++ D K++DFGLA+
Sbjct: 129 LRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE---FVNEIGMISALQ 629
++N+ ++G+G F V + + G A K ++ K R+ E + LQ
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQ 63
Query: 630 HPNLVKLYGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGL 684
HPN+V+L+ E + L+++ + L AR + + +
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---------HCIQQI 114
Query: 685 ARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRIAG 741
+AY H IVHR++K N+LL K K++DFGLA + AG
Sbjct: 115 LESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAG 169
Query: 742 TFGYMAPEYAMRGYLTDKADVYSFGIV 768
T GY++PE + + D+++ G++
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVI 196
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQG-NREFVNEIGMISALQHPN 632
+ +K+GEG + VYKG ++A+K++ + ++G + E+ ++ L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+V L+ L L++EY++ + L + L ++ ++ L RGLAY H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKD-LKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE--Y 750
+ K++HRD+K N+L+++ K++DFGLA+ + T Y P+
Sbjct: 118 RQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILL 173
Query: 751 AMRGYLTDKADVYSFGIVALEIVSGR 776
Y T + D++ G + E+ +GR
Sbjct: 174 GSTDYST-QIDMWGVGCIFYEMATGR 198
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-25
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVKLYGC 639
++G G FG V++ A G A K + + ++E V EI +S L+HP LV L+
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLAR----GLAYLHEES 695
+ N++++IYE+M L + + + + R GL ++HE
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE-------AVEYMRQVCKGLCHMHE-- 273
Query: 696 RLKIVHRDIKATNVLL-DKDLNP-KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR 753
VH D+K N++ K N K+ DFGL + + GT + APE A
Sbjct: 274 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEG 330
Query: 754 GYLTDKADVYSFGIVALEIVSGRS 777
+ D++S G+++ ++SG S
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLS 354
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-25
Identities = 45/198 (22%), Positives = 87/198 (43%), Gaps = 24/198 (12%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLS-SKSKQGNREFV-NEIGMISALQHPNLVKLYG 638
++G+G F V + + + G+ A ++ K + + + E + L+HPN+V+L+
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 639 CCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
E LI++ + L AR + + + + + H+
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---------HCIQQILEAVLHCHQ 128
Query: 694 ESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY 750
+ +VHR++K N+LL K K++DFGLA E + AGT GY++PE
Sbjct: 129 ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTPGYLSPEV 184
Query: 751 AMRGYLTDKADVYSFGIV 768
+ D+++ G++
Sbjct: 185 LRKDPYGKPVDLWACGVI 202
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGN-REFVN-----EIGMISAL 628
+ KIGEG +G VYK G+ A+K K + E + EI ++ L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALK----KIRLEKEDEGIPSTTIREISILKEL 57
Query: 629 QHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGL 688
+H N+VKLY +L+L++E+++ + L + L + L+ T S + L G+
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL---DVCEGGLESVTAKSFLLQLLNGI 113
Query: 689 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAP 748
AY H+ +++HRD+K N+L++++ KI+DFGLA+ + I T Y AP
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAP 169
Query: 749 E--YAMRGYLTDKADVYSFGIVALEIVSGR 776
+ + Y T D++S G + E+V+G
Sbjct: 170 DVLMGSKKYST-TIDIWSVGCIFAEMVNGT 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 9e-25
Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGN-REFVN-----EIGMISA 627
+ KIGEG +G V+K G+++A+K K + + EI M+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQ 58
Query: 628 LQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARG 687
L+HPNLV L +L L++EY ++ + L + ++ + SI +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHEL---DRYQRGVPEHLVKSITWQTLQA 114
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725
+ + H+ +HRD+K N+L+ K K+ DFG A
Sbjct: 115 VNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFA 149
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGN-REFVN-----EIGMISA 627
+ +GEG +G V K G+++A+K K + + + V EI ++
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----KFLESDDDKMVKKIAMREIKLLKQ 80
Query: 628 LQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARG 687
L+H NLV L C + + L++E++++ + L E LD+ + G
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDL---ELFPNGLDYQVVQKYLFQIING 136
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725
+ + H I+HRDIK N+L+ + K+ DFG A
Sbjct: 137 IGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 16/162 (9%)
Query: 572 AATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN-----EIGMI 625
++++ F K+G G + VYKGL G +A+K + K + E EI ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK----EVKLDSEEGTPSTAIREISLM 57
Query: 626 SALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRH--SICIG 683
L+H N+V+LY N+L L++E+M+N+ L + +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725
L +GLA+ HE KI+HRD+K N+L++K K+ DFGLA
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 26/215 (12%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNL 633
+ IG G FG V++ L + +A+K++ + NR E+ ++ ++HPN+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94
Query: 634 VKLYGCCIEGNQ------LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARG 687
V L L L+ EY+ + RA + + + L R
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAK--LDEEDNTH-ISTRIAGTF 743
LAY+H + I HRDIK N+LLD K+ DFG AK + E N I +R
Sbjct: 154 LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY---- 206
Query: 744 GYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 776
Y APE + Y T D++S G V E++ G+
Sbjct: 207 -YRAPELIFGATNY-TTNIDIWSTGCVMAELMQGQ 239
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 56/228 (24%), Positives = 93/228 (40%), Gaps = 61/228 (26%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN--------------------- 620
IG+G +G V D A+K LS K K +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLS-KKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 621 ------EIGMISALQHPNLVKLYGCCIEG---NQLLLIYEYMENNSLARALFGPEEHRLK 671
EI ++ L HPN+VKL ++ + L +++E + +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV------------- 125
Query: 672 LDWPTRHSICIGLAR--------GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723
++ PT + AR G+ YLH KI+HRDIK +N+L+ +D + KI+DFG
Sbjct: 126 MEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 724 LAKLDEEDNTHISTRIAGTFGYMAPE---YAMRGYLTDKADVYSFGIV 768
++ + + +S GT +MAPE + + DV++ G+
Sbjct: 183 VSNEFKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 27/218 (12%)
Query: 563 GSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE---F 618
F + ++N+ ++G+G F V + + G A K ++ K R+
Sbjct: 17 SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKL 75
Query: 619 VNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLD 673
E + LQHPN+V+L+ E + L+++ + L AR + +
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---- 131
Query: 674 WPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEE 730
+ +AY H IVHR++K N+LL K K++DFGLA E
Sbjct: 132 -----HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI--EV 181
Query: 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIV 768
+++ AGT GY++PE + + D+++ G++
Sbjct: 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 64/205 (31%), Positives = 86/205 (41%), Gaps = 41/205 (20%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN-EIGMISALQHPNLVKLYGCC 640
+GEG +G V + + +AVK + K E + EI + L H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 641 IEGNQLLLIYEYMENNSL--------------ARALFGPEEHRLKLDWPTRHSICIGLAR 686
EGN L EY L A+ F +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF-------------HQLMA----- 116
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRIAGTFG 744
G+ YLH + I HRDIK N+LLD+ N KISDFGLA + ++ GT
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLP 172
Query: 745 YMAPE-YAMRGYLTDKADVYSFGIV 768
Y+APE R + + DV+S GIV
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIV 197
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 3e-24
Identities = 41/159 (25%), Positives = 79/159 (49%), Gaps = 18/159 (11%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGN-REFVN-----EIGMISA 627
+ KIGEG +G V+K +++A+K + + + E V EI ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALK----RVRLDDDDEGVPSSALREICLLKE 57
Query: 628 LQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARG 687
L+H N+V+L+ +L L++E+ + + L + + LD S L +G
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYF---DSCNGDLDPEIVKSFLFQLLKG 113
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726
L + H ++HRD+K N+L++++ K+++FGLA+
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 41/212 (19%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLS-SKSKQGNREFVN-EIGMISALQHPNLVKLYGC 639
IG+G F V + G+ +A+K + ++ + + + E+ ++ L HPN+VKL+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 640 CIEGNQLLLIYEYMENNSL--------------ARALFGPEEHRLKLDWPTRHSICIGLA 685
L LI EY + AR+ F R +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF-------------RQIVS---- 125
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGY 745
+ Y H + +IVHRD+KA N+LLD D+N KI+DFG + + G Y
Sbjct: 126 -AVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNE-FTVGGKLDAF-CGAPPY 179
Query: 746 MAPE-YAMRGYLTDKADVYSFGIVALEIVSGR 776
APE + + Y + DV+S G++ +VSG
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 64/205 (31%), Positives = 86/205 (41%), Gaps = 41/205 (20%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN-EIGMISALQHPNLVKLYGCC 640
+GEG +G V + + +AVK + K E + EI + L H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 641 IEGNQLLLIYEYMENNSL--------------ARALFGPEEHRLKLDWPTRHSICIGLAR 686
EGN L EY L A+ F +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF-------------HQLMA----- 116
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRIAGTFG 744
G+ YLH + I HRDIK N+LLD+ N KISDFGLA + ++ GT
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLP 172
Query: 745 YMAPE-YAMRGYLTDKADVYSFGIV 768
Y+APE R + + DV+S GIV
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIV 197
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 55/197 (27%), Positives = 85/197 (43%), Gaps = 27/197 (13%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVKLYGC 639
++G G VY+ K A+K L K +++ V EIG++ L HPN++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 640 CIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
++ L+ E + L + + + + +AYLHE
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAA---------DAVKQILEAVAYLHE- 166
Query: 695 SRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYA 751
IVHRD+K N+L D KI+DFGL+K+ E + GT GY APE
Sbjct: 167 --NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEIL 222
Query: 752 MRGYLTDKADVYSFGIV 768
+ D++S GI+
Sbjct: 223 RGCAYGPEVDMWSVGII 239
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 26/201 (12%)
Query: 578 APDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVK 635
D +GEG F K + + AVK +S K + N + EI + + HPN+VK
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQ--KEITALKLCEGHPNIVK 70
Query: 636 LYGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
L+ + L+ E + L + F E I L +++
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS---------YIMRKLVSAVSH 121
Query: 691 LHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMA 747
+H+ + +VHRD+K N+L + +L KI DFG A+L DN + T T Y A
Sbjct: 122 MHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAA 177
Query: 748 PEYAMRGYLTDKADVYSFGIV 768
PE + + D++S G++
Sbjct: 178 PELLNQNGYDESCDLWSLGVI 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 9e-24
Identities = 66/218 (30%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPN 632
++ IG G FG VY+ L D G+++A+K++ + NRE + ++ L H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCN 108
Query: 633 LVKLYGCCIEGNQ------LLLIYEYMENNSLARALFGPEEHRLKLDWPTRH--SICIGL 684
+V+L + L L+ +Y+ + R + L P + L
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTL--PVIYVKLYMYQL 165
Query: 685 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAK--LDEEDNTH-ISTRIA 740
R LAY+H I HRDIK N+LLD D K+ DFG AK + E N I +R
Sbjct: 166 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 221
Query: 741 GTFGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 776
Y APE + Y T DV+S G V E++ G+
Sbjct: 222 ----YRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 254
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 38/208 (18%)
Query: 582 KIGEGGFGPVYK------GLLADGKVIAVKQLSSKSKQGNREFV-NEIGMISALQHPNLV 634
++G G F V K GL K I +Q + + +RE + E+ ++ + H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 635 KLYGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLAR--- 686
L+ ++LI E + L + EE +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE-------------ATSFIKQIL 125
Query: 687 -GLAYLHEESRLKIVHRDIKATNVLL-DKDLNP---KISDFGLAKLDEEDNTHISTRIAG 741
G+ YLH KI H D+K N++L DK++ K+ DFGLA E+ I G
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFG 180
Query: 742 TFGYMAPEYAMRGYLTDKADVYSFGIVA 769
T ++APE L +AD++S G++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 38/208 (18%)
Query: 582 KIGEGGFGPVYK------GLLADGKVIAVKQLSSKSKQGNREFV-NEIGMISALQHPNLV 634
++G G F V K GL K I ++ S + +RE + E+ ++ +QHPN++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 635 KLYGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLAR--- 686
L+ ++LI E + L + EE +
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE-------------ATEFLKQIL 124
Query: 687 -GLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLAKLDEEDNTHISTRIAG 741
G+ YLH L+I H D+K N++L KI DFGLA + N I G
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFG 179
Query: 742 TFGYMAPEYAMRGYLTDKADVYSFGIVA 769
T ++APE L +AD++S G++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 38/208 (18%)
Query: 582 KIGEGGFGPVYK------GLLADGKVIAVKQLSSKSKQGNREFV-NEIGMISALQHPNLV 634
++G G F V K GL K I +Q + + RE + E+ ++ + HPN++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 635 KLYGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLAR--- 686
L+ ++LI E + L + EE +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE-------------ATSFIKQIL 125
Query: 687 -GLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLAKLDEEDNTHISTRIAG 741
G+ YLH KI H D+K N++L + K+ DFGLA E+ I G
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFG 180
Query: 742 TFGYMAPEYAMRGYLTDKADVYSFGIVA 769
T ++APE L +AD++S G++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 38/208 (18%)
Query: 582 KIGEGGFGPVYK------GLLADGKVIAVKQLSSKSKQGNREFV-NEIGMISALQHPNLV 634
++G G F V K G K I ++LSS + +RE + E+ ++ ++HPN++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 635 KLYGCCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLAR--- 686
L+ ++LI E + L + +E +
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE-------------ATQFLKQIL 118
Query: 687 -GLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLAKLDEEDNTHISTRIAG 741
G+ YLH +I H D+K N++L + K+ DFG+A E N I G
Sbjct: 119 DGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFG 173
Query: 742 TFGYMAPEYAMRGYLTDKADVYSFGIVA 769
T ++APE L +AD++S G++
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 33/238 (13%)
Query: 549 HTLEQELKGLDLHTGSFTLRQIKAATNNFA-PDNKIGEGGFGPVYKGL-LADGKVIAVKQ 606
H G+DL T + + ++ N + ++G G F V + + + G+ A K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKF 61
Query: 607 LS-SKSKQGNREFV-NEIGMISALQH-PNLVKLYGCCIEGNQLLLIYEYM---ENNSLAR 660
L + Q R + +EI ++ + P ++ L+ ++++LI EY E
Sbjct: 62 LKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE------ 115
Query: 661 ALFGPEEHRLKLDWPTRHS--ICIGLAR----GLAYLHEESRLKIVHRDIKATNVLL--- 711
+F + S I L + G+ YLH+ IVH D+K N+LL
Sbjct: 116 -IF----SLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSI 167
Query: 712 DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVA 769
+ KI DFG+++ I GT Y+APE +T D+++ GI+A
Sbjct: 168 YPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 24/208 (11%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMI-----------SALQH 630
+G+GGFG V+ G L D +A+K + +++ +++ + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 631 PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
P +++L +L+ E A+ LF + L + + +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLP---AQDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAKLDEEDNTHISTRIAGTFGYMAPE 749
H +VHRDIK N+L+D K+ DFG L ++ GT Y PE
Sbjct: 155 CH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVYSPPE 208
Query: 750 Y-AMRGYLTDKADVYSFGIVALEIVSGR 776
+ + Y A V+S GI+ ++V G
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 22/206 (10%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN-------EIGMISALQH--PN 632
+G GGFG VY G+ ++D +A+K + K + + + E+ ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHV-EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+++L + +LI E E + LF R L S + + + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 693 EESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY- 750
++HRDIK N+L+D + K+ DFG L ++ GT Y PE+
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWI 220
Query: 751 AMRGYLTDKADVYSFGIVALEIVSGR 776
Y A V+S GI+ ++V G
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 55/221 (24%), Positives = 82/221 (37%), Gaps = 50/221 (22%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN-----EIGMISALQHPNLVKL 636
+GEG +G V + L AVK L K K EI ++ L+H N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILK-KKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 637 YG--CCIEGNQLLLIYEYMENNSLARALFGPEE-------HRLKLDWPTRHSICIGLAR- 686
E ++ ++ EY G +E R + A
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVC--------GMQEMLDSVPEKRFPVC----------QAHG 113
Query: 687 -------GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE--DNTHIST 737
GL YLH IVH+DIK N+LL KIS G+A+ + T
Sbjct: 114 YFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 738 RIAGTFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGR 776
G+ + PE A + K D++S G+ I +G
Sbjct: 171 S-QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 9e-23
Identities = 37/200 (18%), Positives = 73/200 (36%), Gaps = 30/200 (15%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
+G G FG V++ + + K K + EI +++ +H N++ L+
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 641 IEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLAR----GLAYL 691
+L++I+E++ + A E + L +L
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNERE------------IVSYVHQVCEALQFL 118
Query: 692 HEESRLKIVHRDIKATNVLL--DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE 749
H I H DI+ N++ + KI +FG A+ + + + Y APE
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPE 173
Query: 750 YAMRGYLTDKADVYSFGIVA 769
++ D++S G +
Sbjct: 174 VHQHDVVSTATDMWSLGTLV 193
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 24/164 (14%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGN-REFVN-----EIGMISA 627
+ + K+GEG +G VYK + + +A+K + + + E V E+ ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIK----RIRLEHEEEGVPGTAIREVSLLKE 89
Query: 628 LQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARG 687
LQH N+++L ++L LI+EY EN+ L + + + + S L G
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYM----DKNPDVSMRVIKSFLYQLING 144
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNP-----KISDFGLAK 726
+ + H + +HRD+K N+LL KI DFGLA+
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 24/165 (14%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLS-SKSKQGNREF----VNEIGMISAL 628
+ + KIG+G FG V+K G+ +A+K++ K+G F + EI ++ L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73
Query: 629 QHPNLVKLYGCCIE--------GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSI 680
+H N+V L C + L++++ E++ LA L +K +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL---SNVLVKFTLSEIKRV 129
Query: 681 CIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725
L GL Y+H KI+HRD+KA NVL+ +D K++DFGLA
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 51/209 (24%), Positives = 80/209 (38%), Gaps = 37/209 (17%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFV-NEIGMISALQ-HPNLVKLYGC 639
+GEG V + L + AVK + K R V E+ M+ Q H N+++L
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 640 CIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
E ++ L++E M S+ R F E + +A L +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS---------VVVQDVASALDFLHN- 129
Query: 695 SRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTR------IAGTFGY 745
I HRD+K N+L ++ KI DF L + + G+ Y
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 746 MAPE------YAMRGYLTDKADVYSFGIV 768
MAPE Y + D++S G++
Sbjct: 188 MAPEVVEAFSEEASIY-DKRCDLWSLGVI 215
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 568 RQIKAATNNFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSK---SKQGNREFVNE-- 621
I N+F+ IG GGFG VY AD GK+ A+K L K KQG +NE
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 622 -IGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSI 680
+ ++S P +V + ++L I + M L L + ++
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAA 299
Query: 681 CIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIA 740
I L L ++H +V+RD+K N+LLD+ + +ISD GLA + H
Sbjct: 300 EIILG--LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--AS-V 351
Query: 741 GTFGYMAPEYAMRGYLTDKA-DVYSFGIVALEIVSGRS 777
GT GYMAPE +G D + D +S G + +++ G S
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 44/214 (20%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN----EIGMISALQHPNLVKLY 637
+G G FG V G G +AVK L+ + K + + V EI + +HP+++KLY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 638 GCCIEGNQLLLIYEYMENNSL--------------ARALFGPEEHRLKLDWPTRHSICIG 683
++ EY+ L AR LF + +
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF-------------QQILS-- 122
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF 743
+ Y H R +VHRD+K NVLLD +N KI+DFGL+ + D + T G+
Sbjct: 123 ---AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTS-CGSP 174
Query: 744 GYMAPE-YAMRGYLTDKADVYSFGIVALEIVSGR 776
Y APE + R Y + D++S G++ ++ G
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 52/278 (18%), Positives = 94/278 (33%), Gaps = 29/278 (10%)
Query: 12 RLPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTL 69
+ ++E+DL+ N L+ ++ A L L L + S+STL
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL-DLESLSTL 82
Query: 70 ADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTG 129
L L N EL ++E LH +NN + + +++N T
Sbjct: 83 RTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKKNIY---LANNKITM 134
Query: 130 QIPDYIQNWTKLEKLFIEGSGLAG-PIPSGIASLVELTDL-----RISDLNGPEGPFPRL 183
++++ L ++ + + AS L L I D+
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-------KGQ 187
Query: 184 SNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLT 242
+ L L S N + M G+ + L NKL +I L + L
Sbjct: 188 VVFAKLKTLDL-SSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLR 245
Query: 243 GNLLT-GPVPDWIVR-KRNKHIDLSYNNFIDGSSDSNC 278
GN G + D+ + +R + + + G ++ C
Sbjct: 246 GNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 40/214 (18%), Positives = 83/214 (38%), Gaps = 15/214 (7%)
Query: 58 AIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRL 117
AI + + + + + L + + N+++L L+ N + A T+L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 118 KHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPE 177
+ +S N + D +++ + L L + + + + + L ++ N
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 178 GPFPRLSNLKNMNYLILRSGNIIGEMPEY-LGQMIGLRVLDLSFNKLSGVIPSNFSGS-- 234
R KN + L + N I + + G ++ LDL N++ V + + S
Sbjct: 114 VSCSRGQGKKN---IYL-ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 235 GLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNN 268
L ++ L N + V +V + K +DLS N
Sbjct: 170 TLEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNK 202
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 47/259 (18%), Positives = 93/259 (35%), Gaps = 27/259 (10%)
Query: 20 LPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWK-QANGAIPKAVASISTLADLTLEFN 77
+ +T + L + S S + L L + +A + L L L N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 78 QFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQN 137
+ +L +L L L LN+N ++ ++N+ + ++
Sbjct: 69 VLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR-- 118
Query: 138 WTKLEKLFIEGSGLAGPIPSGIASLVELTDL-----RISDLNGPEGPFPRLSNLKNMNYL 192
+ +++ + + + L I +N E ++ + +L
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL----AASSDTLEHL 174
Query: 193 ILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVP 251
L N I ++ + L+ LDLS NKL+ + F +G+T++ L N L +
Sbjct: 175 NL-QYNFIYDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IE 230
Query: 252 DWIVRKRN-KHIDLSYNNF 269
+ +N +H DL N F
Sbjct: 231 KALRFSQNLEHFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 17/110 (15%), Positives = 26/110 (23%), Gaps = 24/110 (21%)
Query: 12 RLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLAD 71
+ PE + I L N L I KA+ L
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-----------------------LIEKALRFSQNLEH 241
Query: 72 LTLEFNQFSGD-LPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHF 120
L N F L ++ + + E + L H+
Sbjct: 242 FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYG 638
+G GGFG V+ + GK+ A K+L+ K ++G + + E +++ + +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 639 CCIEGNQLLLIYEYMENNSLARALF--GPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
L L+ M + ++ + + ++ I L +LH+
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG--LEHLHQ--- 307
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR-GY 755
I++RD+K NVLLD D N +ISD GLA + T AGT G+MAPE + Y
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AGTPGFMAPELLLGEEY 366
Query: 756 LTDKADVYSFGIVALEIVSGRS 777
D ++ G+ E+++ R
Sbjct: 367 -DFSVDYFALGVTLYEMIAARG 387
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 59/283 (20%), Positives = 91/283 (32%), Gaps = 41/283 (14%)
Query: 12 RLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLAD 71
LP L L +L +PS L + L ++P L +
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQL-----TSLP---VLPPGLQE 145
Query: 72 LTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQI 131
L++ NQ + LPA L KL +N T LP + L L +SDN +
Sbjct: 146 LSVSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPSGLQEL---SVSDNQLA-SL 196
Query: 132 PDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELT--DLRISDLNGPEGPFPRLSNLKNM 189
P KL + L P+ + L EL R++ L P S LK +
Sbjct: 197 PTLPSELYKLWAYNNRLTSL----PALPSGLKELIVSGNRLTSL--PVL----PSELKEL 246
Query: 190 NYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTG 248
SGN + +P L L + N+L+ +P + S T + L GN L+
Sbjct: 247 MV----SGNRLTSLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS- 297
Query: 249 PVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSE 291
+ I + ++
Sbjct: 298 -ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 48/249 (19%), Positives = 91/249 (36%), Gaps = 39/249 (15%)
Query: 23 LQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGD 82
+++ + L T+P + + L + ++P A L L + NQ +
Sbjct: 42 NAVLNVGESGLT-TLPDCLPAH-ITTLVIPDNNLTSLP---ALPPELRTLEVSGNQLT-S 95
Query: 83 LPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLE 142
LP L+ L + LP + L +L I N T +P L+
Sbjct: 96 LPVLPPGLLELSIFSNPLTH----LPALPSGLCKL---WIFGNQLT-SLPVLPPG---LQ 144
Query: 143 KLFIEGSGLAGPIPSGIASLVELT--DLRISDLNGPEGPFPRLSNLKNMNYLILRSGNII 200
+L + + LA +P+ + L +L + +++ L P S L+ L + S N +
Sbjct: 145 ELSVSDNQLAS-LPALPSELCKLWAYNNQLTSL--PML----PSGLQE---LSV-SDNQL 193
Query: 201 GEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNK 260
+P ++ L + L + L + ++GN LT +P K
Sbjct: 194 ASLPTLPSELYKLWAYNNRLTSLPALPSG------LKELIVSGNRLTS-LPVLP--SELK 244
Query: 261 HIDLSYNNF 269
+ +S N
Sbjct: 245 ELMVSGNRL 253
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 8e-06
Identities = 27/131 (20%), Positives = 47/131 (35%), Gaps = 17/131 (12%)
Query: 139 TKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGN 198
L + SGL +P + + +T L I D N P L+ L + SGN
Sbjct: 40 NGNAVLNVGESGLTT-LPDCLPA--HITTLVIPDNNLTSLP-ALPPELRT---LEV-SGN 91
Query: 199 IIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKR 258
+ +P ++ L + L + L +++ GN LT +P
Sbjct: 92 QLTSLPVLPPGLLELSIFSNPLTHLPALPSG------LCKLWIFGNQLTS-LPVLP--PG 142
Query: 259 NKHIDLSYNNF 269
+ + +S N
Sbjct: 143 LQELSVSDNQL 153
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-22
Identities = 55/267 (20%), Positives = 97/267 (36%), Gaps = 23/267 (8%)
Query: 17 LTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLE 75
T L + L + + T+ L + L + V ++ L +
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQA-DRLGIKSIDGVEYLNNLTQINFS 76
Query: 76 FNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYI 135
NQ + D+ L NL L + +N+N ANLT L + +N T P +
Sbjct: 77 NNQLT-DIT-PLKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--L 130
Query: 136 QNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILR 195
+N T L +L + + ++ ++ L L L N P L+NL + L +
Sbjct: 131 KNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG--NQVTDLKP-LANLTTLERLDIS 185
Query: 196 SGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIP-SNFSGSGLTYMYLTGNLLTGPVPDWI 254
S + L ++ L L + N++S + P + L + L GN L +
Sbjct: 186 SNKVSD--ISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDIGT--L 239
Query: 255 VRKRN-KHIDLSYNNFIDGSSDSNCEN 280
N +DL+ N + + S
Sbjct: 240 ASLTNLTDLDLANNQISNLAPLSGLTK 266
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 53/264 (20%), Positives = 100/264 (37%), Gaps = 29/264 (10%)
Query: 14 PPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADL 72
L L L+ +D++ N + + S A L L +L I + ++ L +L
Sbjct: 170 LKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDIT-PLGILTNLDEL 226
Query: 73 TLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIP 132
+L NQ L +L NL L L +N + + LT+L ++ N + P
Sbjct: 227 SLNGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISP 282
Query: 133 DYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDL-----RISDLNGPEGPFPRLSNLK 187
+ T L L + + L P I++L LT L ISD++ +S+L
Sbjct: 283 --LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-------VSSLT 331
Query: 188 NMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLL 246
+ L N + ++ L + + L N++S + P + + +T + L
Sbjct: 332 KLQRLFF-YNNKVSDVSS-LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387
Query: 247 TGPVPDWIVRKRNKHIDLSYNNFI 270
T ++ + + +
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGAL 411
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-20
Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 27/272 (9%)
Query: 14 PPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADL 72
+ L L +I+ + N L P +L LV++ + I +A+++ L L
Sbjct: 61 IDGVEYLNNLTQINFSNNQLTDITPL--KNLTKLVDILMNNNQIADIT-PLANLTNLTGL 117
Query: 73 TLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIP 132
TL NQ + D+ L NL NL +L L+SN + + + LT L+ N T P
Sbjct: 118 TLFNNQIT-DIDP-LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP 172
Query: 133 DYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD--LNGPEGPFPRLSNLKNMN 190
+ N T LE+L I + ++ S +A L L L ++ ++ L L N++
Sbjct: 173 --LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP----LGILTNLD 224
Query: 191 YLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGP 249
L L +GN + ++ L + L LDL+ N++S + P SG + LT + L N ++
Sbjct: 225 ELSL-NGNQLKDIGT-LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI 280
Query: 250 VPDWIVRKRN-KHIDLSYNNFIDGSSDSNCEN 280
P + +++L+ N D S SN +N
Sbjct: 281 SP--LAGLTALTNLELNENQLEDISPISNLKN 310
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-20
Identities = 76/274 (27%), Positives = 115/274 (41%), Gaps = 33/274 (12%)
Query: 15 PELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLP-LWKQANGAIPKAVASISTLADLT 73
L L L + L N + P + L NL L +N ++ IS L+ LT
Sbjct: 106 TPLANLTNLTGLTLFNNQITDIDPLK----NLTNLNRLELSSNT-----ISDISALSGLT 156
Query: 74 ----LEF-NQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFT 128
L F NQ + P L NL LE+L ++SN + A LT L+ ++N +
Sbjct: 157 SLQQLSFGNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQIS 212
Query: 129 GQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKN 188
P + T L++L + G+ L +ASL LTDL +++ N LS L
Sbjct: 213 DITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN-NQISN-LAPLSGLTK 266
Query: 189 MNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIP-SNFSGSGLTYMYLTGNLLT 247
+ L L N I + L + L L+L+ N+L + P SN LTY+ L N ++
Sbjct: 267 LTELKL-GANQISNISP-LAGLTALTNLELNENQLEDISPISNL--KNLTYLTLYFNNIS 322
Query: 248 GPVPDWIVRKRN-KHIDLSYNNFIDGSSDSNCEN 280
P + + + N D SS +N N
Sbjct: 323 DISP--VSSLTKLQRLFFYNNKVSDVSSLANLTN 354
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-16
Identities = 50/241 (20%), Positives = 92/241 (38%), Gaps = 18/241 (7%)
Query: 14 PPELTRLPFLQEIDLTRNYLNGTIP-SEWASLPLVNLPLWKQANGAI--PKAVASISTLA 70
L L L ++DL N ++ P S L + L I +A ++ L
Sbjct: 236 IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKL-----GANQISNISPLAGLTALT 290
Query: 71 DLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQ 130
+L L NQ + + NL NL L L NN + ++LT+L+ +N +
Sbjct: 291 NLELNENQLED--ISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVSD- 345
Query: 131 IPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMN 190
+ N T + L + ++ P +A+L +T L ++D P +N+ N
Sbjct: 346 -VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPN 402
Query: 191 YLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPV 250
+ +G +I P + D+++N S +++ S + +G V
Sbjct: 403 TVKNVTGALIA--PATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTV 460
Query: 251 P 251
Sbjct: 461 T 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 27/192 (14%), Positives = 63/192 (32%), Gaps = 20/192 (10%)
Query: 93 LEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLA 152
L + + ++ + L + + T + + ++ L + G+
Sbjct: 3 LGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59
Query: 153 GPIPSGIASLVELTDLRISD--LNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQM 210
G+ L LT + S+ L L NL + +++ + I L +
Sbjct: 60 --SIDGVEYLNNLTQINFSNNQLTDITP----LKNLTKLVDILMNNNQIAD--ITPLANL 111
Query: 211 IGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNN 268
L L L N+++ + P + L + L+ N ++ + + + + N
Sbjct: 112 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG-NQ 166
Query: 269 FIDGSSDSNCEN 280
D +N
Sbjct: 167 VTDLKPLANLTT 178
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 6e-22
Identities = 46/184 (25%), Positives = 83/184 (45%), Gaps = 22/184 (11%)
Query: 582 KIGEGGFGPVYKG---LLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYG 638
K+G G +G VYK D K A+KQ+ + EI ++ L+HPN++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85
Query: 639 CCIE--GNQLLLIYEYMEN--NSLARALFGPEEHRLKLDWPTRH--SICIGLARGLAYLH 692
+ ++ L+++Y E+ + + + ++ + P S+ + G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 693 EESRLKIVHRDIKATNVLLDKDLNP----KISDFGLAKL---DEEDNTHISTRIAGTFGY 745
++HRD+K N+L+ + KI+D G A+L + + + TF Y
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 746 MAPE 749
APE
Sbjct: 202 RAPE 205
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 54/204 (26%), Positives = 81/204 (39%), Gaps = 42/204 (20%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCI 641
IG G FG +++AVK + + + EI +L+HPN+V+ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 642 EGNQLLLIYEYMENNSL--------------ARALFGPEEHRLKLDWPTRHSICIGLARG 687
L +I EY L AR F + + G
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF-------------QQLLS-----G 128
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNP--KISDFGLAKLDEEDNTHISTRIAGTFGY 745
++Y H ++I HRD+K N LLD P KI DFG +K + + + GT Y
Sbjct: 129 VSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV-GTPAY 183
Query: 746 MAPE-YAMRGYLTDKADVYSFGIV 768
+APE + Y ADV+S G+
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVT 207
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFV----NEIGMISALQHPNLVKLY 637
IG+G FG V D K+ A+K ++ K K R V E+ ++ L+HP LV L+
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMN-KQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 638 GCCIEGNQLLLIYEYMEN----NSLARALFGPEEHRLKLDWPTRHSIC-IGLARGLAYLH 692
+ + ++ + + L + + EE + IC + +A L YL
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-------VKLFICELVMA--LDYLQ 132
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE--- 749
+I+HRD+K N+LLD+ + I+DF +A + + + +AGT YMAPE
Sbjct: 133 N---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFS 187
Query: 750 -YAMRGYLTDKA-DVYSFGIVALEIVSGRS 777
GY A D +S G+ A E++ GR
Sbjct: 188 SRKGAGY--SFAVDWWSLGVTAYELLRGRR 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 43/213 (20%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN----EIGMISALQHPNLVKLY 637
+GEG FG V + +A+K +S + + EI + L+HP+++KLY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 638 GCCIEGNQLLLIYEY---------MENNSL----ARALFGPEEHRLKLDWPTRHSICIGL 684
++++ EY +E + R F + IC
Sbjct: 76 DVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFF-------------QQIIC--- 119
Query: 685 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG 744
+ Y H R KIVHRD+K N+LLD +LN KI+DFGL+ + D + T G+
Sbjct: 120 --AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDGNFLKTS-CGSPN 172
Query: 745 YMAPE-YAMRGYLTDKADVYSFGIVALEIVSGR 776
Y APE + Y + DV+S GIV ++ GR
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 50/201 (24%), Positives = 77/201 (38%), Gaps = 32/201 (15%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
+G G G V + G+ A+K L S + +E + A P++V +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEV--DH-HWQASGGPHIVCILDVY 91
Query: 641 ----IEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAYL 691
LL+I E ME L R E I + + +L
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA-------EIMRDIGTAIQFL 144
Query: 692 HEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAP 748
H I HRD+K N+L +KD K++DFG AK ++ + T T Y+AP
Sbjct: 145 HS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT-PCYTPYYVAP 198
Query: 749 E-YAMRGYLTDKADVYSFGIV 768
E Y D++S G++
Sbjct: 199 EVLGPEKY-DKSCDMWSLGVI 218
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 4e-21
Identities = 53/280 (18%), Positives = 96/280 (34%), Gaps = 33/280 (11%)
Query: 12 RLPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQAN--GAIPKAVASIS 67
+ ++E+DL+ N L+ ++ A L L L +N + S+S
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL--SSNVLYETL-DLESLS 80
Query: 68 TLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHF 127
TL L L N EL ++E LH +NN + + +++N
Sbjct: 81 TLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKKNI---YLANNKI 132
Query: 128 TGQIPDYIQNWTKLEKLFIEGSGLAG-PIPSGIASLVELTDL-----RISDLNGPEGPFP 181
T ++++ L ++ + + AS L L I D+
Sbjct: 133 TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-------K 185
Query: 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMY 240
+ L L S N + M G+ + L NKL +I L +
Sbjct: 186 GQVVFAKLKTLDL-SSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFD 243
Query: 241 LTGN-LLTGPVPDWIVR-KRNKHIDLSYNNFIDGSSDSNC 278
L GN G + D+ + +R + + + G ++ C
Sbjct: 244 LRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 4e-20
Identities = 40/214 (18%), Positives = 83/214 (38%), Gaps = 15/214 (7%)
Query: 58 AIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRL 117
AI + + + + + L + + N+++L L+ N + A T+L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 118 KHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPE 177
+ +S N + D +++ + L L + + + + + L ++ N
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 178 GPFPRLSNLKNMNYLILRSGNIIGEMPEY-LGQMIGLRVLDLSFNKLSGVIPSNFSGS-- 234
R KN + L + N I + + G ++ LDL N++ V + + S
Sbjct: 114 VSCSRGQGKKN---IYL-ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 235 GLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNN 268
L ++ L N + V +V + K +DLS N
Sbjct: 170 TLEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNK 202
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 7e-18
Identities = 47/259 (18%), Positives = 92/259 (35%), Gaps = 27/259 (10%)
Query: 20 LPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWK-QANGAIPKAVASISTLADLTLEFN 77
+ +T + L + S S + L L + +A + L L L N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 78 QFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQN 137
+L +L L L LN+N ++ ++N+ + ++
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR-- 118
Query: 138 WTKLEKLFIEGSGLAGPIPSGIASLVELTDL-----RISDLNGPEGPFPRLSNLKNMNYL 192
+ +++ + + + L I +N E ++ + +L
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE----LAASSDTLEHL 174
Query: 193 ILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVP 251
L N I ++ + L+ LDLS NKL+ + F +G+T++ L N L +
Sbjct: 175 NL-QYNFIYDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IE 230
Query: 252 DWIVRKRN-KHIDLSYNNF 269
+ +N +H DL N F
Sbjct: 231 KALRFSQNLEHFDLRGNGF 249
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 31/235 (13%), Positives = 62/235 (26%), Gaps = 9/235 (3%)
Query: 13 LPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIP-KAVASISTLAD 71
+ L L+ DL N + ++ S + KQ + + +
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288
Query: 72 LTLEFNQFSGDLPAELGNLINLEKLHLN----SNNFTGKLPESFANLTRLKHFRISDNHF 127
LI L++ + T +L N R + +
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348
Query: 128 TGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPE--GPFPRLSN 185
I L + L + +G + EL + E S
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSP 408
Query: 186 LKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMY 240
L+ + ++ R + + Q +R D+ +K + + N L
Sbjct: 409 LQLLRAIVKR--YEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEA 461
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 33/239 (13%), Positives = 50/239 (20%), Gaps = 73/239 (30%)
Query: 12 RLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLAD 71
+ PE + I L N L
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV------------------------------------- 227
Query: 72 LTLEFNQFSGDLPAELGNLINLEKLHLNSNNF-TGKLPESFANLTRLKHFRISDNHFTGQ 130
+ L NLE L N F G L + F+ R++ ++
Sbjct: 228 ----------LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT--VAKQTVKKL 275
Query: 131 IPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMN 190
+ T L DL P RL LK
Sbjct: 276 TGQNEEECTVPT-------------------LGHYGAYCCEDL--PAPFADRLIALKRKE 314
Query: 191 YLILR-SGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLT 247
+ +L G+ + R +D + VI + L
Sbjct: 315 HALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 20/208 (9%), Positives = 41/208 (19%), Gaps = 7/208 (3%)
Query: 7 QNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLP---LWKQANGAIPKAV 63
+ L G+ E T L +L +
Sbjct: 273 KKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECER 332
Query: 64 ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRIS 123
+ + ++ Q+ + L ++ L
Sbjct: 333 ENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQ 392
Query: 124 DNHFTG--QIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181
+ L + + S + + D+
Sbjct: 393 AVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENA 452
Query: 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQ 209
RL L L L S N + E + +
Sbjct: 453 RLKKLNGEADLALASANA--TLQELVVR 478
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-21
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 583 IGEGGFGPVYKGLLAD-GKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYG 638
+G+GGFG V + GK+ A K+L K ++G +NE ++ + +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK 698
+ L L+ M L ++ + ++ I L LH E +
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG--LEDLHRE---R 306
Query: 699 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLT 757
IV+RD+K N+LLD + +ISD GLA + I R GT GYMAPE Y T
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQTIKGR-VGTVGYMAPEVVKNERY-T 363
Query: 758 DKADVYSFGIVALEIVSGRS 777
D ++ G + E+++G+S
Sbjct: 364 FSPDWWALGCLLYEMIAGQS 383
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 4e-21
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 44/214 (20%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN----EIGMISALQHPNLVKLY 637
+G G FG V G G +AVK L+ + K + + V EI + +HP+++KLY
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 638 GCCIEGNQLLLIYEYMENNSL--------------ARALFGPEEHRLKLDWPTRHSICIG 683
+ + ++ EY+ L +R LF + +
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF-------------QQILS-- 127
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF 743
G+ Y H R +VHRD+K NVLLD +N KI+DFGL+ + D + T G+
Sbjct: 128 ---GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTS-CGSP 179
Query: 744 GYMAPE-YAMRGYLTDKADVYSFGIVALEIVSGR 776
Y APE + R Y + D++S G++ ++ G
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 573 ATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLS-SKSKQGNREF----VNEIG--- 623
AT+ + P +IG G +G VYK G +A+K + G V E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 624 MISALQHPNLVKLYGCCI-----EGNQLLLIYEYMENNSLARALFGPEEHRLK-LDWPTR 677
+ A +HPN+V+L C ++ L++E+++ + L L ++ L T
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL---DKAPPPGLPAETI 122
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726
+ RGL +LH IVHRD+K N+L+ K++DFGLA+
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 34/210 (16%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKS--KQGNREFVN-EIGMISALQHPNLVK 635
+GEG F V LA + A+K L + K+ +V E ++S L HP VK
Sbjct: 38 LGEGSFSTVV---LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARAL-----FGPEEHRLKLDWPTRHSIC-IGLARGLA 689
LY + +L Y +N L + + F E TR I A L
Sbjct: 95 LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETC-------TRFYTAEIVSA--LE 144
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR-IAGTFGYMAP 748
YLH I+HRD+K N+LL++D++ +I+DFG AK+ ++ GT Y++P
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 749 EYAM-RGYLTDKA-DVYSFGIVALEIVSGR 776
E + K+ D+++ G + ++V+G
Sbjct: 202 ELLTEKSA--CKSSDLWALGCIIYQLVAGL 229
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-21
Identities = 51/284 (17%), Positives = 99/284 (34%), Gaps = 48/284 (16%)
Query: 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP--------------LVN 48
+ S NL +P E + E + P
Sbjct: 17 LRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHE 75
Query: 49 LPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLP 108
L L ++P L L N + +LP +L +L + N + LP
Sbjct: 76 LELNNLGLSSLP---ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSD-LP 130
Query: 109 ESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELT-- 166
L++ +S+N ++P+ +QN + L+ + ++ + L +P SL +
Sbjct: 131 PL------LEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAG 181
Query: 167 DLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGV 226
+ ++ +L P L NL + + N + ++P+ L + N L
Sbjct: 182 NNQLEEL-------PELQNLPFLTAIYA-DNNSLKKLPDLPLS---LESIVAGNNILE-E 229
Query: 227 IPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNF 269
+P + LT +Y NLL +PD + + +++ N
Sbjct: 230 LPELQNLPFLTTIYADNNLLKT-LPDLP---PSLEALNVRDNYL 269
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 54/235 (22%), Positives = 82/235 (34%), Gaps = 55/235 (23%)
Query: 15 PELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTL 74
PEL LPFL I N L +P +L +
Sbjct: 189 PELQNLPFLTAIYADNNSLK-KLPDL-------------------------PLSLESIVA 222
Query: 75 EFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDY 134
N +LP EL NL L ++ ++N LP+ +L L + DN+ T +P+
Sbjct: 223 GNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL---NVRDNYLT-DLPEL 275
Query: 135 IQNWTKLEKLFIEGSGLAGPIPSGIASLVELT--DLRISDLNGPEGPFPRLSNLKNMNYL 192
Q+ T L+ SGL +L L I L ++ L
Sbjct: 276 PQSLTFLDVSENIFSGL----SELPPNLYYLNASSNEIRSL---------CDLPPSLEEL 322
Query: 193 ILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLT 247
+ S N + E+P + L L SFN L+ +P L +++ N L
Sbjct: 323 NV-SNNKLIELPALPPR---LERLIASFNHLA-EVPELP--QNLKQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-18
Identities = 56/259 (21%), Positives = 94/259 (36%), Gaps = 38/259 (14%)
Query: 14 PPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLT 73
PEL LPFL I N L T+P S L L + +P+ +L L
Sbjct: 230 LPELQNLPFLTTIYADNNLLK-TLPDLPPS--LEALNVRDNYLTDLPE---LPQSLTFLD 283
Query: 74 LEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPD 133
+ N FSG L NL L+ +SN L + +L L +S+N ++P
Sbjct: 284 VSENIFSG-LSELPP---NLYYLNASSNEIR-SLCDLPPSLEELN---VSNNKLI-ELPA 334
Query: 134 YIQNWTKLEKLFIEGSGLAGPIPSGIASLVELT--DLRISDLNGPEGPFPRLSNLKNMNY 191
LE+L + LA +P +L +L + + P+ P ++++
Sbjct: 335 LPPR---LERLIASFNHLAE-VPELPQNLKQLHVEYNPLREF--PDIP----ESVED--- 381
Query: 192 LILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVP 251
LR + + E+PE L+ L + N L P + + + + P
Sbjct: 382 --LRMNSHLAEVPELPQN---LKQLHVETNPLR-EFPDIP--ESVEDLRMNSERVVDPYE 433
Query: 252 DWIVRKRNKHIDLSYNNFI 270
D+ ++
Sbjct: 434 FAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 40/224 (17%), Positives = 76/224 (33%), Gaps = 32/224 (14%)
Query: 59 IPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLK 118
I S + L + + + ++P E N+ + + + + + P +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 119 HFRISDNHFTG------------QIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELT 166
R+ D +P+ + LE L + L +P SL L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPELPPH---LESLVASCNSLT-ELPELPQSLKSLL 117
Query: 167 DLRISDLNGPEGPFPRLSNL-KNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSG 225
+ L LS+L + YL + S N + ++PE L L+++D+ N L
Sbjct: 118 VDNNN-LK-------ALSDLPPLLEYLGV-SNNQLEKLPE-LQNSSFLKIIDVDNNSLK- 166
Query: 226 VIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNF 269
+P L ++ N L +P+ I N+
Sbjct: 167 KLPDLP--PSLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSL 207
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 44/244 (18%), Positives = 79/244 (32%), Gaps = 57/244 (23%)
Query: 6 SQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVAS 65
N LP L FL D++ N + L
Sbjct: 265 RDNYLTDLPELPQSLTFL---DVSENIFS--------GLS------------------EL 295
Query: 66 ISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN 125
L L N+ L +LE+L++++N +LP L RL S N
Sbjct: 296 PPNLYYLNASSNEIR-SLCDLPP---SLEELNVSNNKLI-ELPALPPRLERL---IASFN 347
Query: 126 HFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELT-DLRISDLNGPEGPFPRLS 184
H ++P+ QN L++L +E + L P S+ +L + ++++
Sbjct: 348 HLA-EVPELPQN---LKQLHVEYNPLRE-FPDIPESVEDLRMNSHLAEV------PELPQ 396
Query: 185 NLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNF-SGSGLTYMYLTG 243
NLK L + N + E P+ + L ++ ++ + L
Sbjct: 397 NLK---QLHV-ETNPLREFPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEH 449
Query: 244 NLLT 247
+
Sbjct: 450 HHHH 453
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-21
Identities = 43/287 (14%), Positives = 93/287 (32%), Gaps = 37/287 (12%)
Query: 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPK 61
+ + ++ L ++ + + R ++ L
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETVTIRRLHIP--------QFYLFYDL---------ST 304
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPES---FANLTRLK 118
+ + + +T+E ++ + +L +LE L L+ N + ++ L+
Sbjct: 305 VYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364
Query: 119 HFRISDNHFT--GQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGP 176
+S NH + + + L L I + P+P ++ L +S
Sbjct: 365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR 423
Query: 177 EGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGL 236
L+ L + S N + +L + L+ L +S NKL + ++ L
Sbjct: 424 VVKTCIPQTLE---VLDV-SNNNLDSFSLFLPR---LQELYISRNKLKTLPDASLFPV-L 475
Query: 237 TYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNFIDGSSDSNCENQS 282
M ++ N L R + + I L N + D +C
Sbjct: 476 LVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW-----DCSCPRID 517
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 41/226 (18%), Positives = 85/226 (37%), Gaps = 10/226 (4%)
Query: 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126
+ + L L FN+ + +L NL+ L L S+ ++F +L L+H +SDNH
Sbjct: 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNH 85
Query: 127 FTGQIPDYIQNWTKLEKLFIEGSGLAG-PIPSGIASLVELTDLRISDLNG----PEGPFP 181
+ + + L+ L + G+ + S +L L LRI ++ F
Sbjct: 86 LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF- 144
Query: 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMY 240
+ L ++N L +++ ++ + L + + L L ++ + ++ S + Y+
Sbjct: 145 --AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLF 286
L L + + F N+ + L
Sbjct: 203 LRDTNLAR-FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 8e-17
Identities = 45/310 (14%), Positives = 109/310 (35%), Gaps = 34/310 (10%)
Query: 6 SQNLPGRLPPE-LTRLPFLQEIDLTRNYLNGTIPSEW-ASLP-LVNLPLWKQANG----A 58
+ + + L L+ +DL+ N+L+ ++ S W L L L L N
Sbjct: 58 KSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNL--MGNPYQTLG 114
Query: 59 IPKAVASISTLADLTLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRL 117
+ +++ L L + + ++ L +L +L + + + +S ++ +
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI 174
Query: 118 KHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG-- 175
H + + + + + + L + + LA S + + ++ G
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234
Query: 176 -PEGPFPRLSNLKN--------------MNYLILRSGNIIGEMPEYLG-QMIGLRVLDLS 219
+ F L L +N L + + + E + + +R L +
Sbjct: 235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIP 294
Query: 220 FNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR--KRNKHIDLSYNNFID-GSSD 275
L + + +S + + + + + VP + K + +DLS N ++ +
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVFL-VPCSFSQHLKSLEFLDLSENLMVEEYLKN 353
Query: 276 SNCENQSVNL 285
S C+ +L
Sbjct: 354 SACKGAWPSL 363
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 49/280 (17%), Positives = 102/280 (36%), Gaps = 39/280 (13%)
Query: 4 LKSQNL---PGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIP 60
+S++ P L + L DL+ N + +
Sbjct: 12 GRSRSFTSIPSGLTAAMKSL------DLSFNKI--------TYIG--------------H 43
Query: 61 KAVASISTLADLTLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKH 119
+ + + L L L+ ++ + + + +L +LE L L+ N+ + F L+ LK+
Sbjct: 44 GDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKY 102
Query: 120 FRISDNHFTG-QIPDYIQNWTKLEKLFIEGSGLAGPIPSG-IASLVELTDLRISDLNGPE 177
+ N + + N T L+ L I I A L L +L I L+
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162
Query: 178 GPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG---- 233
L +++++++L L + + + +R L+L L+ S
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVS 222
Query: 234 SGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGS 273
S + + G++LT + +++ ++LS F D +
Sbjct: 223 SPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCT 262
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 42/278 (15%), Positives = 96/278 (34%), Gaps = 51/278 (18%)
Query: 17 LTRLPFLQEIDLTRNYLNG---------TIPSEWASLPLVNLPLWKQANGAIPKAVASIS 67
L ++ ++L L + S L L ++ + K + I
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251
Query: 68 TLADLTLEFNQFSG---------DLPAELGNL--INLEKLHLNSNNFTGKLPESFANLTR 116
L+++ + +G D+ +ELG + + + +LH+ L ++ L +
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
Query: 117 LKHFRISDNHFTGQIPDYI-QNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG 175
+K + ++ +P Q+ LE L +L++ + +
Sbjct: 312 VKRITVENSKVF-LVPCSFSQHLKSLEFL-------------------DLSENLMVEEYL 351
Query: 176 PEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLG---QMIGLRVLDLSFNKLSGVIPSNFS 232
++ L+L S N + M + + L LD+S N +P +
Sbjct: 352 KNSAC--KGAWPSLQTLVL-SQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQ 407
Query: 233 G-SGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNF 269
+ ++ L+ + V + + + +D+S NN
Sbjct: 408 WPEKMRFLNLSSTGIR--VVKTCIPQTLEVLDVSNNNL 443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 21/138 (15%), Positives = 49/138 (35%), Gaps = 11/138 (7%)
Query: 6 SQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEW-ASLPLVNLPLWKQANGAIPKAVA 64
S+N +P ++ ++L+ + + + +L ++++ +N +
Sbjct: 395 SRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDV-----SNNNLDSFSL 448
Query: 65 SISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISD 124
+ L +L + N+ LP L + ++ N F LT L+ +
Sbjct: 449 FLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506
Query: 125 NHFTG--QIPDYIQNWTK 140
N + DY+ W
Sbjct: 507 NPWDCSCPRIDYLSRWLN 524
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 23/201 (11%), Positives = 48/201 (23%), Gaps = 45/201 (22%)
Query: 582 KIGEGGFGPVYKGLLAD---GKVIAVKQL---SSKSKQGNREFVNEIGMISALQHPNLVK 635
G ++ L D + +A+ + +E ++ +S + P + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
+ L++ E++ SL LA H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAH--- 146
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGY 755
R + + V + D G L M
Sbjct: 147 RAGVALSIDHPSRVRVSID--------GDVVL-------------AYPATMPDA------ 179
Query: 756 LTDKADVYSFGIVALEIVSGR 776
+ D+ G ++ R
Sbjct: 180 -NPQDDIRGIGASLYALLVNR 199
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 8e-20
Identities = 46/172 (26%), Positives = 83/172 (48%), Gaps = 34/172 (19%)
Query: 575 NNFAPDNKIGEGGFGPVYKG--LLADGKVIAVKQLS-SKSKQGN-----REFVNEIGMIS 626
+ +IGEG +G V+K L G+ +A+K++ ++G RE ++
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-------VA 63
Query: 627 ALQ------HPNLVKLYGCCI-----EGNQLLLIYEYMENNSLARALFGPEEHR-LKLDW 674
L+ HPN+V+L+ C +L L++E+++ + L L ++ +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL---DKVPEPGVPT 119
Query: 675 PTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726
T + L RGL +LH ++VHRD+K N+L+ K++DFGLA+
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 8e-20
Identities = 58/256 (22%), Positives = 92/256 (35%), Gaps = 26/256 (10%)
Query: 6 SQNLPGRLPPE-LTRLPFLQEIDLTRNYLNGTIPSEW-ASLP-LVNLPLWKQANGAI--- 59
N +P T L L ++D++ N + + L L +L + + +
Sbjct: 88 RSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEV---GDNDLVYI 143
Query: 60 -PKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLK 118
+A + +++L LTLE + L +L L L L N SF L RLK
Sbjct: 144 SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203
Query: 119 HFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSG-IASLVELTDL-----RISD 172
IS + + L L I L +P + LV L L IS
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPIST 262
Query: 173 LNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEY-LGQMIGLRVLDLSFNKLSGVIPSNF 231
+ L + + L G + + Y + LRVL++S N+L+ + S F
Sbjct: 263 I--EGSML---HELLRLQEIQL-VGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVF 316
Query: 232 SG-SGLTYMYLTGNLL 246
L + L N L
Sbjct: 317 HSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-19
Identities = 66/273 (24%), Positives = 98/273 (35%), Gaps = 50/273 (18%)
Query: 9 LPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASIST 68
+P +P E L DL +N + E+AS P
Sbjct: 26 VPEGIPTETRLL------DLGKNRIKTLNQDEFASFPH---------------------- 57
Query: 69 LADLTLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHF 127
L +L L N S + NL NL L L SN F L+ L IS+N
Sbjct: 58 LEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKI 116
Query: 128 TGQIPDYI-QNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDL-----RISDLNGPEGPF 180
+ DY+ Q+ L+ L + + L I + L L L ++ + P
Sbjct: 117 V-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLTSI--PTEAL 172
Query: 181 PRLSNLKNMNYLILRSGNIIGEMPEY-LGQMIGLRVLDLSFNKLSGVIPSN-FSGSGLTY 238
L L L L I + +Y ++ L+VL++S + N G LT
Sbjct: 173 SHLHGLI---VLRL-RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTS 228
Query: 239 MYLTGNLLTGPVPDWIVR--KRNKHIDLSYNNF 269
+ +T LT VP VR + ++LSYN
Sbjct: 229 LSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPI 260
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 26/146 (17%), Positives = 44/146 (30%), Gaps = 24/146 (16%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAV 63
+ + P L + +T L +P AV
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVP---------------------YLAV 244
Query: 64 ASISTLADLTLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRI 122
+ L L L +N S + L L+ L+++ L P +F L L+ +
Sbjct: 245 RHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNV 303
Query: 123 SDNHFTGQIPDYIQNWTKLEKLFIEG 148
S N T + LE L ++
Sbjct: 304 SGNQLTTLEESVFHSVGNLETLILDS 329
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 1e-19
Identities = 53/230 (23%), Positives = 87/230 (37%), Gaps = 31/230 (13%)
Query: 4 LKSQNLPGRLPPELTRLPF------LQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANG 57
+ Q LPG E L E+ L R L+ ++P + L + + A
Sbjct: 36 WEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLPPQ-ITVLEITQNALI 93
Query: 58 AIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRL 117
++P ++L L N+ S LP +L + L +++N T LPE A L +
Sbjct: 94 SLP---ELPASLEYLDACDNRLS-TLPELPASL---KHLDVDNNQLT-MLPELPALLEYI 145
Query: 118 KHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDL---RISDLN 174
+N T +P+ + LE L + + L +P SL L D+ + L
Sbjct: 146 ---NADNNQLT-MLPELPTS---LEVLSVRNNQLTF-LPELPESLEAL-DVSTNLLESL- 195
Query: 175 GPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLS 224
P P R + + N I +PE + + + L N LS
Sbjct: 196 -PAVPV-RNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLS 243
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 2e-17
Identities = 55/269 (20%), Positives = 95/269 (35%), Gaps = 50/269 (18%)
Query: 20 LPFLQEIDLTRNYLNGTIP----------SEWASLPLVNLPLWKQANGAIPKAVASISTL 69
LP L++N TI +W L +A + + I+
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGE-NRNEAVSLLKEC--LINQF 61
Query: 70 ADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTG 129
++L L S LP L + L + N LPE A+L L DN +
Sbjct: 62 SELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPASLEYLD---ACDNRLS- 113
Query: 130 QIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDL---RISDLNGPEGPFPRLSNL 186
+P+ + L+ L ++ + L +P A L + + +++ L PE ++L
Sbjct: 114 TLPELPAS---LKHLDVDNNQLTM-LPELPALLEYI-NADNNQLTML--PE----LPTSL 162
Query: 187 KNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-----SGLTYMYL 241
+ L + N + +PE L LD+S N L +P+ +
Sbjct: 163 E---VLSV-RNNQLTFLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEETEIFFRC 214
Query: 242 TGNLLTGPVPDWIVRKRN-KHIDLSYNNF 269
N +T +P+ I+ I L N
Sbjct: 215 RENRITH-IPENILSLDPTCTIILEDNPL 242
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 9e-11
Identities = 28/145 (19%), Positives = 43/145 (29%), Gaps = 31/145 (21%)
Query: 12 RLPPELTRLPFLQEIDLTRNYLNGTIPSEWASL--------PLVNLPLWKQANGAIPKAV 63
LP L + I+ N L +P SL L LP
Sbjct: 134 MLPELPALL---EYINADNNQLT-MLPELPTSLEVLSVRNNQLTFLP------------- 176
Query: 64 ASISTLADLTLEFNQFSGDLPAELGNLINLEK----LHLNSNNFTGKLPESFANLTRLKH 119
+L L + N LPA + E+ N T +PE+ +L
Sbjct: 177 ELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCT 234
Query: 120 FRISDNHFTGQIPDYIQNWTKLEKL 144
+ DN + +I + + T
Sbjct: 235 IILEDNPLSSRIRESLSQQTAQPDY 259
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 25/144 (17%), Positives = 44/144 (30%), Gaps = 19/144 (13%)
Query: 6 SQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASL--------PLVNLPLWKQANG 57
N LP T L + + + N L +P SL L +LP
Sbjct: 148 DNNQLTMLPELPTSL---EVLSVRNNQLT-FLPELPESLEALDVSTNLLESLPAV----- 198
Query: 58 AIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRL 117
+ S T N+ + +P + +L + L N + ++ ES + T
Sbjct: 199 -PVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ 256
Query: 118 KHFRISDNHFTGQIPDYIQNWTKL 141
+ +F+ L
Sbjct: 257 PDYHGPRIYFSMSDGQQNTLHRPL 280
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 47/200 (23%), Positives = 75/200 (37%), Gaps = 29/200 (14%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYG-- 638
+G G G V + + A+K L + RE E+ A Q P++V++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVY 124
Query: 639 --CCIEGNQLLLIYEYMENNSL-----ARALFGPEEHRLKLDWPTRHSICIGLARGLAYL 691
LL++ E ++ L R E I + + YL
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-------EIMKSIGEAIQYL 177
Query: 692 HEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAP 748
H + I HRD+K N+L + K++DFG AK N+ T T Y+AP
Sbjct: 178 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAP 232
Query: 749 EYAMRGYLTDKADVYSFGIV 768
E D++S G++
Sbjct: 233 EVLGPEKYDKSCDMWSLGVI 252
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 567 LRQIKAATNNFAPDNKIGEGGFGPVY----KGLLADGKVIAVKQLSSKS--KQGNREFVN 620
++Q++ +F IG G FG V K KV A+K L+ K+
Sbjct: 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFR 122
Query: 621 -EIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHS 679
E ++ + L+ + N L L+ +Y L L E RL + +
Sbjct: 123 EERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEMARFYL 181
Query: 680 ICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRI 739
+ +A + +H+ L VHRDIK N+L+D + + +++DFG ED T S+
Sbjct: 182 AEMVIA--IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 740 AGTFGYMAPE------YAMRGYLTDKADVYSFGIVALEIVSGRS 777
GT Y++PE Y + D +S G+ E++ G +
Sbjct: 237 VGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGET 279
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 14/196 (7%)
Query: 58 AIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRL 117
+P +++ L L NQ +L +LE L L+ N+ +F L L
Sbjct: 57 EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 118 KHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDLRISDLNG- 175
+ DN T +KL++L++ + + IPS + L L + +L
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRL 173
Query: 176 ---PEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFS 232
EG F LSNL+ YL L + + E+P L +I L LDLS N LS + P +F
Sbjct: 174 SYISEGAFEGLSNLR---YLNL-AMCNLREIPN-LTPLIKLDELDLSGNHLSAIRPGSFQ 228
Query: 233 G-SGLTYMYLTGNLLT 247
G L +++ + +
Sbjct: 229 GLMHLQKLWMIQSQIQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 47/250 (18%), Positives = 92/250 (36%), Gaps = 32/250 (12%)
Query: 9 LPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQAN--GAIP-KAVA 64
+P + L +L N + + + L L L L N I A
Sbjct: 58 VPDGISTNTRLL------NLHENQIQIIKVNSFKHLRHLEILQL--SRNHIRTIEIGAFN 109
Query: 65 SISTLADLTLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRIS 123
++ L L L N+ + +P L L++L L +N +F + L+ +
Sbjct: 110 GLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLG 168
Query: 124 D-NHFTGQIPDYI-QNWTKLEKLFIEGSGLAGPIPSGIASLVELTDL-----RISDLNGP 176
+ + I + + + L L + L IP+ + L++L +L +S +
Sbjct: 169 ELKRLS-YISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSAI--R 223
Query: 177 EGPFPRLSNLKNMNYLILRSGNIIGEMPEY-LGQMIGLRVLDLSFNKLSGVIPSNFSG-S 234
G F L +L+ L + + I + + L ++L+ N L+ + F+
Sbjct: 224 PGSFQGLMHLQK---LWM-IQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279
Query: 235 GLTYMYLTGN 244
L ++L N
Sbjct: 280 HLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 34/147 (23%), Positives = 53/147 (36%), Gaps = 6/147 (4%)
Query: 6 SQNLPGRLPPEL-TRLPFLQEIDLTRNYLNGTIPSEWASLPLVNL-PLWKQANG--AIPK 61
N +P R+P L+ +DL I A L NL L IP
Sbjct: 144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG-AFEGLSNLRYLNLAMCNLREIP- 201
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+ + L +L L N S P L++L+KL + + +F NL L
Sbjct: 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEG 148
++ N+ T D LE++ +
Sbjct: 262 LAHNNLTLLPHDLFTPLHHLERIHLHH 288
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 51/188 (27%), Positives = 79/188 (42%), Gaps = 14/188 (7%)
Query: 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126
S L L N +L +LE L L N+ +F L L + DN
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 127 FTGQIPDYI-QNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDLRISDLNG----PEGPF 180
T IP + +KL +L++ + + IPS + L L + +L EG F
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192
Query: 181 PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYM 239
L NLK YL L I +MP L ++GL L++S N + P +F G S L +
Sbjct: 193 EGLFNLK---YLNL-GMCNIKDMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL 247
Query: 240 YLTGNLLT 247
++ + ++
Sbjct: 248 WVMNSQVS 255
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 44/251 (17%), Positives = 84/251 (33%), Gaps = 45/251 (17%)
Query: 6 SQNLPGRLPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVA 64
+N + + L L+ + L RN + I A
Sbjct: 83 MENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIE---------------------VGAFN 120
Query: 65 SISTLADLTLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRIS 123
+++L L L N + +P+ L L +L L +N +F + L +
Sbjct: 121 GLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLG 179
Query: 124 D-NHFTGQIPDYI-QNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG------ 175
+ I + + L+ L + + + +L L L +++G
Sbjct: 180 ELKKLE-YISEGAFEGLFNLKYLNLGMCNI-----KDMPNLTPLVGLEELEMSGNHFPEI 233
Query: 176 PEGPFPRLSNLKNMNYLILRSGNIIGEMPEY-LGQMIGLRVLDLSFNKLSGVIPSNFSG- 233
G F LS+LK L + + + + + L L+L+ N LS + F+
Sbjct: 234 RPGSFHGLSSLK---KLWV-MNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289
Query: 234 SGLTYMYLTGN 244
L ++L N
Sbjct: 290 RYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 23/146 (15%), Positives = 45/146 (30%), Gaps = 25/146 (17%)
Query: 4 LKSQNLPGRLPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKA 62
L + L L+ ++L + +P+ L L
Sbjct: 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN------LTPLV------------ 218
Query: 63 VASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRI 122
L +L + N F P L +L+KL + ++ + +F L L +
Sbjct: 219 -----GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNL 273
Query: 123 SDNHFTGQIPDYIQNWTKLEKLFIEG 148
+ N+ + D L +L +
Sbjct: 274 AHNNLSSLPHDLFTPLRYLVELHLHH 299
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 50/211 (23%), Positives = 79/211 (37%), Gaps = 13/211 (6%)
Query: 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGK--LPESFANLTRLKHFRISD 124
S+ L LE N+ L L KL L+SN + K +S T LK+ +S
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 125 NHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDLRISDLN---GPEGPF 180
N + +LE L + S L + SL L L IS + G F
Sbjct: 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 146
Query: 181 PRLSNLKNMNYLILRSGNIIGEMPEY-LGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTY 238
LS+L+ L + + ++ L LDLS +L + P+ F+ S L
Sbjct: 147 NGLSSLE---VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 203
Query: 239 MYLTGNLLTGPVPDWIVRKRN-KHIDLSYNN 268
+ ++ N + + +D S N+
Sbjct: 204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 234
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 47/269 (17%), Positives = 85/269 (31%), Gaps = 41/269 (15%)
Query: 12 RLPP-ELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNL-PLWKQANG--AIPKAVASIS 67
LP +L L ++ L+ N L+ + +L L NG + +
Sbjct: 42 SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLE 101
Query: 68 TLADLTLEFNQFSGDLPAE--LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN 125
L L + + + +L NL L ++ + F L+ L+ +++ N
Sbjct: 102 QLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160
Query: 126 HFTGQIPDYI-QNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLS 184
F I L L + ++ L F LS
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQC-------------------QLEQL--SPTAFNSLS 199
Query: 185 NLKNMNYLILRSGNIIGEMPEY-LGQMIGLRVLDLSFNKLSGVIPSNFSG--SGLTYMYL 241
+L+ L + S N + + + L+VLD S N + S L ++ L
Sbjct: 200 SLQ---VLNM-SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 255
Query: 242 TGNLLT-----GPVPDWIVRKRNKHIDLS 265
T N WI +R +++
Sbjct: 256 TQNDFACTCEHQSFLQWIKDQRQLLVEVE 284
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-18
Identities = 47/217 (21%), Positives = 76/217 (35%), Gaps = 17/217 (7%)
Query: 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126
+ +L L FN + L+ L L+ ++ +L+ L ++ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 127 FTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDL-----RISDLNGPEGPFP 181
+ L+KL + LA I L L +L I PE F
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE-YFS 146
Query: 182 RLSNLKNMNYLILRSGNIIGEMPE----YLGQM-IGLRVLDLSFNKLSGVIPSNFSGSGL 236
L+NL+ +L L S N I + L QM + LDLS N ++ + P F L
Sbjct: 147 NLTNLE---HLDL-SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202
Query: 237 TYMYLTGNLLTGPVPDWIVRK--RNKHIDLSYNNFID 271
+ L N + V ++ + L F +
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-18
Identities = 44/240 (18%), Positives = 83/240 (34%), Gaps = 19/240 (7%)
Query: 15 PELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTL 74
+ + Q ++L + SL + G + + +L L L
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF---TSNKGGNAFSEVDLPSLEFLDL 354
Query: 75 EFNQ--FSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIP 132
N F G +L+ L L+ N + +F L +L+H ++ Q+
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMS 412
Query: 133 DYI--QNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD----LNGPEGPFPRLSNL 186
++ + L L I + L L L+++ N F L NL
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 187 KNMNYLILRSGNIIGEMPEY-LGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGN 244
+L L S + ++ + L+VL+++ N+L V F + L ++L N
Sbjct: 473 T---FLDL-SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 9e-17
Identities = 45/274 (16%), Positives = 84/274 (30%), Gaps = 36/274 (13%)
Query: 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPK 61
R+ + L + L + + + +L L G P
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPT 321
Query: 62 AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFT--GKLPESFANLTRLKH 119
+ +L LT N+ + +E+ +L +LE L L+ N + G +S T LK+
Sbjct: 322 L--KLKSLKRLTFTSNKGG-NAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 120 FRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGP 179
+S N + +LE L + ++
Sbjct: 378 LDLSFNGVI-TMSSNFLGLEQLEHLD-------------------FQHSNLKQMS-EFSV 416
Query: 180 FPRLSNLKNMNYLILRSGNIIGEMPEY-LGQMIGLRVLDLSFNKLSGVIPSNFSG--SGL 236
F L NL YL + S + L VL ++ N + L
Sbjct: 417 FLSLRNLI---YLDI-SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 237 TYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNF 269
T++ L+ L P + + ++++ N
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-16
Identities = 43/245 (17%), Positives = 74/245 (30%), Gaps = 36/245 (14%)
Query: 9 LPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASIST 68
+P LP L DL+ N L + S + P
Sbjct: 22 IPDNLPFSTKNL------DLSFNPLR-HLGSY----SFFSFPE----------------- 53
Query: 69 LADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFT 128
L L L + +L +L L L N +F+ L+ L+ + +
Sbjct: 54 LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA 113
Query: 129 GQIPDYIQNWTKLEKLFIEGSGLA-GPIPSGIASLVELTDLRISDLNG----PEGPFPRL 183
I + L++L + + + +P ++L L L +S N L
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS-NKIQSIYCTDLRVL 172
Query: 184 SNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG--SGLTYMYL 241
+ +N + S N + + + I L L L N S + +GL L
Sbjct: 173 HQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRL 232
Query: 242 TGNLL 246
Sbjct: 233 VLGEF 237
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 52/319 (16%), Positives = 97/319 (30%), Gaps = 50/319 (15%)
Query: 6 SQNLPGRLPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAV 63
S N L P LQ +DL+R + + SL L L L ++
Sbjct: 36 SFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGA 95
Query: 64 -ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFT-GKLPESFANLTRLKHFR 121
+ +S+L L + +G+L L++L++ N KLPE F+NLT L+H
Sbjct: 96 FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155
Query: 122 ISDNHFTG---------------------------QIPDYIQNWTKLEKLFIEGSGLAGP 154
+S N I +L KL + + +
Sbjct: 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLN 215
Query: 155 IPSGIASLVELTDLRISDLNG------------PEGPFPRLSNLKNMNYLILRSGNIIG- 201
+ + L L + L + L NL + L +
Sbjct: 216 VMKTC--IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL-TIEEFRLAYLDYYLD 272
Query: 202 EMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKH 261
++ + + + L + + G ++ L + K K
Sbjct: 273 DIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQF--PTLKLKSLKR 329
Query: 262 IDLSYNNFIDGSSDSNCEN 280
+ + N + S+ + +
Sbjct: 330 LTFTSNKGGNAFSEVDLPS 348
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-13
Identities = 48/286 (16%), Positives = 87/286 (30%), Gaps = 26/286 (9%)
Query: 6 SQNLPGRLPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNL--------PLWKQAN 56
+ L + L L+E+++ N + + L NL +
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
Query: 57 GAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPE-SFANLT 115
+ L L N + + I L KL L +N + + + L
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLA 225
Query: 116 RLKHFRISDNHFTGQI------PDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLR 169
L+ R+ F + ++ L + L + I LT++
Sbjct: 226 GLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVS 285
Query: 170 ISDLNGPEGP-FPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIP 228
L S +L L G+ P ++ L+ L + NK
Sbjct: 286 SFSLVSVTIERVKDFSYNFGWQHLEL-VNCKFGQFPT--LKLKSLKRLTFTSNKGGN-AF 341
Query: 229 SNFSGSGLTYMYLTGNLLT--GPVPDWIVRKRN-KHIDLSYNNFID 271
S L ++ L+ N L+ G + K++DLS+N I
Sbjct: 342 SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 53/295 (17%), Positives = 96/295 (32%), Gaps = 32/295 (10%)
Query: 13 LPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQAN----GAIPKAVASI 66
L + L LQ++ L L L L + N +P+ +++
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV--AHNLIQSFKLPEYFSNL 148
Query: 67 STLADLTLEFNQFSGDLPAELGNLINLE----KLHLNSNNFTGKLPESFANLTRLKHFRI 122
+ L L L N+ +L L + L L+ N P +F + RL +
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTL 207
Query: 123 SDNHFTGQIPD-YIQNWTKLEKL------FIEGSGLAGPIPSGIASLVELT--DLRISDL 173
+N + + IQ LE F L S + L LT + R++ L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 174 NGPEGPFPRL-SNLKNMNYLILRSGNIIGEMPE--YLGQMIGLRVLDLSFNKLSGVIPSN 230
+ L + L N++ L I + + Y L +++ F + + +
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSL-VSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 231 FSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNL 285
L + T N + + +DLS N S + + +L
Sbjct: 327 -----LKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 29/148 (19%), Positives = 51/148 (34%), Gaps = 6/148 (4%)
Query: 6 SQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNL-PLWKQANG--AIPKA 62
S N + L L+ +D + L + L L NL L
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 63 V-ASISTLADLTLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHF 120
+ +S+L L + N F + + L NL L L+ P +F +L+ L+
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 121 RISDNHFTGQIPDYIQNWTKLEKLFIEG 148
++ N T L+K+++
Sbjct: 500 NMASNQLKSVPDGIFDRLTSLQKIWLHT 527
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 54/247 (21%), Positives = 88/247 (35%), Gaps = 57/247 (23%)
Query: 574 TNNFAPDNKIGEGGFGPVYKG-LLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPN 632
+ ++ +G G FG V + + GK A+K++ + NRE + ++ L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPT---------------- 676
++KL ++ +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 677 -------RHSICIG--------------LARGLAYLHEESRLKIVHRDIKATNVLLD-KD 714
+ I G L R + ++H L I HRDIK N+L++ KD
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKD 178
Query: 715 LNPKISDFGLAK--LDEEDNTH-ISTRIAGTFGYMAPE--YAMRGYLTDKADVYSFGIVA 769
K+ DFG AK + E + I +R Y APE Y T D++S G V
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY-TPSIDLWSIGCVF 232
Query: 770 LEIVSGR 776
E++ G+
Sbjct: 233 GELILGK 239
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 64/236 (27%), Positives = 112/236 (47%), Gaps = 21/236 (8%)
Query: 551 LEQELKGLDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVY----KGLLADGKVIAVKQ 606
+E +K + + T KA + F +G+G FG V+ ++ A+K
Sbjct: 1 MEGSIKEIAI-THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV 59
Query: 607 LSSKSKQGNREFVN---EIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALF 663
L K+ R+ V E ++ + HP +VKL+ +L LI +++ L L
Sbjct: 60 LK-KATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS 118
Query: 664 GPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723
+E + + + LA L +LH L I++RD+K N+LLD++ + K++DFG
Sbjct: 119 --KEVMFTEEDVKFYLAELALA--LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFG 171
Query: 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGRS 777
L+K + + GT YMAPE R G+ ++ D +SFG++ E+++G
Sbjct: 172 LSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGH--TQSADWWSFGVLMFEMLTGTL 224
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-18
Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREF---VNEIGMISALQHPNLVK 635
+G+G FG V +L G+ A+K L + E + E ++ +HP L
Sbjct: 156 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
L ++L + EY L L E D + I A L YLH S
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSA--LDYLH--S 266
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR-G 754
+V+RD+K N++LDKD + KI+DFGL K +D + T GT Y+APE
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDND 325
Query: 755 YLTDKADVYSFGIVALEIVSGRS 777
Y D + G+V E++ GR
Sbjct: 326 Y-GRAVDWWGLGVVMYEMMCGRL 347
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 6e-18
Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 7/149 (4%)
Query: 630 HPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRH---SICIGLAR 686
P +K I +Q ++E SL+ L D+ T +A+
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT-FGY 745
G+ +L SR K +HRD+ A N+LL + KI DFGLA+ +D ++ A +
Sbjct: 205 GMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261
Query: 746 MAPEYAMRGYLTDKADVYSFGIVALEIVS 774
MAPE T ++DV+SFG++ EI S
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 32/156 (20%), Positives = 58/156 (37%), Gaps = 20/156 (12%)
Query: 580 DNKIGEGGFGPVYKGLL------ADGKVIAVKQL-SSKSKQGNREFVNEIG-MISALQHP 631
+G G FG V + A + +AVK L + +R ++E+ +I H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 632 NLVKLYGCCI-EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
N+V L G C G L++I E+ + +L+ L R+ +G +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----------RSKRNEFVPYKTKGARF 135
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726
+ + + D+K + + S F K
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 53/213 (24%), Positives = 84/213 (39%), Gaps = 17/213 (7%)
Query: 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126
+ + L N+ S A NL L L+SN +F L L+ +SDN
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 127 FTGQIPDYI-QNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDLRISDLNG----PEGPF 180
+ +L L ++ GL + G+ L L L + D N P+ F
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQD-NALQALPDDTF 149
Query: 181 PRLSNLKNMNYLILRSGNIIGEMPEY-LGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTY 238
L NL +L L GN I +PE + L L L N+++ V P F L
Sbjct: 150 RDLGNLT---HLFL-HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205
Query: 239 MYLTGNLLTGPVPDWIVR--KRNKHIDLSYNNF 269
+YL N L+ +P + + +++ L+ N +
Sbjct: 206 LYLFANNLSA-LPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 35/196 (17%), Positives = 66/196 (33%), Gaps = 39/196 (19%)
Query: 6 SQNLPGRLPPE-LTRLPFLQEIDLTRNYLNGTIPSE-WASLPLVNLPLWKQANGAIPKAV 63
N+ R+ T L L+++DL+ N ++ + L
Sbjct: 64 HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLG------------------ 105
Query: 64 ASISTLADLTLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPE-SFANLTRLKHFR 121
L L L+ +L L L+ L+L N LP+ +F +L L H
Sbjct: 106 ----RLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLF 159
Query: 122 ISDNHFTGQIPDYI-QNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG----- 175
+ N + +P+ + L++L + + +A + + +L L L
Sbjct: 160 LHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH-VHPH--AFRDLGRLMTLYLFANNLSA 215
Query: 176 -PEGPFPRLSNLKNMN 190
P L L+ +
Sbjct: 216 LPTEALAPLRALQYLR 231
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 9e-18
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 583 IGEGGFGPVY----KGLLADGKVIAVKQLSSKSKQGNREFV----NEIGMISALQHPNLV 634
+G+GG+G V+ GK+ A+K L N + E ++ ++HP +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 635 KLYGCCIEGNQLLLIYEYM---ENNSLARALFG--PEEHRLKLDWPTRHSICIGLARGLA 689
L G +L LI EY+ E LF E D + I +A L
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGE-------LFMQLEREGIFMEDTACFYLAEISMA--LG 135
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE 749
+LH+ I++RD+K N++L+ + K++DFGL K D T T GT YMAPE
Sbjct: 136 HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMAPE 191
Query: 750 YAMR-GYLTDKA-DVYSFGIVALEIVSGRS 777
MR G+ ++A D +S G + ++++G
Sbjct: 192 ILMRSGH--NRAVDWWSLGALMYDMLTGAP 219
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-17
Identities = 58/276 (21%), Positives = 108/276 (39%), Gaps = 37/276 (13%)
Query: 6 SQNLPGRLPPEL-TRLPFLQEIDLTRNYLNGTIPSE-WASLP-LVNLPLWKQAN--GAIP 60
N LPP + +P L + L RN L+ ++P + + P L L + N I
Sbjct: 107 GFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSM--SNNNLERIE 163
Query: 61 KAV-ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKH 119
+ ++L +L L N+ + + L + +L +++ N + + A ++
Sbjct: 164 DDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEE 215
Query: 120 FRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG---- 175
S N + + +L L ++ + L + A L+ L DL+
Sbjct: 216 LDASHNSIN-VVRGPVN--VELTILKLQHNNL-----TDTAWLLNYPGLVEVDLSYNELE 267
Query: 176 --PEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG 233
PF ++ L+ L + S N + + Y + L+VLDLS N L V +
Sbjct: 268 KIMYHPFVKMQRLE---RLYI-SNNRLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQF 323
Query: 234 SGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNF 269
L +YL N + K++ LS+N++
Sbjct: 324 DRLENLYLDHNSIVTLKLSTH--HTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 8e-17
Identities = 43/235 (18%), Positives = 84/235 (35%), Gaps = 22/235 (9%)
Query: 59 IPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLK 118
I + D+ ++ E L N + + ++ + +++
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 119 HFRISDNHFTGQIPDYI-QNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDL-----RIS 171
++D +I Y ++KL++ + + +P + ++ LT L +S
Sbjct: 79 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 136
Query: 172 DLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQ-MIGLRVLDLSFNKLSGVIPSN 230
L P G F L L + S N + + + Q L+ L LS N+L+ V S
Sbjct: 137 SL--PRGIFHNTPKLT---TLSM-SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSL 190
Query: 231 FSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNL 285
L + ++ NLL+ V +D S+N+ N E + L
Sbjct: 191 I--PSLFHANVSYNLLSTLAIPIAVE----ELDASHNSINVVRGPVNVELTILKL 239
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 9e-16
Identities = 47/265 (17%), Positives = 82/265 (30%), Gaps = 49/265 (18%)
Query: 13 LPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADL 72
E L + + + + +P+ + S + L
Sbjct: 43 FGFEDITLNNQKIVTFKNSTMR-KLPAA---------------------LLDSFRQVELL 80
Query: 73 TLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQI 131
L Q ++ ++KL++ N P F N+ L + N + +
Sbjct: 81 NLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SL 138
Query: 132 PDYI-QNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDL-----RISDLNGPEGPFPRLS 184
P I N KL L + + L I + L +L R++ + P L
Sbjct: 139 PRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTHV--DLSLIPSLF 195
Query: 185 NLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGN 244
+ S N++ + I + LD S N ++ V LT + L N
Sbjct: 196 HAN-------VSYNLLSTLAI----PIAVEELDASHNSINVVRGPVN--VELTILKLQHN 242
Query: 245 LLTGPVPDWIVRKRNKHIDLSYNNF 269
LT + +DLSYN
Sbjct: 243 NLT-DTAWLLNYPGLVEVDLSYNEL 266
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 42/221 (19%), Positives = 70/221 (31%), Gaps = 19/221 (8%)
Query: 6 SQNLPGRLPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAV 63
S N R+ + LQ + L+ N L + +P L + + + +
Sbjct: 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLSTLAIPI 211
Query: 64 ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRIS 123
A + +L N + + + + L L L NN T N L +S
Sbjct: 212 A----VEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLS 262
Query: 124 DNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRL 183
N + +LE+L+I + L + + L L +S N
Sbjct: 263 YNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSH-NHLLHVERNQ 320
Query: 184 SNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLS 224
+ L L N I + L L+ L LS N
Sbjct: 321 PQFDRLENLYL-DHNSIVTLK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 36/188 (19%), Positives = 59/188 (31%), Gaps = 34/188 (18%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAV 63
L N+ L L ++E+D + N +N + V L
Sbjct: 194 LFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGP----VNVELT------------- 235
Query: 64 ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRIS 123
L L+ N + D L N L ++ L+ N + F + RL+ IS
Sbjct: 236 -------ILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 286
Query: 124 DNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG----PEGP 179
+N + Y Q L+ L + + L + L +L + N
Sbjct: 287 NNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDH-NSIVTLKLST 343
Query: 180 FPRLSNLK 187
L NL
Sbjct: 344 HHTLKNLT 351
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 24/131 (18%), Positives = 47/131 (35%), Gaps = 14/131 (10%)
Query: 13 LPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANG--AIPKAVASIST 68
+ ++ L+ + ++ N L + +P L L L N + +
Sbjct: 269 IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL--SHNHLLHVERNQPQFDR 325
Query: 69 LADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTG-KLPESFANLTRLKHFRISDNHF 127
L +L L+ N L L L+ L L+ N++ L F N+ R + D
Sbjct: 326 LENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARP---AVDDADQ 379
Query: 128 TGQIPDYIQNW 138
+I +++
Sbjct: 380 HCKIDYQLEHG 390
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 51/254 (20%), Positives = 99/254 (38%), Gaps = 33/254 (12%)
Query: 13 LPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNL-PLWKQAN--GAIPKAVASIST 68
+ L L + L N ++ I A PLV L L+ N +P+ + T
Sbjct: 67 IKDGDFKNLKNLHTLILINNKIS-KISPG-AFAPLVKLERLYLSKNQLKELPEKMPK--T 122
Query: 69 LADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKL--PESFANLTRLKHFRISDNH 126
L +L + N+ + + L + + L +N +F + +L + RI+D +
Sbjct: 123 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 182
Query: 127 FTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG------PEGPF 180
T IP + L +L ++G+ + + + SL L +L L+ G
Sbjct: 183 IT-TIPQGL--PPSLTELHLDGNKITK-VDAA--SLKGLNNLAKLGLSFNSISAVDNGSL 236
Query: 181 PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSG----- 235
+L+ L L + N + ++P L ++V+ L N +S + ++F G
Sbjct: 237 ANTPHLR---ELHL-NNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 292
Query: 236 --LTYMYLTGNLLT 247
+ + L N +
Sbjct: 293 ASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 43/219 (19%), Positives = 92/219 (42%), Gaps = 20/219 (9%)
Query: 58 AIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRL 117
+PK + A L L+ N+ + + NL NL L L +N + P +FA L +L
Sbjct: 45 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 118 KHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDL-----RIS 171
+ +S N ++P+ + L++L + + + + + L ++ + +
Sbjct: 103 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLK 158
Query: 172 DLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNF 231
G F +K ++Y+ + + I +P+ L L L L NK++ V ++
Sbjct: 159 SSGIENGAF---QGMKKLSYIRI-ADTNITTIPQGL--PPSLTELHLDGNKITKVDAASL 212
Query: 232 SG-SGLTYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNN 268
G + L + L+ N ++ + + + + L+ N
Sbjct: 213 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 251
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 29/195 (14%), Positives = 66/195 (33%), Gaps = 20/195 (10%)
Query: 12 RLPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNL-PLWKQANG--AIPKAVASIS 67
++ L + ++L N L + A + L + IP+ +
Sbjct: 135 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PP 192
Query: 68 TLADLTLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126
+L +L L+ N+ + + A L L NL KL L+ N+ + S AN L+ +++N
Sbjct: 193 SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 251
Query: 127 FTGQIPDYIQNWTKLEKLFIEG------SGLAGPIPSGIASLVELTDLRISD-----LNG 175
++P + + ++ +++ P + + +
Sbjct: 252 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI 310
Query: 176 PEGPFPRLSNLKNMN 190
F + +
Sbjct: 311 QPSTFRCVYVRAAVQ 325
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 53/259 (20%), Positives = 91/259 (35%), Gaps = 35/259 (13%)
Query: 4 LKSQNLPGRLPPELTRL---PFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIP 60
+++ +P R+ R+ LQE+ L + GT P +L
Sbjct: 75 VRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL----------- 123
Query: 61 KAVASISTLADLTLE-FNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKH 119
+I L +++ + + +L L L+ L + + E L
Sbjct: 124 ----NILNLRNVSWATRDAWLAELQQWL--KPGLKVLSIAQAHSLNFSCEQVRVFPALST 177
Query: 120 FRISDNHFTGQIPDYIQ----NWTKLEKLFI---EGSGLAGPIPSGIASLVELTDLRIS- 171
+SDN G+ + L+ L + +G + A+ V+L L +S
Sbjct: 178 LDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSH 237
Query: 172 -DLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSN 230
L G P +N L L S + ++P+ L L VLDLS+N+L PS
Sbjct: 238 NSLRDAAGA-PSCDWPSQLNSLNL-SFTGLKQVPKGLPA--KLSVLDLSYNRLDR-NPSP 292
Query: 231 FSGSGLTYMYLTGNLLTGP 249
+ + L GN
Sbjct: 293 DELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 45/237 (18%), Positives = 77/237 (32%), Gaps = 21/237 (8%)
Query: 68 TLADLTLEFNQFSGDLPAELGNLIN---LEKLHLNSNNFTGKLPESFANLT--RLKHFRI 122
+L LT+ + + ++ L++L L + TG P T L +
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 123 SDNHFTGQIPDY--IQNW--TKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD--LNGP 176
+ + + +Q W L+ L I + + L+ L +SD G
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 177 EGPFP-----RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNF 231
G + L+ + G + L+ LDLS N L +
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 232 SG--SGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCEN-QSVNL 285
S L + L+ L VP + K +DLSYN S +++L
Sbjct: 249 CDWPSQLNSLNLSFTGLKQ-VPKGLPAKL-SVLDLSYNRLDRNPSPDELPQVGNLSL 303
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFV----NEIGMISALQHPNLV 634
+G G FG V L G A+K L K K + + NE ++ A+ P LV
Sbjct: 49 LGTGSFGRVM---LVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
KL + + L ++ EY+ + L R ++ I L YLH
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLT--FEYLHS- 159
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM-R 753
L +++RD+K N+L+D+ +++DFG AK + T T + GT +APE + +
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW--T-LCGTPEALAPEIILSK 213
Query: 754 GYLTDKA-DVYSFGIVALEIVSGRS 777
GY +KA D ++ G++ E+ +G
Sbjct: 214 GY--NKAVDWWALGVLIYEMAAGYP 236
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 56/243 (23%), Positives = 102/243 (41%), Gaps = 42/243 (17%)
Query: 561 HTGSFTLRQIKAAT----NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLS--SKSKQG 614
G +R + A + + I G +G V G+ ++G +A+K++ +
Sbjct: 4 AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRT 63
Query: 615 NREFVN---------EIGMISALQHPNLVKLYGCCI-----EGNQLLLIYEYMENNSLAR 660
+ EI +++ HPN++ L + ++L L+ E M + LA+
Sbjct: 64 VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQ 122
Query: 661 ALFGPEEHRLKLDWPTRH--SICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 718
+ H ++ +H + GL LHE +VHRD+ N+LL + +
Sbjct: 123 VI-----HDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDIT 174
Query: 719 ISDFGLAKLDEEDNT---HISTRIAGTFGYMAPE--YAMRGYLTDKADVYSFGIVALEIV 773
I DF LA+ D D +++ R Y APE +G+ T D++S G V E+
Sbjct: 175 ICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGF-TKLVDMWSAGCVMAEMF 228
Query: 774 SGR 776
+ +
Sbjct: 229 NRK 231
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 40/218 (18%), Positives = 80/218 (36%), Gaps = 22/218 (10%)
Query: 59 IPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLK 118
I + D+ ++ E L N + + ++ + +++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 119 HFRISDNHFTGQIPDYI-QNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDL-----RIS 171
++D +I Y ++KL++ + + +P + ++ LT L +S
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 130
Query: 172 DLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQ-MIGLRVLDLSFNKLSGVIPSN 230
L P G F L L + S N + + + Q L+ L LS N+L+ V S
Sbjct: 131 SL--PRGIFHNTPKLT---TLSM-SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSL 184
Query: 231 FSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNN 268
L + ++ NLL+ V +D S+N+
Sbjct: 185 I--PSLFHANVSYNLLSTLAIPIAVE----ELDASHNS 216
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 49/265 (18%), Positives = 96/265 (36%), Gaps = 51/265 (19%)
Query: 12 RLPPEL-TRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLA 70
LP + P L + ++ N L I + + ++L
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDD---------------------TFQATTSLQ 168
Query: 71 DLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQ 130
+L L N+ + + L + +L +++ N + + A ++ S N
Sbjct: 169 NLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-V 219
Query: 131 IPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG------PEGPFPRLS 184
+ + +L L ++ + L + A L+ L DL+ PF ++
Sbjct: 220 VRGPVN--VELTILKLQHNNL-----TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272
Query: 185 NLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGN 244
L+ L + S N + + Y + L+VLDLS N L V + L +YL N
Sbjct: 273 RLE---RLYI-SNNRLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHN 328
Query: 245 LLTGPVPDWIVRKRNKHIDLSYNNF 269
+ + K++ LS+N++
Sbjct: 329 SIV-TLKLSTH-HTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 58/268 (21%), Positives = 103/268 (38%), Gaps = 31/268 (11%)
Query: 12 RLPPE-LTRLPFLQEIDLTRNYLNGTIPSEW-ASLP-LVNLPLWKQANGAIPKAV-ASIS 67
+LP L ++ ++L + I + A + L + A +P V ++
Sbjct: 59 KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 117
Query: 68 TLADLTLEFNQFSGDLPAEL-GNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126
L L LE N S LP + N L L +++NN ++F T L++ ++S N
Sbjct: 118 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 176
Query: 127 FTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG----PEGPFPR 182
T + L + + L S +A + + +L S N
Sbjct: 177 LT-HVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDASH-NSINVVRGPVNVE 227
Query: 183 LSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYL 241
L+ L L N + + L GL +DLS+N+L ++ F L +Y+
Sbjct: 228 LTIL----KL---QHNNLTDTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 279
Query: 242 TGNLLTGPVPDWIVRKRN-KHIDLSYNN 268
+ N L + + K +DLS+N+
Sbjct: 280 SNNRLVA-LNLYGQPIPTLKVLDLSHNH 306
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 35/188 (18%), Positives = 58/188 (30%), Gaps = 34/188 (18%)
Query: 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAV 63
L N+ L L ++E+D + N +N +
Sbjct: 188 LFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGP----------------------- 223
Query: 64 ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRIS 123
L L L+ N + D L N L ++ L+ N + F + RL+ IS
Sbjct: 224 -VNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 280
Query: 124 DNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG----PEGP 179
+N + Y Q L+ L + + L + L +L + N
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDH-NSIVTLKLST 337
Query: 180 FPRLSNLK 187
L NL
Sbjct: 338 HHTLKNLT 345
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 26/224 (11%)
Query: 567 LRQIKAATNNFAPDNKIGEGGFGPVY----KGLLADGKVIAVKQLSSKSKQGNRE----F 618
+R ++ ++ IG G FG V K KV A+K LS K + R F
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLS-KFEMIKRSDSAFF 116
Query: 619 VNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRH 678
E +++ P +V+L+ + L ++ EYM L + + + W R
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKW-ARF 172
Query: 679 SIC-IGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 737
+ LA L +H + +HRD+K N+LLDK + K++DFG ++
Sbjct: 173 YTAEVVLA--LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227
Query: 738 RIAGTFGYMAPE----YAMRGYLTDKADVYSFGIVALEIVSGRS 777
GT Y++PE GY + D +S G+ E++ G +
Sbjct: 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 51/219 (23%), Positives = 91/219 (41%), Gaps = 35/219 (15%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN---------EIG 623
+ IG G G V + +A+K+LS R F N E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 624 MISALQHPNLVKLY------GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTR 677
++ + H N++ L E + ++ E M+ N L + + +++LD
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI------QMELDHERM 129
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 737
+ + G+ +LH I+HRD+K +N+++ D KI DFGLA+ + + T
Sbjct: 130 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT 184
Query: 738 RIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
T Y APE + + D++S G + E++ G
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 66/233 (28%), Positives = 103/233 (44%), Gaps = 24/233 (10%)
Query: 559 DLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVY----KGLLADGKVIAVKQLSSKSKQG 614
+L T + T K NF +G G +G V+ GK+ A+K L +
Sbjct: 38 ELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ 97
Query: 615 NREFV------NEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEH 668
+ ++ + Q P LV L+ +L LI +Y+ L L +
Sbjct: 98 KAKTTEHTRTERQV-LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRE 154
Query: 669 RLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728
R + I LA L +LH+ L I++RDIK N+LLD + + ++DFGL+K
Sbjct: 155 RFTEHEVQIYVGEIVLA--LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209
Query: 729 EEDNTHISTRIAGTFGYMAPE---YAMRGYLTDKA-DVYSFGIVALEIVSGRS 777
D T + GT YMAP+ G+ DKA D +S G++ E+++G S
Sbjct: 210 VADETERAYDFCGTIEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGAS 260
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 62/205 (30%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFVN----EIGMISALQHPNLV 634
+G+G FG V +L G+ A+K L K ++ V E ++ +HP L
Sbjct: 13 LGKGTFGKV---ILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
L ++L + EY L L E + + I A L YLH
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSA--LEYLHS- 123
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR- 753
+V+RDIK N++LDKD + KI+DFGL K D + T GT Y+APE
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDN 180
Query: 754 GYLTDKA-DVYSFGIVALEIVSGRS 777
Y +A D + G+V E++ GR
Sbjct: 181 DY--GRAVDWWGLGVVMYEMMCGRL 203
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 42/222 (18%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN---------EIG 623
+ +G G +G V + G+ +A+K+LS R F + E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 624 MISALQHPNLVKLY------GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTR 677
++ +QH N++ L L+ +M+ + L + + LK
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-LQKIM------GLKFSEEKI 128
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH-IS 736
+ + +GL Y+H +VHRD+K N+ +++D KI DFGLA+ + + T +
Sbjct: 129 QYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV 185
Query: 737 TRIAGTFGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 776
TR Y APE + Y D++S G + E+++G+
Sbjct: 186 TRW-----YRAPEVILSWMHY-NQTVDIWSVGCIMAEMLTGK 221
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 56/227 (24%), Positives = 92/227 (40%), Gaps = 27/227 (11%)
Query: 567 LRQIKAATNNFAPDNKIGEGGFGPVY----KGLLADGKVIAVKQLSSKSKQGNRE----F 618
L++++ ++F IG G F V K G+V A+K ++ K R F
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMN-KWDMLKRGEVSCF 108
Query: 619 VNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRH 678
E ++ + +L+ + N L L+ EY L L R+ + R
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEM-ARF 166
Query: 679 SIC-IGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 737
+ I +A + +H L VHRDIK N+LLD+ + +++DFG D T S
Sbjct: 167 YLAEIVMA--IDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221
Query: 738 RIAGTFGYMAPEYAMRGYLTDKADVY-------SFGIVALEIVSGRS 777
GT Y++PE Y + G+ A E+ G++
Sbjct: 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-17
Identities = 37/183 (20%), Positives = 66/183 (36%), Gaps = 8/183 (4%)
Query: 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126
ST S + +L + L + N T L +K I++ H
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIH 77
Query: 127 FTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNL 186
T P I + LE+L I G + ++ L LT L IS + +++ L
Sbjct: 78 ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 187 KNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIP-SNFSGSGLTYMYLTGNL 245
+N + L I ++ L + L+ L++ F+ + +F L +Y
Sbjct: 136 PKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIEDF--PKLNQLYAFSQT 192
Query: 246 LTG 248
+ G
Sbjct: 193 IGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 8e-08
Identities = 17/134 (12%), Positives = 47/134 (35%), Gaps = 7/134 (5%)
Query: 17 LTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWK-QANGAIPKAVASISTLADLTL 74
+ ++++ + + T + + L L L + ++ +++L L +
Sbjct: 62 IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 75 EFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDY 134
+ + ++ L + + L+ N + L LK I +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG-- 176
Query: 135 IQNWTKLEKLFIEG 148
I+++ KL +L+
Sbjct: 177 IEDFPKLNQLYAFS 190
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 21/101 (20%), Positives = 46/101 (45%), Gaps = 7/101 (6%)
Query: 8 NLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAI--PKAVA 64
++ P L+ L L +D++ + + +I ++ +LP + ++ L NGAI +
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL--SYNGAITDIMPLK 156
Query: 65 SISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTG 105
++ L L ++F+ D + + L +L+ S G
Sbjct: 157 TLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-17
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFVNEIG----MISALQHPNLV 634
IG+G FG V LLA + AVK L K+ +E + + ++ ++HP LV
Sbjct: 46 IGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPE-------EHRLKLDWPTRHSICIGLARG 687
L+ ++L + +Y+ G E E ++ I A
Sbjct: 103 GLHFSFQTADKLYFVLDYIN---------GGELFYHLQRERCFLEPRARFYAAEIASA-- 151
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMA 747
L YLH L IV+RD+K N+LLD + ++DFGL K + E N+ ST GT Y+A
Sbjct: 152 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLA 207
Query: 748 PEYAMR-GYLTDKA-DVYSFGIVALEIVSGRS 777
PE + Y D+ D + G V E++ G
Sbjct: 208 PEVLHKQPY--DRTVDWWCLGAVLYEMLYGLP 237
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFVNEIG-----MISALQHPNL 633
IG G + V LL ++ A+K + K + E ++ + A HP L
Sbjct: 17 IGRGSYAKV---LLVRLKKTDRIYAMKVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
V L+ C ++L + EY+ L + + +L + +S I LA L YLHE
Sbjct: 73 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLA--LNYLHE 128
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR 753
I++RD+K NVLLD + + K++D+G+ K ST GT Y+APE
Sbjct: 129 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRG 184
Query: 754 -GYLTDKA-DVYSFGIVALEIVSGRS 777
Y + D ++ G++ E+++GRS
Sbjct: 185 EDY--GFSVDWWALGVLMFEMMAGRS 208
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-16
Identities = 44/199 (22%), Positives = 70/199 (35%), Gaps = 22/199 (11%)
Query: 89 NLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYI-QNWTKLEKLFIE 147
L E+L L+ N SF L +L+ + + I +N L L +
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 148 GSGLAGPIPSGIASLVELTDL-----RISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGE 202
S + P L L +L +SD +G F L L L L S N I
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT---RLDL-SKNQIRS 137
Query: 203 MPE--YLGQMIGLRVLDLSFNKLSGVIPSNFSG---SGLTYMYLTGNLLTGPVPDWIVRK 257
+ G++ L+ +D S N++ V L++ L N L V +
Sbjct: 138 LYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197
Query: 258 RN-------KHIDLSYNNF 269
N + +D+S N +
Sbjct: 198 MNPFRNMVLEILDVSGNGW 216
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-16
Identities = 58/299 (19%), Positives = 96/299 (32%), Gaps = 28/299 (9%)
Query: 6 SQNLPGRLPPE-LTRLPFLQEIDLTRNYLNGTIPSEW-ASLP-LVNLPLWKQANGAIPKA 62
S N + L LQ ++L Y TI E +LP L L L +
Sbjct: 32 SFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91
Query: 63 V-ASISTLADLTLEFNQFSGDL--PAELGNLINLEKLHLNSNNFTG-KLPESFANLTRLK 118
+ L +L L F S + NL L +L L+ N L SF L LK
Sbjct: 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLK 151
Query: 119 HFRISDNHFTGQIPDYIQNWT--KLEKLFIEGSGLAGPIPSGIASLVEL---TDLRISDL 173
S N ++ L + + L + + L I D+
Sbjct: 152 SIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDV 211
Query: 174 NGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG 233
+G N ++ S I L + F+ + + F+G
Sbjct: 212 SG---------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG 262
Query: 234 ---SGLTYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNF--IDGSSDSNCEN-QSVNL 285
S + ++ L+ + ++ K ++L+YN I + +N Q +NL
Sbjct: 263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-16
Identities = 52/276 (18%), Positives = 96/276 (34%), Gaps = 29/276 (10%)
Query: 20 LPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAV-ASISTLADLTLEFN 77
L L+ ++L N +N + L L L L G + + + +A + L+ N
Sbjct: 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 78 QFSGDLPAELGNLINLEKLHLNSNNFT--------GKLPESFANLTRLK-------HFRI 122
+ L L+ L L N T + S L L +
Sbjct: 349 HIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHL 408
Query: 123 SDNHFTG-QIPDYIQNWTKLEKLFIEGSGLAGPIPSGIAS-LVELTDL-----RISDLNG 175
S+N I ++ L+ L + + + S L L +
Sbjct: 409 SENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWE 468
Query: 176 PEGPFPRLSNLKNMNYLILRSGNIIGEMP-EYLGQMIGLRVLDLSFNKLSGVIPSNFSGS 234
E + L ++ L L + N + +P + LR L L+ N+L+ + ++ +
Sbjct: 469 TELCWDVFEGLSHLQVLYL-NHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPAN 527
Query: 235 GLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFI 270
L + ++ N L P PD +D+++N FI
Sbjct: 528 -LEILDISRNQLLAPNPDVF--VSLSVLDITHNKFI 560
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 5e-16
Identities = 43/284 (15%), Positives = 83/284 (29%), Gaps = 33/284 (11%)
Query: 6 SQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVAS 65
S + L + + + P + L
Sbjct: 225 SNAISKSQAFSLILAHHIMGAGFGFHNI--KDPDQNTFAGLAR----------------- 265
Query: 66 ISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN 125
S++ L L L +L+ L+L N E+F L L+ +S N
Sbjct: 266 -SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324
Query: 126 HFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSN 185
K+ + ++ + +A L +L L + D N +
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD-N----ALTTIHF 379
Query: 186 LKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG--SGLTYMYLTG 243
+ ++ + L SGN + +P+ + ++ LS N+L + F L + L
Sbjct: 380 IPSIPDIFL-SGNKLVTLPKIN---LTANLIHLSENRLENLDILYFLLRVPHLQILILNQ 435
Query: 244 NLLTGPVPDWIVRKRN--KHIDLSYNNFIDGSSDSNCENQSVNL 285
N + D + + + L N C + L
Sbjct: 436 NRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGL 479
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 46/279 (16%), Positives = 86/279 (30%), Gaps = 52/279 (18%)
Query: 20 LPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQF 79
L + + L+ NY+ T+ + + L L L
Sbjct: 23 LNTTERLLLSFNYIR-TVT---------------------ASSFPFLEQLQLLELGSQYT 60
Query: 80 SGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQI--PDYIQ 136
+ E NL NL L L S+ P++F L L R+ + + Y +
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120
Query: 137 NWTKLEKLFIEGSGLAG-PIPSGIASLVELTDLRISDLN---GPEGPFPRLSNLKNMNYL 192
N L +L + + + + L L + S E L ++
Sbjct: 121 NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTL-SFF 179
Query: 193 ILRSGNIIGEMPEYLG------QMIGLRVLDLSFNKLSGVIPSNFSGS------------ 234
L + ++ + G + + L +LD+S N + I NFS +
Sbjct: 180 SLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILA 239
Query: 235 -GLTYMYLTGNLLTGPVPDWIVRKRN---KHIDLSYNNF 269
+ + + P + +H+DLS+
Sbjct: 240 HHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFV 278
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 6e-10
Identities = 32/205 (15%), Positives = 61/205 (29%), Gaps = 23/205 (11%)
Query: 99 NSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSG 158
L + L + +S N+ +L+ L + I
Sbjct: 11 YRFC---NLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKE 67
Query: 159 I-ASLVELTDLRISDLNG----PEGPFPRLSNLKNMNYLILRSGNIIGEM---PEYLGQM 210
+L L L + + F L +L L L + + Y +
Sbjct: 68 AFRNLPNLRILDLGS-SKIYFLHPDAFQGLFHLF---ELRL-YFCGLSDAVLKDGYFRNL 122
Query: 211 IGLRVLDLSFNKLSGV-IPSNFSG-SGLTYMYLTGNLLTGPVPD---WIVRKRNKHIDLS 265
L LDLS N++ + + +F + L + + N + + K L+
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 266 YNNFIDGSSDSNCENQSVNLFASSS 290
N+ S S + +N F +
Sbjct: 183 ANSLY--SRVSVDWGKCMNPFRNMV 205
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 36/151 (23%), Positives = 52/151 (34%), Gaps = 28/151 (18%)
Query: 17 LTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEF 76
L R+P LQ + L +N + + S +L L L
Sbjct: 422 LLRVPHLQILILNQNRFSSCSGDQTPSEN---------------------PSLEQLFLGE 460
Query: 77 NQFSGDLPAEL-----GNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQI 131
N EL L +L+ L+LN N P F++LT L+ ++ N T +
Sbjct: 461 NMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VL 519
Query: 132 PDYIQNWTKLEKLFIEGSGLAGPIPSGIASL 162
LE L I + L P P SL
Sbjct: 520 SHNDLP-ANLEILDISRNQLLAPNPDVFVSL 549
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 48/269 (17%), Positives = 82/269 (30%), Gaps = 62/269 (23%)
Query: 12 RLPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLA 70
L + L L + L N ++ I KA + + L
Sbjct: 68 ELRKDDFKGLQHLYALVLVNNKIS-KIH---------------------EKAFSPLRKLQ 105
Query: 71 DLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFT-G 129
L + N ++P L +L +L ++ N F+ L + + N
Sbjct: 106 KLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS 162
Query: 130 QIPDYIQNWTKLEKLFIEGSGLAGPIPSGI-ASLVELT--DLRISDLNGPEGPFPRLSNL 186
+ KL L I + L G IP + +L EL +I + R S L
Sbjct: 163 GFEPGAFDGLKLNYLRISEAKLTG-IPKDLPETLNELHLDHNKIQAI--ELEDLLRYSKL 219
Query: 187 K---------------------NMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSG 225
+ L L N + +P L + L+V+ L N ++
Sbjct: 220 YRLGLGHNQIRMIENGSLSFLPTLRELHL-DNNKLSRVPAGLPDLKLLQVVYLHTNNITK 278
Query: 226 VIPSNFSGSG-------LTYMYLTGNLLT 247
V ++F G + L N +
Sbjct: 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 49/240 (20%), Positives = 88/240 (36%), Gaps = 38/240 (15%)
Query: 58 AIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRL 117
A+PK ++ L L+ N S + L +L L L +N + ++F+ L +L
Sbjct: 47 AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 118 KHFRISDNHFTG--------------------QIPDYI-QNWTKLEKLFIEGSGLA-GPI 155
+ IS NH ++P + + + + G+ L
Sbjct: 105 QKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGF 164
Query: 156 PSGIASLVELTDLRISDLNG---PEGPFPRLSNLKNMNYLILRSGNIIGEMPE-YLGQMI 211
G ++L LRIS+ P+ L+ L +L N I + L +
Sbjct: 165 EPGAFDGLKLNYLRISEAKLTGIPKDLPETLNEL----HL---DHNKIQAIELEDLLRYS 217
Query: 212 GLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNF 269
L L L N++ + + S L ++L N L+ VP + + + + L NN
Sbjct: 218 KLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNI 276
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 32/198 (16%), Positives = 66/198 (33%), Gaps = 22/198 (11%)
Query: 12 RLPPE-LTRLPFLQEIDLTRNYL-NGTIPSEW-ASLPLVNLPLWKQANGAIPKAVASIST 68
++P + L + I++ N L N L L L + + IPK + T
Sbjct: 137 KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDL--PET 194
Query: 69 LADLTLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHF 127
L +L L+ N+ + E L L +L L N S + L L+ + +N
Sbjct: 195 LNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL 253
Query: 128 TGQIPDYIQNWTKLEKLFIEG---SGLAGPIPSGIASLVELTDLRISDLNG--------P 176
+ ++P + + L+ +++ + + + V+ L
Sbjct: 254 S-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQ 312
Query: 177 EGPFPRLSNLKNMNYLIL 194
F + + +
Sbjct: 313 PATF---RCVTDRLAIQF 327
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFVNEIG-----MISALQHPNL 633
IG G + V LL ++ A++ + K + E ++ + A HP L
Sbjct: 60 IGRGSYAKV---LLVRLKKTDRIYAMRVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
V L+ C ++L + EY+ L + + +L + +S I LA L YLHE
Sbjct: 116 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLA--LNYLHE 171
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR 753
I++RD+K NVLLD + + K++D+G+ K ST GT Y+APE
Sbjct: 172 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRG 227
Query: 754 -GYLTDKA-DVYSFGIVALEIVSGRS 777
Y + D ++ G++ E+++GRS
Sbjct: 228 EDY--GFSVDWWALGVLMFEMMAGRS 251
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 41/222 (18%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN---------EIG 623
+ IG G G V + +A+K+LS R F N E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 624 MISALQHPNLVKLY------GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTR 677
++ + H N++ L E + L+ E M+ N L + + +++LD
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI------QMELDHERM 166
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT---H 734
+ + G+ +LH I+HRD+K +N+++ D KI DFGLA+ +
Sbjct: 167 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223
Query: 735 ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
+ TR Y APE + + D++S G + E+V +
Sbjct: 224 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 80.3 bits (197), Expect = 2e-16
Identities = 44/255 (17%), Positives = 75/255 (29%), Gaps = 57/255 (22%)
Query: 573 ATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQL--------SSKSKQGNREFVNEIGM 624
T KIGEG FG V++ +AD +A+K + + ++ E + EI +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 625 ISALQ---------HPNLVKLYGCCI----EGNQLLLIYEYM--ENNSLARALFGPEEHR 669
L + L LL +++ S ++ +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 670 L-------------------KLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVL 710
L T SI L LA L+ HRD+ NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 711 LDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAP--EYAMRGYLTDKADVYSFGIV 768
L K K+ K + + G +Y + D V+ +
Sbjct: 195 LKKTSLKKLHYTLNGK----------SSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244
Query: 769 ALEIVSGRSNVICRT 783
++ +G +
Sbjct: 245 DEDLFTGDGDYQFDI 259
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.4 bits (203), Expect = 2e-16
Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFVNEIGM-----ISALQHPNL 633
+G+G FG V +L+ ++ AVK L K + V + + P L
Sbjct: 349 LGKGSFGKV---MLSERKGTDELYAVKILK-KDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
+L+ C ++L + EY+ L + + R K ++ I + L +L
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIG--LFFLQS 460
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR 753
I++RD+K NV+LD + + KI+DFG+ K + D T GT Y+APE
Sbjct: 461 ---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAY 516
Query: 754 -GYLTDKADVYSFGIVALEIVSGRS 777
Y D ++FG++ E+++G++
Sbjct: 517 QPY-GKSVDWWAFGVLLYEMLAGQA 540
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 66/217 (30%), Positives = 104/217 (47%), Gaps = 51/217 (23%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFV----NEIGMISALQHPNLV 634
+G G FG V+ L +G+ A+K L K + V +E M+S + HP ++
Sbjct: 14 LGTGSFGRVH---LIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIVTHPFII 69
Query: 635 KLYGCCIEGNQLLLIYEYMENNSL------------ARALFGPEEHRLKLDWPTRHSICI 682
+++G + Q+ +I +Y+E L A F E +
Sbjct: 70 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE--------------V 115
Query: 683 GLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT 742
LA L YLH I++RD+K N+LLDK+ + KI+DFG AK D T+ T + GT
Sbjct: 116 CLA--LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTY--T-LCGT 166
Query: 743 FGYMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGRS 777
Y+APE Y +K+ D +SFGI+ E+++G +
Sbjct: 167 PDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYT 201
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN---------EIG 623
+ +G G +G V + G +A+K+L R F + E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76
Query: 624 MISALQHPNLVKLY------GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTR 677
++ ++H N++ L + L+ +M + L + + KL
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-LGKLM-----KHEKLGEDRI 130
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HIS 736
+ + +GL Y+H I+HRD+K N+ +++D KI DFGLA+ + + T ++
Sbjct: 131 QFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 187
Query: 737 TRIAGTFGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 776
TR Y APE Y T D++S G + E+++G+
Sbjct: 188 TRW-----YRAPEVILNWMRY-TQTVDIWSVGCIMAEMITGK 223
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 5e-16
Identities = 45/275 (16%), Positives = 85/275 (30%), Gaps = 17/275 (6%)
Query: 7 QNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWAS----LPLVNLPLWKQANGAIPKA 62
L L I+ T N + W + + N+ L Q +
Sbjct: 211 SILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDY 270
Query: 63 VA-SISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
S+ L+ + + F N+ + + + ++ H
Sbjct: 271 SGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLD 330
Query: 122 ISDNHFTGQIPDYIQNWTKLEKLFIEGSGLA--GPIPSGIASLVELTDLRISD----LNG 175
S+N T + + + T+LE L ++ + L I + L L IS +
Sbjct: 331 FSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDE 390
Query: 176 PEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSG 235
+G +L L + S + + L ++VLDL NK+ +
Sbjct: 391 KKGDCSWTKSLL---SLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIKSIPKQVVKLEA 445
Query: 236 LTYMYLTGNLLTGPVPDWIVRKRN-KHIDLSYNNF 269
L + + N L R + + I L N +
Sbjct: 446 LQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 42/293 (14%), Positives = 86/293 (29%), Gaps = 27/293 (9%)
Query: 13 LPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADL 72
+ E + L+ + L+ +L + A L + + L + +
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166
Query: 73 TLEFN-----QFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTR----------- 116
+L +F L + + NLE ++ K + L +
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLT 226
Query: 117 LKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIA-----SLVELTDLRIS 171
L + + N F + + T + I L G + SL L+ ++
Sbjct: 227 LNNIETTWNSFIRILQ--LVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVV 284
Query: 172 DLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNF 231
NMN ++ LD S N L+ + N
Sbjct: 285 SDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENC 344
Query: 232 SG-SGLTYMYLTGNLLT--GPVPDWIVRKRN-KHIDLSYNNFIDGSSDSNCEN 280
+ L + L N L + + + ++ + +D+S N+ +C
Sbjct: 345 GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSW 397
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 32/231 (13%), Positives = 71/231 (30%), Gaps = 10/231 (4%)
Query: 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126
L + N S +++ +L L L ++ N F L++ +S N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 127 FTGQIPDYIQNWTKLEKLFIEGSGLAG-PIPSGIASLVELTDLRISDLNGPEGPFPRLSN 185
I L+ L + + PI ++ +L L +S + + +++
Sbjct: 81 LVK-IS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 186 LKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDL------SFNKLSGVIPSNFSGSGLTYM 239
L L++ + Q L + F+ + V + L+ +
Sbjct: 138 LNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 240 YLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSS 290
I+ K + LS + + N + + L ++
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 33/169 (19%), Positives = 53/169 (31%), Gaps = 14/169 (8%)
Query: 155 IPSGIASLVELTDL---RISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPE-YLGQM 210
+P ++ + ++ IS+L LS L+ LI+ S N I +
Sbjct: 15 VPKDLSQKTTILNISQNYISEL--WTSDILSLSKLR---ILII-SHNRIQYLDISVFKFN 68
Query: 211 IGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTG-PVPDWIVRKRN-KHIDLSYNN 268
L LDLS NKL + L ++ L+ N P+ K + LS +
Sbjct: 69 QELEYLDLSHNKLVKISCHPTVN--LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTH 126
Query: 269 FIDGSSDSNCENQSVNLFASSSEGSNSTGIVSCLKSFTCPTNHSSLHIN 317
S + E L+ F + H N
Sbjct: 127 LEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN 175
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 25/206 (12%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFVNEIGM-----ISALQHPNL 633
+G+G FG V +LA G + AVK L K + V A HP L
Sbjct: 31 LGKGSFGKV---MLARVKETGDLYAVKVLK-KDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
+L+ C ++L + E++ L + + R ++ I A L +LH+
Sbjct: 87 TQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISA--LMFLHD 142
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR 753
I++RD+K NVLLD + + K++DFG+ K + +T GT Y+APE
Sbjct: 143 ---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPEILQE 198
Query: 754 -GYLTDKA-DVYSFGIVALEIVSGRS 777
Y A D ++ G++ E++ G +
Sbjct: 199 MLY--GPAVDWWAMGVLLYEMLCGHA 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-16
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFVNEIGM-----ISALQHPNL 633
+G+G FG V LA + A+K L K + V + A +HP L
Sbjct: 25 LGKGSFGKV---FLAEFKKTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
++ L + EY+ L + H+ L T ++ I L L +LH
Sbjct: 81 THMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILG--LQFLHS 136
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR 753
IV+RD+K N+LLDKD + KI+DFG+ K + + +T GT Y+APE +
Sbjct: 137 ---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLG 192
Query: 754 -GYLTDKA-DVYSFGIVALEIVSGRS 777
Y + + D +SFG++ E++ G+S
Sbjct: 193 QKY--NHSVDWWSFGVLLYEMLIGQS 216
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 50/238 (21%), Positives = 74/238 (31%), Gaps = 33/238 (13%)
Query: 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126
L L N A L L +L+L+ T KL L L +S N
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQ 88
Query: 127 FTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDL-----RISDLNGPEGPF 180
+P Q L L + + L +P G L EL +L + L P G
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKTL--PPGLL 144
Query: 181 PRLSNLKNMNYLILRSGNIIGEMPEYL-GQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYM 239
L+ L L + N + E+P L + L L L N L + F L +
Sbjct: 145 TPTPKLE---KLSL-ANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFA 200
Query: 240 YLTGN-------LLTGPVPDWIVRKRNK-------HIDLSYNNFIDGSSDSNCENQSV 283
+L GN +L W+ + + + N + V
Sbjct: 201 FLHGNPWLCNCEIL--YFRRWLQDNAENVYVWKQGVDVKAMTSNVASVQCDNSDKFPV 256
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 37/139 (26%), Positives = 53/139 (38%), Gaps = 10/139 (7%)
Query: 15 PELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANG--AIPKAV-ASISTLA 70
LP L +DL+ N L ++P +LP L L + N ++P + L
Sbjct: 71 QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV--SFNRLTSLPLGALRGLGELQ 127
Query: 71 DLTLEFNQFSGDLPAEL-GNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTG 129
+L L+ N+ LP L LEKL L +NN T L L + +N
Sbjct: 128 ELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT 186
Query: 130 QIPDYIQNWTKLEKLFIEG 148
IP L F+ G
Sbjct: 187 -IPKGFFGSHLLPFAFLHG 204
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 52/205 (25%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 583 IGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFVNEIG----MISALQHPNLV 634
+G+G FG V +L+ ++ AVK L + + + + + P L
Sbjct: 28 LGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
+L+ C ++L + EY+ L + + R K ++ I + L +L
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIG--LFFLQS- 139
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR- 753
I++RD+K NV+LD + + KI+DFG+ K + D T GT Y+APE
Sbjct: 140 --KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQ 196
Query: 754 GYLTDKA-DVYSFGIVALEIVSGRS 777
Y K+ D ++FG++ E+++G++
Sbjct: 197 PY--GKSVDWWAFGVLLYEMLAGQA 219
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 50/300 (16%), Positives = 90/300 (30%), Gaps = 69/300 (23%)
Query: 8 NLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASIS 67
++P L + L DL+ N + + +
Sbjct: 45 SIPSGLTEAVKSL------DLSNNRI--------TYIS--------------NSDLQRCV 76
Query: 68 TLADLTLEFNQFSGDLPAEL-GNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126
L L L N + + + +L +LE L L+ N + F L+ L + N
Sbjct: 77 NLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNP 135
Query: 127 FTGQIPDYI--QNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDLRIS------------ 171
+ + + + TKL+ L + I A L L +L I
Sbjct: 136 YK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSL 194
Query: 172 ---------DLNG------PEGPFPRLSNLK--NMNYLILRSGN---IIGEMPEYLGQMI 211
L+ E S+++ + L + + + L +
Sbjct: 195 KSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKF 254
Query: 212 GLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVR--KRNKHIDLSYNNF 269
R + ++ L V+ SGL + + N L VPD I + I L N +
Sbjct: 255 TFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 42/271 (15%), Positives = 76/271 (28%), Gaps = 55/271 (20%)
Query: 6 SQNLPGRLPPEL-TRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLP-LWKQANGAI---- 59
S N L L L ++L N T+ L L L
Sbjct: 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQ 166
Query: 60 PKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKH 119
K A ++ L +L ++ + P L ++ N+ L L+ L + ++
Sbjct: 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVEC 226
Query: 120 FRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGP 179
+ D L S+L G
Sbjct: 227 LELRDTD--------------------------------------LDTFHFSEL--STGE 246
Query: 180 FPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTY 238
L + + + + ++ + L Q+ GL L+ S N+L V F + L
Sbjct: 247 TNSLIKKFTFRNVKI-TDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQK 305
Query: 239 MYLTGNLLT------GPVPDWIVRKRNKHID 263
++L N + W+ + K
Sbjct: 306 IWLHTNPWDCSCPRIDYLSRWLNKNSQKEQG 336
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN---------EIG 623
+ + +G G +G V G +AVK+LS R F + E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 624 MISALQHPNLVKLY------GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTR 677
++ ++H N++ L E N + L+ M + L + KL
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIV-----KCQKLTDDHV 134
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HIS 736
+ + RGL Y+H I+HRD+K +N+ +++D KI DFGLA+ ++ T +++
Sbjct: 135 QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA 191
Query: 737 TRIAGTFGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 776
TR Y APE Y D++S G + E+++GR
Sbjct: 192 TRW-----YRAPEIMLNWMHY-NQTVDIWSVGCIMAELLTGR 227
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 38/162 (23%), Positives = 62/162 (38%), Gaps = 35/162 (21%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
+G G G V + + A+K L + RE E+ A Q P++V++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVY 80
Query: 641 ----IEGNQLLLIYEYM---ENNSLARALFGPEEHRLKLDWPTRHS------ICIGLARG 687
LL++ E + E LF R++ + I +
Sbjct: 81 ENLYAGRKCLLIVMECLDGGE-------LF----SRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 688 LAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAK 726
+ YLH + I HRD+K N+L + K++DFG AK
Sbjct: 130 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 48/222 (21%), Positives = 95/222 (42%), Gaps = 47/222 (21%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSS-KSKQGNREFVNEIGMISALQ-- 629
+++ K+G G + V++ + + + + + VK L K K+ RE I L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-------IKILENL 87
Query: 630 --HPNLVKLYGCCI--EGNQLLLIYEYMENNSLARAL--FGPEEHRLKLDWPTRHSICIG 683
PN++ L L++E++ N + + R + + I
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM-----YEIL-- 140
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAKL---DEEDNTHIST 737
+ L Y H S I+HRD+K NV++D + L ++ D+GLA+ +E N +++
Sbjct: 141 --KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKL--RLIDWGLAEFYHPGQEYNVRVAS 193
Query: 738 RIAGTFGYMAPE--YAMRGYLTDKA-DVYSFGIVALEIVSGR 776
R + PE + Y D + D++S G + ++ +
Sbjct: 194 RY-----FKGPELLVDYQMY--DYSLDMWSLGCMLASMIFRK 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLS--SKSKQGNREFVNEIGMISALQH 630
+ + IGEG +G V + +A+K++S R EI ++ +H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 84
Query: 631 PNLVKLYGCCI-----EGNQLLLIYEYMENNSLARALFGP---EEHRLKLDWPTRHSICI 682
N++ + + + ++ + ME + L + L +H
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHI--------CYFLY 135
Query: 683 GLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRIA 740
+ RGL Y+H + ++HRD+K +N+LL+ + KI DFGLA++ + D+T T
Sbjct: 136 QILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 741 GTFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGR 776
T Y APE + +GY T D++S G + E++S R
Sbjct: 193 ATRWYRAPEIMLNSKGY-TKSIDIWSVGCILAEMLSNR 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 39/205 (19%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN---------EIG 623
+N+ + IG G +G VY K +A+K+++ R F + EI
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77
Query: 624 MISALQHPNLVKLYGCCI-----EGNQLLLIYEYMENNSLARALFGP----EEHRLKLDW 674
+++ L+ +++LY I + ++L ++ E +++ L + P EEH
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD-LKKLFKTPIFLTEEHI----- 131
Query: 675 PTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNT 733
+I L G ++HE I+HRD+K N LL++D + K+ DFGLA ++ E +T
Sbjct: 132 ---KTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 734 HISTRIAGTFGYMAPEYAMRGYLTD 758
+I + ++ LT
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 51/211 (24%), Positives = 78/211 (36%), Gaps = 24/211 (11%)
Query: 72 LTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPES-FANLTRLKHFRISDNHFTGQ 130
L L FN + L+ L L+ + + + +L+ L ++ N
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-S 90
Query: 131 IPDYI-QNWTKLEKLFIEGSGLAGPIPSGIAS-LVELTDL-----RISDLNGPEGPFPRL 183
+ + L+KL + LA + + L L +L I P F L
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLP-EYFSNL 148
Query: 184 SNLKNMNYLILRSGNIIGEMPE----YLGQMIGLRV-LDLSFNKLSGVIPSNFSGSGLTY 238
+NL+ +L L S N I + L QM L + LDLS N ++ + P F L
Sbjct: 149 TNLE---HLDL-SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKE 204
Query: 239 MYLTGNLLTGPVPDWIVR--KRNKHIDLSYN 267
+ L N L VPD I + I L N
Sbjct: 205 LALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 52/268 (19%), Positives = 84/268 (31%), Gaps = 54/268 (20%)
Query: 6 SQNLPGRLPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVA 64
S N L P LQ +DL+R + TI A
Sbjct: 36 SFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIE---------------------DGAYQ 73
Query: 65 SISTLADLTLEFNQFSGDLPAEL-GNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRIS 123
S+S L+ L L N L L +L+KL N +L LK ++
Sbjct: 74 SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 124 DNHFTG-QIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPR 182
N ++P+Y N T LE L + + ++ +
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSN--------------KIQSI-------YCTDLRV 171
Query: 183 LSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYL 241
L + +N + S N + + + I L+ L L N+L V F + L ++L
Sbjct: 172 LHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWL 231
Query: 242 TGNLLT------GPVPDWIVRKRNKHID 263
N + W+ + K
Sbjct: 232 HTNPWDCSCPRIDYLSRWLNKNSQKEQG 259
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 40/192 (20%), Positives = 73/192 (38%), Gaps = 24/192 (12%)
Query: 92 NLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYI-QNWTKLEKLFIEGSG 150
+ + L L+ N SF + L+ +S I D Q+ + L L + G+
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 151 LAGPIPSGI-ASLVELTDL-----RISDLNGPEGPFPRLSNLKNMNYLILRSGNIIG--E 202
+ + G + L L L ++ L P L LK L + + N+I +
Sbjct: 88 IQS-LALGAFSGLSSLQKLVAVETNLASL--ENFPIGHLKTLK---ELNV-AHNLIQSFK 140
Query: 203 MPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYM----YLTGNLLTGPVPDWIVRK 257
+PEY + L LDLS NK+ + ++ + + L+ N + + ++
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKE 199
Query: 258 RN-KHIDLSYNN 268
K + L N
Sbjct: 200 IRLKELALDTNQ 211
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 42/210 (20%), Positives = 83/210 (39%), Gaps = 44/210 (20%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN---------EIG 623
+ + + IG G +G V + + +V+A+K++ R F + EI
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 624 MISALQHPNLVKLYGCCI-----EGNQLLLIYEYMENNSLARALFGP----EEHRLKLDW 674
+++ L H ++VK+ I + ++L ++ E +++ + P E H
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD-FKKLFRTPVYLTELHI----- 158
Query: 675 PTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA------KLD 728
++ L G+ Y+H I+HRD+K N L+++D + K+ DFGLA +
Sbjct: 159 ---KTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212
Query: 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
++ LT
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 6e-14
Identities = 38/273 (13%), Positives = 80/273 (29%), Gaps = 45/273 (16%)
Query: 17 LTRLP----FLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADL 72
L ++P + +DL+ N + A L + + + L L
Sbjct: 22 LHQVPELPAHVNYVDLSLNSI--------AELN--------------ETSFSRLQDLQFL 59
Query: 73 TLEFNQFSGDLPAEL-GNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQI 131
+E + L +L L L+ N F +F L L+ ++ + G +
Sbjct: 60 KVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAV 119
Query: 132 --PDYIQNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDL-----RISDLNGPEGPFPRL 183
++ + T LE L + + + P+ ++ L ++ + E
Sbjct: 120 LSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSI--CEEDLLNF 177
Query: 184 S-------NLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGL 236
L ++ + + E + + LDLS N + F +
Sbjct: 178 QGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFF-DAI 236
Query: 237 TYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNF 269
+ +L+ D F
Sbjct: 237 AGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 46/302 (15%), Positives = 88/302 (29%), Gaps = 39/302 (12%)
Query: 4 LKSQNLPGRLPPEL-TRLPFLQEIDLTRNYLNGTIPSEWASLPLVNL-PLWKQAN----G 57
++ Q + L L + L N + + A L NL L
Sbjct: 61 VEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQLETG-AFNGLANLEVLTLTQCNLDGA 118
Query: 58 AIPKAV-ASISTLADLTLEFNQFSGDLPAEL-GNLINLEKLHLNSNNFTGKLPESFANLT 115
+ +++L L L N PA N+ L L N E N
Sbjct: 119 VLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQ 178
Query: 116 RL----------KHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVEL 165
+++ + T + L + G+G + +
Sbjct: 179 GKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG 238
Query: 166 TDLRISDLNGPEGPFPRLS-------------NLKNMNYLILR-SGNIIGEMPEYL-GQM 210
T ++ L+ L+ S + I + + +
Sbjct: 239 TKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHF 298
Query: 211 IGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRK-RN-KHIDLSYN 267
L L L+ N+++ + + F G + L + L+ N L + + + +DLSYN
Sbjct: 299 TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYN 357
Query: 268 NF 269
+
Sbjct: 358 HI 359
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 36/235 (15%), Positives = 72/235 (30%), Gaps = 48/235 (20%)
Query: 19 RLPFLQEIDLTRNYLNGTIPSE-WASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFN 77
+ + +DL+ N ++ + ++ + +N + + D
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD--NF 267
Query: 78 QFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQN 137
F G + ++ L+ + L F++ T L+ ++ N
Sbjct: 268 TFKGLEAS------GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQN------------ 309
Query: 138 WTKLEKLFIEGSGLAGPIPSGI-ASLVELTDL-----RISDLNGPEGPFPRLSNLKNMNY 191
++ K I L L L + + F L L+
Sbjct: 310 --EINK-----------IDDNAFWGLTHLLKLNLSQNFLGSI--DSRMFENLDKLE---V 351
Query: 192 LILRSGNIIGEMPEYL-GQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGN 244
L L S N I + + + L+ L L N+L V F + L ++L N
Sbjct: 352 LDL-SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 34/140 (24%), Positives = 56/140 (40%), Gaps = 15/140 (10%)
Query: 7 QNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNL-PLWKQAN--GAIPKAV 63
L + T L +++ L +N +N I A L +L L N G+I +
Sbjct: 288 FALLKSVFSHFTDL---EQLTLAQNEIN-KIDDN-AFWGLTHLLKLNLSQNFLGSIDSRM 342
Query: 64 -ASISTLADLTLEFNQFSGDLPAEL-GNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
++ L L L +N L + L NL++L L++N F LT L+
Sbjct: 343 FENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIW 401
Query: 122 ISDNHFT---GQIPDYIQNW 138
+ N + +I DY+ W
Sbjct: 402 LHTNPWDCSCPRI-DYLSRW 420
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 46/231 (19%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPN 632
+ + +G GG G V+ + K +A+K++ Q + + EI +I L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 633 LVKLY--------------GCCIEGNQLLLIYEYMENNSLARALFG---PEEHRLKLDWP 675
+VK++ G E N + ++ EYME + LA L EEH
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVLEQGPLLEEHA------ 122
Query: 676 TRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTH 734
L RGL Y+H + ++HRD+K N+ ++ +DL KI DFGLA++ + +H
Sbjct: 123 --RLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 735 -------ISTRIAGTFGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 776
+ T+ Y +P + Y T D+++ G + E+++G+
Sbjct: 178 KGHLSEGLVTK-----WYRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGK 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLS--SKSKQGNREFVNEIGMISALQH 630
+++F + +GEG +G V G+++A+K++ K R EI ++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKH 68
Query: 631 PNLVKLY-----GCCIEGNQLLLIYEYMENNSLARALFGP---EEHRLKLDWPTRHSICI 682
N++ ++ N++ +I E M+ + L R + ++H
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTD-LHRVISTQMLSDDHI--------QYFIY 119
Query: 683 GLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT 742
R + LH + ++HRD+K +N+L++ + + K+ DFGLA++ +E S
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 743 FG---------YMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 776
G Y APE Y + DV+S G + E+ R
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKY-SRAMDVWSCGCILAELFLRR 220
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 50/270 (18%), Positives = 89/270 (32%), Gaps = 51/270 (18%)
Query: 14 PPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLT 73
L + + + TI + L L L
Sbjct: 34 TVTQADLDGITTLSAFGTGVT-TIE------GVQYLN-----------------NLIGLE 69
Query: 74 LEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPD 133
L+ NQ + DL L NL + +L L+ N + A L +K ++ T P
Sbjct: 70 LKDNQIT-DLA-PLKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP- 124
Query: 134 YIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDL-----RISDLNGPEGPFPRLSNLKN 188
+ + L+ L+++ + + S +A L L L ++SDL L+NL
Sbjct: 125 -LAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDLTP-------LANLSK 174
Query: 189 MNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLT 247
+ L N I ++ L + L + L N++S V S + S L + LT +T
Sbjct: 175 LTTLKA-DDNKISDISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTIT 230
Query: 248 GPVPDWIVRKRNKHIDLSYNNFIDGSSDSN 277
++ + +
Sbjct: 231 N--QPVFYNNNLVVPNVVKGPSGAPIAPAT 258
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 37/215 (17%), Positives = 74/215 (34%), Gaps = 32/215 (14%)
Query: 87 LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFI 146
L N K+ +N T + A+L + T I +Q L L +
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70
Query: 147 EGSGLAGPIPSGIASLVELTDL-----RISDLNGPEGP---------------FPRLSNL 186
+ + + + + +L ++T+L + +++ G L+ L
Sbjct: 71 KDNQITD--LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 187 KNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNL 245
N+ L L N I + L + L+ L + ++S + + + S LT + N
Sbjct: 129 SNLQVLYL-DLNQITNISP-LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNK 184
Query: 246 LTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCEN 280
++ + + L N D S +N N
Sbjct: 185 ISD-ISPLASLPNLIEVHLKNNQISDVSPLANTSN 218
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 52/238 (21%), Positives = 90/238 (37%), Gaps = 54/238 (22%)
Query: 15 PELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTL 74
+ +L L ++ T N + +L L L L
Sbjct: 58 TGIEKLTGLTKLICTSNNIT--------TLDLSQNT-----------------NLTYLAC 92
Query: 75 EFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDY 134
+ N+ + +L + L L L+ ++N T KL S L + + N T +I
Sbjct: 93 DSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVS--QNPLLTYLNCARNTLT-EID-- 143
Query: 135 IQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDL-----RISDLNGPEGPFPRLSNLKNM 189
+ + T+L +L + + + +LT L +I++L+ +S K +
Sbjct: 144 VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELD--------VSQNKLL 193
Query: 190 NYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLT 247
N L N I ++ L Q I L LD S NKL+ + + + LTY + N LT
Sbjct: 194 NRLNC-DTNNITKLD--LNQNIQLTFLDCSSNKLTEIDVTPL--TQLTYFDCSVNPLT 246
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 42/258 (16%), Positives = 79/258 (30%), Gaps = 45/258 (17%)
Query: 14 PPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLT 73
++T L +D + N + L + L L L
Sbjct: 163 KLDVTPQTQLTTLDCSFNKIT--------ELDVSQNKL-----------------LNRLN 197
Query: 74 LEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPD 133
+ N + L L I L L +SN T ++ LT+L +F S N T ++
Sbjct: 198 CDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD- 249
Query: 134 YIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLI 193
+ +KL L + L I + +L + + +++ + L
Sbjct: 250 -VSTLSKLTTLHCIQTDLLE-ID--LTHNTQLIYFQAEGCR--KIKELDVTHNTQLYLLD 303
Query: 194 LRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDW 253
I E+ L Q L L L+ +L+ + S+ + L + +
Sbjct: 304 C-QAAGITELD--LSQNPKLVYLYLNNTELTELDVSHN--TKLKSLSCVNAHIQD-FSSV 357
Query: 254 IVRKRNKHIDLSYNNFID 271
+ + I
Sbjct: 358 GKIPALNNNFEAEGQTIT 375
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 37/259 (14%), Positives = 76/259 (29%), Gaps = 54/259 (20%)
Query: 16 ELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLE 75
++++ L ++ N + L L L L
Sbjct: 186 DVSQNKLLNRLNCDTNNIT--------KLDLNQNIQ-----------------LTFLDCS 220
Query: 76 FNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYI 135
N+ + ++ + L L + N T +L S L++L +I +
Sbjct: 221 SNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EID--L 271
Query: 136 QNWTKLEKLFIEGSGLAGPIPSGIASLVELTDL-----RISDLNGPEGPFPRLSNLKNMN 190
+ T+L EG + + +L L I++L+ LS +
Sbjct: 272 THNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITELD--------LSQNPKLV 321
Query: 191 YLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPV 250
YL L + + E+ + L+ L + S L + +
Sbjct: 322 YLYL-NNTELTELD--VSHNTKLKSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQTIT-M 376
Query: 251 PDWIVRKRNKHIDLSYNNF 269
P + + I +S +
Sbjct: 377 PKETLTNNSLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 33/200 (16%), Positives = 60/200 (30%), Gaps = 36/200 (18%)
Query: 69 LADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFT-----GKLPE-------------- 109
A + L L L ++++ T KL
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNITTL 79
Query: 110 SFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVEL--TD 167
+ T L + N T + + TKL L + + L S L L
Sbjct: 80 DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCAR 136
Query: 168 LRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVI 227
+++++ +S+ + L I ++ + L LD SFNK++ +
Sbjct: 137 NTLTEID--------VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELD 186
Query: 228 PSNFSGSGLTYMYLTGNLLT 247
S L + N +T
Sbjct: 187 VSQN--KLLNRLNCDTNNIT 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 34/189 (17%), Positives = 54/189 (28%), Gaps = 36/189 (19%)
Query: 92 NLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGL 151
N + S L L ++ T + I+ T L KL +
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSN-- 74
Query: 152 AGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMI 211
I+ L+ LS N+ YL N + + + +
Sbjct: 75 -----------------NITTLD--------LSQNTNLTYLAC-DSNKLTNLD--VTPLT 106
Query: 212 GLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFID 271
L L+ NKL+ + S LTY+ N LT D + +D N I
Sbjct: 107 KLTYLNCDTNKLTKLDVSQN--PLLTYLNCARNTLT--EIDVSHNTQLTELDCHLNKKIT 162
Query: 272 GSSDSNCEN 280
+
Sbjct: 163 KLDVTPQTQ 171
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 37/188 (19%), Positives = 61/188 (32%), Gaps = 14/188 (7%)
Query: 92 NLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYI-QNWTKLEKLFIEGSG 150
N +L +F+ L+ IS N I + N KL ++ IE +
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 151 LAGPIPSGI-ASLVELTDLRISDLNG----PEGPFPRLSNLKNMNYLILRSGNIIGEMPE 205
I +L L L IS+ G P+ L ++ I +
Sbjct: 91 NLLYINPEAFQNLPNLQYLLISN-TGIKHLPDVHKIHSLQKV---LLDIQDNINIHTIER 146
Query: 206 YL--GQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTG-NLLTGPVPDWIVR-KRNKH 261
G +L L+ N + + S F+G+ L + L+ N L D
Sbjct: 147 NSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 206
Query: 262 IDLSYNNF 269
+D+S
Sbjct: 207 LDISRTRI 214
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 43/250 (17%), Positives = 77/250 (30%), Gaps = 27/250 (10%)
Query: 7 QNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWK-QANGAIPK-AV 63
+P LP L L ++ L + + + I
Sbjct: 22 TEIPSDLPRNAIEL------RFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 75
Query: 64 ASISTLADLTLE-FNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFR 121
+++ L ++ +E N + E NL NL+ L +++ + +
Sbjct: 76 SNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 134
Query: 122 ISDNHFTGQIPDYI--QNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG---- 175
I DN I + L++ +G+ I + + +L +L +SD N
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEEL 193
Query: 176 PEGPFPRLSNLKNMNYLILRSGNIIGEMPEY-LGQMIGLRVLDLSFNKLSGVIPSNFSGS 234
P F L + S I +P Y L + LR K +P+
Sbjct: 194 PNDVF---HGASGPVILDI-SRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTLEKLV 246
Query: 235 GLTYMYLTGN 244
L LT
Sbjct: 247 ALMEASLTYP 256
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 43/260 (16%), Positives = 91/260 (35%), Gaps = 17/260 (6%)
Query: 23 LQEIDLTRNYLNGTIPSEWAS----LPLVNLPLWKQANGAIPK-AVASISTLADLTLEFN 77
LQ I+ T W L + NL + ++ + + ++ +L ++
Sbjct: 256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQ 315
Query: 78 QFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQN 137
F A + L+ ++ + + + N FT +
Sbjct: 316 VFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCST 375
Query: 138 WTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG---PEGPFPRL-SNLKNMNYLI 193
+L+ L ++ +GL ++ L D++ + R + +++ L
Sbjct: 376 LKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLN 434
Query: 194 LRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPD 252
L S + G + L ++VLDL N++ IP + + L + + N L VPD
Sbjct: 435 LSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPD 490
Query: 253 WIVR--KRNKHIDLSYNNFI 270
+ ++I L N +
Sbjct: 491 GVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 39/226 (17%), Positives = 66/226 (29%), Gaps = 10/226 (4%)
Query: 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPES-FANLTRLKHFRISDN 125
L+L N S ++ L L L L+ N L F L++ +S N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHN 110
Query: 126 HFTGQIPDYIQNWTKLEKLFIEGSGLAG-PIPSGIASLVELTDLRISDLNGPEGPFPRLS 184
I L L + + P+ +L +LT L +S + ++
Sbjct: 111 RLQN-ISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVA 167
Query: 185 NLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLS----GVIPSNFSGSGLTYMY 240
+L L+ I Q+ VL L F+ S V S + L
Sbjct: 168 HLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLF 286
+ N + + + L + C + F
Sbjct: 228 IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 28/136 (20%), Positives = 54/136 (39%), Gaps = 7/136 (5%)
Query: 7 QNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVAS- 65
+N + + L+ +D++ N LN + L L +N + +V
Sbjct: 390 KNFFK-VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNM-LTGSVFRC 447
Query: 66 -ISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISD 124
+ L L N+ +P ++ +L L++L++ SN F LT L++ + D
Sbjct: 448 LPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHD 506
Query: 125 NHFTGQIPD--YIQNW 138
N + P Y+ W
Sbjct: 507 NPWDCTCPGIRYLSEW 522
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 48/189 (25%), Positives = 78/189 (41%), Gaps = 32/189 (16%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQH-PN 632
N + KIG G FG +Y G +A G+ +A+K K+K E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGP--EEHRLKLD--WPTRHSICIG--LAR 686
+ + C EG+ +++ ME L GP E+ + + + + +
Sbjct: 67 IPTIRWCGAEGDYNVMV---ME-------LLGPSLEDLFNFCSRKFSLKTVLLLADQMIS 116
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPK---ISDFGLAK--LDEEDNTHISTR--- 738
+ Y+H ++ +HRD+K N L+ I DFGLAK D + HI R
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173
Query: 739 -IAGTFGYM 746
+ GT Y
Sbjct: 174 NLTGTARYA 182
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 49/191 (25%), Positives = 76/191 (39%), Gaps = 34/191 (17%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQH-PN 632
NF KIG G FG + G L + +A+K KS+ E L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGP--EEHRLKLD--WPTRHSICIG--LAR 686
+ ++Y G ++ +E L GP E+ D + + + I L
Sbjct: 67 IPQVYYFGPCGKYNAMV---LE-------LLGPSLEDLFDLCDRTFSLKTVLMIAIQLIS 116
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPK-----ISDFGLAK--LDEEDNTHISTR- 738
+ Y+H ++ +++RD+K N L+ + N I DF LAK +D E HI R
Sbjct: 117 RMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173
Query: 739 ---IAGTFGYM 746
+ GT YM
Sbjct: 174 HKSLTGTARYM 184
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 46/192 (23%), Positives = 80/192 (41%), Gaps = 36/192 (18%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQH-PN 632
++ +IGEG FG +++G L + + +A+K +S + +E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTG 67
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGP--EEHRLKLD--WPTRHSICIG---LA 685
+ +Y EG +L+ ++ L GP E+ + + LA
Sbjct: 68 IPNVYYFGQEGLHNVLV---ID-------LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLA 117
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK-----ISDFGLAK--LDEEDNTHISTR 738
R + +HE+S +V+RDIK N L+ + + + DFG+ K D HI R
Sbjct: 118 R-VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 739 ----IAGTFGYM 746
++GT YM
Sbjct: 174 EKKNLSGTARYM 185
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 46/201 (22%), Positives = 84/201 (41%), Gaps = 35/201 (17%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVN---------EIG 623
+ K+G+G +G V+K + G+V+AVK++ F N EI
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 624 MISALQ-HPNLVKLYGCCI--EGNQLLLIYEYMENNSLARALFGP---EEHRLKLDWPTR 677
+++ L H N+V L + L+++YME + L + H+
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD-LHAVIRANILEPVHK-------- 111
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 737
+ L + + YLH S ++HRD+K +N+LL+ + + K++DFGL++ +
Sbjct: 112 QYVVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 738 RIAGTFGYMAPEYAMRGYLTD 758
+ LTD
Sbjct: 169 IPLSINENTENFDDDQPILTD 189
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 51/212 (24%), Positives = 82/212 (38%), Gaps = 33/212 (15%)
Query: 72 LTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPES-FANLTRLKHFRISDNHFTGQ 130
L L+ N+ S L L L+LN N LP F L L+ ++DN
Sbjct: 42 LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-A 99
Query: 131 IPDYI-QNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDLRISDLNG------PEGPFPR 182
+P + L +L ++ + L +P + SL +LT L L P+G F +
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYL---SLGYNELQSLPKGVFDK 155
Query: 183 LSNLKNMNYLILRSGNIIGEMPE----YLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLT 237
L++LK + L N + +PE L + L+ L L N+L V F L
Sbjct: 156 LTSLKEL-RL---YNNQLKRVPEGAFDKLTE---LKTLKLDNNQLKRVPEGAFDSLEKLK 208
Query: 238 YMYLTGNLLTGPVPD------WIVRKRNKHID 263
+ L N W+ +K ++ +
Sbjct: 209 MLQLQENPWDCTCNGIIYMAKWLKKKADEGLG 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 8e-12
Identities = 47/328 (14%), Positives = 113/328 (34%), Gaps = 38/328 (11%)
Query: 72 LTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQI 131
L+ + + L +++++ N+++ + + L + ++ N ++
Sbjct: 26 DNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGN----KL 77
Query: 132 PD--YIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDL-----RISDLNGPEGPFPRLS 184
D + N L LF++ + + + S + L +L L ISD+NG L
Sbjct: 78 TDIKPLTNLKNLGWLFLDENKIKD-L-SSLKDLKKLKSLSLEHNGISDING-------LV 128
Query: 185 NLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTG 243
+L + L L N I ++ L ++ L L L N++S + +G + L +YL+
Sbjct: 129 HLPQLESLYL-GNNKITDI-TVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSK 184
Query: 244 NLLTGPVPDWIVRKRN-KHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVSCL 302
N ++ + +N ++L ++ N NL ++ N+ G +
Sbjct: 185 NHISDLRA--LAGLKNLDVLELFSQECLN-----KPINHQSNLVVPNTV-KNTDGSLVTP 236
Query: 303 KSFTCPTNHSSLHINCGGKQVIANGSTTFEDDLDAAGPSRFFISRTNWAFSTTGHFIDNS 362
+ + ++ ++ + S F + F R +
Sbjct: 237 EIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDV 296
Query: 363 TRENSYIQINTSRLLMDDSQLYTEARIS 390
++ + + +
Sbjct: 297 DGTVIKTKVEAGTRITAPKPPTKQGYVF 324
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 49/263 (18%), Positives = 96/263 (36%), Gaps = 29/263 (11%)
Query: 15 PELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLT 73
L + +I + + ++ LP + L L I K + ++ L L
Sbjct: 37 VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDI-KPLTNLKNLGWLF 93
Query: 74 LEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPD 133
L+ N+ DL + L +L L+ L L N + + +L +L+ + +N +I D
Sbjct: 94 LDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNN----KITD 145
Query: 134 --YIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDL-----RISDLNGPEGPFPRLSNL 186
+ TKL+ L +E + ++ +A L +L +L ISDL L+ L
Sbjct: 146 ITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHISDLRA-------LAGL 196
Query: 187 KNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLL 246
KN++ L L S + + + ++ + + L + +L
Sbjct: 197 KNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV-TPEIISDDGDYEKPNVKWHLP 255
Query: 247 TGPVPDWIVRKRNKHIDLSYNNF 269
+ + I + F
Sbjct: 256 EFTNEVSFIFYQPVTIGKAKARF 278
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 35/203 (17%), Positives = 67/203 (33%), Gaps = 31/203 (15%)
Query: 62 AVASIST-LADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPE-SFANLTRLKH 119
+ S+ L L NL N+ +++++ + +L SF NL+++ H
Sbjct: 25 RIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTH 84
Query: 120 FRISDNHFTGQIP-DYIQNWTKLEKLFIEGSGLAG-PIPSGIASLVELTDLRISDLNG-- 175
I + I D ++ L+ L I +GL P + + S L I+D
Sbjct: 85 IEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMT 144
Query: 176 --PEGPFPRLSNLK---------------------NMNYLILRSGNIIGEMPEYL--GQM 210
P F L N ++ + L + + + G
Sbjct: 145 SIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204
Query: 211 IGLRVLDLSFNKLSGVIPSNFSG 233
G +LD+S ++ +
Sbjct: 205 SGPSLLDVSQTSVTALPSKGLEH 227
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 30/161 (18%), Positives = 55/161 (34%), Gaps = 11/161 (6%)
Query: 92 NLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYI-QNWTKLEKLFIEGSG 150
+ + L L + +F+NL + +S + Q+ + N +K+ + I +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 151 LAGPIPSGI-ASLVELTDLRISDLNG----PEGPFPRLSNLKNMNYLILRSGNIIGEMPE 205
I L L L I + G P+ + + L + + +P
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFN-TGLKMFPDLTK--VYSTDIFFILEITDNPYMTSIPV 148
Query: 206 YL--GQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGN 244
G L L N + V F+G+ L +YL N
Sbjct: 149 NAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKN 189
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 50/189 (26%), Positives = 78/189 (41%), Gaps = 32/189 (16%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPN 632
N F KIG G FG +Y G + + +A+K + K+K + + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTG 64
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGP------EEHRLKLDWPTRHSICIGLAR 686
+ + +EG+ +L+ M+ L GP KL T + +
Sbjct: 65 IPNVRWFGVEGDYNVLV---MD-------LLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPK---ISDFGLAKL--DEEDNTHISTR--- 738
+ ++H +S +HRDIK N L+ I DFGLAK D + HI R
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
Query: 739 -IAGTFGYM 746
+ GT Y
Sbjct: 172 NLTGTARYA 180
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 42/201 (20%), Positives = 79/201 (39%), Gaps = 26/201 (12%)
Query: 87 LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFI 146
K +L + T + L + +++ + IQ + KLF+
Sbjct: 20 DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 75
Query: 147 EGSGLAGPIPSGIASLVELTDL-----RISDLNGPEGPFPRLSNLKNMNYLILRSGNIIG 201
G+ L I +A+L L L ++ DL+ L +LK + L L N I
Sbjct: 76 NGNKLTD-I-KPLANLKNLGWLFLDENKVKDLSS-------LKDLKKLKSLSL-EHNGIS 125
Query: 202 EMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRN- 259
++ L + L L L NK++ + + S + L + L N ++ VP +
Sbjct: 126 DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKL 180
Query: 260 KHIDLSYNNFIDGSSDSNCEN 280
+++ LS N+ D + + +N
Sbjct: 181 QNLYLSKNHISDLRALAGLKN 201
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 47/217 (21%), Positives = 89/217 (41%), Gaps = 28/217 (12%)
Query: 15 PELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLT 73
L + +I + + ++ LP + L L I K +A++ L L
Sbjct: 40 VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDI-KPLANLKNLGWLF 96
Query: 74 LEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPD 133
L+ N+ DL + L +L L+ L L N + + +L +L+ + +N +I D
Sbjct: 97 LDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNN----KITD 148
Query: 134 --YIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDL-----RISDLNGPEGPFPRLSNL 186
+ TKL+ L +E + ++ +A L +L +L ISDL L+ L
Sbjct: 149 ITVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHISDLRA-------LAGL 199
Query: 187 KNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKL 223
KN++ L L S + + + ++ + + L
Sbjct: 200 KNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 41/185 (22%), Positives = 65/185 (35%), Gaps = 31/185 (16%)
Query: 9 LPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNL-PLWKQANG--AIPKAV-A 64
+P LP L DL+ N L + +EW L NL L N I
Sbjct: 33 VPQSLPSYTALL------DLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFV 85
Query: 65 SISTLADLTLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRIS 123
+ L L L N L +L LE L L +N+ +F ++ +L+ +S
Sbjct: 86 PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLS 144
Query: 124 DNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRL 183
N + + I++ KL KL L++L+ ++ L P +L
Sbjct: 145 QNQISRFPVELIKDGNKLPKL----------------MLLDLSSNKLKKL--PLTDLQKL 186
Query: 184 SNLKN 188
Sbjct: 187 PAWVK 191
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 43/183 (23%), Positives = 67/183 (36%), Gaps = 37/183 (20%)
Query: 72 LTLEFNQFSGDLPAE--LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTG 129
L L N S L AE L NL L L+ N+ E+F + L++ +S NH
Sbjct: 44 LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH- 101
Query: 130 QIPDYI-QNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKN 188
+ +++ + LE L L + I + F ++ L+
Sbjct: 102 TLDEFLFSDLQALEVLL-------------------LYNNHIVVV--DRNAFEDMAQLQ- 139
Query: 189 MNYLILRSGNIIGEMPE----YLGQMIGLRVLDLSFNKLSGVIPSNFSG---SGLTYMYL 241
L L S N I P ++ L +LDLS NKL + ++ +YL
Sbjct: 140 --KLYL-SQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYL 196
Query: 242 TGN 244
N
Sbjct: 197 HNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 29/98 (29%), Positives = 40/98 (40%), Gaps = 10/98 (10%)
Query: 155 IPSGIASLVELTDL---RISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEY-LGQM 210
+P + S L DL +S L E RL+NL L+L S N + + +
Sbjct: 33 VPQSLPSYTALLDLSHNNLSRLR-AEWTPTRLTNLH---SLLL-SHNHLNFISSEAFVPV 87
Query: 211 IGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLT 247
LR LDLS N L + FS L + L N +
Sbjct: 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV 125
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 32/217 (14%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSK---QGNRE-----FVNEIGMI--SALQH 630
K+G G F V+ + + +A+K + E VN+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 631 PNLVKLYGC----CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLAR 686
+++KL G +++++E + N L + E + L I L
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGEN-LLALIKKYEHRGIPL--IYVKQISKQLLL 142
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLD------KDLNPKISDFGLA-KLDEEDNTHISTRI 739
GL Y+H I+H DIK NVL++ + KI+D G A DE I TR
Sbjct: 143 GLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 200
Query: 740 AGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
Y +PE + AD++S + E+++G
Sbjct: 201 -----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 50/218 (22%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSK---QGNREFVNEIGMISALQH------PN 632
IG+G FG V K + +A+K + ++ + Q EI ++ L+ N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMN 160
Query: 633 LVKLYGC-------CI--EGNQLLLI--YEYMENNSLARALFGPEEHRLKLDWPTRHSIC 681
++ + C+ E LL + YE ++ N F P
Sbjct: 161 VIHMLENFTFRNHICMTFE---LLSMNLYELIKKNK-----FQG------FSLPLVRKFA 206
Query: 682 IGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP--KISDFGLA-KLDEEDNTHISTR 738
+ + L LH + +I+H D+K N+LL + K+ DFG + + T+I +R
Sbjct: 207 HSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR 263
Query: 739 IAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
F Y APE + D++S G + E+++G
Sbjct: 264 ----F-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 38/203 (18%), Positives = 66/203 (32%), Gaps = 40/203 (19%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL------LADGKVIAVKQLSSKSKQ-----------GNRE 617
+ IG+GGFG +Y + VK S + E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 618 FVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGP------EEHRLK 671
+ + L++ + K +G + + FG E + +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKN------GKSYRFMIMDRFGSDLQKIYEANAKR 148
Query: 672 LDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI--SDFGLAK--L 727
T + + + L Y+HE VH DIKA+N+LL+ ++ D+GLA
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYC 205
Query: 728 DEEDNTHISTR----IAGTFGYM 746
E + + GT +
Sbjct: 206 PEGVHKAYAADPKRCHDGTIEFT 228
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 37/181 (20%), Positives = 73/181 (40%), Gaps = 30/181 (16%)
Query: 87 LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFI 146
L N K +L + T S L+ +++F +++ + +Q +T L++L +
Sbjct: 15 DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70
Query: 147 EGSGLAGPIPSGIASLVELTDL-----RISDLNGPEGP--------------FPRLSNLK 187
+ ++ S + L +L +L R+ +LNG L +LK
Sbjct: 71 SHNQISD--LSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDTDSLIHLK 128
Query: 188 NMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIP-SNFSGSGLTYMYLTGNLL 246
N+ L + N + + LG + L VLDL N+++ + + ++ LTG
Sbjct: 129 NLEILSI-RNNKLKSIVM-LGFLSKLEVLDLHGNEITNTGGLTRL--KKVNWIDLTGQKC 184
Query: 247 T 247
Sbjct: 185 V 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 35/169 (20%), Positives = 56/169 (33%), Gaps = 45/169 (26%)
Query: 61 KAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHF 120
+ + L +L L NQ S DL L +L LE+L +N N A L+RL
Sbjct: 57 AGMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRL--- 111
Query: 121 RISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDL-----RISDLNG 175
+ +N ++ D + L L L ++ +
Sbjct: 112 FLDNN----ELRD----------------------TDSLIHLKNLEILSIRNNKLKSIVM 145
Query: 176 PEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLS 224
L L + L L GN I L ++ + +DL+ K
Sbjct: 146 -------LGFLSKLEVLDL-HGNEITNT-GGLTRLKKVNWIDLTGQKCV 185
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 45/163 (27%), Positives = 63/163 (38%), Gaps = 23/163 (14%)
Query: 94 EKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAG 153
EKL L S +F LT+L + N + T+L L + + LA
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 154 PIPSGI-ASLVELTDLRISDLNG------PEGPFPRLSNLKNMNYLILRSGNIIGEMPE- 205
+P G+ L +L L L G P G F RL+ LK + L + N + +P
Sbjct: 98 -LPLGVFDHLTQLDKL---YLGGNQLKSLPSGVFDRLTKLKEL-RL---NTNQLQSIPAG 149
Query: 206 ---YLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGN 244
L L+ L LS N+L V F L + L GN
Sbjct: 150 AFDKLTN---LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 35/133 (26%), Positives = 52/133 (39%), Gaps = 22/133 (16%)
Query: 19 RLPFLQEIDLTRNYLNGTIPSEWASLP------LVNL-PLWKQAN--GAIPKAV-ASIST 68
L L + L N L ASLP L L L+ N ++P V ++
Sbjct: 81 DLTELGTLGLANNQL--------ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTK 132
Query: 69 LADLTLEFNQFSGDLPAEL-GNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHF 127
L +L L NQ +PA L NL+ L L++N +F L +L+ + N F
Sbjct: 133 LKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
Query: 128 TGQIPD--YIQNW 138
+ Y+ W
Sbjct: 192 DCSRCEILYLSQW 204
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 28/183 (15%), Positives = 55/183 (30%), Gaps = 28/183 (15%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL---------LADGKVIAVKQLSSKSKQGNREFVNEIGMI 625
+ + G +Y+ + ++K L +K + E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 626 SALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARAL----FGP-------EEHRLKLDW 674
LQ KLY + + + + R L G + L
Sbjct: 101 KPLQVNKWKKLYSTPLLA--IPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSE 158
Query: 675 PTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI--SDFGLAKLDEEDN 732
+ + L L +LHE VH ++ A N+ +D + ++ + +G A
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 733 THI 735
H+
Sbjct: 216 KHV 218
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 48/222 (21%), Positives = 86/222 (38%), Gaps = 52/222 (23%)
Query: 581 NKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHP----- 631
+ IG+G FG V K + + +A+K + +K Q E+ ++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115
Query: 632 -NLVKLYGC-------CI--EGNQLLL---IYEYMENNSLARALFGPEEHRLKLDWPTRH 678
+V L C+ E +L +Y+ + N + F +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFE----MLSYNLYDLLRNTN-----FRG------VSLNLTR 160
Query: 679 SICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP--KISDFGLA-KLDEEDNTHI 735
+ L +L L I+H D+K N+LL KI DFG + +L + +I
Sbjct: 161 KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 219
Query: 736 STRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGR 776
+R F Y +PE + Y D++S G + +E+ +G
Sbjct: 220 QSR----F-YRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGE 255
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 19/95 (20%), Positives = 32/95 (33%), Gaps = 2/95 (2%)
Query: 58 AIPKAVASISTLADLTLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTR 116
+ L +L +E Q L L L L L + + P++F R
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 117 LKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGL 151
L +S N + L++L + G+ L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 23/138 (16%), Positives = 46/138 (33%), Gaps = 8/138 (5%)
Query: 166 TDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEY-LGQMIGLRVLDLSFNKLS 224
+ LR + + L +N+ L + + + + L + LR L + + L
Sbjct: 11 SGLRCTRDGALDSL-HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 225 GVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSV 283
V P F L+ + L+ N L + + + LS N +C + +
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL-----HCSCALRWL 124
Query: 284 NLFASSSEGSNSTGIVSC 301
+ G + C
Sbjct: 125 QRWEEEGLGGVPEQKLQC 142
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 7e-07
Identities = 21/98 (21%), Positives = 33/98 (33%), Gaps = 9/98 (9%)
Query: 155 IPSGIASLVELTDLRISDLNG----PEGPFPRLSNLKNMNYLILRSGNIIGEMPEY-LGQ 209
+ LT+L I + L L+N L + + + +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN---LTI-VKSGLRFVAPDAFHF 78
Query: 210 MIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLT 247
L L+LSFN L + G L + L+GN L
Sbjct: 79 TPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 1e-04
Identities = 16/116 (13%), Positives = 32/116 (27%), Gaps = 24/116 (20%)
Query: 14 PPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLT 73
L L E+ + + L L L +LT
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRD----LRGLG-----------------ELRNLT 62
Query: 74 LEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFT 128
+ + + + L +L+L+ N ++ L+ L+ +S N
Sbjct: 63 IVKSGLR-FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 45/256 (17%), Positives = 77/256 (30%), Gaps = 19/256 (7%)
Query: 23 LQEIDLTRNYLNGTIPSEWASL-PLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSG 81
L L T W L K + A+ L L + S
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK-ST 362
Query: 82 DLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQ---IPDYIQNW 138
L +EL + L++L + + L L + + + +F+ P
Sbjct: 363 VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL 422
Query: 139 TKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGN 198
L F+ + + + + L L ++ L L L + +L L S N
Sbjct: 423 DDLRSKFLLENSVLKMEYADVRVLH-LAHKDLTVLCH-------LEQLLLVTHLDL-SHN 473
Query: 199 IIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRK 257
+ +P L + L VL S N L V + L + L N L +
Sbjct: 474 RLRALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQQSAAIQPLVS 531
Query: 258 RN--KHIDLSYNNFID 271
++L N+
Sbjct: 532 CPRLVLLNLQGNSLCQ 547
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 23/123 (18%), Positives = 41/123 (33%), Gaps = 27/123 (21%)
Query: 15 PELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTL 74
L +L + +DL+ N L A+P A+A++ L L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-----------------------ALPPALAALRCLEVLQA 493
Query: 75 EFNQFSGDLPAELGNLINLEKLHLNSNNFTG-KLPESFANLTRLKHFRISDNHFTGQIPD 133
N ++ + NL L++L L +N + + RL + N Q
Sbjct: 494 SDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEG 550
Query: 134 YIQ 136
+
Sbjct: 551 IQE 553
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 52/259 (20%), Positives = 94/259 (36%), Gaps = 74/259 (28%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-----HPN--- 632
K+G G F V+ + K +A+K + S ++EI ++ +++ PN
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102
Query: 633 LVKLYGC----CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGL 688
+V+L + G + +++E + + L + + L L P I + +GL
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPL--PCVKKIIQQVLQGL 159
Query: 689 AYLHEESRLKIVHRDIKATNVLL------------------------------------- 711
YLH ++ +I+H DIK N+LL
Sbjct: 160 DYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 712 ------------DKDLNPKISDFGLA-KLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
+ L KI+D G A + + I TR Y + E +
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNT 272
Query: 759 KADVYSFGIVALEIVSGRS 777
AD++S +A E+ +G
Sbjct: 273 PADIWSTACMAFELATGDY 291
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 35/189 (18%), Positives = 66/189 (34%), Gaps = 29/189 (15%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
KIG GGFG +Y + A + + ++ F +E+ + + +K +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-SELKFYQRVAKKDCIKKWIER 102
Query: 641 IEGNQL---------LLIYEYMENNSLARALFGP------EEHRLKLDWPTRHSICIGLA 685
+ + L L ++ + G ++ T + I +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRML 161
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI--SDFGLAK--LDEEDNTHISTR--- 738
L Y+HE VH DIKA N+LL ++ +D+GL+ ++
Sbjct: 162 DVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRK 218
Query: 739 -IAGTFGYM 746
GT +
Sbjct: 219 GHNGTIEFT 227
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 35/167 (20%), Positives = 59/167 (35%), Gaps = 33/167 (19%)
Query: 71 DLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQ 130
+L + A L L + L L++NN K+ S + + L+ + N +
Sbjct: 29 ELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-K 84
Query: 131 IPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMN 190
I + LE+L+I + +I+ L+G + L N+
Sbjct: 85 IENLDAVADTLEELWISYN-------------------QIASLSG-------IEKLVNLR 118
Query: 191 YLILRSGNIIGEMPE--YLGQMIGLRVLDLSFNKLSGVIPSNFSGSG 235
L + S N I E L + L L L+ N L N + S
Sbjct: 119 VLYM-SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 27/145 (18%), Positives = 49/145 (33%), Gaps = 15/145 (10%)
Query: 10 PGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNL-PLWKQANG--AIPKAV-AS 65
P +P L L N + + L L + N I +
Sbjct: 27 PEHIPQYTAEL------RLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEG 79
Query: 66 ISTLADLTLEFNQFSGDLPAEL-GNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISD 124
S + ++ L N+ ++ ++ L +L+ L L SN T +SF L+ ++ + D
Sbjct: 80 ASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYD 138
Query: 125 NHFTGQIPDYI-QNWTKLEKLFIEG 148
N T + L L +
Sbjct: 139 NQIT-TVAPGAFDTLHSLSTLNLLA 162
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 26/129 (20%), Positives = 48/129 (37%), Gaps = 10/129 (7%)
Query: 6 SQNLPGRLPPE--LTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNL-PLWKQAN--GAIP 60
+ N L +LP L++I+ + N + I E A + + +N +
Sbjct: 40 NNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIE-EGAFEGASGVNEILLTSNRLENVQ 97
Query: 61 KAV-ASISTLADLTLEFNQFSGDLPAEL-GNLINLEKLHLNSNNFTGKLPESFANLTRLK 118
+ + +L L L N+ + + + L ++ L L N T P +F L L
Sbjct: 98 HKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLS 156
Query: 119 HFRISDNHF 127
+ N F
Sbjct: 157 TLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 35/166 (21%), Positives = 57/166 (34%), Gaps = 48/166 (28%)
Query: 92 NLEKLHLNSNNFTGKLPES--FANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGS 149
+L LN+N FT L + F L +L+ S+N T
Sbjct: 33 YTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITD-------------------- 71
Query: 150 GLAGPIPSGI-ASLVELTDL-----RISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEM 203
I G + ++ R+ ++ F L +LK L+L N I +
Sbjct: 72 -----IEEGAFEGASGVNEILLTSNRLENV--QHKMFKGLESLK---TLML-RSNRITCV 120
Query: 204 PE----YLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGN 244
L +R+L L N+++ V P F L+ + L N
Sbjct: 121 GNDSFIGLSS---VRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 59/293 (20%), Positives = 97/293 (33%), Gaps = 81/293 (27%)
Query: 7 QNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASI 66
Q P E + +L + + ++ + + ++ + +
Sbjct: 11 QIFPDDAFAETIKA------NLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQ-GIQYL 62
Query: 67 STLADLTLEFNQFSGDLPAELG---NLINLEKLHLNSNNFTGKLPES-FANLTRLKHFRI 122
+ L L N+ ++ L NL L L N LP F LT LK +
Sbjct: 63 PNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVL 116
Query: 123 SDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDLRISD-----LNGP 176
+N +L+ L P G+ L LT L ++ L P
Sbjct: 117 VEN--------------QLQSL-----------PDGVFDKLTNLTYLNLAHNQLQSL--P 149
Query: 177 EGPFPRLSNLKNMNYLILRSGNIIGEMPE----YLGQMIGLRVLDLSFNKLSGVIPSNF- 231
+G F +L+NL L L S N + +PE L Q L+ L L N+L V F
Sbjct: 150 KGVFDKLTNLT---ELDL-SYNQLQSLPEGVFDKLTQ---LKDLRLYQNQLKSVPDGVFD 202
Query: 232 SGSGLTYMYLTGNLLTGPVP------------DWIVRKRNKHIDLSYNNFIDG 272
+ L Y++L N P +WI + + + + D
Sbjct: 203 RLTSLQYIWLHDN------PWDCTCPGIRYLSEWINKHSGVVRNSAGSVAPDS 249
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 29/122 (23%), Positives = 53/122 (43%), Gaps = 9/122 (7%)
Query: 12 RLPPE-LTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNL-PLWKQAN--GAIPKAV-ASI 66
+PP + L+ IDL+ N ++ + + A L +L L N +PK++ +
Sbjct: 46 VIPPGAFSPYKKLRRIDLSNNQIS-ELAPD-AFQGLRSLNSLVLYGNKITELPKSLFEGL 103
Query: 67 STLADLTLEFNQFSGDLPAEL-GNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN 125
+L L L N+ + L + +L NL L L N +F+ L ++ ++ N
Sbjct: 104 FSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
Query: 126 HF 127
F
Sbjct: 163 PF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 30/144 (20%), Positives = 52/144 (36%), Gaps = 14/144 (9%)
Query: 10 PGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLP-LWKQANG--AIPKAV-AS 65
P LP +T + L +N + IP A P L + N +
Sbjct: 27 PTNLPETITEI------RLEQNTIK-VIPP-GAFSPYKKLRRIDLSNNQISELAPDAFQG 78
Query: 66 ISTLADLTLEFNQFSGDLPAEL-GNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISD 124
+ +L L L N+ + +LP L L +L+ L LN+N ++F +L L + D
Sbjct: 79 LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYD 137
Query: 125 NHFTGQIPDYIQNWTKLEKLFIEG 148
N ++ + +
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQ 161
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 39/122 (31%), Positives = 56/122 (45%), Gaps = 6/122 (4%)
Query: 72 LTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPES-FANLTRLKHFRISDNHFTGQ 130
L L NQ + P +LINL++L+L SN LP F +LT+L + N T
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVL 103
Query: 131 IPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD---LNGPEGPFPRLSNLK 187
L++LF+ + L +P GI L LT L + + P G F RLS+L
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLT 162
Query: 188 NM 189
+
Sbjct: 163 HA 164
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 43/158 (27%), Positives = 62/158 (39%), Gaps = 38/158 (24%)
Query: 94 EKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAG 153
+ L+L+ N T P F +L LK + N +L L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSN--------------QLGAL--------- 79
Query: 154 PIPSGI-ASLVELTDLRISD-----LNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYL 207
P G+ SL +LT L + L P F RL +LK L + N + E+P +
Sbjct: 80 --PVGVFDSLTQLTVLDLGTNQLTVL--PSAVFDRLVHLK---ELFM-CCNKLTELPRGI 131
Query: 208 GQMIGLRVLDLSFNKLSGVIPSNF-SGSGLTYMYLTGN 244
++ L L L N+L + F S LT+ YL GN
Sbjct: 132 ERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 54/249 (21%), Positives = 90/249 (36%), Gaps = 90/249 (36%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSK---QGNREFVNEIGMISALQH-----PN 632
K+G+G FG V + + K AVK + + K E ++ +Q+ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 633 LVKLYGC-------CI--EGNQLLL---IYEYMENNSLARALFGPEEHRLKLDWPTRH-- 678
+VK +G C+ E L +YE + N+ + +
Sbjct: 98 IVKYHGKFMYYDHMCLIFE----PLGPSLYEIITRNN-----YNG--------FHIEDIK 140
Query: 679 SICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP--------------------- 717
CI + + L YL + + + H D+K N+LLD
Sbjct: 141 LYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 718 ----KISDFGLAKLDEED-NTHISTRIAGTFGYMAPE------YAMRGYLTDKADVYSFG 766
K+ DFG A + + I+TR Y APE + + +D++SFG
Sbjct: 198 STGIKLIDFGCATFKSDYHGSIINTR----Q-YRAPEVILNLGWDV------SSDMWSFG 246
Query: 767 IVALEIVSG 775
V E+ +G
Sbjct: 247 CVLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 52/237 (21%), Positives = 85/237 (35%), Gaps = 70/237 (29%)
Query: 582 KIGEGGFGPVYKG--LLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHP------NL 633
+GEG FG V + +A+K + + K + EI ++ ++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFLC 84
Query: 634 VKLYGC-------CI--EGNQLLL---IYEYMENNSLARALFGPEEHRLKLDWPTRH--S 679
V + CI E LL +E+++ N+ F P +P H
Sbjct: 85 VLMSDWFNFHGHMCIAFE----LLGKNTFEFLKENN-----FQP--------YPLPHVRH 127
Query: 680 ICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP-------------------KIS 720
+ L L +LHE ++ H D+K N+L +++
Sbjct: 128 MAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 721 DFGLAKLDEED-NTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSG 775
DFG A D E T ++TR Y PE + G+ DV+S G + E G
Sbjct: 185 DFGSATFDHEHHTTIVATR----H-YRPPEVILELGWAQ-PCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 54/245 (22%), Positives = 89/245 (36%), Gaps = 86/245 (35%)
Query: 582 KIGEGGFGPVYKG--LLADGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHP----- 631
+GEG FG V + A G+ +AVK + + + +EI ++ L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76
Query: 632 -NLVKLYGC-------CI--EGNQLLL---IYEYMENNSLARALFGPEEHRLKLDWPTRH 678
V++ CI E LL Y++++ N F P + H
Sbjct: 77 FRCVQMLEWFEHHGHICIVFE----LLGLSTYDFIKENG-----FLP--------FRLDH 119
Query: 679 --SICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP------------------- 717
+ + + + +LH K+ H D+K N+L +
Sbjct: 120 IRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 718 KISDFGLAKLDEED-NTHISTRIAGTFGYMAPE------YAMRGYLTDKADVYSFGIVAL 770
K+ DFG A D+E +T +STR Y APE ++ DV+S G + +
Sbjct: 177 KVVDFGSATYDDEHHSTLVSTR----H-YRAPEVILALGWSQ------PCDVWSIGCILI 225
Query: 771 EIVSG 775
E G
Sbjct: 226 EYYLG 230
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 43/277 (15%), Positives = 79/277 (28%), Gaps = 62/277 (22%)
Query: 17 LTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEF 76
+ L+ + + + +L + +A+ L + L
Sbjct: 56 IASKKDLEIAEFSDIFTGRVKDEIPEAL------------RLLLQALLKCPKLHTVRLSD 103
Query: 77 NQFSGDLPAELGNLI----NLEKLHLNSNNFT-------------GKLPESFANLTRLKH 119
N F L + + LE L+L++N + + N L+
Sbjct: 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRS 163
Query: 120 FRISDNHFTGQ----IPDYIQNWTKLEKLF-----IEGSGLAGPIPSGIASLVELTDLRI 170
N Q+ L + I G+ + G+A EL L +
Sbjct: 164 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDL 223
Query: 171 SDLN--GPEGPF---PRLSNLKNMNYLILRSGNIIGEM-PEYLGQMIG------LRVLDL 218
D N G L + N+ L L + ++ + L+ L L
Sbjct: 224 QD-NTFTHLGSSALAIALKSWPNLRELGL-NDCLLSARGAAAVVDAFSKLENIGLQTLRL 281
Query: 219 SFNK--------LSGVIPSNFSGSGLTYMYLTGNLLT 247
+N+ L VI L ++ L GN +
Sbjct: 282 QYNEIELDAVRTLKTVIDEK--MPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 34/234 (14%), Positives = 73/234 (31%), Gaps = 57/234 (24%)
Query: 65 SISTLADLTLEFNQFSGD----LPAELGNLINLEKLHLNSNNFTGK----LPESFANLTR 116
+ ++ +L+ + + + + A L +++++ L+ N + L E+ A+
Sbjct: 2 ARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 61
Query: 117 LKHFRISDNHFTGQIPDYI-----------QNWTKLEKLFIEGSGL----AGPIPSGIAS 161
L+ SD FTG++ D I KL + + + P+ ++
Sbjct: 62 LEIAEFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120
Query: 162 LVELTDLRISDLN--GPEG------------PFPRLSNLKNMNYLILRSGNIIGE----- 202
L L + + N GP+ + N + +I N +
Sbjct: 121 HTPLEHLYLHN-NGLGPQAGAKIARALQELAVNKKAKNAPPLRSIIC-GRNRLENGSMKE 178
Query: 203 MPEYLGQMIGLRVLDLSFNK---------LSGVIPSNFSGSGLTYMYLTGNLLT 247
+ L + + N L + L + L N T
Sbjct: 179 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC---QELKVLDLQDNTFT 229
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 46/270 (17%), Positives = 84/270 (31%), Gaps = 64/270 (23%)
Query: 58 AIPKAVASISTLADLTLEFNQFSGDLPAE-----LGNLINLEKLHLNSNNFTGK------ 106
++ + ++ ++ L N G A + + +LE S+ FTG+
Sbjct: 23 SVFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDLEIAEF-SDIFTGRVKDEIP 80
Query: 107 -----LPESFANLTRLKHFRISDNHFTGQ----IPDYIQNWTKLEKLFIEGSGL------ 151
L ++ +L R+SDN F + D++ T LE L++ +GL
Sbjct: 81 EALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGA 140
Query: 152 ----AGPIPSGIASLVELTDLRISDLN----GPEGPF---PRLSNLKNMNYLILRSGNII 200
A + LR + + ++ + + N I
Sbjct: 141 KIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKM-VQNGI 199
Query: 201 GE------MPEYLGQMIGLRVLDLSFNK--------LSGVIPSNFSGSGLTYMYLTGNLL 246
+ E L L+VLDL N L+ + S L + L LL
Sbjct: 200 RPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW---PNLRELGLNDCLL 256
Query: 247 T-------GPVPDWIVRKRNKHIDLSYNNF 269
+ + + + L YN
Sbjct: 257 SARGAAAVVDAFSKLENIGLQTLRLQYNEI 286
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 34/125 (27%), Positives = 48/125 (38%), Gaps = 38/125 (30%)
Query: 72 LTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPE-SFANLTRLKHFRISDNHFTGQ 130
L L+ NQF+ +P EL N +L + L++N + L SF+N+T+L +S N
Sbjct: 36 LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC- 92
Query: 131 IPDYIQNWTKLEKLFIEGSGLAGPIPSGI-ASLVELTDLRISDLNG------PEGPFPRL 183
IP L L L L+G PEG F L
Sbjct: 93 ------------------------IPPRTFDGLKSLRLL---SLHGNDISVVPEGAFNDL 125
Query: 184 SNLKN 188
S L +
Sbjct: 126 SALSH 130
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-05
Identities = 43/255 (16%), Positives = 80/255 (31%), Gaps = 48/255 (18%)
Query: 58 AIPKAVASISTLADLTLEFNQFSGDLPAEL------GNLINLEKLHLNSNNFTGK----L 107
+ + + +LT+ N + + + LE L L S T L
Sbjct: 161 PLASVLRAKPDFKELTVSNNDI-NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL 219
Query: 108 PESFANLTRLKHFRISDNHFTGQ-----IPDYIQNWTKLEKLFIEGSGL----AGPIPSG 158
A+ L+ + N P + ++L L+I G+ G +
Sbjct: 220 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 279
Query: 159 IASLVELTDLRISDLN-GPEGPFPRLSN-LKNMN----YLILRSGNIIGEMPEYLGQMIG 212
+ + L +L ++ G EG L L L ++S + + ++
Sbjct: 280 LRAKESLKELSLAGNELGDEG-ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLA 338
Query: 213 ----LRVLDLSFNKL--SGVIP-------SNFSGSGLTYMYLTGNLLTGPVPDWIVR--K 257
L L +S N+L +GV S L ++L ++ +
Sbjct: 339 QNRFLLELQISNNRLEDAGVRELCQGLGQPG---SVLRVLWLADCDVSDSSCSSLAATLL 395
Query: 258 RNK---HIDLSYNNF 269
N +DLS N
Sbjct: 396 ANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 48/256 (18%), Positives = 88/256 (34%), Gaps = 46/256 (17%)
Query: 58 AIPKAVASISTLADLTLEFNQFSGDLPAELGNLI-----NLEKLHLNSNNFTGK----LP 108
I A+ LA+L L N+ + + ++KL L + TG L
Sbjct: 47 DISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 106
Query: 109 ESFANLTRLKHFRISDNHFTGQIPDYI-----QNWTKLEKLFIEGSGL----AGPIPSGI 159
+ L L+ +SDN + +LEKL +E L P+ S +
Sbjct: 107 STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVL 166
Query: 160 ASLVELTDLRISDLN-GPEGPFPRLS-----NLKNMNYLILRSGNIIGEMPEYLGQMIG- 212
+ + +L +S+ + G L + + L L S + + L ++
Sbjct: 167 RAKPDFKELTVSNNDINEAG-VRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS 225
Query: 213 ---LRVLDLSFNKLS---------GVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVR--KR 258
LR L L NKL G++ + L +++ +T + R +
Sbjct: 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSR---LRTLWIWECGITAKGCGDLCRVLRA 282
Query: 259 NK---HIDLSYNNFID 271
+ + L+ N D
Sbjct: 283 KESLKELSLAGNELGD 298
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 2e-04
Identities = 22/185 (11%), Positives = 57/185 (30%), Gaps = 41/185 (22%)
Query: 56 NGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFA--- 112
+ + ++ L +L ++ +L NL+ L + S + E
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217
Query: 113 --NLTRLKHFRISDNHFTGQIPDYI------QNWTKLEKLFIEGSGLAGPIPSGIASLVE 164
NL +L + +++ + + L+ L I + +
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277
Query: 165 LTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIG-----EMPEYLGQMIGLRVLDLS 219
L L D+ S ++ + +++ ++ L+ +++
Sbjct: 278 LPQLETMDI----------------------SAGVLTDEGARLLLDHVDKIKHLKFINMK 315
Query: 220 FNKLS 224
+N LS
Sbjct: 316 YNYLS 320
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 39/160 (24%), Positives = 62/160 (38%), Gaps = 39/160 (24%)
Query: 37 IPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGN-LINLEK 95
IP++ L L L +++L L L N+ LP + N L +L
Sbjct: 26 IPAQTTYLDLETNSLKSLP----NGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTY 80
Query: 96 LHLNSNNFTGKLPES-FANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGP 154
L+L++N LP F LT+LK ++ N
Sbjct: 81 LNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQS------------------------- 114
Query: 155 IPSGI-ASLVELTDLRISDLNG----PEGPFPRLSNLKNM 189
+P G+ L +L DLR+ N P+G F RL++L+ +
Sbjct: 115 LPDGVFDKLTQLKDLRLYQ-NQLKSVPDGVFDRLTSLQYI 153
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 809 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.98 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.98 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.98 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.98 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.98 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.98 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.98 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.98 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.98 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.98 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.98 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.98 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.98 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.98 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.97 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.97 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.97 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.97 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.97 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.97 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.96 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.96 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.96 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.95 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.94 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.94 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.92 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.91 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.91 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.82 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.73 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.6 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.59 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.58 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.56 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.55 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.42 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.41 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.4 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.39 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.3 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.25 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.24 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.91 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.91 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.84 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.84 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.83 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.67 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.64 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.46 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.42 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.4 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.37 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.37 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.32 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.17 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.06 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.05 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.82 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.73 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.73 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.65 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.63 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.52 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.43 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.31 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.3 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.17 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.81 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.75 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.73 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.71 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.66 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.48 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.18 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.08 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.05 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.76 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.18 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.61 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 87.3 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.52 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 80.87 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 80.76 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 80.65 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=403.06 Aligned_cols=206 Identities=30% Similarity=0.540 Sum_probs=179.3
Q ss_pred cCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46777899999999999999863 478899999987666667889999999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCC---------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEE
Q 043333 649 IYEYMENNSLARALFGPE---------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 719 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~---------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 719 (809)
|||||++|+|.++|+... .....++|.++..++.|||+||+|||++ +||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999996432 2345799999999999999999999998 8999999999999999999999
Q ss_pred EecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 720 SDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 720 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
+|||+|+....... .......||+.|||||++.++.++.++|||||||++|||+| |+.||...+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999986644332 22334579999999999999999999999999999999999 899997653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=403.45 Aligned_cols=206 Identities=30% Similarity=0.510 Sum_probs=173.4
Q ss_pred cCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
++|...++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45666789999999999999864 478999999987666667889999999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCce
Q 043333 649 IYEYMENNSLARALFGPEE-----------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 717 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 717 (809)
|||||++|+|.++++.... ...+++|.+++.|+.|||+||+|||++ +||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999975432 234699999999999999999999998 89999999999999999999
Q ss_pred EEEecCCccccCCCC-cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 718 KISDFGLAKLDEEDN-THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 718 kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
||+|||+|+...... .......+||+.|||||++.+..++.++|||||||++|||+| |+.||...+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 999999998664332 223345679999999999999999999999999999999999 899997643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=397.42 Aligned_cols=205 Identities=30% Similarity=0.456 Sum_probs=176.8
Q ss_pred CCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
+++..+.||+|+||+||+|.+. +++.||||+++.... ...++|.+|++++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3456788999999999999863 468899999976543 335689999999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc
Q 043333 649 IYEYMENNSLARALFGPEE------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 716 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 716 (809)
|||||++|+|.++|+.... ....++|..+..|+.|||+||+|||++ +||||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 9999999999999965321 234699999999999999999999998 8999999999999999999
Q ss_pred eEEEecCCccccCCCC-cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 717 PKISDFGLAKLDEEDN-THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 717 ~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
+||+|||+|+...... .......+||+.|||||++.++.++.++|||||||++|||+| |+.||...+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 9999999998654322 223345679999999999999999999999999999999999 899997653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=397.48 Aligned_cols=200 Identities=28% Similarity=0.501 Sum_probs=181.1
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
+.|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56888999999999999999965 68999999997666566677999999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.+++. +..+++..+..++.||+.||+|||++ +||||||||+||||+.++++||+|||+|+.......
T Consensus 154 ~gg~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 9999999983 34689999999999999999999998 899999999999999999999999999987654332
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.....+||+.|||||++.+..++.++||||+||++|||++|+.||...+
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 2345789999999999999999999999999999999999999997643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=393.31 Aligned_cols=202 Identities=26% Similarity=0.414 Sum_probs=180.3
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEeccc---CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688999999999999999995 46899999999654 2334567899999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999994 345689999999999999999999998 899999999999999999999999999997754
Q ss_pred CCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... ......+||+.|||||++.+..++.++||||+||++|||+||+.||...+
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 238 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 332 23445789999999999999999999999999999999999999997643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=391.33 Aligned_cols=200 Identities=30% Similarity=0.488 Sum_probs=168.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.+++...++||+|+||+||+|++.+ .||||+++... .+..++|.+|++++++++|||||+++|+|.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3567778999999999999998753 58999986542 3345679999999999999999999998864 56899999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
||++|+|.++|+.. ..+++|..+..|+.|||+||+|||++ +||||||||+||||++++++||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999999643 34699999999999999999999998 8999999999999999999999999999876433
Q ss_pred C-cceeccccccccccchhhhcc---CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 732 N-THISTRIAGTFGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 732 ~-~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
. .......+||+.|||||++.+ +.++.++|||||||++|||+||+.||...
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~ 240 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI 240 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC
Confidence 2 223345689999999999864 46899999999999999999999999764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=397.04 Aligned_cols=204 Identities=24% Similarity=0.420 Sum_probs=173.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
.++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.|.+|++++++++|||||++++++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999964 68999999996542 233567899999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
|||++|+|.+++... ....+++..+..++.||+.||+|||++ +||||||||+||||++++++||+|||+|+....
T Consensus 103 Ey~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp ECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred eCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 999999999999532 234578999999999999999999998 899999999999999999999999999987643
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. ......+||+.|||||++.+..++.++||||+||++|||+||+.||...+
T Consensus 178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 21 22334679999999999999999999999999999999999999997653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=399.00 Aligned_cols=201 Identities=28% Similarity=0.499 Sum_probs=181.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
.+.|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+.+|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356899999999999999999964 6899999999776666667899999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
|++|+|.+++. ...+++..+..++.||+.||+|||++ +||||||||+||||+.++++||+|||+|+......
T Consensus 230 ~~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 99999999983 34589999999999999999999998 89999999999999999999999999998765433
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
. .....+||+.|||||++.+..++.++|||||||++|||++|+.||...+
T Consensus 302 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 302 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp C-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred c-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 2 2345789999999999999999999999999999999999999997643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=387.71 Aligned_cols=201 Identities=27% Similarity=0.389 Sum_probs=170.6
Q ss_pred cCCCCCCeeccCCCccEEEeEee----CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA----DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
++|++.+.||+|+||+||+|+.. .++.||||+++... ......+.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57899999999999999999852 46899999987542 2234568899999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
|||||++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++++||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999994 344689999999999999999999998 8999999999999999999999999999865
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
..... .....+||+.|||||++.+..++.++||||+||++|||+||+.||...+
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 43322 2335689999999999999999999999999999999999999997654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=374.85 Aligned_cols=199 Identities=29% Similarity=0.483 Sum_probs=162.5
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999985 468999999986542 223457899999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+ +|+|.+++. .+.++++..+..++.|++.||+|||++ +|+||||||+|||+++++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 689999884 345699999999999999999999998 899999999999999999999999999987643
Q ss_pred CCcceeccccccccccchhhhccCCC-CchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||...+
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~ 216 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 32 2234689999999999988765 689999999999999999999997643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=378.95 Aligned_cols=196 Identities=31% Similarity=0.492 Sum_probs=168.0
Q ss_pred CCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEe----CCeEEEEE
Q 043333 578 APDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIE----GNQLLLIY 650 (809)
Q Consensus 578 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ 650 (809)
+..+.||+|+||+||+|... +++.||||++.... ....+.|.+|++++++++|||||+++++|.+ ++..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999965 58899999986542 2335679999999999999999999999875 34579999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCCceEEEecCCccccC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDE 729 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~ 729 (809)
|||++|+|.+++. ....+++..+..++.||+.||+|||+++ ++||||||||+||||+ +++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999994 3456899999999999999999999983 2499999999999998 47999999999998644
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. .....+||+.|||||++.+ .++.++|||||||++|||+||+.||...
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 32 2335689999999998865 6899999999999999999999999653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=385.82 Aligned_cols=197 Identities=29% Similarity=0.334 Sum_probs=170.9
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
+.|...++||+|+||+||+|+.. +|+.||||+++... .+.+|++++++++|||||++++++.+++..++|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777889999999999999964 68999999996532 2347999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-ceEEEecCCccccCCCC
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDEEDN 732 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~ 732 (809)
++|+|.+++. ....+++..+..++.||+.||+|||++ +||||||||+||||+.++ ++||+|||+|+......
T Consensus 133 ~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999994 334699999999999999999999998 899999999999999987 69999999998765432
Q ss_pred cc----eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 733 TH----ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 733 ~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. .....+||+.|||||++.+..++.++||||+||++|||+||+.||...+
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 21 1223579999999999999999999999999999999999999997644
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=378.69 Aligned_cols=198 Identities=33% Similarity=0.450 Sum_probs=162.6
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHH--HHHHHHhhcCCCceEeEEeEEEeCC----eEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFV--NEIGMISALQHPNLVKLYGCCIEGN----QLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~--~Ei~~l~~l~H~nIv~l~~~~~~~~----~~~l 648 (809)
++|...+.||+|+||+||+|++ +|+.||||++.... .+++. .|+..+.+++|||||+++|+|.+++ .+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 3466778999999999999987 58999999986432 23344 4555567889999999999998754 6899
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE-----SRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
|||||++|+|.++|+ ..+++|..+.+++.|+|+||+|||++ +.++||||||||+|||+++++++||+|||
T Consensus 79 V~Ey~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EecCCCCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 999999999999994 34689999999999999999999976 24589999999999999999999999999
Q ss_pred CccccCCCCcce---eccccccccccchhhhccC------CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 724 LAKLDEEDNTHI---STRIAGTFGYMAPEYAMRG------YLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 724 la~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
+|+......... ....+||+.|||||++.+. .++.++|||||||++|||+||++||..
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 998765433221 2245799999999998754 367899999999999999999887743
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=385.23 Aligned_cols=215 Identities=27% Similarity=0.391 Sum_probs=182.6
Q ss_pred cHHHHHHHhcCCCCCCeeccCCCccEEEeEeeC------CeEEEEEEecccCc-ccchhHHHHHHHHhhcCC-CceEeEE
Q 043333 566 TLRQIKAATNNFAPDNKIGEGGFGPVYKGLLAD------GKVIAVKQLSSKSK-QGNREFVNEIGMISALQH-PNLVKLY 637 (809)
Q Consensus 566 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H-~nIv~l~ 637 (809)
...+.+...++|+..+.||+|+||+||+|.+.. ++.||||++..... ...++|.+|+++|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 344455567889999999999999999998642 36899999976543 335679999999999965 8999999
Q ss_pred eEEEeC-CeEEEEEEcccCCchhhhccCCCc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 043333 638 GCCIEG-NQLLLIYEYMENNSLARALFGPEE------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDI 704 (809)
Q Consensus 638 ~~~~~~-~~~~lV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl 704 (809)
|+|.++ +..++|||||++|+|.++|+.... ....++|..+..++.|||+||+|||++ +||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 999775 568999999999999999964321 234589999999999999999999998 8999999
Q ss_pred CCCCEEEcCCCceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 705 KATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 705 kp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
||+|||+++++.+||+|||+|+....... ......+||+.|||||++.++.++.++|||||||++|||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654433 23445679999999999999999999999999999999998 99999764
Q ss_pred C
Q 043333 783 T 783 (809)
Q Consensus 783 ~ 783 (809)
+
T Consensus 292 ~ 292 (353)
T 4ase_A 292 K 292 (353)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=365.07 Aligned_cols=200 Identities=25% Similarity=0.451 Sum_probs=161.5
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCC--------
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGN-------- 644 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~-------- 644 (809)
++|+..+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45888999999999999999964 689999999865433 23467899999999999999999999987654
Q ss_pred ----eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEE
Q 043333 645 ----QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 720 (809)
Q Consensus 645 ----~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 720 (809)
..++|||||++|+|.+++..... ....++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 36899999999999999965322 23457788899999999999999998 89999999999999999999999
Q ss_pred ecCCccccCCCCcc-----------eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 721 DFGLAKLDEEDNTH-----------ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 721 DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
|||+|+........ ..+..+||+.|||||++.+..++.++|||||||++|||++ ||..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 99999876543211 1223579999999999999999999999999999999996 7754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=369.39 Aligned_cols=205 Identities=22% Similarity=0.371 Sum_probs=174.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeC------C
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEG------N 644 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~------~ 644 (809)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++... +
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999964 689999999975432 2345688999999999999999999998643 5
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
..|+|||||+ |+|.+++.. ..++++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999996 689998843 45799999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCC---cceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCccc
Q 043333 725 AKLDEEDN---THISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRTKEA 786 (809)
Q Consensus 725 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~~~~ 786 (809)
|+.+.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~ 270 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH 270 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH
Confidence 98664321 2223457899999999998774 57999999999999999999999998765433
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=382.49 Aligned_cols=223 Identities=28% Similarity=0.377 Sum_probs=181.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHH---HHHHhhcCCCceEeEEeEEEeCCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNE---IGMISALQHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~E---i~~l~~l~H~nIv~l~~~~~~~~~~ 646 (809)
.++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ......+.+| +++++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999965 68999999996542 2222333344 5667778999999999999999999
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
|+|||||++|+|.++|. ....+++..+..++.||+.||+|||++ +||||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999994 345689999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhccCCCCc
Q 043333 727 LDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPL 805 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~~~~p~ 805 (809)
...... ....+||+.|||||++.+ ..++.++||||+||++|||++|+.||...+..+...+.+.+ .-....+|+
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p~ 415 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPD 415 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCCT
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCCc
Confidence 765432 234689999999999975 57899999999999999999999999764333322222222 223455665
Q ss_pred CCC
Q 043333 806 FLS 808 (809)
Q Consensus 806 ~~~ 808 (809)
.+|
T Consensus 416 ~~S 418 (689)
T 3v5w_A 416 SFS 418 (689)
T ss_dssp TSC
T ss_pred cCC
Confidence 543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.23 Aligned_cols=198 Identities=27% Similarity=0.426 Sum_probs=170.2
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEee----CCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeE
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 646 (809)
...++|++.+.||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|..+ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34678999999999999999999853 46789999986543 245678999999998 699999999999999999
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CceEEEecCCc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLA 725 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla 725 (809)
++||||+++|+|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +++||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 99999999999999882 378999999999999999999998 89999999999999877 79999999999
Q ss_pred cccCCCCc---------------------------ceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCC
Q 043333 726 KLDEEDNT---------------------------HISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRS 777 (809)
Q Consensus 726 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~ 777 (809)
+....... ......+||+.|||||++.+. .++.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 75533211 112235799999999999775 58999999999999999999999
Q ss_pred CCCC
Q 043333 778 NVIC 781 (809)
Q Consensus 778 P~~~ 781 (809)
||..
T Consensus 246 Pf~~ 249 (361)
T 4f9c_A 246 PFYK 249 (361)
T ss_dssp SSSC
T ss_pred CCCC
Confidence 9965
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=375.97 Aligned_cols=202 Identities=25% Similarity=0.384 Sum_probs=180.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|+.++|||||++++++.+.+..++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999964 6899999999766555567788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC--CceEEEecCCccccCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD--LNPKISDFGLAKLDEE 730 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DfGla~~~~~ 730 (809)
|++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999843 234689999999999999999999998 89999999999999854 8999999999997754
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. .....+||+.|||||++.+..++.++||||+||++|||++|+.||...+
T Consensus 310 ~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~ 360 (573)
T 3uto_A 310 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360 (573)
T ss_dssp TS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 33 2334689999999999999999999999999999999999999997654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=346.71 Aligned_cols=243 Identities=42% Similarity=0.775 Sum_probs=209.2
Q ss_pred CCccHHHHHHHhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEE
Q 043333 563 GSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCI 641 (809)
Q Consensus 563 ~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~ 641 (809)
..++..++....++|+..+.||+|+||.||+|...+|+.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 46888999999999999999999999999999988899999999876543 33457899999999999999999999999
Q ss_pred eCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEe
Q 043333 642 EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 721 (809)
Q Consensus 642 ~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 721 (809)
+.+..++||||+++|+|.+++.........++|..+..++.|++.||+|||+++.++|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999977666666799999999999999999999998666899999999999999999999999
Q ss_pred cCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC--CcccchhHHHHHHHhhc
Q 043333 722 FGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR--TKEAQFCLLDWVTLALT 799 (809)
Q Consensus 722 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~--~~~~~~~l~~~~~~~~~ 799 (809)
||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||... .......+.+|+.....
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 9999877655555555567999999999999889999999999999999999999999642 12344556777776666
Q ss_pred cCCCCc
Q 043333 800 DFRFPL 805 (809)
Q Consensus 800 ~~~~p~ 805 (809)
....+.
T Consensus 258 ~~~~~~ 263 (326)
T 3uim_A 258 EKKLEA 263 (326)
T ss_dssp SCCSTT
T ss_pred chhhhh
Confidence 554443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=360.18 Aligned_cols=212 Identities=25% Similarity=0.329 Sum_probs=185.3
Q ss_pred cHHHHHHHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc---CcccchhHHHHHHHHhhcCCCceEeEEeEEE
Q 043333 566 TLRQIKAATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYGCCI 641 (809)
Q Consensus 566 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~ 641 (809)
.++++....++|+..++||+|+||+||+|+.. +++.||||++... .....+.+.+|++++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556666789999999999999999999975 4789999998653 2233455889999999999999999999999
Q ss_pred eCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEe
Q 043333 642 EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 721 (809)
Q Consensus 642 ~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 721 (809)
+.+..++|||||++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999542 34689999999999999999999998 899999999999999999999999
Q ss_pred cCCccccCCCCcceeccccccccccchhhhc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 722 FGLAKLDEEDNTHISTRIAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 722 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
||+++.............+||+.|+|||++. .+.++.++|||||||++|||++|+.||...+
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 9999876555444445578999999999987 5678999999999999999999999997654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.78 Aligned_cols=229 Identities=45% Similarity=0.826 Sum_probs=198.2
Q ss_pred HHHHHhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 569 QIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 569 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
++..++++|+..+.||+|+||.||+|...+++.||||++........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34457789999999999999999999988899999999877666666789999999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++.........++|..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999976554555799999999999999999999998 8999999999999999999999999999865
Q ss_pred CCCC-cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccchhHHHHHHHhhcc
Q 043333 729 EEDN-THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTD 800 (809)
Q Consensus 729 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~~l~~~~~~~~~~ 800 (809)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+...+.+|.......
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence 4322 22233456899999999999999999999999999999999999999876555556667776554433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=347.38 Aligned_cols=209 Identities=23% Similarity=0.341 Sum_probs=182.7
Q ss_pred HHHHHHHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc---CcccchhHHHHHHHHhhcCCCceEeEEeEEEe
Q 043333 567 LRQIKAATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYGCCIE 642 (809)
Q Consensus 567 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~ 642 (809)
.+++....++|+..+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3445556789999999999999999999965 5889999998653 22335668899999999999999999999999
Q ss_pred CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 643 GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 643 ~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
.+..++||||+++|+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~-----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 999999999999999999983 23588999999999999999999998 8999999999999999999999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhccCC----CCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGY----LTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
|+++.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 999876654433444678999999999998655 7889999999999999999999997644
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=326.96 Aligned_cols=201 Identities=28% Similarity=0.523 Sum_probs=180.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
.++|+..+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999985 56899999999766655567789999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++|+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||++.......
T Consensus 99 ~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999983 23589999999999999999999998 89999999999999999999999999998765433
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 171 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp CC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 234679999999999999999999999999999999999999997643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=346.10 Aligned_cols=212 Identities=23% Similarity=0.310 Sum_probs=184.2
Q ss_pred cHHHHHHHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEE
Q 043333 566 TLRQIKAATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCI 641 (809)
Q Consensus 566 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~ 641 (809)
.+++.....++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|.+++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44555556789999999999999999999964 68999999996532 233456889999999999999999999999
Q ss_pred eCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEe
Q 043333 642 EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 721 (809)
Q Consensus 642 ~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 721 (809)
+.+..++||||+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 99999999999999999999942 234689999999999999999999998 899999999999999999999999
Q ss_pred cCCccccCCCCcceeccccccccccchhhhc-------cCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 722 FGLAKLDEEDNTHISTRIAGTFGYMAPEYAM-------RGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 722 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 9999876554443344568999999999987 3568999999999999999999999997654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.17 Aligned_cols=216 Identities=30% Similarity=0.506 Sum_probs=186.7
Q ss_pred ccCCCCCccHHHHHHHhcC----------CCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHh
Q 043333 558 LDLHTGSFTLRQIKAATNN----------FAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMIS 626 (809)
Q Consensus 558 ~~~~~~~~~~~~l~~~~~~----------f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~ 626 (809)
...+.+.++.++++.+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++++
T Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~ 97 (321)
T 2c30_A 18 LYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR 97 (321)
T ss_dssp -------CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHT
T ss_pred eeecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHH
Confidence 3445567888888888764 666779999999999999965 69999999997766666677899999999
Q ss_pred hcCCCceEeEEeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 043333 627 ALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKA 706 (809)
Q Consensus 627 ~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp 706 (809)
+++||||+++++++...+..++||||+++|+|.+++. ...+++..+..++.|++.||+|||+. +|+||||||
T Consensus 98 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp 169 (321)
T 2c30_A 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKS 169 (321)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred hCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCH
Confidence 9999999999999999999999999999999999983 34689999999999999999999998 899999999
Q ss_pred CCEEEcCCCceEEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 707 TNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 707 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+||+++.++++||+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 170 DSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred HHEEECCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999866543222 23467999999999999999999999999999999999999999764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.85 Aligned_cols=201 Identities=28% Similarity=0.437 Sum_probs=177.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46788999999999999999996 578999999986542 233466889999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999842 34689999999999999999999998 899999999999999999999999999986654
Q ss_pred CCcceeccccccccccchhhhccCCCC-chHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLT-DKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... ....+||+.|+|||++.+..+. .++||||+||++|||++|+.||...+
T Consensus 167 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 167 GGK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp SCG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 322 3456799999999999887764 79999999999999999999997654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.76 Aligned_cols=202 Identities=28% Similarity=0.373 Sum_probs=177.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc---CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|+..+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357888999999999999999965 6899999999754 233456788999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999884 234689999999999999999999998 89999999999999999999999999998643
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 157 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 3222 2335679999999999999999999999999999999999999997643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=335.11 Aligned_cols=203 Identities=25% Similarity=0.420 Sum_probs=173.1
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc---CcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK---SKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 647 (809)
..++|+..+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|.+++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3468999999999999999999965 5899999999754 223345678899999988 6999999999999999999
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 101 lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 9999999999999984 234689999999999999999999998 899999999999999999999999999985
Q ss_pred cCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 728 DEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 43322 22335679999999999998889999999999999999999999997654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=334.78 Aligned_cols=200 Identities=25% Similarity=0.381 Sum_probs=174.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~l 648 (809)
.++|+..+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 457889999999999999999965 58899999997642 23345688899999887 89999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999884 234689999999999999999999998 8999999999999999999999999999853
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3222 223456899999999999999999999999999999999999999965
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=323.62 Aligned_cols=202 Identities=30% Similarity=0.523 Sum_probs=177.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
.++|...+.||+|+||+||+|... +++.||+|++........+.|.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357788899999999999999964 5899999998766666677899999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999943 245689999999999999999999998 89999999999999999999999999998654332
Q ss_pred cce-------------eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 733 THI-------------STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 733 ~~~-------------~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~ 224 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence 211 1145799999999999999999999999999999999999999865
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=325.64 Aligned_cols=199 Identities=28% Similarity=0.448 Sum_probs=176.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|+..+.||+|+||.||+|+.. +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357888999999999999999965 68999999986542 23345678899999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999842 34689999999999999999999998 89999999999999999999999999998654
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 32 234579999999999999999999999999999999999999997643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=329.25 Aligned_cols=205 Identities=27% Similarity=0.441 Sum_probs=177.5
Q ss_pred HHHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCe
Q 043333 571 KAATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 571 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 645 (809)
....++|...+.||+|+||.||+|+.. +|+.||||+++... ....+.+..|.+++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999965 68999999997542 23345678899999877 89999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999842 34689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 726 KLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 726 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
+....... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 166 KENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp BCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 85432222 2345679999999999999999999999999999999999999997644
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=322.01 Aligned_cols=203 Identities=29% Similarity=0.415 Sum_probs=172.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc---cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ---GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|+..+.||+|+||.||+|... +++.||+|++...... ..+.|.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467889999999999999999854 6889999998654322 245788999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++|+|.+++. ...++++..+..++.|++.||+|||++ +|+||||||+||+++.++++||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999983 234689999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
...........||+.|+|||.+.+..++.++||||+||++|||++|+.||...+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 443333345679999999999999999999999999999999999999997643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=330.55 Aligned_cols=201 Identities=27% Similarity=0.436 Sum_probs=176.3
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57888999999999999999965 58899999986542 334567889999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999843 34689999999999999999999998 899999999999999999999999999987653
Q ss_pred CCcceeccccccccccchhhhcc---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
.. .....+||+.|+|||++.. ..++.++|||||||++|||++|+.||.....
T Consensus 168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~ 222 (384)
T 4fr4_A 168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222 (384)
T ss_dssp TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT
T ss_pred CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC
Confidence 32 2345679999999999864 4589999999999999999999999976443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.55 Aligned_cols=204 Identities=28% Similarity=0.455 Sum_probs=173.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcc--cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++|+..+.||+|+||+||+|+..+|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4678899999999999999999888999999998654322 24578899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++ +|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9985 88887743 334589999999999999999999998 8999999999999999999999999999876433
Q ss_pred Ccceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcc
Q 043333 732 NTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTKE 785 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~~ 785 (809)
.. ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......
T Consensus 173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 226 (311)
T 3niz_A 173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT
T ss_pred cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH
Confidence 22 2234568999999999876 56899999999999999999999999775433
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=328.02 Aligned_cols=203 Identities=25% Similarity=0.363 Sum_probs=177.0
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 647 (809)
..++|+..+.||+|+||.||+|+.. +|+.||||+++... ....+.+..|.+++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999975 47899999987542 23346678899999988 7999999999999999999
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999842 34689999999999999999999998 899999999999999999999999999985
Q ss_pred cCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 728 DEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 171 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp CCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 432222 2335679999999999999999999999999999999999999997643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.79 Aligned_cols=202 Identities=27% Similarity=0.378 Sum_probs=177.8
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc------cchhHHHHHHHHhhcCCCceEeEEeEEEeCCe
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ------GNREFVNEIGMISALQHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 645 (809)
..++|+..+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3567889999999999999999965 6899999998765322 23568899999999999999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC----ceEEEe
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISD 721 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~D 721 (809)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999943 34689999999999999999999998 899999999999998877 799999
Q ss_pred cCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 722 FGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 722 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
||++........ ....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 163 FG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp CSSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred cCCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 999987654322 234679999999999999899999999999999999999999997643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.40 Aligned_cols=199 Identities=26% Similarity=0.381 Sum_probs=174.7
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV 649 (809)
++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|.+++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999999999999965 589999999975432 2245578899999988 899999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999884 234689999999999999999999998 89999999999999999999999999998543
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 162 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 162 RPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 2222 23456799999999999999999999999999999999999999965
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=322.60 Aligned_cols=209 Identities=33% Similarity=0.510 Sum_probs=170.0
Q ss_pred HHHhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 571 KAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 571 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
....++|++.+.||+|+||+||+|.. +|+.||||++..... ...++|.+|++++++++||||+++++++.+.+..++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 33457888999999999999999986 588999999875532 234578899999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++.... ....+++..+..++.|++.||+|||++++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999995432 12248999999999999999999999821 2999999999999999999999999999754
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 190 ASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4322 12234578999999999999999999999999999999999999997643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.70 Aligned_cols=202 Identities=27% Similarity=0.423 Sum_probs=167.6
Q ss_pred hcCCCCCCeeccCCCccEEEeEe----eCCeEEEEEEecccC----cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL----ADGKVIAVKQLSSKS----KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~~~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 645 (809)
.++|+..+.||+|+||.||+++. .+|+.||||+++... ......+.+|++++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46788999999999999999986 468999999987542 2234567889999999999999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE----REGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999984 234688999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 726 KLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 726 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
+....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 169 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 169 KESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 75433222 2234679999999999999899999999999999999999999997643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.63 Aligned_cols=199 Identities=23% Similarity=0.355 Sum_probs=177.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367889999999999999999965 68999999986542 23346788999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999842 34689999999999999999999998 89999999999999999999999999998654
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 32 234579999999999999999999999999999999999999997643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=331.91 Aligned_cols=203 Identities=17% Similarity=0.195 Sum_probs=174.3
Q ss_pred HhcCCCCCCeeccCCCccEEEeE------eeCCeEEEEEEecccCcccchhHHHHHHHHhhcC---CCceEeEEeEEEeC
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGL------LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ---HPNLVKLYGCCIEG 643 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~------~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~~~~~~~ 643 (809)
..++|...+.||+|+||+||+|. ..+++.||||++... ...++..|++++..++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45678889999999999999994 446889999998654 3456778888888886 99999999999999
Q ss_pred CeEEEEEEcccCCchhhhccCCCc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---------
Q 043333 644 NQLLLIYEYMENNSLARALFGPEE-HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK--------- 713 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--------- 713 (809)
+..++||||+++|+|.+++..... ....++|..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999953221 245699999999999999999999998 8999999999999998
Q ss_pred --CCceEEEecCCccccCC-CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 714 --DLNPKISDFGLAKLDEE-DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 714 --~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
++.+||+|||+++.... .........+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 89999999999975432 222334456799999999999999999999999999999999999999854
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.99 Aligned_cols=203 Identities=32% Similarity=0.468 Sum_probs=174.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++|+..+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999865 689999999865432 334678899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999999843 34589999999999999999999998 8999999999999999999999999999865432
Q ss_pred Cc-ceeccccccccccchhhhccCCC-CchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 NT-HISTRIAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 22 22334679999999999987665 778999999999999999999997643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.30 Aligned_cols=207 Identities=29% Similarity=0.460 Sum_probs=176.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEee--------CCeEEEEEEecccCc-ccchhHHHHHHHHhhc-CCCceEeEEeEEEeC
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA--------DGKVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLYGCCIEG 643 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~ 643 (809)
.++|...+.||+|+||.||+|... ++..||||+++.... ...+++.+|+++++++ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888999999999999999852 356799999975532 3346789999999999 899999999999999
Q ss_pred CeEEEEEEcccCCchhhhccCCCc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043333 644 NQLLLIYEYMENNSLARALFGPEE------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL 711 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 711 (809)
+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999964321 123589999999999999999999998 89999999999999
Q ss_pred cCCCceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 712 DKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 712 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999986543322 12233457889999999999999999999999999999999 999997643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=339.13 Aligned_cols=206 Identities=28% Similarity=0.425 Sum_probs=181.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+..|++++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888999999999999999975 68999999996542 23346788999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++|+|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999976554456799999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 43322 234579999999999999999999999999999999999999997643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=314.10 Aligned_cols=203 Identities=30% Similarity=0.533 Sum_probs=178.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.++|+..+.||+|+||.||+|...+++.||||++.... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 35788889999999999999998888999999997543 23467999999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 88 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 99999999943 234689999999999999999999998 899999999999999999999999999986644332
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
.......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 22334557788999999999999999999999999999999 999997643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.17 Aligned_cols=201 Identities=20% Similarity=0.330 Sum_probs=177.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
.++|...+.||+|+||.||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467889999999999999999965 58899999986442 3345688999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC--CCceEEEecCCccccCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK--DLNPKISDFGLAKLDEE 730 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~~~~ 730 (809)
+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999843 234689999999999999999999998 8999999999999987 78999999999987654
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 332 234578999999999998888999999999999999999999997643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.54 Aligned_cols=206 Identities=29% Similarity=0.469 Sum_probs=162.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++|+..+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467889999999999999999854 689999999875533 334678899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCC--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 652 YMENNSLARALFGPE--EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 652 y~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|++ |+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59998884321 2234589999999999999999999998 89999999999999999999999999998764
Q ss_pred CCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.
T Consensus 160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 214 (317)
T 2pmi_A 160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214 (317)
T ss_dssp SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 33221 234568999999999876 4689999999999999999999999977543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=313.44 Aligned_cols=203 Identities=31% Similarity=0.480 Sum_probs=179.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.++|+..+.||+|+||.||+|...++..||||++..... ..+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 467888999999999999999988888999999975433 3467899999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 99999999843 234589999999999999999999998 899999999999999999999999999987655444
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
.......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 33344556778999999998889999999999999999999 999997643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=323.78 Aligned_cols=201 Identities=24% Similarity=0.397 Sum_probs=176.1
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
..++|+..+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999864 689999999965432 2345688999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CceEEEecCCcc
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKISDFGLAK 726 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~ 726 (809)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999998843 34689999999999999999999998 89999999999999865 459999999998
Q ss_pred ccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 727 LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 180 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 180 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp CCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 6653322 23467999999999999989999999999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=318.39 Aligned_cols=201 Identities=26% Similarity=0.381 Sum_probs=176.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc------cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ------GNREFVNEIGMISALQHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 646 (809)
.++|...+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456888999999999999999965 5899999998654321 245688999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC----ceEEEec
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISDF 722 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~Df 722 (809)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999843 34689999999999999999999998 899999999999999887 8999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 163 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 163 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp TTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 99987643322 234579999999999998899999999999999999999999997643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=318.77 Aligned_cols=202 Identities=23% Similarity=0.261 Sum_probs=176.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46788999999999999999995 578999999986543 245788999999999 89999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc-----eEEEecCCcc
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN-----PKISDFGLAK 726 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DfGla~ 726 (809)
|+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 99999998432 34789999999999999999999998 8999999999999998887 9999999998
Q ss_pred ccCCCCcc------eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 727 LDEEDNTH------ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 727 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence 65433221 12346799999999999999999999999999999999999999987543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.62 Aligned_cols=205 Identities=23% Similarity=0.373 Sum_probs=177.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-----cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-----KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
.++|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356888999999999999999864 68999999986431 123567899999999999999999999999999999
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc---eEEEecCC
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---PKISDFGL 724 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DfGl 724 (809)
+||||+++|+|.+++.........+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988854333445689999999999999999999998 8999999999999987654 99999999
Q ss_pred ccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+........ .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 987654322 223457999999999999989999999999999999999999999763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=314.67 Aligned_cols=201 Identities=29% Similarity=0.444 Sum_probs=171.1
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
++|+..+.||+|+||+||+|...+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 56888999999999999999987799999999865432 2346788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 985 898888432 34689999999999999999999998 89999999999999999999999999998654322
Q ss_pred cceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
. ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 1234568999999999876 458999999999999999999999997654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.85 Aligned_cols=202 Identities=28% Similarity=0.406 Sum_probs=167.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHH-HhhcCCCceEeEEeEEEeCCeEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGM-ISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~-l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
.++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 356888999999999999999965 578999999976532 233456677766 567899999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999842 34688999999999999999999998 8999999999999999999999999999864
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 190 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 190 IEHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp BCCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred ccCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 33222 2345679999999999999999999999999999999999999997643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=325.90 Aligned_cols=201 Identities=25% Similarity=0.380 Sum_probs=177.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
.++|+..+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467899999999999999999864 6889999999766554556789999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC--CCceEEEecCCccccCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK--DLNPKISDFGLAKLDEE 730 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~~~~ 730 (809)
+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999843 234689999999999999999999998 8999999999999974 47899999999987654
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 253 (387)
T 1kob_A 204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253 (387)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence 332 23356999999999999999999999999999999999999999764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.75 Aligned_cols=200 Identities=28% Similarity=0.432 Sum_probs=169.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--------------------------ccchhHHHHHHHHh
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--------------------------QGNREFVNEIGMIS 626 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--------------------------~~~~~f~~Ei~~l~ 626 (809)
.++|+..+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367889999999999999999854 689999999865421 12356889999999
Q ss_pred hcCCCceEeEEeEEEe--CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 043333 627 ALQHPNLVKLYGCCIE--GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDI 704 (809)
Q Consensus 627 ~l~H~nIv~l~~~~~~--~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl 704 (809)
+++||||+++++++.+ .+..++||||+++|+|.+++ ...++++..+..++.|++.||+|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999987 56889999999999998876 234689999999999999999999998 8999999
Q ss_pred CCCCEEEcCCCceEEEecCCccccCCCCcceeccccccccccchhhhccCC---CCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 705 KATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGY---LTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 705 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. .+.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654332 233457999999999987655 37889999999999999999999975
Q ss_pred C
Q 043333 782 R 782 (809)
Q Consensus 782 ~ 782 (809)
.
T Consensus 243 ~ 243 (298)
T 2zv2_A 243 E 243 (298)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=312.33 Aligned_cols=216 Identities=43% Similarity=0.698 Sum_probs=187.1
Q ss_pred CCCccHHHHHHHhcCCCCC------CeeccCCCccEEEeEeeCCeEEEEEEecccC----cccchhHHHHHHHHhhcCCC
Q 043333 562 TGSFTLRQIKAATNNFAPD------NKIGEGGFGPVYKGLLADGKVIAVKQLSSKS----KQGNREFVNEIGMISALQHP 631 (809)
Q Consensus 562 ~~~~~~~~l~~~~~~f~~~------~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~----~~~~~~f~~Ei~~l~~l~H~ 631 (809)
...|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3578999999999999888 9999999999999986 57899999986542 22346788999999999999
Q ss_pred ceEeEEeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043333 632 NLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL 711 (809)
Q Consensus 632 nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 711 (809)
||+++++++.+.+..++||||+++|+|.+++.... ...+++|..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 99999999999999999999999999999985432 345689999999999999999999998 89999999999999
Q ss_pred cCCCceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 712 DKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 712 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
++++.+||+|||++........ .......||+.|+|||.+.+ .++.++|||||||++|||++|+.||....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 9999999999999986654322 22334578999999998765 57899999999999999999999997643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=337.09 Aligned_cols=202 Identities=27% Similarity=0.367 Sum_probs=167.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc---CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|+..+.||+|+||.||+|... +|+.||||++... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999954 6899999998754 233346678899999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
|||+++|+|.+++. ....+++..+..++.|++.||+|||+ . +|+||||||+|||++.++++||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999883 23468999999999999999999998 6 8999999999999999999999999999864
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 300 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 300 IKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 33222 2334679999999999999999999999999999999999999997643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.17 Aligned_cols=203 Identities=31% Similarity=0.486 Sum_probs=173.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee----CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA----DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
.++|++.+.||+|+||.||+|... .+..||||++.... ....+.|.+|++++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356778899999999999999964 35579999997653 3345679999999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999943 234689999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcc--eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 729 EEDNTH--ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 729 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 543221 2223446778999999998999999999999999999999 99999664
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=336.86 Aligned_cols=203 Identities=30% Similarity=0.411 Sum_probs=179.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999965 68999999986542 23345688999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 263 mEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999985432 33589999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 338 ~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 338 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp TTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred cCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 4322 234579999999999999889999999999999999999999997754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=310.37 Aligned_cols=199 Identities=23% Similarity=0.393 Sum_probs=170.1
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc--cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
++|+..+.||+|+||+||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57888999999999999999965 5899999998754332 23678899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++ ++.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 55555522 235689999999999999999999998 8999999999999999999999999999876433
Q ss_pred CcceeccccccccccchhhhccCC-CCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGY-LTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.. ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||..
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 22 223457899999999997765 79999999999999999999888643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=329.59 Aligned_cols=202 Identities=23% Similarity=0.355 Sum_probs=175.4
Q ss_pred HhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
..++|+..+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 457799999999999999999985 468999999986543 22345688999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc---CCCceEEEecCCcc
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAK 726 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DfGla~ 726 (809)
|||+++|+|.+++. .+..+++..+..++.|++.||+|||++ +|+||||||+|||++ +++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~----~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999884 334689999999999999999999998 899999999999998 56789999999998
Q ss_pred ccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 727 LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~ 216 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE 216 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence 6654332 223467999999999999989999999999999999999999999764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.83 Aligned_cols=204 Identities=28% Similarity=0.450 Sum_probs=171.3
Q ss_pred HhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc-----ccchhHHHHHHHHhhcC---CCceEeEEeEEEeC
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK-----QGNREFVNEIGMISALQ---HPNLVKLYGCCIEG 643 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~-----~~~~~f~~Ei~~l~~l~---H~nIv~l~~~~~~~ 643 (809)
..++|+..+.||+|+||+||+|+. .+++.||||++..... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999995 4689999999864321 12346777887777765 99999999999876
Q ss_pred C-----eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceE
Q 043333 644 N-----QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 718 (809)
Q Consensus 644 ~-----~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 718 (809)
. ..++||||++ |+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 5 5799999997 59999985432 23489999999999999999999998 899999999999999999999
Q ss_pred EEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 719 ISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 719 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 161 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 224 (308)
T 3g33_A 161 LADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 224 (308)
T ss_dssp ECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH
T ss_pred EeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998664332 22456789999999999999999999999999999999999999977543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=326.01 Aligned_cols=196 Identities=27% Similarity=0.426 Sum_probs=168.3
Q ss_pred CCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCch
Q 043333 580 DNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSL 658 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 658 (809)
.+.||+|+||.||+|.. .+|+.||||+++.......+++.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56799999999999986 46899999999876555567899999999999999999999999999999999999999999
Q ss_pred hhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE--cCCCceEEEecCCccccCCCCccee
Q 043333 659 ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL--DKDLNPKISDFGLAKLDEEDNTHIS 736 (809)
Q Consensus 659 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl--~~~~~~kl~DfGla~~~~~~~~~~~ 736 (809)
.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 998843 234589999999999999999999998 89999999999999 5678999999999987654332 2
Q ss_pred ccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 737 TRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 737 ~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 33569999999999998899999999999999999999999997653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=326.74 Aligned_cols=203 Identities=31% Similarity=0.510 Sum_probs=164.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEee----CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA----DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
.++|+..+.||+|+||.||+|+.. ++..||||+++... ....++|.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999864 46789999987543 3335679999999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999953 234689999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcce--eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 729 EEDNTHI--STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 729 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
....... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 5432211 112345778999999999999999999999999999998 99999654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.10 Aligned_cols=203 Identities=28% Similarity=0.463 Sum_probs=175.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.++|+..+.||+|+||.||+|.+.++..||||++..... ..+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 457888899999999999999988888999999975433 3467899999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++++||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 102 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp TTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 999999999542 34689999999999999999999998 899999999999999999999999999986644322
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
.......+|+.|+|||.+.+..++.++||||+|+++|||+| |+.||....
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 22233456788999999999999999999999999999998 999997643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=320.00 Aligned_cols=199 Identities=28% Similarity=0.453 Sum_probs=173.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEeccc---CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35788999999999999999996 56899999998653 223346788999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+ +|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIV----EKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 689988884 234689999999999999999999998 89999999999999999999999999998665
Q ss_pred CCCcceeccccccccccchhhhccCCC-CchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
... .....+||+.|+|||++.+..+ ++++||||+||++|||++|+.||...
T Consensus 160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 432 2234579999999999987765 78999999999999999999999754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.17 Aligned_cols=203 Identities=32% Similarity=0.424 Sum_probs=170.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCC----eEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGN----QLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~----~~~lV 649 (809)
.++|+..+.||+|+||+||+|+.. ++.||||++..... ....+..|+.++++++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467888999999999999999875 79999999865432 2344566888999999999999999998754 47999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE-------SRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
|||+++|+|.+++. ...++|..+..++.|++.||+|||+. +..+|+||||||+|||++.++.+||+||
T Consensus 101 ~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLK-----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 99999999999993 23589999999999999999999986 1237999999999999999999999999
Q ss_pred CCccccCCCCc-ceeccccccccccchhhhccC-----CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 723 GLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRG-----YLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 723 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
|+++....... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||....
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 99986644322 222345799999999998763 45668899999999999999999997643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=314.19 Aligned_cols=203 Identities=25% Similarity=0.350 Sum_probs=175.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCC--eEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGN--QLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~--~~~lV 649 (809)
.++|...+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357888999999999999999965 48999999997543 233567889999999999999999999998765 78999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----cCCCceEEEecCCc
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLA 725 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla 725 (809)
|||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999996432 233489999999999999999999998 89999999999999 78888999999999
Q ss_pred cccCCCCcceeccccccccccchhhhc--------cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 726 KLDEEDNTHISTRIAGTFGYMAPEYAM--------RGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 726 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+........ ....||+.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 164 RELEDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp EECCTTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred eecCCCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 876543322 3456899999999986 577899999999999999999999999753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=323.91 Aligned_cols=216 Identities=26% Similarity=0.403 Sum_probs=181.6
Q ss_pred ccHHHHHHHhcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCc-ccchhHHHHHHHHhhc-CCCceEeE
Q 043333 565 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKL 636 (809)
Q Consensus 565 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l 636 (809)
+.........++|+..+.||+|+||.||+|.+. +++.||||+++.... ...+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 455566667889999999999999999999742 457899999976432 3346789999999999 79999999
Q ss_pred EeEEEeCCe-EEEEEEcccCCchhhhccCCCcc-----------------------------------------------
Q 043333 637 YGCCIEGNQ-LLLIYEYMENNSLARALFGPEEH----------------------------------------------- 668 (809)
Q Consensus 637 ~~~~~~~~~-~~lV~ey~~~gsL~~~L~~~~~~----------------------------------------------- 668 (809)
+++|.+.+. .++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999988654 89999999999999999654321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 669 ---------------RLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 669 ---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12289999999999999999999998 899999999999999999999999999986543322
Q ss_pred -ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 734 -HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 734 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 23334568899999999999999999999999999999998 999997643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=315.49 Aligned_cols=203 Identities=24% Similarity=0.430 Sum_probs=171.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCC-------
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGN------- 644 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~------- 644 (809)
.++|+..+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||++++++|.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457888999999999999999975 789999999875433 34567899999999999999999999987643
Q ss_pred --------------------------------------------------eEEEEEEcccCCchhhhccCCCccCCCCCH
Q 043333 645 --------------------------------------------------QLLLIYEYMENNSLARALFGPEEHRLKLDW 674 (809)
Q Consensus 645 --------------------------------------------------~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~ 674 (809)
..++||||+++|+|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 37999999999999999965432 334578
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc-----------ceeccccccc
Q 043333 675 PTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-----------HISTRIAGTF 743 (809)
Q Consensus 675 ~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~ 743 (809)
..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 88999999999999999998 899999999999999999999999999987654321 1123356999
Q ss_pred cccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 043333 744 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVI 780 (809)
Q Consensus 744 ~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~ 780 (809)
.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 9999999999999999999999999999999988763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=318.07 Aligned_cols=204 Identities=25% Similarity=0.443 Sum_probs=167.5
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
++|...+.||+|+||+||+|... +++.||||++...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57888999999999999999965 6899999998654322 233566799999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
++ |+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 98 589888843 234689999999999999999999998 89999999999999999999999999997654322
Q ss_pred cceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCccc
Q 043333 733 THISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTKEA 786 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~ 786 (809)
. ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 208 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 2 2234568999999999876 568999999999999999999999998755443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=328.42 Aligned_cols=204 Identities=27% Similarity=0.443 Sum_probs=175.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++|...+.||+|+||.||+|.+. +++.||||+++... ....++|.+|++++++++||||++++++|.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457788899999999999999975 68999999987543 2334678999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999943 234589999999999999999999998 8999999999999999999999999999864332
Q ss_pred Cccee-ccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 732 NTHIS-TRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 732 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
..... ....+++.|+|||.+.++.++.++|||||||++|||+| |+.||....
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 11111 11235678999999998899999999999999999998 999997643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=335.41 Aligned_cols=204 Identities=30% Similarity=0.471 Sum_probs=176.6
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
..++|...+.||+|+||.||+|.+.+++.||||+++... ...++|.+|++++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 456788889999999999999999888999999997543 34678999999999999999999999986 5678999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 264 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 264 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 9999999999542 223578999999999999999999998 89999999999999999999999999998764322
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
........+++.|+|||++..+.++.++|||||||++|||+| |+.||...+
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~ 390 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence 222223446788999999999999999999999999999999 999997643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=312.64 Aligned_cols=202 Identities=29% Similarity=0.477 Sum_probs=171.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-----eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-----ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEG--NQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 646 (809)
.++|+..+.||+|+||+||+|++ .+++.||||++........+.|.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46788899999999999999984 25889999999876655567899999999999999999999999754 458
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++++||+|||+++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999999432 33589999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCc--ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 727 LDEEDNT--HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 727 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
....... .......++..|+|||.+.+..++.++|||||||++|||+||+.|+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 7644322 122234577789999999999999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.97 Aligned_cols=196 Identities=30% Similarity=0.470 Sum_probs=166.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhh--cCCCceEeEEeEEEeC----CeEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISA--LQHPNLVKLYGCCIEG----NQLL 647 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~~~~~~~----~~~~ 647 (809)
.++|+..+.||+|+||+||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 56788999999999999999987 6899999998643 23556677777766 7899999999997653 4579
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEcCCCCCCEEEcCCCceEE
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH--------EESRLKIVHRDIKATNVLLDKDLNPKI 719 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiH~Dlkp~NILl~~~~~~kl 719 (809)
+||||+++|+|.+++. ...+++..+..++.|++.||+||| +. +|+||||||+|||++.++++||
T Consensus 83 lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence 9999999999999993 346899999999999999999999 65 8999999999999999999999
Q ss_pred EecCCccccCCCCcce---eccccccccccchhhhccC------CCCchHHHHHHHHHHHHHHcC----------CCCCC
Q 043333 720 SDFGLAKLDEEDNTHI---STRIAGTFGYMAPEYAMRG------YLTDKADVYSFGIVALEIVSG----------RSNVI 780 (809)
Q Consensus 720 ~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~ksDVwSlGvil~elltG----------k~P~~ 780 (809)
+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999997654433322 2234799999999999876 445799999999999999999 88886
Q ss_pred C
Q 043333 781 C 781 (809)
Q Consensus 781 ~ 781 (809)
.
T Consensus 235 ~ 235 (301)
T 3q4u_A 235 D 235 (301)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=323.37 Aligned_cols=204 Identities=27% Similarity=0.444 Sum_probs=164.3
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEeccc--CcccchhHHHHHHHHhhcC-CCceEeEEeEEEeCC--e
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSK--SKQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGN--Q 645 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~--~ 645 (809)
...++|+..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3467899999999999999999985 46899999998654 2233456788999999997 999999999998654 6
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++|||||+ |+|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIR-----ANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHH-----HTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999998 58998883 24689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCC--------------------Ccceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 726 KLDEED--------------------NTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 726 ~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
+..... ........+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 865321 1112234679999999999876 6789999999999999999999999977543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.49 Aligned_cols=203 Identities=23% Similarity=0.384 Sum_probs=167.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcc---cchhHHHHHHHHhhcCCCceEeEEeEEEeCC----e
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQ---GNREFVNEIGMISALQHPNLVKLYGCCIEGN----Q 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~----~ 645 (809)
.++|+..+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++++++||||+++++++...+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788999999999999999995 57899999999765322 2356889999999999999999999988654 3
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999842 34689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCc--ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 726 KLDEEDNT--HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 726 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 86543322 12234568999999999999999999999999999999999999997643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=307.54 Aligned_cols=201 Identities=21% Similarity=0.293 Sum_probs=175.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|++++..+ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46788999999999999999995 578999999986432 345788999999999 79999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc-----eEEEecCCcc
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN-----PKISDFGLAK 726 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DfGla~ 726 (809)
|+ +++|.+++.. ...++++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++
T Consensus 87 ~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 9999999943 234589999999999999999999998 8999999999999987776 9999999998
Q ss_pred ccCCCCcc------eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 727 LDEEDNTH------ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 727 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 76543221 1234579999999999999999999999999999999999999997744
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=334.92 Aligned_cols=204 Identities=26% Similarity=0.461 Sum_probs=178.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC-CeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
.++|...+.||+|+||.||+|.+.. ++.||||+++... ...++|.+|++++++++||||++++++|.+.+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4567788999999999999999764 8899999987543 3457899999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
|++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 298 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred cCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 9999999999532 234689999999999999999999998 89999999999999999999999999998765443
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
........+++.|+|||++.+..++.++|||||||++|||+| |+.||...+
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 333334456789999999999999999999999999999999 999997643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=343.28 Aligned_cols=203 Identities=25% Similarity=0.365 Sum_probs=177.7
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc---CcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK---SKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 647 (809)
..++|+..+.||+|+||.||+|... +++.||||+++.. .....+.+..|.+++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4568999999999999999999965 5889999998754 233456678899999988 7999999999999999999
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999942 34689999999999999999999998 899999999999999999999999999986
Q ss_pred cCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 728 DEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 492 ~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 492 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp CCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 433222 2345689999999999999999999999999999999999999997643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=318.97 Aligned_cols=199 Identities=28% Similarity=0.413 Sum_probs=160.6
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567889999999999999999975 57899999987543 34568889999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCceEEEecCCcccc
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAKLD 728 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~~~ 728 (809)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999843 34589999999999999999999998 8999999999999975 889999999999865
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 253 (349)
T 2w4o_A 202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 4322 223457899999999999989999999999999999999999999653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=326.64 Aligned_cols=200 Identities=26% Similarity=0.450 Sum_probs=175.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357888999999999999999965 68999999986542 22345788999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999943 34689999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcceeccccccccccchhhhccCCC-CchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
... .....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||...
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 219 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence 432 2234579999999999988765 78999999999999999999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=316.72 Aligned_cols=200 Identities=27% Similarity=0.366 Sum_probs=164.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
.++|+..+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467889999999999999999965 68999999986543 3346788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc--eEEEecCCccccCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN--PKISDFGLAKLDEE 730 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DfGla~~~~~ 730 (809)
+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERIC----NAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999883 234689999999999999999999998 8999999999999987765 99999999974332
Q ss_pred CCcceeccccccccccchhhhccCCCCch-HHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDK-ADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. ......||+.|+|||++.+..++.+ +||||+||++|||++|+.||....
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 22 1234569999999999988777665 899999999999999999997643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=319.64 Aligned_cols=203 Identities=27% Similarity=0.365 Sum_probs=174.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEe----eCCeEEEEEEecccC----cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCC
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL----ADGKVIAVKQLSSKS----KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGN 644 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 644 (809)
.++|+..+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36788999999999999999986 368999999986542 23345677899999999 6999999999999999
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999842 34689999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeccccccccccchhhhcc--CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
++.............+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 98664433333345679999999999985 347899999999999999999999997543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.10 Aligned_cols=200 Identities=30% Similarity=0.545 Sum_probs=163.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCc----ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSK----QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~----~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|+..+.||+|+||.||+|... ++.||||+++.... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999874 88999999865432 2246788999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC--------CCceEEEe
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK--------DLNPKISD 721 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--------~~~~kl~D 721 (809)
|||+++++|.+++. ...+++..+..++.|++.||+|||+++..+|+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999983 346899999999999999999999984334999999999999986 67899999
Q ss_pred cCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 722 FGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 722 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
||++........ ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999986543322 2356899999999999999999999999999999999999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=325.59 Aligned_cols=207 Identities=29% Similarity=0.415 Sum_probs=174.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEeccc-CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 646 (809)
.++|+..+.||+|+||.||+|.+. +++.||||+++.. ......++.+|++++++++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 356888899999999999999843 4678999998654 233456788999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhccCCC---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---ceEEE
Q 043333 647 LLIYEYMENNSLARALFGPE---EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NPKIS 720 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~ 720 (809)
++||||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999995432 2234689999999999999999999998 899999999999999554 59999
Q ss_pred ecCCccccCCC-CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 721 DFGLAKLDEED-NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 721 DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999754221 1112233567899999999999999999999999999999998 999997643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=312.01 Aligned_cols=193 Identities=26% Similarity=0.398 Sum_probs=151.0
Q ss_pred CCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCeEEEEEEcccCCc
Q 043333 580 DNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEYMENNS 657 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~~~gs 657 (809)
.+.||+|+||.||+|... +++.||||++... ....+.+|++++..++ ||||+++++++.+.+..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999965 6899999998643 3456788999999997 9999999999999999999999999999
Q ss_pred hhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---ceEEEecCCccccCCCCcc
Q 043333 658 LARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 658 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGla~~~~~~~~~ 734 (809)
|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++........
T Consensus 93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 9999843 35689999999999999999999998 899999999999998765 8999999999865443222
Q ss_pred eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 735 ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 166 -~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 166 -LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred -ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 234568999999999999999999999999999999999999997643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=319.19 Aligned_cols=209 Identities=30% Similarity=0.476 Sum_probs=177.3
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCC
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGN 644 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~ 644 (809)
...++|+..+.||+|+||.||+|... +++.||||+++.... ...+.|.+|++++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34678899999999999999999975 348899999975532 33567899999999999999999999999999
Q ss_pred eEEEEEEcccCCchhhhccCCCc--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEE--------------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDI 704 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl 704 (809)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 99999999999999999854321 125789999999999999999999998 8999999
Q ss_pred CCCCEEEcCCCceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 705 KATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 705 kp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999976543221 12233567889999999999999999999999999999999 99999764
Q ss_pred C
Q 043333 783 T 783 (809)
Q Consensus 783 ~ 783 (809)
.
T Consensus 281 ~ 281 (343)
T 1luf_A 281 A 281 (343)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.30 Aligned_cols=211 Identities=24% Similarity=0.311 Sum_probs=173.1
Q ss_pred HHHHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc-----CcccchhHHHHHHHHhhcCCCceEeEEeEEEeC
Q 043333 570 IKAATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK-----SKQGNREFVNEIGMISALQHPNLVKLYGCCIEG 643 (809)
Q Consensus 570 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~ 643 (809)
+....++|+..+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3456788999999999999999999864 6789999998653 233456789999999999999999999999999
Q ss_pred CeEEEEEEcccCCchhhhccCCCc------------------------------------cCCCCCHHHHHHHHHHHHHH
Q 043333 644 NQLLLIYEYMENNSLARALFGPEE------------------------------------HRLKLDWPTRHSICIGLARG 687 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~------------------------------------~~~~l~~~~~~~i~~~ia~~ 687 (809)
+..++||||+++|+|.+++..... ....+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999998842100 01223567788899999999
Q ss_pred HHHHHhCCCCCeEEcCCCCCCEEEcCCC--ceEEEecCCccccCCCCc---ceeccccccccccchhhhcc--CCCCchH
Q 043333 688 LAYLHEESRLKIVHRDIKATNVLLDKDL--NPKISDFGLAKLDEEDNT---HISTRIAGTFGYMAPEYAMR--GYLTDKA 760 (809)
Q Consensus 688 L~yLH~~~~~~iiH~Dlkp~NILl~~~~--~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~ks 760 (809)
|+|||+. +|+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999998 899999999999998776 899999999986533221 12234579999999999865 6789999
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCC
Q 043333 761 DVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 761 DVwSlGvil~elltGk~P~~~~~ 783 (809)
|||||||++|||++|+.||....
T Consensus 258 DiwslG~il~el~~g~~pf~~~~ 280 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVN 280 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999997643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=313.28 Aligned_cols=208 Identities=27% Similarity=0.413 Sum_probs=174.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeC-------
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEG------- 643 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~------- 643 (809)
.++|+..+.||+|+||.||+|+. .+|+.||||++..... .....+.+|++++++++||||+++++++.+.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36788999999999999999996 4689999999865432 2345788999999999999999999999874
Q ss_pred -CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 644 -NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 644 -~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
+..++||||+++ +|.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 468999999985 77777643 234589999999999999999999998 8999999999999999999999999
Q ss_pred CCccccCCCC---cceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcccch
Q 043333 723 GLAKLDEEDN---THISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQF 788 (809)
Q Consensus 723 Gla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~~~ 788 (809)
|+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+..
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 238 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 9998654221 122234578999999999876 45799999999999999999999999876544433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=309.56 Aligned_cols=203 Identities=28% Similarity=0.406 Sum_probs=162.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC----CeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD----GKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
.++|+..+.||+|+||.||+|.... +..||||+..... ....+.+.+|++++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678889999999999999998642 4679999986543 233467899999999999999999999984 567899
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 93 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999843 234689999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence 5433332334457789999999998999999999999999999997 999997643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.48 Aligned_cols=201 Identities=23% Similarity=0.371 Sum_probs=176.8
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
..++|+..+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3467889999999999999999965 477899999977666667789999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---cCCCceEEEecCCcccc
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLD 728 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~ 728 (809)
|+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVV----HKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999999884 234589999999999999999999998 89999999999999 78899999999999866
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
..... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 160 ~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 160 KPGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp CTTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 54322 234568999999998865 48999999999999999999999997643
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=327.98 Aligned_cols=303 Identities=19% Similarity=0.176 Sum_probs=261.0
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCch-hhcCCccCcEEeecccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPK-AVASISTLADLTLEFNQ 78 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~-~l~~l~~L~~L~L~~N~ 78 (809)
+|+|++|++.+..|..|..+++|++|+|++|.+++..|..|..++ |+.|++++|.+..+|. .+.++++|++|+|++|.
T Consensus 36 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 115 (477)
T 2id5_A 36 LLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENK 115 (477)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSC
T ss_pred EEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCc
Confidence 478999999988888999999999999999999988888898886 9999999999999986 46889999999999999
Q ss_pred cccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCcc
Q 043333 79 FSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSG 158 (809)
Q Consensus 79 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 158 (809)
+++..+..|.++++|++|+|++|++++..+..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|++.+..+..
T Consensus 116 i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~ 195 (477)
T 2id5_A 116 IVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYS 195 (477)
T ss_dssp CCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTC
T ss_pred cccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhh
Confidence 99888888999999999999999999888888999999999999999999777777999999999999999999888888
Q ss_pred ccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCcc
Q 043333 159 IASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLT 237 (809)
Q Consensus 159 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~ 237 (809)
|..+++|+.|++++|......+.......+|+.|+|++|+++...+..|..+++|+.|+|++|++++.++..+.. ++|+
T Consensus 196 ~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 275 (477)
T 2id5_A 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQ 275 (477)
T ss_dssp SCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCC
T ss_pred cccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCC
Confidence 999999999999998776655555555669999999999999877788999999999999999999988888876 9999
Q ss_pred EEEeeCccCCCCCChhhhh-ccCccccccCCccccCCCCCcccccccceeccccCCCCCCccccccccCCCCCCCcceee
Q 043333 238 YMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVSCLKSFTCPTNHSSLHI 316 (809)
Q Consensus 238 ~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~ 316 (809)
.|+|++|++++..|..+.. .+++.|+|++|.++..++..+. .|.+.......+|||.|
T Consensus 276 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---------------------~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 276 EIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFH---------------------SVGNLETLILDSNPLAC 334 (477)
T ss_dssp EEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBS---------------------CGGGCCEEECCSSCEEC
T ss_pred EEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcC---------------------CCcccCEEEccCCCccC
Confidence 9999999999988877755 6779999999999876443332 34455566788999999
Q ss_pred cCCCceee
Q 043333 317 NCGGKQVI 324 (809)
Q Consensus 317 ~C~~~~~~ 324 (809)
+|.+.++.
T Consensus 335 ~c~~~~~~ 342 (477)
T 2id5_A 335 DCRLLWVF 342 (477)
T ss_dssp SGGGHHHH
T ss_pred ccchHhHH
Confidence 99877753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=315.72 Aligned_cols=203 Identities=29% Similarity=0.524 Sum_probs=167.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCe----EEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGK----VIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
.++|+..+.||+|+||+||+|++. +++ .||+|.+.... ....++|.+|++++++++||||++++++|.+.+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 356888999999999999999854 344 46888876443 344578999999999999999999999998754 78
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+|+||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999853 234689999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 728 DEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
....... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 224 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence 6443322 2233456889999999999999999999999999999999 999997644
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=321.28 Aligned_cols=207 Identities=30% Similarity=0.444 Sum_probs=177.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee--------CCeEEEEEEecccCc-ccchhHHHHHHHHhhc-CCCceEeEEeEEEeC
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA--------DGKVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLYGCCIEG 643 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~ 643 (809)
.++|...+.||+|+||.||+|... .++.||||++..... ...+++.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467888999999999999999852 236799999976532 3346788999999999 899999999999999
Q ss_pred CeEEEEEEcccCCchhhhccCCCc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043333 644 NQLLLIYEYMENNSLARALFGPEE------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL 711 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 711 (809)
+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 999999999999999999854321 124589999999999999999999998 89999999999999
Q ss_pred cCCCceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 712 DKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 712 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
++++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999986643322 22334567889999999999999999999999999999999 999997643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=320.00 Aligned_cols=206 Identities=19% Similarity=0.271 Sum_probs=176.4
Q ss_pred HhcCCCCCCeeccC--CCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 573 ATNNFAPDNKIGEG--GFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 573 ~~~~f~~~~~LG~G--~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
..++|++.+.||+| +||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35678999999999 99999999965 68999999997543 223456788999999999999999999999999999
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.+..
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 999999999999998532 224589999999999999999999998 899999999999999999999999998864
Q ss_pred cCCCCc------ceeccccccccccchhhhcc--CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 728 DEEDNT------HISTRIAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 422211 11123468999999999987 578999999999999999999999997643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.32 Aligned_cols=208 Identities=32% Similarity=0.481 Sum_probs=177.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEe------eCCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL------ADGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 646 (809)
.++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 56788899999999999999985 235789999987543 23346788999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhccCCCc--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 043333 647 LLIYEYMENNSLARALFGPEE--------------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKA 706 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp 706 (809)
++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999964322 123488999999999999999999998 899999999
Q ss_pred CCEEEcCCCceEEEecCCccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 043333 707 TNVLLDKDLNPKISDFGLAKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRTK 784 (809)
Q Consensus 707 ~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~~ 784 (809)
+||++++++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999866443322 2223457789999999999889999999999999999999 9999976543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.81 Aligned_cols=202 Identities=28% Similarity=0.466 Sum_probs=170.0
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCe----EEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGK----VIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
++|+..+.||+|+||.||+|.+. +++ .||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56888899999999999999854 444 37888875443 334567889999999999999999999986 456899
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++... +..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999998542 34688899999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 729 EEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
...... ......+|..|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 543322 2334567889999999999999999999999999999999 999997644
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.90 Aligned_cols=204 Identities=27% Similarity=0.406 Sum_probs=172.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 357888999999999999999864 58899999987653 3345778999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---cCCCceEEEecCCcccc
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLD 728 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~ 728 (809)
|+++|+|.+++.........+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999998854433446799999999999999999999998 89999999999999 45688999999999865
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
..... .....||+.|+|||.+. +.++.++|||||||++|||++|+.||....
T Consensus 178 ~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 178 KSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 43322 23456899999999875 568999999999999999999999997643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=304.90 Aligned_cols=203 Identities=28% Similarity=0.461 Sum_probs=156.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35688899999999999999986 478999999986542 22246788999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++++|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999853 234689999999999999999999998 89999999999999999999999999998654
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 164 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 164 MPHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred CCCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 32221 223568999999999998889999999999999999999999997643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.46 Aligned_cols=200 Identities=24% Similarity=0.363 Sum_probs=174.9
Q ss_pred HhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc--------ccchhHHHHHHHHhhcCCCceEeEEeEEEeC
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK--------QGNREFVNEIGMISALQHPNLVKLYGCCIEG 643 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~ 643 (809)
..++|+..+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456899999999999999999985 4689999999876431 1334678899999999999999999999999
Q ss_pred CeEEEEEEcccCC-chhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 644 NQLLLIYEYMENN-SLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 644 ~~~~lV~ey~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
+..++||||+..| +|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999877 99998843 34689999999999999999999998 8999999999999999999999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhccCCC-CchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
|++........ .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 99987654332 234569999999999988776 8899999999999999999999964
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=305.11 Aligned_cols=201 Identities=29% Similarity=0.497 Sum_probs=173.1
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
+.++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3567889999999999999999865 57799999986532 2234678899999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999883 234689999999999999999999998 8999999999999999999999999998654
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 3322 234568999999999999999999999999999999999999997644
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=330.12 Aligned_cols=204 Identities=31% Similarity=0.513 Sum_probs=170.7
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
..++|+..+.||+|+||.||+|.+.++..||||+++... ...++|.+|++++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 346678889999999999999998888889999997543 335679999999999999999999999876 678999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 260 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 9999999999431 234589999999999999999999998 89999999999999999999999999998765433
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
........++..|+|||.+.++.++.++|||||||++|||++ |+.||....
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 386 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence 222233456789999999999999999999999999999999 999997643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=305.44 Aligned_cols=202 Identities=30% Similarity=0.521 Sum_probs=177.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.++|+..+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 356788899999999999999988889999999976433 3467899999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++++|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 86 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp TTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 99999999843 234689999999999999999999998 899999999999999999999999999986543222
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 22233457788999999998899999999999999999999 89999764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=307.61 Aligned_cols=203 Identities=26% Similarity=0.381 Sum_probs=170.6
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc--cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
++|+..+.||+|+||+||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999965 5899999998654322 24567899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999988742 34589999999999999999999998 8999999999999999999999999999876533
Q ss_pred Ccceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcc
Q 043333 732 NTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTKE 785 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~~ 785 (809)
.. ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 209 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV 209 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 22 2234568999999999876 67899999999999999999999999775443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.35 Aligned_cols=210 Identities=27% Similarity=0.359 Sum_probs=180.0
Q ss_pred CccHHHHHHHhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcC-----CCceEeEE
Q 043333 564 SFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-----HPNLVKLY 637 (809)
Q Consensus 564 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-----H~nIv~l~ 637 (809)
.+++++.....++|...+.||+|+||+||+|+. .+++.||||+++.. ....+.+..|+++++.++ ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 344455555678999999999999999999996 46889999998643 233456778999999986 99999999
Q ss_pred eEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC----
Q 043333 638 GCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK---- 713 (809)
Q Consensus 638 ~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---- 713 (809)
+++...+..++||||+ +++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccc
Confidence 9999999999999999 89999998532 223589999999999999999999998 8999999999999975
Q ss_pred ---------------------CCceEEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHH
Q 043333 714 ---------------------DLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEI 772 (809)
Q Consensus 714 ---------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~el 772 (809)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 7899999999998654322 245789999999999999999999999999999999
Q ss_pred HcCCCCCCCCCc
Q 043333 773 VSGRSNVICRTK 784 (809)
Q Consensus 773 ltGk~P~~~~~~ 784 (809)
++|+.||...+.
T Consensus 253 l~g~~pf~~~~~ 264 (360)
T 3llt_A 253 YTGSLLFRTHEH 264 (360)
T ss_dssp HHSSCSCCCSSH
T ss_pred HHCCCCCCCCcH
Confidence 999999977543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=309.96 Aligned_cols=201 Identities=26% Similarity=0.367 Sum_probs=176.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc------cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ------GNREFVNEIGMISALQHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 646 (809)
.++|+..+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456889999999999999999965 6899999998754322 245689999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC----ceEEEec
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISDF 722 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~Df 722 (809)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999943 34689999999999999999999998 899999999999999887 7999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
|++........ .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 222 (321)
T 2a2a_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (321)
T ss_dssp TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence 99987654322 234568999999999999999999999999999999999999997643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=318.23 Aligned_cols=202 Identities=20% Similarity=0.273 Sum_probs=167.3
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeC------CeEEEEEEecccCcc-----------cchhHHHHHHHHhhcCCCceEe
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLAD------GKVIAVKQLSSKSKQ-----------GNREFVNEIGMISALQHPNLVK 635 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~~~-----------~~~~f~~Ei~~l~~l~H~nIv~ 635 (809)
..++|...+.||+|+||.||+|.+.+ ++.||||++...... ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34678899999999999999998754 478999998654321 1123445666777888999999
Q ss_pred EEeEEEeC----CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043333 636 LYGCCIEG----NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL 711 (809)
Q Consensus 636 l~~~~~~~----~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 711 (809)
+++++... ...++||||+ +++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99999874 4589999999 9999999843 235699999999999999999999998 89999999999999
Q ss_pred c--CCCceEEEecCCccccCCCCcc------eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 712 D--KDLNPKISDFGLAKLDEEDNTH------ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 712 ~--~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
+ .++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9 8899999999999765432211 11234599999999999999999999999999999999999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=324.17 Aligned_cols=198 Identities=32% Similarity=0.464 Sum_probs=171.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCC-eEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGN-QLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~-~~~lV~ey 652 (809)
.++|+..+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|++++++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 456788899999999999999875 7899999997543 4578999999999999999999999998765 78999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
|++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 9999999999532 223478999999999999999999998 89999999999999999999999999998543221
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
....+++.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 12356889999999999999999999999999999998 999997643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=309.66 Aligned_cols=198 Identities=28% Similarity=0.334 Sum_probs=164.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|+..++||+|+||+||+|... +|+.||||++..... ....++..|+..+.++ +||||++++++|.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357889999999999999999975 689999999865432 2233455666666555 899999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+ +++|.+++.. ....++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 6789888743 234699999999999999999999998 89999999999999999999999999998664
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
... ......||+.|+|||++.+ .++.++|||||||++|||++|+.|+..
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 209 TAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred cCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 332 2234569999999998875 789999999999999999999776643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=301.57 Aligned_cols=200 Identities=24% Similarity=0.406 Sum_probs=175.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
.++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578899999999999999999864 58899999986543 223466889999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc---eEEEecCCccc
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---PKISDFGLAKL 727 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DfGla~~ 727 (809)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999988884 234689999999999999999999998 8999999999999986655 99999999976
Q ss_pred cCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 728 DEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 728 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
...... .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||...
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 210 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence 654322 23457899999999999999999999999999999999999999664
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=313.41 Aligned_cols=199 Identities=26% Similarity=0.396 Sum_probs=166.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccC--cccchhHHHHHHHHhhcCC--CceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQH--PNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H--~nIv~l~~~~~~~~~~~lV 649 (809)
.++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|++++.+++| |||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45688899999999999999998889999999986543 2234678899999999986 9999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|| +.+|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 56889999984 344689999999999999999999998 899999999999997 5789999999998765
Q ss_pred CCCcc-eeccccccccccchhhhcc-----------CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 730 EDNTH-ISTRIAGTFGYMAPEYAMR-----------GYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 730 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 43322 2334679999999999865 6789999999999999999999999965
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=314.00 Aligned_cols=208 Identities=30% Similarity=0.438 Sum_probs=175.4
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccC-cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCC
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGN 644 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 644 (809)
..++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++.++ +||||+++++++.+.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3467888999999999999999852 35689999997543 33457799999999999 8999999999999999
Q ss_pred eEEEEEEcccCCchhhhccCCCcc-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEH-------------------RLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIK 705 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk 705 (809)
..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||++ +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 999999999999999999653221 13489999999999999999999998 89999999
Q ss_pred CCCEEEcCCCceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 706 ATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 706 p~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
|+||+++.++.+||+|||++........ .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986544332 22334567889999999999999999999999999999998 999997643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=307.14 Aligned_cols=205 Identities=27% Similarity=0.457 Sum_probs=180.4
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
..++|+..+.||+|+||.||+|... +++.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4567888999999999999999975 48899999986543 335678999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999998532 234689999999999999999999998 8999999999999999999999999999877655
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 4444445567889999999999999999999999999999999 999997643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=313.42 Aligned_cols=198 Identities=23% Similarity=0.390 Sum_probs=170.7
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
..++|+..+.||+|+||.||+|... +|+.||||++.... ..+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567899999999999999999965 68999999986543 2345788888888 7999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC----CceEEEecCCcc
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD----LNPKISDFGLAK 726 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DfGla~ 726 (809)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+.++ +.+||+|||+++
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999998843 34689999999999999999999998 89999999999998543 359999999998
Q ss_pred ccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 727 LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
........ ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 169 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 169 QLRAENGL-LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp ECBCTTCC-BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cCcCCCCc-eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 76543322 23457899999999998878899999999999999999999999764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=327.71 Aligned_cols=199 Identities=25% Similarity=0.369 Sum_probs=166.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeC------C
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEG------N 644 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~------~ 644 (809)
.++|+..+.||+|+||+||+|... +|+.||||++... .....+++.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468899999999999999999854 6899999999754 223356788999999999999999999999754 4
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
..++|||||+++ |.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+
T Consensus 141 ~~~lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 679999999864 666552 2488999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
++...... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~ 268 (464)
T 3ttj_A 211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 268 (464)
T ss_dssp C-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 98654322 23456799999999999999999999999999999999999999987543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=309.00 Aligned_cols=203 Identities=23% Similarity=0.360 Sum_probs=169.0
Q ss_pred hcCCCCC-CeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEE
Q 043333 574 TNNFAPD-NKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 574 ~~~f~~~-~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
.+.|.+. +.||+|+||.||+|.. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567664 7899999999999985 46899999999766555567889999999985 7999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc---eEEEecCCccc
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---PKISDFGLAKL 727 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DfGla~~ 727 (809)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999843 34689999999999999999999998 8999999999999998776 99999999875
Q ss_pred cCCCCc------ceeccccccccccchhhhcc-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 728 DEEDNT------HISTRIAGTFGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
...... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 532211 11223468999999999875 457889999999999999999999997643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=302.59 Aligned_cols=200 Identities=26% Similarity=0.444 Sum_probs=175.6
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357888999999999999999965 57899999986542 22346788999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999842 34689999999999999999999998 89999999999999999999999999987654
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 322 224568999999999999899999999999999999999999997643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=314.54 Aligned_cols=196 Identities=32% Similarity=0.526 Sum_probs=171.0
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcc---cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQ---GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
+.|+..+.||+|+||.||+|.. .+|+.||||++...... ..+++.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4577889999999999999995 57899999998654322 2356889999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||++ |+|.+++.. ....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 688887732 345689999999999999999999998 899999999999999999999999999986543
Q ss_pred CCcceeccccccccccchhhhc---cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
. ....||+.|+|||++. .+.++.++|||||||++|||++|+.||...
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2 2356899999999984 567899999999999999999999999654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=310.62 Aligned_cols=219 Identities=23% Similarity=0.367 Sum_probs=179.3
Q ss_pred ccCCCCCccHHHHHHHhcCCCCC-CeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcC-CCc
Q 043333 558 LDLHTGSFTLRQIKAATNNFAPD-NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQ-HPN 632 (809)
Q Consensus 558 ~~~~~~~~~~~~l~~~~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~-H~n 632 (809)
.+...+...++......++|... +.||+|+||.||+|... +++.||||++.... .....++.+|++++..++ |||
T Consensus 11 ~~~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 90 (327)
T 3lm5_A 11 VDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90 (327)
T ss_dssp -----CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTT
T ss_pred ccccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCC
Confidence 33334444455556677778877 88999999999999865 58999999987543 233567889999999995 699
Q ss_pred eEeEEeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc
Q 043333 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD 712 (809)
Q Consensus 633 Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 712 (809)
|+++++++.+.+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++
T Consensus 91 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~ 165 (327)
T 3lm5_A 91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLS 165 (327)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEES
T ss_pred EEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEe
Confidence 999999999999999999999999999998432 235689999999999999999999998 899999999999999
Q ss_pred C---CCceEEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 713 K---DLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 713 ~---~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 166 ~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 166 SIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp CBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCCCcEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8 78999999999987643322 234579999999999999999999999999999999999999997643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=313.00 Aligned_cols=204 Identities=27% Similarity=0.405 Sum_probs=168.3
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-----ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-----QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-----~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 645 (809)
...++|+..+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999964 589999999865322 123568899999999999999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++||||+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999986 88888843 234578889999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 726 KLDEEDNTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 726 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
+....... ......||+.|+|||++.+. .++.++|||||||++|||++|++||...+
T Consensus 160 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~ 217 (346)
T 1ua2_A 160 KSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217 (346)
T ss_dssp STTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 87643322 22345789999999998764 58999999999999999999999997654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=301.93 Aligned_cols=198 Identities=32% Similarity=0.589 Sum_probs=169.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCccc-------chhHHHHHHHHhhcCCCceEeEEeEEEeCCe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQG-------NREFVNEIGMISALQHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~-------~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 645 (809)
.++|+..+.||+|+||.||+|+. .+++.||||++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46788899999999999999996 468999999986543322 267889999999999999999999987655
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCEEEcCCCc-----eE
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLK--IVHRDIKATNVLLDKDLN-----PK 718 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~Dlkp~NILl~~~~~-----~k 718 (809)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ + |+||||||+||+++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 699999999999998854 334689999999999999999999998 6 999999999999988776 99
Q ss_pred EEecCCccccCCCCcceeccccccccccchhhh--ccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 719 ISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYA--MRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 719 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
|+|||+++.... ......||+.|+|||.+ ....++.++|||||||++|||++|+.||....
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 999999975432 22345789999999998 34567899999999999999999999997643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=303.15 Aligned_cols=203 Identities=34% Similarity=0.536 Sum_probs=176.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.++|+..+.||+|+||.||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 46788899999999999999998888899999986543 33567899999999999999999999986 45689999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 90 ENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp TTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999998432 223689999999999999999999998 899999999999999999999999999987655433
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence 33334557889999999998889999999999999999999 999997643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=345.21 Aligned_cols=276 Identities=31% Similarity=0.449 Sum_probs=247.9
Q ss_pred CccccCCCCCccCCccCCC--CCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCC-CCchhhcCCccCcEEeecc
Q 043333 1 HRILKSQNLPGRLPPELTR--LPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANG-AIPKAVASISTLADLTLEF 76 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~--l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~-~ip~~l~~l~~L~~L~L~~ 76 (809)
+|+|++|++.+.+|+.+.. +++|++|+|++|.+++.+|..+..++ |+.|++++|.+. .+|..+..+++|+.|+|++
T Consensus 372 ~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 451 (768)
T 3rgz_A 372 TLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 451 (768)
T ss_dssp EEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred EEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCC
Confidence 4788999999999988877 88999999999999988999888886 889999988885 6788999999999999999
Q ss_pred cccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCC
Q 043333 77 NQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIP 156 (809)
Q Consensus 77 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 156 (809)
|.+++.+|..+..+++|++|+|++|++++.+|..+.++++|++|+|++|++++.+|..++++++|+.|+|++|++++.+|
T Consensus 452 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 531 (768)
T 3rgz_A 452 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531 (768)
T ss_dssp SCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECC
T ss_pred CcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCEEeccCCCCCCCCC--------------------------------------------------------
Q 043333 157 SGIASLVELTDLRISDLNGPEGPF-------------------------------------------------------- 180 (809)
Q Consensus 157 ~~~~~l~~L~~L~l~~n~l~~~~~-------------------------------------------------------- 180 (809)
..+..+++|+.|++++|.+....+
T Consensus 532 ~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (768)
T 3rgz_A 532 AELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN 611 (768)
T ss_dssp GGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTC
T ss_pred HHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcccccc
Confidence 999999999999999987762211
Q ss_pred --------------ccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCcc
Q 043333 181 --------------PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNL 245 (809)
Q Consensus 181 --------------~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~ 245 (809)
..+.++++|+.|+|++|++++.+|..|+++++|+.|+|++|+++|.+|..+.. ++|+.|||++|+
T Consensus 612 ~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~ 691 (768)
T 3rgz_A 612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691 (768)
T ss_dssp CSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence 13455788999999999999999999999999999999999999999998887 999999999999
Q ss_pred CCCCCChhhhh-ccCccccccCCccccCCCCC
Q 043333 246 LTGPVPDWIVR-KRNKHIDLSYNNFIDGSSDS 276 (809)
Q Consensus 246 l~~~~p~~~~~-~~l~~L~Ls~N~l~~~~~~~ 276 (809)
++|.+|..+.. ..++.|||++|++++.+|..
T Consensus 692 l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~ 723 (768)
T 3rgz_A 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723 (768)
T ss_dssp CEECCCGGGGGCCCCSEEECCSSEEEEECCSS
T ss_pred ccCcCChHHhCCCCCCEEECcCCcccccCCCc
Confidence 99999998876 46799999999999988754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=311.81 Aligned_cols=203 Identities=25% Similarity=0.384 Sum_probs=165.2
Q ss_pred HhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
..++|+..+.||+|+||+||+|.. .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 346788999999999999999985 4689999999865432 2245678999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-----CCCceEEEecCC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD-----KDLNPKISDFGL 724 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-----~~~~~kl~DfGl 724 (809)
|||++ |+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++ +++.+||+|||+
T Consensus 112 ~e~~~-~~L~~~~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAE-NDLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCS-EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCC-CCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 99998 59999884 234589999999999999999999998 899999999999994 555699999999
Q ss_pred ccccCCCCcceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 986643322 22345689999999999874 589999999999999999999999976543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=344.45 Aligned_cols=316 Identities=26% Similarity=0.327 Sum_probs=278.2
Q ss_pred CccccCCCCCccCCccCCCCC-CCCEEEccCCCCCCCCCcccCC--C-CccccccccccCC-CCchhhcCCccCcEEeec
Q 043333 1 HRILKSQNLPGRLPPELTRLP-FLQEIDLTRNYLNGTIPSEWAS--L-PLVNLPLWKQANG-AIPKAVASISTLADLTLE 75 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~-~L~~L~Ls~n~l~~~~p~~~~~--l-~L~~L~l~~n~~~-~ip~~l~~l~~L~~L~L~ 75 (809)
+|+|++|++.+.+|..+..++ +|++|+|++|.+++.+|..+.. + .|+.|++++|.+. .+|..+.++++|+.|+|+
T Consensus 347 ~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 426 (768)
T 3rgz_A 347 VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426 (768)
T ss_dssp EEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECC
T ss_pred EEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECc
Confidence 478999999999999999887 9999999999999999988876 4 3999999999886 789999999999999999
Q ss_pred ccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCC
Q 043333 76 FNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPI 155 (809)
Q Consensus 76 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 155 (809)
+|++++.+|..|+++++|++|+|++|++++.+|..+..+++|+.|+|++|++++.+|..+.++++|+.|+|++|++++.+
T Consensus 427 ~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 506 (768)
T 3rgz_A 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506 (768)
T ss_dssp SSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCC
T ss_pred CCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhh---------------------------
Q 043333 156 PSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLG--------------------------- 208 (809)
Q Consensus 156 p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--------------------------- 208 (809)
|..++.+++|+.|++++|++....+..+.++++|+.|+|++|++.+.+|..+.
T Consensus 507 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (768)
T 3rgz_A 507 PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKE 586 (768)
T ss_dssp CGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTT
T ss_pred ChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccc
Confidence 99999999999999999999988888999999999999999999988886543
Q ss_pred -------------------------------------------ccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCc
Q 043333 209 -------------------------------------------QMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGN 244 (809)
Q Consensus 209 -------------------------------------------~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N 244 (809)
.+++|+.|||++|+++|.+|..+.. ++|+.|+|++|
T Consensus 587 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N 666 (768)
T 3rgz_A 587 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666 (768)
T ss_dssp CCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCC
Confidence 3577999999999999999998887 99999999999
Q ss_pred cCCCCCChhhhh-ccCccccccCCccccCCCCCcccccccceeccccCCCCCCcccccc---ccCCCCCCCcceeec
Q 043333 245 LLTGPVPDWIVR-KRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVSCL---KSFTCPTNHSSLHIN 317 (809)
Q Consensus 245 ~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~---~~~~~~~~~~~~~~~ 317 (809)
+++|.+|..+.. ..++.|||++|++++.+|..+.....+..+..+.+. ..+.+|.-. ........+||+-|.
T Consensus 667 ~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~-l~g~iP~~~~~~~~~~~~~~gN~~Lcg 742 (768)
T 3rgz_A 667 DISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN-LSGPIPEMGQFETFPPAKFLNNPGLCG 742 (768)
T ss_dssp CCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSE-EEEECCSSSSGGGSCGGGGCSCTEEES
T ss_pred ccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCc-ccccCCCchhhccCCHHHhcCCchhcC
Confidence 999999998876 567999999999999999988877777666554432 222222211 112233557777764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=316.61 Aligned_cols=197 Identities=22% Similarity=0.305 Sum_probs=161.7
Q ss_pred cCCCCC-CeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhh-cCCCceEeEEeEEEe----CCeEE
Q 043333 575 NNFAPD-NKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISA-LQHPNLVKLYGCCIE----GNQLL 647 (809)
Q Consensus 575 ~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~-l~H~nIv~l~~~~~~----~~~~~ 647 (809)
++|... +.||+|+||+||+|... +|+.||||++.. ...+.+|++++.+ .+||||+++++++.. .+..+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456555 68999999999999864 688999999853 2457788888744 589999999999876 56789
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCceEEEecCC
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGL 724 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGl 724 (809)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence 999999999999999543 234689999999999999999999998 8999999999999997 78999999999
Q ss_pred ccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 98654322 2234678999999999999999999999999999999999999997643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=317.15 Aligned_cols=198 Identities=26% Similarity=0.391 Sum_probs=167.1
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccC--cccchhHHHHHHHHhhcC--CCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQ--HPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~--H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4588899999999999999998779999999986543 233467899999999996 599999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
| +.+++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 678899999843 34688999999999999999999998 899999999999996 57899999999987654
Q ss_pred CCcc-eeccccccccccchhhhcc-----------CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 731 DNTH-ISTRIAGTFGYMAPEYAMR-----------GYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 731 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 3222 2334679999999999865 4689999999999999999999999965
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=310.31 Aligned_cols=208 Identities=25% Similarity=0.439 Sum_probs=161.1
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeC-Ce---EEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLAD-GK---VIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~---~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 646 (809)
..++|+..+.||+|+||.||+|.... ++ .||||+++.. .....+.+.+|++++++++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45689999999999999999998653 32 7999998754 233457789999999999999999999999887665
Q ss_pred ------EEEEEcccCCchhhhccCCC--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceE
Q 043333 647 ------LLIYEYMENNSLARALFGPE--EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 718 (809)
Q Consensus 647 ------~lV~ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 718 (809)
++||||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 99999999999999885322 2333689999999999999999999998 899999999999999999999
Q ss_pred EEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 719 ISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 719 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 999999986543322 12223456789999999999999999999999999999999 999997643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.89 Aligned_cols=204 Identities=32% Similarity=0.460 Sum_probs=176.2
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
..++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3467888999999999999999965 68999999986543 233467889999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999999843 34589999999999999999999998 899999999999999999999999999976543
Q ss_pred CCc-ceeccccccccccchhhhccCCC-CchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNT-HISTRIAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 221 12234578999999999987664 779999999999999999999997643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=320.04 Aligned_cols=201 Identities=26% Similarity=0.412 Sum_probs=163.9
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--------cccchhHHHHHHHHhhcCCCceEeEEeEEEe
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--------KQGNREFVNEIGMISALQHPNLVKLYGCCIE 642 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--------~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~ 642 (809)
...++|...+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 35678999999999999999999864 57899999986532 122346889999999999999999999975
Q ss_pred CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---ceEE
Q 043333 643 GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NPKI 719 (809)
Q Consensus 643 ~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl 719 (809)
.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred cCceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 5568999999999999998843 34689999999999999999999998 899999999999997544 5999
Q ss_pred EecCCccccCCCCcceeccccccccccchhhhcc---CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 720 SDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 720 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+|||+++...... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 9999998765322 2334679999999999853 67788999999999999999999999753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.19 Aligned_cols=202 Identities=26% Similarity=0.399 Sum_probs=176.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467888999999999999999965 57899999986542 22345688999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++++|.+++. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999873 234689999999999999999999998 89999999999999999999999999998664
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 167 YDGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp STTCC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCccc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 33222 234568999999999998889999999999999999999999997643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.41 Aligned_cols=200 Identities=27% Similarity=0.403 Sum_probs=172.9
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc------cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ------GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
++|+..+.||+|+||.||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999965 6899999998654221 2467899999999999999999999999999999
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC----ceEEEecC
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISDFG 723 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DfG 723 (809)
+||||+++++|.+++. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLA----EKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999983 234689999999999999999999998 899999999999998877 89999999
Q ss_pred CccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 724 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 9986643322 234568999999999998999999999999999999999999997643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=307.26 Aligned_cols=202 Identities=24% Similarity=0.317 Sum_probs=165.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc---cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ---GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|+..+.||+|+||.||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999964 6899999998754322 236788999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999842 34689999999999999999999998 89999999999999999999999999997665
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
...........||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 43333333456899999999999989999999999999999999999999763
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=316.43 Aligned_cols=204 Identities=26% Similarity=0.361 Sum_probs=168.9
Q ss_pred HHHhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeC------
Q 043333 571 KAATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEG------ 643 (809)
Q Consensus 571 ~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~------ 643 (809)
....++|+..+.||+|+||.||+|.. .+|+.||||++.... +...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999985 568999999986442 2234799999999999999999998543
Q ss_pred --------------------------------CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHH
Q 043333 644 --------------------------------NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYL 691 (809)
Q Consensus 644 --------------------------------~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yL 691 (809)
...++||||++ |+|.+.+.........+++..+..++.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34889999998 588877754333456799999999999999999999
Q ss_pred HhCCCCCeEEcCCCCCCEEEc-CCCceEEEecCCccccCCCCcceeccccccccccchhhhccC-CCCchHHHHHHHHHH
Q 043333 692 HEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVA 769 (809)
Q Consensus 692 H~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil 769 (809)
|+. +|+||||||+|||++ +++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 899999999999998 689999999999986644332 2345689999999998764 489999999999999
Q ss_pred HHHHcCCCCCCCCCc
Q 043333 770 LEIVSGRSNVICRTK 784 (809)
Q Consensus 770 ~elltGk~P~~~~~~ 784 (809)
|||++|+.||...+.
T Consensus 233 ~ell~g~~pf~~~~~ 247 (383)
T 3eb0_A 233 GELILGKPLFSGETS 247 (383)
T ss_dssp HHHHHSSCSSCCSSH
T ss_pred HHHHhCCCCCCCCCh
Confidence 999999999987543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=304.15 Aligned_cols=200 Identities=30% Similarity=0.461 Sum_probs=171.1
Q ss_pred cCCCCCCeeccCCCccEEEeEe-----eCCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-----ADGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEG--NQL 646 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 646 (809)
++|+..+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4577889999999999999983 358899999997543 33456789999999999999999999999876 668
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 999999999999999843 334689999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCc--ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 043333 727 LDEEDNT--HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVI 780 (809)
Q Consensus 727 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~ 780 (809)
....... .......||..|+|||.+.+..++.++||||+||++|||++|+.|+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 7654432 12234567888999999999999999999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.77 Aligned_cols=195 Identities=25% Similarity=0.427 Sum_probs=169.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC-C-------eEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD-G-------KVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g-------~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 645 (809)
.++|...+.||+|+||.||+|.... + +.||+|++........+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578888999999999999998542 3 5799999977666666789999999999999999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc--------e
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN--------P 717 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~ 717 (809)
.++||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999943 233489999999999999999999998 8999999999999998887 9
Q ss_pred EEEecCCccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCC
Q 043333 718 KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNV 779 (809)
Q Consensus 718 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~ 779 (809)
||+|||++...... ....||+.|+|||.+.+ ..++.++|||||||++|||++|..|+
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 99999998754321 23457889999999987 77899999999999999999965544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.52 Aligned_cols=202 Identities=26% Similarity=0.399 Sum_probs=176.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 356888899999999999999965 57899999986542 22346688999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999873 234689999999999999999999998 89999999999999999999999999998664
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 193 YDGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp STTCC-BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCccc-ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 33222 234568999999999999889999999999999999999999997643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=303.27 Aligned_cols=204 Identities=27% Similarity=0.412 Sum_probs=170.4
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeC----CeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLAD----GKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
..++|...+.||+|+||.||+|...+ +..||||++.... ....+.|.+|++++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35678889999999999999998643 3469999987653 3345678999999999999999999999865 4568
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 99999999999999843 334689999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 728 DEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~ 219 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC
Confidence 65433333334557889999999998999999999999999999998 999997543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=308.23 Aligned_cols=207 Identities=30% Similarity=0.456 Sum_probs=177.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEe------eCCeEEEEEEecccCc-ccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL------ADGKVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 645 (809)
.++|+..+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46788899999999999999984 2467899999975533 2346789999999999 89999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043333 646 LLLIYEYMENNSLARALFGPEE--------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL 711 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 711 (809)
.++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 9999999999999999854321 123589999999999999999999998 89999999999999
Q ss_pred cCCCceEEEecCCccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 712 DKDLNPKISDFGLAKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 712 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
+.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999876544322 2233457889999999999999999999999999999999 999997643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=309.75 Aligned_cols=207 Identities=29% Similarity=0.458 Sum_probs=175.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEe--------eCCeEEEEEEecccCc-ccchhHHHHHHHHhhc-CCCceEeEEeEEEeC
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL--------ADGKVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLYGCCIEG 643 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~--------~~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~ 643 (809)
.++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 56788899999999999999985 3467899999875432 3346788999999999 899999999999999
Q ss_pred CeEEEEEEcccCCchhhhccCCCc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043333 644 NQLLLIYEYMENNSLARALFGPEE------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL 711 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 711 (809)
+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999965432 123489999999999999999999998 89999999999999
Q ss_pred cCCCceEEEecCCccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 712 DKDLNPKISDFGLAKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 712 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999866543321 2223457789999999998889999999999999999999 999997643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.13 Aligned_cols=200 Identities=34% Similarity=0.499 Sum_probs=176.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.+.|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 456888999999999999999854 68899999986553 3345778999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++++|.+++. ..++++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999983 34689999999999999999999998 8999999999999999999999999999866443
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 22 123456899999999999999999999999999999999999999764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=323.90 Aligned_cols=193 Identities=25% Similarity=0.422 Sum_probs=153.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeC-----Ce
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEG-----NQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~ 645 (809)
.++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... +.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999854 68999999986542 22346788999999999999999999999543 56
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++||||++ |+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||++
T Consensus 132 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 899999985 68999884 334689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCc--------------------------ceeccccccccccchhhh-ccCCCCchHHHHHHHHHHHHHHc
Q 043333 726 KLDEEDNT--------------------------HISTRIAGTFGYMAPEYA-MRGYLTDKADVYSFGIVALEIVS 774 (809)
Q Consensus 726 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDVwSlGvil~ellt 774 (809)
+....... ......+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 86542211 122345789999999986 45679999999999999999999
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=333.60 Aligned_cols=203 Identities=32% Similarity=0.516 Sum_probs=175.3
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
..++|+..+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 356778889999999999999998888889999997543 335679999999999999999999999876 678999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
|++|+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 343 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 9999999999431 234589999999999999999999998 89999999999999999999999999998654322
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
........++..|+|||++.++.++.++|||||||++|||++ |+.||...
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 112223456789999999999999999999999999999999 99999764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=298.82 Aligned_cols=199 Identities=23% Similarity=0.341 Sum_probs=169.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEG--NQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lV 649 (809)
.++|...+.||+|+||.||+|+.. ++.||||++.... ....+.|.+|++++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357888999999999999999974 8899999987553 23346789999999999999999999999887 778999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ .+++||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999999542 2336899999999999999999999972 139999999999999999999999998875432
Q ss_pred CCCcceeccccccccccchhhhccCCCCc---hHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTD---KADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDVwSlGvil~elltGk~P~~~~ 782 (809)
. ....||+.|+|||.+.+...+. ++|||||||++|||++|+.||...
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 2 2346889999999998755444 899999999999999999999764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=300.24 Aligned_cols=202 Identities=29% Similarity=0.478 Sum_probs=172.1
Q ss_pred cCCCCCC-eeccCCCccEEEeEee---CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 575 NNFAPDN-KIGEGGFGPVYKGLLA---DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 575 ~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
++|...+ .||+|+||.||+|.+. +++.||||+++... ....+++.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455555 8999999999999853 57889999997653 23456789999999999999999999999 55678999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999843 344689999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcce--eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 730 EDNTHI--STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
...... .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 433221 123456889999999998889999999999999999999 999997643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=317.84 Aligned_cols=203 Identities=25% Similarity=0.348 Sum_probs=173.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCC--eEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGN--QLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~--~~~lV 649 (809)
.++|...+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457888999999999999999965 48999999997543 233567889999999999999999999998765 78999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----cCCCceEEEecCCc
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLA 725 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla 725 (809)
|||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999995432 233489999999999999999999998 89999999999999 77788999999999
Q ss_pred cccCCCCcceeccccccccccchhhhcc--------CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 726 KLDEEDNTHISTRIAGTFGYMAPEYAMR--------GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 726 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 8764332 2234579999999999865 56788999999999999999999999653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=314.55 Aligned_cols=198 Identities=24% Similarity=0.409 Sum_probs=165.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCC------
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGN------ 644 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 644 (809)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46788899999999999999996 468999999986542 223466889999999999999999999998653
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
..++||||+ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 789999883 24689999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
++..... ....++|+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 231 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9875432 234578999999999877 6789999999999999999999999987543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.00 Aligned_cols=201 Identities=32% Similarity=0.527 Sum_probs=160.5
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
..++|+..+.||+|+||+||+|+.. ..||||+++.... ...+.|.+|++++++++||||+++++++ ..+..++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3567888999999999999999864 3599999865432 3346789999999999999999999965 456789999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999853 334689999999999999999999998 899999999999999999999999999976543
Q ss_pred CC-cceeccccccccccchhhhc---cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DN-THISTRIAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. ........||+.|+|||.+. +..++.++|||||||++|||++|+.||...
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 21 22223456899999999986 567889999999999999999999999764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=309.59 Aligned_cols=207 Identities=24% Similarity=0.424 Sum_probs=178.1
Q ss_pred HHHHHHHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc--------cchhHHHHHHHHhhc-CCCceEeE
Q 043333 567 LRQIKAATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ--------GNREFVNEIGMISAL-QHPNLVKL 636 (809)
Q Consensus 567 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--------~~~~f~~Ei~~l~~l-~H~nIv~l 636 (809)
........++|...+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++.++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3344556678999999999999999999975 6899999998654321 134578899999999 79999999
Q ss_pred EeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc
Q 043333 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 716 (809)
Q Consensus 637 ~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 716 (809)
++++...+..++||||+++|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 999999999999999999999999984 234689999999999999999999998 8999999999999999999
Q ss_pred eEEEecCCccccCCCCcceeccccccccccchhhhcc------CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 717 PKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR------GYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 717 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 239 ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp EEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 99999999987654322 234679999999999863 35788999999999999999999999764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=298.42 Aligned_cols=202 Identities=25% Similarity=0.321 Sum_probs=168.5
Q ss_pred HhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEE-EeCCeEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC-IEGNQLLLIY 650 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~-~~~~~~~lV~ 650 (809)
..++|+..+.||+|+||.||+|.. .+++.||||++..... .+++.+|+++++.++|++++..++++ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999995 5789999998754432 35688999999999988877666555 5678889999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---cCCCceEEEecCCccc
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKL 727 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~ 727 (809)
||+ +|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||+ ++++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 9999999842 234689999999999999999999998 89999999999999 7889999999999987
Q ss_pred cCCCCc------ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 728 DEEDNT------HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 654322 11234578999999999999999999999999999999999999997643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=311.86 Aligned_cols=209 Identities=26% Similarity=0.422 Sum_probs=171.7
Q ss_pred cHHHHHHHhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCccc-----------chhHHHHHHHHhhcCCCceE
Q 043333 566 TLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQG-----------NREFVNEIGMISALQHPNLV 634 (809)
Q Consensus 566 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~-----------~~~f~~Ei~~l~~l~H~nIv 634 (809)
...++....++|...+.||+|+||.||+|...+|+.||||++....... .+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3567778889999999999999999999998789999999986542221 26788999999999999999
Q ss_pred eEEeEEEeC-----CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 043333 635 KLYGCCIEG-----NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNV 709 (809)
Q Consensus 635 ~l~~~~~~~-----~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI 709 (809)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999999653 36899999998 688888853 344689999999999999999999998 899999999999
Q ss_pred EEcCCCceEEEecCCccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 710 LLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 710 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
+++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999997544322 2234578999999999877 678999999999999999999999997754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=304.61 Aligned_cols=200 Identities=25% Similarity=0.414 Sum_probs=173.4
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
..++|...+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467889999999999999999964 689999999976554455678899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---cCCCceEEEecCCcccc
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLD 728 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~ 728 (809)
|+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRIL----ERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999883 234689999999999999999999998 89999999999999 78899999999998754
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 322 122356899999999999999999999999999999999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=324.18 Aligned_cols=200 Identities=30% Similarity=0.467 Sum_probs=175.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467888999999999999999965 68999999986542 23456789999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---cCCCceEEEecCCcc
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAK 726 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~ 726 (809)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999998843 34689999999999999999999998 89999999999999 567899999999998
Q ss_pred ccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 727 LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
....... ....+||+.|+|||++.+ .++.++||||+||++|||++|+.||...+
T Consensus 178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 7654332 234579999999999866 68999999999999999999999997643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=322.72 Aligned_cols=201 Identities=27% Similarity=0.441 Sum_probs=173.4
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
..++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467899999999999999999965 68999999986542 33456789999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc---CCCceEEEecCCcc
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAK 726 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DfGla~ 726 (809)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999998842 34689999999999999999999998 899999999999995 45679999999998
Q ss_pred ccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 727 LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
...... .....+||+.|+|||++.+ .++.++||||+||++|||++|+.||...+
T Consensus 173 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 664332 2234579999999999875 58999999999999999999999997643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=309.96 Aligned_cols=200 Identities=21% Similarity=0.274 Sum_probs=164.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEee----CCeEEEEEEecccCcc-----------cchhHHHHHHHHhhcCCCceEeEEe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA----DGKVIAVKQLSSKSKQ-----------GNREFVNEIGMISALQHPNLVKLYG 638 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~~~-----------~~~~f~~Ei~~l~~l~H~nIv~l~~ 638 (809)
.++|...+.||+|+||.||+|... .+..||||+....... ..+.+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 356888999999999999999965 5678999998654321 2234677888999999999999999
Q ss_pred EEEe----CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC
Q 043333 639 CCIE----GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD 714 (809)
Q Consensus 639 ~~~~----~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~ 714 (809)
++.+ .+..++||||+ +++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9998 67899999999 9999999843 22789999999999999999999998 89999999999999988
Q ss_pred C--ceEEEecCCccccCCCCc------ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 715 L--NPKISDFGLAKLDEEDNT------HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 715 ~--~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
+ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 7 999999999986543211 111345799999999999999999999999999999999999999965
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=303.53 Aligned_cols=209 Identities=29% Similarity=0.461 Sum_probs=174.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEe--CCeEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIE--GNQLLL 648 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~l 648 (809)
.++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+ .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467888999999999999999965 68999999986543 2334678899999999999999999998865 568899
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES--RLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
||||+++|+|.+++.........+++..+..++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999654444556999999999999999999999982 0129999999999999999999999999998
Q ss_pred ccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 727 LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 6644322 1223568999999999999899999999999999999999999997643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=319.37 Aligned_cols=198 Identities=26% Similarity=0.411 Sum_probs=166.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeC-----Ce
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEG-----NQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~ 645 (809)
.++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468899999999999999999864 58899999997542 22346788999999999999999999999876 57
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++||||++ |+|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999987 599998843 34689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCc---------------------ceeccccccccccchhhh-ccCCCCchHHHHHHHHHHHHHHcCCCCC
Q 043333 726 KLDEEDNT---------------------HISTRIAGTFGYMAPEYA-MRGYLTDKADVYSFGIVALEIVSGRSNV 779 (809)
Q Consensus 726 ~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDVwSlGvil~elltGk~P~ 779 (809)
+....... ......+||+.|+|||++ ....++.++||||+||++|||++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 87643221 112456799999999986 5567999999999999999999865554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=323.02 Aligned_cols=320 Identities=18% Similarity=0.154 Sum_probs=186.1
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCC-CcccCCCC-ccccccccccCCCC-chhhcCCccCcEEeeccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTI-PSEWASLP-LVNLPLWKQANGAI-PKAVASISTLADLTLEFN 77 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~-L~~L~l~~n~~~~i-p~~l~~l~~L~~L~L~~N 77 (809)
+|+|++|++.+..|..|.++++|++|+|++|.+.+.+ +..|..++ |+.|++++|.+..+ |..+.++++|++|+|++|
T Consensus 34 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 113 (455)
T 3v47_A 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQC 113 (455)
T ss_dssp EEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTS
T ss_pred EEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCC
Confidence 3678888888777788888888888888888876444 45677765 78888888877766 667788888888888888
Q ss_pred ccccCCCcc--ccCCCCCCEEEccCCccCccCchh-hhcccccceeeeecccccCcCchhhhcc--cccceEecccCcCC
Q 043333 78 QFSGDLPAE--LGNLINLEKLHLNSNNFTGKLPES-FANLTRLKHFRISDNHFTGQIPDYIQNW--TKLEKLFIEGSGLA 152 (809)
Q Consensus 78 ~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~ 152 (809)
++++..+.. |.++++|++|+|++|++++..|.. +.++++|++|+|++|++++..|..+..+ .+|+.|++++|.+.
T Consensus 114 ~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~ 193 (455)
T 3v47_A 114 NLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ 193 (455)
T ss_dssp CCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCT
T ss_pred CCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCccc
Confidence 887644444 777888888888888888776665 7778888888888888887777666655 23333333333333
Q ss_pred CCCCcc--------ccCCCCCCEEeccCCCCCCCCCcc-------------------------------------cc--C
Q 043333 153 GPIPSG--------IASLVELTDLRISDLNGPEGPFPR-------------------------------------LS--N 185 (809)
Q Consensus 153 ~~~p~~--------~~~l~~L~~L~l~~n~l~~~~~~~-------------------------------------l~--~ 185 (809)
+..+.. +..+++|+.|++++|.+....+.. +. .
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (455)
T 3v47_A 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLE 273 (455)
T ss_dssp TCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGT
T ss_pred ccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCccccccccc
Confidence 222111 112234444444444332211000 00 1
Q ss_pred CcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhh-ccCcccc
Q 043333 186 LKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHID 263 (809)
Q Consensus 186 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~ 263 (809)
.++|+.|+|++|++.+..|..|..+++|+.|+|++|++++.+|..+.. ++|+.|+|++|.+++..|..+.. .+++.|+
T Consensus 274 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 353 (455)
T 3v47_A 274 ASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD 353 (455)
T ss_dssp TSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEE
T ss_pred ccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEE
Confidence 134555555555555555555555555555555555555554544443 55555555555555444444432 3445555
Q ss_pred ccCCccccCCCCCcccccccceeccccCCCC---CCccccccccCCCCCCCcceeecCCC
Q 043333 264 LSYNNFIDGSSDSNCENQSVNLFASSSEGSN---STGIVSCLKSFTCPTNHSSLHINCGG 320 (809)
Q Consensus 264 Ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~c~~~~~~~~~~~~~~~~C~~ 320 (809)
|++|+++...+..+.....+..+..+.+... ......+++.......+|+|.|+|..
T Consensus 354 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 354 LSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 5555555444444443333333322222111 11122445566677889999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=322.23 Aligned_cols=200 Identities=29% Similarity=0.459 Sum_probs=169.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
.++|+..+.||+|+||+||+|+.. +++.||||++.... ......+.+|+++++.++||||++++++|.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456888999999999999999965 68899999987553 334567899999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CceEEEecCCccc
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKISDFGLAKL 727 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~ 727 (809)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.. +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999998883 334689999999999999999999998 89999999999999764 5599999999987
Q ss_pred cCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 728 DEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
..... .....+||+.|+|||++. +.++.++||||+||++|||++|+.||...+
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 65432 223467999999999886 568999999999999999999999997644
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.27 Aligned_cols=202 Identities=24% Similarity=0.423 Sum_probs=170.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc--cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
.++|+..+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357888999999999999999965 5899999998654322 2455789999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999988763 234589999999999999999999998 899999999999999999999999999976543
Q ss_pred CCcceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 322 22345689999999999875 78999999999999999999999997754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=332.19 Aligned_cols=195 Identities=29% Similarity=0.473 Sum_probs=164.8
Q ss_pred eeccCCCccEEEeEee---CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccCCc
Q 043333 582 KIGEGGFGPVYKGLLA---DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNS 657 (809)
Q Consensus 582 ~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gs 657 (809)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|++++++++||||++++++|.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 45679999997653 3345789999999999999999999999976 56899999999999
Q ss_pred hhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce--
Q 043333 658 LARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI-- 735 (809)
Q Consensus 658 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-- 735 (809)
|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 9999954 244689999999999999999999998 89999999999999999999999999998764332221
Q ss_pred eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 736 STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 736 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||...+
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 122345689999999999999999999999999999998 999997643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=296.43 Aligned_cols=201 Identities=30% Similarity=0.433 Sum_probs=170.3
Q ss_pred CCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
+|.....||+|+||.||+|.. .+++.||||++........+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455566999999999999995 4688999999977665556789999999999999999999999999999999999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCceEEEecCCccccCCCCc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~~ 733 (809)
+++|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999985321 234567899999999999999999998 8999999999999997 89999999999986543222
Q ss_pred ceeccccccccccchhhhccCC--CCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGY--LTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 123456899999999987643 78999999999999999999999965
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.91 Aligned_cols=204 Identities=27% Similarity=0.454 Sum_probs=165.3
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5688899999999999999985 468999999987532 223466889999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++.........+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999854333455689999999999999999999998 899999999999999999999999999986543
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 322 122356899999999999999999999999999999999999999653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.97 Aligned_cols=200 Identities=24% Similarity=0.365 Sum_probs=171.4
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~l 648 (809)
..++|+..+.||+|+||.||+|... +++.||||++.... .....++.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567889999999999999999965 68999999987542 23356788899999999 89999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC--------------
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD-------------- 714 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-------------- 714 (809)
||||+++|+|.+++.........+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999954333335789999999999999999999998 89999999999999844
Q ss_pred -----CceEEEecCCccccCCCCcceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCC
Q 043333 715 -----LNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVI 780 (809)
Q Consensus 715 -----~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~ 780 (809)
..+||+|||.+....... ...||+.|+|||.+.+. .++.++|||||||++|||++|++|+.
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 479999999998765432 23589999999999765 56689999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=308.82 Aligned_cols=202 Identities=30% Similarity=0.456 Sum_probs=175.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-----eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEe--CCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-----ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIE--GNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~ 646 (809)
.++|+..+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. .+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35788899999999999999984 3588999999987665556779999999999999999999999874 5668
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 999999999999999843 234589999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcc--eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 727 LDEEDNTH--ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 727 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 76543322 22334578889999999998899999999999999999999999854
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.38 Aligned_cols=197 Identities=31% Similarity=0.470 Sum_probs=170.3
Q ss_pred CCCCCeeccCCCccEEEeEee-----CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeC--CeEEE
Q 043333 577 FAPDNKIGEGGFGPVYKGLLA-----DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEG--NQLLL 648 (809)
Q Consensus 577 f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~l 648 (809)
|+..+.||+|+||+||++.+. +++.||||++..... ...+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 378899999999999888642 578999999976532 3356789999999999999999999999984 67899
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999993 33489999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcc--eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 729 EEDNTH--ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 729 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
...... ......+|..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 544321 22335678889999999998999999999999999999999999965
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=297.37 Aligned_cols=201 Identities=25% Similarity=0.325 Sum_probs=171.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEE-EeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC-IEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~-~~~~~~~lV~e 651 (809)
.++|+..+.||+|+||.||+|+. .+|+.||||++.... ..+++.+|+++++.++|++++..+.++ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 56889999999999999999995 578999999986543 245788999999999988876655555 56778899999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---cCCCceEEEecCCcccc
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLD 728 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~ 728 (809)
|+ +++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++ ++++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 8999999842 234689999999999999999999998 89999999999999 58899999999999876
Q ss_pred CCCCcc------eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 729 EEDNTH------ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 543321 1234579999999999999999999999999999999999999997643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.37 Aligned_cols=198 Identities=34% Similarity=0.540 Sum_probs=163.9
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
++|+..+.||+|+||.||+|.+. ++.||||++... ...+.|.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 56778899999999999999874 788999998643 33567899999999999999999999886 44789999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc-eEEEecCCccccCCCCc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN-PKISDFGLAKLDEEDNT 733 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-~kl~DfGla~~~~~~~~ 733 (809)
+|+|.+++.... ....+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++.......
T Consensus 83 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~- 160 (307)
T 2eva_A 83 GGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM- 160 (307)
T ss_dssp TCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-
Confidence 999999996532 2235788999999999999999999943338999999999999998886 7999999997553321
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 161 ---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 161 ---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred ---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 2346899999999999999999999999999999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=306.76 Aligned_cols=203 Identities=23% Similarity=0.371 Sum_probs=175.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCccc---c--------------hhHHHHHHHHhhcCCCceEeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQG---N--------------REFVNEIGMISALQHPNLVKL 636 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~---~--------------~~f~~Ei~~l~~l~H~nIv~l 636 (809)
.++|...+.||+|+||.||+|.. +|+.||||++....... . +.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999999998 89999999986542211 1 778999999999999999999
Q ss_pred EeEEEeCCeEEEEEEcccCCchhhhccC----CCccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEE
Q 043333 637 YGCCIEGNQLLLIYEYMENNSLARALFG----PEEHRLKLDWPTRHSICIGLARGLAYLHE-ESRLKIVHRDIKATNVLL 711 (809)
Q Consensus 637 ~~~~~~~~~~~lV~ey~~~gsL~~~L~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl 711 (809)
++++.+.+..++||||+++|+|.+++.. .......+++..+..++.|++.||+|||+ . +|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999998321 11124678999999999999999999998 7 89999999999999
Q ss_pred cCCCceEEEecCCccccCCCCcceeccccccccccchhhhccC-CCCc-hHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 712 DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG-YLTD-KADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 712 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
+.++.+||+|||++...... ......||+.|+|||.+.+. .++. ++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999865433 23346789999999999877 5666 9999999999999999999997643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=297.40 Aligned_cols=197 Identities=27% Similarity=0.474 Sum_probs=172.1
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEe---------
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIE--------- 642 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~--------- 642 (809)
..++|+..+.||+|+||.||+|... +++.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567889999999999999999975 78999999986542 467889999999999999999999865
Q ss_pred -------CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC
Q 043333 643 -------GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL 715 (809)
Q Consensus 643 -------~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 715 (809)
....++||||+++|+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 34579999999999999999532 234689999999999999999999998 899999999999999999
Q ss_pred ceEEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 043333 716 NPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVI 780 (809)
Q Consensus 716 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~ 780 (809)
.+||+|||++........ .....||+.|+|||.+.+..++.++|||||||++|||++|+.|+.
T Consensus 160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 999999999987654322 234568999999999999999999999999999999999998874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.83 Aligned_cols=200 Identities=15% Similarity=0.181 Sum_probs=163.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEeccc---CcccchhHHHHH---HHHhhcCCCceEeEE-------eE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSK---SKQGNREFVNEI---GMISALQHPNLVKLY-------GC 639 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~---~~~~~~~f~~Ei---~~l~~l~H~nIv~l~-------~~ 639 (809)
.++|...+.||+|+||.||+|+. .+|+.||||++... .....+.|.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999995 56899999998743 223356788999 555666899999998 66
Q ss_pred EEeCCe-----------------EEEEEEcccCCchhhhccCCC---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 043333 640 CIEGNQ-----------------LLLIYEYMENNSLARALFGPE---EHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699 (809)
Q Consensus 640 ~~~~~~-----------------~~lV~ey~~~gsL~~~L~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 699 (809)
+.+.+. .++||||+ +|+|.+++.... .....+++..+..++.|++.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 665532 78999999 689999985321 1122345788899999999999999998 89
Q ss_pred EEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceeccccccccccchhhhccC-----------CCCchHHHHHHHHH
Q 043333 700 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG-----------YLTDKADVYSFGIV 768 (809)
Q Consensus 700 iH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDVwSlGvi 768 (809)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985332 2234567 999999999887 89999999999999
Q ss_pred HHHHHcCCCCCCCC
Q 043333 769 ALEIVSGRSNVICR 782 (809)
Q Consensus 769 l~elltGk~P~~~~ 782 (809)
+|||++|+.||...
T Consensus 303 l~elltg~~Pf~~~ 316 (377)
T 3byv_A 303 IYWIWCADLPITKD 316 (377)
T ss_dssp HHHHHHSSCCC---
T ss_pred HHHHHHCCCCCccc
Confidence 99999999999653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=310.85 Aligned_cols=211 Identities=27% Similarity=0.423 Sum_probs=178.4
Q ss_pred HHHHHhcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEE
Q 043333 569 QIKAATNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCI 641 (809)
Q Consensus 569 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~ 641 (809)
+.....++|...+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34456788999999999999999999854 367899999875432 23456889999999999999999999999
Q ss_pred eCCeEEEEEEcccCCchhhhccCCCc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC
Q 043333 642 EGNQLLLIYEYMENNSLARALFGPEE------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL 715 (809)
Q Consensus 642 ~~~~~~lV~ey~~~gsL~~~L~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 715 (809)
+.+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence 99999999999999999999853211 124578999999999999999999998 899999999999999999
Q ss_pred ceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 716 NPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 716 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 999999999976543221 11223457889999999999999999999999999999999 89999764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=307.24 Aligned_cols=216 Identities=27% Similarity=0.412 Sum_probs=180.7
Q ss_pred ccHHHHHHHhcCCCCCCeeccCCCccEEEeEe------eCCeEEEEEEecccCc-ccchhHHHHHHHHhhc-CCCceEeE
Q 043333 565 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGLL------ADGKVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKL 636 (809)
Q Consensus 565 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l 636 (809)
+.........++|+..+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34445555678899999999999999999974 2468899999976533 2345788999999999 79999999
Q ss_pred EeEEEeCC-eEEEEEEcccCCchhhhccCCCcc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcC
Q 043333 637 YGCCIEGN-QLLLIYEYMENNSLARALFGPEEH------------RLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRD 703 (809)
Q Consensus 637 ~~~~~~~~-~~~lV~ey~~~gsL~~~L~~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~D 703 (809)
++++...+ ..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99998765 489999999999999999654321 22378999999999999999999998 899999
Q ss_pred CCCCCEEEcCCCceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 043333 704 IKATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVIC 781 (809)
Q Consensus 704 lkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~ 781 (809)
|||+||+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986644332 22334567889999999999999999999999999999998 9999976
Q ss_pred CC
Q 043333 782 RT 783 (809)
Q Consensus 782 ~~ 783 (809)
..
T Consensus 254 ~~ 255 (316)
T 2xir_A 254 VK 255 (316)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=313.45 Aligned_cols=201 Identities=25% Similarity=0.425 Sum_probs=174.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 457889999999999999999965 68999999987653 2335678999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999842 346899999999999999999999842 6999999999999999999999999999754321
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1224578999999999999999999999999999999999999997643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=317.38 Aligned_cols=200 Identities=29% Similarity=0.386 Sum_probs=165.4
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeC----C--eEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEG----N--QLL 647 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~----~--~~~ 647 (809)
.+|+..+.||+|+||.||+|+.. +|+.||||++.... +.+.+|++++++++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46788899999999999999975 58999999986432 2334799999999999999999998652 2 367
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CceEEEecCCcc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAK 726 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~ 726 (809)
+||||+++ +|.+.+.........+++..+..++.|+++||+|||++ +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 66665533223456799999999999999999999998 89999999999999965 678999999998
Q ss_pred ccCCCCcceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 727 LDEEDNTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~ 262 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 262 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 7643322 2345789999999998764 789999999999999999999999987543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=305.06 Aligned_cols=203 Identities=32% Similarity=0.489 Sum_probs=170.7
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeE--EEEEEeccc-CcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKV--IAVKQLSSK-SKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~--vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV 649 (809)
++|+..+.||+|+||.||+|+.. ++.. ||||++... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999964 5664 499988654 333456789999999999 899999999999999999999
Q ss_pred EEcccCCchhhhccCCC------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCce
Q 043333 650 YEYMENNSLARALFGPE------------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 717 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 717 (809)
|||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999996543 2335789999999999999999999998 89999999999999999999
Q ss_pred EEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 718 KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 718 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
||+|||+++...... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 245 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence 999999987432211 1123456789999999998889999999999999999998 99999764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.55 Aligned_cols=203 Identities=29% Similarity=0.521 Sum_probs=165.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCe----EEEEEEeccc-CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGK----VIAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
.++|+..+.||+|+||.||+|... +++ .||+|.+... .....+++.+|++++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367888999999999999999854 444 3577777544 3344677999999999999999999999998765 78
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+|+||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999843 234689999999999999999999998 899999999999999999999999999986
Q ss_pred cCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 728 DEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
...... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 643322 12223456788999999999999999999999999999999 999997644
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=297.72 Aligned_cols=198 Identities=30% Similarity=0.481 Sum_probs=168.2
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEe----CCeEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIE----GNQLL 647 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~ 647 (809)
+.|...+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34677788999999999999864 57899999986542 3335678899999999999999999999876 35689
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCCceEEEecCCcc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAK 726 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~ 726 (809)
+||||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ .+|+||||||+||+++ +++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHH----HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999993 2346899999999999999999999982 1399999999999998 78999999999997
Q ss_pred ccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 727 LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
...... .....||+.|+|||++. +.++.++||||+||++|||++|+.||..
T Consensus 181 ~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 181 LKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 654332 22456899999999876 4589999999999999999999999965
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=302.08 Aligned_cols=208 Identities=29% Similarity=0.425 Sum_probs=169.1
Q ss_pred ccHHHHHHHhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhc--CCCceEeEEeEEEe
Q 043333 565 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISAL--QHPNLVKLYGCCIE 642 (809)
Q Consensus 565 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l--~H~nIv~l~~~~~~ 642 (809)
..........++|+..+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++... +||||+++++++.+
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 334444456688999999999999999999875 8999999985432 34455666666655 89999999999998
Q ss_pred C----CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEcCCCCCCEEEcC
Q 043333 643 G----NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES-----RLKIVHRDIKATNVLLDK 713 (809)
Q Consensus 643 ~----~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiH~Dlkp~NILl~~ 713 (809)
. ...++||||+++|+|.+++. ...+++..+..++.|++.||+|||+++ ..+|+||||||+|||++.
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred CCCCCCceEEEEeccCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence 7 78999999999999999993 336899999999999999999999861 237999999999999999
Q ss_pred CCceEEEecCCccccCCCCcce---eccccccccccchhhhccCCCCch------HHHHHHHHHHHHHHcC---------
Q 043333 714 DLNPKISDFGLAKLDEEDNTHI---STRIAGTFGYMAPEYAMRGYLTDK------ADVYSFGIVALEIVSG--------- 775 (809)
Q Consensus 714 ~~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------sDVwSlGvil~elltG--------- 775 (809)
++++||+|||+++......... .....||+.|+|||++.+.....+ +|||||||++|||+||
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999997654332221 123579999999999987766554 9999999999999999
Q ss_pred -CCCCCC
Q 043333 776 -RSNVIC 781 (809)
Q Consensus 776 -k~P~~~ 781 (809)
+.||..
T Consensus 258 ~~~p~~~ 264 (337)
T 3mdy_A 258 YQLPYHD 264 (337)
T ss_dssp CCCTTTT
T ss_pred ccccHhh
Confidence 777754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=306.10 Aligned_cols=202 Identities=31% Similarity=0.496 Sum_probs=166.6
Q ss_pred cCCCCCCeeccCCCccEEEeEeeC-----CeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLAD-----GKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
++|...+.||+|+||.||+|.... +..||||+++.... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456678999999999999998653 24699999875432 334578899999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 124 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999843 234689999999999999999999998 8999999999999999999999999999866
Q ss_pred CCCCcc--eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 729 EEDNTH--ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 729 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
...... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 433221 1122346788999999999999999999999999999999 99999654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=312.47 Aligned_cols=198 Identities=26% Similarity=0.418 Sum_probs=155.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeC------C
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEG------N 644 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~------~ 644 (809)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46888999999999999999985 468999999986542 22346788999999999999999999999754 5
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
..++|+||+ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 689998883 24689999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 235 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9865432 234578999999999877 6789999999999999999999999977543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=307.05 Aligned_cols=205 Identities=24% Similarity=0.355 Sum_probs=172.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEe----CCeEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIE----GNQLLL 648 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~l 648 (809)
.++|+..+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46788999999999999999996 5789999999876655556788999999999999999999999973 347899
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++.........+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999864433456799999999999999999999998 8999999999999999999999999998754
Q ss_pred CCCCcc--------eeccccccccccchhhhccCC---CCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 729 EEDNTH--------ISTRIAGTFGYMAPEYAMRGY---LTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 729 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
...... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 321100 011245789999999987543 68899999999999999999999954
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=314.18 Aligned_cols=201 Identities=29% Similarity=0.456 Sum_probs=159.8
Q ss_pred CCCCCCeeccCCCccEEEeEee--CC--eEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEe-CCeEEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA--DG--KVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIE-GNQLLLI 649 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~--~g--~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~~lV 649 (809)
.|...+.||+|+||.||+|.+. ++ ..||||.++.... ...++|.+|++++++++||||++++++|.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4566789999999999999864 22 4689999865432 345678999999999999999999999865 4578999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++|+|.+++.. ....+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999953 334578999999999999999999998 89999999999999999999999999998654
Q ss_pred CCCc---ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 730 EDNT---HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 730 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
.... .......+|+.|+|||.+.+..++.++|||||||++|||+| |++||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 3221 11223457789999999999999999999999999999999 67788654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=321.12 Aligned_cols=201 Identities=29% Similarity=0.457 Sum_probs=172.1
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-------------ccchhHHHHHHHHhhcCCCceEeEEe
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-------------QGNREFVNEIGMISALQHPNLVKLYG 638 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-------------~~~~~f~~Ei~~l~~l~H~nIv~l~~ 638 (809)
..++|...+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578899999999999999999965 578999999865421 22456889999999999999999999
Q ss_pred EEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---
Q 043333 639 CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL--- 715 (809)
Q Consensus 639 ~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~--- 715 (809)
++.+.+..++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQII----NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999883 234689999999999999999999998 899999999999998775
Q ss_pred ceEEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 716 NPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 716 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.+||+|||++........ ....+||+.|+|||++. +.++.++||||+||++|||++|+.||...+
T Consensus 187 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp SEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 699999999987654322 23457999999999986 468999999999999999999999997654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.99 Aligned_cols=203 Identities=27% Similarity=0.464 Sum_probs=170.7
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
..++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578889999999999999999975 588999999977666667789999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++++|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999998842 234689999999999999999999998 8999999999999999999999999987532211
Q ss_pred Ccceeccccccccccchhhhc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 171 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 171 L-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp H-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred c-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 0 1112346899999999983 567899999999999999999999999764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=310.53 Aligned_cols=198 Identities=24% Similarity=0.358 Sum_probs=163.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCC------
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGN------ 644 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 644 (809)
.++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467889999999999999999854 68999999986542 223456889999999999999999999998765
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
..++||||+++ +|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999974 7888773 2488999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 98654321 2234578999999999999899999999999999999999999997654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=298.34 Aligned_cols=201 Identities=30% Similarity=0.484 Sum_probs=171.9
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
..++|+..+.||+|+||.||+|... +|+.||||++.... ..+++.+|++++.+++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999965 58999999986543 35778999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999842 345689999999999999999999998 8999999999999999999999999999765433
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 22 223456899999999999989999999999999999999999999764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.13 Aligned_cols=256 Identities=26% Similarity=0.343 Sum_probs=234.8
Q ss_pred CCCCEEEccCCCCCC--CCCcccCCCC-cccccccc-ccC-CCCchhhcCCccCcEEeecccccccCCCccccCCCCCCE
Q 043333 21 PFLQEIDLTRNYLNG--TIPSEWASLP-LVNLPLWK-QAN-GAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEK 95 (809)
Q Consensus 21 ~~L~~L~Ls~n~l~~--~~p~~~~~l~-L~~L~l~~-n~~-~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 95 (809)
.++++|+|++|.+.+ .+|..+..++ |+.|++++ |.+ +.+|..+.++++|++|+|++|.+++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 678999999999998 8888888886 88899983 555 578999999999999999999999999999999999999
Q ss_pred EEccCCccCccCchhhhcccccceeeeecccccCcCchhhhccc-ccceEecccCcCCCCCCccccCCCCCCEEeccCCC
Q 043333 96 LHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWT-KLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLN 174 (809)
Q Consensus 96 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~ 174 (809)
|+|++|++++.+|..+.++++|++|+|++|++++.+|..+..++ +|+.|+|++|++++.+|..+..+. |+.|++++|.
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 99999999999999999999999999999999999999999998 999999999999999999999997 9999999999
Q ss_pred CCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChh
Q 043333 175 GPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDW 253 (809)
Q Consensus 175 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~ 253 (809)
+....+..+..+++|+.|+|++|++.+.+|. +..+++|++|+|++|+|++.+|..+.. ++|+.|+|++|++++.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 9998888999999999999999999988777 888999999999999999999988876 99999999999999999988
Q ss_pred hhhccCccccccCCccccCCCCCcc
Q 043333 254 IVRKRNKHIDLSYNNFIDGSSDSNC 278 (809)
Q Consensus 254 ~~~~~l~~L~Ls~N~l~~~~~~~~~ 278 (809)
....+++.+++++|+..|+.|...|
T Consensus 288 ~~l~~L~~l~l~~N~~lc~~p~~~C 312 (313)
T 1ogq_A 288 GNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp TTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred ccccccChHHhcCCCCccCCCCCCC
Confidence 6567889999999997776554444
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=300.77 Aligned_cols=209 Identities=26% Similarity=0.427 Sum_probs=165.2
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEee----CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLLA----DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 645 (809)
...++|...+.||+|+||.||+|... .++.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34577888999999999999999854 34589999986543 2234678999999999999999999999987653
Q ss_pred -----EEEEEEcccCCchhhhccCCC--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceE
Q 043333 646 -----LLLIYEYMENNSLARALFGPE--EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 718 (809)
Q Consensus 646 -----~~lV~ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 718 (809)
.++||||+++|+|.+++.... .....+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 499999999999999884322 3345699999999999999999999998 899999999999999999999
Q ss_pred EEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 719 ISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 719 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 999999986543321 12223457889999999999999999999999999999999 899997643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=308.50 Aligned_cols=202 Identities=26% Similarity=0.403 Sum_probs=172.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeC-----CeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEG-----NQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~ 646 (809)
.++|+..+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 467899999999999999999854 688999999875432 2346788999999999999999999999765 368
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++||||++ |+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 59999883 34589999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcce--eccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 727 LDEEDNTHI--STRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 727 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
......... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 664332211 234579999999998754 4589999999999999999999999977543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-33 Score=295.34 Aligned_cols=202 Identities=25% Similarity=0.412 Sum_probs=174.7
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc---------ccchhHHHHHHHHhhcC-CCceEeEEeEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---------QGNREFVNEIGMISALQ-HPNLVKLYGCCI 641 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---------~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~ 641 (809)
..++|+..+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578899999999999999999965 689999999865431 12356788999999996 999999999999
Q ss_pred eCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEe
Q 043333 642 EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 721 (809)
Q Consensus 642 ~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 721 (809)
+.+..++||||+++++|.+++. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999984 234689999999999999999999998 899999999999999999999999
Q ss_pred cCCccccCCCCcceeccccccccccchhhhc------cCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 722 FGLAKLDEEDNTHISTRIAGTFGYMAPEYAM------RGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 722 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
||++........ .....||+.|+|||++. ...++.++||||||+++|||++|+.||...+
T Consensus 168 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 168 FGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 999986654322 23456899999999985 4567899999999999999999999997643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=301.29 Aligned_cols=203 Identities=27% Similarity=0.463 Sum_probs=172.0
Q ss_pred HhcCCCCCCeeccCCCccEEEeEe--eCCeEEEEEEecccCc--ccchhHHHHHHHHhhc---CCCceEeEEeEEE----
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLL--ADGKVIAVKQLSSKSK--QGNREFVNEIGMISAL---QHPNLVKLYGCCI---- 641 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~--~~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~~~~~---- 641 (809)
+.++|+..+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999996 4688999999865432 2245677888877766 8999999999997
Q ss_pred -eCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEE
Q 043333 642 -EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 720 (809)
Q Consensus 642 -~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 720 (809)
.....++||||++ |+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 69999885322 23489999999999999999999998 89999999999999999999999
Q ss_pred ecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 721 DFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 721 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999997654322 2234568999999999999999999999999999999999999997654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=301.48 Aligned_cols=200 Identities=26% Similarity=0.411 Sum_probs=168.0
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--------ccchhHHHHHHHHhhcCCCceEeEEeEEEeC
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--------QGNREFVNEIGMISALQHPNLVKLYGCCIEG 643 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~ 643 (809)
..++|...+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567899999999999999999864 589999999865321 2234688999999999999999999998765
Q ss_pred CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc---eEEE
Q 043333 644 NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---PKIS 720 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~ 720 (809)
+ .++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 8999999999999998843 34689999999999999999999998 8999999999999987654 9999
Q ss_pred ecCCccccCCCCcceeccccccccccchhhhc---cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 721 DFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 721 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
|||+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 160 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 160 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp CCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred cCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 999998764322 223456899999999874 467889999999999999999999999754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=311.62 Aligned_cols=201 Identities=27% Similarity=0.374 Sum_probs=165.6
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe------EE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ------LL 647 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~------~~ 647 (809)
..+|...+.||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 356888999999999999999987777799998854322 22369999999999999999999976443 78
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCCceEEEecCCcc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAK 726 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~ 726 (809)
+||||++++.+ +.+.........+++..+..++.|+++||+|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 115 lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999987543 33322222345789999999999999999999998 899999999999999 78999999999998
Q ss_pred ccCCCCcceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 727 LDEEDNTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 727 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
........ ....||+.|+|||++.+. .++.++||||+||++|||++|+.||...+.
T Consensus 191 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 247 (394)
T 4e7w_A 191 ILIAGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247 (394)
T ss_dssp ECCTTCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccCCCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 76443322 345689999999998764 589999999999999999999999987543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=330.38 Aligned_cols=195 Identities=30% Similarity=0.449 Sum_probs=164.3
Q ss_pred CeeccCCCccEEEeEee---CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLA---DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
+.||+|+||.||+|.+. .++.||||+++.... ...++|.+|++++++++|||||+++++|.+ +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 467899999976432 235679999999999999999999999964 568899999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc--
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-- 733 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-- 733 (809)
|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999994 334689999999999999999999998 899999999999999999999999999987654332
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 12233456789999999999999999999999999999998 999997643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=295.83 Aligned_cols=200 Identities=25% Similarity=0.426 Sum_probs=167.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367888999999999999999975 68999999986542 23345788999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999842 34589999999999999999999998 89999999999999999999999999998664
Q ss_pred CCCcceeccccccccccchhhhccCCC-CchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 163 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 163 DGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 3321 234568999999999987665 68999999999999999999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=300.85 Aligned_cols=201 Identities=27% Similarity=0.410 Sum_probs=165.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEE-----------
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCI----------- 641 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~----------- 641 (809)
.++|...+.||+|+||.||+|... +++.||||++........+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467889999999999999999975 48999999987665555678899999999999999999999873
Q ss_pred ---eCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCCce
Q 043333 642 ---EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNP 717 (809)
Q Consensus 642 ---~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~ 717 (809)
+.+..++||||++ |+|.+++. ..++++..+..++.|++.||+|||++ +|+||||||+||+++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 3467899999998 69999983 34688999999999999999999998 899999999999997 56799
Q ss_pred EEEecCCccccCCCCc--ceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 718 KISDFGLAKLDEEDNT--HISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 718 kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
||+|||+++....... .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999986643221 11223457889999998865 678999999999999999999999997654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=323.30 Aligned_cols=334 Identities=17% Similarity=0.165 Sum_probs=224.4
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeecccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFS 80 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~ 80 (809)
|+|++|++.+..|..|..+++|++|+|++|++++..|..|..++ |+.|++++|.+..+|.. .+++|++|+|++|.++
T Consensus 26 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L~~N~l~ 103 (520)
T 2z7x_B 26 LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLSFNAFD 103 (520)
T ss_dssp EECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEECCSSCCS
T ss_pred EECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEeccCCccc
Confidence 55666666655555666666666666666666655566666654 66666666666666655 5666666666666666
Q ss_pred c-CCCccccCCCCCCEEEccCCccCccCchhhhccccc--ceeeeecccc--cCcCchhhhccc----------------
Q 043333 81 G-DLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRL--KHFRISDNHF--TGQIPDYIQNWT---------------- 139 (809)
Q Consensus 81 ~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~---------------- 139 (809)
+ .+|..|+++++|++|+|++|++++ ..+..+++| +.|+|++|++ .+..|..+..+.
T Consensus 104 ~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~ 180 (520)
T 2z7x_B 104 ALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHF 180 (520)
T ss_dssp SCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCC
T ss_pred cccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhh
Confidence 4 345566666666666666666653 234444444 5555555555 444444444322
Q ss_pred -------------------------------------------------------------------ccceEecccCcCC
Q 043333 140 -------------------------------------------------------------------KLEKLFIEGSGLA 152 (809)
Q Consensus 140 -------------------------------------------------------------------~L~~L~L~~N~l~ 152 (809)
+|++|++++|+++
T Consensus 181 ~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~ 260 (520)
T 2z7x_B 181 ILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260 (520)
T ss_dssp CCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEE
T ss_pred hhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeeccccc
Confidence 5666777777777
Q ss_pred CCCCccc-----------------------------------------------------cCCCCCCEEeccCCCCCCCC
Q 043333 153 GPIPSGI-----------------------------------------------------ASLVELTDLRISDLNGPEGP 179 (809)
Q Consensus 153 ~~~p~~~-----------------------------------------------------~~l~~L~~L~l~~n~l~~~~ 179 (809)
+.+|..+ ..+++|+.|++++|.+....
T Consensus 261 ~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~ 340 (520)
T 2z7x_B 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTV 340 (520)
T ss_dssp SCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTT
T ss_pred CccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhh
Confidence 6666554 56778889999999988877
Q ss_pred CccccCCcCCceeeeccccccC--CCChhhhccccccEEeccCCCCCCCCC-CCCCC-CCccEEEeeCccCCCCCChhhh
Q 043333 180 FPRLSNLKNMNYLILRSGNIIG--EMPEYLGQMIGLRVLDLSFNKLSGVIP-SNFSG-SGLTYMYLTGNLLTGPVPDWIV 255 (809)
Q Consensus 180 ~~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~-~~L~~L~Ls~N~l~~~~p~~~~ 255 (809)
+..+.++++|++|+|++|++.+ .+|..+..+++|+.|+|++|++++.+| ..+.. ++|+.|+|++|++++..|..+.
T Consensus 341 ~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 420 (520)
T 2z7x_B 341 FENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP 420 (520)
T ss_dssp TTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC
T ss_pred hhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc
Confidence 7888999999999999999987 566789999999999999999998444 44555 8999999999999887776654
Q ss_pred hccCccccccCCccccCCCCCcccccccceeccccCCCC--CC-ccccccccCCCCCCCcceeecCCCcee-ee---cCC
Q 043333 256 RKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSN--ST-GIVSCLKSFTCPTNHSSLHINCGGKQV-IA---NGS 328 (809)
Q Consensus 256 ~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~c~~~~~~~~~~~~~~~~C~~~~~-~~---~~~ 328 (809)
..++.|+|++|+++.. +..+.....+..+..+.+... +. ....+.+.......+|||.|+|...++ .. ...
T Consensus 421 -~~L~~L~Ls~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~~~~~~~~ 498 (520)
T 2z7x_B 421 -PRIKVLDLHSNKIKSI-PKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNS 498 (520)
T ss_dssp -TTCCEEECCSSCCCCC-CGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHHHHHHHHHHHHTT
T ss_pred -ccCCEEECCCCccccc-chhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCchHHHHHHHHhcc
Confidence 5789999999999854 443434444444444333222 11 133455667778999999999998777 21 223
Q ss_pred eeecCCCCCCCCcc
Q 043333 329 TTFEDDLDAAGPSR 342 (809)
Q Consensus 329 ~~~~~~~~~~g~~~ 342 (809)
....++..|.+|+.
T Consensus 499 ~~~~~~~~C~~p~~ 512 (520)
T 2z7x_B 499 QKEQGSAKCSGSGK 512 (520)
T ss_dssp TTEESCCBBTTTCC
T ss_pred ccCCCCCCcCCccc
Confidence 34567888988853
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.37 Aligned_cols=198 Identities=17% Similarity=0.217 Sum_probs=169.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC---------CeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEe---------
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD---------GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVK--------- 635 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~---------g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~--------- 635 (809)
.++|...+.||+|+||.||+|.... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3678899999999999999999653 789999998643 56889999999999999987
Q ss_pred ------EEeEEEe-CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 043333 636 ------LYGCCIE-GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATN 708 (809)
Q Consensus 636 ------l~~~~~~-~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N 708 (809)
+++++.. .+..++||||+ +|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 6788876 67889999999 99999999532 135699999999999999999999998 89999999999
Q ss_pred EEEcCCC--ceEEEecCCccccCCCCcc------eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 043333 709 VLLDKDL--NPKISDFGLAKLDEEDNTH------ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVI 780 (809)
Q Consensus 709 ILl~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~ 780 (809)
||++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 9999999999865432211 1133579999999999999899999999999999999999999997
Q ss_pred CC
Q 043333 781 CR 782 (809)
Q Consensus 781 ~~ 782 (809)
..
T Consensus 270 ~~ 271 (352)
T 2jii_A 270 NC 271 (352)
T ss_dssp GG
T ss_pred cC
Confidence 64
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-33 Score=301.35 Aligned_cols=207 Identities=30% Similarity=0.441 Sum_probs=174.6
Q ss_pred CccHHHHHHHhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhh--cCCCceEeEEeEEE
Q 043333 564 SFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISA--LQHPNLVKLYGCCI 641 (809)
Q Consensus 564 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~~~~~ 641 (809)
..+........++|...+.||+|+||.||+|+. +|+.||||++... ..+.+.+|++++.. ++||||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 344445556678999999999999999999987 5899999998643 34567889998887 78999999999999
Q ss_pred eCC----eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEcCCCCCCE
Q 043333 642 EGN----QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH--------EESRLKIVHRDIKATNV 709 (809)
Q Consensus 642 ~~~----~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiH~Dlkp~NI 709 (809)
..+ ..++||||+++|+|.+++. ...+++..+..++.|++.||+||| +. +|+||||||+||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NI 178 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNI 178 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHE
Confidence 876 7899999999999999993 236899999999999999999999 55 899999999999
Q ss_pred EEcCCCceEEEecCCccccCCCCcc---eeccccccccccchhhhccCC------CCchHHHHHHHHHHHHHHcC-----
Q 043333 710 LLDKDLNPKISDFGLAKLDEEDNTH---ISTRIAGTFGYMAPEYAMRGY------LTDKADVYSFGIVALEIVSG----- 775 (809)
Q Consensus 710 Ll~~~~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~ksDVwSlGvil~elltG----- 775 (809)
+++.++++||+|||++......... ......||+.|+|||++.+.. ++.++|||||||++|||+||
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 9999999999999999866543322 123457899999999987652 33689999999999999999
Q ss_pred -----CCCCCCC
Q 043333 776 -----RSNVICR 782 (809)
Q Consensus 776 -----k~P~~~~ 782 (809)
+.||...
T Consensus 259 ~~~~~~~p~~~~ 270 (342)
T 1b6c_B 259 IHEDYQLPYYDL 270 (342)
T ss_dssp BCCCCCCTTTTT
T ss_pred cccccccCcccc
Confidence 7788653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=308.22 Aligned_cols=207 Identities=30% Similarity=0.428 Sum_probs=175.6
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeC------CeEEEEEEecccCc-ccchhHHHHHHHHhhc-CCCceEeEEeEEEeCC
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLAD------GKVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLYGCCIEGN 644 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 644 (809)
..++|...+.||+|+||.||+|.... ++.||||++..... ...+.+.+|+++++++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45778889999999999999998532 24799999876532 3356789999999999 8999999999999999
Q ss_pred eEEEEEEcccCCchhhhccCCCc----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEE----------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD 714 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~ 714 (809)
..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence 99999999999999999853211 134579999999999999999999998 89999999999999999
Q ss_pred CceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 715 LNPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 715 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
+.+||+|||++........ .......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999986543322 22233457889999999999999999999999999999999 99999764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=313.72 Aligned_cols=200 Identities=21% Similarity=0.312 Sum_probs=171.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhc------CCCceEeEEeEEEeCCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISAL------QHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l------~H~nIv~l~~~~~~~~~~ 646 (809)
..+|+..+.||+|+||.||+|... +++.||||+++.. ....+++.+|+++++.+ .|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457889999999999999999854 5899999999653 22345677888888777 577999999999999999
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc--eEEEecCC
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN--PKISDFGL 724 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DfGl 724 (809)
++||||++ ++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999996 6899888532 223589999999999999999999998 8999999999999999987 99999999
Q ss_pred ccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
++..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 9764432 2245789999999999999999999999999999999999999977543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=299.15 Aligned_cols=203 Identities=25% Similarity=0.369 Sum_probs=158.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc-ccc-hhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK-QGN-REFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~-~~~-~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
.++|+..+.||+|+||.||+|.. .+|+.||||++..... ... +.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788999999999999999996 4789999999875422 222 33444555688889999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||++ |+|.+++.........+++..+..++.|++.||+|||++. +|+||||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 5888877543334567999999999999999999999862 699999999999999999999999999986543
Q ss_pred CCcceeccccccccccchhhh----ccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYA----MRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
... .....||+.|+|||.+ .+..++.++||||+||++|||++|+.||..
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 322 2234689999999996 556789999999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=297.16 Aligned_cols=202 Identities=30% Similarity=0.441 Sum_probs=169.1
Q ss_pred hcCCCCCC-eeccCCCccEEEeEee---CCeEEEEEEecccCcc--cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 574 TNNFAPDN-KIGEGGFGPVYKGLLA---DGKVIAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 574 ~~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
.++|...+ .||+|+||.||+|.+. .++.||||++...... ..+++.+|+++++.++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 8999999999999643 4688999998755322 246789999999999999999999999 667789
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999943 34589999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcce--eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 728 DEEDNTHI--STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 65443322 122346788999999998889999999999999999999 999997643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=304.86 Aligned_cols=202 Identities=29% Similarity=0.478 Sum_probs=173.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-----eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCC--eE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-----ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGN--QL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~--~~ 646 (809)
.++|+..+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35677889999999999999984 358899999997765555678999999999999999999999987654 67
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 999999999999999943 234589999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcce--eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 727 LDEEDNTHI--STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 727 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
......... .....++..|+|||.+.+..++.++|||||||++|||+||+.|+..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 765443221 2234567789999999988899999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=305.55 Aligned_cols=210 Identities=24% Similarity=0.336 Sum_probs=162.4
Q ss_pred HHHHHHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe-
Q 043333 568 RQIKAATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ- 645 (809)
Q Consensus 568 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~- 645 (809)
.......++|+..+.||+|+||.||+|+.. +|+.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 344566789999999999999999999964 68999999985543 334567788899999999999999999976443
Q ss_pred ------EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEEcCCCCCCEEEcC-CCc
Q 043333 646 ------LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH--EESRLKIVHRDIKATNVLLDK-DLN 716 (809)
Q Consensus 646 ------~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~iiH~Dlkp~NILl~~-~~~ 716 (809)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999987 444444222234456889999999999999999999 66 8999999999999997 899
Q ss_pred eEEEecCCccccCCCCcceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 717 PKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 717 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 99999999987654332 2345689999999998664 489999999999999999999999987543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.43 Aligned_cols=209 Identities=27% Similarity=0.425 Sum_probs=159.0
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
...++|+..+.||+|+||.||+|.. .+++.||||++.... ....+++.+|++++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3467899999999999999999985 468899999986543 33456788999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCC----CccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 650 YEYMENNSLARALFGP----EEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
|||+++|+|.+++... ......+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999988421 11244689999999999999999999998 8999999999999999999999999998
Q ss_pred cccCCCCc----ceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 726 KLDEEDNT----HISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 726 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 76543221 11233568999999999876 568999999999999999999999997643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=313.11 Aligned_cols=202 Identities=25% Similarity=0.341 Sum_probs=172.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCC-CceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQH-PNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .+++..|+++++.++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999995 5689999998765433 3568899999999986 566677777788889999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---cCCCceEEEecCCcccc
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLD 728 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~ 728 (809)
|+ +++|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 9999999842 234689999999999999999999998 89999999999999 68899999999999876
Q ss_pred CCCCcc------eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 729 EEDNTH------ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 729 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 543321 12246799999999999999999999999999999999999999977443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=299.83 Aligned_cols=203 Identities=29% Similarity=0.441 Sum_probs=167.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC----CeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEe-CCeEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD----GKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIE-GNQLL 647 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~~ 647 (809)
..+|+..+.||+|+||.||+|...+ +..||||.+..... ...+.+.+|++++++++||||++++++|.+ .+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3467788999999999999998542 23689999875432 335678999999999999999999999764 45789
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999953 334678999999999999999999998 899999999999999999999999999986
Q ss_pred cCCCCc---ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 728 DEEDNT---HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 728 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
...... .......+|+.|+|||.+.+..++.++||||+|+++|||++ |++||...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence 543221 11233557889999999999999999999999999999999 55566543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.37 Aligned_cols=193 Identities=19% Similarity=0.357 Sum_probs=169.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcC-CCceEeEEeEEEe--CCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLYGCCIE--GNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~--~~~~~lV 649 (809)
.++|+..+.||+|+||.||+|.. .+++.||||++... ..+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36788999999999999999985 46899999998643 3467889999999997 9999999999998 5678999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-ceEEEecCCcccc
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLD 728 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~ 728 (809)
|||+++++|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999872 378899999999999999999998 899999999999999776 8999999999876
Q ss_pred CCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 54332 234568999999999877 6789999999999999999999999954
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=297.70 Aligned_cols=198 Identities=30% Similarity=0.429 Sum_probs=166.9
Q ss_pred CCCCCCeeccCCCccEEEeEeeC----CeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeE-EEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLAD----GKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQL-LLI 649 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~-~lV 649 (809)
.|...+.||+|+||+||+|.+.+ +..||+|++..... ...+.|.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45566899999999999998542 23799999875433 3356789999999999999999999999876665 999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+.+|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999954 234689999999999999999999998 89999999999999999999999999997553
Q ss_pred CCC---cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCC
Q 043333 730 EDN---THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNV 779 (809)
Q Consensus 730 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~ 779 (809)
... ........+++.|+|||.+.+..++.++|||||||++|||++|+.|+
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 321 11223356788999999999999999999999999999999966554
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=303.43 Aligned_cols=206 Identities=29% Similarity=0.417 Sum_probs=170.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEe------eCCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL------ADGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 646 (809)
.++|...+.||+|+||.||+|++ .+++.||||++.... .....++.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46788899999999999999984 246789999986542 33456789999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhccCCCc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCceEEE
Q 043333 647 LLIYEYMENNSLARALFGPEE---HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKIS 720 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~ 720 (809)
++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999964321 224589999999999999999999998 8999999999999984 4569999
Q ss_pred ecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 721 DFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 721 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
|||++........ .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 9999875432221 22233567889999999999999999999999999999998 99999764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=310.18 Aligned_cols=203 Identities=27% Similarity=0.440 Sum_probs=155.3
Q ss_pred cCCCC-CCeeccCCCccEEEeEee---CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEe--CCeEEE
Q 043333 575 NNFAP-DNKIGEGGFGPVYKGLLA---DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIE--GNQLLL 648 (809)
Q Consensus 575 ~~f~~-~~~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~l 648 (809)
+.|+. .++||+|+||+||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34554 568999999999999965 47889999986432 24578899999999999999999999965 668999
Q ss_pred EEEcccCCchhhhccCCC-----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----cCCCceEE
Q 043333 649 IYEYMENNSLARALFGPE-----EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKI 719 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl 719 (809)
||||++ |+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999997 47877774211 1233589999999999999999999998 89999999999999 77899999
Q ss_pred EecCCccccCCCCc--ceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 720 SDFGLAKLDEEDNT--HISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 720 ~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
+|||+++....... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999987643221 22234678999999999987 458999999999999999999999997643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=311.72 Aligned_cols=198 Identities=12% Similarity=0.055 Sum_probs=152.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc---ccchhHHHHHHHHhhc--CCCceEeEE-------eEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK---QGNREFVNEIGMISAL--QHPNLVKLY-------GCC 640 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l--~H~nIv~l~-------~~~ 640 (809)
..+|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999999999964 789999999976543 2245567775544444 699988755 455
Q ss_pred EeC-----------------CeEEEEEEcccCCchhhhccCCCccCCCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 043333 641 IEG-----------------NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTR------HSICIGLARGLAYLHEESRL 697 (809)
Q Consensus 641 ~~~-----------------~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~ 697 (809)
... ...++||||++ |+|.+++... ...+.+..+ ..++.|++.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 443 33799999999 8999999532 223455556 78889999999999998
Q ss_pred CeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceeccccccccccchhhhcc--CCCCchHHHHHHHHHHHHHHcC
Q 043333 698 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSG 775 (809)
Q Consensus 698 ~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltG 775 (809)
+|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 8999999999999999999999999999865422 113456799999999987 6789999999999999999999
Q ss_pred CCCCCCC
Q 043333 776 RSNVICR 782 (809)
Q Consensus 776 k~P~~~~ 782 (809)
+.||...
T Consensus 290 ~~Pf~~~ 296 (371)
T 3q60_A 290 FLPFGLV 296 (371)
T ss_dssp SCSTTBC
T ss_pred CCCCCCc
Confidence 9999764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=303.88 Aligned_cols=201 Identities=24% Similarity=0.407 Sum_probs=170.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeC-----CeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEG-----NQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~ 646 (809)
.++|...+.||+|+||.||+|... +|+.||||++..... .....+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467889999999999999999965 689999999864432 2345688999999999999999999998764 678
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++||||++ |+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIS-----TQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 68999883 24689999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcc---------eeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 727 LDEEDNTH---------ISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 727 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 66432211 1123568999999998765 678999999999999999999999997754
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-32 Score=319.45 Aligned_cols=316 Identities=20% Similarity=0.196 Sum_probs=237.8
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeeccccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQF 79 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l 79 (809)
+|+|++|++.+..|..|..+++|++|+|++|++++..|..|..++ |+.|++++|.+..+|.. .+++|++|+|++|++
T Consensus 56 ~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~Ls~N~l 133 (562)
T 3a79_B 56 ALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC--PMASLRHLDLSFNDF 133 (562)
T ss_dssp EEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC--CCTTCSEEECCSSCC
T ss_pred EEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc--ccccCCEEECCCCCc
Confidence 367888888877777888888888888888888877788888775 88888888888888877 788888888888888
Q ss_pred cc-CCCccccCCCCCCEEEccCCccCccCchhhhccccc--ceeeeecccc--cCcCchhhhccc---------------
Q 043333 80 SG-DLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRL--KHFRISDNHF--TGQIPDYIQNWT--------------- 139 (809)
Q Consensus 80 ~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~--------------- 139 (809)
++ .+|..|+++++|++|+|++|++++ ..+..+++| +.|+|++|++ ++..|..+..+.
T Consensus 134 ~~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~ 210 (562)
T 3a79_B 134 DVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFS 210 (562)
T ss_dssp SBCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCC
T ss_pred cccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchh
Confidence 85 345788888888888888888874 244455555 7788887777 555555554432
Q ss_pred ------------------------------------------------------------------ccceEecccCcCCC
Q 043333 140 ------------------------------------------------------------------KLEKLFIEGSGLAG 153 (809)
Q Consensus 140 ------------------------------------------------------------------~L~~L~L~~N~l~~ 153 (809)
+|++|++++|++++
T Consensus 211 ~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 290 (562)
T 3a79_B 211 VQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITE 290 (562)
T ss_dssp CCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECS
T ss_pred hhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeec
Confidence 67777777888877
Q ss_pred CCCccc-----------------------------------------------------cCCCCCCEEeccCCCCCCCCC
Q 043333 154 PIPSGI-----------------------------------------------------ASLVELTDLRISDLNGPEGPF 180 (809)
Q Consensus 154 ~~p~~~-----------------------------------------------------~~l~~L~~L~l~~n~l~~~~~ 180 (809)
.+|..+ ..+++|+.|++++|.++...+
T Consensus 291 ~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 370 (562)
T 3a79_B 291 RIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVF 370 (562)
T ss_dssp CCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTT
T ss_pred cccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccccchh
Confidence 777655 567889999999999998888
Q ss_pred ccccCCcCCceeeeccccccCCC--ChhhhccccccEEeccCCCCCC-CCCCCCCC-CCccEEEeeCccCCCCCChhhhh
Q 043333 181 PRLSNLKNMNYLILRSGNIIGEM--PEYLGQMIGLRVLDLSFNKLSG-VIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR 256 (809)
Q Consensus 181 ~~l~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~ 256 (809)
..+.++++|++|+|++|++.+.. |..|..+++|+.|+|++|++++ +++..+.. ++|+.|+|++|++++.+|..+.
T Consensus 371 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~- 449 (562)
T 3a79_B 371 QGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP- 449 (562)
T ss_dssp TTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC-
T ss_pred hhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc-
Confidence 88899999999999999998754 5678899999999999999998 44455555 8999999999999887776554
Q ss_pred ccCccccccCCccccCCCCCcccccccceeccccCCCC--CC-ccccccccCCCCCCCcceeecCCCcee
Q 043333 257 KRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSN--ST-GIVSCLKSFTCPTNHSSLHINCGGKQV 323 (809)
Q Consensus 257 ~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~c~~~~~~~~~~~~~~~~C~~~~~ 323 (809)
..++.|+|++|+++..+.... ....+..+..+.+... +. ....+++.......+|||.|+|.+.++
T Consensus 450 ~~L~~L~L~~N~l~~ip~~~~-~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~ 518 (562)
T 3a79_B 450 PKVKVLDLHNNRIMSIPKDVT-HLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRY 518 (562)
T ss_dssp TTCSEEECCSSCCCCCCTTTT-SSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHHHH
T ss_pred CcCCEEECCCCcCcccChhhc-CCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchHHH
Confidence 578999999999986544333 4444444433333221 11 133455666778999999999987665
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=293.81 Aligned_cols=204 Identities=25% Similarity=0.331 Sum_probs=169.6
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC----cccchhHHHHHHHHhhcCCCceEeEEeEEEe--CCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS----KQGNREFVNEIGMISALQHPNLVKLYGCCIE--GNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~ 646 (809)
.++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.. .+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999964 68899999986542 2335678999999999999999999999853 4578
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++||||++++ |.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 66666332 234689999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCC-cceeccccccccccchhhhccCC--CCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 727 LDEEDN-THISTRIAGTFGYMAPEYAMRGY--LTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 727 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
...... ........||+.|+|||++.+.. .+.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 664322 22233456899999999987644 3789999999999999999999997643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=299.25 Aligned_cols=200 Identities=22% Similarity=0.358 Sum_probs=172.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEe--eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCc------eEeEEeEEEeCCe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL--ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPN------LVKLYGCCIEGNQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~--~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~~~~~~~~~ 645 (809)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+++++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46888999999999999999985 368899999986432 33466888999999887664 9999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC------------
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK------------ 713 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~------------ 713 (809)
.++||||+ +++|.+++... ...++++..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 88999988432 224688999999999999999999998 8999999999999987
Q ss_pred -------CCceEEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 714 -------DLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 714 -------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 6789999999998654322 245789999999999998999999999999999999999999977543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-33 Score=295.44 Aligned_cols=198 Identities=32% Similarity=0.464 Sum_probs=164.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeC-CeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEG-NQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~lV~ey 652 (809)
.++|+..+.||+|+||.||+|.. .|+.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46788899999999999999986 48899999986543 456789999999999999999999997655 468999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+++|+|.+++... ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 97 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 9999999998432 122378999999999999999999998 89999999999999999999999999987544321
Q ss_pred cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 12357889999999999999999999999999999998 999997643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.9e-33 Score=295.26 Aligned_cols=202 Identities=28% Similarity=0.470 Sum_probs=162.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEee--CCe--EEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA--DGK--VIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~--~g~--~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 646 (809)
.++|+..+.||+|+||.||+|.+. +++ .||||+++... ....+.+.+|++++++++||||+++++++.+.+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357888999999999999999864 233 68999886542 233567889999999999999999999998765 8
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++|+||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 899999999999999843 234589999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcce--eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 727 LDEEDNTHI--STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 727 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
......... .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 765433221 223457888999999998889999999999999999999 99999764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-33 Score=304.03 Aligned_cols=205 Identities=25% Similarity=0.328 Sum_probs=157.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcC-CCceEeEEeEEEe--------C
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLYGCCIE--------G 643 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~--------~ 643 (809)
..+|+..+.||+|+||.||+|... +++.||||++........+.+.+|++++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457888999999999999999964 68999999986665555677899999999996 9999999999953 3
Q ss_pred CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 644 NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
...++||||++ |+|.+++.... ....+++..+..++.|++.||+|||+++ ++|+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 45799999996 79998884321 2346899999999999999999999982 129999999999999999999999999
Q ss_pred CccccCCCCcce-----------eccccccccccchhhh---ccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 724 LAKLDEEDNTHI-----------STRIAGTFGYMAPEYA---MRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 724 la~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
+++......... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 998664432211 1134589999999998 566789999999999999999999999965
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=307.38 Aligned_cols=200 Identities=24% Similarity=0.344 Sum_probs=168.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcC--------CCceEeEEeEEE---
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ--------HPNLVKLYGCCI--- 641 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~--------H~nIv~l~~~~~--- 641 (809)
.++|+..+.||+|+||+||+|+. .+++.||||++... ....+.+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46788999999999999999985 46899999998643 233467889999999986 788999999998
Q ss_pred -eCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-----
Q 043333 642 -EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL----- 715 (809)
Q Consensus 642 -~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----- 715 (809)
.....++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence 445789999999 55666655322 2346899999999999999999999963 699999999999999775
Q ss_pred --------------------------------------------ceEEEecCCccccCCCCcceeccccccccccchhhh
Q 043333 716 --------------------------------------------NPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYA 751 (809)
Q Consensus 716 --------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 751 (809)
.+||+|||++...... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999866432 2335689999999999
Q ss_pred ccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 752 MRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 752 ~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.+..++.++|||||||++|||++|+.||...+
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 99999999999999999999999999997644
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=298.01 Aligned_cols=204 Identities=30% Similarity=0.477 Sum_probs=168.5
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEe------C
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIE------G 643 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~------~ 643 (809)
...++|+..+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|++++.++ +||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 3567899999999999999999996 468999999986543 3457789999999999 79999999999987 4
Q ss_pred CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 644 NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCc
Confidence 6789999999999999998532 234689999999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCcceeccccccccccchhhhc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 724 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
++........ ......||+.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 175 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 175 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp TTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 9876543221 123356899999999986 567899999999999999999999999664
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=9.1e-33 Score=300.91 Aligned_cols=199 Identities=32% Similarity=0.501 Sum_probs=160.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHH--HhhcCCCceEeEEeEEEe-----CCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGM--ISALQHPNLVKLYGCCIE-----GNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~--l~~l~H~nIv~l~~~~~~-----~~~~ 646 (809)
.++|+..+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46788899999999999999976 68999999986432 2345555555 445899999999987653 2357
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEcCCCCCCEEEcCCCceEEE
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES------RLKIVHRDIKATNVLLDKDLNPKIS 720 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~iiH~Dlkp~NILl~~~~~~kl~ 720 (809)
++||||+++|+|.+++. ....++..+..++.|++.||+|||+.. .++|+||||||+|||++.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHh-----hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 89999999999999993 234589999999999999999999872 2279999999999999999999999
Q ss_pred ecCCccccCCCC-------cceeccccccccccchhhhcc-------CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 721 DFGLAKLDEEDN-------THISTRIAGTFGYMAPEYAMR-------GYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 721 DfGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 999998664321 111224569999999999876 3566789999999999999999877643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-32 Score=289.74 Aligned_cols=202 Identities=26% Similarity=0.432 Sum_probs=173.8
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
...++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999965 68999999986543 2345678899999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CceEEEecCCc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKISDFGLA 725 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla 725 (809)
|+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999998842 34689999999999999999999998 89999999999999764 47999999999
Q ss_pred cccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 726 KLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 726 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
........ .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||...+
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 86543322 223458899999998865 48999999999999999999999997643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-31 Score=319.77 Aligned_cols=342 Identities=18% Similarity=0.176 Sum_probs=221.2
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCC------CCch----hhcCCccCc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANG------AIPK----AVASISTLA 70 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~------~ip~----~l~~l~~L~ 70 (809)
|+|++|++.+..|..|..+++|++|+|++|.+.+..|..|..++ |+.|++.+|..+ .+|. .+..+++|+
T Consensus 253 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~ 332 (680)
T 1ziw_A 253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE 332 (680)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCC
T ss_pred EECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCC
Confidence 67777777777777778888888888888888777777776664 666666655443 3443 566777788
Q ss_pred EEeecccccccCCCccccCCCCCCEEEccC----------------------------CccCccCchhhhcccccceeee
Q 043333 71 DLTLEFNQFSGDLPAELGNLINLEKLHLNS----------------------------NNFTGKLPESFANLTRLKHFRI 122 (809)
Q Consensus 71 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~----------------------------N~l~~~~p~~~~~l~~L~~L~L 122 (809)
+|+|++|.+++..+..|.++++|++|+|++ |++++..|..|..+++|+.|+|
T Consensus 333 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 412 (680)
T 1ziw_A 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL 412 (680)
T ss_dssp EEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred EEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeC
Confidence 888888888776666677666666666554 4455555666666777777777
Q ss_pred ecccccCcCc-hhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCC--CCCccccCCcCCceeeeccccc
Q 043333 123 SDNHFTGQIP-DYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPE--GPFPRLSNLKNMNYLILRSGNI 199 (809)
Q Consensus 123 s~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~--~~~~~l~~l~~L~~L~Ls~N~l 199 (809)
++|++++.+| ..|.++++|++|+|++|++++..+..|..+++|+.|++++|.+.. ..+..+.++++|+.|+|++|++
T Consensus 413 ~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l 492 (680)
T 1ziw_A 413 GLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNI 492 (680)
T ss_dssp CSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCC
T ss_pred CCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCC
Confidence 7777765554 456677777777777777766666666666777777777666653 3345577788888888888888
Q ss_pred cCCCChhhhccccccEEeccCCCCCCCCCC--------CCCC-CCccEEEeeCccCCCCCChhhhh-ccCccccccCCcc
Q 043333 200 IGEMPEYLGQMIGLRVLDLSFNKLSGVIPS--------NFSG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNF 269 (809)
Q Consensus 200 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--------~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l 269 (809)
++..+..|.++++|+.|+|++|++++..+. .+.. ++|+.|+|++|+++..++..+.. ..++.|+|++|++
T Consensus 493 ~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l 572 (680)
T 1ziw_A 493 ANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNL 572 (680)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCC
Confidence 877777788888888888888888765322 2333 78888888888888655555543 5678888888888
Q ss_pred ccCCCCCcccccccceeccccCCCCCCc---cc-cccccCCCCCCCcceeecCCC-ceeeec--CC-e---eecCCCCCC
Q 043333 270 IDGSSDSNCENQSVNLFASSSEGSNSTG---IV-SCLKSFTCPTNHSSLHINCGG-KQVIAN--GS-T---TFEDDLDAA 338 (809)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-~c~~~~~~~~~~~~~~~~C~~-~~~~~~--~~-~---~~~~~~~~~ 338 (809)
+..++..+.....+..+..+.+...... .. .+.+.......+|||.|+|.+ .++..- .. . ....+..|.
T Consensus 573 ~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~~~~~~~~~~~~~~~~~C~ 652 (680)
T 1ziw_A 573 NTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCN 652 (680)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSEECCSSCC--------------
T ss_pred CcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHHHHHHHHhcCcccccccCCcEEC
Confidence 8776665555555554444433221111 11 355667778899999999996 776531 11 1 123456788
Q ss_pred CCcce
Q 043333 339 GPSRF 343 (809)
Q Consensus 339 g~~~~ 343 (809)
+|..+
T Consensus 653 ~p~~~ 657 (680)
T 1ziw_A 653 TPPHY 657 (680)
T ss_dssp -----
T ss_pred CchHH
Confidence 88754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=304.79 Aligned_cols=196 Identities=24% Similarity=0.441 Sum_probs=167.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeE----
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQL---- 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~---- 646 (809)
.++|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999854 689999999875432 2246788999999999999999999999877654
Q ss_pred --EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 647 --LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 647 --~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
++||||++ ++|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 68888772 2489999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865432 234568999999999887 688999999999999999999999997654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.9e-32 Score=319.46 Aligned_cols=300 Identities=20% Similarity=0.155 Sum_probs=263.3
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCC-chhhcCCccCcEEeecccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAI-PKAVASISTLADLTLEFNQ 78 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~i-p~~l~~l~~L~~L~L~~N~ 78 (809)
+|+|++|++.+..+..|..+++|++|+|++|.++ .+|..+..++ |+.|++++|.+..+ |..+..+++|++|+|++|.
T Consensus 258 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 336 (606)
T 3t6q_A 258 SINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNT 336 (606)
T ss_dssp EEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCS
T ss_pred EEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCC
Confidence 3688999999888888999999999999999999 7788888875 99999999999887 5588999999999999999
Q ss_pred cccCCCc-cccCCCCCCEEEccCCccCccC--chhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCC
Q 043333 79 FSGDLPA-ELGNLINLEKLHLNSNNFTGKL--PESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPI 155 (809)
Q Consensus 79 l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 155 (809)
+.+.+|. .+..+++|++|+|++|++++.. +..+.++++|++|+|++|++.+..|..|..+++|+.|+|++|++++..
T Consensus 337 ~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 416 (606)
T 3t6q_A 337 KRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416 (606)
T ss_dssp SCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCT
T ss_pred cccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcc
Confidence 9877765 5899999999999999999765 778999999999999999999888999999999999999999999876
Q ss_pred Cc-cccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCC---CChhhhccccccEEeccCCCCCCCCCCCC
Q 043333 156 PS-GIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGE---MPEYLGQMIGLRVLDLSFNKLSGVIPSNF 231 (809)
Q Consensus 156 p~-~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 231 (809)
|. .+..+++|+.|++++|.+....+..+.++++|++|+|++|++.+. .+..+..+++|+.|+|++|++++.+|..+
T Consensus 417 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 496 (606)
T 3t6q_A 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAF 496 (606)
T ss_dssp TCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTT
T ss_pred cchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhh
Confidence 65 489999999999999999999989999999999999999999873 44679999999999999999999999888
Q ss_pred CC-CCccEEEeeCccCCCCCChhhhh-ccCccccccCCccccCCCCCcccccccceeccccCCCCCCccccccccCCCCC
Q 043333 232 SG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVSCLKSFTCPT 309 (809)
Q Consensus 232 ~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~ 309 (809)
.. ++|+.|+|++|++++.+|..+.. ..+ .|+|++|++++.++..+. .+.+......
T Consensus 497 ~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~---------------------~l~~L~~L~l 554 (606)
T 3t6q_A 497 TSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLP---------------------ILSQQRTINL 554 (606)
T ss_dssp TTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHH---------------------HHHTSSEEEC
T ss_pred ccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcc---------------------cCCCCCEEeC
Confidence 77 99999999999999999988876 455 999999999876554443 2334455677
Q ss_pred CCcceeecCCCcee
Q 043333 310 NHSSLHINCGGKQV 323 (809)
Q Consensus 310 ~~~~~~~~C~~~~~ 323 (809)
.+|||.|+|...++
T Consensus 555 ~~N~~~c~c~~~~~ 568 (606)
T 3t6q_A 555 RQNPLDCTCSNIYF 568 (606)
T ss_dssp TTCCEECSGGGHHH
T ss_pred CCCCccccCCcHHH
Confidence 89999999986654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=326.19 Aligned_cols=204 Identities=28% Similarity=0.405 Sum_probs=170.3
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee----CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA----DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
..++|+..+.||+|+||.||+|.+. .+..||||++..... ...+.|.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 3567888999999999999999864 246799999865432 33467899999999999999999999985 46689
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 467 lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCee
Confidence 99999999999999943 234689999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 728 DEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 597 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 65443333334557789999999999999999999999999999997 999997643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=306.03 Aligned_cols=205 Identities=22% Similarity=0.292 Sum_probs=172.0
Q ss_pred HHHhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcC-CC-----ceEeEEeEEEeC
Q 043333 571 KAATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HP-----NLVKLYGCCIEG 643 (809)
Q Consensus 571 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~-----nIv~l~~~~~~~ 643 (809)
....++|+..+.||+|+||+||+|... +++.||||+++.. ....+++..|+++++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 345688999999999999999999864 6889999999643 223456778888888875 54 499999999999
Q ss_pred CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc--CCCceEEEe
Q 043333 644 NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD--KDLNPKISD 721 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~D 721 (809)
+..++||||++ |+|.+++.... ...+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999996 59999885322 23589999999999999999999953 13899999999999994 578899999
Q ss_pred cCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 722 FGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 722 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 205 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 205 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999876432 2245789999999999999999999999999999999999999987543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=321.15 Aligned_cols=208 Identities=14% Similarity=0.101 Sum_probs=139.3
Q ss_pred hhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCC-ccccCCcCCceeeeccccccCCCChhhhccccc
Q 043333 135 IQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPF-PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGL 213 (809)
Q Consensus 135 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 213 (809)
+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|.+....+ ..+.++++|++|++++|.+.+..|..+..+++|
T Consensus 372 ~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 450 (606)
T 3vq2_A 372 DLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450 (606)
T ss_dssp HHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC
T ss_pred hccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCC
Confidence 333444444444444444 234556666777777777777766655 567788888888888888888888888888888
Q ss_pred cEEeccCCCCCC-CCCCCCCC-CCccEEEeeCccCCCCCChhhhh-ccCccccccCCccccCCCCCcccccccceecccc
Q 043333 214 RVLDLSFNKLSG-VIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSS 290 (809)
Q Consensus 214 ~~L~Ls~N~l~~-~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~ 290 (809)
+.|+|++|++++ .+|..+.. ++|+.|+|++|++++.+|..+.. .+++.|+|++|++++..+..++....+..+..+.
T Consensus 451 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 530 (606)
T 3vq2_A 451 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530 (606)
T ss_dssp CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTT
T ss_pred CEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCC
Confidence 888888888887 46777666 89999999999999888877654 6679999999999888777777666665555444
Q ss_pred CCCC--CCcccccc-ccCCCCCCCcceeecCCCceeeec-----CCeeecCCCCCCCCcce
Q 043333 291 EGSN--STGIVSCL-KSFTCPTNHSSLHINCGGKQVIAN-----GSTTFEDDLDAAGPSRF 343 (809)
Q Consensus 291 ~~~~--~~~~~~c~-~~~~~~~~~~~~~~~C~~~~~~~~-----~~~~~~~~~~~~g~~~~ 343 (809)
+... +.....++ +.......+|||.|+|...++..- ......++..|..|..+
T Consensus 531 N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~ 591 (606)
T 3vq2_A 531 NRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWVKEQKQFLVNVEQMTCATPVEM 591 (606)
T ss_dssp SCCCCEESCGGGSCTTCCEEECCSCCCCCSSTTHHHHTTTTTSSSSBSSGGGCCCC-----
T ss_pred CcCcccCHhHhhhcccCcEEEccCCCcccCCccHHHHHHHHcCcccccCCccceeCCChHh
Confidence 4322 11122333 245667899999999998765331 11112345667777643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=297.67 Aligned_cols=202 Identities=25% Similarity=0.378 Sum_probs=167.5
Q ss_pred HHHhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccC--cccchhHHHHHHHHhhcC--CCceEeEEeEEEeCCeE
Q 043333 571 KAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQ--HPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 571 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~--H~nIv~l~~~~~~~~~~ 646 (809)
....++|+..+.||+|+||.||++...+++.||||++.... ....+.+.+|++++.+++ ||||+++++++.+.+..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 34567899999999999999999998889999999986543 233467889999999997 59999999999999999
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
++||| +.+++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||++++ +.+||+|||++.
T Consensus 104 ~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccc
Confidence 99999 668899999842 34689999999999999999999998 8999999999999975 899999999998
Q ss_pred ccCCCCcc-eeccccccccccchhhhcc-----------CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 727 LDEEDNTH-ISTRIAGTFGYMAPEYAMR-----------GYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 727 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
........ ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 66433221 2234568999999999865 4788899999999999999999999965
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=300.24 Aligned_cols=196 Identities=24% Similarity=0.443 Sum_probs=166.6
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe-----
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ----- 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~----- 645 (809)
.++|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467888999999999999999964 689999999865422 224678899999999999999999999987654
Q ss_pred -EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 646 -LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 646 -~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
.++||||++ |+|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 68888772 2489999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865432 223568999999999877 678999999999999999999999997754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=296.49 Aligned_cols=202 Identities=23% Similarity=0.391 Sum_probs=167.2
Q ss_pred HhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
..++|+..+.||+|+||.||+|.... .||||++.... ....+.|.+|++++++++||||+++++++.+.+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35678899999999999999998753 48999986542 233466888999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++++|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++ ++.+||+|||++.....
T Consensus 109 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp BCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999999943 234688999999999999999999998 899999999999998 67999999999875432
Q ss_pred CC----cceeccccccccccchhhhcc---------CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DN----THISTRIAGTFGYMAPEYAMR---------GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 111223458999999999864 457899999999999999999999997643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=296.46 Aligned_cols=201 Identities=24% Similarity=0.361 Sum_probs=172.6
Q ss_pred HHHhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcc------cchhHHHHHHHHhhcC--CCceEeEEeEEE
Q 043333 571 KAATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQ------GNREFVNEIGMISALQ--HPNLVKLYGCCI 641 (809)
Q Consensus 571 ~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~------~~~~f~~Ei~~l~~l~--H~nIv~l~~~~~ 641 (809)
....++|+..+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999999985 46899999998655322 2356778999999996 599999999999
Q ss_pred eCCeEEEEEEcccC-CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCCceEE
Q 043333 642 EGNQLLLIYEYMEN-NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKI 719 (809)
Q Consensus 642 ~~~~~~lV~ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl 719 (809)
+.+..++|+||+.+ ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++ +++.+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999986 899999842 34689999999999999999999998 899999999999999 7899999
Q ss_pred EecCCccccCCCCcceeccccccccccchhhhccCCC-CchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 720 SDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 720 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 192 ~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 192 IDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp CCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred eeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 9999998765332 224568999999999887665 6889999999999999999999964
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-32 Score=307.08 Aligned_cols=274 Identities=18% Similarity=0.150 Sum_probs=240.6
Q ss_pred CccccCCCCCccC-CccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCC-Cchh--hcCCccCcEEeec
Q 043333 1 HRILKSQNLPGRL-PPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGA-IPKA--VASISTLADLTLE 75 (809)
Q Consensus 1 ~L~L~~nnl~~~l-p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~-ip~~--l~~l~~L~~L~L~ 75 (809)
+|+|++|.+.+.+ |..|..+++|++|+|++|++++..|..|..++ |+.|++++|.+.. +|.. +..+++|++|+|+
T Consensus 58 ~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~ 137 (455)
T 3v47_A 58 FLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137 (455)
T ss_dssp EEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECC
T ss_pred EEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECC
Confidence 4789999998666 56789999999999999999988899999886 9999999999876 4544 8899999999999
Q ss_pred ccccccCCCcc-ccCCCCCCEEEccCCccCccCchhhhcc----------------------------------ccccee
Q 043333 76 FNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANL----------------------------------TRLKHF 120 (809)
Q Consensus 76 ~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l----------------------------------~~L~~L 120 (809)
+|++++..|.. +.++++|++|+|++|++++..|..+..+ ++|++|
T Consensus 138 ~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L 217 (455)
T 3v47_A 138 DNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTL 217 (455)
T ss_dssp SSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEE
T ss_pred CCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeE
Confidence 99999877776 8999999999999999998888777655 678899
Q ss_pred eeecccccCcCchhhhcc---------------------------------------cccceEecccCcCCCCCCccccC
Q 043333 121 RISDNHFTGQIPDYIQNW---------------------------------------TKLEKLFIEGSGLAGPIPSGIAS 161 (809)
Q Consensus 121 ~Ls~N~l~~~~p~~~~~l---------------------------------------~~L~~L~L~~N~l~~~~p~~~~~ 161 (809)
+|++|++++..|..+..+ ++|+.|+|++|++++..|..+..
T Consensus 218 ~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 297 (455)
T 3v47_A 218 DLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSH 297 (455)
T ss_dssp ECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTT
T ss_pred ecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhccc
Confidence 999998887776655433 57899999999999888999999
Q ss_pred CCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEE
Q 043333 162 LVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMY 240 (809)
Q Consensus 162 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~ 240 (809)
+++|+.|++++|.+..+.+..|.++++|++|+|++|.+.+..|..|..+++|+.|+|++|++++.+|..+.. ++|++|+
T Consensus 298 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 377 (455)
T 3v47_A 298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELA 377 (455)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEE
Confidence 999999999999999998889999999999999999999999999999999999999999999998888877 9999999
Q ss_pred eeCccCCCCCChhhhh-ccCccccccCCccccCCC
Q 043333 241 LTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDGSS 274 (809)
Q Consensus 241 Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~~~ 274 (809)
|++|++++.++..+.. .+++.|+|++|+++|..+
T Consensus 378 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 378 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 9999999877776644 678999999999998654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=306.98 Aligned_cols=201 Identities=27% Similarity=0.339 Sum_probs=156.9
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
+.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 3445568899999999987666679999999986432 34678899999886 8999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-------------Cce
Q 043333 654 ENNSLARALFGPEEHRLK---LDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD-------------LNP 717 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-------------~~~ 717 (809)
+ |+|.+++......... ..+..+..++.||+.||+|||++ +|+||||||+|||++.+ +++
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 6999999654322211 13335678999999999999998 89999999999999754 489
Q ss_pred EEEecCCccccCCCCcc---eeccccccccccchhhhcc-------CCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 718 KISDFGLAKLDEEDNTH---ISTRIAGTFGYMAPEYAMR-------GYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 718 kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||...
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 99999999876543321 1224579999999999965 678999999999999999999 99999653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=295.21 Aligned_cols=201 Identities=24% Similarity=0.367 Sum_probs=163.8
Q ss_pred HHHhcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc------ccchhHHHHHHHHhhc----CCCceEeEEeE
Q 043333 571 KAATNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK------QGNREFVNEIGMISAL----QHPNLVKLYGC 639 (809)
Q Consensus 571 ~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~------~~~~~f~~Ei~~l~~l----~H~nIv~l~~~ 639 (809)
....++|+..+.||+|+||.||+|.. .+++.||||++..... .....+.+|++++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34567899999999999999999985 4688999999865432 1234567899999998 89999999999
Q ss_pred EEeCCeEEEEEEc-ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCCce
Q 043333 640 CIEGNQLLLIYEY-MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNP 717 (809)
Q Consensus 640 ~~~~~~~~lV~ey-~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~ 717 (809)
+.+.+..++|+|| +++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9999999999999 789999999842 34689999999999999999999998 899999999999999 88999
Q ss_pred EEEecCCccccCCCCcceeccccccccccchhhhccCCCC-chHHHHHHHHHHHHHHcCCCCCCC
Q 043333 718 KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLT-DKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 718 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwSlGvil~elltGk~P~~~ 781 (809)
||+|||++....... .....||..|+|||++.+..+. .++|||||||++|||++|+.||..
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 999999998765432 2345689999999998876654 589999999999999999999964
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=296.30 Aligned_cols=200 Identities=23% Similarity=0.343 Sum_probs=170.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CC-eEEEEEEecccCcccchhHHHHHHHHhhcCCCc------eEeEEeEEEeCCe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DG-KVIAVKQLSSKSKQGNREFVNEIGMISALQHPN------LVKLYGCCIEGNQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g-~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~~~~~~~~~ 645 (809)
.++|+..+.||+|+||.||+|... ++ +.||||+++.. ....+.+.+|++++++++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468899999999999999999864 34 78999998643 233466788999999998766 8999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE--------------
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL-------------- 711 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl-------------- 711 (809)
.++||||+ ++++.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence 99999999 56676666332 224689999999999999999999998 89999999999999
Q ss_pred -----cCCCceEEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 712 -----DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 712 -----~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 678899999999998654322 245789999999999999999999999999999999999999987543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=290.24 Aligned_cols=195 Identities=29% Similarity=0.477 Sum_probs=160.8
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEe---------
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIE--------- 642 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~--------- 642 (809)
..++|+..+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3567889999999999999999964 6899999998543 2335678899999999999999999999875
Q ss_pred ----CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceE
Q 043333 643 ----GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 718 (809)
Q Consensus 643 ----~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 718 (809)
.+..++||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 3467999999999999999953 234578889999999999999999998 899999999999999999999
Q ss_pred EEecCCccccCCCC-------------cceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHc
Q 043333 719 ISDFGLAKLDEEDN-------------THISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVS 774 (809)
Q Consensus 719 l~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~ellt 774 (809)
|+|||++....... ........||+.|+|||.+.+. .++.++|||||||++|||++
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 99999997654221 1112345689999999998764 78999999999999999998
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-32 Score=319.55 Aligned_cols=285 Identities=18% Similarity=0.222 Sum_probs=173.7
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCC-CCC-CCCcccCCC-------CccccccccccCCCCch--hhcCCccCc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNY-LNG-TIPSEWASL-------PLVNLPLWKQANGAIPK--AVASISTLA 70 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~-l~~-~~p~~~~~l-------~L~~L~l~~n~~~~ip~--~l~~l~~L~ 70 (809)
|+|++|++.+.+|+.|.++++|++|+|++|+ +++ .+|..+..+ .|+.|++++|.+..+|. .++++++|+
T Consensus 254 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~ 333 (636)
T 4eco_A 254 VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG 333 (636)
T ss_dssp EEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCC
T ss_pred EEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCC
Confidence 5666666666666666666666666666666 665 566655543 36666666666666666 666666666
Q ss_pred EEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccc-cceeeeecccccCcCchhhhccc--ccceEecc
Q 043333 71 DLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTR-LKHFRISDNHFTGQIPDYIQNWT--KLEKLFIE 147 (809)
Q Consensus 71 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~ 147 (809)
+|+|++|+++|.+| .|+.+++|++|+|++|+++ .+|..+.++++ |++|+|++|+++ .+|..+..++ +|+.|+|+
T Consensus 334 ~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls 410 (636)
T 4eco_A 334 MLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFS 410 (636)
T ss_dssp EEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECC
T ss_pred EEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECc
Confidence 66666666666666 6666666666666666666 56666666666 666666666666 5565555543 66666666
Q ss_pred cCcCCCCCCcccc-------CCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccc-------cc
Q 043333 148 GSGLAGPIPSGIA-------SLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMI-------GL 213 (809)
Q Consensus 148 ~N~l~~~~p~~~~-------~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-------~L 213 (809)
+|++++.+|..+. .+++|+.|++++|.++.++...+..+++|+.|+|++|+++...+..+..+. +|
T Consensus 411 ~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L 490 (636)
T 4eco_A 411 YNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490 (636)
T ss_dssp SSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGC
T ss_pred CCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCc
Confidence 6666666666665 556666666666666666655566666666666666666633333333222 66
Q ss_pred cEEeccCCCCCCCCCCCC--CCCCccEEEeeCccCCCCCChhh-hhccCccccc------cCCccccCCCCCcccccccc
Q 043333 214 RVLDLSFNKLSGVIPSNF--SGSGLTYMYLTGNLLTGPVPDWI-VRKRNKHIDL------SYNNFIDGSSDSNCENQSVN 284 (809)
Q Consensus 214 ~~L~Ls~N~l~~~~p~~~--~~~~L~~L~Ls~N~l~~~~p~~~-~~~~l~~L~L------s~N~l~~~~~~~~~~~~~~~ 284 (809)
+.|+|++|+|+.++...+ ..++|+.|+|++|++++ +|..+ ....++.|+| ++|++.+..|..++....+.
T Consensus 491 ~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~ 569 (636)
T 4eco_A 491 TSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLT 569 (636)
T ss_dssp CEEECCSSCCCBCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCC
T ss_pred cEEECcCCcCCccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCC
Confidence 666666666664333333 33666666666666666 34333 3345566666 34555555555555544444
Q ss_pred eecccc
Q 043333 285 LFASSS 290 (809)
Q Consensus 285 ~~~~~~ 290 (809)
.+..+.
T Consensus 570 ~L~Ls~ 575 (636)
T 4eco_A 570 QLQIGS 575 (636)
T ss_dssp EEECCS
T ss_pred EEECCC
Confidence 443333
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=313.80 Aligned_cols=136 Identities=25% Similarity=0.282 Sum_probs=121.6
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCch-hhcCCccCcEEeecccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPK-AVASISTLADLTLEFNQ 78 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~-~l~~l~~L~~L~L~~N~ 78 (809)
+|+|++|+|.+..|.+|.++++|++|||++|+|++..|..|..++ |+.|++++|.+..+|. .|.++++|++|+|++|+
T Consensus 56 ~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~ 135 (635)
T 4g8a_A 56 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 135 (635)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSC
T ss_pred EEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCc
Confidence 489999999988888999999999999999999988888899986 9999999999999976 67999999999999999
Q ss_pred cccCCCccccCCCCCCEEEccCCccCc-cCchhhhcccccceeeeecccccCcCchhhh
Q 043333 79 FSGDLPAELGNLINLEKLHLNSNNFTG-KLPESFANLTRLKHFRISDNHFTGQIPDYIQ 136 (809)
Q Consensus 79 l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 136 (809)
+++..+..|+++++|++|+|++|++++ .+|..++++++|++|+|++|+|++..+..|.
T Consensus 136 l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~ 194 (635)
T 4g8a_A 136 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 194 (635)
T ss_dssp CCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGH
T ss_pred CCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccccc
Confidence 997777789999999999999999986 4688899999999999999998866555443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=292.95 Aligned_cols=197 Identities=23% Similarity=0.306 Sum_probs=145.8
Q ss_pred HhcCCCCCC-eeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHH-HHHHhhcCCCceEeEEeEEEe----CCe
Q 043333 573 ATNNFAPDN-KIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNE-IGMISALQHPNLVKLYGCCIE----GNQ 645 (809)
Q Consensus 573 ~~~~f~~~~-~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~E-i~~l~~l~H~nIv~l~~~~~~----~~~ 645 (809)
..++|.+.+ .||+|+||.||+|... +|+.||||++... ....+| ...+..++||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 356787754 6999999999999965 6899999998543 122233 344667799999999999986 445
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCceEEEec
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDF 722 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~Df 722 (809)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 89999999999999999543 234689999999999999999999998 8999999999999976 455999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
|+++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 176 g~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 176 GFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 9998654322 22456899999999998888999999999999999999999999654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-32 Score=303.09 Aligned_cols=198 Identities=24% Similarity=0.338 Sum_probs=157.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
..+|...+.||+|+||+||.....+|+.||||++.... ...+.+|+++++++ +||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 34677889999999999765555678999999986432 34467899999999 799999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-----CCceEEEecCCccc
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK-----DLNPKISDFGLAKL 727 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DfGla~~ 727 (809)
++ |+|.+++.... ....+..+..++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++.
T Consensus 100 ~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 96 69999985432 2334445678999999999999998 8999999999999953 34688999999986
Q ss_pred cCCCCc--ceeccccccccccchhhhc---cCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 043333 728 DEEDNT--HISTRIAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVS-GRSNVIC 781 (809)
Q Consensus 728 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwSlGvil~ellt-Gk~P~~~ 781 (809)
...... ......+||+.|+|||++. ...++.++|||||||++|||++ |+.||..
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~ 232 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence 643321 2233467999999999997 4567889999999999999999 9999954
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=291.51 Aligned_cols=203 Identities=28% Similarity=0.416 Sum_probs=150.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHH-HHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIG-MISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
.++|+..+.||+|+||.||+|... +|+.||||++..... ....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367888999999999999999964 689999999875432 23345566665 677789999999999999999999999
Q ss_pred EcccCCchhhhccCC-CccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 651 EYMENNSLARALFGP-EEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 651 ey~~~gsL~~~L~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
||+++ +|.+++... ......+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 787766321 112456899999999999999999999862 69999999999999999999999999997654
Q ss_pred CCCcceeccccccccccchhhh----ccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYA----MRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||..
T Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 3322 2234689999999998 456789999999999999999999999965
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=303.43 Aligned_cols=272 Identities=19% Similarity=0.169 Sum_probs=253.2
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCC-chhhcCCccCcEEeecccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAI-PKAVASISTLADLTLEFNQ 78 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~i-p~~l~~l~~L~~L~L~~N~ 78 (809)
+|+|++|++.+..|..|.++++|++|+|++|+++...+..|..++ |+.|++++|.+..+ |..+..+++|++|+|++|.
T Consensus 60 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~ 139 (477)
T 2id5_A 60 ELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDND 139 (477)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTT
T ss_pred EEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCc
Confidence 478999999999999999999999999999999977777788886 99999999999887 5688999999999999999
Q ss_pred cccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCcc
Q 043333 79 FSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSG 158 (809)
Q Consensus 79 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 158 (809)
+++..+..|.++++|++|+|++|++++..+..+.++++|+.|+|++|.+.+..+..|..+++|+.|+|++|.+.+.+|..
T Consensus 140 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~ 219 (477)
T 2id5_A 140 LVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN 219 (477)
T ss_dssp CCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTT
T ss_pred cceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcc
Confidence 99888889999999999999999999887788999999999999999999888888999999999999999988888887
Q ss_pred ccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCcc
Q 043333 159 IASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLT 237 (809)
Q Consensus 159 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~ 237 (809)
.....+|+.|++++|.++.++...+.++++|+.|+|++|.+.+..+..|..+++|+.|+|++|++++..|..+.. ++|+
T Consensus 220 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 299 (477)
T 2id5_A 220 CLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLR 299 (477)
T ss_dssp TTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCC
T ss_pred cccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCC
Confidence 777789999999999999998889999999999999999999999999999999999999999999999998877 9999
Q ss_pred EEEeeCccCCCCCChhhhh-ccCccccccCCccccC
Q 043333 238 YMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDG 272 (809)
Q Consensus 238 ~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~ 272 (809)
.|+|++|+|++..+..+.. .+++.|+|++|+|.|.
T Consensus 300 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~ 335 (477)
T 2id5_A 300 VLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACD 335 (477)
T ss_dssp EEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECS
T ss_pred EEECCCCcCceeCHhHcCCCcccCEEEccCCCccCc
Confidence 9999999999888877654 6789999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=297.00 Aligned_cols=200 Identities=23% Similarity=0.304 Sum_probs=167.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcC-----------CCceEeEEeEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-----------HPNLVKLYGCCI 641 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~~~~~ 641 (809)
.++|...+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35788999999999999999995 46899999998643 223466788999998886 899999999998
Q ss_pred eCC----eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-----
Q 043333 642 EGN----QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD----- 712 (809)
Q Consensus 642 ~~~----~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~----- 712 (809)
..+ ..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+++ +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 654 789999999 889999885322 335899999999999999999999963 699999999999994
Q ss_pred -CCCceEEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 713 -KDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 713 -~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
..+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 44589999999998664322 23568999999999999999999999999999999999999997643
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=324.72 Aligned_cols=230 Identities=17% Similarity=0.144 Sum_probs=150.0
Q ss_pred CCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccC
Q 043333 93 LEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD 172 (809)
Q Consensus 93 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 172 (809)
|+.|+|++|.+++..|..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|++++
T Consensus 268 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 347 (844)
T 3j0a_A 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347 (844)
T ss_dssp CCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCS
T ss_pred ccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCC
Confidence 44444444444444455566667777777777777777777777777788888888877777777777777888888888
Q ss_pred CCCCCCCCccccCCcCCceeeeccccccCCC----------------------------------------Chhhhcccc
Q 043333 173 LNGPEGPFPRLSNLKNMNYLILRSGNIIGEM----------------------------------------PEYLGQMIG 212 (809)
Q Consensus 173 n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~----------------------------------------p~~~~~l~~ 212 (809)
|.+..++...|.++++|+.|+|++|.+++.. +..+..+++
T Consensus 348 N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~ 427 (844)
T 3j0a_A 348 NHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPH 427 (844)
T ss_dssp CCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTT
T ss_pred CCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCc
Confidence 8777777777777777777777777665421 011335566
Q ss_pred ccEEeccCCCCCCCCC------------------------------CCCCC-CCccEEEeeCccCCCCCChhhhh-ccCc
Q 043333 213 LRVLDLSFNKLSGVIP------------------------------SNFSG-SGLTYMYLTGNLLTGPVPDWIVR-KRNK 260 (809)
Q Consensus 213 L~~L~Ls~N~l~~~~p------------------------------~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~ 260 (809)
|+.|+|++|++++..+ ..+.. ++|+.|+|++|.|++.+|..+.. ..++
T Consensus 428 L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 507 (844)
T 3j0a_A 428 LQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507 (844)
T ss_dssp CCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCS
T ss_pred cceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhh
Confidence 6666666666654322 23444 78888999999998888877654 5678
Q ss_pred cccccCCccccCCCCCcccccccceeccccCCCCCCccccccccCCCCCCCcceeecCCCceee
Q 043333 261 HIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVSCLKSFTCPTNHSSLHINCGGKQVI 324 (809)
Q Consensus 261 ~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~~C~~~~~~ 324 (809)
.|+|++|++++.++..+. ..+..+..+.+...........+.......+|||.|+|...++.
T Consensus 508 ~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~~~f~ 569 (844)
T 3j0a_A 508 GLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFI 569 (844)
T ss_dssp EEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSCCSHH
T ss_pred eeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccccccHHHH
Confidence 889999998887766554 22222222222211111111224455678899999999876653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-32 Score=321.07 Aligned_cols=192 Identities=22% Similarity=0.361 Sum_probs=165.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEee--CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCe-----
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA--DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQ----- 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~----- 645 (809)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.|.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999965 58999999986542 2334578899999999999999999999997665
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++||||+++++|.+++.. .++|..+..++.||+.||+|||++ +|+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999987722 689999999999999999999998 89999999999999986 8999999999
Q ss_pred cccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 726 KLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 726 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
+..... ....||+.|+|||++.++. +.++|||||||++|||++|..||..
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 876433 3456999999999987765 8999999999999999999998864
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=311.80 Aligned_cols=282 Identities=18% Similarity=0.204 Sum_probs=252.7
Q ss_pred CccccCCCCCcc-----------------CCccCC--CCCCCCEEEccCCCCCCCCCcccCCCC-cccccccccc-CC--
Q 043333 1 HRILKSQNLPGR-----------------LPPELT--RLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQA-NG-- 57 (809)
Q Consensus 1 ~L~L~~nnl~~~-----------------lp~~l~--~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~-~~-- 57 (809)
+|+|++|++.+. +|+.+. ++++|++|+|++|.+.+.+|..+..++ |+.|++++|. +.
T Consensus 210 ~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~ 289 (636)
T 4eco_A 210 QFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289 (636)
T ss_dssp EEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHH
T ss_pred EEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccc
Confidence 478999999986 999999 999999999999999999999999996 9999999997 76
Q ss_pred CCchhhcCC------ccCcEEeecccccccCCCc--cccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccC
Q 043333 58 AIPKAVASI------STLADLTLEFNQFSGDLPA--ELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTG 129 (809)
Q Consensus 58 ~ip~~l~~l------~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 129 (809)
.+|..++.+ ++|++|+|++|+++ .+|. .++++++|++|+|++|+++|.+| .++++++|+.|+|++|+++
T Consensus 290 ~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~- 366 (636)
T 4eco_A 290 QLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT- 366 (636)
T ss_dssp HHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-
T ss_pred cchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-
Confidence 599998887 99999999999999 8898 99999999999999999999999 9999999999999999999
Q ss_pred cCchhhhcccc-cceEecccCcCCCCCCccccCCC--CCCEEeccCCCCCCCCCcccc-------CCcCCceeeeccccc
Q 043333 130 QIPDYIQNWTK-LEKLFIEGSGLAGPIPSGIASLV--ELTDLRISDLNGPEGPFPRLS-------NLKNMNYLILRSGNI 199 (809)
Q Consensus 130 ~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~l~~n~l~~~~~~~l~-------~l~~L~~L~Ls~N~l 199 (809)
.+|..+.++++ |+.|+|++|+++ .+|..+..+. +|+.|++++|.+....+..+. .+++|+.|+|++|++
T Consensus 367 ~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l 445 (636)
T 4eco_A 367 EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQI 445 (636)
T ss_dssp ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCC
T ss_pred cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCcc
Confidence 89999999999 999999999999 8898887765 999999999999998888887 888999999999999
Q ss_pred cCCCChhhhccccccEEeccCCCCCCCCCCCCCCC--------CccEEEeeCccCCCCCChhh---hhccCccccccCCc
Q 043333 200 IGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGS--------GLTYMYLTGNLLTGPVPDWI---VRKRNKHIDLSYNN 268 (809)
Q Consensus 200 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~--------~L~~L~Ls~N~l~~~~p~~~---~~~~l~~L~Ls~N~ 268 (809)
....+..+..+++|+.|+|++|+|+.+++..+... +|+.|+|++|+++ .+|..+ ....++.|+|++|+
T Consensus 446 ~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~ 524 (636)
T 4eco_A 446 SKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNS 524 (636)
T ss_dssp CSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSC
T ss_pred CcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCC
Confidence 97666677889999999999999997666666543 9999999999999 566555 45788999999999
Q ss_pred cccCCCCCcccccccceecc
Q 043333 269 FIDGSSDSNCENQSVNLFAS 288 (809)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~ 288 (809)
+++ .|..+.....+..+..
T Consensus 525 l~~-ip~~~~~l~~L~~L~L 543 (636)
T 4eco_A 525 FSK-FPTQPLNSSTLKGFGI 543 (636)
T ss_dssp CSS-CCCGGGGCSSCCEEEC
T ss_pred CCC-cChhhhcCCCCCEEEC
Confidence 998 5666666666655544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=292.79 Aligned_cols=191 Identities=21% Similarity=0.233 Sum_probs=161.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCc--------ccchhHHHHHHHHhhcC---------CCceEeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSK--------QGNREFVNEIGMISALQ---------HPNLVKL 636 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~--------~~~~~f~~Ei~~l~~l~---------H~nIv~l 636 (809)
.++|+..+.||+|+||+||+|+. +|+.||||++..... ...+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45688899999999999999987 689999999975532 12367889999998886 8888888
Q ss_pred EeEEE------------------------------eCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHH
Q 043333 637 YGCCI------------------------------EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLAR 686 (809)
Q Consensus 637 ~~~~~------------------------------~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~ 686 (809)
.+.+. +.+..++||||+++|++.+.+. +..+++..+..++.|++.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence 87754 2678999999999998777662 245799999999999999
Q ss_pred HHHHHH-hCCCCCeEEcCCCCCCEEEcCCC--------------------ceEEEecCCccccCCCCcceeccccccccc
Q 043333 687 GLAYLH-EESRLKIVHRDIKATNVLLDKDL--------------------NPKISDFGLAKLDEEDNTHISTRIAGTFGY 745 (809)
Q Consensus 687 ~L~yLH-~~~~~~iiH~Dlkp~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y 745 (809)
||+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ..+||+.|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 77 899999999999999887 8999999999866432 24799999
Q ss_pred cchhhhccCCCCchHHHHHHHHH-HHHHHcCCCCCC
Q 043333 746 MAPEYAMRGYLTDKADVYSFGIV-ALEIVSGRSNVI 780 (809)
Q Consensus 746 ~aPE~~~~~~~~~ksDVwSlGvi-l~elltGk~P~~ 780 (809)
+|||++.+.. +.++||||++++ .+++++|..||.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 9999998766 899999998776 778899999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=286.65 Aligned_cols=200 Identities=27% Similarity=0.430 Sum_probs=149.6
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc-cc-hhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ-GN-REFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~-~~-~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
.++|+..+.||+|+||.||+|... +|+.||||++...... .. +.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356788899999999999999975 6899999998754322 22 33444556788889999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+ ++.+..+.. .....+++..+..++.|++.||+|||++. +++||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 444544442 12356899999999999999999999831 799999999999999999999999999976543
Q ss_pred CCcceeccccccccccchhhhc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
... .....||+.|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 178 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 178 DKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred Ccc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 222 23456899999999984 55788999999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=312.19 Aligned_cols=202 Identities=30% Similarity=0.458 Sum_probs=171.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEeccc-CcccchhHHHHHHHHhhcCCCceEeEEeEEEe------CCe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLYGCCIE------GNQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~------~~~ 645 (809)
.++|+..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999986 46899999998654 23335678999999999999999999998765 567
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc---eEEEec
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---PKISDF 722 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~Df 722 (809)
.++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999996532 233588889999999999999999998 8999999999999997765 899999
Q ss_pred CCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
|++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 169 G~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 169 GYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 99987654332 2346789999999999999999999999999999999999999954
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=316.35 Aligned_cols=266 Identities=19% Similarity=0.214 Sum_probs=176.1
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEc-cCCCCCCCCCcc---------------------------------------
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDL-TRNYLNGTIPSE--------------------------------------- 40 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~L-s~n~l~~~~p~~--------------------------------------- 40 (809)
+|+|++|++.|.+|++|++|++|++|+| ++|.+.+..|-.
T Consensus 327 ~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~ 406 (876)
T 4ecn_A 327 GLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406 (876)
T ss_dssp EEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHH
T ss_pred EEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHH
Confidence 4789999999999999999999999999 888765542211
Q ss_pred -------------cCCCCccccccc--cccCCCCchhhcCCccCcEEeeccccccc-----------------CCCcccc
Q 043333 41 -------------WASLPLVNLPLW--KQANGAIPKAVASISTLADLTLEFNQFSG-----------------DLPAELG 88 (809)
Q Consensus 41 -------------~~~l~L~~L~l~--~n~~~~ip~~l~~l~~L~~L~L~~N~l~~-----------------~~p~~~~ 88 (809)
...+.++.+.+. .|.+..||..++++++|+.|+|++|+|++ .+|..++
T Consensus 407 ~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~ 486 (876)
T 4ecn_A 407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELS 486 (876)
T ss_dssp HHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCC
T ss_pred HhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhh
Confidence 001112223332 24444477777777777777777777776 2666665
Q ss_pred --CCCCCCEEEccCCccCccCchhhhcccccceeeeeccc-ccC-cCchhhhccc-------ccceEecccCcCCCCCCc
Q 043333 89 --NLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH-FTG-QIPDYIQNWT-------KLEKLFIEGSGLAGPIPS 157 (809)
Q Consensus 89 --~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~p~ 157 (809)
++++|++|+|++|++.+.+|..|+++++|+.|+|++|+ +++ .+|..+++++ +|+.|+|++|+++ .+|.
T Consensus 487 f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~ 565 (876)
T 4ecn_A 487 WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPA 565 (876)
T ss_dssp GGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCC
T ss_pred hccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCC
Confidence 77777777777777777777777777777777777776 666 6676666655 7777777777777 6666
Q ss_pred --cccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhcccc-ccEEeccCCCCCCCCCCCCCC-
Q 043333 158 --GIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIG-LRVLDLSFNKLSGVIPSNFSG- 233 (809)
Q Consensus 158 --~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~- 233 (809)
.|..+++|+.|++++|.+..++ .|.++++|+.|+|++|++. .+|..+..+++ |+.|+|++|+|+ .+|..+..
T Consensus 566 ~~~l~~L~~L~~L~Ls~N~l~~lp--~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~ 641 (876)
T 4ecn_A 566 SASLQKMVKLGLLDCVHNKVRHLE--AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAK 641 (876)
T ss_dssp HHHHTTCTTCCEEECTTSCCCBCC--CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTT
T ss_pred hhhhhcCCCCCEEECCCCCcccch--hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhcc
Confidence 6777777777777777776444 6677777777777777776 66666777776 777777777776 34444433
Q ss_pred --CCccEEEeeCccCCCCCChhh------hhccCccccccCCcccc
Q 043333 234 --SGLTYMYLTGNLLTGPVPDWI------VRKRNKHIDLSYNNFID 271 (809)
Q Consensus 234 --~~L~~L~Ls~N~l~~~~p~~~------~~~~l~~L~Ls~N~l~~ 271 (809)
++|+.|+|++|++++.+|... ...+++.|+|++|+++.
T Consensus 642 ~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~ 687 (876)
T 4ecn_A 642 SVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK 687 (876)
T ss_dssp CSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCS
T ss_pred ccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCc
Confidence 236666666666666554322 11244555556655553
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=281.74 Aligned_cols=231 Identities=22% Similarity=0.326 Sum_probs=216.2
Q ss_pred CccccccccccCC---CCchhhcCCccCcEEeecc-cccccCCCccccCCCCCCEEEccCCccCccCchhhhccccccee
Q 043333 45 PLVNLPLWKQANG---AIPKAVASISTLADLTLEF-NQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHF 120 (809)
Q Consensus 45 ~L~~L~l~~n~~~---~ip~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 120 (809)
.++.|++++|.+. .+|..+.++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|.++++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 5889999999997 5899999999999999995 99999999999999999999999999999999999999999999
Q ss_pred eeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCC-CCCEEeccCCCCCCCCCccccCCcCCceeeeccccc
Q 043333 121 RISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLV-ELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNI 199 (809)
Q Consensus 121 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l 199 (809)
+|++|++++.+|..+..+++|++|+|++|++++.+|..+..++ +|+.|++++|.+....+..+..++ |+.|+|++|++
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 9999999999999999999999999999999999999999998 999999999999988888898887 99999999999
Q ss_pred cCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhh-ccCccccccCCccccCCCCC
Q 043333 200 IGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDGSSDS 276 (809)
Q Consensus 200 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~~~~~ 276 (809)
.+..|..|..+++|+.|+|++|++++.+|.....++|++|+|++|++++.+|..+.. ..++.|+|++|++++..|..
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred cCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 999999999999999999999999998888544599999999999999999988865 57799999999999766643
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=288.90 Aligned_cols=292 Identities=17% Similarity=0.098 Sum_probs=199.6
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCch-hhcCCccCcEEeeccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPK-AVASISTLADLTLEFNQF 79 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~-~l~~l~~L~~L~L~~N~l 79 (809)
|++++|.+....+..+..+++|++|+|++|.++...+..|..++ |+.|++++|.+..+|. .+..+++|++|+|++|++
T Consensus 50 l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 129 (390)
T 3o6n_A 50 VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 129 (390)
T ss_dssp EEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCcc
Confidence 44555555533333356666666666666666655555666654 6666666666666643 456666666666666666
Q ss_pred ccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhccc-------------------c
Q 043333 80 SGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWT-------------------K 140 (809)
Q Consensus 80 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-------------------~ 140 (809)
+...+..|.++++|++|+|++|++++..|..+.++++|++|+|++|++++.. +..++ +
T Consensus 130 ~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~~~~~~~ 206 (390)
T 3o6n_A 130 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIA 206 (390)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSEEECCSS
T ss_pred CcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeecccccccccCCCCc
Confidence 6333334566666666666666666655656666666666666666666432 23333 4
Q ss_pred cceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccC
Q 043333 141 LEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSF 220 (809)
Q Consensus 141 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 220 (809)
|+.|++++|+++.. |.. ..++|+.|++++|.++.. +.+..+++|++|+|++|.+.+..|..|..+++|+.|+|++
T Consensus 207 L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 281 (390)
T 3o6n_A 207 VEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 281 (390)
T ss_dssp CSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCS
T ss_pred ceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCC
Confidence 55555555555532 222 246888999999988875 5788999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhhccCccccccCCccccCCCCCcccccccceeccccCCCCCCcccc
Q 043333 221 NKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVS 300 (809)
Q Consensus 221 N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (809)
|++++.+......++|+.|+|++|++++.++......+++.|+|++|+++..+.. .
T Consensus 282 n~l~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~N~i~~~~~~------------------------~ 337 (390)
T 3o6n_A 282 NRLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLKLS------------------------T 337 (390)
T ss_dssp SCCCEEECSSSCCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCSSCCCCCCCC------------------------T
T ss_pred CcCcccCcccCCCCCCCEEECCCCcceecCccccccCcCCEEECCCCccceeCch------------------------h
Confidence 9999876555445899999999999996655554557889999999998764321 2
Q ss_pred ccccCCCCCCCcceeecCCCceeee
Q 043333 301 CLKSFTCPTNHSSLHINCGGKQVIA 325 (809)
Q Consensus 301 c~~~~~~~~~~~~~~~~C~~~~~~~ 325 (809)
+++.......+|+|.|+|....+..
T Consensus 338 ~~~L~~L~l~~N~~~~~~~~~~~~~ 362 (390)
T 3o6n_A 338 HHTLKNLTLSHNDWDCNSLRALFRN 362 (390)
T ss_dssp TCCCSEEECCSSCEEHHHHHHHTTT
T ss_pred hccCCEEEcCCCCccchhHHHHHHH
Confidence 3344556678999999996655443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=300.43 Aligned_cols=318 Identities=16% Similarity=0.115 Sum_probs=211.6
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchh-hcCCccCcEEeecccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKA-VASISTLADLTLEFNQ 78 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~-l~~l~~L~~L~L~~N~ 78 (809)
+|+|++|++.+..|..|..+++|++|+|++|++++..|..|..++ |+.|++++|.+..+|.. ++.+++|++|+|++|.
T Consensus 30 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 109 (549)
T 2z81_A 30 SLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNP 109 (549)
T ss_dssp EEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCC
T ss_pred EEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCc
Confidence 478999999988888999999999999999999988888888886 99999999999888764 8999999999999999
Q ss_pred ccc-CCCccccCCCCCCEEEccCCccCccC-chhhhcccccceeeeecccccCcCchhhhc-------------------
Q 043333 79 FSG-DLPAELGNLINLEKLHLNSNNFTGKL-PESFANLTRLKHFRISDNHFTGQIPDYIQN------------------- 137 (809)
Q Consensus 79 l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------------------- 137 (809)
+++ ..|..++++++|++|+|++|++.+.+ +..|.++++|++|+|++|++++..|..+..
T Consensus 110 l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~ 189 (549)
T 2z81_A 110 YQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE 189 (549)
T ss_dssp CSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHH
T ss_pred ccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccch
Confidence 986 35678888999999999998844344 467888888888888888888777666543
Q ss_pred -----ccccceEecccCcCCCC----------------------------------------------------------
Q 043333 138 -----WTKLEKLFIEGSGLAGP---------------------------------------------------------- 154 (809)
Q Consensus 138 -----l~~L~~L~L~~N~l~~~---------------------------------------------------------- 154 (809)
+++|+.|+|++|++++.
T Consensus 190 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~ 269 (549)
T 2z81_A 190 IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDF 269 (549)
T ss_dssp HHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCC
T ss_pred hhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccc
Confidence 45666666666666542
Q ss_pred -------------------------------------------------------CCccc-cCCCCCCEEeccCCCCCCC
Q 043333 155 -------------------------------------------------------IPSGI-ASLVELTDLRISDLNGPEG 178 (809)
Q Consensus 155 -------------------------------------------------------~p~~~-~~l~~L~~L~l~~n~l~~~ 178 (809)
+|..+ ..+++|+.|++++|.+...
T Consensus 270 ~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~ 349 (549)
T 2z81_A 270 NPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEE 349 (549)
T ss_dssp CCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHH
T ss_pred cccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccc
Confidence 11111 2345555555555555442
Q ss_pred CC---ccccCCcCCceeeeccccccCCCC--hhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChh
Q 043333 179 PF---PRLSNLKNMNYLILRSGNIIGEMP--EYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDW 253 (809)
Q Consensus 179 ~~---~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~ 253 (809)
.+ ..+..+++|++|+|++|++++..+ ..+..+++|+.|+|++|+++.+++.....++|++|+|++|+++......
T Consensus 350 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~ 429 (549)
T 2z81_A 350 YLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCI 429 (549)
T ss_dssp HHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSCCCTTS
T ss_pred cccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCcccccchh
Confidence 21 124455666666666666655432 4467777777777777777754333222266666666666665322211
Q ss_pred h------------------hhccCccccccCCccccCCCCCcccccccceeccccC---CCCCCccccccccCCCCCCCc
Q 043333 254 I------------------VRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSE---GSNSTGIVSCLKSFTCPTNHS 312 (809)
Q Consensus 254 ~------------------~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~c~~~~~~~~~~~ 312 (809)
. ....++.|+|++|+++..+.. .....+..+..+.+ ...+.....+.+.......+|
T Consensus 430 ~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~~ip~~--~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 507 (549)
T 2z81_A 430 PQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTLPDA--SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507 (549)
T ss_dssp CTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCG--GGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSS
T ss_pred cCCceEEECCCCChhhhcccCChhcEEECCCCccCcCCCc--ccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCC
Confidence 1 123556677777777644321 22222333322222 222223345566677789999
Q ss_pred ceeecCCC
Q 043333 313 SLHINCGG 320 (809)
Q Consensus 313 ~~~~~C~~ 320 (809)
||.|+|..
T Consensus 508 ~~~~~~~~ 515 (549)
T 2z81_A 508 PWDCSCPR 515 (549)
T ss_dssp CBCCCHHH
T ss_pred CccCCCcc
Confidence 99999974
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=304.08 Aligned_cols=338 Identities=19% Similarity=0.181 Sum_probs=209.4
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCc-hhhcCCccCcEEeeccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIP-KAVASISTLADLTLEFNQF 79 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip-~~l~~l~~L~~L~L~~N~l 79 (809)
|+|++|++.+..+..|..+++|++|+|++|++++..|..|..++ |+.|++++|.+..+| ..|..+++|++|+|++|++
T Consensus 33 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 112 (570)
T 2z63_A 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112 (570)
T ss_dssp EECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred EEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccccccc
Confidence 56666666666666666666677777766666665566666654 666666666666554 4556666666666666666
Q ss_pred ccCCCccccCCCCCCEEEccCCccCc-cCchhhhcccccceeeeecccccCcCchhhhc---------------------
Q 043333 80 SGDLPAELGNLINLEKLHLNSNNFTG-KLPESFANLTRLKHFRISDNHFTGQIPDYIQN--------------------- 137 (809)
Q Consensus 80 ~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--------------------- 137 (809)
++..+..|+++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..|..++.
T Consensus 113 ~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~ 192 (570)
T 2z63_A 113 ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192 (570)
T ss_dssp CCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEE
T ss_pred ccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceec
Confidence 64333345666666666666666654 24555666666666666655554433332222
Q ss_pred --------------------------------------------------------------------------------
Q 043333 138 -------------------------------------------------------------------------------- 137 (809)
Q Consensus 138 -------------------------------------------------------------------------------- 137 (809)
T Consensus 193 ~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~ 272 (570)
T 2z63_A 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLD 272 (570)
T ss_dssp CTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEES
T ss_pred CHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhh
Confidence
Q ss_pred --------ccccceEecccCcCCCCCCccc------------------------------------------cCCCCCCE
Q 043333 138 --------WTKLEKLFIEGSGLAGPIPSGI------------------------------------------ASLVELTD 167 (809)
Q Consensus 138 --------l~~L~~L~L~~N~l~~~~p~~~------------------------------------------~~l~~L~~ 167 (809)
+++|+.|++++|.++ .+|..+ ..+++|+.
T Consensus 273 ~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~ 351 (570)
T 2z63_A 273 DIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEF 351 (570)
T ss_dssp CSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCE
T ss_pred hchhhhcCcCcccEEEecCccch-hhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCE
Confidence 233333333333333 122111 23344455
Q ss_pred EeccCCCCC--------------------------CCCCccccCCcCCceeeeccccccCCCC-hhhhccccccEEeccC
Q 043333 168 LRISDLNGP--------------------------EGPFPRLSNLKNMNYLILRSGNIIGEMP-EYLGQMIGLRVLDLSF 220 (809)
Q Consensus 168 L~l~~n~l~--------------------------~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~ 220 (809)
|++++|.+. .++.. +..+++|+.|++++|.+.+..| ..+..+++|+.|+|++
T Consensus 352 L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~ 430 (570)
T 2z63_A 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430 (570)
T ss_dssp EECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTT
T ss_pred EeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcC
Confidence 555555443 33322 6677778888888888877766 5678888888888888
Q ss_pred CCCCCCCCCCCCC-CCccEEEeeCccCC-CCCChhhhh-ccCccccccCCccccCCCCCcccccccceeccccCC---CC
Q 043333 221 NKLSGVIPSNFSG-SGLTYMYLTGNLLT-GPVPDWIVR-KRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEG---SN 294 (809)
Q Consensus 221 N~l~~~~p~~~~~-~~L~~L~Ls~N~l~-~~~p~~~~~-~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~~~---~~ 294 (809)
|++++.+|..+.. ++|+.|+|++|.++ +.+|..+.. ..++.|+|++|++++..+..+.....+..+..+.+. ..
T Consensus 431 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 510 (570)
T 2z63_A 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVP 510 (570)
T ss_dssp SCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCC
Confidence 8888888887776 88999999999887 466665544 567889999999988877777665555554443332 22
Q ss_pred CCccccccccCCCCCCCcceeecCCCceee-e---cCCeeecCCCCCCCCc
Q 043333 295 STGIVSCLKSFTCPTNHSSLHINCGGKQVI-A---NGSTTFEDDLDAAGPS 341 (809)
Q Consensus 295 ~~~~~~c~~~~~~~~~~~~~~~~C~~~~~~-~---~~~~~~~~~~~~~g~~ 341 (809)
......|++.......+|+|.|+|...++. . .......+...|.+|.
T Consensus 511 ~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~~C~~~~ 561 (570)
T 2z63_A 511 DGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSAKCSGSG 561 (570)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGGGEESCCBBTTTC
T ss_pred HHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhccccCCCchhhCCCC
Confidence 233445677778889999999999876653 1 1222333334676664
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=274.32 Aligned_cols=173 Identities=11% Similarity=0.029 Sum_probs=150.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcc---cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ---GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|+..+.||+|+||.||+|... +++.||||++...... ..+.|.+|++++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 357888999999999999999965 4899999999765332 236789999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++++|.+++.. . .....+..++.|++.||+|||++ +|+||||||+|||++.++.+||+++
T Consensus 110 ~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~------- 173 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP------- 173 (286)
T ss_dssp EECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC-------
T ss_pred EEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec-------
Confidence 999999999999832 1 34557888999999999999998 8999999999999999999999744
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
+|++| ++.++|||||||++|||+||+.||...+
T Consensus 174 --------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 174 --------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp --------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred --------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 34443 6889999999999999999999997644
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-29 Score=274.48 Aligned_cols=261 Identities=23% Similarity=0.250 Sum_probs=226.3
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCC-chhhcCCccCcEEeeccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAI-PKAVASISTLADLTLEFNQF 79 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~i-p~~l~~l~~L~~L~L~~N~l 79 (809)
++++++++. .+|..+. ++|++|+|++|++++..+..|..++ |+.|++++|.+..+ |..+..+++|++|+|++|++
T Consensus 36 l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (330)
T 1xku_A 36 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112 (330)
T ss_dssp EECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcC
Confidence 567777777 6777665 6899999999999988787888886 99999999999888 77899999999999999999
Q ss_pred ccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccC--cCchhhhcccccceEecccCcCCCCCCc
Q 043333 80 SGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTG--QIPDYIQNWTKLEKLFIEGSGLAGPIPS 157 (809)
Q Consensus 80 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 157 (809)
+ .+|..+. ++|++|++++|++++..+..+.++++|+.|+|++|.+.. ..+..+.++++|+.|++++|+++ .+|.
T Consensus 113 ~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~ 188 (330)
T 1xku_A 113 K-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 188 (330)
T ss_dssp S-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCS
T ss_pred C-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCc
Confidence 9 6666554 799999999999998888889999999999999999963 67888999999999999999999 4666
Q ss_pred cccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCcc
Q 043333 158 GIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLT 237 (809)
Q Consensus 158 ~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~ 237 (809)
.+. ++|+.|++++|.++.+.+..+.++++|+.|+|++|.+.+..+..|..+++|+.|+|++|+++.++......++|+
T Consensus 189 ~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~ 266 (330)
T 1xku_A 189 GLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQ 266 (330)
T ss_dssp SCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCC
T ss_pred ccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcC
Confidence 554 899999999999999988999999999999999999999999899999999999999999996555444449999
Q ss_pred EEEeeCccCCCCCChhhhh-------ccCccccccCCcccc
Q 043333 238 YMYLTGNLLTGPVPDWIVR-------KRNKHIDLSYNNFID 271 (809)
Q Consensus 238 ~L~Ls~N~l~~~~p~~~~~-------~~l~~L~Ls~N~l~~ 271 (809)
.|+|++|++++..+..+.. ..++.|++++|++..
T Consensus 267 ~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 267 VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp EEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred EEECCCCcCCccChhhcCCcccccccccccceEeecCcccc
Confidence 9999999999887776642 355789999999864
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-30 Score=302.00 Aligned_cols=291 Identities=18% Similarity=0.104 Sum_probs=203.8
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCch-hhcCCccCcEEeeccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPK-AVASISTLADLTLEFNQF 79 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~-~l~~l~~L~~L~L~~N~l 79 (809)
|++++|.+....+..+..+++|++|+|++|.+++..|..|..++ |+.|++++|.+..+|. .++++++|++|+|++|.+
T Consensus 56 l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 135 (597)
T 3oja_B 56 VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 135 (597)
T ss_dssp EEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCC
Confidence 34555666544444456677777777777777766666666664 6777777777766654 456677777777777777
Q ss_pred ccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccc-------------------
Q 043333 80 SGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTK------------------- 140 (809)
Q Consensus 80 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~------------------- 140 (809)
++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++.. +..+++
T Consensus 136 ~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l~~~~~ 212 (597)
T 3oja_B 136 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIA 212 (597)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEEECCTT
T ss_pred CCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccccCCch
Confidence 7444445667777777777777777666666777777777777777776442 333444
Q ss_pred cceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccC
Q 043333 141 LEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSF 220 (809)
Q Consensus 141 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 220 (809)
|+.|++++|.++.. +..+ .++|+.|++++|.++.. ..+..+++|+.|+|++|.+.+..|..|..+++|+.|+|++
T Consensus 213 L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 287 (597)
T 3oja_B 213 VEELDASHNSINVV-RGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287 (597)
T ss_dssp CSEEECCSSCCCEE-ECSC--CSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTT
T ss_pred hheeeccCCccccc-cccc--CCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCC
Confidence 45555555555422 2111 25788888888888764 6788999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhhccCccccccCCccccCCCCCcccccccceeccccCCCCCCcccc
Q 043333 221 NKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVS 300 (809)
Q Consensus 221 N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (809)
|+++++++.....++|+.|+|++|.+++.++......+++.|+|++|+++..+.. .
T Consensus 288 N~l~~l~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~l~~L~~L~L~~N~l~~~~~~------------------------~ 343 (597)
T 3oja_B 288 NRLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLKLS------------------------T 343 (597)
T ss_dssp SCCCEEECSSSCCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCSSCCCCCCCC------------------------T
T ss_pred CCCCCCCcccccCCCCcEEECCCCCCCccCcccccCCCCCEEECCCCCCCCcChh------------------------h
Confidence 9999875555445899999999999996554544557889999999998764321 2
Q ss_pred ccccCCCCCCCcceeecCCCceee
Q 043333 301 CLKSFTCPTNHSSLHINCGGKQVI 324 (809)
Q Consensus 301 c~~~~~~~~~~~~~~~~C~~~~~~ 324 (809)
++........+|||.|+|...++.
T Consensus 344 ~~~L~~L~l~~N~~~~~~~~~~~~ 367 (597)
T 3oja_B 344 HHTLKNLTLSHNDWDCNSLRALFR 367 (597)
T ss_dssp TCCCSEEECCSSCEEHHHHHHHTT
T ss_pred cCCCCEEEeeCCCCCChhHHHHHH
Confidence 334455667899999999655543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-30 Score=301.86 Aligned_cols=270 Identities=20% Similarity=0.251 Sum_probs=248.1
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCC-CCch-hhcCCccCcEEeeccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANG-AIPK-AVASISTLADLTLEFN 77 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~-~ip~-~l~~l~~L~~L~L~~N 77 (809)
+|+|++|++. .+|+.+..+++|++|++++|.+.+..|..+..++ |+.|++++|.+. .+|. .+..+++|++|+|++|
T Consensus 282 ~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n 360 (606)
T 3t6q_A 282 ELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360 (606)
T ss_dssp EEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSS
T ss_pred EEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCC
Confidence 4789999998 8999999999999999999999988888888886 999999999876 6766 5899999999999999
Q ss_pred ccccCC--CccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchh-hhcccccceEecccCcCCCC
Q 043333 78 QFSGDL--PAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDY-IQNWTKLEKLFIEGSGLAGP 154 (809)
Q Consensus 78 ~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~ 154 (809)
.+++.. +..+..+++|++|+|++|++++..|..|.++++|+.|+|++|++.+..|.. +.++++|+.|+|++|.+++.
T Consensus 361 ~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 440 (606)
T 3t6q_A 361 DIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440 (606)
T ss_dssp CCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTT
T ss_pred ccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCc
Confidence 999765 778999999999999999999999999999999999999999999876654 89999999999999999999
Q ss_pred CCccccCCCCCCEEeccCCCCCCC---CCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCC
Q 043333 155 IPSGIASLVELTDLRISDLNGPEG---PFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNF 231 (809)
Q Consensus 155 ~p~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 231 (809)
.|..+..+++|+.|++++|.+... ....+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++.+|..+
T Consensus 441 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 520 (606)
T 3t6q_A 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520 (606)
T ss_dssp CTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGG
T ss_pred CHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHh
Confidence 999999999999999999999863 23568999999999999999999999999999999999999999999999988
Q ss_pred CC-CCccEEEeeCccCCCCCChhhhh-ccCccccccCCccccC
Q 043333 232 SG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDG 272 (809)
Q Consensus 232 ~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~ 272 (809)
.. ++| .|+|++|++++.+|..+.. ..++.|++++|+|.|.
T Consensus 521 ~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 562 (606)
T 3t6q_A 521 SHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562 (606)
T ss_dssp TTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred Cccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence 87 899 9999999999999887765 6789999999999984
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=305.03 Aligned_cols=282 Identities=18% Similarity=0.185 Sum_probs=242.5
Q ss_pred CccccCCCCCc-----------------cCCccCC--CCCCCCEEEccCCCCCCCCCcccCCCC-cccccccccc-CC--
Q 043333 1 HRILKSQNLPG-----------------RLPPELT--RLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQA-NG-- 57 (809)
Q Consensus 1 ~L~L~~nnl~~-----------------~lp~~l~--~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~-~~-- 57 (809)
+|+|++|++.+ .+|+.++ ++++|++|+|++|.+.+.+|..|..++ |+.|++++|. +.
T Consensus 452 ~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~ 531 (876)
T 4ecn_A 452 IIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAA 531 (876)
T ss_dssp EEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHH
T ss_pred EEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccc
Confidence 47899999998 4999998 999999999999999999999999996 9999999997 76
Q ss_pred CCchhhcCCc-------cCcEEeecccccccCCCc--cccCCCCCCEEEccCCccCccCchhhhcccccceeeeeccccc
Q 043333 58 AIPKAVASIS-------TLADLTLEFNQFSGDLPA--ELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFT 128 (809)
Q Consensus 58 ~ip~~l~~l~-------~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 128 (809)
.+|..++.++ +|+.|+|++|+++ .+|. .|+++++|++|+|++|+++ .+| .|+++++|+.|+|++|+++
T Consensus 532 ~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~ 608 (876)
T 4ecn_A 532 QLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE 608 (876)
T ss_dssp HHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS
T ss_pred cchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc
Confidence 4898887776 9999999999999 8888 9999999999999999999 888 9999999999999999999
Q ss_pred CcCchhhhcccc-cceEecccCcCCCCCCccccCCCC--CCEEeccCCCCCCCCCc---ccc--CCcCCceeeecccccc
Q 043333 129 GQIPDYIQNWTK-LEKLFIEGSGLAGPIPSGIASLVE--LTDLRISDLNGPEGPFP---RLS--NLKNMNYLILRSGNII 200 (809)
Q Consensus 129 ~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~l~~n~l~~~~~~---~l~--~l~~L~~L~Ls~N~l~ 200 (809)
.+|..+.++++ |+.|+|++|+++ .+|..+..+.. |+.|++++|.+....+. .+. .+++|+.|+|++|++.
T Consensus 609 -~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~ 686 (876)
T 4ecn_A 609 -EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ 686 (876)
T ss_dssp -CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC
T ss_pred -cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC
Confidence 89999999999 999999999999 88988877755 99999999999775432 222 4458999999999999
Q ss_pred CCCChhhhccccccEEeccCCCCCCCCCCCCCCC--------CccEEEeeCccCCCCCChhh---hhccCccccccCCcc
Q 043333 201 GEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGS--------GLTYMYLTGNLLTGPVPDWI---VRKRNKHIDLSYNNF 269 (809)
Q Consensus 201 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~--------~L~~L~Ls~N~l~~~~p~~~---~~~~l~~L~Ls~N~l 269 (809)
...+..+..+++|+.|+|++|+|+.+++..+... +|+.|+|++|+|+ .+|..+ ...+++.|+|++|++
T Consensus 687 ~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L 765 (876)
T 4ecn_A 687 KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF 765 (876)
T ss_dssp SCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCC
T ss_pred ccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCC
Confidence 6555556689999999999999997776666543 8999999999999 566655 457889999999999
Q ss_pred ccCCCCCcccccccceeccc
Q 043333 270 IDGSSDSNCENQSVNLFASS 289 (809)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~ 289 (809)
++ .|..+.....+..+..+
T Consensus 766 ~~-lp~~l~~L~~L~~L~Ls 784 (876)
T 4ecn_A 766 SS-FPTQPLNSSQLKAFGIR 784 (876)
T ss_dssp SS-CCCGGGGCTTCCEEECC
T ss_pred Cc-cchhhhcCCCCCEEECC
Confidence 98 46566665555555443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=273.60 Aligned_cols=270 Identities=22% Similarity=0.213 Sum_probs=229.7
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCC-chhhcCCccCcEEeeccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAI-PKAVASISTLADLTLEFNQF 79 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~i-p~~l~~l~~L~~L~L~~N~l 79 (809)
++++++++. .+|..+. ++|++|+|++|.+++..|..|..++ |+.|++++|.+..+ |..+..+++|++|+|++|++
T Consensus 38 l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 114 (332)
T 2ft3_A 38 VQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114 (332)
T ss_dssp EECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCC
T ss_pred EECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcC
Confidence 577888887 7787775 7899999999999988888898886 99999999999888 77899999999999999999
Q ss_pred ccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeeccccc--CcCchhhhcccccceEecccCcCCCCCCc
Q 043333 80 SGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFT--GQIPDYIQNWTKLEKLFIEGSGLAGPIPS 157 (809)
Q Consensus 80 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 157 (809)
+ .+|..+. ++|++|+|++|++++..+..|.++++|+.|+|++|.++ +..|..+..+ +|+.|++++|++++ +|.
T Consensus 115 ~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~ 189 (332)
T 2ft3_A 115 V-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPK 189 (332)
T ss_dssp C-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCS
T ss_pred C-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCc
Confidence 9 6676555 79999999999999777778999999999999999996 4677888888 99999999999995 666
Q ss_pred cccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCcc
Q 043333 158 GIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLT 237 (809)
Q Consensus 158 ~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~ 237 (809)
.+. ++|+.|++++|.+..+++..+.++++|+.|+|++|++.+..+..|..+++|+.|+|++|+|+.+++.....++|+
T Consensus 190 ~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~ 267 (332)
T 2ft3_A 190 DLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQ 267 (332)
T ss_dssp SSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCC
T ss_pred ccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCC
Confidence 554 799999999999999998999999999999999999999999999999999999999999996555443449999
Q ss_pred EEEeeCccCCCCCChhhhh-------ccCccccccCCccc--cCCCCCccccc
Q 043333 238 YMYLTGNLLTGPVPDWIVR-------KRNKHIDLSYNNFI--DGSSDSNCENQ 281 (809)
Q Consensus 238 ~L~Ls~N~l~~~~p~~~~~-------~~l~~L~Ls~N~l~--~~~~~~~~~~~ 281 (809)
.|+|++|++++..+..+.. ..++.|++++|++. +..+..+....
T Consensus 268 ~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~ 320 (332)
T 2ft3_A 268 VVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320 (332)
T ss_dssp EEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBC
T ss_pred EEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccc
Confidence 9999999999887776643 34678999999987 44444343333
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-29 Score=268.85 Aligned_cols=251 Identities=22% Similarity=0.256 Sum_probs=218.5
Q ss_pred CCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCch-hhcCCccCcEEeecccccccCCCccccCCCCCCEEEcc
Q 043333 21 PFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPK-AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLN 99 (809)
Q Consensus 21 ~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 99 (809)
.+|+.++++++.++ .+|..+. -.++.|++++|.+..++. .+.++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~-~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP-PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC-TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCCeEEEecCCCcc-ccCccCC-CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 47999999999998 5665544 247889999999999876 78999999999999999998889999999999999999
Q ss_pred CCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCC--CCCccccCCCCCCEEeccCCCCCC
Q 043333 100 SNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAG--PIPSGIASLVELTDLRISDLNGPE 177 (809)
Q Consensus 100 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~n~l~~ 177 (809)
+|+++ .+|..+. ++|++|++++|++++..+..|.++++|+.|+|++|.++. ..+..+..+++|+.|++++|.++.
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 99999 5666554 799999999999998888889999999999999999964 678889999999999999999998
Q ss_pred CCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhh-
Q 043333 178 GPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIV- 255 (809)
Q Consensus 178 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~- 255 (809)
++...+ ++|+.|+|++|++.+..|..|..+++|+.|+|++|++++.++..+.. ++|+.|+|++|+++ .+|..+.
T Consensus 186 l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 186 IPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp CCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred CCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 875543 78999999999999999999999999999999999999988877766 89999999999999 4555444
Q ss_pred hccCccccccCCccccCCCCCcccc
Q 043333 256 RKRNKHIDLSYNNFIDGSSDSNCEN 280 (809)
Q Consensus 256 ~~~l~~L~Ls~N~l~~~~~~~~~~~ 280 (809)
...++.|++++|++++.++..+|..
T Consensus 262 l~~L~~L~l~~N~i~~~~~~~f~~~ 286 (330)
T 1xku_A 262 HKYIQVVYLHNNNISAIGSNDFCPP 286 (330)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCS
T ss_pred CCCcCEEECCCCcCCccChhhcCCc
Confidence 4678999999999999888888754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=291.56 Aligned_cols=200 Identities=16% Similarity=0.171 Sum_probs=153.6
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc---ccchhHHHHHHHHhhcCC-Cce---------------E
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK---QGNREFVNEIGMISALQH-PNL---------------V 634 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H-~nI---------------v 634 (809)
..|...+.||+|+||.||+|.. .+|+.||||++..... ...+.|.+|+.+++.++| +|. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4566778999999999999995 4689999999874322 235778999999999987 221 1
Q ss_pred e------EEeEEEe-----CCeEEEEEEcccCCchhhhccCC---CccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 043333 635 K------LYGCCIE-----GNQLLLIYEYMENNSLARALFGP---EEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIV 700 (809)
Q Consensus 635 ~------l~~~~~~-----~~~~~lV~ey~~~gsL~~~L~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 700 (809)
. +..++.. ....+++|+++ +++|.+++... ......+++..+..++.|+++||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 1 1111111 12356777754 68999887311 12244578899999999999999999998 899
Q ss_pred EcCCCCCCEEEcCCCceEEEecCCccccCCCCcceeccccccccccchhhh----------ccCCCCchHHHHHHHHHHH
Q 043333 701 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYA----------MRGYLTDKADVYSFGIVAL 770 (809)
Q Consensus 701 H~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDVwSlGvil~ 770 (809)
||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998764432 334567 999999999 5556888999999999999
Q ss_pred HHHcCCCCCCCCC
Q 043333 771 EIVSGRSNVICRT 783 (809)
Q Consensus 771 elltGk~P~~~~~ 783 (809)
||++|+.||....
T Consensus 309 elltg~~Pf~~~~ 321 (413)
T 3dzo_A 309 WIWCADLPNTDDA 321 (413)
T ss_dssp HHHHSSCCCCTTG
T ss_pred HHHHCCCCCCCcc
Confidence 9999999997643
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-29 Score=270.21 Aligned_cols=260 Identities=22% Similarity=0.243 Sum_probs=220.1
Q ss_pred ccCCccCCCC------CCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCc-hhhcCCccCcEEeecccccccCC
Q 043333 11 GRLPPELTRL------PFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIP-KAVASISTLADLTLEFNQFSGDL 83 (809)
Q Consensus 11 ~~lp~~l~~l------~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip-~~l~~l~~L~~L~L~~N~l~~~~ 83 (809)
..+|+.+... .+|+.+++++|.++ .+|..+. -.++.|++++|.+..++ ..+.++++|++|+|++|++++..
T Consensus 17 ~~lp~~~~~~cp~~c~c~l~~l~~~~~~l~-~ip~~~~-~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 94 (332)
T 2ft3_A 17 DSLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS-PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIH 94 (332)
T ss_dssp --------CCCCSSCEEETTEEECCSSCCS-SCCSCCC-TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred ccCCCcccCCCCCCCcccCCEEECCCCCcc-ccCCCCC-CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccC
Confidence 3566655433 37999999999998 5666554 25889999999999885 48999999999999999999888
Q ss_pred CccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCC--CCCCccccC
Q 043333 84 PAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLA--GPIPSGIAS 161 (809)
Q Consensus 84 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~ 161 (809)
|..|+++++|++|+|++|+++ .+|..+. ++|++|+|++|++++..+..|.++++|+.|+|++|.++ +..|..+..
T Consensus 95 ~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~ 171 (332)
T 2ft3_A 95 EKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171 (332)
T ss_dssp GGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCS
T ss_pred HhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccC
Confidence 999999999999999999999 5666655 79999999999999777778999999999999999996 367888888
Q ss_pred CCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEE
Q 043333 162 LVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMY 240 (809)
Q Consensus 162 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~ 240 (809)
+ +|+.|++++|.++.++...+ ++|+.|+|++|.+.+..+..|..+++|+.|+|++|++++.++..+.. ++|+.|+
T Consensus 172 l-~L~~L~l~~n~l~~l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 247 (332)
T 2ft3_A 172 L-KLNYLRISEAKLTGIPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELH 247 (332)
T ss_dssp C-CCSCCBCCSSBCSSCCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEE
T ss_pred C-ccCEEECcCCCCCccCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEE
Confidence 8 99999999999999876543 78999999999999999999999999999999999999999877776 9999999
Q ss_pred eeCccCCCCCChhhh-hccCccccccCCccccCCCCCcccc
Q 043333 241 LTGNLLTGPVPDWIV-RKRNKHIDLSYNNFIDGSSDSNCEN 280 (809)
Q Consensus 241 Ls~N~l~~~~p~~~~-~~~l~~L~Ls~N~l~~~~~~~~~~~ 280 (809)
|++|+++ .+|..+. ...++.|++++|++++.++..++..
T Consensus 248 L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~ 287 (332)
T 2ft3_A 248 LDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPV 287 (332)
T ss_dssp CCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCS
T ss_pred CCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccc
Confidence 9999999 5555454 4678999999999999888877754
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=269.60 Aligned_cols=276 Identities=18% Similarity=0.203 Sum_probs=237.9
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCC---chhhcCCccCcEEeeccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAI---PKAVASISTLADLTLEFN 77 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~i---p~~l~~l~~L~~L~L~~N 77 (809)
++++++++. .+|..+. ++|++|+|++|+++...+..|..++ |+.|++++|.+..+ |..+..+++|++|+|++|
T Consensus 12 l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n 88 (306)
T 2z66_A 12 IRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88 (306)
T ss_dssp EECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSC
T ss_pred EEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCC
Confidence 567777777 7777665 7899999999999966666678885 99999999999876 678888999999999999
Q ss_pred ccccCCCccccCCCCCCEEEccCCccCccCc-hhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCC-CC
Q 043333 78 QFSGDLPAELGNLINLEKLHLNSNNFTGKLP-ESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAG-PI 155 (809)
Q Consensus 78 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~ 155 (809)
.++ .+|..+..+++|++|+|++|++++..+ ..+.++++|++|+|++|.+.+..+..+.++++|++|+|++|++++ .+
T Consensus 89 ~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 167 (306)
T 2z66_A 89 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 167 (306)
T ss_dssp SEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEE
T ss_pred ccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccc
Confidence 999 577789999999999999999996655 589999999999999999998899999999999999999999987 57
Q ss_pred CccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC--
Q 043333 156 PSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-- 233 (809)
Q Consensus 156 p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-- 233 (809)
|..+..+++|+.|++++|.++.+.+..+.++++|+.|+|++|++++..+..+..+++|+.|+|++|++++.+|..+..
T Consensus 168 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 247 (306)
T 2z66_A 168 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 247 (306)
T ss_dssp CSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCC
T ss_pred hhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhh
Confidence 899999999999999999999998899999999999999999999999989999999999999999999999988776
Q ss_pred CCccEEEeeCccCCCCCCh-h-hhh-ccCccccccCCccccCCCCCccccc
Q 043333 234 SGLTYMYLTGNLLTGPVPD-W-IVR-KRNKHIDLSYNNFIDGSSDSNCENQ 281 (809)
Q Consensus 234 ~~L~~L~Ls~N~l~~~~p~-~-~~~-~~l~~L~Ls~N~l~~~~~~~~~~~~ 281 (809)
++|+.|+|++|++++..+. . ... ...+.+.+..+.+.|..|..+.+..
T Consensus 248 ~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g~~ 298 (306)
T 2z66_A 248 SSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 298 (306)
T ss_dssp TTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTTCB
T ss_pred ccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCCce
Confidence 4899999999999875431 1 121 2345666777888887766655433
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=296.84 Aligned_cols=135 Identities=25% Similarity=0.297 Sum_probs=96.5
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCC-chhhcCCccCcEEeecccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAI-PKAVASISTLADLTLEFNQ 78 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~i-p~~l~~l~~L~~L~L~~N~ 78 (809)
+|+|++|++.+..+..|.++++|++|+|++|.+++..|..|..++ |+.|++++|.+..+ |..+.++++|++|+|++|.
T Consensus 36 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~ 115 (606)
T 3vq2_A 36 NIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115 (606)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSC
T ss_pred EEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCc
Confidence 367777777777776777777777777777777776677777765 77777777777666 6677777777777777777
Q ss_pred cccCCCccccCCCCCCEEEccCCccCc-cCchhhhcccccceeeeecccccCcCchhh
Q 043333 79 FSGDLPAELGNLINLEKLHLNSNNFTG-KLPESFANLTRLKHFRISDNHFTGQIPDYI 135 (809)
Q Consensus 79 l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 135 (809)
+++..+..|+++++|++|+|++|++++ .+|..|+++++|++|+|++|++++..|..|
T Consensus 116 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 173 (606)
T 3vq2_A 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDL 173 (606)
T ss_dssp CCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTT
T ss_pred cccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhh
Confidence 775555667777777777777777765 457777777777777777777665555433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-29 Score=303.13 Aligned_cols=283 Identities=20% Similarity=0.213 Sum_probs=193.8
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCC-CcccCCCC-ccccccccccCCCC-chhhcCCccCcEEeeccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTI-PSEWASLP-LVNLPLWKQANGAI-PKAVASISTLADLTLEFN 77 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~-L~~L~l~~n~~~~i-p~~l~~l~~L~~L~L~~N 77 (809)
+|+|++|++.+..|..|.++++|++|||++|.+.+.+ |..|..++ |+.|++++|.+..+ |..|.++++|++|+|++|
T Consensus 28 ~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n 107 (844)
T 3j0a_A 28 RLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107 (844)
T ss_dssp EEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTC
T ss_pred EEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCC
Confidence 4789999999888899999999999999999665555 77788886 88999999888877 778899999999999999
Q ss_pred ccccCCCcc--ccCCCCCCEEEccCCccCccCc-hhhhcccccceeeeecccccCcCchhhhcc--cccceEecccCcCC
Q 043333 78 QFSGDLPAE--LGNLINLEKLHLNSNNFTGKLP-ESFANLTRLKHFRISDNHFTGQIPDYIQNW--TKLEKLFIEGSGLA 152 (809)
Q Consensus 78 ~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~ 152 (809)
.+++.+|.. |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..+..+ ++|+.|+|++|.+.
T Consensus 108 ~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~ 187 (844)
T 3j0a_A 108 GLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY 187 (844)
T ss_dssp CCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSC
T ss_pred CCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccc
Confidence 998766654 8889999999999999987654 578899999999999999988888888777 67777777777777
Q ss_pred CCCCccccCCCC------CCEEeccCCCCCCCCCccc------------------------------------cC--CcC
Q 043333 153 GPIPSGIASLVE------LTDLRISDLNGPEGPFPRL------------------------------------SN--LKN 188 (809)
Q Consensus 153 ~~~p~~~~~l~~------L~~L~l~~n~l~~~~~~~l------------------------------------~~--l~~ 188 (809)
+..|..+..+.+ |+.|++++|.+....+..+ .+ .++
T Consensus 188 ~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~ 267 (844)
T 3j0a_A 188 SRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSS 267 (844)
T ss_dssp CCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSC
T ss_pred cccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCC
Confidence 666655554443 6666666664432221111 11 134
Q ss_pred CceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhh-ccCccccccC
Q 043333 189 MNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSY 266 (809)
Q Consensus 189 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~ 266 (809)
|+.|+|++|.+.+..|..|..+++|+.|+|++|++++..|..+.. ++|+.|+|++|++++..|..+.. ..++.|++++
T Consensus 268 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 347 (844)
T 3j0a_A 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347 (844)
T ss_dssp CCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCS
T ss_pred ccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCC
Confidence 555555555555555555555555555555555555555555444 55555555555555554444433 3445555555
Q ss_pred CccccCCCCCccccccc
Q 043333 267 NNFIDGSSDSNCENQSV 283 (809)
Q Consensus 267 N~l~~~~~~~~~~~~~~ 283 (809)
|++...++..+.....+
T Consensus 348 N~i~~~~~~~~~~l~~L 364 (844)
T 3j0a_A 348 NHIAIIQDQTFKFLEKL 364 (844)
T ss_dssp CCCCCCCSSCSCSCCCC
T ss_pred CCCCccChhhhcCCCCC
Confidence 55555444444333333
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-29 Score=267.90 Aligned_cols=174 Identities=21% Similarity=0.340 Sum_probs=149.2
Q ss_pred cCCCCC-CeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHH-hhcCCCceEeEEeEEEe----CCeEE
Q 043333 575 NNFAPD-NKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMI-SALQHPNLVKLYGCCIE----GNQLL 647 (809)
Q Consensus 575 ~~f~~~-~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l-~~l~H~nIv~l~~~~~~----~~~~~ 647 (809)
++|... +.||+|+||.||+|.. .+++.||||++.. ...+.+|++++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 7799999999999986 4689999999853 34577888888 55689999999999987 66789
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCceEEEecCC
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGL 724 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGl 724 (809)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 999999999999999542 234689999999999999999999998 8999999999999998 78999999999
Q ss_pred ccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
+..... ..++.++|||||||++|||++|+.||..
T Consensus 167 a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~ 200 (299)
T 3m2w_A 167 AKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYS 200 (299)
T ss_dssp CEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 864321 2357789999999999999999999964
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=286.98 Aligned_cols=278 Identities=15% Similarity=0.100 Sum_probs=216.2
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCC-CccccccccccCCCCc--hhhcCCccCcEEeeccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASL-PLVNLPLWKQANGAIP--KAVASISTLADLTLEFN 77 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l-~L~~L~l~~n~~~~ip--~~l~~l~~L~~L~L~~N 77 (809)
+|+|++|++.+..|..|..+++|++|||++|+|+ .+|.. .+ .|+.|++++|.+..+| ..+.++++|++|+|++|
T Consensus 80 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n 156 (562)
T 3a79_B 80 VLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAA 156 (562)
T ss_dssp EEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECS
T ss_pred EEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCC
Confidence 4789999999999999999999999999999999 56665 44 4999999999998875 79999999999999999
Q ss_pred ccccCCCccccCCCCC--CEEEccCCcc--CccCchhhhccc--------------------------------------
Q 043333 78 QFSGDLPAELGNLINL--EKLHLNSNNF--TGKLPESFANLT-------------------------------------- 115 (809)
Q Consensus 78 ~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~l~-------------------------------------- 115 (809)
++++. .+..+++| ++|+|++|++ ++..|..+..+.
T Consensus 157 ~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~ 233 (562)
T 3a79_B 157 KFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE 233 (562)
T ss_dssp BCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCST
T ss_pred ccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEeccccccc
Confidence 99853 34444454 8888888888 666665555433
Q ss_pred -------------------------------------------ccceeeeecccccCcCchhh-----------------
Q 043333 116 -------------------------------------------RLKHFRISDNHFTGQIPDYI----------------- 135 (809)
Q Consensus 116 -------------------------------------------~L~~L~Ls~N~l~~~~p~~~----------------- 135 (809)
+|++|++++|+++|.+|..+
T Consensus 234 ~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~ 313 (562)
T 3a79_B 234 NCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVK 313 (562)
T ss_dssp THHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEE
T ss_pred ccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcc
Confidence 67777777888877776554
Q ss_pred ------------------------------------hcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCC
Q 043333 136 ------------------------------------QNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGP 179 (809)
Q Consensus 136 ------------------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~ 179 (809)
..+++|++|+|++|++++.+|..+..+++|+.|++++|+++.++
T Consensus 314 ~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 393 (562)
T 3a79_B 314 NQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFF 393 (562)
T ss_dssp ECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTT
T ss_pred cceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcc
Confidence 56788899999999998888888888999999999999888766
Q ss_pred C--ccccCCcCCceeeeccccccCCCCh-hhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhh
Q 043333 180 F--PRLSNLKNMNYLILRSGNIIGEMPE-YLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVR 256 (809)
Q Consensus 180 ~--~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~ 256 (809)
. ..+.++++|++|+|++|++.+.+|. .+..+++|+.|+|++|++++..|..+. ++|+.|+|++|+++..++..+..
T Consensus 394 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~-~~L~~L~L~~N~l~~ip~~~~~l 472 (562)
T 3a79_B 394 KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP-PKVKVLDLHNNRIMSIPKDVTHL 472 (562)
T ss_dssp HHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC-TTCSEEECCSSCCCCCCTTTTSS
T ss_pred cchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc-CcCCEEECCCCcCcccChhhcCC
Confidence 3 4578888999999999998885554 577888888888888888776666544 67888888888888544445544
Q ss_pred ccCccccccCCccccCCCCCcccccccce
Q 043333 257 KRNKHIDLSYNNFIDGSSDSNCENQSVNL 285 (809)
Q Consensus 257 ~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~ 285 (809)
..++.|+|++|+++..++..+.....+..
T Consensus 473 ~~L~~L~L~~N~l~~l~~~~~~~l~~L~~ 501 (562)
T 3a79_B 473 QALQELNVASNQLKSVPDGVFDRLTSLQY 501 (562)
T ss_dssp CCCSEEECCSSCCCCCCTTSTTTCTTCCC
T ss_pred CCCCEEECCCCCCCCCCHHHHhcCCCCCE
Confidence 66788888888888655443444444433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=285.27 Aligned_cols=280 Identities=17% Similarity=0.115 Sum_probs=213.3
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCC--CchhhcCCccCcEEeecccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGA--IPKAVASISTLADLTLEFNQ 78 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~--ip~~l~~l~~L~~L~L~~N~ 78 (809)
+|+|++|++.+..|..|..+++|++|||++|+|+ .+|.. ..-.|+.|++++|.+.. +|..++++++|++|+|++|.
T Consensus 49 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~-~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~ 126 (520)
T 2z7x_B 49 ILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH-PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTH 126 (520)
T ss_dssp EEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC-CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESS
T ss_pred EEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc-ccCCccEEeccCCccccccchhhhccCCcceEEEecCcc
Confidence 4789999999988999999999999999999999 56655 33349999999999986 57899999999999999999
Q ss_pred cccCCCccccCCCCC--CEEEccCCcc--CccCchhhhccc---------------------------------------
Q 043333 79 FSGDLPAELGNLINL--EKLHLNSNNF--TGKLPESFANLT--------------------------------------- 115 (809)
Q Consensus 79 l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~l~--------------------------------------- 115 (809)
+++ ..+..+++| ++|+|++|++ ++..|..+..+.
T Consensus 127 l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 203 (520)
T 2z7x_B 127 LEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLED 203 (520)
T ss_dssp CCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCST
T ss_pred cch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccc
Confidence 874 344555555 6666666666 444444443322
Q ss_pred --------------------------------------------ccceeeeecccccCcCchhh----------------
Q 043333 116 --------------------------------------------RLKHFRISDNHFTGQIPDYI---------------- 135 (809)
Q Consensus 116 --------------------------------------------~L~~L~Ls~N~l~~~~p~~~---------------- 135 (809)
+|++|++++|+++|.+|..+
T Consensus 204 ~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l 283 (520)
T 2z7x_B 204 NKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQV 283 (520)
T ss_dssp TTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEE
T ss_pred cccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccc
Confidence 45555666666555554433
Q ss_pred -------------------------------------hcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCC
Q 043333 136 -------------------------------------QNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEG 178 (809)
Q Consensus 136 -------------------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~ 178 (809)
..+++|++|+|++|++++.+|..+..+++|+.|++++|+++.+
T Consensus 284 ~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 363 (520)
T 2z7x_B 284 VSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKEL 363 (520)
T ss_dssp EECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBH
T ss_pred cccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCcc
Confidence 5678899999999999988899999999999999999999875
Q ss_pred CC--ccccCCcCCceeeeccccccCCCCh-hhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhh
Q 043333 179 PF--PRLSNLKNMNYLILRSGNIIGEMPE-YLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIV 255 (809)
Q Consensus 179 ~~--~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 255 (809)
+. ..+.++++|++|+|++|++.+.+|. .+..+++|+.|+|++|++++..|..+. ++|+.|+|++|+++..++....
T Consensus 364 ~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-~~L~~L~Ls~N~l~~ip~~~~~ 442 (520)
T 2z7x_B 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP-PRIKVLDLHSNKIKSIPKQVVK 442 (520)
T ss_dssp HHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC-TTCCEEECCSSCCCCCCGGGGG
T ss_pred ccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc-ccCCEEECCCCcccccchhhhc
Confidence 43 4588899999999999999986665 478888999999999999877776554 7889999999998844444445
Q ss_pred hccCccccccCCccccCCCCCccccccccee
Q 043333 256 RKRNKHIDLSYNNFIDGSSDSNCENQSVNLF 286 (809)
Q Consensus 256 ~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~ 286 (809)
...++.|+|++|+++..+...+.....+..+
T Consensus 443 l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L 473 (520)
T 2z7x_B 443 LEALQELNVASNQLKSVPDGIFDRLTSLQKI 473 (520)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCcCCccCHHHhccCCcccEE
Confidence 5677888999998886655435444444443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-28 Score=292.55 Aligned_cols=284 Identities=17% Similarity=0.191 Sum_probs=181.7
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCch-hhcCCccCcEEeeccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPK-AVASISTLADLTLEFNQF 79 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~-~l~~l~~L~~L~L~~N~l 79 (809)
|+|++|++.+..+..|.++++|++|+|++|.+++..|..|..++ |+.|++++|.+..+|. .|.++++|++|+|++|++
T Consensus 30 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l 109 (680)
T 1ziw_A 30 LNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSI 109 (680)
T ss_dssp EECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCC
T ss_pred EECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCcc
Confidence 56777777766666677777777777777777766666666664 7777777777777765 467777777777777777
Q ss_pred ccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhh--cccccceEecccCcCCCCCCc
Q 043333 80 SGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQ--NWTKLEKLFIEGSGLAGPIPS 157 (809)
Q Consensus 80 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~ 157 (809)
++..|..|+++++|++|+|++|++++..|..++++++|++|+|++|.+++..+..+. .+++|+.|+|++|++++..|.
T Consensus 110 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~ 189 (680)
T 1ziw_A 110 QKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPG 189 (680)
T ss_dssp CCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTT
T ss_pred CccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChh
Confidence 755556677777777777777777766666677777777777777777766665554 346777777777777766666
Q ss_pred cccCC---------------------------CCCCEEeccCCCCCCCCCccccCCcC--CceeeeccccccCCCChhhh
Q 043333 158 GIASL---------------------------VELTDLRISDLNGPEGPFPRLSNLKN--MNYLILRSGNIIGEMPEYLG 208 (809)
Q Consensus 158 ~~~~l---------------------------~~L~~L~l~~n~l~~~~~~~l~~l~~--L~~L~Ls~N~l~~~~p~~~~ 208 (809)
.+..+ ++|+.|++++|.+....+..+.+++. |+.|+|++|++.+..|..|.
T Consensus 190 ~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~ 269 (680)
T 1ziw_A 190 CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFA 269 (680)
T ss_dssp GGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTT
T ss_pred hhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCccccc
Confidence 55543 34455555555555555555555543 66666666666666666666
Q ss_pred ccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCC-----CCh----hhh-hccCccccccCCccccCCCCCc
Q 043333 209 QMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGP-----VPD----WIV-RKRNKHIDLSYNNFIDGSSDSN 277 (809)
Q Consensus 209 ~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~-----~p~----~~~-~~~l~~L~Ls~N~l~~~~~~~~ 277 (809)
.+++|+.|+|++|++++.+|..+.. ++|+.|+|++|...+. +|. .+. ...++.|++++|.+++..+..+
T Consensus 270 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 349 (680)
T 1ziw_A 270 WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMF 349 (680)
T ss_dssp TCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTT
T ss_pred CcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHh
Confidence 6666666666666666666655555 6666666666544431 121 121 2455667777777766655555
Q ss_pred ccccccce
Q 043333 278 CENQSVNL 285 (809)
Q Consensus 278 ~~~~~~~~ 285 (809)
.....+..
T Consensus 350 ~~l~~L~~ 357 (680)
T 1ziw_A 350 TGLINLKY 357 (680)
T ss_dssp TTCTTCCE
T ss_pred ccccCCcE
Confidence 44444333
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=276.87 Aligned_cols=226 Identities=20% Similarity=0.188 Sum_probs=105.7
Q ss_pred CCEEEccCCCCCCCCCcccCCCCccccccccccCCCCc-hhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCC
Q 043333 23 LQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIP-KAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSN 101 (809)
Q Consensus 23 L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 101 (809)
.+.++.+++.++ .+|..+. -.++.|++++|.+..++ ..|.++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~-~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS-TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC-TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CCEEEeCCCCcC-cCCCCCC-CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 345555555555 3333322 12344444444444443 34444555555555555554444444455555555555555
Q ss_pred ccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccC-cCCCCCCccccCCCCCCEEeccCCCCCCCCC
Q 043333 102 NFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGS-GLAGPIPSGIASLVELTDLRISDLNGPEGPF 180 (809)
Q Consensus 102 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~ 180 (809)
+|+...+..|.++++|++|+|++|+|+...+..|.++++|+.|+|++| .+....+..|.++++|+.|++++|.++.++
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~- 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP- 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC-
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc-
Confidence 555433334444555555555555554444444444555555555542 222222234444555555555555444433
Q ss_pred ccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCCh
Q 043333 181 PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPD 252 (809)
Q Consensus 181 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~ 252 (809)
.+..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|+++.+..|.. ++|+.|+|++|+|++.++.
T Consensus 202 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 273 (440)
T 3zyj_A 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHD 273 (440)
T ss_dssp -CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTT
T ss_pred -ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChh
Confidence 2444445555555555554444444555555555555555555444444443 4455555555544443333
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=271.83 Aligned_cols=261 Identities=17% Similarity=0.170 Sum_probs=222.6
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchh-hcCCccCcEEeecccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKA-VASISTLADLTLEFNQ 78 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~-l~~l~~L~~L~L~~N~ 78 (809)
+|+|++|++.+..+..|..+++|++|+|++|.+++..|..|..++ |+.|++++|.+..+|.. +..+++|++|+|++|.
T Consensus 73 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~ 152 (390)
T 3o6n_A 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN 152 (390)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCc
Confidence 478999999988888999999999999999999988888898886 99999999999999986 5899999999999999
Q ss_pred cccCCCccccCCCCCCEEEccCCccCccCchhhhccccc-------------------ceeeeecccccCcCchhhhccc
Q 043333 79 FSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRL-------------------KHFRISDNHFTGQIPDYIQNWT 139 (809)
Q Consensus 79 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-------------------~~L~Ls~N~l~~~~p~~~~~l~ 139 (809)
+++..+..|..+++|++|+|++|++++.. +..+++| +.|++++|.+... |.. ..+
T Consensus 153 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~-~~~--~~~ 226 (390)
T 3o6n_A 153 LERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVV-RGP--VNV 226 (390)
T ss_dssp CCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEE-ECC--CCS
T ss_pred cCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeecccccccccCCCCcceEEECCCCeeeec-ccc--ccc
Confidence 99888888999999999999999999653 3444444 4455555555422 222 246
Q ss_pred ccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEecc
Q 043333 140 KLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLS 219 (809)
Q Consensus 140 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 219 (809)
+|+.|+|++|++++. ..+..+++|+.|++++|.+..+.+..|.++++|+.|+|++|++++. |..+..+++|+.|+|+
T Consensus 227 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~L~ 303 (390)
T 3o6n_A 227 ELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLS 303 (390)
T ss_dssp SCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEE-ECSSSCCTTCCEEECC
T ss_pred cccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCccc-CcccCCCCCCCEEECC
Confidence 899999999999964 6789999999999999999999889999999999999999999874 5566889999999999
Q ss_pred CCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhhccCccccccCCccccC
Q 043333 220 FNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDG 272 (809)
Q Consensus 220 ~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~ 272 (809)
+|+++++++.....++|+.|+|++|+++..... ....++.|++++|+|.|.
T Consensus 304 ~n~l~~~~~~~~~l~~L~~L~L~~N~i~~~~~~--~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 304 HNHLLHVERNQPQFDRLENLYLDHNSIVTLKLS--THHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp SSCCCCCGGGHHHHTTCSEEECCSSCCCCCCCC--TTCCCSEEECCSSCEEHH
T ss_pred CCcceecCccccccCcCCEEECCCCccceeCch--hhccCCEEEcCCCCccch
Confidence 999997766544449999999999999976433 235789999999999874
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-28 Score=272.66 Aligned_cols=243 Identities=18% Similarity=0.186 Sum_probs=219.5
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCc-hhhcCCccCcEEeeccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIP-KAVASISTLADLTLEFNQF 79 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip-~~l~~l~~L~~L~L~~N~l 79 (809)
++.+++++. .+|..+. ++++.|+|++|+|+...+..|..++ |+.|++++|.+..++ ..|.++++|++|+|++|++
T Consensus 48 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 48 VICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp EECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred EEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 345666666 7888776 7899999999999988889999986 999999999999886 5889999999999999999
Q ss_pred ccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeeccc-ccCcCchhhhcccccceEecccCcCCCCCCcc
Q 043333 80 SGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH-FTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSG 158 (809)
Q Consensus 80 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 158 (809)
++..+..|..+++|++|+|++|+|+...+..|.++++|+.|+|++|. +....+..|.++++|+.|+|++|+++ .+| .
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~ 202 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-N 202 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-C
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-c
Confidence 97666789999999999999999998878899999999999999954 55444557999999999999999999 555 4
Q ss_pred ccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCcc
Q 043333 159 IASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLT 237 (809)
Q Consensus 159 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~ 237 (809)
+..+++|+.|++++|.++.+.+..|.++++|+.|+|++|++.+..+..|.++++|+.|+|++|+|+++++..+.. ++|+
T Consensus 203 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 282 (440)
T 3zyj_A 203 LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLE 282 (440)
T ss_dssp CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCC
T ss_pred cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCC
Confidence 889999999999999999999999999999999999999999999999999999999999999999999988876 9999
Q ss_pred EEEeeCccCCCC
Q 043333 238 YMYLTGNLLTGP 249 (809)
Q Consensus 238 ~L~Ls~N~l~~~ 249 (809)
.|+|++|++...
T Consensus 283 ~L~L~~Np~~Cd 294 (440)
T 3zyj_A 283 RIHLHHNPWNCN 294 (440)
T ss_dssp EEECCSSCEECS
T ss_pred EEEcCCCCccCC
Confidence 999999998753
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-28 Score=274.28 Aligned_cols=246 Identities=18% Similarity=0.163 Sum_probs=204.2
Q ss_pred CCEEEccCCCCCCCCCcccCCCCccccccccccCCCC-chhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCC
Q 043333 23 LQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAI-PKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSN 101 (809)
Q Consensus 23 L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~i-p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 101 (809)
...++.+++.++ .+|..+. -.++.|++++|.+..+ |..|.++++|+.|+|++|++++..+..|.++++|++|+|++|
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~-~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP-SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC-TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CcEEEECCCCcC-ccCCCCC-CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 567777777777 4555443 2367778888777776 457888899999999999999888888999999999999999
Q ss_pred ccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccC-cCCCCCCccccCCCCCCEEeccCCCCCCCCC
Q 043333 102 NFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGS-GLAGPIPSGIASLVELTDLRISDLNGPEGPF 180 (809)
Q Consensus 102 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~ 180 (809)
+|++..+..|.++++|++|+|++|+|+...+..|.++++|+.|+|++| .+....+..|..+++|+.|++++|.+..++
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~- 212 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP- 212 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCC-
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccc-
Confidence 999777777888999999999999998777778889999999999984 455444457888999999999999988764
Q ss_pred ccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhh-cc
Q 043333 181 PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR-KR 258 (809)
Q Consensus 181 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~ 258 (809)
.+..+++|+.|+|++|++.+..|..|.++++|+.|+|++|++++..+..+.. ++|+.|+|++|+|++.++..+.. .+
T Consensus 213 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 291 (452)
T 3zyi_A 213 -NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRY 291 (452)
T ss_dssp -CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTT
T ss_pred -cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccC
Confidence 5888899999999999999999999999999999999999999888888876 89999999999999877776654 56
Q ss_pred CccccccCCccccC
Q 043333 259 NKHIDLSYNNFIDG 272 (809)
Q Consensus 259 l~~L~Ls~N~l~~~ 272 (809)
++.|+|++|+|.|.
T Consensus 292 L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 292 LVELHLHHNPWNCD 305 (452)
T ss_dssp CCEEECCSSCEECS
T ss_pred CCEEEccCCCcCCC
Confidence 78999999999875
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=278.37 Aligned_cols=254 Identities=19% Similarity=0.207 Sum_probs=225.5
Q ss_pred ccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecc
Q 043333 46 LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN 125 (809)
Q Consensus 46 L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 125 (809)
...++..++.+..+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp SCEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CcEEEECCCCcCccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 4567788888999998765 68999999999999888999999999999999999999988899999999999999999
Q ss_pred cccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccC-CCCCCCCCccccCCcCCceeeeccccccCCCC
Q 043333 126 HFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD-LNGPEGPFPRLSNLKNMNYLILRSGNIIGEMP 204 (809)
Q Consensus 126 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 204 (809)
+|++..+..|.++++|++|+|++|+++...+..|..+++|+.|++++ |.+..++...|.++++|++|+|++|++.+. |
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~ 212 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P 212 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c
Confidence 99987778899999999999999999977778999999999999998 677778888899999999999999999876 3
Q ss_pred hhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhh-ccCccccccCCccccCCCCCcccccc
Q 043333 205 EYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDGSSDSNCENQS 282 (809)
Q Consensus 205 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~~~~~~~~~~~ 282 (809)
.+..+++|+.|+|++|+|++..|..+.. ++|+.|+|++|++++..|..+.. .+++.|+|++|+++..++..+..
T Consensus 213 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--- 288 (452)
T 3zyi_A 213 -NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP--- 288 (452)
T ss_dssp -CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT---
T ss_pred -cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc---
Confidence 4889999999999999999999998887 99999999999999998887765 67899999999999776554432
Q ss_pred cceeccccCCCCCCccccccccCCCCCCCcceeecCCCceee
Q 043333 283 VNLFASSSEGSNSTGIVSCLKSFTCPTNHSSLHINCGGKQVI 324 (809)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~~C~~~~~~ 324 (809)
+.+.......+|||.|||.+.++.
T Consensus 289 ------------------l~~L~~L~L~~Np~~CdC~~~~l~ 312 (452)
T 3zyi_A 289 ------------------LRYLVELHLHHNPWNCDCDILWLA 312 (452)
T ss_dssp ------------------CTTCCEEECCSSCEECSTTTHHHH
T ss_pred ------------------ccCCCEEEccCCCcCCCCCchHHH
Confidence 233445567899999999988753
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=284.20 Aligned_cols=287 Identities=18% Similarity=0.158 Sum_probs=210.6
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCC--chhhcCCccCcEEeeccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAI--PKAVASISTLADLTLEFN 77 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~i--p~~l~~l~~L~~L~L~~N 77 (809)
+|+|++|++.+..|..|..+++|++|+|++|++++..|..|..++ |+.|++++|.+..+ |..+.++++|++|+|++|
T Consensus 54 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n 133 (549)
T 2z81_A 54 VLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNV 133 (549)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEES
T ss_pred EEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCC
Confidence 478888888888888888888888888888888877777677775 88888888888743 567777888888888888
Q ss_pred ccccCCC-ccccCCCCCCEEEccCCccCccCchhhhc------------------------ccccceeeeecccccCc--
Q 043333 78 QFSGDLP-AELGNLINLEKLHLNSNNFTGKLPESFAN------------------------LTRLKHFRISDNHFTGQ-- 130 (809)
Q Consensus 78 ~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------------------------l~~L~~L~Ls~N~l~~~-- 130 (809)
.+.+.+| ..|.++++|++|+|++|++++..|..+++ +++|+.|+|++|++++.
T Consensus 134 ~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 213 (549)
T 2z81_A 134 ETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQF 213 (549)
T ss_dssp SSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCC
T ss_pred ccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccc
Confidence 7433443 46777777777777777777665555433 44555666666655541
Q ss_pred --------------------------------------------------------------------------------
Q 043333 131 -------------------------------------------------------------------------------- 130 (809)
Q Consensus 131 -------------------------------------------------------------------------------- 130 (809)
T Consensus 214 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i 293 (549)
T 2z81_A 214 SPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHI 293 (549)
T ss_dssp CCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBC
T ss_pred cccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhccccccccccccc
Confidence
Q ss_pred -------------------------------Cchhh-hcccccceEecccCcCCCCCC---ccccCCCCCCEEeccCCCC
Q 043333 131 -------------------------------IPDYI-QNWTKLEKLFIEGSGLAGPIP---SGIASLVELTDLRISDLNG 175 (809)
Q Consensus 131 -------------------------------~p~~~-~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~l~~n~l 175 (809)
+|..+ ..+++|+.|+|++|++++.+| ..+..+++|+.|++++|++
T Consensus 294 ~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l 373 (549)
T 2z81_A 294 PQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373 (549)
T ss_dssp SCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCC
T ss_pred chhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcc
Confidence 23333 468899999999999987664 3467888999999999988
Q ss_pred CCCCC--ccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCC------------------CCCC
Q 043333 176 PEGPF--PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNF------------------SGSG 235 (809)
Q Consensus 176 ~~~~~--~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~------------------~~~~ 235 (809)
+.++. ..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|+.++.... ..++
T Consensus 374 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~ 452 (549)
T 2z81_A 374 RSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPR 452 (549)
T ss_dssp CCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCCCCTT
T ss_pred cccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhhhcccCCh
Confidence 87754 45788888999999888887 567777777778888777777765433211 2378
Q ss_pred ccEEEeeCccCCCCCChhhhhccCccccccCCccccCCCCCcccccccceeccc
Q 043333 236 LTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASS 289 (809)
Q Consensus 236 L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~ 289 (809)
|+.|+|++|+|+ .+|.......++.|+|++|++++.++..+.....+..+..+
T Consensus 453 L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 505 (549)
T 2z81_A 453 LQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLH 505 (549)
T ss_dssp CCEEECCSSCCS-SCCCGGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECC
T ss_pred hcEEECCCCccC-cCCCcccCccCCEEecCCCccCCcCHHHHhcCcccCEEEec
Confidence 999999999998 45555455778999999999998887767666555555443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=258.08 Aligned_cols=254 Identities=17% Similarity=0.172 Sum_probs=199.4
Q ss_pred CEEEccCCCCCCCCCcccCCCCccccccccccCCCCch-hhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCc
Q 043333 24 QEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPK-AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNN 102 (809)
Q Consensus 24 ~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 102 (809)
++++++++.++ .+|..+. -.++.|++++|.+..+|. .+..+++|++|+|++|.+++..|..|..+++|++|+|++|+
T Consensus 14 ~~~~c~~~~l~-~ip~~~~-~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 91 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGIP-AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (285)
T ss_dssp CEEECCSSCCS-SCCTTCC-TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred eEEEcCcCCcc-cCCcCCC-CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCC
Confidence 45666666665 3333221 135555666666655553 56778899999999999987778888889999999999997
Q ss_pred -cCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCc
Q 043333 103 -FTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181 (809)
Q Consensus 103 -l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~ 181 (809)
++...|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|++++|.++.++..
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 171 (285)
T 1ozn_A 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (285)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred CccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHH
Confidence 7766688888899999999999999887788888899999999999999877777788899999999999999888888
Q ss_pred cccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhhccCc
Q 043333 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRNK 260 (809)
Q Consensus 182 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~~~l~ 260 (809)
.+.++++|+.|+|++|.+.+..|..|..+++|+.|+|++|++++.++..+.. ++|+.|+|++|++++..+.......++
T Consensus 172 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~ 251 (285)
T 1ozn_A 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQ 251 (285)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHH
T ss_pred HhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHH
Confidence 8888999999999999999888889999999999999999999887776665 889999999999887655432223445
Q ss_pred cccccCCccccCCCCCccc
Q 043333 261 HIDLSYNNFIDGSSDSNCE 279 (809)
Q Consensus 261 ~L~Ls~N~l~~~~~~~~~~ 279 (809)
.+..+.|.+.|..|..+.+
T Consensus 252 ~~~~~~~~~~c~~p~~l~g 270 (285)
T 1ozn_A 252 KFRGSSSEVPCSLPQRLAG 270 (285)
T ss_dssp HCCSEECCCBEEESGGGTT
T ss_pred hcccccCccccCCchHhCC
Confidence 6667778887776655443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-28 Score=285.24 Aligned_cols=262 Identities=18% Similarity=0.176 Sum_probs=223.7
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchh-hcCCccCcEEeecccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKA-VASISTLADLTLEFNQ 78 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~-l~~l~~L~~L~L~~N~ 78 (809)
+|+|++|++.+..|..|..+++|++|+|++|.+++..|..|..++ |+.|++++|.+..+|.. +.++++|++|+|++|.
T Consensus 79 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~ 158 (597)
T 3oja_B 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN 158 (597)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCc
Confidence 478999999998889999999999999999999998888899886 99999999999999886 5899999999999999
Q ss_pred cccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccC------------------cCchhhhcccc
Q 043333 79 FSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTG------------------QIPDYIQNWTK 140 (809)
Q Consensus 79 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~------------------~~p~~~~~l~~ 140 (809)
+++..|..|+++++|++|+|++|++++.. +..+++|+.|++++|.+++ .++..+ .++
T Consensus 159 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~--~~~ 233 (597)
T 3oja_B 159 LERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPV--NVE 233 (597)
T ss_dssp CCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSC--CSC
T ss_pred CCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccccCCchhheeeccCCccccccccc--CCC
Confidence 99888889999999999999999999653 3444555555555544442 122211 368
Q ss_pred cceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccC
Q 043333 141 LEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSF 220 (809)
Q Consensus 141 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 220 (809)
|+.|+|++|.+++ +..+..+++|+.|++++|.+..+.+..|.++++|+.|+|++|.+++. |..+..+++|+.|+|++
T Consensus 234 L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~Ls~ 310 (597)
T 3oja_B 234 LTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSH 310 (597)
T ss_dssp CCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEE-ECSSSCCTTCCEEECCS
T ss_pred CCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCC-CcccccCCCCcEEECCC
Confidence 9999999999996 47899999999999999999999999999999999999999999884 66678899999999999
Q ss_pred CCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhhccCccccccCCccccC
Q 043333 221 NKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDG 272 (809)
Q Consensus 221 N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~ 272 (809)
|+++++++.....++|+.|+|++|.+++..+.. ...++.|+|++|+|.|.
T Consensus 311 N~l~~i~~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 311 NHLLHVERNQPQFDRLENLYLDHNSIVTLKLST--HHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp SCCCCCGGGHHHHTTCSEEECCSSCCCCCCCCT--TCCCSEEECCSSCEEHH
T ss_pred CCCCccCcccccCCCCCEEECCCCCCCCcChhh--cCCCCEEEeeCCCCCCh
Confidence 999976655434499999999999999775443 35789999999999874
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=259.35 Aligned_cols=225 Identities=22% Similarity=0.276 Sum_probs=199.2
Q ss_pred CCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEc
Q 043333 20 LPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHL 98 (809)
Q Consensus 20 l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 98 (809)
.+++++|+|++|.++ .+|..+..++ |+.|++++|.+..+|..++.+++|++|+|++|.++ .+|..++++++|++|+|
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 477889999999988 6777777775 88899999888889988999999999999999999 78888999999999999
Q ss_pred cCCccCccCchhhhc---------ccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEe
Q 043333 99 NSNNFTGKLPESFAN---------LTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLR 169 (809)
Q Consensus 99 ~~N~l~~~~p~~~~~---------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 169 (809)
++|++.+.+|..+.. +++|++|+|++|+++ .+|..+.++++|++|+|++|+++ .+|..+..+++|+.|+
T Consensus 158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~ 235 (328)
T 4fcg_A 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELD 235 (328)
T ss_dssp EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEE
T ss_pred CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEE
Confidence 998888888887764 899999999999998 78888999999999999999999 4677789999999999
Q ss_pred ccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCC
Q 043333 170 ISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTG 248 (809)
Q Consensus 170 l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~ 248 (809)
+++|++....+..+.++++|+.|+|++|++.+.+|..+.++++|+.|+|++|++.+.+|..+.. ++|+.+++..|.+..
T Consensus 236 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp CTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred CcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHH
Confidence 9999988888888999999999999999999999999999999999999999999999988877 899999999887763
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=257.38 Aligned_cols=224 Identities=23% Similarity=0.285 Sum_probs=196.3
Q ss_pred CccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeec
Q 043333 45 PLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISD 124 (809)
Q Consensus 45 ~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 124 (809)
.++.|++++|.+..+|..+..+++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++++++|++|+|++
T Consensus 82 ~l~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~ 159 (328)
T 4fcg_A 82 GRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRA 159 (328)
T ss_dssp TCCEEEEESSCCSSCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEE
T ss_pred ceeEEEccCCCchhcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCC
Confidence 478889999999999999988999999999999999 88888999999999999999999 7788899999999999999
Q ss_pred ccccCcCchhhhc---------ccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeec
Q 043333 125 NHFTGQIPDYIQN---------WTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILR 195 (809)
Q Consensus 125 N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 195 (809)
|++.+.+|..+.. +++|+.|+|++|+++ .+|..+..+++|+.|++++|.+..++. .+..+++|++|+|+
T Consensus 160 n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~-~l~~l~~L~~L~Ls 237 (328)
T 4fcg_A 160 CPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGP-AIHHLPKLEELDLR 237 (328)
T ss_dssp ETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCG-GGGGCTTCCEEECT
T ss_pred CCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCch-hhccCCCCCEEECc
Confidence 8888888887664 899999999999998 888889999999999999999987664 58889999999999
Q ss_pred cccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhh-ccCccccccCCccccC
Q 043333 196 SGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDG 272 (809)
Q Consensus 196 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~ 272 (809)
+|++.+.+|..|..+++|+.|+|++|++.+.+|..+.. ++|+.|+|++|++.+.+|..+.. .+++.+++..|.+...
T Consensus 238 ~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~l 316 (328)
T 4fcg_A 238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQL 316 (328)
T ss_dssp TCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC-
T ss_pred CCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHHH
Confidence 99999999999999999999999999998888887766 89999999999999999988766 4568888887766543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-29 Score=269.85 Aligned_cols=248 Identities=20% Similarity=0.196 Sum_probs=212.4
Q ss_pred CCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCC--Cchhhc-------CCccCcEEeecccccccCCCccc
Q 043333 17 LTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGA--IPKAVA-------SISTLADLTLEFNQFSGDLPAEL 87 (809)
Q Consensus 17 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~--ip~~l~-------~l~~L~~L~L~~N~l~~~~p~~~ 87 (809)
+...++|++|++++|.+ .+|..+... ++.|++++|.+.. +|..+. ++++|++|+|++|++++.+|..+
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~-L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI-IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH-HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH-HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 45567899999999999 677766555 8899999998854 677666 79999999999999999999876
Q ss_pred --cCCCCCCEEEccCCccCccCchhhhcc-----cccceeeeecccccCcCchhhhcccccceEecccCcCCCC--CCcc
Q 043333 88 --GNLINLEKLHLNSNNFTGKLPESFANL-----TRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGP--IPSG 158 (809)
Q Consensus 88 --~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~ 158 (809)
..+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|+++++|++|+|++|++.+. .|..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 8999999999999999977 8888888 9999999999999988889999999999999999998765 2334
Q ss_pred c--cCCCCCCEEeccCCCCCCCC---CccccCCcCCceeeeccccccCCCC-hhhhccccccEEeccCCCCCCCCCCCCC
Q 043333 159 I--ASLVELTDLRISDLNGPEGP---FPRLSNLKNMNYLILRSGNIIGEMP-EYLGQMIGLRVLDLSFNKLSGVIPSNFS 232 (809)
Q Consensus 159 ~--~~l~~L~~L~l~~n~l~~~~---~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 232 (809)
+ ..+++|++|++++|.++.++ ...+.++++|++|+|++|++.+..| ..+..+++|+.|+|++|+|+.+ |..+.
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~i-p~~~~ 273 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQV-PKGLP 273 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSC-CSSCC
T ss_pred HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChh-hhhcc
Confidence 4 88999999999999998543 3345788999999999999999886 5577789999999999999954 44444
Q ss_pred CCCccEEEeeCccCCCCCChhhhhccCccccccCCcccc
Q 043333 233 GSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFID 271 (809)
Q Consensus 233 ~~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~ 271 (809)
++|+.|+|++|+|++. |......+++.|+|++|++++
T Consensus 274 -~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 274 -AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp -SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTTC
T ss_pred -CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCCC
Confidence 8999999999999987 554445678999999999976
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-28 Score=259.04 Aligned_cols=247 Identities=17% Similarity=0.179 Sum_probs=220.8
Q ss_pred CCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchh-hcCCccCcEEeecccccccC--CCccccCCCCCCEEEcc
Q 043333 23 LQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKA-VASISTLADLTLEFNQFSGD--LPAELGNLINLEKLHLN 99 (809)
Q Consensus 23 L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~-l~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~ 99 (809)
-+.++++++.++ .+|..+. -.++.|++++|.+..+|.. +.++++|++|+|++|.++.. .+..+..+++|++|+|+
T Consensus 9 ~~~l~c~~~~l~-~ip~~~~-~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 9 GTEIRCNSKGLT-SVPTGIP-SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TTEEECCSSCCS-SCCSCCC-TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CCEEEcCCCCcc-cCCCCCC-CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 368999999998 5565544 2588999999999999875 68999999999999999833 36778889999999999
Q ss_pred CCccCccCchhhhcccccceeeeecccccCcCc-hhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCC-
Q 043333 100 SNNFTGKLPESFANLTRLKHFRISDNHFTGQIP-DYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPE- 177 (809)
Q Consensus 100 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~- 177 (809)
+|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|++|+|++|++++..+..+..+++|+.|++++|.+..
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 165 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence 99999 567789999999999999999996655 579999999999999999998889999999999999999999986
Q ss_pred CCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhh
Q 043333 178 GPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR 256 (809)
Q Consensus 178 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~ 256 (809)
..+..+..+++|++|+|++|++.+..|..|..+++|+.|+|++|++++.++..+.. ++|+.|+|++|++++..|..+..
T Consensus 166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 245 (306)
T 2z66_A 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245 (306)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCC
T ss_pred cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHh
Confidence 55677999999999999999999999999999999999999999999998877776 99999999999999999887765
Q ss_pred --ccCccccccCCccccC
Q 043333 257 --KRNKHIDLSYNNFIDG 272 (809)
Q Consensus 257 --~~l~~L~Ls~N~l~~~ 272 (809)
..++.|+|++|+|+|.
T Consensus 246 ~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 246 FPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp CCTTCCEEECTTCCEECS
T ss_pred hhccCCEEEccCCCeecc
Confidence 3689999999999875
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-28 Score=263.43 Aligned_cols=279 Identities=17% Similarity=0.119 Sum_probs=210.9
Q ss_pred CCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCch-hhcCCccCcEEeecccccccCCCccccCCCCCCEE
Q 043333 18 TRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPK-AVASISTLADLTLEFNQFSGDLPAELGNLINLEKL 96 (809)
Q Consensus 18 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 96 (809)
..++.....++++|.++ .+|..+.. .++.|++++|.+..+|. .+..+++|++|+|++|++++..|..|.++++|++|
T Consensus 28 ~~C~~~~~c~~~~~~l~-~iP~~~~~-~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 28 LSCDRNGICKGSSGSLN-SIPSGLTE-AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CEECTTSEEECCSTTCS-SCCTTCCT-TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCeEeeCCCCCcc-cccccccc-cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 34455666788888877 45554443 57778888888877766 67888899999999999887777888888999999
Q ss_pred EccCCccCccCchhhhcccccceeeeecccccCcCc-hhhhcccccceEecccC-cCCCCCCccccCCCCCCEEeccCCC
Q 043333 97 HLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIP-DYIQNWTKLEKLFIEGS-GLAGPIPSGIASLVELTDLRISDLN 174 (809)
Q Consensus 97 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~n~ 174 (809)
+|++|++++..+..|+++++|++|+|++|++++..+ ..+.++++|++|++++| .++...+..|..+++|+.|++++|.
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 999999986666568888899999999998884443 36888899999999988 4666667788888999999999998
Q ss_pred CCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC----CCccEEEeeCccCCC--
Q 043333 175 GPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG----SGLTYMYLTGNLLTG-- 248 (809)
Q Consensus 175 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~----~~L~~L~Ls~N~l~~-- 248 (809)
+....+..+.++++|++|+|++|++....+..+..+++|+.|+|++|++++..+..+.. ..++.++|++|.+++
T Consensus 186 l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~ 265 (353)
T 2z80_A 186 LQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDES 265 (353)
T ss_dssp CCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHH
T ss_pred cCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcc
Confidence 88888888888999999999998886555555667889999999999998877665432 678888888888876
Q ss_pred --CCChhhhh-ccCccccccCCccccCCCCCcccccccceeccccCCCCCCccccccccCCCCCCCcceeecCC
Q 043333 249 --PVPDWIVR-KRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNSTGIVSCLKSFTCPTNHSSLHINCG 319 (809)
Q Consensus 249 --~~p~~~~~-~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~~C~ 319 (809)
.+|..+.. .+++.|+|++|+++..+...+. .+++.......+|+|.|+|.
T Consensus 266 l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~---------------------~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 266 LFQVMKLLNQISGLLELEFSRNQLKSVPDGIFD---------------------RLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTT---------------------TCTTCCEEECCSSCBCCCHH
T ss_pred hhhhHHHHhcccCCCEEECCCCCCCccCHHHHh---------------------cCCCCCEEEeeCCCccCcCC
Confidence 34554443 5678889999988754333222 23334455677888888885
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=279.97 Aligned_cols=285 Identities=19% Similarity=0.199 Sum_probs=187.1
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCch-hhcCCccCcEEeecccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPK-AVASISTLADLTLEFNQ 78 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~-~l~~l~~L~~L~L~~N~ 78 (809)
+|+|++|++.+..|..|.++++|++|+|++|.++...|..|..++ |+.|++++|.+..+|. .++++++|++|+|++|.
T Consensus 56 ~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~ 135 (570)
T 2z63_A 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135 (570)
T ss_dssp EEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCc
Confidence 367778888777777778888888888888888776667777764 7777777777777665 56677777777777777
Q ss_pred ccc-CCCccccCCCCCCEEEccCCccCccCchhhh---------------------------------------------
Q 043333 79 FSG-DLPAELGNLINLEKLHLNSNNFTGKLPESFA--------------------------------------------- 112 (809)
Q Consensus 79 l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--------------------------------------------- 112 (809)
+++ .+|..|+++++|++|+|++|++++..|..++
T Consensus 136 l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~ 215 (570)
T 2z63_A 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLN 215 (570)
T ss_dssp CCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTT
T ss_pred cceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEeccccccccc
Confidence 765 3566677777777777777666543332221
Q ss_pred ----------------------------------------------------------------cccccceeee------
Q 043333 113 ----------------------------------------------------------------NLTRLKHFRI------ 122 (809)
Q Consensus 113 ----------------------------------------------------------------~l~~L~~L~L------ 122 (809)
.+++|+.|++
T Consensus 216 ~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~ 295 (570)
T 2z63_A 216 VMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295 (570)
T ss_dssp HHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC
T ss_pred chhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch
Confidence 1222333333
Q ss_pred -----------------------------------------------------------ecccccCcC--chhhhccccc
Q 043333 123 -----------------------------------------------------------SDNHFTGQI--PDYIQNWTKL 141 (809)
Q Consensus 123 -----------------------------------------------------------s~N~l~~~~--p~~~~~l~~L 141 (809)
++|++++.. |..+.++++|
T Consensus 296 ~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L 375 (570)
T 2z63_A 296 RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375 (570)
T ss_dssp SCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCC
T ss_pred hhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccccccccccccCcc
Confidence 333333221 3445555666
Q ss_pred ceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCC-ccccCCcCCceeeeccccccCCCChhhhccccccEEeccC
Q 043333 142 EKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPF-PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSF 220 (809)
Q Consensus 142 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 220 (809)
+.|+|++|++++.. ..+..+++|+.|++++|.+....+ ..+.++++|++|+|++|.+.+..|..|.++++|+.|+|++
T Consensus 376 ~~L~l~~n~l~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 454 (570)
T 2z63_A 376 KYLDLSFNGVITMS-SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454 (570)
T ss_dssp CEEECCSCSEEEEE-EEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTT
T ss_pred CEEECCCCcccccc-ccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcC
Confidence 66666666665333 336777777888888777776654 4577777788888887777777777777777777777777
Q ss_pred CCCC-CCCCCCCCC-CCccEEEeeCccCCCCCChhhhh-ccCccccccCCccccCCCCCccccccccee
Q 043333 221 NKLS-GVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDGSSDSNCENQSVNLF 286 (809)
Q Consensus 221 N~l~-~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~~~~~~~~~~~~~~~ 286 (809)
|+++ +.+|..+.. ++|+.|+|++|++++..|..+.. .+++.|++++|++++.++..+.....+..+
T Consensus 455 n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 523 (570)
T 2z63_A 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKI 523 (570)
T ss_dssp CEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEE
Confidence 7776 456666655 77777777777777776666554 456777777777777666555544444433
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.9e-28 Score=264.02 Aligned_cols=267 Identities=20% Similarity=0.158 Sum_probs=207.0
Q ss_pred cccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCc-hhhcCCccCcEEeecccccc
Q 043333 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIP-KAVASISTLADLTLEFNQFS 80 (809)
Q Consensus 3 ~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip-~~l~~l~~L~~L~L~~N~l~ 80 (809)
+++++++. .+|..+. ++|++|+|++|.+++..+..|..++ |+.|++++|.+..++ ..+.++++|++|+|++|+++
T Consensus 37 ~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 113 (353)
T 2z80_A 37 KGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113 (353)
T ss_dssp ECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred eCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCC
Confidence 56677777 6777665 5899999999999877666788875 888999999888874 56888999999999999998
Q ss_pred cCCCccccCCCCCCEEEccCCccCccCc-hhhhcccccceeeeecc-cccCcCchhhhcccccceEecccCcCCCCCCcc
Q 043333 81 GDLPAELGNLINLEKLHLNSNNFTGKLP-ESFANLTRLKHFRISDN-HFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSG 158 (809)
Q Consensus 81 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 158 (809)
+..+..|.++++|++|+|++|++++..+ ..+.++++|++|++++| .+....+..|.++++|++|++++|++++..|..
T Consensus 114 ~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 193 (353)
T 2z80_A 114 NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKS 193 (353)
T ss_dssp SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTT
T ss_pred cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHH
Confidence 5544558889999999999999985433 47888999999999998 477666778889999999999999998888888
Q ss_pred ccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhh---ccccccEEeccCCCCCCC----CCCCC
Q 043333 159 IASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLG---QMIGLRVLDLSFNKLSGV----IPSNF 231 (809)
Q Consensus 159 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~ 231 (809)
+..+++|+.|++++|.+..++...+..+++|+.|+|++|++.+..+..+. ....++.++|++|.+++. +|..+
T Consensus 194 l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l 273 (353)
T 2z80_A 194 LKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLL 273 (353)
T ss_dssp TTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHH
T ss_pred HhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHH
Confidence 99999999999999998777766677788999999999998887665443 356677777777777652 33333
Q ss_pred CC-CCccEEEeeCccCCCCCChhhh-hccCccccccCCccccC
Q 043333 232 SG-SGLTYMYLTGNLLTGPVPDWIV-RKRNKHIDLSYNNFIDG 272 (809)
Q Consensus 232 ~~-~~L~~L~Ls~N~l~~~~p~~~~-~~~l~~L~Ls~N~l~~~ 272 (809)
.. ++|+.|+|++|+++..++..+. ..+++.|+|++|+++|.
T Consensus 274 ~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 274 NQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp HTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred hcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 33 7788888888888854444433 35668888888888764
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-26 Score=253.05 Aligned_cols=254 Identities=20% Similarity=0.263 Sum_probs=134.3
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeecccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFS 80 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~ 80 (809)
|++++|++. .+| .+..+++|++|++++|.++...+ +..++ |+.|++++|.+..+| .+..+++|++|+|++|.++
T Consensus 49 L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~~-~~~~l~~L~~L~l~~n~i~ 123 (347)
T 4fmz_A 49 LVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDIS-ALQNLTNLRELYLNEDNIS 123 (347)
T ss_dssp EECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG-GGTTCTTCSEEECTTSCCC
T ss_pred EEEeCCccc-cch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCch-HHcCCCcCCEEECcCCccc
Confidence 556666665 333 36667777777777777764333 55554 667777777666664 4666677777777777766
Q ss_pred cCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCcccc
Q 043333 81 GDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIA 160 (809)
Q Consensus 81 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 160 (809)
+ ++. +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|+.|++++|++.+..+ +.
T Consensus 124 ~-~~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~ 196 (347)
T 4fmz_A 124 D-ISP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LA 196 (347)
T ss_dssp C-CGG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GG
T ss_pred C-chh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--cc
Confidence 3 333 6666666666666664443333 35566666666666666553322 5556666666666666553222 44
Q ss_pred CCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEE
Q 043333 161 SLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMY 240 (809)
Q Consensus 161 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ 240 (809)
.+++|+.|++++|.+..... +..+++|+.|+|++|++++..+ +..+++|+.|++++|++++. +.....++|+.|+
T Consensus 197 ~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~ 271 (347)
T 4fmz_A 197 SLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLN 271 (347)
T ss_dssp GCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEE
T ss_pred CCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEE
Confidence 45555555555554444432 4444455555555554444333 44444455555555544443 1111124444444
Q ss_pred eeCccCCCCCChhhhhccCccccccCCccccCC
Q 043333 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGS 273 (809)
Q Consensus 241 Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~~ 273 (809)
+++|++++. +......+++.|++++|++++..
T Consensus 272 l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~ 303 (347)
T 4fmz_A 272 VGSNQISDI-SVLNNLSQLNSLFLNNNQLGNED 303 (347)
T ss_dssp CCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGG
T ss_pred ccCCccCCC-hhhcCCCCCCEEECcCCcCCCcC
Confidence 444444432 22222234444444444444433
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-26 Score=252.87 Aligned_cols=257 Identities=22% Similarity=0.284 Sum_probs=207.4
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeeccccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQF 79 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l 79 (809)
+|+|++|++.+ +|+ +..+++|++|+|++|.++. + +.+..++ |+.|++++|.+..+|. +..+++|+.|++++|..
T Consensus 70 ~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~l~~n~~ 144 (347)
T 4fmz_A 70 YLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-I-SALQNLTNLRELYLNEDNISDISP-LANLTKMYSLNLGANHN 144 (347)
T ss_dssp EEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCSEEECTTSCCCCCGG-GTTCTTCCEEECTTCTT
T ss_pred EEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-c-hHHcCCCcCCEEECcCCcccCchh-hccCCceeEEECCCCCC
Confidence 47888888884 444 8889999999999998885 3 3567765 8889999999888877 88889999999999966
Q ss_pred ccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccc
Q 043333 80 SGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGI 159 (809)
Q Consensus 80 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 159 (809)
...+ ..+..+++|++|++++|.+++..+ +..+++|+.|++++|++.+..+ +..+++|+.|++++|++++..+ +
T Consensus 145 ~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~ 217 (347)
T 4fmz_A 145 LSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--V 217 (347)
T ss_dssp CCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--G
T ss_pred cccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--h
Confidence 6444 448888999999999999885444 8888999999999999885433 8888999999999998885544 7
Q ss_pred cCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEE
Q 043333 160 ASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYM 239 (809)
Q Consensus 160 ~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L 239 (809)
..+++|+.|++++|.++..+. +..+++|++|+|++|.+.+. ..+..+++|+.|++++|++++. +.....++|+.|
T Consensus 218 ~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L 292 (347)
T 4fmz_A 218 ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSL 292 (347)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEE
T ss_pred hcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEE
Confidence 888899999999998888765 88889999999999988875 5688889999999999999876 333334889999
Q ss_pred EeeCccCCCCCChhhhh-ccCccccccCCccccCCC
Q 043333 240 YLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDGSS 274 (809)
Q Consensus 240 ~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~~~ 274 (809)
+|++|++++..|..+.. ..++.|++++|++++.++
T Consensus 293 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp ECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred ECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 99999998888877665 567899999999887543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-27 Score=248.60 Aligned_cols=224 Identities=22% Similarity=0.240 Sum_probs=207.3
Q ss_pred cccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeeccc
Q 043333 47 VNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126 (809)
Q Consensus 47 ~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 126 (809)
..++.+++.+..+|..+ .++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 14 ~~~~c~~~~l~~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 91 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (285)
T ss_dssp CEEECCSSCCSSCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred eEEEcCcCCcccCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCC
Confidence 46778888999999765 4799999999999998777889999999999999999998889999999999999999998
Q ss_pred -ccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCCh
Q 043333 127 -FTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPE 205 (809)
Q Consensus 127 -l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 205 (809)
+....|..|..+++|++|+|++|++++..|..|..+++|+.|++++|.+..++...|.++++|+.|+|++|++++..+.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 171 (285)
T 1ozn_A 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (285)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred CccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHH
Confidence 8877788999999999999999999988899999999999999999999999998999999999999999999998888
Q ss_pred hhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhh-ccCccccccCCccccC
Q 043333 206 YLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDG 272 (809)
Q Consensus 206 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~ 272 (809)
.|..+++|+.|+|++|++++..|..+.. ++|+.|+|++|++++.++..+.. ..++.|+|++|+|.|.
T Consensus 172 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 240 (285)
T 1ozn_A 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (285)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred HhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCC
Confidence 9999999999999999999998988877 99999999999999887776654 6779999999999874
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=277.46 Aligned_cols=113 Identities=21% Similarity=0.249 Sum_probs=100.3
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCch-hhcCCccCcEEeecccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPK-AVASISTLADLTLEFNQ 78 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~-~l~~l~~L~~L~L~~N~ 78 (809)
+|+|++|+|.+..|.+|.++++|++|+|++|+|++..+..|..++ |+.|++++|.+..+|. .|+++++|++|+|++|.
T Consensus 80 ~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~ 159 (635)
T 4g8a_A 80 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 159 (635)
T ss_dssp EEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCc
Confidence 489999999988888999999999999999999987778899886 9999999999999976 68999999999999999
Q ss_pred ccc-CCCccccCCCCCCEEEccCCccCccCchhhhc
Q 043333 79 FSG-DLPAELGNLINLEKLHLNSNNFTGKLPESFAN 113 (809)
Q Consensus 79 l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 113 (809)
+++ .+|..++.+++|++|+|++|+|++..|..|..
T Consensus 160 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 195 (635)
T 4g8a_A 160 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 195 (635)
T ss_dssp CCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHH
T ss_pred cccCCCchhhccchhhhhhcccCccccccccccccc
Confidence 986 45788999999999999999998766655443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-26 Score=260.89 Aligned_cols=253 Identities=27% Similarity=0.344 Sum_probs=122.7
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeecccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFS 80 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~ 80 (809)
|+|++|++.+.. + +..+++|++|++++|.+.+..+ +..++ |+.|++++|.+..+|. +..+++|++|+|++|.++
T Consensus 73 L~Ls~n~l~~~~-~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~ 147 (466)
T 1o6v_A 73 INFSNNQLTDIT-P-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELSSNTIS 147 (466)
T ss_dssp EECCSSCCCCCG-G-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCSEEEEEEEEEC
T ss_pred EECCCCccCCch-h-hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH-HcCCCCCCEEECCCCccC
Confidence 455566555332 2 5566666666666666654333 44443 5666666666666554 556666666666666655
Q ss_pred cCCCc--------------------cccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccc
Q 043333 81 GDLPA--------------------ELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTK 140 (809)
Q Consensus 81 ~~~p~--------------------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 140 (809)
+ ++. .+.++++|++|+|++|++++. + .+..+++|++|++++|++++..| ++.+++
T Consensus 148 ~-~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~ 222 (466)
T 1o6v_A 148 D-ISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI-S-VLAKLTNLESLIATNNQISDITP--LGILTN 222 (466)
T ss_dssp C-CGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEECCSSCCCCCGG--GGGCTT
T ss_pred C-ChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC-h-hhccCCCCCEEEecCCccccccc--ccccCC
Confidence 3 221 123334444444444444421 1 24444444444444444443322 344444
Q ss_pred cceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccC
Q 043333 141 LEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSF 220 (809)
Q Consensus 141 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 220 (809)
|+.|+|++|++++. ..+..+++|+.|++++|.+...+. +..+++|+.|+|++|++.+..+ +..+++|+.|+|++
T Consensus 223 L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~ 296 (466)
T 1o6v_A 223 LDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE 296 (466)
T ss_dssp CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCS
T ss_pred CCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCC
Confidence 44444444444421 234444555555555554444332 4455555555555555544433 44555555555555
Q ss_pred CCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhhccCccccccCCccccC
Q 043333 221 NKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDG 272 (809)
Q Consensus 221 N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~ 272 (809)
|++++.++ ....++|+.|+|++|++++..| ......++.|++++|++++.
T Consensus 297 n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 297 NQLEDISP-ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp SCCSCCGG-GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC
T ss_pred CcccCchh-hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc
Confidence 55554433 1122555555555555554443 12224445555555555543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-28 Score=285.05 Aligned_cols=185 Identities=18% Similarity=0.131 Sum_probs=128.8
Q ss_pred eccCCCccEEEeE-eeCCeEEEEEEecccC----------cccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEEE
Q 043333 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKS----------KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 583 LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~----------~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
.+.|++|.+..++ +--|+.+|||++.... ....++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666655544 3358889999986541 12235699999999999 6999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||++||+|.++|.. ..+++.. +|+.||+.||+|+|++ +||||||||+|||+++++++||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999943 3345543 5889999999999999 899999999999999999999999999987654
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNV 779 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~ 779 (809)
.... ....+||++|||||++.+ .+..++|+||+|+++++|.++..|+
T Consensus 392 ~~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DCSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCcc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 3322 334679999999999875 4577899999999988776654443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-26 Score=258.29 Aligned_cols=256 Identities=22% Similarity=0.318 Sum_probs=211.9
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCch------------------
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPK------------------ 61 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~------------------ 61 (809)
+|+|++|++.+..| +..+++|++|+|++|.+++..+ +..++ |+.|++++|.+..+|.
T Consensus 94 ~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~ 169 (466)
T 1o6v_A 94 DILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD 169 (466)
T ss_dssp EEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC
T ss_pred EEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCChhhccCCcccEeecCCcccC
Confidence 46788888885544 8888999999999998886543 66665 8888888877766653
Q ss_pred --hhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhccc
Q 043333 62 --AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWT 139 (809)
Q Consensus 62 --~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 139 (809)
.+.++++|+.|++++|.+++ + ..+..+++|++|++++|++++..| ++.+++|+.|+|++|++++ + ..+..++
T Consensus 170 ~~~~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~l~~l~ 243 (466)
T 1o6v_A 170 LKPLANLTTLERLDISSNKVSD-I-SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLT 243 (466)
T ss_dssp CGGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCT
T ss_pred chhhccCCCCCEEECcCCcCCC-C-hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCccc-c-hhhhcCC
Confidence 36677889999999999984 3 358899999999999999997655 7889999999999999985 3 3588999
Q ss_pred ccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEecc
Q 043333 140 KLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLS 219 (809)
Q Consensus 140 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 219 (809)
+|+.|+|++|++++..+ +..+++|+.|++++|.+..++. +..+++|+.|+|++|++.+..+ +..+++|+.|+|+
T Consensus 244 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~ 317 (466)
T 1o6v_A 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLY 317 (466)
T ss_dssp TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECC
T ss_pred CCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECc
Confidence 99999999999996655 8899999999999999988765 8899999999999999988765 8899999999999
Q ss_pred CCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhhccCccccccCCccccCCC
Q 043333 220 FNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSS 274 (809)
Q Consensus 220 ~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~~~ 274 (809)
+|++++.+| ....++|+.|++++|++++. +......+++.|++++|++++..+
T Consensus 318 ~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~ 370 (466)
T 1o6v_A 318 FNNISDISP-VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQISDLTP 370 (466)
T ss_dssp SSCCSCCGG-GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred CCcCCCchh-hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCccCccch
Confidence 999998877 33449999999999999976 444444678999999999987654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.9e-26 Score=256.47 Aligned_cols=247 Identities=17% Similarity=0.107 Sum_probs=166.4
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeecccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFS 80 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~ 80 (809)
|+|++|++.+. | .+..+++|++|+|++|++++. | +..++ |+.|++++|.+..+| ++.+++|++|+|++|+++
T Consensus 47 L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~~--~~~l~~L~~L~L~~N~l~ 119 (457)
T 3bz5_A 47 LDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNLD--VTPLTKLTYLNCDTNKLT 119 (457)
T ss_dssp EECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCC--CTTCTTCCEEECCSSCCS
T ss_pred EEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCceee--cCCCCcCCEEECCCCcCC
Confidence 66777777753 4 577777777777777777753 3 55554 777777777777775 677777777777777777
Q ss_pred cCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCcccc
Q 043333 81 GDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIA 160 (809)
Q Consensus 81 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 160 (809)
+ +| ++.+++|++|+|++|++++. + ++++++|++|++++|+..+.+ .+..+++|+.|+|++|++++ +| +.
T Consensus 120 ~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~ 188 (457)
T 3bz5_A 120 K-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VS 188 (457)
T ss_dssp C-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CT
T ss_pred e-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cc
Confidence 4 33 67777777777777777753 3 667777777777777555455 36677777777777777775 34 66
Q ss_pred CCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-C-----
Q 043333 161 SLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-S----- 234 (809)
Q Consensus 161 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~----- 234 (809)
.+++|+.|++++|.++.++ +..+++|+.|+|++|++++ +| +..+++|+.|++++|++++.++..+.. .
T Consensus 189 ~l~~L~~L~l~~N~l~~~~---l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~ 262 (457)
T 3bz5_A 189 QNKLLNRLNCDTNNITKLD---LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCI 262 (457)
T ss_dssp TCTTCCEEECCSSCCSCCC---CTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECT
T ss_pred cCCCCCEEECcCCcCCeec---cccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEecc
Confidence 7777777777777777763 6677777777777777777 34 677777777777777777766544332 1
Q ss_pred --CccEEEeeCccCCCCCChhhhhccCccccccCCccccCC
Q 043333 235 --GLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGS 273 (809)
Q Consensus 235 --~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~~ 273 (809)
+|+.|++++|.+.+.+|. ....+++.|++++|++.+..
T Consensus 263 ~n~L~~L~l~~n~~~~~~~~-~~l~~L~~L~Ls~n~~l~~l 302 (457)
T 3bz5_A 263 QTDLLEIDLTHNTQLIYFQA-EGCRKIKELDVTHNTQLYLL 302 (457)
T ss_dssp TCCCSCCCCTTCTTCCEEEC-TTCTTCCCCCCTTCTTCCEE
T ss_pred CCCCCEEECCCCccCCcccc-cccccCCEEECCCCccccee
Confidence 344555555555555542 12256677777777655443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.2e-26 Score=239.95 Aligned_cols=221 Identities=20% Similarity=0.157 Sum_probs=192.8
Q ss_pred ccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccC
Q 043333 50 PLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTG 129 (809)
Q Consensus 50 ~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 129 (809)
+..+..+..+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++
T Consensus 13 ~c~~~~l~~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 90 (276)
T 2z62_A 13 QCMELNFYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90 (276)
T ss_dssp ECTTSCCSSCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred EecCCCccccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCc
Confidence 334445556666553 579999999999997777789999999999999999998777789999999999999999998
Q ss_pred cCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCC-CccccCCcCCceeeeccccccCCCChhhh
Q 043333 130 QIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGP-FPRLSNLKNMNYLILRSGNIIGEMPEYLG 208 (809)
Q Consensus 130 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~-~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 208 (809)
..+..|.++++|++|++++|++++..+..+..+++|+.|++++|.+..+. +..+.++++|+.|+|++|++++..+..|.
T Consensus 91 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 170 (276)
T 2z62_A 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170 (276)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGH
T ss_pred cChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhh
Confidence 88888999999999999999999777778999999999999999998876 56789999999999999999999888888
Q ss_pred cccccc----EEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhh-ccCccccccCCccccC
Q 043333 209 QMIGLR----VLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDG 272 (809)
Q Consensus 209 ~l~~L~----~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~ 272 (809)
.+++|+ .|++++|++++.++..+...+|+.|+|++|++++.++..+.. .+++.|+|++|+|+|.
T Consensus 171 ~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 171 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp HHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred hhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence 888888 899999999999888888889999999999999887776654 6779999999999875
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-27 Score=258.67 Aligned_cols=258 Identities=19% Similarity=0.099 Sum_probs=215.9
Q ss_pred cccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeeccccccc
Q 043333 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSG 81 (809)
Q Consensus 3 ~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~ 81 (809)
+++.+++...++..+..+++|++|+|++|++++..|..|..++ |+.|++++|.+..+++ +..+++|++|+|++|++++
T Consensus 16 ~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls~n~l~~ 94 (317)
T 3o53_A 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQE 94 (317)
T ss_dssp SCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-ETTCTTCCEEECCSSEEEE
T ss_pred eccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-hhhcCCCCEEECcCCcccc
Confidence 4566777655555667788999999999999988888898886 9999999999987765 8999999999999999984
Q ss_pred CCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCcccc-
Q 043333 82 DLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIA- 160 (809)
Q Consensus 82 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~- 160 (809)
. + ..++|++|+|++|++++..+.. +++|+.|+|++|++++..+..+..+++|+.|+|++|++++..+..+.
T Consensus 95 l-~----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 166 (317)
T 3o53_A 95 L-L----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166 (317)
T ss_dssp E-E----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGG
T ss_pred c-c----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhh
Confidence 3 2 3489999999999999765543 67899999999999988888899999999999999999987777764
Q ss_pred CCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEE
Q 043333 161 SLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMY 240 (809)
Q Consensus 161 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ 240 (809)
.+++|+.|++++|.++.++ ....+++|++|+|++|++.+..+. +..+++|+.|+|++|+|+++++.....++|+.|+
T Consensus 167 ~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~l~~~-~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~ 243 (317)
T 3o53_A 167 SSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFD 243 (317)
T ss_dssp GTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEE
T ss_pred ccCcCCEEECCCCcCcccc--cccccccCCEEECCCCcCCcchhh-hcccCcccEEECcCCcccchhhHhhcCCCCCEEE
Confidence 7899999999999998874 344699999999999999976554 9999999999999999997654433349999999
Q ss_pred eeCccCC-CCCChhhhh-ccCccccccCC-ccccC
Q 043333 241 LTGNLLT-GPVPDWIVR-KRNKHIDLSYN-NFIDG 272 (809)
Q Consensus 241 Ls~N~l~-~~~p~~~~~-~~l~~L~Ls~N-~l~~~ 272 (809)
|++|+++ +.+|..+.. ..++.+++++| .+.+.
T Consensus 244 l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~ 278 (317)
T 3o53_A 244 LRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278 (317)
T ss_dssp CTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSS
T ss_pred ccCCCccCcCHHHHHhccccceEEECCCchhccCC
Confidence 9999999 666666654 45688888854 45544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.7e-27 Score=266.25 Aligned_cols=239 Identities=20% Similarity=0.110 Sum_probs=200.7
Q ss_pred ccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCC
Q 043333 15 PELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINL 93 (809)
Q Consensus 15 ~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 93 (809)
.....+++|++|+|++|.+++..|..|..++ |+.|++++|.+..+++ +..+++|++|+|++|.|++.. ..++|
T Consensus 28 ~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~-----~~~~L 101 (487)
T 3oja_A 28 SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELL-----VGPSI 101 (487)
T ss_dssp TTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEE-----ECTTC
T ss_pred HhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCC-----CCCCc
Confidence 3344555899999999999988888898886 9999999999987665 899999999999999998533 23899
Q ss_pred CEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCcccc-CCCCCCEEeccC
Q 043333 94 EKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIA-SLVELTDLRISD 172 (809)
Q Consensus 94 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~ 172 (809)
++|+|++|+|++..+. .+++|+.|+|++|.+++..|..++++++|+.|+|++|.+++..|..+. .+++|+.|++++
T Consensus 102 ~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~ 178 (487)
T 3oja_A 102 ETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178 (487)
T ss_dssp CEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTT
T ss_pred CEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCC
Confidence 9999999999976654 457899999999999998898999999999999999999988888876 799999999999
Q ss_pred CCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCC-CCCC
Q 043333 173 LNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLT-GPVP 251 (809)
Q Consensus 173 n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~-~~~p 251 (809)
|.++.++ .+..+++|+.|+|++|.+++..|. |..+++|+.|+|++|+|+++++.....++|+.|+|++|++. +.+|
T Consensus 179 N~l~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~~~ 255 (487)
T 3oja_A 179 NFIYDVK--GQVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLR 255 (487)
T ss_dssp SCCCEEE--CCCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHHHHH
T ss_pred Ccccccc--ccccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCcchH
Confidence 9998773 455699999999999999986665 88999999999999999986555334499999999999998 5555
Q ss_pred hhhhh-ccCcccccc
Q 043333 252 DWIVR-KRNKHIDLS 265 (809)
Q Consensus 252 ~~~~~-~~l~~L~Ls 265 (809)
..+.. ..++.++++
T Consensus 256 ~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 256 DFFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHHTTCHHHHHHHHH
T ss_pred HHHHhCCCCcEEecc
Confidence 55543 344666665
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-25 Score=233.58 Aligned_cols=215 Identities=20% Similarity=0.191 Sum_probs=175.1
Q ss_pred cCCccCCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCC
Q 043333 12 RLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLI 91 (809)
Q Consensus 12 ~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 91 (809)
.+|..+. ++|++|+|++|++++..+. .+..+++|++|+|++|++++..+..|.+++
T Consensus 21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~----------------------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 76 (276)
T 2z62_A 21 KIPDNLP--FSTKNLDLSFNPLRHLGSY----------------------SFFSFPELQVLDLSRCEIQTIEDGAYQSLS 76 (276)
T ss_dssp SCCSSSC--TTCCEEECTTCCCCEECTT----------------------TTTTCTTCSEEECTTCCCCEECTTTTTTCT
T ss_pred ccCCCCC--CCccEEECCCCcccccCHh----------------------HhccccCCcEEECCCCcCCccCHHHccCCc
Confidence 4555443 4566666666666643332 456678889999999988877777888889
Q ss_pred CCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCC-CCccccCCCCCCEEec
Q 043333 92 NLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGP-IPSGIASLVELTDLRI 170 (809)
Q Consensus 92 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l 170 (809)
+|++|+|++|++++..+..|.++++|++|++++|++.+..+..+..+++|++|+|++|++++. +|..+..+++|+.|++
T Consensus 77 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~L 156 (276)
T 2z62_A 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEEC
T ss_pred CCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEEC
Confidence 999999999998887778888889999999999998877666788889999999999998864 5888888999999999
Q ss_pred cCCCCCCCCCccccCCcCCc----eeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCcc
Q 043333 171 SDLNGPEGPFPRLSNLKNMN----YLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNL 245 (809)
Q Consensus 171 ~~n~l~~~~~~~l~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~ 245 (809)
++|.++.++...+..+++|+ .|+|++|.+.+..+..+.. .+|+.|+|++|+|++.++..+.. ++|+.|+|++|+
T Consensus 157 s~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 235 (276)
T 2z62_A 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 235 (276)
T ss_dssp CSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSC
T ss_pred CCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCc
Confidence 99999888877777777776 8999999999877776655 48999999999999998888776 999999999999
Q ss_pred CCCCCC
Q 043333 246 LTGPVP 251 (809)
Q Consensus 246 l~~~~p 251 (809)
+++..|
T Consensus 236 ~~c~c~ 241 (276)
T 2z62_A 236 WDCSCP 241 (276)
T ss_dssp BCCCTT
T ss_pred ccccCC
Confidence 998765
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-26 Score=244.92 Aligned_cols=240 Identities=22% Similarity=0.244 Sum_probs=193.7
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCC-CCCCcccC-------CC-CccccccccccCC-CCchhh--cCCcc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLN-GTIPSEWA-------SL-PLVNLPLWKQANG-AIPKAV--ASIST 68 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~-~~~p~~~~-------~l-~L~~L~l~~n~~~-~ip~~l--~~l~~ 68 (809)
+|+|++|++ .+|..+... |++|+|++|.+. ..+|..+. .+ .|++|++++|.+. .+|..+ ..+++
T Consensus 47 ~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~ 122 (312)
T 1wwl_A 47 YLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPD 122 (312)
T ss_dssp THHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCC
T ss_pred eEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCC
Confidence 356788888 778776644 888899988884 44555443 34 4888899888886 678776 88999
Q ss_pred CcEEeecccccccCCCccccCC-----CCCCEEEccCCccCccCchhhhcccccceeeeecccccCc--Cchhh--hccc
Q 043333 69 LADLTLEFNQFSGDLPAELGNL-----INLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQ--IPDYI--QNWT 139 (809)
Q Consensus 69 L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~--~~l~ 139 (809)
|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|+++++|++|+|++|++.+. .|..+ ..++
T Consensus 123 L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~ 201 (312)
T 1wwl_A 123 LNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP 201 (312)
T ss_dssp CSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCT
T ss_pred ccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCC
Confidence 99999999999976 7777776 8999999999999988888999999999999999998765 33444 8899
Q ss_pred ccceEecccCcCCCC--CC-ccccCCCCCCEEeccCCCCCCCC-CccccCCcCCceeeeccccccCCCChhhhccccccE
Q 043333 140 KLEKLFIEGSGLAGP--IP-SGIASLVELTDLRISDLNGPEGP-FPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRV 215 (809)
Q Consensus 140 ~L~~L~L~~N~l~~~--~p-~~~~~l~~L~~L~l~~n~l~~~~-~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 215 (809)
+|++|+|++|++++. ++ ..+..+++|+.|++++|.+.... ...+..+++|++|+|++|+++ .+|..+. ++|+.
T Consensus 202 ~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~ 278 (312)
T 1wwl_A 202 TLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSV 278 (312)
T ss_dssp TCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEE
T ss_pred CCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceE
Confidence 999999999999832 22 34467889999999999998866 466778899999999999998 6666665 89999
Q ss_pred EeccCCCCCCCCCCCCCCCCccEEEeeCccCCCC
Q 043333 216 LDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGP 249 (809)
Q Consensus 216 L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~ 249 (809)
|+|++|+|++. |.....++|+.|+|++|++++.
T Consensus 279 L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 279 LDLSYNRLDRN-PSPDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp EECCSSCCCSC-CCTTTSCEEEEEECTTCTTTCC
T ss_pred EECCCCCCCCC-hhHhhCCCCCEEeccCCCCCCC
Confidence 99999999988 5533349999999999999863
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=246.74 Aligned_cols=243 Identities=21% Similarity=0.143 Sum_probs=206.7
Q ss_pred CCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeecccccccCCCc
Q 043333 7 QNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPA 85 (809)
Q Consensus 7 nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~ 85 (809)
++..+..+..+..+++|++|++++|.+++. | .+..++ |+.|++++|.+..+| ++.+++|++|+|++|++++. +
T Consensus 28 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~~--~~~l~~L~~L~Ls~N~l~~~-~- 101 (457)
T 3bz5_A 28 FEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTLD--LSQNTNLTYLACDSNKLTNL-D- 101 (457)
T ss_dssp TTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCC-C-
T ss_pred cCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeEc--cccCCCCCEEECcCCCCcee-e-
Confidence 445556667788999999999999999964 5 577775 999999999999997 89999999999999999964 4
Q ss_pred cccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCC
Q 043333 86 ELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVEL 165 (809)
Q Consensus 86 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 165 (809)
++++++|++|+|++|++++ +| ++++++|++|++++|++++. + ++++++|++|++++|+..+.+ .+..+++|
T Consensus 102 -~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L 172 (457)
T 3bz5_A 102 -VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQL 172 (457)
T ss_dssp -CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTC
T ss_pred -cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcC
Confidence 8999999999999999996 45 89999999999999999974 3 889999999999999766566 48899999
Q ss_pred CEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCcc
Q 043333 166 TDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNL 245 (809)
Q Consensus 166 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~ 245 (809)
+.|++++|+++.++ +..+++|+.|++++|++++. .+..+++|+.|+|++|+++++ | ....++|+.|++++|+
T Consensus 173 ~~L~ls~n~l~~l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p-~~~l~~L~~L~l~~N~ 244 (457)
T 3bz5_A 173 TTLDCSFNKITELD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D-VTPLTQLTYFDCSVNP 244 (457)
T ss_dssp CEEECCSSCCCCCC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C-CTTCTTCSEEECCSSC
T ss_pred CEEECCCCccceec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C-ccccCCCCEEEeeCCc
Confidence 99999999999976 78899999999999999987 388999999999999999995 4 3344999999999999
Q ss_pred CCCCCChhhhhc--------cCccccccCCccccC
Q 043333 246 LTGPVPDWIVRK--------RNKHIDLSYNNFIDG 272 (809)
Q Consensus 246 l~~~~p~~~~~~--------~l~~L~Ls~N~l~~~ 272 (809)
+++.++..+... +++.|++++|++.+.
T Consensus 245 l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~ 279 (457)
T 3bz5_A 245 LTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIY 279 (457)
T ss_dssp CSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCE
T ss_pred CCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCc
Confidence 999776554321 345556666655443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=230.86 Aligned_cols=204 Identities=20% Similarity=0.196 Sum_probs=149.2
Q ss_pred hcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccc
Q 043333 63 VASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLE 142 (809)
Q Consensus 63 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 142 (809)
+.++++++.+++++|+++ .+|..+. ++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 456677777777777777 5555443 5677777777777766677777777777777777777743332 6677777
Q ss_pred eEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCC
Q 043333 143 KLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNK 222 (809)
Q Consensus 143 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 222 (809)
.|+|++|+++ .+|..+..+++|+.|++++|+++.+++..|.++++|++|+|++|++.+..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 7777777777 666677777777777777777777777777777778888888777777777777777788888888888
Q ss_pred CCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhhccCccccccCCccccC
Q 043333 223 LSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDG 272 (809)
Q Consensus 223 l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~ 272 (809)
|+++++..+.. ++|+.|+|++|+|+..++..+....++.|+|++|+|.|.
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCc
Confidence 87777776664 778888888888775555555556677788888887763
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-24 Score=226.90 Aligned_cols=184 Identities=21% Similarity=0.222 Sum_probs=142.2
Q ss_pred ccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEec
Q 043333 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFI 146 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 146 (809)
++|+.|+|++|++++..+..|.++++|++|+|++|+++...+..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 37 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 46778888888887665567778888888888888887655556677888888888888887666666777888888888
Q ss_pred ccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCC
Q 043333 147 EGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGV 226 (809)
Q Consensus 147 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 226 (809)
++|++++..+..|..+++|+.|++++|.+..++...|..+++|+.|+|++|++.+..+..|..+++|+.|+|++|+|+++
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 196 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRV 196 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcC
Confidence 88888876677777788888888888888777777777888888888888888877777788888888888888888877
Q ss_pred CCCCCCC-CCccEEEeeCccCCCCC
Q 043333 227 IPSNFSG-SGLTYMYLTGNLLTGPV 250 (809)
Q Consensus 227 ~p~~~~~-~~L~~L~Ls~N~l~~~~ 250 (809)
++..+.. ++|+.|+|++|++...-
T Consensus 197 ~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 197 PEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred CHHHhccccCCCEEEecCCCeeCCC
Confidence 7776665 77888888888776544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=251.46 Aligned_cols=244 Identities=20% Similarity=0.229 Sum_probs=164.8
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC--------------ccccccccccCCCCchhhcCC
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP--------------LVNLPLWKQANGAIPKAVASI 66 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~--------------L~~L~l~~n~~~~ip~~l~~l 66 (809)
+|++++|++ +.+|++++++++|++|++++|.+.+.+|..++.+. ++.|++++|.+..+|.. .
T Consensus 15 ~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~---~ 90 (454)
T 1jl5_A 15 EPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL---P 90 (454)
T ss_dssp --------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC---C
T ss_pred hhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC---c
Confidence 478899999 79999999999999999999999999999988875 37888999988888863 3
Q ss_pred ccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEec
Q 043333 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFI 146 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 146 (809)
++|++|+|++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|+|++|++++ +| .|+++++|++|++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l 160 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDV 160 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEEC
Confidence 688999999999985 6643 3678888888888874 3321 1578888888888885 66 4888888888888
Q ss_pred ccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCC
Q 043333 147 EGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGV 226 (809)
Q Consensus 147 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 226 (809)
++|++++ +|..+ .+|+.|++++|.+..++ .+.++++|+.|++++|++.+. |.. .++|+.|++++|+++.
T Consensus 161 ~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~--~~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~n~l~~- 229 (454)
T 1jl5_A 161 DNNSLKK-LPDLP---PSLEFIAAGNNQLEELP--ELQNLPFLTAIYADNNSLKKL-PDL---PLSLESIVAGNNILEE- 229 (454)
T ss_dssp CSSCCSC-CCCCC---TTCCEEECCSSCCSSCC--CCTTCTTCCEEECCSSCCSSC-CCC---CTTCCEEECCSSCCSS-
T ss_pred CCCcCcc-cCCCc---ccccEEECcCCcCCcCc--cccCCCCCCEEECCCCcCCcC-CCC---cCcccEEECcCCcCCc-
Confidence 8888874 55433 47888888888887754 577888888888888887763 322 2477778888887774
Q ss_pred CCCCCCCCCccEEEeeCccCCCCCChhhhhccCccccccCCccccC
Q 043333 227 IPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDG 272 (809)
Q Consensus 227 ~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~ 272 (809)
+|.....++|+.|++++|++++. |... ..++.|++++|++++.
T Consensus 230 lp~~~~l~~L~~L~l~~N~l~~l-~~~~--~~L~~L~l~~N~l~~l 272 (454)
T 1jl5_A 230 LPELQNLPFLTTIYADNNLLKTL-PDLP--PSLEALNVRDNYLTDL 272 (454)
T ss_dssp CCCCTTCTTCCEEECCSSCCSSC-CSCC--TTCCEEECCSSCCSCC
T ss_pred ccccCCCCCCCEEECCCCcCCcc-cccc--cccCEEECCCCccccc
Confidence 34433337778888888877753 3322 4667777777777763
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=259.75 Aligned_cols=185 Identities=16% Similarity=0.231 Sum_probs=146.4
Q ss_pred CCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcc--------cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 578 APDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQ--------GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 578 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~--------~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
...+.||+|+||.||+|.. .++.+|+|+...+... ..+.|.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4567899999999999954 4677888886543211 124578999999999999999777777788888999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++|+|.+++.. +..++.|+++||+|||++ +|+||||||+|||+++ ++||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999943 457999999999999998 8999999999999999 99999999998765
Q ss_pred CCCcce------eccccccccccchhhhcc--CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 043333 730 EDNTHI------STRIAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNVI 780 (809)
Q Consensus 730 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~ksDVwSlGvil~elltGk~P~~ 780 (809)
...... .....||+.|||||++.. ..|+..+|+||..+-.++.+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 432211 234679999999999976 567788899999999999988887763
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-24 Score=242.54 Aligned_cols=231 Identities=23% Similarity=0.322 Sum_probs=117.5
Q ss_pred CCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEcc
Q 043333 21 PFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLN 99 (809)
Q Consensus 21 ~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 99 (809)
++|++|++++|++++ +| .+..++ |+.|++++|.+..+|..+ .+|++|+|++|++++ +| .++++++|++|+++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 355555555555553 44 344443 555555555555555332 355555555555553 33 35555555555555
Q ss_pred CCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCC
Q 043333 100 SNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGP 179 (809)
Q Consensus 100 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~ 179 (809)
+|++++ +|... ++|++|++++|+++ .+|. ++.+++|+.|++++|++++ +|.. +++|+.|++++|.+..++
T Consensus 204 ~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~l~ 273 (454)
T 1jl5_A 204 NNSLKK-LPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDLP 273 (454)
T ss_dssp SSCCSS-CCCCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCCC
T ss_pred CCcCCc-CCCCc---CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccccC
Confidence 555553 22211 34555555555555 3442 4555555555555555542 2321 244444444444444432
Q ss_pred CccccCCcCCceeeeccccccC--CCChhh-------------hcc-ccccEEeccCCCCCCCCCCCCCCCCccEEEeeC
Q 043333 180 FPRLSNLKNMNYLILRSGNIIG--EMPEYL-------------GQM-IGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTG 243 (809)
Q Consensus 180 ~~~l~~l~~L~~L~Ls~N~l~~--~~p~~~-------------~~l-~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~ 243 (809)
.. +++|+.|++++|++++ .+|..+ ..+ ++|+.|++++|++++++ .. .++|+.|++++
T Consensus 274 ~~----~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~lp-~~--~~~L~~L~L~~ 346 (454)
T 1jl5_A 274 EL----PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELP-AL--PPRLERLIASF 346 (454)
T ss_dssp CC----CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCC-CC--CTTCCEEECCS
T ss_pred cc----cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccccc-cc--CCcCCEEECCC
Confidence 11 1333333333333333 111111 122 47777888888877643 32 36788888888
Q ss_pred ccCCCCCChhhhhccCccccccCCcccc--CCCCCcc
Q 043333 244 NLLTGPVPDWIVRKRNKHIDLSYNNFID--GSSDSNC 278 (809)
Q Consensus 244 N~l~~~~p~~~~~~~l~~L~Ls~N~l~~--~~~~~~~ 278 (809)
|++++ +|. ....++.|++++|++++ ..|..+.
T Consensus 347 N~l~~-lp~--~l~~L~~L~L~~N~l~~l~~ip~~l~ 380 (454)
T 1jl5_A 347 NHLAE-VPE--LPQNLKQLHVEYNPLREFPDIPESVE 380 (454)
T ss_dssp SCCSC-CCC--CCTTCCEEECCSSCCSSCCCCCTTCC
T ss_pred Ccccc-ccc--hhhhccEEECCCCCCCcCCCChHHHH
Confidence 88875 343 23566778888888877 3444443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-24 Score=227.99 Aligned_cols=205 Identities=20% Similarity=0.177 Sum_probs=178.3
Q ss_pred CCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEE
Q 043333 17 LTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKL 96 (809)
Q Consensus 17 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 96 (809)
+.++++|++|++++|.++ .+|. .+. ++++.|+|++|.+++..+..|.++++|++|
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~----------------------~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L 60 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPP----------------------DLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL 60 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCS----------------------CCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEE
T ss_pred ccccCCccEEECCCCCCC-cCCC----------------------CCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEE
Confidence 567788888888888887 3332 222 578899999999998778889999999999
Q ss_pred EccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCC
Q 043333 97 HLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGP 176 (809)
Q Consensus 97 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~ 176 (809)
+|++|+|++..+ .+.+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..|..|..+++|+.|++++|+++
T Consensus 61 ~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~ 137 (290)
T 1p9a_G 61 NLDRAELTKLQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137 (290)
T ss_dssp ECTTSCCCEEEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred ECCCCccCcccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCC
Confidence 999999995433 278899999999999998 77888889999999999999999777788999999999999999999
Q ss_pred CCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCC
Q 043333 177 EGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGP 249 (809)
Q Consensus 177 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~ 249 (809)
.++...|..+++|+.|+|++|+++...+..|..+++|+.|+|++|+|+.+++..+...+|+.|+|++|++...
T Consensus 138 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred ccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCc
Confidence 9998889999999999999999998888889999999999999999998877777779999999999999864
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.5e-24 Score=223.71 Aligned_cols=203 Identities=20% Similarity=0.262 Sum_probs=185.9
Q ss_pred ccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEec
Q 043333 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFI 146 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 146 (809)
.+++.+++++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+++...+..|.++++|++|+|
T Consensus 16 ~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l 92 (270)
T 2o6q_A 16 NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92 (270)
T ss_dssp TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence 46889999999999 6777654 68999999999999877779999999999999999999766677899999999999
Q ss_pred ccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCC
Q 043333 147 EGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGV 226 (809)
Q Consensus 147 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 226 (809)
++|++++..+..|..+++|+.|++++|.++.++...|.++++|++|+|++|++.+..+..|..+++|+.|+|++|+++++
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence 99999987778899999999999999999999999999999999999999999999888899999999999999999999
Q ss_pred CCCCCCC-CCccEEEeeCccCCCCCChhhhh-ccCccccccCCccccC
Q 043333 227 IPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDG 272 (809)
Q Consensus 227 ~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~ 272 (809)
++..+.. ++|+.|+|++|++++.++..+.. .+++.|+|++|+|.|.
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 9988876 99999999999999887776654 6789999999999875
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=229.05 Aligned_cols=208 Identities=17% Similarity=0.206 Sum_probs=146.7
Q ss_pred hcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccc
Q 043333 63 VASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLE 142 (809)
Q Consensus 63 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 142 (809)
+..+++|+.|++++|.++ .++ .+..+++|++|+|++|++++ + ..+.++++|++|+|++|++++..+..|.++++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 345567777777777766 332 46667777777777777774 2 3666777777777777777766666667777777
Q ss_pred eEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCC
Q 043333 143 KLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNK 222 (809)
Q Consensus 143 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 222 (809)
+|+|++|++++..+..|..+++|+.|++++|.++.++...+..+++|+.|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 77777777776666667777777777777777777776667777777777777777777777777777777777777777
Q ss_pred CCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhhccCccccccCCccccCCCCCcccc
Q 043333 223 LSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCEN 280 (809)
Q Consensus 223 l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~~~~~~~~~ 280 (809)
+++.++..+.. ++|+.|+|++|++.+..| .++.++++.|.+++..|..++..
T Consensus 193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~------~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 193 LKSVPDGVFDRLTSLQYIWLHDNPWDCTCP------GIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCCTT------TTHHHHHHHHHTGGGBBCTTSCB
T ss_pred CCccCHHHHhCCcCCCEEEccCCCccccCc------HHHHHHHHHHhCCCcccCccccc
Confidence 77777766655 777777777777776554 35566777777777766655543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=226.40 Aligned_cols=223 Identities=17% Similarity=0.169 Sum_probs=162.4
Q ss_pred CCCEEEccCCCCCCCCCcccCCC-CccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccC
Q 043333 22 FLQEIDLTRNYLNGTIPSEWASL-PLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNS 100 (809)
Q Consensus 22 ~L~~L~Ls~n~l~~~~p~~~~~l-~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 100 (809)
++..+++..+.+..... ...+ .++.|++.++.+..++ .+..+++|++|+|++|.+++ + ..+..+++|++|+|++
T Consensus 20 ~l~~l~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~ 94 (272)
T 3rfs_A 20 ETIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTG 94 (272)
T ss_dssp HHHHHHHTCSCTTSEEC--HHHHTTCCEEECTTSCCCCCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTT
T ss_pred HHHHHHhcCcccccccc--cccccceeeeeeCCCCccccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCC
Confidence 34445555665553322 2223 2667777777777665 46777788888888888774 2 3677778888888888
Q ss_pred CccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCC
Q 043333 101 NNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPF 180 (809)
Q Consensus 101 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~ 180 (809)
|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|++++|+++.++.
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 174 (272)
T 3rfs_A 95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE 174 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence 88887666667778888888888888876666667778888888888888876666667778888888888888877777
Q ss_pred ccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhh
Q 043333 181 PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIV 255 (809)
Q Consensus 181 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 255 (809)
..+.++++|+.|+|++|++.+..+..|..+++|+.|+|++|.+.+.. ++|+.|+++.|.++|.+|..+.
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~------~~l~~l~~~~n~~~g~ip~~~~ 243 (272)
T 3rfs_A 175 GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC------PGIRYLSEWINKHSGVVRNSAG 243 (272)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT------TTTHHHHHHHHHTGGGBBCTTS
T ss_pred HHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccC------cHHHHHHHHHHhCCCcccCccc
Confidence 77777888888888888888777777777888888888888776443 3577777888888887777654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-23 Score=218.82 Aligned_cols=210 Identities=20% Similarity=0.234 Sum_probs=166.3
Q ss_pred ccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEec
Q 043333 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFI 146 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 146 (809)
.+.++++++++.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 46778888888888 6676654 57888888888888887878888888999999999888877878888889999999
Q ss_pred ccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCC
Q 043333 147 EGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGV 226 (809)
Q Consensus 147 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 226 (809)
++|++++..+..|..+++|+.|++++|.++.++...|..+++|++|+|++|++.+..+..|..+++|+.|+|++|+|++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 99998877777888889999999999999888888888999999999999999988888899999999999999999999
Q ss_pred CCCCCCC-CCccEEEeeCccCCCCCChh------hhhccCccccccCCccccCCCCCccc
Q 043333 227 IPSNFSG-SGLTYMYLTGNLLTGPVPDW------IVRKRNKHIDLSYNNFIDGSSDSNCE 279 (809)
Q Consensus 227 ~p~~~~~-~~L~~L~Ls~N~l~~~~p~~------~~~~~l~~L~Ls~N~l~~~~~~~~~~ 279 (809)
++..+.. ++|+.|+|++|++++..... +.....+..+.++|.+.+.+....|.
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~C~ 230 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQWIRENSNKVKDGTGQNLHESPDGVTCS 230 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCTTSTTHHHHHHHHHHSGGGBCC-------CCGGGCBBT
T ss_pred CHHHHhCCCCCCEEEeeCCceeCCccccHHHHHHHHhcccceeeccCcccccCCCcCccC
Confidence 8887776 89999999999999874432 22222344455666665554444443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-25 Score=241.76 Aligned_cols=237 Identities=20% Similarity=0.153 Sum_probs=195.1
Q ss_pred CCCEEEccCCCCCCCCCcccCCC-CccccccccccCCCCc-hhhcCCccCcEEeecccccccCCCccccCCCCCCEEEcc
Q 043333 22 FLQEIDLTRNYLNGTIPSEWASL-PLVNLPLWKQANGAIP-KAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLN 99 (809)
Q Consensus 22 ~L~~L~Ls~n~l~~~~p~~~~~l-~L~~L~l~~n~~~~ip-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 99 (809)
+++.++++.+.+.......+..+ .+++|++++|.+..++ ..+..+++|++|+|++|++++..+ +..+++|++|+|+
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 45666777777765555555555 3899999999998886 588999999999999999986554 8999999999999
Q ss_pred CCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCC
Q 043333 100 SNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGP 179 (809)
Q Consensus 100 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~ 179 (809)
+|++++.. ..++|++|++++|++++..+.. +++|++|+|++|++++..+..+..+++|+.|++++|.+....
T Consensus 89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (317)
T 3o53_A 89 NNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (317)
T ss_dssp SSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred CCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence 99999432 3489999999999999665543 678999999999999887888999999999999999999988
Q ss_pred Cccc-cCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhh-hc
Q 043333 180 FPRL-SNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIV-RK 257 (809)
Q Consensus 180 ~~~l-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~-~~ 257 (809)
+..+ ..+++|++|+|++|.+++..+ ...+++|+.|+|++|+|+++++.....++|+.|+|++|++++. |..+. ..
T Consensus 161 ~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~l-~~~~~~l~ 237 (317)
T 3o53_A 161 FAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLI-EKALRFSQ 237 (317)
T ss_dssp GGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEE-CTTCCCCT
T ss_pred HHHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccch-hhHhhcCC
Confidence 7776 478999999999999987733 3358999999999999998877744449999999999999964 44443 36
Q ss_pred cCccccccCCcccc
Q 043333 258 RNKHIDLSYNNFID 271 (809)
Q Consensus 258 ~l~~L~Ls~N~l~~ 271 (809)
+++.|++++|++.|
T Consensus 238 ~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 238 NLEHFDLRGNGFHC 251 (317)
T ss_dssp TCCEEECTTCCCBH
T ss_pred CCCEEEccCCCccC
Confidence 78999999999984
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=256.76 Aligned_cols=229 Identities=16% Similarity=0.097 Sum_probs=200.5
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeeccccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQF 79 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l 79 (809)
+|+|++|++.+..|..|..+++|++|+|++|.+++..| +..++ |+.|++++|.+..+|.. ++|+.|+|++|.+
T Consensus 38 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~----~~L~~L~L~~N~l 111 (487)
T 3oja_A 38 ELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG----PSIETLHAANNNI 111 (487)
T ss_dssp EEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC----TTCCEEECCSSCC
T ss_pred EEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC----CCcCEEECcCCcC
Confidence 48999999999888999999999999999999997665 77775 99999999999888743 8999999999999
Q ss_pred ccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhh-cccccceEecccCcCCCCCCcc
Q 043333 80 SGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQ-NWTKLEKLFIEGSGLAGPIPSG 158 (809)
Q Consensus 80 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~ 158 (809)
++..+. .+++|++|+|++|+|++..|..++++++|+.|+|++|.|++.+|..+. .+++|+.|+|++|.|++..+
T Consensus 112 ~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~-- 186 (487)
T 3oja_A 112 SRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG-- 186 (487)
T ss_dssp CCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--
T ss_pred CCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--
Confidence 966554 468899999999999999899999999999999999999998888886 79999999999999996633
Q ss_pred ccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCC-CCCCCCCCC-CCc
Q 043333 159 IASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLS-GVIPSNFSG-SGL 236 (809)
Q Consensus 159 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~-~~L 236 (809)
+..+++|+.|++++|.++.+++. +..+++|+.|+|++|++.+ +|..+..+++|+.|+|++|.+. +.+|..+.. +.|
T Consensus 187 ~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L 264 (487)
T 3oja_A 187 QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264 (487)
T ss_dssp CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHH
T ss_pred cccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCC
Confidence 44699999999999999988765 8899999999999999997 6777999999999999999998 555555444 666
Q ss_pred cEEEee
Q 043333 237 TYMYLT 242 (809)
Q Consensus 237 ~~L~Ls 242 (809)
+.|+++
T Consensus 265 ~~l~~~ 270 (487)
T 3oja_A 265 QTVAKQ 270 (487)
T ss_dssp HHHHHH
T ss_pred cEEecc
Confidence 666664
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-23 Score=242.27 Aligned_cols=239 Identities=23% Similarity=0.275 Sum_probs=151.1
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeecccccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFS 80 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~ 80 (809)
+|++++|++. .+|..+. ++|++|+|++|.|+ .+|..+ -.|+.|++++|.+..+|. .+++|++|+|++|+++
T Consensus 44 ~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~~l--~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~l~ 114 (622)
T 3g06_A 44 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALP--PELRTLEVSGNQLTSLPV---LPPGLLELSIFSNPLT 114 (622)
T ss_dssp EEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCCCC--TTCCEEEECSCCCSCCCC---CCTTCCEEEECSCCCC
T ss_pred EEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCCcC--CCCCEEEcCCCcCCcCCC---CCCCCCEEECcCCcCC
Confidence 3788999988 7888776 78999999999998 455522 247889999999998887 6788999999999998
Q ss_pred cCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCcccc
Q 043333 81 GDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIA 160 (809)
Q Consensus 81 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 160 (809)
+ +|. .+++|++|+|++|+|++ +|.. +++|++|+|++|++++ +|.. +++|+.|+|++|+|++ +| .
T Consensus 115 ~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~---~ 178 (622)
T 3g06_A 115 H-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LP---M 178 (622)
T ss_dssp C-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CC---C
T ss_pred C-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCCc---cCCCCEEECCCCCCCC-Cc---c
Confidence 4 554 56788888888888884 5543 4788888888888884 3432 3455555555555552 33 2
Q ss_pred CCCCCCEEeccCCCCCCCCCcc--c--------------cCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCC
Q 043333 161 SLVELTDLRISDLNGPEGPFPR--L--------------SNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLS 224 (809)
Q Consensus 161 ~l~~L~~L~l~~n~l~~~~~~~--l--------------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 224 (809)
.+++|+.|++++|.++.++... + ..+++|+.|+|++|++++. | ..+++|+.|+|++|+|+
T Consensus 179 ~~~~L~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~L~~l-p---~~l~~L~~L~Ls~N~L~ 254 (622)
T 3g06_A 179 LPSGLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSL-P---VLPSELKELMVSGNRLT 254 (622)
T ss_dssp CCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCS
T ss_pred cCCCCcEEECCCCCCCCCCCccchhhEEECcCCcccccCCCCCCCCEEEccCCccCcC-C---CCCCcCcEEECCCCCCC
Confidence 3455555555555555433210 0 1124555566666555542 2 33455666666666665
Q ss_pred CCCCCCCCCCCccEEEeeCccCCCCCChhhhh-ccCccccccCCccccC
Q 043333 225 GVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDG 272 (809)
Q Consensus 225 ~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~ 272 (809)
.+++ ..++|+.|+|++|+|+ .+|..+.. .+++.|+|++|++++.
T Consensus 255 ~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~ 299 (622)
T 3g06_A 255 SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSER 299 (622)
T ss_dssp CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHH
T ss_pred cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCc
Confidence 4333 2355666666666666 33333332 4445666666665543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.2e-23 Score=213.31 Aligned_cols=177 Identities=13% Similarity=0.162 Sum_probs=94.6
Q ss_pred hcCCccCcEEeecccc-cccCCCccccCCCCCCEEEccC-CccCccCchhhhcccccceeeeecccccCcCchhhhcccc
Q 043333 63 VASISTLADLTLEFNQ-FSGDLPAELGNLINLEKLHLNS-NNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTK 140 (809)
Q Consensus 63 l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 140 (809)
+..+++|++|+|++|. +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+|++|++++ +|. |..+++
T Consensus 51 ~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~ 128 (239)
T 2xwt_C 51 FSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYS 128 (239)
T ss_dssp TTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCB
T ss_pred ccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccc
Confidence 3444555555555554 5544444555555555555555 55554444455555555555555555553 343 555555
Q ss_pred cc---eEecccC-cCCCCCCccccCCCCCC-EEeccCCCCCCCCCccccCCcCCceeeecccc-ccCCCChhhhcc-ccc
Q 043333 141 LE---KLFIEGS-GLAGPIPSGIASLVELT-DLRISDLNGPEGPFPRLSNLKNMNYLILRSGN-IIGEMPEYLGQM-IGL 213 (809)
Q Consensus 141 L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L 213 (809)
|+ .|++++| ++++..+..|..+++|+ .|++++|.++.++...+.. ++|+.|+|++|. +.+..+..|..+ ++|
T Consensus 129 L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L 207 (239)
T 2xwt_C 129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207 (239)
T ss_dssp CCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCC
T ss_pred cccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCC
Confidence 55 5555555 55544444455555555 5555555555555444444 555555555553 555555555555 555
Q ss_pred cEEeccCCCCCCCCCCCCCCCCccEEEeeCc
Q 043333 214 RVLDLSFNKLSGVIPSNFSGSGLTYMYLTGN 244 (809)
Q Consensus 214 ~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N 244 (809)
+.|+|++|+|+++++. ..++|+.|+++++
T Consensus 208 ~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 208 SLLDVSQTSVTALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp SEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred cEEECCCCccccCChh--HhccCceeeccCc
Confidence 5555555555544443 2245555555543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-23 Score=213.82 Aligned_cols=211 Identities=19% Similarity=0.194 Sum_probs=178.3
Q ss_pred cccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCc-cCccCchhhhcccccceeeeec-cc
Q 043333 49 LPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNN-FTGKLPESFANLTRLKHFRISD-NH 126 (809)
Q Consensus 49 L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~ 126 (809)
+.+..+.++.+|. +. ++|++|+|++|++++..+..|.++++|++|+|++|+ ++...+..|.++++|++|+|++ |+
T Consensus 16 ~~v~c~~l~~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~ 92 (239)
T 2xwt_C 16 FRVTCKDIQRIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92 (239)
T ss_dssp TEEEECSCSSCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETT
T ss_pred ceeEccCccccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCC
Confidence 3333444777887 43 489999999999997777789999999999999997 8877777899999999999999 99
Q ss_pred ccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCC---EEeccCC-CCCCCCCccccCCcCCc-eeeeccccccC
Q 043333 127 FTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELT---DLRISDL-NGPEGPFPRLSNLKNMN-YLILRSGNIIG 201 (809)
Q Consensus 127 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~l~~n-~l~~~~~~~l~~l~~L~-~L~Ls~N~l~~ 201 (809)
+++..+..|.++++|++|+|++|++++ +|. |..+++|+ .|++++| .++.++...|.++++|+ .|+|++|+++.
T Consensus 93 l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~ 170 (239)
T 2xwt_C 93 LTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS 170 (239)
T ss_dssp CCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCE
T ss_pred eeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcc
Confidence 997777889999999999999999996 666 88888888 9999999 99999988899999999 99999999986
Q ss_pred CCChhhhccccccEEeccCCC-CCCCCCCCCCC--CCccEEEeeCccCCCCCChhhhhccCccccccCC
Q 043333 202 EMPEYLGQMIGLRVLDLSFNK-LSGVIPSNFSG--SGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYN 267 (809)
Q Consensus 202 ~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N 267 (809)
..+..|.. ++|+.|+|++|+ ++++++..|.. ++|+.|+|++|++++.++. ....++.|+++++
T Consensus 171 i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 171 VQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp ECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred cCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCc
Confidence 55556666 899999999995 99888887764 6899999999999976655 3356778887765
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=225.17 Aligned_cols=227 Identities=18% Similarity=0.154 Sum_probs=182.2
Q ss_pred CCCCccccccccccCCC--Cch--hhcCCccCcEEeecccccccCCCccc--cCCCCCCEEEccCCccCccCc----hhh
Q 043333 42 ASLPLVNLPLWKQANGA--IPK--AVASISTLADLTLEFNQFSGDLPAEL--GNLINLEKLHLNSNNFTGKLP----ESF 111 (809)
Q Consensus 42 ~~l~L~~L~l~~n~~~~--ip~--~l~~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~ 111 (809)
..+.++.+.+.++.+.. +.. ....+++|++|+|++|.+++..|..+ ..+++|++|+|++|++++..+ ..+
T Consensus 62 ~~~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~ 141 (310)
T 4glp_A 62 KALRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQ 141 (310)
T ss_dssp SSCCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHT
T ss_pred hhcceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHh
Confidence 33345556665554422 111 12234679999999999999999888 899999999999999997655 445
Q ss_pred hcccccceeeeecccccCcCchhhhcccccceEecccCcCCCC--C--CccccCCCCCCEEeccCCCCCCCCCc---ccc
Q 043333 112 ANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGP--I--PSGIASLVELTDLRISDLNGPEGPFP---RLS 184 (809)
Q Consensus 112 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~l~~n~l~~~~~~---~l~ 184 (809)
..+++|++|+|++|++.+..|..|+.+++|++|+|++|++.+. + +..+..+++|++|++++|.++.++.. .+.
T Consensus 142 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~ 221 (310)
T 4glp_A 142 WLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAA 221 (310)
T ss_dssp TBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHH
T ss_pred hhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHh
Confidence 6799999999999999988889999999999999999998752 2 33457899999999999999765432 357
Q ss_pred CCcCCceeeeccccccCCCChhhhcc---ccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhhccCcc
Q 043333 185 NLKNMNYLILRSGNIIGEMPEYLGQM---IGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKH 261 (809)
Q Consensus 185 ~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~~ 261 (809)
++++|++|+|++|++.+..|..+..+ ++|++|+|++|+|+.+ |..+. ++|+.|+|++|+|++. |.......++.
T Consensus 222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~l-p~~~~-~~L~~L~Ls~N~l~~~-~~~~~l~~L~~ 298 (310)
T 4glp_A 222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQV-PKGLP-AKLRVLDLSSNRLNRA-PQPDELPEVDN 298 (310)
T ss_dssp HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSC-CSCCC-SCCSCEECCSCCCCSC-CCTTSCCCCSC
T ss_pred cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCch-hhhhc-CCCCEEECCCCcCCCC-chhhhCCCccE
Confidence 88999999999999999988887777 6999999999999965 44433 8999999999999975 33333467899
Q ss_pred ccccCCcccc
Q 043333 262 IDLSYNNFID 271 (809)
Q Consensus 262 L~Ls~N~l~~ 271 (809)
|+|++|+|+.
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 9999999975
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.8e-23 Score=214.63 Aligned_cols=202 Identities=17% Similarity=0.193 Sum_probs=160.3
Q ss_pred cccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeeccccc
Q 043333 49 LPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFT 128 (809)
Q Consensus 49 L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 128 (809)
+++.++.+..+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|+
T Consensus 19 l~~~~~~l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 96 (251)
T 3m19_A 19 VDCQGKSLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA 96 (251)
T ss_dssp EECTTCCCSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC
T ss_pred EecCCCCccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCccc
Confidence 3444444445554443 57899999999999888888999999999999999999888888999999999999999999
Q ss_pred CcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhh
Q 043333 129 GQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLG 208 (809)
Q Consensus 129 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 208 (809)
+..+..|..+++|++|+|++|+|++..+..|..+++|+.|++++|.++.++...|..+++|+.|+|++|++.+..+..|.
T Consensus 97 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 176 (251)
T 3m19_A 97 SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFD 176 (251)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHh
Confidence 87778889999999999999999977777788999999999999999999888899999999999999999999888999
Q ss_pred ccccccEEeccCCCCCCCCCCCCC------CCCccEEEeeCccCCCCCCh
Q 043333 209 QMIGLRVLDLSFNKLSGVIPSNFS------GSGLTYMYLTGNLLTGPVPD 252 (809)
Q Consensus 209 ~l~~L~~L~Ls~N~l~~~~p~~~~------~~~L~~L~Ls~N~l~~~~p~ 252 (809)
.+++|+.|+|++|+++....+... ....+..+..+|.+.+.++.
T Consensus 177 ~l~~L~~L~l~~N~~~c~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (251)
T 3m19_A 177 RLGKLQTITLFGNQFDCSRCEILYLSQWIRENSNKVKDGTGQNLHESPDG 226 (251)
T ss_dssp TCTTCCEEECCSCCBCTTSTTHHHHHHHHHHSGGGBCC-------CCGGG
T ss_pred CCCCCCEEEeeCCceeCCccccHHHHHHHHhcccceeeccCcccccCCCc
Confidence 999999999999999876443321 12333445566666654444
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.89 E-value=6.6e-26 Score=257.71 Aligned_cols=270 Identities=21% Similarity=0.203 Sum_probs=172.9
Q ss_pred ccccCCCCCc----cCCccCCCCCCCCEEEccCCCCCCCCCcccCC------CCccccccccccCCC-----CchhhcCC
Q 043333 2 RILKSQNLPG----RLPPELTRLPFLQEIDLTRNYLNGTIPSEWAS------LPLVNLPLWKQANGA-----IPKAVASI 66 (809)
Q Consensus 2 L~L~~nnl~~----~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~------l~L~~L~l~~n~~~~-----ip~~l~~l 66 (809)
|+|++|++.. .+|..+..+++|++|+|++|.++...+..+.. ..|++|++++|.+.. ++..+..+
T Consensus 90 L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~ 169 (461)
T 1z7x_W 90 LSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAK 169 (461)
T ss_dssp EECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHC
T ss_pred EEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhC
Confidence 5666666663 45666677777777777777765433332221 136667777766654 34555666
Q ss_pred ccCcEEeecccccccCCCcccc-----CCCCCCEEEccCCccCcc----CchhhhcccccceeeeecccccCcCc-----
Q 043333 67 STLADLTLEFNQFSGDLPAELG-----NLINLEKLHLNSNNFTGK----LPESFANLTRLKHFRISDNHFTGQIP----- 132 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p----- 132 (809)
++|++|+|++|.++...+..+. .+++|++|+|++|+++.. ++..+..+++|++|+|++|+++....
T Consensus 170 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~ 249 (461)
T 1z7x_W 170 PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCP 249 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHH
T ss_pred CCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHH
Confidence 7777777777777644333332 255777777777777753 45666677777777777777764322
Q ss_pred hhhhcccccceEecccCcCCCC----CCccccCCCCCCEEeccCCCCCCCCCcccc-----CCcCCceeeeccccccCC-
Q 043333 133 DYIQNWTKLEKLFIEGSGLAGP----IPSGIASLVELTDLRISDLNGPEGPFPRLS-----NLKNMNYLILRSGNIIGE- 202 (809)
Q Consensus 133 ~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~-----~l~~L~~L~Ls~N~l~~~- 202 (809)
..+..+++|++|+|++|+++.. ++..+..+++|+.|++++|.+.......+. ..++|+.|+|++|.+++.
T Consensus 250 ~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 329 (461)
T 1z7x_W 250 GLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC 329 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred HHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHH
Confidence 2223467777777777777743 455666677777788777776554433332 235788888888877765
Q ss_pred ---CChhhhccccccEEeccCCCCCCCCCCCCC------CCCccEEEeeCccCCC----CCChhhhh-ccCccccccCCc
Q 043333 203 ---MPEYLGQMIGLRVLDLSFNKLSGVIPSNFS------GSGLTYMYLTGNLLTG----PVPDWIVR-KRNKHIDLSYNN 268 (809)
Q Consensus 203 ---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~------~~~L~~L~Ls~N~l~~----~~p~~~~~-~~l~~L~Ls~N~ 268 (809)
++..+..+++|+.|+|++|++++..+..+. .++|+.|+|++|.+++ .+|..+.. ..++.|+|++|+
T Consensus 330 ~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~ 409 (461)
T 1z7x_W 330 CSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 409 (461)
T ss_dssp HHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSS
T ss_pred HHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCC
Confidence 456666778888888888887765443332 3578888888888875 55555433 566888888887
Q ss_pred ccc
Q 043333 269 FID 271 (809)
Q Consensus 269 l~~ 271 (809)
++.
T Consensus 410 i~~ 412 (461)
T 1z7x_W 410 LGD 412 (461)
T ss_dssp CCH
T ss_pred CCH
Confidence 765
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.6e-24 Score=234.84 Aligned_cols=253 Identities=15% Similarity=0.126 Sum_probs=178.3
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCc-cCcEEeecccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASIS-TLADLTLEFNQFS 80 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~-~L~~L~L~~N~l~ 80 (809)
+.|++|++++.+|..+...++|++|||++|.++...+.. +...+..++ +|++|+|++|.++
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~------------------l~~~l~~~~~~L~~L~Ls~N~l~ 64 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVE------------------LIQAFANTPASVTSLNLSGNSLG 64 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHH------------------HHHHHHTCCTTCCEEECCSSCGG
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHH------------------HHHHHHhCCCceeEEECcCCCCC
Confidence 568889999988888888888999999999988544311 113456666 7888888888888
Q ss_pred cCCCccccCC-----CCCCEEEccCCccCccCchhhhcc-----cccceeeeecccccCcCchhhhc-----ccccceEe
Q 043333 81 GDLPAELGNL-----INLEKLHLNSNNFTGKLPESFANL-----TRLKHFRISDNHFTGQIPDYIQN-----WTKLEKLF 145 (809)
Q Consensus 81 ~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~ 145 (809)
+..+..+..+ ++|++|+|++|++++..+..+..+ ++|++|+|++|++++..+..+.. .++|++|+
T Consensus 65 ~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~ 144 (362)
T 3goz_A 65 FKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLN 144 (362)
T ss_dssp GSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEE
T ss_pred HHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEE
Confidence 7666666654 788888888888887666655443 78888888888887666655543 25888888
Q ss_pred cccCcCCCCCCc----cccCCC-CCCEEeccCCCCCCCCCccc----cCC-cCCceeeeccccccCC----CChhhhc-c
Q 043333 146 IEGSGLAGPIPS----GIASLV-ELTDLRISDLNGPEGPFPRL----SNL-KNMNYLILRSGNIIGE----MPEYLGQ-M 210 (809)
Q Consensus 146 L~~N~l~~~~p~----~~~~l~-~L~~L~l~~n~l~~~~~~~l----~~l-~~L~~L~Ls~N~l~~~----~p~~~~~-l 210 (809)
|++|+++...+. .+..++ +|+.|++++|.++......+ ..+ ++|+.|+|++|.+... ++..+.. .
T Consensus 145 Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~ 224 (362)
T 3goz_A 145 LRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIP 224 (362)
T ss_dssp CTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSC
T ss_pred ccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCC
Confidence 888888754433 334454 78888888888877765443 344 5888888888888774 3445555 3
Q ss_pred ccccEEeccCCCCCCCCCC----CCCC-CCccEEEeeCccCCCCCChhhh--------hccCccccccCCccccC
Q 043333 211 IGLRVLDLSFNKLSGVIPS----NFSG-SGLTYMYLTGNLLTGPVPDWIV--------RKRNKHIDLSYNNFIDG 272 (809)
Q Consensus 211 ~~L~~L~Ls~N~l~~~~p~----~~~~-~~L~~L~Ls~N~l~~~~p~~~~--------~~~l~~L~Ls~N~l~~~ 272 (809)
++|+.|+|++|+|++..+. .+.. ++|+.|+|++|.+.+..+..+. ..+++.||+++|++...
T Consensus 225 ~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 225 NHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp TTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred CCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 5888888888888876552 2233 7888888888886655544222 13467788888887653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-25 Score=256.08 Aligned_cols=273 Identities=18% Similarity=0.174 Sum_probs=196.2
Q ss_pred ccccCCCCCc----cCCccCCCCCCCCEEEccCCCCCCCCCcccC-CC-----CccccccccccCC-----CCchhhcCC
Q 043333 2 RILKSQNLPG----RLPPELTRLPFLQEIDLTRNYLNGTIPSEWA-SL-----PLVNLPLWKQANG-----AIPKAVASI 66 (809)
Q Consensus 2 L~L~~nnl~~----~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~-~l-----~L~~L~l~~n~~~-----~ip~~l~~l 66 (809)
|+|++|++.. .++..+..+++|++|+|++|.++...+..+. .+ .|++|++++|.++ .+|..+..+
T Consensus 33 L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~ 112 (461)
T 1z7x_W 33 VRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTL 112 (461)
T ss_dssp EEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSC
T ss_pred EEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccC
Confidence 6777777764 4566677778888888888887754333322 22 3788888888877 457778888
Q ss_pred ccCcEEeecccccccCCCccc-----cCCCCCCEEEccCCccCccC----chhhhcccccceeeeecccccCcCchhhhc
Q 043333 67 STLADLTLEFNQFSGDLPAEL-----GNLINLEKLHLNSNNFTGKL----PESFANLTRLKHFRISDNHFTGQIPDYIQN 137 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 137 (809)
++|++|+|++|.+++..+..+ ..+++|++|+|++|++++.. +..+..+++|++|+|++|.+....+..+..
T Consensus 113 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~ 192 (461)
T 1z7x_W 113 PTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQ 192 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHH
T ss_pred CceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHH
Confidence 888888888888875434332 23567888888888888633 556667788888888888887555544433
Q ss_pred -----ccccceEecccCcCCCC----CCccccCCCCCCEEeccCCCCCCCCCcc-----ccCCcCCceeeeccccccCC-
Q 043333 138 -----WTKLEKLFIEGSGLAGP----IPSGIASLVELTDLRISDLNGPEGPFPR-----LSNLKNMNYLILRSGNIIGE- 202 (809)
Q Consensus 138 -----l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~n~l~~~~~~~-----l~~l~~L~~L~Ls~N~l~~~- 202 (809)
.++|+.|+|++|+++.. ++..+..+++|+.|++++|.+....... +..+++|++|+|++|+++..
T Consensus 193 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~ 272 (461)
T 1z7x_W 193 GLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKG 272 (461)
T ss_dssp HHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred HHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHH
Confidence 56888999999888864 4667778889999999998876644322 23578899999999988875
Q ss_pred ---CChhhhccccccEEeccCCCCCCCCCCCCC-----C-CCccEEEeeCccCCCCC----Chhhhh-ccCccccccCCc
Q 043333 203 ---MPEYLGQMIGLRVLDLSFNKLSGVIPSNFS-----G-SGLTYMYLTGNLLTGPV----PDWIVR-KRNKHIDLSYNN 268 (809)
Q Consensus 203 ---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~-~~L~~L~Ls~N~l~~~~----p~~~~~-~~l~~L~Ls~N~ 268 (809)
++..+..+++|++|+|++|.+++..+..+. . ++|+.|+|++|.+++.. +..+.. ..++.|+|++|+
T Consensus 273 ~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 352 (461)
T 1z7x_W 273 CGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNR 352 (461)
T ss_dssp HHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSB
T ss_pred HHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCc
Confidence 577778889999999999988654433222 1 58899999999888653 333332 577888999998
Q ss_pred cccCCC
Q 043333 269 FIDGSS 274 (809)
Q Consensus 269 l~~~~~ 274 (809)
++...+
T Consensus 353 i~~~~~ 358 (461)
T 1z7x_W 353 LEDAGV 358 (461)
T ss_dssp CHHHHH
T ss_pred cccccH
Confidence 876543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=8.1e-24 Score=230.08 Aligned_cols=250 Identities=16% Similarity=0.177 Sum_probs=177.2
Q ss_pred CCCEEEccCCCCCCCCCcccCCC---CccccccccccCCCCchhhcCCccCcEEeecccccccC-CCccccCCCCCCEEE
Q 043333 22 FLQEIDLTRNYLNGTIPSEWASL---PLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGD-LPAELGNLINLEKLH 97 (809)
Q Consensus 22 ~L~~L~Ls~n~l~~~~p~~~~~l---~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ 97 (809)
.+++||+++|.+. +..+..+ .++.|++.+|.+...+..+..+++|++|+|++|.+++. ++..+..+++|++|+
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 3677777777766 2333332 36677777777777766677788888888888888755 677778888888888
Q ss_pred ccCCccCccCchhhhcccccceeeeecc-cccCc-CchhhhcccccceEecccC-cCCCC-CCccccCCC-CCCEEeccC
Q 043333 98 LNSNNFTGKLPESFANLTRLKHFRISDN-HFTGQ-IPDYIQNWTKLEKLFIEGS-GLAGP-IPSGIASLV-ELTDLRISD 172 (809)
Q Consensus 98 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~L~~L~l~~ 172 (809)
|++|++++..+..++.+++|++|+|++| .+++. ++..+.++++|++|+|++| .+++. ++..+..++ +|+.|++++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 8888888777778888888888888888 56642 5666778888888888888 77753 466677788 888888888
Q ss_pred C--CCCCCC-CccccCCcCCceeeecccc-ccCCCChhhhccccccEEeccCCCCCCCCCC---CCCC-CCccEEEeeCc
Q 043333 173 L--NGPEGP-FPRLSNLKNMNYLILRSGN-IIGEMPEYLGQMIGLRVLDLSFNKLSGVIPS---NFSG-SGLTYMYLTGN 244 (809)
Q Consensus 173 n--~l~~~~-~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~-~~L~~L~Ls~N 244 (809)
| .++... +..+.++++|+.|+|++|. ++...+..+..+++|+.|+|++|. +..+. .+.. ++|+.|+|++|
T Consensus 205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCHHHHHHHhcCCCCCEEeccCc
Confidence 8 343221 2345678888888888888 666777788888888888888885 23333 2333 88888888888
Q ss_pred cCCCCCChhhhhccCccccccCCccccCCCCCcc
Q 043333 245 LLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNC 278 (809)
Q Consensus 245 ~l~~~~p~~~~~~~l~~L~Ls~N~l~~~~~~~~~ 278 (809)
++...-..+. ..+..|++++|++++..+....
T Consensus 283 -i~~~~~~~l~-~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 283 -VPDGTLQLLK-EALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp -SCTTCHHHHH-HHSTTSEESCCCSCCTTCSSCS
T ss_pred -cCHHHHHHHH-hhCcceEEecccCccccCCccc
Confidence 3322211111 2467888888888887665554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.8e-21 Score=224.00 Aligned_cols=218 Identities=22% Similarity=0.188 Sum_probs=178.1
Q ss_pred CCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCC
Q 043333 22 FLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSN 101 (809)
Q Consensus 22 ~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 101 (809)
++++|++++|.|+ .+|..+. -.|+.|++++|.+..||. .+++|++|+|++|+|+ .+|. .+++|++|+|++|
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~-~~L~~L~L~~N~l~~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N 111 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP-AHITTLVIPDNNLTSLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSN 111 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC-TTCSEEEECSCCCSCCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSC
T ss_pred CCcEEEecCCCcC-ccChhhC-CCCcEEEecCCCCCCCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCC
Confidence 5899999999999 6777665 458999999999999998 6789999999999999 5665 6799999999999
Q ss_pred ccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCc
Q 043333 102 NFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181 (809)
Q Consensus 102 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~ 181 (809)
+|++ +|. .+++|+.|+|++|+|++ +|.. +++|++|+|++|++++ +|. .+.+|+.|++++|.++.++
T Consensus 112 ~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~l~-- 177 (622)
T 3g06_A 112 PLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTSLP-- 177 (622)
T ss_dssp CCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCC--
T ss_pred cCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCCCc--
Confidence 9995 454 67899999999999995 6653 5899999999999995 454 3578999999999999987
Q ss_pred cccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhhccCcc
Q 043333 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKH 261 (809)
Q Consensus 182 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~~ 261 (809)
..+++|+.|+|++|++++..+ .+++|+.|++++|.|+.++.. .++|+.|+|++|.|++. |.. ..+++.
T Consensus 178 --~~~~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~l~~~---~~~L~~L~Ls~N~L~~l-p~~--l~~L~~ 245 (622)
T 3g06_A 178 --MLPSGLQELSVSDNQLASLPT----LPSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTSL-PVL--PSELKE 245 (622)
T ss_dssp --CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCC-CCC--CTTCCE
T ss_pred --ccCCCCcEEECCCCCCCCCCC----ccchhhEEECcCCcccccCCC---CCCCCEEEccCCccCcC-CCC--CCcCcE
Confidence 567899999999999987433 247888888888888865432 27788888888888863 322 256788
Q ss_pred ccccCCccccCCC
Q 043333 262 IDLSYNNFIDGSS 274 (809)
Q Consensus 262 L~Ls~N~l~~~~~ 274 (809)
|+|++|.++..+.
T Consensus 246 L~Ls~N~L~~lp~ 258 (622)
T 3g06_A 246 LMVSGNRLTSLPM 258 (622)
T ss_dssp EECCSSCCSCCCC
T ss_pred EECCCCCCCcCCc
Confidence 8888888886544
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=8.6e-22 Score=211.63 Aligned_cols=173 Identities=25% Similarity=0.363 Sum_probs=105.5
Q ss_pred hcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccc
Q 043333 63 VASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLE 142 (809)
Q Consensus 63 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 142 (809)
+..+++|++|+|++|.+++ ++. +..+++|++|+|++|++++ ++ .+..+++|++|+|++|++++ ++. +..+++|+
T Consensus 59 ~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~ 132 (308)
T 1h6u_A 59 VQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQ 132 (308)
T ss_dssp GGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCC
T ss_pred hhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCC
Confidence 4455666666666666663 333 6666666666666666663 23 46666666666666666664 232 66666666
Q ss_pred eEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCC
Q 043333 143 KLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNK 222 (809)
Q Consensus 143 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 222 (809)
.|+|++|++++..+ +..+++|+.|++++|.+..++. +..+++|+.|+|++|++.+..+ +..+++|+.|+|++|+
T Consensus 133 ~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~ 206 (308)
T 1h6u_A 133 VLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ 206 (308)
T ss_dssp EEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSC
T ss_pred EEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCc
Confidence 66666666664322 5666666666666666665443 6666666666666666665543 6666677777777777
Q ss_pred CCCCCCCCCCCCCccEEEeeCccCCC
Q 043333 223 LSGVIPSNFSGSGLTYMYLTGNLLTG 248 (809)
Q Consensus 223 l~~~~p~~~~~~~L~~L~Ls~N~l~~ 248 (809)
+++.++ ....++|+.|+|++|++++
T Consensus 207 l~~~~~-l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 207 ISDVSP-LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCBCGG-GTTCTTCCEEEEEEEEEEC
T ss_pred cCcccc-ccCCCCCCEEEccCCeeec
Confidence 766553 2223667777777776664
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=5.6e-22 Score=213.10 Aligned_cols=208 Identities=20% Similarity=0.270 Sum_probs=179.6
Q ss_pred ccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeecccccccC
Q 043333 4 LKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGD 82 (809)
Q Consensus 4 L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~ 82 (809)
+..+++...++ +..+++|++|++++|.++. ++ .+..++ |+.|++++|.+..++. +..+++|++|+|++|.+++
T Consensus 26 l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~- 99 (308)
T 1h6u_A 26 AGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKN- 99 (308)
T ss_dssp TTCSSTTSEEC--HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSC-
T ss_pred hCCCCcCceec--HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCC-
Confidence 44455554332 4568899999999999985 44 566665 9999999999999988 9999999999999999995
Q ss_pred CCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCC
Q 043333 83 LPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASL 162 (809)
Q Consensus 83 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 162 (809)
++ .+..+++|++|+|++|++++ ++ .+..+++|++|+|++|++++..+ +..+++|+.|+|++|++++..+ +..+
T Consensus 100 ~~-~~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l 172 (308)
T 1h6u_A 100 VS-AIAGLQSIKTLDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANL 172 (308)
T ss_dssp CG-GGTTCTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTC
T ss_pred ch-hhcCCCCCCEEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCC
Confidence 44 69999999999999999996 44 39999999999999999996544 8999999999999999996443 8999
Q ss_pred CCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCC
Q 043333 163 VELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIP 228 (809)
Q Consensus 163 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 228 (809)
++|+.|++++|.+..++. +..+++|+.|+|++|++.+..+ +..+++|+.|+|++|++++.+.
T Consensus 173 ~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~~ 234 (308)
T 1h6u_A 173 SKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV 234 (308)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCCE
T ss_pred CCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecCCe
Confidence 999999999999998764 8999999999999999998774 8999999999999999986543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=4.8e-24 Score=236.79 Aligned_cols=243 Identities=19% Similarity=0.183 Sum_probs=158.6
Q ss_pred cCCccCCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeeccc---ccccCCCccc-
Q 043333 12 RLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFN---QFSGDLPAEL- 87 (809)
Q Consensus 12 ~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N---~l~~~~p~~~- 87 (809)
.++..+..+++|++|+|++|.++...+.. ++..+..+++|++|+|++| ++++.+|..+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~------------------l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~ 84 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARW------------------LSENIASKKDLEIAEFSDIFTGRVKDEIPEALR 84 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHH------------------HHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHH------------------HHHHHHhCCCccEEeCcccccCccccchhHHHH
Confidence 56677778888999999999887543322 2233455667777777764 3444444443
Q ss_pred ------cCCCCCCEEEccCCccCc----cCchhhhcccccceeeeecccccCcCchhhh----cc---------cccceE
Q 043333 88 ------GNLINLEKLHLNSNNFTG----KLPESFANLTRLKHFRISDNHFTGQIPDYIQ----NW---------TKLEKL 144 (809)
Q Consensus 88 ------~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l---------~~L~~L 144 (809)
..+++|++|+|++|+++. .+|..+.++++|++|+|++|.++...+..+. .+ ++|++|
T Consensus 85 ~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L 164 (386)
T 2ca6_A 85 LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 164 (386)
T ss_dssp HHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEE
T ss_pred HHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEE
Confidence 566777777777777775 3566667777777777777777643333333 33 677777
Q ss_pred ecccCcCC-CCCC---ccccCCCCCCEEeccCCCCCCC-----CCccccCCcCCceeeecccccc----CCCChhhhccc
Q 043333 145 FIEGSGLA-GPIP---SGIASLVELTDLRISDLNGPEG-----PFPRLSNLKNMNYLILRSGNII----GEMPEYLGQMI 211 (809)
Q Consensus 145 ~L~~N~l~-~~~p---~~~~~l~~L~~L~l~~n~l~~~-----~~~~l~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~ 211 (809)
+|++|+++ +.++ ..+..+++|+.|++++|.+... ....+..+++|+.|+|++|.++ ..+|..+..++
T Consensus 165 ~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~ 244 (386)
T 2ca6_A 165 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 244 (386)
T ss_dssp ECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred ECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCC
Confidence 77777776 2333 3555667777777777766532 1125667777777777777775 55677777777
Q ss_pred cccEEeccCCCCCCC----CCCCC---CCCCccEEEeeCccCCC----CCChhh-hh-ccCccccccCCccccC
Q 043333 212 GLRVLDLSFNKLSGV----IPSNF---SGSGLTYMYLTGNLLTG----PVPDWI-VR-KRNKHIDLSYNNFIDG 272 (809)
Q Consensus 212 ~L~~L~Ls~N~l~~~----~p~~~---~~~~L~~L~Ls~N~l~~----~~p~~~-~~-~~l~~L~Ls~N~l~~~ 272 (809)
+|+.|+|++|+|++. ++..+ ..++|+.|+|++|.+++ .+|..+ .. .+++.|+|++|++++.
T Consensus 245 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~ 318 (386)
T 2ca6_A 245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 318 (386)
T ss_dssp TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred CcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcc
Confidence 888888888877655 33332 13777888888888776 355555 32 6677888888877654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=209.98 Aligned_cols=222 Identities=19% Similarity=0.161 Sum_probs=158.9
Q ss_pred CCCEEEccCCCCCCCCC----cccCCCCccccccccccCC-CCchhh--cCCccCcEEeecccccccCCC----ccccCC
Q 043333 22 FLQEIDLTRNYLNGTIP----SEWASLPLVNLPLWKQANG-AIPKAV--ASISTLADLTLEFNQFSGDLP----AELGNL 90 (809)
Q Consensus 22 ~L~~L~Ls~n~l~~~~p----~~~~~l~L~~L~l~~n~~~-~ip~~l--~~l~~L~~L~L~~N~l~~~~p----~~~~~l 90 (809)
.++.|++.++.+..... ..+....|++|++++|.+. .+|..+ ..+++|++|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 46777777777653111 1111223777888777765 446666 778888888888888886555 344567
Q ss_pred CCCCEEEccCCccCccCchhhhcccccceeeeecccccCc--C--chhhhcccccceEecccCcCCCCCCc----cccCC
Q 043333 91 INLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQ--I--PDYIQNWTKLEKLFIEGSGLAGPIPS----GIASL 162 (809)
Q Consensus 91 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l 162 (809)
++|++|+|++|++++..|..|+++++|++|+|++|++.+. + +..+..+++|++|+|++|+++ .++. .+..+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence 8888888888888877777888888888888888887642 2 222467788888888888886 3333 24677
Q ss_pred CCCCEEeccCCCCCCCCCccccCC---cCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEE
Q 043333 163 VELTDLRISDLNGPEGPFPRLSNL---KNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYM 239 (809)
Q Consensus 163 ~~L~~L~l~~n~l~~~~~~~l~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L 239 (809)
++|++|++++|.+....+..+..+ ++|++|+|++|+++ .+|..+. ++|+.|+|++|+|++. |.....++|+.|
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L 299 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDNL 299 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSCE
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccEE
Confidence 888888888888888765555555 68889999988888 4565553 7899999999999876 333334889999
Q ss_pred EeeCccCCC
Q 043333 240 YLTGNLLTG 248 (809)
Q Consensus 240 ~Ls~N~l~~ 248 (809)
+|++|+++.
T Consensus 300 ~L~~N~l~~ 308 (310)
T 4glp_A 300 TLDGNPFLV 308 (310)
T ss_dssp ECSSTTTSC
T ss_pred ECcCCCCCC
Confidence 999999874
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.2e-22 Score=211.91 Aligned_cols=151 Identities=18% Similarity=0.088 Sum_probs=120.2
Q ss_pred HHHHHhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcc------------------cchhHHHHHHHHhhcCC
Q 043333 569 QIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQ------------------GNREFVNEIGMISALQH 630 (809)
Q Consensus 569 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~------------------~~~~f~~Ei~~l~~l~H 630 (809)
.+......|...+.||+|+||.||+|...+|+.||||+++..... ....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 334445567777999999999999999977999999998643211 2345889999999999
Q ss_pred CceEeEEeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043333 631 PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVL 710 (809)
Q Consensus 631 ~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL 710 (809)
| +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||+|||+. +|+||||||+|||
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 4 666665543 45699999999999998 511 12446999999999999998 8999999999999
Q ss_pred EcCCCceEEEecCCccccCCCCcceeccccccccccchhhhc
Q 043333 711 LDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM 752 (809)
Q Consensus 711 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 752 (809)
++ ++.+||+|||+|+. +..|+|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99 99999999999863 23578999874
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.85 E-value=6.7e-23 Score=222.79 Aligned_cols=248 Identities=19% Similarity=0.224 Sum_probs=200.2
Q ss_pred ccccCCCCCccCCccCCCC--CCCCEEEccCCCCCCCCCcccCCCCccccccccccCCC--CchhhcCCccCcEEeeccc
Q 043333 2 RILKSQNLPGRLPPELTRL--PFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGA--IPKAVASISTLADLTLEFN 77 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l--~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~--ip~~l~~l~~L~~L~L~~N 77 (809)
++++++++. |..+..+ ++++.|++++|.+.+..+..+....|+.|++++|.+.. +|..+..+++|++|+|++|
T Consensus 52 l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~ 128 (336)
T 2ast_B 52 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 128 (336)
T ss_dssp EECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred eccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCc
Confidence 567777766 4556666 88999999999999877775544459999999988764 7888899999999999999
Q ss_pred ccccCCCccccCCCCCCEEEccCC-ccCc-cCchhhhcccccceeeeecc-cccCc-Cchhhhccc-ccceEecccC--c
Q 043333 78 QFSGDLPAELGNLINLEKLHLNSN-NFTG-KLPESFANLTRLKHFRISDN-HFTGQ-IPDYIQNWT-KLEKLFIEGS--G 150 (809)
Q Consensus 78 ~l~~~~p~~~~~l~~L~~L~L~~N-~l~~-~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~-~L~~L~L~~N--~ 150 (809)
.+++..+..++.+++|++|+|++| .+++ .++..+.++++|++|+|++| .+++. ++..+..++ +|++|+|++| .
T Consensus 129 ~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~ 208 (336)
T 2ast_B 129 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 208 (336)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGG
T ss_pred ccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCccc
Confidence 998888888999999999999999 6875 36777889999999999999 88854 677788999 9999999999 4
Q ss_pred CC-CCCCccccCCCCCCEEeccCCC-CCCCCCccccCCcCCceeeecccc-ccCCCChhhhccccccEEeccCCCCCCCC
Q 043333 151 LA-GPIPSGIASLVELTDLRISDLN-GPEGPFPRLSNLKNMNYLILRSGN-IIGEMPEYLGQMIGLRVLDLSFNKLSGVI 227 (809)
Q Consensus 151 l~-~~~p~~~~~l~~L~~L~l~~n~-l~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 227 (809)
++ +.+|..+..+++|+.|++++|. ++...+..+.++++|+.|+|++|. +.......+.++++|+.|+|++| ++
T Consensus 209 ~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~--- 284 (336)
T 2ast_B 209 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP--- 284 (336)
T ss_dssp SCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---
T ss_pred CCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---
Confidence 55 4556777889999999999998 676777788999999999999996 22222236888999999999999 32
Q ss_pred CCCCCC--CCccEEEeeCccCCCCCChhhhh
Q 043333 228 PSNFSG--SGLTYMYLTGNLLTGPVPDWIVR 256 (809)
Q Consensus 228 p~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~ 256 (809)
...+.. .+|+.|++++|++++..|..+..
T Consensus 285 ~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 285 DGTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence 222322 45788889999999988877654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=9.9e-21 Score=207.19 Aligned_cols=239 Identities=16% Similarity=0.110 Sum_probs=178.6
Q ss_pred CEEEccCCCCCCCCCcccCCCCccccccccccCCCCch-hhcCCccCcEEeecccccccCCC-ccccCCCCCCE-EEccC
Q 043333 24 QEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPK-AVASISTLADLTLEFNQFSGDLP-AELGNLINLEK-LHLNS 100 (809)
Q Consensus 24 ~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~-~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L~~ 100 (809)
++++.++++++ .+|..+. -.+++|++++|.++.||. +|.++++|++|+|++|++.+.+| ..|.++++|++ +.++.
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~-~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP-RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC-TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred CEEEecCCCCC-ccCcCcC-CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 56777777777 4555442 136677777777777775 57888999999999999866555 46888888775 66677
Q ss_pred CccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEeccc-CcCCCCCCccccCCC-CCCEEeccCCCCCCC
Q 043333 101 NNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEG-SGLAGPIPSGIASLV-ELTDLRISDLNGPEG 178 (809)
Q Consensus 101 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~l~~n~l~~~ 178 (809)
|+++.+.|..|.++++|++|++++|+|+...+..+....++..|++.+ |++....+..|..+. .|+.|++++|.++.+
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i 169 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 169 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCC
Confidence 899988788899999999999999999877777777778888888865 567755566777765 688899999999988
Q ss_pred CCccccCCcCCceeeeccc-cccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhhc
Q 043333 179 PFPRLSNLKNMNYLILRSG-NIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRK 257 (809)
Q Consensus 179 ~~~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~ 257 (809)
+...|. ..+|+.|++++| .+....++.|.++++|+.|||++|+|+.+++..+ .+|+.|.+.++.--..+|..-...
T Consensus 170 ~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~--~~L~~L~~l~~~~l~~lP~l~~l~ 246 (350)
T 4ay9_X 170 HNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL--ENLKKLRARSTYNLKKLPTLEKLV 246 (350)
T ss_dssp CTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSC--TTCCEEECTTCTTCCCCCCTTTCC
T ss_pred Chhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhh--ccchHhhhccCCCcCcCCCchhCc
Confidence 876664 467999999864 4554445678999999999999999998877654 466777765554444566544446
Q ss_pred cCccccccCC
Q 043333 258 RNKHIDLSYN 267 (809)
Q Consensus 258 ~l~~L~Ls~N 267 (809)
+++.++++++
T Consensus 247 ~L~~l~l~~~ 256 (350)
T 4ay9_X 247 ALMEASLTYP 256 (350)
T ss_dssp SCCEEECSCH
T ss_pred ChhhCcCCCC
Confidence 6777787643
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.84 E-value=9.5e-23 Score=226.34 Aligned_cols=236 Identities=19% Similarity=0.240 Sum_probs=185.5
Q ss_pred CccccCCCCCcc----CCccCCCCCCCCEEEccCCCCC---CCCCcccCCCCccccccccccCCCCchhhcCCccCcEEe
Q 043333 1 HRILKSQNLPGR----LPPELTRLPFLQEIDLTRNYLN---GTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLT 73 (809)
Q Consensus 1 ~L~L~~nnl~~~----lp~~l~~l~~L~~L~Ls~n~l~---~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~ 73 (809)
+|+|++|++... ++..|..+++|++|+|++|.+. +.+|..+ ..+...+..+++|++|+
T Consensus 36 ~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~---------------~~l~~~l~~~~~L~~L~ 100 (386)
T 2ca6_A 36 EIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL---------------RLLLQALLKCPKLHTVR 100 (386)
T ss_dssp EEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHH---------------HHHHHHHTTCTTCCEEE
T ss_pred EEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHH---------------HHHHHHHhhCCcccEEE
Confidence 478999999876 4455889999999999997655 2223221 12234557889999999
Q ss_pred eccccccc----CCCccccCCCCCCEEEccCCccCccCchhhh----cc---------cccceeeeeccccc-CcCc---
Q 043333 74 LEFNQFSG----DLPAELGNLINLEKLHLNSNNFTGKLPESFA----NL---------TRLKHFRISDNHFT-GQIP--- 132 (809)
Q Consensus 74 L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~Ls~N~l~-~~~p--- 132 (809)
|++|.+++ .+|..+..+++|++|+|++|.|+...+..+. .+ ++|++|+|++|+++ +.++
T Consensus 101 Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~ 180 (386)
T 2ca6_A 101 LSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 180 (386)
T ss_dssp CCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHH
T ss_pred CCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHH
Confidence 99999986 4677888999999999999999854444444 44 89999999999997 4455
Q ss_pred hhhhcccccceEecccCcCCC-----CCCccccCCCCCCEEeccCCCCC----CCCCccccCCcCCceeeeccccccCC-
Q 043333 133 DYIQNWTKLEKLFIEGSGLAG-----PIPSGIASLVELTDLRISDLNGP----EGPFPRLSNLKNMNYLILRSGNIIGE- 202 (809)
Q Consensus 133 ~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~l~~n~l~----~~~~~~l~~l~~L~~L~Ls~N~l~~~- 202 (809)
..+..+++|+.|+|++|+++. ..|..+..+++|+.|+|++|.++ ..-+..+..+++|+.|+|++|.+.+.
T Consensus 181 ~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 260 (386)
T 2ca6_A 181 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARG 260 (386)
T ss_dssp HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHH
T ss_pred HHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhh
Confidence 467788999999999999872 34457888999999999999985 22234678899999999999999877
Q ss_pred ---CChhhhc--cccccEEeccCCCCCC----CCCCCC-C-CCCccEEEeeCccCCCCCC
Q 043333 203 ---MPEYLGQ--MIGLRVLDLSFNKLSG----VIPSNF-S-GSGLTYMYLTGNLLTGPVP 251 (809)
Q Consensus 203 ---~p~~~~~--l~~L~~L~Ls~N~l~~----~~p~~~-~-~~~L~~L~Ls~N~l~~~~p 251 (809)
++..+.. +++|+.|+|++|+|++ .+|..+ . .++|+.|+|++|++++..+
T Consensus 261 ~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 261 AAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 5666644 8999999999999998 355554 4 3899999999999998775
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=206.64 Aligned_cols=216 Identities=18% Similarity=0.153 Sum_probs=175.4
Q ss_pred ccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCc-hhhhcccccce-eeee
Q 043333 46 LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLP-ESFANLTRLKH-FRIS 123 (809)
Q Consensus 46 L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~Ls 123 (809)
...++.+++.+.+||..+. +++++|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++|+. +.++
T Consensus 11 ~~~v~C~~~~Lt~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 11 NRVFLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TTEEEEESTTCCSCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CCEEEecCCCCCccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 4567778889999998773 689999999999996556689999999999999999876555 46888988775 6777
Q ss_pred cccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccC-CCCCCCCCccccCCc-CCceeeeccccccC
Q 043333 124 DNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD-LNGPEGPFPRLSNLK-NMNYLILRSGNIIG 201 (809)
Q Consensus 124 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-n~l~~~~~~~l~~l~-~L~~L~Ls~N~l~~ 201 (809)
.|+|+...|..|.++++|+.|++++|+++...+..+....++..|++.+ +.+..++...|..+. .++.|+|++|+++.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 8999988888999999999999999999977777777888888999865 678888888888775 68899999999987
Q ss_pred CCChhhhccccccEEeccC-CCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhhccCccccccC
Q 043333 202 EMPEYLGQMIGLRVLDLSF-NKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSY 266 (809)
Q Consensus 202 ~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~ 266 (809)
+.+..|. ..+|+.|++++ |.++.++++.|.. ++|+.|+|++|+|+..++..+. .++.|.+.+
T Consensus 169 i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~--~L~~L~~l~ 232 (350)
T 4ay9_X 169 IHNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE--NLKKLRARS 232 (350)
T ss_dssp ECTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT--TCCEEECTT
T ss_pred CChhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc--cchHhhhcc
Confidence 6666664 56899999974 7788777778777 9999999999999977665543 445554433
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=2e-20 Score=188.78 Aligned_cols=177 Identities=16% Similarity=0.141 Sum_probs=114.6
Q ss_pred cEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccC
Q 043333 70 ADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGS 149 (809)
Q Consensus 70 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 149 (809)
+.++++++.++ .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 45556666665 344333 245666666666666555555666666666666666666554555566666666666666
Q ss_pred cCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCC
Q 043333 150 GLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPS 229 (809)
Q Consensus 150 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 229 (809)
++++..+..|..+++|+.|++++|.++.++...|.++++|+.|+|++|++++..+..|..+++|+.|+|++|.+.+..
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~-- 164 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC-- 164 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT--
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCC--
Confidence 666554555666666666666666666666666667777777777777777766666777777777777777766432
Q ss_pred CCCCCCccEEEeeCccCCCCCChhhh
Q 043333 230 NFSGSGLTYMYLTGNLLTGPVPDWIV 255 (809)
Q Consensus 230 ~~~~~~L~~L~Ls~N~l~~~~p~~~~ 255 (809)
++|++|+++.|+++|.+|..+.
T Consensus 165 ----~~l~~L~~~~n~~~g~ip~~~~ 186 (208)
T 2o6s_A 165 ----PGIRYLSEWINKHSGVVRNSAG 186 (208)
T ss_dssp ----TTTHHHHHHHHHCTTTBBCTTS
T ss_pred ----CCHHHHHHHHHhCCceeeccCc
Confidence 4677777777777777776654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.3e-20 Score=215.57 Aligned_cols=185 Identities=20% Similarity=0.233 Sum_probs=100.9
Q ss_pred cCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecc
Q 043333 68 TLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIE 147 (809)
Q Consensus 68 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 147 (809)
+|+.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +.+ +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 56666666666663 444332 45666666666666 444 334566666666666664 444 433 66666666
Q ss_pred cCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCC
Q 043333 148 GSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVI 227 (809)
Q Consensus 148 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 227 (809)
+|+|++ +|. .+++|+.|++++|.++.++. .+++|+.|+|++|++++ +|. |. ++|+.|+|++|+|+.++
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp 196 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTMLPE----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLP 196 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCcCCC----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchh
Confidence 666664 444 45566666666666665443 45566666666666655 333 43 56666666666666333
Q ss_pred CCCCCCCCc-------cEEEeeCccCCCCCChhhhhccCccccccCCccccCCCCCcc
Q 043333 228 PSNFSGSGL-------TYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNC 278 (809)
Q Consensus 228 p~~~~~~~L-------~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~~~~~~~ 278 (809)
+ +.. +| +.|+|++|+|+.+++.......++.|+|++|++++..+..++
T Consensus 197 ~--~~~-~L~~~~~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 251 (571)
T 3cvr_A 197 A--VPV-RNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIRESLS 251 (571)
T ss_dssp C--CC---------CCEEEECCSSCCCCCCGGGGGSCTTEEEECCSSSCCHHHHHHHH
T ss_pred h--HHH-hhhcccccceEEecCCCcceecCHHHhcCCCCCEEEeeCCcCCCcCHHHHH
Confidence 3 222 45 666666666664333333334556666666666554444333
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.6e-20 Score=187.99 Aligned_cols=176 Identities=22% Similarity=0.268 Sum_probs=131.8
Q ss_pred cccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeeccccc
Q 043333 49 LPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFT 128 (809)
Q Consensus 49 L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 128 (809)
++..++.+..+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|+++
T Consensus 12 v~c~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 89 (208)
T 2o6s_A 12 VECYSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ 89 (208)
T ss_dssp EECCSSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred EEecCCCccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCC
Confidence 334444444555433 247888888888888666666778888888888888888666666778888888888888888
Q ss_pred CcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhh
Q 043333 129 GQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLG 208 (809)
Q Consensus 129 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 208 (809)
+..+..|.++++|++|+|++|++++..+..|..+++|+.|++++|.++.++...+..+++|+.|+|++|.+.+.
T Consensus 90 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~------ 163 (208)
T 2o6s_A 90 SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT------ 163 (208)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC------
T ss_pred ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC------
Confidence 66666678888888888888888866666677888888888888888877777788888888888888877643
Q ss_pred ccccccEEeccCCCCCCCCCCCCCC
Q 043333 209 QMIGLRVLDLSFNKLSGVIPSNFSG 233 (809)
Q Consensus 209 ~l~~L~~L~Ls~N~l~~~~p~~~~~ 233 (809)
+++|+.|+++.|+++|.+|..+..
T Consensus 164 -~~~l~~L~~~~n~~~g~ip~~~~~ 187 (208)
T 2o6s_A 164 -CPGIRYLSEWINKHSGVVRNSAGS 187 (208)
T ss_dssp -TTTTHHHHHHHHHCTTTBBCTTSS
T ss_pred -CCCHHHHHHHHHhCCceeeccCcc
Confidence 457888888888888888876553
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.1e-21 Score=210.51 Aligned_cols=214 Identities=18% Similarity=0.184 Sum_probs=174.0
Q ss_pred CchhhcCCccCcEEeecccccccCCC----ccccCCC-CCCEEEccCCccCccCchhhhcc-----cccceeeeeccccc
Q 043333 59 IPKAVASISTLADLTLEFNQFSGDLP----AELGNLI-NLEKLHLNSNNFTGKLPESFANL-----TRLKHFRISDNHFT 128 (809)
Q Consensus 59 ip~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~ 128 (809)
+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|+|++..+..+..+ ++|++|+|++|+++
T Consensus 14 ~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~ 93 (362)
T 3goz_A 14 VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLS 93 (362)
T ss_dssp HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGG
T ss_pred HHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCC
Confidence 34444555679999999999997766 7788898 99999999999998888888886 99999999999999
Q ss_pred CcCchhhhcc-----cccceEecccCcCCCCCCccccC-----CCCCCEEeccCCCCCCCCCccc----cCCc-CCceee
Q 043333 129 GQIPDYIQNW-----TKLEKLFIEGSGLAGPIPSGIAS-----LVELTDLRISDLNGPEGPFPRL----SNLK-NMNYLI 193 (809)
Q Consensus 129 ~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~l~~n~l~~~~~~~l----~~l~-~L~~L~ 193 (809)
+..+..+... ++|++|+|++|++++..+..+.. .++|++|++++|.++......+ ..++ +|++|+
T Consensus 94 ~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~ 173 (362)
T 3goz_A 94 YKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLN 173 (362)
T ss_dssp GSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEE
T ss_pred hHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEee
Confidence 8877765554 89999999999999776655443 3699999999999987665543 4555 999999
Q ss_pred eccccccCCCChhhhcc-----ccccEEeccCCCCCCCCC----CCCCC--CCccEEEeeCccCCCCCChhhhh-----c
Q 043333 194 LRSGNIIGEMPEYLGQM-----IGLRVLDLSFNKLSGVIP----SNFSG--SGLTYMYLTGNLLTGPVPDWIVR-----K 257 (809)
Q Consensus 194 Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p----~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~-----~ 257 (809)
|++|++++..+..+... ++|+.|||++|+|++... ..+.. ++|+.|+|++|++++..+..+.. .
T Consensus 174 Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~ 253 (362)
T 3goz_A 174 LRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLK 253 (362)
T ss_dssp CTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTT
T ss_pred ecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCC
Confidence 99999999988766554 699999999999987432 22222 58999999999999877644432 5
Q ss_pred cCccccccCCccccC
Q 043333 258 RNKHIDLSYNNFIDG 272 (809)
Q Consensus 258 ~l~~L~Ls~N~l~~~ 272 (809)
.++.|+|++|.+...
T Consensus 254 ~L~~L~L~~n~l~~i 268 (362)
T 3goz_A 254 HLQTVYLDYDIVKNM 268 (362)
T ss_dssp TCSEEEEEHHHHTTC
T ss_pred CccEEEeccCCcccc
Confidence 679999999997654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.5e-20 Score=211.88 Aligned_cols=166 Identities=19% Similarity=0.237 Sum_probs=109.8
Q ss_pred ccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEec
Q 043333 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFI 146 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 146 (809)
++|+.|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|+.|+|++|+|++ +|. .+++|+.|+|
T Consensus 80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 45666666666666 455 335666666666666664 454 443 66666666666664 444 4566666666
Q ss_pred ccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccc-------cEEecc
Q 043333 147 EGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGL-------RVLDLS 219 (809)
Q Consensus 147 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls 219 (809)
++|+|++ +|. .+++|+.|++++|.++.++. |. ++|+.|+|++|+|+ .+|. |.. +| +.|+|+
T Consensus 148 s~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~--l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls 215 (571)
T 3cvr_A 148 DNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE--LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCR 215 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC--CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECC
T ss_pred CCCccCc-CCC---cCCCcCEEECCCCCCCCcch--hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecC
Confidence 6666664 444 45666667777666666554 43 67777777777776 3343 443 55 999999
Q ss_pred CCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhh
Q 043333 220 FNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVR 256 (809)
Q Consensus 220 ~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~ 256 (809)
+|+|+.+++..+..++|+.|+|++|+|++.+|..+..
T Consensus 216 ~N~l~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 216 ENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252 (571)
T ss_dssp SSCCCCCCGGGGGSCTTEEEECCSSSCCHHHHHHHHH
T ss_pred CCcceecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHH
Confidence 9999976665666689999999999999988887765
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=7.7e-20 Score=200.96 Aligned_cols=145 Identities=20% Similarity=0.168 Sum_probs=86.2
Q ss_pred cCcEEeecccccccCCCcccc-CCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEec
Q 043333 68 TLADLTLEFNQFSGDLPAELG-NLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFI 146 (809)
Q Consensus 68 ~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 146 (809)
.++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 119 (361)
T 2xot_A 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL 119 (361)
T ss_dssp TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEEC
Confidence 456666666666655555555 6666666666666666555556666666666666666666555555666666666666
Q ss_pred ccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccc---cCCcCCceeeeccccccCCCChhhhcccc
Q 043333 147 EGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRL---SNLKNMNYLILRSGNIIGEMPEYLGQMIG 212 (809)
Q Consensus 147 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 212 (809)
++|+|++..|..|..+++|+.|+|++|.++.++...| ..+++|+.|+|++|++.+..+..|..++.
T Consensus 120 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~ 188 (361)
T 2xot_A 120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPA 188 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCH
T ss_pred CCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccH
Confidence 6666665555566666666666666666655554444 34555555555555555444444444443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.5e-19 Score=190.74 Aligned_cols=186 Identities=22% Similarity=0.289 Sum_probs=139.2
Q ss_pred ccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccC
Q 043333 50 PLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTG 129 (809)
Q Consensus 50 ~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 129 (809)
.+..+.+..+. .+..+++|+.|++++|.++. ++ .+..+++|++|+|++|++++..+ +.++++|+.|+|++|++++
T Consensus 30 ~l~~~~~~~~~-~~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 104 (291)
T 1h6t_A 30 NLKKKSVTDAV-TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD 104 (291)
T ss_dssp HTTCSCTTSEE-CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred HhcCCCccccc-chhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC
Confidence 34444443332 23567888888998888884 44 47888888999999888886544 8888888999999888884
Q ss_pred cCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhc
Q 043333 130 QIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQ 209 (809)
Q Consensus 130 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 209 (809)
+| .+..+++|+.|+|++|++++. ..+..+++|+.|++++|.++.+ +.+..+++|+.|+|++|++.+..+ +..
T Consensus 105 -~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~ 176 (291)
T 1h6t_A 105 -LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAG 176 (291)
T ss_dssp -GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTT
T ss_pred -Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcC
Confidence 33 388888888888888888853 4677888888888888888776 567788888888888888877655 778
Q ss_pred cccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCC
Q 043333 210 MIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGP 249 (809)
Q Consensus 210 l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~ 249 (809)
+++|+.|+|++|+|++.. .....++|+.|+|++|+++..
T Consensus 177 l~~L~~L~L~~N~i~~l~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 177 LTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEEEEEEECC
T ss_pred CCccCEEECCCCcCCCCh-hhccCCCCCEEECcCCcccCC
Confidence 888888888888887653 333337788888888877753
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.8e-19 Score=182.16 Aligned_cols=152 Identities=21% Similarity=0.319 Sum_probs=95.7
Q ss_pred cEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccC
Q 043333 70 ADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGS 149 (809)
Q Consensus 70 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 149 (809)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 46677777776 4555443 46666666666666555556666666666666666666555666666666666666666
Q ss_pred cCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCC
Q 043333 150 GLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPS 229 (809)
Q Consensus 150 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 229 (809)
+|+ .++...|.++++|++|+|++|++.+..|..|..+++|+.|+|++|+|+++++.
T Consensus 91 ~l~------------------------~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 146 (220)
T 2v9t_B 91 KIT------------------------ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKG 146 (220)
T ss_dssp CCC------------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cCC------------------------ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHH
Confidence 555 34434445555566666666666666666666667777777777777766666
Q ss_pred CCCC-CCccEEEeeCccCCC
Q 043333 230 NFSG-SGLTYMYLTGNLLTG 248 (809)
Q Consensus 230 ~~~~-~~L~~L~Ls~N~l~~ 248 (809)
.+.. ++|+.|+|++|++..
T Consensus 147 ~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 147 TFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp TTTTCTTCCEEECCSSCEEC
T ss_pred HHhCCCCCCEEEeCCCCcCC
Confidence 5554 667777777777664
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-19 Score=198.63 Aligned_cols=157 Identities=21% Similarity=0.141 Sum_probs=104.3
Q ss_pred CcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhh-cccccceeeeecccccCcCchhhhcccccceEecc
Q 043333 69 LADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFA-NLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIE 147 (809)
Q Consensus 69 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 147 (809)
-+.+++++|+|+ .+|..+. ..++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..+..|.++++|++|+|+
T Consensus 20 ~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 20 SNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 367888888888 5666554 3578888888888877776676 78888888888888887777778888888888888
Q ss_pred cCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhh---hccccccEEeccCCCCC
Q 043333 148 GSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYL---GQMIGLRVLDLSFNKLS 224 (809)
Q Consensus 148 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~ 224 (809)
+|+|+...+..|..+++|+.|+|++|.+..+.+..|.++++|+.|+|++|++.+..+..| ..+++|+.|+|++|+|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 888776656666666666666666666665555555555555555555555555444444 34455555555555555
Q ss_pred CCCC
Q 043333 225 GVIP 228 (809)
Q Consensus 225 ~~~p 228 (809)
++++
T Consensus 177 ~l~~ 180 (361)
T 2xot_A 177 KLPL 180 (361)
T ss_dssp CCCH
T ss_pred ccCH
Confidence 4433
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.3e-19 Score=209.50 Aligned_cols=192 Identities=21% Similarity=0.277 Sum_probs=145.1
Q ss_pred cccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeeccc
Q 043333 47 VNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126 (809)
Q Consensus 47 ~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 126 (809)
..+.+..+.+..++. +..+++|+.|+|++|.++ .++ .+..+++|+.|+|++|+|++..| +.++++|+.|+|++|+
T Consensus 24 ~~l~l~~~~i~~~~~-~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 98 (605)
T 1m9s_A 24 IKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENK 98 (605)
T ss_dssp HHHHTTCSCTTSEEC-HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred HHHhccCCCcccccc-hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCC
Confidence 344445555544432 466778888888888887 444 57888888888888888886544 8888888888888888
Q ss_pred ccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChh
Q 043333 127 FTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEY 206 (809)
Q Consensus 127 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 206 (809)
|++ +| .+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.+..+ ..+..+++|+.|+|++|.+.+..|
T Consensus 99 l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-- 170 (605)
T 1m9s_A 99 IKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-- 170 (605)
T ss_dssp CCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--
T ss_pred CCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--
Confidence 874 33 578888888888888888853 4577888888888888888876 678888888888888888887766
Q ss_pred hhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCCh
Q 043333 207 LGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPD 252 (809)
Q Consensus 207 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~ 252 (809)
+..+++|+.|+|++|+|+++ +....+++|+.|+|++|++++.+..
T Consensus 171 l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~p~~ 215 (605)
T 1m9s_A 171 LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNKPIN 215 (605)
T ss_dssp GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECCCCC
T ss_pred hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCCccc
Confidence 88888888888888888875 4433448888888888888765443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-19 Score=184.98 Aligned_cols=153 Identities=18% Similarity=0.257 Sum_probs=78.6
Q ss_pred cEEeecccccccCCCccccCCCCCCEEEccCCccCccCc-hhhhcccccceeeeecccccCcCchhhhcccccceEeccc
Q 043333 70 ADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLP-ESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEG 148 (809)
Q Consensus 70 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 148 (809)
+.+++++|.++ .+|..+. ..+++|+|++|+|++..| ..|.++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 35666666665 3454432 234566666666665433 2355566666666666666655555555555555555555
Q ss_pred CcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCC
Q 043333 149 SGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIP 228 (809)
Q Consensus 149 N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 228 (809)
|++++..+..|..+++|+.|++++ |++.+..|..|..+++|+.|+|++|+|++.+|
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~------------------------N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 146 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRS------------------------NRITCVGNDSFIGLSSVRLLSLYDNQITTVAP 146 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTT------------------------SCCCCBCTTSSTTCTTCSEEECTTSCCCCBCT
T ss_pred CccCccCHhHhcCCcCCCEEECCC------------------------CcCCeECHhHcCCCccCCEEECCCCcCCEECH
Confidence 555544444444444444444444 44444444444444444455555555554444
Q ss_pred CCCCC-CCccEEEeeCccCCCC
Q 043333 229 SNFSG-SGLTYMYLTGNLLTGP 249 (809)
Q Consensus 229 ~~~~~-~~L~~L~Ls~N~l~~~ 249 (809)
..+.. ++|+.|+|++|++++.
T Consensus 147 ~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 147 GAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp TTTTTCTTCCEEECCSCCEECS
T ss_pred HHhcCCCCCCEEEecCcCCcCC
Confidence 44443 4555555555555543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.8e-19 Score=181.20 Aligned_cols=151 Identities=17% Similarity=0.186 Sum_probs=111.9
Q ss_pred eeeeecccccCcCchhhhcccccceEecccCcCCCCCC-ccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccc
Q 043333 119 HFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIP-SGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSG 197 (809)
Q Consensus 119 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N 197 (809)
.+++++|.++ .+|..+. ..++.|+|++|+|++..+ ..|..+++|+.|++++|.++.++...|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4444444444 2333221 233455555555554433 23555566666666666666666666777788888888889
Q ss_pred cccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhh-ccCccccccCCccccC
Q 043333 198 NIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDG 272 (809)
Q Consensus 198 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~ 272 (809)
++++..+..|..+++|++|+|++|+|++++|..+.. ++|+.|+|++|+|++..|..+.. .+++.|+|++|+|.|.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 998888899999999999999999999999998887 99999999999999998888765 5679999999999985
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=6.5e-19 Score=179.44 Aligned_cols=153 Identities=17% Similarity=0.212 Sum_probs=125.8
Q ss_pred ccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecc
Q 043333 46 LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN 125 (809)
Q Consensus 46 L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 125 (809)
-..++++++.+..+|..+. ++|+.|+|++|++++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 13 ~~~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 13 NNIVDCRGKGLTEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TTEEECTTSCCSSCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CCEEEcCCCCcCcCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 4567888999999998775 78999999999999877779999999999999999999988999999999999999999
Q ss_pred cccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeecccccc
Q 043333 126 HFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNII 200 (809)
Q Consensus 126 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 200 (809)
+|+...+..|.++++|+.|+|++|+|++..|..|..+++|+.|++++|.++.++...|..+++|+.|+|++|.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 999766677899999999999999999877777777777777766666666655555555555555555554443
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.3e-19 Score=174.92 Aligned_cols=117 Identities=23% Similarity=0.345 Sum_probs=97.5
Q ss_pred ccCchhhhcccccCceeeeeeeeeeeCceEEEEEEEEeeEecCCcccccCCceeEEEEecCeeeccccceeeccCCcCce
Q 043333 377 LMDDSQLYTEARISPISLTYYGYCMVNGNYTVNLHFAEILFTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKA 456 (809)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (809)
.+.+++||+|||..|.+++|+.-|..||+|+|+||||||.+.+ +|+|+|||||||+.+++||||..++|+ .++
T Consensus 50 ~~~~~~lY~TaR~~~~~~tY~f~v~~~G~Y~VrLhF~ei~~~~------~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~ 122 (174)
T 2jwp_A 50 NPEDQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFAEVYFAQ------SQQKVFDVRVNGHTVVKDLDIFDRVGH-STA 122 (174)
T ss_dssp CHHHHHTTTCCCCCCSCEEEEEECCSCEEEEEEEEEECCSCCC------SSSSCEEEEETTEEEEEEECHHHHHSS-SSC
T ss_pred CCCCchhhhhhccCCCCeEEEEEeCCCeEEEEEEEEeccccCC------CCCeEeEEEECCEEeecCcCHHHhhCC-Cee
Confidence 4567899999999999999999999999999999999998753 799999999999999999999999987 788
Q ss_pred EEEeeeeeeecCeeEEEEEec-CCCccccC--CCCCcCCcccccccc
Q 043333 457 IVKPFSAAVTNGTMEIRLYWA-GKGTTDIP--YKGVYGPLISAISLY 500 (809)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~~w~-g~~~~~~p--~~~~~~p~~~~~~~~ 500 (809)
+.+.+...|.++.++++..|. +.|+..+. ....++|.+.++...
T Consensus 123 ~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~~a~inaIEI~ 169 (174)
T 2jwp_A 123 HDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIM 169 (174)
T ss_dssp EEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSCSSSEEEEEEE
T ss_pred EEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCCCcEEEEEEEE
Confidence 999999999999888887775 45552222 122566777666554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4e-19 Score=189.17 Aligned_cols=175 Identities=21% Similarity=0.277 Sum_probs=139.1
Q ss_pred CCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEE
Q 043333 18 TRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLH 97 (809)
Q Consensus 18 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 97 (809)
..+++|++|++++|.+. .++ .+..+++|++|+|++|++++. +. +..+++|++|+
T Consensus 43 ~~l~~L~~L~l~~~~i~-----------------------~~~-~~~~l~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~ 96 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIK-----------------------SVQ-GIQYLPNVTKLFLNGNKLTDI-KP-LANLKNLGWLF 96 (291)
T ss_dssp HHHHTCCEEECTTSCCC-----------------------CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEE
T ss_pred hhcCcccEEEccCCCcc-----------------------cCh-hHhcCCCCCEEEccCCccCCC-cc-cccCCCCCEEE
Confidence 34566666666666665 333 266678888999999988854 33 88888899999
Q ss_pred ccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCC
Q 043333 98 LNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPE 177 (809)
Q Consensus 98 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~ 177 (809)
|++|++++ +| .+..+++|++|+|++|++++. ..+..+++|+.|+|++|++++. ..+..+++|+.|++++|.+..
T Consensus 97 l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~ 170 (291)
T 1h6t_A 97 LDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 170 (291)
T ss_dssp CCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred CCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcccc
Confidence 99998885 34 488888999999999988853 4588888999999999988864 678888999999999998888
Q ss_pred CCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCC
Q 043333 178 GPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIP 228 (809)
Q Consensus 178 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 228 (809)
++. +..+++|+.|+|++|.+... + .+..+++|+.|+|++|+++..+.
T Consensus 171 ~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~~~ 217 (291)
T 1h6t_A 171 IVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNKPI 217 (291)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECCCE
T ss_pred chh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCCcc
Confidence 765 88899999999999998875 3 48899999999999999986543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.9e-18 Score=175.74 Aligned_cols=155 Identities=23% Similarity=0.285 Sum_probs=102.0
Q ss_pred CcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEeccc
Q 043333 69 LADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEG 148 (809)
Q Consensus 69 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 148 (809)
.+.++.++++++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|+.|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 455667666666 5554443 5666666666666666666666666666666666666644444455556666666655
Q ss_pred CcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCC
Q 043333 149 SGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIP 228 (809)
Q Consensus 149 N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 228 (809)
|+|++ ++...|..+++|++|+|++|++. .+|..+..+++|+.|+|++|+|+++++
T Consensus 98 N~l~~------------------------l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 98 NQLTV------------------------LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPH 152 (229)
T ss_dssp SCCCC------------------------CCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred CcCCc------------------------cChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCH
Confidence 55554 43344455556666666666666 456667788888888888888888777
Q ss_pred CCCCC-CCccEEEeeCccCCCCCC
Q 043333 229 SNFSG-SGLTYMYLTGNLLTGPVP 251 (809)
Q Consensus 229 ~~~~~-~~L~~L~Ls~N~l~~~~p 251 (809)
..+.. ++|+.|+|++|++++..+
T Consensus 153 ~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 153 GAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp TTTTTCTTCCEEECTTSCBCTTBG
T ss_pred HHHhCCCCCCEEEeeCCCccCCcc
Confidence 76665 888888888888887654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.77 E-value=7.1e-19 Score=205.32 Aligned_cols=193 Identities=20% Similarity=0.265 Sum_probs=146.1
Q ss_pred CCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCC
Q 043333 23 LQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSN 101 (809)
Q Consensus 23 L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 101 (809)
+..+.|+.+.+....+ +..++ |+.|++++|.+..+| .+..+++|+.|+|++|+|++..+ +..+++|+.|+|++|
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N 97 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDEN 97 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCC
Confidence 3344455555443222 12222 555666666666665 47778888999999998885443 888888999999999
Q ss_pred ccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCc
Q 043333 102 NFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFP 181 (809)
Q Consensus 102 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~ 181 (809)
+|++ +| .+..+++|+.|+|++|+|++ + ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.+..+.+
T Consensus 98 ~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~- 170 (605)
T 1m9s_A 98 KIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP- 170 (605)
T ss_dssp CCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-
T ss_pred CCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-
Confidence 8885 34 68888889999999998885 3 3588888999999999988864 678888899999999998887765
Q ss_pred cccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCC
Q 043333 182 RLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSN 230 (809)
Q Consensus 182 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 230 (809)
+..+++|+.|+|++|++.+. ..+..+++|+.|+|++|++++.+...
T Consensus 171 -l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~ 216 (605)
T 1m9s_A 171 -LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINH 216 (605)
T ss_dssp -GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCC
T ss_pred -hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccc
Confidence 88889999999999988875 46888999999999999998765543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.3e-18 Score=173.87 Aligned_cols=153 Identities=19% Similarity=0.192 Sum_probs=102.0
Q ss_pred cCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccce
Q 043333 64 ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEK 143 (809)
Q Consensus 64 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 143 (809)
..+++|+.|+|++|.++ .+| .+..+++|++|+|++|.++ .+ ..+..+++|++|+|++|++++..+..++.+++|+.
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 56677888888888887 555 5777788888888888666 33 36777778888888888877666777777777777
Q ss_pred EecccCcCCCCCCccccCCCCCCEEeccCCC-CCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCC
Q 043333 144 LFIEGSGLAGPIPSGIASLVELTDLRISDLN-GPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNK 222 (809)
Q Consensus 144 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~-l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 222 (809)
|+|++|++++..|..+..+++|+.|++++|. ++.++ .+..+++|+.|+|++|.+.+.. .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~--~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM--PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG--GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH--hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcc
Confidence 7777777776666667777777777776665 55543 4555555555555555555432 45555555555555555
Q ss_pred CC
Q 043333 223 LS 224 (809)
Q Consensus 223 l~ 224 (809)
+.
T Consensus 193 i~ 194 (197)
T 4ezg_A 193 IG 194 (197)
T ss_dssp --
T ss_pred cC
Confidence 43
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.3e-18 Score=175.40 Aligned_cols=153 Identities=22% Similarity=0.271 Sum_probs=120.9
Q ss_pred ccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecc
Q 043333 46 LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN 125 (809)
Q Consensus 46 L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 125 (809)
...++.+++.++.+|..+. ++|+.|+|++|++++..|..|.++++|++|+|++|+|+...+..|.++++|+.|+|++|
T Consensus 21 ~~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 21 GTTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 4456666666677776554 89999999999999888999999999999999999999776777899999999999999
Q ss_pred cccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccC
Q 043333 126 HFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIG 201 (809)
Q Consensus 126 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 201 (809)
+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|++..++...|..+++|+.|+|++|.+..
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 999877778899999999999999999 778777777777777766666665555445555444444444444443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.6e-18 Score=181.58 Aligned_cols=171 Identities=22% Similarity=0.288 Sum_probs=109.8
Q ss_pred CccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEe
Q 043333 66 ISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLF 145 (809)
Q Consensus 66 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 145 (809)
+.++..+++++|.+++ ++ .+..+++|++|++++|+++ .+| .+..+++|+.|+|++|+|++..+ +.++++|+.|+
T Consensus 18 l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 3445555666666652 22 3555666666666666666 334 45566666666666666664333 66666666666
Q ss_pred cccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCC
Q 043333 146 IEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSG 225 (809)
Q Consensus 146 L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 225 (809)
|++|++++ +|.. .. ++|+.|++++|.++.+ +.+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++
T Consensus 92 L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~--~~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 92 VNRNRLKN-LNGI-PS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CCSSCCSC-CTTC-CC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC--GGGGGCTTCCEEECTTSCCCB
T ss_pred CCCCccCC-cCcc-cc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC--hHHccCCCCCEEECCCCcCcc
Confidence 66666663 2222 22 6667777777766664 3477777888888888887775 267888888888888888887
Q ss_pred CCCCCCCCCCccEEEeeCccCCCCC
Q 043333 226 VIPSNFSGSGLTYMYLTGNLLTGPV 250 (809)
Q Consensus 226 ~~p~~~~~~~L~~L~Ls~N~l~~~~ 250 (809)
. +.....++|+.|+|++|++++.+
T Consensus 165 ~-~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 165 T-GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp C-TTSTTCCCCCEEEEEEEEEECCC
T ss_pred h-HHhccCCCCCEEeCCCCcccCCc
Confidence 7 33333388888888888888664
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=4.6e-20 Score=214.07 Aligned_cols=181 Identities=17% Similarity=0.164 Sum_probs=112.4
Q ss_pred CCccCcEEeecccccccCCCccccCCCCCCEEEccCCc-------------cCccCchhhhcccccceee-eecccccCc
Q 043333 65 SISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNN-------------FTGKLPESFANLTRLKHFR-ISDNHFTGQ 130 (809)
Q Consensus 65 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-Ls~N~l~~~ 130 (809)
.+++|+.|+|++|+|+ .+|..++++++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+. .
T Consensus 347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-~ 424 (567)
T 1dce_A 347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-D 424 (567)
T ss_dssp TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-H
T ss_pred cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-h
Confidence 3455555555555555 455555555555555554443 4445566666666666666 4555433 1
Q ss_pred Cch------hhhcc--cccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCC
Q 043333 131 IPD------YIQNW--TKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGE 202 (809)
Q Consensus 131 ~p~------~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 202 (809)
++. .+..+ ..|+.|+|++|+|++ +|. |..+++|+.|++++|.++.++ ..+.++++|+.|+|++|++++
T Consensus 425 L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~lp-~~~~~l~~L~~L~Ls~N~l~~- 500 (567)
T 1dce_A 425 LRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRALP-PALAALRCLEVLQASDNALEN- 500 (567)
T ss_dssp HHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCCC-GGGGGCTTCCEEECCSSCCCC-
T ss_pred hhhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCcccccccc-hhhhcCCCCCEEECCCCCCCC-
Confidence 111 11111 246777777777774 554 777777777777777777554 367777777777777777776
Q ss_pred CChhhhccccccEEeccCCCCCCCC-CCCCCC-CCccEEEeeCccCCCCCCh
Q 043333 203 MPEYLGQMIGLRVLDLSFNKLSGVI-PSNFSG-SGLTYMYLTGNLLTGPVPD 252 (809)
Q Consensus 203 ~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~-~~L~~L~Ls~N~l~~~~p~ 252 (809)
+| .|..+++|+.|+|++|+|++.+ |..+.. ++|+.|+|++|+|++.+|.
T Consensus 501 lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 501 VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 45 6777777777777777777775 555554 7777777777777766553
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.4e-18 Score=180.33 Aligned_cols=169 Identities=20% Similarity=0.262 Sum_probs=142.0
Q ss_pred ccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecc
Q 043333 46 LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN 125 (809)
Q Consensus 46 L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 125 (809)
+..+.+.++.+..++ .+..+++|+.|++++|+++ .++ .+..+++|++|+|++|+|++..+ +.++++|+.|+|++|
T Consensus 21 l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N 95 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRN 95 (263)
T ss_dssp HHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSS
T ss_pred HHHHHhcCCCccccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCC
Confidence 667788888888888 6788899999999999998 555 68889999999999999996544 889999999999999
Q ss_pred cccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCCh
Q 043333 126 HFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPE 205 (809)
Q Consensus 126 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 205 (809)
++++ +|.. .. ++|+.|+|++|++++. ..+..+++|+.|++++|+++.++ .+..+++|+.|+|++|++.+. .
T Consensus 96 ~l~~-l~~~-~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~~--~l~~l~~L~~L~L~~N~i~~~--~ 166 (263)
T 1xeu_A 96 RLKN-LNGI-PS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIV--MLGFLSKLEVLDLHGNEITNT--G 166 (263)
T ss_dssp CCSC-CTTC-CC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBCG--GGGGCTTCCEEECTTSCCCBC--T
T ss_pred ccCC-cCcc-cc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCCh--HHccCCCCCEEECCCCcCcch--H
Confidence 9985 4432 23 8999999999999863 35888999999999999998874 688899999999999999887 6
Q ss_pred hhhccccccEEeccCCCCCCCCC
Q 043333 206 YLGQMIGLRVLDLSFNKLSGVIP 228 (809)
Q Consensus 206 ~~~~l~~L~~L~Ls~N~l~~~~p 228 (809)
.+..+++|+.|+|++|+++..+.
T Consensus 167 ~l~~l~~L~~L~l~~N~~~~~~~ 189 (263)
T 1xeu_A 167 GLTRLKKVNWIDLTGQKCVNEPV 189 (263)
T ss_dssp TSTTCCCCCEEEEEEEEEECCCE
T ss_pred HhccCCCCCEEeCCCCcccCCcc
Confidence 78889999999999999987643
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.74 E-value=9.9e-19 Score=209.07 Aligned_cols=166 Identities=15% Similarity=0.160 Sum_probs=118.0
Q ss_pred CcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEeccc
Q 043333 69 LADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEG 148 (809)
Q Consensus 69 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 148 (809)
+..++++.|.+. ..+..|..+++|+.|+|++|++. .+|..+.++++|++|+|++|.|+ .+|..|+++++|+.|+|++
T Consensus 203 i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~ 279 (727)
T 4b8c_D 203 IDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSH 279 (727)
T ss_dssp --------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTT
T ss_pred ccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcC
Confidence 344455666666 66778888889999999999988 67777778889999999999988 7888888899999999999
Q ss_pred CcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhcccc-ccEEeccCCCCCCCC
Q 043333 149 SGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIG-LRVLDLSFNKLSGVI 227 (809)
Q Consensus 149 N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~ 227 (809)
|+|+ .+|..|..+++|+.|+|++|.++.++.. |.++++|+.|+|++|.+.+.+|..+..+.. +..|+|++|.+++.+
T Consensus 280 N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~ 357 (727)
T 4b8c_D 280 NRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWE-FGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPL 357 (727)
T ss_dssp SCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSS-TTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_pred CcCC-ccChhhcCCCCCCEEECCCCCCCccChh-hhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcC
Confidence 9988 7788888999999999999988877654 889999999999999999999988876533 345889999999888
Q ss_pred CCCCCCCCccEEEeeCc
Q 043333 228 PSNFSGSGLTYMYLTGN 244 (809)
Q Consensus 228 p~~~~~~~L~~L~Ls~N 244 (809)
|. .|+.|+++.|
T Consensus 358 p~-----~l~~l~l~~n 369 (727)
T 4b8c_D 358 PH-----ERRFIEINTD 369 (727)
T ss_dssp CC-----C---------
T ss_pred cc-----ccceeEeecc
Confidence 76 4667777777
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.73 E-value=7.8e-19 Score=209.98 Aligned_cols=191 Identities=17% Similarity=0.167 Sum_probs=125.7
Q ss_pred CCCCEEEccCCCCCCCCCcccCCCC-----ccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCE
Q 043333 21 PFLQEIDLTRNYLNGTIPSEWASLP-----LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEK 95 (809)
Q Consensus 21 ~~L~~L~Ls~n~l~~~~p~~~~~l~-----L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 95 (809)
+.++.|+|++|.+.......+..+. +..+++..|.+...|..+..+++|+.|+|++|.+. .+|..+.++++|++
T Consensus 173 ~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~ 251 (727)
T 4b8c_D 173 PLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTR 251 (727)
T ss_dssp -------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSC
T ss_pred CccceEEeeCCCCCcchhhHhhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCE
Confidence 5688889999988864444444333 33444555666766888999999999999999999 78888889999999
Q ss_pred EEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCC
Q 043333 96 LHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG 175 (809)
Q Consensus 96 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l 175 (809)
|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+|..|+++++|++|+|++|.|+ .+|..|..+++|+.|+|++|.+
T Consensus 252 L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l 328 (727)
T 4b8c_D 252 LYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPL 328 (727)
T ss_dssp CBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCC
T ss_pred EEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCcc
Confidence 999999999 88999999999999999999999 78999999999999999999998 7888899999999999999999
Q ss_pred CCCCCccccCCcC-CceeeeccccccCCCChhhhccccccEEeccCC
Q 043333 176 PEGPFPRLSNLKN-MNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFN 221 (809)
Q Consensus 176 ~~~~~~~l~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 221 (809)
+...+..+..+.. +..|+|++|.+++.+|. .|+.|+++.|
T Consensus 329 ~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n 369 (727)
T 4b8c_D 329 EKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTD 369 (727)
T ss_dssp CSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C---------
T ss_pred CCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecc
Confidence 9877777655432 34588999999999985 4566778777
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.7e-18 Score=180.94 Aligned_cols=137 Identities=19% Similarity=0.149 Sum_probs=105.2
Q ss_pred CCCCCCeeccCCCccEEEeEe-eCCeE--EEEEEecccCcc------------------------cchhHHHHHHHHhhc
Q 043333 576 NFAPDNKIGEGGFGPVYKGLL-ADGKV--IAVKQLSSKSKQ------------------------GNREFVNEIGMISAL 628 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~--vAVK~~~~~~~~------------------------~~~~f~~Ei~~l~~l 628 (809)
-|+..+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999997 68998 999987543111 012578899999999
Q ss_pred CCCce--EeEEeEEEeCCeEEEEEEcccC-C----chhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeE
Q 043333 629 QHPNL--VKLYGCCIEGNQLLLIYEYMEN-N----SLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH-EESRLKIV 700 (809)
Q Consensus 629 ~H~nI--v~l~~~~~~~~~~~lV~ey~~~-g----sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ii 700 (809)
+|+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 88864 334432 356899999953 4 55554421 123456789999999999999 77 899
Q ss_pred EcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 701 HRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 701 H~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||||+|||+++ .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999754
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.73 E-value=2.7e-19 Score=209.76 Aligned_cols=272 Identities=14% Similarity=0.056 Sum_probs=195.2
Q ss_pred CccccCCCCC----ccCCccCCCCCCCCEEEccCCCCCC--------------------------CCCcccCCCC-cccc
Q 043333 1 HRILKSQNLP----GRLPPELTRLPFLQEIDLTRNYLNG--------------------------TIPSEWASLP-LVNL 49 (809)
Q Consensus 1 ~L~L~~nnl~----~~lp~~l~~l~~L~~L~Ls~n~l~~--------------------------~~p~~~~~l~-L~~L 49 (809)
+|+|++|.+. +.++..+..+++|++|+|++|.+.+ ..+..+..++ |+.+
T Consensus 196 ~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L 275 (592)
T 3ogk_B 196 VLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRL 275 (592)
T ss_dssp EEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEE
T ss_pred EEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhcccccccccchHHHHHHhhcccccccc
Confidence 3667777776 3444445667777888877776543 1112222232 5666
Q ss_pred ccccccCCCCchhhcCCccCcEEeecccccccCCC-ccccCCCCCCEEEccCCccC-ccCchhhhcccccceeeeec---
Q 043333 50 PLWKQANGAIPKAVASISTLADLTLEFNQFSGDLP-AELGNLINLEKLHLNSNNFT-GKLPESFANLTRLKHFRISD--- 124 (809)
Q Consensus 50 ~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~--- 124 (809)
.++++....+|..+..+++|++|+|++|.+++... ..+..+++|++|+|+ |.+. +.++..+..+++|++|+|++
T Consensus 276 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~ 354 (592)
T 3ogk_B 276 GLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGAD 354 (592)
T ss_dssp EETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCC
T ss_pred CccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCcc
Confidence 66666667788888889999999999999775433 346889999999999 4444 34444557789999999993
Q ss_pred --------ccccCcC-chhhhcccccceEecccCcCCCCCCccccC-CCCCCEEecc----CCCCCCCCCc-----cccC
Q 043333 125 --------NHFTGQI-PDYIQNWTKLEKLFIEGSGLAGPIPSGIAS-LVELTDLRIS----DLNGPEGPFP-----RLSN 185 (809)
Q Consensus 125 --------N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~l~----~n~l~~~~~~-----~l~~ 185 (809)
|.+++.. +..+..+++|++|+++.|++++..+..+.. +++|+.|+++ .|.++..+.. .+.+
T Consensus 355 ~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~ 434 (592)
T 3ogk_B 355 EQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIG 434 (592)
T ss_dssp SSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHH
T ss_pred ccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHh
Confidence 6666432 233566899999999999998776666665 8999999996 6677765433 2677
Q ss_pred CcCCceeeecccc--ccCCCChhhhc-cccccEEeccCCCCCCCC-CCCCCC-CCccEEEeeCccCCCCCChhh--hhcc
Q 043333 186 LKNMNYLILRSGN--IIGEMPEYLGQ-MIGLRVLDLSFNKLSGVI-PSNFSG-SGLTYMYLTGNLLTGPVPDWI--VRKR 258 (809)
Q Consensus 186 l~~L~~L~Ls~N~--l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~-p~~~~~-~~L~~L~Ls~N~l~~~~p~~~--~~~~ 258 (809)
+++|+.|+|+.|. +++..+..+.. +++|+.|+|++|++++.. +..+.. ++|+.|+|++|++++.....+ ...+
T Consensus 435 ~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~ 514 (592)
T 3ogk_B 435 CKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPS 514 (592)
T ss_dssp CTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSS
T ss_pred CCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCc
Confidence 9999999998543 66666666554 899999999999998632 333333 899999999999876533333 2367
Q ss_pred CccccccCCccccCC
Q 043333 259 NKHIDLSYNNFIDGS 273 (809)
Q Consensus 259 l~~L~Ls~N~l~~~~ 273 (809)
++.|+|++|+++...
T Consensus 515 L~~L~ls~n~it~~~ 529 (592)
T 3ogk_B 515 LRYLWVQGYRASMTG 529 (592)
T ss_dssp CCEEEEESCBCCTTC
T ss_pred cCeeECcCCcCCHHH
Confidence 899999999987653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-19 Score=210.30 Aligned_cols=180 Identities=17% Similarity=0.134 Sum_probs=96.1
Q ss_pred cCCCCCCEEEccCCccCccCchhhhcccccceeeeeccc-------------ccCcCchhhhcccccceEe-cccCcCCC
Q 043333 88 GNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH-------------FTGQIPDYIQNWTKLEKLF-IEGSGLAG 153 (809)
Q Consensus 88 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~ 153 (809)
..+++|+.|+|++|+++ .+|..++++++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+..
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~ 424 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD 424 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccch
Confidence 34556666666666665 556666666666666665553 3445555555555555555 34333220
Q ss_pred CCCc------cccC--CCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCC
Q 043333 154 PIPS------GIAS--LVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSG 225 (809)
Q Consensus 154 ~~p~------~~~~--l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 225 (809)
++. .+.. ...|+.|++++|.++.++. +.++++|+.|+|++|+++ .+|..|+.+++|+.|+|++|+|++
T Consensus 425 -L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~lp~--~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~ 500 (567)
T 1dce_A 425 -LRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN 500 (567)
T ss_dssp -HHHHHHHHHHHHHHHHTTCSEEECTTSCCSSCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC
T ss_pred -hhhhhhhcccccccCccCceEEEecCCCCCCCcC--ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC
Confidence 000 0000 1135566666666665442 566666666666666665 455566666666666666666665
Q ss_pred CCCCCCCCCCccEEEeeCccCCCCC-Chhhhh-ccCccccccCCccccCC
Q 043333 226 VIPSNFSGSGLTYMYLTGNLLTGPV-PDWIVR-KRNKHIDLSYNNFIDGS 273 (809)
Q Consensus 226 ~~p~~~~~~~L~~L~Ls~N~l~~~~-p~~~~~-~~l~~L~Ls~N~l~~~~ 273 (809)
+ |.....++|+.|+|++|+|++.+ |..+.. .+++.|+|++|++++.+
T Consensus 501 l-p~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 549 (567)
T 1dce_A 501 V-DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 549 (567)
T ss_dssp C-GGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred C-cccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence 3 32222266666666666666554 444433 44566666666665543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-17 Score=166.13 Aligned_cols=146 Identities=21% Similarity=0.229 Sum_probs=108.2
Q ss_pred cccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeeccccc
Q 043333 49 LPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFT 128 (809)
Q Consensus 49 L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 128 (809)
|++++|.+..+| .+..+++|++|+|++|.++ .+..+..+++|++|+|++|++++..|..++.+++|++|+|++|+++
T Consensus 49 L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~ 125 (197)
T 4ezg_A 49 ITLANINVTDLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125 (197)
T ss_dssp EEEESSCCSCCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCB
T ss_pred EeccCCCccChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccC
Confidence 333333333444 4666778888888888665 3346778888888888888888767777888888888888888888
Q ss_pred CcCchhhhcccccceEecccCc-CCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccC
Q 043333 129 GQIPDYIQNWTKLEKLFIEGSG-LAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIG 201 (809)
Q Consensus 129 ~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 201 (809)
+..|..+..+++|++|+|++|+ ++ .+| .+..+++|+.|++++|.+..++ .+..+++|+.|++++|++.+
T Consensus 126 ~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 126 DSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp GGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC----
T ss_pred cHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcccCC
Confidence 7777788888888888888887 55 455 6788888888888888887765 67888888888888888754
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=7.5e-18 Score=167.71 Aligned_cols=129 Identities=18% Similarity=0.268 Sum_probs=72.2
Q ss_pred cEEeecccccccCCCccccCCCCCCEEEccCCccCccCch-hhhcccccceeeeecccccCcCchhhhcccccceEeccc
Q 043333 70 ADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPE-SFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEG 148 (809)
Q Consensus 70 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 148 (809)
+.|++++|+++ .+|..+.. +|++|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56667777665 55554432 666666666666654443 356666666666666666655565566666666666666
Q ss_pred CcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCC
Q 043333 149 SGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSG 225 (809)
Q Consensus 149 N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 225 (809)
|+|++..+..|. ++++|++|+|++|++++..|..|..+++|+.|+|++|.+++
T Consensus 88 N~l~~~~~~~~~------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 88 NKIKEISNKMFL------------------------GLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCCEECSSSST------------------------TCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CcCCccCHHHhc------------------------CCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 655544444343 34444444444455555555555555555555555555543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=7.6e-17 Score=160.43 Aligned_cols=140 Identities=16% Similarity=0.114 Sum_probs=96.3
Q ss_pred ccceEecccCcCCCCCCc-cccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEec
Q 043333 140 KLEKLFIEGSGLAGPIPS-GIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDL 218 (809)
Q Consensus 140 ~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 218 (809)
+|++|+|++|+|++..+. .|..+++|+.|++++|.++.+.+..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 444444444444433332 2445555555555555555555555666777777888888888888889999999999999
Q ss_pred cCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhhccCccccccCCccccCCCCCccc
Q 043333 219 SFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCE 279 (809)
Q Consensus 219 s~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~~~~~~~~ 279 (809)
++|+|++.+|..+.. ++|+.|+|++|++++..+...-...++...+..+...|..|..+.+
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~~l~~ 171 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRD 171 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTTTTT
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCChHHcC
Confidence 999999999998877 9999999999999987664322222333355666777766655544
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.5e-18 Score=203.45 Aligned_cols=224 Identities=14% Similarity=0.066 Sum_probs=122.0
Q ss_pred ccccccccccCCCCchhhcCCccCcEEeecccccc---cCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeee
Q 043333 46 LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFS---GDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRI 122 (809)
Q Consensus 46 L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~---~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 122 (809)
|+.|++.++.+..+|..+..+++|+.|+++++... +..+..+..+++|+.|+++++... .+|..+..+++|++|+|
T Consensus 222 L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~L 300 (592)
T 3ogk_B 222 LVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDL 300 (592)
T ss_dssp CCEEECSSCBGGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEE
T ss_pred CcEEeccCccHHHHHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEec
Confidence 44455544444444444444455555555432211 122233444555555555554322 55666677777777777
Q ss_pred ecccccCcCc-hhhhcccccceEecccCcCC-CCCCccccCCCCCCEEeccC-----------CCCCCCCCcc-ccCCcC
Q 043333 123 SDNHFTGQIP-DYIQNWTKLEKLFIEGSGLA-GPIPSGIASLVELTDLRISD-----------LNGPEGPFPR-LSNLKN 188 (809)
Q Consensus 123 s~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~-----------n~l~~~~~~~-l~~l~~ 188 (809)
++|.+++... ..+..+++|+.|+|+ |.+. +.++..+..+++|+.|++++ |.++...... ...+++
T Consensus 301 s~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~ 379 (592)
T 3ogk_B 301 LYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQE 379 (592)
T ss_dssp TTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTT
T ss_pred CCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCcc
Confidence 7777654333 335667777777777 3333 22233335567777777773 3443332222 344677
Q ss_pred CceeeeccccccCCCChhhhc-cccccEEecc----CCCCCCCCCC-----CCC-CCCccEEEeeCc--cCCCCCChhhh
Q 043333 189 MNYLILRSGNIIGEMPEYLGQ-MIGLRVLDLS----FNKLSGVIPS-----NFS-GSGLTYMYLTGN--LLTGPVPDWIV 255 (809)
Q Consensus 189 L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~~p~-----~~~-~~~L~~L~Ls~N--~l~~~~p~~~~ 255 (809)
|++|+|+.|++++..+..+.. +++|+.|+|+ .|++++.+.+ .+. .++|+.|+|+.| .+++..+..+.
T Consensus 380 L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~ 459 (592)
T 3ogk_B 380 LEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIG 459 (592)
T ss_dssp CSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHH
T ss_pred CeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHH
Confidence 777777777777666666654 7777777775 5666654221 122 366777777632 35544443332
Q ss_pred h--ccCccccccCCcccc
Q 043333 256 R--KRNKHIDLSYNNFID 271 (809)
Q Consensus 256 ~--~~l~~L~Ls~N~l~~ 271 (809)
. ..++.|+|++|++++
T Consensus 460 ~~~~~L~~L~L~~n~l~~ 477 (592)
T 3ogk_B 460 QYSPNVRWMLLGYVGESD 477 (592)
T ss_dssp HSCTTCCEEEECSCCSSH
T ss_pred HhCccceEeeccCCCCCH
Confidence 2 446667777666653
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.9e-16 Score=153.79 Aligned_cols=135 Identities=17% Similarity=0.131 Sum_probs=72.7
Q ss_pred CCCEEEccCCccC-ccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEec
Q 043333 92 NLEKLHLNSNNFT-GKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRI 170 (809)
Q Consensus 92 ~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 170 (809)
+|++|+|++|+++ +.+|..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|++++.+|..+..+++|+.|++
T Consensus 25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 3444444444444 33343444444444444444444432 33444444444444444444334444444444444444
Q ss_pred cCCCCCCCCC-ccccCCcCCceeeeccccccCCCC---hhhhccccccEEeccCCCCCCCCC
Q 043333 171 SDLNGPEGPF-PRLSNLKNMNYLILRSGNIIGEMP---EYLGQMIGLRVLDLSFNKLSGVIP 228 (809)
Q Consensus 171 ~~n~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p 228 (809)
++|.++.++. ..+..+++|+.|+|++|.+++..+ ..+..+++|+.|++++|.+...+.
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 164 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPD 164 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCS
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhccc
Confidence 4444444432 456666777777777777776666 567788888888888888765543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.63 E-value=3.2e-16 Score=169.77 Aligned_cols=227 Identities=18% Similarity=0.136 Sum_probs=126.4
Q ss_pred CCCCCEEEccCCCCC--CCCCcccCCCCccccccccccCCCCch-hhcC--------CccCcEEeecccccccCCCcccc
Q 043333 20 LPFLQEIDLTRNYLN--GTIPSEWASLPLVNLPLWKQANGAIPK-AVAS--------ISTLADLTLEFNQFSGDLPAELG 88 (809)
Q Consensus 20 l~~L~~L~Ls~n~l~--~~~p~~~~~l~L~~L~l~~n~~~~ip~-~l~~--------l~~L~~L~L~~N~l~~~~p~~~~ 88 (809)
+++|++|||++|++. ......+.. +..+.+..+ .||. +|.+ +++|+.|+|.+ .++.+-+.+|.
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~--~~~~~~~~~---~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~ 121 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPN--GKFYIYMAN---FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFK 121 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGG--GCCEEECTT---EECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTT
T ss_pred hccCeEEecCcceeEEecCccccccc--ccccccccc---ccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhh
Confidence 678888999888887 222222221 111222222 5554 5666 88888888888 77766667888
Q ss_pred CCCCCCEEEccCCccCccCchhhhcccccceeeeecccc----cCcCchhhhcccccc----------------------
Q 043333 89 NLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHF----TGQIPDYIQNWTKLE---------------------- 142 (809)
Q Consensus 89 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l----~~~~p~~~~~l~~L~---------------------- 142 (809)
++++|+.|+|++|.++.+.+..|.++.++..+.+..+.. .......|.++.+|+
T Consensus 122 ~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~ 201 (329)
T 3sb4_A 122 GCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQP 201 (329)
T ss_dssp TCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCG
T ss_pred cCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCc
Confidence 888888888888888767777787777777666655321 111112222222222
Q ss_pred ----eEecccCcCCCCCCccc-cCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhcccccc-EE
Q 043333 143 ----KLFIEGSGLAGPIPSGI-ASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLR-VL 216 (809)
Q Consensus 143 ----~L~L~~N~l~~~~p~~~-~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L 216 (809)
.+.+.++-.. .....+ ..+++|+.|++++|+++.++...|.++++|+.|+|.+| +..+.+.+|.++++|+ .|
T Consensus 202 ~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l 279 (329)
T 3sb4_A 202 RDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTL 279 (329)
T ss_dssp GGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred cccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEE
Confidence 1111111000 000000 12455666666665666666666666666666666555 5555555566666665 66
Q ss_pred eccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhh
Q 043333 217 DLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIV 255 (809)
Q Consensus 217 ~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~ 255 (809)
+|.+ .++.+.+..|.. ++|+.|++++|.++.+.+..|.
T Consensus 280 ~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~ 318 (329)
T 3sb4_A 280 ELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFG 318 (329)
T ss_dssp EECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTC
T ss_pred EEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhc
Confidence 6655 555555555555 5666666666666555554443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=4.5e-16 Score=151.08 Aligned_cols=135 Identities=18% Similarity=0.205 Sum_probs=107.8
Q ss_pred CccCcEEeecccccc-cCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceE
Q 043333 66 ISTLADLTLEFNQFS-GDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKL 144 (809)
Q Consensus 66 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 144 (809)
.++|+.|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|+.|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 367888888888887 67777778888888888888888855 677888888888888888887777777778888888
Q ss_pred ecccCcCCCCC-CccccCCCCCCEEeccCCCCCCCCC---ccccCCcCCceeeeccccccCC
Q 043333 145 FIEGSGLAGPI-PSGIASLVELTDLRISDLNGPEGPF---PRLSNLKNMNYLILRSGNIIGE 202 (809)
Q Consensus 145 ~L~~N~l~~~~-p~~~~~l~~L~~L~l~~n~l~~~~~---~~l~~l~~L~~L~Ls~N~l~~~ 202 (809)
+|++|++++.. +..+..+++|+.|++++|.+...+. ..+..+++|++|++++|.+...
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 88888887542 2677888888888888888887776 5678888888888888877654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.4e-15 Score=149.59 Aligned_cols=125 Identities=19% Similarity=0.243 Sum_probs=70.9
Q ss_pred cEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccC
Q 043333 70 ADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGS 149 (809)
Q Consensus 70 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 149 (809)
+.+++++|+++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45666666666 4554432 46666666666666 55566666666666666666666555556666666666666666
Q ss_pred cCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeecccc
Q 043333 150 GLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGN 198 (809)
Q Consensus 150 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~ 198 (809)
+|++..|..|..+++|+.|++++|.++.++...|..+++|+.|+|++|.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 137 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANP 137 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCC
Confidence 6665555555555555555544444444443333333333333333333
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=5.7e-16 Score=147.15 Aligned_cols=129 Identities=20% Similarity=0.238 Sum_probs=95.7
Q ss_pred CccCcEEeecccccc-cCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceE
Q 043333 66 ISTLADLTLEFNQFS-GDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKL 144 (809)
Q Consensus 66 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 144 (809)
.++|+.|++++|.++ +.+|..+..+++|++|+|++|++++. ..++++++|++|+|++|++++.+|..+..+++|+.|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 467888888888887 67787888888888888888888865 677888888888888888887677777778888888
Q ss_pred ecccCcCCCC-CCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCC---hhhhccccccEEeccC
Q 043333 145 FIEGSGLAGP-IPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMP---EYLGQMIGLRVLDLSF 220 (809)
Q Consensus 145 ~L~~N~l~~~-~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~ 220 (809)
+|++|++++. .+..+ ..+++|++|++++|.+++..+ ..+..+++|+.||+++
T Consensus 94 ~ls~N~i~~~~~~~~~------------------------~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPL------------------------KKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGG------------------------GGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHH------------------------hhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 8888887742 12334 445555666666666666655 5677777777777763
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=5.8e-16 Score=147.11 Aligned_cols=127 Identities=20% Similarity=0.206 Sum_probs=81.1
Q ss_pred CCCCEEEccCCccC-ccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEe
Q 043333 91 INLEKLHLNSNNFT-GKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLR 169 (809)
Q Consensus 91 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 169 (809)
++|+.|++++|+++ +.+|..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|+++
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~----------------- 77 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVS----------------- 77 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCC-----------------
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCccc-----------------
Confidence 44555555555555 44454555555555555555555533 33444455555555555544
Q ss_pred ccCCCCCCCCCccccCCcCCceeeeccccccCC-CChhhhccccccEEeccCCCCCCCCC---CCCCC-CCccEEEeeC
Q 043333 170 ISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGE-MPEYLGQMIGLRVLDLSFNKLSGVIP---SNFSG-SGLTYMYLTG 243 (809)
Q Consensus 170 l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~-~~L~~L~Ls~ 243 (809)
...+..+..+++|++|+|++|++++. .+..+..+++|+.|++++|++++.++ ..+.. ++|+.|++++
T Consensus 78 -------~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 78 -------GGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp -------SCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred -------chHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 43333445566777777777777764 35789999999999999999998877 44544 9999999874
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=3.2e-15 Score=148.76 Aligned_cols=108 Identities=22% Similarity=0.298 Sum_probs=68.7
Q ss_pred ccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEecc
Q 043333 140 KLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLS 219 (809)
Q Consensus 140 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 219 (809)
+|+.|+|++|+|+ .+|..|..+++|+.|++++|.++.++...|.++++|++|+|++|++++..|..|..+++|+.|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 3444444444444 334444444444555555555555555555666666666666777777777777777778888888
Q ss_pred CCCCCCCCCCCCCC-CCccEEEeeCccCCC
Q 043333 220 FNKLSGVIPSNFSG-SGLTYMYLTGNLLTG 248 (809)
Q Consensus 220 ~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~ 248 (809)
+|+|+.+++..|.. ++|+.|+|++|++.+
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 111 GNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 88887777766665 778888888888775
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=4.9e-15 Score=145.08 Aligned_cols=91 Identities=22% Similarity=0.271 Sum_probs=54.5
Q ss_pred CCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEE
Q 043333 161 SLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYM 239 (809)
Q Consensus 161 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L 239 (809)
.+++|+.|++++|.++.++...|.++++|++|+|++|++++..+..|..+++|+.|+|++|+|+++++..+.. ++|+.|
T Consensus 50 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 129 (177)
T 2o6r_A 50 KLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKI 129 (177)
T ss_dssp TCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEE
Confidence 3333333333333333333333444555555555555555555555666777777777777777777666554 778888
Q ss_pred EeeCccCCCCCC
Q 043333 240 YLTGNLLTGPVP 251 (809)
Q Consensus 240 ~Ls~N~l~~~~p 251 (809)
+|++|++++..|
T Consensus 130 ~l~~N~~~~~~~ 141 (177)
T 2o6r_A 130 WLHTNPWDCSCP 141 (177)
T ss_dssp ECCSSCBCCCHH
T ss_pred EecCCCeeccCc
Confidence 888888877665
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.1e-14 Score=161.46 Aligned_cols=232 Identities=10% Similarity=0.059 Sum_probs=158.7
Q ss_pred CCccCCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCc-hhhcCCccCcEEeecccccccCCCccccCCC
Q 043333 13 LPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIP-KAVASISTLADLTLEFNQFSGDLPAELGNLI 91 (809)
Q Consensus 13 lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 91 (809)
-..+|.+. +|+.++|.++ ++......|....|+.+.+.+ .+..|+ .+|.++++|+.++|++|+++......|. ..
T Consensus 128 ~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~ 203 (401)
T 4fdw_A 128 PKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNSTVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YA 203 (401)
T ss_dssp CTTTTTTC-CCSEEECCTT-CCEECTTTTTTCCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TC
T ss_pred hHhhcccC-CccEEEeCCC-ccEECHHhcCCCCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ec
Confidence 34456654 6888887766 665666667776677777765 555664 4677777888888877777744444555 47
Q ss_pred CCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEecc
Q 043333 92 NLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRIS 171 (809)
Q Consensus 92 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 171 (809)
+|+.+.|.++ ++.+...+|.++++|+.++|.+| ++.....+|.+ .+|+.+.| .|.++.....+|.++++|+.+.+.
T Consensus 204 ~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~ 279 (401)
T 4fdw_A 204 GIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTY 279 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEE
T ss_pred ccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeC
Confidence 7888887744 66566667777778888887765 45455556666 67777777 455665556677777788888777
Q ss_pred CCCCC-----CCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccC
Q 043333 172 DLNGP-----EGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLL 246 (809)
Q Consensus 172 ~n~l~-----~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l 246 (809)
+|.+. .++...|.++++|+.+.|. +++..+...+|.++++|+.|+|..| ++.+....|...+|+.|++++|.+
T Consensus 280 ~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~~L~~l~l~~n~~ 357 (401)
T 4fdw_A 280 GSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNTGIKEVKVEGTTP 357 (401)
T ss_dssp SSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSSCCCEEEECCSSC
T ss_pred CccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCCCCCEEEEcCCCC
Confidence 76655 4666677777777777777 4566666777777777777777544 666666777666777777777776
Q ss_pred CCCCChhh
Q 043333 247 TGPVPDWI 254 (809)
Q Consensus 247 ~~~~p~~~ 254 (809)
....+..+
T Consensus 358 ~~l~~~~F 365 (401)
T 4fdw_A 358 PQVFEKVW 365 (401)
T ss_dssp CBCCCSSC
T ss_pred cccccccc
Confidence 65444444
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=5.8e-15 Score=144.57 Aligned_cols=132 Identities=17% Similarity=0.225 Sum_probs=70.3
Q ss_pred CcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEeccc
Q 043333 69 LADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEG 148 (809)
Q Consensus 69 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 148 (809)
.+.+++++|+++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 355666666665 3443322 4566666666666654444555666666666666666644444455555555555555
Q ss_pred CcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCC
Q 043333 149 SGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVI 227 (809)
Q Consensus 149 N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 227 (809)
|++++..+..|..+++ |++|+|++|++++..+..|..+++|+.|+|++|.+++..
T Consensus 86 N~l~~~~~~~~~~l~~------------------------L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQ------------------------LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp SCCCCCCTTTTTTCTT------------------------CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCccccCHHHhhCCcc------------------------cCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 5555444444444444 444444444444444444455555555555555555443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=3.8e-16 Score=169.79 Aligned_cols=138 Identities=15% Similarity=0.181 Sum_probs=99.0
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCc-----ccc---------hh--------HHHHHHHHhhcCCCc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSK-----QGN---------RE--------FVNEIGMISALQHPN 632 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~-----~~~---------~~--------f~~Ei~~l~~l~H~n 632 (809)
.-|++.++||+|+||.||+|...+|+.||||+++.... ... .. ...|...|.++.+..
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34888999999999999999988899999998764311 000 01 123556666665444
Q ss_pred eEeEEeEEEeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc
Q 043333 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD 712 (809)
Q Consensus 633 Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 712 (809)
+....-+... ..++||||+++++|.++... .....++.|++.+|.|||+. +||||||||.|||++
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 3221111112 23799999999988765411 12356889999999999998 899999999999998
Q ss_pred CCC----------ceEEEecCCccc
Q 043333 713 KDL----------NPKISDFGLAKL 727 (809)
Q Consensus 713 ~~~----------~~kl~DfGla~~ 727 (809)
+++ .+.|+||+=+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 876 389999996643
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.58 E-value=4.9e-17 Score=162.61 Aligned_cols=155 Identities=21% Similarity=0.302 Sum_probs=114.6
Q ss_pred hcCCccCcEEeecccccccCCCc------cccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhh
Q 043333 63 VASISTLADLTLEFNQFSGDLPA------ELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQ 136 (809)
Q Consensus 63 l~~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 136 (809)
+.....++.++++.+.+++.+|. .+..+++|++|+|++|++++ +| .+.++++|+.|+|++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44556777788888888877776 78888888888888888885 56 7888888888888888888 6777777
Q ss_pred cccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCC-ccccCCcCCceeeeccccccCCCCh----------
Q 043333 137 NWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPF-PRLSNLKNMNYLILRSGNIIGEMPE---------- 205 (809)
Q Consensus 137 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~---------- 205 (809)
.+++|+.|+|++|++++ +| .+..+++|+.|++++|.+..++. ..+..+++|++|++++|.+.+..|.
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 168 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence 77888888888888875 34 56677777777777777766543 4567777777777777777666554
Q ss_pred hhhccccccEEeccCCCCC
Q 043333 206 YLGQMIGLRVLDLSFNKLS 224 (809)
Q Consensus 206 ~~~~l~~L~~L~Ls~N~l~ 224 (809)
.+..+++|+.|| +|.++
T Consensus 169 ~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 169 VVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHCSSCSEEC--CGGGT
T ss_pred HHHhCCCcEEEC--CcccC
Confidence 266777777765 55554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.5e-17 Score=195.02 Aligned_cols=266 Identities=17% Similarity=0.137 Sum_probs=164.7
Q ss_pred ccccCCC--CCc-cCCccCCCCCCCCEEEccCC-CCCCCCCcccCCCC-ccccccc------------------------
Q 043333 2 RILKSQN--LPG-RLPPELTRLPFLQEIDLTRN-YLNGTIPSEWASLP-LVNLPLW------------------------ 52 (809)
Q Consensus 2 L~L~~nn--l~~-~lp~~l~~l~~L~~L~Ls~n-~l~~~~p~~~~~l~-L~~L~l~------------------------ 52 (809)
|+|++|+ +.. .++.-+..+++|++|+|++| .+. .++..+..++ |++|.+.
T Consensus 189 L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L 267 (594)
T 2p1m_B 189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKEL 267 (594)
T ss_dssp EECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTC
T ss_pred EEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCc
Confidence 5677765 211 11111245688999999988 333 2343333332 4444422
Q ss_pred -------cccCCCCchhhcCCccCcEEeecccccccCCC-ccccCCCCCCEEEccCCccCcc-Cchhhhcccccceeeee
Q 043333 53 -------KQANGAIPKAVASISTLADLTLEFNQFSGDLP-AELGNLINLEKLHLNSNNFTGK-LPESFANLTRLKHFRIS 123 (809)
Q Consensus 53 -------~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls 123 (809)
+.....+|..+..+++|++|+|++|.+++... ..+..+++|++|+|++| ++.. ++.....+++|+.|+|+
T Consensus 268 ~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~ 346 (594)
T 2p1m_B 268 RCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVF 346 (594)
T ss_dssp CEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEE
T ss_pred ccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEe
Confidence 22223344444567788888888888664322 23567788888888877 4422 22223357888888884
Q ss_pred c---------ccccCcCchhhh-cccccceEecccCcCCCCCCcccc-CCCCCCEEecc--C----CCCCCCCCcc----
Q 043333 124 D---------NHFTGQIPDYIQ-NWTKLEKLFIEGSGLAGPIPSGIA-SLVELTDLRIS--D----LNGPEGPFPR---- 182 (809)
Q Consensus 124 ~---------N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~--~----n~l~~~~~~~---- 182 (809)
+ |.+++.....+. ++++|+.|.+..|++++..+..+. .+++|+.|+++ + +.++..+...
T Consensus 347 ~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~ 426 (594)
T 2p1m_B 347 PSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGA 426 (594)
T ss_dssp CSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHH
T ss_pred cCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHH
Confidence 3 445433333333 478888888888888765555554 57888888888 4 5555444321
Q ss_pred -ccCCcCCceeeeccccccCCCChhhhc-cccccEEeccCCCCCCCCCCCC-C-CCCccEEEeeCccCCCCCChhh-h-h
Q 043333 183 -LSNLKNMNYLILRSGNIIGEMPEYLGQ-MIGLRVLDLSFNKLSGVIPSNF-S-GSGLTYMYLTGNLLTGPVPDWI-V-R 256 (809)
Q Consensus 183 -l~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~-~~~L~~L~Ls~N~l~~~~p~~~-~-~ 256 (809)
+..+++|+.|+|++ +++...+..+.. +++|+.|+|++|.+++..+..+ . .++|+.|+|++|++++..+..+ . .
T Consensus 427 l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l 505 (594)
T 2p1m_B 427 IVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKL 505 (594)
T ss_dssp HHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGG
T ss_pred HHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhC
Confidence 56778888888876 666655555655 7888888888888865544333 2 3788888888888865443322 2 3
Q ss_pred ccCccccccCCccc
Q 043333 257 KRNKHIDLSYNNFI 270 (809)
Q Consensus 257 ~~l~~L~Ls~N~l~ 270 (809)
.+++.|++++|+++
T Consensus 506 ~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 506 ETMRSLWMSSCSVS 519 (594)
T ss_dssp GGSSEEEEESSCCB
T ss_pred CCCCEEeeeCCCCC
Confidence 57788888888774
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.3e-16 Score=186.94 Aligned_cols=265 Identities=14% Similarity=0.093 Sum_probs=127.0
Q ss_pred ccccCC-CCCcc-CCccCCCCCCCCEEEccCCCCCCCCCcccCC----C-CccccccccccCCCCc-----hhhcCCccC
Q 043333 2 RILKSQ-NLPGR-LPPELTRLPFLQEIDLTRNYLNGTIPSEWAS----L-PLVNLPLWKQANGAIP-----KAVASISTL 69 (809)
Q Consensus 2 L~L~~n-nl~~~-lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~----l-~L~~L~l~~n~~~~ip-----~~l~~l~~L 69 (809)
|+|++| .+... ++..+..+++|++|+|++|.+++..+..+.. + .|+.|+++++. ..++ ..+..+++|
T Consensus 135 L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L 213 (594)
T 2p1m_B 135 LVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVTRCPNL 213 (594)
T ss_dssp EEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHHHCTTC
T ss_pred EeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHHhCCCC
Confidence 556666 33321 3333446777777777777766544443332 2 26677776665 2332 122345777
Q ss_pred cEEeeccc-ccccCCCccccCC------------------------------------------------------CCCC
Q 043333 70 ADLTLEFN-QFSGDLPAELGNL------------------------------------------------------INLE 94 (809)
Q Consensus 70 ~~L~L~~N-~l~~~~p~~~~~l------------------------------------------------------~~L~ 94 (809)
++|+|++| .+++ ++..+..+ ++|+
T Consensus 214 ~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~ 292 (594)
T 2p1m_B 214 KSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLT 292 (594)
T ss_dssp CEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCC
T ss_pred cEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhhCCCC
Confidence 77777766 2222 33333333 4444
Q ss_pred EEEccCCccCccCc-hhhhcccccceeeeecccccCc-CchhhhcccccceEeccc---------CcCCCCCCcccc-CC
Q 043333 95 KLHLNSNNFTGKLP-ESFANLTRLKHFRISDNHFTGQ-IPDYIQNWTKLEKLFIEG---------SGLAGPIPSGIA-SL 162 (809)
Q Consensus 95 ~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~---------N~l~~~~p~~~~-~l 162 (809)
+|+|++|.+++... ..+.++++|+.|+|++| +... ++.....+++|++|+|.+ +.+++.....+. .+
T Consensus 293 ~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~ 371 (594)
T 2p1m_B 293 TLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGC 371 (594)
T ss_dssp EEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHC
T ss_pred EEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhc
Confidence 44444444432111 11234444444544444 2211 111122344555555422 222221111111 24
Q ss_pred CCCCEEeccCCCCCCCCCcccc-CCcCCceeeec--c----ccccCCC-----ChhhhccccccEEeccCCCCCCCCCCC
Q 043333 163 VELTDLRISDLNGPEGPFPRLS-NLKNMNYLILR--S----GNIIGEM-----PEYLGQMIGLRVLDLSFNKLSGVIPSN 230 (809)
Q Consensus 163 ~~L~~L~l~~n~l~~~~~~~l~-~l~~L~~L~Ls--~----N~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 230 (809)
++|+.|.++.|.++......+. .+++|+.|+|+ + |+++... +..+..+++|+.|+|++ .+++..+..
T Consensus 372 ~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~ 450 (594)
T 2p1m_B 372 PKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEY 450 (594)
T ss_dssp TTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHH
T ss_pred hhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHH
Confidence 5555555555555443333332 35666666666 2 3333221 11245566666666655 444332222
Q ss_pred CC--CCCccEEEeeCccCCCCCChhh--hhccCccccccCCccc
Q 043333 231 FS--GSGLTYMYLTGNLLTGPVPDWI--VRKRNKHIDLSYNNFI 270 (809)
Q Consensus 231 ~~--~~~L~~L~Ls~N~l~~~~p~~~--~~~~l~~L~Ls~N~l~ 270 (809)
+. .++|+.|+|++|.+++..+..+ ...+++.|+|++|+++
T Consensus 451 l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 451 IGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp HHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred HHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence 22 3667777777777765444333 1256677777777764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.54 E-value=5e-15 Score=160.29 Aligned_cols=96 Identities=14% Similarity=0.008 Sum_probs=84.6
Q ss_pred CcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCcc-EEEeeCccCCCCCChhhhh-ccCccc
Q 043333 186 LKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLT-YMYLTGNLLTGPVPDWIVR-KRNKHI 262 (809)
Q Consensus 186 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~-~L~Ls~N~l~~~~p~~~~~-~~l~~L 262 (809)
+++|+.|+|++|+++.+.+.+|.++++|+.|+|++| ++.+.+..|.. .+|+ .+++.+ .++.+.+..|.. ..++.+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 789999999999999999999999999999999998 88899999988 8899 999999 888777888865 678999
Q ss_pred cccCCccccCCCCCccccccc
Q 043333 263 DLSYNNFIDGSSDSNCENQSV 283 (809)
Q Consensus 263 ~Ls~N~l~~~~~~~~~~~~~~ 283 (809)
++++|.++......+.....+
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L 323 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPS 323 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCC
T ss_pred EeCCCccCccchhhhcCCcch
Confidence 999999998887777654443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=1.1e-14 Score=142.44 Aligned_cols=133 Identities=20% Similarity=0.273 Sum_probs=65.8
Q ss_pred cCCccCcEEeecccccccCCCccccCCC-CCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccc
Q 043333 64 ASISTLADLTLEFNQFSGDLPAELGNLI-NLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLE 142 (809)
Q Consensus 64 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 142 (809)
.++.+|+.|+|++|+++ .+|. +..+. +|++|+|++|+|++. ..+..+++|+.|+|++|+|++..+..+..+++|+
T Consensus 16 ~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 16 TNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp ECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred CCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 34455555555555555 2332 22222 555555555555533 3445555555555555555533333334445555
Q ss_pred eEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCC-ccccCCcCCceeeeccccccCCCCh---hhhccccccEEec
Q 043333 143 KLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPF-PRLSNLKNMNYLILRSGNIIGEMPE---YLGQMIGLRVLDL 218 (809)
Q Consensus 143 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L 218 (809)
.|+|++|+++ .++. ..+..+++|+.|+|++|.+....+. .+..+++|+.||+
T Consensus 92 ~L~L~~N~i~------------------------~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~ 147 (176)
T 1a9n_A 92 ELILTNNSLV------------------------ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 147 (176)
T ss_dssp EEECCSCCCC------------------------CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred EEECCCCcCC------------------------cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCC
Confidence 5555555443 3321 2344555555555555655533222 3666666666666
Q ss_pred cCCCCC
Q 043333 219 SFNKLS 224 (809)
Q Consensus 219 s~N~l~ 224 (809)
++|.+.
T Consensus 148 ~~n~~~ 153 (176)
T 1a9n_A 148 QKVKLK 153 (176)
T ss_dssp EECCHH
T ss_pred CcCCHH
Confidence 666553
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.52 E-value=9.8e-14 Score=153.94 Aligned_cols=230 Identities=13% Similarity=0.087 Sum_probs=195.0
Q ss_pred CCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeecccccccCCCccc
Q 043333 9 LPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAEL 87 (809)
Q Consensus 9 l~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~ 87 (809)
+...-..+|.+ .+|+.++|.+ .++...+..|..+. |+.+.+.+|.+..||.......+|+.+.|.++ ++.+-...|
T Consensus 146 i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF 222 (401)
T 4fdw_A 146 LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFVYAGIEEVLLPVT-LKEIGSQAF 222 (401)
T ss_dssp CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTTTCCCSEEECCTT-CCEECTTTT
T ss_pred ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEeecccCEEEeCCc-hheehhhHh
Confidence 55455556777 4799999996 78877778899885 99999999999999886655799999999855 776777799
Q ss_pred cCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCC-----CCCCccccCC
Q 043333 88 GNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLA-----GPIPSGIASL 162 (809)
Q Consensus 88 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l 162 (809)
.++++|+.++|.+| ++.+...+|.+ .+|+.+.| .|.++...+.+|.++++|+.+++.+|.+. ...+.+|.++
T Consensus 223 ~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c 299 (401)
T 4fdw_A 223 LKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGC 299 (401)
T ss_dssp TTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTC
T ss_pred hCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCC
Confidence 99999999999985 66566778888 79999999 55677667788999999999999998875 4557789999
Q ss_pred CCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC--CCccEEE
Q 043333 163 VELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG--SGLTYMY 240 (809)
Q Consensus 163 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~ 240 (809)
++|+.+.+. +.++.+....|.++++|+.|.|.. +++.....+|.++ +|+.|++++|.+..+.+..|.. .+++.|+
T Consensus 300 ~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~-~l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~ 376 (401)
T 4fdw_A 300 PKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPA-NVTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIR 376 (401)
T ss_dssp TTCCEECCC-TTCCEECTTTTTTCCSCCEEEECT-TCCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEE
T ss_pred ccCCeEEeC-CceEEEhhhhhcCCCCccEEEECc-cccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEE
Confidence 999999999 569999999999999999999965 4888888899999 9999999999999888888876 5788998
Q ss_pred eeCccCC
Q 043333 241 LTGNLLT 247 (809)
Q Consensus 241 Ls~N~l~ 247 (809)
+..|.+.
T Consensus 377 vp~~~~~ 383 (401)
T 4fdw_A 377 VPAESVE 383 (401)
T ss_dssp ECGGGHH
T ss_pred eCHHHHH
Confidence 8877654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=9.4e-15 Score=142.98 Aligned_cols=128 Identities=15% Similarity=0.100 Sum_probs=106.1
Q ss_pred CCccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeee
Q 043333 44 LPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRIS 123 (809)
Q Consensus 44 l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 123 (809)
..++.|++++|.+..+|......++|+.|+|++|.+++. ..|..+++|++|+|++|+|++..+..+..+++|++|+|+
T Consensus 19 ~~L~~L~l~~n~l~~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 96 (176)
T 1a9n_A 19 VRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 96 (176)
T ss_dssp TSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred CCceEEEeeCCCCchhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECC
Confidence 358999999999999976434445999999999999965 679999999999999999997666667999999999999
Q ss_pred cccccCcCch--hhhcccccceEecccCcCCCCCCcc----ccCCCCCCEEeccCCCC
Q 043333 124 DNHFTGQIPD--YIQNWTKLEKLFIEGSGLAGPIPSG----IASLVELTDLRISDLNG 175 (809)
Q Consensus 124 ~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~l~~n~l 175 (809)
+|+|+ .+|. .+..+++|+.|+|++|.++ .+|.. +..+++|+.|++++|..
T Consensus 97 ~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 97 NNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp SCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 99997 5665 7899999999999999998 45553 66666676666666554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.2e-16 Score=159.75 Aligned_cols=136 Identities=19% Similarity=0.161 Sum_probs=85.1
Q ss_pred ccCCCCCCEEEccCCccCccCch------hhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCcccc
Q 043333 87 LGNLINLEKLHLNSNNFTGKLPE------SFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIA 160 (809)
Q Consensus 87 ~~~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 160 (809)
+.....++.++++.|.+++.+|. .+.++++|++|+|++|++++ +| .+..+++|+.|+|++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44456677777777777776665 77888888888888888875 56 7777888888888888877 5666555
Q ss_pred CCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCC-hhhhccccccEEeccCCCCCCCC
Q 043333 161 SLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMP-EYLGQMIGLRVLDLSFNKLSGVI 227 (809)
Q Consensus 161 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~ 227 (809)
.+++|+.|++++|.++.++ .+..+++|+.|+|++|++....+ ..+..+++|+.|++++|++++.+
T Consensus 91 ~~~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 156 (198)
T 1ds9_A 91 VADTLEELWISYNQIASLS--GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp HHHHCSEEEEEEEECCCHH--HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHH
T ss_pred cCCcCCEEECcCCcCCcCC--ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccc
Confidence 5566666666665555432 34455555555555555544322 34444555555555555544443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.42 E-value=3.2e-13 Score=131.24 Aligned_cols=86 Identities=23% Similarity=0.296 Sum_probs=45.1
Q ss_pred ccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEec
Q 043333 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFI 146 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 146 (809)
++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 44555555555555444555555555555555555555444444455555555555555555444444555555555555
Q ss_pred ccCcCC
Q 043333 147 EGSGLA 152 (809)
Q Consensus 147 ~~N~l~ 152 (809)
++|.+.
T Consensus 110 ~~N~~~ 115 (170)
T 3g39_A 110 LNNPWD 115 (170)
T ss_dssp CSSCBC
T ss_pred CCCCCC
Confidence 555554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.41 E-value=5.4e-13 Score=129.66 Aligned_cols=105 Identities=18% Similarity=0.223 Sum_probs=67.3
Q ss_pred cCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecc
Q 043333 68 TLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIE 147 (809)
Q Consensus 68 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 147 (809)
..+.|++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3466777777777 4565442 667777777777776666677777777777777777776555556666666666666
Q ss_pred cCcCCCCCCccccCCCCCCEEeccCCCC
Q 043333 148 GSGLAGPIPSGIASLVELTDLRISDLNG 175 (809)
Q Consensus 148 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l 175 (809)
+|+|++..+..|..+++|+.|++++|.+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 114 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPW 114 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCB
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCC
Confidence 6666654444455555555554444443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=4.3e-13 Score=130.88 Aligned_cols=86 Identities=26% Similarity=0.371 Sum_probs=40.4
Q ss_pred ccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEec
Q 043333 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFI 146 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 146 (809)
++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 34445555555554444444444555555555555554433333444444555555555444333333444444444444
Q ss_pred ccCcCC
Q 043333 147 EGSGLA 152 (809)
Q Consensus 147 ~~N~l~ 152 (809)
++|.+.
T Consensus 113 ~~N~~~ 118 (174)
T 2r9u_A 113 YNNPWD 118 (174)
T ss_dssp CSSCBC
T ss_pred CCCCcc
Confidence 444444
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.39 E-value=9.8e-13 Score=128.34 Aligned_cols=105 Identities=19% Similarity=0.248 Sum_probs=69.7
Q ss_pred CcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEeccc
Q 043333 69 LADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEG 148 (809)
Q Consensus 69 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 148 (809)
-+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 356777777776 5666553 6777777777777776677777777777777777777765555566677777777777
Q ss_pred CcCCCCCCccccCCCCCCEEeccCCCCC
Q 043333 149 SGLAGPIPSGIASLVELTDLRISDLNGP 176 (809)
Q Consensus 149 N~l~~~~p~~~~~l~~L~~L~l~~n~l~ 176 (809)
|+|++..+..|..+++|+.|++++|.+.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcc
Confidence 7776444444555555555555555443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.1e-14 Score=157.77 Aligned_cols=158 Identities=15% Similarity=0.162 Sum_probs=85.3
Q ss_pred ccCcEEeecccccccCCCccccC-----CCCCCEEEccCCccCccCchhh-hcccccceeeeecccccCcCchhhh----
Q 043333 67 STLADLTLEFNQFSGDLPAELGN-----LINLEKLHLNSNNFTGKLPESF-ANLTRLKHFRISDNHFTGQIPDYIQ---- 136 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~---- 136 (809)
++|+.|+|++|.++......+.. .++|++|+|++|.|+......+ ..+++|+.|+|++|.|+......+.
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 46777777777776433333222 2577777777777764322232 2356677777777777644333332
Q ss_pred -cccccceEecccCcCCCC----CCccccCCCCCCEEeccCCCCCCCC----CccccCCcCCceeeeccccccCC----C
Q 043333 137 -NWTKLEKLFIEGSGLAGP----IPSGIASLVELTDLRISDLNGPEGP----FPRLSNLKNMNYLILRSGNIIGE----M 203 (809)
Q Consensus 137 -~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~n~l~~~~----~~~l~~l~~L~~L~Ls~N~l~~~----~ 203 (809)
..++|+.|+|++|.|+.. ++..+..+++|+.|+|++|.++... ...+...++|+.|+|++|.++.. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 245677777777776532 2233345556666666666554433 12234445555555555555442 2
Q ss_pred ChhhhccccccEEeccCCCCC
Q 043333 204 PEYLGQMIGLRVLDLSFNKLS 224 (809)
Q Consensus 204 p~~~~~l~~L~~L~Ls~N~l~ 224 (809)
+..+...++|++|||++|.|+
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCC
T ss_pred HHHHHhCCCCCEEeccCCCCC
Confidence 223334455555555555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.2e-13 Score=151.66 Aligned_cols=166 Identities=16% Similarity=0.120 Sum_probs=124.6
Q ss_pred CCCCCEEEccCCccCccCchhhhcc-----cccceeeeecccccCcCchhh-hcccccceEecccCcCCCCCCccc----
Q 043333 90 LINLEKLHLNSNNFTGKLPESFANL-----TRLKHFRISDNHFTGQIPDYI-QNWTKLEKLFIEGSGLAGPIPSGI---- 159 (809)
Q Consensus 90 l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~---- 159 (809)
+++|+.|+|++|.|+......+..+ ++|+.|+|++|.|+......+ ..+++|+.|+|++|+|+......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 4689999999999996555555544 699999999999975444343 456899999999999985444444
Q ss_pred -cCCCCCCEEeccCCCCCCCCCcc----ccCCcCCceeeeccccccCCC----ChhhhccccccEEeccCCCCCCCCCCC
Q 043333 160 -ASLVELTDLRISDLNGPEGPFPR----LSNLKNMNYLILRSGNIIGEM----PEYLGQMIGLRVLDLSFNKLSGVIPSN 230 (809)
Q Consensus 160 -~~l~~L~~L~l~~n~l~~~~~~~----l~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 230 (809)
...++|+.|+|++|.++...... +..+++|++|+|++|.+.... +..+...++|+.|+|++|.|+......
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 24678999999999887654443 467889999999999987643 566777889999999999987543322
Q ss_pred C-----CCCCccEEEeeCccCCCCCChhhh
Q 043333 231 F-----SGSGLTYMYLTGNLLTGPVPDWIV 255 (809)
Q Consensus 231 ~-----~~~~L~~L~Ls~N~l~~~~p~~~~ 255 (809)
+ ..++|+.|+|++|.|+......+.
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred HHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 2 237899999999998865555443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.8e-11 Score=133.20 Aligned_cols=130 Identities=19% Similarity=0.223 Sum_probs=91.5
Q ss_pred EecccC-cCCCCCCccccCCCCCCEEeccC-CCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCC
Q 043333 144 LFIEGS-GLAGPIPSGIASLVELTDLRISD-LNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFN 221 (809)
Q Consensus 144 L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~-n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 221 (809)
++++++ +|+ .+|. +..+++|+.|+|++ |.+..++...|.++++|+.|+|++|+|.+..|..|.+|++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455555 555 3455 66666666666664 6666666666777888888888888888888888999999999999999
Q ss_pred CCCCCCCCCCCCCCccEEEeeCccCCCCCC-hhhhh-ccCccccccCCccccCCCC
Q 043333 222 KLSGVIPSNFSGSGLTYMYLTGNLLTGPVP-DWIVR-KRNKHIDLSYNNFIDGSSD 275 (809)
Q Consensus 222 ~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p-~~~~~-~~l~~L~Ls~N~l~~~~~~ 275 (809)
+|+++++..+....|+.|+|++|++...-. .++.. .......+..+.++|..+.
T Consensus 91 ~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 91 ALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp CCSCCCSTTTCSCCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred ccceeCHHHcccCCceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 999888888877559999999999986433 22221 2223344556677776554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.1e-11 Score=135.00 Aligned_cols=96 Identities=20% Similarity=0.256 Sum_probs=51.2
Q ss_pred cCCCCchhhcCCccCcEEeecc-cccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCch
Q 043333 55 ANGAIPKAVASISTLADLTLEF-NQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPD 133 (809)
Q Consensus 55 ~~~~ip~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 133 (809)
.+..||. +..+++|+.|+|++ |.|++..+..|.++++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..+.
T Consensus 20 ~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 98 (347)
T 2ifg_A 20 ALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWK 98 (347)
T ss_dssp CCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCST
T ss_pred CCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHH
Confidence 4444555 55555555555554 555544445555555555555555555555555555555555555555555544444
Q ss_pred hhhcccccceEecccCcCC
Q 043333 134 YIQNWTKLEKLFIEGSGLA 152 (809)
Q Consensus 134 ~~~~l~~L~~L~L~~N~l~ 152 (809)
.|..++ |+.|+|++|.+.
T Consensus 99 ~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 99 TVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp TTCSCC-CCEEECCSSCCC
T ss_pred HcccCC-ceEEEeeCCCcc
Confidence 344333 555555555544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=3.8e-11 Score=125.13 Aligned_cols=146 Identities=14% Similarity=0.072 Sum_probs=113.9
Q ss_pred HHhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCeEEEEE
Q 043333 572 AATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 572 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 650 (809)
..-..|.....++.|+.+.||++... ++.+++|+...........+.+|+++++.+. |..+.++++++.+.+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34456777788888889999998754 6789999986533233456889999999885 677889999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE------------------------------------ 694 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------ 694 (809)
||++|.+|.+.+.. ......++.+++++|..||+.
T Consensus 90 e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 90 SEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp ECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999876411 112346888999999999981
Q ss_pred --------------------CCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 695 --------------------SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 695 --------------------~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
.+..++|||++|.||+++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 113589999999999998766667999997753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=2.9e-10 Score=117.82 Aligned_cols=129 Identities=17% Similarity=0.117 Sum_probs=98.0
Q ss_pred ccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCc--eEeEEeEEEeCCeEEEEEEcccCCchhhh
Q 043333 584 GEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPN--LVKLYGCCIEGNQLLLIYEYMENNSLARA 661 (809)
Q Consensus 584 G~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~ 661 (809)
+.|..+.||++...+|+.+++|+.... ....+..|+++++.+++.+ +.+++++....+..++||||+++.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355669999998777888999997543 2356788999999986545 456888888888899999999998884
Q ss_pred ccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 043333 662 LFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES---------------------------------------------- 695 (809)
Q Consensus 662 L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------------- 695 (809)
... .+ ...++.++++.|..||+..
T Consensus 104 ~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 104 SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 211 11 2356778888888888642
Q ss_pred ---------CCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 696 ---------RLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 696 ---------~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+..++|||++|.||+++++..+.|+|||.+..
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12389999999999998876677999998754
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.91 E-value=8.4e-09 Score=114.13 Aligned_cols=150 Identities=14% Similarity=0.056 Sum_probs=64.8
Q ss_pred cccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccC----------------
Q 043333 86 ELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGS---------------- 149 (809)
Q Consensus 86 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N---------------- 149 (809)
+|.++++|+.+.+.++. ..+....|.++++|+.+.+..| ++......|.++..|+.+.+..+
T Consensus 157 aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~~~~~~~~~l~~ 234 (394)
T 4fs7_A 157 AFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLGDFALSKTGVKN 234 (394)
T ss_dssp TTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCCCCE
T ss_pred hhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEeehhhcccCCCce
Confidence 34455555555554432 2233444555555555555444 22222333444444333333221
Q ss_pred -----cCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCC
Q 043333 150 -----GLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLS 224 (809)
Q Consensus 150 -----~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 224 (809)
.++......|..+..|+.+.+..+ ...+....|.++..|+.+.+..+.+ ....|..+.+|+.+.+.++ ++
T Consensus 235 i~ip~~~~~i~~~~f~~~~~l~~~~~~~~-~~~i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~ 309 (394)
T 4fs7_A 235 IIIPDSFTELGKSVFYGCTDLESISIQNN-KLRIGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VK 309 (394)
T ss_dssp EEECTTCCEECSSTTTTCSSCCEEEECCT-TCEECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CC
T ss_pred EEECCCceecccccccccccceeEEcCCC-cceeeccccccccccceeccCceee---ccccccccccccccccccc-cc
Confidence 112122344556666777766554 2333444444444444444433321 1223444444444444332 33
Q ss_pred CCCCCCCCC-CCccEEEee
Q 043333 225 GVIPSNFSG-SGLTYMYLT 242 (809)
Q Consensus 225 ~~~p~~~~~-~~L~~L~Ls 242 (809)
.+....|.. .+|+.++|.
T Consensus 310 ~I~~~aF~~c~~L~~i~lp 328 (394)
T 4fs7_A 310 FIGEEAFESCTSLVSIDLP 328 (394)
T ss_dssp EECTTTTTTCTTCCEECCC
T ss_pred eechhhhcCCCCCCEEEeC
Confidence 333344433 444444443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.91 E-value=3.8e-10 Score=122.89 Aligned_cols=157 Identities=18% Similarity=0.230 Sum_probs=86.3
Q ss_pred hhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCcccc--CCCCCCEEeccC--CC-CCCCCC---
Q 043333 109 ESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIA--SLVELTDLRISD--LN-GPEGPF--- 180 (809)
Q Consensus 109 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~l~~--n~-l~~~~~--- 180 (809)
..+..+++|+.|+|++|.-. .++. + .+++|+.|+|..|.+.......+. .+++|+.|+|+. |. ......
T Consensus 166 ~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l 242 (362)
T 2ra8_A 166 PVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242 (362)
T ss_dssp HHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred HHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence 33444555555555555211 1121 2 245555555555554422222222 455566555532 11 111000
Q ss_pred -ccc--cCCcCCceeeeccccccCCCChhhh---ccccccEEeccCCCCCCCCC----CCCC-CCCccEEEeeCccCCCC
Q 043333 181 -PRL--SNLKNMNYLILRSGNIIGEMPEYLG---QMIGLRVLDLSFNKLSGVIP----SNFS-GSGLTYMYLTGNLLTGP 249 (809)
Q Consensus 181 -~~l--~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~~p----~~~~-~~~L~~L~Ls~N~l~~~ 249 (809)
..+ ..+++|+.|+|++|.+....+..+. .+++|++|+|+.|.|++..+ ..+. +++|+.|+|++|.++..
T Consensus 243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 112 3478899999988888765544444 47889999999999876422 2212 27899999999988754
Q ss_pred CChhhhhccCccccccCCc
Q 043333 250 VPDWIVRKRNKHIDLSYNN 268 (809)
Q Consensus 250 ~p~~~~~~~l~~L~Ls~N~ 268 (809)
.-..+...-...++++.|+
T Consensus 323 ~~~~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 323 MKKELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHHCCSEEECCSBC
T ss_pred HHHHHHHHcCCEEEecCCc
Confidence 4444432113557777776
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.89 E-value=4.3e-09 Score=114.88 Aligned_cols=142 Identities=18% Similarity=0.269 Sum_probs=105.9
Q ss_pred CCCeeccCCCccEEEeEeeCCeEEEEEEec--ccC-cccchhHHHHHHHHhhcC--CCceEeEEeEEEeC---CeEEEEE
Q 043333 579 PDNKIGEGGFGPVYKGLLADGKVIAVKQLS--SKS-KQGNREFVNEIGMISALQ--HPNLVKLYGCCIEG---NQLLLIY 650 (809)
Q Consensus 579 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~--~~~-~~~~~~f~~Ei~~l~~l~--H~nIv~l~~~~~~~---~~~~lV~ 650 (809)
..+.++.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999988654 567788765 322 123457888999999987 45578899988776 4479999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES----------------------------------- 695 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------- 695 (809)
||+++..+.+.. ...++...+..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999998775422 123677888899999999999999731
Q ss_pred --------------------CCCeEEcCCCCCCEEEcCCCc--eEEEecCCccc
Q 043333 696 --------------------RLKIVHRDIKATNVLLDKDLN--PKISDFGLAKL 727 (809)
Q Consensus 696 --------------------~~~iiH~Dlkp~NILl~~~~~--~kl~DfGla~~ 727 (809)
+..++|||+++.||+++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247899999999999997753 58999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=1.6e-09 Score=115.42 Aligned_cols=186 Identities=18% Similarity=0.206 Sum_probs=122.0
Q ss_pred CCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcC-CCc--eEeEEeEEEeCC---eEEEEEEcc
Q 043333 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPN--LVKLYGCCIEGN---QLLLIYEYM 653 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~n--Iv~l~~~~~~~~---~~~lV~ey~ 653 (809)
.+.++.|....||+.. ..+++|+.... .....+.+|+++++.+. +.. +.+.+......+ ..++||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 5679999999999864 45788875432 23456888999998873 433 334554443333 347899999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE--------------------------------------- 694 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------- 694 (809)
+|.++.+... ..++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988865331 2356667778888888888888861
Q ss_pred ----------------CCCCeEEcCCCCCCEEEcC--CCceEEEecCCccccCCCCcceecc--------------cccc
Q 043333 695 ----------------SRLKIVHRDIKATNVLLDK--DLNPKISDFGLAKLDEEDNTHISTR--------------IAGT 742 (809)
Q Consensus 695 ----------------~~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~--------------~~gt 742 (809)
.++.++|+|++|.||++++ +..+.|+||+.+....... ..... ....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHHH
Confidence 1245799999999999998 4567899999886542211 00000 0001
Q ss_pred ccccc-hhhhccCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 043333 743 FGYMA-PEYAMRGYLTDKADVYSFGIVALEIVSGRSNVI 780 (809)
Q Consensus 743 ~~y~a-PE~~~~~~~~~ksDVwSlGvil~elltGk~P~~ 780 (809)
.+... |+..... ....+.|+++.++|++.+|+.+|.
T Consensus 252 Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11222 3322211 223689999999999999998874
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.84 E-value=4.3e-08 Score=108.44 Aligned_cols=247 Identities=13% Similarity=0.129 Sum_probs=159.7
Q ss_pred CccCCCCCCCCEEEccCCC---CCCCCCcccCCCC-ccccccccccCCCCc-hhhcCCccCcEEeecccccccCCCcccc
Q 043333 14 PPELTRLPFLQEIDLTRNY---LNGTIPSEWASLP-LVNLPLWKQANGAIP-KAVASISTLADLTLEFNQFSGDLPAELG 88 (809)
Q Consensus 14 p~~l~~l~~L~~L~Ls~n~---l~~~~p~~~~~l~-L~~L~l~~n~~~~ip-~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 88 (809)
..+|.++++|+.+.++.|. ++......|.... |+.+.+.++ +..|+ .++..+.+|+.+.+..+- .......|.
T Consensus 80 ~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~~-~~I~~~~F~ 157 (394)
T 4gt6_A 80 SNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEGV-TSVADGMFS 157 (394)
T ss_dssp TTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTTC-CEECTTTTT
T ss_pred HHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccccccee-eeeccccee
Confidence 3457777888888887764 5544455666553 666655544 44443 366777888888886543 325555777
Q ss_pred CCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCc------------------
Q 043333 89 NLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSG------------------ 150 (809)
Q Consensus 89 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~------------------ 150 (809)
.+.+|+.+.+.++ ++.+...+|.+ .+|+.+.+..+-.. ....+|.++.+|+......+.
T Consensus 158 ~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (394)
T 4gt6_A 158 YCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYA 234 (394)
T ss_dssp TCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEE
T ss_pred cccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceecccccccccccceeeccccccccc
Confidence 7778888877654 44344444543 46776666554332 334445555555544332221
Q ss_pred ------------------CCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhcccc
Q 043333 151 ------------------LAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIG 212 (809)
Q Consensus 151 ------------------l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 212 (809)
++.....+|.++..|+.+.+.++ ...+....|.++++|+.+.+. +.++.....+|.++.+
T Consensus 235 ~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~-~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~ 312 (394)
T 4gt6_A 235 LIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDS-VVSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCIS 312 (394)
T ss_dssp EEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTT-CCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTT
T ss_pred ccccccccccceEEcCCcceEcccceeeecccccEEecccc-cceecCcccccccccccccCC-CcccccCceeecCCCC
Confidence 12122346677788888888653 455667778888888888885 5666677778888888
Q ss_pred ccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhh-ccCccccccCCcc
Q 043333 213 LRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNF 269 (809)
Q Consensus 213 L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l 269 (809)
|+.++|..+ ++.+....|.. .+|+.+.|..+ ++.+....|.. ..|+.+++.+|..
T Consensus 313 L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 313 LKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp CCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred cCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 999888765 77677777877 88888888654 66566666655 6778888887754
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.84 E-value=9.6e-10 Score=119.73 Aligned_cols=84 Identities=14% Similarity=0.176 Sum_probs=48.0
Q ss_pred CCCCCEEeccCCCCCCCCCccc---cCCcCCceeeeccccccCCC----ChhhhccccccEEeccCCCCCCCCCCCCCCC
Q 043333 162 LVELTDLRISDLNGPEGPFPRL---SNLKNMNYLILRSGNIIGEM----PEYLGQMIGLRVLDLSFNKLSGVIPSNFSGS 234 (809)
Q Consensus 162 l~~L~~L~l~~n~l~~~~~~~l---~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 234 (809)
+++|+.|++.+|.+.......+ ..+++|+.|+|+.|.+.... +..+..+++|+.|+|++|.|+...-..+...
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a 330 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence 4566666666655543211112 24667777788777776643 3334567788888888887764322222211
Q ss_pred CccEEEeeCcc
Q 043333 235 GLTYMYLTGNL 245 (809)
Q Consensus 235 ~L~~L~Ls~N~ 245 (809)
-...+++++|+
T Consensus 331 lg~~~~~~~~~ 341 (362)
T 2ra8_A 331 LPMKIDVSDSQ 341 (362)
T ss_dssp CCSEEECCSBC
T ss_pred cCCEEEecCCc
Confidence 13557787776
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.83 E-value=3.2e-08 Score=109.42 Aligned_cols=218 Identities=13% Similarity=0.086 Sum_probs=133.6
Q ss_pred ccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCc-hhhcCCccCcEEeecccccccCCCccccCCCC
Q 043333 15 PELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIP-KAVASISTLADLTLEFNQFSGDLPAELGNLIN 92 (809)
Q Consensus 15 ~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 92 (809)
.+|..+++|+.+++.++. .......|.... |+.+.+..+ +..|+ .++.++..|+.+.+..+... +...+....+
T Consensus 156 ~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~ 231 (394)
T 4fs7_A 156 EAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTG 231 (394)
T ss_dssp TTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCC
T ss_pred hhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCC
Confidence 346666677777776543 324444555543 666666544 44443 35566666666666655433 2222333456
Q ss_pred CCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccC
Q 043333 93 LEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISD 172 (809)
Q Consensus 93 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 172 (809)
|+.+.+..+ ++.+....|.++.+|+.+.+..+... .....|.++..|+.+.+..+.+. ...|..+.+|+.+.+.+
T Consensus 232 l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~ 306 (394)
T 4fs7_A 232 VKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLD 306 (394)
T ss_dssp CCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECT
T ss_pred CceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---ccccccccccccccccc
Confidence 666666543 33344556667777777777666544 55556777777777766655432 34566777777777765
Q ss_pred CCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCc
Q 043333 173 LNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGN 244 (809)
Q Consensus 173 n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N 244 (809)
+ ++.+....|.++.+|+.++|.+ .++.....+|.++++|+.++|..| ++.+....|.. .+|+.+++..+
T Consensus 307 ~-i~~I~~~aF~~c~~L~~i~lp~-~v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 307 S-VKFIGEEAFESCTSLVSIDLPY-LVEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp T-CCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred c-cceechhhhcCCCCCCEEEeCC-cccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 3 6666667777777777777754 365566667777777777777766 66666667766 77777777544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.67 E-value=1.9e-07 Score=102.47 Aligned_cols=245 Identities=11% Similarity=-0.001 Sum_probs=157.3
Q ss_pred CccCCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCC
Q 043333 14 PPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINL 93 (809)
Q Consensus 14 p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 93 (809)
..+|.++.+|+.++|..+ ++......|...+|+.+.+..+ +..|+.......+|+.++|..+-.. .-...|.+. +|
T Consensus 62 ~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c~l~~i~~~~~-l~~I~~~aF~~~~L~~i~lp~~~~~-i~~~~F~~~-~l 137 (379)
T 4h09_A 62 EANFNSCYNMTKVTVAST-VTSIGDGAFADTKLQSYTGMER-VKKFGDYVFQGTDLDDFEFPGATTE-IGNYIFYNS-SV 137 (379)
T ss_dssp TTTTTTCTTCCEEEECTT-CCEECTTTTTTCCCCEEEECTT-CCEECTTTTTTCCCSEEECCTTCCE-ECTTTTTTC-CC
T ss_pred HHHhhCCCCCCEEEeCCc-ceEechhhhcCCCCceEECCce-eeEeccceeccCCcccccCCCcccc-ccccccccc-ee
Confidence 446889999999999754 7766677788877777776543 5566553333357888888765322 333344433 45
Q ss_pred CEEEccCCccCccCchhhhcccccceeeeecccc-----------------------------------cCcCchhhhcc
Q 043333 94 EKLHLNSNNFTGKLPESFANLTRLKHFRISDNHF-----------------------------------TGQIPDYIQNW 138 (809)
Q Consensus 94 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-----------------------------------~~~~p~~~~~l 138 (809)
+.+.+..+ ++.+....|..+.+|+.+.+..+.. .......+...
T Consensus 138 ~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~~~ 216 (379)
T 4h09_A 138 KRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYGFSYG 216 (379)
T ss_dssp CEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTTTTTC
T ss_pred eeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeEEeecccccc
Confidence 55555442 3323344555555555544433211 11223345566
Q ss_pred cccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEec
Q 043333 139 TKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDL 218 (809)
Q Consensus 139 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 218 (809)
.+|+.+.+..+ +.......|.++..|+.+.+..+ ++.+....|.++.+|+.+.+.. ++......+|.++++|+.+.+
T Consensus 217 ~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~-~i~~i~~~aF~~c~~L~~i~l 293 (379)
T 4h09_A 217 KNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYA-KVKTVPYLLCSGCSNLTKVVM 293 (379)
T ss_dssp SSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECC-CCSEECTTTTTTCTTCCEEEE
T ss_pred cccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccccc-cceeccccccccccccccccc
Confidence 77777777654 34345567777888888888764 6777777788888888888854 466666667888888888888
Q ss_pred cCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhh-ccCccccccCC
Q 043333 219 SFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYN 267 (809)
Q Consensus 219 s~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N 267 (809)
.++.++.+....|.. .+|+.+.|..+ ++.+....|.. ..|+.+.+..+
T Consensus 294 ~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 294 DNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred cccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 888888777777777 78888888654 66555556654 56677776543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.64 E-value=2.1e-07 Score=102.86 Aligned_cols=244 Identities=10% Similarity=0.077 Sum_probs=148.9
Q ss_pred CccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCc-hhhcCCccCcEEeecccccccCCCccccCCC
Q 043333 14 PPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIP-KAVASISTLADLTLEFNQFSGDLPAELGNLI 91 (809)
Q Consensus 14 p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 91 (809)
..+|..+.+|+.+.+..+ ++......|.... |+.+.+..+ +..|+ .++..+.+|+.+.+.++ ++..-...|.. .
T Consensus 107 ~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~ 182 (394)
T 4gt6_A 107 RQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-T 182 (394)
T ss_dssp TTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-C
T ss_pred hhhchhcccceeeccCCc-cceehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-c
Confidence 345666777777776654 4434444555543 566666543 33333 35566677777777654 33233334443 4
Q ss_pred CCCEEEccCCccCccCchhhhcccccceeeeecc------------------------------------cccCcCchhh
Q 043333 92 NLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN------------------------------------HFTGQIPDYI 135 (809)
Q Consensus 92 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N------------------------------------~l~~~~p~~~ 135 (809)
+|+.+.+..+-.. .....|.++.+|+......+ .+...-..+|
T Consensus 183 ~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF 261 (394)
T 4gt6_A 183 ALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAF 261 (394)
T ss_dssp CCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTT
T ss_pred ceeEEEECCcccc-cccchhhhccccceecccccccccccceeecccccccccccccccccccceEEcCCcceEccccee
Confidence 5666666543222 33444555444444332221 1222234567
Q ss_pred hcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccE
Q 043333 136 QNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRV 215 (809)
Q Consensus 136 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 215 (809)
.++++|+.+.+..+... .....|.++.+|+.+.+. +.++.++...|.++.+|+.+.|..+ ++.....+|.++.+|+.
T Consensus 262 ~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~ 338 (394)
T 4gt6_A 262 DSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLER 338 (394)
T ss_dssp TTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCE
T ss_pred eecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCE
Confidence 88889999988766544 556788889999999986 5678888888999999999999754 66677788999999999
Q ss_pred EeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhhccCccccccCCc
Q 043333 216 LDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNN 268 (809)
Q Consensus 216 L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~ 268 (809)
+.|..+ ++.+....|.. .+|+.+++.+|.... ........++.+.+..|.
T Consensus 339 i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~--~~~~~~~~L~~i~i~~~~ 389 (394)
T 4gt6_A 339 IAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW--NAISTDSGLQNLPVAPGS 389 (394)
T ss_dssp EEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH--HTCBCCCCC---------
T ss_pred EEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh--hhhhccCCCCEEEeCCCC
Confidence 999755 77777888887 899999998876431 111222445666665554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.46 E-value=2.8e-08 Score=97.62 Aligned_cols=115 Identities=15% Similarity=0.146 Sum_probs=61.6
Q ss_pred hhcCCccCcEEeeccc-ccccC----CCccccCCCCCCEEEccCCccCcc----CchhhhcccccceeeeecccccCc--
Q 043333 62 AVASISTLADLTLEFN-QFSGD----LPAELGNLINLEKLHLNSNNFTGK----LPESFANLTRLKHFRISDNHFTGQ-- 130 (809)
Q Consensus 62 ~l~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-- 130 (809)
.+...++|++|+|++| .+... +...+...++|++|+|++|+|... +...+...++|++|+|++|.|...
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 4445566666666666 55421 223344556666666666666532 223334445666666666666532
Q ss_pred --CchhhhcccccceEec--ccCcCCCCC----CccccCCCCCCEEeccCCCCC
Q 043333 131 --IPDYIQNWTKLEKLFI--EGSGLAGPI----PSGIASLVELTDLRISDLNGP 176 (809)
Q Consensus 131 --~p~~~~~l~~L~~L~L--~~N~l~~~~----p~~~~~l~~L~~L~l~~n~l~ 176 (809)
+...+...++|++|+| ++|.|+... ...+...++|++|++++|.+.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2334455556666666 566665322 233344466666666666553
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.42 E-value=4e-08 Score=96.45 Aligned_cols=118 Identities=19% Similarity=0.155 Sum_probs=87.4
Q ss_pred CCccccCCCCCCEEEccCC-ccCcc----CchhhhcccccceeeeecccccCc----CchhhhcccccceEecccCcCCC
Q 043333 83 LPAELGNLINLEKLHLNSN-NFTGK----LPESFANLTRLKHFRISDNHFTGQ----IPDYIQNWTKLEKLFIEGSGLAG 153 (809)
Q Consensus 83 ~p~~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~ 153 (809)
+...+...++|++|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3456677888999999998 88742 334455668899999999998743 33445566889999999999875
Q ss_pred C----CCccccCCCCCCEEec--cCCCCCCCCCc----cccCCcCCceeeecccccc
Q 043333 154 P----IPSGIASLVELTDLRI--SDLNGPEGPFP----RLSNLKNMNYLILRSGNII 200 (809)
Q Consensus 154 ~----~p~~~~~l~~L~~L~l--~~n~l~~~~~~----~l~~l~~L~~L~Ls~N~l~ 200 (809)
. +...+...++|+.|++ ++|.+...... .+...++|++|+|++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3 3456677788999999 78888765433 3556688999999998875
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.41 E-value=4.4e-08 Score=101.33 Aligned_cols=80 Identities=21% Similarity=0.338 Sum_probs=47.8
Q ss_pred cCCCCCCEEEccCCccCc--cCchhhhcccccceeeeecccccCcCchhhhccc--ccceEecccCcCCCCCCc------
Q 043333 88 GNLINLEKLHLNSNNFTG--KLPESFANLTRLKHFRISDNHFTGQIPDYIQNWT--KLEKLFIEGSGLAGPIPS------ 157 (809)
Q Consensus 88 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~------ 157 (809)
.++++|++|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 456677777777777775 3345566677777777777777643 2233443 677777777776654442
Q ss_pred -cccCCCCCCEEe
Q 043333 158 -GIASLVELTDLR 169 (809)
Q Consensus 158 -~~~~l~~L~~L~ 169 (809)
.+..+++|+.|+
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 234455555554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.37 E-value=2.6e-06 Score=93.32 Aligned_cols=146 Identities=14% Similarity=0.097 Sum_probs=111.8
Q ss_pred cCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccC
Q 043333 106 KLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSN 185 (809)
Q Consensus 106 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~ 185 (809)
.....+....+|+.+.+..+ +.......|.++..|+.+.+..+ ++......|.++.+|+.+.+.. .+..++...|.+
T Consensus 208 i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~-~i~~i~~~aF~~ 284 (379)
T 4h09_A 208 VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYA-KVKTVPYLLCSG 284 (379)
T ss_dssp ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECC-CCSEECTTTTTT
T ss_pred Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccccc-cceecccccccc
Confidence 33445666778888888665 44355667888899999998766 5545567888888999998865 477778888999
Q ss_pred CcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhh
Q 043333 186 LKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR 256 (809)
Q Consensus 186 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~ 256 (809)
+.+|+.+.+.++.++.....+|.++.+|+.++|..+ ++.+....|.. .+|+.+.+..+ ++.+....|..
T Consensus 285 c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~ 354 (379)
T 4h09_A 285 CSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEG 354 (379)
T ss_dssp CTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTT
T ss_pred ccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhC
Confidence 999999999888888888888999999999999755 77777788877 88998888655 55444555543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.37 E-value=1e-07 Score=98.49 Aligned_cols=81 Identities=17% Similarity=0.170 Sum_probs=49.1
Q ss_pred hcccccceEecccCcCCC--CCCccccCCCCCCEEeccCCCCCCC-CCccccCCcCCceeeeccccccCCCC-------h
Q 043333 136 QNWTKLEKLFIEGSGLAG--PIPSGIASLVELTDLRISDLNGPEG-PFPRLSNLKNMNYLILRSGNIIGEMP-------E 205 (809)
Q Consensus 136 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~n~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~p-------~ 205 (809)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|++..+ ....+..+ +|++|+|++|.+.+.+| .
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcCccccCcchhHHHH
Confidence 345666666666666665 3344555666666666666666555 12233334 77777777777776655 2
Q ss_pred hhhccccccEEe
Q 043333 206 YLGQMIGLRVLD 217 (809)
Q Consensus 206 ~~~~l~~L~~L~ 217 (809)
.+..+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 366777777765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=6.5e-06 Score=87.42 Aligned_cols=137 Identities=18% Similarity=0.169 Sum_probs=92.1
Q ss_pred CCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCC---ceEeEEeEEE-eCCeEEEEEEcccC
Q 043333 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHP---NLVKLYGCCI-EGNQLLLIYEYMEN 655 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~~~~~-~~~~~~lV~ey~~~ 655 (809)
.+.++.|....||+. |..++||+-.. ......+.+|.++|..+.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888899987 45677887432 22345688999999999753 3556777765 34557899999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE----------------------------------------- 694 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------------- 694 (809)
.++.+.... .++...+..++.++++.|..||+.
T Consensus 98 ~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 887653210 123334444444444444444432
Q ss_pred ----------------CCCCeEEcCCCCCCEEEcC---CCce-EEEecCCcccc
Q 043333 695 ----------------SRLKIVHRDIKATNVLLDK---DLNP-KISDFGLAKLD 728 (809)
Q Consensus 695 ----------------~~~~iiH~Dlkp~NILl~~---~~~~-kl~DfGla~~~ 728 (809)
.++.++|+|++|.||+++. ++.+ .|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2346799999999999987 4554 89999988654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=5.9e-06 Score=85.83 Aligned_cols=135 Identities=16% Similarity=0.116 Sum_probs=93.4
Q ss_pred eeccCCCc-cEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCeEEEEEEcccCCch
Q 043333 582 KIGEGGFG-PVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEYMENNSL 658 (809)
Q Consensus 582 ~LG~G~fG-~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 658 (809)
.+..|..| .||+.... ++..++||+-... ....+.+|.+.|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45555555 58987654 4567888886432 2356778999888874 33466889999999999999999999877
Q ss_pred hhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 043333 659 ARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE-------------------------------------------- 694 (809)
Q Consensus 659 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------------------------------------------- 694 (809)
.+..... ......++.+++..|.-||..
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 6543110 112234555555566666631
Q ss_pred -----------CCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 695 -----------SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 695 -----------~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
.++.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112478999999999999887778999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=8.2e-06 Score=88.55 Aligned_cols=81 Identities=6% Similarity=0.030 Sum_probs=56.4
Q ss_pred CCee-ccCCCccEEEeEee-------CCeEEEEEEecccC---cccchhHHHHHHHHhhcC-C--CceEeEEeEEEeC--
Q 043333 580 DNKI-GEGGFGPVYKGLLA-------DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQ-H--PNLVKLYGCCIEG-- 643 (809)
Q Consensus 580 ~~~L-G~G~fG~Vy~~~~~-------~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~-H--~nIv~l~~~~~~~-- 643 (809)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+++++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88888999988754 26678888765432 112356788999888885 3 2466788887655
Q ss_pred -CeEEEEEEcccCCchhh
Q 043333 644 -NQLLLIYEYMENNSLAR 660 (809)
Q Consensus 644 -~~~~lV~ey~~~gsL~~ 660 (809)
+..++||||+++..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 34689999999876653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.82 E-value=3e-05 Score=83.28 Aligned_cols=142 Identities=15% Similarity=0.221 Sum_probs=80.7
Q ss_pred CeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCC--CceEeEEe------EEEeCCeEEEEEEc
Q 043333 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQH--PNLVKLYG------CCIEGNQLLLIYEY 652 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~~------~~~~~~~~~lV~ey 652 (809)
+.|+.|..+.||+....+| .+++|+.... ..++..|.+++..+.. -.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4466677899999876555 4889988642 2333445555554431 12233332 22346778999999
Q ss_pred ccCCchh--------------hhccCCCc----c------CCCCCHHHHH------------------------------
Q 043333 653 MENNSLA--------------RALFGPEE----H------RLKLDWPTRH------------------------------ 678 (809)
Q Consensus 653 ~~~gsL~--------------~~L~~~~~----~------~~~l~~~~~~------------------------------ 678 (809)
+++..+. ..+|.... . ...-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11221100 0 0112343211
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 679 -SICIGLARGLAYLHE----------ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 679 -~i~~~ia~~L~yLH~----------~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
.+...+..++++|++ ..+..++|||+++.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223446667763 1245799999999999998888999999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=8.9e-05 Score=81.64 Aligned_cols=75 Identities=13% Similarity=0.183 Sum_probs=49.7
Q ss_pred CCeeccCCCccEEEeEee-CCeEEEEEEecccCc-------ccchhHHHHHHHHhhcCC--Cc-eEeEEeEEEeCCeEEE
Q 043333 580 DNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-------QGNREFVNEIGMISALQH--PN-LVKLYGCCIEGNQLLL 648 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-------~~~~~f~~Ei~~l~~l~H--~n-Iv~l~~~~~~~~~~~l 648 (809)
.+.+|.|..+.||++... +++.++||....... .....+..|.+++..+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 467899998653221 123456789888887742 33 3455543 4455689
Q ss_pred EEEcccCC
Q 043333 649 IYEYMENN 656 (809)
Q Consensus 649 V~ey~~~g 656 (809)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.73 E-value=1.7e-05 Score=76.11 Aligned_cols=84 Identities=13% Similarity=0.100 Sum_probs=45.3
Q ss_pred ccCcEEeecccccccCCCccccCCCCCCEEEccCCc-cCccCchhhhcc----cccceeeeeccc-ccCcCchhhhcccc
Q 043333 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNN-FTGKLPESFANL----TRLKHFRISDNH-FTGQIPDYIQNWTK 140 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 140 (809)
-+|+.|||+++.++..--..+..+++|++|+|++|. |+..--..++.+ ++|++|+|++|. ++..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356667777666654434445666666666666663 553222333332 246666666653 54332333455555
Q ss_pred cceEecccCc
Q 043333 141 LEKLFIEGSG 150 (809)
Q Consensus 141 L~~L~L~~N~ 150 (809)
|+.|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 6666655553
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00016 Score=75.73 Aligned_cols=79 Identities=20% Similarity=0.196 Sum_probs=57.3
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcC-CC--ceEeEEeEEEeCCeEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HP--NLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~--nIv~l~~~~~~~~~~~lV~e 651 (809)
......+.+|.|..+.||+.+..||+.|.||+...........|..|++.|+.+. .. -+.+.+++ +. -++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEE
Confidence 3455677899999999999999999999999876554444456788999988874 22 23445543 22 368999
Q ss_pred cccCCc
Q 043333 652 YMENNS 657 (809)
Q Consensus 652 y~~~gs 657 (809)
|++.+.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 988764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.63 E-value=2e-05 Score=75.61 Aligned_cols=83 Identities=12% Similarity=0.169 Sum_probs=48.7
Q ss_pred CCCCEEEccCCccCccCchhhhcccccceeeeeccc-ccCcCchhhhcc----cccceEecccCc-CCCCCCccccCCCC
Q 043333 91 INLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH-FTGQIPDYIQNW----TKLEKLFIEGSG-LAGPIPSGIASLVE 164 (809)
Q Consensus 91 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~ 164 (809)
.+|+.|||+++.|+..--..+.++++|+.|+|++|. ++..--..++.+ ++|++|+|++|. ++...-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 468888888888775555566777888888888885 553323334443 357777777663 55322223334444
Q ss_pred CCEEeccCC
Q 043333 165 LTDLRISDL 173 (809)
Q Consensus 165 L~~L~l~~n 173 (809)
|+.|+++++
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 444444443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00038 Score=73.70 Aligned_cols=140 Identities=14% Similarity=0.127 Sum_probs=92.4
Q ss_pred CCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcC---CCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 579 PDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ---HPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 579 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
..+.|+.|....+|+... ++..++||+.... ....|..|.+.|+.+. ...+.++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356799999999999875 4567788886532 2456788988888874 35677889988888889999999998
Q ss_pred Cchh-----------hhccCCCc---c---------------CCCCCHHHHH---HHHH----------------HHH-H
Q 043333 656 NSLA-----------RALFGPEE---H---------------RLKLDWPTRH---SICI----------------GLA-R 686 (809)
Q Consensus 656 gsL~-----------~~L~~~~~---~---------------~~~l~~~~~~---~i~~----------------~ia-~ 686 (809)
..+. ..||.... . ...-+|.... ++.. .+. .
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7642 12232211 0 0012565432 1111 111 1
Q ss_pred HHHHHHh-CCCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 687 GLAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 687 ~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
....|.. ..++.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1223322 2346799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.43 E-value=9.4e-05 Score=82.15 Aligned_cols=79 Identities=11% Similarity=0.115 Sum_probs=49.7
Q ss_pred CCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcceecccc-ccccccchhhhccC---CCCchHHHHHHHHHHHH
Q 043333 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIA-GTFGYMAPEYAMRG---YLTDKADVYSFGIVALE 771 (809)
Q Consensus 696 ~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~-gt~~y~aPE~~~~~---~~~~ksDVwSlGvil~e 771 (809)
+..++|||++|.|||++.++ ++|+||+.+....... ....... -...|++|+..... ......++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 45799999999999998876 9999999887532110 0000000 01346777665421 11224566688888888
Q ss_pred HHcCC
Q 043333 772 IVSGR 776 (809)
Q Consensus 772 lltGk 776 (809)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.31 E-value=6.5e-05 Score=73.48 Aligned_cols=64 Identities=19% Similarity=0.249 Sum_probs=27.9
Q ss_pred CCccCcEEeeccc-cccc----CCCccccCCCCCCEEEccCCccCcc----Cchhhhcccccceeeeeccccc
Q 043333 65 SISTLADLTLEFN-QFSG----DLPAELGNLINLEKLHLNSNNFTGK----LPESFANLTRLKHFRISDNHFT 128 (809)
Q Consensus 65 ~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 128 (809)
+-+.|++|+|++| +|.. .+...+...+.|+.|+|++|+|... +...+..-+.|+.|+|++|.|.
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 3345555555553 4432 1222344444555555555555521 1222223344444444444444
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.30 E-value=5.1e-05 Score=74.23 Aligned_cols=94 Identities=16% Similarity=0.163 Sum_probs=64.1
Q ss_pred CchhhcCCccCcEEeecccccccC----CCccccCCCCCCEEEccCCccCccC----chhhhcccccceeeeeccc---c
Q 043333 59 IPKAVASISTLADLTLEFNQFSGD----LPAELGNLINLEKLHLNSNNFTGKL----PESFANLTRLKHFRISDNH---F 127 (809)
Q Consensus 59 ip~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~---l 127 (809)
|-.++..-+.|+.|+|++|+|... +...+...+.|++|+|+.|+|+... .+.+..-+.|++|+|++|. +
T Consensus 62 la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~i 141 (197)
T 1pgv_A 62 LIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVL 141 (197)
T ss_dssp HHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCC
T ss_pred HHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCc
Confidence 445666678899999999998842 3334556788999999999998432 2334445679999998763 3
Q ss_pred cC----cCchhhhcccccceEecccCcCC
Q 043333 128 TG----QIPDYIQNWTKLEKLFIEGSGLA 152 (809)
Q Consensus 128 ~~----~~p~~~~~l~~L~~L~L~~N~l~ 152 (809)
.. .+...+..-++|+.|+++.|.+.
T Consensus 142 g~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 142 GNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp CHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred CHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 32 13344555678888888776643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0015 Score=69.37 Aligned_cols=160 Identities=14% Similarity=0.127 Sum_probs=90.0
Q ss_pred ccHHHHHHHhcCCCC-----CCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCc--eEeEE
Q 043333 565 FTLRQIKAATNNFAP-----DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPN--LVKLY 637 (809)
Q Consensus 565 ~~~~~l~~~~~~f~~-----~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~ 637 (809)
++.+++...-..|.. .+.|+.|....+|+....+| .+++|+.... ....++..|++++..+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 455566666556654 23466788889999887666 5678887642 12345667777777764222 23333
Q ss_pred eE------EEeCCeEEEEEEcccCCchhh--------------hccCC----CccC----CCCCHHHHHH----------
Q 043333 638 GC------CIEGNQLLLIYEYMENNSLAR--------------ALFGP----EEHR----LKLDWPTRHS---------- 679 (809)
Q Consensus 638 ~~------~~~~~~~~lV~ey~~~gsL~~--------------~L~~~----~~~~----~~l~~~~~~~---------- 679 (809)
.. ....+..++|++|+++..+.. .+|.. .... ....|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 223466789999999865321 12211 0000 0012433111
Q ss_pred --HHHHHHHHHHHHHhC----CCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 680 --ICIGLARGLAYLHEE----SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 680 --i~~~ia~~L~yLH~~----~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+...+...++++++. .+..++|+|+.+.||+++.+..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244456666532 234789999999999999876668999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0043 Score=66.17 Aligned_cols=143 Identities=17% Similarity=0.164 Sum_probs=72.8
Q ss_pred CeeccCCCcc-EEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCC--ceEeEEeEEEeCCeEEEEEEcccCCc
Q 043333 581 NKIGEGGFGP-VYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHP--NLVKLYGCCIEGNQLLLIYEYMENNS 657 (809)
Q Consensus 581 ~~LG~G~fG~-Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~~~~~~~~~~~lV~ey~~~gs 657 (809)
+.|+.|.... +|+....+|+.+++|....... .++..|++++..+... .+.+++.+..+.+ ++|||++++..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4465554443 6676554466677776443221 3445677777666422 2456666643333 68999997766
Q ss_pred hhhhc---------------------cCCCccC-CCCCHHHHH--------------------HHHHHHHHHHHHHH---
Q 043333 658 LARAL---------------------FGPEEHR-LKLDWPTRH--------------------SICIGLARGLAYLH--- 692 (809)
Q Consensus 658 L~~~L---------------------~~~~~~~-~~l~~~~~~--------------------~i~~~ia~~L~yLH--- 692 (809)
+.+++ |...... ...+..... .....+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 54333 1111000 111111100 00011222233331
Q ss_pred hCCCCCeEEcCCCCCCEEEcCC----CceEEEecCCcccc
Q 043333 693 EESRLKIVHRDIKATNVLLDKD----LNPKISDFGLAKLD 728 (809)
Q Consensus 693 ~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DfGla~~~ 728 (809)
...+..++|||+.+.||+++.+ ..+.|+||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1224578999999999999875 67899999988653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0018 Score=71.80 Aligned_cols=73 Identities=19% Similarity=0.255 Sum_probs=49.3
Q ss_pred CCeeccCCCccEEEeEeeC--------CeEEEEEEecccCcccchhHHHHHHHHhhcCCCce-EeEEeEEEeCCeEEEEE
Q 043333 580 DNKIGEGGFGPVYKGLLAD--------GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNL-VKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ 650 (809)
.+.|+.|....||+....+ ++.+++|+.... .....+..|..++..+...++ .++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 4568888889999988653 467889987432 111456689888888853344 46666543 3 3899
Q ss_pred EcccCCch
Q 043333 651 EYMENNSL 658 (809)
Q Consensus 651 ey~~~gsL 658 (809)
||+++.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0057 Score=64.94 Aligned_cols=143 Identities=13% Similarity=0.119 Sum_probs=82.4
Q ss_pred CeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCc--eEeEEeE-----EEeCCeEEEEEEcc
Q 043333 581 NKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPN--LVKLYGC-----CIEGNQLLLIYEYM 653 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~~~-----~~~~~~~~lV~ey~ 653 (809)
..++ |....||+....+|+.+++|...... .....+..|.+++..+.... +++++.. ....+..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 77889999877677778999986432 12345667888777764222 3444432 22355678899999
Q ss_pred cCCchhh--------------hccCC----C-ccCCCCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 043333 654 ENNSLAR--------------ALFGP----E-EHRLKLDWPTR----HSI---------------CIGLARGLAYLHE-- 693 (809)
Q Consensus 654 ~~gsL~~--------------~L~~~----~-~~~~~l~~~~~----~~i---------------~~~ia~~L~yLH~-- 693 (809)
++..+.. .+|.. . ......++... ..+ ...+...++.+.+
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8855421 01210 0 01112232211 000 1111222333322
Q ss_pred --CCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 694 --ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 694 --~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
..+..++|||+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234678999999999999 4 899999988764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0037 Score=65.68 Aligned_cols=139 Identities=12% Similarity=0.148 Sum_probs=75.7
Q ss_pred CCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCce-EeEEeEEEeCCeEEEEEEcc-cCCc
Q 043333 580 DNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNL-VKLYGCCIEGNQLLLIYEYM-ENNS 657 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ey~-~~gs 657 (809)
.+.|+.|....+|+. +.+++|+....... .....+|+++++.+....+ .+++++ +.+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678999999999998 44778877543221 2233467777777643233 355544 343457899999 5544
Q ss_pred hhh------------------hccCCCc-cCCCCC-HHHHHHHHH--------------HHHHHH----HHHHh-CCCCC
Q 043333 658 LAR------------------ALFGPEE-HRLKLD-WPTRHSICI--------------GLARGL----AYLHE-ESRLK 698 (809)
Q Consensus 658 L~~------------------~L~~~~~-~~~~l~-~~~~~~i~~--------------~ia~~L----~yLH~-~~~~~ 698 (809)
+.. .+|.... .....+ +.....+.. .+...+ +.+.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 421 1122111 000011 111111110 011111 11211 23345
Q ss_pred eEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 699 IVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 699 iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
++|+|+.+.||+ ..++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 6667889999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0093 Score=66.56 Aligned_cols=74 Identities=19% Similarity=0.117 Sum_probs=47.8
Q ss_pred CCeeccCCCccEEEeEeeC-CeEEEEEEecccCcccchhHHHHHHHHhhcCCCce-EeEEeEEEeCCeEEEEEEcccCCc
Q 043333 580 DNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNL-VKLYGCCIEGNQLLLIYEYMENNS 657 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ey~~~gs 657 (809)
.+.|+.|-...+|+....+ +..+++|+....... .-.-.+|..++..+...++ .++++++ .+. +|+||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~G--~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TNG--RIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TTE--EEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CCe--EEEEeeCCcc
Confidence 4568888889999988764 477888887433211 1112578888888865555 4677666 232 5999998755
Q ss_pred h
Q 043333 658 L 658 (809)
Q Consensus 658 L 658 (809)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0053 Score=66.71 Aligned_cols=143 Identities=18% Similarity=0.226 Sum_probs=83.1
Q ss_pred CCeeccCCCccEEEeEee--------CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCc-eEeEEeEEEeCCeEEEEE
Q 043333 580 DNKIGEGGFGPVYKGLLA--------DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPN-LVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~~~~~~~~~~~lV~ 650 (809)
.+.+..|-...+|+.... +++.+++|+.... ........+|.++++.+.-.. ..++++++. + .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEE
Confidence 456777888899998764 2467888886332 223455668988888775222 346666553 3 2899
Q ss_pred EcccCCchhh-----------------hccCCCc-cCCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 043333 651 EYMENNSLAR-----------------ALFGPEE-HRLKLD--WPTRHSICIGLAR-------------------GLAYL 691 (809)
Q Consensus 651 ey~~~gsL~~-----------------~L~~~~~-~~~~l~--~~~~~~i~~~ia~-------------------~L~yL 691 (809)
||+++..|.. .||.... ...+.. |.+..++..++.. .++.|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9999865531 1232211 111122 4455555443321 23333
Q ss_pred H----h-CCCCCeEEcCCCCCCEEEcCC----CceEEEecCCccc
Q 043333 692 H----E-ESRLKIVHRDIKATNVLLDKD----LNPKISDFGLAKL 727 (809)
Q Consensus 692 H----~-~~~~~iiH~Dlkp~NILl~~~----~~~kl~DfGla~~ 727 (809)
. . ..+..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 2 233468899999999999876 7899999998763
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.18 E-value=0.0061 Score=55.41 Aligned_cols=55 Identities=20% Similarity=0.319 Sum_probs=24.9
Q ss_pred EEeecccccc-cCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccc
Q 043333 71 DLTLEFNQFS-GDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHF 127 (809)
Q Consensus 71 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 127 (809)
.++.++++|+ ..+|..+. .+|++|+|++|+|+.+.+..|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4555555554 22332221 2355555555555543344444445555555554443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.08 E-value=0.0049 Score=56.03 Aligned_cols=38 Identities=26% Similarity=0.328 Sum_probs=33.6
Q ss_pred ccCcEEeecccccccCCCccccCCCCCCEEEccCCccC
Q 043333 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFT 104 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 104 (809)
++|+.|+|++|+|+...+..|..+++|++|+|++|.+.
T Consensus 31 ~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 31 VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 46899999999999666678899999999999999886
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.05 E-value=0.0077 Score=65.26 Aligned_cols=74 Identities=11% Similarity=0.114 Sum_probs=43.5
Q ss_pred CCeeccCCCccEEEeEeeC---------CeEEEEEEecccCcccchhHHHHHHHHhhcCCCc-eEeEEeEEEeCCeEEEE
Q 043333 580 DNKIGEGGFGPVYKGLLAD---------GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPN-LVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~---------g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~~~~~~~~~~~lV 649 (809)
.+.++.|....+|+....+ ++.+++|+....... ......|.+++..+.... ..++++.. .+ ++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence 3457778888999987654 267888886543221 123357888888775333 33566543 22 689
Q ss_pred EEcccCCch
Q 043333 650 YEYMENNSL 658 (809)
Q Consensus 650 ~ey~~~gsL 658 (809)
|||+++..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.76 E-value=0.035 Score=59.32 Aligned_cols=32 Identities=31% Similarity=0.427 Sum_probs=28.0
Q ss_pred CCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 696 ~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34789999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.61 E-value=0.091 Score=57.79 Aligned_cols=142 Identities=13% Similarity=0.134 Sum_probs=84.3
Q ss_pred CCeeccCCCccEEEeEeeC--------CeEEEEEEecccCcccchhHHHHHHHHhhcCCCce-EeEEeEEEeCCeEEEEE
Q 043333 580 DNKIGEGGFGPVYKGLLAD--------GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNL-VKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ 650 (809)
.+.+..|-...+|+....+ ++.+++|+....... .-+-.+|.++++.+.-..+ .++++.+ .+ ++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 4567778888999988653 577888886443221 2233578888877753233 4555533 22 6899
Q ss_pred EcccCCchhh-----------------hccCCCc---------cCCCCCHHHHHHHHHHH-------------------H
Q 043333 651 EYMENNSLAR-----------------ALFGPEE---------HRLKLDWPTRHSICIGL-------------------A 685 (809)
Q Consensus 651 ey~~~gsL~~-----------------~L~~~~~---------~~~~l~~~~~~~i~~~i-------------------a 685 (809)
||+++..|.. .||.... ...+.-|.+..++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999866421 1122111 11222344444443322 2
Q ss_pred HHHHHHHh---------------------CCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 686 RGLAYLHE---------------------ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 686 ~~L~yLH~---------------------~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
..+++|.+ ..+..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 12346789999999999 8888999999998863
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=87.30 E-value=1.1 Score=43.96 Aligned_cols=103 Identities=15% Similarity=0.100 Sum_probs=66.1
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
.-||.+.|. ....++++.+++.++.|.+.+|.-+-. .. + ..+=+.|..|++..+|.+...+ ..+.
T Consensus 32 ~vSL~eIL~---~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 32 ALSLEEILR---LYNQPINEEQAWAVCYQCCGSLRAAARRRQ--P-RHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--C-CCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred cccHHHHHH---HcCCCcCHHHHHHHHHHHHHHHHhhhhccc--C-CceecCCcceEEecCCceeccc-cccc-------
Confidence 347888883 356789999999999999999877621 11 1 1233457889999999887764 1110
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSN 778 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P 778 (809)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0112467888753 3457889999999999987754433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.52 E-value=0.63 Score=50.66 Aligned_cols=30 Identities=23% Similarity=0.393 Sum_probs=25.1
Q ss_pred CeEEcCCCCCCEEE------cCCCceEEEecCCccc
Q 043333 698 KIVHRDIKATNVLL------DKDLNPKISDFGLAKL 727 (809)
Q Consensus 698 ~iiH~Dlkp~NILl------~~~~~~kl~DfGla~~ 727 (809)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 45799999999999 4567799999998863
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.87 E-value=1.3 Score=31.26 Aligned_cols=26 Identities=19% Similarity=0.367 Sum_probs=11.1
Q ss_pred eeehhHHHHHHHHHH-HHHHHhhhccc
Q 043333 520 MVVGIVAAAAFILIL-IVSILWWKGCF 545 (809)
Q Consensus 520 ~i~~~~~~~~~~~~l-~~~~~~~~~~~ 545 (809)
++.++++++++++++ ++.+++|++++
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 344444444443333 33344454443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=80.76 E-value=0.65 Score=32.73 Aligned_cols=25 Identities=16% Similarity=0.267 Sum_probs=10.9
Q ss_pred eeehhHHHHHHHHHH-HHHHHhhhcc
Q 043333 520 MVVGIVAAAAFILIL-IVSILWWKGC 544 (809)
Q Consensus 520 ~i~~~~~~~~~~~~l-~~~~~~~~~~ 544 (809)
.+++.++++++++++ ++.++|+||+
T Consensus 13 ~Ia~~vVGvll~vi~~l~~~~~~RRR 38 (44)
T 2jwa_A 13 SIISAVVGILLVVVLGVVFGILIKRR 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHHHHhheehh
Confidence 355555554433333 3334444443
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=80.65 E-value=1.1 Score=30.67 Aligned_cols=16 Identities=13% Similarity=0.150 Sum_probs=9.4
Q ss_pred ccceeehhHHHHHHHH
Q 043333 517 NVGMVVGIVAAAAFIL 532 (809)
Q Consensus 517 ~~~~i~~~~~~~~~~~ 532 (809)
..+.++|+++++++.+
T Consensus 9 s~GaIAGiVvG~v~gv 24 (38)
T 2k1k_A 9 TGGEIVAVIFGLLLGA 24 (38)
T ss_dssp CHHHHHHHHHHHHHHH
T ss_pred CCCceeeeehHHHHHH
Confidence 3466677776665433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 809 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-13 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-63
Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 634
+IG G FG VYKG + + +++ + Q + F NE+G++ +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
G QL ++ ++ E +SL L E K + I A+G+ YLH +
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK 123
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL-DEEDNTHISTRIAGTFGYMAPEYAM- 752
I+HRD+K+ N+ L +DL KI DFGLA + +H +++G+ +MAPE
Sbjct: 124 ---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 753 --RGYLTDKADVYSFGIVALEIVSGR 776
+ + ++DVY+FGIV E+++G+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQ 206
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 4e-63
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 11/206 (5%)
Query: 573 ATNNFAPDNKIGEGGFGPVYKG-LLADGKVIAVKQLSSKSKQGNRE-FVNEIGMISALQH 630
++F +++G G G V+K G V+A K + + K R + E+ ++
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 631 PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
P +V YG ++ + E+M+ SL + L + ++ + I + +GL Y
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTY 119
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY 750
L + KI+HRD+K +N+L++ K+ DFG++ + GT YM+PE
Sbjct: 120 LR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPER 174
Query: 751 AMRGYLTDKADVYSFGIVALEIVSGR 776
+ + ++D++S G+ +E+ GR
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 8e-61
Identities = 66/202 (32%), Positives = 99/202 (49%), Gaps = 7/202 (3%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 634
++G G FG V+ G +AVK L + F+ E ++ LQH LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
+LY + + +I EYMEN SL L P +KL + +A G+A++ E
Sbjct: 72 RLYAVVTQEP-IYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG 754
+HRD++A N+L+ L+ KI+DFGLA+L E++ + APE G
Sbjct: 129 ---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 755 YLTDKADVYSFGIVALEIVSGR 776
T K+DV+SFGI+ EIV+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHG 207
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 2e-59
Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 7/200 (3%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 634
+ ++G G FG V G +A+K + + EF+ E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
+LYG C + + +I EYM N L L E R + +C + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLE-- 117
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG 754
+ +HRD+ A N L++ K+SDFGL++ +D S + PE M
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 755 YLTDKADVYSFGIVALEIVS 774
+ K+D+++FG++ EI S
Sbjct: 177 KFSSKSDIWAFGVLMWEIYS 196
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 7e-59
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 634
+ +IG G FG V+ G + +A+K + + +F+ E ++ L HP LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
+LYG C+E + L++E+ME+ L+ R T +C+ + G+AYL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG 754
++HRD+ A N L+ ++ K+SDFG+ + +D ST + +PE
Sbjct: 121 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 755 YLTDKADVYSFGIVALEIVSGR 776
+ K+DV+SFG++ E+ S
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEG 199
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 7e-57
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 8/208 (3%)
Query: 576 NFAPDNKIGEGGFGPVYKG-LLADGKVIAVKQL--SSKSKQGNREFVNEIGMISALQHPN 632
++ IG G +G K +DGK++ K+L S ++ + V+E+ ++ L+HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 633 LVKLYGCCIE--GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
+V+ Y I+ L ++ EY E LA + + R LD + L L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 691 LHEESR--LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAP 748
H S ++HRD+K NV LD N K+ DFGLA++ D + + GT YM+P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMSP 183
Query: 749 EYAMRGYLTDKADVYSFGIVALEIVSGR 776
E R +K+D++S G + E+ +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALM 211
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 7e-57
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 634
+ + K+G+G FG V+ G +A+K L F+ E ++ L+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
+LY + ++ EYM SL L G E L P + +A G+AY+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE-- 130
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG 754
R+ VHRD++A N+L+ ++L K++DFGLA+L E++ + APE A+ G
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 755 YLTDKADVYSFGIVALEIVSGR 776
T K+DV+SFGI+ E+ +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKG 211
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (493), Expect = 2e-56
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 577 FAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGN---REFVNEIGMISALQHPN 632
F+ +IG G FG VY + + +V+A+K++S KQ N ++ + E+ + L+HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
++ GC + + L+ EY ++ H+ L ++ G +GLAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM 752
++HRD+KA N+LL + K+ DFG A + N+ + GT +MAPE +
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVIL 184
Query: 753 ---RGYLTDKADVYSFGIVALEIVSGRS 777
G K DV+S GI +E+ +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKP 212
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 3e-56
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 581 NKIGEGGFGPVYKG-LLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGC 639
++G+G FG VYK + A K + +KS++ +++ EI ++++ HPN+VKL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 640 CIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKI 699
N L ++ E+ ++ + E L +C L YLH+ KI
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHD---NKI 131
Query: 700 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM-----RG 754
+HRD+KA N+L D + K++DFG++ + + I GT +MAPE M
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 190
Query: 755 YLTDKADVYSFGIVALEIVSGR 776
KADV+S GI +E+
Sbjct: 191 PYDYKADVWSLGITLIEMAEIE 212
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 5e-56
Identities = 67/218 (30%), Positives = 95/218 (43%), Gaps = 11/218 (5%)
Query: 575 NNFAPDNKIGEGGFGPVYKG-LLADGKVIAVKQLSSKSKQGNRE-FVNEIGMISALQHPN 632
++ +GEG +G V + +AVK + K E EI + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+VK YG EGN L EY L + E + + P L G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIAGTFGYMAPEYA 751
+ I HRDIK N+LLD+ N KISDFGLA + + ++ GT Y+APE
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 752 MRG-YLTDKADVYSFGIVALEIVSGRSNVICRTKEAQF 788
R + + DV+S GIV +++G + Q
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-55
Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 580 DNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKL 636
D +IG G F VYKGL + +A +L + +K + F E M+ LQHPN+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 637 YGCCIE----GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
Y ++L+ E M + +L L + S C + +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 693 EESRLKIVHRDIKATNVLL-DKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYA 751
+ I+HRD+K N+ + + KI D GLA L + GT +MAPE
Sbjct: 130 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMY 185
Query: 752 MRGYLTDKADVYSFGIVALEIVSGR 776
Y + DVY+FG+ LE+ +
Sbjct: 186 EEKY-DESVDVYAFGMCMLEMATSE 209
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (485), Expect = 2e-55
Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 565 FTLRQIKAATNNFAP---------DNKIGEGGFGPVYKGLLA----DGKVIAVKQL-SSK 610
FT A FA + IG G FG V G L +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 611 SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRL 670
+++ R+F++E ++ HPN++ L G + +++I E+MEN SL ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL---DSFLRQNDG 123
Query: 671 KLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730
+ + G+A G+ YL + VHRD+ A N+L++ +L K+SDFGL++ E+
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 731 DNTHISTR----IAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 774
D + + + APE T +DV+S+GIV E++S
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 8e-55
Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 15/204 (7%)
Query: 580 DNKIGEGGFGPVYKGLLAD---GKVIAVKQLSSKSKQGN--REFVNEIGMISALQHPNLV 634
D ++G G FG V KG K +AVK L +++ E + E ++ L +P +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
++ G C E +L+ E E L + L + + ++ G+ YL E
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR--IAGTFGYMAPEYAM 752
VHRD+ A NVLL KISDFGL+K D + + + APE
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 753 RGYLTDKADVYSFGIVALEIVSGR 776
+ K+DV+SFG++ E S
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYG 207
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (479), Expect = 9e-55
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNL 633
+ +K+G G +G VY+G+ +AVK L + + EF+ E ++ ++HPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
V+L G C +I E+M +L L E +R ++ + ++ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE- 132
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR 753
+ +HRD+ A N L+ ++ K++DFGL++L D + APE
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 754 GYLTDKADVYSFGIVALEIVSGR 776
+ K+DV++FG++ EI +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYG 213
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-54
Identities = 61/214 (28%), Positives = 110/214 (51%), Gaps = 13/214 (6%)
Query: 567 LRQIKAA---TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEI 622
LR I + + KIG+G G VY + +A G+ +A++Q++ + + +NEI
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 623 GMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICI 682
++ ++PN+V + G++L ++ EY+ SL + +D ++C
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCR 123
Query: 683 GLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGT 742
+ L +LH +++HRDIK+ N+LL D + K++DFG + + ST + GT
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 179
Query: 743 FGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
+MAPE R K D++S GI+A+E++ G
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 2e-54
Identities = 67/231 (29%), Positives = 103/231 (44%), Gaps = 26/231 (11%)
Query: 582 KIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCI 641
IG+G FG V++G G+ +AVK SS+ ++ + EI L+H N++
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 642 EGN----QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE--- 694
+ N QL L+ +Y E+ SL L +R + + + A GLA+LH E
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 695 --SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS---TRIAGTFGYMAPE 749
+ I HRD+K+ N+L+ K+ I+D GLA + I GT YMAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 750 Y------AMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWV 794
+AD+Y+ G+V EI S + ++ Q D V
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCS-IGGIHEDYQLPYYDLV 232
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 4e-54
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 580 DNKIGEGGFGPVYKGLLA---DGKVIAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVK 635
D ++G G FG V +G+ +A+K L +++ + E + E ++ L +P +V+
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 636 LYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES 695
L G C + L+L+ E L + L G E + + ++ G+ YL
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLE--- 126
Query: 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR--IAGTFGYMAPEYAMR 753
VHRD+ A NVLL KISDFGL+K D+++ + R + APE
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186
Query: 754 GYLTDKADVYSFGIVALEIVS 774
+ ++DV+S+G+ E +S
Sbjct: 187 RKFSSRSDVWSYGVTMWEALS 207
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 8e-54
Identities = 61/203 (30%), Positives = 88/203 (43%), Gaps = 13/203 (6%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 634
IG+G FG V G G +AVK + + + + F+ E +++ L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 635 KLYGCCIEG-NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
+L G +E L ++ EYM SL L R L + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 694 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR 753
VHRD+ A NVL+ +D K+SDFGL K + APE
Sbjct: 122 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALRE 174
Query: 754 GYLTDKADVYSFGIVALEIVSGR 776
+ K+DV+SFGI+ EI S
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFG 197
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-53
Identities = 62/239 (25%), Positives = 99/239 (41%), Gaps = 22/239 (9%)
Query: 575 NNFAPDNKIGEGGFGPVYKG-LLADGKVIAVKQLSSK---SKQGNREFVNEIGMISALQH 630
+F +G+G FG VY ++A+K L + E+ + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 631 PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
PN+++LYG + ++ LI EY ++ R L K D + LA L+Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSY 121
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY 750
H +++HRDIK N+LL KI+DFG + + GT Y+ PE
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEM 175
Query: 751 AMRGYLTDKADVYSFGIVALEIVSGR--------SNVICRTKEAQFCLLDWVTLALTDF 801
+K D++S G++ E + G+ R +F D+VT D
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 234
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (470), Expect = 2e-53
Identities = 65/238 (27%), Positives = 103/238 (43%), Gaps = 31/238 (13%)
Query: 567 LRQIKAATNNFAPDNKIGEGGFGPVYKGLL------ADGKVIAVKQLSSKSKQGNR-EFV 619
L ++ NN IGEG FG V++ ++AVK L ++ + +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 620 NEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRL--------- 670
E +++ +PN+VKL G C G + L++EYM L L H +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 671 -----------KLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 719
L + I +A G+AYL E K VHRD+ N L+ +++ KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181
Query: 720 SDFGLAK-LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
+DFGL++ + D A +M PE T ++DV+++G+V EI S
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-52
Identities = 64/225 (28%), Positives = 95/225 (42%), Gaps = 26/225 (11%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSKQGNRE-FVNEIGMISA 627
N + +G G FG V + +AVK L + RE ++E+ ++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 628 L-QHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFG--------------PEEHRLKL 672
L H N+V L G C G L+I EY L L E+ L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 673 DWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEED 731
D S +A+G+A+L + +HRD+ A N+LL KI DFGLA+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
N + +MAPE T ++DV+S+GI E+ S
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 3e-52
Identities = 65/229 (28%), Positives = 93/229 (40%), Gaps = 31/229 (13%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLL------ADGKVIAVKQLSSKSKQGNRE-FVNEIGMISA 627
N +G G FG V +AVK L K+ RE ++E+ M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 628 L-QHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFG-------------------PEE 667
L H N+V L G C + LI+EY L L EE
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 668 HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK- 726
L + +A+G+ +L + VHRD+ A NVL+ KI DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 727 LDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 775
+ + N + +MAPE G T K+DV+S+GI+ EI S
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 5e-52
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 576 NFAPDNKIGEGGFGPVYKGLLADGK----VIAVKQLSSKSKQGN-REFVNEIGMISALQH 630
+F + IG G FG VY G L D AVK L+ + G +F+ E ++ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 631 PNLVKLYGCCIEG-NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLA 689
PN++ L G C+ L++ YM++ L + +A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF---IRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL---DEEDNTHISTRIAGTFGYM 746
+L K VHRD+ A N +LD+ K++DFGLA+ E D+ H T +M
Sbjct: 145 FLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 747 APEYAMRGYLTDKADVYSFGIVALEIVSGR 776
A E T K+DV+SFG++ E+++
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRG 231
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 4e-51
Identities = 64/218 (29%), Positives = 116/218 (53%), Gaps = 16/218 (7%)
Query: 567 LRQIKAATNNFAPDNKIGEGGFGPVYKG-LLADGKV----IAVKQLS-SKSKQGNREFVN 620
LR +K F +G G FG VYKG + +G+ +A+K+L + S + N+E ++
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 621 EIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSI 680
E +++++ +P++ +L G C+ + LI + M L L EH+ + +
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCL---LDYVREHKDNIGSQYLLNW 116
Query: 681 CIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRI 739
C+ +A+G+ YL + ++VHRD+ A NVL+ + KI+DFGLAK L E+ + +
Sbjct: 117 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 740 AGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRS 777
+MA E + T ++DV+S+G+ E+++ S
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 5e-51
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 14/210 (6%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLADG-----KVIAVKQLSSKSKQGNR-EFVNEIGMISAL 628
+ IG G FG VYKG+L +A+K L + + R +F+ E G++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 629 QHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGL 688
H N+++L G + +++I EYMEN +L + E + + G+A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKF---LREKDGEFSVLQLVGMLRGIAAGM 123
Query: 689 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRIAGTFGYM 746
YL + VHRD+ A N+L++ +L K+SDFGL+++ D+ + T+ ++ +
Sbjct: 124 KYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 747 APEYAMRGYLTDKADVYSFGIVALEIVSGR 776
APE T +DV+SFGIV E+++
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYG 210
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (456), Expect = 7e-51
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNL 633
+++ ++G G FG V++ A G A K + + + EI +S L+HP L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 634 VKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHE 693
V L+ + N++++IYE+M L + + K+ + +GL ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 694 ESRLKIVHRDIKATNVLLDKDLNP--KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYA 751
VH D+K N++ + K+ DFGL + + T GT + APE A
Sbjct: 143 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVA 197
Query: 752 MRGYLTDKADVYSFGIVALEIVSGR 776
+ D++S G+++ ++SG
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 7e-50
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 22/219 (10%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLADG---KVIAVKQLS-SKSKQGNREFVNEIGMISAL-Q 629
N+ + IGEG FG V K + A+K++ SK +R+F E+ ++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 630 HPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFG------------PEEHRLKLDWPTR 677
HPN++ L G C L L EY + +L L L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 737
+ARG+ YL + + +HRD+ A N+L+ ++ KI+DFGL++ E T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 738 RIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
+MA E T +DV+S+G++ EIVS
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 223
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (447), Expect = 1e-49
Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 11/198 (5%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
++G G FG V++ + A G+V K +++ NEI +++ L HP L+ L+
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 641 IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIV 700
+ +++LI E++ L + K+ + GL ++HE IV
Sbjct: 96 EDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIV 149
Query: 701 HRDIKATNVLLDKDLNP--KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
H DIK N++ + KI DFGLA D T T + APE R +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGF 207
Query: 759 KADVYSFGIVALEIVSGR 776
D+++ G++ ++SG
Sbjct: 208 YTDMWAIGVLGYVLLSGL 225
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-49
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 582 KIGEGGFGPVYKGLLAD----GKVIAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKL 636
IGEG FG V++G+ +A+K + + RE F+ E + HP++VKL
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 637 YGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESR 696
G E N + +I E L + + LD + L+ LAYL
Sbjct: 74 IGVITE-NPVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQLSTALAYLES--- 126
Query: 697 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYL 756
+ VHRDI A NVL+ + K+ DFGL++ E+ + +++ +MAPE
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 757 TDKADVYSFGIVALEIVSG 775
T +DV+ FG+ EI+
Sbjct: 187 TSASDVWMFGVCMWEILMH 205
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-49
Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 12/211 (5%)
Query: 571 KAATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSK---SKQGNREFVNEIGMIS 626
K +F +GEG F V LA + A+K L + + E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 627 ALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLAR 686
L HP VKLY + +L Y +N L + + D +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVS 119
Query: 687 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL-DEEDNTHISTRIAGTFGY 745
L YLH I+HRD+K N+LL++D++ +I+DFG AK+ E + GT Y
Sbjct: 120 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 746 MAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
++PE +D+++ G + ++V+G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 3e-49
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLL----ADGKVIAVKQLSSK---SKQGNREFVNEIGMISA 627
+ K+G+G FG V +G +AVK L + +F+ E+ + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 628 LQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARG 687
L H NL++LYG + + ++ E SL L +H+ T + +A G
Sbjct: 68 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRIAGTFGY 745
+ YL + + +HRD+ A N+LL KI DFGL + +D+ + F +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 746 MAPEYAMRGYLTDKADVYSFGIVALEIVS 774
APE + +D + FG+ E+ +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFT 209
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 17/216 (7%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLL------ADGKVIAVKQLS-SKSKQGNREFVNEIGMISA 627
++G+G FG VY+G+ +A+K ++ + S + EF+NE ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 628 LQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALF------GPEEHRLKLDWPTRHSIC 681
++V+L G +G L+I E M L L +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 682 IGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRIA 740
+A G+AYL+ K VHRD+ A N ++ +D KI DFG+ + + E D +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 741 GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
+M+PE G T +DV+SFG+V EI +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 167 bits (425), Expect = 2e-46
Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 18/210 (8%)
Query: 575 NNFAPDNKIGEGGFGPVYKG-LLADGKVIAVKQLSSK---SKQGNREFVNEIGMISALQ- 629
N+F+ IG GGFG VY GK+ A+K L K KQG +NE M+S +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 630 --HPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARG 687
P +V + ++L I + M L L + G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILG 119
Query: 688 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMA 747
L ++H +V+RD+K N+LLD+ + +ISD GLA + H S GT GYMA
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 173
Query: 748 PEYAMRG-YLTDKADVYSFGIVALEIVSGR 776
PE +G AD +S G + +++ G
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 3e-45
Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 8/211 (3%)
Query: 568 RQIKAATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE-FVNEIGMI 625
+Q + + + + +G G F V K++A+K ++ K+ +G NEI ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 626 SALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLA 685
++HPN+V L G L LI + + L + + + +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVL 117
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGY 745
+ YLH+ + + LD+D ISDFGL+K+ ED + + GT GY
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGY 175
Query: 746 MAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
+APE + + D +S G++A ++ G
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 3e-45
Identities = 40/198 (20%), Positives = 80/198 (40%), Gaps = 12/198 (6%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
+G G FG V++ + + K K + K EI +++ +H N++ L+
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 641 IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIV 700
+L++I+E++ + + +L+ S + L +LH I
Sbjct: 71 ESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHS---HNIG 124
Query: 701 HRDIKATNVLLDKDLNP--KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTD 758
H DI+ N++ + KI +FG A+ + + Y APE ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVST 182
Query: 759 KADVYSFGIVALEIVSGR 776
D++S G + ++SG
Sbjct: 183 ATDMWSLGTLVYVLLSGI 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 4e-45
Identities = 52/241 (21%), Positives = 101/241 (41%), Gaps = 9/241 (3%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE-FVNEIGMISALQHP 631
+ + IGEG +G V + +A+K++S Q + + EI ++ +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 632 NLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYL 691
N++ + + Y+ + + L+ + + L + RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125
Query: 692 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRIAGTFGYMAPE 749
H ++HRD+K +N+LL+ + KI DFGLA++ + D+T T T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 750 YAMRGYLTD-KADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFLS 808
+ D++S G + E++S R + Q + + + + ++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 809 L 809
L
Sbjct: 243 L 243
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-44
Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 25/223 (11%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL------LADGKVIAVKQLSSKSKQG-NREFVNEIGMISA 627
+ +G G FG V + A + +AVK L + +R ++E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 628 -LQHPNLVKLYGCCIE-GNQLLLIYEYMENNSLARALFG------------PEEHRLKLD 673
H N+V L G C + G L++I E+ + +L+ L + ++ L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 674 WPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDN 732
+A+G+ +L K +HRD+ A N+LL + KI DFGLA+ + ++ +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 733 THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 775
+MAPE T ++DV+SFG++ EI S
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 232
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 2e-44
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 9/204 (4%)
Query: 576 NFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQL--SSKSKQGNREFVNEIGMISALQHPN 632
NF KIGEG +G VYK G+V+A+K++ ++++ + EI ++ L HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+VKL N+L L++E++ + F + P S L +GLA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM 752
+++HRD+K N+L++ + K++DFGLA+ + + +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 753 RGYLTDKADVYSFGIVALEIVSGR 776
Y + D++S G + E+V+ R
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 159 bits (402), Expect = 3e-44
Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 9/204 (4%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQL--SSKSKQGNREFVNEIGMISALQHPN 632
+ KIGEG +G VYK G+ A+K++ + + + EI ++ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+VKLY +L+L++E+++ + L+ T S + L G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 693 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAM 752
+ +++HRD+K N+L++++ KI+DFGLA+ + I +
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 753 RGYLTDKADVYSFGIVALEIVSGR 776
+ D++S G + E+V+G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-44
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 26/225 (11%)
Query: 575 NNFAPDNKIGEGGFGPVYKGLL--------ADGKVIAVKQLSSKSKQGN-REFVNEIGMI 625
+ +GEG FG V +AVK L S + + + + ++E+ M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 626 SAL-QHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALF------------GPEEHRLKL 672
+ +H N++ L G C + L +I EY +L L +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 673 DWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732
S +ARG+ YL + K +HRD+ A NVL+ +D KI+DFGLA+ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 733 THIST-RIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
+ T +MAPE T ++DV+SFG++ EI +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (405), Expect = 3e-44
Identities = 58/239 (24%), Positives = 101/239 (42%), Gaps = 23/239 (9%)
Query: 575 NNFAPDNKIGEGGFGPVYKG-LLADGKVIAVKQLSSK---SKQGNREFVNEIGMISALQH 630
+F +G G FG V+ +G+ A+K L + + +E M+S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 631 PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
P +++++G + Q+ +I +Y+E L F + P + L Y
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY 750
LH I++RD+K N+LLDK+ + KI+DFG AK + + GT Y+APE
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEV 172
Query: 751 AMRGYLTDKADVYSFGIVALEIVSGRS--------NVICRTKEAQFCLLDWVTLALTDF 801
D +SFGI+ E+++G + + A+ + + D
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL 231
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 158 bits (401), Expect = 4e-44
Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 26/218 (11%)
Query: 576 NFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLS---------SKSKQGNREFVNEIGMI 625
N+ P +G G V + + K AVK + + ++ + E+ ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 626 SALQ-HPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGL 684
+ HPN+++L L+++ M+ L L ++ L I L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRAL 119
Query: 685 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFG 744
+ LH+ L IVHRD+K N+LLD D+N K++DFG + + + GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPS 174
Query: 745 YMAPEYAM------RGYLTDKADVYSFGIVALEIVSGR 776
Y+APE + D++S G++ +++G
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 9e-44
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 13/208 (6%)
Query: 575 NNFAPDNKIGEGGFGPVYKG-LLADGKVIAVKQLSSKSKQGNRE---FVNEIGMIS-ALQ 629
+F +G+G FG V+ + A+K L + + + E ++S A +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 630 HPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLA 689
HP L ++ L + EY+ L + + K D + GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQ 117
Query: 690 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE 749
+LH IV+RD+K N+LLDKD + KI+DFG+ K + + +T GT Y+APE
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPE 173
Query: 750 YAMRGYLTDKADVYSFGIVALEIVSGRS 777
+ D +SFG++ E++ G+S
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (390), Expect = 1e-42
Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 17/213 (7%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLS---SKSKQGNREFVNEIGMISALQ 629
++ + +G GG V+ L + +AVK L ++ F E +AL
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 630 HPNLVKLYGCCIE----GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLA 685
HP +V +Y G ++ EY++ +L + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADAC 121
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRIAGTF 743
+ L + H+ I+HRD+K N+++ K+ DFG+A+ D ++ + + GT
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 744 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
Y++PE A + ++DVYS G V E+++G
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-42
Identities = 59/236 (25%), Positives = 106/236 (44%), Gaps = 15/236 (6%)
Query: 581 NKIGEGGFGPVYKG-LLADGKVIAVKQLSSKSKQG-----NREFVNEIGMISALQHPNLV 634
+ +GEG F VYK +++A+K++ + NR + EI ++ L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
L + + L++++ME + +++ L L + + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE----VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 695 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMR- 753
I+HRD+K N+LLD++ K++DFGLAK N T T Y APE
Sbjct: 120 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGA 175
Query: 754 GYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFPLFLSL 809
D+++ G + E++ + + Q + T+ ++P SL
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-42
Identities = 54/246 (21%), Positives = 105/246 (42%), Gaps = 14/246 (5%)
Query: 573 ATNNFAPDNKIGEGGFGPVYKG--LLADGKVIAVKQLSSKSKQGN--REFVNEIGMISAL 628
A + +IGEG +G V+K L G+ +A+K++ ++ + + E+ ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 629 ---QHPNLVKLYGCCIEGNQLLLIYEYMENNSLAR--ALFGPEEHRLKLDWPTRHSICIG 683
+HPN+V+L+ C + + + + + + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTF 743
L RGL +LH ++VHRD+K N+L+ K++DFGLA++ T + T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 744 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRF 803
Y APE ++ D++S G + E+ + + Q + V + +
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 804 PLFLSL 809
P ++L
Sbjct: 240 PRDVAL 245
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-41
Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 20/234 (8%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNR------EFVNEIGMISALQHPNLV 634
++G G F V K + G A K + + + +R + E+ ++ +QHPN++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 635 KLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE 694
L+ ++LI E + LF + L + G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQILNGVYYLHS- 131
Query: 695 SRLKIVHRDIKATNVLLDKDLNP----KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY 750
L+I H D+K N++L P KI DFGLA + N I GT ++APE
Sbjct: 132 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEI 187
Query: 751 AMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALTDFRFP 804
L +AD++S G++ ++SG S + TK+ + V D F
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 1e-40
Identities = 49/230 (21%), Positives = 83/230 (36%), Gaps = 20/230 (8%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNL 633
N + KIG G FG +Y G +A G+ +A+K K+K + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 634 VKLYG-CCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+ C EG+ +++ E + + K T + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLE----DLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 693 EESRLKIVHRDIKATNVL---LDKDLNPKISDFGLAKLDEEDNTHI------STRIAGTF 743
+HRD+K N L K I DFGLAK + TH + + GT
Sbjct: 121 S---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 744 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDW 793
Y + + + + D+ S G V + G + +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 7e-40
Identities = 56/209 (26%), Positives = 85/209 (40%), Gaps = 17/209 (8%)
Query: 576 NFAPDNKIGEGGFGPVYKG-LLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 634
++ IG G FG VY+ L G+++A+K++ + NRE + ++ L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 635 KLYGCCIEGNQ------LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGL 688
+L + L L+ +Y+ A + L L R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQLFRSL 135
Query: 689 AYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLDEEDNTHISTRIAGTFGYMA 747
AY+H I HRDIK N+LLD D K+ DFG AK + I +
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAP 191
Query: 748 PEYAMRGYLTDKADVYSFGIVALEIVSGR 776
T DV+S G V E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 9e-40
Identities = 49/207 (23%), Positives = 81/207 (39%), Gaps = 20/207 (9%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE------FVNEIGMISALQ--HPN 632
+G GGFG VY G+ ++D +A+K + E E+ ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+++L + +LI E E R L S + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCH 127
Query: 693 EESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYA 751
++HRDIK N+L+D + K+ DFG L ++ T GT Y PE+
Sbjct: 128 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 181
Query: 752 M-RGYLTDKADVYSFGIVALEIVSGRS 777
Y A V+S GI+ ++V G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (367), Expect = 2e-39
Identities = 41/215 (19%), Positives = 83/215 (38%), Gaps = 22/215 (10%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQH-PN 632
++ +IGEG FG +++G L + + +A+K +S + +E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 633 LVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLH 692
+ +Y EG +L+ + + + + K T + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 693 EESRLKIVHRDIKATNVLLDKDLNP-----KISDFGLAKLDEEDNTHI------STRIAG 741
E +V+RDIK N L+ + + + DFG+ K + T ++G
Sbjct: 119 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 742 TFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
T YM+ + + + D+ + G V + + G
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 58/245 (23%), Positives = 109/245 (44%), Gaps = 22/245 (8%)
Query: 575 NNFAPDNKIGEGGFGPVYKG-LLADGKVIAVKQLSSKSKQGN--REFVNEIGMISALQHP 631
+ + KIG+G FG V+K G+ +A+K++ ++++ + EI ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 632 NLVKLYGCCIEG--------NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIG 683
N+V L C + L++++ E++ +K +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQM 125
Query: 684 LARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEEDNTHISTRIA 740
L GL Y+H KI+HRD+KA NVL+ +D K++DFGLA+ L + + T
Sbjct: 126 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 741 GTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFCLLDWVTLALT 799
T Y PE + D++ G + E+ + + T++ Q L+ + ++T
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 800 DFRFP 804
+P
Sbjct: 243 PEVWP 247
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-38
Identities = 58/206 (28%), Positives = 83/206 (40%), Gaps = 12/206 (5%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSK---SKQGNREFVNEIGMISALQH 630
N+F +G+G FG V A G+ A+K L + +K V E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 631 PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
P L L ++L + EY L L + L Y
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEY 120
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY 750
LH +V+RDIK N++LDKD + KI+DFGL K D GT Y+APE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176
Query: 751 AMRGYLTDKADVYSFGIVALEIVSGR 776
D + G+V E++ GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-38
Identities = 45/202 (22%), Positives = 77/202 (38%), Gaps = 19/202 (9%)
Query: 583 IGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC- 640
+G G G V + + A+K L + RE E+ A Q P++V++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYE 75
Query: 641 ---IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRL 697
LL++ E ++ L + + I + + YLH +
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 698 KIVHRDIKATNVLLDKDLNP---KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRG 754
I HRD+K N+L K++DFG AK N+ + T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPE 188
Query: 755 YLTDKADVYSFGIVALEIVSGR 776
D++S G++ ++ G
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGY 210
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 8e-38
Identities = 43/206 (20%), Positives = 89/206 (43%), Gaps = 10/206 (4%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQL--SSKSKQGNREFVNEIGMISALQHP 631
+ KIGEG +G V+K +++A+K++ + + EI ++ L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 632 NLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYL 691
N+V+L+ +L L++E+ + + + LD S L +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLK----KYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 692 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYA 751
H ++HRD+K N+L++++ K+++FGLA+ S + +
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 752 MRGYLTDKADVYSFGIVALEIVSGRS 777
+ D++S G + E+ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 6e-37
Identities = 43/232 (18%), Positives = 91/232 (39%), Gaps = 13/232 (5%)
Query: 565 FTLRQIKAAT----NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQL--SSKSKQGNRE 617
F +++ + +G G +G V + G +A+K+L +S+ +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 618 FVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTR 677
E+ ++ ++H N++ L L ++ G KL
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 678 HSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 737
+ + +GL Y+H I+HRD+K N+ +++D KI DFGLA+ + ++ ++
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTG 177
Query: 738 RIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQFC 789
+ + T D++S G + E+++G++ Q
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (343), Expect = 9e-36
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 15/222 (6%)
Query: 559 DLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNRE 617
D T Q A + F +G G FG V G A+K L + ++
Sbjct: 25 DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ 84
Query: 618 ---FVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDW 674
+NE ++ A+ P LVKL + + L ++ EY+ + L +
Sbjct: 85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSE 140
Query: 675 PTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734
P + YLH L +++RD+K N+L+D+ +++DFG AK +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197
Query: 735 ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 776
+ GT +APE + D ++ G++ E+ +G
Sbjct: 198 LC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-34
Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 18/229 (7%)
Query: 559 DLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGLLA----DGKVIAVKQLS----SK 610
+L T + T K NF +G G +G V+ GK+ A+K L +
Sbjct: 8 ELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ 67
Query: 611 SKQGNREFVNEIGMISALQH-PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHR 669
+ E ++ ++ P LV L+ +L LI +Y+ L L + R
Sbjct: 68 KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRER 125
Query: 670 LKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729
+ I + + L +L I++RDIK N+LLD + + ++DFGL+K
Sbjct: 126 FTEHE-----VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180
Query: 730 EDNTHISTRIAGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGR 776
D T + GT YMAP+ G D +S G++ E+++G
Sbjct: 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-34
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 21/223 (9%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLS--SKSKQGNREFVNEIGMISALQHP 631
+ IG G G V + +A+K+LS +++ + E+ ++ + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 632 NLVKLYGCCI------EGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLA 685
N++ L E + L+ E M+ N + +++LD + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-------QVIQMELDHERMSYLLYQML 129
Query: 686 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGY 745
G+ +LH I+HRD+K +N+++ D KI DFGLA+ T T Y
Sbjct: 130 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYY 184
Query: 746 MAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEAQF 788
APE + + D++S G + E+V + R Q+
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (321), Expect = 6e-33
Identities = 38/209 (18%), Positives = 86/209 (41%), Gaps = 21/209 (10%)
Query: 575 NNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPN 632
+++ K+G G + V++ + + + + + VK L K+ + EI ++ L+ PN
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 633 LVKLYGCCIE--GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
++ L + L++E++ N ++ L + + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDF-------KQLYQTLTDYDIRFYMYEILKALDY 144
Query: 691 LHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPE 749
H + I+HRD+K NV++D + ++ D+GLA+ + + + PE
Sbjct: 145 CHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPE 199
Query: 750 YAMR-GYLTDKADVYSFGIVALEIVSGRS 777
+ D++S G + ++ +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 5e-32
Identities = 46/206 (22%), Positives = 85/206 (41%), Gaps = 9/206 (4%)
Query: 574 TNNFAPDNKIGEGGFGPVYKGL-LADGKVIAVKQLS--SKSKQGNREFVNEIGMISALQH 630
+ + +G G +G V G +AVK+LS +S + E+ ++ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 631 PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
N++ L L + L A KL + + RGL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEY 750
+H I+HRD+K +N+ +++D KI DFGLA+ + ++ +A +
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 190
Query: 751 AMRGYLTDKADVYSFGIVALEIVSGR 776
+ D++S G + E+++GR
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 1e-26
Identities = 41/210 (19%), Positives = 70/210 (33%), Gaps = 18/210 (8%)
Query: 582 KIGEGGFGPVYKGL-LADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCC 640
K+G G F V+ + + +A+K + K +EI ++ + + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 641 IEGNQLLLIYEY------------MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGL 688
LL + E + + I L GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 689 AYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLDEEDNTHISTR-IAGTFGYM 746
Y+H R I+H DIK NVL++ D + +A L T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 747 APEYAMRGYLTDKADVYSFGIVALEIVSGR 776
+PE + AD++S + E+++G
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.3 bits (231), Expect = 2e-22
Identities = 28/156 (17%), Positives = 48/156 (30%), Gaps = 21/156 (13%)
Query: 581 NKIGEGGFGPVYKGLLADGKVIAVK----------QLSSKSKQGNREFVNEIGMISALQH 630
+GEG V+ VK ++ K G+ F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 631 PNLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAY 690
L KL G + Y + N++ L +E + + +A
Sbjct: 66 RALQKLQGLAVPKV-----YAWEG-NAVLMELIDAKELYRVRVENPDE-VLDMILEEVAK 118
Query: 691 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726
+ IVH D+ NVL+ + I DF +
Sbjct: 119 FYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.8 bits (185), Expect = 2e-15
Identities = 54/281 (19%), Positives = 92/281 (32%), Gaps = 37/281 (13%)
Query: 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNH 126
A L L+ N+ + + NL NL L L +N + P +FA L +L+ +S N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 127 FTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGI--ASLVELTDLRISDLNGPEGPFPRLS 184
+ +L E + + + +G+ +VEL + G F +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 185 NLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG----------- 233
L + + I +P+ G L L L NK++ V ++ G
Sbjct: 151 KLSYIRI----ADTNITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204
Query: 234 --------------SGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCE 279
L ++L N L K + + L NN S+ C
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 280 NQSVNLFASSSE---GSNSTGIVSCL-KSFTCPTNHSSLHI 316
AS S SN +F C +++ +
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.7 bits (130), Expect = 2e-08
Identities = 42/258 (16%), Positives = 83/258 (32%), Gaps = 49/258 (18%)
Query: 3 ILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPS---EWASLPLVNLPLWK------ 53
IL + + P L L+ + L++N L L + + K
Sbjct: 61 ILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVF 120
Query: 54 ----------------QANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLH 97
+++G A + L+ + + + +P G +L +LH
Sbjct: 121 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELH 177
Query: 98 LNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPS 157
L+ N T S L L +S N + + N L +L + + L +P
Sbjct: 178 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPG 236
Query: 158 GIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLD 217
G+A + + + + N +S + + ++ P Y + +
Sbjct: 237 GLADHKYIQVVYLHNNN--------ISAIGSNDFCP----------PGYNTKKASYSGVS 278
Query: 218 LSFNKLS--GVIPSNFSG 233
L N + + PS F
Sbjct: 279 LFSNPVQYWEIQPSTFRC 296
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.5 bits (179), Expect = 2e-14
Identities = 45/197 (22%), Positives = 82/197 (41%), Gaps = 16/197 (8%)
Query: 72 LTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQI 131
L NQ S P + NL++L LN N + A+LT L +++N +
Sbjct: 202 LIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 257
Query: 132 PDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNY 191
P + TKL +L + + ++ P + + +L + L +SNLKN+ Y
Sbjct: 258 P--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE----DISPISNLKNLTY 311
Query: 192 LILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPV 250
L L NI P + + L+ L + NK+S S+ + + + ++ N ++
Sbjct: 312 LTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367
Query: 251 PDWIVRKRNKHIDLSYN 267
P + R + L+
Sbjct: 368 PLANL-TRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 2e-05
Identities = 41/269 (15%), Positives = 80/269 (29%), Gaps = 20/269 (7%)
Query: 64 ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRIS 123
+ + L + + + L NL +++ ++N T P NLT+L ++
Sbjct: 41 TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN 96
Query: 124 DNHF------------TGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRIS 171
+N TG Q + + I+ + L+ L
Sbjct: 97 NNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSL 156
Query: 172 DLNGPEGPFPRLSNLKNMNYLILRSGNI-IGEMPEYLGQMIGLRVLDLSFNKLSGVIPSN 230
L L N+ L + L ++ L L + N++S + P
Sbjct: 157 QQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG 216
Query: 231 FSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCEN-QSVNLFASS 289
+ L + L GN L +DL+ N + + S + L A+
Sbjct: 217 ILTN-LDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQ 274
Query: 290 SEGSNSTGIVSCLKSFTCPTNHSSLHINC 318
+ ++ L + N
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPI 303
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 4e-04
Identities = 17/112 (15%), Positives = 28/112 (25%), Gaps = 50/112 (44%)
Query: 14 PPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLT 73
++ L LQ + N ++
Sbjct: 322 ISPVSSLTKLQRLFFANNKVSD-------------------------------------- 343
Query: 74 LEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN 125
+ L NL N+ L N + P ANLTR+ ++D
Sbjct: 344 ----------VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.8 bits (169), Expect = 2e-13
Identities = 66/267 (24%), Positives = 104/267 (38%), Gaps = 7/267 (2%)
Query: 18 TRLPFLQEIDLTRNYLNG--TIPSEWASLP-LVNLPLWKQAN--GAIPKAVASISTLADL 72
T+ + +DL+ L IPS A+LP L L + N G IP A+A ++ L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 73 TLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIP 132
+ SG +P L + L L + N +G LP S ++L L N +G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 133 DYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYL 192
D +++KL + + L + +S N EG L
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSR-NMLEGDASVLFGSDKNTQK 225
Query: 193 ILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVP 251
I + N + +G L LDL N++ G +P + L + ++ N L G +P
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 252 DWIVRKRNKHIDLSYNNFIDGSSDSNC 278
+R + N + GS C
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 14/51 (27%), Positives = 23/51 (45%), Gaps = 2/51 (3%)
Query: 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEW--ASLPLVNL 49
L++ + G LP LT+L FL ++++ N L G IP +
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (165), Expect = 4e-13
Identities = 46/268 (17%), Positives = 86/268 (32%), Gaps = 15/268 (5%)
Query: 7 QNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGA--IPKAVA 64
Q +P +P R+ L N ++ + + + + + A A
Sbjct: 24 QAVPVGIPAASQRI------FLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77
Query: 65 SISTLADLTLEFNQFSGDL-PAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRIS 123
++ L L L N + PA L L LHL+ P F L L++ +
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137
Query: 124 DNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRL 183
DN D ++ L LF+ G+ ++ L L L + N P
Sbjct: 138 DNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ-NRVAHVHPHA 196
Query: 184 SNLKNMNYLILRSGNIIGE-MPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLT 242
+ N + E L + L+ L L+ N + + L +
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGS 256
Query: 243 GNLLTGPVPDWIVRKRNKHI-DLSYNNF 269
+ + +P + + + L+ N+
Sbjct: 257 SSEVPCSLPQRL---AGRDLKRLAANDL 281
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 1e-07
Identities = 39/253 (15%), Positives = 66/253 (26%), Gaps = 37/253 (14%)
Query: 83 LPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDY-------I 135
LP +L + LHL+ N + TRL + T D +
Sbjct: 25 LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL 82
Query: 136 QNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDL-------------NGPEGPFPR 182
+ + S LT L + L N + P
Sbjct: 83 DLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG 142
Query: 183 LSNLKNMNYLILRSGN-IIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYL 241
L + + N + L + L L L N L + F L + +L
Sbjct: 143 LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFL 202
Query: 242 TGNLLT-----GPVPDWIVRKRNKHIDLSYNNFIDGSSDSNCENQSVNLFASSSEGSNST 296
GN W+ + N + + + N+ + + S+
Sbjct: 203 HGNPWLCNCEILYFRRWLQD--------NAENVYVWKQGVDVKAMTSNVASVQCDNSDKF 254
Query: 297 GIVSCLKSFTCPT 309
+ CPT
Sbjct: 255 PVYKYP-GKGCPT 266
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 4e-07
Identities = 22/111 (19%), Positives = 42/111 (37%), Gaps = 8/111 (7%)
Query: 14 PPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLT 73
L +L + +DL+ N L P+ A+L + + VA++ L +L
Sbjct: 13 LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQELL 71
Query: 74 LEFNQF-SGDLPAELGNLINLEKLHLNSNNFTG------KLPESFANLTRL 117
L N+ L + L L+L N+ +L E +++ +
Sbjct: 72 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.002
Identities = 24/132 (18%), Positives = 40/132 (30%), Gaps = 30/132 (22%)
Query: 96 LHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPI 155
LHL + T L + H +S N P
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP----------------------- 37
Query: 156 PSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIG-EMPEYLGQMIGLR 214
+A+L L L+ S + ++NL + L+L + + + L L
Sbjct: 38 --ALAALRCLEVLQAS--DNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV 93
Query: 215 VLDLSFNKLSGV 226
+L+L N L
Sbjct: 94 LLNLQGNSLCQE 105
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 26/98 (26%), Positives = 46/98 (46%), Gaps = 12/98 (12%)
Query: 74 LEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPD 133
N S ++ + +LE+L++++N +LP L RL S NH ++P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPE 321
Query: 134 YIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRIS 171
QN L++L +E + L P S + DLR++
Sbjct: 322 LPQN---LKQLHVEYNPLRE-FPDIPES---VEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 5e-06
Identities = 19/76 (25%), Positives = 34/76 (44%), Gaps = 9/76 (11%)
Query: 66 ISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN 125
+L +L + N+ +LPA L E+L + N+ ++PE NL +L + N
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELPQNLKQL---HVEYN 334
Query: 126 HFTGQIPDYIQNWTKL 141
+ PD ++ L
Sbjct: 335 PLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 7e-04
Identities = 17/70 (24%), Positives = 28/70 (40%), Gaps = 8/70 (11%)
Query: 185 NLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGN 244
++ L + S N + E+P + L L SFN L+ +P L +++ N
Sbjct: 282 LPPSLEELNV-SNNKLIELPALPPR---LERLIASFNHLAE-VPELP--QNLKQLHVEYN 334
Query: 245 LLTGPVPDWI 254
L PD
Sbjct: 335 PLRE-FPDIP 343
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.004
Identities = 16/82 (19%), Positives = 29/82 (35%), Gaps = 6/82 (7%)
Query: 188 NMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLT 247
+ + E+ L L++S NKL +P+ L + + N L
Sbjct: 261 ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP--PRLERLIASFNHLA 317
Query: 248 GPVPDWIVRKRNKHIDLSYNNF 269
VP+ + K + + YN
Sbjct: 318 E-VPELP--QNLKQLHVEYNPL 336
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 2e-06
Identities = 12/89 (13%), Positives = 31/89 (34%), Gaps = 5/89 (5%)
Query: 91 INLEKLHLNSNNFTGK-LPESFANLTRLKHFRISDNHFTGQ----IPDYIQNWTKLEKLF 145
++++ L + + E L + + R+ D T I ++ L +L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 146 IEGSGLAGPIPSGIASLVELTDLRISDLN 174
+ + L + ++ +I L+
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLS 90
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 16/81 (19%), Positives = 28/81 (34%), Gaps = 9/81 (11%)
Query: 65 SISTLADLTLEFNQFSGD----LPAELGNLINLEKLHLNSNNFTGKLPESFA-----NLT 115
S L L L S L A L +L +L L++N
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 116 RLKHFRISDNHFTGQIPDYIQ 136
L+ + D +++ ++ D +Q
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQ 447
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 3e-06
Identities = 13/86 (15%), Positives = 26/86 (30%), Gaps = 10/86 (11%)
Query: 69 LADLTLEFNQFSGDLPAEL-GNLINLEKLHLNSNNFTGK----LPESFANLTRLKHFRIS 123
+ L ++ + S AEL L + + L+ T + + L +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 124 DNHFTGQIPDYI-----QNWTKLEKL 144
N + K++KL
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKL 89
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 5e-06
Identities = 14/97 (14%), Positives = 29/97 (29%), Gaps = 10/97 (10%)
Query: 84 PAELGNLINLEKLHLNSNNFTGK----LPESFANLTRLKHFRISDNHFTGQIPDYI---- 135
L L L + + L + L+ +S+N +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 136 -QNWTKLEKLFIEGSGLAGPIPSGIASLVE-LTDLRI 170
Q LE+L + + + + +L + LR+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 6e-04
Identities = 16/93 (17%), Positives = 26/93 (27%), Gaps = 12/93 (12%)
Query: 183 LSNLKNMNYLILRSGNIIGEMPEYLGQMIG----LRVLDLSFNKLSGVIPSNFS------ 232
+ L L ++ L + LR LDLS N L
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 233 GSGLTYMYLTGNLLTGPVPDWI--VRKRNKHID 263
G L + L + + D + + K +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 14/86 (16%), Positives = 33/86 (38%), Gaps = 6/86 (6%)
Query: 43 SLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLI-----NLEKLH 97
L L + + + ++ + + +L +L L N +L + LE+L
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432
Query: 98 LNSNNFTGKLPESFANLTRLK-HFRI 122
L ++ ++ + L + K R+
Sbjct: 433 LYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 12/127 (9%), Positives = 35/127 (27%), Gaps = 30/127 (23%)
Query: 23 LQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGD 82
+Q +D+ L+ + + + + + L+ +
Sbjct: 4 IQSLDIQCEELS---------------------DARWAELLPLLQQCQVVRLDDCGLTEA 42
Query: 83 ----LPAELGNLINLEKLHLNSNNFTGKLPESFA-----NLTRLKHFRISDNHFTGQIPD 133
+ + L L +L+L SN +++ + + TG
Sbjct: 43 RCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 102
Query: 134 YIQNWTK 140
+ + +
Sbjct: 103 VLSSTLR 109
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 14/76 (18%), Positives = 25/76 (32%), Gaps = 13/76 (17%)
Query: 161 SLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIG----LRVL 216
EL+D R ++L L L+ + L + + + + L L
Sbjct: 10 QCEELSDARWAEL---------LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 217 DLSFNKLSGVIPSNFS 232
+L N+L V
Sbjct: 61 NLRSNELGDVGVHCVL 76
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.3 bits (95), Expect = 2e-04
Identities = 32/172 (18%), Positives = 56/172 (32%), Gaps = 13/172 (7%)
Query: 7 QNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP--LVNLPLWKQANGAIPKAVA 64
+ +P +P T L L N L LV L L + I
Sbjct: 21 KEIPRDIPLHTTEL------LLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF 74
Query: 65 SISTLADLTLEFNQFSGDLPAE-LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRIS 123
++ ++ + L L+ L+L N + +P SF +L L ++
Sbjct: 75 EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA 134
Query: 124 DNHFTGQIP-DYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLN 174
N F + W + K + G PS + + ++ DL S+
Sbjct: 135 SNPFNCNCHLAWFAEWLR--KKSLNGGAARCGAPSKVRDV-QIKDLPHSEFK 183
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 2e-04
Identities = 39/267 (14%), Positives = 83/267 (31%), Gaps = 33/267 (12%)
Query: 6 SQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVAS 65
++ + E +Q +DL+ + + + ++
Sbjct: 31 PRSFMDQPLAEHFSPFRVQHMDLSNSVIEV---------------------STLHGILSQ 69
Query: 66 ISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN 125
S L +L+LE + S + L NL +L+L+ + + + + ++ +
Sbjct: 70 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLS 129
Query: 126 HFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDL---------NGP 176
++Q I L+G + S + R +L
Sbjct: 130 WCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLK 189
Query: 177 EGPFPRLSNLKNMNYLILRSGNII-GEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSG 235
F L + +L L I E LG++ L+ L + G +
Sbjct: 190 NDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL--LKEA 247
Query: 236 LTYMYLTGNLLTGPVPDWIVRKRNKHI 262
L ++ + + T I K+N+ I
Sbjct: 248 LPHLQINCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 0.001
Identities = 11/60 (18%), Positives = 23/60 (38%)
Query: 214 RVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGS 273
+ LDL+ L + G+ + + P+ + R +H+DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 62
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 2e-04
Identities = 19/152 (12%), Positives = 38/152 (25%), Gaps = 29/152 (19%)
Query: 83 LPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRI--SDNHFTGQIPDYIQNWTK 140
L + + + L+ S +L + + + +N +
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR-----SDPDLVAQNIDVVLNRRSSMAATLRIIEENIPE 66
Query: 141 LEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNII 200
L L +L + L + + N+ L L +
Sbjct: 67 LLSL----------------------NLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104
Query: 201 GEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFS 232
E + + L L L N LS +
Sbjct: 105 SERELDKIKGLKLEELWLDGNSLSDTFRDQST 136
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 3e-04
Identities = 13/92 (14%), Positives = 36/92 (39%), Gaps = 8/92 (8%)
Query: 68 TLADLTLEFNQFSGD----LPAELGNLINLEKLHLNSNNFTGK----LPESFANLTRLKH 119
++ +L+ + + + + A L +++++ L+ N + L E+ A+ L+
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 120 FRISDNHFTGQIPDYIQNWTKLEKLFIEGSGL 151
SD + + L + ++ L
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 4e-04
Identities = 23/139 (16%), Positives = 47/139 (33%), Gaps = 7/139 (5%)
Query: 85 AELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKL 144
A+ N + +L L + A L + SDN + D +L+ L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68
Query: 145 FIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMP 204
+ + + +L +LT+L +++ + E + N +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 205 EY----LGQMIGLRVLDLS 219
Y + ++ +RVLD
Sbjct: 129 HYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.003
Identities = 12/90 (13%), Positives = 26/90 (28%), Gaps = 2/90 (2%)
Query: 181 PRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMY 240
+ +N L L G I + + +D S N++ + L +
Sbjct: 12 AQYTNAVRDRELDL-RGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLL 69
Query: 241 LTGNLLTGPVPDWIVRKRNKHIDLSYNNFI 270
+ N + + + NN +
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSL 99
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 9e-04
Identities = 13/61 (21%), Positives = 23/61 (37%), Gaps = 4/61 (6%)
Query: 87 LGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFI 146
L NL L L + N + A+L L + +N + P + N + L + +
Sbjct: 169 LANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 147 E 147
Sbjct: 225 T 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 13/48 (27%), Positives = 24/48 (50%), Gaps = 4/48 (8%)
Query: 77 NQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISD 124
N+ S + L +L NL ++HL +N + P AN + L +++
Sbjct: 183 NKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 32/213 (15%), Positives = 50/213 (23%), Gaps = 27/213 (12%)
Query: 60 PKAVASISTLADLT------LEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFAN 113
P A+ I L + + + +L + L T E
Sbjct: 6 PTAINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQY 61
Query: 114 LTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDL 173
L L + DN T P +L I +
Sbjct: 62 LNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD 121
Query: 174 NGPEGPFPRLSNLKNMNYLILRSGNIIG--------------EMPEYLGQMIGLRVLDLS 219
P L L I + G L + L L
Sbjct: 122 VTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD 181
Query: 220 FNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVP 251
NK+S + P + L ++L N ++ P
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.001
Identities = 33/180 (18%), Positives = 56/180 (31%), Gaps = 13/180 (7%)
Query: 64 ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRIS 123
++++ + + + L N+ KL LN N T + ANL L +
Sbjct: 43 NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD--IKPLANLKNLGWLFLD 98
Query: 124 DNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRL 183
+N K L S I LV L L L + +
Sbjct: 99 ENKVKDLSSLKDLKKLKSLSLE-------HNGISDINGLVHLPQLESLYLGNNKITDITV 151
Query: 184 SNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTG 243
+ + N I ++ L + L+ L LS N +S + + L + L
Sbjct: 152 LSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFS 209
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 23/169 (13%), Positives = 41/169 (24%), Gaps = 18/169 (10%)
Query: 72 LTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQI 131
L + + +L + L + + L L S+N T
Sbjct: 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDIT 78
Query: 132 PDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNY 191
P + P+ + P L+ L+ +
Sbjct: 79 PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN 138
Query: 192 LILRSGNIIGEMPEY--------------LGQMIGLRVLDLSFNKLSGV 226
I + G L + L LD+S NK+S +
Sbjct: 139 TISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDI 187
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 809 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.91 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.69 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.55 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.53 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.47 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.45 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.4 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.38 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.36 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.36 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.26 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.46 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.4 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.4 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.74 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.73 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.64 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.1 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.07 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.96 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.16 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.56 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.24 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 83.34 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-44 Score=376.43 Aligned_cols=200 Identities=28% Similarity=0.521 Sum_probs=180.1
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
++|+..+.||+|+||+||+|.. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999985 468999999997665555677999999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|+.......
T Consensus 100 ~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 9999999873 34689999999999999999999998 899999999999999999999999999987654332
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.....+||+.|+|||++.+..++.++||||+||++|||+||+.||...+
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 2345679999999999999999999999999999999999999997643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=372.04 Aligned_cols=199 Identities=29% Similarity=0.500 Sum_probs=177.6
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc---CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56888999999999999999965 6889999998643 2334567889999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999984 334689999999999999999999998 899999999999999999999999999986543
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||...+
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence 32 234679999999999999999999999999999999999999997654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-44 Score=372.55 Aligned_cols=203 Identities=32% Similarity=0.466 Sum_probs=175.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357889999999999999999964 68999999986553 3345679999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++++||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999999943 34689999999999999999999998 8999999999999999999999999999876443
Q ss_pred Cc-ceeccccccccccchhhhccCCC-CchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 NT-HISTRIAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||....
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 32 23345689999999999988765 678999999999999999999997643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-44 Score=372.43 Aligned_cols=201 Identities=30% Similarity=0.521 Sum_probs=166.9
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
++|+..+.||+|+||+||+|.+.+++.||||+++.. ....++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 467788999999999999999988899999998754 3345789999999999999999999999999999999999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
+|+|.+++.. ....++|..+..++.|+|+||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 9999999854 335689999999999999999999998 8999999999999999999999999999876554444
Q ss_pred eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcC-CCCCCCC
Q 043333 735 ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG-RSNVICR 782 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltG-k~P~~~~ 782 (809)
......||+.|+|||++.+..++.++|||||||++|||+|+ ++||...
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~ 206 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence 44456789999999999999999999999999999999995 5555443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-44 Score=374.42 Aligned_cols=208 Identities=29% Similarity=0.462 Sum_probs=168.0
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEe--CCeEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIE--GNQLLLI 649 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~lV 649 (809)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.|.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57889999999999999999864 68999999986553 2234568899999999999999999999975 4568999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES--RLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
|||+++|+|.+++.........+++..+..++.|++.||+|||+++ ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998654445567999999999999999999999863 12499999999999999999999999999987
Q ss_pred cCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 728 DEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
...... .....+||+.|||||++.+..++.++|||||||++|||+||+.||...+
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence 654322 2345679999999999999999999999999999999999999997643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=371.19 Aligned_cols=202 Identities=28% Similarity=0.449 Sum_probs=177.8
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
+.|++.+.||+|+||+||+|+.. +|+.||||++........+.|.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999964 68999999998766666788999999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.+++.. ...++++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+......
T Consensus 92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 99999998742 234699999999999999999999998 89999999999999999999999999997543221
Q ss_pred ceeccccccccccchhhhc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
......+||+.|||||++. ...++.++|||||||++|||+||+.||...+
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~ 219 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence 1223467999999999984 4567899999999999999999999997654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=371.20 Aligned_cols=202 Identities=25% Similarity=0.408 Sum_probs=176.0
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56889999999999999999964 68999999986532 233467899999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999883 345689999999999999999999998 899999999999999999999999999987654
Q ss_pred CC-cceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DN-THISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. .......+||+.|||||++.+..++.++||||+||++|||++|+.||...+
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC
Confidence 32 222334679999999999999999999999999999999999999997643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-43 Score=368.28 Aligned_cols=201 Identities=32% Similarity=0.522 Sum_probs=168.6
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++|+..+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467889999999999999999864 35999998654 23345789999999999999999999998754 56899999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++|+|.++++.. ..+++|..+..++.|+|+||+|||++ +||||||||+|||++.++++||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999542 34689999999999999999999998 8999999999999999999999999999876433
Q ss_pred C-cceeccccccccccchhhhcc---CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 N-THISTRIAGTFGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~-~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
. ........||+.|||||++.+ +.++.++|||||||++|||+||+.||...+
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 2 223345679999999999864 357999999999999999999999997643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=367.35 Aligned_cols=200 Identities=34% Similarity=0.529 Sum_probs=175.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.++|+..+.||+|+||+||+|.+++++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 45788889999999999999999888999999996543 345789999999999999999999998754 5679999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.++++.. ...+++|..++.++.|||+||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 90 ~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 90 ENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp TTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 999999987542 334689999999999999999999998 899999999999999999999999999998765554
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVI 780 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~ 780 (809)
.......||+.|||||++.++.++.++|||||||++|||+||+.|+.
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 44455678999999999999999999999999999999999766553
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=362.43 Aligned_cols=202 Identities=28% Similarity=0.468 Sum_probs=181.8
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEccc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYME 654 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 654 (809)
++|+..++||+|+||+||+|++++++.||||+++... ...++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5789999999999999999999888999999997643 345789999999999999999999999999999999999999
Q ss_pred CCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcc
Q 043333 655 NNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 734 (809)
Q Consensus 655 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 734 (809)
+|+|.+++.. ....+++..+.+++.|+|+||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999998743 344689999999999999999999998 8999999999999999999999999999876655444
Q ss_pred eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 735 ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 735 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence 4445678999999999999999999999999999999998 899997654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=378.68 Aligned_cols=201 Identities=25% Similarity=0.434 Sum_probs=176.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++|+..+.||+|+||+||+|+.. +|+.||||+++.... ...+++.+|+++|++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999964 689999999875533 334678999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
||++|+|.+++. ....+++..+..++.|++.||.|||+++ +|+||||||+|||+++++++||+|||+|+...+.
T Consensus 85 y~~gg~L~~~l~----~~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999994 2346899999999999999999999742 6999999999999999999999999999865322
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.....+||+.|||||++.+..++.++||||+||++|||++|+.||...+
T Consensus 159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1234689999999999999999999999999999999999999997643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-43 Score=371.04 Aligned_cols=203 Identities=26% Similarity=0.447 Sum_probs=180.2
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
..++|+..+.||+|+||+||+|++. +|+.||||+++... ...++|.+|++++++++|||||+++++|.+.+..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3567888899999999999999975 58899999986543 345789999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+++|+|.+++... ....++|..+..++.|+|+||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 94 ~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 94 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp CCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred cccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 99999999998532 345789999999999999999999998 8999999999999999999999999999987665
Q ss_pred CcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.........|++.|+|||++.++.++.++|||||||++|||++|+.|+..
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 55545556789999999999999999999999999999999998777643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.6e-43 Score=371.14 Aligned_cols=203 Identities=32% Similarity=0.507 Sum_probs=163.6
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CC---eEEEEEEeccc-CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DG---KVIAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g---~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
++|+..+.||+|+||+||+|.+. ++ ..||||++... .....++|.+|+++|++++|||||+++|+|.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 34556789999999999999864 23 36899988654 333456799999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
||||++|+|.+++.. ....++|..+..++.|||+||+|||++ +|+||||||+|||++.++++||+|||+|+...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998853 334689999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcce----eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 730 EDNTHI----STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
...... .....||+.|||||++.++.++.++|||||||++|||+| |+.||...+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 432211 122457899999999999999999999999999999998 899997643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=370.89 Aligned_cols=202 Identities=29% Similarity=0.377 Sum_probs=179.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEeccc---CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35789999999999999999996 47899999999754 233456788999999999999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
||||++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++++||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999884 344688999999999999999999998 89999999999999999999999999998654
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 157 ~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 3322 2345789999999999999999999999999999999999999997754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-42 Score=367.24 Aligned_cols=198 Identities=28% Similarity=0.456 Sum_probs=176.9
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEeccc---CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5688899999999999999996 46899999998653 2334567899999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999998883 345678889999999999999999998 899999999999999999999999999987653
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. ...+||+.|||||++.+..++.++||||+||++|||+||+.||...+
T Consensus 157 ~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 157 VT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp CB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence 32 34679999999999999999999999999999999999999997643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=363.09 Aligned_cols=202 Identities=29% Similarity=0.471 Sum_probs=172.6
Q ss_pred cCCCCCC-eeccCCCccEEEeEee---CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEE
Q 043333 575 NNFAPDN-KIGEGGFGPVYKGLLA---DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 575 ~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
++|...+ .||+|+||+||+|.++ ++..||||+++... ....++|.+|+++|++++|||||+++|+|.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455556 4999999999999864 35689999997553 3345779999999999999999999999865 568999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
|||+++|+|.+++.. .+..+++..+..++.|+|+||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999998843 345689999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcce--eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 730 EDNTHI--STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 730 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
...... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||...+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 443322 234568999999999999999999999999999999998 999997643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-42 Score=357.45 Aligned_cols=196 Identities=31% Similarity=0.485 Sum_probs=167.2
Q ss_pred CCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEe----CCeEEEEE
Q 043333 578 APDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIE----GNQLLLIY 650 (809)
Q Consensus 578 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ 650 (809)
+..+.||+|+||+||+|+.. +++.||||++.... ....+.|.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45668999999999999965 58899999986542 2334678999999999999999999999875 34679999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCCceEEEecCCccccC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDE 729 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~ 729 (809)
||+++|+|.+++. ....+++..+..++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHh----ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999984 3346899999999999999999999982 2499999999999996 57899999999998654
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
... ....+||+.|||||++.+ .++.++|||||||++|||++|+.||...
T Consensus 167 ~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 167 ASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp TTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 322 234679999999998865 6899999999999999999999999653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-42 Score=364.32 Aligned_cols=200 Identities=26% Similarity=0.423 Sum_probs=161.4
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
.+.|+..+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467889999999999999999965 689999999875532 334568899999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc---CCCceEEEecCCcccc
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAKLD 728 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DfGla~~~ 728 (809)
|+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999943 44699999999999999999999998 899999999999994 5789999999999865
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.... .....+||+.|||||++.+..++.++||||+||++|||++|+.||...
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence 4332 223467999999999999999999999999999999999999999764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.8e-42 Score=371.63 Aligned_cols=202 Identities=25% Similarity=0.399 Sum_probs=179.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
.++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999996 46899999999766555567789999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc--CCCceEEEecCCccccCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD--KDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DfGla~~~~~ 730 (809)
|++|+|.+++.. ...++++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999843 234689999999999999999999998 899999999999996 458899999999987654
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... .....||+.|||||++.+..++.++||||+||++|||++|+.||...+
T Consensus 179 ~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 229 (350)
T d1koaa2 179 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229 (350)
T ss_dssp TSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence 332 234679999999999999999999999999999999999999997653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-42 Score=360.72 Aligned_cols=195 Identities=30% Similarity=0.444 Sum_probs=165.9
Q ss_pred CeeccCCCccEEEeEeeC---CeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcccC
Q 043333 581 NKIGEGGFGPVYKGLLAD---GKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYMEN 655 (809)
Q Consensus 581 ~~LG~G~fG~Vy~~~~~~---g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 655 (809)
++||+|+||+||+|.+++ ++.||||+++.... ...++|.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 569999999999998653 46899999865422 234679999999999999999999999965 567899999999
Q ss_pred CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCcce
Q 043333 656 NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 735 (809)
Q Consensus 656 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 735 (809)
|+|.+++. ....++|..+..++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999984 345699999999999999999999998 89999999999999999999999999998765443322
Q ss_pred --eccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 736 --STRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 736 --~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
.....||+.|||||.+.+..++.++|||||||++|||+| |+.||...+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 234568999999999999999999999999999999998 899997643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-41 Score=368.86 Aligned_cols=202 Identities=26% Similarity=0.388 Sum_probs=179.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
.++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35789999999999999999996 46999999999766555566788999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc--CCCceEEEecCCccccCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD--KDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DfGla~~~~~ 730 (809)
+++|+|.+++.. ...++++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999988733 344689999999999999999999998 899999999999998 578999999999987764
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... .....||+.|+|||++.+..++.++||||+||++|||+||+.||...+
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 182 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 432 334678999999999999999999999999999999999999997643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-42 Score=365.12 Aligned_cols=197 Identities=30% Similarity=0.516 Sum_probs=172.9
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcc---cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQ---GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
+.|+..+.||+|+||+||+|+. .+|+.||||++...... ..+.|.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3588899999999999999985 46899999998755322 2356889999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
|||++|+|..++. .+.++++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999977652 345799999999999999999999998 899999999999999999999999999986543
Q ss_pred CCcceeccccccccccchhhhcc---CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
. ....||+.|||||++.+ +.++.++|||||||++|||++|+.||...+
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 2 24579999999999863 468999999999999999999999997643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=363.93 Aligned_cols=207 Identities=30% Similarity=0.443 Sum_probs=174.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC------CeEEEEEEeccc-CcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD------GKVIAVKQLSSK-SKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 645 (809)
.++|+..+.||+|+||+||+|++.. ...||||++... .......|.+|++++.++ +|||||+++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578889999999999999998643 236999998654 334456789999999998 89999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCc-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 043333 646 LLLIYEYMENNSLARALFGPEE-------------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKA 706 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp 706 (809)
.++||||+++|+|.++|+.... ....++|..++.++.||++||+|||++ +|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999965431 123589999999999999999999998 899999999
Q ss_pred CCEEEcCCCceEEEecCCccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 707 TNVLLDKDLNPKISDFGLAKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 707 ~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
+|||++.++++||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||...+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999876544332 2334668999999999999999999999999999999998 899997643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-42 Score=360.10 Aligned_cols=201 Identities=30% Similarity=0.491 Sum_probs=168.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.++|++.+.||+|+||+||+|++++++.||||+++.. ....++|.+|++++++++|||||+++|+|. .++.++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 3578899999999999999999988889999998644 334578999999999999999999999985 45689999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.++++.. ....++|..++.++.|||.||+|||++ +|+||||||+|||+|+++++||+|||+++.......
T Consensus 94 ~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 999999988542 234689999999999999999999998 899999999999999999999999999987654444
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
.......||+.|+|||++..+.++.++|||||||++|||++|+.|+..
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 444456789999999999999999999999999999999997766644
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-41 Score=355.51 Aligned_cols=201 Identities=26% Similarity=0.380 Sum_probs=177.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc------ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK------QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 646 (809)
.++|+..+.||+|+||+||+|+. .+|+.||||++..... ...+.|.+|+++|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46789999999999999999996 4689999999865422 1245789999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC----ceEEEec
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISDF 722 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~Df 722 (809)
++|||||++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~----~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhc----cccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999984 334699999999999999999999998 899999999999998776 4999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
|+|+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 162 G~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 162 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp TTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 99987654332 234578999999999999999999999999999999999999997654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=355.94 Aligned_cols=201 Identities=30% Similarity=0.491 Sum_probs=165.8
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCC-----eEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADG-----KVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g-----~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
+.|+..++||+|+||+||+|.++.. ..||||++.... .....+|.+|++++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999997642 479999986543 3334579999999999999999999999999999999
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+.+|++.+++.. ....++|..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999987732 345689999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCc--ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 729 EEDNT--HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 729 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
..... .......||+.|||||++.++.++.++|||||||++|||++|+.|+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 44322 222345689999999999999999999999999999999997666543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.4e-41 Score=363.68 Aligned_cols=198 Identities=23% Similarity=0.360 Sum_probs=177.2
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEeccc---CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 650 (809)
++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++|+.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999964 6899999998643 2233467889999999999999999999999999999999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 730 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 730 (809)
||+.+|+|.+++. ....+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999883 334689999999999999999999998 899999999999999999999999999987653
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. ....||+.|||||++.+..++.++|||||||++|||+||+.||...+
T Consensus 194 ~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 194 RT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp CB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence 22 24679999999999999999999999999999999999999997643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=357.47 Aligned_cols=202 Identities=27% Similarity=0.453 Sum_probs=176.1
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHHHHHHh-hcCCCceEeEEeEEEeCCeEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNEIGMIS-ALQHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~Ei~~l~-~l~H~nIv~l~~~~~~~~~~~lV 649 (809)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999964 68999999996532 233456677777665 68999999999999999999999
Q ss_pred EEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccC
Q 043333 650 YEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 729 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 729 (809)
||||++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999994 344688999999999999999999998 89999999999999999999999999998654
Q ss_pred CCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
.... ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+.
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~ 208 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH
Confidence 3322 23346799999999999999999999999999999999999999976543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-40 Score=362.78 Aligned_cols=200 Identities=31% Similarity=0.419 Sum_probs=171.9
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC---cccchhHHHH---HHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS---KQGNREFVNE---IGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~f~~E---i~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+| +++++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67889999999999999999964 68999999986432 2223334444 66777788999999999999999999
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+||||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHH----hcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999984 345678999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 728 DEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 728 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
..... ....+||+.|+|||++.. ..++.++||||+||++|||+||+.||.....
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 65432 234679999999999975 5689999999999999999999999976543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1e-39 Score=342.52 Aligned_cols=200 Identities=25% Similarity=0.415 Sum_probs=175.3
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcc---------cchhHHHHHHHHhhcC-CCceEeEEeEEEeC
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQ---------GNREFVNEIGMISALQ-HPNLVKLYGCCIEG 643 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~---------~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~ 643 (809)
++|+..+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|++++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6788999999999999999996 47899999998654321 1235789999999997 99999999999999
Q ss_pred CeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 644 NQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
+..++|||||++|+|.+++. .+.++++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999994 345799999999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCcceeccccccccccchhhhcc------CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAMR------GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 724 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
+++....... ....+||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+
T Consensus 156 ~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 156 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred heeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 9987654322 244679999999999853 346889999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=348.09 Aligned_cols=204 Identities=28% Similarity=0.404 Sum_probs=163.6
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC----CeEEEEEEecccCc-ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD----GKVIAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
.++|+..+.||+|+||.||+|++.. +..||||+++.... ...+.|.+|++++++++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4578889999999999999998642 35789999865433 33567999999999999999999999985 467899
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
||||+++|+|.+++.. ....+++..+..++.||++||+|||++ +|+||||||+||++++++.+||+|||+|+..
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998742 345689999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 043333 729 EEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRTK 784 (809)
Q Consensus 729 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~~ 784 (809)
............||+.|+|||++.+..++.++|||||||++|||+| |++||...+.
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~ 215 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH
Confidence 5544444455678999999999999999999999999999999998 8999976543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-41 Score=356.50 Aligned_cols=212 Identities=29% Similarity=0.459 Sum_probs=178.5
Q ss_pred HHHHHhcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCcc-cchhHHHHHHHHhhcCCCceEeEEeEEE
Q 043333 569 QIKAATNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLYGCCI 641 (809)
Q Consensus 569 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~~~~~ 641 (809)
+++...++|+..+.||+|+||+||+|++. +++.||||+++..... ..++|.+|++++++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999864 3578999998765333 3567999999999999999999999999
Q ss_pred eCCeEEEEEEcccCCchhhhccCCC--------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 043333 642 EGNQLLLIYEYMENNSLARALFGPE--------------------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVH 701 (809)
Q Consensus 642 ~~~~~~lV~ey~~~gsL~~~L~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 701 (809)
+.+..++||||+++|+|.++++... .....++|..++.++.|+|.||+|||++ +|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence 9999999999999999999985322 1233589999999999999999999998 8999
Q ss_pred cCCCCCCEEEcCCCceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCC-CCC
Q 043333 702 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR-SNV 779 (809)
Q Consensus 702 ~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk-~P~ 779 (809)
|||||+|||+|.++.+||+|||+|+....... .......||+.|+|||.+.+..++.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999999986643322 2233467889999999999999999999999999999999996 567
Q ss_pred CCCC
Q 043333 780 ICRT 783 (809)
Q Consensus 780 ~~~~ 783 (809)
...+
T Consensus 244 ~~~~ 247 (301)
T d1lufa_ 244 YGMA 247 (301)
T ss_dssp TTSC
T ss_pred CCCC
Confidence 6543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=354.98 Aligned_cols=203 Identities=29% Similarity=0.524 Sum_probs=169.2
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCe----EEEEEEeccc-CcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGK----VIAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 648 (809)
.+|+..+.||+|+||+||+|.+. +|+ +||||+++.. .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888999999999999999864 443 6899988654 344567899999999999999999999999875 5678
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 728 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 728 (809)
|+||+.+|+|.+++.. ....+++..+..++.|||.||+|||++ +|+||||||+|||++.++++||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8999999999988743 345789999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 043333 729 EEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRTK 784 (809)
Q Consensus 729 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~~ 784 (809)
...... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||...+.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~ 219 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH
Confidence 543332 2334568999999999999999999999999999999998 7899976543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-40 Score=348.39 Aligned_cols=203 Identities=23% Similarity=0.369 Sum_probs=169.0
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc---ccchhHHHHHHHHhhcCCCceEeEEeEEEeCC----e
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLYGCCIEGN----Q 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~----~ 645 (809)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.|.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999995 4799999999975432 22456899999999999999999999998754 3
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++||||+++|+|.+++. ...++++..+..++.|++.||+|||++ +|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 789999999999999883 344689999999999999999999998 8999999999999999999999999998
Q ss_pred cccCCCCc--ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 726 KLDEEDNT--HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 726 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
........ ......+||+.|+|||++.+..++.++||||+||++|||+||+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 75533221 22334679999999999999999999999999999999999999997643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-40 Score=351.93 Aligned_cols=201 Identities=20% Similarity=0.329 Sum_probs=176.7
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
.++|++.+.||+|+||+||+|... +|+.||||+++.... ....+.+|+++|++++|||||++++++.+++..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467899999999999999999964 689999999975432 245688999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC--CceEEEecCCccccCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD--LNPKISDFGLAKLDEE 730 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DfGla~~~~~ 730 (809)
|++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999943 234689999999999999999999998 89999999999999854 5899999999987654
Q ss_pred CCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 731 DNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 731 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
... .....+|+.|+|||.+.+..++.++||||+||++|||++|+.||...+
T Consensus 157 ~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~ 207 (321)
T d1tkia_ 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC
Confidence 322 234578999999999999999999999999999999999999997654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-40 Score=347.92 Aligned_cols=197 Identities=27% Similarity=0.385 Sum_probs=166.6
Q ss_pred CCeeccCCCccEEEeEee-CCeEEEEEEecccCcc-----cchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEcc
Q 043333 580 DNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQ-----GNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYM 653 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 653 (809)
.++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999964 6899999998654221 2356889999999999999999999999999999999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
+++++..+.. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9988776652 344678889999999999999999998 899999999999999999999999999986654332
Q ss_pred ceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 734 HISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
. ....+||+.|+|||++.. ..++.++||||+||++|||+||+.||...+.
T Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~ 206 (299)
T d1ua2a_ 156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 206 (299)
T ss_dssp C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred c-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH
Confidence 2 234579999999999865 4679999999999999999999999977543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-40 Score=342.22 Aligned_cols=207 Identities=31% Similarity=0.433 Sum_probs=168.4
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeC-CeEEEEEEcc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEG-NQLLLIYEYM 653 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~lV~ey~ 653 (809)
++|+..+.||+|+||.||+|.+ .|+.||||+++.. ...++|.+|++++++++||||++++|+|.+. +.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4677789999999999999998 4789999999643 3457899999999999999999999999654 5689999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.++++.. ....++|..+++++.|||.||+|||+. +|+||||||+|||++.++.+|++|||+++......
T Consensus 84 ~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 84 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp TTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 999999999532 233589999999999999999999998 89999999999999999999999999998654322
Q ss_pred ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHHHHH
Q 043333 734 HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRTKEAQFCLLDWVTL 796 (809)
Q Consensus 734 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~~~~~~~l~~~~~~ 796 (809)
....+|+.|+|||++.++.+++++|||||||++|||+| |+.||...+. .++..++..
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~~ 215 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEK 215 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTT
T ss_pred ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHc
Confidence 23457889999999999999999999999999999998 6888865432 234555543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-40 Score=343.97 Aligned_cols=202 Identities=27% Similarity=0.469 Sum_probs=163.3
Q ss_pred cCCCCCCeeccCCCccEEEeEeeC--C--eEEEEEEecccC---cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLAD--G--KVIAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~--g--~~vAVK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 647 (809)
++|+..+.||+|+||.||+|++.. + ..||||++.... .+..++|.+|++++++++||||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568888999999999999998642 2 378999886542 2334679999999999999999999999965 4678
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+||||+++|++.+++.. ....+++..+..++.|+|+||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999988743 334689999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcc--eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 728 DEEDNTH--ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 728 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
....... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 6544332 2233567889999999999999999999999999999998 899997643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-39 Score=343.55 Aligned_cols=202 Identities=29% Similarity=0.451 Sum_probs=170.9
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|++++++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5789999999999999999996 568999999996543 2335778999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
|+.++.+..... .....+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 997654443322 2344689999999999999999999998 8999999999999999999999999999876543
Q ss_pred CcceeccccccccccchhhhccCC-CCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGY-LTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.. ......||+.|+|||.+.... ++.++||||+||++|||++|+.||...+
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 32 233457999999999877654 5889999999999999999999997654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=345.51 Aligned_cols=207 Identities=27% Similarity=0.396 Sum_probs=165.1
Q ss_pred HhcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccC-cccchhHHHHHHHHhhc-CCCceEeEEeEEEeC-
Q 043333 573 ATNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLYGCCIEG- 643 (809)
Q Consensus 573 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~- 643 (809)
..++|+..+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|.+++.++ +|+||+.+++++.+.
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3467889999999999999999854 24689999987543 33456788888888877 689999999998765
Q ss_pred CeEEEEEEcccCCchhhhccCCCc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043333 644 NQLLLIYEYMENNSLARALFGPEE------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL 711 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 711 (809)
+..++|||||++|+|.++++.... ....++|..+..++.||++||+|||++ +|+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeE
Confidence 468999999999999999964322 234589999999999999999999998 89999999999999
Q ss_pred cCCCceEEEecCCccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCC-CCCCCC
Q 043333 712 DKDLNPKISDFGLAKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR-SNVICR 782 (809)
Q Consensus 712 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk-~P~~~~ 782 (809)
++++++||+|||+|+........ ......||+.|+|||++.++.++.++|||||||++|||+||. .||...
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999866443322 233467999999999999999999999999999999999975 577653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-39 Score=341.14 Aligned_cols=196 Identities=29% Similarity=0.449 Sum_probs=168.4
Q ss_pred CCeeccCCCccEEEeEeeCC----eEEEEEEeccc-CcccchhHHHHHHHHhhcCCCceEeEEeEEEeC-CeEEEEEEcc
Q 043333 580 DNKIGEGGFGPVYKGLLADG----KVIAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLYGCCIEG-NQLLLIYEYM 653 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~g----~~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~lV~ey~ 653 (809)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|++++++++||||++++|+|.+. ...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999996432 36899998653 334457799999999999999999999998874 5889999999
Q ss_pred cCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCCc
Q 043333 654 ENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 733 (809)
Q Consensus 654 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 733 (809)
++|+|.++++. .....++..++.++.|+|+||.|+|+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999998854 344578899999999999999999998 899999999999999999999999999987644322
Q ss_pred c---eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 734 H---ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 734 ~---~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
. ......||+.|+|||.+.++.++.++||||||+++|||+||+.||..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 2 22335689999999999999999999999999999999998888854
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-39 Score=342.08 Aligned_cols=203 Identities=31% Similarity=0.472 Sum_probs=170.5
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCe--EEEEEEeccc-CcccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCeEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGK--VIAVKQLSSK-SKQGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQLLLI 649 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~--~vAVK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV 649 (809)
++|+..+.||+|+||+||+|++. +|. .||||+++.. .....++|.+|+++|+++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57778899999999999999975 444 5788887544 334567899999999999 799999999999999999999
Q ss_pred EEcccCCchhhhccCCC------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCce
Q 043333 650 YEYMENNSLARALFGPE------------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 717 (809)
Q Consensus 650 ~ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 717 (809)
|||+++|+|.++|+... .....++|..+.+++.|||+||.|||++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997542 2345799999999999999999999998 89999999999999999999
Q ss_pred EEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCC-CCCCC
Q 043333 718 KISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRS-NVICR 782 (809)
Q Consensus 718 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~-P~~~~ 782 (809)
||+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|.. ||...
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence 9999999986543222 223468999999999999999999999999999999999765 67554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-39 Score=348.50 Aligned_cols=197 Identities=22% Similarity=0.311 Sum_probs=169.1
Q ss_pred hcCCCCCC-eeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhc-CCCceEeEEeEEEe----CCeE
Q 043333 574 TNNFAPDN-KIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLYGCCIE----GNQL 646 (809)
Q Consensus 574 ~~~f~~~~-~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~----~~~~ 646 (809)
.++|.+.. .||+|+||+||+|+. .+++.||||+++. .+.+.+|++++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35787764 699999999999996 5689999999853 35577899987655 89999999999876 3568
Q ss_pred EEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCceEEEecC
Q 043333 647 LLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFG 723 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfG 723 (809)
++|||||++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||+++ ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence 9999999999999999542 234689999999999999999999998 8999999999999985 4679999999
Q ss_pred CccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 724 LAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 724 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
+|+....... ....+||+.|||||++.+..++.++||||+||++|||+||+.||...
T Consensus 160 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 160 FAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp TCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred eeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 9987654332 23467999999999999999999999999999999999999999654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.9e-39 Score=338.98 Aligned_cols=202 Identities=28% Similarity=0.428 Sum_probs=172.9
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEEc
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 652 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 652 (809)
++|+..+.||+|+||+||+|+..+|+.||||+++... ....+.|.+|+.+|++++||||+++++++...+..++|+||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788999999999999999998889999999996543 23357799999999999999999999999999999999999
Q ss_pred ccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCCC
Q 043333 653 MENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 732 (809)
Q Consensus 653 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 732 (809)
+.++.+..+.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 98877766652 345699999999999999999999998 89999999999999999999999999998765432
Q ss_pred cceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 733 THISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 733 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
. ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+.
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~ 206 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH
Confidence 2 2234568999999999875 4579999999999999999999999976543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-39 Score=343.26 Aligned_cols=198 Identities=32% Similarity=0.443 Sum_probs=162.0
Q ss_pred cCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHH--HHhhcCCCceEeEEeEEEeCC----eEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIG--MISALQHPNLVKLYGCCIEGN----QLLL 648 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~--~l~~l~H~nIv~l~~~~~~~~----~~~l 648 (809)
++|...+.||+|+||.||+|++ +|+.||||+++... .+++..|.+ .+.+++|||||+++++|.+.+ .+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 3456678899999999999986 58999999986432 334444544 456789999999999998754 6899
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEcCCCCCCEEEcCCCceEEEecC
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEE-----SRLKIVHRDIKATNVLLDKDLNPKISDFG 723 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 723 (809)
|||||++|+|.++|+ +..++|..+..++.|+|.||+|+|+. ...+|+||||||+|||+++++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~-----~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 999999999999994 34689999999999999999999973 12489999999999999999999999999
Q ss_pred CccccCCCCcc---eeccccccccccchhhhccCC------CCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 724 LAKLDEEDNTH---ISTRIAGTFGYMAPEYAMRGY------LTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 724 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
+++........ .....+||+.|+|||++.... ++.++|||||||++|||+||..||..
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 99876543322 223467999999999987542 56789999999999999999988743
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=340.62 Aligned_cols=205 Identities=25% Similarity=0.433 Sum_probs=170.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-C-CeEEEEEEecccC--cccchhHHHHHHHHhhc---CCCceEeEEeEEEe----
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-D-GKVIAVKQLSSKS--KQGNREFVNEIGMISAL---QHPNLVKLYGCCIE---- 642 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~-g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l---~H~nIv~l~~~~~~---- 642 (809)
.++|++.+.||+|+||+||+|+.. + ++.||||+++... ......+.+|+++++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999863 3 6789999986542 22345677888777665 79999999999864
Q ss_pred -CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEe
Q 043333 643 -GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 721 (809)
Q Consensus 643 -~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 721 (809)
....++||||+++|++..... .....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 246799999999987765442 2344688999999999999999999998 899999999999999999999999
Q ss_pred cCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCccc
Q 043333 722 FGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTKEA 786 (809)
Q Consensus 722 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~~~ 786 (809)
||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+
T Consensus 160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 222 (305)
T d1blxa_ 160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 222 (305)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH
Confidence 99987654322 2345679999999999999999999999999999999999999998765443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-39 Score=341.62 Aligned_cols=207 Identities=30% Similarity=0.444 Sum_probs=172.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEeeC--------CeEEEEEEecccCc-ccchhHHHHHHHHhhc-CCCceEeEEeEEEeC
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLAD--------GKVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLYGCCIEG 643 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~ 643 (809)
.++|+..+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4678888999999999999998532 34799999976543 3357788999999888 899999999999999
Q ss_pred CeEEEEEEcccCCchhhhccCCCc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043333 644 NQLLLIYEYMENNSLARALFGPEE------------HRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL 711 (809)
Q Consensus 644 ~~~~lV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 711 (809)
+..++||||+++|+|.+++..... ....+++.+++.++.|+|.||+|||+. +||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 999999999999999999964431 234689999999999999999999998 89999999999999
Q ss_pred cCCCceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 043333 712 DKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICRT 783 (809)
Q Consensus 712 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~~ 783 (809)
+.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||++ |+.||...+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 9999999999999986654332 22345678999999999999999999999999999999998 688887643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-39 Score=336.04 Aligned_cols=198 Identities=24% Similarity=0.366 Sum_probs=169.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc------ccchhHHHHHHHHhhcC--CCceEeEEeEEEeCC
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK------QGNREFVNEIGMISALQ--HPNLVKLYGCCIEGN 644 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~------~~~~~f~~Ei~~l~~l~--H~nIv~l~~~~~~~~ 644 (809)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... ....++.+|++++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35788999999999999999996 4689999999865421 12345778999999986 999999999999999
Q ss_pred eEEEEEEcccC-CchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CceEEEec
Q 043333 645 QLLLIYEYMEN-NSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDF 722 (809)
Q Consensus 645 ~~~lV~ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~Df 722 (809)
..++||||+.+ +++.+++. .+..+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 57777773 345689999999999999999999998 89999999999999854 79999999
Q ss_pred CCccccCCCCcceeccccccccccchhhhccCCC-CchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 723 GLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 723 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
|+|+...... .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||..
T Consensus 156 G~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 156 GSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp TTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 9998654322 234679999999999987665 6778999999999999999999965
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-39 Score=342.64 Aligned_cols=206 Identities=31% Similarity=0.456 Sum_probs=175.9
Q ss_pred hcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccCc-ccchhHHHHHHHHhhc-CCCceEeEEeEEEeCCe
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLYGCCIEGNQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 645 (809)
.++|+..+.||+|+||.||+|++. +++.||||+++.... ....+|.+|+++++++ +|||||+++++|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 467788899999999999999852 457899999976533 3345789999999999 69999999999999999
Q ss_pred EEEEEEcccCCchhhhccCCC--------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043333 646 LLLIYEYMENNSLARALFGPE--------------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLL 711 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~--------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 711 (809)
.++|||||++|+|.++++... .....+++..+..++.|||+||+|||++ +++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999986432 1334689999999999999999999998 89999999999999
Q ss_pred cCCCceEEEecCCccccCCCCc-ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 043333 712 DKDLNPKISDFGLAKLDEEDNT-HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNVICR 782 (809)
Q Consensus 712 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~ellt-Gk~P~~~~ 782 (809)
+.++.+|++|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+| |++||...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 9999999999999987654433 33345679999999999999999999999999999999999 55555543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-39 Score=341.78 Aligned_cols=206 Identities=27% Similarity=0.411 Sum_probs=176.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEee------CCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA------DGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQL 646 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 646 (809)
.++|...+.||+|+||+||+|.+. +++.||||+++... ......|.+|++++++++|||||+++|+|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467788899999999999999863 35789999997543 23345689999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhccCCC------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEE
Q 043333 647 LLIYEYMENNSLARALFGPE------EHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 720 (809)
Q Consensus 647 ~lV~ey~~~gsL~~~L~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 720 (809)
++||||+++|+|.++++... .....++|..+.+++.|+|+||.|||++ +|+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 99999999999999885422 2234579999999999999999999998 89999999999999999999999
Q ss_pred ecCCccccCCCCcc-eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCC-CCCCCC
Q 043333 721 DFGLAKLDEEDNTH-ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR-SNVICR 782 (809)
Q Consensus 721 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk-~P~~~~ 782 (809)
|||+|+........ ......||+.|+|||.+.++.++.++|||||||++|||+||+ .||...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC
Confidence 99999866443322 233456899999999999999999999999999999999985 677554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-37 Score=332.03 Aligned_cols=206 Identities=26% Similarity=0.391 Sum_probs=169.8
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEeccc--CcccchhHHHHHHHHhhcCCCceEeEEeEEEe--------
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLYGCCIE-------- 642 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~-------- 642 (809)
-++|++.+.||+|+||+||+|+. .+|+.||||++... .....+++.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36788999999999999999996 47999999998654 23345678999999999999999999999865
Q ss_pred CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEec
Q 043333 643 GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 722 (809)
Q Consensus 643 ~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 722 (809)
.+..++||||++++.+..+. .....++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 34579999999988776554 2344678889999999999999999998 8999999999999999999999999
Q ss_pred CCccccCCCCc---ceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCccc
Q 043333 723 GLAKLDEEDNT---HISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRTKEA 786 (809)
Q Consensus 723 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~~~~ 786 (809)
|+++....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...+..+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~ 229 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH
Confidence 99976543221 112235799999999998764 68999999999999999999999997754433
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.6e-37 Score=325.66 Aligned_cols=202 Identities=21% Similarity=0.287 Sum_probs=173.1
Q ss_pred hcCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCC-CceEeEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQH-PNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e 651 (809)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ..+.+.+|++.+..++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 467899999999999999999954 68999999885443 34567889999999975 899999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-----CCceEEEecCCcc
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDK-----DLNPKISDFGLAK 726 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DfGla~ 726 (809)
|+ +|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 98 6899888743 234689999999999999999999998 8999999999999974 5789999999998
Q ss_pred ccCCCCc------ceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 727 LDEEDNT------HISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 727 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
....... ......+||+.|||||.+.+..++.++|||||||++|||+||+.||.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 7643321 112346799999999999999999999999999999999999999976543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-37 Score=330.55 Aligned_cols=203 Identities=27% Similarity=0.381 Sum_probs=173.8
Q ss_pred cCCCCCCeeccCCCccEEEeEee----CCeEEEEEEecccC----cccchhHHHHHHHHhhcCC-CceEeEEeEEEeCCe
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA----DGKVIAVKQLSSKS----KQGNREFVNEIGMISALQH-PNLVKLYGCCIEGNQ 645 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~----~~~~~~f~~Ei~~l~~l~H-~nIv~l~~~~~~~~~ 645 (809)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 66999999999999999999842 47899999986542 2334678899999999976 899999999999999
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++||||+.+|+|.+++. ....+....+..++.|++.||+|+|+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999984 333567788899999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcceeccccccccccchhhhccC--CCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 726 KLDEEDNTHISTRIAGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 726 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
+..............|++.|+|||.+.+. .++.++||||+||++|||++|+.||...+.
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~ 237 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 87654444444456799999999998754 478899999999999999999999977543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-37 Score=333.51 Aligned_cols=203 Identities=25% Similarity=0.375 Sum_probs=167.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC-cccchhHHHHHHHHhhcCCCceEeEEeEEEeCC----eEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLYGCCIEGN----QLL 647 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~----~~~ 647 (809)
+.+|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+++|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45788999999999999999985 479999999997543 233467899999999999999999999997643 234
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
++++|+.+|+|.+++. ...+++..+..++.|++.||+|||++ +||||||||+|||+++++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 4556677999999983 33689999999999999999999998 899999999999999999999999999986
Q ss_pred cCCCCcc--eeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 728 DEEDNTH--ISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 728 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
....... .....+||+.|+|||++.. ..++.++||||+||++|||++|+.||...+.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 5433221 2234679999999999854 5678999999999999999999999977543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-37 Score=332.33 Aligned_cols=199 Identities=29% Similarity=0.371 Sum_probs=164.7
Q ss_pred CCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceEeEEeEEEeC------CeEEE
Q 043333 576 NFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEG------NQLLL 648 (809)
Q Consensus 576 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~------~~~~l 648 (809)
+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5777889999999999999964 689999999865432 234799999999999999999999753 24789
Q ss_pred EEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-ceEEEecCCccc
Q 043333 649 IYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKL 727 (809)
Q Consensus 649 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~ 727 (809)
|||||++|.+.... ........+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~~~l~-~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVAR-HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHH-HHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHH-hhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999876443332 2223455799999999999999999999998 899999999999999775 899999999987
Q ss_pred cCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 728 DEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 728 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
...... ....+||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+.
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 654332 234579999999998765 5789999999999999999999999976543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-36 Score=321.01 Aligned_cols=199 Identities=23% Similarity=0.364 Sum_probs=173.0
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeCCeEEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 651 (809)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+++.+|++++++++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5789999999999999999996 4789999999865432 234678999999999999999999999999999999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCccccCCC
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 731 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 731 (809)
++.+++|..++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999888773 344678999999999999999999998 8999999999999999999999999999876543
Q ss_pred CcceeccccccccccchhhhccCC-CCchHHHHHHHHHHHHHHcCCCCCCC
Q 043333 732 NTHISTRIAGTFGYMAPEYAMRGY-LTDKADVYSFGIVALEIVSGRSNVIC 781 (809)
Q Consensus 732 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwSlGvil~elltGk~P~~~ 781 (809)
... .....+++.|+|||.+.... ++.++||||+||++|||++|+.||..
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 322 23345788999999987654 68999999999999999999999744
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-37 Score=332.43 Aligned_cols=197 Identities=24% Similarity=0.415 Sum_probs=164.3
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeCC------
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEGN------ 644 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 644 (809)
.++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46888999999999999999996 469999999997542 223457889999999999999999999998754
Q ss_pred eEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCC
Q 043333 645 QLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 724 (809)
Q Consensus 645 ~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 724 (809)
+.++||||+ +++|..+. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM-----KHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHH-----HhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 579999999 55777766 234699999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeccccccccccchhhhcc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 725 AKLDEEDNTHISTRIAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 725 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
|+...... +...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+
T Consensus 168 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 168 ARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp CEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 98754332 34678999999999876 457899999999999999999999997754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-36 Score=320.14 Aligned_cols=201 Identities=25% Similarity=0.324 Sum_probs=166.2
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCceE-eEEeEEEeCCeEEEEEE
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLV-KLYGCCIEGNQLLLIYE 651 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~lV~e 651 (809)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ..+++..|+++++.++|+|++ .+.++..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 35799999999999999999996 468999999986543 245688999999999877655 55566677888999999
Q ss_pred cccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc---CCCceEEEecCCcccc
Q 043333 652 YMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAKLD 728 (809)
Q Consensus 652 y~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DfGla~~~ 728 (809)
|+++ ++.+.+. .....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+|++|||+|+..
T Consensus 84 ~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LLGP-SLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CCCC-BHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EcCC-chhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 9954 5655542 2344689999999999999999999998 899999999999985 4567999999999876
Q ss_pred CCCCcc------eeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 729 EEDNTH------ISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 729 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
...... ......||+.|||||.+.+..++.++|||||||++|||+||+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 543221 2234679999999999999999999999999999999999999997643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-35 Score=318.64 Aligned_cols=193 Identities=19% Similarity=0.348 Sum_probs=167.2
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcC-CCceEeEEeEEEeC--CeEEEEE
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLYGCCIEG--NQLLLIY 650 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~ 650 (809)
++|++.++||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999996 46899999998643 3467889999999995 99999999999854 5689999
Q ss_pred EcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-ceEEEecCCccccC
Q 043333 651 EYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDE 729 (809)
Q Consensus 651 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~ 729 (809)
||+++|+|.++. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 999999997764 2488999999999999999999998 899999999999998654 68999999998765
Q ss_pred CCCcceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 043333 730 EDNTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICR 782 (809)
Q Consensus 730 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~ 782 (809)
.... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 4332 2345789999999998765 4799999999999999999999999664
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-35 Score=322.60 Aligned_cols=199 Identities=24% Similarity=0.391 Sum_probs=166.5
Q ss_pred hcCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCc--ccchhHHHHHHHHhhcCCCceEeEEeEEEeC-----Ce
Q 043333 574 TNNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLYGCCIEG-----NQ 645 (809)
Q Consensus 574 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~ 645 (809)
.++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+++.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999995 4799999999975432 2345688999999999999999999998743 34
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++|+||+.+|+|.+++. ..++++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 467778889999999983 23689999999999999999999998 8999999999999999999999999998
Q ss_pred cccCCCCcceeccccccccccchhhhccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 043333 726 KLDEEDNTHISTRIAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNVICRTK 784 (809)
Q Consensus 726 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwSlGvil~elltGk~P~~~~~~ 784 (809)
...... .....||+.|+|||...+. .++.++||||+||++|||++|+.||.+.+.
T Consensus 169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224 (348)
T ss_dssp -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH
Confidence 754322 2345689999999987664 568999999999999999999999977543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-35 Score=319.91 Aligned_cols=197 Identities=25% Similarity=0.356 Sum_probs=159.7
Q ss_pred cCCCCCCeeccCCCccEEEeEee-CCeEEEEEEecccC--cccchhHHHHHHHHhhcCCCceEeEEeEEEeC------Ce
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLLA-DGKVIAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLYGCCIEG------NQ 645 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~~~~~~~------~~ 645 (809)
++|++.++||+|+||+||+|+.. +|+.||||++.... ....+++.+|++++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67899999999999999999965 69999999997543 22345688999999999999999999999743 67
Q ss_pred EEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEEecCCc
Q 043333 646 LLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 725 (809)
Q Consensus 646 ~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 725 (809)
.++||||+.++.+. .++ ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 89999999765544 442 2478999999999999999999998 8999999999999999999999999998
Q ss_pred cccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 726 KLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 726 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
+...... .....++|+.|+|||++.+..+++++||||+||+++||++|+.||...+
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 7654322 2234578999999999999999999999999999999999999997654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.3e-30 Score=284.63 Aligned_cols=201 Identities=22% Similarity=0.249 Sum_probs=159.0
Q ss_pred cCCCCCCeeccCCCccEEEeEe-eCCeEEEEEEecccCcccchhHHHHHHHHhhcC-----------CCceEeEEeEEEe
Q 043333 575 NNFAPDNKIGEGGFGPVYKGLL-ADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-----------HPNLVKLYGCCIE 642 (809)
Q Consensus 575 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~~~~~~ 642 (809)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3588999999999999999996 4799999999975432 2356778888888775 5789999998864
Q ss_pred --CCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-----
Q 043333 643 --GNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDL----- 715 (809)
Q Consensus 643 --~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----- 715 (809)
....++|++++..+........ ......+++..+..++.|++.||+|||+.. +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCccccc
Confidence 4567777777665543322211 123456788999999999999999999842 899999999999998665
Q ss_pred -ceEEEecCCccccCCCCcceeccccccccccchhhhccCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 043333 716 -NPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNVICRT 783 (809)
Q Consensus 716 -~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwSlGvil~elltGk~P~~~~~ 783 (809)
.++++|||.+....... ...+||+.|+|||++....++.++||||+||+++||++|+.||....
T Consensus 169 ~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 38999999998654322 34579999999999999999999999999999999999999997643
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=3e-30 Score=275.85 Aligned_cols=256 Identities=26% Similarity=0.338 Sum_probs=222.6
Q ss_pred CCCCEEEccCCCCCC--CCCcccCCCC-cccccccc-cc-CCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCE
Q 043333 21 PFLQEIDLTRNYLNG--TIPSEWASLP-LVNLPLWK-QA-NGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEK 95 (809)
Q Consensus 21 ~~L~~L~Ls~n~l~~--~~p~~~~~l~-L~~L~l~~-n~-~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 95 (809)
.+++.|||++|.+.+ .+|..+.+++ |+.|++++ |. .+.||..|+++++|++|+|++|++.+..+..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 468888888888877 4678888875 88888864 44 4588999999999999999999999988999999999999
Q ss_pred EEccCCccCccCchhhhcccccceeeeecccccCcCchhhhccccc-ceEecccCcCCCCCCccccCCCCCCEEeccCCC
Q 043333 96 LHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKL-EKLFIEGSGLAGPIPSGIASLVELTDLRISDLN 174 (809)
Q Consensus 96 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~ 174 (809)
++++.|++.+.+|..++++++|+.+++++|.+.+.+|..+..+.++ +.+++++|++++..|..+..+..+ .++++++.
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~ 208 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 9999999999999999999999999999999999999999888876 889999999999999888877655 79999988
Q ss_pred CCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChh
Q 043333 175 GPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDW 253 (809)
Q Consensus 175 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~ 253 (809)
.....+..+..+++|+.|++++|.+.+.+| .+..+++|+.|+|++|+|+|.+|..+.. ++|++|+|++|+|+|.+|..
T Consensus 209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~ 287 (313)
T d1ogqa_ 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred cccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCc
Confidence 888888888999999999999999988765 5888999999999999999988887776 99999999999999999976
Q ss_pred hhhccCccccccCCccccCCCCCcc
Q 043333 254 IVRKRNKHIDLSYNNFIDGSSDSNC 278 (809)
Q Consensus 254 ~~~~~l~~L~Ls~N~l~~~~~~~~~ 278 (809)
....+++.+++++|++.|+.|-..|
T Consensus 288 ~~L~~L~~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 288 GNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp TTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred ccCCCCCHHHhCCCccccCCCCCCC
Confidence 5557789999999997776554444
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.94 E-value=2.2e-27 Score=253.32 Aligned_cols=230 Identities=22% Similarity=0.327 Sum_probs=212.5
Q ss_pred CccccccccccCC---CCchhhcCCccCcEEeecc-cccccCCCccccCCCCCCEEEccCCccCccCchhhhccccccee
Q 043333 45 PLVNLPLWKQANG---AIPKAVASISTLADLTLEF-NQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHF 120 (809)
Q Consensus 45 ~L~~L~l~~n~~~---~ip~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 120 (809)
++++|+++++.+. .||+.++++++|++|+|++ |+++|.+|..|+++++|++|+|++|+|++..+..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 4788999988775 5899999999999999997 89999999999999999999999999999999999999999999
Q ss_pred eeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCC-CEEeccCCCCCCCCCccccCCcCCceeeeccccc
Q 043333 121 RISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVEL-TDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNI 199 (809)
Q Consensus 121 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l 199 (809)
++++|.+.+.+|..+.++++|+.+++++|.+.+.+|..+..+..+ +.+++++|++....+..+.++..+ .+++++|..
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 999999999999999999999999999999999999999988886 889999999998888888887665 699999999
Q ss_pred cCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhh-ccCccccccCCccccCCCC
Q 043333 200 IGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFIDGSSD 275 (809)
Q Consensus 200 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~~~~~~ 275 (809)
.+.+|..+..+++|+.|++++|.+++.+|.....++|+.|+|++|+|+|.+|..+.. .+++.|+|++|+|++..|.
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 286 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred cccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence 999999999999999999999999998887655699999999999999999998876 5679999999999976653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.1e-25 Score=236.57 Aligned_cols=219 Identities=21% Similarity=0.243 Sum_probs=175.0
Q ss_pred ccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeee-ccccc
Q 043333 50 PLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRIS-DNHFT 128 (809)
Q Consensus 50 ~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l~ 128 (809)
..+++.+..+|..+. +++++|+|++|+|++..+..|.++++|++|++++|++....+..+.+++.++.++.. .|.++
T Consensus 17 ~c~~~~L~~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~ 94 (284)
T d1ozna_ 17 SCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 94 (284)
T ss_dssp ECCSSCCSSCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCC
T ss_pred EcCCCCCCccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccc
Confidence 344455556665543 567888888888886666678888888888888888888777788888888887664 56677
Q ss_pred CcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhh
Q 043333 129 GQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLG 208 (809)
Q Consensus 129 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 208 (809)
...+..|.++++|++|+|++|.+....+..+....+|+.+++++|+++.++...|..+++|+.|+|++|++....+.+|.
T Consensus 95 ~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~ 174 (284)
T d1ozna_ 95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174 (284)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhc
Confidence 66677788888888888888888866777788888888888988888888888888888899999999988888888888
Q ss_pred ccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhh-ccCccccccCCccc
Q 043333 209 QMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLSYNNFI 270 (809)
Q Consensus 209 ~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls~N~l~ 270 (809)
++++|+.|++++|+++++.|..|.. ++|++|++++|++++.+|..+.. .+++.|+|++|+|.
T Consensus 175 ~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred cccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 8999999999999998888888877 88999999999998887777754 44566666655443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.1e-25 Score=234.47 Aligned_cols=254 Identities=17% Similarity=0.174 Sum_probs=201.1
Q ss_pred EEEccCCCCCCCCCcccCCCCccccccccccCCCCch-hhcCCccCcEEeecccccccCCCccccCCCCCCEEEcc-CCc
Q 043333 25 EIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPK-AVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLN-SNN 102 (809)
Q Consensus 25 ~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~N~ 102 (809)
.++.++++++ .+|..+.. .+++|++++|.+..+|. .|.++++|++|++++|++....+..+..+..++.+... .|.
T Consensus 15 ~v~c~~~~L~-~iP~~ip~-~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIPA-ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EEECCSSCCS-SCCTTCCT-TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEEcCCCCCC-ccCCCCCC-CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 3455555555 33433321 14555555666656654 57778899999999999998888888888889988764 567
Q ss_pred cCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCcc
Q 043333 103 FTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPR 182 (809)
Q Consensus 103 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~ 182 (809)
++...+..|.++++|++|+|++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|++++|++..++...
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~ 172 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred cccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhh
Confidence 77777888999999999999999998777777888899999999999999777788889999999999999999998889
Q ss_pred ccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhhccCcc
Q 043333 183 LSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRNKH 261 (809)
Q Consensus 183 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~~~l~~ 261 (809)
|.++++|+.|++++|++++..|..|..+++|++||+++|++.+.++..+.. ++|++|+|++|++.+.-+...-...++.
T Consensus 173 f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~ 252 (284)
T d1ozna_ 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQK 252 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHH
T ss_pred hccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHh
Confidence 999999999999999999999999999999999999999999998888876 8999999999999876543222233456
Q ss_pred ccccCCccccCCCCCcccc
Q 043333 262 IDLSYNNFIDGSSDSNCEN 280 (809)
Q Consensus 262 L~Ls~N~l~~~~~~~~~~~ 280 (809)
+....+.+.|..|..+.+.
T Consensus 253 ~~~~~~~~~C~~p~~l~g~ 271 (284)
T d1ozna_ 253 FRGSSSEVPCSLPQRLAGR 271 (284)
T ss_dssp CCSEECCCBEEESGGGTTC
T ss_pred CcCCCCceEeCCchHHcCC
Confidence 6667778887666665543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.91 E-value=7.7e-24 Score=224.69 Aligned_cols=261 Identities=23% Similarity=0.259 Sum_probs=218.1
Q ss_pred ccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCC-chhhcCCccCcEEeeccccc
Q 043333 2 RILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAI-PKAVASISTLADLTLEFNQF 79 (809)
Q Consensus 2 L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~i-p~~l~~l~~L~~L~L~~N~l 79 (809)
++-++++++ .+|..+. ++|++|+|++|+|+...+..|..++ |+.|++++|.+..+ |..|.++++|+.|+|++|++
T Consensus 15 ~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l 91 (305)
T d1xkua_ 15 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91 (305)
T ss_dssp EECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCcc
Confidence 344556666 7788775 6899999999999977677888875 99999999999988 55789999999999999999
Q ss_pred ccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeeccccc--CcCchhhhcccccceEecccCcCCCCCCc
Q 043333 80 SGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFT--GQIPDYIQNWTKLEKLFIEGSGLAGPIPS 157 (809)
Q Consensus 80 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 157 (809)
+ .+|..+ ...++.|++.+|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|+++ .+|.
T Consensus 92 ~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~ 167 (305)
T d1xkua_ 92 K-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 167 (305)
T ss_dssp S-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCS
T ss_pred C-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCc
Confidence 9 566543 358999999999999877777888888999999988644 345567889999999999999998 4555
Q ss_pred cccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCcc
Q 043333 158 GIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLT 237 (809)
Q Consensus 158 ~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~ 237 (809)
.+ .++|+.|++++|.........|.+++.++.|++++|.+.+..+..|.++++|++|+|++|+|+.+++.....++|+
T Consensus 168 ~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~ 245 (305)
T d1xkua_ 168 GL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQ 245 (305)
T ss_dssp SC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCC
T ss_pred cc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccccCCC
Confidence 43 5899999999999999999999999999999999999999999999999999999999999997754333349999
Q ss_pred EEEeeCccCCCCCChhhh-------hccCccccccCCcccc
Q 043333 238 YMYLTGNLLTGPVPDWIV-------RKRNKHIDLSYNNFID 271 (809)
Q Consensus 238 ~L~Ls~N~l~~~~p~~~~-------~~~l~~L~Ls~N~l~~ 271 (809)
.|+|++|+|+......+. ...++.|+|++|++..
T Consensus 246 ~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 246 VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp EEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred EEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 999999999976554442 2456889999999864
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.91 E-value=1.4e-23 Score=222.55 Aligned_cols=250 Identities=20% Similarity=0.246 Sum_probs=218.1
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeeccccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQF 79 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l 79 (809)
+|+|++|+|....+.+|.++++|++|++++|.+....|..|..++ |+.|++.+|.++.+|..+. ..++.|++++|.+
T Consensus 35 ~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~~~--~~l~~L~~~~n~l 112 (305)
T d1xkua_ 35 LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMP--KTLQELRVHENEI 112 (305)
T ss_dssp EEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCC--TTCCEEECCSSCC
T ss_pred EEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCccchh--hhhhhhhccccch
Confidence 479999999966666899999999999999999988888999986 9999999999999997544 6899999999999
Q ss_pred ccCCCccccCCCCCCEEEccCCccC--ccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCc
Q 043333 80 SGDLPAELGNLINLEKLHLNSNNFT--GKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPS 157 (809)
Q Consensus 80 ~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 157 (809)
.+..+..+.....++.++...|... ...+..+..+++|+.+++++|.+. .+|..+ +++|+.|++++|.+++..+.
T Consensus 113 ~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~ 189 (305)
T d1xkua_ 113 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAA 189 (305)
T ss_dssp CBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTG
T ss_pred hhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChh
Confidence 9777777888899999999998654 345667889999999999999998 556543 68999999999999999999
Q ss_pred cccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCC-----
Q 043333 158 GIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFS----- 232 (809)
Q Consensus 158 ~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----- 232 (809)
.|..++.++.|++++|.+..++...+.++++|++|+|++|+++. +|.+|..+++|+.|+|++|+|+.+....|.
T Consensus 190 ~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~ 268 (305)
T d1xkua_ 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN 268 (305)
T ss_dssp GGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCC
T ss_pred Hhhccccccccccccccccccccccccccccceeeecccccccc-cccccccccCCCEEECCCCccCccChhhccCcchh
Confidence 99999999999999999999999999999999999999999985 477999999999999999999988766654
Q ss_pred -C-CCccEEEeeCccCC--CCCChhhhh
Q 043333 233 -G-SGLTYMYLTGNLLT--GPVPDWIVR 256 (809)
Q Consensus 233 -~-~~L~~L~Ls~N~l~--~~~p~~~~~ 256 (809)
. .+|+.|+|++|+++ ...|..+..
T Consensus 269 ~~~~~L~~L~L~~N~~~~~~~~~~~f~~ 296 (305)
T d1xkua_ 269 TKKASYSGVSLFSNPVQYWEIQPSTFRC 296 (305)
T ss_dssp TTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred cccCCCCEEECCCCcCccCcCCHhHhcc
Confidence 2 78999999999986 344555443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=9.4e-24 Score=219.49 Aligned_cols=200 Identities=20% Similarity=0.189 Sum_probs=114.0
Q ss_pred ccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEec
Q 043333 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFI 146 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 146 (809)
..+.+++.++++|+ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|+.|+|
T Consensus 10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~L 84 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDL 84 (266)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEEC
T ss_pred CCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccc
Confidence 34444555555555 3444432 34555566655555444445555555666666666555 232 2345555666666
Q ss_pred ccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCC
Q 043333 147 EGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGV 226 (809)
Q Consensus 147 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 226 (809)
++|+++ ..+..+..+++|+.|++++|.+..+....+..+.+++.|++++|.+....+..+..+++|+.|++++|+|+++
T Consensus 85 s~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (266)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred cccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccccc
Confidence 666555 3344555556666666666666666555566666666666666666666566666666666666666666666
Q ss_pred CCCCCCC-CCccEEEeeCccCCCCCChhhhhccCccccccCCccccC
Q 043333 227 IPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDG 272 (809)
Q Consensus 227 ~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~ 272 (809)
+++.+.. ++|++|+|++|+|+..++..+....++.|+|++|+|.|.
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCC
Confidence 6655554 666666666666664333344445556666666666653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.2e-23 Score=218.79 Aligned_cols=179 Identities=22% Similarity=0.174 Sum_probs=162.0
Q ss_pred ccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEec
Q 043333 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFI 146 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 146 (809)
++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|+++ ..+..+.++++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 57899999999999766678999999999999999998 444 4678899999999999998 45777899999999999
Q ss_pred ccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCC
Q 043333 147 EGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGV 226 (809)
Q Consensus 147 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 226 (809)
++|.+....+..+..+.+|+.|++++|.+..++...+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+.+
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~l 187 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTI 187 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCccc
Confidence 99999988888889999999999999999999999999999999999999999999999999999999999999999977
Q ss_pred CCCCCCCCCccEEEeeCccCCC
Q 043333 227 IPSNFSGSGLTYMYLTGNLLTG 248 (809)
Q Consensus 227 ~p~~~~~~~L~~L~Ls~N~l~~ 248 (809)
+++.+..++|+.|+|++|++..
T Consensus 188 p~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 188 PKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CTTTTTTCCCSEEECCSCCBCC
T ss_pred ChhHCCCCCCCEEEecCCCCCC
Confidence 7777777999999999999875
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=6e-22 Score=216.30 Aligned_cols=257 Identities=21% Similarity=0.266 Sum_probs=186.0
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCCchhhcCCccCcEEeeccccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAIPKAVASISTLADLTLEFNQF 79 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l 79 (809)
+|++++++|.. + +.+..+++|++|||++|+|++.. .++.++ |++|++++|.+..++. ++.+++|+.|++++|.+
T Consensus 48 ~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~~-l~~l~~L~~L~~~~~~~ 122 (384)
T d2omza2 48 TLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQI 122 (384)
T ss_dssp EEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred EEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccccccc-ccccccccccccccccc
Confidence 36778888774 3 45777888888888888888543 266665 8888888888887764 77888888888887776
Q ss_pred ccCC---------------------------------------------------------------CccccCCCCCCEE
Q 043333 80 SGDL---------------------------------------------------------------PAELGNLINLEKL 96 (809)
Q Consensus 80 ~~~~---------------------------------------------------------------p~~~~~l~~L~~L 96 (809)
++.. ...+..+++++.|
T Consensus 123 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l 202 (384)
T d2omza2 123 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESL 202 (384)
T ss_dssp CCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccccccccccccccee
Confidence 6321 1123445677788
Q ss_pred EccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCC
Q 043333 97 HLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGP 176 (809)
Q Consensus 97 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~ 176 (809)
++++|.+++..| +...++|+.|++++|+++. ++ .+..+++|+.|++++|++++.. .+..+++|+.|++++|.+.
T Consensus 203 ~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~ 276 (384)
T d2omza2 203 IATNNQISDITP--LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQIS 276 (384)
T ss_dssp ECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCC
T ss_pred eccCCccCCCCc--ccccCCCCEEECCCCCCCC-cc-hhhcccccchhccccCccCCCC--cccccccCCEeeccCcccC
Confidence 888888775544 4556778888888888773 33 5777888888888888887543 3677788888888888777
Q ss_pred CCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhh
Q 043333 177 EGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVR 256 (809)
Q Consensus 177 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~ 256 (809)
.++ .+.++..++.++++.|.+.+. ..+..+++++.|++++|+++++.+ .-..++|+.|+|++|+|++ ++..-..
T Consensus 277 ~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~-l~~l~~L~~L~L~~n~l~~-l~~l~~l 350 (384)
T d2omza2 277 NIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD-VSSLANL 350 (384)
T ss_dssp CCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCC-CGGGGGC
T ss_pred CCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCcc-cccCCCCCEEECCCCCCCC-ChhHcCC
Confidence 554 467777788888888877763 457888888999999999887654 2234889999999998885 3443344
Q ss_pred ccCccccccCCccccCCC
Q 043333 257 KRNKHIDLSYNNFIDGSS 274 (809)
Q Consensus 257 ~~l~~L~Ls~N~l~~~~~ 274 (809)
.+++.|++++|++++.++
T Consensus 351 ~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 351 TNINWLSAGHNQISDLTP 368 (384)
T ss_dssp TTCCEEECCSSCCCBCGG
T ss_pred CCCCEEECCCCcCCCChh
Confidence 677889999998887543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.87 E-value=1.4e-21 Score=213.39 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=202.6
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCC-ccccccccccCCCC--------------------
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLP-LVNLPLWKQANGAI-------------------- 59 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-L~~L~l~~n~~~~i-------------------- 59 (809)
+|+|++|++.+ +| .|.++++|++|++++|++.+..+ ++.++ |+.|++.++.+..+
T Consensus 70 ~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 145 (384)
T d2omza2 70 QINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTIS 145 (384)
T ss_dssp EEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEEC
T ss_pred EEeCcCCcCCC-Cc-cccCCcccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc
Confidence 48999999985 44 39999999999999999986433 55554 66666555444321
Q ss_pred --------------------------------------------chhhcCCccCcEEeecccccccCCCccccCCCCCCE
Q 043333 60 --------------------------------------------PKAVASISTLADLTLEFNQFSGDLPAELGNLINLEK 95 (809)
Q Consensus 60 --------------------------------------------p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 95 (809)
+.....+++++.+++++|.+++..| +...++|++
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~ 223 (384)
T d2omza2 146 DISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDE 223 (384)
T ss_dssp CCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCE
T ss_pred ccccccccccccccccccccchhhhhccccccccccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCE
Confidence 2345667889999999999996544 566789999
Q ss_pred EEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCC
Q 043333 96 LHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNG 175 (809)
Q Consensus 96 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l 175 (809)
|++++|+++. ++ .+..+++|+.|++++|++++..+ +..+++|+.|++++|++++.. .+..++.++.+.++.|.+
T Consensus 224 L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l 297 (384)
T d2omza2 224 LSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQL 297 (384)
T ss_dssp EECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCC
T ss_pred EECCCCCCCC-cc-hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccc
Confidence 9999999995 34 78899999999999999996543 888999999999999998543 477899999999999999
Q ss_pred CCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhh
Q 043333 176 PEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIV 255 (809)
Q Consensus 176 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 255 (809)
..+ ..+..+++++.|++++|++.+.. .+..+++|+.|+|++|+|+++. ..-..++|++|+|++|++++.+| ...
T Consensus 298 ~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~ 371 (384)
T d2omza2 298 EDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDVS-SLANLTNINWLSAGHNQISDLTP-LAN 371 (384)
T ss_dssp SCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCCCBCGG-GTT
T ss_pred ccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCCh-hHcCCCCCCEEECCCCcCCCChh-hcc
Confidence 874 45889999999999999999864 3899999999999999999753 33334999999999999998765 334
Q ss_pred hccCccccccCCc
Q 043333 256 RKRNKHIDLSYNN 268 (809)
Q Consensus 256 ~~~l~~L~Ls~N~ 268 (809)
..+++.|+|++|.
T Consensus 372 l~~L~~L~L~~Na 384 (384)
T d2omza2 372 LTRITQLGLNDQA 384 (384)
T ss_dssp CTTCSEEECCCEE
T ss_pred CCCCCEeeCCCCc
Confidence 4688999999983
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=4.3e-22 Score=195.98 Aligned_cols=162 Identities=20% Similarity=0.171 Sum_probs=118.2
Q ss_pred CCCeeccCCCccEEEeEeeCCeEEEEEEecccCcc------------------cchhHHHHHHHHhhcCCCceEeEEeEE
Q 043333 579 PDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQ------------------GNREFVNEIGMISALQHPNLVKLYGCC 640 (809)
Q Consensus 579 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~------------------~~~~f~~Ei~~l~~l~H~nIv~l~~~~ 640 (809)
+.++||+|+||+||+|+..+|+.||||+++..... ....+..|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 46789999999999999888999999987532110 012234678889999999998887653
Q ss_pred EeCCeEEEEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCceEEE
Q 043333 641 IEGNQLLLIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 720 (809)
Q Consensus 641 ~~~~~~~lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 720 (809)
. .++||||+++..+.+. +......++.|++++++|||++ +|+||||||+|||++++ .++|+
T Consensus 84 --~--~~lvme~~~~~~~~~l-----------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 84 --G--NAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp --T--TEEEEECCCCEEGGGC-----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred --C--CEEEEEeeccccccch-----------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 2 2799999998765432 2233567899999999999998 89999999999999975 48999
Q ss_pred ecCCccccCCCCcceeccccccccccc------hhhhccCCCCchHHHHHHHHHH
Q 043333 721 DFGLAKLDEEDNTHISTRIAGTFGYMA------PEYAMRGYLTDKADVYSFGIVA 769 (809)
Q Consensus 721 DfGla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~ksDVwSlGvil 769 (809)
|||.|......... .|.. .|. ..+.++.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 99999765432211 1111 122 235567788999976543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=3.6e-19 Score=174.92 Aligned_cols=175 Identities=18% Similarity=0.210 Sum_probs=98.6
Q ss_pred CcEEeecccccccCCCccccCCCCCCEEEccCCccCcc-CchhhhcccccceeeeecccccCcCchhhhcccccceEecc
Q 043333 69 LADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGK-LPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIE 147 (809)
Q Consensus 69 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 147 (809)
.+.++.++++|+ .+|..+. +++++|+|++|+|++. .+..|.++++|+.|+|++|++.+..+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 346777777777 5565442 4666777777777643 34455666666666666666666666666666666666666
Q ss_pred cCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCC
Q 043333 148 GSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVI 227 (809)
Q Consensus 148 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 227 (809)
+|+|+...|..|.++++|++|+|++| +|++..+.+|..+++|++|+|++|.+....
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N------------------------~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDN------------------------QISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSS------------------------CCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred cccccccCHHHHhCCCcccccccCCc------------------------cccccCHHHhcCCccccccccccccccccc
Confidence 66666544555555555555444444 444444444555555555555555554332
Q ss_pred CCCCCCCCccEEEeeCccCCCCCChhhhhccCccccccCCccccC
Q 043333 228 PSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDG 272 (809)
Q Consensus 228 p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~ 272 (809)
...+-...++.+.+..|.++...|..+. .++.++|+.|.|.|.
T Consensus 143 ~~~~~~~~l~~~~l~~~~~~c~~p~~l~--~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 143 HLAWFAEWLRKKSLNGGAARCGAPSKVR--DVQIKDLPHSEFKCS 185 (192)
T ss_dssp GGHHHHHHHHHHCCSGGGCBBCSSTTTT--TSBGGGSCTTTCCCC
T ss_pred chHHHhhhhhhhcccCCCeEeCCChhhc--CCEeeecCHhhCcCC
Confidence 2211113344445555666655555442 345567777877764
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=3e-18 Score=172.95 Aligned_cols=181 Identities=23% Similarity=0.297 Sum_probs=99.0
Q ss_pred ccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccc
Q 043333 48 NLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHF 127 (809)
Q Consensus 48 ~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 127 (809)
.|++.++.+..++ .+..+++|++|+|++|.+++.. .+..+++|++|++++|.++ .++ .+.++++|+.|++++|+.
T Consensus 45 ~L~l~~~~i~~l~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~ 119 (227)
T d1h6ua2 45 TLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQI 119 (227)
T ss_dssp EEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCC
T ss_pred EEECCCCCCCcch-hHhcCCCCcEeecCCceeeccc--ccccccccccccccccccc-ccc-cccccccccccccccccc
Confidence 3333333333442 3555666666666666665322 2566666666666666665 233 455666666666666665
Q ss_pred cCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhh
Q 043333 128 TGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYL 207 (809)
Q Consensus 128 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 207 (809)
.+. ..+...+.++.+.++.+.+... ..+..+++|+.|++++|.+.... .+.++++|+.|+|++|++++.. .+
T Consensus 120 ~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~--~l 191 (227)
T d1h6ua2 120 TDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDIS--PL 191 (227)
T ss_dssp CCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GG
T ss_pred ccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCccCCCh--hh
Confidence 532 2244555666666666665532 22455566666666666554332 3556666666666666655432 25
Q ss_pred hccccccEEeccCCCCCCCCCCCCCCCCccEEEee
Q 043333 208 GQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLT 242 (809)
Q Consensus 208 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls 242 (809)
.++++|++|+|++|+|+++.| .-..++|+.|+++
T Consensus 192 ~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~ls 225 (227)
T d1h6ua2 192 ASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLT 225 (227)
T ss_dssp GGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEE
T ss_pred cCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEee
Confidence 666666666666666665443 1122666666665
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=2.4e-18 Score=175.33 Aligned_cols=216 Identities=16% Similarity=0.124 Sum_probs=100.9
Q ss_pred CEEEccCCCCCCCCCcccCCCCccccccccccCCCCch-hhcCCccCcEEeecccccccCC-CccccCCCCCCEEEccC-
Q 043333 24 QEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPK-AVASISTLADLTLEFNQFSGDL-PAELGNLINLEKLHLNS- 100 (809)
Q Consensus 24 ~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~-~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~- 100 (809)
+.++.+++.++ .+|..+. -.+++|++++|.+..+|. +|.++++|++|+|++|.+...+ +..|.+++++++|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~-~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP-RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC-SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred CEEEEeCCCCC-CcCCCCC-CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 45555555555 3333221 012333333333333333 3445556666666666554332 23455555666555542
Q ss_pred CccCccCchhhhcccccceeeeecccccCcCch-hhhcccccceEecccCcCCCCCCccccCCC-CCCEEeccCCCCCCC
Q 043333 101 NNFTGKLPESFANLTRLKHFRISDNHFTGQIPD-YIQNWTKLEKLFIEGSGLAGPIPSGIASLV-ELTDLRISDLNGPEG 178 (809)
Q Consensus 101 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~n~l~~~ 178 (809)
|++....+..|.++++|+.|++++|++....+. .+..+..|..+...++++....+..|..++ .++.|++++|.++.+
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i 168 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 168 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccc
Confidence 445545555555556666666666655532221 133344444444455555543344444433 455555555555554
Q ss_pred CCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEe
Q 043333 179 PFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYL 241 (809)
Q Consensus 179 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~L 241 (809)
....+.....++.+++++|+++...+..|.++++|+.|+|++|+|+.+++..+.. ++|+.+++
T Consensus 169 ~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 169 HNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp CTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred ccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 4444333222233334444454444444555555555555555555444444433 34443333
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=4e-18 Score=173.59 Aligned_cols=218 Identities=17% Similarity=0.130 Sum_probs=169.9
Q ss_pred ccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccC-chhhhcccccceeeeec
Q 043333 46 LVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKL-PESFANLTRLKHFRISD 124 (809)
Q Consensus 46 L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~ 124 (809)
.+.++.+++.+..+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.++++++.|.+..
T Consensus 10 ~~~i~c~~~~l~~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 10 NRVFLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SSEEEEESCSCSSCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CCEEEEeCCCCCCcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 3456677778889998764 58999999999999666668999999999999999987644 45788899999998864
Q ss_pred -ccccCcCchhhhcccccceEecccCcCCCCCCc-cccCCCCCCEEeccCCCCCCCCCccccCCc-CCceeeeccccccC
Q 043333 125 -NHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPS-GIASLVELTDLRISDLNGPEGPFPRLSNLK-NMNYLILRSGNIIG 201 (809)
Q Consensus 125 -N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~-~L~~L~Ls~N~l~~ 201 (809)
|++....+..|.++++|+.|++++|++....+. .+..+..|..+..+++.+..++...|.+++ .++.|++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 678877788899999999999999999754332 345566777777788888888888888775 78899999999987
Q ss_pred CCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhh-ccCcccccc
Q 043333 202 EMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVR-KRNKHIDLS 265 (809)
Q Consensus 202 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~L~Ls 265 (809)
..+..|.....++.+++++|+|+.+++..|.. ++|++|+|++|+|+..++..+.. ..++.+++.
T Consensus 168 i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 168 IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 77766655444455578889999888888876 99999999999999766655543 334555543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=5.6e-18 Score=166.27 Aligned_cols=159 Identities=16% Similarity=0.127 Sum_probs=118.2
Q ss_pred ceeeeecccccCcCchhhhcccccceEecccCcCCCCC-CccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeecc
Q 043333 118 KHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPI-PSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRS 196 (809)
Q Consensus 118 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~ 196 (809)
+.++.++|+|+ .+|..+. +++++|+|++|+|++.+ +..|..+++|+.|++++|.+..++...|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 34555566655 4444332 45666666666665433 44566677777777777777777777777888888888888
Q ss_pred ccccCCCChhhhccccccEEeccCCCCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhhccCccccccCCccccCCCC
Q 043333 197 GNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGSSD 275 (809)
Q Consensus 197 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~~~~ 275 (809)
|++..+.|.+|.++++|++|+|++|+|++++++.|.. ++|++|+|++|++.+......-...++.+.+..|.++|..|.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCCh
Confidence 8888888999999999999999999999999999987 999999999999987655433333456778888999887776
Q ss_pred Cccc
Q 043333 276 SNCE 279 (809)
Q Consensus 276 ~~~~ 279 (809)
.+.+
T Consensus 168 ~l~~ 171 (192)
T d1w8aa_ 168 KVRD 171 (192)
T ss_dssp TTTT
T ss_pred hhcC
Confidence 5543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=1.4e-17 Score=168.01 Aligned_cols=203 Identities=20% Similarity=0.219 Sum_probs=162.3
Q ss_pred cccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeeccccc
Q 043333 49 LPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFT 128 (809)
Q Consensus 49 L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 128 (809)
+++..+.+..+. .+..+.+|+.|++.+|+++ .++ .+..+++|++|+|++|++++..| +..+++|+.|++++|.++
T Consensus 24 ~~l~~~~~~d~~-~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~ 98 (227)
T d1h6ua2 24 IAAGKSNVTDTV-TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK 98 (227)
T ss_dssp HHTTCSSTTSEE-CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS
T ss_pred HHhCCCCcCCcC-CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc
Confidence 344444444432 4567889999999999999 454 58999999999999999996544 899999999999999998
Q ss_pred CcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhh
Q 043333 129 GQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLG 208 (809)
Q Consensus 129 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 208 (809)
.++ .+..+++|+.|++++|...+. ..+...+.+..+.++.+.+... ..+.++++|+.|++++|.+.... .+.
T Consensus 99 -~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~ 170 (227)
T d1h6ua2 99 -NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLA 170 (227)
T ss_dssp -CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGT
T ss_pred -ccc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhc
Confidence 444 588999999999999988743 3467788999999999887654 35788999999999999987654 388
Q ss_pred ccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhhccCccccccC
Q 043333 209 QMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSY 266 (809)
Q Consensus 209 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~ 266 (809)
++++|+.|+|++|+++++.+ .-..++|++|+|++|++++..| .-....++.|++++
T Consensus 171 ~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 171 NLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp TCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEE
T ss_pred ccccceecccCCCccCCChh-hcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEeeC
Confidence 99999999999999997643 3334999999999999996543 33446778888763
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=2.4e-17 Score=164.16 Aligned_cols=165 Identities=22% Similarity=0.310 Sum_probs=101.2
Q ss_pred CccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEe
Q 043333 66 ISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLF 145 (809)
Q Consensus 66 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 145 (809)
+.+|++|++++|.++. ++ .+..+++|++|+|++|+|++. + .++++++|+.|++++|+|++ +| .+.++++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-cccccccccccc
Confidence 4556666666666663 22 255666666666666666643 2 24566666666666666663 33 366666666666
Q ss_pred cccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCC
Q 043333 146 IEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSG 225 (809)
Q Consensus 146 L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 225 (809)
+++|.+.. ...+..+++|+.+++++|.++.. ..+..+++|+.+++++|++.+.. .+.++++|+.|+|++|+|+.
T Consensus 119 l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~ 192 (210)
T d1h6ta2 119 LEHNGISD--INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD 192 (210)
T ss_dssp CTTSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB
T ss_pred cccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC
Confidence 66666652 23456666666666666666543 34566677777777777776543 26677777777777777765
Q ss_pred CCCCCCCCCCccEEEeeC
Q 043333 226 VIPSNFSGSGLTYMYLTG 243 (809)
Q Consensus 226 ~~p~~~~~~~L~~L~Ls~ 243 (809)
+ +.....++|++|+|++
T Consensus 193 l-~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 193 L-RALAGLKNLDVLELFS 209 (210)
T ss_dssp C-GGGTTCTTCSEEEEEE
T ss_pred C-hhhcCCCCCCEEEccC
Confidence 4 3322337777777764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=5.4e-17 Score=160.05 Aligned_cols=147 Identities=23% Similarity=0.313 Sum_probs=70.3
Q ss_pred ccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEec
Q 043333 67 STLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFI 146 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 146 (809)
.+|++|++++|+++ .++ .+..+++|++|+|++|+|++..| ++++++|++|++++|.+. .++ .+.++++|+.|++
T Consensus 40 ~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccccccc
Confidence 44444555555444 221 24444555555555555543221 444555555555555444 222 2444555555555
Q ss_pred ccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCC
Q 043333 147 EGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSG 225 (809)
Q Consensus 147 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 225 (809)
++|.+... ..+..+++|+.|++++|++..+ +.+..+++|+.|++++|++++.. .+.++++|+.|+|++|+|++
T Consensus 114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 114 FNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred cccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC
Confidence 55444421 2244455555555555554432 23455555555555555554432 25555566666666666554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=5.5e-17 Score=161.44 Aligned_cols=180 Identities=17% Similarity=0.259 Sum_probs=100.5
Q ss_pred EeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcC
Q 043333 72 LTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGL 151 (809)
Q Consensus 72 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 151 (809)
.++..+.+++.++. ..+.+|+.|++++|.++.. + .+..+++|++|+|++|+|++. + .++.+++|+.|++++|++
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccc
Confidence 34455555433332 2345566666666666632 2 355666666666666666642 2 245666666666666666
Q ss_pred CCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCC
Q 043333 152 AGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNF 231 (809)
Q Consensus 152 ~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 231 (809)
++ +| .+..+++|+.|++++|.+..+ +.+..+++|+.++++.|.++. +..+..+++|+.+++++|+++++.+ ..
T Consensus 103 ~~-l~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~-l~ 175 (210)
T d1h6ta2 103 KD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP-LA 175 (210)
T ss_dssp CC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG-GT
T ss_pred cc-cc-ccccccccccccccccccccc--ccccccccccccccccccccc--ccccccccccccccccccccccccc-cc
Confidence 63 33 356666666666666665543 345666666666666666653 2345556666666666666665432 22
Q ss_pred CCCCccEEEeeCccCCCCCChhhhhccCcccccc
Q 043333 232 SGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLS 265 (809)
Q Consensus 232 ~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls 265 (809)
..++|+.|+|++|+++. +|..-...+++.|+|+
T Consensus 176 ~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 176 GLTKLQNLYLSKNHISD-LRALAGLKNLDVLELF 208 (210)
T ss_dssp TCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEE
T ss_pred CCCCCCEEECCCCCCCC-ChhhcCCCCCCEEEcc
Confidence 22666666666666664 3332223455666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=5.9e-17 Score=159.81 Aligned_cols=168 Identities=22% Similarity=0.299 Sum_probs=113.4
Q ss_pred cCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecc
Q 043333 68 TLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIE 147 (809)
Q Consensus 68 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 147 (809)
++..+.++.+.+++.++ ...+.+|++|++++|.++. ++ .+..+++|++|+|++|++++..| ++++++|++|+++
T Consensus 19 ~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~ 92 (199)
T d2omxa2 19 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN 92 (199)
T ss_dssp HHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred HHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCccccccccc
Confidence 33445566666664332 3456677778888877773 33 46777778888888887774333 7777778888888
Q ss_pred cCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEeccCCCCCCCC
Q 043333 148 GSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVI 227 (809)
Q Consensus 148 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 227 (809)
+|.+.. ++ .+.++++|+.|++++|.....+ .+..+++|+.|++++|++... +.+..+++|+.|++++|+++++.
T Consensus 93 ~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~ 166 (199)
T d2omxa2 93 NNQIAD-IT-PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK 166 (199)
T ss_dssp SSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG
T ss_pred cccccc-cc-cccccccccccccccccccccc--ccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc
Confidence 777763 33 3677777888887777766543 466777788888877777543 34777777888888888777654
Q ss_pred CCCCCCCCccEEEeeCccCCC
Q 043333 228 PSNFSGSGLTYMYLTGNLLTG 248 (809)
Q Consensus 228 p~~~~~~~L~~L~Ls~N~l~~ 248 (809)
+ ....++|+.|++++|++++
T Consensus 167 ~-l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 167 P-LANLTTLERLDISSNKVSD 186 (199)
T ss_dssp G-GTTCTTCCEEECCSSCCCC
T ss_pred c-ccCCCCCCEEECCCCCCCC
Confidence 3 2233777888888887775
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.69 E-value=3e-16 Score=167.93 Aligned_cols=246 Identities=22% Similarity=0.227 Sum_probs=150.2
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeecccccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFS 80 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~ 80 (809)
+|+|++++++ .+|+. +++|++|+|++|+|+ .+|..+.+ |++|++.+|.+..++.- .+.|++|+|++|.++
T Consensus 42 ~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~~~--L~~L~l~~n~l~~l~~l---p~~L~~L~L~~n~l~ 111 (353)
T d1jl5a_ 42 ELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQS--LKSLLVDNNNLKALSDL---PPLLEYLGVSNNQLE 111 (353)
T ss_dssp EEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCCTT--CCEEECCSSCCSCCCSC---CTTCCEEECCSSCCS
T ss_pred EEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccchhh--hhhhhhhhcccchhhhh---ccccccccccccccc
Confidence 3789999987 67863 468999999999998 66766553 67888888888887642 246999999999998
Q ss_pred cCCCccccCCCCCCEEEccCCccCccCc------------------hhhhcccccceeeeecccccCcCc----------
Q 043333 81 GDLPAELGNLINLEKLHLNSNNFTGKLP------------------ESFANLTRLKHFRISDNHFTGQIP---------- 132 (809)
Q Consensus 81 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p------------------~~~~~l~~L~~L~Ls~N~l~~~~p---------- 132 (809)
.+|. ++.+++|++|++++|.++...+ ..+..++.++.|++++|.+.....
T Consensus 112 -~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~ 189 (353)
T d1jl5a_ 112 -KLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVA 189 (353)
T ss_dssp -SCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEEC
T ss_pred -cccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccccccccccccc
Confidence 5664 6789999999999998873322 112333445555555554442110
Q ss_pred --------hhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccC---
Q 043333 133 --------DYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIG--- 201 (809)
Q Consensus 133 --------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~--- 201 (809)
..+..++.|+.+++++|... .++. ...++..+.+.++.+.... ....++..+++..|.+.+
T Consensus 190 ~~~~~~~~~~~~~l~~L~~l~l~~n~~~-~~~~---~~~~l~~~~~~~~~~~~~~----~~~~~l~~~~~~~~~~~~l~~ 261 (353)
T d1jl5a_ 190 GNNILEELPELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTDLP----ELPQSLTFLDVSENIFSGLSE 261 (353)
T ss_dssp CSSCCSSCCCCTTCTTCCEEECCSSCCS-SCCS---CCTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCSEESC
T ss_pred cccccccccccccccccccccccccccc-cccc---ccccccccccccccccccc----ccccccccccccccccccccc
Confidence 01223344444444444433 1221 1223333333333333221 111223333333322211
Q ss_pred -------------CCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCChhhhhccCccccccCCc
Q 043333 202 -------------EMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNN 268 (809)
Q Consensus 202 -------------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~ 268 (809)
.++.....+++|++|+|++|+|+.++ .. .++|+.|+|++|+|+. +|... .+++.|+|++|+
T Consensus 262 l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~lp-~~--~~~L~~L~L~~N~L~~-l~~~~--~~L~~L~L~~N~ 335 (353)
T d1jl5a_ 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELP-AL--PPRLERLIASFNHLAE-VPELP--QNLKQLHVEYNP 335 (353)
T ss_dssp CCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCC-CC--CTTCCEEECCSSCCSC-CCCCC--TTCCEEECCSSC
T ss_pred ccchhcccccccCccccccccCCCCCEEECCCCccCccc-cc--cCCCCEEECCCCcCCc-ccccc--CCCCEEECcCCc
Confidence 11122233578999999999998654 32 3789999999999984 55432 468999999999
Q ss_pred cccC
Q 043333 269 FIDG 272 (809)
Q Consensus 269 l~~~ 272 (809)
++..
T Consensus 336 L~~l 339 (353)
T d1jl5a_ 336 LREF 339 (353)
T ss_dssp CSSC
T ss_pred CCCC
Confidence 8864
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.55 E-value=6.3e-14 Score=149.55 Aligned_cols=228 Identities=21% Similarity=0.189 Sum_probs=160.8
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeecccccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFS 80 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~ 80 (809)
+|+|++|+|. .+|+.+ .+|++|++++|+++ .++.... .|+.|++++|.+..+|. ++.+++|+.|++++|.+.
T Consensus 62 ~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp~--~L~~L~L~~n~l~~lp~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 62 SLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLPP--LLEYLGVSNNQLEKLPE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp EEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCCT--TCCEEECCSSCCSSCCC-CTTCTTCCEEECCSSCCS
T ss_pred EEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhhcc--ccccccccccccccccc-hhhhccceeecccccccc
Confidence 4889999998 778654 57999999999998 3333211 28899999999999985 678999999999999887
Q ss_pred cCCC------------------ccccCCCCCCEEEccCCccCccC------------------chhhhcccccceeeeec
Q 043333 81 GDLP------------------AELGNLINLEKLHLNSNNFTGKL------------------PESFANLTRLKHFRISD 124 (809)
Q Consensus 81 ~~~p------------------~~~~~l~~L~~L~L~~N~l~~~~------------------p~~~~~l~~L~~L~Ls~ 124 (809)
.... ..+..++.++.|+++.|.+.... ...+..++.|+.+++++
T Consensus 134 ~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~ 213 (353)
T d1jl5a_ 134 KLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213 (353)
T ss_dssp CCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCS
T ss_pred ccccccccccchhhccccccccccccccccceeccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4322 23556778899999888776321 11345678999999999
Q ss_pred ccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCCCCCCC---C-------------ccccCCcC
Q 043333 125 NHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGP---F-------------PRLSNLKN 188 (809)
Q Consensus 125 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~---~-------------~~l~~l~~ 188 (809)
|... .++. ...++..+.+..|.+.. .+.. ...+...++..+.+..+. . .....+++
T Consensus 214 n~~~-~~~~---~~~~l~~~~~~~~~~~~-~~~~---~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
T d1jl5a_ 214 NLLK-TLPD---LPPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPS 285 (353)
T ss_dssp SCCS-SCCS---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTT
T ss_pred cccc-cccc---ccccccccccccccccc-cccc---cccccccccccccccccccccchhcccccccCccccccccCCC
Confidence 9877 3443 24567788888888763 2222 223333333332222111 0 11233579
Q ss_pred CceeeeccccccCCCChhhhccccccEEeccCCCCCCCCCCCCCCCCccEEEeeCccCCCCCCh
Q 043333 189 MNYLILRSGNIIGEMPEYLGQMIGLRVLDLSFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPVPD 252 (809)
Q Consensus 189 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~ 252 (809)
|++|+|++|++.. +|. .+++|+.|+|++|+|+.+ |.. ..+|+.|+|++|+|+. +|.
T Consensus 286 L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~~l-~~~--~~~L~~L~L~~N~L~~-lp~ 341 (353)
T d1jl5a_ 286 LEELNVSNNKLIE-LPA---LPPRLERLIASFNHLAEV-PEL--PQNLKQLHVEYNPLRE-FPD 341 (353)
T ss_dssp CCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCC-CCC--CTTCCEEECCSSCCSS-CCC
T ss_pred CCEEECCCCccCc-ccc---ccCCCCEEECCCCcCCcc-ccc--cCCCCEEECcCCcCCC-CCc
Confidence 9999999999985 453 368999999999999965 432 3689999999999985 454
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=7.9e-16 Score=160.44 Aligned_cols=208 Identities=14% Similarity=0.158 Sum_probs=121.1
Q ss_pred cCCccCcEEeecccccccC-CCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecc-cccCc-Cchhhhcccc
Q 043333 64 ASISTLADLTLEFNQFSGD-LPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDN-HFTGQ-IPDYIQNWTK 140 (809)
Q Consensus 64 ~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~ 140 (809)
....+|++|||+++.++.. ++..+..+++|++|+|++|.++...+..++.+++|++|+|++| .++.. +.....++++
T Consensus 43 ~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~ 122 (284)
T d2astb2 43 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122 (284)
T ss_dssp CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT
T ss_pred ccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHh
Confidence 3445677777777766532 3344566777777777777777666666777777777777774 34421 1222345677
Q ss_pred cceEecccC-cCCCC-CCccccC-CCCCCEEeccCCC--CCCCCCcc-ccCCcCCceeeeccc-cccCCCChhhhccccc
Q 043333 141 LEKLFIEGS-GLAGP-IPSGIAS-LVELTDLRISDLN--GPEGPFPR-LSNLKNMNYLILRSG-NIIGEMPEYLGQMIGL 213 (809)
Q Consensus 141 L~~L~L~~N-~l~~~-~p~~~~~-l~~L~~L~l~~n~--l~~~~~~~-l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L 213 (809)
|++|+|+++ .++.. +...+.. .++|+.|+++++. ++...... +.++++|++|+|++| .++......+.++++|
T Consensus 123 L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L 202 (284)
T d2astb2 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202 (284)
T ss_dssp CCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred ccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcC
Confidence 777777765 33311 1122222 3567777777542 33222222 345677888888775 3565666677777888
Q ss_pred cEEeccCC-CCCCCCCCCCCC-CCccEEEeeCccCCCCCChhhhhccCccccccCCccccCC
Q 043333 214 RVLDLSFN-KLSGVIPSNFSG-SGLTYMYLTGNLLTGPVPDWIVRKRNKHIDLSYNNFIDGS 273 (809)
Q Consensus 214 ~~L~Ls~N-~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~~~l~~L~Ls~N~l~~~~ 273 (809)
++|+|++| .+++.....+.. ++|+.|+++++ ++...-..+. ..+..|.+..++++...
T Consensus 203 ~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~-~~lp~L~i~~~~ls~~~ 262 (284)
T d2astb2 203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLK-EALPHLQINCSHFTTIA 262 (284)
T ss_dssp CEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHH-HHSTTSEESCCCSCCTT
T ss_pred CEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHH-HhCccccccCccCCCCC
Confidence 88888874 565544444444 77888888776 3321111111 23455666667776543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=9.1e-15 Score=138.60 Aligned_cols=127 Identities=20% Similarity=0.250 Sum_probs=68.2
Q ss_pred cCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccce
Q 043333 64 ASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEK 143 (809)
Q Consensus 64 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 143 (809)
.+..+|++|+|++|+|+ .++..+..+++|++|+|++|+|+. ++ .|..+++|++|+|++|+++...+..+..+++|+.
T Consensus 15 ~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp ECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred cCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccccc
Confidence 34455666666666665 344444555566666666666652 22 3555556666666666655443444445555555
Q ss_pred EecccCcCCCCCCccccCCCCCCEEeccCCCCCCCC-CccccCCcCCceeeeccccccCCC---ChhhhccccccEEe
Q 043333 144 LFIEGSGLAGPIPSGIASLVELTDLRISDLNGPEGP-FPRLSNLKNMNYLILRSGNIIGEM---PEYLGQMIGLRVLD 217 (809)
Q Consensus 144 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~-~~~l~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~ 217 (809)
|+|++|+|+ .++ ...+..+++|++|++++|.++... +..+..+++|+.||
T Consensus 92 L~L~~N~i~------------------------~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 92 LILTNNSLV------------------------ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EECCSCCCC------------------------CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ceecccccc------------------------ccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 555555554 332 133455555566666666554432 12456666666665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=5.4e-14 Score=126.76 Aligned_cols=117 Identities=20% Similarity=0.286 Sum_probs=54.0
Q ss_pred EEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCcCCCCCCccccCCCCCCEEeccCCC
Q 043333 95 KLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSGLAGPIPSGIASLVELTDLRISDLN 174 (809)
Q Consensus 95 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~ 174 (809)
.|+|++|+|+ .++ .+.++++|++|++++|+|+ .+|..++.+++|+.|++++|+|+. +| .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 3444444444 222 2444444444444444444 333344444444444444444442 22 24444444444444444
Q ss_pred CCCCCC-ccccCCcCCceeeeccccccCC---CChhhhccccccEE
Q 043333 175 GPEGPF-PRLSNLKNMNYLILRSGNIIGE---MPEYLGQMIGLRVL 216 (809)
Q Consensus 175 l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L 216 (809)
+..++. ..+..+++|+.|++++|.+... ....+..+|+|+.|
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 444432 3455555556666666655432 23334445666554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=8.6e-16 Score=160.13 Aligned_cols=252 Identities=18% Similarity=0.197 Sum_probs=179.4
Q ss_pred CccccCCCCCccCCccCCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCC--CchhhcCCccCcEEeecccc
Q 043333 1 HRILKSQNLPGRLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGA--IPKAVASISTLADLTLEFNQ 78 (809)
Q Consensus 1 ~L~L~~nnl~~~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~--ip~~l~~l~~L~~L~L~~N~ 78 (809)
+|||+++++.......+.. ..+..+.++.+.+.......+....|+.|+++++.+.. ++..+..+++|++|+|+++.
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~ 82 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCB
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccC
Confidence 3678888776443333322 24667778777766555555566678999998877643 45567889999999999999
Q ss_pred cccCCCccccCCCCCCEEEccCC-ccCcc-Cchhhhcccccceeeeeccc-ccCc-Cchhhhc-ccccceEecccC--cC
Q 043333 79 FSGDLPAELGNLINLEKLHLNSN-NFTGK-LPESFANLTRLKHFRISDNH-FTGQ-IPDYIQN-WTKLEKLFIEGS--GL 151 (809)
Q Consensus 79 l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~-l~~~-~p~~~~~-l~~L~~L~L~~N--~l 151 (809)
+++..+..++.+++|++|+|+++ .++.. +..-+.++++|++|+|+++. ++.. +...+.. .++|+.|+++++ .+
T Consensus 83 l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i 162 (284)
T d2astb2 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNL 162 (284)
T ss_dssp CCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGS
T ss_pred CCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccc
Confidence 98877888999999999999995 67632 22234678999999999964 4421 2233444 478999999975 34
Q ss_pred CCC-CCccccCCCCCCEEeccCC-CCCCCCCccccCCcCCceeeeccc-cccCCCChhhhccccccEEeccCCCCCCCCC
Q 043333 152 AGP-IPSGIASLVELTDLRISDL-NGPEGPFPRLSNLKNMNYLILRSG-NIIGEMPEYLGQMIGLRVLDLSFNKLSGVIP 228 (809)
Q Consensus 152 ~~~-~p~~~~~l~~L~~L~l~~n-~l~~~~~~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 228 (809)
+.. +...+.++++|++|++++| .++......+.++++|++|+|++| +++......++++++|+.|+++++ ++...-
T Consensus 163 ~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l 241 (284)
T d2astb2 163 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTL 241 (284)
T ss_dssp CHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCH
T ss_pred ccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHH
Confidence 422 2233457899999999986 467667778999999999999995 677777778899999999999988 332111
Q ss_pred CCCCCCCccEEEeeCccCCCCCChhhh
Q 043333 229 SNFSGSGLTYMYLTGNLLTGPVPDWIV 255 (809)
Q Consensus 229 ~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 255 (809)
..+. ..+..|.+..+.++...++.+.
T Consensus 242 ~~l~-~~lp~L~i~~~~ls~~~~~~~~ 267 (284)
T d2astb2 242 QLLK-EALPHLQINCSHFTTIARPTIG 267 (284)
T ss_dssp HHHH-HHSTTSEESCCCSCCTTCSSCS
T ss_pred HHHH-HhCccccccCccCCCCCCCccC
Confidence 1111 3445566788889877665554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=5.7e-15 Score=140.01 Aligned_cols=129 Identities=16% Similarity=0.088 Sum_probs=105.6
Q ss_pred CcccCCCCccccccccccCCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhccccc
Q 043333 38 PSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRL 117 (809)
Q Consensus 38 p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 117 (809)
|.......+++|++++|++..||..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+++...+..+..+++|
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp CEEECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred HhccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 3333344689999999999999987788999999999999999 444 58999999999999999997666667889999
Q ss_pred ceeeeecccccCcCc-hhhhcccccceEecccCcCCCCCCc----cccCCCCCCEEe
Q 043333 118 KHFRISDNHFTGQIP-DYIQNWTKLEKLFIEGSGLAGPIPS----GIASLVELTDLR 169 (809)
Q Consensus 118 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~ 169 (809)
++|+|++|+|+.... ..+..+++|++|++++|.++. .|. .+..+++|+.||
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 999999999984322 458889999999999999973 332 456667777665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.47 E-value=6e-14 Score=126.47 Aligned_cols=101 Identities=23% Similarity=0.290 Sum_probs=47.1
Q ss_pred EEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEecccCc
Q 043333 71 DLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLFIEGSG 150 (809)
Q Consensus 71 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 150 (809)
.|+|++|+++ .++ .+..+++|++|+|++|+|+ .+|..++.+++|+.|++++|+|+. +| .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 4455555554 232 2444455555555555554 334444455555555555555542 22 24445555555555555
Q ss_pred CCCCC-CccccCCCCCCEEeccCCCCC
Q 043333 151 LAGPI-PSGIASLVELTDLRISDLNGP 176 (809)
Q Consensus 151 l~~~~-p~~~~~l~~L~~L~l~~n~l~ 176 (809)
|+... ...+..+++|+.|++++|.+.
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 54222 133444555555555555444
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.45 E-value=1.4e-15 Score=163.09 Aligned_cols=242 Identities=18% Similarity=0.099 Sum_probs=116.8
Q ss_pred cCCccCCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeecccccccC---------
Q 043333 12 RLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEFNQFSGD--------- 82 (809)
Q Consensus 12 ~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~N~l~~~--------- 82 (809)
.+...+....+|++|+|++|.+.......+ ...+...++|+.|+++++.....
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l------------------~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~ 83 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWL------------------SENIASKKDLEIAEFSDIFTGRVKDEIPEALR 83 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHH------------------HHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHH------------------HHHHHhCCCCCEEECCCCcccccccccchHHH
Confidence 344556667889999999988763222211 12233334455555544432210
Q ss_pred -CCccccCCCCCCEEEccCCccCcc----CchhhhcccccceeeeecccccCcCchh-------------hhcccccceE
Q 043333 83 -LPAELGNLINLEKLHLNSNNFTGK----LPESFANLTRLKHFRISDNHFTGQIPDY-------------IQNWTKLEKL 144 (809)
Q Consensus 83 -~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-------------~~~l~~L~~L 144 (809)
+...+...++|+.|+|++|.++.. +...+...++|++|++++|.+...-... ....+.|+.|
T Consensus 84 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l 163 (344)
T d2ca6a1 84 LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 163 (344)
T ss_dssp HHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEE
T ss_pred HHHHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCccccee
Confidence 011233344555555555555432 1222333445555555555443110000 1123445555
Q ss_pred ecccCcCCCCC----CccccCCCCCCEEeccCCCCCCCC-----CccccCCcCCceeeeccccccCC----CChhhhccc
Q 043333 145 FIEGSGLAGPI----PSGIASLVELTDLRISDLNGPEGP-----FPRLSNLKNMNYLILRSGNIIGE----MPEYLGQMI 211 (809)
Q Consensus 145 ~L~~N~l~~~~----p~~~~~l~~L~~L~l~~n~l~~~~-----~~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~ 211 (809)
++++|+++... ...+...+.|+.|++++|.+.... ...+..+++|+.|+|++|.++.. +...+..++
T Consensus 164 ~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~ 243 (344)
T d2ca6a1 164 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243 (344)
T ss_dssp ECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred ecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccc
Confidence 55555554211 122334455555555555554321 12245556666666666665433 234455666
Q ss_pred cccEEeccCCCCCCCCCCCC-------CCCCccEEEeeCccCCCCC----Chhhh--hccCccccccCCcccc
Q 043333 212 GLRVLDLSFNKLSGVIPSNF-------SGSGLTYMYLTGNLLTGPV----PDWIV--RKRNKHIDLSYNNFID 271 (809)
Q Consensus 212 ~L~~L~Ls~N~l~~~~p~~~-------~~~~L~~L~Ls~N~l~~~~----p~~~~--~~~l~~L~Ls~N~l~~ 271 (809)
+|++|+|++|.|++.....+ ....|+.|++++|.++... ...+. ...++.|+|++|.+..
T Consensus 244 ~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred cchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 67777777776654322111 1245777777777765422 22221 1346677777777653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=6.7e-15 Score=144.48 Aligned_cols=92 Identities=20% Similarity=0.293 Sum_probs=51.1
Q ss_pred CCCCchhhcCCccCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhh
Q 043333 56 NGAIPKAVASISTLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYI 135 (809)
Q Consensus 56 ~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 135 (809)
+..+|..+..+++|++|+|++|+|+ .++ .+..+++|++|+|++|+|+ .+|..+..+++|+.|++++|+++. + ..+
T Consensus 37 i~~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~ 111 (198)
T d1m9la_ 37 IEKMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGI 111 (198)
T ss_dssp CCCCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHH
T ss_pred hhhhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccc
Confidence 4455555666666666666666665 333 3555666666666666665 344444444556666666666552 2 235
Q ss_pred hcccccceEecccCcCC
Q 043333 136 QNWTKLEKLFIEGSGLA 152 (809)
Q Consensus 136 ~~l~~L~~L~L~~N~l~ 152 (809)
..+++|+.|+|++|+|+
T Consensus 112 ~~l~~L~~L~L~~N~i~ 128 (198)
T d1m9la_ 112 EKLVNLRVLYMSNNKIT 128 (198)
T ss_dssp HHHHHSSEEEESEEECC
T ss_pred cccccccccccccchhc
Confidence 55555666666555555
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=1.3e-15 Score=168.72 Aligned_cols=271 Identities=18% Similarity=0.176 Sum_probs=159.3
Q ss_pred CccccCCCCCccC-CccCCCCCCCCEEEccCCCCCCCC----CcccCCCC-ccccccccccCCC-----CchhhcC-Ccc
Q 043333 1 HRILKSQNLPGRL-PPELTRLPFLQEIDLTRNYLNGTI----PSEWASLP-LVNLPLWKQANGA-----IPKAVAS-IST 68 (809)
Q Consensus 1 ~L~L~~nnl~~~l-p~~l~~l~~L~~L~Ls~n~l~~~~----p~~~~~l~-L~~L~l~~n~~~~-----ip~~l~~-l~~ 68 (809)
+||+++|++++.- ..-+..++++++|+|++|.|+... ...+...+ |++|++++|.++. +...+.. ..+
T Consensus 6 ~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~ 85 (460)
T d1z7xw1 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 85 (460)
T ss_dssp EEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCC
T ss_pred EEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCC
Confidence 4789999998632 233466789999999999988422 23344454 8999999998753 2333332 357
Q ss_pred CcEEeecccccccC----CCccccCCCCCCEEEccCCccCccCchh---------------------------------h
Q 043333 69 LADLTLEFNQFSGD----LPAELGNLINLEKLHLNSNNFTGKLPES---------------------------------F 111 (809)
Q Consensus 69 L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~---------------------------------~ 111 (809)
|++|+|++|+++.. ++..+..+++|++|+|++|.++...... +
T Consensus 86 L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (460)
T d1z7xw1 86 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVL 165 (460)
T ss_dssp CCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHH
T ss_pred CCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccccc
Confidence 99999999999743 3456788999999999999876311100 1
Q ss_pred hcccccceeeeecccccC-----------------------------c----CchhhhcccccceEecccCc--------
Q 043333 112 ANLTRLKHFRISDNHFTG-----------------------------Q----IPDYIQNWTKLEKLFIEGSG-------- 150 (809)
Q Consensus 112 ~~l~~L~~L~Ls~N~l~~-----------------------------~----~p~~~~~l~~L~~L~L~~N~-------- 150 (809)
.....++.++++++.+.. . ....+...+.++.+++.+|+
T Consensus 166 ~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~ 245 (460)
T d1z7xw1 166 RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAE 245 (460)
T ss_dssp HHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccch
Confidence 112344444444433220 0 00112223444444444444
Q ss_pred ---------------------CCCCC----CccccCCCCCCEEeccCCCCCCCCCccc-----cCCcCCceeeecccccc
Q 043333 151 ---------------------LAGPI----PSGIASLVELTDLRISDLNGPEGPFPRL-----SNLKNMNYLILRSGNII 200 (809)
Q Consensus 151 ---------------------l~~~~----p~~~~~l~~L~~L~l~~n~l~~~~~~~l-----~~l~~L~~L~Ls~N~l~ 200 (809)
+.... ...+...+.++.+++++|.+.......+ .....|+.+++++|.+.
T Consensus 246 ~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~ 325 (460)
T d1z7xw1 246 LCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 325 (460)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCB
T ss_pred hhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchh
Confidence 33111 1112234455555555554432222111 23456788888888777
Q ss_pred CCCChh----hhccccccEEeccCCCCCCCC----CCCC-C-CCCccEEEeeCccCCCCC----Chhhh-hccCcccccc
Q 043333 201 GEMPEY----LGQMIGLRVLDLSFNKLSGVI----PSNF-S-GSGLTYMYLTGNLLTGPV----PDWIV-RKRNKHIDLS 265 (809)
Q Consensus 201 ~~~p~~----~~~l~~L~~L~Ls~N~l~~~~----p~~~-~-~~~L~~L~Ls~N~l~~~~----p~~~~-~~~l~~L~Ls 265 (809)
...... +...++|++|+|++|+|+... +..+ . .+.|+.|+|++|.|+... +..+. ..++++|+|+
T Consensus 326 ~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls 405 (460)
T d1z7xw1 326 AACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLS 405 (460)
T ss_dssp GGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECC
T ss_pred hhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECC
Confidence 654333 345567888899888886422 1112 2 267888999988887532 22222 2567888888
Q ss_pred CCcccc
Q 043333 266 YNNFID 271 (809)
Q Consensus 266 ~N~l~~ 271 (809)
+|+++.
T Consensus 406 ~N~i~~ 411 (460)
T d1z7xw1 406 NNCLGD 411 (460)
T ss_dssp SSSCCH
T ss_pred CCcCCH
Confidence 888864
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=1e-12 Score=123.38 Aligned_cols=138 Identities=17% Similarity=0.152 Sum_probs=101.8
Q ss_pred ccceEecccCcCCCCCCccccCCCCCCEEeccCC-CCCCCCCccccCCcCCceeeeccccccCCCChhhhccccccEEec
Q 043333 140 KLEKLFIEGSGLAGPIPSGIASLVELTDLRISDL-NGPEGPFPRLSNLKNMNYLILRSGNIIGEMPEYLGQMIGLRVLDL 218 (809)
Q Consensus 140 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n-~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 218 (809)
..+.++++++++. ..|..+..+++|++|++++| .++.++...|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3445666666666 45666777777788887655 477888888888999999999999999998999999999999999
Q ss_pred cCCCCCCCCCCCCCCCCccEEEeeCccCCCCC-Chhh-hhccCccccccCCccccCCCCCcc
Q 043333 219 SFNKLSGVIPSNFSGSGLTYMYLTGNLLTGPV-PDWI-VRKRNKHIDLSYNNFIDGSSDSNC 278 (809)
Q Consensus 219 s~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~-p~~~-~~~~l~~L~Ls~N~l~~~~~~~~~ 278 (809)
++|+|+.++++.+...+|+.|+|++|++...- ..++ .........+..+.++|..|..+.
T Consensus 88 s~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~ 149 (156)
T d2ifga3 88 SFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLA 149 (156)
T ss_dssp CSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSS
T ss_pred cCCCCcccChhhhccccccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHHC
Confidence 99999998888888888999999999986421 1222 112223344445677776655444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=1.8e-15 Score=167.60 Aligned_cols=270 Identities=17% Similarity=0.142 Sum_probs=176.6
Q ss_pred ccccCCCCCc----cCCccCCCCCCCCEEEccCCCCCCC----CCcccC--CCCccccccccccCCC-----CchhhcCC
Q 043333 2 RILKSQNLPG----RLPPELTRLPFLQEIDLTRNYLNGT----IPSEWA--SLPLVNLPLWKQANGA-----IPKAVASI 66 (809)
Q Consensus 2 L~L~~nnl~~----~lp~~l~~l~~L~~L~Ls~n~l~~~----~p~~~~--~l~L~~L~l~~n~~~~-----ip~~l~~l 66 (809)
|+|++|+++. .++..+..+++|++|||++|.|+.. +...+. ..+|++|++++|.++. ++..+..+
T Consensus 32 L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~ 111 (460)
T d1z7xw1 32 VRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTL 111 (460)
T ss_dssp EEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSC
T ss_pred EEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhcc
Confidence 6788888873 4556678889999999999998632 122222 2358899999998865 45677888
Q ss_pred ccCcEEeecccccccCCC---------------------------------ccccCCCCCCEEEc---------------
Q 043333 67 STLADLTLEFNQFSGDLP---------------------------------AELGNLINLEKLHL--------------- 98 (809)
Q Consensus 67 ~~L~~L~L~~N~l~~~~p---------------------------------~~~~~l~~L~~L~L--------------- 98 (809)
++|++|+|++|.++.... ..+.....++.+++
T Consensus 112 ~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~ 191 (460)
T d1z7xw1 112 PTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQ 191 (460)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHH
T ss_pred ccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccccccccccccccccccccccccccccccc
Confidence 999999999998653100 00011122333333
Q ss_pred ------------------------------------------cCCccCc-----cCchhhhcccccceeeeecccccCcC
Q 043333 99 ------------------------------------------NSNNFTG-----KLPESFANLTRLKHFRISDNHFTGQI 131 (809)
Q Consensus 99 ------------------------------------------~~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~~~~ 131 (809)
.+|++.. ..+........|+.|++++|.+....
T Consensus 192 ~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~ 271 (460)
T d1z7xw1 192 GLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKG 271 (460)
T ss_dssp HHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred ccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhcccccccccccccccccccccccc
Confidence 2222211 00111122346777777777766322
Q ss_pred ----chhhhcccccceEecccCcCCCCCCccc-----cCCCCCCEEeccCCCCCCCCCccc----cCCcCCceeeecccc
Q 043333 132 ----PDYIQNWTKLEKLFIEGSGLAGPIPSGI-----ASLVELTDLRISDLNGPEGPFPRL----SNLKNMNYLILRSGN 198 (809)
Q Consensus 132 ----p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~l~~n~l~~~~~~~l----~~l~~L~~L~Ls~N~ 198 (809)
...+...+.++.+++++|.++......+ .....|+.+++++|.+.......+ ...++|++|+|++|+
T Consensus 272 ~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~ 351 (460)
T d1z7xw1 272 CGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNR 351 (460)
T ss_dssp HHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSB
T ss_pred cccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeec
Confidence 2335667899999999999874322222 234689999999998877654444 456789999999999
Q ss_pred ccCC----CChhhh-ccccccEEeccCCCCCCCC----CCCCC-CCCccEEEeeCccCCCCCChhhhh------ccCccc
Q 043333 199 IIGE----MPEYLG-QMIGLRVLDLSFNKLSGVI----PSNFS-GSGLTYMYLTGNLLTGPVPDWIVR------KRNKHI 262 (809)
Q Consensus 199 l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~~----p~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~------~~l~~L 262 (809)
+... +++.+. ..+.|+.|+|++|+|+... ++.+. .++|++|+|++|+|+......+.. ..++.|
T Consensus 352 i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l 431 (460)
T d1z7xw1 352 LEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQL 431 (460)
T ss_dssp CHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEE
T ss_pred ccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEE
Confidence 8754 333333 4577999999999997532 22222 389999999999998654443321 257899
Q ss_pred cccCCcccc
Q 043333 263 DLSYNNFID 271 (809)
Q Consensus 263 ~Ls~N~l~~ 271 (809)
++++|.+..
T Consensus 432 ~l~~~~~~~ 440 (460)
T d1z7xw1 432 VLYDIYWSE 440 (460)
T ss_dssp ECTTCCCCH
T ss_pred ECCCCCCCH
Confidence 999998864
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.36 E-value=2.8e-14 Score=152.72 Aligned_cols=238 Identities=18% Similarity=0.166 Sum_probs=164.2
Q ss_pred CccccCCCCCc----cCCccCCCCCCCCEEEccCCCCCCCCCcccCCCCccccccccccCCCCchhhcCCccCcEEeecc
Q 043333 1 HRILKSQNLPG----RLPPELTRLPFLQEIDLTRNYLNGTIPSEWASLPLVNLPLWKQANGAIPKAVASISTLADLTLEF 76 (809)
Q Consensus 1 ~L~L~~nnl~~----~lp~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~L~~L~l~~n~~~~ip~~l~~l~~L~~L~L~~ 76 (809)
+|+|++|.+.. .+...+..+++|+.|+++++.+....... ......+...+...++|+.|+|++
T Consensus 35 ~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~------------~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 35 EIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEI------------PEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp EEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGS------------HHHHHHHHHHHTTCTTCCEEECCS
T ss_pred EEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCccccccccc------------chHHHHHHHHHhhCCCcccccccc
Confidence 36788888754 45566888999999999998765211100 001122334566778899999999
Q ss_pred cccccC----CCccccCCCCCCEEEccCCccCccCchh-------------hhcccccceeeeecccccCc----Cchhh
Q 043333 77 NQFSGD----LPAELGNLINLEKLHLNSNNFTGKLPES-------------FANLTRLKHFRISDNHFTGQ----IPDYI 135 (809)
Q Consensus 77 N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~-------------~~~l~~L~~L~Ls~N~l~~~----~p~~~ 135 (809)
|.++.. +...+...++|+.|+|++|.++...... ....+.|+.|++++|.+... +...+
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l 182 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence 988753 2334556788999999999876211111 12456788999999988732 23345
Q ss_pred hcccccceEecccCcCCCC-----CCccccCCCCCCEEeccCCCCCCCCC----ccccCCcCCceeeeccccccCCCChh
Q 043333 136 QNWTKLEKLFIEGSGLAGP-----IPSGIASLVELTDLRISDLNGPEGPF----PRLSNLKNMNYLILRSGNIIGEMPEY 206 (809)
Q Consensus 136 ~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~l~~n~l~~~~~----~~l~~l~~L~~L~Ls~N~l~~~~p~~ 206 (809)
...++|+.|+|++|+++.. +...+..+++|+.|++++|.++.... ..+..+++|++|+|++|.+.......
T Consensus 183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~ 262 (344)
T d2ca6a1 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262 (344)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred hhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHH
Confidence 6678899999999988742 23456778899999999998765432 34678899999999999987664433
Q ss_pred h----hc--cccccEEeccCCCCCCCC----CCCCC--CCCccEEEeeCccCCCCC
Q 043333 207 L----GQ--MIGLRVLDLSFNKLSGVI----PSNFS--GSGLTYMYLTGNLLTGPV 250 (809)
Q Consensus 207 ~----~~--l~~L~~L~Ls~N~l~~~~----p~~~~--~~~L~~L~Ls~N~l~~~~ 250 (809)
+ .. .+.|++|+|++|+|+... ...+. .++|+.|+|++|++....
T Consensus 263 l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~~ 318 (344)
T d2ca6a1 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 318 (344)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCcc
Confidence 3 33 367999999999986432 12221 368999999999997543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=1.7e-14 Score=141.48 Aligned_cols=149 Identities=22% Similarity=0.282 Sum_probs=118.9
Q ss_pred cCcEEeeccc--ccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcCchhhhcccccceEe
Q 043333 68 TLADLTLEFN--QFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQIPDYIQNWTKLEKLF 145 (809)
Q Consensus 68 ~L~~L~L~~N--~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 145 (809)
.++.++++++ .++ .++..+..+++|++|+|++|+|+. ++ .+.++++|+.|+|++|+|+ .+|..+..+++|+.|+
T Consensus 24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~ 99 (198)
T d1m9la_ 24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99 (198)
T ss_dssp TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEE
T ss_pred ccceeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccc
Confidence 4555666654 344 556788899999999999999994 45 5899999999999999998 6676677778999999
Q ss_pred cccCcCCCCCCccccCCCCCCEEeccCCCCCCCCC-ccccCCcCCceeeeccccccCCCChh----------hhcccccc
Q 043333 146 IEGSGLAGPIPSGIASLVELTDLRISDLNGPEGPF-PRLSNLKNMNYLILRSGNIIGEMPEY----------LGQMIGLR 214 (809)
Q Consensus 146 L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~ 214 (809)
+++|+++.. ..+..+++|+.|++++|.++.++. ..+..+++|+.|+|++|.+....+.. +..+++|+
T Consensus 100 l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~ 177 (198)
T d1m9la_ 100 ISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK 177 (198)
T ss_dssp CSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCC
T ss_pred ccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcC
Confidence 999999843 457888999999999999988753 57899999999999999887654432 67899999
Q ss_pred EEeccCCCCC
Q 043333 215 VLDLSFNKLS 224 (809)
Q Consensus 215 ~L~Ls~N~l~ 224 (809)
.|| +..++
T Consensus 178 ~LD--~~~I~ 185 (198)
T d1m9la_ 178 KLD--GMPVD 185 (198)
T ss_dssp EES--SGGGT
T ss_pred EeC--CccCC
Confidence 987 44443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=4.3e-12 Score=118.95 Aligned_cols=80 Identities=18% Similarity=0.179 Sum_probs=36.6
Q ss_pred cccccccCCCCchhhcCCccCcEEeeccc-ccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccc
Q 043333 49 LPLWKQANGAIPKAVASISTLADLTLEFN-QFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHF 127 (809)
Q Consensus 49 L~l~~n~~~~ip~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 127 (809)
++..++.+..+|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+.+.|.+|..+++|++|+|++|+|
T Consensus 13 l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l 92 (156)
T d2ifga3 13 LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL 92 (156)
T ss_dssp EECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCC
T ss_pred EEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCC
Confidence 34444444444444444444444444433 24433333444444444444444444444444444444444444444444
Q ss_pred c
Q 043333 128 T 128 (809)
Q Consensus 128 ~ 128 (809)
+
T Consensus 93 ~ 93 (156)
T d2ifga3 93 E 93 (156)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.46 E-value=4.1e-09 Score=98.84 Aligned_cols=80 Identities=19% Similarity=0.099 Sum_probs=41.6
Q ss_pred cCcEEeecccccccCCCccccCCCCCCEEEccCCccCccCchhhhcccccceeeeecccccCcC--chhhhcccccceEe
Q 043333 68 TLADLTLEFNQFSGDLPAELGNLINLEKLHLNSNNFTGKLPESFANLTRLKHFRISDNHFTGQI--PDYIQNWTKLEKLF 145 (809)
Q Consensus 68 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~ 145 (809)
..+.|+++++... ..+..+..+..+.+.+|.+. .++..+.++++|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 4555666554422 12333444444444444433 44444456666777777777666332 23355556666666
Q ss_pred cccCcCC
Q 043333 146 IEGSGLA 152 (809)
Q Consensus 146 L~~N~l~ 152 (809)
|++|+|+
T Consensus 98 Ls~N~i~ 104 (162)
T d1koha1 98 LSGNELK 104 (162)
T ss_dssp CTTSCCC
T ss_pred cccCccc
Confidence 6666655
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.40 E-value=8e-07 Score=89.52 Aligned_cols=149 Identities=14% Similarity=0.103 Sum_probs=101.1
Q ss_pred HHHHHhcCCCCCCeeccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcC-CCceEeEEeEEEeCCeEE
Q 043333 569 QIKAATNNFAPDNKIGEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLYGCCIEGNQLL 647 (809)
Q Consensus 569 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~ 647 (809)
++...-+.|+..+..+.++.+.||+... +++.+.||+...........+.+|..++..+. +--+.+++++..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4444555666555544455578998765 44556788876555555566788988887774 433567888888889999
Q ss_pred EEEEcccCCchhhhccCCCccCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 043333 648 LIYEYMENNSLARALFGPEEHRLKLDWPTRHSICIGLARGLAYLHEES-------------------------------- 695 (809)
Q Consensus 648 lV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------- 695 (809)
+||+++++.++.+..... .....++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 999999998876543110 112234555666666666421
Q ss_pred ------------------------CCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 696 ------------------------RLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 696 ------------------------~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
+..++|+|+.|.||++++++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999877677999997753
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=8.7e-09 Score=96.55 Aligned_cols=86 Identities=15% Similarity=-0.001 Sum_probs=39.9
Q ss_pred chhhhcccccceEecccCcCCCCC--CccccCCCCCCEEeccCCCCCCCCCccccCCcCCceeeeccccccCCCCh----
Q 043333 132 PDYIQNWTKLEKLFIEGSGLAGPI--PSGIASLVELTDLRISDLNGPEGPFPRLSNLKNMNYLILRSGNIIGEMPE---- 205 (809)
Q Consensus 132 p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~---- 205 (809)
+..+..+++|++|+|++|+|+..- +..+..+++|+.|++++|.++.++.-.+....+|+.|+|++|.+......
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y 137 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhH
Confidence 333344555555555555554321 22334445555555555555554433333333455555555555444332
Q ss_pred ---hhhccccccEEe
Q 043333 206 ---YLGQMIGLRVLD 217 (809)
Q Consensus 206 ---~~~~l~~L~~L~ 217 (809)
.+..+|+|+.||
T Consensus 138 ~~~i~~~~P~L~~LD 152 (162)
T d1koha1 138 ISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHTTSTTCCEET
T ss_pred HHHHHHHCCCCCEEC
Confidence 144556666554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.74 E-value=4.5e-05 Score=75.74 Aligned_cols=143 Identities=16% Similarity=0.121 Sum_probs=85.4
Q ss_pred eeccCCC-ccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCC--CceEeEEeEEEeCCeEEEEEEcccCCch
Q 043333 582 KIGEGGF-GPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQH--PNLVKLYGCCIEGNQLLLIYEYMENNSL 658 (809)
Q Consensus 582 ~LG~G~f-G~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~~~~~~~~~~~lV~ey~~~gsL 658 (809)
.+..|.. +.||+....++..+.+|...... ...+..|++.++.+.. -.+.++++++.+++..++||+|+++-++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445543 67899887777778889765432 3456778888877743 3356788888888889999999988665
Q ss_pred hhhc-----------------cCCCccCCCC--CHHHHHHHH--------------------HHHHHHHHHHHhC----C
Q 043333 659 ARAL-----------------FGPEEHRLKL--DWPTRHSIC--------------------IGLARGLAYLHEE----S 695 (809)
Q Consensus 659 ~~~L-----------------~~~~~~~~~l--~~~~~~~i~--------------------~~ia~~L~yLH~~----~ 695 (809)
.+.. |.......+. .+.....-. ......+..+... .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 4311 1111000000 000000000 0011122223222 1
Q ss_pred CCCeEEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 696 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 696 ~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
++.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 23479999999999999876678999997653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.73 E-value=7.1e-06 Score=76.49 Aligned_cols=63 Identities=19% Similarity=0.262 Sum_probs=27.1
Q ss_pred CccCcEEeeccc-ccccC----CCccccCCCCCCEEEccCCccCcc----Cchhhhcccccceeeeeccccc
Q 043333 66 ISTLADLTLEFN-QFSGD----LPAELGNLINLEKLHLNSNNFTGK----LPESFANLTRLKHFRISDNHFT 128 (809)
Q Consensus 66 l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 128 (809)
.++|++|+|+++ .++.. +...+...++|++|+|++|.++.. +...+...+.|++|+|++|.|+
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 355555555542 33321 112344445555555555555421 1122233344444444444444
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.64 E-value=1.1e-05 Score=75.00 Aligned_cols=110 Identities=10% Similarity=0.151 Sum_probs=64.1
Q ss_pred CCCCCCEEEccCC-ccCcc----CchhhhcccccceeeeecccccCc----CchhhhcccccceEecccCcCCCCC----
Q 043333 89 NLINLEKLHLNSN-NFTGK----LPESFANLTRLKHFRISDNHFTGQ----IPDYIQNWTKLEKLFIEGSGLAGPI---- 155 (809)
Q Consensus 89 ~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~---- 155 (809)
+.++|++|+|+++ .++.. +-..+...++|+.|+|++|.+... +...+...+.|++|+|++|.++...
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4567777777763 45521 222344556677777777776622 2233445567777777777776322
Q ss_pred CccccCCCCCCEEeccCCCCCCCCC-------ccccCCcCCceeeecccc
Q 043333 156 PSGIASLVELTDLRISDLNGPEGPF-------PRLSNLKNMNYLILRSGN 198 (809)
Q Consensus 156 p~~~~~l~~L~~L~l~~n~l~~~~~-------~~l~~l~~L~~L~Ls~N~ 198 (809)
-..+...++|++|++++|.+..+.. ..+...++|+.|+++.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 2234555667777777776655431 124556677777776543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.10 E-value=0.00054 Score=72.54 Aligned_cols=76 Identities=12% Similarity=0.143 Sum_probs=48.0
Q ss_pred CCeeccCCCccEEEeEeeC-CeEEEEEEecccC-------cccchhHHHHHHHHhhcC-C--CceEeEEeEEEeCCeEEE
Q 043333 580 DNKIGEGGFGPVYKGLLAD-GKVIAVKQLSSKS-------KQGNREFVNEIGMISALQ-H--PNLVKLYGCCIEGNQLLL 648 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~-------~~~~~~f~~Ei~~l~~l~-H--~nIv~l~~~~~~~~~~~l 648 (809)
.+.||.|....||+....+ ++.|+||.-.... .....+...|.+.|..+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999988654 6778899654321 112234456888887663 3 335556544 4556689
Q ss_pred EEEcccCCc
Q 043333 649 IYEYMENNS 657 (809)
Q Consensus 649 V~ey~~~gs 657 (809)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.07 E-value=6.6e-05 Score=69.50 Aligned_cols=40 Identities=10% Similarity=0.077 Sum_probs=18.7
Q ss_pred CCccCcEEeecc-cccccC----CCccccCCCCCCEEEccCCccC
Q 043333 65 SISTLADLTLEF-NQFSGD----LPAELGNLINLEKLHLNSNNFT 104 (809)
Q Consensus 65 ~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 104 (809)
+.++|++|+|++ +.++.. +...+...++|++|+|++|.++
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence 445555666554 334321 1122334455555555555554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.96 E-value=8e-05 Score=68.91 Aligned_cols=113 Identities=19% Similarity=0.161 Sum_probs=64.9
Q ss_pred ccCCCCCCEEEccC-CccCcc----CchhhhcccccceeeeecccccCcCc----hhhhcccccceEecccCcCCCCC--
Q 043333 87 LGNLINLEKLHLNS-NNFTGK----LPESFANLTRLKHFRISDNHFTGQIP----DYIQNWTKLEKLFIEGSGLAGPI-- 155 (809)
Q Consensus 87 ~~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~-- 155 (809)
..+.++|++|+|++ +.++.. +-..+...++|++|+|++|.+....- ..+...++|+.|++++|.++...
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 34567777777776 446521 22334456677777777777663322 23455677777777777765322
Q ss_pred --CccccCCCCCCEEecc--CCCCCCCCC----ccccCCcCCceeeeccccc
Q 043333 156 --PSGIASLVELTDLRIS--DLNGPEGPF----PRLSNLKNMNYLILRSGNI 199 (809)
Q Consensus 156 --p~~~~~l~~L~~L~l~--~n~l~~~~~----~~l~~l~~L~~L~Ls~N~l 199 (809)
...+...++|+.++|+ +|.+..... ..+...++|+.|+++.+..
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 2445566677765553 444443221 2245677777777765543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.16 E-value=0.0048 Score=63.11 Aligned_cols=136 Identities=14% Similarity=0.133 Sum_probs=78.4
Q ss_pred ccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCce--EeEE-----eEEEeCCeEEEEEEcccCCchhh-
Q 043333 589 GPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNL--VKLY-----GCCIEGNQLLLIYEYMENNSLAR- 660 (809)
Q Consensus 589 G~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~-----~~~~~~~~~~lV~ey~~~gsL~~- 660 (809)
-.||++...+|+.|++|+.+... ...+++..|.+.+..+....+ +..+ ......+..+.|+++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 57999999899999999986542 234667788888777643222 1111 12334567788999998643310
Q ss_pred -------------hcc----CCC-ccCCCCCHHH-------------------HHHHHHHHHHHHHHHH----hCCCCCe
Q 043333 661 -------------ALF----GPE-EHRLKLDWPT-------------------RHSICIGLARGLAYLH----EESRLKI 699 (809)
Q Consensus 661 -------------~L~----~~~-~~~~~l~~~~-------------------~~~i~~~ia~~L~yLH----~~~~~~i 699 (809)
.+| ... ..+...++.. +..+...+.+.++.+. +..+.++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 011 110 1111222211 1112222233333332 2234578
Q ss_pred EEcCCCCCCEEEcCCCceEEEecCCccc
Q 043333 700 VHRDIKATNVLLDKDLNPKISDFGLAKL 727 (809)
Q Consensus 700 iH~Dlkp~NILl~~~~~~kl~DfGla~~ 727 (809)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.56 E-value=0.01 Score=62.36 Aligned_cols=73 Identities=19% Similarity=0.246 Sum_probs=47.6
Q ss_pred CCeeccCCCccEEEeEeeCC--------eEEEEEEecccCcccchhHHHHHHHHhhcCCCce-EeEEeEEEeCCeEEEEE
Q 043333 580 DNKIGEGGFGPVYKGLLADG--------KVIAVKQLSSKSKQGNREFVNEIGMISALQHPNL-VKLYGCCIEGNQLLLIY 650 (809)
Q Consensus 580 ~~~LG~G~fG~Vy~~~~~~g--------~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ 650 (809)
.+.|+.|---.+|+....++ +.|.+++.-. . .......+|.++++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 45688888889999876532 4566666542 2 222344578888888753344 477777642 5899
Q ss_pred EcccCCch
Q 043333 651 EYMENNSL 658 (809)
Q Consensus 651 ey~~~gsL 658 (809)
||+++..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.24 E-value=0.024 Score=57.24 Aligned_cols=159 Identities=12% Similarity=0.051 Sum_probs=83.8
Q ss_pred ccHHHHHHHhcCCCCCCee-----ccCCCccEEEeEeeCCeEEEEEEecccCcccchhHHHHHHHHhhcCCCce--EeEE
Q 043333 565 FTLRQIKAATNNFAPDNKI-----GEGGFGPVYKGLLADGKVIAVKQLSSKSKQGNREFVNEIGMISALQHPNL--VKLY 637 (809)
Q Consensus 565 ~~~~~l~~~~~~f~~~~~L-----G~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~ 637 (809)
.+.+++.....+|...+.. ..|---+.|+....+|+ +++|+..... ..++...|++++..+...++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 4667778888888775544 35555778998876665 7888875432 23445556777766643222 1111
Q ss_pred e------EEEeCCeEEEEEEcccCCchhh--------------hcc------CCCccCCCCC-H----------------
Q 043333 638 G------CCIEGNQLLLIYEYMENNSLAR--------------ALF------GPEEHRLKLD-W---------------- 674 (809)
Q Consensus 638 ~------~~~~~~~~~lV~ey~~~gsL~~--------------~L~------~~~~~~~~l~-~---------------- 674 (809)
. +.........++.+..+..... .+| .......... |
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 1222455666777766543211 000 0000000000 0
Q ss_pred HHHHHHHHHHHHHHHHHH-hCCCCCeEEcCCCCCCEEEcCCCceEEEecCCcc
Q 043333 675 PTRHSICIGLARGLAYLH-EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 726 (809)
Q Consensus 675 ~~~~~i~~~ia~~L~yLH-~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 726 (809)
......+......+.-.+ ...+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011111222222222222 1234579999999999999998777899999875
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=83.34 E-value=1.4 Score=38.16 Aligned_cols=63 Identities=17% Similarity=0.278 Sum_probs=44.0
Q ss_pred eeeeeeeCceEEEEEEEEeeEecCCcccccCCceeEEEEecCeeeccccceeeccCCcCceEEEeeeeeeecCeeEEEEE
Q 043333 396 YYGYCMVNGNYTVNLHFAEILFTDDKSYCSLGRRIFDVYIQGKLVLKDFNIENEAGGVGKAIVKPFSAAVTNGTMEIRLY 475 (809)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 475 (809)
+|-+=+-||+|.|++.|++.. -.++.+.|.....+ .++ ....+.+...|+++.+.+++.
T Consensus 66 ~f~v~vPnG~Y~Vtv~~Gd~~-------------~~~~~~eg~~~~~~-----~~g---~~~~~~~~V~VtDG~L~l~ft 124 (146)
T d2o14a1 66 TFNVDLPNGLYEVKVTLGNTA-------------RASVAAEGVFQVIN-----MTG---DGAEDTFQIPVTDGQLNLLVT 124 (146)
T ss_dssp CEEEECCSEEEEEEEEESSCS-------------EEEEEETTEEEEEE-----EES---TTCEEEEEEEECSSEEEEEEE
T ss_pred eEEEECCCCeEEEEEEEecCC-------------CccEEEeeEEeccc-----cCC---ccEEEEEEEEEECCeEEEEEe
Confidence 577888999999999999832 13566677665433 233 233567788999999998876
Q ss_pred ecCC
Q 043333 476 WAGK 479 (809)
Q Consensus 476 w~g~ 479 (809)
-+..
T Consensus 125 ~~~~ 128 (146)
T d2o14a1 125 EGKA 128 (146)
T ss_dssp ESST
T ss_pred cCCC
Confidence 4443
|